10,000 Matching Annotations
  1. Jul 2025
    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      The manuscript is well written and presents solid data, most of which is statistically analyzed and sound. Given that the author's previous comprehensive publications on seipin organization and interactions, it might be beneficial (particularly in the title and abstract) to emphasize that this manuscript focuses on the metabolic regulation of lipid droplet assembly by Ldb16, to distinguish it from previous work. Perhaps one consideration, potentially interesting, involves changes in lipid droplet formation under the growth conditions used for galactose-mediated gene induction.

      Comments:

      1. Fig. 3 and 4. The galactose induction of lipid droplet biogenesis in are1∆/2∆ dga1∆ lro1∆ cells though activation of a GAL1 promoter fusion to DGA1 is a sound approach for regulating lipid droplet formation. Although unlikely, carbon sources can impact lipid droplet proliferation and (potentially interesting) metabolic changes under growth in non-fermentable carbon sources may impact lipid droplet biogenesis; in fact, oleate has significant effects (e.g. PMID: 21422231; PMID: 21820081). The GAL1 promoter is a very strong promoter and the overexpression of DGA1 via this heterologous promoter might itself cause unforeseen changes. Affirmation of the results using another induction system might be beneficial.
      2. Fig. 3B. Although only representative images are shown, the panel convincingly shows that lipid droplets do form upon galactose induction of DGA1 in are1∆/2∆ dga1∆ lro1∆ cells. However, it does not show to what extent. Are lipid droplets synthesized at WT levels? How many cells were counted? How many lipid droplets per cell? Is there a statistical difference with respect to WT cells?
      3. Fig. 2D. It is not clear how standard deviation can be meaningfully applied to two data points, let alone providing a p-value. For some of these experiments, triplicate trials might provide a more robust statistical sampling.

      Significance

      Klug and Carvalho report on the lipid droplet architecture of the yeast seipin complex. Specifically, the mechanism of yeast seipin Sei1 binding to Ldo16 and the subsequent recruitment of Ldb45 is analyzed. These results follow from a recent publication (PMID: 34625558) from the same authors and aims to define a more precise role for the components of the seipin complex. Using photo-crosslinking, Ldo45 and Ldo16 interactions are analyzed in the context of lipid droplet assembly.

    1. 🚀 Ultimate 5-Month Full-Stack Developer Roadmap (MERN + Next.js)📌 Monthly Breakdown + Key ProjectsMonthFocus AreaKey Skills & ToolsProjectsAugustFrontend FoundationsHTML/CSS (Tailwind), JS (ES6+), React BasicsWeather App, GitHub PortfolioSeptemberAdvanced React + APIsTypeScript, Zustand, Testing (RTL), REST APIsTodo App (TS), Twitter UI CloneOctoberBackend + DatabasesNode.js, Express, MongoDB, PostgreSQL (Prisma)Blog API (JWT Auth), CRUD with SQLNovemberFullstack (Next.js)Next.js (App Router), NextAuth, Docker BasicsTask Manager (Fullstack + TS)DecemberDevOps + Job PrepCI/CD, AWS (S3/EC2), System Design Mock InterviewsDeploy All Projects, Resume Polish🔍 Detailed Weekly Breakdown1️⃣ August: Frontend FoundationsWeek 1-2:HTML5 (Semantic tags, accessibility)CSS (Flexbox, Grid, Tailwind)JavaScript (DOM, Fetch API, ES6+)Week 3-4:React (Components, Hooks, State Management)Project: Weather App (API integration)Weekend Focus:Build a portfolio site (Tailwind + GitHub Pages)Learn Git (branches, PRs)2️⃣ September: React + TypeScript + TestingWeek 1-2:TypeScript (Interfaces, Generics)Zustand (or Redux Toolkit)React Testing Library (Simple component tests)Week 3-4:REST APIs (Axios, error handling)Project: Todo App with TypeScript + TestsWeekend Focus:Clone a Twitter UI (Responsive + Dark Mode)Deploy to Vercel3️⃣ October: Backend + DatabasesWeek 1-2:Node.js/Express (REST APIs, Middleware)MongoDB (Mongoose, Aggregation)Week 3-4:PostgreSQL + Prisma (Relations, Migrations)Project: Blog API (JWT Auth + SQL/NoSQL)Weekend Focus:Postman (API testing, docs)Dockerize your Node app4️⃣ November: Next.js FullstackWeek 1-2:Next.js 14 (App Router, Server Actions)NextAuth (OAuth + Credentials)Week 3-4:Project: Task Manager (Next.js + TypeScript + Prisma)Weekend Focus:Optimize performance (Lazy loading, caching)Learn T3 Stack (Next.js + Prisma + Tailwind)5️⃣ December: DevOps + Job PrepWeek 1-2:AWS Basics (S3, EC2) or Railway/RenderGitHub Actions (CI/CD)Week 3-4:System Design (Design a Todo App at scale)Mock Interviews (Pramp, LeetCode Easy)Weekend Focus:Polish GitHub (READMEs, pinned repos)Write case studies for LinkedIn✨ Key Upgrades from Your Original PlanTypeScript Integration (September) → Critical for jobs.Testing Early (September) → Employers love this.SQL (PostgreSQL) + Prisma (October) → NoSQL + SQL exposure.System Design Basics (December) → Helps in interviews.T3 Stack (Next.js + Prisma + Tailwind) → Industry-relevant combo.📌 Projects to Build (Priority Order)Portfolio Site (August) → Showcases all work.Todo App (September) → TypeScript + Testing.Blog API (October) → JWT Auth + SQL/NoSQL.Task Manager (November) → Fullstack Next.js.Twitter UI Clone (September) → UI/UX practice.🛠️ Tools to MasterFrontend: VSCode, Tailwind, React DevToolsBackend: Postman, Prisma, MongoDB CompassDevOps: Docker, GitHub Actions, Vercel/RailwayCareer: LinkedIn, LeetCode, ChatGPT (for debugging)⏳ Time CommitmentWeekdays: 2-3 hours/day (focus on coding).Weekends: 4-5 hours (projects + deployments).🎯 Final AdviceFocus on Depth → Build 2-3 complex projects (e.g., fullstack app with auth, tests, TypeScript).

      Full Stack Roadmap

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The authors aim to explore the effects of the electrogenic sodium-potassium pump (Na<sup>+</sup>/K<sup>+</sup>-ATPase) on the computational properties of highly active spiking neurons, using the weakly-electric fish electrocyte as a model system. Their work highlights how the pump's electrogenicity, while essential for maintaining ionic gradients, introduces challenges in neuronal firing stability and signal processing, especially in cells that fire at high rates. The study identifies compensatory mechanisms that cells might use to counteract these effects, and speculates on the role of voltage dependence in the pump's behavior, suggesting that Na<sup>+</sup>/K<sup>+</sup>-ATPase could be a factor in neuronal dysfunctions and diseases

      Strengths:

      (1) The study explores a less-examined aspect of neural dynamics-the effects of (Na<sup>+</sup>/K<sup>+</sup>-ATPase) electrogenicity. It offers a new perspective by highlighting the pump's role not only in ion homeostasis but also in its potential influence on neural computation.

      (2) The mathematical modeling used is a significant strength, providing a clear and controlled framework to explore the effects of the Na+/K+-ATPase on spiking cells. This approach allows for the systematic testing of different conditions and behaviors that might be difficult to observe directly in biological experiments.

      (3) The study proposes several interesting compensatory mechanisms, such as sodium leak channels and extracellular potassium buffering, which provide useful theoretical frameworks for understanding how neurons maintain firing rate control despite the pump's effects.

      Weaknesses:

      (1) While the modeling approach provides valuable insights, the lack of experimental data to validate the model's predictions weakens the overall conclusions.

      (2) The proposed compensatory mechanisms are discussed primarily in theoretical terms without providing quantitative estimates of their impact on the neuron's metabolic cost or other physiological parameters.

      We thank the reviewer for their concise and accurate summary and appreciate the constructive feedback on the article’s strengths and weaknesses. Experimental work is beyond the scope of our modeling-based study. However, we would like our work to serve as a framework for future experimental studies into the role of the electrogenic pump current (and its possible compensatory currents) in disease, and its role in evolution of highly specialized excitable cells (such as electrocytes).

      Quantitative estimates of metabolic costs in this study are limited to the ATP that is required to fuel the pump. By integrating the net pump current over time and dividing by one elemental charge, one can find the rate of ATP that is consumed by the Na<sup>+</sup>/K<sup>+</sup>pump for either compensatory mechanism. The difference in net pump current is thus proportional to ATP consumption, which allows for a direct comparison of the cost efficiency of the Na<sup>+</sup>/K<sup>+</sup> pump for each proposed compensatory mechanism. The Na<sup>+</sup>/K<sup>+</sup> pump is, however, not the only ATP-consuming element in the electrocyte, and some of the compensatory mechanisms induce other costs related to cell

      ‘housekeeping’ or presynaptic processes. We now added a section in the appendix titled

      ‘Considerations on metabolic costs of compensatory mechanisms’ (section 11.4), where we provide ballpark estimates for the influence of the compensatory mechanisms on the total metabolic costs of the cell and membrane space occupation. Although we argue that according these estimates, the impact of discussed compensatory mechanisms could be significant, due to the absence of more detailed experimental quantification, a plausible quantitative cost approximation on the whole cell level remains beyond the scope of this article.

      Reviewer #1 (Recommendations for the authors):

      (1)  For the f-I curves in Figures 1 and 6, the firing rate increases as the input current increases. I am curious to know: (a) whether the amplitudes of the action potentials (APs) vary with increased input current; (b) whether the waveform of APs (such as in Fig. 1I) transitions into smaller amplitude oscillations at higher input currents; and (c) if the waveform does change at higher input currents, how do the "current contributions," "current," and "ion exchanges per action potential" in Figures 1HJ and 6AB respond?

      To fully answer these questions, we added a supplemental figure with accompanied text in section 11.1 (Fig. A1). We also added a reference to this figure in the main text (section 4.1). Here, it is shown that, as previously illustrated in [1], AP amplitude decreases when the input current increases (Fig. A1 A, left). This effect remains upon addition of either a pump with constant pump rate and co-expressed sodium leak channels (Fig. A1 A, center), or a voltage-dependent pump (Fig. A1 A, right). Interestingly, even though the shape of the current contributions (Fig. A1 B) and the APs (Fig. A1 C) look very different for low (Fig. A1 C, top) and high inputs (Fig. A1 C, bottom), the total sodium and potassium displacement per AP, and thus the pump rate, is roughly the same (Fig. A1 D). Under the assumption that voltage-gated sodium channel (NaV) expression is adjusted to facilitate fixed-AP amplitudes, however, (as in [1]) more NaV channels would be expressed in fish with higher synaptic drives. This would then result in an additional sodium influx per AP and result in higher energetic requirements per AP for electrocytes with higher firing rates (also shown in [1]).

      (2) Could the authors clarify what the vertical dashed line represents in Figures 1B and 1F? Does it correspond to an input current of 0.63uA?

      (Reviewer comment refers to Fig. 1C and 1F in new version): Yes, it corresponds to the input current that is also used in figures 1D and 1G. We clarified this by adding an additional tick label on the x-axis in 1F. The current input of 0.63uA was chosen as a representative input for this cell as follows: we first modeled an electrocyte with a periodic synaptic drive as in [1]. The frequency of this drive was set to 400 Hz, which is an intermediate value in the range of reported EODfs (and thus presumably pacemaker firing rates) of 200-600Hz [2]. Then, acetylcholine receptor currents I<sub>AChRNa</sub> and I<sub>AChRNa</sub> were summed and averaged to obtain the average input current of 0.63uA. This is now also explained in new Methods section 6.2.1.

      (3) What input current was used for Figures 1H, 1I, and 1J?

      Response: In a physiological setting, where the electrocyte is electrochemically coupled to the pacemaker nucleus, stimulation of the electrocyte occurs through neurotransmitter release in the synaptic cleft, which then leads to the opening of acetylcholine receptor channels. As figures 1H-J concern different ion fluxes, we aimed to also include currents stemming from acetylcholine receptor channels. We therefore did not stimulate the electrocyte with a constant input current as in Fig. 1C and F, but simulated elevated constant neurotransmitter levels in the synaptic cleft, which then leads to elevated acetylcholine receptor currents. In the model, this neurotransmitter level, or ‘synaptic drive’ is represented by parameter syn<sub>clamp</sub>. A physiologically relevant value for syn<sub>clamp</sub> was deduced by averaging the synaptic drive during a 400 Hz pacemaker stimulus. This is now also explained in new Methods section 6.2.1.

      (4) In Figure 4A, there is a slight delay between the PN spikes (driver) and the EO (receiver), and no EO spikes occur without PN spikes. However, the firing rate of EO (receiver) appears to decrease before the chirp initiations in Fig 4B; and this delay seems to disappear in Fig 4C. Could the authors explain these observations?

      As shown in the bottom right of figure 4A, when plotting the instantaneous firing rate as one over the inter-spike-interval (1/ISI), the firing rate of a cell is only plotted at the end of every ISI. Therefore, even though the PN drives the electrocyte and thus spikes earlier in time than the electrocyte, when it initiates chirps, these will only be plotted as an instantaneous firing rate at the end of the chirp. If the electrocyte fires spontaneously within this chirp, its instantaneous firing rate will appear earlier in time than the initiation of the chirp of the PN. The PN did, however, initiate the chirp before that and causality between the PN and electrocyte is not disturbed.

      (5) Regarding Figure 6, could the authors specify the input current used in Figures 6A and 6B?

      Figure 6A and 6B have the same synaptic drive as Fig. 1 H, I and J (syn<sub>clamp</sub>=0.13).

      (6) In Section 6, I would recommend that the authors provide a table of parameters and their corresponding values for clarity.

      Thank you for your suggestion. We now reorganized the method section and added two tables with parameters for clarity. Table 1 (see Methods 6.1) includes all parameters that differ from the parameters reported in [1], and parameters that arise from the additionally modeled equations to simulate ion concentration dynamics and pump. We also added the parameters used to simulate the different stimulus protocols (and corresponding tuned parameters) that are presented in the article in Table 2 (see Methods 6.2).

      Reviewer #2 (Public review):

      Summary:

      The paper 'The electrogenicity of the Na<sup>+</sup>/K<sup>+</sup>-ATPase poses challenges for computation in highly active spiking cells' by Weerdmeester, Schleimer, and Schreiber uses computational models to present the biological constraints under which electrocytes-specialized highly active cells that facilitate electro-sensing in weakly electric fish-may operate. The authors suggest potential solutions these cells could employ to circumvent these constraints.

      Electrocytes are highly active or spiking (greater than 300Hz) for sustained periods (for minutes to hours), and such activity is possible due to an influx of sodium and efflux of potassium ions into these cells for each spike. This ion imbalance must be restored after each spike, which in electrocytes, as with many other biological cells, is facilitated by the Na-K pumps at the expense of biological energy, i.e., ATP molecules. For each ATP molecule the pump uses, three positively charged sodium ions from the intracellular space are exchanged for two positively charged potassium ions from the extracellular volume. This creates a net efflux of positive ions into the extracellular space, resulting in hyperpolarized potentials for the cell over time. This does not pose an issue in most cells since the firing rate is much slower, and other compensatory mechanisms and other pumps can effectively restore the ion imbalances. In electrocytes of weakly electric fish, however, that operate under very different circumstances, the firing rate is exceptionally high. On top of this, these cells are also involved in critical communication and survival behaviors, emphasizing their reliable functioning.

      In a computation model, the authors test four increasingly complex solutions to the problem of counteracting the hyperpolarized states that occur due to continuous NaK pump action to sustain baseline activity. First, they propose a solution for a well-matched Na leak channel that operates in conjunction with the NaK pump, counteracting the hyperpolarizing states naturally. Additionally, their model shows that when such an orchestrated Na leak current is not included, quick changes in the firing rates could have unexpected side effects. Secondly, they study the implication of this cell in the context of chirps - a means of communication between individual fishes. Here, an upstream pacemaking neuron entrains the electrocyte to spike, which ceases to produce a so-called chirp - a brief pause in the sustained activity of the electrocytes. In their model, the authors show that it is necessary to include the extracellular potassium buffer to have a reliable chirp signal. Thirdly, they tested another means of communication in which there was a sudden increase in the firing rate of the electrocyte followed by a decay to the baseline. For reliable occurrence of this, they emphasize that a strong synaptic connection between the pacemaker neuron and the electrocyte is warranted. Finally, since these cells are energy-intensive, they hypothesize that electrocytes may have energyefficient action potentials, for which their NaK pumps may be sensitive to the membrane voltages and perform course correction rapidly.

      Strengths:

      The authors extend an existing electrocyte model (Joos et al., 2018) based on the classical Hodgkin and Huxley conductance-based models of Na and K currents to include the dynamics of the NaK pump. The authors estimate the pump's properties based on reasonable assumptions related to the leak potential. Their proposed solutions are valid and may be employed by weakly electric fish. The authors explore theoretical solutions that compound and suggest that all these solutions must be simultaneously active for the survival and behavior of the fish. This work provides a good starting point for exploring and testing in in vivo experiments which of these proposed solutions the fish use and their relative importance.

      Weaknesses:

      The modeling work makes assumptions and simplifications that should be listed explicitly. For example, it assumes only potassium ions constitute the leak current, which may not be true as other ions (chloride and calcium) may also cross the cell membrane. This implies that the leak channels' reversal potential may differ from that of potassium. Additionally, the spikes are composed of sodium and potassium currents only and no other ion type (no calcium). Further, these ion channels are static and do not undergo any post-translational modifications. For instance, a sodium-dependent potassium pump could fine-tune the potassium leak currents and modulate the spike amplitude (Markham et al., 2013).

      This model considers only NaK pumps. In many cell types, several other ion pumps/exchangers/symporters are simultaneously present and actively participate in restoring the ion gradients. It may be true that only NaK pumps are expressed in the weakly electric fish Eigenmannia virescens. This limits the generalizability of the results to other cell types. While this does not invalidate the results of the present study, biological processes may find many other solutions to address the non-electroneutral nature of the NaK pump. For example, each spike could include a small calcium ion influx that could be buffered or extracted via a sodium-calcium exchanger.

      Finally, including testable hypotheses for these computational models would strengthen this work.

      We thank the reviewer for the detailed summary and the identified weaknesses according to which we improved our article. Our model assumptions and simplifications are now mentioned in more detail in the introduction of the article (section 3), and justified in the Methods (section 6.1).

      Furthermore, we added a discussion section (section 5.1) where we outline the conditions under which the present study can be extended to other cell types. We now also state more clearly that the pump current will be present for any excitable cell with significant sodium flux (assuming that the NaK pump carries out the majority of its active transport), but that compensatory mechanisms (if employed at all in a particular cell) could also be implemented via other ionic currents and transporters. We furthermore now highlight the testable hypotheses that we put forward with our computational study on the weakly electric fish electrocyte more explicitly in the first paragraph of the discussion.

      Reviewer #2 (Recommendations for the authors):

      Main text

      Please explicitly state this model's assumptions in the introduction and elaborate on them in the discussion if necessary. For example, some assumptions that I find relevant to mention are: - The Na and K channels are classic HH conductance-based channels, with no post-translational modifications or beta subunit modifications as seen in other high-frequency firing cells (10.1523/JNEUROSCI.23-12-04899.2003).

      Neither calcium nor chloride ions are considered in the spike generation. Nor are Na-dependent K channels (10.1152/jn.00875.2012).

      Only the Na-K pump (and not the Na-Ca exchanger, Ca-pump, or Cl pumps) is modeled,

      Calmodulin, which can buffer calcium, is highly expressed in electric eels, but it is not considered. If some of these assumptions have valid justifications in weakly electric fish electrocytes, please state so with the citations. I recognize that including these in your models is beyond the scope of the current paper.

      We thank the reviewer for pointing out this issue. We now specified in the introduction that the model only contains sodium and potassium ions and only classic HH conductance-based channels. We there also explicitly specify the details on the Na<sup>+</sup>/K<sup>+</sup>-ATPase: it is the only active transporter in this model, thus solely responsible for maintaining ionic homeostasis; its activity is only modulated by intracellular sodium and extracellular potassium concentrations. In the discussion (6.1), we now elaborate on how ion-channel-related aspects (i.e., the addition of resurgent Na<sup>+</sup> or Na<sup>+</sup> -dependent K<sup>+</sup> channels), additional ion fluxes (including some not relevant for the electrocyte but for other excitable cells), and additional active transporters and pumps would influence the results presented in the article.

      In addition, there might be other factors that the authors and the reviewers have yet to consider. The model is a specific case study about the weakly electric fish electrocyte with high-frequency firing. It is almost guaranteed that biology will find other compensatory ways in different cell types, systems, and species (auditory nerve, for example). Given this, it would be prudent to use phrases such as 'this model suggests,' 'perhaps,' 'could,' 'may,' and 'eludes to,' etc., to accommodate other possible solutions to ion homeostasis in rapidly spiking neurons. The solutions the authors are proposing are some of many.

      We rephrased some of the statements to highlight more the hypothetical nature of the compensatory mechanisms in specific cells and to draw attention to the fact that there can be many more such factors. This fact is now also explicitly mentioned in discussion section 5.2.

      Figures

      Some of my comments on the figures are stylistic, others are to improve clarity, and some are critical for accuracy.

      The research problem concerns weakly electric fish E. virescens. I suggest introducing a picture of an electric fish in the beginning (such as that in Figure 3, but not exactly; see specific comments on this fish figure) along with a schema of the research question. 

      We agree, and added an overview schema in Fig. 1A.

      Font sizes change between the panels in all the figures. Please maintain consistency. The figure panel titles and axis labels should start with a capital letter.

      Thank you for pointing this out, both issues have been resolved in the new version of the article.

      Figure 1:

      Please rearrange the figure - BCFG belong together and should appear in the same order. The x-axis labels could be better placed.

      Consider using fewer pump current f-I curves (B, D, E, F). Five is sufficient to make the point. Having 10 curves adds to the clutter. The placement of the color bar could be better. Similarly, the placement of the panel titles 'without co-expression' and 'with co-expression' and the panel labeling (BCFG) makes it confusing. The panel labels should be above the panel title.

      Response (C, D, F, G in new version): We improved the layout of figure 1. Panels B, C, F, G are now C, D, F, G. We opted to include panel E before panels F and G, because it shows the coexpression mechanism before its effect on the tuning curve. We did move the colorbar, added x-axis labels to B and C, and adjusted the location of the panel labels for clarity. We also plotted fewer pump currents.

      B, F: What does the dashed line indicate?

      Response (C, F in new version): The dashed line indicates the input current that was used in figures 1D and 1G. We now clarified this by adding this value on the x-axis.

      C: Any reason not to show the lower firing rates?

      Response (B in new version): In the previous version of the article, pump currents were estimated for electrocytes that were stimulated with the mean synaptic drive that stems from periodic stimulation in the 200-600 Hz regime. We now extended the range of synaptic inputs to obtain lower (and higher) firing rates. The linear relationship between firing rate and pump current also holds for these additional firing rates.

      D: There is no difference between the curves at the top and the bottom. One fills the area between the curve and the zero line; the other shows the curve itself. Please use only one of the two representations.

      Response (panel I in new version): In the previous version, the difference between the plots was that one showed the absolute values of the currents (the curves), and the other plot showed the contributions of the currents to the total (area between the curves). We now only depict the current contributions.

      The I and H orders can be swapped.

      Thank you, they are now swapped.

      The colors used for Na and K are very dull (light blue and pink).

      We now use darker colors in the new version of the article.

      Figure 2:

      Please verify that without the synaptic input perturbations (i.e., baseline in A, D), the firing rate (B, E) and pump current (C, F) converge to the baseline. There is a noticeable drift (downward for firing rate and upward for pump currents) at the 10-second time point.

      Thanks to you noticing, we identified a version mismatch in the code that estimates the pump current required for ionic homeostasis (see Methods 6.1.2). We have now corrected the code and made sure to start the simulation in the steady state so that there is no drift at baseline firing. We also used this corrected code to present tuned parameters for different stimulus protocols in Table 2 (Methods 6.2).

      Figure 3:

      A. The dipole orientation with respect to the fish in panel B needs to be corrected. Consider removing this as this work is not about the dipole.

      This panel has been removed.

      B. This figure has already been overused in multiple papers; please redraw it. Localized expressions of different pumps and ion channels are present within each electrocyte, which generates the dipole. Either show this correctly or don't at all (the subfigure pointed out by the red arrow).

      This panel has been moved to Fig. 1A. We opted to remove the localized expressions.

      C and D belong together; please place them next to each other. Consider introducing panel D first since it follows a similar protocol to the last figure.

      Response (A in new version): Panel placement has been adjusted. We opted to maintain the order to maintain the flow of the text, but we do now combine them in one panel.

      E and F are very similar in that they are swapped on the x and y axes. Either that or I have severely misunderstood something, in which case it needs to be shown better.

      Response (B and C in new version): We adjusted the placement of these panels. They are not the same, panel B shows the mean of physiological periodic inputs, and figure C shows that when this mean is fed to the electrocyte, it also induces tonic firing. The range of mean currents that result from periodic synaptic stimulation in the physiological regime (panel B, y-axis) is now indicated in panel C by a grey box along the x-axis.

      G. Why show the lines with double arrow ends? The curves are diverging - that's enough.

      Good point, we updated this panel accordingly (now panel D).

      Figure 4

      Please verify the time units in these plots. Something seems amiss. B and D lower plots-perhaps this is seconds? B could use an inset box/ background gray color (t1, t2) indicating the plots of the C panel (left, right). Likewise, for D (t1, t2), connect to E (left, right).

      You are right, the x-axes were supposed to be in seconds, we updated this. We indicated the relations between D-C and D-E by gray backgrounds and by adding the corresponding panel label on the x-axis.

      A: Indicate the perturbation in the schematic, i.e., extracellular K buffer.

      The perturbation is now indicated.

      D: Even with the extracellular K buffer, there is a decay (slower than in B) of the pump current over time. Please verify (you do not have to show in your paper) that this decay saturates.

      After the ten chirps are initiated, pacemaker firing goes back to baseline. In both cases (panel B and panel D), the pump current goes back to baseline after some time. With extracellular potassium buffering, this happens more slowly due to a decreased reaction speed of the pump to changes in firing rate (in comparison to the case without extracellular potassium buffer).

      The decrease in reaction speed however merely delays the effects of changes in firing rates on the pump current in time. Therefore, even with an extracellular potassium buffer, when more chirps are initiated in a short period of time, the pump current can still decrease to an extent that impairs entrainment. Using the same protocol as in panel B and D, we increased the number of chirps and found that with an extracellular potassium buffer, a maximum of 13 chirps could be encoded without entrainment failure (as opposed to 2 chirps without the buffer as shown in panel B).

      Figure 5

      Please verify the time units in these plots, as for Figure 4. B and E lower plots-perhaps this is seconds? B could use an inset box/ background gray color (t1, t2) indicating the plots of the panels C and D. Likewise, for E (t1, t2), connect to F and G.

      The time axis in this figure was indeed also in seconds, which we corrected here. The relations between plots B-C/D and E-F/G are now indicated through gray backgrounds and corresponding panel references on the x-axis.

      A: Indicate the perturbation in the schematic, i.e., the synapse's strength. There is no need to include the arrow or to mention freq. rise. The placement of the time scale can be misinterpreted as a current clamp. Instead, plot it as a zoomed inset.

      The arrow is removed and we now also show a zoomed inset. Also, the perturbation is now indicated.

      E: Verify that the pump current in the strong synapse case already starts at 1.25

      We verified this and noticed that the pump current in the strong synapse case is indeed lower than that in the weak synapse case. This is because to ensure a fair comparison for this stimulation protocol, voltage-gated sodium channel conductance was tuned to maintain a spike amplitude of 13 mV in both cases (see Methods 6.2). In this case, a weak synapse leads to a lower influx of sodium via AChR channels, but a higher influx via voltage-gated sodium channels. The total sodium influx in this case is larger than that for a stronger synapse with relatively less voltage-gated sodium currents, and thus a larger pump current. In the previous version of the article, this was wrongly commented on in the figure captions, and we removed the erroneous statement.

      This is not critical, but because the R-value here can be obtained as a continuous value, it would be appropriate to show it for the whole duration of the weak and strong synapses in B and E. Maybe consider including a schema that shows how R is calculated in panel A.The caption has a typo, 'during frequency rises before (D) and after (E)'. It should be before C) and after (D) instead.

      The caption typo has been corrected. The R-value for the whole duration of the weak and strong synapses in B and E is 1.000. This is because the R-value is the variance of all phase relations between the PN and the electrocyte, and for the entire duration of the stimulus protocol, there are only a few outliers in phase relations at the maxima of the frequency rises. We decided to include this R-value to show that in general, synchronization between the PN and the electrocyte is very stable. The schema that explains how R is calculated has not been included in favor of not overcrowding the figure. We did add a reference in the figure caption to the methods section in which the calculation of R is explained.

      Figure 6:

      A: The top and bottom plots are redundant. Use one of the two. They show the same thing. It may be better to plot Na, K, pump, and net currents on the top panels and the Na leak, which is of smaller magnitude, in a different panel.

      We now only show current contributions.

      B: Please change the color schema. It is barely visible on my prints.

      D: Pump current, instantaneous case, is barely visible

      Color schemes were adjusted.

      Figure A1: It's all good.

      Methods:

      Please provide some internal citations for where specific equations were used in the results/figures. You do this for sections 6.2.3, referencing Figure 5 (c,d,e,g), and 6.2.4, referencing Fig 5 C-E.

      There are now internal references in each methods section to where in the figures they were used. We also included a table with stimulus parameters for each figure with a stimulus protocol (Table 2).

      Also, the methods could be ordered in the same order as the results are presented. Please consider if some details in the methods could be moved to the appendix.

      The ordering of the methods has now been changed to separately explain the model expansions (6.1) and the stimulus protocols (6.2). Both sections are in corresponding order of the figures presented in the article. We opted to maintain all details in the methods.

      6.1.1 Please cite 26 after the first line. Where was this used? In Figure 3C, 4, 5?

      We added the citation. The effects of co-expressed leak channels are shown in Fig. 1 EG, and were used to compensate for pump currents at baseline firing in figures 1 D, H-J (left, with pump), 2, 4, 5, and 6 A-B (left), C (top). This is now also added to the text for clarity.

      Traditionally (Hodgkin, A. L. and Huxley, A. F. (1952). J. Physiol. (Lond.), 117:500-544. Table 3; & Hodgkin, A. L. and Huxley, A. F. (1952). J. Physiol. (Lond.), 116:473-496 Table 5 and the paragraph around it), leak potential is set such that it accounts for all leak from all ions. While in your work, this potential is equal to the reversal of potassium - it need not be so in the animal. There may be leaks from other ions as well, particularly sodium and chloride. Please verify that assuming the leak reversal is the same as that of potassium (Ek, in Equation 3) does not lead to having to model Na leak currents separately.

      In the original model [1], it was assumed that the reversal potential of the leak was the same as that of potassium, which contains the implicit assumption that only potassium ions contribute to the leak. In our article, we also assume that sodium ions contribute to the leak. This can be modeled by adjusting the leak reversal potential accordingly, or by adding an additional leak current that solely models the sodium leak. We opted for the latter in order to track all sodium and potassium ions separately so that ion concentration dynamics could also be modeled properly. Chloride ions were neglected in this study; in our model they do not contribute to the leak. If one were to also model chloride currents and chloride concentration dynamics, it would be beneficial to model these as an additional separate leak current.

      The notation of I_pump_0 needs to be more convenient. Please consider another notation instead of the _0 (pump at baseline). Similarly for [Na<sup>+</sup>]_in_0 [Na<sup>+</sup>]_out_0 and [K<sup>+</sup>]_in_0 and [K+]_out_0

      We changed the notation for baseline similarly to [3], with ‘0’ as a superscript instead of a subscript.

      Equation 11: Please mention why AChRs do not let calcium ions through. Please cite a justification for this. If this is an assumption of the model, please state this explicitly.

      The AChR channels that were found in the E. virescence electrocytes are muscle-type acetylcholine nicotinic receptors [4], which are non-selective cation channels that could indeed support calcium flux [5]. No calcium currents were, however, modeled in the original electrocyte model [1], presumably due to the lack of significant contributions of calcium currents or extracellular calcium concentrations to electrocyte action potentials of a similar weakly electric electrogenic wave-type fish Sternopygus macrurus [6].

      Due to the lack of calcium currents in the original electrocyte model, and due to the limitation of this study to sodium and potassium ions, we chose not to include calcium currents stemming from AChR channels. This assumption is now explicitly stated in Methods 6.1.

      Equation 12, V_in, where the intracellular volume. If possible, avoid the notation of 'V' - you already use a small v for membrane potential.

      We changed the notation for volume to ‘ω’ similarly to [3]. As we previously used ω as a notation for the firing rate, we changed the notation for firing rate to ‘r’.

      Equation 17: Does this have any assumptions? Would the I_AchRNa, and thus Sum(mean(I_Na))) not change depending on the synaptic drive?

      The assumptions of this equations are the following (now also mentioned in Methods 6.1.2):

      The sum of all sodium currents also includes sodium currents through acetylcholine channels (I_AChRNa).

      All active sodium transport (from intra- to extracellular space) is carried out by the Na<sup>+</sup>/K<sup>+</sup>-ATPase, and active sodium transport through additional transporters and pumps is negligible.

      The time-average of sodium currents is either taken in a tonic firing regime where the timeinterval that is averaged over is a multiple of the spiking period, nT, or if it is taken for a more variable firing regime, the size of the averaging window should be sufficiently large to properly sample all firing statistics.

      Under these assumptions, Eq. 17 can be used to compute suitable pump currents for different synaptic drives (as Sum(mean(I_Na))) and thus I_pump0 indeed change with the synaptic drive, see Table 2 in Methods 6.2). 

      6.2: Please rewrite the first sentence of this paragraph.

      The first sentence of this paragraph, which has been moved to section 6.2.2 for improved structuring of the text, has been rewritten.

      6.2.1: The text section could use a rewrite.

      Please elaborate on what t_p is. If it is not time, please do not use 't.' What is p here? What are the units of the equation (22), t_p < 0.05 (?)

      This section has now also been moved to 6.2.2. It has been rewritten to improve clarity and t_p has been renamed to t_pn (as it does reflect time, which is now better explained). The units have now also been added to the equation (which is now Eq. 26).

      6.2.4: Please rewrite this.

      This section has been rewritten (and has been moved to section 6.1.4).

      Bibliography

      Some references are omitted (left anonymous) or inconsistent on multiple occasions.

      Thank you for pointing this out! It is now rectified.

      References used for author response

      (1) Joos B, Markham MR, Lewis JE, Morris CE. A model for studying the energetics of sustained high frequency firing. PLOS ONE. 2018 Apr;13:e0196508.

      (2) Hopkins CD. Electric communication: Functions in the social behavior of eigenmannia virescens. Behaviour. 1974;50(3-4):270–304.

      (3) Hübel N, Dahlem MA. Dynamics from seconds to hours in hodgkin-huxley model with time-dependent ion concentrations and buer reservoirs. PLoS computational biology.ff2014;10(12):e1003941.

      (4) BanY, Smith BE, Markham MR. A highly polarized excitable cell separates sodium channels from sodium-activated potassium channels by more than a millimeter. Journal of neurophysiology. 2015; 114(1):520–30.

      (5) Vernino S, Rogers M, Radcliffe KA, Dani JA. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. Journal of Neuroscience. 1994;14(9):5514-5524.

      (6) Ferrari M, Zakon H. Conductances contributing to the action potential of sternopygus electro-cytes. Journal of Comparative Physiology A. 1993;173:281–92.

    1. Andrews will sometimes list words that are spelled with ʻokina and kahakō. aʻo and ʻao and . Andrews will not distinguish words with different pronunciation. Do not stop at the first entry. Be aware that entries may mix words of different pronunciation. And tehre might be separate or duplicate entries of the same pronunciation later on. Some words are dividied in. Many entries include definitions from multiple words that are spelled the same under the old orthography. Conversely, some words which have the same pronunication are divided under multiple entries. Ao, aʻo, are good examples. Syllabification and pronunciation guides are unreliable (look at ao). Andrews is the most thorough for looking at words in the Hawaiian bible. Andrews has more, Many texts available to andrews contain thorough coverage, such as Malo’s Moolelo Hawaii, Laiekawai. Introduction talks about the sources consulted.

      replace with the following:

      1. Order of entries. The first thing to remember in working with Andrews dictionary is that its entries are arranged according to the Hawaiian pī]āpā, not the English alphabet (like Pukui-Elbert). Some researchers have wrongly concluded that a word is not found in Andrews' dictionary simply because they looked in the wrong place.

      2. Orthography. The use of the ʻokina and kahakō in spelling Hawaiian words did not become common until the 2nd half of the 20th century. Andrews published his dictionary in 1865, so that words that are distinguished today by the ʻokina and kahakō are lumped together under a single spelling. Thus, au, au, āu, ʻau, and aʻu were all defined under the headwords spelled as AU. Also, because of the way Andrews collected and assembled his data, you will often encounter the same headword multiple times, usually, but not always, with a different set of definitions. For example, there are eleven separate headwords for AU. These separate headwords are sometimes based on pronunciation differences, but sometimes words that are pronounced differently were defined under the same headword entry other words with the same pronunciation are listed under separate headword entries. Andrews worked tirelessly on his dictionary for decades, but his health failed before he was able to fully consolidate and organize all the information he had collected.

      3. Missing definitions in Pukui-Elbert. There are thousands of words in Pukui-Elbert that are not found in Andrews, but there are also some words in Andrews that are not found in Pukui-Elbert, particularly those found in older others or the Bible. On the other hand, hunderds of Anderews' definitions for words found in both dictionaries were not transfered into Pukui-Elbert. Thus, when you don't find a contextually appropropriate definition for a word in Pukui-Elbert, be sure to read through all of Andrews definitions for all of the headwords (mius the ʻokina and kahakō) that might represent the 19th century spelling of the word you are researching.

      4. Hawaiian definitions. Andrews often asked Native Hawaiian scholards to send him definitions of words and many of these are preserved in his dictionary. Pay particularly close attention to these because the often represent uncommoin meanings of wors as used in mele.

      5. Abbreviations. Make sure you understand the abbreviations uses by Andrews. We will go over some of these in one of the following sections.

      6. Andrews' word book. As he collected words, Andrews wrote them down in various notebooks together with samples of their use and, sometimes, a Hawaiian definition provided by a native speaker. Whenever you see a Hawaiian sentence or phrase in his dictionary, it probably is taken directly from his notebook. In the printed text, many of these Hawaiian language quotations contain misprints, in which case you can consult Andrews final word book which is now at the Bishop Museum, but which you can consult as an IHLRT web resource (link???).

    1. Reviewer #2 (Public review):

      Summary:

      In this study, the authors find that deletion of a sulfate transporter in yeast, Sul1, leads to extension of replicative lifespan. They investigate mechanisms underlying this extension, and claim that the effects on longevity can be separated from sulfate transport, and are instead linked to a previously proposed transceptor function of the Sul1 transporter. Through RNA sequencing analysis, the authors find that Sul1 loss triggers activation of several stress response pathways, and conclude that deletion of two pathways, autophagy or Msn2/4, partially prevents lifespan extension in cells lacking Sul1. Overall, while it is well-appreciated that activation of Msn2/4 or autophagy is beneficial for lifespan extension in yeast, the results of this study would add an important new mechanism by which this could achieved, through perceived sulfate starvation. However, as described below, several of the experiments utilized to support the authors conclusion are not experimentally sound, and significant additional experimentation is required to support the authors claims throughout the manuscript.

      Strengths:

      The major strength of the study is the robust RNA-seq data that identified differentially expressed genes in cells lacking Sul1. This facilitated the authors focus on two of these pathways, autophagy and the Msn2/4 stress response pathway.

      Weaknesses:

      Several critical experimental flaws need to be addressed by the authors to more rigorously test their hypothesis.

      (1) The lifespan assays throughout the manuscript contain inconsistencies in the mean lifespan of the wild type strain, BY4741. For example, in Figure 1A, the lifespan of BY4741 is 24.3, and the extended lifespan of the sul1 mutant is 31. However, although all mutants tested in Figure 1B also have lifespans close to 30 cell divisions, the wild type control is also at 30 divisions in those experiments as well. This is problematic, as it makes it impossible to conclude anything about the lifespan extension of various mutants with the inconsistencies in the wild type lifespan. Additionally, the mutants analyzed in 1B are what the authors use to claim that loss of the transporter does not extend lifespan through sulfate limitation, but instead through a signaling function. Thus, it remains unclear whether loss of sul1 extends lifespan at all, and if it does, whether this is separable from cellular sulfate levels.

      (2) While the authors use mutants in Figure 1 that should have differential effects on sulfate levels in cells, the authors need to include experiments to measure sulfate levels in their various mutant cells to draw any conclusions about their data.

      (3) Similar to point 2, the authors focused their RNA sequencing analysis on deletion of sul1 and did not include important RNA seq analysis of the specific Sul1 mutation or other mutants in Figure 1B that do not exhibit lifespan extension. The prediction is that they should not see activation of stress response pathways in these mutants as they do not see lifespan extension, but this needs to be tested.

      (4) While the RNA-seq data is robust in Figure 2 as well as the follow up quantitative PCR and trehalose/glycogen assays in 2A-B, the follow-up imaging assays for Msn2/4 localization in Figure 2 are not robust and are difficult to interpret. The authors need to include more high-resolution imaging or at least a close up of the cells in Figure 3C.

      (5) The autophagy assays utilized in Figure 4 appear to all be done with a C-terminal GFP-tagged Atg8 protein. As C-terminal GFP is removed from Atg8 prior to conjugation to phosphatidylethanolamine, microscopy assays of this reporter cannot be utilized to report on autophagy activity or flux. Instead, the authors need to utilize N-terminally tagged Atg8, which they can monitor for vacuole uptake as an appropriate readout of autophagy levels. As it stands, the authors cannot draw any conclusions about autophagy activity in their studies.

      Comments on revisions:

      Their autophagy conclusions are weak at best. As was highlighted in the previous review, they need to use an N-terminal Atg8 fusion for these experiments.

    2. Reviewer #3 (Public review):

      Summary:

      In the revised manuscript, Long et al., showed that sul1∆ mutants have extended replicative lifespan in budding yeast. In comparison, other mutants that have sulfate transport deficiency did not show extended lifespan, suggesting SUL1 deletion extends lifespan independently of sulfate intake. The authors then explored the transcriptome of sul1∆ mutants by RNA-seq, which suggests that SUL1 deletion impacts common longevity pathways. Furthermore, the authors characterized how the PKA pathway is affected in sul1∆ mutants: SUL1 deletion promotes the nuclear localization of Msn2, as well as autophagy, indicating down-regulation of the PKA pathway.

      Strengths:

      This study raised an interesting point that inorganic transporters may impact cellular stress response pathways and affect lifespan. Some of the characterizations on the sul1∆ mutants, including the RNA-seq and MSN2 localization could provide valuable sources for people in related fields. Compared with the previous version, the writing is significantly improved, making the manuscript clearer.

      Weaknesses:

      Several critical flaws have not been revised. The claims are still not well supported by the data.

      (1) The revised manuscript still uses Atg8-EGFP, in which GFP is likely tagging at the C-terminus of Atg8. No strain information was provided for this strain, so it is unclear whether it is N- or C- terminal tagged. As pointed by reviewers of the previous version, C-terminal tagged Atg8 is not functional. As a result, the conclusions on autophagy (Figure 4) is questionable.

      (2) The nuclear localization of Msn2 is much more convincing after the authors updated Figure 3C. However, the rest of the microscopy images (e.g. Figure 3E, 4B, 4E) are still of low resolution. Again, I suggest to separate the DIC and GFP channels. It is really hard to tell where is the GFP signal from these figures.

      (3) In the Kankipati et al. 2015 paper, which is cited by the authors, SUL1E427Q is incorporated on a pRS316 (URA3) plasmic and expressed in sul1∆sul2∆ mutants. In this manuscript, the authors used SUL1E427Q mutants but did not give detailed information on how this construct is expressed. Is it endogenously mutated, incorporated into somewhere in the genome, or expressed from an extrachromosomal plasmid?<br /> In Figure 1B, they simply used BY4741 as a control for the SUL1E427Q mutant. This makes me thinking they are using a SUL1E427Q endogenous point mutation mutant. If so, the authors may want to include the information about this strain in their Supplementary table. Or if it is expressed from an extra copy on chromosomes or extrachromosomal plasmids, the authors would need to express this construct in sul1∆ mutant. In this case, the authors may want to use sul1∆ and sul1∆+empty vector as controls, instead of BY4741. As the authors mentioned in their rebuttal letter, lifespan experiments vary between each individual trials and are not comparable between different trials. Thus proper controls are essential to make the results convincing.

      (4) As suggested by reviewers of the previous version, the authors tested the sulfate uptake in different mutants within 10 minute of Na2SO4 addition (Figure 1B). The authors concluded from the data that wild type takes up sulfate faster than the mutants but they reach similar concentrations at the end point (as fast as 10 minutes). Are all these cells sulfate-starved before the experiment? If not, the experiment might be affected by the basal level of sulfate in each mutants.

    1. Reviewer #1 (Public review):

      The authors aimed to explore the prognostic and therapeutic relevance of immunogenic cell death (ICD)-related genes in bladder cancer, focusing on a risk-scoring model involving CALR, IL1R1, IFNB1, and IFNG. The research indicates that higher expression of certain ICD-related genes is associated with enhanced immune infiltration, prolonged survival, and improved responsiveness to PD1-targeted therapy in bladder cancer patients.

      Major strengths:

      • The establishment of an ICD-related gene risk model based on publicly available datasets (TCGA and GEO) and further validated through tissue arrays and preliminary single-cell RNA sequencing data provides potential but weak clinical guidance.

      • The integration of multi-dimensional data (gene expression, mutation burden, immune infiltration, and treatment responses) strengthens the clinical applicability of the model.

      Key limitations and concerns:

      (1) Gene Selection and Novelty:

      The selection of genes predominantly reflects known regulators of immune responses, somewhat limiting the novelty. Exploring less-characterized ICD markers or extending validation beyond bladder cancer could improve the model's innovative aspect and wider clinical relevance.

      (2) Reliance on RNA-Seq for Immune Infiltration:

      Immune infiltration analyses based primarily on bulk RNA-Seq data have inherent methodological limitations, such as inability to distinguish cell subsets accurately. Incorporation of robust single-cell sequencing would significantly enhance the reliability of these findings. Although the authors recognize this limitation, future studies should directly address it.

      (3) Drug Sensitivity and Immunotherapy Response Data:

      While the authors clarify that the drug sensitivity analysis was performed using established databases (TCGA via pRRophetic), the unexpected correlations between ICD-related genes and various targeted therapies need further mechanistic validation. The observed relationships may reflect indirect associations rather than direct biological relevance, which warrants cautious interpretation.

      (4) Presentation and Clarity Issues:

      Initially noted formatting inconsistencies across figures compromised professional presentation; these have been corrected by the authors. Additionally, the authors have now provided essential methodological details, including clear sample sizes and database versions, enhancing reproducibility.

      (5) Immunotherapy Response Evidence:

      Conclusions regarding differences in immunotherapy response rates between patient subgroups, although intriguing, remain based on retrospective database analyses with relatively limited demographic and clinical detail. Future prospective studies or more detailed patient characterization would be required to robustly confirm these associations.

      (6) Interpretation of ICD Gene Signatures:

      The ICD-related gene set includes many genes broadly associated with immune activation rather than specifically ICD. Although this was addressed by the authors, clearly distinguishing ICD-specific versus general immune-response genes in future studies would help clarify biological implications.

      Summary and Recommendations for Readers:

      Overall, this study presents an interesting and clinically relevant risk-scoring approach to stratify bladder cancer patients based on ICD-related gene expression profiles. It provides useful information about prognosis, immune infiltration, and potential immunotherapy responsiveness. However, readers should interpret the results within the context of its limitations, notably the need for broader validation and careful consideration of the biological significance underlying the observed associations. This work lays a valuable foundation for further investigation into the integration of ICD and immune response signatures in personalized cancer therapy.

    2. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for the authors):

      Thank you for your thorough review of our manuscript and your valuable suggestions. Here are our responses to each point you raised:

      (1) Novelty: Exploring the feasibility of extending the risk-scoring model to diverse cancer types could emphasize the broader impact of the research.

      Thank you so much for your thoughtful and insightful feedback. Your suggestion to explore extending the risk-scoring model to diverse cancer types is truly valuable and demonstrates your broad vision in this field. We deeply appreciate your interest in our research and the effort you put into providing such constructive input.

      After careful consideration, we have decided to focus our current study on the specific cancer type(s) we initially set out to explore. This decision was made to ensure that we can thoroughly address the research questions at hand, given our current resources, time constraints, and the complexity of the topic. By maintaining this focused approach, we aim to achieve more in-depth and reliable results that can contribute meaningfully to the understanding of this particular area.

      However, we fully recognize the potential significance of your proposed direction and firmly believe that it could be an excellent avenue for future research. We will definitely keep your suggestion in mind and may explore it in subsequent studies as our research progresses and evolves.

      (2) Improvement in Figure Presentation: The inconsistency in font formatting across figures, particularly in Figure 2 (A-D, E, F-H, I), Figure 3 (A-C, D-J, H, K), and the distinct style change in Figure 5, raises concerns about the professionalism of the visual presentation. It is recommended to standardize font sizes and styles for a more cohesive and visually appealing layout. This ensures that readers can easily follow and comprehend the graphical data presented in the article.

      The text in the picture has been revised as requested.

      (3) Enhancing Reliability of Immune Cell Infiltration Data: Address the potential limitations associated with relying solely on RNASeq data for immune cell infiltration analysis between ICD and ICD high groups in Figure 2. It is advisable to discuss the inherent challenges and potential biases in this methodology. To strengthen the evidence, consider incorporating bladder cancer single-cell sequencing data, which could provide a more comprehensive and reliable understanding of immune cell dynamics within the tumor microenvironment.

      Thank you very much for your meticulous review and the highly constructive suggestions. Your insight regarding the limitations of relying on RNASeq data for immune cell infiltration analysis and the proposal to incorporate bladder cancer single-cell sequencing data truly reflect your profound understanding of the field. We deeply appreciate your efforts in guiding our research and the valuable perspectives you've offered.

      After careful deliberation, given our current research scope, timeline, and available resources, we've decided to focus on further discussing and addressing the challenges and biases inherent in RNASeq-based immune cell infiltration analysis. By delving deeper into the methodological limitations and conducting more in-depth statistical validations, we aim to provide a comprehensive and reliable interpretation of the data within our study framework. This focused approach allows us to maintain the integrity of our original research design and deliver robust findings on the relationship between immune cell infiltration and ICD in the current context.

      However, we fully acknowledge the significant value of your proposed single-cell sequencing approach. It is indeed a powerful method that could offer more detailed insights into immune cell dynamics, and we believe it holds great promise for future research in this area. We will keep your suggestion in mind as an important direction for potential future studies, especially when we plan to expand and deepen our exploration of the tumor microenvironment.

      (4) Clarity in Data Sources and Interpretation of Figure 5: In the results section, provide a detailed and transparent explanation of the sources of data used in Figure 5. This includes specifying the databases or platforms from which the chemotherapy, targeted therapy, and immunotherapy data were obtained. Additionally, elucidate the rationale behind the chosen data sources and how they contribute to the overall interpretation of the study's findings. And, strangely, these immune-related genes are associated with cancer sensitivities to different targeted therapies.

      Thank you very much for your detailed and valuable feedback on Figure 5. We sincerely appreciate your careful review and insightful suggestions, which have provided us with important directions for improvement.

      Regarding the data sources in Figure 5, we used the pRRophetic algorithm to conduct a drug sensitivity analysis on the TCGA database. The reason for choosing these data sources is multi - faceted. Firstly, these databases and platforms are well - established and widely recognized in the field. They have strict data collection and verification processes, ensuring the accuracy and reliability of the data. For example, TCGA has a large - scale, long - term - accumulated chemotherapy case database, which can comprehensively reflect the clinical application and treatment effects of various chemotherapeutic drugs.

      Secondly, these data sources cover a wide range of cancer types and patient information, which can meet the requirements of our study's diverse sample size and variety. This comprehensiveness enables us to conduct a more in - depth and representative analysis of the relationships between different therapies and immune - related genes.

      In terms of the overall interpretation of the study's findings, the use of these data sources provides a solid foundation. The accurate chemotherapy, targeted therapy, and immunotherapy data help us clearly demonstrate the associations between immune - related genes and cancer sensitivities to different treatments. This allows us to draw more reliable conclusions and provides a scientific basis for understanding the complex mechanisms of cancer treatment from the perspective of immune - gene - therapy interactions.

      As for the unexpected association between immune - related genes and cancer sensitivities to different targeted therapies, this is indeed a fascinating discovery. In our analysis, we hypothesized that immune - related genes may affect the tumor microenvironment, thereby influencing the response of cancer cells to targeted therapies. Although this finding is currently beyond our initial expectations, it has opened up a new research direction for us. We will further explore and verify the underlying mechanisms in future research.

      Once again, thank you for your guidance. We will make corresponding revisions and improvements according to your suggestions to make our research more rigorous and complete.

      (5) Legends and Methods: Address the brevity and lack of crucial details in the figure legends and methods section. Expand the figure legends to include essential information, such as the number of samples represented in each figure. In the methods section, provide comprehensive details, including the release dates of databases used, versions of coding packages, and any other pertinent information that is crucial for the reproducibility and reliability of the study.

      We would like to express our sincere gratitude for your valuable feedback on the figure legends and methods section of our study. We highly appreciate your sharp observation of the issues regarding the brevity and lack of key details, which are crucial for further improving our research.

      We have supplemented the methods section with data including the number of samples, the release dates of the databases used, and the versions of the coding packages, etc. For TCGA samples: 421 tumor samples and 19 normal samples.Database release date: March 29, 2022, v36 versions.Coding package version: R version 4.1.1.We will immediately proceed to supplement these key details, making the research process and methods transparent. This will allow other researchers to reproduce our study more accurately and enhance the persuasiveness of our research conclusions.

      (6) Evidence Supporting Immunotherapy Response Rates: The importance of providing a robust foundation for the conclusion regarding lower immunotherapy response rates. Strengthen this section by offering a more detailed description of sample parameters, specifying patient demographics, and presenting any statistical measures that validate the observed trends in Figure 5Q-T. More survival data are required to conclude. Avoid overinterpretation of the results and emphasize the need for further investigation to solidify this aspect of the study.

      Thank you very much for your professional and meticulous feedback on the content related to immunotherapy response rates in our study! Your suggestions, such as providing a solid foundation for the conclusions and supplementing key information, are of great value in enhancing the quality of our research, and we sincerely appreciate them.

      The data in Figures 5Q to T are from the TCGA database, which has already been provided. The statistical measure used for Figures 5Q to T is the P-value, which has been marked in the figures. The survival data have been provided in Figure 3D.

      Reviewer #2 (Recommendations for the authors):

      Thank you for your thorough review of our manuscript and your valuable suggestions. Here are our responses to each point you raised:

      (1) There is no information on the samples studied. Are all TCGA bladder cancer samples studied? Are these samples all treatment naïve? Were any excluded? Even simply, how many samples were studied?

      Thank you so much for pointing out the lack of sample - related information. Your attention to these details has been extremely helpful in identifying areas for improvement in our study.

      All the samples in our study were sourced from the TCGA (The Cancer Genome Atlas) and TCIA (The Cancer Immunome Atlas) databases. It should be noted that the patient data in the TCIA database are originally from the TCGA database. Regarding whether the patients received prior treatment, this information was not specifically mentioned in our current report. Instead, we mainly relied on the scores of the prediction model for evaluation. Since all samples were obtained from publicly available databases, we understand the importance of clarifying their origin and characteristics.

      We sincerely apologize for the omission of the sample size and other relevant details. We will promptly supplement this crucial information in the revised version, including a detailed description of the sample sources and any relevant characteristics. This will ensure greater transparency and help readers better understand the basis of our research.

      For TCGA samples: 421 tumor samples and 19 normal samples.Database release date: March 29, 2022, v36 versions.Coding package version: R version 4.1.1.

      (2) What clustering method was used to divide patients into ICD high/low? The authors selected two clusters from their "unsupervised" clustering of samples with respect to the 34 gene signatures. A Delta area curve showing the relative change in area under the cumulative distribution function (CDF) for k clusters is omitted, but looking at the heatmap one could argue there are more than k=2 groups in that data. Why was k=2 chosen? While "ICD-mid" may not fit the authors' narrative, how would k=3 affect their Figure1C KM curve and subsequent results?

      Thank you very much for raising these insightful and constructive questions, which have provided us with a clear direction for further improving our research.

      When dividing patients into ICD high and low groups, we used the unsupervised clustering method. This method was chosen because it has good adaptability and reliability in handling the gene signature data we have, and it can effectively classify the samples.

      Regarding the choice of k = 2, it is mainly based on the following considerations. Firstly, in the preliminary exploratory analysis, we found that when k = 2, the two groups showed significant and meaningful differences in key clinical characteristics and gene expression patterns. These differences are closely related to the core issues of our study and help to clearly illustrate the distinctions between the ICD high and low groups. At the same time, considering the simplicity and interpretability of the study, the division of k = 2 makes the results easier to understand and present. Although there may seem to be trends of more groups from the heatmap, after in-depth analysis, the biological significance and clinical associations of other possible groupings are not as clear and consistent as when k = 2.

      As for the impact of k = 3 on the KM curve in Figure 1C and subsequent results, we have conducted some preliminary simulation analyses. The results show that if the "ICD-mid" group is introduced, the KM curve in Figure 1C may become more complex, and the survival differences among the three groups may present different patterns. This may lead to a more detailed understanding of the response to immunotherapy and patient prognosis, but it will also increase the difficulty of interpreting the results. Since the biological characteristics and clinical significance of the "ICD-mid" group are relatively ambiguous, it may interfere with the presentation of our main conclusions to a certain extent. Therefore, in this study, we believe that the division of k = 2 is more conducive to highlighting the key research results and conclusions.

      Thank you again for your valuable comments. We will further improve the explanation and description of the relevant content in the paper to ensure the rigor and readability of the research.

      (3) The 'ICD' gene set contains a lot of immune response genes that code for pleiotropic proteins, as well as genes certainly involved in ICD. It is not convincing that the gene expression differences thus DEGs between the two groups, are not simply "immune-response high" vs "immune-response low". For the DEGS analysis, how many of the 34 ICD gene sets are DEGS between the two groups? Of those, which markers of ICD are DEGs vs. those that are related to immune activation?

      a. The pathway analysis then shows that the DEGs found are associated with the immune response.

      b. Are HMGB1, HSP, NLRP3, and other "ICD genes" and not just the immune activation ones, actually DEGs here?

      c. Figures D, I-J are not legible in the manus.

      We sincerely appreciate your profound insights and valuable questions regarding our research. These have provided us with an excellent opportunity to think more deeply and refine our study.

      We fully acknowledge and are grateful for your incisive observations on the "ICD" gene set and your valid concerns about the differential expression gene (DEG) analysis. During the research design phase, we were indeed aware of the complexity of gene functions within the "ICD" gene set and the potential confounding factors between immune responses and ICD. To distinguish the impacts of these two aspects as effectively as possible, we employed a variety of bioinformatics methods and validation strategies in our analysis.

      Regarding the DEG analysis, among the 34 ICD gene sets, 30 genes showed significant differential expression between the groups, excluding HMGB1, HSP90AA1, ATG5, and PIK3CA. We further conducted detailed classification and functional annotation analyses on these DEGs. The ICD gene set is from a previous article and is related to the process of ICD. Relevant literature is in the materials section. HMGB1: A damage-associated molecular pattern (DAMP) that activates immune cells (e.g., via TLR4) upon release, but its core function is to mediate the release of "danger signals" in ICD, with immune activation being a downstream effect.HSP90AA1: A heat shock protein involved in antigen presentation and immune cell function regulation, though its primary role is to assist in protein folding, with immune-related effects being auxiliary.NLRP3: A member of the NOD-like receptor family that forms an inflammasome, activating CASP1 and promoting the maturation and release of IL-1β and IL-18.Among the 34 DEGs, the majority are associated with immune activation, such as IL1B, IL6, IL17A/IL17RA, IFNG/IFNGR1, etc.

      (4) I may be missing something, but I cannot work out what was done in the paragraph reporting Figure 2I. Where is the ICB data from? How has this been analysed? What is the cohort? Where are the methods?

      The samples used in the analysis corresponding to Figure 2I were sourced from the TCGA (The Cancer Genome Atlas) and TCIA (The Cancer Immunome Atlas) databases. These databases are widely recognized in the field for their comprehensive and rigorously curated cancer - related data, ensuring the reliability and representativeness of our sample cohort.

      Regarding the data analysis, the specific methods employed are fully described in the "Methods" section of our manuscript.

      (5) How were the four genes for your risk model selected? It is not clear whether a multivariate model and perhaps LASSO regularisation was used to select these genes, or if they were selected arbitrarily.

      As you inquired about how the four genes for our risk model were selected, we'd like to elaborate based on the previous analysis steps. In the Cox univariate analysis, we systematically examined a series of ICD-related genes in relation to the overall survival (OS) of patients. Through this analysis, we successfully identified four ICD-related genes, namely CALR (with a p-value of 0.003), IFNB1 (p = 0.037), IFNG (p = 0.022), and IF1R1 (p = 0.047), that showed a significant association with OS, as illustrated in Figure 3A.

      Subsequently, to further refine and optimize the model for better prediction performance, we subjected these four genes to a LASSO regression analysis. In the LASSO regression analysis (as depicted in Figure 3B and C), we aimed to address potential multicollinearity issues among the genes and select the most relevant ones that could contribute effectively to the construction of a reliable predictive model. This process allowed us to confirm the significance of these four genes in predicting patient outcomes and incorporate them into our final predictive model.

      (6) How related are the high-risk and ICD-high groups? It is not clear. In the 'ICD-high' group in the 1A heatmap, patients typically have a z-score>0 for CALR, IL1R, IFNg, and some patients do also for IFNB1. However, in 3H, the 'high risk' group has a different expression pattern of these four genes.

      Patients were divided into ICD high-expression and low-expression groups based on gene expression levels. However, the relationship between these genes and patient prognosis is complex. As shown in Figure 3A, some genes such as IFNB1 and IFNG have an HR < 1, while CALR and IL1R1 have an HR > 1. Therefore, an algorithm was used to derive high-risk and low-risk groups based on their prognostic associations.

      (7) In the four-gene model, CALR is related to ICD, as outlined by the authors briefly in the discussion. IFNg, IL1R1, IFNB1 have a wide range of functions related to immune activity. The data is not convincing that this signature is related to ICD-adjuvancy. This is not discussed as a limitation, nor is it sufficiently argued, speculated, or referenced from the literature, why this is an ICD-signature, and why CALR-high status is related to poor prognosis.

      We acknowledge that the functions of these genes are indeed complex and extensive. In the current manuscript, we have included a preliminary discussion of their roles in the "Discussion" section. As demonstrated by the data presented earlier, these genes do exhibit associations with ICD, and we firmly believe in the validity of these findings.

      However, we are fully aware that our current discussion is not sufficient to fully elucidate the intricate relationships among these genes, ICD, and other biological processes. In response to your valuable feedback, we will conduct an in - depth review of the latest literature, aiming to gain a more comprehensive understanding of the underlying mechanisms.

      (8) Score is spelt incorrectly in Figures 3F-J.

      Figures 3F-J have been revised as requested.

      (9) The authors 'comprehensive analysis' in lines 165-173, is less convincing than the preceding survival curves associating their risk model with survival. Their 'correlations' have no statistics.

      We understand your concern regarding the persuasiveness of the content in this part, especially about the lack of statistical support for the correlations we presented. While we currently have our reasons for presenting the information in this way and are unable to make changes to the core data and descriptions at the moment, we deeply respect your perspective that it could be more convincing with proper statistical analysis.

      (10) The authors performed immunofluorescence imaging to "validate the reliability of the aforementioned results". There is no information on the imaging used, the panel (apart from four antibodies), the patient cohort, the number of images, where the 'normal' tissue is from, how the data were analysed etc. This data is not interpretable without this information.

      a. Is CD39 in the panel? CD8, LAG3? It's not clear what this analysis is.

      The color of each antibody has been marked in Fig 2B. The cohort information and its source have been supplemented. The staining experiment was carried out using a tissue microarray, and the analysis method can be found in the "Methods" section.Formalin-fixed, paraffin-embedded human tissue microarrays (HBlaU079Su01) were purchased from Shanghai Outdo Biotech Co., Ltd. (China), comprising a total of 63 cancer tissues and 16 adjacent normal tissues from bladder cancer patients. Detailed clinical information was downloaded from the company's website.The Remmele and Stegner’s semiquantitative immunoreactive score (IRS) scale was employed to assess the expression levels of each marker,as detailed inMethods2.5.CD39, CD8, and LAG3 were also stained, but the results were not presented.

      (11) The single-cell RNA sequencing analysis from their previous dataset is tagged at the end. CALR expression in most identified cells is interesting. Not clear what this adds to the work beyond 'we did scRNA-seq'. How were these data analysed? scRNA-seq analysis is complex and small nuances in pre-processing parameters can lead to divergent results. The details of such analysis are required!

      We understand your concern about the contribution of the single-cell RNA sequencing results. The main purpose of this analysis is to observe the expression changes of the four genes at the single-cell level. As you mentioned, single-cell RNA sequencing analysis is indeed complex, and we fully recognize the importance of detailed information. We performed the analysis using common analytical methods for single-cell sequencing.It has been supplemented in the Methods section.

    1. Reviewer #1 (Public review):

      Summary:

      In this study, the authors investigate the role of deubiquitinases (DUBs) in modulating the efficacy of PROTAC-mediated degradation of the cell-cycle kinase AURKA. Using a focused siRNA screen of 97 human DUBs, they identify UCHL5 and OTUD6A as negative regulators of AURKA degradation by PROTACs. They further offer a mechanistic explanation of enhanced AURKA degradation in the nucleus via OTUD6A expression being restricted to the cytosol, thereby protecting the cytoplasmic pool of AURKA. These findings provide important insight into how subcellular localization and DUB activity influence the efficiency of targeted protein degradation strategies, which could have implications for therapy.

      Strengths:

      (1) The manuscript is well-structured, with clearly defined objectives and well-supported conclusions.

      (2) The study employs a broad range of well-validated techniques - including live-cell imaging, proximity ligation assays, HiBiT reporter systems, and ubiquitin pulldowns - to dissect the regulation of PROTAC activity.

      (3) The authors use informative experimental controls, including assessment of cell-cycle progression effects, rescue experiments with siRNA-resistant constructs to confirm specificity, and the application of both AURKA-targeting PROTACs with different warheads and orthogonal degrader systems (e.g., dTAG-13 and dTAGv-1) to differentiate between target- and ligase-specific effects.

      (4) The identification of OTUD6A as a cytosol-restricted DUB that protects cytoplasmic but not nuclear AURKA is novel and may have therapeutic relevance for selectively targeting oncogenic nuclear AURKA pools.

      Weaknesses:

      (1) Although UCHL5 and OTUD6A are shown to limit AURKA degradation, direct physical interaction was not assessed.

      (2) Although the authors identify a correlation between DUB knockdown-induced cell cycle progression and enhanced PROTAC activity, only one DUB (USP36) is excluded on this basis. In addition, one DUB is shown in the correlation plot (Figure 3B) whose knockdown enhances PROTAC sensitivity without significantly altering cell cycle progression, but it is not identified/discussed.

      (3) While the authors suggest that combining PROTACs with DUB inhibition could enhance degradation, this was not experimentally tested.

      (4) The study identifies UCHL5 as a general antagonist of CRBN-recruiting PROTACs, yet the ubiquitin pulldown experiments (Figure 5G, H) show no change in AURKA ubiquitination upon UCHL5 knockdown. This raises questions about the precise step or mechanism by which UCHL5 exerts its protective effect.

    1. Reviewer #1 (Public review):

      Summary:

      This manuscript presents a high-quality, chromosome-level genome assembly of the European cuttlefish (Sepia officinalis), a representative species of the cephalopod lineage. Using state-of-the-art sequencing and scaffolding technologies -including PacBio HiFi long reads and Hi-C chromatin conformation capture - the authors deliver a genome assembly with exceptional contiguity and completeness, as evidenced by high BUSCO scores. This genome resource fills a significant gap in cephalopod genomics and offers a valuable foundation for studies in neurobiology, behavior, and evolutionary biology. However, there are several major aspects that need to be strengthened.

      Major Revisions Recommended:

      (1) Single-individual genome limitation

      The genome assembly is based on a single individual, which appears to be male. While this approach is common in genome projects, it does not capture the full genetic diversity of the species. As S. officinalis exhibits a wide geographical range and possible population structure, future efforts (or discussion in this manuscript) should consider re-sequencing multiple individuals - of both sexes and from diverse geographic origins - to characterize population-level variation, sex-linked features, and structural polymorphisms.

      (2) Limited experimental validation of chromosomal inferences

      The study reports chromosome-scale scaffolding using Hi-C data and proposes a revised karyotype for S. officinalis. However, these inferences would be significantly strengthened by orthogonal validation methods. In particular, fluorescence in situ hybridization (FISH) or karyotyping from cytogenetic preparations would provide direct confirmation of chromosome number and structural arrangements. The reliance solely on Hi-C contact maps for inferring chromosomal organization should be acknowledged as a limitation or supplemented with such validations.

      (3) Shallow discussion of chromosomal evolution

      The manuscript briefly mentions chromosomal number differences among cephalopods but does not explore their evolutionary or functional implications. A more thorough comparative analysis - linking chromosomal rearrangements (e.g., fusions, fissions) with ecological adaptation, life history, or neural complexity - would greatly enhance the impact of the findings. Referencing chromosomal dynamics in related taxa and possible links to behavioral innovations would contextualize these results more effectively.

      (4) Underdeveloped gene family and pathway analysis

      While the authors identify expansions in gene families such as protocadherins and C2H2 zinc finger transcription factors, the functional significance of these expansions remains speculative. The manuscript would benefit from:

      a) Functional enrichment analyses (e.g., GO, KEGG) targeting these gene families.

      b) Expression profiling across tissues or developmental stages to infer regulatory roles.

      c) Comparison with expression or expansion patterns in other cephalopods with known behavioral complexity (e.g., Octopus bimaculoides, Euprymna scolopes).

      d) Potential integration of transcriptomic or epigenomic data to support regulatory hypotheses.

    1. Reviewer #1 (Public review):

      Summary:

      This research investigates how the cellular protein quality control machinery influences the effectiveness of cystic fibrosis (CF) treatments across different genetic variants. CF is caused by mutations in the CFTR gene, with over 1,700 known disease-causing variants that primarily work through protein misfolding mechanisms. While corrector drugs like those in Trikafta therapy can stabilize some misfolded CFTR proteins, the reasons why certain variants respond to treatment while others don't remain unclear. The authors hypothesized that the cellular proteostasis network-the machinery that manages protein folding and quality control-plays a crucial role in determining drug responsiveness across different CFTR variants. The researchers focused on calnexin (CANX), a key chaperone protein that recognizes misfolded glycosylated proteins. Using CRISPR-Cas9 gene editing combined with deep mutational scanning, they systematically analyzed how CANX affects the expression and corrector drug response of 234 clinically relevant CF variants in HEK293 cells.

      In terms of findings, this study revealed that CANX is generally required for robust plasma membrane expression of CFTR proteins, and CANX disproportionately affects variants with mutations in the C-terminal domains of CFTR and modulates later stages of protein assembly. Without CANX, many variants that would normally respond to corrector drugs lose their therapeutic responsiveness. Furthermore, loss of CANX caused broad changes in how CF variants interact with other cellular proteins, though these effects were largely separate from changes in CFTR channel activity.

      This study has some limitations: the research was conducted in HEK293 cells rather than lung epithelial cells, which may not fully reflect the physiological context of CF. Additionally, the study only examined known disease-causing variants and used methodological approaches that could potentially introduce bias in the data analysis.

      How cellular quality control mechanisms influence the therapeutic landscape of genetic diseases is an emerging field. Overall, this work provides important cellular context for understanding CF mutation severity and suggests that the proteostasis network significantly shapes how different CFTR variants respond to corrector therapies. The findings could pave the way for more personalized CF treatments tailored to patients' specific genetic variants and cellular contexts.

      Strengths:

      (1) This work makes an important contribution to the field of variant effect prediction by advancing our understanding of how genetic variants impact protein function.

      (2) The study provides valuable cellular context for CFTR mutation severity, which may pave the way for improved CFTR therapies that are customized to patient-specific cellular contexts.

      (3) The research provides further insight into the biological mechanisms underlying approved CFTR therapies, enhancing our understanding of how these treatments work.

      (4) The authors conducted a comprehensive and quantitative analysis, and they made their raw and processed data as well as analysis scripts publicly available, enabling closer examination and validation by the broader scientific community.

      Weaknesses:

      (1) The study only considers known disease-causing variants, which limits the scope of findings and may miss important insights from variants of uncertain significance.

      (2) The cellular context of HEK293 cells is quite removed from lung epithelia, the primary tissue affected in cystic fibrosis, potentially limiting the clinical relevance of the findings.

      (3) Methodological choices, such as the expansion of sorted cell populations before genetic analysis, may introduce possible skew or bias in the data that could affect interpretation.

      (4) While the impact on surface trafficking is convincingly demonstrated, how cellular proteostasis affects CFTR function requires further study, likely within a lung-specific cellular context to be more clinically relevant.

    2. Reviewer #2 (Public review):

      In this work, the authors use deep mutational scanning (DMS) to examine the effect of the endogenous chaperone calnexin (CANX) on the plasma membrane expression (PME) and potential pharmacological stabilization cystic fibrosis disease variants. This is important because there are over 1,700 loss-of-function mutations that can lead to the disease Cystic Fibrosis (CF), and some of these variants can be pharmacologically rescued by small-molecule "correctors," which stabilize the CFTR protein and prevent its degradation. This study expands on previous work to specifically identify which mutations affect sensitivity to CFTR modulators, and further develops the work by examining the effect of a known CFTR interactor-CANX-on PME and corrector response.

      Overall, this approach provides a useful atlas of CF variants and their downstream effects, both at a basal level as well as in the context of a perturbed proteostasis. Knockout of CANX leads to an overall reduced plasma membrane expression of CFTR with CF variants located at the C-terminal domains of CFTR, which seem to be more affected than the others. This study then repeats their DMS approach, using PME as a readout, to probe the effect of either VX-445 or VX-455 + VX-661-which are two clinically relevant CFTR pharmacological modulators. I found this section particularly interesting for the community because the exact molecular features that confer drug resistance/sensitivity are not clear. When CANX is knocked out, cells that normally respond to VX-445 are no longer able to be rescued, and the DMS data show that these non-responders are CF variants that lie in the VX-445 binding site. Based on computational data, the authors speculate that NBD2 assembly is compromised, but that remains to be experimentally examined. Cells lacking CANX were also resistant to combinatorial treatment of VX-445 + VX-661, showing that these two correctors were unable to compensate for the lack of this critical chaperone.

      One major strength of this manuscript is the mass spectrometry data, in which 4 CF variants were profiled in parental and CANX KO cells. This analysis provides some explanatory power to the observation that the delF508 variant is resistant to correctors in CANX KO cells, which is because correctors were found not to affect protein degradation interactions in this context. Findings such as this provide potential insights into intriguing new hypothesis, such as whether addition of an additional proteostasis regulators, such as a proteosome inhibitor, would facilitate a successful rescue. Taken together, the data provided can be generative to researchers in the field and may be useful in rationalizing some of the observed phenotypes conferred by the various CF variants, as well as the impact of CANX on those effects.

      To complete their analysis of CF variants in CANX KO cells, the research also attempted to relate their data, primarily based on PME, to functional relevance. They observed that, although CANX KO results in a large reduction in PME (~30% reduction), changes in the actual activation of CFTR (and resultant quenching of their hYFP sensor) were "quite modest." This is an important experiment and caveat to the PME data presented above since changes in CFTR activity does not strictly require changes in PME. In addition, small molecule correctors also do not drastically alter CFTR function in the context of CANX KO. The authors reason that this difference is due to a sort of compensatory mechanism in which the functionally active CFTR molecules that are successfully assembled in an unbalanced proteostasis system (CANX KO) are more active than those that are assembled with the assistance of CANX. While I generally agree with this statement, it is not directly tested and would be challenging to actually test.

      The selected model for all the above experiments was HEK293T cells. The authors then demonstrate some of their major findings in Fischer rat thyroid cell monolayers. Specifically, cells lacking CANX are less sensitive to rescue by CFTR modulators than the WT. This highlights the importance of CANX in supporting the maturation of CFTR and the dependence of chemical correctors on the chaperone. Although this is demonstrated specifically for CANX in this manuscript, I imagine a more general claim can be made that chemical correctors depend on a functional/balanced proteostasis system, which is supported by the manuscript data. I am surprised by the discordance between HEK293T PME levels compared to the CTFR activity. The authors offer a reasonable explanation about the increase in specific activity of the mature CFTR protein following CANX loss.

      For the conclusions and claims relevant to CANX and CF variant surveying of PME/function, I find the manuscript to provide solid evidence to achieve this aim. The manuscript generates a rich portrait of the influence of CF mutations both in WT and CANX KO cells. While the focus of this study is a specific chaperone, CANX, this manuscript has the potential to impact many researchers in the broad field of proteostasis.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for the authors):

      Line 122: There were a number of qualitative descriptors in the paper. For instance, if the authors want to say massive campaign, how massive? How rapid? These are relative terms in this context.

      We have revised the text to minimize qualitative descriptors and to provide concrete numbers where possible. The revised sentence (line 121) now reads “We began our structural investigation of nitrogenase evolutionary history by conducting on a large-scale structure prediction analysis of 5378 protein structures, a more than threefold increase compared to available nitrogenase structures in the PDB. We then analyzed our phylogenetic dataset to identify notable structural changes.”

      Line 179: "massively scale up" How massive?

      We agree with the reviewer’s observation, in response, we have removed the phrase “massively scale up” and revised the text.

      Line 182: "no compromise on alignment depth and negligible cost to prediction accuracy". How do you know this? Is this shown somewhere? Was there a comparison between known structures and the predicted structure for those nitrogenases that have structures?

      In response to this comment, we have made several clarifications and revisions in the manuscript:

      We modified Figure S1, which now shows the pLDDT (per-residue confidence metric from Alphafold) values of all our predictions. These scores are consistently high (over 90 for the D and K subunits, and approximetly 90 for the H subunits) regardless of whether the recycling protocol or the bona-fide protocol was used.

      The reviewer’s comment demonstrated to us that the Figure S1 needed to more clearly representing these values, we therefore updated it accordingly.

      To prevent any misinterpretation of our claims about the accuracy and cost of the method , we have revised the text at line 179, as follows:

      “In total, 2,689 unique extant and ancestral nitrogenase variants were targeted. All structures were generated in approximately 805 hours, including GPU computations and MMseqs2 alignments performed using two different protocols: one for extant or most likely ancestral sequences, and another for ancestral variants.”

      To support our analyses further, Figure S10A compares our model predictions with available PDB structures for nitrogenases.

      Additionally, Figure S10B compare our predicted structures with the experimental structures reported in this article. In all cases, we observe low RMSD values.

      Line 220: "fall within 2 angstroms" instead of "fall 2A"?

      We have updated it in the text.

      Line 315: It is not clear how the binding affinities and other measurements in Figure 4 and S6C were measured, and it is not discussed in the material and methods.

      We thank the reviewer for pointing out this lack of clarity. The binding affinity estimations were performed using Prodigy. We have updated the main text (see line 322) to explicitly state that binding affinities were estimated using Prodigy. In addition, we have expanded the Materials and Methods section to include additional information about the structure characterization methods (lines 745-749). Previously, these details were only noted in Supplementary Table S6.

      Line 510-511: "Subtle, modular structural adjustments away from the active site were key to the evolution and persistence of nitrogenases over geologic time". This seems like a bit of an overstatement. While the authors see structural differences in the ancestral nitrogenase and speculate these differences could be involved in oxygen protection, there is no evidence that the ancestral nitrogenase is more sensitive to oxygen than the extant nitrogenase.

      We appreciate the reviewer’s comment. Our intention was to emphasize that subtle, modular structural adjustments might have contributed to oxygen protection rather than to assert that ancestral nitrogenases are more oxygen-sensitive than their extant counterparts. We have revised the text to clarify.

      Reviewer #2 (Recommendations for the authors):

      What is the reference for the measured RMSDs in Fig 2A? What is the value on the y-axis? The range of 'Count' is unclear, given that there are 5000 structures predicted in the study.

      Figure 2A presents a histogram of RMSD values from all pairwise alignments among 769 structures (385 extant and 384 ancestral DDKK), totaling 591,361 comparisons. We excluded ancestral DDKK variants due to computational limitations.  

      Similarly, what is the sequence identity in Figure 2B calculated relative to?

      In Figure 2B, sequence identities are derived from pairwise comparisons across all structures in our dataset. Each value represents the identity between two specific structures, rather than being measured against a single reference.

      The claim that 'structural analysis could reproduce sequence-based phylogenetic variation' should probably be tempered or qualified, given that the RMSD differences calculated are so low.

      We hope to have addressed the concerns about the low RMSD values in the previous comments. We have revised the text (line 204), which now reads: “it still strongly correlates with sequence identity (Figure 2B), indicating that even minor structural variations can recapitulate sequence-based phylogenetic distinctions.”

      How are binding affinities (Figure 4) calculated?

      We have now clarified the binding affinity calculations in the main text. The model used is now detailed at line 322, with additional information provided in the Methods section.

      Presumably, crystallized proteins (Anc1A, Anc1B, Anc2) were also among those whose structures were predicted with AF. A comparison should be provided of the predicted and crystallized structures, as this is an excellent opportunity to further comment on the reliability of AlphaFold.

      In the revised manuscript, Figure S10 now present structural comparisons between the crystallized proteins and their AlphaFold-predicted counterparts.

      The labels in Figure 5B are not clear. Are the 3rd and 4th panels also comparative RMSD values? But only one complex name is provided.

      We appreciate this feedback and now revised the Figure 5B for clarity.

      Page 9 line 220, missing word: 'varaints fall within/under 2angstroms'

      We thank the reviewer for the correction, we have updated the text.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      1. Response to reviewers

      We would like to thank the reviewers for carefully reading our manuscript and for their valuable comments in support for the publication of our investigation of rapid promoter evolution of accessory gland genes between Drosophila species and hybrids. We are glad to read that the reviewers find our work interesting and that it provides valuable insights into the regulation and divergence of genes through their promoters. We are encouraged by their acknowledgement of the overall quality of the work and the importance of our analyses in advancing the understanding of cis-regulatory changes in species divergence.

      2. Point-by-point description of the revisions

      Reviewer #

      Reviewer Comment

      Author Response/Revision

      Reviewer 1

      The authors test the hypothesis that promoters of genes involved in insect accessory glands evolved more rapidly than other genes in the genome. They test this using a number of computational and experimental approaches, looking at different species within the Drosophila melanogaster complex. The authors find an increased amount of sequence divergence in promoters of accessory gland proteins. They show that the expression levels of these proteins are more variable among species than randomly selected proteins. Finally, they show that within interspecific hybrids, each copy of the gene maintains its species-specific expression level.

      We thank Reviewer 1 for their detailed review and positive feedback on our manuscript, and for their helpful suggestions. We have now fully addressed the points raised by Reviewer 1 and have provided the suggested clarifications and revisions to improve the flow, readability, and presentation of the data, which we believe have improved the manuscript significantly.

      The work is done with expected standards of controls and analyses. The claims are supported by the analysis. My main criticism of the manuscript has to do not with the experiments or conclusion themselves but with the presentation. The manuscript is just not very well written, and following the logic of the arguments and results is challenging.

      The problem begins with the Abstract, which is representative of the general problems with the manuscript. The Abstract begins with general statements about the evolution of seminal fluid proteins, but then jumps to accessory glands and hybrids, without clarifying what taxon is being studied, and what hybrids they are talking about. Then, the acronym Acp is introduced without explanation. The last two sentences of the Abstract are very cumbersome and one has to reread them to understand how they link to the beginning of the Abstract.

      More generally, if this reviewer is to be seen as an "average reader" of the paper, I really struggled through reading it, and did not understand many of the arguments or rationale until the second read-through, after I had already read the bottom line. The paragraph spanning lines 71-83 is another case in point. It is composed of a series of very strongly worded sentences, almost all starting with a modifier (unexpectedly, interestingly, moreover), and supported by citations, but the logical flow doesn't work. Again, reading the paragraph after I knew where the paper was going was clearer, but on a first read, it was just a list of disjointed statements.

      Since most of the citations are from the authors' own work, I suspect they are assuming too much prior understanding on the part of the reader. I am sure that if the authors read through the manuscript again, trying to look through the eyes of an external reader, they will easily be able to improve the flow and readability of the text.

      We thank the reviewer for their detailed feedback and are glad that they acknowledge our work fully supports the claims of our manuscript. We also appreciate their helpful suggestions for improving the readability of the manuscript and have done our best to re-write the abstract and main text where indicated. In particular, the paragraph between lines 71-83 have been rewritten and we have taken care to write to non-expert readers.

      1) In the analysis of expression level differences, it is not clear what specific stage / tissue the levels taken from the literature refer to. Could it be that the source of the data is from a stage or tissue where seminar fluid proteins will be expressed with higher variability in general (not just inter-specifically) and this could be skewing the results? Please add more information on the original source of the data and provide support for their validity for this type of comparison.

      These were taken from publicly available adult male Drosophila datasets, listed in the data availability statement and throughout the manuscript. We have provided more detail on the tissue used for analysis of Acp gene expression levels.

      2) The sentence spanning lines 155-157 needs more context.

      We have added more context to lines 155-157.

      3) Line 203-204: What are multi-choice enhancers?

      We replaced the sentence with "... such as rapidly evolving enhancers or nested epistasis enhancer networks"

      4) Figure 1: The terminology the authors use, comparing the gene of interest to "Genome" is very confusing. They are not comparing to the entire genome but to all genes in the genome, which is not the same.

      We have changed the word "genome" to "all genes in the genome" on the reviewer's suggestion.

      5) Figure 2: Changes between X vs. Y is redundant (either changes between X and Y or changes in X vs. Y).

      We assume that the reviewer is referring to Fig. 2B, which does not measure changes between X and Y, but changes in distribution between Acps and the control group. We have explained this in the figure legend.

      The manuscript addresses a general question in evolutionary biology - do control regions diverge more quickly protein coding regions. The answer is that yes, they do, but this is actually not very surprising. The work is probably thus of more interest to people interested in the copulatory proteins or in the evolution of mating systems, than to people interested in broader evolutionary questions.

      We appreciate this reviewer's recognition of the significance of our work and would like to point out that there are very few studies looking at promoter evolution as detailed in the introduction. Of particular relevance, our study using Acp genes allows us to directly test the impact of promoter mutations on the expression by comparing two alleles in male accessory glands of Drosophila hybrids. Male accessory glands consist of only two secretory cell types allowing us to study evolution of gene expression in a single cell type (Acps are either expressed in main cells or secondary cells). Amid this unique experimental set up we can conclude that promoter mutations can act dominant, in contrast to mutations in protein coding regions, which are generally recessive. Thus, our study is unique in pointing out a largely overseen aspect of gene evolution.

      Reviewer 2

      This manuscript explores promoter evolution of genes encoding seminal fluid proteins expressed in the male accessory gland of Drosophila and finds cis-regulatory changes underlie expression differences between species. Although these genes evolve rapidly it appears that the coding regions rarely show signs of positive selection inferring that changes in their expression and hence promoter sequences can underlie the evolution of their roles within and among species.

      We thank Reviewer 2 for their thorough review, positive feedback on the importance of our work, and suggestions for improving the manuscript. We have addressed all points raised by the reviewer, including analysis of Acp coding region evolution, additional analyses of hybrid expression data, and improved the clarity of the text.

      Figure 1 illustrates evidence that the promoter regions of these gene have accumulated more changes than other sampled genes from the Drosophila genome. While this convinces that the region upstream of the transcription start site has diverged considerably in sequence (grey line compared to black line), Figure 1A also suggests the "Genespan" region which includes the 5'UTR but presumably also part of the coding region is also highly diverged. It would be useful to see how the pattern extends into the coding region further to compare further to the promoter region (although Fig 1H does illustrate this more convincingly).

      The reviewer raises an interesting point, and certainly all parts of genes evolve. Fig. 1A shows the evolutionary rates of Acps compared to the genome average from phyloP27way scores calculated from 27 insect species. Since these species are quite distant it is unsurprising that they show divergence in coding regions as well as promoter regions. In fact, we addressed whether promoter regions evolve fast in closely related Drosophila species in Fig. 1H compared to coding regions. We have included an additional analysis of coding region evolution in Figure 1B.

      Figure 2 presents evidence for significant changes in (presumably levels of) expression of male accessory gland protein (AcP) genes and ribosomal proteins genes between pairs of species, which is reflected in the skew of expression compared to randomly selected genes.

      Correct, we have rephrased the statement for clarity.

      Figure 3 shows detailed analysis for 3 selected AcP genes with significantly diverged expression. The authors claim this shows 'substitution' hotspots in the promoter regions of all 3 genes but this could be better illustrated by extending the plots in B-D further upstream and downstream to compare to these regions.

      We picked the 300-nucleotide promoter region for this analysis as it accumulated significant changes as shown in Fig. 1E-H, and extending the G plots (Fig. 3B-D) to regions with lower numbers of sequence changes would not substantially change the conclusion. Specifically, this analysis identifies sequence change hotspots within fast-evolving promoter regions, rather than comparing promoter regions to other genomic regions, as we previously addressed. The plot is based on a cumulative distribution function and the significant positive slope in the upstream region where promoters are located identifies a hotspot for accumulation of substitutions. There could be other hotspots, but the point being made is that significant hotspots consistently appear in the promoter region of these three genes.

      Figure 4 shows the results of expression analysis in parental lines of each pair of species and F1 hybrids. However the results are very difficult to follow in the figure and in the relevant text. While the schemes in A, C. E and G are helpful, the gel images are not the best quality and interpretations confusing. An additional scheme is needed to illustrate hypothetical outcomes of trans change, cis change and transvection to help interpret the gels. On line 169 (presumably referring to panels D and F although C and D are cited on the next line) the authors claim that Obp56f and CG11598 'were more expressed in D. melanogaster compared to D. simulans' but in the gel image the D. sim band is stronger for both genes (like D. sechellia) compared to the D. mel band. The authors also claim that the patterns of expression seen in the F1s are dominant for one allele and that this must be because of transvection. I agree this experiment is evidence for cis-regulatory change. However the interpretation that it is caused by transvection needs more explanation/justification and how do the authors rule out that it is not a cis X trans interaction between the species promoter differences and differences in the transcription factors of each species in the F1? Also my understanding is that transvection is relatively rare and yet the authors claim this is the explanation for 2/4 genes tested.

      We appreciate the reviewer's comments on Figure 4 and the opportunity to improve its clarity. To address these concerns, we have carefully checked the figure citations and corrected any inconsistencies.

      The reviewer raises an important point about our interpretation of transvection. We have expanded our discussion of this result to consider why transvection is a plausible explanation for the observed dominance patterns and also consider cis x trans interactions between species-specific promoters and transcription factor binding. While rare, transvection likely has more relevance in hybrid regulatory contexts involving homologous chromosome pairing which we discuss this in the revised text.

      Line 112 states that the melanogaster subgroup contains 5 species - this is incorrect - while this study looked at 5 species there are more species in this subgroup such as mauritiana and santomea.

      We have corrected the statement about the number of species in the melanogaster subgroup.

      Lines 131-134 could explain better what the conservation scores and their groupings mean and the rationale for this approach.

      We have clarified what the conservation scores and their groupings mean and the rationale for this approach.

      Line 162 - the meaning of the sentence starting on this line is unclear - it sounds very circular.

      We have rephrased the statement for more clarity.

      Line 168 should cite Fig 4 H instead of F.

      We have amended citation of Fig 4F to H.

      Reviewer 3

      In this study, McQuarrie et al. investigate the evolution of promoters of genes encoding accessory gland proteins (Acps) in species within the D. melanogaster subgroup. Using computational analyses and available genomic and transcriptomic datasets, they demonstrate that promoter regions of Acp genes are highly diverse compared to the promoters of other genes in the genome. They further show that this diversification correlates with changes in gene expression levels between closely related species. Complementing these computational analyses, the authors conduct experiments to test whether differences in expression levels of four Acp genes with highly diverged promoter regions are maintained in hybrids of closely related species. They find that while two Acp genes maintain their expression level differences in hybrids, the other two exhibit dominance of one allele. The authors attribute these findings to transvection. Based on their data, they conclude that rapid evolution of Acp gene promoters, rather than changes in trans, drives changes in Acp gene expression that contribute to speciation.

      We thank Reviewer 3 for their thorough review and suggestions. We further thank the reviewer for acknowledging the importance of our findings and for pointing out that it contributes to our understanding of speciation. We have thoroughly addressed all comments from the reviewer and significantly revised the manuscript. We believe that this has greatly improved the manuscript.

      Unfortunately, the presented data are not sufficient to fully support the conclusions. While many of the concerns can be addressed by revising the text to moderate the claims and acknowledge the methodological limitations, some key experiments require repetition with more controls, biological replicates, and statistical analyses to validate the findings.

      Specifically, some of the main conclusions heavily rely on the RT-PCR experiments presented in Figure 4, which analyze the expression of four Acp genes in hybrid flies. The authors use PCR and RFLP to distinguish species-specific alleles but draw quantitative conclusions from what is essentially a qualitative experiment. There are several issues with this approach. First, the experiment includes only two biological replicates per sample, which is inadequate for robust statistical analysis. Second, the authors did not measure the intensity of the gel fragments, making it impossible to quantify allele-specific expression accurately. Third, no control genes were used as standards to ensure the comparability of samples.

      The gold standard for quantifying allele-specific expression is using real-time PCR methods such as TaqMan assays, which allow precise SNP genotyping. To address this major limitation, the authors should ideally repeat the experiments using allele-specific real-time PCR assays. This would provide a reliable and quantitative measurement of allele-specific expression.

      If the authors cannot implement real-time PCR, an alternative (though less rigorous) approach would be to continue using their current method with the following adjustments:

      • Include a housekeeping gene in the analysis as an internal control (this would require identifying a region distinguishable by RFLP in the control).

      • Quantify the intensity of the PCR products on the gel relative to the internal standard, ensuring proper normalization.

      • Increase the sample size to allow for robust statistical analysis.

      These experiments could be conducted relatively quickly and would significantly enhance the validity of the study's conclusions.

      We thank the reviewer for their detailed suggestions for improving the conclusions in Fig. 4. Indeed, incorporating a housekeeping gene as a control supports our results for qualitative analysis of gene expression in hybrids assessing each allele individually (Fig 4), and improves interpretation for non-experts. We have also quantified differential gene expression in hybrids between species alleles and the log2 fold change from D. melanogaster. In addition, we have included an additional analysis in the new Fig. 5 which analyses RNA-seq expression changes in D. melanogaster x D. simulans hybrid male accessory glands. We believe these additions have significantly improved the manuscript and its conclusions.

      While the following comments are not necessarily minor, they can be addressed through revisions to the text without requiring additional experimental work. Some comments are more conceptual in nature, while others concern the interpretation and presentation of the experimental results. They are provided in no particular order.

      1. A key limitation of this study is the use of RNA-seq datasets from whole adult flies for interspecies gene expression comparisons. Whole-body RNA-seq inherently averages gene expression across all tissues, potentially masking tissue-specific expression differences. While Acp genes are likely restricted to accessory glands, the non-Acp genes and the random gene sets used in the analysis may have broader expression profiles. As a result, their expression might be conserved in certain tissues while diverging in others- an aspect that whole-body RNA-seq cannot capture. The authors should acknowledge that tissue-specific RNA-seq analyses could provide a more precise understanding of expression divergence and potentially reveal reduced conservation when considering specific tissues independently.

      We have added a section discussing the limitations in gene expression analysis in the discussion. In addition, we have included an additional Figure analysing gene expression in hybrid male accessory glands (Fig. 5).

      1. The statement in line 128, "Consistent with this model," does not accurately reflect the findings presented in Figures 2A and B. Specifically, the data in Figure 2A show that Acp gene expression divergence is significantly different from the divergence of non-Acp genes or a random sample only in the comparison between D. melanogaster and D. simulans. However, when these species are compared to D. yakuba, Acp gene expression divergence aligns with the divergence patterns of non-Acp genes or random samples. In contrast, Figure 2B shows that the distribution of expression changes is skewed for Acp genes compared to random control samples when D. melanogaster or D. simulans are compared to D. yakuba. However, this skew is absent when the two D. melanogaster and D. simulans are compared. Therefore, the statement in line 128 should be revised to accurately reflect these nuanced results and the trends shown in Figure 2A and B.

      We have updated the statement for clarity. Here, the percentage of Acps showing significant gene expression changes is greater between more closely related species, but the distribution of expression changes increases between more distantly related species.

      1. The statement in lines 136-138, "Acps were enriched for significant expression changes in the faster evolving group across all species," while accurate, overlooks a key observation. This trend was also observed in other groups, including those with slower evolving promoters, in some of the species' comparisons. Therefore, the enrichment is not unique to Acps with rapidly evolving promoters, and this should be explicitly acknowledged in the text.

      This is a valid point, and we have updated this statement as suggested.

      1. It would be helpful for the authors to explain the meaning of the d score at the beginning of the paragraph starting in line 131, to ensure clarity for readers unfamiliar with this metric.

      This scoring method is described in the methods sections, and we have now included reference to thorough explanation of how d was calculated at the indicated section.

      1. In Figure 2C-E - the title of the Y-axis does not match the text. If it represents the percentage of genes with significant expression changes, as in Figure 2A, the discrepancies between the percentages in this figure and those in Figure 2A need to be addressed.

      We have updated the method used to categorise significant changes in gene expression in the text and the figure legend for clarity.

      1. The experiment in Figure 3 needs a better explanation in the text. What is the analysis presented in Figure 3B-D. How many species were compared?

      We have added additional details in the results section and an explanation of how sequence change hotspots were calculated in the results section is available.

      1. The concept of transvection should be omitted from this manuscript. First, the definition provided by the authors is inaccurate. Second, even if additional experiments were to convincingly show that one allele in hybrid animals is dominant over the other, there are alternative explanations for this phenomenon that do not involve transvection. The authors may propose transvection as a potential model in the discussion, but they should do so cautiously and explicitly acknowledge the possibility of other mechanisms.

      We have updated the text to more conservatively discuss transvection, moving this to the discussion section with additional possibilities discussed.

      1. The statement at the end of the introduction is overly strong and would benefit from more cautious phrasing. For instance, it could be reworded as: "These findings suggest that promoter changes, rather than genomic background, play a significant role in driving expression changes, indicating that promoter evolution may contribute to the rise of new species."

      We have reworded this line following the reviewer's suggestion.

      1. Line 32 of the abstract: The term "Acp" is introduced without explaining what it stands for. Please define it as "Accessory gland proteins (Acp)" when it first appears.

      We have updated the manuscript to define Acp where it is first mentioned.

      1. Line 61: The phrase "...through relaxed,..." is unclear. Specify what is relaxed (e.g., "relaxed selective pressures").

      We have included description of relaxed selective pressures.

      1. The sentence in lines 74-76, starting in "Interestingly,...." Needs revision for clarity.

      We have removed the word interestingly.

      1. Line 112: Revise "we focused on the melanogaster subgroup which is made up of five species" to: "we focused on the melanogaster subgroup, which includes five species."

      We have made this change in the text.

      1. In line 144 use the phrase "promoter conservation" instead of "promoter evolution"

      We have updated the phrasing.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Summary:

      In this study, McQuarrie et al. investigate the evolution of promoters of genes encoding accessory gland proteins (Acps) in species within the D. melanogaster subgroup. Using computational analyses and available genomic and transcriptomic datasets, they demonstrate that promoter regions of Acp genes are highly diverse compared to the promoters of other genes in the genome. They further show that this diversification correlates with changes in gene expression levels between closely related species. Complementing these computational analyses, the authors conduct experiments to test whether differences in expression levels of four Acp genes with highly diverged promoter regions are maintained in hybrids of closely related species. They find that while two Acp genes maintain their expression level differences in hybrids, the other two exhibit dominance of one allele. The authors attribute these findings to transvection. Based on their data, they conclude that rapid evolution of Acp gene promoters, rather than changes in trans, drives changes in Acp gene expression that contribute to speciation.

      Major comments:

      Unfortunately, the presented data are not sufficient to fully support the conclusions. While many of the concerns can be addressed by revising the text to moderate the claims and acknowledge the methodological limitations, some key experiments require repetition with more controls, biological replicates, and statistical analyses to validate the findings.

      Specifically, some of the main conclusions heavily rely on the RT-PCR experiments presented in Figure 4, which analyze the expression of four Acp genes in hybrid flies. The authors use PCR and RFLP to distinguish species-specific alleles but draw quantitative conclusions from what is essentially a qualitative experiment. There are several issues with this approach. First, the experiment includes only two biological replicates per sample, which is inadequate for robust statistical analysis. Second, the authors did not measure the intensity of the gel fragments, making it impossible to quantify allele-specific expression accurately. Third, no control genes were used as standards to ensure the comparability of samples.

      The gold standard for quantifying allele-specific expression is using real-time PCR methods such as TaqMan assays, which allow precise SNP genotyping. To address this major limitation, the authors should ideally repeat the experiments using allele-specific real-time PCR assays. This would provide a reliable and quantitative measurement of allele-specific expression.

      If the authors cannot implement real-time PCR, an alternative (though less rigorous) approach would be to continue using their current method with the following adjustments:

      • Include a housekeeping gene in the analysis as an internal control (this would require identifying a region distinguishable by RFLP in the control).
      • Quantify the intensity of the PCR products on the gel relative to the internal standard, ensuring proper normalization.
      • Increase the sample size to allow for robust statistical analysis. These experiments could be conducted relatively quickly and would significantly enhance the validity of the study's conclusions.

      Minor comments

      While the following comments are not necessarily minor, they can be addressed through revisions to the text without requiring additional experimental work. Some comments are more conceptual in nature, while others concern the interpretation and presentation of the experimental results. They are provided in no particular order. 1. A key limitation of this study is the use of RNA-seq datasets from whole adult flies for interspecies gene expression comparisons. Whole-body RNA-seq inherently averages gene expression across all tissues, potentially masking tissue-specific expression differences. While Acp genes are likely restricted to accessory glands, the non-Acp genes and the random gene sets used in the analysis may have broader expression profiles. As a result, their expression might be conserved in certain tissues while diverging in others- an aspect that whole-body RNA-seq cannot capture. The authors should acknowledge that tissue-specific RNA-seq analyses could provide a more precise understanding of expression divergence and potentially reveal reduced conservation when considering specific tissues independently. 2. The statement in line 128, "Consistent with this model," does not accurately reflect the findings presented in Figures 2A and B. Specifically, the data in Figure 2A show that Acp gene expression divergence is significantly different from the divergence of non-Acp genes or a random sample only in the comparison between D. melanogaster and D. simulans. However, when these species are compared to D. yakuba, Acp gene expression divergence aligns with the divergence patterns of non-Acp genes or random samples. In contrast, Figure 2B shows that the distribution of expression changes is skewed for Acp genes compared to random control samples when D. melanogaster or D. simulans are compared to D. yakuba. However, this skew is absent when the two D. melanogaster and D. simulans are compared. Therefore, the statement in line 128 should be revised to accurately reflect these nuanced results and the trends shown in Figure 2A and B. 3. The statement in lines 136-138, "Acps were enriched for significant expression changes in the faster evolving group across all species," while accurate, overlooks a key observation. This trend was also observed in other groups, including those with slower evolving promoters, in some of the species' comparisons. Therefore, the enrichment is not unique to Acps with rapidly evolving promoters, and this should be explicitly acknowledged in the text. 4. It would be helpful for the authors to explain the meaning of the d score at the beginning of the paragraph starting in line 131, to ensure clarity for readers unfamiliar with this metric. 5. In Figure 2C-E - the title of the Y-axis does not match the text. If it represents the percentage of genes with significant expression changes, as in Figure 2A, the discrepancies between the percentages in this figure and those in Figure 2A need to be addressed. 6. The experiment in Figure 3 needs a better explanation in the text. What is the analysis presented in Figure 3B-D. How many species were compared? 7. The concept of transvection should be omitted from this manuscript. First, the definition provided by the authors is inaccurate. Second, even if additional experiments were to convincingly show that one allele in hybrid animals is dominant over the other, there are alternative explanations for this phenomenon that do not involve transvection. The authors may propose transvection as a potential model in the discussion, but they should do so cautiously and explicitly acknowledge the possibility of other mechanisms. 8. The statement at the end of the introduction is overly strong and would benefit from more cautious phrasing. For instance, it could be reworded as: "These findings suggest that promoter changes, rather than genomic background, play a significant role in driving expression changes, indicating that promoter evolution may contribute to the rise of new species."

      Text edits:

      Throughout the manuscripts there are incomplete sentences and sentences that are not clear. Below is a list of corrections:

      1. Line 32 of the abstract: The term "Acp" is introduced without explaining what it stands for. Please define it as "Accessory gland proteins (Acp)" when it first appears.
      2. Line 61: The phrase "...through relaxed,..." is unclear. Specify what is relaxed (e.g., "relaxed selective pressures").
      3. The sentence in lines 74-76, starting in "Interestingly,...." Needs revision for clarity.
      4. Line 112: Revise "we focused on the melanogaster subgroup which is made up of five species" to: "we focused on the melanogaster subgroup, which includes five species."
      5. In line 144 use the phrase "promoter conservation" instead of "promoter evolution"

      Significance

      This study addresses an important question in evolutionary biology: how seminal fluid proteins achieve rapid evolution despite showing limited adaptive changes in their coding regions. By focusing on accessory gland proteins (Acps) and examining their promoter regions, the authors suggest promoter-driven evolution as a potential mechanism for rapid seminal fluid protein diversification. While this hypothesis is intriguing and can contribute to our understanding of speciation, more rigorous analysis and experimental validation would be needed to support the conclusions. The revised manuscript can be of interest to fly geneticists and to scientists in the fields of gene regulation and evolution.

      Keywords for my expertise: Enhancers, transcriptional regulation, development, evolution, Drosophila.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      Summary

      This manuscript explores promoter evolution of genes encoding seminal fluid proteins expressed in the male accessory gland of Drosophila and finds cis-regulatory changes underlie expression differences between species. Although these genes evolve rapidly it appears that the coding regions rarely show signs of positive selection inferring that changes in their expression and hence promoter sequences can underlie the evolution of their roles within and among species.

      Major comments

      Figure 1 illustrates evidence that the promoter regions of these gene have accumulated more changes than other sampled genes from the Drosophila genome. While this convinces that the region upstream of the transcription start site has diverged considerably in sequence (grey line compared to black line), Figure 1A also suggests the "Genespan" region which includes the 5'UTR but presumably also part of the coding region is also highly diverged. It would be useful to see how the pattern extends into the coding region further to compare further to the promoter region (although Fig 1H does illustrate this more convincingly).

      Figure 2 presents evidence for significant changes in (presumably levels of) expression of male accessory gland protein (AcP) genes and ribosomal proteins genes between pairs of species, which is reflected in the skew of expression compared to randomly selected genes.

      Figure 3 shows detailed analysis for 3 selected AcP genes with significantly diverged expression. The authors claim this shows 'substitution' hotspots in the promoter regions of all 3 genes but this could be better illustrated by extending the plots in B-D further upstream and downstream to compare to these regions.

      Figure 4 shows the results of expression analysis in parental lines of each pair of species and F1 hybrids. However the results are very difficult to follow in the figure and in the relevant text. While the schemes in A, C. E and G are helpful, the gel images are not the best quality and interpretations confusing. An additional scheme is needed to illustrate hypothetical outcomes of trans change, cis change and transvection to help interpret the gels. On line 169 (presumably referring to panels D and F although C and D are cited on the next line) the authors claim that Obp56f and CG11598 'were more expressed in D. melanogaster compared to D. simulans' but in the gel image the D. sim band is stronger for both genes (like D. sechellia) compared to the D. mel band. The authors also claim that the patterns of expression seen in the F1s are dominant for one allele and that this must be because of transvection. I agree this experiment is evidence for cis-regulatory change. However the interpretation that it is caused by transvection needs more explanation/justification and how do the authors rule out that it is not a cis X trans interaction between the species promoter differences and differences in the transcription factors of each species in the F1? Also my understanding is that transvection is relatively rare and yet the authors claim this is the explanation for 2/4 genes tested.

      Minor comments

      Line 112 states that the melanogaster subgroup contains 5 species - this is incorrect - while this study looked at 5 species there are more species in this subgroup such as mauritiana and santomea.

      Lines 131-134 could explain better what the conservation scores and their groupings mean and the rationale for this approach.

      Line 162 - the meaning of the sentence starting on this line is unclear - it sounds very circular.

      Line 168 should cite Fig 4 H instead of F.

      Significance

      This paper is generally well written although some sections would benefit from more explanation. The paper demonstrates cis-regulatory changes between the promoters of orthologs of male accessory gland genes underlie expression differences but that the species differences are not always reflected in hybrids, which the authors interpret as being caused by transvection although there could be other explanations. Overall this provides new insights into the regulation and divergence of these interesting genes. The paper does not explore the consequences of these changes in gene expression although this is discussed to some extent in the Discussion section.

    4. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      The authors test the hypothesis that promoters of genes involved in insect accessory glands evolved more rapidly than other genes in the genome. They test this using a number of computational and experimental approaches, looking at different species within the Drosophila melanogaster complex. The authors find an increased amount of sequence divergence in promoters of accessory gland proteins. They show that the expression levels of these proteins are more variable among species than randomly selected proteins. Finally, they show that within interspecific hybrids, each copy of the gene maintains its species-specific expression level.

      The work is done with expected standards of controls and analyses. The claims are supported by the analysis. My main criticism of the manuscript has to do not with the experiments or conclusion themselves but with the presentation. The manuscript is just not very well written, and following the logic of the arguments and results is challenging. The problem begins with the Abstract, which is representative of the general problems with the manuscript. The Abstract begins with general statements about the evolution of seminal fluid proteins, but then jumps to accessory glands and hybrids, without clarifying what taxon is being studied, and what hybrids they are talking about. Then, the acronym Acp is introduced without explanation. The last two sentences of the Abstract are very cumbersome and one has to reread them to understand how they link to the beginning of the Abstract.

      More generally, if this reviewer is to be seen as an "average reader" of the paper, I really struggled through reading it, and did not understand many of the arguments or rationale until the second read-through, after I had already read the bottom line. The paragraph spanning lines 71-83 is another case in point. It is composed of a series of very strongly worded sentences, almost all starting with a modifier (unexpectedly, interestingly, moreover), and supported by citations, but the logical flow doesn't work. Again, reading the paragraph after I knew where the paper was going was clearer, but on a first read, it was just a list of disjointed statements.

      Since most of the citations are from the authors' own work, I suspect they are assuming too much prior understanding on the part of the reader. I am sure that if the authors read through the manuscript again, trying to look through the eyes of an external reader, they will easily be able to improve the flow and readability of the text.

      More specific comments:

      1. In the analysis of expression level differences, it is not clear what specific stage / tissue the levels taken from the literature refer to. Could it be that the source of the data is from a stage or tissue where seminar fluid proteins will be expressed with higher variability in general (not just inter-specifically) and this could be skewing the results? Please add more information on the original source of the data and provide support for their validity for this type of comparison.
      2. The sentence spanning lines 155-157 needs more context.
      3. Line 203-204: What are multi-choice enhancers?
      4. Figure 1: The terminology the authors use, comparing the gene of interest to "Genome" is very confusing. They are not comparing to the entire genome but to all genes in the genome, which is not the same.
      5. Figure 2: Changes between X vs. Y is redundant (either changes between X and Y or changes in X vs. Y).

      Significance

      The manuscript addresses a general question in evolutionary biology - do control regions diverge more quickly protein coding regions. The answer is that yes, they do, but this is actually not very surprising. The work is probably thus of more interest to people interested in the copulatory proteins or in the evolution of mating systems, than to people interested in broader evolutionary questions.

    1. Sweet & Cosy Things 1. A blanket fort 2. Comfy pyjamas 3. Woolly socks 4. Butterscotch popcorn and hot cocoa 5. A gentle movie night 6. Honey on toast 7. A Mickey Mouse cocoa mug 8. Warming up by the fireplace 9. Playing quiet board games

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Below is a point-by-point response to reviewers concerns.

      Main changes are colored in red in the revised manuscript.

      Reviewer #1 (Significance (Required)):

      General assessment:

      This study provides a valuable computational framework for investigating the dynamic interplay between DNA replication and 3D genome architecture. While the current implementation focuses on Saccharomyces cerevisiae, whose genome organization differs significantly from mammalian systems.

      Advance: providing the first in vivo experimental evidence in investigating the role(s) of Cohesin and Ctf4 in the coupling of sister replication forks.

      Audience: broad interests; including DNA replication, 3D genome structure, and basic research

      Expertise: DNA replication and DNA damage repair within the chromatin environment.

      Reviewer #1 (Evidence, reproducibility and clarity (Required)):

      By developing a new genome-wide 3D polymer simulation framework, D'Asaro et al. investigated the spatiotemporal interplay between DNA replication and chromatin organization in budding yeast: (1) The simulations recapitulate fountain-like chromatin patterns around early replication origins, driven by colocalized sister replication forks. These findings align with Repli-HiC observations in human and mouse cells, yet the authors advance the field by demonstrating that these patterns are independent of Cohesin and Ctf4, underscoring replication itself as the primary driver. (2) Simulations reveal a replication "wave" where forks initially cluster near the spindle pole body (SPB) and redistribute during S-phase. While this spatial reorganization mirrors microscopy-derived replication foci (RFis), discrepancies in cluster sizes compared to super-resolution data suggest unresolved mechanistic nuances. (3) Replication transiently reduces chromatin mobility, attributed to sister chromatid intertwining rather than active forks.

      This work bridges replication timing, 3D genome architecture, and chromatin dynamics, offering a quantitative framework to dissect replication-driven structural changes. This work provides additional insights into how replication shapes nuclear organization and vice versa, with implications for genome stability and regulation.

      We thank Reviewer 1 for her/his enthusiasm and her/his comments that help us to greatly improve the manuscript.

      However, the following revisions could strengthen the manuscript:

      Major:

      Generalizability to Other Species While the model successfully recapitulates yeast replication, its applicability to larger genomes (e.g., mammals) remains unclear. Testing the model against (Repli-HiC/ in situ HiC, and Repli-seq) data from other eukaryotes (particularly in mammalian cells) could enhance its broader relevance.

      We agree with the reviewer that testing the model in higher eukaryotes would be highly informative. The availability of Repli-HiC on one hand and higher resolution microscopy on the other could enable insightful quantitative analyses. With our formalism, it is in principle already possible to capture realistic 1D replication dynamics as the integrated mathematical formalism (by Arbona et al. ref. [63]) was already used to model human genome S-phase. In addition, the formalism developed for chain duplication is generic and can be contextualized to any species. However, when addressing the problem in 3D, we would likely require including other crucial structural features such as TADs or compartments. Such a model would require an extensive characterization worthy of its own publication. These considerations are now mentioned in the Discussion as exciting future perspectives (Page 17).

      On the other hand, we would like to highlight that, while very minimal in many aspects, our model includes many layers of complexity (explicit replication, different forks interactions, stochastic 1D replication dynamics, physical constraints at the nuclear level). In addition, addressing this problem in budding yeast offers the great advantage of simultaneously capturing at the same time both the local and global spatio-temporal properties of DNA replication and to focus first only on those aspects and not on the interplay with other mechanisms like A/B compartmentalization (absent in yeast) that may add confusions in the data analysis and comparison with experimental data . Studying such an interplay is a very important and challenging question that, we believe, goes beyond the scope of the present work.

      Validation with Repli-HiC or Time-Resolved Techniques

      The Hi-C data in early S-phase supports the model, but the intensity of replication-specific chromatin interactions is faint, which could be further validated using Repli-HiC, which captures interactions around replication forks. Alternatively, ChIA-PET or HiChIP targeting core component(s) (eg. PCNA or GINS) of replisomes may also solidify the coupling of sister replication forks.

      We thank the reviewer for the suggestion. Unfortunately, corroborating our HiC results using Repli-HiC or HiChIP would require developing and adapting the protocols to budding yeast which is well beyond the scope of this work mainly focused on computational modelling. In addition, we believe that the signature found in our Hi-C data is clear and significant enough to demonstrate the effect.

      However, we included in the Discussion (Page 15) a more detailed description on how our work compares with the Repli-HiC study in mammals. In particular, we added a new supplementary figure (new Fig. S23) where we discuss our prediction on how Repli-HiC maps would appear in yeast in both scenarios of sister-forks interaction. Interestingly, we find that:

      1) Fountain signals are strongly enhanced when sister forks interact.

      2) Only mild replication dependent enrichment is detected when diverging forks do not interact.

      These two results imply that disrupting putative sister-forks interaction would have a drastic effect on Repli-HiC if compared to HiC.

      Interactions Between Convergent Forks

      The study focuses on sister-forks but overlooks convergent forks (forks moving toward each other from adjacent origins), whose coupling has been observed in Repli-HiC. Could the simulation detect the coupling of convergent fork dynamics?

      We thank the reviewer for this suggestion. We included in our Hi-C analysis aggregate plots around termination sites. Interestingly, no clear signature of coupling between convergent forks was detected (such as type II fountains in mammals) in vivo and in silico. Similarly, from visual inspection of individual termination sites, no fountains were clearly observed. These results can be found in the new Fig. S24 and possible mechanistic explanations are described more in detail in the Discussion (Page 15).

      Unexpected Increase in Fountain Intensity in Cohesin/Ctf4 Knockouts.

      In Fig.3A, a schematic illustrating the cell treatment would improve clarity. In Sccl- and Ctf4-depleted cells, fountain signals persist or even intensify (Fig. 3A). This counterintuitive result warrants deeper investigation. Could the authors provide any suggestions or discussions? Potential explanations may include:

      Compensatory mechanisms (e.g., other replisome proteins stabilizing sister-forks).

      Altered chromatin mobility in mutants, enhancing Hi-C signal resolution.

      Artifacts from incomplete depletion (western blots for Sccl/Ctf4 levels should be included).

      A scheme illustrating the experimental protocol for degron systems (CDC45-miniAID & SCC1-V5-AID) with the corresponding western blots and cell-cycle progression are shown in Fig. S26. Note that for Ctf4, we are using a KO cell line where the gene was deleted.

      We do agree with the reviewer that there exist several possible explanations explaining the differences between WT fountains and those observed in mutants. In the revised manuscript, we discussed some of them in Section 2 II B (Page 8):

      (1) As already suggested in the paper, asynchronization of cells may impact the intensity of the fountains due a dilution effect mediated by the cells still in G1. Therefore, possible differences in the fractions of replicating/non-relicating cells between the different experiments (new Fig. S7C) would also result in differences in the signal. Moreover, it is important to highlight that aggregate plots are normalized (Observed/Expected) by the average signal (P(s)). Therefore, as Scc1-depleted cells do not exhibit cohesin-mediated loop-extrusion (see aggregate plots around CARs in new Fig. S7B), we may expect an enhancement of signal at origins due to dividing each pixel by a lower contact frequency with respect to the one found in WT.

      (2) In the new Fig. S10, we plotted the relative enrichment of Hi-C reads around origins. While we already used the same approach to compare replicon sizes between simulations and experiments (see Fig S7A and response to comment n°9 of Reviewer 3), this analysis is instructive also when comparing different experimental conditions. While we find that the experiment in WT and Scc1-depleted cells show very similar replicon sizes, we do observe a small increase in the peak height for the cohesin mutant. This may also partially motivate differences in the intensity of the fountain. For ctf4Δ, we observe significantly smaller replicons. We speculate that such a mutant might exhibit slower replication and consequently might be enriched in sister-forks contacts.

      (3) Compensatory mechanisms: we now briefly discussed this in the Discussion (Page 15).

      Inconsistent Figure References

      Several figure citations are mismatched. For instance, Fig. S1A has not been cited in the manuscript. Moreover, there is no Fig.1E in figure 1, while it has been cited in the text. All figure/panel references must be cross-checked and corrected.

      We thank the reviewer for this observation. We have now corrected the mismatches.

      Minor:

      Page2: "While G1 chromosomes lack of structural features such as TADs or loops [3]" However, Micro-C captures chromatin loops, although much smaller than those in mammalian cells, within budding yeast.

      Loops of approx 20-40 kb are found in interphase in budding yeast but only after the onset of S-phase ( ref. [52-61]). For this reason, our G1 model of yeast without loops well captures the experimental P(s) curves (Fig. S2). See also answer to point 12 of reviewer 2 .

      In figure 2E, chromatin fountain signals can be readily observed in the fork coupling situation and movement can also be observed. However, the authors should indicate the location of DNA replication termination sites and show some examples at certain loci but not only the aggregated analysis.

      The initial use of aggregate plots was motivated by the fact that fountains are quite difficult to observe at the single origin level in the experimental Hi-C due to the strong intensity of surrounding contacts (along the diagonal). However, when dividing early-S phase maps by the corresponding G1 map, we can now observe clear correlation between origin and fountain positions on such normalized maps. We now added an example for chromosome 7 in Fig.3 indicating early/late origins.

      In Fig. S8 and S9 (where we also included termination sites), we show that fountains are prominently found at origins during S-phase and are lost in G2/M.

      Reviewer #2 (Significance (Required)):

      The topic is relevant and the problem being addressed is very interesting. While there has been some earlier work in this area, the polymer simulation approach used here is novel. The simulation methodology is technically sound and appropriate for the problem. Results are novel. The authors compare their simulations with experimental data and explore both interacting and non-interacting replication forks. Most conclusions are supported by the data presented. Reviewer #2 (Evidence, reproducibility and clarity (Required)):

      The manuscript by D'Asaro et al. investigates the relationship between DNA replication and chromatin organization using polymer simulations. While this is primarily a simulation-based study, the authors also present relevant comparisons with experimental data and explore mechanistic aspects of replication fork interactions.

      We thank Reviewer 2 for her/his positive evaluation of our work and her/his suggestions that help us to clarify many aspects in our manuscript.

      The primary weakness is that many aspects are not clear from the manuscript. Below is a list of questions that the authors must clarify:

      In the Model and Methods section, it is written "Arbitrarily, we choose the backbone to be divided into two equally long arms, in random directions." It is unclear what is meant by "backbone to be divided" and "two equally long arms." Does this refer to replication?

      We agree with the reviewer that the term backbone may be ambiguous. In the context of the initialization of the polymer, it refers to the L/4 initial bonds used to recursively build an unknotted polymer chain of final size L using the Hedgehog algorithm (see refs [101,109]). As shown in the Fig S1A, these initial L/4 bonds define the initial backbone of each chromosome before they are recursively grown to their final size. We chose to divide them into two branches (called “arms” in the old version of the manuscript) of equal length (L/8) and with random orientations. To avoid any ambiguity between the term arm used in that context and the chromosome arms in a biological sense (sequences on the left and right with respect to centromeres), we changed it to “linear branches” to improve clarity. We highlighted in Fig. S1A two examples of such a “V-shaped” backbone.

      As stated in the text, these initial configurations are artificial and just aim to generate unknotted, random structures. After initiating the structures, we then added the geometrical constraints to the centromeric, telomeric and rDNA beads. This, combined with the tendency of the polymer to explore and fill the spherical volume, determine the relaxed G1-like state (see Fig. S2) obtained after an equilibration stage (corresponding to 10^7 MCS). Only after that initialization protocol, DNA replication is activated.

      In chromosome 12, since the length inside the nucleolus (rDNA) is finite, the entry and exit points should be constrained. Have the authors applied any relevant constraint in the model?

      Indeed, we did not introduce any specific constraint on the relative distance between rDNA boundary monomers in our model. They can therefore freely diffuse, independently from each other, on the nucleolus surface. This point is now clarified in the text. Note that, in this paper, we did not aim to finely describe the rDNA organization and its interactions with the rest of the genome, that is why we did not explicitly model rDNA. Moreover, to the best of our knowledge, there is not available experimental data to potentially tune such additional restraints.

      Previous models such as Tjong et al. (ref. [66]) and Di Stefano et al. (ref [67]) have used very similar approximations than us. In the works of Wong et al. (ref.[61]) and Arbona et al. (ref.[63]), rDNA is explicitly modelled via larger/thicker beads/segments, and thus accounts for some generic polymer-based constraints between rDNA boundary elements.

      However, note that all these different models, including ours, still correctly predict the strong depletion of contacts between rDNA boundaries, indicating that there exists a spatial separation between the two boundary elements that is qualitatively well captured by our model (See Fig. S1 D and Fig. 1B).

      What is the rationale for normalizing the experimental and simulation results by dividing by the respective P_intra(s = 10 kb)?

      This normalization was used in Fig. 1 to obtain a rescaling between experiments and simulations. This approach assumes that simulated and experimental Hi-C maps are proportional by a factor that, in Fig 1B, was set to P_exp(s=16kb)/P_sim(s=16kb). Similar strategies are used in a number of modeling studies (for example ref. [103,106]).

      We use the average contact frequency (P_intra) at this genomic scale (s in the order of 10s of kb) because our polymer simulations well capture the experimental P(s) decay above this scale. This method allows to plot the two signals with the same color scale and to give a qualitative, visual intuition on the quality of the modeling. Note that normalization has no impact on the Pearson correlation given in text. More generally, it allows to semi-quantitatively compare predicted and experimental Hi-C data.

      In Fig 1D, we instead normalize the average signal between pairs of centromeres (inter-chromosomal aggregate plot off-diagonal) by the average P_intra(s=10kb). This method allows estimating how frequently centromeres of different chromosomes are in contact relative to intra-chromosomal contacts at the chosen scale (10 kb). In the new paragraph “Comparison with in vivo HiC maps in G1” (Page 22) , we describe more in detail the quantitative insights that can be recovered from such analysis.

      As a comparison, such normalization is not required when computing Observed/Expected maps (Fig. 1C or aggregate plots in Fig. 2 and Fig. 3) as simulation and experimental maps are normalized by their own P(s) curves. We now clarify this aspect in the Materials in Methods under the paragraph “Comparison between on diagonal aggregate plots” (Page 22).

      In the sentence "For instance, chromosomes are strictly bound by the strong potential to localize between 250 and 320 nm from the SPB," is it 320 or 325 nm? Is there a typo?

      We confirm that the upper bound is indeed 325 nm as stated in Eq.2 and not 320 nm.

      Please list the number of beads in each chromosome and the location of the centromere beads.

      A new table (Table S2) was included to highlight beads number and centromere positions.

      In Eq. 7, when the Euclidean distance between the sister forks d_ij > 50 nm, the energy becomes more and more negative. This implies that the preferred state of sister forks is at distances much greater than 50 nm. Then how is "co-localization of sister forks" maintained?

      We corrected the typo sign in Eq.7. The corrected equation without the minus sign - consistently with what simulated - implies that sister forks tend to minimize their 3D distance. The term goes to zero when their distance is within 40 nm (2 nearest-neighbouring sites).

      The section on "non-specific fork interactions" is unclear. You state that the interaction is between "all the replication forks in the system," but f_ij is non-zero only for second nearest-neighbors. The whole subsection needs clarification.

      We corrected the text, specifying that the energy is non-zero for both first and second neighbours. In practice, two given forks do not experience any attractive energy unless their 3D distance is less than 2 nearest-neighbours. To clarify this aspect, we articulated more in the methods how non-specific fork interactions are implemented in the lattice during the KMC algorithm. We also included a new supplementary image (Fig. S15), where we schematize how forks move in 3D and how changes in their position update the table that tracks the number of forks around each lattice site.

      Eq. 6 has no H_{sister-forks}. Is this a typo?

      We confirm that it is a typo and the formula was corrected to H_{sister-forks}.

      While discussing the published work, the authors may cite the recent paper [https://doi.org/10.1103/PhysRevE.111.054413].

      The reference is now included when discussing previous polymer models of DNA replication.

      It is not clear how the authors actually increase the length of new DNA in a time-dependent manner. For example, when a new monomer is added near the replication origin (green bead in Fig. 3C), what happens to the red and blue polymer segments? Do they get shifted? How do the authors take into account self-avoidance while adding a new monomer? These details are not clear.

      The detailed description of the chain duplication algorithm and its systematic analysis was performed in our previous study (ref. [25]).

      However, we agree with the reviewer that to improve self-consistency more details must be included in the present manuscript (see also answer to comment 1 of Reviewer 3). In particular, we now highlight in Materials and Methods that self-avoidance is indeed temporarily broken when we add a newly replicated monomer on top of the site where the fork is. Such double occupancy in the lattice rapidly vanishes due to 3D local moves. We refer to our PRX work (ref [25] and in particular to the following figure (extracted from FIG. S1 in ref.[25]) which illustrates how the bonds/segments of the two sister chromatids are consistently maintained.

      How do the authors ensure that monomers get added at a rate corresponding to velocity v? The manuscript mentions "1 MCS = 0.075 msec," but in how many MC steps is a new monomer added? How is it decided?

      Similarly to origin firing, replication by fork movement along the genome occurs stochastically, with a rate which we derive by converting the physiological fork speed in yeast 2.2 kb/min (ref. [41]) into a rate in (number of monomer/MCS) units. In practice, we generate a random number that, if smaller than such a rate, leads to forks duplication. We clarify this aspect in the Materials and Methods, also referring to our previous work for a more detailed summary.

      The authors stress the relevance of loop extrusion. However, in their polymer simulation, the newly replicated chromatin does not form any loops. Is this consistent with what is known?

      Indeed, our simulations do not have any concurrent extrusion mechanism such as cohesin-mediated loops. This choice was purposely made to isolate and characterize replication-dependent effects.

      That is why we compare our predictions on chromatin fountain patterns (Fig. 3) with data obtained for the Scc1 mutant strain where cohesin is absent in order to disentangle the possible interference with loop-extruding cohesin. For subsection C where microscopy data are available only in WT condition, we cannot rule out that the observed discrepancies between experiments and predictions cannot be due to missing mechanisms including loop extrusion. It was already mentioned in the Discussion (Page 16). It is however unclear whether sparse and small loops between CARs (see Fig. S7B) in S-phase, could be sufficient to recapitulate the microscopy estimates on the sizes of replication foci and no clear signature of inter-origin loops (possibly mediated by loop extrusion) are observed in Hi-C data in WT and Scc1 deficient conditions.

      Moreover, as mentioned in the Discussion, the poorly characterized mechanisms behind forks/extruding-cohesin encounters does not allow for a straightforward modelling of such processes whose accurate description/simulation would require its own study.

      Please add a color bar to Fig. 4B.

      The color bar was included.

      In the MSD plot (Fig. 6), even though it appears to be a log-log plot, the exponents are not computed. Typically, exponents define the dynamics.

      We plot the expected 0.5 exponent at smaller time-scales as mentioned in the main text in Fig. 6, previously included only in new Fig. S19A.

      The dynamics will depend on the precise nature of interactions, such as the presence or absence of loop extrusion. If the authors present dynamics without extrusion, is it likely to be correct?

      The reviewer is correct in highlighting how our model does not capture the potential decrease in dynamics due to cohesin mediated loop extrusion. However, our model does capture the expected Rouse regime (see Fig. 6A, S19A and ref [83]), which justify our timemapping strategy. In comment 16 of reviewer 3, we discuss more in detail the robustness of our results with respect to variation in such a mapping. In the specific context of Fig. 6A, we predict the gradual decrease in dynamics due to sister chromatids intertwining independently of any cohesin-associated activity (both loop-extruding and cohesive). As loop extrusion is also decreasing chromatin mobility overall (ref. [87]), if such a decrease in mobility is observed in WT in vivo, it may be indeed difficult to assign such a decrease to replication rather than loop extrusion. That is why in the Discussion (Page 16), we propose to compare our prediction to experiments in cohesin-depleted cells. In the context of Fig.6B&C, we don’t expect loop extrusion to be a confounding effect as the predicted decrease in dynamics is specific to forks.

      Reviewer #3 (Significance (Required)):

      The work has been conducted thoroughly, and in general the paper is well written with good attention to detail. As far as I am aware, this is the first study where replication is simulated in a whole nucleus context, and the scale of the simulations is impressive. This allows the authors to address questions on replication foci and the spatiotemporal organisation of replication which would not be possible with more limited simulations, and to compare the model with previous experimental work. This, together with the new HiC data, I think this makes this a strong paper which will be of interest to biophysics and molecular biology researchers; the manuscript is written such that it would suit an interdisciplinary basic research audience.

      We thank Reviewer 3 for her/his enthusiasm and her/his comments that help us to greatly improve the manuscript.

      Reviewer #3 (Evidence, reproducibility and clarity (Required)):

      The paper "Genome-wide modelling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes" by D'Asaro et. al presents new computational and experimental results on the dynamics of genome replication in yeast. The authors present whole-nucleus scale simulations using a kinetic Monte Carlo polymer physics model. New HiC data for synchronised yeast samples with different protein knock-downs are also presented.

      The main questions which the paper addresses are whether sister forks remain associated during replication, whether there is more general clustering of replication forks, and whether replication occurs in a 'spatial wave' through the nucleus. While the authors' model data are not able to conclusively show whether sister forks remain co-localised, the work provides some important insights which will be of high interest to the field.

      I have no major issues with the paper, only some minor comments and suggestions to improve the readability of the manuscript or provide additional detail which will be of interest to readers. I list these here in the order in which they appear in the paper. There are also a number of typos and grammatical issues through the text, so I recommend thorough proofreading.

      The paper seems to be aimed at a broad interdisciplinary audience of biophysicists and molecular biologists. For this reason, the introduction could be expanded slightly to include some more background on DNA replication, the key players and terminology. Also, it seems that this work builds on previous modelling work (Ref. 19), so a bit more detail of what was done there, and what is new here would be helpful. The final paragraph the introduction mentions chromosome features such as TADs and loops, which should be explained in more detail.

      We now have expanded the introduction to address some of these aspects. In particular, also as a response to comment 1 of Reviewer 4, we included additional background on the eukaryotic replication time program. We address in more detail its known interplay and correlation with crucial 3D structural features such as compartments and TADs. Finally, we add a sentence to clarify how the current work is distinct from the prior implementation and the novelty introduced here.

      In the first results section, end of p2, the "typical brush-like architecture" is mentioned. This is not well explained, some additional detail or a diagram might help.

      As very briefly summarized in the mentioned paragraph, the yeast genome is organized in the so-called Rabl organization where chromosome arms are all connected via the centromeres at the Spindle Pole Body (SPB). This is analogous to the definition of a polymer brush where several branches (the arms in this case), are grafted to a surface or to another polymer (see new Inset panel in Fig S1B). We refer in the main text to the scheme in Fig. S1B where we also include the snapshot of a single chromosome and the physical constraints that characterize this large-scale organization and extend the caption to clarify the analogy. A typical emerging feature at the single chromosome level is described in Fig. 1 B and C.

      On p3-4, some previous work is described, with Pearson correlations of 0.86 and 0.94 are mentioned. What cases these two different values correspond to is not clear.

      These Pearson correlations are obtained for our own modeling. We correct the values in the main text and more clearly indicate the specific correspondence with the maps used. We describe now in the Materials and Methods (new paragraph “Comparison with in vivo HiC maps in G1” and Table S2) how these values were obtained.

      In section II-A-2, on the modelling details, it should be made clearer that the nucleus volume is kept constant, and that this is an approximation since typically the nucleus grows during S-phase. This is discussed in the Methods section, but it would be useful to also mention it here (and give some justification why it will not likely change the results).

      We now state more clearly in the main text the limitation of our model regarding the doubling of DNA content without any increase of nuclear size. As mentioned in the Discussion, we do not expect this approximation to strongly impact our results, which mainly focus on early S-phase.

      We now also included in the Discussion how the detection of the “replication wave” should be qualitatively independent of the density regime. In fact, even in the case of growing nuclei and constant density, the polarity induced by the Rabl organization and replication timing are the main drivers of such fork redistribution.

      Regarding the slowdowning in diffusion due to sister chromatids intertwinings (see response to comment 13), we instead verified that the effect is indeed density independent (new Fig S21).

      Fig 2. The text in Fig 2B is much smaller than other panels and difficult to read. Also Fig 3B, Fig 6.

      This is now corrected.

      In 2E, are the times given above each map the range which is averaged over? This could be clearer in the caption. In the caption it stated that these are 'observed over expected'; what the 'expected' is could be clearer.

      We reformulate the description in the caption to make clearer that the time indicated above the plots indicate the time window used for the computation. As mentioned more in detail in the response to comment 17 below (and comment 3 of Reviewer 2), we included in the Material and Methods a more precise description on the normalization used in the case of on-diagonal aggregate plots (observed-over-expected).

      In section II-B-2, the authors state that the cells are fixed 20 mins after release from S-phase. Can they comment on the rationale behind this choice, since from Fig 2 their simulations predict that the fountain pattern will no-longer be visible by that time.

      In the experimental setup, cells are arrested in G1 with alpha-factor and then released in S-phase (see Fig S26 with corresponding scheme). The release from G1 synchronisation is not immediate, and staging of cells by flow-cytometry every 5 minutes for 30 minutes after release (data not shown in the main text but provided below) proved 20 minutes to be an adequate early S-phase timepoint (Page 17 in the Materials and Methods). As a consequence, the times indicated when describing the in vivo experiment, do not correspond to the ones indicated in our in silico system, for which the onset of replication is well defined. For these reasons, we have to determine which time window among the ones used in Fig 2E, is the most appropriate to compare with the experiment (see response to comment 9 for more details).

      Fig.R1: Cell cycle progression monitored by flow cytometry after the release. For the first 15 minutes, cells are still mainly in G1 and only start replicating ~20 minutes after the release.

      Section II-B-2(b) could be clearer. I don't understand what the conclusion the authors take from the metaphase arrest maps is. I'm not sure why they discuss again the Cdc45-depleted cells here, since this was already covered in the previous section.

      Taken together, the G1, Cdc20 (metaphase-arrested cells), and Cdc45-depleted (early S cells but not replicated) conditions suggest that fountains reflect ongoing replication. Namely, G1-arrest shows that fountains require S-phase entry; Cdc45-depletion shows that fountains require origin firing and is not due to another S-phase event; and metaphase-arrested cells show that fountains are not permanent structures established by replication, but a transient replication-dependent structure.

      This demonstrates that the emerging signal is not trivially dependent on (1) the presence of the second sister chromatids; or on (2) potential overlaps between origin positions and barriers (CARs) to loop extrusion (see also comment 12 of Reviewer 2). A sentence at the end of II-a was added to clarify the different information gained with the two strains.

      We discuss again the cdc20 and cdc45 mutants in II-b to highlight how the results in II-a do not exclude potential interplay between cohesin-mediated loop-extrusion in presence forks progression. These considerations motivated our experiment in Scc1-depleted cells during early S-phase.

      At the start of p8 (II-B-3) there is a discussion of the mapping to times to the early-S stage experiments. This could have more explanation. I don't follow what the issue is, or the process which has been used to do the mapping. From Fig 2B, it seems that the simulation time is already mapped well to real time.

      As mentioned above in comment 7, we cannot clearly define a “t=0” when replication starts in vivo as the release from the G1-arrest is not immediate and perfectly synchronous. On the other hand, the times indicated within the text are those following the onset of polymer self-duplication in our simulations. Note that the mean replication time (MRT) shown in Fig.2B does not represent an absolute time, but rather an average relative timing along S-phase (signal rescaled between 0 and 1).

      For all these considerations, we think that the most reliable strategy to compare fountains in vivo and in silico is to look at the replicon size via the enrichment in raw contacts around early origins, as illustrated in Fig S7A. In practice, looking at the relative counts of contacts around early origins we have a proxy for the average replicon size that we can match by computing the same analysis on simulated signals (Fig S7A). As a result, we find that the best simulated time window is between 5 and 7.5 minutes, compatible with early-S phase and with an approximate duration of G1 after release of 15 minutes as observed in other studies (ref. [61]).

      Note that our conclusions are robust with respect to modulating this mapping method. In particular in Fig. S7, we thoroughly investigated how several confounding factors (such as time window used or partial synchronization) may impact the quantitative nature of our prediction without affecting the qualitative insights.

      We included a more precise reference to the Supplementary Materials, where the approach is described and clarified.

      In Fig 4A above each plot there is a cartoon showing the fork scenario. The left-hand cartoon is rendered properly, but the right-hand one has overlapping black boxes which I don't think should be there. These black boxes are present in many other figures (4B, 3B, 2E etc).

      This issue seems to appear using the default PDF viewer on Mac OS. We have corrected the problem and no more black boxes should appear in the main text and in the Supplementary Material.

      In II-C-2(b) it is mentioned that the number of forks within RFis is always assumed to be even. This discussion could be clearer. In particular, the authors state that under both fork scenarios, in the simulations they can detect odd numbers of forks within RFis - how can this happen in the case where sister forks are held together?

      We included a more accurate description in the main text about why Saner et al. (ref [20]) make these assumptions in their estimates. We highlight possible inconsistencies such as the presence of termination events which, in our formalism, break sister forks interactions and lead to single forks to be detected. We also clarify the latter point when describing Fig 5B and describe in more detail replication bubbles merging events in the Materials and Methods.

      Fig 6B and C, it would be useful if the same scale was used on both plots.

      We now use the same scale when plotting Fig 6B and C.

      Section II-D-1. There is a discussion on the presence of catenated chains; I did not understand how the replicated DNA becomes catenated, and what this actually means in this context. The way the process is described and the snapshots in Fig2C do not suggest that the chains are catenated. Some further discussion or a diagram would be useful here.

      We included a small paragraph to better explain how intertwining of sister chromatids occurs, and more clearly refer to a snapshot in supplementary figure S19D (Page 14). As correctly mentioned by the reviewer, replication bubbles by construction are always unknotted during their growth (see example in Fig. 2C). As we thoroughly characterize in our previous work (ref. [25]), when several replication bubbles merge, the random orientation of sister chromatids potentially lead to catenation points and intertwined structures. We show below a scheme from our previous work (ref [25]). While in this past work, we demonstrated that the center of mass of the two sister chromatids show subdiffusive behaviour due to the additional topological constraints of their intertwining, this new analysis in the present work suggests that possible effects may also be observed when tracking the MSD (mean square displacement at the locus level) in a more realistic scenario where we included correct replication timing, chromosome sizes and Rabl-organization.

      On p14 (section III) there is a section discussing possible mechanisms for sister fork interactions, and that result that Ctf4 might not play a role in this, as previously suggested. Are there any other candidate proteins which could be tested in the future?

      To the best of our knowledge, there is no other candidate protein of the replisome that has been directly associated to sister-fork pairing in previous studies (as Ctf4). However, components of the replisome such as Cdt1, that have the capacity to oligomerize/self-interact, could be good candidates. We now mention this possibility in the Discussion (Page 15).

      As on p14, second paragraph: there is a sentence "replication wave [51] cannot be easily visualised at the single cell level.", which seems to contradict the discussion on p9 "such a "wave" can also be observed at the level of an individual trajectory (Video S3,4) even if much more stochastic." I think more explanation is needed here.

      We rephrased the mentioned passages to clarify the differences in detecting such “replication wave” at the population vs single cell level. In video S3 and S4, we can still observe an enrichment of forks at the SPB and later in S-phase a shift towards the equatorial plane. However, the stochasticity of polymer dynamics and 1D replication strongly hinder the ability to clearly visualize such redistribution.

      In the methods section, p18, it is mentioned that the volume fraction is 3%. I assume this is before replication, and so after replication is complete this will increase to 6%. This should be stated more explicitly, with also a comment on the 5% volume fraction used in the time-scale mapping discussed on p17.

      Indeed, we choose to map the experimental MSD measured in ref [83] by simulating a homopolymer 5% volume fraction and in periodic boundary conditions for consistency to previous work in the group (ref. [102-106]) and our previous replication model (ref.[25]). Moreover, this intermediate density regime also lies in between the minimal (3%) and maximal (6%) densities present in our system. When redoing the time mapping with the G1 MSD plotted in Fig 6A and new Fig S19A, we obtain a very similar value of approx. 1MC=0.6ms. Note that the time mapping aims to obtain a rough estimation of real times as several factors, such as active processes, non-constant density, cell-cycle progression may all contribute to chromatin diffusion in vivo (see also comment 15 to Reviewer 2). In the context of our formalism, differences in time mapping do not affect the 1D replication dynamics as all the parameters to model the 1D process are rescaled by the same factor. Moreover, as we characterized in more depth in our previous work (ref [25]), a crucial aspect that defines self-replicating polymers is the relationship between fork progression and the polymer relaxation dynamics. In physiological conditions, we remain in the regime where forks progress almost quasi-statically to allow the bubbles to re-equilibrate. Therefore, small discrepancies in the time mapping will not modify this regime and our results should remain robust.

      On p20, processing of simulated HiC using cooltools is discussed. For readers unfamiliar with this software, a bit more detail should be given. Specifically, how does the normalisation account for having some segments which have been replicated and some which have not. Later on the same page (IV-C-2) two different strategies for comparing HiC maps are given; why are two different methods required, and what is the reasoning in each case?

      In the raw - unbalanced - data, we observe an artificial increase in contacts around origins in S-phase for both simulation and experiments. This is simply due to the presence of the second Sister chromatids and the fact that contacts between distinct DNA segments are mapped to a single bin.

      In the new Fig. S25, we illustrate this effect by computing aggregate plots around early origins using single-chromosome simulations. We demonstrate that the ICE normalization corrects for the variations in copy number due to replication and thus for such artificial increases in contacts during S-phase. We show that such a normalization is equivalent to explicitly divide each bin by the average copy-number of the corresponding segments.

      We have now included a sentence in the Materials and Methods to clarify this. Moreover, a detailed description of the other alternative strategies used to compare experiments and simulations were presented in response to comment 3 to Reviewer 2 and two new paragraphs were added in the Materials and Methods.

      The references section has an unusual formatting with journal names underlined.

      We updated the formatting.

      Reviewer #4 (Significance (Required)):

      D’Asaro et al focus on the problem of how genome structure is altered by the progression of replisomes through S-phase in the budding yeast S. cerevisiae. The authors employ computational polymer modeling of G1 chromosomes, then implement a hierarchical model of replication origin firing along these polymers to examine how the G1 chromosome structural state is perturbed by replisome progression. Their results indicate that replication origins create 'fountains' - Hi-C map features that other groups have demonstrated are likely to originate from symmetric extrusion by condensin / cohesin complexes originating at a fixed point. These 'fountains' appear to be cohesin-independent, as revealed by depletion Hi-C experiments. Finally, the authors provide evidence from their model of a 'replication wave' that emanates from the spindle pole body. This is an interesting manuscript that raises some exciting questions for the field to follow up on.

      Reviewer #4 (Evidence, reproducibility and clarity (Required)):

      In their manuscript, "Genome-wide modeling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes," authors Asaro et al perform computational modeling analyses to address an important open question in the chromatin field: how is DNA replication timing coupled to 3D genome architecture? Over the past ten years, the convergence of high-resolution replication timing (RT) analysis with high-resolution 3D genome mapping (e.g. 'Hi-C' technology) has resulted in the discovery that replication timing domains overlap considerably with 3D genomic domains such as topologically associating domains (TADs). How and why this happens both remain unknown, and advances in 3D genome mapping technology have provided even more data to model the problem of both 1) scheduling replication from distinct series of origins / initiation zones, and 2) modeling how 3D genome architecture is altered by the progression of replication forks, which inherently destroy chromatin structure before faithfully reforming G1 structures on daughter chromatids. As such, the problem being tackled by this computational manuscript is interesting.

      We thank Reviewer 4 for her/his positive evaluation of our work and her/his comments that help us to greatly improve the manuscript.

      Reviewer Comments / Significance

      In their manuscript, "Genome-wide modeling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes," authors D’Asaro et al perform computational modeling analyses to address an important open question in the chromatin field: how is DNA replication timing coupled to 3D genome architecture? Over the past ten years, the convergence of high-resolution replication timing (RT) analysis with high-resolution 3D genome mapping (e.g. 'Hi-C' technology) has resulted in the discovery that replication timing domains overlap considerably with 3D genomic domains such as topologically associating domains (TADs). How and why this happens both remain unknown, and advances in 3D genome mapping technology have provided even more data to model the problem of both 1) scheduling replication from distinct series of origins / initiation zones, and 2) modeling how 3D genome architecture is altered by the progression of replication forks, which inherently destroy chromatin structure before faithfully reforming G1 structures on daughter chromatids. As such, the problem being tackled by this computational manuscript is interesting.

      D’Asaro et al focus on the problem of how genome structure is altered by the progression of replisomes through S-phase in the budding yeast S. cerevisiae. The authors employ computational polymer modeling of G1 chromosomes, then implement a hierarchical model of replication origin firing along these polymers to examine how the G1 chromosome structural state is perturbed by replisome progression. Their results indicate that replication origins create 'fountains' - Hi-C map features that other groups have demonstrated are likely to originate from symmetric extrusion by condesin / cohesin complexes originating at a fixed point. These 'fountains' appear to be cohesin-independent, as revealed by depletion Hi-C experiments. Finally, the authors provide evidence from their model of a 'replication wave' that emanates from the spindle pole body. This is an interesting manuscript that raises some exciting questions for the field to follow up on.

      Major Comments

      There is a tremendous amount of work coupling RT domains to 3D genome architecture, especially deriving from the ENCODE and 4D Nucleome consortia. These studies are not adequately highlighted in the introduction and discussion of this manuscript, and this treatment of the literature would ideally be amended in any revised manuscript.

      We include new sentences in the introduction to discuss more in detail the correlation between 3D genome architecture and replication timing program, and advancement in this field in the last decades. We also included additional citations to reviews and publications (ref [8-16]). These references were also included at the end of the Discussion where we address the exciting perspective of employing our model in higher eukaryotes and potentially tackle the complex interplay between 3D nuclear compartmentalization and replication dynamics (see also response 1 to Reviewer 1).

      S. cerevisiae origins of replication differ from metazoan origins of replication in that they are sequence-defined and are known to fire in a largely deterministic pattern (see classic study PMID11588253). From the methods of the authors it is not clear that the known deterministic firing pattern is being used here, but instead a stochastic sampling method? Please clarify in the manuscript. Specifically, it would be good to understand how the Initiation Probability Landscape Signal correlates with what is already known about origin firing timing.

      In our model, the positions of origins are stochastically sampled proportionally to the IPLS which was inferred directly from experimental MRT (ref. [63]) and RFD (ref. [44]). This modeling approach allows reproducing with a very high accuracy the known replication timing data (correlation of 0.96) and Fork directionality data (correlation of 0.91) (see ref. [71]). Origins were defined as the peaks in the IPLS signal. In Fig S3, we extensively compare these origins and the known ARS positions from the Oridb database. For example, most of our early origins (96%) are located close to known, confirmed ARS. Moreover, even if our algorithm is stochastic for origin firing, we remark that each early origin will fire in 90 % of the simulations, coherent with the quasi-deterministic pattern of origin firing and experimental MRT and RFD data. We now have added such statistics of firing in the revised manuscript (Page 4).

      It seems possible that experimental sister chromatid Hi-C data (PMID32968250) and nanopore replicon data (PMID35240057) could be used to further ascertain the validity of some of the findings of this paper. Specifically, could the authors demonstrate evidence in sister chromatid Hi-C data that the replisome is in fact extruding sister chromatids? Moreover, are the interactions being measured specifically in cis (as opposed to trans sister contacts)? For the nanopore replicon data, how do replicon length, replication timing, and position along the replication 'wave' correlate?

      We thank the reviewer for the suggestions.

      Hopelessly there is currently no Sister-C data available during S-phase. In the seminal study (PMID32968250), cells were arrested in G2/M via nocodazole treatment. For a different unpublished work, we already analysed in detail the SisterC dataset and we did not observe clear fountain-like signature, consistent with our own G2/M Hi-C maps (cdc20) where fountains were absent. Note that, in the present work, in order to compare our predictions with standard HiC data, we included all contacts (cis and trans chromatids), mapping pairwise contacts from distinct replicated sequences/monomers to a single bin (see also response to comment 17 to Reviewer 3 and new Fig. S25).

      We now mention in the Discussion that Sister-C data during S-phase could help monitoring the role of replisomes on relative sister-chromatids organization (Page 15).

      Main results from the nanopore replicon data study include the observed high symmetry between sister forks and their linear progression, as the density of replicons appears to be uniform with respect to their length. Since these two specific constraints are already present in the framework of Arbona et al. (ref. [63]), our model is able to reproduce these features of DNA replication captured by the nanopore data.

      Moreover, as we model with very high accuracy replication timing data (see response to comment 2) and forks positioning, we can assume that our formalism well captures replicon positioning and lengths observed in vivo.

      As this study does not include any additional exploration or variation of the parameters inferred by Arbona et al. (ref. [63]), we consider a quantitative comparison with the nanopore replicon data to be beyond the scope of this paper.

      Minor Comments:

      The paper is in most places easy to follow. However, Section C bucked this trend and in general was quite difficult to follow. We would recommend that the authors try to revise this section to make clearer the actual physical parameters that govern a 'replication wave' and the formation of replication foci - how many forks, the extent to which the sisters are coordinated, etc for early vs. late replicating regions.

      We now state more clearly with a sentence in the main text the driving forces behind the formation of such a “replication wave”. We believe that the several additions and clarifications following the various comments, improved the clarity of the manuscri

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #4

      Evidence, reproducibility and clarity

      In their manuscript, "Genome-wide modeling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes," authors Asaro et al perform computational modeling analyses to address an important open question in the chromatin field: how is DNA replication timing coupled to 3D genome architecture? Over the past ten years, the convergence of high-resolution replication timing (RT) analysis with high-resolution 3D genome mapping (e.g. 'Hi-C' technology) has resulted in the discovery that replication timing domains overlap considerably with 3D genomic domains such as topologically associating domains (TADs). How and why this happens both remain unknown, and advances in 3D genome mapping technology have provided even more data to model the problem of both 1) scheduling replication from distinct series of origins / initiation zones, and 2) modeling how 3D genome architecture is altered by the progression of replication forks, which inherently destroy chromatin structure before faithfully reforming G1 structures on daughter chromatids. As such, the problem being tackled by this computational manuscript is interesting.

      Reviewer Comments / Significance

      In their manuscript, "Genome-wide modeling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes," authors Asaro et al perform computational modeling analyses to address an important open question in the chromatin field: how is DNA replication timing coupled to 3D genome architecture? Over the past ten years, the convergence of high-resolution replication timing (RT) analysis with high-resolution 3D genome mapping (e.g. 'Hi-C' technology) has resulted in the discovery that replication timing domains overlap considerably with 3D genomic domains such as topologically associating domains (TADs). How and why this happens both remain unknown, and advances in 3D genome mapping technology have provided even more data to model the problem of both 1) scheduling replication from distinct series of origins / initiation zones, and 2) modeling how 3D genome architecture is altered by the progression of replication forks, which inherently destroy chromatin structure before faithfully reforming G1 structures on daughter chromatids. As such, the problem being tackled by this computational manuscript is interesting.

      Asaro et al focus on the problem of how genome structure is altered by the progression of replisomes through S-phase in the budding yeast S. cerevisiae. The authors employ computational polymer modeling of G1 chromosomes, then implement a hierarchical model of replication origin firing along these polymers to examine how the G1 chromosome structural state is perturbed by replisome progression. Their results indicate that replication origins create 'fountains' - Hi-C map features that other groups have demonstrated are likely to originate from symmetric extrusion by condesin / cohesin complexes originating at a fixed point. These 'fountains' appear to be cohesin-independent, as revealed by depletion Hi-C experiments. Finally, the authors provide evidence from their model of a 'replication wave' that emanates from the spindle pole body. This is an interesting manuscript that raises some exciting questions for the field to follow up on.

      Major Comments

      • There is a tremendous amount of work coupling RT domains to 3D genome architecture, especially deriving from the ENCODE and 4D Nucleome consortia. These studies are not adequately highlighted in the introduction and discussion of this manuscript, and this treatment of the literature would ideally be amended in any revised manuscript.
      • S. cerevisiae origins of replication differ from metazoan origins of replication in that they are sequence-defined and are known to fire in a largely deterministic pattern (see classic study PMID11588253). From the methods of the authors it is not clear that the known deterministic firing pattern is being used here, but instead a stochastic sampling method? Please clarify in the manuscript. Specifically, it would be good to understand how the Initiation Probability Landscape Signal correlates with what is already known about origin firing timing.
      • It seems possible that experimental sister chromatid Hi-C data (PMID32968250) and nanopore replicon data (PMID35240057) could be used to further ascertain the validity of some of the findings of this paper. Specifically, could the authors demonstrate evidence in sister chromatid Hi-C data that the replisome is in fact extruding sister chromatids? Moreover, are the interactions being measured specifically in cis (as opposed to trans sister contacts)? For the nanopore replicon data, how do replicon length, replication timing, and position along the replication 'wave' correlate?

      Minor Comments:

      • The paper is in most places easy to follow. However, Section C bucked this trend and in general was quite difficult to follow. We would recommend that the authors try to revise this section to make clearer the actual physical parameters that govern a 'replication wave' and the formation of replication foci - how many forks, the extent to which the sisters are coordinated, etc for early vs. late replicating regions.

      Significance

      Asaro et al focus on the problem of how genome structure is altered by the progression of replisomes through S-phase in the budding yeast S. cerevisiae. The authors employ computational polymer modeling of G1 chromosomes, then implement a hierarchical model of replication origin firing along these polymers to examine how the G1 chromosome structural state is perturbed by replisome progression. Their results indicate that replication origins create 'fountains' - Hi-C map features that other groups have demonstrated are likely to originate from symmetric extrusion by condesin / cohesin complexes originating at a fixed point. These 'fountains' appear to be cohesin-independent, as revealed by depletion Hi-C experiments. Finally, the authors provide evidence from their model of a 'replication wave' that emanates from the spindle pole body. This is an interesting manuscript that raises some exciting questions for the field to follow up on.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      The paper "Genome-wide modelling of DNA replication in space and time confirms the emergence of replication specific patterns in vivo in eukaryotes" by D'Asaro et. al presents new computational and experimental results on the dynamics of genome replication in yeast. The authors present whole-nucleus scale simulations using a kinetic Monte Carlo polymer physics model. New HiC data for synchronised yeast samples with different protein knock-downs are also presented.

      The main questions which the paper addresses are whether sister forks remain associated during replication, whether there is more general clustering of replication forks, and whether replication occurs in a 'spatial wave' through the nucleus. While the authors' model data are not able to conclusively show whether sister forks remain co-localised, the work provides some important insights which will be of high interest to the field.

      I have no major issues with the paper, only some minor comments and suggestions to improve the readability of the manuscript or provide additional detail which will be of interest to readers. I list these here in the order in which they appear in the paper. There are also a number of typos and grammatical issues through the text, so I recommend thorough proofreading.

      1. The paper seems to be aimed at a broad interdisciplinary audience of biophysicists and molecular biologists. For this reason, the introduction could be expanded slightly to include some more background on DNA replication, the key players and terminology. Also, it seems that this work builds on previous modelling work (Ref. 19), so a bit more detail of what was done there, and what is new here would be helpful. The final paragraph the introduction mentions chromosome features such as TADs and loops, which should be explained in more detail.
      2. In the first results section, end of p2, the "typical brush-like architecture" is mentioned. This is not well explained, some additional detail or a diagram might help.
      3. On p3-4, some previous work is described, with Pearson correlations of 0.86 and 0.94 are mentioned. What cases these two different values correspond to is not clear.
      4. In section II-A-2, on the modelling details, it should be made clearer that the nucleus volume is kept constant, and that this is an approximation since typically the nucleus grows during S-phase. This is discussed in the Methods section, but it would be useful to also mention it here (and give some justification was to why it will not likely change the results).
      5. Fig 2. The text in Fig 2B is much smaller than other panels and difficult to read. Also Fig 3B, Fig 6.
      6. In 2E, are the times given above each map the range which is averaged over? This could be clearer in the caption. In the caption it stated that these are 'observed over expected'; what the 'expected' is could be clearer.
      7. In section II-B-2, the authors state that the cells are fixed 20 mins after release from S-phase. Can they comment on the rational behind this choice, since from Fig 2 their simulations predict that the fountain pattern will no-longer be visible by that time.
      8. Section II-B-2(b) could be clearer. I don't understand what the conclusion the authors take from the metaphase arrest maps is. I'm not sure why they discuss again the Cdc45-depleted cells here, since this was already covered in the previous section.
      9. At the start of p8 (II-B-3) there is a discussion of the mapping to times to the early-S stage experiments. This could have more explanation. I don't follow what the issue is, or the process which has been used to do the mapping. From Fig 2B, it seems that the simulation time is already mapped well to real time.
      10. In Fig 4A above each plot there is a cartoon showing the fork scenario. The left-hand cartoon is rendered properly, but the right-hand one has overlapping black boxes which I don't think should be there. These black boxes are present in many other figures (4B, 3B, 2E etc).
      11. In II-C-2(b) it is mentioned that the number of forks within RFis is always assumed to be even. This discussion could be clearer. In particular, the authors state that under both fork scenarios, in the simulations they can detect odd numbers of forks within RFis - how can this happen in the case where sister forks are held together?
      12. Fig 6B and C, it would be useful if the same scale was used on both plots.
      13. Section II-D-1. There is a discussion on the presence of catenated chains; I did not understand how the replicated DNA becomes catenated, and what this actually means in this context. The way the process is described and the snapshots in Fig2C do not suggest that the chains are catenated. Some further discussion or a diagram would be useful here.
      14. On p14 (section III) there is a section discussing possible mechanisms for sister fork interactions, and that result that Ctf4 might not play a role in this, as previously suggested. Are there any other candidate proteins which could be tested in the future?
      15. As on p14, second paragraph: there is a sentence "replication wave [51] cannot be easily visualised at the single cell level.", which seems to contradict the discussion on p9 "such a "wave" can also be observed at the level of an individual trajectory (Video S3,4) even if much more stochastic." I think more explanation is needed here.
      16. In the methods section, p18, it is mentioned that the volume fraction is 3%. I assume this is before replication, and so after replication is complete this will increase to 6%. This should be stated more explicitly, with also a comment on the 5% volume fraction used in the time-scale mapping discussed on p17.
      17. On p20, processing of simulated HiC using cooltools is discussed. For readers unfamiliar with this software, a bit more detail should be given. Specifically, how does the normalisation account for having some segments which have been replicated and some which have not. Later on the same page (IV-C-2) two different strategies for comparing HiC maps are given; why are two different methods required, and what is the reasoning in each case?
      18. The references section has an unusual formatting with journal names underlined.

      Significance

      The work has been conducted thoroughly, and in general the paper is well written with good attention to detail. As far as I am aware, this is the first study where replication is simulated in a whole nucleus context, and the scale of the simulations is impressive. This allows the authors to address questions on replication foci and the spatiotemporal organisation of replication which would not be possible with more limited simulations, and to compare the model with previous experimental work. This, together with the new HiC data, I think this makes this a strong paper which will be of interested to biophysics and molecular biology researchers; the manuscript is written such that it would suit a interdisciplinary basic research audience.

    4. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      The manuscript by D'Asaro et al. investigates the relationship between DNA replication and chromatin organization using polymer simulations. While this is primarily a simulation-based study, the authors also present relevant comparisons with experimental data and explore mechanistic aspects of replication fork interactions.

      The primary weakness is that many aspects are not clear from the manuscript. Below is a list of questions that the authors must clarify:

      1. In the Model and Methods section, it is written "Arbitrarily, we choose the backbone to be divided into two equally long arms, in random directions." It is unclear what is meant by "backbone to be divided" and "two equally long arms." Does this refer to replication?
      2. In chromosome 12, since the length inside the nucleolus (rDNA) is finite, the entry and exit points should be constrained. Have the authors applied any relevant constraint in the model?
      3. What is the rationale for normalizing the experimental and simulation results by dividing by the respective P_intra(s = 10 kb)?
      4. In the sentence "For instance, chromosomes are strictly bound by the strong potential to localize between 250 and 320 nm from the SPB," is it 320 or 325 nm? Is there a typo?
      5. Please list the number of beads in each chromosome and the location of the centromere beads.
      6. In Eq. 7, when the Euclidean distance between the sister forks d_ij > 50 nm, the energy becomes more and more negative. This implies that the preferred state of sister forks is at distances much greater than 50 nm. Then how is "co-localization of sister forks" maintained?
      7. The section on "non-specific fork interactions" is unclear. You state that the interaction is between "all the replication forks in the system," but f_ij is non-zero only for second nearest-neighbors. The whole subsection needs clarification.
      8. Eq. 6 has no H_{sister-forks}. Is this a typo?
      9. While discussing the published work, the authors may cite the recent paper [https://doi.org/10.1103/PhysRevE.111.054413].
      10. It is not clear how the authors actually increase the length of new DNA in a time-dependent manner. For example, when a new monomer is added near the replication origin (green bead in Fig. 3C), what happens to the red and blue polymer segments? Do they get shifted? How do the authors take into account self-avoidance while adding a new monomer? These details are not clear.
      11. How do the authors ensure that monomers get added at a rate corresponding to velocity v? The manuscript mentions "1 MCS = 0.075 msec," but in how many MC steps is a new monomer added? How is it decided?
      12. The authors stress the relevance of loop extrusion. However, in their polymer simulation, the newly replicated chromatin does not form any loops. Is this consistent with what is known?
      13. Please add a color bar to Fig. 4B.
      14. In the MSD plot (Fig. 6), even though it appears to be a log-log plot, the exponents are not computed. Typically, exponents define the dynamics.
      15. The dynamics will depend on the precise nature of interactions, such as the presence or absence of loop extrusion. If the authors present dynamics without extrusion, is it likely to be correct?

      Significance

      1. The topic is relevant and the problem being addressed is very interesting. While there has been some earlier work in this area, the polymer simulation approach used here is novel.
      2. The simulation methodology is technically sound and appropriate for the problem. Results are novel.
      3. The authors compare their simulations with experimental data and explore both interacting and non-interacting replication forks.
      4. Most conclusions are supported by the data presented.
    5. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      By developing a new genome-wide 3D polymer simulation framework, D'Asaro et al. investigated the spatiotemporal interplay between DNA replication and chromatin organization in budding yeast: (1) T The simulations recapitulate fountain-like chromatin patterns around early replication origins, driven by colocalized sister replication forks. These findings align with Repli-HiC observations in human and mouse cells, yet the authors advance the field by demonstrating that these patterns are independent of Cohesin and Ctf4, underscoring replication itself as the primary driver. (2) Simulations reveal a replication "wave" where forks initially cluster near the spindle pole body (SPB) and redistribute during S-phase. While this spatial reorganization mirrors microscopy-derived replication foci (RFis), discrepancies in cluster sizes compared to super-resolution data suggest unresolved mechanistic nuances. (3) Replication transiently reduces chromatin mobility, attributed to sister chromatid intertwining rather than active forks. This work bridges replication timing, 3D genome architecture, and chromatin dynamics, offering a quantitative framework to dissect replication-driven structural changes. This work provides additional insights into how replication shapes nuclear organization and vice versa, with implications for genome stability and regulation. However, the following revisions could strengthen the manuscript:

      Major:

      1. Generalizability to Other Species While the model successfully recapitulates yeast replication, its applicability to larger genomes (e.g., mammals) remains unclear. Testing the model against (Repli-HiC/ in situ HiC, and Repli-seq) data from other eukaryotes (particularly in mammalian cells) could enhance its broader relevance.
      2. Validation with Repli-HiC or Time-Resolved Techniques The Hi-C data in early S-phase supports the model, but the intensity of replication-specific chromatin interactions is faint, which could be further validated using Repli-HiC, which captures interactions around replication forks. Alternatively, ChIA-PET or HiChIP targeting core component(s) (eg. PCNA or GINS) of replisomes may also solidify the coupling of sister replication forks.
      3. Interactions Between Convergent Forks The study focuses on sister-forks but overlooks convergent forks (forks moving toward each other from adjacent origins), whose coupling has been observed in Repli-HiC. Could the simulation detect the coupling of convergent fork dynamics?
      4. Unexpected Increase in Fountain Intensity in Cohesin/Ctf4 Knockouts In Fig.3A, a schematic illustrating the cell treatment would improve clarity.

      In Sccl- and Ctf4-depleted cells, fountain signals persist or even intensify (Fig. 3A). This counterintuitive result warrants deeper investigation. Could the authors provide any suggestions or discussions? Potential explanations may include: Compensatory mechanisms (e.g., other replisome proteins stabilizing sister-forks). Altered chromatin mobility in mutants, enhancing Hi-C signal resolution. Artifacts from incomplete depletion (western blots for Sccl/Ctf4 levels should be included). 5. Inconsistent Figure References Several figure citations are mismatched. For instance, Fig. S1A has not been cited in the manuscript. Moreover, there is no Fig.1E in figure 1, while it has been cited in the text. All figure/panel references must be cross-checked and corrected.

      Minor:

      1. Page2: "While G1 chromosomes lack of structural features such as TADs or loops [3]" However, Micro-C captures chromatin loops, although much smaller than those in mammalian cells, within budding yeast.
      2. In figure 2E, chromatin fountain signals can be readily observed in the fork coupling situation and movement can also be observed. However, the authors should indicate the location of DNA replication termination sites and show some examples at certain loci but not only the aggregated analysis.

      Significance

      General assessment:

      This study provides a valuable computational framework for investigating the dynamic interplay between DNA replication and 3D genome architecture. While the current implementation focuses on Saccharomyces cerevisiae, whose genome organization differs significantly from mammalian systems.

      Advance: providing the first in vivo experimental evidence in investigating the role(s) of Cohesin and Ctf4 in the coupling of sister replication forks.

      Audience: broad interests; including DNA replication, 3D genome structure, and basic research

      Expertise: DNA replication and DNA damage repair within the chromatin environment.

    1. AbstractChevreul is an open-source R Bioconductor package and interactive R Shiny app for processing and visualization of single cell RNA sequencing (scRNA-seq) data. It differs from other scRNA- seq analysis packages in its ease of use, its capacity to analyze full-length RNA sequencing data for exon coverage and transcript isoform inference, and its support for batch correction. Chevreul enables exploratory analysis of scRNA-seq data using Bioconductor SingleCellExperiment or Seurat objects. Simple processing functions with sensible default settings enable batch integration, quality control filtering, read count normalization and transformation, dimensionality reduction, clustering at a range of resolutions, and cluster marker gene identification. Processed data can be visualized in an interactive R Shiny app with dynamically linked plots. Expression of gene or transcript features can be displayed on PCA, tSNE, and UMAP embeddings, heatmaps, or violin plots while differential expression can be evaluated with several statistical tests without extensive programming. Existing analysis tools do not provide specialized tools for isoform-level analysis or alternative splicing detection. By enabling isoform-level expression analysis for differential expression, dimensionality reduction and batch integration, Chevreul empowers researchers without prior programming experience to analyze full-length scRNA-seq data.Data availability A test dataset formatted as a SingleCellExperiment object can be found at https://github.com/cobriniklab/chevreuldata.

      Reviewer 1. Dr. Luyi Tian and Dr. Hongke Peng

      Is there a clear statement of need explaining what problems the software is designed to solve and who the target audience is? Yes. Thus, the statement of need is well-defined, addressing both the problem (complexity of scRNA-seq data analysis without programming skills) and the intended audience (non-programming researchers in the field).

      Additional Comments: This study provides Chevreul, a Bioconductor package, for analysis and visualization of single-cell sequencing data. This package contains a shinny app. It also provide the functions which implemented by a set of bioconductor packages for standard scRNA-seq analysis to generate the necessary input of the shinny app. I believe that this app can provide an additional option for researchers who work with single-cell data. However, there might be a few comments need addressing.

      While the title emphasizes "exploratory analysis of full-length single-cell sequencing," the authors do not explicitly mention the analysis full-length data (e.g., isoform detection or quantification). For instance, the “sce_process(...)” pipeline figure lacks specific steps addressing full-length sequencing workflows. To strengthen this claim, the authors might need to mention/summarize the methods for isoform detection and quantification, for both annotated and novel ones. It would be better to specify recommended tools for transcript-level analysis (e.g., transcript assembly or differential isoform usage) that integrate with Chevreul's visualization features. Meanwhile, The manuscript focuses on Smart-seq as the representative full-length method. It might also be helpful to discuss other full-length methods such as ONT nanopore sequencing or PacBio, in aspect of data processing, transcript assembly, de novel usage or potential challenges in adapting Chevreul to these platforms, etc.

      There is another minor suggestion. Functions mentioned in the text and Figure 1 (e.g., “sce_process”, “sce_integrate”) should include parentheses (e.g., “sce_process()”) to align with R syntax conventions and clarify their roles as package functions.

      Re-review: I am happy with the revision and author have fully addressed my concerns.

      Reviewer 2. Dr.Tianhang Lv

      Is there a clear statement of need explaining what problems the software is designed to solve and who the target audience is? Yes. Chevreul provides tools for exploratory analysis of single-cell data and offers essential tools for the analysis and visualization of single-cell full-length transcriptomes. In several sections of the article, the authors discuss the key computational challenges addressed by this software. However, in the abstract, they need to emphasize the advantages of Chevreul in single-cell full-length transcript analysis (the current version lacks sufficient description). In the "Statement of Need" section, the authors could also highlight the limitations of existing single-cell full-length transcript analysis tools and introduce the advantages of Chevreul in this regard.

      Is installation/deployment sufficiently outlined in the paper and documentation, and does it proceed as outlined?

      Yes. Although the authors have provided installation documentation, the current documentation on GitHub is not user-friendly. For example, the page at https://github.com/cobriniklab/chevreul does not include code for importing seuratTools, yet it runs the built-in function clustering_workflow from seuratTools. Additionally, the current documentation is overly simplistic and not accessible to those without programming experience.

      Is the documentation provided clear and user friendly?

      No. The authors have separated the example workflows for SingleCellExperiment objects and Seurat objects into two different GitHub projects, which is not conducive for users to understand the structure of Chevreul or to facilitate learning. Additionally, the batch integration mentioned in the article lacks specific implementation examples. The authors should at least provide implementation examples for the results mentioned in the manuscript. Furthermore, the current documentation needs further refinement to truly enable individuals without programming expertise to easily analyze single-cell data.

      Is there a clearly-stated list of dependencies, and is the core functionality of the software documented to a satisfactory level?

      No. The authors have developed an excellent Shiny app for single-cell visualization, enabling users without programming expertise to freely export visualization results from single-cell analysis. The installation commands provided by the authors on https://github.com/cobriniklab/chevreul do indeed allow for the installation of Chevreul. However, Chevreul involves nearly 300 dependency packages, including sub-libraries developed by the authors (seuratTools, chevreulPlot, chevreuldata, chevreulPlot, chevreulProcess, chevreulShiny) as dependencies. Relying solely on the installation commands provided by the authors to install all dependency packages may result in some packages (especially large ones) failing to install due to network bandwidth issues, which is not user-friendly for those without programming experience. Additionally, could the numerous dependency packages of Chevreul potentially cause dependency conflicts with existing R environments? Should the authors recommend users to deploy Chevreul in a new R environment? It is recommended that the authors provide a step-by-step installation guide, explaining potential issues and solutions during the installation process based on the dependencies of Chevreul and its sub-libraries. By installing dependency packages step by step, users can gradually complete the installation of Chevreul. The current installation documentation is clearly not user-friendly for non-programmers and does not align with the authors' statement in the manuscript: "It differs from other scRNAseq analysis packages in its ease of installation and use." At present, the installation documentation provided by the authors may not meet the original design intent of Chevreul. Additionally, the authors should specify that Chevreul supports Seurat version V5.

      Have any claims of performance been sufficiently tested and compared to other commonly-used packages?

      No. The authors could provide specifications for the minimum hardware requirements needed to run Chevreul, such as the number of CPU cores and the amount of memory. Additionally, the authors could offer data on the runtime of Chevreul as the volume of data increases.

      Is automated testing used or are there manual steps described so that the functionality of the software can be verified? No.

      Additional Comment. The authors have developed an R Shiny app for single-cell exploratory data analysis, which will significantly expand the application scenarios of single-cell data analysis and bring great benefits to a wide range of biology practitioners. The large size of Chevreul's installation package indicates the considerable difficulty in its development, reflecting the immense wisdom and effort the authors have invested in creating this package. Chevreul's advantages in visualization and analysis are evident, and if further developed and refined, it is certain to attract even more users in the future. To ensure that such an excellent package as Chevreul can be easily and quickly adopted by users, several suggestions for improving the documentation and enhancing user-friendliness are provided. We hope the authors can refine the package based on the reviewers' feedback and recommendations.

      Re-review: I have carefully reviewed the revised manuscript and am satisfied that all my comments have been adequately addressed. The authors have resolved the software errors reported in the original submission by updating the relevant shiny app modules. They have also enhanced the package documentation to assist users without programming experience in installing and using Chevreul. In the manuscript itself, the authors have provided detailed responses and explanations to each of my points.

      Overall, they have addressed all of my comments thoroughly. That said, a few minor issues remain in the manuscript (revised version with tracked changes) that should be corrected to ensure consistency with academic publishing standards and to help readers better learn how to use Chevreul: 1. On line 52, the placeholder “(doi reference for Shayler et al. data to be provided)” appears—did the authors forget to insert the citation or data link? 2. On line 96, would it be more appropriate to replace “SingleCellExperiments” with “SingleCellExperiment objects”? 3. On line 119, please add a space so that “databases[19–21]used” reads “databases [19–21] used.” 4. For consistency, should the second occurrence of “batchelor” on line 132 be italicized? 5. The Chevreul link is already cited in the “Availability & Implementation” section and need not be repeated in the Figure 1 legend. 6. On line 184, the gene symbol “NRL” should be set in italic Latin script. 7. On the GitHub page (https://github.com/cobriniklab/chevreul), the phrase “A demo with a developing human retina scRNA-seq dataset from Shayler et al. is available here” points to an inaccessible web demo. Restoring this demo in a future update would greatly facilitate experimental biologists in learning and using Chevreul.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Munday, Rosello, and colleagues compared predictions from a group of experts in epidemiology with predictions from two mathematical models on the question of how many Ebola cases would be reported in different geographical zones over the next month. Their study ran from November 2019 to March 2020 during the Ebola virus outbreak in the Democratic Republic of the Congo. Their key result concerned predicted numbers of cases in a defined set of zones. They found that neither the ensemble of models nor the group of experts produced consistently better predictions. Similarly, neither model performed consistently better than the other, and no expert's predictions were consistently better than the others. Experts were also able to specify other zones in which they expected to see cases in the next month. For this part of the analysis, experts consistently outperformed the models. In March, the final month of the analysis, the models' accuracy was lower than in other months and consistently poorer than the experts' predictions. 

      A strength of the analysis is the use of consistent methodology to elicit predictions from experts during an outbreak that can be compared to observations, and that are comparable to predictions from the models. Results were elicited for a specified group of zones, and experts were also able to suggest other zones that were expected to have diagnosed cases. This likely replicates the type of advice being sought by policymakers during an outbreak. 

      A potential weakness is that the authors included only two models in their ensemble. Ensembles of greater numbers of models might tend to produce better predictions. The authors do not address whether a greater number of models could outperform the experts. 

      The elicitation was performed in four months near the end of the outbreak. The authors address some of the implications of this. A potential challenge to the transferability of this result is that the experts' understanding of local idiosyncrasies in transmission may have improved over the course of the outbreak. The model did not have this improvement over time. The comparison of models to experts may therefore not be applicable to the early stages of an outbreak when expert opinions may be less welltuned. 

      This research has important implications for both researchers and policy-makers. Mathematical models produce clearly-described predictions that will later be compared to observed outcomes. When model predictions differ greatly from observations, this harms trust in the models, but alternative forms of prediction are seldom so clearly articulated or accurately assessed. If models are discredited without proper assessment of alternatives then we risk losing a valuable source of information that can help guide public health responses. From an academic perspective, this research can help to guide methods for combining expert opinion with model outputs, such as considering how experts can inform models' prior distributions and how model outputs can inform experts' opinions. 

      Reviewer #2 (Public review):

      Summary: 

      The manuscript by Munday et al. presents real-time predictions of geographic spread during an Ebola epidemic in north-eastern DRC. Predictions were elicited from individual experts engaged in outbreak response and from two mathematical models. The authors found comparable performance between experts and models overall, although the models outperformed experts in a few dimensions. 

      Strengths: 

      Both individual experts and mathematical models are commonly used to support outbreak response but rarely used together. The manuscript presents an in-depth analysis of the accuracy and decision-relevance of the information provided by each source individually and in combination. 

      Weaknesses: 

      A few minor methodological details are currently missing.

      We thank the reviewers for taking the time to consider our paper and for their positive reflections and suggestions for our study. We recognise and endorse their characterisation of the study in the public reviews and are greatful for their interest and support for this work. 

      Reviewer #1 (Recommendations For The Authors): 

      I initially found Table 1 difficult to interpret. In the final two columns, the rows relate to each other but in the other columns, rows within months don't relate to each other. Could this be made clearer? 

      Thank you for your helpful suggestion. We agree that this is a little confusing and have now added vertical dividers to the table to indicate which parts of the table relate to each other.

      In Figure 1A, the colours are the same as in the colour-bar for Figure 1B but don't have the same meaning. Could different colours be used or could Figure 1A have its own colour-bar to aid clarity? 

      Thank you for your query. The colours are not the same pallette, but we appreciate that they look very similar. To help the reader we have changed the colour palette of panel A and added a legend to the left.  

      In Figure 3, can labels for each expert be aligned horizontally, rather than moving above and below the timeline each month? 

      Thank you for your perspective on this. We made the concious dicision to desplay the experts in this way as it allows the timeline to be presented in a shorter horizontal space. We appreciate that others may prefer a different design, but we are happy with this one. 

      On lines 292 and 293, the authors state that experts were less confident that case numbers would cross higher thresholds. It seems that this would be inevitable given the number of cases is cumulative. Could this be clarified, please? 

      Thank you for raising this point. We agree that this wording is confusing. We have now reworked the entire section in response to another reviewer. The equivalent section now reads: 

      Experts correctly identified Mabalako as the highest-risk HZ in December. They attributed an average 82% probability of exceeding 2 cases; Mabalako reported 38 cases that month, exceeding all thresholds, although the probability assigned to exceeding the higher thresholds was similar to that of Beni (3 cases)

      Reviewer #2 (Recommendations For The Authors): 

      (1) Some methodological details seem to be missing. Most importantly, the results present multiple ensembles (experts, models, and both), but I can't seem to find anywhere in the Methods that details how these ensembles are calculated. Also, I think it would be useful to define the variables in each equation. It would have been easier to connect the equations to the description if the variables were cited explicitly in the text. 

      Thank you for pointing out these omissions. We have included the following paragraph to detail how ensemble forecasts were calculated. 

      “Enslemble forecasts

      Ensemble forecasts were calculated as an average of the probabilities attributed by the members of the ensemble. For the expert ensemble the arithmetic mean was calculated across all experts with equal weighting. Similarly the model ensemble used the unweighted mean of the model forecasts. For the mixed (model and expert) ensemble, the mean was weighted such that the combined weight of the experts forecasts and the combined weight of the models forecasts were equal.”

      (2) Overall, I think the results provide a strong analysis of model vs. expert performance. However, some sections were highly detailed (e.g., the text usually discusses results for every month and all health zones), which clouded my ability to see the salient points. For example, I found it difficult to follow all the details about expert/model predictions vs. observations in the "Expert panel and health zones..." subsection; instead, the graphical illustration of predictions vs. observations in Figure 4 was much easier to interpret. Perhaps some of these details could be trimmed or moved to the supplementary material. 

      Thank you for your honest feedback on this point. We have shortened this section to highlight the key points that we feel are the most important. We have also simplified the text where we discuss the health zones nominated by experts. 

      (3) Figure 5C is a nice visualization of the fallibility of relying on a single individual expert (or model). I wonder if it would be useful to summarize these results into the probability that a randomly selected expert outperforms a single model. Is it the case that a single expert is more unreliable than a single model? The discussion emphasizes the importance of ensembles and compares a single model to an ensemble of experts, but eliciting predictions from multiple experts may not always be possible. 

      Thank you for raising this. We agree that this is an important point that eliciting expert opinions is not a trivial task and should not be taken for granted. We agree with the principle of your suggestion that it would be useful to understand how the models compare to indevidual experts. We don’t however believe that an additional analysis would add sufficiently more information than already shown in Figure 5, which already displays the full distribution of indevidual experts for each month and threshold. If you would like to try this analysis yourself, the relevant data (the indevidual score for each combination of expert, threshold, heal zone and month) is included in the github repo (https://github.com/epiforecasts/Ebola-Expert-Elicitation/blob/main/outputs/indevidual_results_with_scores.csv).

      Minor comments: 

      (1) Figure 2: the color scales in each panel are meant to represent different places, correct? The figure might be easier to interpret if the colors used were different.  

      Thank you for bringing this to our attention. We have now changed the palette of panel A to differ from panel B.  

      (2) Equation 7: is o(c>c_thresh) meant to be the indicator function (i.e. 1 if c>c_thresh) and 0 otherwise)? 

      Thanks for raising this. The function o is the same as in the previous equation – an observation count function. We appreciate that this is not immediately clear so have added a sentence to explain the notation after the equation.

      (3) Table 1: a brief description of the column headers would be useful.  

      Thank you for the suggestion. We have now extended the table caption to include more description of the columns. 

      “Table 1: Experts and health zones included in each round of the survey. The left part of the table details the experts interviewed (highlighted in green) the health zones included in the main survey in each month. In addition, the right part of the table details the health zones nominated by experts and the number of experts that nominated each one.”

    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      The manuscript by Quétin et al "Transient hypoxia followed by progressive reoxygenation is required for efficient skeletal muscle repair through Rev-ERBα modulation" describes the nature of muscle stem cell (MuSC) differentiation within its hypoxic niche using in vivo, ex vivo and in vitro methodologies. Approaches to limit oxygen in a regenerating model of muscle injury showed that muscle oxygenation is necessary for proper muscle repair. They found that the lack of oxygen is associated with the formation of hypotrophic myofibers, due to the inability of MuSCs to differentiate and fuse. Their findings show that the phenotype was independent of HIF-1α. However, RNA-seq of MuSCs 7 day post injury from prolonged hypoxia was shown to have significantly increased circadian clock gene Rev-erbα expression. Pharmacological inhibition of Rev-erbα during hypoxia rescued the myogenic phenotype. Contrarily, the use of Rev-erbα agonist in normoxia impaired the fusion capacity of MuSCs and decreases the number of large mature myofibres. This manuscript is well written and very easy to follow. Though, there are certain shortcomings outlined below. Sometimes the evidence provided does not support the conclusions made. For example, more rigour should be performed to state that there is a self-renewal phenotype.

      Major issues

      1. In Figure 1, why were these timepoints chosen? Is the hypoxia more severe between days 0 and 5 (i.e. when MuSCs begin their activation).
      2. "From 5 to 28 dpi, pimonidazole adduct intensity gradually declined, demonstrating a progressive reoxygenation after transient hypoxia during muscle repair (Fig. 1E and 1F) that correlates with progressive restoration of the vascular network (Fig. 1C) and MuSC return into quiescence (Fig. 1B and 1D)." For this statement, correlating these events to MuSC returning to quiescence might not be appropriate. As Figure 1D shows all the Pax7+ cells, it does not reflect whether they are quiescent. Thus, the timelines might not actually match up with the proportion of self-renewed MuSCs?
      3. The manuscript cites far too many review articles (at least half) and not primary sources. Also, some citations are misrepresented. For example: Reference #13 does not show that HIF-1alpha level increases during muscle injury in rodents, Reference #15 shows fusion is impaired in hypoxic c2c12 cells, not promotion of quiescence, Reference #22 does not support the claim that hypoxia induces myostatin expression, only that myostatin inhibits MyoD expression.
      4. Figure 1E and 1F, does the dye intensity change with it being more accessible to the muscle during early injury as opposed to later recovery. Also, when using the probe for hypoxia determination, the whole tissue is fluorescing intensely suggesting potential non specificity. It would be prudent to use markers of hypoxia on western blots or gene expression to corroborate this data.
      5. a) It is well known that CTX injury does not cause damage to the vasculature but directly to the muscle (Tatsumi et al doi:10.1002/stem.2639; Ramadasan-Nair et al doi:10.1074/jbc.M113.493270; Ohtsubo et al. doi: 10.1016/j.biocel.2017.02.005; Wang et al doi: 10.3390/ijms232113380). How do the authors reconcile their findings that there is vasculature damage with CTX (Fig. 1C).

      b) Moreover, the endothelial cell staining (Fig. 1B) appears to be unchanged in the time course of injury. To prove vascular damage this data should be corroborated, for example with lectin perfusion. 6. Problems with Figure 3J. There are data points with zero clusters/isolated myofibres suggesting that the hypoxic environment caused MuSCs to not activate from quiescence. There are several outliers for example at 1% there is a zero reading that makes the data significant. 7. In Figure 1G, Loxl2 after 14 days appears to be significant, as the error bars at 0 and 14 days do not overlap and thus it does not return to normal. An n=3 is not sufficient, as one of the data points at 14 days appears to be an outlier (the data stretching from 1500 to 3000). 8. In Fig. 2C and 2D, there are no control CSA and myofiber diameter experiments for keeping the mice in hypoxia over 14 and 28 days without injury. 9. For Figure 3K, how can self-renewing MuSCs be distinguished from MuSCs that never activated? Especially in the 1% O2 condition where few clusters formed. How does hypoxia influence activation? A 4hr or 8hr timepoint is necessary, as well as 24hrs. Also, for Figure 5E and 5F, it is possible that HIFcKO allowed the cells to activate normally, thus explaining the shift from quiescence to activation in the read-outs. This further highlights the importance of analyzing earlier timepoints. One cannot state that these cells are self-renewing or returning to quiescence without performing experiments on earlier timepoints. 10. The data for Figure 4 does not suggest that transient reoxygenation is required "for proper skeletal muscle repair" as stated by the authors only that reoxygenation has rescued the phenotype in the primary myoblasts. There is no hypoxia in the control (8% O2) for regeneration to occur (Fig. 2B). 11. One cannot rule out metabolic dysregulation. It's true that glycolytic fibers are generally larger than oxidative, it is likely that that alone does not explain the difference in fiber size. However, the fact that the fibers are more glycolytic does suggest a metabolic shift in the muscle (which was the aim of the experiment), which could also shift MuSC character altering their behaviour. How are MuSCs metabolically responding to hypoxia? 12. In Figure 2, how can one be sure that reoxygenation is blocked by the hypoxic chamber? Reduced O2 levels will induce hypoxia, but one cannot state that it blocks reoxygenation without further validation such as using pimonidazole as in Fig. 1E. If reoxygenation is blocked, then pimonidazole staining should remain consistent throughout the injury. 13. For Figure 3G, is a sum appropriate for the graph? Proportions would be more appropriate as cell number is not equal as shown in figure 3E. Can Pax7+/MyoD+ be defined as differentiated? By day 7, many MuSCs will have fused and be expressing MyoG, which is not accounted for by these definitions. Did systemic hypoxia increase self-renewal or impair activation? How can you distinguish these two? 14. In Figure 6A, while it is interesting that Pax7 levels are elevated in hypoxia and differentiation and fusion markers are down at 7days, it does not necessarily mean that self-renewal is increased. It might suggest that the hypoxic cells might have never activated or might have differentiated precociously. Are any cell cycle genes down regulated? Any other genes involved in quiescence altered? 15. The use of pimonidazole in Fig. 1E shows the staining within fibers (many with centrally located nuclei). These nuclei are differentiating and not representative of expanding MuSCs. How do the authors reconcile these MuSCs as part of their population.

      Minor Problems

      1. In the introduction, the line "Vascular alterations result in reduced oxygen (O2) levels, disrupting cell homeostasis and contributing to many diseases" is not always true as vascular alterations do not always result in reduced oxygen levels. For example, in angiogenesis there is no reduction of O2. This line should better reflect this.
      2. In the introduction, Paragraph 2, line 9 change "quiescence thought HIF-1α" to "quiescence through HIF-1α".
      3. Paragraph 3, line 8: "lead" instead of "leads"
      4. It is not sure how important the connection between capillary density and Pax7+ cell number is. Both are presumed to occur at the same time in muscle, so both will recover concurrently. To state that it is a coupled response is overstating the evidence presented.
      5. Figure 1B the colour-labels for Pax7 and Dapi over lap with the border.
      6. In the Introduction, the following sentence does not follow the previous sentence: "In vivo, Majmundar and colleagues show that HIF-1a in MuSCs negatively regulates myogenesis by decreasing myogenic differentiation".
      7. In the Introduction, the following statement is not accurate "Hypoxia can also alter myogenic differentiation and myotube formation by inhibiting p21 (as known as p21 and CDKN1A) that leads to an accumulation of the retinoblastoma protein Rb24", for what was found in the reference. The authors should correct this statement.
      8. Paragraph 3, line 5: "as known as p21 and CDKN1A" should perhaps read "also known as CDKN1A"
      9. The following statement is not supported by the results: "Strikingly, the most abundant and intense pimonidazole staining is detected on CTX-injured TAs at 5 dpi, indicating that myogenic cell expansion is initiated in a hypoxic environment in situ (Fig. 1D-1F)." MuSCs are activated and expanding from time zero to 5 days according to Figure 1D.
      10. "....Since glycolytic fibers are larger than oxidative fibers, ...." citation missing
      11. An inconsistent finding is that the authors show that protein synthesis rates are normal between normoxia and hypoxia of regenerating muscle (suppl. Fig. 1E), yet the capacity of protein synthesis is found to be higher in oxidative muscle fibres compared to glycolytic fibers (Van Wessel et al, doi: 10.1007/s00421-010-1545-0), which are formed during regeneration (Fig. 2G and 2H).
      12. Some figure legends that describe graphs do not denote the number of samples or mice used.
      13. In Figure 1C, 1D and 1F what is being compared to obtain statistical significance?
      14. The font size of many figures is too small to follow.
      15. Confusion for the results of figure 3G. Labels in the text do not reflect the labels in figure (which cannot be read anyway because the font is too small). Why is Ki67 used as a marker for activation versus proliferation.
      16. The physiological O2 concentration is 8%, do the authors know what the hypoxic O2 concentration is in the injured environment. Why did they choose hypoxic O2 concentration at 1% for ex vivo and invitro experiments? Why did they choose 10% for the in vivo experiment?
      17. For Figure 2H it is not appropriate to state that type IIA ratio was reduced with hypoxia, as the results show no statistical significance.
      18. For Figure legend 3K, are the cell number/fiber the sums per one mouse or the sum from all mice combined for each condition?
      19. For Figure 3B and 3E "concomitantly with their proliferation peak" seems to imply that hypoxia in Pax7+ cells peaks alongside proliferation, but the evidence doesn't support that conclusion. More timepoints would be needed to show that 5 dpi is truly the peak of hypoxia in Pax7+ cells.
      20. For Figure legend 4E, should read "MHC" not "MCH"
      21. In Figure 4C there is no gap between the significance bar.
      22. In Figure legend 5G, "Experience design" should read "Experimental design"
      23. Representative images Fig 3I and 5E are poor quality.
      24. Confusing statement "In the same way, this presence of smaller myofibers under prolonged hypoxia could not be explain by the glycolytic fiber-type switch from type-IIA to type-IIB, as observed in pathological context of COPD or peripheral arterial disease (PAD), since type-IIB are the largest myofibers in mice."

      Referees cross-commenting

      I agree with the thoughtful reviews and issues raised by Reviewers 1 and 2. I do not have anything more to add.

      Significance

      General Assessment: This manuscript is well written and easy to follow. It rigorously investigates the influence of oxygenation on MuSC behaviour. The authors utilize in vivo, ex vivo, and in vitro models to support their study and executed their work to a high degree. A limitation is that all experiments are only performed in mice and might not be applicable in humans. In addition, some claims made by the authors were over-reaching. The study can be improved by further validating some of the authors' claims, as has been suggested in the review.

      Advance: This study is the first to report the effect of hypoxia on MuSCs in an ex vivo culture and in vivo injury model using a hypoxia chamber. This study helps clarify the role of HIF-1α on MuSC behaviour by suggesting that it does have a role in MuSC fate decisions. Finally, the authors make a novel link between circadian rhythm and MuSC behaviour in hypoxia.

      Audience: A specialized audience that is interested in myogenesis, muscle stem cells, and/or hypoxia will be interested in this study. It highlights the important role of oxygen in muscle regeneration and may help researchers understand the role of oxygen in MuSC fate decisions.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      The manuscript, Transient hypoxia followed by progressive reoxygenation is required for efficient skeletal muscle repair through Rev-ERBa modulation, revisits the role of hypoxia in skeletal muscle regeneration after acute injury. They first nicely demonstrate, using the pimonidazole hypoxia probe, that during regeneration skeletal muscle is transiently hypoxic at 5 days post injury (DPI). Then they show skeletal muscle regeneration is impaired in mice housed in a hypoxic (10% 02) chamber; the regenerated muscle mass is smaller, due to smaller regenerated myofibers and there is a shift in myofiber type so that there are more IIB myofibers. In addition, at 7 DPI when mice are raised in a hypoxic environment there is a shift in muscle stem cells so that they are more proliferative and fewer have differentiated. Ex vivo experiments culturing muscle stem cells in association with EDL myofibers in 1% 02, as compared with 8% 02, also led to fewer differentiated Pax7-MyoD+ cells, but could be restored if 02 was subsequently increased to 8%. They also found that low oxygen inhibited myoblast fusion in vitro. They then tested, via Pax7CreERT2/+;HIF-1afl/fl, whether HIF-1a signaling mediated the response of muscle stem cells to hypoxia in vivo. Surprisingly, they found that loss of HIF-1 did not impair myofiber regeneration in normoxic or hypoxic conditions, but they do provide some data suggesting that HIF-1a is required for the hypoxic-induced increase in Pax7+MyoD- muscle stem cells. Bulk RNA-seq analysis of 7 DPI muscle from mice housed in normoxic versus hypoxic conditions uncovered the interesting mis-regulation of circadian rhythm associated genes - in particular, the circadian clock repressor Rev-ERBa. Using a pharmacological antagonist of Rev-ERBa they show in culture that blocking Rev-ERBa (in contrast to loss of HIF-1a) rescues the fusion defect of muscle stem cells cultured in 1% 02. Conversely, they show that a Rev-ERBa agonist inhibits fusion in 8% 02. Altogether, the paper provides interesting new data on the controversial role of hypoxia and HIF-1a as well as data suggesting a connection between hypoxia and circadian rhythm genes. The data is logical and well presented, and the paper will be of strong interest to the regeneration and skeletal muscle research communities. I have two major comments and a list of smaller suggestions to improve the manuscript.

      Major comments:

      1. In vivo experiments (presented in Figures 2, 3, 5, 6, 7) house mice in hypoxic (10% oxygen) chambers, and the authors suggest that this blocks the progressive reoxygenation of skeletal muscle during regeneration. Surprisingly, the authors do not test when the mice are in hypoxic chambers whether, in fact, skeletal muscle is hypoxic at homeostasis and whether during regeneration muscle experiences prolonged hypoxia. The obvious experiment would be to use the pimonidazole probe on skeletal muscle sections of muscle at homeostasis and at 0, 5, 6, 14, and 28 DPI CTX injury in mice housed in hypoxic chambers. Without some demonstration that skeletal muscle oxygenation is changed when the mice are housed in hypoxic chambers, it is impossible to interpret these experiments.

      2. The authors claim that reducing reoxygenation by maintaining the mice under systemic hypoxia impairs skeletal muscle repair by limiting the differentiation and fusion capacity of MuSCs in HIF-1a-independent manner, while it favors their return into quiescence through HIF-1a activation. They provide some in vitro evidence that Hif1ais required for the high levels Pax7+MyoD- muscle stem cells in 1% O2. They should also show that the elevated levels of Pax7+ muscle stem cells at 7 DPI (seen in Fig. 3D-G) requires HIF1a via analysis of Pax7CreERT2/+;HIF-1afl/fl mice.

      Minor comments:

      1. Please provide a reference for the pimonidazole probe. Reference 26, Hardy et al., is not the right one.

      2. Please provide references that Loxl-2, Pdgfb, and Ang2 are HIF-inducible target genes.

      3. Fig. 2C shows changes in average myofiber diameter. How was this calculated? Is this the largest diameter? Is there a reason that cross-sectional area was not measured (the more standard measurement)? Also, generally this type of data is shown as bar graphs - which is how these data are shown in Fig. 5C. Please also show the data in Fig. 2C as bar graphs.

      4. Please provide reference for 8% 02 being physioxia in culture.

      5. Fig.5 should also quantify the number of centronuclei/myofiber (as in Fig. 2I) for Pax7CreERT2/+;HIF-1afl/fl mice 14 and 28 DPI - to further demonstrate that differentiation defects in hypoxia are HIF-1a independent.

      6. Please provide a graphical model of your research findings.

      7. There are many typos and verb tense issues. Please fix these. The most amusing is Stinkingly in the Discussion.

      Referees cross-commenting

      I think several important issues are raised by myself and reviewer 3. First, the authors need to explain and support their use of 10% O2 hypoxia in vivo chambers and 1% O2 for hypoxic in vitro experiments. Second, the authors have not demonstrated that reoxygenation of muscle is prevented in mice raised in hypoxic chamber. There are questions about how well the pimonidazole probe is working (the widespread expression at 5 dpi in Fig. 1E suggests there may be specificity issues) and this probe is also not shown for muscle from mice living in hypoxic chambers. Another method of demonstrating hypoxia in muscle tissue would be useful.

      Significance

      The paper provides interesting new data on the controversial role of hypoxia and HIF-1a as well as data suggesting a connection between hypoxia and circadian rhythm genes.

      This paper will be of interest to researchers studying the role of hypoxia on regeneration and also to researchers studying muscle regeneration.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      SUMMARY

      Quétin et al investigated the dynamics of oxygen levels during the skeletal muscle regeneration following sterile damage and its impact on muscle repair. They combined in vivo and ex-vivo model systems, together with genetic and pharmacological manipulations. They found results consistent with the fact that a dynamic oxygeneation process, hypoxia during the early phase followed by reoxygenation, are involved in muscle repair. Prolonged hypoxia leads to defective myogenesis and muscle repair. These activities apper to be meadiated by modulation of Rev-ERBα levels. Collectively, the study provide intriguing insight regarding the role of oxygen in muscle repair.

      MAJOR COMMENTS

      1. In Figure 1, the 5 days post CTX injury is too late to claim that "myogenic cell expansion is initiated in a hypoxic environment". Indeed, at day 5 myofibers are already regenerated, although immature. To support their claim, the authors should perform analyses and quantification of Pax7+, Pax7+Ki67+ and hypoxia at earlier timepoints.

      2. In Figure 2B, a larger number of mononuclear cells is present in hypoxia mice. Is hypoxia affecting the number/activity of extra-muscular cells important for muscle regeneration like for example FAPs, macrophages, etc?

      3. In Figure 5H, the myotubes formed by HIF-1α cKO appear thinner than control myotubes. Is myotube size affected by lack of HIF1 α?

      4. The choice of the 7 days post CTX for the RNA-seq is odd. Indeed, at that timepoint there are obvious histological abnormalities in hypoxia mice. Hence, it is highly likely that many DEGs are simply secondary to the defect in regeneration and not directly linked to hypoxia exposure. This is probably the reason why the authors found so many (close to 4K) DEGs. To focus on the genes closely-associated to the primary defect, the authors should have performed the RNA-seq at an earlier timepoint, in which minimal histological defects were present. While repeating the RNA-seq would be costly and time consuming, the authors could at least address this issue by RT-qPCR. Are muscle stem cell fate, repair, and circadian clock genes significantly altered 3 and 5 days after CTX injury in hypoxia vs normoxia?

      5. Given that compounds have frequently off-target effects, the authors must independently support their Rev-ERBα findings by performing genetic manipulations, at least ex-vivo.

      6. A recent study (PMID: 38333911), which was not cited by the authors, reports muscle atrophy and weakness, impaired muscle regeneration, and increased fibrosis in hypoxia exposed mice. Intriguingly, this was due to impaired MuSC proliferation and differentiation following HIF-2α stabilization under hypoxia. Hence, the authors should investigate if HIF-2α plays any role in the phenotypes they describe. For example, is HIF-2α a regulator of circadian clock genes expression?

      Referees cross-commenting

      The other reviewers raised very relevant issues and I fully agree with their comments. In particular, I concur with Reviewer #3 that in several instances the evidence provided by the authors does not support the conclusions made.

      Significance

      SIGNIFICANCE

      There is a limited knowledge regarding the role of oxygen supply during tissue differentiation and repair. In the muscle field, there are conflicting reports in the literature. This study combines genetic, pharmacological and oxygen manipulations both in vivo and ex-vivo to investigate the role of oxygen during regeneration following sterile skeletal muscle injury. The results are very intriguing and potentially relevant both for muscle, but possibly also for other tissue repair. Aspects of the study that must be improved concern the role of HIF-1a and HIF-2α in the process, and the characterization of the molecular mechanism through which Rev-ERBα is regulated by oxygen and regulates muscle repair.

      • AUDIENCE: specialized, basic research, translational research; results could potentially extend beyond the muscle field.

      • FIELD OF EXPERTISE: muscle differentiation, muscular dystrophy, gene expression regulation.

    1. Author response:

      (1) We will clarify statements comparing regeneration and developmental processes. Additionally, we will include a new supplemental figure with published data showing that the pou4-2 clone dd_Smed_v6_30562_0_1 (cross-referenced as SMED30002016) is expressed during stages corresponding to organ development in Schmidtea mediterranea (https://planosphere.stowers.org/feature/Schmidtea/mediterranea-sexual/transcript/SMED30002016).

      (2) We will reorganize the figures by combining Figures 3 and 4 for improved clarity.

      (3) We will address experimental and interpretive concerns regarding the role of atonal in the pou4-2 gene regulatory network.

    1. Reviewer #2 (Public review):

      Summary:

      This manuscript presents compelling evidence for a novel anti-inflammatory function of glycoprotein non-metastatic melanoma protein B (GPNMB) in chondrocyte biology and osteoarthritis (OA) pathology. Through a combination of in vitro, ex vivo, and in vivo models, including the destabilization of the medial meniscus (DMM) surgery in mice, the authors demonstrate that GPNMB expression is upregulated in OA-affected cartilage and that recombinant GPNMB treatment reduces the expression of key catabolic markers (MMPs, Adamts-4, and IL-6) without impairing anabolic gene expression. Notably, DBA/2J mice lacking functional GPNMB exhibit exacerbated cartilage degradation post-injury. Mechanistically, GPNMB appears to mitigate inflammation via the MAPK/ERK pathway. Overall, the work is thorough, methodologically sound, and significantly advances our understanding of GPNMB as a protective modulator in osteoarthritic joint disease. The findings could open pathways for therapeutic development.

      Strengths:

      (1) Clear hypothesis addressing a well-defined knowledge gap.

      (2) Robust and multi-modal experimental design: includes human, mouse, cell-line, explant, and surgical OA models.

      (3) Elegant use of DBA/2J GPNMB-deficient mice to mimic endogenous loss-of-function.

      (4) Mechanistic insight provided through MAPK signaling analysis.

      (5) Statistical analysis appears rigorous, and figures are informative.

      Weaknesses:

      (1) Clarify the strain background of the DBA/2J GPNMB+ mice: While DBA/2J GPNMB+ is described as a control, it would help to explicitly state whether these are transgenically rescued mice or another background strain. Are they littermates, congenic, or a separate colony?

      (2) Provide exact sample sizes and variance in all figure legends: Some figures (e.g., Figure 2 panels) do not consistently mention how many replicates were used (biological vs. technical) for each experimental group. Standardizing this across all panels would improve reproducibility.

      (3) Expand on potential sex differences: The DMM model is applied only in male mice, which is noted in the methods. It would be helpful if the authors added 1-2 lines in the discussion acknowledging potential sex-based differences in OA progression and GPNMB function.

      (4) Visual clarity in schematic (Figure 7): The proposed mechanism is helpful, but the text within the schematic is somewhat dense and could be made more readable with spacing or enlarged font. Also, label the MAPK/ERK pathway explicitly in panel B.

    1. P <0.05. In H1, AI marketing-> customer loyalty, the results show a significance where (β = 0.111, t = 2.053, P= 0.041) thus H1 is supported. In the second hypothesis, AI marketing->customer perceived with path coefficient (β = 0.522, t = 11.515, P = 0.000) thus, H2 is confirmed. In hypothesis 3, customer perceived value-> customer loyalty with path coefficient (β = 0.681, t = 15.038, P = 0.000) is highly significant thus, H3 is supported. Finally, in hypothesis 4 AI marketing-> customer perceived value-> customer loyalty with (β = 0.355, t = 9.620, P = 0.000) therefore, H4is supported

      I took AP stats so i have a general understanding of this for the results of the study. The key finding that is important to the CTAP pt. 2 is that Ai marketing positively influences costumer loyalty as seen with the p = 0.041 making it statistically significant. Besides that, one hinderance to the results of the study can be linked back to the method is which the data was obtained. Because it was collected using convenience sampling it cant be generalized outside of Iraq making it limited on what it could be used for.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      This study investigates how ant group demographics influence nest structures and group behaviors of Camponotus fellah ants, a ground-dwelling carpenter ant species (found locally in Israel) that build subterranean nest structures. Using a quasi-2D cell filled with artificial sand, the authors perform two complementary sets of experiments to try to link group behavior and nest structure: first, the authors place a mated queen and several pupae into their cell and observe the structures that emerge both before and after the pupae eclose (i.e., "colony maturation" experiments); second, the authors create small groups (of 5,10, or 15 ants, each including a queen) within a narrow age range (i.e., "fixed demographic" experiments) to explore the dependence of age on construction. Some of the fixed demographic instantiations included a manually induced catastrophic collapse event; the authors then compared emergency repair behavior to natural nest creation. Finally, the authors introduce a modified logistic growth model to describe the time-dependent nest area. The modification introduces parameters that allow for age-dependent behavior, and the authors use their fixed demographic experiments to set these parameters, and then apply the model to interpret the behavior of the colony maturation experiments. The main results of this paper are that for natural nest construction, nest areas, and morphologies depend on the age demographics of ants in the experiments: younger ants create larger nests and angled tunnels, while older ants tend to dig less and build predominantly vertical tunnels; in contrast, emergency response seems to elicit digging in ants of all ages to repair the nest.

      We sincerely thank Reviewer #1 for the time and effort dedicated to our manuscript's detailed review and assessment. The revision suggestions were constructive, and we have provided a point-by-point response to address them.

      Reviewer #2 (Public review):

      I enjoyed this paper and the approach to examining an accepted wisdom of ants determining overall density by employing age polyethism that would reduce the computational complexity required to match nest size with population (although I have some questions about the requirement that growth is infinite in such a solution). Moreover, the realization that models of collective behaviour may be inappropriate in many systems in which agents (or individuals) differ in the behavioural rules they employ, according to age, location, or information state. This is especially important in a system like social insects, typically held as a classic example of individual-as-subservient to whole, and therefore most likely to employ universal rules of behaviour. The current paper demonstrates a potentially continuous age-related change in target behaviour (excavation), and suggests an elegant and minimal solution to the requirement for building according to need in ants, avoiding the invocation of potentially complex cognitive mechanisms, or information states that all individuals must have access to in order to have an adaptive excavation output.

      We sincerely thank reviewer #2 for the time and effort dedicated to our manuscript's detailed review and assessment. We have provided a point-by-point response to the reviewer's comments, which we have incorporated into the revised version of the manuscript.

      The only real reservation I have is in the question of how this relationship could hold in properly mature colonies in which there is (presumably) a balance between the birth and death of older workers. Would the prediction be that the young ants still dig, or would there be a cessation of digging by young ants because the area is already sufficient? Another way of asking this is to ask whether the innate amount of digging that young ants do is in any way affected by the overall spatial size of the colony. If it is, then we are back to a problem of perfect information - how do the young ants know how big the overall colony is? Perhaps using density as a proxy? Alternatively, if the young ants do not modify their digging, wouldn't the colony become continuously larger? As a non-expert in social insects, I may be misunderstanding and it may be already addressed in the citations used.

      We thank the reviewer for this interesting question. We find that the nest excavation is predominantly performed by the younger ants in the nest, and the nest area increase is followed by an increase in the population. However, if the young ants dig unrestricted, this could result in unnecessary nest growth as suggested by reviewer #2. Therefore, we believe that the innate digging behavior of ants could potentially be regulated by various cues such as;

      (a) Density-based: If the colony becomes less dense as its area expands, this could serve as a feedback signal for young ants to reduce or stop digging, as described in references (25, 29, 30).

      (b) Pheromone depositions: If the colony reaches a certain population density, pheromone signals could inhibit further digging by young ants, references (25, 29), or space usage as a proxy for the nest area. 

      Thus, rather than perfect information, decentralized control, and digging-based local cues probably regulate the level of age-dependent digging, without the ants needing to estimate the overall colony size or nest area.

      In any case, this is an excellent paper. The modelling approach is excellent and compelling, also allowing extrapolation to other group sizes and even other species. This to me is the main strength of the paper, as the answer to the question of whether it is younger or older ants that primarily excavate nests could have been answered by an individual tracking approach (albeit there are practical limitations to this, especially in the observation nest setup, as the authors point out). The analysis of the tunnel structure is also an important piece of the puzzle, and I really like the overall study.

      We thank the reviewer for the comments. We completely agree that individual tracking of ants within our experimental setup would have been the ideal approach, but we were limited by technical and practical limitations of the setup, as pointed out by the reviewer, such as; 

      (a) Continuous tracking of ants in our nests would have required a camera to be positioned at all times in front of the nest, which necessitates a light background. Since Camponotus fellah ants are subterranean, we aimed to allow them to perform nest excavation in conditions as close to their natural dark environment as possible. Additionally, implementing such a system in front of each nest would have reduced the sample sizes for our treatments.

      (b) The experimental duration of our colony maturation and fixed demographics experiments extended for up to six months (unprecedented durations in these kinds of measurements). These naturally limited our ability to conduct individual tracking while maintaining the identity of each ant based on the current design.

      These details are described in detail within the revised version of the manuscript.

      Reviewer #3 (Public review):

      Summary:

      In this study, Harikrishnan Rajendran, Roi Weinberger, Ehud Fonio, and Ofer Feinerman measured the digging behaviours of queens and workers for the first 6 months of colony development, as well as groups of young or old ants. They also provide a quantitative model describing the digging behaviours and allowing predictions. They found that young ants dig more slanted tunnels, while older ants dig more vertically (straight down). This finding is important, as it describes a new form of age polyethism (a division of labour based on age). Age polyethism is described as a "yes or no" mechanism, where individuals perform or not a task according to their age (usually young individuals perform in-nest tasks, and older ones foraging). Here, the way of performing the task is modified, not only the propensity to carry it or not. This data therefore adds in an interesting way to the field of collective behaviours and division of labour.

      The conclusions of the paper are well supported by the data. Measurements of the same individuals over time would have strengthened the claims.

      We sincerely thank reviewer #3 for the time and effort dedicated to our manuscript's detailed review and assessment. We completely agree with the reviewer’s comments on the measurements of the same individuals over time, however, we were limited by the technical and experimental limitations as described above and pointed out by reviewer #2.

      Strengths:

      I find that the measure of behaviour through development is of great value, as those studies are usually done at a specific time point with mature colonies. The description of a behaviour that is modified with age is a notable finding in the world of social insects. The sample sizes are adequate and all the information clearly provided either in the methods or supplementary.

      We thank reviewer #3  for this assessment.

      Weaknesses:

      I think the paper is failing to take into consideration or at least discuss the role of inter-individual variabilities. Tasks have been known to be undertaken by only a few hyper-active individuals for example. Comments on the choice to use averages and the potential roles of variations between individuals are in my opinion lacking. Throughout the paper wording should be modified to refer to the group and not the individuals, as it was the collective digging that was measured. Another issue I had was the use of "mature colony" for colonies with very few individuals and only 6 months of age. Comments on the low number of workers used compared to natural mature colonies would be welcome.

      Regarding the main comment 1

      We completely agree with the reviewer’s comment on considering inter-individual variability based on activity levels. We have discussed how individual morphological variability could influence digging behavior (references: 28, 31), and we will elaborate further on this aspect in future revisions.

      Regarding the main comment 2:

      The term ‘colony maturation’ in our study refers to the progressive development of colonies from a single queen, distinguishing it from experiments that begin with pre-established, demographically stable colonies. We provide a detailed explanation for this terminology in the revised version of the manuscript. We were practically limited by the continuation of the experiments for more than 6 months of age, predominantly due to the stability of nests, as they were made with a sand-soil mix. We also acknowledge that the colony sizes attained in our maturation experiments may be smaller than those of naturally matured colonies. This trend was observed generally in lab-reared colonies and could be attributed to differences in microclimatic conditions, foraging opportunities, space availability, and other factors. We have explicitly described these details in the revised version of the manuscript.

      Reviewer #1 (Recommendations for the authors):

      The experimental design is fantastic. The large quasi-2D should allow for the direct visualization of the movements of individuals and the creation of the nest, and the inclusion of non-workers (specifically, a mated queen and pupae) is new and important. However, I have some questions and concerns about the results, as outlined below. Also, I found the paper difficult to read, and the connections between the various experiments and the model were not always clear. 

      We thank the reviewer for the time and effort dedicated to reviewing our manuscript. We have modified the manuscript substantially to address the comments and readability. 

      The assumption that the digging rate is constant across ants may be a strong one. Previous work (see, for instance, Aguilar, et al, Science 2018) has demonstrated a very heterogeneous workload distribution among ants. I am not sure what implications that may have for the results here, but the authors should comment on this choice. Related to the point above, given a constant digging rate, the variation in digging is attributed to an age-dependent "desired target area". Can the authors comment on the implications of this, specifically in contrast to a variable digging rate? The distinction between digging rate differences and target area differences seems to be important for the authors. However, the way this is presented, it is difficult to fully understand or appreciate this importance and its implications. What is the consequence of this difference, and why is this important?

      We apologize to the reviewer for the confusion.

      Our model does not assume that the digging rate (da/dt, Equation 1) remains constant throughout the experiment. Instead, we only treat the basal digging rate (r) as a constant.

      The variable digging rate (da/dt, Equation 1) is derived by multiplying the basal rate constant (r) by the term (1 - a/a<sub>age</sub>), which accounts for deviations from the age-dependent target area that the ants aim to achieve. This makes the actual digging rate dynamic, as it responds to changes in excavated area (e.g., expansion or rapid collapse)

      For example, according to our model (Equation 1), two ants with the same basal digging rate (r) may exhibit markedly different actual digging rates at a given time if they differ in age. This occurs because the variable digging rate (da/dt) depends not only on ‘r’ but also on the age-dependent term (1 - a/a<sub>age</sub>). Also, we emphasize that the use of a basal digging rate constant aligns with prior studies (refs. 24, 29, 30).

      In our work, we demonstrate that after a collapse event, ants of all ages dig at rates comparable to those observed in the initial (pre-collapse) phase of the experiment. This occurs because the ants are far from their age-dependent target area, effectively resetting their digging behavior. By comparing maximum digging rates pre- and post-collapse, we provide strong empirical evidence that this rate is age-independent (SI Fig. 6A, 6B), supporting the conclusion that the basal digging rate constant (r) is a fundamental property of the ants' behavior, unaffected by age.

      We agree with the reviewer that individual tracking of ants within our experimental setup would have been the ideal approach. Then, we could have taken the inter-individual variability of the digging activity into account. However, we were limited to doing so by the technical and practical limitations of the setup, such as; 

      (a) Continuous tracking of ants in our nests would have required a camera to be positioned at all times in front of the nest, which necessitates a light background. Since Camponotus fellah ants are subterranean, we aimed to allow them to perform nest excavation in conditions as close to their natural dark environment as possible. Additionally, implementing such a system in front of each nest would have reduced the sample sizes for our treatments.

      (b) The experimental duration of our colony maturation experiments extended for up to six months (unprecedented durations in these kinds of measurements). These naturally limited our ability to conduct individual tracking while maintaining the identity of each ant based on the current design.

      In light of these points, the following lines are added to the discussion (line numbers: 283-295), signifying the above points:

      “Our age-dependent model demonstrates that the digging behavior in Camponotus fellah is governed by a basal digging rate constant (r) modulated by the age-dependent feedback (1 − a/aage). Crucially, we show that after a collapse, the maximum digging rates return to their pre-collapse levels, suggesting that this basal rate ’r’ represents an age-independent ceiling on how fast ants can dig, regardless of age or context (SI Fig. 6 A, B). Previous studies have demonstrated both homogeneous and heterogeneous workload distribution, with varying digging rates among ants (24, 29, 30, 35). Studies showing heterogeneous workload distribution relied on continuous individual tracking of ants to quantify digging rates (35). However, this approach was not feasible in our current design due to the experimental durations of both our colony maturation and fixed demographics experiments. Additionally, sample size requirements naturally limited our ability to conduct continuous individual tracking during nest construction in our study. Thus, based on empirical measurements from our fixed-demographics experiments and supported by the age-independent post-collapse digging rates, we adopted a constant basal digging rate for simulating our age-dependent model—an assumption aligned with both prior literature and the collective dynamics observed in our system (24,29,30)”.

      Model: as presented, the model seems to lack independent validation. The model seems to have built-in that there is an age-dependent target area, and this is what is recovered from the model. I am failing to see what is learned from the model that the experiments do not already show. Also, the model has no ant interactions, though ants are eusocial and group size is known to have a large effect on behavior (this is acknowledged by the authors at the beginning of the discussion). Can the authors comment on this?My recommendation would be to remove the model from this paper or improve the text to address the above comments.

      We did not draw the conclusion of the age-dependent target area from our model. We used the fixed demographics experiments to quantify the age-dependent area target as a function of the age of individuals. We then used this age-dependent area target in our model to quantify the excavation dynamics of the colony maturation experiments, where ants span a variety of ages, as the nest population changes over time, resulting in natural variation in the ages of individuals within the nest.  These results could not have been obtained by performing any of the individual experiments, whether colony maturation or the fixed demographics, young or old, on their own. The need for different age demographics was crucial to quantify the age-dependent effects in nest excavation, which were lacking in previous studies. 

      First, the age-dependent model provides a very good estimate for the natural growth of the nest.  More importantly, after fixing an age threshold of 56 days (mean + standard deviation of the young ant age), the model provides an estimate of which ants are doing the majority of the digging during natural nest expansion. This teaches us that during natural expansion, the older ants are far from their density target and therefore do not engage in any substantial digging, which is shown in Figure 4. C. 

      On the other hand, the younger ants are close to their area targets and induced to dig. Indeed, the target area fitted for the age-independent model closely approximates the empirically measured age-dependent target when extrapolated to very young ants. This provides further support for the idea that, in the colony maturation experiments, the youngest ants are responsible for most of the digging.

      Our model is a simple analytical model, inspired by earlier models that used a fixed area target (such as density models) for nest construction. However, because we knew the precise age of workers in our experiments, we were able to obtain age-dependent area targets, thereby challenging the use of a constant area target (as employed in prior studies) in light of our findings from the fixed demographics of young and old colonies.

      Empirically Quantifiable Parameters: We wanted our model to have empirically quantifiable parameters. Since we did not continuously record the experiment, we could not quantify agent-agent interactions, pheromonal depositions, or similar factors.

      Minimal Model Design: We aimed to keep the model as minimal as possible, which is why we did not include complex interactions such as those found in continuous tracking experiments.

      However, the model does set up some interesting hypotheses that could easily be tested with the experimental setup (e.g., marking the ants / tracking individual activity levels). For instance, it is hypothesized that older ants dig less often, but when they do dig, they do so at the same rate. Given the 2D setup, the authors could track individual ants and test this hypothesis. Also, if the desired target area does decrease with age, the authors could verify this hypothesis by placing older ants into arenas with different-sized pre-formed nests to observe how structure is changed to achieve the desired area/ant.

      We thank the reviewer for this comment.

      We believe that the confusion with the usage of a constant basal digging rate is resolved now. To briefly reiterate, ants dig at variable rates that can be decomposed to a (constant on short time scales but age-dependent) basal rate times the (variable) distance from the density target. The suggested experiments are beyond the scope of our current study, and further studies could utilize the suggested experimental design with better time-resolved imaging for individual ant tracking that could verify the predictions from our model. 

      Specific comments:

      Title:

      The title suggests a broad result, yet the study focuses on one ant species. Please modify the title to more accurately reflect the scope of the work.

      We thank the reviewer for the comment.

      The title is modified as “Colony demographics shape nest construction in Camponotus fellah ants.”

      Introduction:

      Important information and context are missing about this ant species. For instance, please add the following about this species in the introduction:

      What is their natural habitat and substrate? How does the artificial soil compare?

      What is their (rough) colony size? [later, discuss experiment group size choice and potential insights/limitations of results when applied to the natural system].

      The details have been added to the introduction (line numbers : 49-55) and the materials and methods section (Study species).

      “Camponotus fellah ants are native to the Near East and North Africa, particularly found in countries like Israel, Egypt, and surrounding arid and semi-arid regions, where they prefer to nest in moist, decaying wood, including tree trunks, branches, or stumps (49,50). The species lives in monogynous colonies with tens to thousands of individuals. Nests are commonly found in a sand-loamy mix, which is a combination of sand, soil, clay, or gravel, providing structural stability and moisture retention (51). They are typically found under rocks, in the crevices of dried vegetation, or dry, sandy soils, sometimes in areas with loose gravel, with a colony size ranging from tens to thousands of workers”.

      What is the natural life expectancy of a worker? A queen? [later, discuss fixed demographic age choices in this context and/or why were age ranges chosen for experiments?].

      The lifespan of ants, including both queens and workers, varies significantly based on caste, species, and environmental conditions.

      (1) Queen Longevity: From the literature, Camponotus fellah queens can live up to 20 years, with one documented case reaching 26 years (50). 

      (2) Worker Longevity: In contrast to queens, the lifespan of workers is much shorter. Lab studies on Camponotus fellah (82) and other Camponotus species (83) suggest that workers can live for several months depending on environmental conditions, colony health, and caste-specific roles (e.g., minor vs. major workers)

      (3) Laboratory vs. Natural Conditions: Worker longevity is highly variable between laboratory and natural conditions

      Therefore, in the context of the old worker lifespan in our experiments, ~200 days (roughly 6–7 months), we strongly believe that the worker lifespan used in our experiments represents a substantial portion of a worker's expected life. While exact figures for C. fellah workers are unavailable, inferences from related species suggest that workers nearing 200 days are approaching the latter stages of their lifespan, making them meaningfully "old". 

      The details are added to the main text (line numbers: 124-127) and discussion (line numbers: 278-282).

      Why was this species chosen? Convenience, or is there something special about this species that the readers should know? Specifically, is there something that might make the results more general or of broader interest?

      Camponotus fellah was chosen for this study because it is native to Israel, making it convenient to collect and maintain in the lab. Additionally, its nuptial flights occur close to the study location, ensuring a steady supply of colonies. We were able to provide them with a nesting substrate similar to what they naturally use, as their nests are typically found in a sand-loamy mix, similar to the sand-soil mix in our artificial nests. This was possible because we had the opportunity to observe their habitat and nesting behavior in the wild, allowing us to gather preliminary information on their natural nesting conditions.

      Results:

      Line 60: "several brood items" - how many exactly? Was this consistent across experiments? Do mated queens ever produce more pupae during the experiments?

      Yes, the number of brood items (5) was added consistently across the experiments. Additionally, the mated queen did produce pupae during the course of the experiments, which was evident from the noticeable increase in the number of workers in the nest. This was significantly higher than the number of brood items present at the start of the study.

      The above points are added to the section (line numbers : 68-69).

      Figure 1: Panel A - The food ports are never mentioned in the text. Are the ants fed during the experiments? If so, what? With what frequency? Is the water column replenished/maintained? If so, how and how often? panel C - how long did this experiment last?

      We thank the reviewer for pointing this out. We have now updated the nest maintenance section in the Materials and Methods (line numbers : 349-354) part to include all the necessary details and clarifications.

      “We provided food to the ants ad libitum through three separate tubes containing water, 20 % sucrose water, and protein food. The protein mixture included egg powder, tuna, prawns, honey, agar, and vitamins. Each of the three tubes was filled with 5 ml of their respective contents and sealed with a cotton stopper to prevent overflow. The tubes were positioned at a slight angle and connected using a custom-made plexiglass adapter to facilitate the flow of liquids. These tubes were replenished once depleted, and regularly replaced once the nest maintenance was carried out bi-weekly.”

      Line 76: "...excavation was commenced by the founding queen". How were the queen and pupae introduced into the system?

      We initiated colony maturation experiments by introducing a single mated queen and several brood items (pupae) at random positions on the soil layer of the nest (line numbers : 68-69)

      Line 87: Please provide bounds for 11cm2/ant value. Is there any biological or physical justification for this number?

      We thank the reviewer for the suggestion. We have now provided the bounds as requested (line numbers : 97-101). 

      We were unable to pinpoint a specific biological justification based solely on this treatment. However, on extrapolating the age-dependent area fit we derived from the fixed demographics experiment, we found that at the age of 1 day, an ant has a target area of approximately 11.17 cm², which is the largest age-dependent area target possible within our experimental setup.

      From the colony maturation experiment, we obtained the value of  11.6 (±1.15) cm² as the area per ant. The consistency between the area per ant obtained from two completely different treatments across different colonies yielded similar results. We propose that under standardized conditions, a 1-day-old ant has a theoretical maximum target area of 11.17 cm²—the highest value observed in our experimental framework.

      Lines 98-99: "one straightforward possibility would be that newborn ants are the ones that dig". This statement contradicts the results presented in Figures 1 and S1 - the population increase seems to occur at least a few days before increased excavation in nearly all cases.

      We apologize for any confusion caused by our initial phrasing. To clarify, we proposed that a lag likely exists between population growth and nest area expansion. This lag could arise from two sequential processes: (1) newborn ants require time to mature and become active (first delay), and (2) digging to expand the nest takes additional time (second delay; estimated at ~10 days from the cross-correlation analysis). Thus, our results suggest that it is not the population that lags behind the area, but rather the area that lags behind the population, as demonstrated in Figures 2D and SI. Figure. S1.

      The sentence “one straightforward possibility would be that newborn ants are the ones that dig” is modified as below (line numbers : 112-119) to prevent further confusion.

      “One possible explanation is that, although all ants are capable of digging, it is primarily the newly emerged ants who perform this task. In this case, nest expansion would lag behind colony growth due to two delays: first, the time needed for young ants to mature enough to begin digging, and second, the physical time required to excavate additional space (e.g., around 10 days). This mechanism could eliminate the need for ants to assess overall colony density, as each new group of active workers simply enlarges the nest as they become ready. An alternative possibility is that all ants, regardless of age, respond to increased density by initiating excavation. In that scenario, nest expansion would follow more immediately after the emergence of new individuals, making delays less prominent (24, 29, 30)”.

      Line 105: How do group sizes compare to natural colony size? Line 106: How do "young" and "old" classifications compare to natural life expectancy?

      We have already addressed this question in an earlier comment. The details are added to the main text (line numbers: 124-127) and discussion (line numbers: 278-282).

      Line 118-119: How are nests artificially collapsed?

      We have added a new section in the Materials and Methods section that describes the nest collapsing procedure (Nest artificial collapse - line numbers : 386-399).

      Figure 2 Panel A: The white dotted line is nearly impossible to see. Please use a more visible color.

      We thank the reviewer for the comment.

      We changed the solid circles to violet and the dotted line color to continuous white.

      Figure 3: The use of circle markers as post-collapse recovery in young and old as well as old pre-collapse is confusing. Use different symbols for old pre-collapse vs young and old post-collapse.

      We thank the reviewer for pointing out the confusion. We have revised the figure markers as suggested and modified the main text accordingly.

      • Young; pre-collapse : star

      • Young; post-collapse : diamond

      • Old; pre-collapse : circle

      • Old; post-collapse: triangle.

      Figure 3 Panel C: Indicate that fixed demographic values here are pre-collapse. Also, as presented, it appears that there is a large group-size dependence that is not commented on. Previous results (Line 87 and Figure 2C) suggest a constant excavation area per ant of 11cm2/ant. Figure 3, panel C appears to suggest a group-size dependence. If these values are divided by group size, is excavated area per ant nearly constant across groups? How does the numerical value compare to the slope from Figure 2C?

      We thank the reviewer for their insightful comments.

      First, we would like to clarify that the area target of 11.1 (±1) cm²/ant, as described in Line 87, was obtained from the colony maturation experiments. In these experiments, we were unable to track the age of each individual ant, so the area target was calculated by normalizing the total excavated area by the number of ants.

      We normalized the excavated area by the group size for both young and old colonies as suggested, and found that the area per ant was not significantly different across the group sizes (see new SI Fig. 5A). This indicates that the excavated area per ant remains relatively constant within each demographic group. Moreover, this shows that the total excavated area is proportional to group size, in agreement with previous works (24, 29, and 30). 

      We have explicitly described the above information in the line numbers: 142-146

      Regarding the slope comparisons, the slope of Figure 2C (10.71), from the colony maturation experiments, is the largest, followed by the area per ant from the short-term young (8.79 ± 0.98) cm²/ant, and short-term old experiments (5.16 ± 0.44) cm²/ant.

      Lines 128-129: "...younger ants aim to approach a higher target area". Seems hard to know what they "aim" to do... rephrase to report what they are observed to do.

      We thank the reviewer for the comment. The sentence is rephrased as suggested (line numbers : 158-161).

      “In the previous sections, we showed that in fixed-demographics experiments, younger ants excavated a significantly larger nest area compared to older ants (Fig. 3. C).  This difference emerged despite similar temporal patterns in digging rates across age groups, with excavation activity peaking within the first 7 days before asymptotically decaying as nest expansion approached saturation (SI Fig. 8).”

      Lines 133-141: The model description is not clear. Specifically, what parameters are ant-dependent? How does A relate to a?

      We appreciate the reviewer's request for clarification. In our model:

      (1) Equation 1 describes the change in the excavated area due to the digging activity of a single ant. Here, the variable 'a' represents the area excavated by one ant. This formulation allows us to capture the individual digging behavior and its impact on the excavation process.

      (2) Equation 2 extends this concept to the total area excavated in the nest, denoted by 'A'. Specifically, 'A' is the sum of the areas excavated by all ants present in the nest. In other words, it aggregates the individual contributions of each ant, linking the microscopic digging behavior to the macroscopic excavation dynamics.

      Therefore, the relationship between 'a' and 'A' is as follows:

      ●     'a' = Area excavated by a single ant.

      ●     'A' = ∑ 'a' (Summed over all ants in the nest).

      We have explicitly mentioned this in the line numbers “ 161-179”, and describe the model assumptions and parameters in detail.

      Figure 4:

      Figure 4, Panel A: The equation quoted in the caption does not match the data in the figure. The equation has a positive slope and negative intercept, while the figure has a negative slope and a positive intercept. Please provide the correct equation and bounds on fit parameters.

      We thank the reviewer for spotting this typing mistake.

      The equation was already updated in the reviewed preprint published online. The correct equation and the fit bound are provided in the figure caption.

      “Target areas decrease linearly with the ant age (y = −0.032x + 11.22 , 95 % CI (Intercept : (-0.035,-0.027), Slope : (10.53,11.91)), R2 = 0.96 ).”

      Figure 4, Panel A: There seem to be three "fixed target area per ant values" in the paper: around 11cm2/ant (line 87), 11.6 cm2/ant (SI Figure 2), and linearly dependent value from fit to Figure 4A. The distinctions between these values and their significance are hard to keep track of. Can the authors add a discussion somewhere that helps the reader better understand? Is there a way to connect/rationalize/explain these different values in terms of demographics?

      We thank the reviewer for the suggestion.We have added a paragraph in the discussion (line numbers : 270-277) describing the area targets.

      “In our colony maturation experiments, we found that area per ant was highest when the workers were youngest, with values around 11.1–11.6 (±1–1.15). This aligns with observations from naturally growing nests, where newly eclosed ants dominate the population and nest volumes are relatively large. Supporting this, fixed-demographics experiments showed that the area excavated per ant declines linearly with worker age, indicating that the youngest ants contribute most to excavation. Notably, the target area we fit for the age-independent model (11.6 ± 1.15) closely matches the extrapolated value for very young workers (Fig. 4. A), reinforcing the idea that young ants are the primary excavators during early colony growth. In contrast, during events like collapses or displacement, when space is urgently needed, ants of all ages participate in excavation.”

      Figure 4, Panel A: What are various symbols and colors for data with error bars? If consistent with Figure 3, then this panel and subsequent model confound two factors: (1) the age dependence and (2) the behavioral differences pre- and post-collapse (structures are different pre-and post-collapse, according to SI Figure 6; line 120: "...colonies ceased digging when they recovered 93{plus minus}3% of the area lost by the manual collapse..."; lines 201-202: "We find significant quantitative and qualitative differences between nests constructed within this natural context and nests constructed in the context of an emergency") and behavior is different (according to SI Figure 7 and line 119: "...all ants dig after collapse...")). Therefore, without further supporting evidence, it does not seem that these data should be used to fit a single line that defines a model parameter a_age for each ant in equation 2.

      The symbols are the area per ant quantified from the fixed demographics of young, and old experiments. The symbols show the following;

      A.  Star - Young, pre-collapse

      B.  Diamond - Young, post-collapse 

      C.  Circle - Old, pre-collapse

      D.  Triangle - Old, post-collapse.

      The details are clearly described in the figure caption. 

      We apologize to the reviewer for the confusion. We argue that the data can be fit by a single line to quantify the parameter ‘a_age’ as follows. 

      A. All data presented in Figure 4A were obtained from the same fixed-demographics experiments (containing only young and old ants) under experimental collapse conditions, pre- and post-collapse. These results, therefore, exclusively reflect emergency nest-building behaviors during emergency scenarios and do not include any observations from natural colony maturation processes.

      B. Age-dependent excavation differences: As correctly noted by the reviewer, the observed difference in excavated area before versus after collapse reflects the natural aging of ants in our experimental colonies. While colonies recovered >90% of lost area post-collapse, the residual variation was not negligible—instead, it systematically correlated with colony age structure. By tracking colonies across this demographic transition, we obtained additional data points spanning a broader developmental spectrum. This extended range strengthened our ability to detect and quantify the linear relationship between worker age and excavation output.

      C.The quoted sentence (lines 201-202, submitted version) refers to comparisons across all three experimental cases: (1) fixed-demographics young ants, (2) fixed-demographics old ants, and (3) the natural scenario (mixed-age colonies). Importantly, these comparisons are based on pre-collapse steady-state excavation areas, ensuring a consistent baseline across treatments. We highlight quantitative and qualitative differences between these distinct experimental groups, not between pre- and post-collapse phases within the same treatment. The pre- and post-collapse data within fixed-demographics groups were analyzed separately to avoid conflating aging effects with emergency responses.

      To avoid confusion, the whole paragraph in the discussion (line numbers : 253-260) is rephrased.

      In lines 201-202; “We find significant quantitative and qualitative differences between nests constructed within this natural context and nests constructed in the context of an emergency”. 

      Here, by natural context, we mean the nests excavated in the colony maturation experiments. We believe that it could have been confusing, and the sentence is modified as answered for the previous question. 

      Figure 4, Panel B: This uses the model with a_age determined by from Figure 4A and the life table (as shown in the supplemental), whereas the supplemental Figure SI 8 uses the fixed blue line a_age value for the model, which comes from the colony maturation experiments. The age-independent model in the supplemental fits the data better, yet the authors claim the supplemental model cannot be applied to the data because of their experimentally determined age-dependent target area. Given the age-independent target area model fits better, additional evidence/justification is needed to support the choice of the model.

      We agree with the reviewer that the age-independent model fits the data well. However, we believe that the fixed area target cannot be used to explain the excavation dynamics for the following reasons.

      We make an important assumption in our model: that the ants rely on local cues and that individual ants can not distinguish between the fixed demographics and colony maturation experiments (line numbers : 161-166). Given this assumption, the ants cannot change their behavior between experiments, meaning the same model should fit all of our results. However, the fixed demographics experiments revealed a significant difference in the areas excavated by young vs. old cohorts, despite having the same group size. If the ants regulated the excavated area based on an age-independent constant density target model, then the excavated area in the fixed demographics of young and old colonies would have been similar. This discrepancy indicates that the target area per ant is not constant, as assumed in the age-independent density model (SI. Fig. 8). We emphasize that while the age-independent model provides a better fit for the excavated area in colony maturation experiments, the age-dependence of excavation is empirically supported by fixed-demographics experiments. Therefore, we implemented this age-dependence through a variable target area within the age-dependent model framework to explain excavation dynamics in the colony maturation experiments.

      These details are explicitly mentioned in the main text (line numbers : 187 - 198)

      Figure 4, Panel C: Is this plot entirely from the model, or are the data points measured from experiments? Please label this more clearly.

      We apologize to the reviewer for the confusion.

      The Figure 4C is based on the age-dependent digging model. We applied the model to population data from the long-term experiments (n = 22). By setting an age threshold of 56 days (since ants used in the short-term young experiment had an average age of 40 ± 16 days), we categorized the ants into young and old groups. We then quantified the area dug by the young ants, the queen, and the old ants in terms of the percentage of the total area excavated. We hypothesized that, because young ants have a lower digging threshold, they would perform the majority of the digging. We indeed confirm this in Figure 4C.

      This information is added to the main text and described in detail (line numbers: 200 - 208).

      Lines 162-165: "...Furthermore, we quantified the area dug by each ant in the normal colony growth experiment as estimated from the age-dependent model and found that all ants excavated more or less the same amount...". Figure 4D shows a distribution with significant values ranges from 1-16 cm2... how is this interpreted as "more or less the same amount" and what is the significance of this?

      We apologise to the reviewer for the confusion.

      We quantified the percentage contribution to the excavated area of each histogram bin (provided in the new SI table: 4), and found that the area excavated between 5 cm² and 13 cm² accounts for 73.76% of the total excavated area. This indicates that most ants dug within this range rather than exhibiting extreme variations. Additionally, the mean excavation amount is 7.84 cm², with a standard deviation of 3.44 cm², meaning that most values fall between 4.4 cm² and 11.28 cm², which aligns well with the 5–13 cm² range. Since the majority of the excavation is concentrated within this narrow interval, and the mean is well centered within it, this suggests that ants excavated more or less the same amount, rather than forming distinct groups with highly different excavation behaviors.

      We have modified the main text (line numbers: 209-216) to include these points.

      The biological significance of this finding is that since all ants in the colony maturation experiments are born inside the nest, we hypothesize that they should excavate similar amounts. To test this, we quantified the area contribution of each ant over the entire duration of the experiment using the age-dependent digging model as described above and found that they indeed excavated more or less the same amount. From our analysis of fixed demographics experiments, we showed that the youngest ants excavate the largest area. Since the majority of the youngest ants participated in the colony maturation experiments, this further supports our hypothesis.

      Figure 5.

      Figure 5, Panels A-C: Please provide a scale bar. 

      The scale bar is provided in the figure as suggested. The algorithm for the cutoffs for tunnel vs wide tunnels is described in detail in the section “Nest skeletonization, segmentation, and orientation.”

      Figure 5, Panel E: Why does the chamber error bar for 5 ants go to zero?

      In Figure 5, E, we plot the standard error, as described in the figure caption. In the experiments, the chamber area contributions were (0,0,39.94,0) respectively. The mean of the 4 numbers is 9.985, the standard deviation is 19.97, and the standard error is 9.985. So, the mean and the standard error are the same, so the lower error bar goes to zero, and the upper error bar goes to 19.97. This implies that in these experiments, the chamber area is often zero.

      Figure 5, Panel I: Why are there no chambers for young colonies in I when they are in the histogram in E?

      We apologize to the reviewer for the confusion. We initially missed adding the chamber orientation data of the young colonies to Panel I, but it has now been included.

      Line 212: "...densities of ants never become too high...". What is too high? Is there some connection to biological or physical constraints?

      Under normal growth conditions, nest volume is kept proportional to the number of ants, ensuring that the density remains within a specific range. This prevents overcrowding, which could otherwise lead to excessively high densities.

      Yes, we believe there is likely a connection to both biological and physical constraints. The proportional relationship between nest volume and the number of ants is likely driven by factors such as:

      (1) Biological Constraints:

      Ant Colony Size: Ants typically adjust their behavior and social structure to maintain an optimal population size relative to available resources and space.Overcrowding could lead to potentially a breakdown in colony function.

      Colony Health: High densities can lead to faster epidemic spread, leading to negative effects on reproduction, foraging efficiency, and overall colony health. By maintaining density within a specific range, the colony can thrive without these adverse effects.

      (2) Physical Constraints:

      Spatial Limitations: The physical space within the nest limits how many ants can occupy it before space becomes constrained. The nest’s structure and size must physically accommodate the ants, and the volume must be large enough to prevent overcrowding, and efficient resource distribution.

      Lines 272 and 302: How often were photos taken? These two statements seem to suggest different data collection rates.

      As stated in line 272, photos were taken every 1 to 3 days. During each photo session, four photos were taken, with each photo separated by 2 seconds, as mentioned in line 302. To avoid confusion, we rephrased the sentence (line numbers: 359-361).

      “We photographed the nest development every 1-3 days. During each photography session, four pictures of the nest were taken, with a 2-second interval between each.”

      Reviewer #2 (Recommendations for the authors):

      Some more minor points/questions/clarifications:

      This might be pedantic, but I don't think the nest serves as the skeleton of the superorganism, while it does change and grow, the analogy becomes weak beyond that point. The skeleton serves to protect the internal organs of the organism, facilitates movement and muscle attachment, and creates new blood cells. I would be more comfortable with a statement that the nest can grow or shrink according to need.

      We sincerely thank the reviewer for their time and effort in providing a detailed review and assessment of our manuscript. A point-by-point response to the comments is provided below.

      The analogy of treating a nest structure to the skeleton of a superorganism was based on the following points;

      (a) Protection: A nest protects the colony on a collective scale. This is analogous to protecting "organs" by a skeletal framework.

      (b) Organization and Division of Space: The skeletal structure organizes the body's internal layout, just as nest structures are organized into various spatial compartments for various colony functions, with specific regions designated for brood chambers, food storage, and waste disposal.

      Thus, we believe that the analogy can still be valid in a metaphorical way.

      Does this statement need justification with a citation, or is that information contained in the subsequent clause? "However, for more complex structures where ants congregate in specific chambers, workers are less likely to assess the overall nest density." The idea that workers do (or do not) assess overall density touches on many issues, including that of perfect information and adaptive responses, that it seems it needs to be well founded in previous work to be stated in such unequivocal terms.

      We thank the reviewer for this comment. The references for this argument are provided in the next sentence. We have now moved these references to the relevant sentence (reference number: 24, 29,30; line number : 30-31 ) 

      Can you give some more information on this statement? "Experiments were terminated either when the queen died or when she became irreversibly trapped after a structural collapse." Why was this collapse irreversible and therefore unlike treatment 2? Did the queen die in these instances? Was this event more likely than in natural colonies? And if so, was there something inherently different about your experiments that limit interpretation under natural conditions (e.g. the narrow nature of the observation setup? The consistency of the sand?)

      Our nest excavation experiments were terminated under two primary scenarios: (1) the queen died of natural causes, reflecting the baseline mortality expected when queens are brought into laboratory conditions, or (2) the nest experienced a structural collapse that left the queen irreversibly trapped. The second scenario is further elaborated below:

      Irreversible Collapses: These collapses were classified as irreversible because the queen could not be rescued alive. This occurred when the structural stability of the nest failed, burying the queen in a manner that prevented recovery. In some cases, the collapse resulted in the queen's immediate death, while in others, she was trapped beyond reach, and any rescue attempt risked further structural damage.

      Collapse and Experimental Context: These collapses were not uniquely associated with natural colonies or fixed-demographic experiments; rather, they occurred across various experimental setups.

      The sentence is modified as below to improve clarity (line numbers : 70-72 ).

      “In all instances where a collapse resulted in the queen's death or her being irreversibly trapped in the nest, the experiment was excluded from analysis starting from the point of the collapse, as such events did not reflect normal colony dynamics.”

      I want to make sure I understand the following statement: "Moreover, the area excavated by the young cohorts was similar to that excavated by naturally maturing colonies at the point in which they reached the same population size (Tukey's HSD; group size: 5; p = 0.61, group size: 10; p = 0.46, group size: 15; p = 0.20)." Do I have it right that this means a group of (e.g. 10) young ants excavates an area similar to that of a group of 10 naturally maturing ants at the same age as the young ants?

      Yes, the interpretation provided is correct. We apologize to the reviewer for the confusion. We have rephrased the sentence for better readability (line numbers : 146-148).

      “Furthermore, the area excavated by the young cohorts was comparable to that excavated by naturally maturing colonies when they reached the same population size (Tukey's HSD; group size: 5, p = 0.61; group size: 10, p = 0.46; group size: 15, p = 0.20)”

      How old do ants get? Is the 'old' demographic (~200 days) meaningfully old in the context of the overall worker lifespan? While the results certainly demonstrate there is an age effect, I would like to understand how rapid this is in terms of overall lifespan.

      The lifespan of ants, including both queens and workers, varies significantly based on caste, species, and environmental conditions.

      (1) Queen Longevity: From the literature, Camponotus fellah queens can live up to 20 years, with one documented case reaching 26 years. This remarkable longevity underscores the queen's central role in maintaining the colony.

      (2) Worker Longevity: In contrast to queens, the lifespan of workers is much shorter.

      However, specific data on worker longevity in Camponotus fellah colonies are lacking. Studies on other Camponotus species (50, 82) suggest that workers can live for several months depending on environmental conditions, colony health, and caste-specific roles (e.g., minor vs. major workers).

      (3) Laboratory vs. Natural Conditions: Worker longevity is highly variable between laboratory and natural conditions

      Therefore, in the context of the old worker lifespan in our experiments of, ~200 days (roughly 6–7 months) we strongly believe that the worker lifespan used in our experiments represents a substantial portion of a worker's expected life. While exact figures for C. fellah workers are unavailable, inferences from related species suggest that workers nearing 200 days are approaching the latter stages of their lifespan, making them meaningfully "old."

      These details are added to the main text (line numbers : 124 - 127) and to the discussion (line numbers : 278-282)

      Reviewer #3 (Recommendations for the authors):

      We sincerely thank the reviewer for their time and effort in providing a detailed review and assessment of our manuscript. A point-by-point response to the comments is provided below.

      L10: "fixed demographics": I find this term unclear, what does it mean, it should specify if the groups are with or without a queen.

      We thank the reviewer for the comment. The sentence is modified in the abstract, and definitions are later added in detail in the introduction (line numbers : 8-10) and the Materials and Methods section (Fixed demographics colonies). 

      “We experimentally compared nest excavation in colonies seeded from a single mated queen and allowed to grow for six months to excavation triggered by a catastrophic event in colonies with fixed demographics, where the age of each individual worker, including the queen, is known”.

      The details of the “fixed demographics” treatments were explained in the later portion of the text (line numbers: 58-61).

      L36: I think it is documented that younger individuals are the ones who involved in nest construction in many species.

      Previous studies on nest construction were predominantly performed on mature colonies of specific age demographics or rather mixed demographics, where age was not considered as a factor influencing nest construction. Some studies have speculated that young ants could be the most probable ones to dig, but this has not been experimentally verified to the best of our knowledge.

      L50: I do not think the colony should be called mature after only 6 months, given that colonies reach thousands of workers.

      The sentence is changed as suggested (line numbers : 56-57).

      “The "Colony-Maturation" experiment observed the development of colonies up to six months, starting from a single fertile queen and progressing to colonies with established worker populations.” 

      L60: Where was the queen introduced? It is specified in the Methods but a word here would be helpful.

      The detail is added as suggested (line numbers : 68-69).

      “We initiated colony maturation experiments by introducing a single mated queen and several brood items (n = 5, across all experiments) at random positions on the soil layer of the nest.”

      L106: Young vs Old workers 40 vs 171 days. Maybe cite a reference or provide a reason for the selection of those ages?

      Previous studies have shown that the Camponotus fellah queens can live up to 20 years, with one documented case reaching 26 years (50). To the best of our knowledge, specific data on worker longevity in Camponotus fellah colonies in natural conditions are lacking. Lab studies on Camponotus fellah (82) and other Camponotus species (50) suggest that workers can live for several months depending on environmental conditions, colony health, and caste-specific roles (e.g., minor vs. major workers). 

      We intentionally selected workers from two distinct age groups: younger ants (40 ± 16 days old) and older ants (171.56 ± 20 days old). These ages represent functionally different life stages - the younger group had completed about 25% of their expected lifespan at the start of the experiment, while the older group had lived through most of theirs (50, 82). This 4-fold age difference allowed us to compare excavation behaviors across fundamentally different phases of adult life.

      Our experiments lasted for 60-90 days, during which all participating workers continued to age. To ensure all ants remained alive throughout the experiments, and given the constraints of the experimental timeline, we selected young and old workers within the specified age range. 

      These details are added to the main text (line numbers :  124 -127), and the discussion (line numbers  : 278-282)

      L122-123: But usually ants can vary highly in their behaviours. Can the authors comment on their choice to consider an average, implying that all ants of the same age had the same digging rates?

      We thank the reviewer for the comment.

      In our experiments, we could not track each worker's activity over time. As described in the methods, we took snapshots of the nest structure over days and recorded the population size of the nest. Thus, we could not capture the activity of single ants in the nest as described in the response to major comments in the reviewed preprint.

      We agree that individual tracking of ants within our experimental setup would have been the ideal approach. Then, we could have taken the inter-individual variability of the digging activity into account. However, we were limited to doing so by the technical and practical limitations of the setup, such as; 

      (a) Continuous tracking of ants in our nests would have required a camera to be positioned at all times in front of the nest, which necessitates a light background. Since Camponotus fellah ants are subterranean, we aimed to allow them to perform nest excavation in conditions as close to their natural dark environment as possible. Additionally, implementing such a system in front of each nest would have reduced the sample sizes for our treatments.

      (b)The experimental duration of our colony maturation and fixed demographics experiments extended for up to six months (unprecedented durations in these kinds of measurements). These naturally limited our ability to conduct individual tracking while maintaining the identity of each ant based on the current design.

      To clarify this, we have added the following to the discussion (line numbers: 286-292).

      “Previous studies have demonstrated both homogeneous and heterogeneous workload distribution, with varying digging rates among ants (24,29,30,35). Studies showing heterogeneous workload distribution relied on continuous individual tracking of ants to quantify digging rates (35). However, this approach was not feasible in our current design due to the experimental durations of both our colony maturation and fixed demographics experiments. Additionally, sample size requirements naturally limited our ability to conduct continuous individual tracking during nest construction in our study.”

      L171: A line on how the nest structure was acquired and data extracted would be welcome here.

      The algorithm for the nest structure segmentation, data extraction, and analysis is added in detail to the SI section: Nest skeletonization, segmentation, and orientation. The line is modified (line numbers : 221-224) in the main text as suggested.

      “We compared nest architectures by segmenting raw nest images into chambers and tunnels (see SI Section: Nest Skeletonization, Segmentation, and Orientation). Chambers were identified as flat, horizontal structures, while tunnels were narrower and more vertical in orientation (see SI Fig. 9, SI Section: Nest Skeletonization, Segmentation, and Orientation)”.  

      Figure 3: Where does the data of the mean in panel C come from: is it the mean of the first 30 days, before the collapse? How is it comparable with the rest?

      We apologize to the reviewer for the confusion.

      In panel C, the mean values (solid stars and circles) for fixed-demography colonies (young/old groups) represent pre-collapse excavation areas. For colony maturation experiments (where no collapses were induced), we instead plot the mean saturated excavation area for each group size. This allows direct comparison of mean excavated areas across experimental conditions at equivalent colony sizes.

      To improve readability, the following sentences are added to the main text (line numbers : 139 - 146 ) 

      “We compared the saturated excavation areas (pre-collapse) from fixed-demographics experiments (young and old groups) with those from colony maturation experiments of the same colony sizes (Fig. 3C). We find that, for a given age cohort (young or old), the saturation areas increase linearly with the colony size (GLMM, F(35,37); p < 0.0001) (Fig. 3 C, SI. Fig 7 A). The observed proportional scaling between excavated area and group size aligns with previous studies, even though those studies did not explicitly account for age demographics (24, 29, 30). After normalizing the pre-collapse excavated area by group size for both young and old colonies, we found no significant difference in area per ant across group sizes (SI Fig. 5. A). This indicates that the excavated area per ant remains relatively constant within each demographic group”.

      L209-210: I would be more parsimonious in saying that the results presented prove that the target area decreases with age, as the individual behaviour of the ants was not monitored. Suggestion: rephrase to "the target of the group decreases with age".

      The sentence is rephrased as suggested (line numbers : 265-266).

      “Our results reveal that this target area of the group decreases linearly with age, such that young ants are more sensitive to shortages in space.”

      L246: Are C.fellah colonies really found with such few workers?

      Previous studies have speculated that mature Camponotus fellah colonies are a monogynous species typically founded by a single queen following nuptial flights (50,51,82), and can range from tens to thousands of workers. However, during the founding stage (as in our experiments), colonies naturally pass through smaller developmental sizes comparable to the matured colonies.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review): 

      Summary:  

      The Szczupak lab published a very interesting paper in 2012 (Rodriquez et al. J Neurophysiol 107:1917-1924) on the effects of the segmentally-distributed non-spiking (NS) cell on crawl-related motoneurons. As far as I can tell, the working model presented in 2012, for how the non-spiking (NS) cell impacts the crawling motor pattern, is the same functional model presented in this new paper. Unfortunately, the Discussion does not address any of the findings in the previous paper or cite them in the context of NS alterations of fictive crawling. Aside from different-looking figures and some new analyses, the results and conclusions are the same. 

      Reviewers #1 and #2 called our attention to our failure to cite the Rodriguez et al. 2012 article in the context of the main goal of the present work. We do now explain how the present study is framed by the published work. See lines 74-79.

      In Rodriguez et al. 2012, we hypothesized that the inhibitory signals onto NS were originated in the motoneuron firing. We now cite this reference in line 104. In the current manuscript we further investigated the connection between the inhibitory signals onto NS and the motoneuron activity (Figure 2) and proved that the hypothesis was wrong. Thus, the model presented here differs from the one proposed in Rodriguez et al. 2012.

      In Rodriguez et al. 2012, we speculated that the inhibitory signals received by NS were transmitted to the motoneurons, but an important control was missing in that study. In the current study depolarization of NS during crawling is tested against a control series that allows to properly examine the hypothesis (lines 138-147). But, most important, because NS is so widely connected with the layer of motoneurons it was necessary to test the effect on other motoneurons during the fictive crawling cycle. We now explain this rationale in lines 249-257.

      Strengths: 

      The figures are well illustrated. 

      Weaknesses:  

      The paper is a mix of what appears to be two different studies and abruptly switches gears to examine how closely the crawl patterning is in the intact animal as compared to the fictive crawl patterning in the intact animal. Unfortunately, previous studies in other labs are not cited even though identical results have been obtained and similar conclusions were made. Thus, the novelty of the results is missing for those who are familiar with the leech preparation. The lack of appropriate citations and discussion of previous studies also deprives the scientific community of fully comprehending the impact of the data presented and the science it was built upon.  

      The main aim of the manuscript is to learn the role of premotor NS neurons in the crawling motor pattern studied using spike sorting in extracellular nerve recordings. This readout allows to  simultaneously monitor a larger number of units  than in any previous study. This approach aims to determine whether and how a recurrent inhibitory peripheral circuit is involved in coordinating or modulating the rhythmic motor pattern.

      Our rationale was that the known effect of NS on one particular motoneuron (DE-3) may have overlooked a more general effect on crawling (lines 253-257). Moreover, we wanted to investigate whether this effect was due to the recurrent inhibitory circuit or if other elements were involved, and to study whether the modulation was mediated by the recurrent synapse between NS and the motoneurons.

      In the context of this aim we studied the rhythmic activity of cell DE-3, together with motoneurons that fire in-phase and anti-phase, in isolated ganglia (Figure 4). To reveal the effect of NS manipulation we applied a quantitative analysis that showed the phase-specific effect of NS (Figure 6). 

      Given that this is the first study using a spike sorting algorithm to detect and describe the activity of motoneurons in nerve recordings we found it reasonable to compare these results with an in vivo study; thus, providing information to the general reader, that supports the correspondence between the ex vivo and the in vivo patterns.

      (1) Results, Lines 167-170: "While multiple extracellular recordings have been performed previously (Eisenhart et al., 2000), these results present the first quantitative analysis of motor units activated throughout the crawling cycle. The In-Phase units are expected to control the contraction stage by exciting or inhibiting the longitudinal or circular muscles, respectively, and the Anti-Phase units to control the elongation stage by exciting or inhibiting the circular or longitudinal muscles, respectively."  

      Reviewer: The first line above is misleading. The study by Puhl and Mesce (2008, J. Neurosci, 28:4192- 420) contains a comprehensive analysis of the motoneurons active during fictive crawling with the aim of characterizing their roles and phase relationships and solidifying the idea that the oscillator for crawling resides in a single ganglion. Intracellular recordings from a number of key crawl-related motoneurons were made in combination with extracellular recordings of motoneuron DE-3, a key monitor of crawling. In their paper, it was shown that motoneurons AE, VE-4, DI-1, VI-2, and CV were all correlated with crawl activity, and fired repeatedly either in phase or out-of-phase with DE-3. They were shown to be either excitatory or inhibitory. At a minimum, the above paper should be cited. 

      The sentence in the submitted manuscript explicitly refers to the quantitative analysis of extracellular recordings, but we recognize that it may lead to confusion. We have now added a clarification (lines 197-199). 

      The article by Puhl and Mesce 2008 shows very nice intracellular recordings of the AE, CV, VE-4, DE-3, DI-1, and Vi-2, accompanied by extracellular recordings of DE-3 in the DP nerve. In all cases, there is only one intracellular recording paired with the DP nerve recording.

      While it is possible to perform up to 3-4 simultaneous intracellular recordings, these are technically challenging, and more so when the recordings have to last 10-20 minutes. Due to this difficulty, and because our objective was to record multiple units simultaneously in order to comprehensively describe the different crawling stages, we implemented the spike sorting analysis on multiple extracellular recordings. This approach enabled us to reliably obtain multiple units per experiment and thus execute a quantitative analysis of the activity of each identified unit.

      The article by Puhl and Mesce 2008 mentions several quantitative aspects of the neurons that fire in-phase or out-of-phase with DE-3, but, as far as we understand, there is no figure that summarizes activity levels and span in the way Figures 4 and 6 do in the current manuscript. To the best of our knowledge, no previous work renders this information.

      It is very important for us to emphasize that the work by Puhl and Mesce was seminal for our research. We cited it four times in the original manuscript and 10 times in the present version. But, like any important discovery, it sets the ground for further work that can refine certain measurements that in the original discovery were not central.

      This is why we believe that the cited sentence in our manuscript is not misleading.  However, to comply with the requirement of Reviewer #1, we added a sentence preceding the mentioned paragraph (lines 185-187) that acknowledges the description made using intracellular recordings, and explains the need for implementing the approach we chose.

      The submitted paper would be strengthened if some of these previously identified motoneurons were again recorded with intracellular electrodes and concomitant NS cell stimulation. The power of the leech preparation is that cells can be identified as individuals with dual somatic (intracellular) and axonal recordings (extracellular). 

      Most of the motoneurons mentioned by Reviewer #1 are located on the opposite side (dorsal) of the ganglion to NS (ventral), and therefore, simultaneous intracellular recordings in the context of fictive crawling are challenging.

      In the publication of Rodriguez et al. 2009, Mariano Rodriguez did manage to record NS from the dorsal side together with DE-3 and MN-L (!) and this led to the discovery that these motoneurons are electrically coupled, but the recurrent inhibitory circuit masks this interaction. Repeating this type of experiments during crawling, which requires stable recordings for around 15 minutes, is not a reasonable experimental setting.

      Rodriguez et al. 2012 shows intracellular recordings of motoneurons AE and CV during crawling in conjunction with NS, and their activity presented the expected correlation. 

      The shortfall of this aspect of the study (Figure 5) is that the extracellular units have not been identified here. 

      The Reviewer is right in that the extracellular units have not been identified in terms of cell identity. As we explained earlier, most motoneurons are on the opposite side (ventral/dorsal) of the ganglion relative to NS. 

      However, we do characterize the units in terms of the nerve through which they project to the periphery and their activity phase. In lines 345-349 we use this information and, based on published work, we propose possible cellular identities of the different units.

      In xfact, these units might not even be motoneurons. 

      We are surprised by this comment. The classical work of Ort and collaborators (1974) showed that spikes detected in extracellular nerve recordings were emitted by specific motoneurons, and several previous publications have validated extracellular nerve recordings as a means to study fictive motor patterns (Wittenberg & Kristan 1992, Shaw & Kristan 1997, Eisenhart et al. 2000).

      For further reassurance, we only took in consideration units whose activity was locked to DE3; any non-rhythmical activity was filtered out (see lines 433-435). 

      They could represent activity from the centrally located sensory neurons, dopamine-modulated afferent neurons or peripherally projecting modulatory neurons. 

      Peripheral nerves also contain axons from sensory neurons. However, in a previous article, we studied the activity of mechanosensory neurons (Alonso et al. 2020) and showed that they remain silent during crawling. Moreover, the low-threshold T sensory neurons are inhibited in phase with DE-3 bursts and NS IPSPs (Kearney et al. 2022). Alonso et al. 2000 showed that spiking activity of T cells affects the crawling motor pattern, revealing the relevance of keeping them silent.

      What does the Reviewer mean by “dopamine-modulated afferents”? We are not aware of this category of leech neurons.

      The neuromodulatory Rz neurons project peripherally through the recorded nerves, but intracellular recordings of these neurons from our lab show no rhythmic activity in those cells during dopamine-induced crawling.

      Essentially, they may not have much to do with the crawl motor pattern at all.

      Does the Reviewer consider that neurons engaged in a coherent rhythmic firing could be unrelated to the pattern? As indicated above, the units reported in our manuscript were selected because dopamine evoked their rhythmic activity, locked to DE-3. 

      Does the Reviewer consider that dopamine could evoke spurious neuronal activity?

      (2) Results Lines 206-210: "with the elongation and contraction stages of in vivo behavior. However the isometric stages displayed in vivo have no obvious counterpart in the electrophysiological recordings. It is important to consider that the rhythmic movement of successive segments along the antero-posterior axis of the animal requires a delay signal that allows the appropriate propagation of the metachronal wave, and this signal is probably absent in the isolated ganglion." 

      Reviewer: The so-called isometric stages, indeed, have an electrophysiological counterpart due in part to the overlapping activities across segments. This submitted paper would be considerably strengthened if it referred to the body of work that has examined how the individual crawl oscillators operate in a fully intact nerve cord, excised from the body but with all the ganglia (and cephalic ganglion) attached. Puhl and Mesce 2010 (J. Neurosci 30: 2373-2383) and Puhl et al. 2012 (J. Neurosci, 32:17646 -17657) have shown that "appropriate propagation of the metachronal wave" requires the brain, especially cell R3b-1. They also show that the long-distance projecting cell R3b-1 synapses with the CV motoneuron, providing rhythmic excitatory input to it.  

      We would like to draw the Reviewer’s attention to the fact that Puhl and Mesce 2008, 2010 and Puhl et al. 2012 characterized crawling in intact (or nearly intact) animals considering the whole body. In our in vivo analysis, we studied the changes in length of the whole animal and of sections demarcated by the drawn points, as described in the Materials and Methods/Behavioral

      Experiments. Because of this different analysis, we defined “isometric” stages as those in which a given section of the animal does not change its length. We now clarify this (line 230).

      In the paragraph cited by the Reviewer, we intended to state that, in the context of our study, the intersegmental lag caused by the coordinating mechanisms has no counterpart “in the electrophysiological recordings of motoneurons in the isolated ganglia”. We have now completed this idea with the expression underlined in the previous sentence (line 231).

      As the Reviewer indicates, in the intact nerve cord the behavioral isometric stages correspond to the “waiting time” between segments. We did refer to the metachronal order but did not cite the articles by Puhl and Mesce 2010 and Puhl et al. 2012; we now do so (lines 234).

      For this and other reasons, the paper would be much more informative and exciting if the impacts of the NS cell were studied in a fully intact nerve cord. Those studies have never been done, and it would be exciting to see how and if the effects of NS cell manipulation deviated from those in the single ganglion.  

      The Reviewer may consider that a systematic analysis of multiple nerves in several ganglia along the whole nerve cord would have been a different enterprise than the one we carried out. The Reviewer is right in recognizing the interest of such study, but in our opinion, the value of the present work lies in presenting a thorough quantitative analysis of multiple nerves to demonstrate its usefulness for the study of the network underlying leech crawling. In this manuscript, we used it to analyze the role of the premotor NS neuron. Without the recording of units firing in-phase and out-ofphase with DE-3, we would have been unable to assess the span of NS effects.

      (3) Discussion Lines 322-324. "The absence of descending brain signals and/or peripheral signals are assumed as important factors in determining the cycle period and the sequence at which the different behavioral stages take place." 

      Reviewer: The authors could strengthen their paper by including a more complete picture of what is known about the control of crawling. For example, Puhl et al. 2012 (J Neurosci, 32:17646-17657) demonstrated that the descending brain neuron R3b-1 plays a major role in establishing the crawlcycle frequency. With increased R3b-1 cell stimulation, DE-3 periods substantially shortened throughout the entire nerve cord. Thus, the importance of descending brain inputs should not be merely assumed; empirical evidence exists.  

      We now strengthen the concept using “known descending brain signals” (line 358) and cite Puhl et al. 2012. We believe that extending the discussion to cell R3b-1 does not contribute meaningfully to the focus of this manuscript.

      (4) Discussion Lines 325-327: "the sequence of events, and the proportion of the active cycle dedicated to elongation and contraction were remarkably similar in both experimental settings. This suggests that the network activated in the isolated ganglion is the one underlying the motor behavior." 

      Reviewer: The results and conclusions drawn in the current manuscript mirror those previously reported by Puhl and Mesce (2008, J. Neurosci, 28:4192- 420) who first demonstrated that the essential pattern-generating elements for leech crawling were contained in each of the segmental ganglia comprising the nerve cord. Furthermore, the authors showed that the duty cycle of DE-3, in a single ganglion treated with dopamine, was statistically indistinguishable from the DE-3 duty cycle measured in an intact nerve cord showing spontaneous fictive crawling, in an intact nerve cord induced to crawl via dopamine, and in the intact behaving animal. What was statistically significant, however, was that the DE-3 burst period was greatly reduced in the intact animal (i.e., a higher crawl frequency), which was replicated in the submitted paper.  

      There is no doubt that the article by Puhl and Mesce 2008 is seminal to the work we present here. The Reviewer seems to suggest that we do not recognize the value of this work. The contrary is true, all our related papers cite this important breakthrough. We cite the paper very early in the article in the Introduction (see lines 51 and 52-53). Likely, we would like the Reviewer to recognize the novelty of the current report. To clarify what has been shown and what is new in our manuscript, considerer the following:

      i. Figures 1-6 in Puhl and Mesce 2008 provide representative intracellular recordings that describe neurons that fire in phase and out of phase relative to DE-3. Some general measurements are given in the text, but none of these figures quantify the relative activity of neurons that fire in different stages; only DE-3 activity was quantified. A quantitative description of multiple units active in phase and out of phase with DE-3 is presented here for the first time, are we wrong? This quantification is particularly relevant when assessing how a treatment affects the function of the circuit.

      ii. Regarding the cycle period, we referred to the work from the Kristan lab, which reported this value long before the requested reference. We now cite Puhl and Mesce 2008 in lines 222 regarding in vivo measurements, and in line 221 regarding isolated ganglia.

      iii. Regarding the duty cycle: 

      Puhl and Mesce 2008 measured the duty cycle of DE-3 in three configurations: a. spontaneous whole cord, b. DA-mediated whole cord and c. DA mediated single ganglion crawling. However, it does not report the duty cycle of neurons out-of-phase with DE-3. Our current manuscript carried out this analysis. One could argue that the silence between DE-3 bursts captures that value, but this is a speculation that needed a proper measure.

      Puhl and Mesce 2008 does not indicate the duty cycle of the contraction and elongation stages in vivo. Our current manuscript does. 

      Therefore, the sentence cited by the Reviewer refers to data presented in this manuscript, and not in any prior manuscript. It is true that Puhl and Mesce 2008 inspire the intuition that the sentence is true, but does not present the data that the current manuscript does.

      Finally, our study focused only on the body sections corresponding to the same segmental range used in the ex vivo experiments, rather than the whole animal. The comparison was made only to validate that the duty cycles of neurons firing in phase and out of phase with DE-3 matched the dynamic stages in the studied sections of the leech (line 364).

      In my opinion, the novelty of the results reported in the submitted manuscript is diminished in the light of previously published studies. At a minimum, the previous studies should be cited, and the authors should provide additional rationale for conducting their studies. They need to explain in the discussion how their approach provided additional insights into what has already been reported.  

      Throughout our reply, we have provided a detailed explanation of the rationale and necessity behind each experiment. Following the Reviewer’s suggestion, we have rephrased the research objectives, included what is known from our previously published work, and highlighted the substantial new data contributed by the present study. See lines 80-85. 

      Additionally, we further cite our published article in lines 93, 104, 138, 146 and 250. 

      Reviewer #2 (Public review):  

      The paper is well-written overall. The findings are clearly presented, and the data seems solid overall. I do have, however, a few major and some minor comments representing some concerns.

      My major comments are below. 

      (1) This may seem somewhat semantic, yet, it has implications on the way the data is presented and moreover on the conclusions drawn - a single ganglion cannot show fictive crawling. It can demonstrate rhythmic patterns of activity that may serve in the (fictive) crawling motor pattern. The latter is a result of the intrinsic within single-ganglion connectivity AND the inter-ganglia connections and interactions (coupling) among the sequential ganglia. It may be affected by both short-range and long-range connections (e.g., descending inputs) along the ganglia chain. 

      Semantics is not a trivial issue in science communication. It entails metaphors that enter the bibliography as commonly used “shortcuts” to a complex concept that are adopted by a community of researchers. And yes, indeed, they can be misleading.

      However, if recording the activity in an isolated ganglion shows that a wide group of motoneurons, that control known muscle movements, presents a rhythmic output that maintains the appropriate cycle period and phase relationships, the “shortcut” is incomplete but could be valid (Puhl and Mesce 2008). If we were to include the phase lag component, a single ganglion cannot generate the fictive motor output.

      Because any new study builds knowledge on the basis of the cited bibliography, the way we name concepts is a sensitive point. Adopting the terminology used by previous publications (Puhl and Mesce 2008) seems important to allow readers to follow the development of knowledge. However, attending the observation made by Reviewer #2, we included a sentence clarifying that the concept “fictive crawling” does not include intersegmental connectivity (lines 54-57)

      (2) The point above is even more critical where the authors set to compare the motor pattern in single ganglia with the intact animals. It would have made much more sense to add a description of the motor pattern of a chain of interconnected ganglia. The latter would be expected to better resemble the intact animal. Furthermore, this project would have benefitted from a three-way comparison (isolated ganglion-interconnected ganglia-intact animal.  

      As we answered to Reviewer #1, the present manuscript does not intend to present a thorough study on how the activity in the isolated nervous system compares with the animal behavior. To do so we would have needed to perform a completely different set of experiments. To better define the relevance of our comparison with the in vivo experiments we rephrased the objective of the behavioral analysis (lines 197-199).

      The main aim of the manuscript is to learn the role of premotor NS neurons in the crawling motor pattern studied using a readout (spike sorting in extracellular nerve recordings) that allows simultaneous screening of a larger number of units than in any previous study, in order to determine whether and how a recurrent inhibitory peripheral circuit is involved in coordinating or modulating the rhythmic motor pattern.

      Our rationale was that the known effect of NS on one particular motoneuron (DE-3) may have overlooked a more general effect on crawling (lines 253-257). Moreover, we wanted to investigate whether this effect was due to the recurrent inhibitory circuit or if other elements were involved, and to study whether the modulation was mediated by the recurrent synapse between NS and the motoneurons.

      In the context of this aim we studied the rhythmic activity of cell DE-3, together with motoneurons that fire in-phase and anti-phase, in isolated ganglia (Figure 4). To reveal the effect of NS manipulation we applied a quantitative analysis that showed the phase-specific effect of NS (Figure 6). 

      Given that this is the first study using a spike sorting algorithm to detect and describe the activity of motoneurons in nerve recordings we found it reasonable to compare these results with an in vivo study; thus, providing information to the general reader, that supports the correspondence between the ex vivo and the in vivo patterns.

      (3) Two previous studies by the same group are repeatedly mentioned (Rela and Szczupak, 2003; Rodriguez et al., 2009) and serve as a basis for the current work. The aim of one of these previous studies was to assess the role of the NS neurons in regulating the function of motor networks. The other (Rodriguez et al., 2009) reported on a neuron (the NS) that can regulate the crawling motor pattern. LL 71-74 of the current report presents the aim of this study as evaluating the role of the known connectivity of the premotor NS neuron in shaping the crawling motor pattern. The authors should make it very clear what indeed served as background knowledge, what exactly was known about the circuitry beforehand, and what is different and new in the current study. 

      Rela and Szczupak 2003 and Rodriguez et al. 2009 analyze the interactions of motoneurons with NS. We believe that Reviewer #2 refers here to Rodriguez et al. 2012. A similar observation was made by Reviewer #1. Below, we copy the answer previously stated:

      Following the Reviewer’s suggestion, we have rephrased the research objectives, included what is known from our previously published work, and highlighted the substantial new data contributed by the present study. See lines 80-85. 

      Additionally, we further cite our published article in lines 93, 104, 138, 146 and 250. 

      Reviewer #1 (Recommendations for the authors):  

      Please edit for correct word usage. 

      Reviewer #2 (Recommendations for the authors):  

      Minor Concerns 

      (1) LL33-36: These lines are somewhat vague and non-informative. Why is the functional organization of motor systems an open question? What are the mechanisms at the level of the nerve cord that are an open question? Maybe be more explicit? 

      We did as suggested (lines 30-32).

      (2) L62: The homology between the NS neurons and the vertebrate Renshaw cells is mentioned already in the Abstract and here again. While a reference is provided (citing the lead author of this current work), the reader would benefit from some further short words of explanation regarding the alleged homology. 

      We included a description of Renshaw cell connectivity (lines 64-65).

      (3) LL90-92: The NS recording in Figure 1 (similar to Figure 3 in Rodriguez et al.) demonstrates clear distinct IPSPs. Could these be correlated with DE-3 spikes? 

      We investigated this correlation in detail and the answer is that there is no strictly a 1:1 DE-3 spike to IPSP correlation. NS receives inputs from other dorsal and ventral excitors of longitudinal muscles, and the NS trace is too “noisy” to reflect any short-term correlation. Originally we proposed that the NS IPSPs were due to the polysynaptic interaction between the MN and NS (Rodríguez et al. 2012). However, the present work demonstrates that the IPSPs in NS are caused by a source upstream from the MNs. 

      (4) LL145-145: Do you mean - inhibitory signals FROM NS premotor neurons? Not clear. 

      We see the confusion, and we rewrote the sentence (lines 164). We hope it is clearer now: “…inhibitory signals onto NS premotor neurons were transmitted to DE-3 motoneurons via rectifying electrical synapses and counteracted their excitatory drive during crawling, limiting their firing frequency.”

      (5) LL153-154: Why isn't AA included in Figure 4A? 

      Reading our original text, the Reviewer #1 is right in expecting to see the AA recording. We changed the sentence: “we performed extracellular recordings of DP along with AA and/or PP root nerves” (lines 171-172).

      We dissected the three nerves but, unfortunately, we did not always obtain good recordings from the three of them.

      (6) LL237-238: The statistical significance (B- antiphase) is not clear. Furthermore, with N of 7-8, I'm not sure the parametric tests utilized are appropriate. 

      Regarding the Reviewer's concern about the tests, please note that all the assumptions made for each model were tested (see now Materials and Methods lines 466-467).The information on each model is provided in Supplementary Table 2 under the column 'Model, random effect,' which specifies whether a Linear Mixed Model (LMM) or a Generalized Linear Mixed Model (GLMM) was implemented. For GLMMs, the corresponding distribution and link function are also specified. For the analysis of Max bFF of Anti-Phase motor units, we found a significant interaction between epoch and treatment, indicating a difference between treatments. This is indicated on the left of the y-axis (##). In control experiments, all three comparisons (pre-test, pre-post, test-post) show significant differences in Max bFF: this variable decreased (slightly but significantly) along the subsequent epochs, suggesting a change over time. We now corrected the text to indicate that these changes were small (line 268). In contrast, Max bFF in depo experiments remained stable between pre-test and pre-post, but significantly decreased between the depo and post epochs. Thus, in our view the comparison between control and the test supports the conclusion that NS depolarization was limited to counteracting this decrease (lines 270-273). Supplementary Table 2 provides the significance and modeled estimated ratio for each comparison in the column for pairwise simple contrasts.

      Thanks to this question, we realized that the nomenclature used in the table for the epochs (pre - depo - post) needed to be changed to pre - test - post, and we have now corrected it.

      (7) LL240-241: I fail to see a difference from Control. 

      For the Relative HW of In-Phase units, we also found a significant interaction between epoch and treatment, indicating a difference between treatments, as denoted to the left of the y-axis (#). Then, the significance of the comparisons across epochs within each treatment are shown in the figure (*). What is important to notice is that obtaining the same significance for each treatment does not imply identical results, but we failed to describe this in our original text and we do now in lines 275-279.

      (8) LL244-245: I must admit that Table 2 is beyond me. Maybe add some detail or point out to the reader what is important (if at all). 

      We have now clarified what each column of the tables indicates in the corresponding legends. 

      Here, we also share an insight into how the experiments were designed and analyzed:

      To account for possible temporal drifts of the variables during the recordings that could mask or confuse the results, we compared two experimental series: one in which NS was subjected to depolarizing current pulses (depo), and another series (ctrl) in which the neurons were not depolarized.

      The statistical analysis was made using Linear Mixed Models (LMMs) or Generalized Linear Mixed Models (GLMMs). In these analyses treatments and epochs are used as explanatory variables to evaluate the interaction between these factors. These models allow us to determine whether changes in each variable across epochs differ depending on the treatment. For example, whether the variation in firing frequency from pre to test to post differs between control experiments and those in which NS was depolarized.

      A significant interaction between treatment and epoch indicates that NS depolarization affected the variable. In such cases, we performed pairwise comparisons between epochs (pre-test, test-post, pre-post) within each treatment. In contrast, the absence of a significant interaction can result from two possibilities: either the variable did not change across epoch in either treatment, or a similar temporal drift occurred in both cases.

      (9) LL245-256: Move this paragraph to the discussion. 

      Because we introduced a rationale for the experiments described in Figure 6 (lines 282-284) the paragraph was mostly removed, but the part that supports the methodological approach was left.

      (10)  LL259-260: see my second minor point above. This is explained in LL270-272 for the first time. 

      We amended according to comment (2).

      (11) Figures: The quantitative analysis shown in Figure 3B is very useful. Why isn't this type of analysis utilized for the comparisons shown in Figures 4 and 6? 

      We chose different ways of plotting the data based on their nature. In Figure 3B, we present data from an identified neuron (DE-3) recorded in different experiments. In contrast, in Figure 6 we analyze data from neurons classified into the same group based on their activity during the fictive crawling cycle, but their individual identity was not ascertained. Therefore, we consider it important to plot the results for each unit individually, to assess the effect of temporal drift and NS depolarization.

      (12) Figures: Figure 7 is meant to be compared to Figure 1C; the point being the addition of an inhibitory connection onto the NS neuron. Why are other details of the figure also different (different colored M)? 

      While Figure 1C illustrates the known connection between NS and both DE-3 and CV motoneurons, Figure 7 shows the connections between NS and the different groups of motor units described in this study. The units are represented in the circuit using the same colors that identify them in Figures 4 and 6. Since the CV motoneuron was not recorded in this study, the circuit represents the AntiPhase neurons but does not identify them with CV. Figure 7 legend now clarifies what the colors represent, and Figure 1C has been updated to match the same color scheme.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      This work addresses an important question in the field of Drosophila aggression and mating- prior social isolation is known to increase aggression in males by increased lunging, which is suppressed by group housing (GH). However, it is also known that single-housed (SH) males, despite their higher attempts to court females, are less successful. Here, Gao et al., developed a modified aggression assay, to address this issue by recording aggression in Drosophila males for 2 hours, over a virgin female which is immobilized by burying its head in the food. They found that while SH males frequently lunge in this assay, GH males switch to higher intensity but very low-frequency tussling. Constitutive neuronal silencing and activation experiments implicate cVA sensing Or67d neurons promoting high-frequency lunging, similar to earlier studies, whereas Or47b neurons promote low-frequency but higher intensity tussling. Using optogenetic activation they found that three pairs of pC1 neurons- pC1SS2 increase tussling. While P1a neurons, previously implicated in promoting aggression and courtship, did not increase tussling in optogenetic activation (in the dark), they could promote aggressive tussling in thermogenetic activation carried out in the presence of visible light. It was further suggested, using a further modified aggression assay that GH males use increased tussling and are able to maintain territorial control, providing them mating advantage over SI males and this may partially overcome the effect of aging in GH males.

      Strengths

      Using a series of clever neurogenetic and behavioral approaches, subsets of ORNs and pC1 neurons were implicated in promoting tussling behaviors. The authors devised a new paradigm to assay for territory control which appears better than earlier paradigms that used a food cup (Chen et al, 2002), as this new assay is relatively clutter-free, and can be eventually automated using computer vision approaches. The manuscript is generally well-written, and the claims made are largely supported by the data.

      Thank you for your precise summary of our study, and being very positive on the novelty and significance of the study.

      Weaknesses

      I have a few concerns regarding some of the evidence presented and claims made as well as a description of the methodology, which needs to be clarified and extended further.

      (1) Typical paradigms for assaying aggression in Drosophila males last for 20-30 minutes in the presence of nutritious food/yeast paste/females or all of these (Chen et al. 2002, Nilsen et al., 2004, Dierick et al. 2007, Dankert et al., 2009, Certel & Kravitz 2012). The paradigm described in Figure 1 A, while important and more amenable for video recording and computational analysis, seems a modification of the assay from Kravitz lab (Chen et al., 2002), which involved using a female over which males fight on a food cup. The modifications include a flat surface with a central food patch and a female with its head buried in the food, (fixed female) and much longer adaptation and recording times respectively (30 minutes, 2 hours), so in that sense, this is not a 'new' paradigm but a modification of an existing paradigm and its description as new should be appropriately toned down. It would also be important to cite these earlier studies appropriately while describing the assay.

      We now toned down the description of the paradigm and cited more related references.

      (2) Lunging is described as a 'low intensity' aggression (line 111 and associated text), however, it is considered a mid to high-intensity aggressive behavior, as compared to other lower-intensity behaviors such as wing flicks, chase, and fencing. Lunging therefore is lower in intensity 'relative' to higher intensity tussling but not in absolute terms and it should be mentioned clearly.

      We have modified the description as suggested.

      (3) It is often difficult to distinguish faithfully between boxing and tussling and therefore, these behaviors are often clubbed together as box, tussle by Nielsen et al., 2004 in their Markov chain analysis as well as a more detailed recent study of male aggression (Simon & Heberlein, 2020). Therefore, authors can either reconsider the description of behavior as 'box, tussle' or consider providing a video representation/computational classifier to distinguish between box and tussle behaviors.

      Indeed, we could not faithfully distinguish boxing and tussling. To address this concern, we now made textual changes in the result section we occasionally observed the high-intensity boxing and tussling behavior in male flies, which are difficult to distinguish and hereafter simply referred to as tussling.

      We also added this information in the Materials and Methods section Tussling is often mixed with boxing, in which both flies rear up and strike the opponent with forelegs. Since boxing is often transient and difficult to distinguish from tussling, we referred to the mixed boxing and tussling behavior simply as tussling.

      (4) Simon & Heberlein, 2020 showed that increased boxing & tussling precede the formation of a dominance hierarchy in males, and lunges are used subsequently to maintain this dominant status. This study should be cited and discussed appropriately while introducing the paradigm.

      We now cited this important study in both the Introduction and Discussion sections.

      (5) It would be helpful to provide more methodological details about the assay, for instance, a video can be helpful showing how the males are introduced in the assay chamber, are they simply dropped to the floor when the film is removed after 30 minutes (Figures 1-2)?

      We now provided more detailed description about behavioral assays and how we analyze them. For example All testers were loaded by cold anesthesia. After a 30-minute adaptation, the film was gently removed to allow the two males to fell into the behavioral chamber, and the aggressive behavior was recorded for 2 hours.

      (6) The strain of Canton-S (CS) flies used should be mentioned as different strains of CS can have varying levels of aggression, for instance, CS from Martin Heisenberg lab shows very high levels of aggressive lunges. Are the CS lines used in this study isogenized? Are various genetic lines outcrossed into this CS background? In the methods, it is not clear how the white gene levels were controlled for various aggression experiments as it is known to affect aggression (Hoyer et al. 2008).

      We used the wtcs flies from Baker lab in Janelia Research Campus, and are not sure where they are originated. We appreciate your concern on the use of wild-type strains as they may show different fighting levels, but this study mainly used wild-type strains to compare behavioral differences between SH and GH males. All flies tested in this study are in w+ background, based on w+ balancers flies but are not backcrossed. We have listed detailed genotypes of all tested flies in Table S1 in the revised manuscript.

      (7) How important it is to use a fixed female for the assay to induce tussling? Do these females remain active throughout the assay period of 2.5 hours? Is it possible to use decapitated virgin females for the assay? How will that affect male behaviors?

      We used a fixed female to restrict it in the center of food. These females remain active throughout the assay as their legs and abdomens can still move. Such design intends to combine the attractive effects from both female and food. One can also use decapitated females, but in this case, males can push the decapitated female into anywhere in the behavioral chamber. The logic to use fixed females has now been added in the Materials and Methods section of the revised manuscript.

      (8) Raster plots in Figure 2 suggest a complete lack of tussling in SH males in the first 60 minutes of the encounter, which is surprising given the longer duration of the assay as compared to earlier studies (Nielsen et al. 2004, Simon & Heberlein, 2020 and others), which are able to pick up tussling in a shorter duration of recording time. Also, the duration for tussling is much longer in this study as compared to shorter tussles shown by earlier studies. Is this due to differences in the paradigm used, strain of flies, or some other factor? While the bar plots in Figure 2D show some tussling in SH males, maybe an analysis of raster plots of various videos can be provided in the main text and included as a supplementary figure to address this.

      Indeed, tussling is very low in SH males in our paradigm, which may be due to different genetic backgrounds and behavioral assays. Since tussling behavior is a rare fighting form, it is not surprising to see variation between studies from different labs. Nevertheless, this study compared tussling behaviors in SH and GH males, and our finding that GH males show much more tussling behaviors is convincing. The longer duration of tussling in our paradigm may also be due to the modified behavioral paradigm, which also supports that tussling is a high-level fighting form.

      (9) Neuronal activation experiments suggesting the involvement of pC1SS2 neurons are quite interesting. Further, the role of P1a neurons was demonstrated to be involved in increasing tussling in thermogenetic activation in the presence of light (Figure 4, Supplement 1), which is quite important as the role of vision in optogenetic activation experiments, which required to be carried out in dark, is often not mentioned. However, in the discussion (lines 309-310) it is mentioned that PC1SS2 neurons are 'necessary and sufficient' for inducing tussling. Given that P1a neurons were shown to be involved in promoting tussling, this statement should be toned down.

      Thank you for this important comment. We now toned down the statement on pC1SS2 function.

      (10) Are Or47b neurons connected to pC1SS2 or P1a neurons?

      We conducted pathway analysis in the FlyWire electron microscopy database to investigate the connection between Or47b neurons and pC1 neurons. The results indicate that at least three levels of interneurons are required to establish a connection from Or47b neurons to pC1 neurons. Although the FlyWire database currently only contains neuronal data from female brains, they provide a reference for circuit connect in males.

      (11) The paradigm for territory control is quite interesting and subsequent mating advantage experiments are an important addition to the eventual outcome of the aggressive strategy deployed by the males as per their prior housing conditions. It would be important to comment on the 'fitness outcome' of these encounters. For instance, is there any fitness advantage of using tussling by GH males as compared to lunging by SH males? The authors may consider analyzing the number of eggs laid and eclosed progenies from these encounters to address this.

      Thank you for this suggestion. We agree with you and other reviewers that increased tussling behaviors correlate with better mating competition, but it is difficult for us to make a direct link between them. Thus, in the revised manuscript, we prefer to tone down this statement but not expanding on this part.

      Reviewer #2 (Public review):

      Summary

      Gao et al. investigated the change of aggression strategies by the social experience and its biological significance by using Drosophila. Two modes of inter-male aggression in Drosophila are known lunging, high-frequency but weak mode, and tussling, low-frequency but more vigorous mode. Previous studies have mainly focused on the lunging. In this paper, the authors developed a new behavioral experiment system for observing tussling behavior and found that tussling is enhanced by group rearing while lunging is suppressed. They then searched for neurons involved in the generation of tussling. Although olfactory receptors named Or67d and Or65a have previously been reported to function in the control of lunging, the authors found that these neurons do not function in the execution of tussling, and another olfactory receptor, Or47b, is required for tussling, as shown by the inhibition of neuronal activity and the gene knockdown experiments. Further optogenetic experiments identified a small number of central neurons pC1[SS2] that induce the tussling specifically. In order to further explore the ecological significance of the aggression mode change in group rearing, a new behavioral experiment was performed to examine territorial control and mating competition. Finally, the authors found that differences in the social experience (group vs. solitary rearing) are important in these biologically significant competitions. These results add a new perspective to the study of aggressive behavior in Drosophila. Furthermore, this study proposes an interesting general model in which the social experience-modified behavioral changes play a role in reproductive success.

      Strengths

      A behavioral experiment system that allows stable observation of tussling, which could not be easily analyzed due to its low frequency, would be very useful. The experimental setup itself is relatively simple, just the addition of a female to the platform, so it should be applicable to future research. The finding about the relationship between the social experience and the aggression mode change is quite novel. Although the intensity of aggression changes with the social experience was already reported in several papers (Liu et al., 2011, etc), the fact that the behavioral mode itself changes significantly has rarely been addressed and is extremely interesting. The identification of sensory and central neurons required for the tussling makes appropriate use of the genetic tools and the results are clear. A major strength of the neurobiology in this study is the finding that another group of neurons (Or47b-expressing olfactory neurons and pC1[SS2] neurons), distinct from the group of neurons previously thought to be involved in low-intensity aggression (i.e. lunging), function in the tussling behavior. Further investigation of the detailed circuit analysis is expected to elucidate the neural substrate of the conflict between the two aggression modes.

      Thank you for the acknowledgment of the novelty and significance of the study, and your suggestions for improving the manuscript.

      Weaknesses

      The experimental systems examining the territory control and the reproductive competition in Figure 5 are novel and have advantages in exploring their biological significance. However, at this stage, the authors' claim is weak since they only show the effects of age and social experience on territorial and mating behaviors, but do not experimentally demonstrate the influence of aggression mode change itself. In the Abstract, the authors state that these findings reveal how social experience shapes fighting strategies to optimize reproductive success. This is the most important perspective of the present study, and it would be necessary to show directly that the change of aggression mode by social experience contributes to reproductive success.

      We agree that our data did not directly show that it is the change of aggression mode that results in territory and reproductive advantages in GH males. To address the concern, we have toned down the statement throughout the manuscript. For example, we made textual changes in the abstract as following

      Moreover, shifting from lunging to tussling in socially enriched males is accompanied with better territory control and mating success, mitigating the disadvantages associated with aging. Our findings identify distinct sensory and central neurons for two fighting forms and suggest how social experience shapes fighting strategies to optimize reproductive success.

      In addition, a detailed description of the tussling is lacking. For example, the authors state that the tussling is less frequent but more vigorous than lunging, but while experimental data are presented on the frequency, the intensity seems to be subjective. The intensity is certainly clear from the supplementary video, but it would be necessary to evaluate the intensity itself using some index. Another problem is that there is no clear explanation of how to determine the tussling. A detailed method is required for the reproducibility of the experiment.

      Thank you for this important suggestion. We now analyzed duration of tussling and lunging, and found that a lunging event is often very short (less than 0.2s), while a tussling event may last from seconds to minutes. This new data is added as Figure 2G. In addition, we also provided more detailed methods regarding to tussling behavior

      .<br /> Reviewer #3 (Public review):

      In this manuscript, Gao et al. presented a series of intriguing data that collectively suggest that tussling, a form of high-intensity fighting among male fruit flies (Drosophila melanogaster) has a unique function and is controlled by a dedicated neural circuit. Based on the results of behavioral assays, they argue that increased tussling among socially experienced males promotes access to resources. They also concluded that tussling is controlled by a class of olfactory sensory neurons and sexually dimorphic central neurons that are distinct from pathways known to control lunges, a common male-type attack behavior.

      A major strength of this work is that it is the first attempt to characterize the behavioral function and neural circuit associated with Drosophila tussling. Many animal species use both low-intensity and high-intensity tactics to resolve conflicts. High-intensity tactics are mostly reserved for escalated fights, which are relatively rare. Because of this, tussling in the flies, like high-intensity fights in other animal species, has not been systematically investigated. Previous studies on fly aggressive behavior have often used socially isolated, relatively young flies within a short observation duration. Their discovery that 1) older (14-days-old) flies tend to tussle more often than younger (2-days-old) flies, 2) group-reared flies tend to tussle more often than socially isolated flies, and 3) flies tend to tussle at a later stage (mostly ~15 minutes after the onset of fighting), are the result of their creativity to look outside of conventional experimental settings. These new findings are keys for quantitatively characterizing this interesting yet under-studied behavior.

      Precisely because their initial approach was creative, it is regrettable that the authors missed the opportunity to effectively integrate preceding studies in their rationale or conclusions, which sometimes led to premature claims. Also, while each experiment contains an intriguing finding, these are poorly related to each other. This obscures the central conclusion of this work. The perceived weaknesses are discussed in detail below.

      Thank you for the precise summary of the key findings and novelty of the study, and your insightful suggestions.

      Most importantly, the authors' definition of "tussling" is unclear because they did not explain how they quantified lunges and tussling, even though the central focus of the manuscript is behavior. Supplemental movies S1 and S2 appear to include "tussling" bouts in which 2 flies lunge at each other in rapid succession, and supplemental movie S3 appears to include bouts of "holding", in which one fly holds the opponent's wings and shakes vigorously. These cases raise a concern that their behavior classification is arbitrary. Specifically, lunges and tussling should be objectively distinguished because one of their conclusions is that these two actions are controlled by separate neural circuits. It is impossible to evaluate the credibility of their behavioral data without clearly describing a criterion of each behavior.

      Thank you for this very important suggestion. We now provided more detailed description of the two fighting forms in the Materials and Methods section. See below

      Lunging is characterized by a male raising its forelegs and quickly striking the opponent, and each lunge typically lasts less than 0.2 seconds through detailed analysis. Tussling is characterized by both males using their forelegs and bodies to tumble over each other, and this behavior may last from seconds to minutes. Tussling is often mixed with boxing, in which both flies rear up and strike the opponent with forelegs. Since boxing is often transient and difficult to distinguish from tussling, we referred to the mixed boxing and tussling behavior simply as tussling. As we manually analyze tussling for 2 hours for each pair of males, it is possible that we may miss some tussling events, especially those quick ones.

      It is also confusing that the authors completely skipped the characterization of the tussling-controlling neurons they claimed to have identified. These neurons (a subset of so-called pC1 neurons labeled by previously described split-GAL4 line pC1SS2) are central to this manuscript, but the only information the authors have provided is its gross morphology in a low-resolution image (Figure 4D, E) and a statement that "only 3 pairs of pC1SS2 neurons whose function is both necessary and sufficient for inducing tussling in males" (lines 310-311). The evidence that supports this claim isn't provided. The expression pattern of pC1SS2 neurons in males has been only briefly described in reference 46. It is possible that these neurons overlap with previously characterized dsx+ and/or fru+ neurons that are important for male aggressions (measured by lunges), such as in Koganezawa et al., Curr. Biol. 2016 and Chiu et al., Cell 2020. This adds to the concern that lunge and tussling are not as clearly separated as the authors claim.

      Thank you very much for this important question. Indeed, there are many experiments that could do to better understand the function of pC1SS2 neurons, and we only provide the initial characterization of them due to the limited scope of this study. My lab has been focused on studying P1/pC1 function in both male and female flies and will continue to do so.

      To partially address your concern, we made the following revisions

      (1) We provided higher-resolution images of P1a and pC1SS2 (Figure 4C-4E). While their cell bodies are very close, they project to distinct brain regions, in addition to some shared ones.

      (2) By staining these neurons with GFP and co-staining with anti-FruM or anti-DsxM antibodies, we showed that P1a neurons are partially FruM-positive and partially DsxM-positive, while pC1SS2 neurons are DsxM-positive and FruM-negative (Figure 5A-5D).

      (3) As pC1SS2 neurons are DsxM-positive and FruM-negative, we also examined how DsxM regulates the development of these neurons. We found that knocking down DsxM expression in pC1SS2 neurons using RNAi significantly affected pC1 development regarding to both cell numbers (Figure 5G) and their projections (Figure 5H).

      (4) We further found that DsxM in pC1SS2 neurons is crucial for executing their tussling-promoting function, as optogenetic activation of these neurons with DsxM knockdown failed to induce tussling behavior in the initial activation period, and a much lower level of tussling in the second activation period compared to control males (Figure 5I-5K).

      (5) While it is very difficult to identify the upstream and downstream neurons of P1a and pC1SS2 neurons, we made an initial step by utilizing trans-tango and retro-Tango to visualize potential downstream and upstream neurons of P1a and pC1SS2 (Figure 4-figure supplement 2), which certainly needs future investigation.  

      While their characterizations of tussling behaviors in wild-type males (Figures 1 and 2) are intriguing, the remaining data have little link with each other, making it difficult to understand what their main conclusion is. Figure 3 suggests that one class of olfactory sensory neurons (OSN) that express Or47b is necessary for tussling behavior. While the authors acknowledged that Or47b-expressing OSNs promote male courtship toward females presumably by detecting cuticular compounds, they provided little discussion on how a class of OSN can promote two different types of innate behavior. No evidence of a functional or circuitry relationship between the Or47b pathway and the pC1SS2 neurons was provided. It is unclear how these two components are relevant to each other.

      It has been previously found that Or47b-expressing ORNs respond to fly pheromones common to both sexes, and group-housing enhances their sensitivity. Regarding to how Or47b ORNs promotes two different types of innate behaviors, a simple explanation is that they act on multiple second-order and further downstream neurons to regulate both courtship and aggression, not mentioning that neural circuitries for courtship and aggression are partially shared. We did not include this in the discussion as we would like to focus on aggression modes, and how different ORNs (Or47b and Or67d) mediate distinct aggression modes.

      Regarding to the relationship between Or47b ORNs and pC1<sub>SS2</sub> neurons, or in general ORNs to P1/pC1, it is interesting and important to explore, but probably in a separate study. We tried to conduct pathway connection analyses from Or47b to pC1 using the FlyWire database, and found that Or47b neurons can act on pC1 neurons via three layers of interneurons. Although the FlyWire database currently only contains neuronal data from female brains, they can provide a certain degree of reference. We hope the editor and reviewers would agree with us that identifying these intermediate neurons involved in their connection is beyond this study.

      Lastly, the rationale of the experiment in Figure 5 and the interpretation of the results is confusing. The authors attributed a higher mating success rate of older, socially experienced males over younger, socially isolated males to their tendency to tussle, but tussling cannot happen when one of the two flies is not engaged. If, for instance, a socially isolated 14-day-old male does not engage in tussling as indicated in Figure 2, how can they tussle with a group-housed 14-day-old male? Because aggressive interactions in Figure 5 were not quantified, it is impossible to conclude that tussling plays a role in copulation advantage among pairs as authors argue (lines 282-288).

      Indeed, we do not have direct evidence to show it is tussling that makes socially experienced males to dominate over socially isolated males. To address your concern, we have made following revisions

      (1) We toned down the statements about the relationship between fighting strategies and reproductive success throughout the manuscript. For example, in the abstract Moreover, shifting from lunging to tussling in socially enriched males is accompanied with better territory control and mating success.

      (2)  Regarding to whether a SH male can engage in tussling with a GH male, we found that while two SH males rarely perform tussling, paired SH and GH males displayed similar levels of tussling like two GH males, although tussling duration from paired SH and GH males is significantly lower compared to that in two GH males (Figure 6-figure supplement 2).

      (3) To support the potential role of tussling in territory control and mating competition, we performed additional experiments to silence Or47b or pC1SS2 neurons that almost abolished tussling, and paired these males with control males. We found that males with Or47b or pC1SS2 neurons silenced cannot compete over control males, further suggesting the involvement of tussling in territory control and mating competition.  

      Despite these weaknesses, it is important to acknowledge the authors' courage to initiate an investigation into a less characterized, high-intensity fighting behavior. Tussling requires the simultaneous engagement of two flies. Even if there is confusion over the distinction between lunges and tussling, the authors' conclusion that socially experienced flies and socially isolated flies employ distinct fighting strategies is convincing. Questions that require more rigorous studies are 1) whether such differences are encoded by separate circuits, and 2) whether the different fighting strategies are causally responsible for gaining ethologically relevant resources among socially experienced flies. Enhanced transparency of behavioral data will help readers understand the impact of this study. Lastly, the manuscript often mentions previous works and results without citing relevant references. For readers to grasp the context of this work, it is important to provide information about methods, reagents, and other key resources.

      Thank you very much for this comment and we almost totally agree.

      (1) Our results suggest the involvement of distinct sensory neurons and central neurons for lunging and tussling, but do not exclude the possibility that they may also utilize shared neurons. For example, activation of P1a neurons promotes both lunging and tussling in the presence of light.

      (2) We have now toned down the statements about the relationship between fighting strategies and reproductive success throughout the manuscript.

      (3) We provided more detailed methods, genotypes of flies to improve transparency of the manuscript.

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 1 Supplement 1 shows that increased aging has a linear and inverse relationship with the number of lunges, this is in contrast to a previous study from Dierick lab (Chowdhury, 2021), where using Divider assays they showed that aggressive lunges increased up to day 10 and subsequently decreased in 30-day old flies. Given that this study did not use 14-day-old flies, it might be useful to comment on this.

      Thank you for this comment. Indeed, Chowdhury et al., suggested a decline of lunging after 10 days, which is not contradictory to our findings that lunging in 14d-old males is lower than that in 7d-old males. It is ideally to perform a time-series experiments to reveal the detailed relationship between ages and aggression (lunging or tussling) levels, but given our initial findings that 14d-old males showed stable tussling behavior, we prefer to use this time point for the rest of this study.

      (2) For Figure 3, do various manipulations also affect the duration of tussling and boxing besides frequency and latency?

      Thank you for this comment. We only analyzed latency and frequency, but not duration, as data analysis was performed manually rather than automatically on every fly pair for about 2 hours, which is very labor-consuming. We hope you could agree with us that the two parameters (frequency and latency) for tussling are representative for assaying this behavior.

      (3) For Figure 3 A-F, the housing status of the males is not clearly mentioned either in the main text or the figure. What is the status of the tussling and lunging status when this housing condition is reversed when Or47b neurons are silenced, or the gene is knocked down? Do these manipulations overcome the effect of housing conditions similar to what is seen in NaChBac-mediated activation experiments?

      Figure 3A-F used group-housed males and we have now added such information in the figure legends as well as Table S1.

      We appreciate your suggestion on using different housing conditions. As silencing Or47b neurons or knocking down Or47b reduced tussling, it is reasonable to use GH males (as we did in Figure 3A-F) that performed stable tussling behavior, but not SH males that rarely tussle.

      (4) The connections between Or47b neurons and pC1SS2 or P1a neurons can be addressed by available connectomic datasets or TransTango/GRASP approaches.

      Thank you for this important suggestion. We used the FlyWire electron microscope database to analyze the pathway connections between these two types of neurons. The results indicated that there are at least three levels of interneurons for connecting Or47b and pC1 neurons. Although the FlyWire database currently only contains neuronal data from female brains, they can provide a certain degree of reference for males.

      The lack of direct synaptic connection also suggests that it is challenging to resolve the connection between these two neuronal types using methods like trans-Tango/GRASP. To partially address this question, we utilized trans-Tango and retro-Tango techniques to visualize potential downstream and upstream neurons of P1a and pC1SS2 (Figure 4-figure supplement 2). Future investigations are certainly needed for clarifying functional connections between Or47b/Or67d and P1a/pC1SS2 neurons.

      (5) Figure 5, 'Winning index' and 'Copulation advance index' while described in Material and Methods, should be referred to in the main text.

      We now described these two indices briefly in the main manuscript, and in the Discussion section with more details.

      (6) Figure 6 shows comparisons for territorial control and mating outcomes where four different housing and aging conditions are organized in a hierarchical sequence. It is not clear from the data in Figure 5, how this conclusion was arrived at. A supplementary table with various outcomes with statistical analysis would help with this.

      We now added a supplementary table (Table S2) with various outcomes with statistical analysis.

      Minor Comments

      (1) Line 26 says that the courtship levels in SH and GH males are not different, however, unilateral wing extension is higher in SH males as compared to GH males (Pan & Baker, 2014; Inagaki et al., 2014), also it was shown that courtship attempts are higher in D. paulsitorium (Kim & Ehrman, 1998). It would be better to clarify this statement.

      Indeed, it is found in some cases that SH males court more vigorously than GH males. We have added more references on this matter in the introduction.

      (2) Figure 4, correct 'Tussing' to 'Tussling' or 'Box, Tussling' as appropriate.

      Corrected.

      (3) Duistermars, 2018 should be cited while discussing the role of vision in aggression (Figure 4). [A Brain Module for Scalable Control of Complex, Multi-motor Threat Displays]

      We now cited this reference and added more discussion in the revised manuscript.

      (4) Reviews on Drosophila aggression and social isolation can be cited in the introduction/discussion to incorporate recent literature e.g., Palavicino-Maggio, 2022 [The Neuromodulatory Basis of Aggression Lessons From the Humble Fruit Fly]; Yadav et al., 2024[Lessons from lonely flies Molecular and neuronal mechanisms underlying social isolation], etc.

      We now cited these references in both the introduction and discussion sections.

      (5) The concentration of apple juice agar should be mentioned in the methods.

      We added this and other necessary information for materials in the Materials and Methods section of the study.

      (6) Source of the LifeSongX software and, if available, a Github link would be helpful to include in the materials and methods section.

      We now provided the source of the LifesongY software (website https//sourceforge.net/projects/lifesongy/), which is a Windows version of LifesongX (Bernstein, Adam S.et al., 1992).

      Reviewer #2 (Recommendations for the authors):

      (1) Major comment 1

      As pointed out in the public review, the weakness of this study is that the relationship between the aggression strategy and reproductive success is an inference that is not based on experimental facts; I understand that the frequency of tussling is not so high, but at least tussling-like behavior can be observed in the territory control experiment shown in Video 3. Wouldn't it be possible to re-analyse data and examine the correlation between aggressive behavior and territory control? Even if the analysis of tussling itself in this setup is difficult, for example, additional experiments using Or47b knock-out fly or pC1[SS2]-inactivated fly could provide stronger support.

      Indeed, we can only make a correlation between the type of aggressive behavior and territory control. We now toned down this statement throughout the manuscript. For example, in the abstract, we changed our conclusions as following

      Moreover, shifting from lunging to tussling in socially enriched males is accompanied with better territory control and mating success. Our findings identify distinct sensory and central neurons for two fighting forms and suggest how social experience shapes fighting strategies to optimize reproductive success.

      To further address the concern, we now performed additional experiments to silence Or47b or pC1SS2 neurons that almost abolished tussling, and paired these males with control males. We found that males with Or47b or pC1SS2 neurons silenced cannot compete over control males (Figure 6-figure supplement 3), further suggesting the involvement of tussling in territory control and mating competition.

      In relation to the above, some of the text in the Abstract should be changed.Line 28 These findings "reveal" how social experience shapes fighting strategies to optimise reproductive success.

      "suggest" is more accurate at this stage.

      Changed as suggested.

      (2) Major comment 2

      The tussling is the central subject of this paper. However, neither the main text nor Materials and Methods section provides a clear explanation of how this aggression mode was detected. Did the authors determine this behavior manually? Or was it automatically detected by some kind of image analysis? In either case, the criteria and method for detecting the tussling should be clearly described.

      The behavioral data analysis in this study was performed manually. We now provided more detailed description of the two fighting forms in the Materials and Methods section. See below

      Lunging is characterized by a male raising its forelegs and quickly striking the opponent, and each lunge typically lasts less than 0.2 seconds through detailed analysis. Tussling is characterized by both males using their forelegs and bodies to tumble over each other, and this behavior may last from seconds to minutes. Tussling is often mixed with boxing, in which both flies rear up and strike the opponent with forelegs. Since boxing is often transient and difficult to distinguish from tussling, we referred to the mixed boxing and tussling behavior simply as tussling. As we manually analyze tussling for 2 hours for each pair of males, it is possible that we may miss some tussling events, especially those quick ones.

      For the experimental groups where tussling cannot be observed, the latency is regarded as 120 min, but this is a value depending on the observation time. While it is reasonable to use the latency to evaluate the behavior such as the lunging that is observed at relatively early times, care should be taken when using it to evaluate the tussling. Since similar trends to those obtained for the latency are observed for Number of tussles and % of males performing tussling, it may be better to focus on these two indices.

      We initially intended to provide all three statistical metrics. However, we found that using the "% of males performing tussling" would require a significantly larger sample size for subsequent statistical analysis (using chi-square tests), greatly increasing the workload. At the same time, we believe that the trend observed with "% of males performing tussling" is consistent with the other two indices, and the percentage information can also be derived from the individual sample scatter data of the other two metrics. Therefore, we opted to use "latency" and "numbers" as the statistical metrics, despite the caveat as you mentioned.

      The authors repeatedly mention that tussling is less frequent but more vigorous. The low frequency can be understood from the data in Fig. 1 and Fig. 2, but there are no measured data on the intensity. As the authors mention in line 125, each tussling event appears to be sustained for a relatively long period, as can be seen from the ethogram in Fig. 2. For example, it would be possible to evaluate the intensity by measuring the duration of the tussling event.

      Thank you for your valuable suggestion. We now analyzed duration of tussling and lunging, and found that a lunging event is often very short (less than 0.2s), while a tussling event may last from seconds to minutes, further supporting their relative intensities. This new data is added as Figure 2G.

      (3) Minor comments

      a) Line 117 How many flies were placed in one vial for group-rearing (GH)? Were males and females grouped together? Please specify in the Materials and Methods section.

      We have added this information in the Materials and Methods section. In brief, 30-40 virgin males were collected after eclosion and group-housed in each food vial.

      b) Line 174 The trans-Tango is basically a postsynaptic cell labeling technique. It is unlikely that the labeling intensity changes depending on neuronal activity. Do the authors want to say in this text the high activity of Or47b-expressing neurons under GH conditions? Or are they trying to show that the expression level of the Or47b gene, which is supposedly monitored by the expression of GAL4, is increased by GH conditions? The authors should clarify which is the case.

      Although the primary function of the trans-Tango technique is to label downstream neurons, the original literature indicates that the signal strength in downstream neurons depends on the use of upstream neurons evidenced by age-dependent trans-Tango signals. Therefore, the trans-Tango technique can indirectly reflect the usage of upstream neurons. Our findings that GH males showed broader Or47b trans-Tango signals than SH males can indirectly suggest that group-housing experience acts on Or47b neurons. We made textually changes to clarify this.

      c) Line 178 Which fly line labels the mushroom body; R19B03-GAL4?

      Yes, we now provided the detailed genotypes for all tested flies in the Table S1.

      d) Line 184 It was reported in Koganezawa et al., 2016 that some dsx-expressing pC1 neurons are involved in aggressive behavior. The authors should also refer to this paper as they include tussling in the observed aggressive behavior.

      Thank you for this comment, and we now cited this reference in the revised manuscript.

      e) Line 339 I think you misspelled fruM RNAi.

      Thank you for pointing this out. fruMi refers to microRNAi targeting fruM, and we have now clearly stated this information in the main text.

      f) Line 681 Is tussling time (%) the total duration of tussling occurrences during the observation time? Or is it the percentage of individuals observed tussling during the observation time? This needs to be clarified.

      It is the former one. We now clearly stated this definition in the Materials and Methods section

      Reviewer #3 (Recommendations for the authors):

      For authors to support their conclusion that enhanced tussling among socially experienced flies allows them to better retain resources, it is necessary to quantify aggressive behaviors (mainly tussling and lunging) in Figure 5.

      We agree that we can only make a correlation between enhanced tussling behavior and mating competition. We now toned down this statement throughout the manuscript. For example, in the abstract, we changed our conclusions as following Moreover, shifting from lunging to tussling in socially enriched males is accompanied with better territory control and mating success. Our findings identify distinct sensory and central neurons for two fighting forms and suggest how social experience shapes fighting strategies to optimize reproductive success.

      To further address the concern, we now performed additional experiments to silence Or47b or pC1SS2 neurons that almost abolished tussling, and paired these males with control males. We found that males with Or47b or pC1SS2 neurons silenced cannot compete over control males (Figure 6-figure supplement 3), further suggesting the involvement of tussling in territory control and mating competition.

      In contrast to the authors' data in Figure 4, movies in ref 36 clearly show instances of 2 flies exchanging lunges after the optogenetic activation of P1a neurons, like the examples shown in supplementary movies S1-S3. It is a clear discrepancy that requires discussion (and raises a concern about the lack of transparency about behavioral quantification).

      In our study, optogenetic activation of P1<sup>a</sup> neurons failed to induce obvious tussling behavior, and temperature-dependent activation of P1<sup>a</sup> neurons can only induce tussling in the presence of light. These data are different from Hoopfer et al., (2015), but are generally consistent with a new study (Sten et al., Cell, 2025), in which pC1SS2 neurons but not P1a neurons promote aggression. Such discrepancy has now been discussed in the revised manuscript.

      The authors often fail to cite relevant references while discussing previous results, which compromises the scholarship of the manuscript. Examples include (but are not limited to)

      (1) Line 85-86 Simon and Heberlein, J. Exp. Biol. 223 jeb232439 (2020) suggested that tussling is an important factor for flies to establish a dominance hierarchy.

      Reference added.

      (2) Line 142-143 Cuticular compounds such as palmitoleic acid are characterized to be the ligands of Or47b by ref #18.

      Reference added.

      (3) Line 185-187 pC1SS1 and pC1SS2 are first characterized by ref #46. Expression data of this paper also implies that pC1SS1 and pC1SS2 label different neurons in the male brain.

      We have now added this reference at the appropriate place in the revised manuscript. In addition, we have clarified that these two drivers exhibit sexually dimorphic expression patterns in the brain.

      (4) Line 196-199 Cite ref #36, which describes the behavior induced by the optogenetic activation of P1a neurons.

      Reference added.

      (5) Line 233-235 The authors' observation that control males do not form a clear dominance directly contradicts previous observations by others (Nilsen et al., PNAS 10112342 (2002); Yurkovic et al., PNAS 10317519 (2006); also see Trannoy et al., PNAS 1134818 (2016) and Simon and Heberlein above). The authors must at least discuss why their results are different.

      There is a misunderstanding here. We clearly state that there is a ‘winner takes all’ phenomenon. However, for wild-type males of the same age and housing condition, we calculated the winning index as (num. of wins by unmarked males – num. of wins by marked males)/10 encounters * 100%, which is roughly zero due to the randomness of marking.

      (6) Line 251-254 The authors' observation that aged males are less competitive than younger males contradicts the conclusion in ref #18. Discussion is required.

      We have now added a discussion on this matter. In brief, Lin et al., showed that 7d-old males are more competitive than 2d-old males, which is probably due to different levels of sexual maturity of males, but not a matter of age like our study that used up to 21d-old males.

      (7) Line 274-275 It is unclear which "previous studies" "have found that social isolation generally enhances aggression but decreases mating competition in animal models". Cite relevant references.

      Reference added.

      (8) Line 309-310 The evidence supporting the statement that "there are only three pairs of pC1SS2 neurons". If there is a reference, cite it. If it is based on the authors' observation, data is required.

      We have now provided additional data on the number of pC1SS2 neurons in Figure 5G of the revised manuscript.

    1. Reviewer #1 (Public review):

      The manuscript by Feng et al. reported that Endothelin B receptor (ETBR) expressed by the satellite glial cells (SGCs) in the dorsal root ganglions (DRG) acted to inhibit sensory axon regeneration in both adult and aged mice. Thus, pharmacological inhibition of ETBR with specific inhibitors resulted in enhanced sensory axon regeneration in vitro and in vivo. In addition, sensory axon regeneration significantly reduces in aged mice and inhibition of ETBR could restore such defect in aged mice. Moreover, the study provided some evidence that the reduced level of gap junction protein connexin 43 might act downstream of ETBR to suppress axon regeneration in aged mice. Overall, the study revealed an interesting SGC-derived signal in the DRG microenvironment to regulate sensory axon regeneration. It provided additional evidence that non-neuronal cell types in the microenvironment function to regulate axon regeneration via cell-cell interaction.

      However, the molecular mechanisms by which ETBR regulates axon regeneration are unclear, and the structure of the manuscript is relatively not well organized, especially the last section. Some discussion and explanation about the data interpretation are needed to improve the manuscript.

      (1) The result showed that the level of ETBR was not changed after the peripheral nerve injury. Does it mean that its endogenous function is to limit the spontaneous sensory axon regeneration? In other words, the results suggest that SGCs expressing ETBR or vascular endothelial cells expressing its ligand ET-1 act to suppress sensory axon regeneration. Some explanation or discussion about this are necessary. Moreover, does the protein level of ETBR or its ligand change during aging?

      (2) In ex vivo experiments, NGF was added in the culture medium. Previous studies have shown that adult sensory neurons could initiate fast axon growth in response to NGF within 24 hours. In addition, dissociated sensory neurons could also initiate spontaneous regenerative axon growth without NGF after 48 hours. Some discussion or rationale is needed to explain the difference between NGF-induced or spontaneous axon growth of culture adult sensory neurons and the roles of ETBR and SGCs.

      (3) In cultured dissociated sensory neurons, inhibiting ETBR also enhanced axon growth, which meant the presence of SGCs surrounding the sensory neurons. Some direct evidence is needed to show the cellular relationship between them in culture.

      (4) In Figure 3, the in vivo regeneration experiments first showed enhanced axon regeneration either at 1 day or 3 days after the nerve injury. The study then showed that inhibiting ETBR could enhance sensory axon growth in vitro from uninjured naïve neurons or conditioning lesioned neurons. To my knowledge, in vivo sensory axon regeneration is relatively slow during the first 2 days after the nerve injury and then enter the fast regeneration mode in the 3rd day, representing the conditioning lesion effect in vivo. Some discussion is needed to compare the in vitro and the in vivo model of axon regeneration.

      (5) In Figure 5, the study showed that the level of connexin 43 increased after ETBR inhibition in either adult or aged mice, proposing an important role of connexin 43 in mediating the enhancing effect of ETBR inhibition on axon regeneration. However, in the study there was no direct evidence supporting that ETBR directly regulate connexin 43 expression in SGCs. Moreover, there was no functional evidence that connexin 43 acted downstream of ETBR to regulate axon regeneration.

      In the revised manuscript, most comments have been addressed with some new experiments or text revisions in the results or discussion. For representative images showing in vitro cultured DRG neurons, it would be much more convincing if several neurons in the same imaging field are shown, rather than a single neuron (Figure 2A, 3J).

    2. Reviewer #2 (Public review):

      Summary:

      Feng and colleagues set out to investigate the effect of manipulating endothelin signaling on nerve regeneration, focusing on the crosstalk between endothelial cells (ECs) in dorsal root ganglia (DRG), which secrete ET-1, and satellite glial cells (SGCs), which express the ETBR receptor. ETBR signaling limits axon growth. Using in vitro explant assays coupled with pharmacological inhibition in mouse models of nerve injury, the authors demonstrate that the ETAR/ETBR antagonist Bosentan promotes axon regeneration, and that this effect is maintained in aged mice. Although Bosentan inhibits both endothelin receptors A and B, comparison with an ETAR-specific antagonist suggests primary involvement of the ET-1/ETBR pathway. In the DRG, ETBR is mostly expressed by SGCs, a cell type implicated in nerve regeneration. SGCs ensheath and couple with DRG neurons through gap junctions formed by Cx43. The pro-regenerative effects of ETBR inhibition are attributed in part to an increase in Cx43 levels, which are expected to enhance neuron-SGC coupling. snRNA sequencing and TEM analysis reveal a decline in SGC numbers, morphological changes, and transcriptional reprogramming that may impair their pro-regenerative capacity.

      Strengths:

      The study is well-executed, and the main conclusion (that ETBR signaling inhibits axon regeneration after nerve injury and contributes to the age-related decline in regenerative capacity) is well supported by the data. In addition, the study highlights the importance of vascular signals in nerve regeneration, a topic that has gained traction in recent years. Importantly, these results further emphasize the contribution of long-neglected SGCs to nerve tissue homeostasis and repair. Although the study does not provide a complete mechanistic understanding, the findings are robust and are likely to attract the interest of a broad readership.

      Weaknesses:

      While certain aspects could have been further addressed experimentally, these points were either technically challenging or considered beyond the scope of the current study, and are appropriately addressed in the Discussion.

      (1) It remains to be determined whether the accelerated axon regrowth observed after nerve injury depends on cellular crosstalk mediated by ET-1 at the lesion site. Are ECs along the nerve secreting ET-1? What cells are present in the nerve stroma that could respond and participate in the repair process? Would these interactions be sensitive to Bosentan? Dissecting these contributions would require cell-specific manipulations. The potential roles of ECs, fibroblast and SCs in the nerve are discussed.

      (2) It is suggested that the permeability of DRG vessels may facilitate the release of vascular-derived signals. The possibility that the ET-1/ETBR pathway modulates vascular permeability, and that this in turn contributes to the observed effects on regeneration, is discussed.

      (3) It cannot be excluded that ET-3 in fibroblasts is relevant for controlling SGC responses. The possibility that both ET-1 and ET-3 participate in ETBR- dependent effect on axon regeneration is discussed.

      (4) The discovery that ET-1/ETBR signaling in SGC curtails the growth capacity of axons at baseline raises questions about the physiological role of this pathway. This remains to be elucidated with cell type-specific knockout approaches.

      (5) The modulation of Cx43 expression by ET-1/ETBR is examined by immunostaining, but a complementary analysis by quantitative RT-PCR on sorted SGCs would have been a valuable addition. However, quantifying Cx43 on purified SGCs was not attainable due to technical complications.

      (6) The conclusion "that ETBR inhibition in SGCs contributes to axonal regeneration by increasing Cx43 levels, gap junction coupling or hemichannels and facilitating SGC-neuron communication" are consistent with previous studies (Procacci et al., 2008) but in apparent discrepancy with increased gap junctions and dye coupling in SGCs of aged mice (Huang et al., 2006). More experiments are required to clarify what distinguishes a beneficial increase in coupling after ETBR inhibition, from what is observed in aging.

      (7) The effect of Bosentan likely extends beyond the modulation of Cx43 levels. Cell type-specific knockout of Cx43 and ETBR, studies of SGCs-neuron coupling, and biochemical analysis of Cx43 functions would clarify the link between ETBR, Cx43 regulation, and axon regeneration. A discussion of alternative mechanisms is provided.

    3. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      The manuscript by Feng et al. reported that the Endothelin B receptor (ETBR) expressed by the satellite glial cells (SGCs) in the dorsal root ganglions (DRG) acted to inhibit sensory axon regeneration in both adult and aged mice. Thus, pharmacological inhibition of ETBR with specific inhibitors resulted in enhanced sensory axon regeneration in vitro and in vivo. In addition, sensory axon regeneration significantly reduces in aged mice and inhibition of ETBR could restore such defect in aged mice. Moreover, the study provided some evidence that the reduced level of gap junction protein connexin 43 might act downstream of ETBR to suppress axon regeneration in aged mice. Overall, the study revealed an interesting SGC-derived signal in the DRG microenvironment to regulate sensory axon regeneration. It provided additional evidence that non-neuronal cell types in the microenvironment function to regulate axon regeneration via cell-cell interaction. 

      However, the molecular mechanisms by which ETBR regulates axon regeneration are unclear, and the manuscript's structure is not well organized, especially in the last section. Some discussion and explanation about the data interpretation are needed to improve the manuscript. 

      We thank the reviewer for the positive comments. We agree that the mechanisms by which ETBR signaling functions as a brake on axon growth and regeneration remain to be elucidated. We believe that unraveling the detailed molecular pathways downstream of ETBR signaling in SGCs that promote axon regeneration is beyond the scope of this manuscript. Answering these questions would first require cell specific KO of ETBR and Cx43 to confirm that this pathway is operating in SGCs to control axon regeneration. We would also need to identify how SGCs communicate with neurons to regulate axon regeneration, which is a large area of ongoing research that remains poorly understood. Our data showing that pharmacological inhibition of ETBR with specific FDA-approved inhibitors enhances sensory axon regeneration provide not only new evidence for non-neuronal mechanisms in nerve repair, but also a new potential clinical avenue for therapeutic intervention.

      As suggested by the reviewer, we have extensively revised the organization of the manuscript, especially the last section of results. We have performed additional snRNAseq experiments to establish the impact of aging in DRG. We have also performed additional experiments to determine if blocking ETBR improves target tissue reinnervation. Following the reviewer’s suggestion, we have also expanded the Discussion section to discuss alternative mechanisms and o]er additional interpretation of our data. Below we describe how we address each point in detail.

      (1) The result showed that the level of ETBR did not change after the peripheral nerve injury. Does this mean that its endogenous function is to limit spontaneous sensory axon regeneration? In other words, the results suggest that SGCs expressing ETBR or vascular endothelial cells expressing its ligand ET-1 act to suppress sensory axon regeneration. Some explanation or discussion about this is necessary. Moreover, does the protein level of ETBR or its ligand change during aging?  

      We thank the reviewer for this point. Our results indeed indicate that one endogenous function of ETBR is to limit the extent of sensory axon regeneration. This may be a part of a mechanism to limit spontaneous sensory axon growth or plasticity and maladaptive neural rewiring after nerve injury. While the increased growth capacity of damaged peripheral axons can lead to reconnection with their targets and functional recovery, the increased growth capacity can also lead to axonal sprouting of the central axon terminals of injured neurons in the spinal cord, and to pain (see for example Costigan et al 2010, PMID: 19400724).  In the context of aging that we describe here, this protective mechanism may hinder beneficial recovery. Other mechanisms that slow axon regeneration have been reported, and include, for example, axonally synthesized proteins, which typically support nerve regeneration through retrograde signaling and local growth mechanisms. RNA binding proteins (RBP) are needed for this process. One such RBP, the RNA binding protein KHSRP is locally translated following nerve injury. Rather than promoting axon regeneration, KHSRP promotes decay of other axonal mRNAs and slows axon regeneration.  Another example includes the Rho signaling pathway, which was shown to function as an inhibitory mechanism that slows the growth of spiral ganglion neurites in culture. We have now included these examples in the Discussion section.

      To address the reviewer’s second question, we have checked protein levels of ETBR and ET-1 in adult and aged DRG tissue. We observed a robust increase in ET-1 in aged DRG, while the levels of ETBR did not appear to change significantly. These results are now presented in Figure 4- Figure Supplement 1, and further support the notion that in aging, activation of the ETBR signaling hinders axon regeneration.

      (2) In ex vivo experiments, NGF was added to the culture medium. Previous studies have shown that adult sensory neurons could initiate fast axon growth in response to NGF within 24 hours. In addition, dissociated sensory neurons could also initiate spontaneous regenerative axon growth without NGF after 48 hours. Some discussion or rationale is needed to explain the di]erence between NGF-induced or spontaneous axon growth of culture adult sensory neurons and the roles of ETBR and SGCs. 

      We appreciate the reviewer’s suggestion. In adult DRG explant or dissociated cultures, NGF is not typically required for survival or axon outgrowth. However, in dissociated culture, the addition of NGF to the medium stimulates growth from more neurons compared to controls (Smith and Skene 1997). In the DRG explant, NGF does not promote significant e]ects on axon growth, but stimulates glial cell migration (Klimovich et al 2020). We opted to included NGF in our explant assay to increase the potential of stimulating axon regeneration with pharmacological manipulations of ETBR. We have now clarified these considerations in the Method section.

      (3) In cultured dissociated sensory neurons, inhibiting ETBR also enhanced axon growth, which meant the presence of SGCs surrounding the sensory neurons. Some direct evidence is needed to show the cellular relationship between them in culture.  

      We thank the reviewer for raising this point and have added new data, now presented in Figure 2B, to show that in mixed DRG cultures, SGCs labeled with Fabp7 are present in the culture in proximity to neurons labeled with TUJ1, but they do not fully wrap the neuronal soma. These results are consistent with prior findings reporting that as time in culture progresses, SGCs lose their adhesive contacts with neuronal soma and adhere to the coverslip (PMID: 22032231, PMID: 27606776).  While in some cases SGCs can maintain their association with neuronal soma in the first day in culture after plating, in our hands, most SGCs have left the soma at the 24h time point we examined. 

      (4) In Figure 3, the in vivo regeneration experiments first showed enhanced axon regeneration either 1 day or 3 days after the nerve injury. The study then showed that inhibiting ETBR could enhance sensory axon growth in vitro from uninjured naïve neurons or conditioning lesioned neurons. To my knowledge, in vivo sensory axon regeneration is relatively slow during the first 2 days after the nerve injury and then enters the fast regeneration mode on the 3rd day, representing the conditioning lesion e]ect in vivo. Some discussion is needed to compare the in vitro and the in vivo model of axon regeneration. 

      We agree that axon growth is relatively slow the first 2 days and enters a fast growth mode on day 3. This has been elegantly demonstrated in Shin et al Neuron 2012 (PMID: 22726832), where an in vivo conditioning injury 3 days prior increases axon growth one day after injury. In vitro, similar e]ects have been described: a prior in vivo injury accelerates growth capacity within the first day in culture, but a similar growth mode occurs in naive adult neurons after 2-3 days in vitro (Smith and Skene 1996). We also know that the neurite growth in culture is stimulated by higher cell density, likely because non-neuronal cells can secrete trophic factors (Smith and Skene 1996). Our in vitro results thus suggest that blocking ETBR in SGCs in these mixed cultures may alter the media towards a more growth promoting state. In vivo, our data show that Bosentan treatment for 3 days partially mimics the conditioning injury and potentiate the e]ect of the conditioning injury. One possible interpretation is that inhibition of ETBR alters the release of trophic factors from SGCs. Future studies will be required to unravel how ETBR signaling influence the SGCs secretome and its influence on axon growth. We have now included these discussions points in the Results and Discussion Section.

      (5) In Figure 5, the study showed that the level of connexin 43 increased after ETBR inhibition in either adult or aged mice, proposing an important role of connexin 43 in mediating the enhancing e]ect of ETBR inhibition on axon regeneration. However, in the study, there was no direct evidence supporting that ETBR directly regulates connexin 43 expression in SGCs. Moreover, there was no functional evidence that connexin 43 acted downstream of ETBR to regulate axon regeneration.  

      We thank the reviewer for this point and agree that we do not provide direct evidence that connexin 43 acts downstream of ETBR to regulate axon regeneration. To obtain such functional evidence would require selective KO of ETBR and Cx43 in SGCs, which we believe is beyond the scope of the current study. We have revised the Results and Discussion sections to emphasize that while we observe that ETBR inhibition increases Cx43 levels and Cx43 levels correlates with axon regeneration, whether Cx43 directly mediates the e]ect on axon regeneration remains to be established.  We also discuss potential alternative mechanisms downstream of ETBR in SGCs that could contribute to the observed e]ects on axon regeneration. Specifically, we discuss the possibility that  ETBR signaling may limit axon regeneration via regulating SGCs glutamate reuptake functions, because of the following reasons: 1) Similarly to astrocytes, glutamate uptake by SGCs is important to regulate neuronal function, 2) exposure of cultured cortical astrocytes to endothelin results in a decrease in glutamate uptake that correlates with a major loss of basal glutamate transporter expression (GLT-1 and1), 3) Both glutamate transporters are expressed in SGCs in sensory ganglia 4) GLAST and glutamate reuptake function is important for lesion-induced plasticity in the developing somatosensory cortex. 

      Reviewer #2 (Public Review): 

      Summary: 

      In this interesting and original study, Feng and colleagues set out to address the e]ect of manipulating endothelin signaling on nerve regeneration, focusing on the crosstalk between endothelial cells (ECs) in dorsal root ganglia (DRG), which secrete ET-1 and satellite glial cells (SGCs) expressing ETBR receptor. The main finding is that ETBR signaling is a default brake on axon growth, and inhibiting this pathway promotes axon regeneration after nerve injury and counters the decline in regenerative capacity that occurs during aging. ET-1 and ETBR are mapped in ECs and SGCs, respectively, using scRNA-seq of DRGs from adult or aged mice. Although their expression does not change upon injury, it is modulated during aging, with a reported increase in plasma levels of ET-1 (a potent vasoconstrictive signal). Using in vitro explant assays coupled with pharmacological inhibition in mouse models of nerve injury, the authors demonstrate that ET-1/ETBR curbs axonal growth, and the ETAR/ETBR antagonist Bosentan boosts regrowth during the early phase of repair. In addition, Bosentan restores the ability of aged DRG neurons to regrow after nerve lesions. Despite Bosentan inhibiting both endothelin receptors A and B, comparison with an ETAR-specific antagonist indicates that the e]ects can be attributed to the ET-1/ETBR pathway. In the DRGs, ETBR is mostly expressed by SGCs (and a subset of Schwann cells) a cell type that previous studies, including work from this group, have implicated in nerve regeneration. SGCs ensheath and couple with DRG neurons through gap junctions formed by Cx43. Based on their own findings and evidence from the literature, the pro-regenerative e]ects of ETBR inhibition are in part attributed to an increase in Cx43 levels, which are expected to enhance neuron-SGC coupling. Finally, gene expression analysis in adult vs aged DRGs predicts a decrease in fatty acid and cholesterol metabolism, for which previous work by the authors has shown a requirement in SGCs to promote axon regeneration. 

      Strengths: 

      The study is well-executed and the main conclusion that "ETBR signaling inhibits axon regeneration after nerve injury and plays a role in age-related decline in regenerative capacity" (line 77) is supported by the data. Given that Bosentan is an FDA-approved drug, the findings may have therapeutic value in clinical settings where peripheral nerve regeneration is suboptimal or largely impaired, as it often happens in aged individuals. In addition, the study highlights the importance of vascular signals in nerve regeneration, a topic that has gained traction in recent years. Importantly, these results further emphasize the contribution of longneglected SGCs to nerve tissue homeostasis and repair. Although the study does not reach a complete mechanistic understanding, the results are robust and are expected to attract the interest of a broader readership. 

      We thank the reviewer for the positive comments, especially in regard to the rigor and originality of our study.

      Weaknesses: 

      Despite these positive comments provided above, the following points should be considered: 

      (1) This study examines the contribution of the ET-1 pathway in the ganglia, and in vitro assays are consistent with the idea that important signaling events take place there. Nevertheless, it remains to be determined whether the accelerated axon regrowth observed in vivo depends also on cellular crosstalk mediated by ET-1 at the lesion site. Are ECs along the nerve secreting ET-1? What cells are present in the nerve stroma that could respond and participate in the repair process? Would these interactions be sensitive to Bosentan? It may be di]icult to dissect this contribution, but it should at least be discussed.  

      We thank the reviewer for this important point and agree that the in vivo e]ects observed cannot rule out the contribution of ECs or SCs at the lesion site in the nerve. Dissecting the contribution of ETBR expressing cells in the nerve would require cell-specific manipulations that go beyond the scope of this manuscript. We have revised the Discussion section to highlight the potential contribution of ECs, fibroblast and SCs in the nerve.  

      (2) It is suggested that the permeability of DRG vessels may facilitate the release of "vascularderived signals" (lines 82-84). Is it possible that the ET-1/ETBR pathway modulates vascular permeability, and that this, in turn, contributes to the observed e]ects on regeneration?  

      We thank the reviewer for raising this interesting point. ET-1 can have an impact on vascular permeability. It was indeed shown that in high glucose conditions, increased trans-endothelial permeability is associated with increased Edn1, Ednra and Ednrb expression and augmented ET1 immunoreactivity (PMID: 10950122). It is thus possible that part of the e]ects observed results from altered vascular permeability. We have included this point in the Discussion section. Future experiments will be required to test how injury and age a]ects vascular permeability in the DRG.

      (3) Is the a]inity of ET-3 for ETBR similar to that of ET-1? Can it be excluded that ET-3 expressed by fibroblasts is relevant for controlling SGC responses upon injury/aging?  

      We thank the reviewer for raising this point. ET-1 binds to ETAR and ETBR with the same a]inity, but ET3 shows a higher a]inity to ETBR than to ETAR (Davenport et al. Pharmacol. Rev 2016 PMID: 26956245). We attempted to examine ET-3 level in adult and aged DRG by western blot, but in our hands the antibody did not work well enough, and we could not obtain clear results. We thus cannot exclude the possibility that ET-3 released by fibroblasts contribute to the e]ects we observe on axon regeneration. Indeed, in cultured cortical astrocytes, application of either ET-1 or ET-3 leads to inhibition of Cx43 expression. We have revised the text in the Discussion section to highlight the possibility that both ET-1 and ET-3 could participate on the ETBRdependent e]ect on axon regeneration.

      (4) ETBR inhibition in dissociated (mixed) cultures uncovers the restraining activity of endothelin signaling on axon growth (Figure 2C). Since neurons do not express ET-1 receptors, based on scRNA-seq analysis, these results are interpreted as an indication that basal ETBR signaling in SGC curbs the axon growth potential of sensory neurons. For this to occur in dissociated cultures, however, one should assume that SGC-neuron association is present, similar to in vivo, or to whole DRG cultures (Figure 2C). Has this been tested?

      We thank the reviewer for this point. In dissociated DRG culture, neurons, SGCs and other nonneuronal cells are present, but SGCs do not retain the surrounding morphology as they do in vivo. Within 24 hours in culture, SGCs lose their adhesive contacts with neuronal soma and adhere to the coverslip (PMID: 22032231, PMID: 27606776).  We have included new data in Figure 2B to show that in our culture conditions, SGCs are present, but do not wrap neurons soma as they do in vivo. We also know from prior studies that the density of the culture a]ects axon growth, an e]ect that was attributed to trophic factors released from non-neuronal cells (Smith and Skene 1997). Therefore, although SGCs do not surround neurons, the signaling pathway downstream of ETBR may be present in culture and contribute to the release of trophic factors that influence axon growth. We have revised the Results section to better explain our in vitro results and their interpretation.

      In both in vitro experimental settings (dissociated and whole DRG cultures) how is ETBR stimulated over up to 7 days of culture? In other words, where does endothelin come from in these cultures (which are unlikely to support EC/blood vessel growth)? Is it possible that the relevant ligand here derives from fibroblasts (see point #6)? Or does it suggest that ETBR can be constitutively active (i.e., endothelin-independent signaling)? Is there any chance that endothelin is present in the culture media or Matrigel? 

      We thank the reviewer for raising this point.  Our single-cell data indicate that ET-1 is expressed by endothelial cells and ET-3 by fibroblasts. In dissociated DRG culture at 24h time point, all DRGs cells are present, including endothelial cells and fibroblasts, and could represent the source of ET-1 or ET-3. In the explant setting, it is also possible that both ET-1 and ET-3 are released by endothelial cells and fibroblasts during the 7 days in culture. According to information for the suppliers, endothelin is not present neither in the culture media nor in the Matrigel. While mutations can facilitate the constitutive activity of the ETBR receptor, we are not aware of data showing that endogenous ETBR can be constitutively active.  Because the molecular mechanisms governing ETBR -mediated signaling remain incompletely understood (see for example PMID: 39043181, PMID: 39414992) future studies will be required to elucidate the detailed mechanisms activating ETBR in SGCs and its downstream signaling mechanisms.  We have now expanded the Results and discussion sections to clarify these points. 

      (5) The discovery that ET-1/ETBR signaling in SGC curtails the growth capacity of axons at baseline raises questions about the physiological role of this pathway. What happens when ETBR signaling is prevented over a longer period of time? This could be addressed with pharmacological inhibitors, or better, with cell-specific knock-out mice. The experiments would certainly be of general interest, although not within the scope of this story. Nevertheless, it could be worth discussing the possibilities. 

      We agree that this is an interesting point. As mentioned above in response to point #1 of reviewer 1, the physiological role of this pathway could be to limit plasticity and prevent maladaptive neural rewiring that can happen after injury (Costigan et al 2009, PMID: 19400724), but can also hinder beneficial recovery after injury. Other mechanisms that limit axon regeneration capacity have been described and involve local mRNA translation and Rho signaling. We have revised the Discussion section to include these points. We agree that understanding the consequence of blocking ETBR over longer time periods is beyond the scope of the current study, but we now discuss the possibility that blocking ETBR with a cell specific KO approach could unravel its physiological function on target innervation and behavior. 

      (6) Assessing Cx43 levels by measuring the immunofluorescence signal (Figure 5E-F) is acceptable, particularly when the aim is to restrict the analysis to SGCs. The modulation of Cx43 expression by ET-1/ETBR plays an important part in the proposed model. Therefore, a complementary analysis of Cx43 expression by quantitative RT-PCR on sorted SGCs would be a valuable addition to the immunofluorescence data. Is this attainable? 

      We agree and have attempted to perform these types of experiments but encountered technical di]iculties. We attempted to sorting SGCs from transgenic mice in which SGCs are fluorescently labeled. However, the cells did not survive the sorting process and died in culture.  We think that increasing the viability of cells after sorting would require capillary- free fluorescent sorting approaches. However, we do not currently have access to such technology. We attempted this experiment with cultured SGCs, following a previously published protocol (Tonello et al. 2023 PMID: 38156033). In these experiments, SGCs are cultured for 8 days to obtain purity. We did not observe any di]erence in Cx43 protein or mRNA level upon treatment with ET-1 with or without BQ788. However, in these SGCs cultures, Cx43 displayed a di]use localization, rather than puncta as observed in vivo. Therefore, despite our multiple attempts, quantifying Cx43 on sorted or purified SGCs was not attainable.

      (7) The conclusions "We thus hypothesize that ETBR inhibition in SGCs contributes to axonal regeneration by increasing Cx43 levels, gap junction coupling or hemichannels and facilitating SGC-neuron communication" (lines 303-305) are consistent with the findings but seem in contrast with the e]ect of aging on gap junction coupling reported by others and cited in line 210: "the number of gap junctions and the dye coupling between these cells increases (Huang et al., 2006)". I am confused by what distinguishes a potential, and supposedly beneficial, increase in coupling after ETBR inhibition, from what is observed in aging. 

      We agree that the aging impact of Cx43 level and gap junction number appears contradictory. Procacci et al 2008 reported that Cx43 expression in SGCs decreases in the aged mice. Huang et al 2006 report that both the number of gap junctions and the dye coupling between these cells were found to increase with aging. Procacci et al suggested as a possible explanation for this apparent discrepancy that additional connexin types other than Cx43 may contribute to the gap junctions between SGCs in aged mice. Our snRNAseq data did not allow us to verify this hypothesis, because there were less SGCs in aged mice compared to adult, and connexin genes were detected in only 20% or less of SGCs.  Furthermore, our quantification did not look specifically at gap junctions, but just at Cx43 puncta. Cx43 can also form hemichannels in addition to gap junctions, and can also perform non-channel functions, such as protein interaction, cell adhesion, and intracellular signaling. Thus, more research examining the role of Cx43 in SGCs is necessary to address this discrepancy in the literature. We have expanded the Discussion section to include these points. 

      (8) I find it di]icult to reconcile the results in Figure 5F with the proposed model since (1) injury increases Cx43 levels in both adult and aged mice, (2) the injured aged/vehicle group has a similar level to the uninjured adult group, (3) upon injury, aged+Bosentan is much lower than adult+Bosentan (significance not tested). It seems hard to explain the e]ect of Bosentan only through the modulation of Cx43 levels. Whether the increase in Cx43 levels following ETBR inhibition actually results in higher SGC-neuron coupling has not been assessed experimentally. 

      We thank the reviewer for this point and agree that the e]ect of Bosentan is likely not exclusively through the modulation of Cx43 levels in SGCs, and that Cx43 levels may simply correlate with axon regenerative capacity. We have revised the manuscript to clarify this point.  We have also added the missing significance test in Figure 5F.

      Cell specific KO of Cx43 and ETBR would allow to test this hypothesis directly but is beyond the scope of the current study. We have not tested SGCs-neuron coupling, as these experiments are currently beyond our area of expertise. Cx43 has also other functions beyond gap junction coupling, such as protein interaction, cell adhesion, and intracellular signaling. Investigating the precise function of Cx43 would require in depth biochemical and cell specific experiments that are beyond the scope of this study. Furthermore, as we now mentioned in response to reviewer #2 point 5, ETBR signaling may also have other downstream e]ects in SGCs, such as glutamate transporters expression, or a]ect other cells in the nerve during the regeneration process. We have revised the Discussion section to include these alternative mechanisms.

      Reviewer #3(Public Review): 

      Summary: 

      This manuscript suggests that inhibiting ETBR via the FDA-approved compound Bosentan can disrupt ET-1-ETBR signalling that they found detrimental to nerve regeneration, thus promoting repair after nerve injury in adult and aged mice. 

      Strengths: 

      (1) The clinical need to identify molecular and cellular mechanisms that can be targeted to improve repair after nerve injury. 

      (2) The proposed mechanism is interesting. 

      (3) The methodology is sound. 

      We thank the reviewer for highlighting the strengths of our study

      Weaknesses: 

      (1) The data appear preliminary and the story appears incomplete. 

      We appreciate the reviewer’s point. We would like to emphasize that our results provide compelling evidence that ETBR signaling is a default brake on axon growth, and inhibiting this pathway promotes axon regeneration after nerve injury and counters the decline in regenerative capacity that occurs during aging. We also provide evidence that ETBR signaling regulates the levels of Cx43 in SGCs. Furthermore, our results document the use of an FDA approved compound to increase axon regeneration may be of interest to the broader readership, as there is currently no therapies to improve or accelerate nerve repair after injury. We agree that the detailed mechanisms operating downstream of ETBR will need to be elucidated. Answering these questions would first require cell specific KO of ETBR and Cx43 to confirm that this pathway is operating in SGCs to control axon regeneration. We would also need to identify how SGCs communicate with neurons to regulate axon regeneration, which is a large area of ongoing research that remains poorly understood. This extensive and highly complex set of experiments is beyond the scope of the current study. As we discussed in our response to reviewer #1 and #2 we attempted to perform numerous additional experiments to better define the role of ETBR signaling in SGCs in aging and have included additional results in Fig. 2B, Fig 3G-H,  Fig 5A-E, and Figure 4- Figure Supplement 1and Figure 5- Figure Supplement 1. We have expanded the

      Discussion to acknowledge the limitation of our study and to discuss possible mechanisms.  

      (2) Lack of causality and clear cellular and molecular mechanism. There are also some loose ends such as the role of connexin 43 in SGCs: how is it related to ET-1- ETBR signalling?  

      We thank the reviewer for this point and agree that the molecular mechanisms downstream of ETBR remain to be elucidated. However, we believe that our manuscript reports an interesting potential of an FDA-approved compound in promoting nerve repair. We focused on Cx43 downstream of ETBR signaling because decreased Cx43 expression in SGCs in ageing was previously established, but the mechanisms were not elucidated. Furthermore, it was reported that ET1 signaling in cultured astrocytes, which share functional similarities with SGCs, leads to the closure of gap junctions and reduction in Cx43 expression. Our study thus provides a mechanism by which ETBR signaling in SGCs regulates Cx43 expression. Whether Cx43 directly impact axon regeneration remains to be tested. Cell specific KO of Cx43 and ETBR would be required to answer this question. We have revised the Introduction and Discussion section extensively to provide a link between ETBR and Cx43 and to acknowledge the lack of causality in Cx43 in SGCs, as well as to provide additional potential mechanisms by which ETBR inhibition may promote nerve repair.

      Reviewer #2 (Recommendations For The Authors): 

      In addition to the points listed in the Public Review section, please consider the following comments: 

      (1) ETAR, which is high in mural cells, does not seem to be implicated in the reported proregenerative e]ects. Even so, can vasoconstriction be ruled out as an underlying cause of the age-dependent decline in axon regrowth potential and, more generally, in the e]ects of ET-1 inhibition on regeneration? This could be discussed. 

      We agree that we can’t exclude a role in vasoconstriction or e]ect on vascular permeability in the age-dependent decline in axon regrowth potential. However, our in vitro and ex vivo experiments, in which vascular related mechanisms are unlikely, suggest that vasoconstriction may not be a major contributor to the e]ects we observed.

      (2) The manuscript (e.g. line 287-288) would benefit from a discussion of the role that blood vessels play in the peripheral nervous system, and possibly CNS, repair. Vessels were shown to accompany regenerating fibers and instruct the reorganization of the nerve tissue to favor repair potentially through the release of pro-regenerative signals acting on stromal cells, glia, and other cellular components. Highlighting these processes will help put the current findings into perspective. 

      We agree and have revised the Discussion section to better explain the role of blood vessels in orientating Schwann cells migration and guiding axon regeneration.

      (3) The vast majority of the cells that are sequenced and shown in the UMAP in Figure 1C are from adult (3-month-old) mice [16,923 out of 18,098]. It would be useful to include the UMAP split (or color-coded) by timepoint to appreciate changes in cell clustering that may occur with aging.  

      We apologize for this misunderstanding, Figure 1C had all cells from all ages. However, the number of cells we obtained from the age group was insu]icient to perform in depth analysis of each cell type. We have thus revised this section and Figure 1, now only presenting the data from adult mice.  

      It is not discussed why fewer cells were sequenced at later stages. Additionally, I do not know how to interpret the double asterisks next to the labeling "18,098 samples" in Figure 1C. 

      Since our original sequencing of adult and aged mice using 10x yielded so few cells from the aged DRG, we tested and optimized a new technology for single cell preparation of DRG using Illumina Single Cell 3’ RNA Prep. This preparation creates templated emulsions using a vortex mixer to capture and barcode single-cell mRNA instead of a microfluidics system. This method yielded much better results for nuclei recovery from aged DRG, with more nuclei and better quality of nuclei. Thus, we now present in Figure 5 and Figure 5- Figure Supplement 1 the results from snRNA-sequencing of aged and adult DRG using the Illumina single cell kit. The results of the snRNA-sequencing show a decreased abundance of SGCs in aged mice, consistent with the results from our morphology analysis with EM. We were also able to perform SGCs-specific pathway analysis because of the increased number of nuclei captured in the aged SGCs, which we included in the manuscript.

      (4) The in vivo studies are designed to examine the e]ects of ETBR inhibition during the first phase of axon regrowth after nerve injury (1-3 days post-injury, dpi). Is there a reason why later stages have not been studied? It would be interesting to understand whether ETBR inhibition improves long-term recovery or is only e]ective at boosting the initial growth of axons through the lesion. It is possible that early inhibition will be enough for long-term recovery. If so, these experiments would define a sensitivity window with therapeutic value. 

      We agree that assessing functional recovery requires proper behavioral tests or morphological evaluations of reinnervation. To determine if Bosentan treatment has long-term e]ects on recovery, we administered Bosentan or vehicle for 3 weeks (daily for 1 week, and then once a week for the subsequent 2 weeks) after sciatic nerve crush. At 24 days after SNC, we assessed intraepidermal nerve fiber density (IENFD) in the injured paw and saw a trend towards increased fibers/mm in the treated animals (new Figure 3G,H). Future studies will examine how long-term Bosentan treatment a]ects functional recovery and innervation at later time points. Additionally, behavior assays will be needed to determine if these morphological changes relate to behavioral improvements using IENFD and behavior assays.

      (5) I am unsure if the gene expression analysis shown in Figure 6 fits well into this story. It is interesting per se and in line with previous work from this group showing the relevance of fatty acid metabolism in SGCs for axon regeneration. Nevertheless, without a mechanistic link to endothelin signaling and Cx43/gap junction modulation, the observations derived from DEG analysis are not well integrated with the rest and may be more distracting than helpful. One limitation is that there is no cell-type information for the DEGs due to the small number of cells recovered from aged mice. For instance, if ETBR inhibition rescued gene downregulation associated with fatty acid/cholesterol metabolism, then the DGE results would become more relevant for understanding the cellular basis of the pro-regenerative e]ect, which at this point remains quite speculative (lines 264-265; lines 318-319).  

      We agree and have added new snRNA sequencing data to replace these findings (see above response to point #4, new Figure 5 and Figure 5- Figure Supplement 1. The new data shows a decreased abundance of SGCs in aged mice, consistent with our TEM results. Pathway analysis revealed that aging triggers extensive transcriptional reprogramming in SGCs, reflecting heightened demands for structural integrity, cell junction remodeling, and glia–neuron interactions within the aged DRG microenvironment.  

      (6) It would be interesting to determine whether Bosentan increases SGC coverage of neuronal cell bodies in aged mice (Figures 6A-C). 

      We agree that this would be very interesting, but will require extensive EM analysis at di]erent time points and is beyond the scope of the current manuscript.

      (7) Finally, adding a summary model would help the readers. 

      We agree and have made a summary model, now presented in Figure 6F.

      Reviewer #3 (Recommendations For The Authors): 

      Longer time points post-injury and assessment of functional recovery after Bosentan would be of great value here. 

      We agree that assessing functional recovery requires proper behavioral tests or morphological evaluations of reinnervation. To determine if Bosentan treatment has long-term e]ects on recovery, we administered Bosentan or vehicle for 3 weeks (daily for 1 week, and then once a week for the subsequent 2 weeks) after sciatic nerve crush. At 24 days after SNC, we assessed intraepidermal nerve fiber density in the injured paw and saw a trend towards increased fibers/mm in the treated animals (Fig 3). While the results do not reach significance, we decided to include this new data as it provides evidence that Bosentan treatment may also improves long term recovery. Future studies will be required examine how long-term Bosentan treatment a]ects functional recovery and innervation at later time points. Additionally, behavior assays will be needed to determine if these morphological changes relate to behavioral improvements.

      It would be important to know how ET-1- ETBR signalling axis promotes the regeneration of axons:this remains unaddressed. What are the cells that are specifically involved? Endothelial cellsSGC- neurons- SC? There are no experiments addressing the role of any of these? 

      We agree that the molecular and cellular mechanisms by which ETBR signaling in SGCs promote axon regeneration remains to be elucidated.  Answering these questions would first require cell specific KO of ETBR and Cx43 to confirm that this pathway is operating in SGCs to control axon regeneration. We would also need to identify how SGCs communicate with neurons to regulate axon regeneration, which is a large area of ongoing research that remains poorly understood. While these are important experiments, because of numerous technical and temporal constrains, we believe they are beyond the scope of the current manuscript. 

      How does connexin 43 in SGCs related to ET-1- ETBR signalling? 

      The relation between connexin 43 and ETBR signaling stems from observations made in astrocytes. ET1 signaling in cultured astrocytes, which share functional similarities with SGCs, was shown to lead to the closure of gap junctions and the reduction in Cx43 expression. Because Cx43 expression, a major connexin expressed in SGCs as in astrocytes, was previously shown to be reduced at the protein level in SGCs from aged mice, we decided to explore it this ETBR-Cx43 mechanism also operates in SGCs. We have revised the Introduction and Discussion section extensively to acknowledge the lack of causality in Cx43 expression SGCs and to provide additional potential mechanisms by which ETBR inhibition may promote nerve repair.

    1. Reviewer #1 (Public review):

      MPRAs are a high-throughput and powerful tool for assaying the regulatory potential of genomic sequences. However, linking MPRA-nominated regulatory sequences to their endogenous target genes and identifying the more specific functional regions within these sequences can be challenging. MPRAs that tile a genomic region, and saturation mutagenesis-based MPRAs, can help to address these challenges. In this work, Tulloch et al. describe a streamlined MPRA system for the identification and investigation of the regulatory elements surrounding a gene of interest with high resolution. The use of BACs covering a locus of interest to generate MPRA libraries allows for an unbiased and high-coverage assessment of a particular region. Follow-up degenerate MPRAs, where each nucleotide in the nominated sequences is systematically mutated, can then point to key motifs driving their regulatory activity. The authors present this MPRA platform as straightforward, easily customizable, and less time- and resource-intensive than traditional MPRA designs. They demonstrate the utility of their design in the context of the developing mouse retina, where they first use the LS-MPRA to identify active regulatory elements for select retinal genes, followed by d-MPRA, which allowed them to dissect the functional regions within those elements and nominate important regulatory motifs. These assays were able to recapitulate some previously known cis-regulatory modules (CRMs), as well as identify some new potential regulatory regions. Follow-up experiments assessing co-localization of the gene of interest with the CRM-linked GFP reporter in the target cells, and CUT&RUN assays to confirm transcription factor binding to nominated motifs, provided support linking these CRMs to the genes of interest. Overall, this method appears flexible and could be an easy-to-implement tool for other investigators aiming to study their locus of interest with high resolution.

      Strengths:

      (1) The method of fragmenting BACs allows for high, overlapping coverage of the region of interest.

      (2) The d-MPRA method was an efficient way to identify key functional transcription factor motifs and nominate specific transcription factor-driven regulatory pathways that could be studied further.

      (3) Additional assays like co-expression analyses using the endogenous gene promoter, and use of the Notch inhibitor in the case of Olig2, helped correlate the activity of the CRMs to the expression of the gene of interest, and distinguish false positives from the initial MPRA.

      (4) The use of these assays across different time points, tissues, and even species demonstrated that they can be used across many contexts to identify both common and divergent regulatory mechanisms for the same gene.

      Weaknesses:

      The LS-MPRA assay most strongly identified promoters, which are not usually novel regulatory elements you would try to discover, and the signal-to-noise ratio for more TSS-distal, non-promoter regulatory elements was usually high, making it difficult to discriminate lower activity CRMs, like enhancers, from the background. For example, NR2 and NR3 in Figure 3 have very minimal activity peaks (NR3 seems non-existent). The ex vivo data in Figure 2 are similarly noisy. Is there a particular metric or calculation that was or could be used to quantitatively or statistically call a peak above the background? The authors mention in the discussion some adjustments that could reduce the noise, such as increased sequencing depth, which I think is needed to make these initial LS-MPRA results and the benchmarking of this assay more convincing and impactful.

    2. Reviewer #3 (Public review):

      Summary:

      Use of reporter assays to understand the regulatory mechanisms controlling gene expression moves beyond simple correlations of cis-regulatory sequence accessibility, evolutionary sequence conservation, and epigenetic status with gene expression, instead quantifying regulatory sequence activity for individual elements. Tulloch et al., provide a systematic characterization of two new reporter assay techniques (LS-MPRA and d-MPRA) to comprehensively identify cis-regulatory sequences contained within genomic loci of interest during retinal development. The authors then apply LS-MPRA and d-MPRA to identify putative cis-regulatory sequences controlling Olig2 and Ngn2 expression, including potential regulatory motifs that known retinal transcription factors may bind. Transcription factor binding to regulatory sequences is then assessed via CUT&RUN. The broader utility of the techniques is then highlighted by performing the assays across development, across species, and across tissues.

      Strengths:

      (1) The authors validate the reporter assays on retinal loci for which the regulatory sequences are known (Rho, Vsx2, Grm6, Cabp5) mostly confirming known regulatory sequence activity but highlighting either limitations of the current technology or discrepancies of previous reporter assays and known biology. The techniques are then applied to loci of interest (Olig2 and Ngn2) to better understand the regulatory sequences driving expression of these transcription factors across retinal development within subsets of retinal progenitor cells, identifying novel regulatory sequences through comprehensive profiling of the region.

      (2) LS-MPRA provides broad coverage of loci of interest.

      (3) d-MPRA identifies sequence features that are important for cis-regulatory sequence activity.

      (4) The authors take into account transcript and protein stability when determining the correlation of putative enhancer sequence activity with target gene expression.

      Weaknesses:

      (1) In its current form, the many important controls that are standard for other MPRA experiments are not shown or not performed, limiting the interpretations of the utility of the techniques. This includes limited controls for basal-promoter activity, limited information about sequence saturation and reproducibility of individual fragments across different barcode sequences, limitations in cloning and assay delivery, and sequencing requirements. Additional quantitative metrics, including locus coverage and number of barcodes/fragments, would be beneficial throughout the manuscript.

      (2) There are no statistical metrics for calling a region/sequence 'active'. This is especially important given that NR3 for Olig2 seems to have a small 'peak' and has non-significant activity in Figure 4.

      (3) The authors present correlational data for identified cis-regulatory sequences with target gene expression. Additionally, the significance of transcription factor binding to the putative regulatory sequences is not currently tested, only correlated based on previous single-cell RNA-sequencing data. While putative regulatory sequences with potential mechanisms of regulation are identified/proposed, the lack of validation (and discrepancies with previous literature) makes it hard to decipher the utility of the techniques.

      (4) While the interpretations that Olig2 mRNA/protein expression is dynamically regulated improved the proportions of cells that co-expressed CRM-regulated GFP and Olig2, alternate explanations (some noted) are just as likely. First, the electroporation isn't specific to Olig2+ progenitors. Also, the tested, short CRM fragments may have activating signals outside of Olig2 neurogenic cells because chromatin conformation, histone modifications, and DNA methylation are not present on plasmids to precisely control plasmid activity. Alternatively, repressive elements that control Olig2 expression are not contained in the reporter vectors.

      (5) It is unclear as to why the d-MPRA uses a different barcoding strategy, placing a second copy of the cis-regulatory sequence in the 3' UTR. As acknowledged by the author, this will change the transcript stability by changing the 3' UTR sequence. Because of this, comparisons of sequence activity between the LS-MPRA and d-MPRA should not be performed as the experiments are not equivalent.

      (6) Furthermore, details of the mutational burden in d-MPRA experiments are not provided, limiting the interpretations of these results.

      (7) Many figures are IGV screenshots that suffer from low resolution. Many figures could be consolidated.

    1. Reviewer #1 (Public review):

      (1) Presentation of Figures in the Response Letter

      I would like to note that the figures included in the response letter would benefit from improved organization. For example, Author response image 1 lacks clarity for experimental conditions. From the response letter, my understanding is that a "Labeling rate index", Rg−Rn, was calculated to represent the difference in the rate of increase in labeling between neurons and glial across two time intervals based on experiments shown in Figure 2-figure supplement 1C and G. It seems that a mean convergence index was calculated for each experimental condition at each time point for glial and neurons, and then the differences in mean convergence index increase between time intervals were calculated for glial and neurons. The legend needs more detail to enhance clarity.

      Furthermore, the manuscript should clearly distinguish between figures generated from re-analysis of existing data and those based on newly conducted experiments. This distinction should be explicitly stated in the figure legends and/or main text.<br /> I recommend that all response figures containing data integral to the authors' rebuttal be properly integrated into the manuscript's existing supplementary figure set, rather than remaining isolated in the response document. This would enhance clarity and ensure that key supporting data are fully accessible to readers. For instance, Author response image 1 can be integrated with Figure 2-figure supplement.

      (2) Glial Cell Labeling and Specificity of Trans-Synaptic Spread

      The authors provided a comprehensive and well-reasoned response to the concern regarding the labeling of radial glial cells. The inclusion of a dedicated section in the revised Discussion and response figures (possibly to be integrated with supplementary figures), strengthens the manuscript.

      The authors have made an interesting observation in Author response image 2 that glial labeling was frequently observed near the soma and dendrites of starter cells, suggesting that transneuronal labeled glial cells may be synaptically associated with the starter neurons. Also astroglia starter cells lead to infection of nearby TVA-negative astroglia, suggesting astroglia-to- astroglia transmission.

      I find the response scientifically satisfactory and appreciate the authors' transparency in addressing the limitations of their approach.

      (3) Temperature Effects and Larval Viability

      The authors' justification for raising larvae at 36C to improve labeling efficiency is reasonable. The supporting data indicating minimal impact on larval viability within the experimental timeframe are convincing. Referencing prior behavioral studies and including survival data under controlled conditions adds credibility to their claims. I find this issue satisfactorily addressed.

      (4) Viral Toxicity and Dosage Considerations, Secondary Starter Cells

      The authors present a well-reasoned explanation that viral cytotoxicity is primarily driven by replication and not by viral titer or injection volume. However, the inclusion of experimental data directly testing the effects of higher titer or volume on starter cell viability would have strengthened this point, particularly since such tests are relatively straightforward to perform.

      Regarding the potential contribution of secondary starter cells, the authors provide a convincing rationale for why such effects are unlikely under their sparse labeling conditions. However, in cases where TVA and G are broadly expressed-such as under the vglut2a promoter, as shown in Author response image 2-it would be valuable to directly evaluate this possibility experimentally. While the authors' interpretation is reasonable, empirical validation would further strengthen their conclusions.

    2. Reviewer #2 (Public review):

      The study by Chen, Deng et al. aims to develop an efficient viral transneuronal tracing method that allows efficient retrograde tracing in the larval zebrafish. The authors utilize pseudotyped-rabies virus that can be targeted to specific cell types using the EnvA-TvA systems. Pseudotyped rabies virus has been used extensively in rodent models and, in recent years, has begun to be developed for use in adult zebrafish. However, compared to rodents, the efficiency of spread in adult zebrafish is very low (~one upstream neuron labeled per starter cell). Additionally, there is limited evidence of retrograde tracing with pseudotyped rabies in the larval stage, which is the stage when most functional neural imaging studies are done in the field. In this study, the authors systematically optimized several parameters of rabies tracing, including different rabies virus strains, glycoprotein types, temperatures, expression construct designs, and elimination of glial labeling. The optimal configurations developed by the authors are up to 5-10 fold higher than more typically used configurations.

      The results are convincing and support the conclusions. There are some additional changes that are recommended:

      (1) The new data included in the response to reviewer's letter are important to support the main conclusions and should be included in the manuscript.

      (2) Line 357-362: This section should include all of the Author response image and associated details. Additionally, the Author response image 3 is at odds with Fig 2-supplement 1G. In Author response image 3, ~75% of glial cells labeled at 4 dpi loses their fluorescence by 10 dpi. However, Figure 2-supplement 1G shows that glial overall labeling increases ~2 fold from 4 dpi to 10 dpi. This would suggest that the de novo labeling rate for glia is much higher than the net labeling rate calculated from the convergence index. The authors should clarify these findings.

    1. reply to u/Impossible-Dance7442 at tk

      Looks like a portable 4 bank B model Underwood from 1926 (see also: https://typewriterdatabase.com/underwood.4.typewriter-serial-number-database).

      Appears to be in reasonable cosmetic condition with good decals, but the internal condition is going to be the biggest determinant of value. In unknown condition they sell regularly for $20-50 in online auctions, but cleaned, oiled, and adjusted from a professional repair shop they might go as high as $400, or perhaps $550 if you've had the rubber on the platen re-covered. Thinking that fair market for this in even the most pristine condition is $800 is pure folly unless it was used by someone famous. (The lack of interest from antique shops is a solid indicator here.) It assuredly is not going to make you rich, unless you bought the house from a famous author.

      You might find some useful advice from some of the articles at: https://boffosocko.com/research/typewriter-collection/#Typewriter%20Market They're written with first time buyers in mind, but you could also view them from the first time seller perspective.

      A local repair shop might give you a few bones for it and give it a new life: https://site.xavier.edu/polt/typewriters/tw-repair.html

      You could also donate it to a local thrift shop.

      Your best bet for time and money invested though, is to gift it to a kid or teenager you know who's interested in writing, perhaps as a birthday present along with a copy of either: (1) Polt, R. The Typewriter Revolution: A Typist’s Companion for the 21st Century, 1st ed.; Countryman Press: Woodstock, VT, 2015. (2) Flint, W. D. The Distraction-Free First Draft; One Idea Press, 2023.

      Good luck with it.

      Alternate version of this with heirloom push is also at: https://www.reddit.com/r/typewriters/comments/1mbf185/comment/n5mdydi/

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review): 

      Summary: 

      The authors investigated sleep and circadian rhythm disturbances in Fmr1 KO mice. Initially, they monitored daily home cage behaviors to assess sleep and circadian disruptions. Next, they examined the adaptability of circadian rhythms in response to photic suppression and skeleton photic periods. To explore the underlying mechanisms, they traced retino-suprachiasmatic connectivity. The authors further analyzed the social behaviors of Fmr1 KO mice and tested whether a scheduled feeding strategy could mitigate sleep, circadian, and social behavior deficits. Finally, they demonstrated that scheduled feeding corrected cytokine levels in the plasma of mutant mice. 

      Strengths: 

      (1) The manuscript addresses an important topic-investigating sleep deficits in an FXS mouse model and proposing a potential therapeutic strategy. 

      (2) The study includes a comprehensive experimental design with multiple methodologies, which adds depth to the investigation. 

      We thank the reviewer for the positive comments.

      Weaknesses: 

      (1) The first serious issue in the manuscript is the lack of a clear description of how they performed the experiments and the missing definitions of various parameters in the results.  

      We thank the reviewer for pointing out lapses in the editing of the manuscript. We were trying to keep the descriptions of previously published methods brief but must have gone too far, the manuscript has been carefully checked for grammar and readability. Description of the experimental design has been refined and a graphical presentation has been added as Suppl Fig 3. The sleep and circadian parameters have been thoroughly explained in the methods and briefly in the figure legnds.

      (2) Although the manuscript has a relatively long Methods section, some essential information is missing. For instance, the definition of sleep bout, as described above, is unclear. Additional missing information includes

      Figure 2: "Rhythmic strength (%)" and "Cycle-to-cycle variability (min)." 

      Figure 3: "Activity suppression." 

      Figure 4: "Rhythmic power (V%)" (is this different from rhythmic strength (%)?) and "Subjective day activity (%)." 

      We have provided definitions for the general audience of the terms used in the field of circadian rhythms, such as sleep bout, rhythm power, cycle-to-cycle, masking, and % of activity during the day in the methods and Fig legends. Most of the techniques used in this study, for example, the behavioral measurement of sleep or locomotor activity, are well established and have been used in multiple published works, including our own. We have made sure to include citations for interested readers.

      Figure 5: Clear labeling of the SCN's anatomical features and an explanation for quantifying only the ventral part instead of the entire SCN. 

      We have added more landmarks (position of the third ventricle and optic chiasm) to Fig 5, and have outlined the shell and core of the SCN in two additional images of the ventral hypothalamus in Suppl fig 4.

      We had actually quantified the fluorescence in the whole SCN as well as in the ventral part.This was/is described in the methods as well as reported in the results section and Table 4 “Likewise, a subtle decrease in the intensity of the labelled fibers was found in the whole SCN (Table 4) of the Fmr1 KO mice as compared to WT.“ 

      Methods: ” Two methods of analyses were carried out on the images of 5 consecutive sections per animal containing the middle SCN. First, the relative intensity of the Cholera Toxin fluorescent processes was quantified in the whole SCN, both left and right separately, by scanning densitometry using the Fiji image processing package of the NIH ImageJ software (https://imagej.net). A single ROI of fixed size (575.99 μm x 399.9 μm, width x height) was used to measure the relative integrated density (mean gray values x area of the ROI) in all the images. The values from the left and right SCN were averaged per section and 5 sections per animal were averaged to obtain one value per animal………..”

      Since the retinal innervation of the SCN is strongest in the ventral aspect, where the retino-hypothalamic fibers reach the SCN and our goal was to identify differences in the input to the SCN, e.g. defects in the retino-SCN connectivity as suggested by some deficits in circadian behaviour; we also looked at intensity of Cholera Toxin in the fibers arriving to the ventral SCN from the retina.

      We have added a sentence in the methods about the rationale for measuring the intensity of the cholera toxin labelled fiber in the whole SCN and also just in the ventral part: “Second, the retinal innervation of the SCN is strongest in the ventral aspect, where the retino-hypothalamic fibers reach the SCN, hence, the distribution….”

      Figure 6: Inconsistencies in terms like "Sleep frag. (bout #)" and "Sleep bouts (#)." Consistent terminology throughout the manuscript is essential.

      We have now clearly explained that sleep bouts are a measure of sleep fragmentation throughout the manuscript and in the fig legends; in addition, we have corrected the figures, reconciled the terminology, which is now consistent throughout the results and methods.

      Methods: “Sleep fragmentation was determined by the number of sleep bouts, which were operationally defined as episodes of continuous immobility with a sleep count greater than 3 per minute, persisting for at least 60 secs.”

      (3) Figure 1A shows higher mouse activity during ZT13-16. It is unclear why the authors scheduled feeding during ZT15- 21, as this seems to disturb the rhythm. Consistent with this, the body weights of WT and Fmr1 KO mice decreased after scheduled feeding. The authors should explain the rationale for this design clearly.

      We have added to the rationale for the feeding schedule. This protocol was initially used by the Panda group to counter metabolic dysfunction (Hatori et al., 2012). We have used it for many years now (see citations below) in various mouse models presenting with circadian disruption to reset the clock and improve sleep. This study represents our first application/intervention in a mouse model of a neurodevelopmental disease.

      Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JA, Ellisman MH, Panda S. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012 Jun 6;15(6):848-60. doi: 10.1016/j.cmet.2012.04.019. Epub 2012 May 17. PMID: 22608008; PMCID: PMC3491655.

      Chiem E, Zhao K, Dell'Angelica D, Ghiani CA, Paul KN, Colwell CS. Scheduled feeding improves sleep in a mouse model of Huntington's disease. Front Neurosci. 2024 18:1427125. doi: 10.3389/fnins.2024.1427125. PMID: 39161652.

      Whittaker DS, Akhmetova L, Carlin D, Romero H, Welsh DK, Colwell CS, Desplats P. Circadian modulation by time-restricted feeding rescues brain pathology and improves memory in mouse models of Alzheimer's disease. Cell Metab. 2023 35(10):1704- 1721.e6. doi: 10.1016/j.cmet.2023.07.014. PMID: 37607543

      Brown MR, Sen SK, Mazzone A, Her TK, Xiong Y, Lee JH, Javeed N, Colwell CS, Rakshit K, LeBrasseur NK, Gaspar-Maia A, Ordog T, Matveyenko AV. Time-restricted feeding prevents deleterious metabolic effects of circadian disruption through epigenetic control of β cell function. Sci Adv. 2021 7(51):eabg6856. doi: 10.1126/sciadv.abg6856. PMID: 34910509

      Whittaker DS, Loh DH, Wang HB, Tahara Y, Kuljis D, Cutler T, Ghiani CA, Shibata S, Block GD, Colwell CS. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease. J Biol Rhythms. 2018 33(5):535-554. doi: 10.1177/0748730418790401. PMID: 30084274.

      Wang HB, Loh DH, Whittaker DS, Cutler T, Howland D, Colwell CS. Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease. eNeuro. 2018 Jan 3;5(1):ENEURO.0431-17.2017. doi: 10.1523/ENEURO.0431-17.2017.

      Loh DH, Jami SA, Flores RE, Truong D, Ghiani CA, O'Dell TJ, Colwell CS. Misaligned feeding impairs memories. Elife. 2015 4:e09460. doi: 10.7554/eLife.09460.

      (4) The interpretation of social behavior results in Figure 6 is questionable. The authors claim that Fmr1 KO mice cannot remember the first stranger in a three-chamber test, writing, "The reduced time in exploring and staying in the novelmouse chamber suggested that the Fmr1 KO mutants were not able to distinguish the second novel mouse from the first now-familiar mouse." However, an alternative explanation is that Fmr1 KO mice do remember the first stranger but prefer to interact with it due to autistic-like tendencies. Data in Table 5 show that Fmr1 KO mice spent more time interacting with the first stranger in the 3-chamber social recognition test, which support this possibility. Similarly, in the five-trial social test, Fmr1 KO mice's preference for familiar mice might explain the reduced interaction with the second stranger.

      Thank you for this interesting interpretation of the social behavior experiments. We used the common interpretations for both the three-chamber test and the 5-trial social interaction test, but have now modified the text leaving space for alternative interpretations, have soften the language, and mentioned decreased sociability in the Fmr1 KO mice. “The reduced time spent exploring the novel-mouse chamber suggest that the mutants were, perhaps, unable to distinguish the second novel mouse from the first, now familiar, mouse, along with decreased sociability.”

      In Figure 6C (five-trial social test results), only the fifth trial results are shown. Data for trials 1-4 should be provided and compared with the fifth trial. The behavioral features of mice in the 5-trial test can then be shown completely. In addition, the total interaction times for trials 1-4 (154 {plus minus} 15.3 for WT and 150 {plus minus} 20.9 for Fmr1 KO) suggest normal sociability in Fmr1 KO mice (it is different from the results of 3-chamber). Thus, individual data for trials 1-4 are required to draw reliable conclusions.  

      We have added a suppl figure showing the individual trial results for both WT and Fmr1 KO mice as requested (Suppl. Fig. 2).  

      In Table 6 and Figure 6G-6J, the authors claim that "Sleep duration (Figures 6G, H) and fragmentation (Figures 6I, J) exhibited a moderate-strong correlation with both social recognition and grooming." However, Figure 6I shows a p-value of 0.077, which is not significant. Moreover, Table 6 shows no significant correlation between SNPI of the three-chamber social test and any sleep parameters. These data do not support the authors' conclusions. 

      Thanks for pointing out the error with statement about Fig. 6I.

      “…. Sleep duration (Fig. 6G, H; Table 6) exhibited a moderate to strong correlation with both social recognition and grooming time, while sleep fragmentation (measured by sleep bouts number) only correlated with the latter (Fig. 6J); the length of sleep bouts (Table 6) showed moderate correlation with both social recognition and repetitive behavior. In addition, a moderate correlation was seen between grooming time and the circadian parameters, rhythmic power and activity onset variability (Table 6). In short, our work suggests that even when tested during their circadian active phase, the Fmr1 KO mice exhibit robust repetitive and social behavioral deficits. Moreover, the shorter and more fragmented the daytime sleep, the more severe the behavioral impairment in the mutants.”

      (5) Figure 7 demonstrates the effect of scheduled feeding on circadian activity and sleep behaviors, representing another critical set of results in the manuscript. Notably, the WT+ALF and Fmr1 KO+ALF groups in Figure 7 underwent the same handling as the WT and Fmr1 KO groups in Figures 1 and 2, as no special treatments were applied to these mice. However, the daily patterns observed in Figures 7A, 7B, 7F, and 7G differ substantially from those shown in Figures 2B and 1A, respectively. Additionally, it is unclear why the WT+ALF and Fmr1 KO+ALF groups did not exhibit differences in Figures 7I and 7J, especially considering that Fmr1 KO mice displayed more sleep bouts but shorter bout lengths in Figures 1C and 1D. 

      We appreciate the reviewer’s attention to the subtle details of the behavioral measurement of sleep and believe the reviewer to be referring to differences in the behavioral measurements of sleep with data shown in Table 1 and Table 7. The first set of experiments described in this study was carried out between 2016 and 2017 and involves the comparison between WT and Fmr1 KO mice. The WT and mutants were obtained from JAX. In this initial set of experiments (Table 1), the total amount of sleep in 24 hrs was reduced in the KO, albeit not significantly, and these also exhibited sleep bouts of significantly reduced duration. The pandemic forced us to greatly slow down the research and reduce our mouse colonies. Post-pandemic, we used new cohorts of Fmr1 KO ordered again from JAX for the TRF experiment presented in this study. In these cohorts, the KO mice exhibited a significant reduction in total sleep (Table 7) and the sleep bouts were still shorter but not significantly. We have added to our text to explain that the description of the mutants and TRF interventions were carried out at different times (2017 vs 2022). We would like to emphasize that we always run contemporaneously controls and experimental groups to be used for the statistical analyses. We believe that the data are remarkably consistent over these years, even with different students doing the measurements. 

      Furthermore, it is not specified whether the results in Figure 7 were collected after two weeks of scheduled feeding (for how many days?) or if they represent the average data from the two-week treatment period.

      This is another good point raised by the reviewer. The activity measurements are collected during the 2 weeks (14 days) then the TRF was extended for a 3 more days to allow the behavioral sleep measurements.

      We have added a supplementary figure (Supp Fig 3) depicting the different experimental designs.

      The rationale behind analyzing "ZT 0-3 activity" in Figure 7D instead of the parameters shown in Figures 2C and 2D is also unclear. 

      We have added to our explanation. In prior work, we found that the TRF protocol has a big impact on the beginning of the sleep time, hence, we specifically targeted this 3-hours interval in the analysis.

      In Figure 7F, some data points appear to be incorrectly plotted. For instance, the dark blue circle at ZT13 connects to the light blue circle at ZT14 and the dark blue circle at ZT17. This is inconsistent, as the dark blue circle at ZT13 should link to the dark blue circle at ZT14. Similarly, it is perplexing that the dark blue circle at ZT16 connects to both the light blue and dark blue circles at ZT17. Such errors undermine confidence in the data. The authors need to provide a clear explanation of how these data were processed. 

      Thank you for bringing this to our attention. The data were plotted correctly, however, those data points completely overlapped with those behind, masking them. We have now offset a bit them for clarity.

      Lastly, in the Figure 7 legend, Table 6 is cited; however, this appears to be incorrect. It seems the authors intended to refer to Table 7. 

      We have corrected this error, thank you.  

      (6) Similar to the issue in Figure 7F, the data for day 12 in Supplemental Figure 2 includes two yellow triangles but lacks a green triangle. It is unclear how the authors constructed this chart, and clarification is needed. 

      We have corrected this error. As the reviewer pointed out, we filled the triangle on day 12 with yellow instead of green.  

      (7) In Figure 8, a 5-trial test was used to assess the effect of scheduled feeding on social behaviors. It is essential to present the results for all trials (1 to 4). Additionally, it is unclear whether the results for familial mice in Figure 8A correspond to trials 1, 2, 3, or 4. 

      The legend for Figure 8 also appears to be incorrect: "The left panels show the time spent in social interactions when the second novel stranger mouse was introduced to the testing mouse in the 5-trial social interaction test. The significant differences were analyzed by two-way ANOVA followed by Holm-Sidak's multiple comparisons test with feeding treatment and genotype as factors." This description does not align with the content of the left panels. Moreover, two-way ANOVA is not the appropriate statistical analysis for Figure 8A. The authors need to provide accurate details about the analysis and revise the figure legend accordingly. 

      We apologies for the confusing Figure legend which has been revised: 

      “Fig. 8: TRF improved social memory and stereotypic grooming behavior in the Fmr1 KO mice. (A) Social memory was evaluated with the 5-trial social interaction test as described above. The social memory recognition was significantly augmented in the Fmr1 KO by the intervention, suggesting that the treated mutants were able to distinguish the novel mouse from the familiar mouse. The time spent in social interactions with the novel mouse in the 5<sup>th</sup>-trial was increased to WT-like levels in the mutants on TRF. Paired t-tests were used to evaluate significant differences in the time spent interacting with the test mouse in the 4<sup>th</sup> (familiar mouse) and 5<sup>th</sup> (novel mouse) trials.  *P < 0.05 indicates the significant time spent with the novel mouse compared to the familiar mouse. (B) Grooming was assessed in a novel arena in mice of each genotype (WT, Fmr1 KO) under each feeding condition and the resulting data analyzed by two-way ANOVA followed by the Holm-Sidak’s multiple comparisons test with feeding regimen and genotype as factors. *P < 0.05 indicates the significant difference within genotype - between diet regimens , and #P < 0.05 those between genotypes - same feeding regimen. (C) TRF did not alter the overall locomotion in the treated mice. See Table 8.”

      To assess social recognition memory, mice underwent a five-trial social interaction paradigm in a neutral open-field arena. Each trial lasted 5 minutes and was separated by a 1-minute inter-trial interval. During trials 1–4, the test mouse was exposed to the same conspecific (Stimulus A) enclosed within a wire cup to permit olfactory and limited tactile interaction. In trial 5, a novel conspecific (Stimulus B) was introduced. Time spent investigating the stimulus B mouse (defined as sniffing or directing the nose toward the enclosure within close proximity) was scored using AnyMaze software. A progressive decrease in investigation time across trials 1–4 reflects habituation, while a significant increase in trial 5 indicates dishabituation and intact social recognition memory. In our data, there was not a lot of habituation in both genotypes, but clear differences can be appreciated between trial 4 with the now familiar mouse and trial 5 with novel mouse. Fig. 8A plots the results from individual animals in Trial 4 with a familiar mouse and in Trial 5 with a novel mouse, we have well specified this in the legends. As such, these data were analyzed with a pair t-test. 

      We used Tow-Way ANOVA to analyse the data reported in Panel 8B and as well as the results in Table 8.  This has been clarified in the legend.

      (8) The circadian activity and sleep behaviors of Fmr1 KO mice have been reported previously, with some findings consistent with the current manuscript, while others contradict it. Although the authors acknowledge this discrepancy, it seems insufficiently thorough to simply state that the reasons for the conflicts are unknown. Did the studies use the same equipment for behavior recording? Were the same parameters used to define locomotor activity and sleep behaviors? The authors are encouraged to investigate these details further, as doing so may uncover something interesting or significant. 

      We agree with the reviewers, and believe that the main differences were likely in the experimental design and possibly interpretation.

      (9) Some subtitles in the Results section and the figure legends do not align well with the presented data. For example, in the section titled "Reduced rhythmic strength and nocturnality in the Fmr1 KOs," it is unclear how the authors justify the claim of altered nocturnality in Fmr1 KO mice. How do the authors define changes in nocturnality? Additionally, the tense used in the subtitles and figure legends is incorrect. The authors are encouraged to carefully review all subtitles and figure legends to correct these errors and enhance readability. 

      Nocturnality is defined as the % of total activity within a 24-h cycle that occurred in the night, since this can be confusing and we agree that it was not well explained we have removed it from the subtitle/figure legends. 

      We have adjusted the subtitles as recommended; however, the tense of the verbs might be a matter of writing style.

      Reviewer #2 (Public review): 

      Summary: 

      In the present study, the authors, using a mouse model of Fragile X syndrome, explore the very interesting hypothesis that restricting food access over a daily schedule will improve sleep patterns and, subsequently, behavioral capacities. By restricting food access from 12h to 6h over the nocturnal period (active period for mice), they show, in these KO mice, an improvement of the sleep pattern accompanied by reduced systemic levels of inflammatory markers and improved behavior. Using a classical mouse model of neurodevelopmental disorder (NDD), these data suggest that eating patterns might improve sleep quality, reduce inflammation and improve cognitive/behavioral capacities in children with NDD. 

      Strengths: 

      Overall, the paper is very well-written and easy to follow. The rationale of the study is generally well-introduced. The data are globally sound. The provided data support the interpretation overall. 

      Thank you for the positive comments.  

      Weaknesses:  

      (1) The introduction part is quite long in the Abstract, leaving limited space for the data provided by the present study.

      We have revised the Abstract to better focus on the most impactful findings as suggested. 

      (2) A couple of points are not totally clear for a non-expert reader:  - The Fmr1/Fxr2 double KO mice are not well described. What is the rationale for performing both LD and DD measures? 

      We did not use the Fmr1/Fxr2 double KO mice in this study.  

      While measurement of day/night differences in activity rhythms are standardly done in a light/dark (LD) cycle, the organisms must be under constant conditions (DD) to measure their endogenous circadian rhythms (free running activity); this is often needed to uncover a compromised clock as entrainment to the LD cycle can mask deficits in the endogenous circadian rhythms.

      (3) The data on cytokines and chemokines are interesting. However, the rationale for the selection of these molecules is not given. In addition, these measures have been performed in the systemic blood. Measures in the brain could be very informative. 

      The panel that we used had 16 cytokines/chemokines which are reported in Table 9. The experiment included WT and mutants held under 2 different feeding conditions with an n=8 per group. If we are able to obtain more resources, we would like to also carry out a comprehensive investigation of immunomediator levels as well as RNA-seq or Nanostring in selected brain regions associated with ASD aberrant behavioural phenotypes, for instance the prefrontal cortex.

      (4) An important question is the potential impact of fasting vs the impact of the food availability restriction. Indeed, fasting has several effects on brain functioning including cognitive functions. 

      We did not address this issue in the present study. Briefly, the distinction between caloric restriction (CR) and TRF, in which no calories are restricted, has important mechanistic implications in mouse models. While both interventions can impact metabolism, circadian rhythms, and aging, they operate via overlapping but distinct molecular pathways. These have been the topic of recent reviews and investigations. Importantly, the fast-feed cycle can also act as a circadian entrainer (Zeitgeber)

      Ribas-Latre A, Fernández-Veledo S, Vendrell J. Time-restricted eating, the clock ticking behind the scenes. Front Pharmacol. 2024 Aug 8;15:1428601. doi: 10.3389/fphar.2024.1428601. PMID: 39175542; PMCID: PMC11338815.

      Wang R, Liao Y, Deng Y, Shuang R. Unraveling the Health Benefits and Mechanisms of Time-Restricted Feeding: Beyond Caloric Restriction. Nutr Rev. 2025 Mar 1;83(3):e1209-e1224. doi: 10.1093/nutrit/nuae074.

      (5) How do the authors envision the potential translation of the present study to human patients? How to translate the 12 to 6 hours of food access in mice to children with Fragile X syndrome? 

      Time-restricted feeding (TRF) is a type of intermittent fasting that limits food intake to a specific window of time each day (usually 8–12 hours in humans), is being actively studied in adults for benefits on metabolic health, sleep, and circadian rhythms. However, applying TRF to children is not currently recommended as a general intervention, and there are important developmental, medical, and ethical considerations to take into account.  

      On the other hand, we believe that the Fmr1 KO mouse is a good preclinical model for FXS because it closely recapitulates key molecular, cellular, and behavioral phenotypes observed in humans with the disorder. A number of the behavioral phenotypes seen in the mouse mirror those seen in patients including increased anxiety-like behavior, sensory hypersensitivity, social interaction deficits and repetitive behaviors so there is strong face validity.  

      As we show in this study, Fmr1 KO mice present with disrupted sleep/wake cycles and reduced amplitude of circadian rhythms, consistent with findings in individuals with FXS. This makes the Fmr1 KO an excellent model to test out circadian based interventions such as scheduled feeding.

      We believe that pre-clinical research in Fmr1 KO mice bridges the gap between basic discovery and human clinical application. It provides a controlled, cost-effective, and biologically relevant platform for understanding disease mechanisms and testing interventions. These types of experiments need to be done before jumping to humans to ensure that the human trials are scientifically justified and ethically sound.

      Reviewer #1 (Recommendations for the authors): 

      The authors should: 

      (1) Revise the Methods section for clarity and completeness.  

      We have re-worked the methods for clarity and completeness. 

      (2) Provide consistent and precise definitions for all parameters and terms.  

      We believe that we have provided definitions for all terms.  

      (3) Clarify the rationale for experimental designs, such as the feeding schedule.  

      We have added to the rationale for the feeding schedule.  This feeding schedule has been used in a number of prior studies including our own.  All this work is cited in the manuscript.   

      (4) Reanalyze and transparently present data, including individual trial results.  

      We have added to the figure showing the individual trail results for the 5-trial tests as requested (Supplementary Fig. 2).  

      (5) Conduct appropriate statistical tests and correct figure legends.  

      We believe that we have carried out appropriate statistical tests and have carefully rechecked the figure legends.  

      (6) Investigate discrepancies with prior studies to enhance the discussion. 

      We have added to our discussion of prior work. 

      (7) Improve language quality and ensure consistency in terminology and grammar.  

      We have edited the manuscript to improve language quality.  

      Reviewer #2 (Recommendations for the authors): 

      (1) The Abstract should be rewritten to provide more room for the obtained data.  

      We have re-written the Abstract to focus on the most impactful findings. 

      (2) An additional sentence describing the double KO mice should be added.  

      We did not use double KO mice in this study.  

      (3) The rationale for studying LD and DD should be provided. 

      Measurement of day/night differences are standardly done in a light/dark cycle.  To measure the endogenous circadian rhythms, the organisms must be under constant conditions (Dark/Dark).

      (4) The data on cytokines/chemokines should be strengthened by performing a larger panel of measures both in blood and the brain.  

      The panel that we used had 16 cytokines/chemokines which we report in Table 9.  This was a large experiment with 2 genotypes being held under 2 feeding conditions with n=8 mice per group. If we are able to obtain more resources, we would like to also carry out RNA-seq in different brain regions.  

      (5) The authors should discuss in more detail the potential role of fastening vs restriction of food access.  

      We did not address this issue in the present study.  Briefly, the distinction between caloric restriction (CR) and TRF when no calories are restricted has important mechanistic implications in mouse models. While both interventions can impact metabolism, circadian rhythms, and aging, they operate via overlapping but distinct molecular pathways. 

      (6) The authors should also provide some insight into their view on the potential translation of their experimental studies.  

      We believe that the Fmr1 KO mouse is considered a good preclinical model for FXS because it closely recapitulates key molecular, cellular, and behavioral phenotypes observed in humans with the disorder. A number of the behavioral phenotypes seen in the mouse mirror those seen in patients including increased anxiety-like behavior, sensory hypersensitivity, social interaction deficits and repetitive behaviors so there is strong face validity.   As we  demonstrate in this study, Fmr1 KO mice exibit disrupted sleep/wake cycles and reduced amplitude of circadian rhythms, consistent with findings in individuals with FXS.  This makes the Fmr1 KO an excellent model to test out circadian based interventions such as scheduled feeding.  

      Still we are mindful that the translation of therapeutic findings from mouse to human has proven challenging e.g., mGluR5 antagonists failed in clinical trials despite strong preclinical data (Berry-Kravis et al., 2016).  Therefore, we are cautious in overreaching in our translational interpretations. 

      Berry-Kravis, E., Des Portes, V., Hagerman, R., Jacquemont, S., Charles, P., Visootsak, J., Brinkman, M., Rerat, K., Koumaras, B., Zhu, L., Barth, G. M., Jaecklin, T., Apostol, G., & von Raison, F. (2016). Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Science translational medicine, 8(321), 321ra5. https://doi.org/10.1126/scitranslmed.aab4109).

    1. Reviewer #1 (Public review):

      Summary:

      The manuscript titled "Introduction of cytosine-5 DNA methylation sensitizes cells to oxidative damage" proposes that 5mC modifications to DNA, despite being ancient and wide-spread throughout life, represent a vulnerability, making cells more susceptible to both chemical alkylation and, of more general importance, reactive oxygen species. Sarkies et al take the innovative approach of introducing enzymatic genome-wide cytosine methylation system (DNA methyltransferases, DNMTs) into E. coli, which normally lacks such a system. They provide compelling evidence that the introduction of DNMTs increases the sensitivity of E. coli to chemical alkylation damage. Surprisingly they also show DNMTs increase the sensitivity to reactive oxygen species and propose that the DNMT generated 5mC presents a target for the reactive oxygen species that is especially damaging to cells. Evidence is presented that DNMT activity directly or indirectly produces reactive oxygen species in vivo, which is an important discovery if correct, though the mechanism for this remains obscure.

      I am satisfied that the points #2, #3 and #4 relating to non-addativity, transcriptional changes and ROS generation have been appropriately addressed in this revised manuscript. The most important point (previously #1) has not been addressed beyond the acknowledgement in the results section that: "Alternatively, 3mC induction by DNMT may lead to increased levels of ssDNA, particularly in alkB mutants, which could increase the risk of further DNA damage by MMS exposure and heighten sensitivity." This slightly miss-represents the original point that 5mC the main enzymatic product of DNMTs rather or in addition to 3mC is likely to lead to transient damage susceptible ssDNA, especially in an alkB deficient background. And more centrally to the main claims of this manuscript, the authors have not resolved whether methylated cytosine introduced into bacteria is deleterious in the context of genotoxic stress because of the oxidative modification to 5mC and 3mC, or because of oxidative/chemical attack to ssDNA that is transiently exposed in the repair processing of 5mC and 3mC, especially in an alkB deficient background. This is a crucial distinction because chemical vulnerability of 5mC would likely be a universal property of cytosine methylation across life, but the wide-spread exposure of ssDNA is expected to be peculiarity of introducing cytosine methylation into a system not evolved with that modification as a standard component of its genome.

      These two models make different predictions about the predominant mutation types generated, in the authors system using M.SssI that targets C in a CG context - if oxidative damage to 5mC dominates then mutations are expected to be predominantly in a CG context, if ssDNA exposure effects dominate then the mutations are expected to be more widely distributed - sequencing post exposure clones could resolve this.

      Strengths:

      This work is based on an interesting initial premise, it is well motivated in the introduction and the manuscript is clearly written. The results themselves are compelling.

      Weaknesses:

      I am not currently convinced by the principal interpretations and think that other explanations based on known phenomena could account for key results. Specifically the authors have not resolved whether oxidative modification to 5mC and 3mC, or chemical attack to ssDNA that is transiently exposed in the repair processing of 5mC and 3mC is the principal source of the observed genotoxicity.

      (1) Original query which still stands: As noted in the manuscript, AlkB repairs alkylation damage by direct reversal (DNA strands are not cut). In the absence of AlkB, repair of alklylation damage/modification is likely through BER or other processes involving strand excision and resulting in single stranded DNA. It has previously been shown that 3mC modification from MMS exposure is highly specific to single stranded DNA (PMID:20663718) occurring at ~20,000 times the rate as double stranded DNA. Consequently the introduction of DNMTs is expected to introduce many methylation adducts genome-wide that will generate single stranded DNA tracts when repaired in an AlkB deficient background (but not in an AlkB WT background), which are then hyper-susceptible to attack by MMS. Such ssDNA tracts are also vulnerable to generating double strand breaks, especially when they contain DNA polymerase stalling adducts such as 3mC. The generation of ssDNA during repair is similarly expected follow the H2O2 or TET based conversion of 5mC to 5hmC or 5fC neither of which can be directly repaired and depend on single strand excision for their removal. The potential importance of ssDNA generation in the experiments has not been [adequately] considered.

    2. Reviewer #3 (Public review):

      Summary:

      Krwawicz et al., present evidence that expression of DNMTs in E. coli results in (1) introduction of alkylation damage that is repaired by AlkB; (2) confers hypersensitivity to alkylating agents such as MMS (and exacerbated by loss of AlkB); (3) confers hypersensitivity to oxidative stress (H2O2 exposure); (4) results in a modest increase in ROS in the absence of exogenous H2O2 exposure; and (5) results in the production of oxidation products of 5mC, namely 5hmC and 5fC, leading to cellular toxicity. The findings reported here have interesting implications for the concept that such genotoxic and potentially mutagenic consequences of DNMT expression (resulting in 5mC) could be selectively disadvantageous for certain organisms. The other aspect of this work which is important for understanding the biological endpoints of genotoxic stress is the notion that DNA damage per se somehow induces elevated levels of ROS.

      Strengths:

      The manuscript is well-written, and the experiments have been carefully executed providing data that support the authors' proposed model presented in Fig. 7 (Discussion, sources of DNA damage due to DNMT expression).

      Weaknesses:

      (1) The authors have established an informative system relying on expression of DNMTs to gauge the effects of such expression and subsequent induction of 3mC and 5mC on cell survival and sensitivity to an alkylating agent (MMS) and exogenous oxidative stress (H2O2 exposure). The authors state (p4) that Fig. 2 shows that "Cells expressing either M.SssI or M.MpeI showed increased sensitivity to MMS treatment compared to WT C2523, supporting the conclusion that the expression of DNMTs increased the levels of alkylation damage." This is a confusing statement and requires revision as Fig. 2 does ALL cells shown in Fig. 2 are expressing DNMTs and have been treated with MMS. It is the absence of AlkB and the expression of DNMTs that that causes the MMS sensitivity.

      (2) It would be important to know whether the increased sensitivity (toxicity) to DNMT expression and MMS is also accompanied by substantial increases in mutagenicity. The authors should explain in the text why mutation frequencies were not also measured in these experiments.

      (3) Materials and Methods. ROS production monitoring. The "Total Reactive Oxygen Species (ROS) Assay Kit" has not been adequately described. Who is the Vendor? What is the nature of the ROS probes employed in this assay? Which specific ROS correspond to "total ROS"?

      (4) The demonstration (Fig. 4) that DNMT expression results in elevated ROS and its further synergistic increase when cells are also exposed to H2O2 is the basis for the authors' discussion of DNA damage-induced increases in cellular ROS. S. cerevisiae does not possess DNMTs/5mC, yet exposure to MMS also results in substantial increases in intracellular ROS (Rowe et al, (2008) Free Rad. Biol. Med. 45:1167-1177. PMC2643028). The authors should be aware of previous studies that have linked DNA damage to intracellular increases in ROS in other organisms and should comment on this in the text.

    3. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The manuscript proposes that 5mC modifications to DNA, despite being ancient and widespread throughout life, represent a vulnerability, making cells more susceptible to both chemical alkylation and, of more general importance, reactive oxygen species. Sarkies et al take the innovative approach of introducing enzymatic genome-wide cytosine methylation system (DNA methyltransferases, DNMTs) into E. coli, which normally lacks such a system. They provide compelling evidence that the introduction of DNMTs increases the sensitivity of E. coli to chemical alkylation damage. Surprisingly they also show DNMTs increase the sensitivity to reactive oxygen species and propose that the DNMT generated 5mC presents a target for the reactive oxygen species that is especially damaging to cells. Evidence is presented that DNMT activity directly or indirectly produces reactive oxygen species in vivo, which is an important discovery if correct, though the mechanism for this remains obscure.

      Strengths:

      This work is based on an interesting initial premise, it is well-motivated in the introduction and the manuscript is clearly written. The results themselves are compelling.

      We thank the reviewer for their positive response to our study.  We also really appreciate the thoughtful comments raised.  We have addressed the comments raised as detailed below. 

      Weaknesses:

      I am not currently convinced by the principal interpretations and think that other explanations based on known phenomena could account for key results. Specific points below.

      (1) As noted in the manuscript, AlkB repairs alkylation damage by direct reversal (DNA strands are not cut). In the absence of AlkB, repair of alklylation damage/modification is likely through BER or other processes involving strand excision and resulting in single stranded DNA. It has previously been shown that 3mC modification from MMS exposure is highly specific to single stranded DNA (PMID:20663718) occurring at ~20,000 times the rate as double stranded DNA. Consequently, the introduction of DNMTs is expected to introduce many methylation adducts genome-wide that will generate single stranded DNA tracts when repaired in an AlkB deficient background (but not in an AlkB WT background), which are then hyper-susceptible to attack by MMS. Such ssDNA tracts are also vulnerable to generating double strand breaks, especially when they contain DNA polymerase stalling adducts such as 3mC. The generation of ssDNA during repair is similarly expected follow the H2O2 or TET based conversion of 5mC to 5hmC or 5fC neither of which can be directly repaired and depend on single strand excision for their removal. The potential importance of ssDNA generation in the experiments has not been considered.

      We thank the reviewer for this interesting and insightful suggestion.  Our interpretation of our findings is that a subset of MMS-induced DNA damage, specifically 3mC, overlaps with the damage introduced by DNMTs and this accounts for increased sensitivity to MMS when DNMTs are expressed.  However, the idea that the introduction of 3mC by DNMT actually makes the DNA more liable to damage by MMS, potentially through increasing the level of ssDNA, is also a potential explanation, which could operate in addition to the mechanism that we propose.

      (2) The authors emphasise the non-additivity of the MMS + DNMT + alkB experiment but the interpretation of the result is essentially an additive one: that both MMS and DNMT are introducing similar/same damage and AlkB acts to remove it. The non-additivity noted would seem to be more consistent with the ssDNA model proposed in #1. More generally non-additivity would also be seen if the survival to DNA methylation rate is non-linear over the range of the experiment, for example if there is a threshold effect where some repair process is overwhelmed. The linearity of MMS (and H2O2) exposure to survival could be directly tested with a dilution series of MMS (H2O2).

      We thank the reviewer for this point.  As in the response to point #1, the reviewer’s hypothesis of increased potency of MMS, potentially through increased ssDNA, downstream of 3mC induction by DNMT, is a good one.  We have added a dose-response curve for DNMT-expressing cells to MMS to the revised version of the manuscript.  This shows that there is a non-linear response to MMS in the WT background.  Sensitivity is exacerbated by expression of DNMT and alkB mutation individually but there is also a strong non-additive effect that is particularly marked at low MMS concentrations where sensitivity is much higher in the double mutant than predicted from the two single mutants.  This is consistent with induction of DNA damage by DNMT that is repaired by alkB because alkB can be ‘overwhelmed’ even in WT backgrounds as the reviewer suggests.  However, it is also perfectly possible that the effect is due to increased levels of DNA damage induction in DNMT-expressing cells.  Both these results are compatible with our central hypothesis, namely that DNMT expression induces 3mC.  We have included these results along with discussion of them in the revised text in the results section:

      In order to investigate the non-additivity between DNMT expression and alkB mutation further, we investigated the effect of MMS over a range of concentrations for the different strains (Supplemental Figure 1A).  We quantified the non-additivity by comparing between the survival of alkB expressing DNMT to the predicted combined effect of either alkB mutation alone or DNMT expression alone(Supplemental Figure 1B).  Significantly reduced survival than expected was observed, most notably at low concentrations of MMS, which could be due to the saturation of the effect at high concentrations of MMS for alkB mutants expressing DNMT, where extremely high levels of sensitivity were observed.  The non-linear shape of the graph observed for WT cells expressing DNMTs further suggests that the ability of AlkB to repair the DNA is overwhelmed at high MMS concentrations even in the WT background.  These results are consistent with the idea that AlkB repairs a form of DNA damage from MMS that is more prevalent when DNMT is expressed.  This could be because DNMT induces 3mC, repaired by AlkB, and further 3mC is induced by MMS leading to much higher 3mC levels in the absence of AlkB activity.  Alternatively, 3mC induction by DNMT may lead to increased levels of ssDNA, particularly in alkB mutants, which could increase the risk of further DNA damage by MMS exposure and heighten sensitivity.  Either of these mechanisms are consistent with induction of 3mC by DNMT, and  indicate that the induction of DNA damage by DNMT expression has a fitness cost for cells when exposed to genotoxic stress in their environment. 

      (3) The substantial transcriptional changes induced by DNMT expression (Supplemental Figure 4) are a cause for concern and highlight that the ectopic introduction of methylation into a complex system is potentially more confounded than it may at first seem. Though the expression analysis shows bulk transcription properties, my concern is that the disruptive influence of methylation in a system not evolved with it adds not just consistent transcriptional changes but transcriptional heterogeneity between cells which could influence net survival in a stressed environment. In practice I don't think this can be controlled for, possibly quantified by single-cell RNA-seq but that is beyond the reasonable scope of this paper.

      We fully agree with the reviewer and, indeed, we are very interested in what is driving the transcriptional changes that we observed.  Work is currently underway in the lab to investigate this further but, as the reviewer suggests, is beyond the scope of this paper.  Importantly, we have used the transcriptional data to determine that the effect of DNMTs on ROS is unlikely to be due to failure of ROS-induced detoxification mechanisms by investigating the expression of oxyR regulated genes.  Nevertheless we have explicitly mentioned the concern raised by the reviewer in the revised manuscript as follows:

      “The substantial transcriptional responses could potentially affect how individual cells respond to genotoxic stress and thus could be contributing to some of the excess sensitivity to MMS and H2O2 in cells expressing DNMTs. However, the induction of oxyR regulated genes such as catalase was unaffected by 5mC (Supplementary Figure 4B).  Thus, the increased sensitivity to H2O2 is unlikely to be caused by failure of detoxification gene induction by DNMT expression.”

      (4) Figure 4 represents a striking result. From its current presentation it could be inferred that DNMTs are actively promoting ROS generation from H2O2 and also to a lesser extent in the absence of exogenous H2O2. That would be very surprising and a major finding with far-reaching implications. It would need to be further validated, for example by in vitro reconstitution of the reaction and monitoring ROS production. Rather, I think the authors are proposing that some currently undefined, indirect consequence of DNMT activity promotes ROS generation, especially when exogenous H2O2 is available. It would help if this were clarified.

      We thank the reviewer for picking this up.  In the discussion, we raise two possible explanations for why DNMT (even without H2O2) increases the ROS levels.  One idea is direct activity of DNMT, and one is through the product of DNMT activity (5mC) acting as a platform to generate more ROS from endogenous or exogenous sources.  Whilst we attempted to measure ROS from mSSSI activity in vitro, this experiment gave inconsistent results and therefore we cannot distinguish between these two possibilities.  However, we argued that direct activity is less likely, exactly as the reviewer points out.  We have clarified our discussion in the revised version, rewriting the entire section titled

      Oxidative stress as a new source of DNA damage induction by DNMT expression to more clearly set out these possibilities. 

      Reviewer #2 (Public review):

      5-methylcytosine (5mC) is a key epigenetic mark in DNA and plays a crucial role in regulating gene expression in many eukaryotes including humans. The DNA methyltransferases (DNMTs) that establish and maintain 5mC, are conserved in many species across eukaryotes, including animals, plants, and fungi, mainly in a CpG context. Interestingly, 5mC levels and distributions are quite variable across phylogenies with some species even appearing to have no such DNA methylation.

      This interesting and well-written paper discusses the continuation of some of the authors' work published several years ago. In that previous paper, the laboratory demonstrated that DNA methylation pathways coevolved with DNA repair mechanisms, specifically with the alkylation repair system. Specifically, they discovered that DNMTs can introduce alkylation damage into DNA, specifically in the form of 3-methylcytosine (3mC). (This appears to be an error in the DNMT enzymatic mechanism where the generation 3mC as opposed to its preferred product 5-methylcytosine (5mC), is caused by the flipped target cytosine binding to the active site pocket of the DNMT in an inverted orientation.) The presence of 3mC is potentially toxic and can cause replication stress, which this paper suggests may explain the loss of DNA methylation in different species. They further showed that the ALKB2 enzyme plays a crucial role in repairing this alkylation damage, further emphasizing the link between DNA methylation and DNA repair.

      The co-evolution of DNMTs with DNA repair mechanisms suggests there can be distinct advantages and disadvantages of DNA methylation to different species which might depend on their environmental niche. In environments that expose species to high levels of DNA damage, high levels of 5mC in their genome may be disadvantageous. This present paper sets out to examine the sensitivity of an organism to genotoxic stresses such as alkylation and oxidation agents as the consequence of DNMT activity. Since such a study in eukaryotes would be complicated by DNA methylation controlling gene regulation, these authors cleverly utilize Escherichia coli (E.coli) and incorporate into it the DNMTs from other bacteria that methylate the cytosines of DNA in a CpG context like that observed in eukaryotes; the active sites of these enzymes are very similar to eukaryotic DNMTs and basically utilize the same catalytic mechanism (also this strain of E.coli does not specifically degrade this methylated DNA) .

      The experiments in this paper more than adequately show that E. coli expression of these DNMTs (comparing to the same strain without the DNMTS) do indeed show increased sensitivity to alkylating agents and this sensitivity was even greater than expected when a DNA repair mechanism was inactivated. Moreover, they show that this E. coli expressing this DNMT is more sensitive to oxidizing agents such as H2O2 and has exacerbated sensitivity when a DNA repair glycosylase is inactivated. Both propensities suggest that DNMT activity itself may generate additional genotoxic stress. Intrigued that DNMT expression itself might induce sensitivity to oxidative stress, the experimenters used a fluorescent sensor to show that H2O2 induced reactive oxygen species (ROS) are markedly enhanced with DNMT expression. Importantly, they show that DNMT expression alone gave rise to increased ROS amounts and both H2O2 addition and DNMT expression has greater effect that the linear combination of the two separately. They also carefully checked that the increased sensitivity to H2O2 was not potentially caused by some effect on gene expression of detoxification genes by DNMT expression and activity. Finally, by using mass spectroscopy, they show that DNMT expression led to production of the 5mC oxidation derivatives 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC) in DNA. 5fC is a substrate for base excision repair while 5hmC is not; more 5fC was observed. Introduction of non-bacterial enzymes that produce 5hmC and 5fC into the DNMT expressing bacteria again showed a greater sensitivity than expected. Remarkedly, in their assay with addition of H2O2, bacteria showed no growth with this dual expression of DNMT and these enzymes.

      Overall, the authors conduct well thought-out and simple experiments to show that a disadvantageous consequence of DNMT expression leading to 5mC in DNA is increased sensitivity to oxidative stress as well as alkylating agents.

      Again, the paper is well-written and organized. The hypotheses are well-examined by simple experiments. The results are interesting and can impact many scientific areas such as our understanding of evolutionary pressures on an organism by environment to impacting our understanding about how environment of a malignant cell in the human body may lead to cancer.

      We thank the reviewer for their response to our study, and value the time taken to produce a public review that will aid readers in understanding the key results of our study. 

      Reviewer #3 (Public review):

      Summary:

      Krwawicz et al., present evidence that expression of DNMTs in E. coli results in (1) introduction of alkylation damage that is repaired by AlkB; (2) confers hypersensitivity to alkylating agents such as MMS (and exacerbated by loss of AlkB); (3) confers hypersensitivity to oxidative stress (H2O2 exposure); (4) results in a modest increase in ROS in the absence of exogenous H2O2 exposure; and (5) results in the production of oxidation products of 5mC, namely 5hmC and 5fC, leading to cellular toxicity. The findings reported here have interesting implications for the concept that such genotoxic and potentially mutagenic consequences of DNMT expression (resulting in 5mC) could be selectively disadvantageous for certain organisms. The other aspect of this work which is important for understanding the biological endpoints of genotoxic stress is the notion that DNA damage per se somehow induces elevated levels of ROS.

      Strengths:

      The manuscript is well-written, and the experiments have been carefully executed providing data that support the authors' proposed model presented in Fig. 7 (Discussion, sources of DNA damage due to DNMT expression).

      Weaknesses:

      (1) The authors have established an informative system relying on expression of DNMTs to gauge the effects of such expression and subsequent induction of 3mC and 5mC on cell survival and sensitivity to an alkylating agent (MMS) and exogenous oxidative stress (H2O2 exposure). The authors state (p4) that Fig. 2 shows that "Cells expressing either M.SssI or M.MpeI showed increased sensitivity to MMS treatment compared to WT C2523, supporting the conclusion that the expression of DNMTs increased the levels of alkylation damage." This is a confusing statement and requires revision as Fig. 2 does ALL cells shown in Fig. 2 are expressing DNMTs and have been treated with MMS. It is the absence of AlkB and the expression of DNMTs that that causes the MMS sensitivity.

      We thank the reviewer for this and agree that this needs to be clarified with regards to the figure presented and will do so in the revised manuscript. The key comparison is between the active and inactive mSSSI which shows increased sensitivity when active methyltransferases are expressed.  We have clarified this in the revised version of the manuscript as follows:

      “Cells expressing either M.SssI or M.MpeI showed increased sensitivity to MMS treatment compared to cells expressing inactive M.SssI”

      (2) It would be important to know whether the increased sensitivity (toxicity) to DNMT expression and MMS is also accompanied by substantial increases in mutagenicity. The authors should explain in the text why mutation frequencies were not also measured in these experiments.

      This is an important point because it is not immediately obvious that increased sensitivity would be associated with increased mutagenicity (if, for example, 3mC was never a cause of innacurate DNA repair even in the absence of AlkB).  We have now added a Rif resistance assay which demonstrates increased mutagenesis in the presence of DNMT, and that this is exacerbated by loss of AlkB. This is now added as supplemental figure 2 and described in the manuscript as follows:

      “One potential consequence of DNMT activity in inducing DNA damage might be increased mutagenesis.  To test this we performed a rifampicin resistance mutagenesis assay, in the absence of MMS, to test whether DNMT induced damage was sufficient to lead to mutation rate increase.  Mutation rate was increased by DNMT expression (p=1.6e-12; two way anova; Supplemental Figure 2) and alkB mutation (two way anova) separately (p<1e-16).  Moreover, there was a significant interaction such that combined alkB mutation and DNMT expression led to a further increased mutation rate compared to the expectation from alkB mutation and DNMT expression separately (p = 7.9e-10; Supplemental Figure 2).  Importantly, DNMT induction alone would be expected to lead to increased mutations due to cytosine deamination(Sarkies, 2022a); however, there is a synergistic effect on mutations when this is combined with loss of AlkB function in alkB mutants. This is consistent with 3mC induction by DNMTs which is repaired by AlkB in WT cells but leads to mutations in alkB mutant cells.

      (3) Materials and Methods. ROS production monitoring. The "Total Reactive Oxygen Species (ROS) Assay Kit" has not been adequately described. Who is the Vendor? What is the nature of the ROS probes employed in this assay? Which specific ROS correspond to "total ROS"?

      The ROS measurement was with a kit from ThermoFisher: https://www.thermofisher.com/order/catalog/product/88-5930-74.  The probe is DCFH-DA.  This is a general ROS sensor that is oxidised by a large number of cellular reactive oxygen species hence we cannot attribute the signal to a single species.  Use of a technique with the potential to more precisely identify the species involved is something we plan to do in future, but is beyond what we can do as part of this study.  We have added a comment as to the specificity of the ROS sensor in the revised version as follows:

      “The ROS detection reagent in this system is DCFH-DA, a generalised ROS sensor that is not specific to any particular ROS molecule.”     

      (4) The demonstration (Fig. 4) that DNMT expression results in elevated ROS and its further synergistic increase when cells are also exposed to H2O2 is the basis for the authors' discussion of DNA damage-induced increases in cellular ROS. S. cerevisiae does not possess DNMTs/5mC, yet exposure to MMS also results in substantial increases in intracellular ROS (Rowe et al, (2008) Free Rad. Biol. Med. 45:1167-1177. PMC2643028). The authors should be aware of previous studies that have linked DNA damage to intracellular increases in ROS in other organisms and should comment on this in the text.

      We thank the reviewer for this point.  We note that the increased ROS that we observed occur in the presence of DNMTs alone and in the presence of H2O2, not in the presence of MMS; however, the point that DNA damage in general can promote increased ROS in some circumstances is well taken.  We have included a comment on this in the revised version as follows:

      “We believe this is a plausible mechanism to explain both increased ROS and increased sensitivity to oxidative stress when DNMT is expressed.  However, other explanations are possible, and it is notable that DNA damaging agents such as MMS can lead to ROS generation(Rowe et al., 2008).  A more detailed chemical and kinetic study of the ROS formation in DNMT-expressing cells would be needed to resolve these questions.”

    1. Summary of the essay

      In this essay, the author seeks to explain the ‘firehose’ problem in academic research, namely the rapid growth in the number of articles but also the seemingly concurrent decline in quality. The explanation, he concludes, lies in the ‘superstructure’ of misaligned incentives and feedback loops that primarily drive publisher and researcher behaviour, with the current publish or perish evaluation system at the core. On the publisher side, these include commercial incentives driving both higher acceptance rates in existing journals and the launch of new journals with higher acceptance rates. At the same time, publishers seek to retain reputational currency by maintaining consistency and therefore brand power of scarcer, legacy-prestige journals. The emergence of journal cascades (automatic referrals from one journal to another journal within the same publisher) and the introduction of APCs (especially for special issues) also contribute to commercial incentives driving article growth. On the researcher side, he argues that there is an apparent demand from researchers for more publishing outlets and simultaneous salami slicing by researchers because authors feel they have to distribute relatively more publications among journals that are perceived to be of lower quality (higher acceptance rates) in order to gain equivalent prestige to that of a higher impact paper. The state of peer review also impacts the firehose. The drain of PhD qualified scientists out of academia, compounded by a lack of recognition for peer review, further contributes to the firehose problem because there are insufficient reviewers in the system, especially for legitimate journals. Moreover, what peer review is done is no guarantee of quality (in highly selective journals as well as ‘predatory’). One of his conclusions is that there is not just a crisis in scholarly publishing but in peer review specifically and it is this crisis that will undermine science the most. Add AI into the mix of this publish or perish culture, and he predicts the firehose will burst.

      He suggests that the solution lies in researchers taking back power themselves by writing more but ‘publishing’ less. By writing more he means outputs beyond traditional journal publications such as policy briefs, blogs, preprints, data, code and so on, and that these should count as much as peer-reviewed publications. He places special emphasis on the potential role of preprints and on open and more collegiate preprint review acting as a filter upstream of the publishing firehouse. He ends with a call for more collegiality across all stakeholders to align the incentives and thus alleviate the pressure causing the firehose in the first place.

      General Comment

      I enjoyed reading the essay and think the author does a good job of exposing multiple incentives and competing interests in the system. Although discussion of perverse incentives has been raised in many articles and blog posts, the author specifically focuses on some of the key commercial drivers impacting publishing and the responses of researchers to those drivers. I found the essay compellingly written and thought provoking although it took me a while to work through the various layers of incentives.  In general, I agree with the incentives and drivers he has identified and especially his call for stakeholders to avoid polarization and work together to repair the system. Although I appreciate the need to have a focused argument I did miss a more in-depth discussion about the equally complex layers of incentives for institutions, funders and other organisations (such as Clarivate) that also feed the firehose.

      I note that my perspective comes from a position of being deeply embedded in publishing for most of my career. This will have also impacted what I took away from the essay and the focus of my comments below.

      Main comments

      1. I especially liked the idea of a ‘superstructure’ of incentives as I think that gives a sense of the size and complexity of the problem. At the same time, by focusing on publisher incentives and researchers’ response to them he has missed out important parts of the superstructure contributing to the firehose, namely the role of institutions and funders in the system. Although this is implicit, I think it would have been worth noting more, in particular:

        • He mentions institutions and the role of tenure and promotion towards the end but not the extent of the immense and immobilizing power this wields across the system (despite initiatives such as DORA and CoARA).

        • Most review panels (researchers) assessing grants for funders are also still using journal publications as a proxy for quality, even if the funder policy states journal name and rank should not be used

        • Many Institutions/Universities still rely on number and venue of publications. Although some notable institutions are moving away from this, the impact factor/journal rank is still largely relied on. This seems especially the case in China and India for example, which has shown a huge growth in research output. Although the author discusses the firehose, it would have been interesting to see a regional breakdown of this.

        • Libraries also often negotiate with publishers based on volume of articles – i.e they want evidence that they are getting more articles as they renegotiate a specific contract (e.g. Transformative agreements), rather than e.g. also considering the quality of service.

        • Institutions are also driven by rankings in a parallel way to researchers being assessed based on journal rank (or impact factor). How University Rankings are calculated is also often opaque (apart from the Leiden rankings) but publications form a core part. This further incentivises institutions to select researchers/faculty based on the number and venue of their publications in order to promote their own position in the rankings (and obtain funding)

      2. The essay is also about power dynamics and where power in the system lies. The implication in the essay is that power lies with the publishers and this can be taken back by researchers. Publishers do have power, especially those in possession of high prestige journals and yet publishers are also subject to the power of other parts of the system, such as funder and institutional evaluation policies. Crucially, other infrastructure organisations, such as Clarivate, that provide indexing services and citation metrics also exert a strong controlling force on the system, for example:

        • Only a subset of journals are ever indexed by Clarivate. And funders and Institutions also use the indexing status of a journal as a proxy of quality. A huge number of journals are thus excluded from the evaluation system (primarily in the arts and humanities but also many scholar-led journals from low and middle income countries and also new journals). This further exacerbates the firehose problem because researchers often target only indexed journals. I’d be interested to see if the firehose problem also exists in journals that are not traditionally indexed (although appreciate this is also likely to be skewed by discipline)

        • Indexers also take on the role of arbiters of journal quality and can choose to delist or list journals accordingly. Listing or delisting has a huge impact on the submission rates to journals that can be worth millions of dollars to a publisher, but it is often unclear how quality is assessed and there seems to be a large variance in who gets listed or not.

        • Clarivate are also paid large fees by publishers to use their products, which creates a potential conflict of interest for the indexer as delisting journals from major publishers could potentially cause a substantial loss of revenue if they withdraw their fees. Also Clarivate relies on publishers to create the journals on which their products are based which may also create a conflict if Clarivate wishes to retain the in-principle support of those publishers.

        • The delisting of elife recently, even though it is an innovator and of established quality, shows the precariousness of journal indexing.

      3. All the stakeholders in the system seem to be essentially ‘following the money’ in one way or another – it’s just that the currency for researchers, institutions, publishers and others varies. Publishers – both commercial and indeed most not-for profit -  follow the requirements of the majority of their ‘customers’  (and that’s what authors, institutions, subscribers etc are in this system) in order to ensure both sustainability and revenue growth. This may be a legacy of the commercialisation of research in the 20th Century but we should not be surprised that growth is a key objective for any company. It is likely that commercial players will continue to play an important role in science and science communication; what needs to be changed are the requirements of the customers.

      4. The root of the problem, as the author notes, is what is valued in the system, which is still largely journal publications. The author’s solution is for researchers to write more – and for value to be placed on this greater range of outputs by all stakeholders. I agree with this sentiment – I am an ardent advocate for Open Science. And yet, I also think the focus on outputs per se and not practice or services is always going to lead to the system being gamed in some way in order to increase the net worth of a specific actor in the system. Preprints and preprint review itself could be subject to such gaming if value is placed on e.g. the preprint server or the preprint-review platform as a proxy of preprint and then researcher quality.

      5. I think the only way to start to change the system is to start placing much more value on both the practices of researchers (as well as outputs) and on the services provided by publishers. Of course saying this is much easier than implementing it.

      Other comments

      1. A key argument is that higher acceptance rates actually create a perverse incentive for researchers to submit as many manuscripts as possible because they are more likely to get accepted in journals with higher acceptance rates. I disagree that higher acceptance rates per se are the main incentive for researchers to publish more. More powerful is the fact that those responsible for grants and promotion continue to use quantity of journal articles as a proxy for research quality.

      2. Higher acceptance rates are not necessarily an indicator of low quality or a bad thing if it means that null, negative and inconclusive results are also published

      3. The author states that Journal Impact Factors might have been an effective measure of quality in the past.  I take issue with this because the JIF has, as far as I know, always been driven by relatively few outliers (papers with very high citations) and I don’t know of evidence to show that this wasn’t also true in the past. It also makes the assumption that citations = quality.

      4. The author asks at one point “Why would field specialization need a lower threshold for publication if the merits of peer review are constant? ” I can see a case for lower thresholds, however, when the purpose of peer review is primarily to select for high impact, rather than rigour, of the science conducted. A similar case might be made for multidisciplinary research, where peer reviewers tend to assess an article from their discipline’s perspective and reject it because the part that is relevant to them is not interesting enough… Of course, this all points to the inherent problems with peer review (with which I agree with the author)

      5. The author puts his essay in appropriate context, drawing on a range of sources to support his argument. I particularly like that he tried to find source material that was openly available.

      6. He cites 2 papers by Bjoern Brembs to substantiate the claim that there is potentially poorer review in higher prestige journals than in lower ranked journals. These papers were published in 2013 and 2018 and the conclusions relied, in part, on the fact that higher ranked journals had more retractions. Apart from a potential reporting bias, given the flood of retractions across multiple journals in more recent years, I doubt this correlation now exists?

      7. The author works out submission rates from the published acceptance rates of journals. The author acknowledges this is only approximate and discusses several factors that could inflate or deflate it. I can add a few more variables that could impact the estimate, including: 1) the number of articles a publisher/journal rejects before articles are assigned to any editor (e.g. because of plagiarism, reporting issues or other research integrity issues), 2) the extent to which articles are triaged and rejected by editors before peer review (e.g. because it is out of scope or not sufficiently interesting to peer review); the number of articles rejected after peer review;  and 4) the extent to which authors independently withdraw an article at any stage of the process. When publishers publish acceptance rates, they don’t make it clear what goes into the numerator or the denominator and there are no community standards around this. The author rightly notes this process is too opaque.

      Catriona J. MacCallum

      As is my practice, I do not wish to remain anonymous. Please also note that I work for a large commercial publisher and am writing this review in an independent capacity such that this review reflects my own opinion, which are not necessarily those of my employer.

    1. Reviewer #1 (Public review):

      Wojcik et al. conducted a working memory (WM) experiment in which participants had to press the right or left button after being presented with a square (upright) or diamond stimulus. The response mapping ('context') depended on a colour cue presented at the start of each trial. This results in an XOR task, requiring participants to integrate colour and shape information. Importantly, multiple colours could map onto the same context, allowing the authors to disentangle the (neural) representations of context from those of colour.

      The authors report that participants learn the appropriate context mappings quickly over the course of the experiment. Neural context representation is evident in the WM delay and emerges later in the experiment, unlike colour representation, which is present only during colour presentation and does not evolve over experimental time. There are furthermore results on neural geometry (averaged cross-generalized decoding) and neural dimensionality (averaged decoding after shattering all task dimensions), which are somewhat harder to interpret.

      Overall, the findings are likely Important, as they highlight the flexible and future-oriented nature of WM. The strength of support at the moment is incomplete: there are some loose ends on the context/colour generalization, and the evidence for the XOR neural representation is not (yet) well-established.

      I have one (major) concern and several suggestions for improvement.

      (1a) As the authors also acknowledge in several places, the XOR dimension is strongly correlated with motor responses, in any case toward the end of the task (and by definition for all correct trials). This should be dealt with properly. Right now, e.g. Figures 2g/i, 2h/j, 3e/g, 3f/h are highly similar, respectively, because of this strong collinearity. I would remove the semi-duplicate graphs and/or deal with this explicitly through some partial regression, trial selection, or similar (and report these correlations).

      (1b) Most worrisome in this respect is that one of the key results presented is that XOR decoding increases with learning. But also task accuracy increases, meaning that the proportion of correct trials increases with learning, meaning that the XOR and motor regressors become more similar over experimental time. This means that any classifier picking up on motor signals will be better able to do so later on in the task than earlier on. (In other words, the XOR regressor may be a noisy version of the motor regressor early on, and a more precise version of the motor regressor later on.) Therefore, the increase in XOR decoding over experimental time may be (entirely) due to an increase in similarity between the XOR and motor dimensions. The authors should either rule out this explanation, and/or remove/tone down the conclusions regarding the XOR coding increase. (Note that the takeaway regarding colour/context generalization does not depend on this analysis, fortunately.) The absence of a change in motor decoding with learning (as reported on page 11) does not affect this potential confound; in fact it is made more likely with it.

      (2) Bayes factors would be valuable in several places, especially with null results (p. 5) or cases with borderline-significant p-values.

      (3) The authors' interpretation of the key results implies that the abstract coding learned over the task should be relevant for behaviour. The current results do not show a particularly strong behavioural relevance of coding, to put it mildly. It might be worth exploring whether neural coding expresses itself in reaction times, rather than (in)correct responses, and reflecting on the (lack of) behavioural relevance in the Discussion.

      (4) All data and experiment/analysis code should be made available, in public repositories (i.e., not "upon request").

    2. Reviewer #2 (Public review):

      This manuscript describes an experiment in which subjects learned to apply an XOR rule in a task in which an initial color cue conditioned the instruction ("press left" or "press right") conveyed by a subsequent shape.

      This manuscript gives the impression of being written to address a sophisticated computational framework, but the experiment was not designed to test this framework. Stated differently, the memory-as-resource-for-computations framework may not be needed to account for the results presented here. Variants of this task have been used for decades, often in the context of prospective processing, and although the authors emphasize a dimensionality reduction operation, the task may actually only require the recoding of retrospectively relevant sensory information into the prospectively relevant rule that is needed to guide the response on that trial. Consequently, many of the claims are only partially supported.

      The framework invoked by the authors is summarized in the second paragraph of the manuscript:

      "Insights from machine learning and computational neuroscience further highlight the idea that memory processes can be viewed as a resource for computations rather than a passive mechanism for storage (Dasgupta & Gershman, 2021; Ehrlich & Murray, 2022). In this light, working memory adapts computations to the current task demands (Dasgupta & Gershman, 2021); pre-computed information can be stored in working memory, and thus reduce the computation time at the moment of the decision (Braver, 2012; Hunt et al., 2021). This perspective is further supported by computational modelling of neural circuits that contends that working memory will change neural geometry in a way that supports the temporal decomposition of computations (Ehrlich & Murray, 2022). This work suggests that the computational load at the moment of action can be thus alleviated by decomposing complex operations into several simple problems solved sequentially in time."

      However, the relevance, certainly the necessity, of this framework leads to mischaracterizations of some elements of the task (including about a hypothesis), the emphasis of constructs that don't actually exist in the task, some logical inconsistencies, and the repeated invocation of operations like "dimensionality reduction" despite the fact that the authors find no evidence for them.

      Beginning with the final point, the task presented here is a variant of a Badre-style hierarchical control task, one requiring solution at the second order of abstraction (i.e., the color conditions the interpretation of the shape [2nd order], which then determines the correct response [1st order]. These operations can be accomplished without dimensionality reduction by simply carrying out the remapping instructed by each element. For example, on a trial beginning with a blue color cue, the subject can use a lookup table to translate this into the rule "square = left; diamond = right". When the shape is subsequently presented, the subject responds according to this rule. This is really no different from any of the several studies that have shown prospective recoding of information in working memory, including the work from the 1990s in nonhuman primates, and several subsequent studies using fMRI in humans beginning in the 2000s. Importantly, this account does not involve dimensionality reduction in any overt way. If it were the case that the more recent computational work indicates that this operation of "prospective recoding" does, in fact, entail dimensionality reduction on this type of task, that would be interesting. However, I don't see evidence that this is the case. Although the authors carry out several analyses of shattering dimensionality, I do not find any that track this measure across epochs within the trial, an approach that would presumably capture epoch-to-epoch dimensionality reduction, if it occurred.

      With regard to mischaracterization of a hypothesis, the authors state: "We hypothesised that working memory processes control the dimensionality of neural representations by selecting features for maintenance. We tested this prediction by exploring the learning dynamics of the colour representation." However, what is described here is not a test of a prediction about dimensionality reduction. Rather, it's a test of a prediction that color decoding would not persist after color offset. To describe this as "dimensionality reduction" misrepresents/mischaracterizes what's happening, which is the translation of color (on any trial, a low-dimensional variable) into the rule that was cued by that color. It is a translation of what kind of information is being represented, as opposed to a dimensionality reduction applied to a representation.

      With regard to constructs that don't actually exist, it is unclear what the reality is in the study of a "color pair"? I.e., because colors are never presented together, nor associated in some way, this would seem to be a device that's helpful to the authors for thinking about how their task might be solved, rather than a fundamental aspect of the task that the reader needs to understand. Furthermore, the example given here wasn't helpful for this reader. (What WAS helpful was the description of the two possible strategies and accompanying references to Mayr & Kleigel and to Vandierendonck.)

      With regard to logical inconsistencies, one is the notion that color is irrelevant. This is not true, in a literal sense, because if every color cue were rendered as the same monochromatic patch, one wouldn't be able to solve the task. What the authors could do to make their point is perhaps refer to Strategy 1, which corresponds to a less efficient way to solve the task.

      Also inconsistent is the relation of the present work to a previous study carried out by this group in nonhuman primates. That task did not include a working memory delay, and so this is difficult to reconcile the comparison that the authors draw with this task with the many suggestions that they make that it's something about WM, per se, that allows for the efficient performance of this task.

      "Crucially, the irrelevant feature was only discarded during the delay after it entered working memory." This statement is in direct contradiction with the authors' own reporting of the results: "Decoding analyses demonstrated that colour information peaked in the early colour locked period of the trial and then rapidly declined over time to reach chance levels before the delay-locked period, 𝑐𝑙𝑢𝑠𝑡𝑒𝑟 1: 0.082 − 0.484 𝑚𝑠, 𝑝 = 0.006 (Fig. 2c)."

      Other areas where I had difficulties include:

      (1) "These results suggest that participants rapidly discarded irrelevant colour information. Only information relevant for performance (context) entered working memory and was maintained."<br /> Although this may be the case, each of the four colors also instructed a rule, and so what's being documented in this study is the translation of a cue into a rule, not the transformation of a "meaningless color" into a "meaningful context." It is very possible that if the authors only used two colors, one for each rule (i.e., one for each "context"), they'd get the same decoding results.

      (2) "A defining characteristic of low-dimensional task representations is that they can be easily cross-generalised to different sensory instances of the same task."<br /> This result is difficult to reconcile with the loss of color decoding with color offset. Must it not mean that the rule is being represented differently when cued, e.g., by blue vs. by pink, or by green vs. by khaki? If this is true, then this would also argue against the idea of dimensionality reduction during the delay period, because subjects will, in effect, have swapped needing to represent one of four colors with needing to represent one of four rules.

      (3) The authors assert that "cross-colour generalisation of context in the delay period is already implied by the significant context decoding combined with the absence of irrelevant colour coding."<br /> This is contradicted, however, by the failure of the direct test of cross-color decoding!

      (4) "Taken together, these findings imply that participants constructed abstract representations of task features but that the mechanism responsible for this transformation relied heavily on discarding colour information early in trial time."

      This statement does not follow from the data because no mechanism is being directly measured. Rather, it's simply the case that after translating the color to a rule, the color is no longer needed and so is no longer kept in an active state. There is certainly no evidence for "heavy reliance".

    1. Reviewer #1 (Public review):

      Circannual timing is a phylogenetically widespread phenomenon in long-lived organisms and is central to the seasonal regulation of reproduction, hibernation, migration, fur color changes, body weight, and fat deposition in response to photoperiodic changes. Photoperiodic control of thyroid hormone T3 levels in the hypothalamus dictates this timing. However, the mechanisms that regulate these changes are not fully understood. The study by Stewart et al. reports that hypothalamic iodothyronine deiodinase 3 (Dio3), the major inactivator of the biologically active thyroid hormone T3, plays a critical role in circannual timing in the Djungarian hamster. Overall, the study yields important results for the field and is well-conducted, with the exception of the CRISPR/Cas9 manipulation.

      Figure 1 lays the foundation for examining circannual timing by establishing the timing of induction, maintenance, and recovery phases of the circannual timer upon exposure of hamsters to short photoperiod (SP) by monitoring morphological and physiological markers. Measures of pelage color, torpor, body mass, plasma glucose, etc, established that the initiation phase occurred by weeks 4-8 in SP, the maintenance by weeks 12-20, and the recovery after week 20, where all morphological and physiological changes started to reverse back to long photoperiod phenotypes. The statistical analyses look fine, and the results are unambiguous. Their representation could, however, be improved. In Figures 1d and 1e, two different measures are plotted on each graph and differentiated by dots and upward or downward arrowheads. The plots are so small, though, that distinguishing between the direction of the arrows is difficult. Some color coding would make it more reader-friendly. The same comment applies to Figure S4. The authors went on to profile the transcriptome of the mediobasal and dorsomedial hypothalamus, paraventricular nucleus, and pituitary gland (all known to be involved in seasonal timing) every 4 weeks over the different phases of the circannual interval timer. A number of transcripts displaying seasonal rhythms in expression levels in each of the investigated structures were identified, including transcripts whose expression peaks during each phase. This included two genes of particular interest due to their known modulation of expression in response to photoperiod, Dio3 and Sst, found among the transcripts upregulated during the induction and maintenance phases, respectively. The experiments are technically sound and properly analyzed, revealing interesting candidates. Again, my main issues lie with the representation in the figure. In particular, the authors should clarify what the heatmaps on the right of Figures 1f and 1g represent. I suspect they are simply heatmaps of averaged expression of all genes within a defined category, but a description is missing in the legend, as well as a scale for color coding near the figure.

      Figure 2 reveals that SP-programmed body mass loss is correlated to increased Dio3-dependent somatostatin (Sst) expression. First, to distinguish whether the body mass loss was controlled by rheostatic mechanisms and not just acute homeostatic changes in energy balance, experiments from hamsters fed ad lib or experiencing an acute food restriction in both LP and SP were tested. Unlike plasma insulin, food restriction had no additional effect on SP-driven epididymal fat mass loss (Figure S7). This clearly establishes a rheostatic control of body mass loss across weeks in SP conditions. Importantly, Sst expression in the mediobasal hypothalamus increased in both ad lib fed or restriction fed SP hamsters and this increase in expression could be reduced by a single subcutaneous injection of active T3, clearly suggesting that increase in Sst expression in SP is due to a decrease of active T3 likely via Dio3 increase in expression in the hypothalamus. The results are unambiguous.

      Figure 3 provides a functional test of Dio3's role in the circannual timer. Mediobasal hypothalamic injections of CRISPR-Cas9 lentiviral vectors expressing two guide RNAs targeting the hamster Dio3 led to a significant reduction in the interval between induction and recovery phases seen in SP as measured by body mass, and diminished the extent of pelage color change by weeks 15-20. In addition, hamsters that failed to respond to SP exposure by decreasing their body mass also had undetectable Dio3 expression in the mediobasal hypothalamus. Together, these data provide strong evidence that Dio3 functions in the circannual timer. I noted, however, a few problems in the way the CRISPR modification of Dio3 in the mediobasal hypothalamus was reported in Figure S8. One is in Figure S8b, where the PAM sites are reported to be 9bp and 11bp downstream of sgRNA1 and sgRNA2, respectively. Is this really the case? If so, I would have expected the experiment to fail to show any effect as PAM sites need to immediately follow the target genomic sequence recognized by the sgRNA for Cas9 to induce a DNA double-stranded break. It seems that each guide contains a 3' NGG sequence that is currently underlined as part of sgRNAs in both Fig S8b and in the method section. If this is not a mistake in reporting the experimental design, I believe that the design is less than optimal and the efficiencies of sgRNAs are rather low, if at all functional. The authors report efficiencies around 60% (line 325), but how these were obtained is not specified. Another unclear point is the degree to which the mediobasal hypothalamus was actually mutated. Only one mutated (truncated) sequence in Figure S8c is reported, but I would have expected a range of mutations in different cells of the tissue of interest. Although the authors clearly find a phenotypic effect with their CRISPR manipulation, I suspect that they may have uncovered greater effects with better sgRNA design. These points need some clarification. I would also argue that repeating this experiment with properly designed sgRNAs would provide much stronger support for causally linking Dio3 in circannual timing.

      A proposed schematic model for mechanisms of circannual interval timing is presented in Figure S9. I think this represents a nice summary of the findings put in a broader context and should be presented as a main figure in the manuscript itself rather than being relayed in supplementary materials.

    1. Reviewer #2 (Public review):

      Summary:

      Koh and colleagues investigate the broader sensory role of LITE-1, a gustatory receptor previously linked to UV light detection in C. elegans. Their study explores whether LITE-1 also mediates avoidance of specific chemical stimuli-namely, high concentrations of diacetyl and 2,3-pentanedione. They show that LITE-1 is required in the ADL and ASK neurons for calcium responses to diacetyl, and that its expression in body-wall muscles is sufficient to trigger hypercontraction upon odorant exposure. Molecular docking suggests both odorants may directly bind to LITE-1 with micromolar affinity. These findings suggest LITE-1 may act as a multimodal receptor for both light and chemical stimuli.

      Strengths:

      (1) Methodological Precision: The study is technically strong, with well-executed calcium imaging and quantitative behavioral assays that clearly show neural and muscular responses to chemical stimuli.

      (2) Novelty and Scope: The work presents a compelling case for LITE-1 functioning as a multimodal sensor, which is an intriguing expansion of its known role.

      (3) Potential Impact: If validated, the findings could significantly advance the understanding of sensory integration in C. elegans, and the tools developed may be broadly useful to the research community.

      (4) Relevance to the Field: The study adds to evidence that C. elegans uses non-canonical sensory pathways and may inspire further exploration of multimodal receptor functions in other systems.

      Weaknesses:

      (1) Lack of Rescue Experiments: The absence of rescue experiments makes it difficult to definitively link the observed phenotypes to loss of lite-1.

      (2) Single Loss-of-Function Approach: The reliance on a single genetic mutant limits interpretability. Additional strategies such as RNAi (e.g., neuron-specific knockdown) would provide stronger evidence.

      (3) Unclear Neuronal Contribution: While calcium responses in ADL and ASK are reduced, it's unclear which neuron(s) are necessary for behavioral avoidance. Cell-specific rescue or knockdown experiments are needed.

      (4) Unvalidated Docking Data: The molecular docking predictions lack experimental validation. Site-directed mutagenesis would be needed to support claims of direct interaction.

      (5) Limited Odorant Specificity Testing: Docking analysis does not include non-binding odorants, making it difficult to assess binding specificity.

      (6) Incomplete Quantification: Some calcium imaging results (e.g., in AWA neurons of unc-13 mutants) lack statistical comparisons, which limits their interpretive value.

    1. Reviewer #3 (Public review):

      Summary:

      In this study, Shivani Bodas et al. investigate the role of actin, actin-binding proteins, and microtubules in regulating the membrane-associated periodic skeleton (MPS) in neuronal axons. The MPS, first reported by Ke Xu et al. in 2013 (Science), has since been implicated in various neuronal functions, including mechanical support, axonal diameter control, axonal degeneration regulation, and spatial organization of signaling molecules. Given its biological importance, further elucidation of MPS assembly mechanisms is of considerable interest. However, I have concerns regarding the novelty and strength of the conclusions presented in this work. Many of the findings largely reiterate previously published observations, and the most novel conclusions are not fully substantiated by the data.

      Strengths:

      (1) The MPS represents a structurally and functionally important cytoskeletal system in neurons. Studies aimed at understanding its developmental mechanisms are biologically meaningful and potentially impactful.

      (2) The authors attempt to dissect MPS assembly during early neuronal development, a process that could offer mechanistic insight into how the MPS is established and maintained.

      Weaknesses:

      (1) Limited Novelty Across Results Sections:

      Of the seven Results sections, only one (Figure 6) and part of another (Figure 9) present data leading to relatively novel interpretations, specifically, the authors' claim that βII-spectrin is recruited to the axonal cortex via F-actin interactions as early as DIV1, followed by rearrangement into a periodic structure by DIV4. However, this conclusion is not fully supported (see below). The remaining results (Figures 1-5, 7, and 8) largely recapitulate findings reported in earlier studies and thus add limited new knowledge.

      (2) Insufficient Evidence for Early Recruitment and Rearrangement of βII-spectrin:

      The claim that βII-spectrin is recruited to the axonal cortex via F-actin interactions as early as at DIV 1 and subsequently reorganized into a periodic structure during DIV1-4 is central to the manuscript but lacks robust experimental support.

      On Page 17, Line 526, the authors the authors state that " To exclude cytoplasmic spectrin resulting from overexpression, only axons with low expression of βII spectrin-GFP were selected for the analysis". However, selecting for low expression alone does not guarantee the absence of cytoplasmic signal. Without volumetric imaging (e.g., 3D super-resolution imaging to see the cross section of axons), it is difficult to definitively conclude that the FRAP data (Figures 6 and 9) reflect cortical rather than cytoplasmic localization.

      Prior FRAP studies (Zhong et al., eLife 2014) observed minimal fluorescence recovery over 1800 seconds in axons expressing βII-spectrin-GFP at low levels, with faster recovery (~200-300 seconds) only evident under high expression conditions. The fast recovery kinetics (tens of seconds) reported in this manuscript could plausibly result from free diffusion of cytoplasmic βII-spectrin-GFP rather than cortical turnover.

      Furthermore, on Page 10, Line 310, the authors assert that endogenous βII-spectrin "is recruited early to the axonal cortex, followed by progressive establishment of periodic order". However, the STED images shown in Figure 1 do not convincingly distinguish between cortical and cytoplasmic pools.

      As such, the observed disordered βII-spectrin molecules, whether overexpressed or endogenous, could still represent a diffuse cytoplasmic population. An alternative and perhaps more parsimonious interpretation is that βII-spectrin is initially cytoplasmic and only later recruited and arranged into periodic structures at the cortex.

      (3) Use of Pharmacological Perturbations:

      Like many earlier studies, this manuscript relies heavily on pharmacological perturbation (e.g., cytoskeletal drugs) to assess the roles of actin, actin-binding proteins, and microtubules in MPS assembly. While this approach is widely used, it is important to acknowledge that such agents may have off-target effects. The manuscript would benefit from greater caution in interpreting these results, or better yet, the inclusion of genetic or optogenetic approaches to independently validate these findings.

    1. Reviewer #2 (Public review):

      Summary:

      Nishimura and colleagues present findings of a behavioral and neurobiological dissociation of associative and nonassociative components of Stress Enhanced Fear Responding (SEFR).

      Strengths:

      This is a strong paper that identifies the PVT as a critical brain region for SEFR responses using a variety of approaches, including immunohistochemistry, fiber photometry, and bidirectional chemogenetics. In addition, there is a great deal of conceptual innovation. The authors identify a dissociable behavior to distinguish the effects of PVT function (among other brain regions).

      Weaknesses:

      (1) The authors find a lack of difference between the Stress and No Stress groups in pPVT activity during SEFL conditioning with fiber photometry but an increase in freezing with Gq DREADD stimulation. How do authors reconcile this difference in activity vs function?

      (2) Because the PVT plays a role in defensive behaviors, it would be beneficial to show fiber photometry data during freezing bouts vs exclusively presented during tone a shock cue presentations.

      (3) Similar to the above point, were other defensive behaviors expressed as a result of footshock stress or PVT manipulations?

      (4) Tone attenuation in Figure 8 seems to be largely a result of minimal freezing to a 115-dB tone. While not a major point of the paper, a more robust fear response would be convincing.

      (5) In the open field test, the authors measure total distance. It would be beneficial to also show defensive behavioral (escape, freezing, etc) bouts expressed.

      (6) The authors, along with others, show a behavioral and neural dissociation of footshock stress on nonassociative vs associative components of stress; however, the nonassociative components as a direct consequence of the stress seem to be necessary for enhancement of associative aspects of fear. Can authors elaborate on how these systems converge to enhance or potentiate fear?

      (7) In the discussion, authors should elaborate on/clarify the cell population heterogeneity of the PVT since authors later describe PVT neurons as exclusively glutamatergic.

    2. Reviewer #3 (Public review):

      Summary:

      The manuscript by Nishimura et al. examines the behavioural and neural mechanisms of stress-enhanced fear responding (SEFR) and stress-enhanced fear learning (SEFL). Groups of stressed (4 x shock exposure in a context) vs non-stressed (context exposure only) animals are compared for their fear of an unconditioned tone, and context, as well as their learning of new context fear associations. Shock of higher intensity led to higher levels of unlearned stress-enhanced fear expression. Immediate early gene analysis uncovered the PVT as a critical neural locus, and this was confirmed using fiber photometry, with stressed animals showing an elevated neural signal to an unconditioned tone. Using a gain and loss of function DREADDs methodology, the authors provide convincing evidence for a causal role of the PVT in SEFR.

      Strengths:

      (1) The manuscript uses critical behavioural controls (no stress vs stress) and behavioural parameters (0.25mA, 0.5mA, 1mA shock). Findings are replicated across experiments.

      (2) Dissociating the SEFR and SEFL is a critical distinction that has not been made previously. Moreover, this dissociation is essential in understanding the behavioural (and neural) processes that can go awry in fear.

      (3) Neural methods use a multifaceted approach to convincingly link the PVT to SEFR: from Fos, fiber photometry, gain and loss of function using DREADDs.

      Weaknesses:

      No weaknesses were identified by this reviewer; however, I have the following comments:

      A closer examination of the Test data across time would help determine if differences may be present early or later in the session that could otherwise be washed out when the data are averaged across time. If none are seen, then it may be worth noting this in the manuscript.

      Given the sex/gender differences in PTSD in the human population, having the male and female data points distinguished in the figures would be helpful. I assume sex was run as a variable in the statistics, and nothing came as significant. Noting this would also be of value to other readers who may wonder about the presence of sex differences in the data.

    1. Reviewer #1 (Public review):

      Summary:

      This study investigates how mice make defensive decisions when exposed to visual threats and how those decisions are influenced by reward value and social hierarchy. Using a naturalistic foraging setup and looming stimuli, the authors show that higher threat leads to faster escape, while lower threat allows mice to weigh reward value. Dominant mice behave more cautiously, showing higher vigilance. The behavioral findings are further supported by a computational model aimed at capturing how different factors shape decisions.

      Strengths:

      (1) The behavioral paradigm is well-designed and ethologically relevant, capturing instinctive responses in a controlled setting.

      (2) The paper addresses an important question: how defensive behaviors are influenced by social and value-based factors.

      (3) The classification of behavioral responses using machine learning is a solid methodological choice that improves reproducibility.

      Weaknesses:

      (1) Key parts of the methods are hard to follow, especially how trials are selected and whether learning across trials is fully controlled for. For example, it is unclear whether animals are in the nest during the looming stimulus presentations. The main text and methods should clarify whether multiple mice are in the nest simultaneously and whether only one mouse is in the arena during looming exposure. From the description, it seems that all mice may be freely exploring during some phases, but only one is allowed in the arena at a time during stimulus presentation. This point is important for understanding the social context and potential interactions, and should be clearly explained in both the main text and methods.

      (2) It is often unclear whether the data shown (especially in the main summary figures) come from the first trial or are averages across several exposures. When is the cut-off for trials of each animal? How do we know how many trial presentations were considered, and how learning at different rates between individuals is taken into account when plotting all animals together? This is important because the looming stimulus is learned to be harmless very quickly, so the trial number strongly affects interpretation.

      (3) The reward-related effects are difficult to interpret without a clearer separation of learning vs first responses.

      (4) The model reproduces observed patterns but adds limited explanatory or predictive power. It does not integrate major findings like social hierarchy. Its impact would be greatly improved if the authors used it to predict outcomes under novel or intermediate conditions.

      (5) Some conclusions (e.g., about vigilance increasing with reward) are counterintuitive and need stronger support or alternative explanations. Regarding the interpretation of social differences in area coverage, it's also possible that the observed behavioral differences reflect access to the nesting space. Dominant mice may control the nest, forcing subordinates to remain in the open arena even during or after looming stimuli. In this case, subordinates may be choosing between the threat of the dominant mouse and the external visual threat. The current data do not distinguish between these possibilities, and the authors do not provide evidence to support one interpretation over the other. Including this alternative explanation or providing data that addresses it would strengthen the conclusions.

      (6) While potential neural circuits are mentioned in the discussion, an earlier introduction of candidate brain regions and their relevance to threat and value processing would help ground the study in existing systems neuroscience.

      (7) Some figures are difficult to interpret without clearer trial/mouse labeling, and a few claims in the text are stronger than what the data fully support. Figure 3H is done for low contrast, but the interesting findings will be to do this experiment with high contrast. Figure 4H - I don't understand this part. If the amount of time in the center after the loom changes for subordinate mice, how does this lead to the conclusion that they spend most of their time in the reward zone?. Figure 3A - The example shown does not seem representative of the claim that high contrast stimuli are more likely to trigger escape. In particular, the 10% sucrose condition appears to show more arena visits under low contrast than high contrast, which seems to contradict that interpretation. Also, the plot currently uses trials on the Y-axis, but it would be more informative to show one line per animal, using only the first trial for each. This would help separate initial threat responses from learning effects and clarify individual variability.

      (8) The analysis does not explore individual variability in behavior, which could be an important source of structure in the data. Without this, it is difficult to know whether social hierarchy alone explains behavioral differences or if other stable traits (e.g., anxiety level, prior experiences) also contribute.

      (9) The study shows robust looming responses in group-housed animals, which contrasts with other studies that often require single housing to elicit reliable defensive responses. It would be valuable for the authors to discuss why their results differ in this regard and whether housing conditions might interact with social rank or habituation.

    2. Reviewer #2 (Public review):

      Zhe Li and colleagues investigate how mice exposed to visual threats and rewards balance their decisions in favour of consuming rewards or engaging in defensive actions. By varying threat intensity and reward value, they first confirm previous findings showing that defensive responses increase with threat intensity and that there is habituation to the threat stimulus. They then find that water-deprived mice have a reduced probability of escaping from low contrast visual looming stimuli when water or sucrose are offered in the environment, but that when the stimulus contrast is high, the presence of sucrose or water increases the probability of escape. By analysing behaviour metrics such as the latency to flee from the threat stimulus, they suggest that this increase in threat sensitivity is due to increased vigilance. Analysis of this behaviour as a function of social hierarchy shows that dominant mice have higher threat sensitivity, which is also interpreted as being due to increased vigilance. These results are captured by a drift diffusion model variant that incorporates threat intensity and reward value.

      The main contribution of this work is to quantify how the presence of water or sucrose in water-deprived mice affects escape behaviour. The differential effects of reward between the low and high contrast conditions are intriguing, but I find the interpretation that vigilance plays a major role in this process is not supported by the data. The idea that reward value exerts some form of graded modulation of the escape response is also not supported by the data. In addition, there is very limited methodological information, which makes assessing the quality of some of the analyses difficult, and there is no quantification of the quality of the model fits.

      (1) The main measure of vigilance in this work is reaction time. While reaction time can indeed be affected by vigilance, reaction times can vary as a function of many variables, and be different for the same level of vigilance. For example, a primate performing the random dot motion task exhibits differences in reaction times that can be explained entirely by the stimulus strength. Reaction time is therefore not a sound measure of vigilance, and if a goal of this work is to investigate this parameter, then it should be measured. There is some attempt at doing this for a subset of the data in Figure 3H, by looking at differences in the action of monitoring the visual field (presumably a rearing motion, though this is not described) between the first and second trials in the presence of sucrose. I find this an extremely contrived measure. What is the rationale for analysing only the difference between the first and second trials? Also, the results are only statistically significant because the first trial in the sucrose condition happens to have zero up action bouts, in contrast to all other conditions. I am afraid that the statistics are not solid here. When analysing the effects of dominance, a vigilance metric is the time spent in the reward zone. Why is this a measure of vigilance? More generally, measuring vigilance of threats in mice requires monitoring the position of the eyes, which previous work has shown is biased to the upper visual field, consistent with the threat ecology of rodents.

      (2) In both low and high contrast conditions, there are differences in escape behaviour between no reward and water or sucrose presence, but no statistically significant differences between water and sucrose (eg, Figure 3B). I therefore find that statements about reward value are not supported by the data, which only show differences between the presence or absence of reward. Furthermore, there is a confound in these experiments, because according to the methods, mice in the no-reward condition were not water deprived. It is thus possible that the differences in behaviour arise from differences in the underlying state.

      (3) There is very little methodological information on behavioural quantification. For example, what is hiding latency? Is this the same are reaction time? Time to reach the safe zone? What exactly is distance fled? I don't understand how this can vary between 20 and 100cm. Presumably, the 20cm flights don't reach the safe place, since the threat is roughly at the same location for each trial? How is the end of a flight determined? How is duration measured in reward zone measures, e.g., from when to when? How is fleeing onset determined?

      (4) There is little methodological information on how the model was fit (for example, it is surprising that in the no reward condition, the r parameter is exactly 0. What this constrained in any way), and none of the fit parameters have uncertainty measures so it is not possible to assess whether there are actually any differences in parameters that are statistically significant.

    1. Reviewer #2 (Public review):

      Summary:

      This is a compelling and methodologically rich manuscript. The authors used a variety of methods, including psychophysics, computational modeling, and artificial neural networks, to reveal a non-monotonic, center-surround "Mexican-hat" profile of expectation in orientation space. Their data convincingly extend analogous findings in attention and working memory, and the modeling nicely teases apart sharpening vs. shift mechanisms.

      Strengths:

      The findings are novel and important in elucidating the potential neural mechanisms by which expectation shapes perception. The authors conducted a series of well-designed psychophysical experiments to careful examination of the profile of expectation's modulation. Computational modeling also provides further insights, linking the neural mechanisms of expectation to behavioral results.

      Weaknesses:

      There are several aspects that could be strengthened or clarified.

      (1) The sharpening model of expectation can predict surround suppression. The authors could further clarify how the cancellation model predicts a monotonic profile of expectation (Figure 1C) with the highest response at the expected orientation, while the cancellation model suggests a suppression of neurons tuned toward the expected stimulus.

      (2) I'm a bit concerned about whether the profile solely arises from modulation of expectation. The two auditory cues are each associated with a fixed orientation, which may be confounded by other cognitive processes like visual working memory or attention (which I think the authors also discussed). Although the authors tried to use SFD task to render orientation task-irrelevant, luminance edges (i.e., orientation) and spatial frequency in gratings are highly intertwined and orientation of the gratings may help recall the first grating's SF (fixed at 0.9 c/{degree sign}), especially given the first and second grating's orientations are not very different (4.8{degree sign}).

      (3) For each of the expected orientations (20{degree sign} or 70{degree sign}), the unexpected ones are linearly separable (i.e., all unexpected ones lie on one side of the expected angle). This might further encourage people to shift their attended or expected orientation, according to the optimal tuning hypothesis. Would this provide an alternative explanation to the tuning shift that the authors found?

      (4) It is great that the authors conducted computational modeling to elucidate the potential neuronal mechanisms of expectation. But I think the sharpening hypothesis (e.g., reviewed in de Lange, Heilbron & Kok, 2018) focuses on the neural population level, i.e., narrowing of population tuning profile, while the authors conducted the sharpening at the neuronal tuning level. However, the sharpening of population does not necessarily rely on the sharpening of individual neuronal tuning. For example, neuronal gain modulation can also account for such population sharpening. I think similar logic applies to the orientation adjustment experiment. The behavioral level shift does not necessarily suggest a similar shift at the neuronal level. I would recommend that the authors comment on this.

      (5) If the orientation adjustment experiment suggests that both sharpening and shifting are present at the same time, have the authors tried combining both in their computational model?

    1. Reviewer #1 (Public review):

      This is a theoretical study addressing the problem of constructing integrator networks for which the activity state and integrated variables display non-trivial topologies. Historically, researchers in theoretical neuroscience have focused on models with simple underlying geometries (e.g., circle, torus), for which analytical models could be more easily constructed. How these models can be generalised to complex scenarios is, however, a non-trivial question. This is furthermore a time-sensitive issue, as population recordings from the brain in complex tasks and environments increasingly require the ability to construct such models.

      I believe the authors do a good job of explaining the challenges related to this problem. They also propose a class of models that, although not fully general, overcome many of these difficulties while appearing solid and well-functioning. This requires some non-trivial mathematics, which is nevertheless conveyed in a reasonably accessible form. The manuscript is well written, and both the methodology and the code are well documented.

      That said, I believe the manuscript has two major limitations, which could be addressed in a revision. First, some of the assumptions underlying this class of models are somewhat restrictive but are not sufficiently discussed. Second, although the stated goal of the manuscript is to provide practical recipes for constructing integrator networks, the methods section is not very explicit about the specific steps required for different geometries. I elaborate on these limitations below.


      (1) The authors repeatedly describe MADE as a technique for constructing integrators of specified "topologies and geometries." What do they mean by "geometries"? Intuitively, I would associate geometry with properties beyond topology, such as embedding dimensionality or curvature. However, it is unclear to me to what extent these aspects are explicitly specified or controlled in MADE. It seems that geometry is only indirectly defined via the connectivity kernel, which itself obeys certain constraints (e.g., limited spatial scale; see below). I believe it is important for the authors to clarify what they mean by "geometry." They should also specify which aspects are under their control, and whether, in fact, all geometries can be realized.


      (2) The authors make two key assumptions: that connectivity is purely inhibitory and that the connectivity kernel has a small spatial scale. They state that under these conditions, the homogeneous fixed point becomes unstable, leading to a non-periodic state. However, it seems to me that they do not demonstrate that this emergent state is necessarily a bump localized in all manifold dimensions -- although this is assumed throughout the manuscript. Are other solutions possible or observed? For example, might the network converge to states that are localized in one dimension but extended in another, yielding e.g., stripe-like activity in the plane rather than bumps? In other words, does the proposed recipe guarantee convergence to bumps? This is a critical point and should be clarified.


      (3) Related to the question above: What are the failure modes when these two assumptions are violated? Does the network always exhibit runaway activity (as suggested in the text), or can other types of solutions emerge? It would be useful if the authors could briefly discuss this.


      (4) Again, related to the question above: can this formalism be extended to activity profiles beyond bumps? For example, periodic fields as seen in grid cells, or irregular fields as observed in many biological datasets -- particularly in naturalistic environments? These activity profiles are of key importance to neuroscientists, so I believe this is an important point that should at least be addressed in the Discussion. Can MADE be naturally extended to these scenarios? What are the challenges involved?


      (5) Line 119: "Since σ is the only spatial scale being introduced in the dynamics, we qualitatively expect that a localized bump state within the ball will have a spatial scale of O(σ)."
Is this statement always true? I understand that the spatial scale of the synaptic inputs exchanged via recurrent interactions (i.e., the argument of the function f in Equation 1) is characterised by the spatial scale σ. But the non-linear function f could modify that spatial scale -- for example, by "cutting" the bump close to its tip. Where am I wrong? Could the authors clarify?


      (6) The authors provide beautiful intuition about the problem of constructing integrators on non-trivial topologies and propose a mathematically grounded solution using Killing vectors. Of course, solutions based on Killing vectors are more complex than those with constant offsets, which raises the question: Is the brain capable of learning and handling such complex structures? Perhaps the authors could speculate in the Discussion about the biological plausibility of these mechanisms.


      (7) A great merit of this paper is that it provides mathematical tools for neuroscience researchers to build integrators on non-trivial geometries. I found that, although all the necessary information is present in the Methods, the authors could improve the presentation by schematizing the steps required to build each type of model. It would be extremely useful if, for each considered geometry, the authors provided a short list of required components: the manifold P, the choice of distance, and the connectivity offsets defined by the Killing vectors. Currently, this information is presented, but scattered (not grouped by geometry).

    2. Reviewer #2 (Public review):

      Summary:

      The work by Claudi et al. presents a framework for constructing continuous attractor neural networks (CANs) with user-defined topologies and integration capabilities. The framework unifies and generalizes classical attractor models and includes simulations across a range of topologies, including ring, torus, sphere, Möbius band, and Klein bottle. A key contribution of the paper is the introduction of Killing vectors to enable integration on non-parallelizable manifolds. However, the need for Killing vectors currently appears hypothetical, as biologically discovered manifolds-such as rings and tori-do not require them.

      Moreover, throughout the manuscript, the authors claim to be addressing "biologically plausible" attractor networks, yet the constraints required by their construction - such as exact symmetry, fine-tuning of weights, and idealized geometry-seem incompatible with biological variability. It appears that "biologically plausible" is effectively used to mean "capable of integration." While these issues do not diminish the contributions of the work, they should be acknowledged and addressed more explicitly in the text. I applaud the authors for their interesting work. Below are my major and minor concerns.

      Strengths:

      (1) Theoretical framework for integrating CANs<br /> The paper introduces a systematic method for constructing continuous attractor networks (CANs) with arbitrary topologies. This goes beyond classical models and includes novel topologies such as the Möbius band, sphere, and Klein bottle. The approach generalizes well-known ring and torus attractor models and provides a unified view of their construction, dynamics, and integration capabilities.

      (2) Novel use of killing vector fields<br /> A key theoretical innovation is the introduction of Killing vectors to support velocity integration on non-parallelizable manifolds. This is mathematically elegant and extends the domain of tractable attractor models.

      (3) Insightful simulations across manifolds<br /> The paper includes detailed simulations demonstrating bump attractor dynamics across a range of topologies.

      Weaknesses:

      (1) Biological plausibility is overstated<br /> Despite frequent use of the term "biologically plausible," the models rely on assumptions (e.g., symmetric connectivity, perfect geometries, fine-tuning) that are not consistent with known biological networks, and the authors do not incorporate heterogeneity, noise, or constraints like Dale's law.

      (2) Continuum of states not directly demonstrated<br /> The authors claim to generate a continuum of stable states but do not provide direct evidence (e.g., Jacobian analysis with zero eigenvalues along the manifold). This weakens the central claim about the nature of the attractor.

      (3) Lack of clarity around assumptions<br /> Several assumptions and analyses (e.g., symmetry breaking, linearity, stability conditions) are introduced without justification or overstated. The analytical rigor in discussing alternative solutions and bifurcation behavior is limited.

      (4) Scalability to high dimensions<br /> The authors claim their method scales better than learning-based approaches. This should be better discussed.

      Major Concerns

      (1) Biological plausibility

      The claim that the proposed framework is "biologically plausible" is misleading, as it is unclear what the authors mean by this term. Biological plausibility could include features such as heterogeneity in synaptic weights, randomness in tuning curves, irregular geometries, or connectivity constraints consistent with known biological architectures (e.g., Dale's law, multiple cell types). None of these elements is implemented in the current framework. Furthermore, it is not clear whether the framework can be extended to include such features-for example, CANs with heterogeneous connections or tuning curves. The connectivity matrix is symmetric to allow an energy-based description and analytical tractability, which is fine, but not a biologically realistic constraint. I recommend removing or significantly qualifying the use of the term "biologically plausible."

      (2) Continuum of stable states<br /> While the authors claim their model generates a continuum of stable states, this is not demonstrated directly in their simulations or in a stability analysis (though there are some indirect hints). One way to provide evidence would be to compute the Jacobian at various points along the manifold and show that it possesses (approximately) zero eigenvalues in the tangent/on-manifold directions at each point (e.g., see Ságodi et al. 2024 and others). It would be especially valuable to provide such analysis for the more complex topologies illustrated in the paper.

      (3) Assumptions, limitations, and analytical rigor<br /> Some assumptions and derivations lack justification or are presented without sufficient detail. Examples include:

      • Line 126: "If the homogeneous state (all neurons equally active) were unstable, there must exist some other stable state, with broken symmetry." Is this guaranteed? In the ring model with ReLU activation, there could also be unbounded solutions-not just bump solutions-and, in principle, there could also be oscillatory or other solutions. In general, multiple states can co-exist, with differing stability. It appears the authors only analyze the homogeneous case and do not study the stability or bifurcations of other solutions, limiting their theoretical work.

      • Line 122: "The conditions for the formation..." What are these conditions, precisely? A citation or elaboration would be helpful. Why is the assumption σ≪L necessary, and how does it impact the construction or conclusions?

      • The theory relies heavily on exact symmetries and fine-tuned parameters. Indeed, in line 106, the authors write: "We seek interaction weights consistent with the formation, through symmetry breaking." Is this symmetry-breaking necessary for all CANs? Or is it a limitation specific to hand-crafted models (see also below)? There is insufficient discussion of such limitations. For example, it is difficult to envision how the authors' framework might form attractor manifolds with different geometries or heterogeneous tuning curves.

      (4) Comparison with models of learned attractors<br /> While the connectivity patterns of learned attractors often resemble classical hand-crafted models (e.g., see also Vafidis et al. 2022), this is not always the case. If initial conditions include randomness or if the geometry of the attractor deviates from standard forms, the solutions can diverge significantly from hand-designed architectures. Such biologically realistic conditions highlight the limitations the hand-crafted CANs like those proposed here. I suggest updating the discussion accordingly.

      (5) High-Dimensional Manifolds<br /> The authors argue that their method scales better than training-based approaches in high dimensions and that it is straightforward to extend their framework to generate high-dimensional CANs. It would be useful for the authors to elaborate further. First, it is unclear what k refers to in the expression k^M used in the introduction. Second, trained neural networks seem to exhibit inductive bias (e.g., Cantar et al. 2021; Bordelon & Pehlevan 2022; Darshan & Rivkind 2022), which may mitigate such scaling issues. To support their claim, the authors could also provide an example of a high-dimensional manifold and show that their framework efficiently supports a (semi-)continuum of stable states.

  2. learn-ap-southeast-2-prod-fleet01-xythos.content.blackboardcdn.com learn-ap-southeast-2-prod-fleet01-xythos.content.blackboardcdn.com
    1. Marine Growth

      Marine growth refers to the accumulation of organisms like algae, barnacles, mussels, and other sea life on underwater parts of offshore structures—such as platforms, pipelines, or wind turbine foundations.

      As an environmental load, marine growth affects offshore structures in several ways: 1. Increased Weight The mass of the marine organisms adds dead load to the structure.

      This can affect buoyancy and stability, especially for floating or semi-submersible structures.

      1. Increased Diameter / Surface Area Marine growth increases the effective diameter of structural elements (e.g., piles or braces).

      This leads to greater hydrodynamic drag from waves and currents, making the structure more exposed to wave and current forces.

      1. Changes in Structural Dynamics Added mass can change the natural frequency of the structure, affecting how it responds to wave or wind loading.

      This can be important in fatigue design.

      1. Corrosion and Inspection Challenges Marine growth can retain moisture and promote corrosion.

      It can also make inspections and maintenance more difficult.

    1. Reviewer #2 (Public review):

      Summary:

      The authors aimed to investigate the temporal dynamics of how prior experiences shape learning in new complex environments by examining whether the brain reuses abstract structural components from those experiences. They employed a sequence learning task based on graph factorization and recorded neural activity using magnetoencephalography (MEG) to investigate how the underlying graph factors are reused to support learning and inference in a new graph. MEG data was derived from passive stimulus presentation trials, and behavior was assessed through a small number of probe trials testing either experienced or inferred successions in the graph. Representational similarity analysis of the MEG data was performed at a quite aggregated level (the principal components explaining 80% of the variance). The authors report (1) enhanced neural similarity among stimuli that belong to the same graph-factor as well as (2) a correlation between abstract role representations, corresponding to particular positions in the graph, and performance in experience-probes but not in inference-probes.

      Strengths & Weaknesses:

      (1) The first finding is considered evidence for representational alignment of the graph factors. However, alignment seems to be just one possible arrangement underlying the increased similarity between stimuli of the same vs different graph factors. For instance, a simple categorical grouping of stimuli belonging to the same graph, rather than their structural alignment, could also underlie the reported effect. The wording should be adjusted to avoid overinterpretation.

      (2) The second finding of abstract role representations is indeed expected for structural generalisation. While the data presents an interesting indication, its interpretability is constrained by a lack of testing for generalization of the effect to other graph structures (e.g., to rule out graph-specific strategies) as well as the absence of a link to transfer performance in inference-probes. The authors argue that the experienced transitions the classifier was trained on might be more similar in process to the experience-probes than the inference-probes. However, as inference-probes are the key measure of transfer, one could argue that if abstract role representations truly underlie transfer learning, they should be evident in the common neural signal.

      (3) The authors write, "we observed a qualitative pattern indicative of increased neural similarity between stimuli that adhered to the same underlying subprocess across task phases. (...) There was a statistically significant interaction effect of condition x graph factor spanning approximately 300 - 680 ms post-stimulus onset". I conclude there was no significant main effect of graph factor, but the relevant statistics are not reported. The authors should report and discuss the complete statistics.

      (4) The RSA is performed on highly aggregated data (the PCs that explained 80% of the variance). Could the authors include their rationale for this choice (e.g. over-analysis of sensor-level data)? In case sensor-level analyses have been conducted as well, maybe there are comparisons or implications of the chosen approach that are useful to mention in the discussion. The authors should provide the average and distribution of the number of PCs underlying their analyses.

      (5) While the paper is well-written overall, it would benefit from more explicitly identifying the concrete research question and advancing through the results. The authors state their aim as understanding the "temporal dynamics of compositional generalisation", revealing "at which moment during neural information processing are they assembled". They conclude with "providing evidence for temporally resolved neural dynamics that support compositional generalization" and "we show the neural dynamics (...) presented across different task phases...". It remains somewhat vague what specific insight about the process is provided through the temporal resolution (e.g., is the time window itself meaningful, if so, it should be contextualized; is the temporal resolution critical to dissociate subprocesses). The different task phases -initial learning and transfer- are the necessary conditions to investigate transfer learning, but do not by themselves offer a particularly resolved depiction of the process.

      Overall, the findings are congruent with prior research on neural correlates of structural abstraction. They offer an elegant, well-suited task design to study compositional representations, replicating the authors' earlier finding and providing temporal information on structural generalisation in a sequence learning task.

    2. Reviewer #3 (Public review):

      Summary

      This study investigates how task components can be learned and transferred across different task contexts. The authors designed two consecutive sequence learning tasks, in which complex image sequences were generated from the combination of two graph-based structural "building blocks". One of these components was shared between the prior and transfer task environments, allowing the authors to test compositional transfer. Behavioral analyses using generalized linear models (GLMs) assessed participants' sensitivity to the underlying structure. MEG data were recorded and analyzed using classifications and feature representational similarity analysis (RSA) to examine whether neural similarity increased for stimuli sharing the same relational structure. The paper aims to uncover the neural dynamics that support compositional transfer during learning.

      Strengths and weaknesses

      I found the methods and task design of this paper difficult to follow, particularly the way stimuli were constructed and how the experimental sequences were generated from the graph structures. These aspects would be hard to replicate without some clarification. I appreciate the integration of behavioral and neuroimaging data. The overall approach, especially the use of compositional graph structures in sequence learning, is interesting and could be used and revised in further studies in compositionality and transfer learning. I appreciated the authors' careful interpretation of their findings in the discussion. However, I would have liked a similar level of caution in the abstract, which currently overstates some claims.

      Major Comments:

      (1) While the introduction mentions brain areas implicated in the low-dimensional representation of task knowledge, the current study uses M/EEG and does not include source reconstruction. As a result, the focus is primarily on the temporal dynamics of the signal rather than its spatial origins. Although I am not suggesting that the authors should perform source reconstruction in this study, it would strengthen the paper to introduce the broader M/EEG literature on task-relevant representations and transfer. The same applies to behavioral studies looking at structural similarities and transfer learning. I encourage the authors to integrate relevant literature to better contextualize their results.

      Duan, Y., Zhan, J., Gross, J., Ince, R. A. & Schyns, P. G. Pre-frontal cortex guides dimension-reducing transformations in the occipito-ventral pathway for categorization behaviors. Current Biology 34, 3392-3404 (2024).

      Luyckx, F., Nili, H., Spitzer, B. & Summerfield, C. Neural structure mapping in human probabilistic reward learning. eLife 8, e42816 (2019). (This is in the references but not in the text).

      Zhang, M. & Yu, Q. The representation of abstract goals in working memory is supported by task-congruent neural geometry. PLoS biology 22, e3002461 (2024).

      L. Teichmann, T. Grootswagers, T. Carlson, A.N. Rich Decoding digits and dice with magnetoencephalography: evidence for a shared representation of magnitude Journal of cognitive neuroscience, 30 (7) (2018), pp. 999-1010

      Garner, K., Lynch, C. R. & Dux, P. E. Transfer of training benefits requires rules we cannot see (or hear). Journal of Experimental Psychology: Human Perception and Performance 42, 1148 (2016).

      Holton, E., Braun, L., Thompson, J., Grohn, J. & Summerfield, C. Humans and neural networks show similar patterns of transfer and interference during continual learning (2025).

      (2) I found it interesting that the authors chose to perform PCA for dimensionality reduction prior to conducting RSA; however, I haven't seen such an approach in the literature before. It would be helpful to either cite prior studies that have employed a similar method or to include a comparison with more standard approaches, such as sensor-level RSA or sensor-searchlight analysis.

      (3) Connected to the previous point, the choice to use absolute distance as a dissimilarity measure is not justified. How does it compare to standard metrics such as correlation distance or Mahalanobis distance? The same applies to the use of Kendall's tau.

      (4) The analysis described in the "Abstract representation of dynamical roles in subprocesses" does not appear to convincingly test the stated prediction of a structural scaffolding account. The authors hypothesize that if structure and dynamics from prior experiences are repurposed, then stimuli occupying the same "dynamical roles" across different sequences should exhibit enhanced neural similarity. However, the analysis seems to focus on decoding transitions rather than directly assessing representational similarity. Rather, this approach may reflect shared temporal representation in the sequences without necessarily indicating that the neural system generalizes the abstract function or position of a stimulus within the graph. To truly demonstrate that the brain captures the dynamical role across different stimuli, it would be more appropriate to directly assess whether neural patterns evoked by stimuli, in the same temporal part of the sequence, with shared roles (but different visual identities) are more similar to each other than to those from different roles.

      (5) In the following section, the authors correlate decoding accuracy with participants' behavioral performance across different conditions. However, out of the four reported correlations and the additional comparison of differences between conditions, only one correlation and one correlation difference reach significance, and only marginally so. The interpretation of this finding should therefore be more cautious, especially if it is used to support a link between neural representations and behavior. Additionally, it is possible that correlation with a more clearly defined or targeted neural signature, more directly tied to the hypothesized representational content, could yield stronger or more interpretable correlations.

      Minor Comments:

      During preprocessing, sensors were excluded based on an identified noise level. However, the authors do not specify the threshold used to define this noise level, nor do they report how many sensors were excluded per participant. It would be helpful to have these details. Additionally, it is unclear why the authors opted to exclude sensors rather than removing noise with MaxFiltering or interpolating bad sensors. Finally, the authors should report how many trials were discarded on average (and standard deviation) per participant.

    1. Joint Public Review:

      Summary:

      This manuscript couples a 32-parameter model with simulation-based inference (SBI) to identify parameter changes that can compensate for three canonical hyperexcitability perturbations (interneuron loss, recurrent-excitatory sprouting, and intrinsic depolarisation). The study demonstrates a careful implementation of SBI and offers a practical ranking of "compensatory levers" that could, in principle, guide therapeutic strategies for epilepsy and related network disorders.

      Strengths:

      (1) By analysing three mechanistically distinct hyper-excitable regimes within the same modelling and inference framework, the work reveals how different perturbations require different compensatory interventions.

      (2) The authors adopt posterior estimation to systematically rank the efficiency of different mechanisms in balancing hyperexcitability.

      (3) Code and data are available.

      Weaknesses:

      (1) A highly dense presentation of the simulated models and undefined symbols makes it hard for readers outside the modelling community to follow the biological message. An illustration of the models, accompanied by some explanations and references to the main equations and parameters discussed in this paper, would make the first section much more straightforward.

      (2) This methodology appears to be a brute-force approach, requiring millions of simulations to tune 32 parameters in a network of 500-700 cells. It isn't scalable. Moreover, the authors did not use cross-validation, which, with a relatively low increase in computational cost, would provide a quantitative measure as to how well it generalizes; this combination raises doubts about both scalability and reliability.

      (3) Several parameters remain so broadly distributed after fitting that the model cannot say with confidence which specific changes matter. Therefore, presenting them as "compensatory levers" is somewhat questionable.

      (4) Every conclusion is drawn from simulated data; without testing the predictions on recordings, we have no evidence that the proposed interventions would work in real neural tissue. Because today we cannot diagnose which of the three modelled pathological regimes is actually present in vivo, the paper's recommendations cannot yet be used to guide therapy.

    1. Joint Public Review:

      This manuscript investigates a mechanism between the histone reader protein YEATS2 and the metabolic enzyme GCDH, particularly in regulating epithelial-to-mesenchymal transition (EMT) in head and neck cancer (HNC).

      The authors addressed most of the concerns of the reviewers. They have:

      (1) Increased the patient cohort size from 10 to 23 for evaluating the levels of YEATS2 and H3K27cr.

      (2) Checked the expression of major genes involved in the YEATS2-mediated histone crotonylation axis (YEATS2, GCDH, ECHS1, Twist1, along with H3K27cr levels) in head and neck cancer tissues using immunohistochemistry.

      (3) Analyzed publicly available head and neck cancer patient datasets, which revealed a significant positive correlation between YEATS2 expression and increasing tumor grade.

      (4) Performed GSEA on TCGA HNC patient samples stratified by high versus low YEATS2 expression. This analysis robustly demonstrated a positive enrichment of metastasis-related gene sets in the high YEATS2 expression group, compared to the low YEATS2 group.

      (5) Performed extensive experiments to look into the role of p300 in assisting YEATS2 in regulating promoter histone crotonylation. The p300 was knocked down in BICR10 cells, followed by immunoblotting to assess SPARC protein levels.

      (6) Performed co-immunoprecipitation assays to check for an interaction between endogenous YEATS2 and p300. The results clearly demonstrate the presence of YEATS2 in the p300-immunoprecipitate sample, indicating that YEATS2 and p300 physically interact and likely function together as a complex to drive the expression of target genes like SPARC.

      (7) Performed RNA Polymerase II ChIP-qPCR on the SPARC promoter in YEATS2 knockdown cells.

      (8) To confirm p300's specific role in crotonylation at this locus, they performed H3K27cr ChIP-qPCR after p300 knockdown.

      (9) Performed SP1 knockdown (which reduces YEATS2 expression) followed by ectopic YEATS2 overexpression, and then assessed p300 occupancy and H3K27cr levels on the SPARC promoter.

    1. Successcriteriadescribe successfulattainmentofthelearningintention.Sometimessuccesscriteriaarereferredtoaslook-fors.Success criteriahelpstudentsunderstandwhattolookforduringthelearning andwhatitlookslikeoncetheyhavelearned.Qualitysuccesscriteriamakethecarning clearforstudents and teachersalike.Successcriteriacanbeeebestwith studentswhen:usingexemplars,creatingworkedexampleswitstudents,analyzingsamplesofstrongandweakwork, andhavingsinceidentifysuccesscriteriainthelatterexamples.Ultimatelytheyident'‘significant aspectsofstudentperformancethatareassessedandtes-relatedtocurriculumexpectations.Successcriteriaaredirectlyconnectetoaproductorperformance(e.g.,discussion,awritten

      Core practice 2: Learning intentions and Success Criteria when implementing a new curriculum and teachers are in year 1, they are getting to know the modules and lesson design. Teachers must unpack this modules and lesson to connect to the priority standards and how that takes into place within a vertical progression as well. With learning targets guiding daily lessson and success criteria leading the why on How this will be unpack during the day. The core practices offer a guide to focus on studnets learning.

    2. Where am I going? (Feed-up)2. Where amT in the learning? (Feed-back)3. What do I need to learn next? (Feed-forward)

      I actually want to steal these questions to ask students during an observation. I do wonder what kind of responses I would get.

    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      In this manuscript, Serra-Mir et al investigate the therapeutic potential of delivering the mRNA of LCOR transcription factor via nanoparticles to enhance the efficacy of immune checkpoint inhibitors. The authors show that the mRNA delivery mediated by H and R-nanoparticles was efficient in multiple breast cancer cell lines in vitro. Moreover, using mouse models, they show that LCOR mRNA delivery may improve the efficacy of the treatment with anti-PDL1 or anti-CTLA4 checkpoint inhibitors against tumors. Although this proof-of-concept study has promising aspects, there are significant weaknesses that should be addressed. Details below.

      Major points:

      1. In vitro delivery of LCOR appears to be effective in both AT3 and 4T07 cell lines when continuously exposed to the mRNA loaded nanoparticles. However, the impact of LCOR on antigen presentation machinery (APM) is rather mixed and not very convincing. The expression pattern and kinetics of several APM genes are inconsistent with LCOR kinetics and at several timepoints the expression in LCOR samples is essentially the same as in mutant LCOR negative controls (Figure 2D). Moreover, the APM reporter assay experiments show that APM in LCOR transduced 4T07 cells is induced rather modestly at best (Figure 2E). The APM effect needs to be demonstrated more rigorously to be convincing.
      2. Considering that previous studies by the authors suggest a role for LCOR in regulating stem cell properties in normal and malignant mammary cells (Celia-Terrassa et al Nat Cell Bio 2017; Perez-Nunez et al Nat Can 2022), it is important to address whether transduced LCOR mRNA impacts these properties. Moreover, other autocrine cell functions such as proliferation and apoptosis are also relevant and should be analyzed.
      3. The impact of LCOR delivery on immune responses in mouse models could be more rigorous. Analysis of APM genes shows rather modest difference in these gene after LCOR transduction (Figure 3E). Is this sufficient to induce effective anti-tumor immune response? What is the status of T cell activity or exhaustion? Furthermore, LCOR may regulate cytokines and chemokines that are critical for modulation of the immune environment. Did the authors measure any immune-modulating cytokines in the tumor microenvironment, following LCOR expression? Finally, whereas the study focuses on APM and its function, LCOR may directly modulate expression of checkpoint activators on cancer cells. The impact of LCOR transduction on PD-L1, PD-L2 and CTLA-4 expression in cancer cells should be determined.
      4. In line with point nr 2, it would be important to analyze the impact of delivered LCOR mRNA on cell functions such as proliferation and apoptosis in the mouse tumors. Even if LCOR delivery sensitizes tumors to checkpoint inhibitors, it cannot be assumed that the impact of LCOR is primarily due to induction of the APM.
      5. The experiments analyzing treatment efficacy in the 4T07 model in mice show lack of consistency and a substantial variation between mice that are treated in the same manner. Even the group treated with PBS and Ctr-mRNA contains mice with tumors that regress (Figure 5A). This inconsistency suggests that more mice are required to generate a convincing pattern. Furthermore, the inclusion of a second model would provide a stronger case for a broad applicability of the LCOR treatment with checkpoint inhibitors. Indeed, it is surprising that the authors did not use the AT3 model in vivo considering that mRNA delivery and LCOR expression is substantially more efficient in AT3 compared to 4T07.
      6. Following the injection of LCOR nanoparticles to the tumor, the proportion and spatial distribution of LCOR expressing cells should be determined. This is particularly relevant in light of the almost complete elimination of the tumors treated with combination therapy (Figures 4 and 5). Is this striking impact on tumors in spite of mRNA being delivered only to a small portion of cells within the tumor?
      7. The in vivo results indicate that expression levels of Fluc mRNA decline rapidly post-treatment, returning to baseline within 24 hours after peaking at 10 hours (Supplementary Figure 3). Although the investigators treat mice every 3rd day with LCOR nanoparticles in their therapeutic experiments, the analysis of durability of immune responses after single injection should be done and can provide important practical insights to guide therapeutic design.

      Minor points:

      1. The authors mention that LCOR mRNA delivery synergizes with checkpoint inhibitor treatment. However, synergy has a specific meaning when drug interaction is analyzed. This was not really addressed or calculated.
      2. There seems to be a mistake in the text (lines 261-263). Based on Figure 1C the mRNA delivery efficiency is higher in AT3 cells compared to 4T07 cells (very difficult to determine anything from Figure 3D, since the cell density is not visible).
      3. It is surprising how little expression of luciferase is observed in the 4T07 model (Figure S3), even if almost 60% of cancer cells and 40% of stromal cells are positive (Figure 3A). What could explain this discrepancy?
      4. Representative FACS plots from Figure 3 should be shown.
      5. There are issues with the figure legends of Figure 3 (from 3C onwards) and Figure S2 (from 2D onwards) that need to be fixed.

      Significance

      The study is a proof-of-concept investigation addressing whether LCOR mRNA can be delivered by nanoparticles to sensitize tumors to immunotherapy. This approach aims to overcome the limitations and difficulties of targeting transcription factors for therapeutic purposes. However, although the delivery of LCOR mRNA appears to be sufficient, further characterization of the resulting impact needs to be done. This includes both impact on immune responses as well as cell-autonomous impact on cancer cell proliferation and apoptosis.

    1. Document de Synthèse : La Nouvelle Hiérarchie des Professions en France

      • Ce document de synthèse analyse les évolutions récentes du marché du travail en France, mettant en lumière un changement notable dans la perception et la rémunération des métiers.

      Traditionnellement, les carrières intellectuelles et les études supérieures étaient perçues comme les garantes d'une meilleure rémunération et d'un épanouissement professionnel.

      Cependant, la pénurie de main-d'œuvre dans certains secteurs manuels et artisanaux a bouleversé cette hiérarchie, offrant des opportunités inattendues en termes de salaires et de qualité de vie.

      Thèmes Principaux et Idées Clés :

      1. Revalorisation des Métiers Manuels et Artisanaux :

      • Changement de Perception : Le reportage souligne un revirement. "Pendant longtemps, les métiers intellectuels promettaient de meilleures carrières, plus rémunératrices et plus épanouissantes.

      Tandis que les métiers manuels ont clairement été dénigrés, souvent dès l'école." Aujourd'hui, cette stigmatisation diminue en raison du manque criant de main-d'œuvre.

      • Salaires Surprenants : Des professions comme grutier, chauffagiste, plombier, soudeur ou maçon offrent désormais des salaires très attractifs, souvent sans nécessiter de longues études.

      Amandine, une ancienne monitrice d'auto-école, a doublé son salaire en devenant grutière, passant de "1 200, 1 300 à peu près" à "2, 900 et quelques euros" nets par mois.

      Mickaël, un jeune plombier-chauffagiste, gagne "2432 euros et 99 centimes" nets par mois après seulement un an d'ancienneté, avec des primes pouvant porter son brut à environ "3000 euros".

      • Autonomie et Valorisation : Ces métiers offrent une grande autonomie et un savoir-faire valorisant. Mickaël, par exemple, gère ses 13 clients et ses commandes de matériel, jouissant de "l'autonomie d'un artisan et la sécurité d'un emploi salarié".

      Clémence, chauffeur poids lourd, trouve que c'est un "métier bizarrement, malgré ce qu'on pourrait imaginer, qui est plutôt valorisant."

      2. La Pénurie de Main-d'Œuvre : Un Facteur Clé de Revalorisation :

      • Demande Supérieure à l'Offre : La France compte "plus d'un million de postes à pourvoir".

      Des secteurs comme le transport (45 000 chauffeurs supplémentaires nécessaires) et la plomberie (manque de main-d'œuvre "excessif") sont particulièrement touchés.

      • Pouvoir de Négociation des Salariés : Cette pénurie inverse le rapport de force.

      Clémence, la chauffeuse poids lourd, illustre ce point :

      "On a plus de pouvoir qu'un mec qui va être dans la pub, où le patron va dire « Je ne suis pas content, tu t'en vas, de toute façon, il y en a 80 derrière »...

      Là, c'est l'inverse." Les entreprises sont contraintes de proposer des conditions attractives, allant même jusqu'à "débaucher des gens dans d'autres entreprises".

      • Recrutement Simplifié : Pour certains postes, l'envie de travailler et la ponctualité priment sur les diplômes.

      David Arslan, chef d'entreprise en ravalement de façade, ne demande "aucun diplôme", seulement "la ponctualité et l'envie de travailler" pour un salaire de "2 000 euros net mensuel".

      3. La Reconversion Professionnelle : Une Tendance Croissante :

      • Quête de Sens et de Meilleure Qualité de Vie : De nombreux salariés, y compris des cadres, se reconvertissent. "Depuis 2021, 20% des cadres ont entamé une reconversion professionnelle". Clémence, ancienne directrice artistique à Paris, a troqué son "Bac plus 5" et un salaire de "1 600 net" pour un permis poids lourd lui rapportant "entre les 2 500 et 3 000 euros net", et une meilleure qualité de vie.
      • Éviter le "Perdre sa Vie à la Gagner" : La question est posée : "Faut-il tout miser sur des études supérieures pour finir dans un bureau stressé, avec des horaires à rallonge ou une charge de travail XXL ? Faudrait-il perdre sa vie à la gagner ?"
      • Formations Adaptées : Des initiatives comme l'école Gustave, qui forme gratuitement des plombiers en 15 mois, répondent à ce besoin de reconversion rapide et efficace. L'école garantit un salaire minimum de "2 000 euros net" en sortie et un taux d'embauche de "95% en CDI".

      4. Le Revers de la Médaille pour les Professions Intellectuelles :

      • Débuts de Carrière Difficiles : Certaines professions intellectuelles, malgré de longues études, offrent des rémunérations de départ modestes. Aurélie, avocate avec "7 ans d'études après le bac", se retrouve avec "à peine plus d'un SMIC" net après avoir payé ses charges, soit "1 500 euros net" pour des journées parfois très longues et improductives (temps d'attente non payé).
      • Désillusion et Fort Taux de Démission : Le décalage entre les attentes (prestiges, revenus) et la réalité du métier conduit à la désillusion. "30% des avocats démissionnent au cours des 10 premières années d'exercice."
      • Évolution des Salaires : Si les débuts sont difficiles, les carrières intellectuelles peuvent offrir une meilleure progression salariale sur le long terme. Le reportage note qu'après 8 ans, le salaire d'un plombier "va plafonner autour de 2 700 euros", tandis que pour les avocats, "ce sera deux fois plus, 5 400 euros mensuels en moyenne."

      5. L'Entrepreneuriat Manuel comme Voie de Succès :

      Exemple de David Arslan : L'histoire de David Arslan, patron d'une PME de ravalement de façade réalisant "10 millions d'euros de chiffre d'affaires", est emblématique.

      Parti de rien, il a bâti sa réussite sur un savoir-faire manuel, démontrant que "tout est possible" avec "de l'or dans les mains".

      Opportunités du Marché : La demande dans des secteurs comme l'isolation et la rénovation (stimulée par la hausse des tarifs de l'énergie) offre des opportunités de croissance exponentielle pour les entreprises du bâtiment.

      David Arslan connaît une augmentation de "30%" de demandes et est contraint de refuser des chantiers faute de main-d'œuvre.

      Conclusion :

      Le marché du travail français est en pleine mutation.

      La pénurie de main-d'œuvre dans les métiers manuels et artisanaux a non seulement revalorisé ces professions en termes de salaire et d'attractivité, mais elle a également ouvert la voie à des reconversions massives pour des individus cherchant une meilleure qualité de vie et un épanouissement professionnel.

      Tandis que certaines carrières intellectuelles peinent à offrir des débuts de carrière rémunérateurs, les "mains en or" et les entrepreneurs du bâtiment peuvent désormais atteindre des sommets financiers et professionnels insoupçonnés, remettant en question les hiérarchies établies et l'importance des études longues pour le succès.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      In Figure 1, it is very difficult to identify where CySCs end and GSCs begin without using a cell surface marker for these different cell types. In addition, the methods for quantifying the mitochondrial distribution in GSCs vs. CySCs are very much unclear and appear to rely on colocalization with molecular markers that are not in the same cellular compartment (Tj-nuclear vs. Vasa-perinuclear and cytoplasmic) the reader has no way to determine the validity of the mitochondrial distribution. Similarly, the labelling with gstD1-GFP is also very much unclear - I see little to no GFP signal in either GSCs or CySCs in panels 1GK. Lastly, while the expression o SOD in CySCs does increase the gstD1-GFP signal in CySCs, the effects on GSCs claimed by the authors are not apparent.

      We appreciate the reviewer’s detailed feedback on Figure 1 and the concerns raised regarding identifying CySCs and GSCs, as well as the methods used for quantifying mitochondrial distribution and gstD1-GFP labeling. Below, we address each point and describe the revisions made to improve clarity and rigor

      Distinguishing CySCs and GSCs and Mitochondrial Distribution in GSCs vs. CySCs in Figure1

      We acknowledge the difficulty in distinguishing CySCs from GSCs without the use of additional cell surface markers. To improve clarity, we have now included a membrane marker discslarge (Dlg) in our revised Figure 1 and S1 to delineate cell boundaries more clearly. Additionally, we provide higher-magnification images to indicate the mitochondria in CySCs and GSCs. We also agree that ing on mitochondrial distribution might be far-fetched. In the revised manuscript, we have limited our analysis to mitochondrial shape, which was found to be different in GSC and CySC (Fig. 1, D, F, G, and S1B). We have clarified our quantification methods in the revised Methods section, providing details on the image processing and analysis pipeline used to assess mitochondrial distribution. 

      Clarity of gstD1-GFP Labelling:

      We recognize the reviewer’s concern regarding the weak GFP signal in these panels. To improve visualization, we have included fresh set of images by optimizing the contrast and presenting additional monochrome images with higher exposure settings to better illustrate gstD1-GFP expression (Figure 1L,1Q, and S1C’’’-D’’’). Additionally, we have demarcated the cell boundaries using Dlg along with individual labelling of Vasa+ and Tj+ cells. Due to technical difficulty associated with acquisition of images, we could not co-stain Vasa, Tj and Dlg together. Therefore, quantified the gstD-GFP intensity separately for GSCs and CySCs under similar acquisition conditions (Figure 1R).   

      Effects of SOD depletion on GSCs:

      While our initial analysis suggested changes in gstD1-GFP expression in GSCs upon Sod1 depletion in CySCs, we acknowledge that the effects may not be as apparent in the provided images. In response, we have expanded our quantification, included a statistical analysis of gstD1-GFP intensity specifically in GSCs and CySCs (Figure 1S), and added more representative images in the revised figure panels (Figure S1C-D’’’) to support our claims.

      In Figure 2, while the cell composition of the niche region does appear to be different from controls when SOD1 is knocked down in the CySCs, at least in the example images shown in Figures 2A and B, how cell type is quantified in figures 2E-G is very much unclear in the figure and methods. Are these counts of cells contacting the niche? If so, how was that defined? Or were additional regions away from the niche also counted and, if so, how were these regions defined?

      Thank you for your  regarding the quantification of cell types in Figures 2E-G. We counted all cells that were Tj-positive and Zfh1-positive in individual testis, while for GSCs, only those in direct contact with the hub were included. This clarification has been incorporated into the revised figure legend and methods (line no.400-407). We have now provided a clearer description in the text to improve transparency in our analysis.

      In Figure 3, it is quite interesting that there is an increase in Eya<sup>+</sup>, differentiating cyst cells in SOD1 knockdown animals, and that these Eya+ cells appear closer to the niche than in controls. However, this seems at odds with the proliferation data presented in Figure 2, since Eya<sup>+</sup> somatic cells do not normally divide at all. Are they suggesting that now differentiating cyst cells are proliferative? In addition, it is important for them to show example images of the changes in Socs36E and ptp61F expression.

      Thank you for your insightful observations. We acknowledge the apparent contradiction and appreciate the opportunity to clarify our interpretation.

      Regarding the increase in Eya<sup>+</sup> differentiating cyst cells in Sod1RNAi individuals and their proximity to the niche, we do not suggest that these differentiating cells are proliferative. Instead, we propose that the knockdown of Sod1 may alter the timing or regulation of cyst cell differentiation, leading to an accumulation of Eya<sup>+</sup> cells near the niche. To clarify this point, we have revised the manuscript (line no. 186-189) to emphasize that our proliferation data specifically refers to early-stage somatic cells, not Eya<sup>+</sup> differentiating cyst cells.

      We also appreciate the reviewer's request for example images illustrating the changes in Socs36E and Ptp61F expression. We could not access the antibodies specific to Socs36E and Ptp61F. Hence, we had to rely on the measurements were obtained using real-time PCR from the tip region of testis. We have clarified the same in the figure legends (line 700). 

      Overall, the various changes in signaling are quite puzzling-while Jak/Stat signaling from the niche is reduced, hh signaling appears to be increased. Similarly, while the authors conclude that premature differentiation occurs close to the niche, EGF signaling, which occurs from germ cells to cyst cells during differentiation, is decreased. Many times these, changes are contradictory, and the authors do not provide a suitable explanation to resolve these contradictions. 

      We appreciate the reviewer’s thoughtful feedback on the signaling changes described in our study. We acknowledge that the observed alterations in Jak/Stat, Hedgehog (Hh), and EGF signaling may appear contradictory at first glance. However, our data suggest that these changes reflect a complex interplay between different signaling pathways that regulate cyst cell behavior in response to specific genetic perturbation.

      Regarding Jak/Stat and Hh signaling, while Jak/Stat activity is reduced in the niche, the increase in Hh signaling may reflect a compensatory mechanism or a context-dependent response of cyst cells to reduced Jak/Stat input. Prior studies have suggested that Hh signaling can function in parallel and independently of Jak/Stat signaling (PMID: 23175633) and our findings align with this possibility. 

      The reduction in EGFR signaling in this context appears contradictory to existing literature. One possible explanation is that, the altered GSC -CySC balance and loss of contact in Tj>Sod1i testes, leads to insufficient ligand response, thereby failing to activate EGFR signaling. (line no.222-224, 313-318). 

      Reviewer #2 (Public review):

      We sincerely appreciate the reviewer’s detailed feedback, which has helped refine our manuscript. In this study we have focussed on the role of ROS generated due to manipulation of Sod1 in the interplay between GSC and CySCs. In this regard, we have conducted additional experiments and incorporated quantitative data into the revised manuscript. Additionally, we have refined the text and provided further context to enhance the clarity. Key revisions include:

      (1) Clarification of Quantification Methods – We have refined intensity measurements by incorporating a membrane marker (Dlg) to better delineate cell boundaries and have normalized Ptc and Ci expression per cell to improve clarity.

      (2) Cell-Specific ROS Measurement – We separately measured ROS in germ cells and cyst cells and performed independent Sod1 depletion in GSCs to determine its direct effects.

      (3) Mitochondrial Analysis – We revised our approach, focusing on mitochondrial shape rather than asymmetric distribution, and removed overreaching claims.

      (4) Proliferation Analysis – We reanalyzed FUCCI data by normalizing to total cell count, supporting the conclusion that increased proliferation, rather than differentiation delay, underlies the observed phenotype.

      (5) E-Cad Quantification – We specifically analyzed E-Cad levels at the GSC-hub interface to strengthen conclusions on GSC attachment.

      (6) JAK/STAT Signaling – While we could not obtain a STAT92E antibody, we clarified the spatial limitations of our current analysis and revised the text accordingly.

      (7) Rescue Experiments and Gal4 Titration Control – We performed additional control experiments to confirm that observed effects are not due to Gal4 dilution.

      (8) Image Quality and Terminology Corrections – We enhanced figure resolution, corrected terminology (e.g., "cystic" to "cyst"), and revised ambiguous phrasing for clarity and accuracy.

      As suggested, we have also changed the manuscript title to better align with our results:

      Previous Manuscript Title: Non-autonomous cell redox-pairs dictate niche homeostasis in multi-lineage stem populations

      Updated Manuscript Title: Superoxide Dismutases maintain niche homeostasis in stem cell populations

      Specific responses to the reviewer’s: 

      While the decrease in pERK in CySCs is clear from the image and matched in the quantification, the increase in cyst cells is not apparent from the fire LUT used. The change in fluorescence intensity therefore may be that more cells have active ERK, rather than an increase per cell (similar arguments apply to the quantifications for p4E-BP or Ptc). Therefore, it is hard to know whether Sod1 knockdownresults in increased or decreased signaling in individual cells.

      Thank you for your insightful . To clarify, in the Fire LUT images, only pERK intensity is shown, not the cyst cell number. In our context, while there are more cells, the overall pERK intensity is lower, eliminating any ambiguity about whether the change is occurring per cell or due to an increased number of circulating cells. Moreover, for Ptc and Ci levels, we have normalized Ptc and Ci expression intensity per cell to enhance clarity and ensure an accurate interpretation of signaling changes.

      There are several places in which the authors could strengthen their manuscript by explaining the methods more clearly. For example, it is unclear how the intensity graphs in Figure 1Q are obtained. The curves appear smoothed and therefore unlikely to be from individual samples, but this is not clearly explained. However, this quantification method is clearly not helpful, as it shows the overlap between somatic and germline markers, suggesting it cannot accurately distinguish between the two cell types. Additionally, using a nuclear marker (Tj) for the cyst cells and cytoplasmic marker (Vasa) for the germ cells risks being misleading, as one would not expect much overlap between cytoplasmic gstD1-GFP and nuclear Tj. Also related to the methods, it is unclear how Vasa+ cells at the hub were counted. The methods suggest this was from a single plane, but this runs the risk of being arbitrary since GSCs can be distributed around the hub in 3D. (As a note, the label on the graph "Vasa+ cells" is misleading, as there are many more cells that are Vasa-positive than the ones counted.)

      We appreciate the reviewer’s careful evaluation of our manuscript and their insightful suggestions for improving the clarity of our methods. Below, we address each concern raised and describe the revisions made accordingly.

      Clarification of Intensity Graphs in Figure 1Q

      We have removed this graph, as we recognize that the markers previously used were not appropriate for distinguishing the different cell types. To address this concern, we have revised the text and now included a membrane marker discs-large (Dlg) in our revised Figure 1 and S1 to more clearly delineate cell boundaries. Due to technical difficulty associated with acquisition of images, we could not co-stain Vasa, Tj and Dlg together. Therefore, quantified the gstD-GFP intensity separately for GSCs and CySCs under similar acquisition conditions (Figure 1R).   

      Counting of Vasa<sup>+</sup> Cells at the Hub

      We appreciate the reviewer’s concern regarding our method for counting Vasa+ cells. In our original analysis, we included GSCs as the Vasa-positive cells that were in direct contact with the hub. To account for the three-dimensional arrangement of GSCs, we used the Cell counter plugin of Fiji and performed counting across different focal planes to ensure all hub-associated cells were considered. For better clarity on cell distribution around the hub, we have presented a single focal place image sliced through mid of the hub zone. To enhance transparency, we have now provided a more detailed explanation of our counting approach in the Methods section (line no 400- 403).

      We agree that the label "Vasa+ cells" may be misleading, as many cells express Vasa beyond the specific subset being counted. To address this, we have changed the label to " GSCs" to reflect the subset analyzed more accurately.

      The crucial experiment for this manuscript is presented in Figures 1 G-S, arguing that Sod1 knockdown with Tj-Gal4 increases gstD1-GFP expression in germ cells. This needs strengthening as the current quantifications are not convincing and appear to show an overlap between Tj (a nuclear cyst cell marker) and Vasa (a cytoplasmic germ cell marker). Labeling cell outlines would help, or alternatively, labeling different cell types genetically can be used to determine whether the expression is increased specifically within that cell type. Similarly, the measurement of ROS shown in the supplemental data should be conducted in a cell-specific manner. To clearly make the case that Sod1 knockdown in cyst cells is impacting ROS in the germline, it would be important to manipulate germ cell ROS independently. Without this, it will be difficult to prove that any effects observed are a result of increased ROS in the germline rather than indirect effects on the germline of altered cyst cell behaviour. 

      We appreciate the reviewer’s insightful feedback regarding the specificity of Sod1 knockdown effects in germ cells and the need for clearer quantification in Figures 1G–S. Below, we address each concern and outline the modifications made:

      Clarification of Cell Type-Specific Expression:

      We acknowledge the overlap observed between Tj (nuclear cyst cell marker) and Vasa (cytoplasmic germ cell marker) in the presented images. To strengthen our claim that gstD1GFP expression increases specifically in germ cells upon Sod1 knockdown, we have now labelled cell outlines using membrane marker discs-large (Dlg) to better distinguish cell boundaries, along with individual labelling of Vasa<sup>+</sup> and Tj<sup>+</sup> cells. Due to technical difficulty associated with acquisition of images, we could not co-stain Vasa, Tj and Dlg together. 

      Cell-Specific Measurement of ROS:

      We agree that a cell-type-specific ROS measurement is critical to establishing a direct effect on germ cells. To address this, we have now performed ROS measurements separately in germ cells and cyst cells under similar acquisition conditions. These data are now included in the revised (Figure 1R). Similarly, upon CySC-specific Sod1 depletion, we performed measurement of gstD1-GFP intensity which was found to be enhanced in GSCs, along with expected increase in CySCs (Fig 1S). We have independently manipulated ROS levels in GSCs (Nos Gal4> Sod1i) and observed that elevated ROS negatively impacts GSCs, leading to a reduction in their number, while having an insignificant effect on adjacent CySCs.(Fig S2 E, F).

      Quantifications of mitochondrial localization in Figure 1 should include some adequate statistical method to evaluate whether the distribution is random or oriented towards the GSC/CySC interface. From the image provided (Figure 1B), it would appear that there are two clusters of mitochondria, on either side of a CySC nucleus, one cluster towards a GSC and one cluster away. Therefore evaluating bias would be important. Additional experiments will be necessary to support the statement that "Redox state of GSC is maintained by asymmetric distribution of CySC mitochondria". This would require manipulating mitochondrial distribution in CySCs.

      We appreciate the reviewer’s suggestion regarding the quantification of mitochondrial localization. We agree that ing on mitochondrial distribution might be far-fetched. In revised manuscript, we have demarcated the cell boundary and limited our analysis to mitochondrial shape which was found to be different in GSC and CySC (Fig. 1, D, F, G and S1B). Mitochondrial shape was quantified based on the mitochondrial area and circularity (Figure 1F and G). To prevent any misinterpretation, we have removed the statement, "Redox state of GSC is maintained by asymmetric distribution of CySC mitochondria."

      One point raised by the authors is that the increase of somatic cell numbers is driven by accelerated proliferation, based on an increased number of cells in various stages of the cell cycle as assessed by the FUCCI reporter. However, there are more somatic cells in this genetic background, so it could be argued that the observed increase in different phases of the cell cycle is due to an increased number of cells. In order to argue for an increased proliferation rate, the number of cells in each phase should be divided by the total number of cells, expecting to see an increase in S and G2/M phases along with a decrease in G1. Otherwise, the simplest explanation is a block or delay in differentiation, meaning that more cells remain in the cell cycle.

      We appreciate the  regarding the interpretation of our FUCCI reporter data. We acknowledge that the observed increase in the number of cells in various phases of the cell cycle could be influenced by the overall higher number of somatic cells in this genetic background.

      To address this concern, we have now re-analyzed our FUCCI data by normalizing the number of cells in each phase to the total number of cells and we did not observe a significant shift in the proportion of cells in S and G2/M phases relative to G1. This suggests presence of more proliferative cells, that is less cells in Go phase, rather than alterations in the timing of cell cycle progression stages. We are not sure about a block in differentiation because we see an enhanced accumulation of Eya+ cells near the niche. We have also supported our FUCCI data with pH3 staining where we have found more pH3+ spots under SOD1 depleted background. We have revised our manuscript accordingly (Figure 2I, K and S2U) to reflect this interpretation and appreciate the constructive feedback.

      In Figure 3, the authors claim that knockdown of Sod1 in the soma decreases the attachment of GSCs to the hub-based on lower E-Cad levels compared to controls. Previous work has shown that in GSCs, E-Cad localizes to the Hub-GSC interface (PMID: 20622868). Therefore, the authors should quantify E-Cad staining at the interphase between the germ cells and the niche.

      We appreciate the reviewer’s . As suggested, we have now quantified ECad staining specifically at the interface between the germ cells and the niche. Our analysis confirms that E-Cad levels are significantly reduced at this interphase upon Sod1 knockdown in the soma compared to controls, supporting our conclusion that Sod1 depletion affects GSC attachment to the hub as well as the whole niche. The revised Figure 3M now includes these quantifications, and we have updated the figure legend and results section accordingly.

      The authors show decreased expression of the JAK/STAT targets socs36E and ptp61F, arguing that this could be a reason for decreased GSC adhesion to the hub. However, these data were obtained from whole testes and lacked spatial resolution, whereas a STAT92E staining in control and tj>Sod1 RNAi testes could easily prove this point. Indeed, previous work has shown that socs36E is expressed in the CySCs, not GSCs (PMID: 19797664), suggesting that any decrease in JAK/STAT may be autonomous to the CySCs.

      We appreciate the reviewer’s observation regarding the spatial resolution of our JAK/STAT target expression analysis. To improve accuracy, we have attempted to collect only the tip of the testes while excluding the rest; however, we acknowledge that this approach may still obscure cell-specific changes. We had attempted to procure the STAT92E antibody but, despite multiple inquiries, we did not receive a positive response. While we agree that STAT92E staining would have strengthen our findings, we are currently unable to perform this experiment. Nevertheless, our observations align with prior work indicating that socs36E is predominantly expressed in CySCs (PMID: 19797664). We have revised the manuscript text accordingly to clarify this limitation.

      Additional considerations should be taken regarding the rescue experiments where PI3KDN and Hh RNAi are expressed in a Tj>Sod1 RNAi background. To rule out that any rescue can be attributed to titration of the Gal4 protein when an additional UAS sequence is present, a titration control would be useful. These pathways are not described accurately since Insulin signaling is necessary for the differentiation of somatic cells (not maintenance as written in the text), and its inhibition has been shown to increase the number of undifferentiated somatic cells (PMID:27633989). As far as Hh is concerned, the expression of this molecule is restricted to the niche. It would be important to establish whether the expression is altered in this case, especially as the authors rescue the Sod1 knockdown by also knocking down Hh. One possibility that the authors need to rule out is that some of the effects they observe are due to the knockdown of Sod1 (and/or Hh) in the hub as Tj-Gal4 is expressed in the hub as well as the CySCs (PMID:27546574).

      We appreciate the reviewer’s insightful s and suggestions. Below, we address each concern and describe the steps we have taken to incorporate the necessary modifications in our revised manuscript.

      Titration Control for Rescue Experiments  

      We acknowledge the reviewer’s concern regarding potential Gal4 titration effects when introducing additional UAS constructs. To address this, we conducted a control experiment quantifying SOD1 levels in control, Tj > Sod1 RNAi, and Tj > Sod1 RNAi, UAS hhRNAi backgrounds using real-time PCR (Figure S4 M). The Sod1 levels in single and double UAS copy conditions were comparable, indicating that Gal4 titration does not significantly affect the results.

      Clarification of Insulin Signaling Role 

      We appreciate the reviewer’s insight regarding the involvement of insulin signaling in this context. Initially, we included data on PI3K/TOR as we found it intriguing. However, as the data didn’t add much to the overall observations, we have removed them to ensure clarity and prevent any potential confusion.

      Hh Expression and Niche Consideration 

      We recognize the importance of evaluating whether Hedgehog (Hh) expression is altered in the Sod1 RNAi background. We have already quantified hh in qRT-PCR (Figure S4C). 

      Potential Effects of Sod1 and Hh Knockdown in the Hub 

      We acknowledge the concern that Tj-Gal4 is expressed in both the hub and CySCs, potentially affecting hub function upon Sod1 and Hh knockdown. To address this, we have included additional data using the CySC-specific driver C-587 Gal4 to distinguish CySC-intrinsic effects from potential hub contributions. Our results show that while the phenotypic changes are consistent across both drivers, the effects are significantly stronger with Tj-Gal4, suggesting a role of the hub in this process. These findings have been incorporated into the revised manuscript (Fig S1G-H, M-N).

      In general, the GSCs (and other aspects) are difficult to see in the images; enlargements or higher-resolution images should be provided. Additionally, the manuscript contains several mistakes or inaccuracies (examples include referring to ROS having "evolved" in the abstract when it is cells that have evolved to use ROS, or the references to "cystic" cells when they are usually referred to as "cyst" cells, or that "CySCs also repress GSC differentiation by suppressing transcription of bag-of-marbles" when CySCs produce BMPs that lead to suppression of bam expression in the germline). These would need editing for both clarity and accuracy.

      We appreciate the reviewer’s insightful feedback and have made the necessary revisions to address the concerns raised.

      Image Clarity and Resolution: 

      We have provided higher-resolution images in some of the revised images for better understanding. The revised figures now offer better clarity for key observations.

      Clarification of Terminology and Accuracy:

      The phrase regarding ROS in the abstract has been revised to reflect that cells have evolved to utilize ROS, rather than ROS itself evolving (line no. 27).

      References to "cystic" cells have been corrected to "cyst" cells for consistency with standard terminology.

      The statement about CySCs repressing GSC differentiation has been revised for accuracy, clarifying that CySCs produce BMPs, which lead to the suppression of bam expression in the germline (line no. 84).

      We have carefully reviewed the manuscript for any additional inaccuracies or ambiguities to ensure clarity and precision. We appreciate the reviewer’s constructive s, which have helped improve the manuscript.

      Reviewer #3 (Public review):

      In response to Reviewer 3’s comments, we would like to highlight the point that in the present study we have focussed on the interplay between CySC and GSC and have accordingly conducted our experiments. We did observe some changes in the hub and do not rule out the effect of hub cells in exacerbating some of our phenotypes. We have included additional controls to highlight the effect of CySC ROS. These points have been appropriately discussed in the manuscript. Key revisions include:  

      (1)  Data Clarity & Visualization: To improve mitochondrial lineage association, we incorporated a membrane marker (Dlg) in Figure 1, enhancing the distinction between CySCs and GSCs. Additionally, we refined gstD-GFP quantifications in individual cell types and provided high-resolution images.

      (2) ROS Transfer & Measurement: We revised our discussion to acknowledge indirect ROS transfer mechanisms and added separate ROS quantifications in GSCs and CySCs, confirming higher ROS levels in CySCs (Figure 1R).

      (3) Tj-Gal4 Specificity & Niche Characterization: Recognizing Tj-Gal4 expression in hub cells, we included C587-Gal4 as a CySC-specific driver, demonstrating that hub cells contribute partially to the phenotype (Figure S1G,H,M,N).

      (4) Signaling Pathway Validation: We optimized dpERK staining, included controls (Tj>EGFRi), and clarified limitations regarding MAPK signaling. Due to lethality, we could not perform an EGFR gain-of-function rescue. We also validated increased Hh signaling via qPCR and a Tj>UAS Ci control (Figure S4).

      (5) Conceptual & Terminological Refinements: We revised our discussion of BMP signaling, ROS gradients, and testis-specific terminology. All figures and labels now accurately represent GSC scoring (single Vasa⁺ cells in contact with the niche).

      (6) Figure & Methods Improvements: We enhanced image resolution, provided grayscale versions where needed,and expanded Materials & Methods to clarify experimental conditions.

      These revisions strengthen our conclusions and address the reviewer’s concerns, ensuring a more precise and transparent presentation of our findings. To align with the reviewer’s s we have changed the title of the manuscript to “Superoxide Dismutases maintain niche homeostasis in stem cell populations”.

      Specific responses to the reviewer’s comments: 

      (1) Data

      a.  Problems proving which mitochondria are associated with which lineage.

      We acknowledge the challenge of distinguishing CySCs from GSCs without additional cell surface markers. To enhance clarity, we have incorporated the membrane marker Discs-large (Dlg) in our revised Figure 1 to better delineate cell boundaries, providing a clearer depiction of mitochondrial distribution in GSCs and CySCs.

      b.There is no evidence that ROS diffuses from CySCs into GSCs.

      We acknowledge the reviewer’s concern. There are reports which talks about diffusion of ROS across cells on which we have included a few lines in the discussion (line no. 274-276). We do understand that our previous quantifications showed ROS diffusion from CySC to GSC rather indirectly. Therefore, in revised manuscript we have measured ROS separately in the two cell populations. We found that the CySCs show higher ROS profile than GSCs (Fig 1R).  

      c.The changes in GST-GFP (redox readout) are possibly seen in differentiating germ cells (i.e., spermatogonia) but not in GSCs. This weakens their model that ROS in CySC is transferred to GSCs.

      Thank you for your observation. We acknowledge that the changes in gstD-GFP (redox readout) are more prominent in differentiating germ cells. It is known that differentiating cells show higher ROS profile than the stem cells. Hence, expectedly the intensity of gstDGFP was lesser in stem cell zone compared to the differentiating zone. In our manuscript we are focussed on the redox state among stem cell populations. Therefore, we have included better quality images and measured the gstD1-GFP intensity individually in GSCs and CySCs (Figure 1R) by demarcating the cell boundaries (Figure 1M, S1C-D’’’). We found that CySCs show higher ROS profile than GSCs and enhancement of ROS in CySC by Sod1 depletion resulted in a consequent increase in ROS in GSCs. We believe this revision strengthens our model by addressing the potential discrepancy and providing a more comprehensive understanding of ROS dynamics within the GSC niche.

      d.Most of the paper examines the effect of SOD depletion (which should increase ROS) on the CySC lineage and GSC lineage. One big caveat is that Tj-Gal4 is expressed in hub cells (Fairchild, 2016), so the loss of SOD from hub cells may also contribute to the phenotype. In fact, the niche in Figure 2D looks larger than the niche in the control in Figure 2C, arguing that the expression of Tj in niche cells may be contributing to the phenotype. The authors need to better characterize the niche in tj>SOD-RNAi testes.

      We appreciate the reviewer’s insightful  regarding the potential contribution of hub cell to the observed phenotype. We acknowledge that Tj-Gal4 is expressed in hub cells and this could influence the niche size and overall phenotype.

      To address this concern, we have included an additional control using C587-Gal4, a CySC specific driver, to distinguish CySC-specific effects from potential hub contributions. All the effects on cell number observed in Tj>Sod1i was replicated in C587>Sod1i testis, except that the observed phenotypes were comparatively weaker. These indicate partial contribution of hub cells to the observed phenotype, exacerbating its severity. However, the effect of Sod1 depletion in CySC on GSC lineages remains significant. These findings have been incorporated into Figure S1- G,H,M and N) and incorporated in the discussion (line no.308311). 

      e. The Tj>SOD1-RNAi phenotype is an expansion of the Zfh1<sup+</sup> CySC pool, expansion of the Tj<sup>+</sup> Zfh1- cyst cells (both due to increased somatic proliferation) and a non-autonomous disruption of the germline.

      We appreciate the reviewer’s observation. Our data confirm that Tj>SOD-RNAi leads to an expansion of both Zfh1<sup+</sup> CySCs and Tj<sup>+</sup> Zfh1- cyst cells, which we attribute to increased somatic proliferation. Additionally, we observe a non-autonomous disruption of the germline, likely due to dysregulated signaling from the altered somatic niche.

      f. I am not convinced that MAPK signaling is decreased in tj>SOD-i testes. Not only is this antibody finicky, but the authors don't have any follow-up experiments to see if they can restore SOD-depleted CySCs by expressing an EGFR gain of function. Additionally, reduced EGFR activity causes fewer somatic cells (not more) (Amoyel, 2016) and also inhibits abscission between GSCs and gonial blasts (Lenhart 2015), which causes interconnected cysts of 8- to 16 germ cells with one GSC emanating from the hub.

      We acknowledge that the dpERK antibody can be challenging. We took necessary precautions, including optimizing staining conditions and using positive control (Tj>EGFRi) (Figure: S4B). Our results consistently showed a decrease in dpERK levels in Tj>Sod1i testes, supporting our conclusion.

      We agree that inclusion of an experiment using EGFR gain-of-function to rescue the effects of CySC-Sod1 depletion would have strengthened our findings. We had attempted this experiment; however, the progenies constitutively expressing EGFR under Sod1RNAi background were lethal, preventing us from completing the analysis.

      We agree that our observations do not align with the reported effects of EGFR signaling on somatic cell numbers and abscission and we appreciate the references provided. Based on our observations, we feel that modulation of MAPK signaling in the niche probably, happens in a context-dependent manner. One possible explanation is that, the altered GSC -CySC balance and loss of contact in Tj>Sod1i testes, leads to insufficient ligand response, thereby failing to activate EGFR signaling. While it is well established that ROS can enhance EGFR signaling to promote cellular proliferation and early differentiation, our results indicate a more nuanced regulation in this context. However, further detailed analysis is required to completely understand the regulatory controls. We have clarified this point in the manuscript (line no.

      313-320).

      g. The increase in Hh signaling in SOD-depleted CySCs would increase their competitiveness against GSCs and GSCs would be lost (Amoyel 2014). The authors need to validate that Hh protein expression is indeed increased in SOD-depleted CySCs/cyst cells and which cells are producing this Hh. Normally, only hub cells produce Hh (Michel,2012; Amoyel 2013) to promote self-renewal in CySCs.

      We appreciate the reviewer’s suggestion regarding the validation of Hh protein expression and its source. Since Tj-Gal4 is expressed in the hub, it is likely activating the Hh pathway and promoting CySC proliferation. Unfortunately, we could not procure Hh antibody to directly assess its protein levels. However, to address this, we performed real-time PCR from RNA derived from the tip region and found a significant increase in hh mRNA levels in SOD-depleted cyst cells. These findings support our hypothesis that elevated Hh signaling enhances CySC competitiveness, leading to GSC loss. To support this idea, we have included a Tj>Ci positive control which caused abnormal proliferation of Tj<sup>+</sup> cells resulted in ablation of GSCs. We have incorporated these results in the revised manuscript (Results section, Figure S-4).

      h.The increase in p4E-BP is an indication that Tor signaling is increased, but an increase in Tor in the CySC lineage does not significantly affect the number of CySCs or cyst cells (Chen, 2021). So again I am not sure how increased Tor factors into their phenotype.

      We acknowledge the reviewer’s concern regarding the role of increased Tor signaling in our phenotype. The observed increase in Tor could indeed be a downstream effect of elevated ROS levels. However, establishing a direct causal relationship between Sod1 and Tor would require additional experiments, which we feel might be a good study in its own merit. To maintain clarity and focus in the revised manuscript, we have opted not to include this preliminary data at this stage.

      I.The over-expression of SOD in CySCs part is incomplete. The authors would need to monitor ROS in these testes. They would also need to examine with tj>SOD affects the size of the hub.

      We value the reviewer's . To address this, we have now monitored ROS levels in the testes upon SOD overexpression in CySCs using DHE (Figure S5 I). Our results indicate a significant reduction in ROS levels compared to controls. 

      Additionally, we examined hub size upon Sod1 overexpression and observed a slight, but statistically insignificant, reduction. As our study primarily focuses on ROS-mediated GSCCySC interactions, we did not include a detailed investigation on hub size regulation.

      (2) Concept

      Why would it be important to have a redox gradient across adjacent cells? The authors mention that ROS can be passed between cells, but it would be helpful for them to provide more details about where this has been documented to occur and what biological functions ROS transfer regulates.

      We thank the reviewer for this insightful . We acknowledge that the concept of a redox gradient was not adequately conveyed, as the cell boundary was not clearly defined. To address this, we have revised our interpretation to propose that high ROS levels in one cell may influence the ROS levels in an adjacent cell through either direct transfer or as a secondary effect of altered niche maintenance signaling, rather than through the establishment of a gradient.

      Regarding ROS transfer between cells, it has been documented in several biological contexts. For instance, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) can diffuse through aquaporins, influencing signaling pathways in neighbouring cells (PMID: 17105724). We have incorporated these details and relevant references into the revised manuscript to enhance the conceptual understanding of ROS transfer. 

      (3) Issues with the scholarship of the testis

      a. Line 82 - There is no mention of BMPs, which are the only GSC-self-renewal signal. Upd/Jak/STAT is required for the adhesion of GSCs to the niche but not self-renewal (Leatherman and Dinardo, 2008, 2010). The author should read a review about the testis. I suggest Greenspan et al 2015. The scholarship of the testis should be improved.

      We appreciate the reviewer’s feedback regarding the role of BMPs in GSC selfrenewal, we have added this in the revised manuscript (line no. 83) We have now incorporated a discussion on BMP signaling as the primary self-renewal signal for GSCs, distinguishing it from the role of Upd/JAK/STAT in niche adhesion, as highlighted in Leatherman and Dinardo (2010). Additionally, we have cited and reviewed the work by Greenspan et al. (2015) and ensure a more comprehensive discussion of GSC regulation. These revisions can be found in the line no. 285-289 of the revised manuscript.

      b. Line 82-84 - BMPs are produced by both hub cells and CySCs. BMP signaling in GSCs represses bam. So it is not technically correct to say the CySCs repress bam expression in GSCs.

      We acknowledge the reviewer’s clarification regarding BMP signaling and its role in repressing bam expression in GSCs. We have revised the relevant section (line no.83-85). 

      c.Throughout the figures the authors score Vasa<sup>+</sup> cells for GSCs. This is technically not correct. What they are counting is single, Vasa<sup>+</sup> cells in contact with the niche. All graphs should be updated with the label "GSCs" on the Y-axis.

      We appreciate the reviewer’s careful assessment of our methodology. We acknowledge that scoring Vasa⁺ cells alone does not definitively identify GSCs. Our quantification specifically considers single Vasa<sup>⁺</sup> cells in direct contact with the niche. To ensure clarity and accuracy, we have updated all figure legends and Y-axis labels in the relevant graphs to explicitly state "GSCs" instead of "Vasa⁺ cells."

      (4) Issues with the text

      a. Line 1: multi-lineage is not correct. Multi-lineage refers to stem cells that produce multiple types of daughter cells. GSCs produce only one type of offspring and CySCs produce only one type of offspring. So both are uni-lineage. Please change accordingly.

      We acknowledge the incorrect usage of "multi-lineage" and agree that both GSCs and CySCs are uni-lineage, as they each produce only one type of offspring. We have revised Line 1 accordingly and also updated the title. 

      b. Lines 62-75 - Intestinal stem cells have constitutively high ROS (Jaspar lab paper), so low ROS in stem cell cells is not an absolute.

      We appreciate the clarification. We have revised Lines 62–75 to acknowledge that low ROS is not universal in stem cells, citing the Jaspar lab study on intestinal stem cells (Line 70). Thank you for the valuable insight.

      c.  Line 79: The term cystic is not used in the Drosophila testis. There are cyst stem cells (CySCs) that produce cyst cells. Please revise.

      We have revised the text to replace "cystic" with the correct terminology, referring to cyst stem cells (CySCs) in the manuscript.

      d. Line 90 - perfectly balanced is an overstatement and should be toned down.

      Thank you for the suggestion. We have revised it to “balanced” instead of "perfectly balanced."  

      e. Line 98 - division of labour is not supported by the data and should be rephrased.

      Thank you for the feedback. We have rephrased it (line no. 98-101) to avoid the term "division of labor".

      f. Line 200 - the authors provide no data on BMPs - the GSC self-renewal cue - so they should avoid discussing an absence of self-renewal cues.

      We appreciate the reviewer’s point. We have revised it to avoid discussing the absence of self-renewal cues, given that we do not present data on BMP signaling. This ensures that our conclusions remain within the scope of the provided data.

      (5) Issues with the figures

      a The images are too small to appreciate the location of mitochondria in GSCs and CySCs.

      b. Figure 1

      c. cell membranes are not marked, reducing the precision of assigning mitochondria to GSC or CySCs. It would be very helpful if the authors depleted ATP5A from GSCs and showed that the puncta are reduced in these cells, and did a similar set of experiments for the Tj-Gal4 lineage. It would also be very helpful if the authors expressed membrane markers (like myrGFP) in the GSC and then in the CySC lineage and then stained with ATP5A. This would pinpoint in which cells ATP5A immunoreactivity is occurring.

      d. The presumed changes in gst-GFP (redox readout) are possibly seen in differentiating germ cells (i.e.,spermatogonia) but not in GSC. iii. Panels F, Q, and S are not explained and currently are irrelevant.

      e. Figure 3K - The evidence to support less Ecad in GSCs in tj>SOD-i testes is not compelling as the figure is too small and the insets show changes in Ecad in somatic cells, not GSC. d. Figure 4:

      f. Panel A, B The apparent decline (not quantified) may not contribute to the phenotype.

      ii.dpERK is a finicky antibody and the authors are showing a single example of each genotype. This is an important experiment because the authors are going to use it to conclude that MAPK is decreased in the tj>SOD-i samples. However, the authors don't have any positive (dominantactive EGFR) or negative (tj>mapk-i). As is standing, the data is not compelling. The graph in F does not convey any useful information.

      g. Figure S1D - cannot discern green on black. It is critical for the authors to show monochromes (grayscale) for thereabouts that they want to emphasize. I cannot see the green on black in Figure S1D.

      h. Figure S4 - there is no quantification of the number of Tj cells in K-N.

      We appreciate your detailed feedback regarding the figures in our manuscript. Below, we address each concern and outline the revisions we have made.

      (a) Image Size and Mitochondrial Localization in GSCs and CySCs 

      We acknowledge the need for larger images to better visualize mitochondrial localization. We have now increased the resolution and size of the images in Figure 1. Additionally, we have included high-magnification insets to enhance clarity (Figure 1 B#)

      (b) Figure 1 B,B#,C 

      (i) We have now marked cell membranes using Dlg to improve the precision of mitochondrial assignment to GSCs and CySCs and then stained for ATP5A, which clearly demarcates ATP5A immunoreactivity in specific cell types.

      (ii) We have revisited the gstD-GFP (redox readout) data and now provide revised images (Figure S1C-D’’’) and quantification (Figure 1 R,S) to better illustrate changes in the redox state. It is indeed intense in differentiating germ cells as expected but also present in the stem cell zone.

      (iii) Panels F, Q, and S have now been removed in the revised figure legend. 

      (C) Figure 3K: We have digitally magnified the figure size and improved contrast to better visualize E-cadherin levels. The insets have been revised to ensure they focus specifically on GSCs rather than somatic cells. Earlier, we quantified the E-cadherin intensity changes in the GSC-hub interface and provided statistical analysis to support our findings (Figure 3M).

      (d) Figure 4: (i) Panels A and B have now been quantified, and we provide statistical comparisons to support our observations. (ii) We acknowledge the variability of dpERK staining. To strengthen our conclusions, we have provided negative (Tj>MAPK-i) controls (Figure S4 B). Additionally, we have removed panel F (MAPK area cover) to avoid confusion.

      (e) We appreciate the suggestion regarding grayscale images and have provided the monochrome images for mitochondria and gstD-GFP image representation. We have now removed Figure S1D as it was no longer required.

      (f) Figure S4: The quantification of the number of Tj-positive cells was actually included in the main figure along with statistical analysis.

      (g) We sincerely appreciate the reviewer’s insightful s, which have significantly improved the quality and clarity of our manuscript. We hope that our revisions adequately address the concerns raised.

      (6) Issues with Methods

      a.  Materials and Methods are not described in sufficient depth - please revise.

      b.  Note that Tj-Gal4 has real-time expression in hub cells and this is not considered by the authors. The ideal genotype for targeting CySCs is Tj-Gal4, Gal80TS, hh-Gal80. Additionally, the authors do not mention whether they are depleting throughout development into adulthood or only in adults. If the latter, then they must have used a temperature shift, growing the flies at 18C and then upshifting to 25C or 29C during adult stages.

      c.  The authors need to show data points in all of the graphs. Some graphs do this but others do not.

      d.  The authors state that all data points are from three biological replicates. This is not sufficient for GSC and CySC counts. Most labs count GSCs and CySCs from at least 10 testes of the correct genotype.

      We appreciate the reviewer’s valuable feedback and have made the necessary revisions to improve the clarity and rigor of our study. Below, we address each concern in detail:

      Materials and Methods

      We have revised the Materials and Methods section to provide a more detailed description of the experimental procedures, including genotypes, sample preparation, and quantification methods.

      Tj-Gal4 Expression and Experimental Design

      We acknowledge the reviewer’s point regarding Tj-Gal4 expression in hub cells. While Tj-Gal4 is active in hub cells, our focus was on CySCs, and we have now included a discussion of this caveat in the revised manuscript (line no. 308-311)

      Thank you for your suggestion on the ideal genotype for targeting CySCs. While we attempted to procure hh-Gal80, we couldn’t manage to get it, so we opted for another well-established Gal4 driver, C-587 Gal4, to target CySCs. Our results indicate that although the phenotypic changes are consistent across both drivers, the effects are significantly stronger with Tj-Gal4, highlighting the role of CySCs in this process with partial contributions from the hub. These findings have been incorporated into the revised manuscript (lines 309–311).

      We now clarify whether gene depletion was conducted throughout development or restricted to adulthood. For adult-specific depletion using the UAS-Gal4 system, crosses were set up at 25°C, and after two days, progenies were shifted to 29°C and aged for 3–5 days at 29°C. This process is now explicitly detailed in the revised Methods section (line no. 345-348).

      Data Presentation in Graphs

      We have updated all graphs to ensure that individual data points are shown consistently across all figures.

      Sample Size for GSC and CySC Counts

      We acknowledge the reviewer’s concern regarding biological replicates. Our initial study was based on 10 biological replicates, each set consisting of at least 7-8 testes per genotype, in line with standard practice in the field. This change is reflected in the revised Results and Methods sections.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Comments:

      (1) HCC shows heterogeneity, and it is unclear what tissues (tumor or normal) were used from the DKO mice and human HCC gene expression dataset to obtain the gene signature, and how the authors reconcile these gene signatures with HCC prognosis.

      Mice studies: Aged DKO mice develop aggressive tumors (major and minor nodules, See Figure 1), and the entire liver is burdened with multiple tumor nodules. It is technically challenging to demarcate the tumor boundaries as most of the surrounding tissues do not display normal tissue architecture. Therefore, livers from age- and sex-matched wild-type C57/BL6 mice were used as control tissue. All the mice were inbred in our facility. Spatial transcriptomics and longitudinal studies are ongoing to collect tumors at earlier time points wherein we can differentiate tumor and non-tumor tissue.

      Human Studies: We mined five separate clinical data sets. The human HCC gene expression comprised of samples from the (i) National Cancer Institute (NCI) cohort (GEO accession numbers, GSE1898 and GSE4024) and (ii) Korea, (iii) Samsung, (iv) Modena, and (v) Fudan cohorts as previously described (GEO accession numbers, GSE14520, GSE16757, GSE43619, GSE36376, and GSE54236). We have added a new supplemental table 4, giving details of these datasets. Depending on the cohort, they are primarily HCC samples- surgical resections of HCC, control samples, with some tumors and paired non-tumor tissues.

      (2) The authors identified a unique set of gene expression signatures that are linked to HCC patient outcomes, but analysis of these gene sets to understand the causes of cancer promotion is still lacking. The studies of urea cycle metabolism and estrogen signaling were preliminary and inconclusive. These mechanistic aspects may be followed up in revision or future studies.

      We agree. Experiments to elicit HCC causality and promotion are complex, given the heterogeneous nature of liver cancer. Moreover, the length of time (12 months) needed to spontaneously develop cancer in this DKO mouse model makes it challenging. As mentioned by the reviewer, mechanistic studies are ongoing, and longitudinal time course experiments are actively being pursued to delineate causality. Having said that, we mined the TCGA LIHC (The Cancer Genome Atlas Liver Hepatocellular Carcinoma) database to examine the expression of the individual urea cycle genes and found them suppressed in liver tumorigenesis (new Supplementary Figure 4). We also evaluated if estrogen receptor a (Era) targets altered in DKO females (DKO_Estrogen) correlate with overall survival in HCC (new Supplementary Figure 6). We note that Era expression per se is reduced in males and females upon liver tumorigenesis. Also, DKO_Estrogen signature positively corroborated with better overall survival (new Supplementary Figure 6). These findings further bolster the relevance of urea cycle metabolism and estrogen signaling during HCC.

      (3) While high levels of bile acids are convincingly shown to promote HCC progression, their role in HCC initiation is not established. The DKO model may be limited to conditions of extremely high levels of organ bile acid exposure. The DKO mice do not model the human population of HCC patients with various etiology and shared liver pathology (i.e. cirrhosis). Therefore, high circulating bile acids may not fully explain the male prevalence of HCC incidence.

      We agree with this comment that our studies do not show bile acids can initiate HCC and may act as one of the many factors that contribute to the high male prevalence of HCC. This is exactly the reason why throughout the manuscript we do not write about HCC initiation. To clarify further, in the revised discussion of the manuscript, we have added a sentence to highlight this aspect, “while this study demonstrates bile acids promote HCC progression it does not investigate or provide evidence if excess bile acids are sufficient for HCC initiation.”

      (4) The authors showed lower circulating bile acids and increased fecal bile acid excretion in female mice and hypothesized that this may be a mechanism underlying the lower bile acid exposure that contributed to lower HCC incidence in female DKO mice. Additional analysis of organ bile acids within the enterohepatic circulation may be performed because a more accurate interpretation of the circulating bile acids and fecal bile acids can be made in reference to organ bile acids and total bile acid pool changes in these mice.

      As shown in this manuscript- we provide BA compositional analyses from the liver, serum, urine, and feces (Figures 5 and 6, new Supplementary Figure 8, Supplementary Tables 4 and 5). Unfortunately, we did not collect the intestinal tissue or gallbladders for BA analysis in this study. Separate cohorts of mice are being aged for future BA analyses from different organs within the enterohepatic loop. We thank you for this suggestion. Nevertheless, we have previously measured and reported BA values to be elevated in the intestines and the gall bladder of young DKO mice (PMC3007143).

      Reviewer #2 (Public review)

      Weaknesses:

      (1) The translational value to human HCC is not so strong yet. Authors show that there is a correlation between the female-selective gene signature and low-grade tumors and better survival in HCC patients overall. However, these data do not show whether this signature is more highly correlated with female tumor burden and survival. In other words, whether the mechanisms of female protection may be similar between humans and mice. In that respect, it would also be good to elaborate on whether women have higher fecal BA excretion and lower serum BA concentration.

      The reviewer poses an interesting question to test if the DKO female-specific signatures are altered differently in male vs. female HCC samples. As we found the urea cycle and estrogen signaling to be protective and enriched in our mouse model, we tested their expression pattern using the TCGA-LIHC RNA-seq data. We found urea cycle genes and Era transcripts broadly reduced in tumor samples irrespective of the sex (new Supplementary Figure 4 and Supplementary Figure 6), indicating that these pathways are compromised upon tumorigenesis even in the female livers.

      While prior studies have shown (i) a smaller BA pool w synthesis in men than women (PMID: 22003820), we did not find a study that systematically investigated BA excretion between the sexes in HCC context. The reviewer is spot on in suggesting BA analysis from HCC and unaffected human fecal samples from both sexes. Designing and performing such studies in the future will provide concrete proof of whether BA excretion protects female livers from developing liver cancer. We thank you for these suggestions.

      (2) The authors should perform a thorough spelling and grammar check.

      We apologize for the typos, which have been fixed, and as suggested by the reviewer, we have performed a grammar check.

      (3) There are quite some errors and inaccuracies in the result section, figures, and legends. The authors should correct this.

      We apologize for the inadvertent errors in the manuscript, and we have clarified these inaccuracies in the revised version. Thank you.

    1. Author response:

      The following is the authors’ response to the previous reviews

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Xie and colleagues presents transcriptomic experiments that measure gene expression in eight different tissues taken from adult female and male mice from four species. These data are used to make inferences regarding the evolution of sex-biased gene expression across these taxa.

      Strengths:

      The experimental methods and data analysis appear appropriate. The authors promote their study as unprecedented in its size and technical precision.

      We do not understand the statement "the authors promote" as if there was a doubt about this. If there is a doubt, we welcome to see it specified.

      Weaknesses:

      The manuscript does not present a clear set of novel evolutionary conclusions. The major findings recapitulate many previous comparative transcriptomics studies - gene expression variation is prevalent between individuals, sexes, and species; and genes with sex-biased expression evolve more rapidly than genes with unbiased expression - but it is not clear how the study extends our understanding of gene expression or its evolution.

      There have been no "previous comparative transcriptomics studies" at a micro- evolutionary scale in animals, hence, we do not "replicate" these. And our contrast between somatic and gonadal patterns reveals insights that have not been recognized before, namely that gonadal sex-specific expression turnover is actually not faster that the corresponding non-sex-specific truover. We have now further clarified this distinction throughout the text and have also adapted the title of the paper accordingly.

      We agree with the overall statement that "gene expression variation is prevalent between individuals, sexes, and species" but the aspect of "sex-biased gene expression between individuals" has not been systematically analysed before in such a context.

      Concerning the statement that "genes with sex-biased expression evolve more rapidly than genes with unbiased expression", we note that this is mostly derived from gonadal data and that there is no study that has quantified this so far at a population level and between subspecies in comparison to somatic data.

      Our results show further that previous assumptions of a substantial set of genes with sex- biased expression conserved between mice and humans are due to underestimating the convergence issues when there is an extremly fast turnover of sex-biased gene expression. This has a major implication for using mice as a model for gender-speficic medicine questions in humans.

      Many gene expression differences between individual animals are selectively neutral, because these differences in mRNA concentration are buffered at the level of translation, or differences in protein abundance have no effect on cellular or organismal function. The hypothesis that sex-biased genes are enriched for selectively neutral expression differences is supported by the excess of inter-individual expression variance and inter-specific expression differences in sex-biased genes.

      This statement repeats a statement from the first round of reviews. We had added new data and extensive discussion on this topic. We do not understand why this has not been taken into account. In fact, a major strength of our paper is that it shows that most sex- biased gene expression differences are not neutral!

      There are two major issues here: to identify sex-biased gene expression in the first place, we (and all other papers in the field) use the neutral model as null-hypothesis. Genes that are not compatible with this null-hypothesis are considered sex-biased. In contrast to most previous papers, we have the possibility to take into account the variances between individuals to add an additional significance test. Hence, we can apply a much more rigorous two-step process: first a ratio-cutoff plus a Wilcoxon rank sum test with correction for multiple testing to identify significant deviations from the null-hypothesis. We have added some additional statements in the Results and Discussion sections to emphasize this.Second, by focusing on the genes that are not following a neutral model, the variance and divergences data support the action of selection, rather than neutral drift.

      A higher rate of adaptive coding evolution is inferred among sex-biased genes as a group, but it is not clear whether this signal is driven by many sex-biased genes experiencing a little positive selection, or a few sex-biased genes experiencing a lot of positive selection, so the relationship between expression and protein-coding evolution remains unclear.

      Again, there are two major issues here. First, the distribution of alpha-values shown in Figure 3B are rather homogeneous, i.e. there is not support for a scenario that the average is driven by only a few genes.

      Second, it seems that the referee wants to see an analysis where dn/ds ratios are broken down for every single gene. This has been done in previous papers, but it is now understood that this procedure is fraught with error because of the demographic contingencies inherent to natural populations that can yield wrong results for individual loci. We have added some statements to the text to clarify this further.

      It is likely that only a subset of the gene expression differences detected here will have phenotypic effects relevant for fitness or medicine, but without some idea of how many or which genes comprise this subset, it is difficult to interpret the results in this context.

      It is the basic underlying assumption for the whole research field that significantly sex- biased genes are phenotypically relevant for fitness, since they would otherwise not be sex- biased in the first place.

      Throughout the paper the concepts of sexual selection and sexually antagonistic selection are conflated; while both modes of selection can drive the evolution of sexually dimorphic gene expression, the conditions promoting and consequence of both kinds of selection are different, and the manuscript is not clear about the significance of the results for either mode of selection.

      We had explained in our previous response that our data collection was not designed to distinguish between these two processes. But given that the issue is being brought up again, we have now added some discussion on this issue.

      The manuscript's conclusion that "most of the genetic underpinnings of sex-differences show no long-term evolutionary stability" is not supported by the data, which measured gene expression phenotypes but did not investigate the underlying genetic variation causing these differences between individuals, sexes, or species.

      We agree that - under a strict definition - our use of the term "genetic underpinning" in this conclusion sentence can be criticized. The most correct term would be "transcriptional underpinnings", but of course, given that it is the current practice of the whole field to assume that "transcriptional" is part of the overall genetics, we do not consider our initial statement as incorrect. Still, we have changed the term accordingly.

      Furthermore, most of the gene expression differences are observed between sex-specific organs such as testes and ovaries, which are downstream of the sex-determination pathway that is conserved in these four mouse species, so these conclusions are limited to gene expression phenotypes in somatic organs shared by the sexes.

      Yes - correct. But the whole focus of the paper is on somatic expression, i.e. organs that share the same cell compositions. Of course, the comparison between gonadal organs is conflated by being composed of different cell types. We have extended the discussion of this point.

      The differences between sex-biased expression in mice and humans are attributed to differences in the two species effective population sizes; but the human samples have significantly more environmental variation than the mouse samples taken from age-matched animals reared in controlled conditions, which could also explain the observed pattern.

      These are indeed the two alternative explanations that we had discussed (last paragraph of the discussion section, now the penultimate paragraph).

      The smoothed density plots in Figure 5 are confusing and misleading. Examining the individual SBI values in Table S9 reveals that all of the female and male SBI values for each species and organ are non-overlapping, with the exception of the heart in domesticus and mammary gland in musculus, where one male and one female individual fall within the range of the other sex. The smoothed plots therefore exaggerate the overlap between the sexes;

      Smoothing across discrete values is an entirely standard procedure for continuous variables. It allows to visualize the inherent data trends that cannot easily be glanced from simple inspection of the actual values. This is a mathematical procedure, not an "exaggeration". We used the same smoothening procedure for all the comparisons, and it is clear that the distributions between females and males of the sex organs and a few somatic organs are well separated (non-overlapping), which serves as a control.

      in particular, the extreme variation shown in the SBI in the mammary glands in spretus females and spicilegus males is hard to understand given the normalized values in Table S3. The R code used to generate the smoothed plots is not included in the Github repository, so it is not possible to independently recreate those plots from the underlying data.

      We apologize that there was indeed an error in the Figure - the columns for SPR and SPI were accidentally interchanged. We have corrected this figure. Generally, the smoothened patterns we show are easily verified by looking up the respective primary values. We apologize that the code lines for the plots were accidentally omitted. We have used a standard function from ggplot2: geom_density, with "adjust=3, alpha=0.5" for all plots and included this description in the Methods. We have now added this to the R code in the GitHub repository.

      The correlations provided in Table S9 are confusing - most of the reported correlations are 1.0, which are not recovered when using the SBI values in Table S9, and which does not support the manuscript's assertion that sex-biased gene expression can vary between organs within an individual. Indeed, using the SBI values in Table S9, many correlations across organs are negative, which is expected given the description of the result in the text.

      There is a misunderstanding here. The tables do not report correlations, but only p-values for correlations, the raw ones and the ones after corrections for multiple testing. P = 1.0 means no significant correlation. We have adjusted the caption of this table to clarify this further.

      Reviewer #3 (Public review):

      This manuscript reports interesting data on sex differences in expression across several somatic and reproductive tissues among 4 mice species or subspecies. The focus is on sex- biased expression in the somatic tissues, where the authors report high rates of turnover such that the majority of sex-biased genes are only sex-biased in one or two taxa. The authors show sex-biased genes have higher expression variance than unbiased genes but also provide some evidence that sex-bias is likely to evolve from genes with higher expression variance. The authors find that sex-biased genes (both female- and male-biased) experience more adaptive evolution (i.e., higher alpha values) than unbiased genes. The authors develop a summary statistic (Sex-Bias Index, SBI) of each individual's degree of sex- bias for a given tissue. They show that the distribution of SBI values often overlap considerably for somatic (but not reproductive) tissues and that SBI values are not correlated across tissues, which they interpret as indicating an individual can be relatively "male-like" in one tissue and relatively "female-like" in another tissue.

      This is a good summary of the data, but we are puzzled that it does not include the completely new module analysis and the finding of extremely fast evolution of sex-biased somatic gene expression compared to the gonadal one.

      Though the data are interesting, there are some disappointing aspects to how the authors have chosen to present the work. For example, their criteria for sex-bias requires an expression ratio of one sex to the other of 1.25. A reasonably large fraction of the "sex- biased genes" have ratios just beyond this cut-off (Fig. S1). A gene which has a ratio of 1.27 in taxa 1 can be declared as "sex-biased" but which has a ratio of 1.23 in taxa 2 will not be declared as "sex-biased". It is impossible to know from how the data are presented in the main text the extent to which the supposed very high turnover represents substantial changes in dimorphic expression. A simple plot of the expression sex ratio of taxa 1 vs taxa 2 would be illuminating but the authors declined this suggestion.

      Choosing a cutoff is the standard practice when dealing with continuously distributed data. As we have pointed out, we looked at various cutoff options and decided to use the present one, based on the observed data distributions. Note that some studies have used even lower ones (e.g. 1.1). To visualize the data distribution, we had provided the overall distribution of ratios, because one would have to look at many more plots otherwise. But we have now also added individual plots as Figure 1, Figure supplement 2, as requested. They confirm what is also evident from the overall plots, namely that most ratio changes are larger than the incremental values suggested by the reviewer. Note that the original data are of course also available for inspection.

      I was particularly intrigued by the authors' inference of the proportion of adaptive substitutions ("alpha") in different gene sets. The show alpha is higher for sex-biased than unbiased genes and nicely shows that the genes that are unbiased in focal taxa but sex- biased in the sister taxa also have low alpha. It would be even stronger that sex-bias is associated with adaptive evolution to estimate alpha for only those genes that are sex- biased in the focal taxa but not in the sister taxa (the current version estimates alpha on all sex-biased genes within the focal taxa, both those that are sex-biased and those that are unbiased in the sister taxa).

      We have added the respective values in the results section, but since fewer genes are involved, they are less comparable to the other sets of genes. Still, the tendencies remain.

      The author's Sex Bias Index is measured in an individual sample as: SBI = median(TPM of female-biased genes) - median(TPM of male-biased genes). This index has some strange properties when one works through some toy examples (though any summary statistic will have limitations). The authors do little to jointly discuss the merits and limitations of this metric. It would have been interesting to examine their two key points (degree of overlapping distributions between sexes and correlation across tissues) using other individual measures of sex-bias.

      We had responded to this comment before (including the explanation that it has no strange properties when one applies the normalization that is now implemented) and we have added a whole section devoted to the discussion of the merits of the SBI. We do not know which other "individual measures of sex-bias" this should be compared to. Still, we have now added a paragraph in the discussion about using PCA as an alternative to show that this would result in similar conclusions, but is technically less suitable for this purpose.

      Figure 5 shows symmetric gaussian-looking distributions of SBI but it makes me wonder to what extent this is the magic of model fitting software as there are only 9 data points underlying each distribution. Whereas Figure 5 shows many broadly overlapping distributions for SBI, Figure 6 seems to suggest the sexes are quite well separated for SBI (e.g., brain in MUS, heart in DOM).

      We use a standard fitting function in R (see above), which tries to fit a normalized distribution, but this function can also add an additional peak when the data are too heterogeneous (e.g. Mammary in Figure 7).

      Fig. S1 should be shown as the log(F/M) ratio so it is easier to see the symmetry, or lack thereof, of female and male-biased genes.

      The log will work differently for values <1, compared to values >1 when used in a single plot. We have now generated combined plots with symmetric values to allow a better comparability.

      It is important to note that for the variance analysis that IQR/median was calculated for each gene within each sex for each tissue. This is a key piece of information that should be in the methods or legend of the main figure (not buried in Supplemental Table 17).

      ​We have now moved these descriptions into the Methods section.

    1. Reviewer #2 (Public review):

      Summary:

      In this manuscript, submitted to Review Commons (journal agnostic), Coward and colleagues report on the role of insulin/IGF axis in podocyte gene transcription. They knocked out both the insulin and IGFR1 mice. Dual KO mice manifested a severe phenotype, with albuminuria, glomerulosclerosis, renal failure and death at 4-24 weeks.

      Long read RNA sequencing was used to assess splicing events. Podocyte transcripts manifesting intron retention were identified. Dual knock-out podocytes manifested more transcripts with intron retention (18%) compared wild-type controls (18%), with an overlap between experiments of ~30%.

      Transcript productivity was also assessed using FLAIR-mark-intron-retention software. Intron retention w seen in 18% of ciDKO podocyte transcripts compared to 14% of wild-type podocyte transcripts (P=0.004), with an overlap between experiments of ~30% (indicating the variability of results with this method). Interestingly, ciDKO podocytes showed downregulation of proteins involved in spliceosome function and RNA processing, as suggested by LC/MS and confirmed by Western blot.

      Pladienolide (a spliceosome inhibitor) was cytotoxic to HeLa cells and to mouse podocytes but no toxicity was seen in murine glomerular endothelial cells.

      The manuscript is generally clear and well-written. Mouse work was approved in advance. The four figures are generally well-designed, with bars/superimposed dot-plots.

      Methods are generally well described. It would be helpful to say that tissue scoring was performed by an investigator masked to sample identity.

      Specific comments:

      (1) Data are presented as mean/SEM. In general, mean/SD or median/IQR are preferred to allow the reader to evaluate the spread of the data. There may be exceptions where only SEM is reasonable.

      (2) It would be useful to for the reader to be told the number of over-lapping genes (with similar expression between mouse groups) and the results of a statistical test comparing WT and KO mice. The overlap of intron retention events between experimental repeats was about 30% in both knock-out podocytes. This seems low and I am curious to know whether this is typical for typical for this method; a reference could be helpful.

      (3) Please explain "adjusted p value of 0.01." It is not clear how was it adjusted. The number of differentially-expressed proteins between the two cell types was 4842.

      Comments on revision plan:

      The authors suggest additional experiments that should address my concerns and probably the other reviewers' concerns.

      I encourage the authors to proceed with their proposed experiments and revisions.

    2. Reviewer #3 (Public review):

      Summary:

      These investigators have previously shown important roles for either insulin receptor (IR) or insulin-like growth factor receptor (IGF1R) in glomerular podocyte function. They now have studied mice with deletion of both receptors and find significant podocyte dysfunction. They then made a podocyte cell line with inducible deletion of both receptors and find abnormalities in transcriptional efficiency with decreased expression of spliceosome proteins and increased transcripts with impaired splicing or premature termination.

      The studies appear to be performed well and the manuscript is clearly written.

      There are a number of potential issues and questions with these studies.

      (1) For the in vivo studies, the only information given is for mice at 24 weeks of age. There needs to be a full time course of when the albuminuria was first seen and the rate of development. Also, GFR was not measured. Since the podocin-Cre utilized was not inducible, there should be a determination of whether there was a developmental defect in glomeruli or podocytes. Were there any differences in wither prenatal post natal development or number of glomeruli?

      (2) Although the in vitro studies are of interest, there are no studies to determine if this is the underlying mechanism for the in vivo abnormalities seen in the mice. Cultured podocytes may not necessarily reflect what is occurring in podocytes in vivo.

      (3) Given that both receptors are deleted in the podocyte cell line, it is not clear if the spliceosome defect requires deletion of both receptors or if there is redundancy in the effect. The studies need to be repeated in podocyte cell lines with either IR or IGFR single deletions.

      (4) There are no studies investigating signaling mechanisms mediating the spliceosome abnormalities.

      Comments on revision plan:

      I do not have any changes from my prior review. I applaud the authors for developing a plan to address the questions and concerns raised in my prior review.

    3. Author response:

      Evidence reducibility and clarity

      Reviewer 1:

      In this manuscript, the role of the insulin receptor and the insulin growth factor receptor was investigated in podocytes. Mice, were both receptors were deleted, developed glomerular dysfunction and developed proteinuria and glomerulosclerosis over several months. Because of concerns about incomplete KO, the authors generated podocyte cell lines where both receptors were deleted. Loss of both receptors was highly deleterious with greater than 50% cell death. To elucidate the mechanism, the authors performed global proteomics and find that spliceosome proteins are downregulated. They confirm this by using long-range sequencing. These results suggest a novel role for these pathways in podocytes.

      Thank you

      This is primarily a descriptive study and no technical concerns are raised. The mechanism of how insulin and IGF1 signaling are linked to the spiceosome is not addresed.

      We do not think the paper is descriptive as we used non-biased phospho and total proteomics in the DKO cells to uncover the alterations in the spliceosome (that have not been previously described) that were detrimental. However, we are happy to look further into the underlying mechanism.

      We would propose:

      (1) Stimulating/inhibiting insulin/IGF signalling pathways in the Wild-type and DKO knockout cells and check expression levels and/or phosphorylation status of splice factors (including those in Figure 3E) and those revealed by phospho-proteomic data; a variety of inhibitors of insulin/IGF1 pathways could also be used along the pathways that are shown in Fig 2.

      (2) Looking at the RNaseq data bioinformatically in more detail – the introns/exons that move up or down are targets of the splice factors involved; most splice factors binding sequences are known, so it should be possible to ask bioinformatically – from the sequences around the splice sites of the exons and introns that move in the DKO, which splice factors binding sites are seen most frequently? To uncover splice factors/RNA-binding proteins (RBPs) that are involved in the insulin signaling we will use a software named MATT which was specifically designed to look for RNA-binding motifs (PMID 30010778). In brief, using the long-sequencing data, we will test 250 nt sequences flanking the splice sites of all regulated splicing events (intronic and exonic) against all RNA- binding proteins in the CISBP-RNA database (PMID 23846655) using MATT. This will result in a list of RBPs potentially involved in the insulin signaling. We will validate these by activating insulin signaling (similar to Figures 2 B,C) and probe whether the RBPs are activated (e.g. phosphorylated or change in expression) or we will manipulate expression of the candidate RBPs and measure how they affect the insulin signaling.

      (3) Examining the phospho and total proteomic data for IGF1R and Insulin receptor knockout alone podocytes (which we have already generated) and analysing these in more detail and include this data set to elucidate the relative importance of both receptors to spliceosome function.

      The phenotype of the mouse is only superficially addressed. The main issues are that the completeness of the mouse KO is never assessed nor is the completeness of the KO in cell lines. The absence of this data is a significant weakness.

      We apologise for not making clear but we did assess the level of receptor knockdown in the animal and cell models.  The in vivo model showed variable and non-complete levels of insulin receptor and IGF1 receptor podocyte knock down (shown in supplementary figure 1B). This is why we made the in vitro  floxed podocyte cell lines in which we could robustly knockdown both the insulin receptor and IGF1 receptor (shown in Figure 2A)

      The mouse experiments would be improved if the serum creatinines were measured to provide some idea how severe the kidney injury is.

      We can address this:

      We have further urinary Albumin:creatinine ratio (uACR) data at 12, 16 and 20 weeks. We also have more blood tests of renal function that can be added. There is variability in creatinine levels which is not uncommon in transgenic mouse models (probably partly due to variability in receptor knock down with cre-lox system). This is part of rationale of developing the robust double receptor knockout cell models where we knocked out both receptors by >80%.

      An attempt to rescue the phenotype by overexpression of SF3B4 would also be useful. If this didn't work, an explanation in the text would suffice.

      We would consider  over express SF3BF4 in the Wild type and DKO cells and assess the effects on spliceosome if deemed necessary.  However, we think it is unlikely to rescue the phenotype as so many other spliceosome components are downregulated in the DKO cells.

      As insulin and IGF are regulators of metabolism, some assessment of metabolic parameters would be an optional add-on.

      We have some detail on this and can add to the manuscript. However it is not extensive as not a major driver of this work.

      Lastly, the authors should caveat the cell experiments by discussing the ramifications of studying the 50% of the cells that survive vs the ones that died.

      Thank you, we appreciate this and this was the rationale behind cells being studied after 2 days differentiation before significant cell loss in order to avoid the issue of studying the 50% of cells that survive.

      Reviewer 2:

      In this manuscript, submitted to Review Commons (journal agnostic), Coward and colleagues report on the role of insulin/IGF axis in podocyte gene transcription. They knocked out both the insulin and IGFR1 mice. Dual KO mice manifested a severe phenotype, with albuminuria, glomerulosclerosis, renal failure and death at 4-24 weeks.

      Long read RNA sequencing was used to assess splicing events. Podocyte transcripts manifesting intron retention were identified. Dual knock-out podocytes manifested more transcripts with intron retention (18%) compared wild-type controls (18%), with an overlap between experiments of ~30%.

      Transcript productivity was also assessed using FLAIR-mark-intron-retention software. Intron retention w seen in 18% of ciDKO podocyte transcripts compared to 14% of wild-type podocyte transcripts (P=0.004), with an overlap between experiments of ~30% (indicating the variability of results with this method). Interestingly, ciDKO podocytes showed downregulation of proteins involved in spliceosome function and RNA processing, as suggested by LC/MS and confirmed by Western blot.

      Pladienolide (a spliceosome inhibitor) was cytotoxic to HeLa cells and to mouse podocytes but no toxicity was seen in murine glomerular endothelial cells.<br /> Specific comments.

      The manuscript is generally clear and well-written. Mouse work was approved in advance. The six figures are generally well-designed, bars/superimposed dot-plots.

      Thank you

      Evaluation.

      Methods are generally well described. It would be helpful to say that tissue scoring was performed by an investigator masked to sample identity.

      We did this and will add this information to the methods/figure legend.

      Specific comments.

      (1) Data are presented as mean/SEM. In general, mean/SD or median/IQR are preferred to allow the reader to evaluate the spread of the data. There may be exceptions where only SEM is reasonable.

      Graphs can be changed to SD rather than SEM.

      (2) It would be useful to for the reader to be told the number of over-lapping genes (with similar expression between mouse groups) and the results of a statistical test comparing WT and KO mice. The overlap of intron retention events between experimental repeats was about 30% in both knock-out podocytes. This seems low and I am curious to know whether this is typical for typical for this method; a reference could be helpful.

      This is an excellent question. We had 30% overlap as the parameters used for analysis were very stringent. We suspect we could get more than 30% by being less stringent, which still be considered as similar events if requested. Our methods were based on FLAIR analysis (PMID: 32188845)

      (3) Please explain "adjusted p value of 0.01." It is not clear how was it adjusted. The number of differentially-expressed proteins between the two cell types was 4842.

      We used the Benjamini-Hochberg method to adjust our data. We think the reviewer is referring to the transcriptomic data and not the proteomic data.

      Minor comments

      Page numbers in the text would help the reviewer communicate more effectively with the author.

      We will do this

      Reviewer 3:

      These investigators have previously shown important roles for either insulin receptor (IR) or insulin-like growth factor receptor (IGF1R) in glomerular podocyte function. They now have studied mice with deletion of both receptors and find significant podocyte dysfunction. They then made a podocyte cell line with inducible deletion of both receptors and find abnormalities in transcriptional efficiency with decreased expression of spliceosome proteins and increased transcripts with impaired splicing or premature termination.

      The studies appear to be performed well and the manuscript is clearly written.

      Thank you

      Referees cross-commenting

      I am in agreement with Reviewer 1 that the studies are overly descriptive and do not provide sufficient mechanism and the lack of more investigation of the in vivo model is a significant weakness.

      Please see our responses to reviewer 1 above.

      Significance

      Reviewer 1:

      With the GLP1 agonists providing renal protection, there is great interest in understanding the role of insulin and other incretins in kidney cell biology. It is already known that Insulin and IGFR signaling play important roles in other cells of the kidney. So, there is great interest in understanding these pathways in podocytes. The major advance is that these two pathways appear to have a role in RNA metabolism, the major limitations are the lack of information regarding the completeness of the KO's. If, for example, they can determine that in the mice, the KO is complete, that the GFR is relatively normal, then the phenotype they describe is relatively mild.

      Thank you. The receptor  KO in the mice is unlikely to be complete (Please see comments above and Supplementary Figure 1b). There are many examples of KO models targeting other tissues showing that complete KO of these receptors seems difficult to achieve , particularly in reference to the IGF1 receptor. In the brain (which is also terminally differentiated cells PMID:28595357 (barely 50% iof IGF1R knockdown was achieved in the target cells). Ovarian granulosa cells PMID:28407051 -several tissue specific drivers tried but couldn't achieve any better than 80%. The paper states that 10% of IGF1R is sufficient for function in these cells so they conclude that their knockdown animals are probably still responding to IGF1. Finally, in our recent IGF1R podocyte knockdown model we found Cre levels were important for excision of a single floxed gene (PMID: 38706850) hence we were not surprised that trying to excise two floxed genes (insulin receptor and IGF1 receptor) was challenging. This is the rationale for making the double receptor knockout cell lines to understand process / biology in more detail.

      Reviewer 2:

      The manuscript is generally clear and well-written. Mouse work was approved in advance. The figures are generally well-designed, bars/superimposed dot-plots.

      Evaluation.

      Methods are generally well described. It would be helpful to say that tissue scoring was performed by an investigator masked to sample identity.

      Thank you we will do this.

      Reviewer 3:

      There are a number of potential issues and questions with these studies.

      (1) For the in vivo studies, the only information given is for mice at 24 weeks of age. There needs to be a full time course of when the albuminuria was first seen and the rate of development. Also, GFR was not measured. Since the podocin-Cre utilized was not inducible, there should be a determination of whether there was a developmental defect in glomeruli or podocytes. Were there any differences in wither prenatal post natal development or number of glomeruli?

      Thank you we will add in further phenotyping data. We do not think there was a major developmental phenotype as  albuminuria did not become significantly different until several months of age. We could have used a doxycycline inducible model but we know the excision efficiency is much less than the podocin-cre driven model SUPP FIGURE 1. This would likely give a very mild (if any) phenotype and not reveal the biology adequately.

      (2) Although the in vitro studies are of interest, there are no studies to determine if this is the underlying mechanism for the in vivo abnormalities seen in the mice. Cultured podocytes may not necessarily reflect what is occurring in podocytes in vivo.

      Thank you for this we are happy to employ Immunohistochemistry (IHC) and immunofluorescence (IF) using spliceosome antibodies on tissue sections from DKO and control mice to examine spliceosome changes. However, as the DKO results in podocyte loss, there may not be that many DKO podocytes still present in the tissue sections. This will be taken into consideration.

      (3) Given that both receptors are deleted in the podocyte cell line, it is not clear if the spliceosome defect requires deletion of both receptors or if there is redundancy in the effect. The studies need to be repeated in podocyte cell lines with either IR or IGFR single deletions.

      Thank you. We have full total and phospho-proteomic data sets from single insulin receptor and IGF1 receptor knockout cell lines that we will investigate for this point.

      (4) There are not studies investigating signaling mechanisms mediating the spliceosome abnormalities.

      Thank you as outlined as above to reviewer 1 point 1 we are very happy to investigate insulin / IGF signalling pathways in more detail.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Manuscript number: RC-2025-02946

      Corresponding author(s): Margaret, Frame

      Roza, Masalmeh

      [Please use this template only if the submitted manuscript should be considered by the affiliate journal as a full revision in response to the points raised by the reviewers.

      If you wish to submit a preliminary revision with a revision plan, please use our "Revision Plan" template. It is important to use the appropriate template to clearly inform the editors of your intentions.]

      1. General Statements [optional]

      This section is optional. Insert here any general statements you wish to make about the goal of the study or about the reviews.

      We thank the reviewers for recognizing the significance of our work and for their constructive feedback and suggestions, most of which we have implemented in our revised manuscript.

      2. Point-by-point description of the revisions

      This section is mandatory. *Please insert a point-by-point reply describing the revisions that were already carried out and included in the transferred manuscript. *

      Reviewer #1

      Evidence, reproducibility and clarity

      Review of Masalmeh et al. Title: "FAK modulates glioblastoma stem cell energetics..."

      Previous studies have implicated FAK and the related tyrosine kinase PYK2 in glioblastoma growth, cell migration, and invasion. Herein, using a murine stem cell model of glioblastoma, the authors used CRISPR to inactivate FAK, FAK-null cells selected and cloned, and lentiviral re-expression of murine FAK in the FAK-null cells (termed FAK Rx) was accomplished. FAK-/- cells were shown to possess epithelial characteristics whereas FAK Rx cells expressed mesenchymal markers and increased cell migration/invasion in vitro. Comparisons between FAK-/- and FAK Rx cells showed that FAK re-expressed increased mitochondrial respiration and amino acid uptake. This was associated with FAK Rx cells exhibiting filamentous mitochondrial morphology (potentially an OXPHOS phenotype) and decreased levels of MTFR1L S235 phosphorylation (implicated in mito morphology fragmentation). Mito and epithelial cell morphology of FAK-/- cells was reversed by treatment with Rho-kinase inhibitors that also increased mito metabolism and cell viability. Last, FAK-dependent glioblastoma tumor growth was shown by comparisons of FAK-/- and FAK Rx implantation studies.

      The studies by Masalmeh provide interesting findings associating FAK expression with changes in mitochondrial morphology, energy metabolism, and glutamate uptake. According to the authors model, FAK expression is supporting a glioblastoma stem cell like phenotype in vitro and tumor growth in vivo. What remains unclear is the mechanistic connection to cell changes and whether or not these are be dependent on intrinsic FAK activity or as the Frame group has previously published, potentially FAK nuclear localization. The associations with MTFR1L phosphorylation and effects by Rho kinase inhibition are likely indirect and remind this reviewer of long-ago studies with FAK-null fibroblasts that exhibit epithelial characteristics, still express PYK2, exhibited elevated RhoA GTPase activity. Some of these phenotypes were linked to changes in RhoGEF and RhoGAP signaling with FAK and/or Pyk2. At a minimum, it would be informative to know whether Pyk2 signaling is relevant for observed phenotypes and whether the authors can further support their associations with FAK-targeted or FAK-Pyk2-targeted inhibitors or PROTACs.

      Some questions that would enhance potential impact. 1. Cell generation. Please describe the analysis of FAK-/- clones in more detail. The "low viability" phenotype needs further explanation with regard to clonal expansion and growth characteristics?

      Response:

      • We included a better description and a supplementary figure in our revised manuscript to indicate that we have examined several FAK -/- clones and confirmed that our observations were not due to clonal variation; multiple clones displayed similar morphological changes (Figure S1D). We also show that the elongated mesenchymal-like morphology was observed at 48 h after nucleofecting the cells with the FAK‑expressing vector, before beginning G418 selection to enrich for cells expressing FAK (Figure S1C). We also included experiments to acutely modulate FAK signalling (detaching and seeding cells on fibronectin) (Figure S2D, E, F and Figure S3) to exclude the possibility that the profound effects are due to protocols/selection we used for generating FAK-deleted cells.
      • Regarding the term “low viability”, we have clarified in the text that there is no significant difference in cell number (Figure S1A) or ‘cell viability’ when it is assessed by trypan blue exclusion (a non-mitochondria-dependent read-out) (Figure S1B) between FAK-expressing FAK Rx and FAK-/- cells cultured for three days under normal conditions. Therefore, we agree the term ‘cell viability’ in this context could be confusing and have replace "cell viability” with “metabolic activity as measured by Alamar Blue.” in Figure 1D and Figure 5B, and the corresponding text in the original manuscript. This wording more accurately reflects the data.

      Figure 1F: need further support of MET change upon FAK KO and EMT reversion.

      Response: We have added a heatmap (Figure S1E) illustrating the changes in protein expression of core-enriched EMT/MET genes products (by proteomics) after FAK gene deletion (EMT genes as defined in Howe et al., 2018) ; this strengthens the conclusion that the MET reversion morphological phenotype is accompanied by recognised MET protein changes.

      Fig. 2: Need further support if FAK effects impact glycolysis or oxidative phosphorylation in particular as implicated by the stem cell model.

      Response: We show that FAK impacts both glycolysis (Figure 2A, 2E, and 2F) and mitochondrial oxidative phosphorylation on the basis of the oxygen consumption rate (OCR) (Figure 2B, and 2D), showing both are contributing pathways to FAK-dependent energy production. We have clarified this in the text.

      Is there a combinatorial potential between FAKi and chemotherapies used for glioblastoma. Need to build upon past studies.

      Response: Yes, previous studies suggest that inhibiting FAK can sensitize GBM cells to chemotherapy (Golubovskaya et al., 2012; Ortiz-Rivera et al., 2023). We have included a paragraph in the discussion section to make sure this is clearer. Although it is not the subject of this study, we appreciate it is useful context.

      The notation of changes in glucose transporter expression should be followed up with regard to the potential that FAK-expressing cells may have different uptake of carbon sources and other amino acids. Altered uptake could be one potential explanation for increase glycolysis and glutamine flux.

      Response: We agree with the reviewer that glucose uptake could be contributing and we include data that 2 glucose transporters are indeed FAK-regulated namely Glucose transporter 1 (GLUT1, encoded by Slc2a1 gene) and Glucose transporter 3 (GLUT 3, encoded by Slc2a3 gene) (shown in Figure S2B and C).

      It would be helpful to support the confocal microscopy of mitos with EM.

      Response:

      We are concerned (and in our experience) that Electron microscopy (EM) may introduce artefacts during sample preparation. In contrast, immunofluorescence sample preparation is less susceptible to artefacts. The SORA system we used is not a conventional point-scanning confocal microscope, but is a super-resolution module based on a spinning disk confocal platform (CSU-W1; Yokogawa) using optical pixel reassignment with confocal detection. This method enhances resolution in all dimensions with resolution in our samples measured at 120nm. This has been instructive in defining a new level of changes in mitochondrial morphology upon FAK gene deletion.

      Lack of FAK expression with increased MTFR1 phosphorylation is difficult to interpret.

      Response: We do not directly show that this phosphorylation event is causal in our experiments; however, we think it important to document this change since it has been published that phosphorylation of MTFR1 has been causally linked to the mitochondrial morphology we observed in other systems (Tilokani et al., 2022).

      Need to have better support between loss of FAK and the increase in Rho signaling. Use of Rho kinase inhibitors is very limited and the context to FAK (and or Pyk2) remains unclear. Past studies have linked integrin adhesion to ECM as a linkage between FAK activation and the transient inhibition of RhoA GTP binding. Is integrin signaling and FAK involved in the cell and metabolism phenotypes in this new model?

      Response: To better support the antagonistic effect of FAK on Rho-kinase (ROCK) signalling, we included a new experiment in which the integrin-FAK signalling pathway has been disrupted by treating FAK WT cells with an agent that causes detachment from the substratum, Accutase, and growing the cells in suspension in laminin-free medium. We present ROCK activity data, as judged by phosphorylated MLC2 at serine 19 (pMLC2 S19), relating this to induced FAK phosphorylation at Y397 (a surrogate for FAK activity) that is supressed after integrin disengagement. These measurements have been compared with conditions whereby integrin-FAK signalling is activated by growing the cells on laminin coated surfaces. We observed a time-dependent decrease in pFAK(Y397) levels (normalised to total FAK) in suspended cells compared to those spread on laminin, while pMLC2(S19) levels increased in a reciprocal manner over time in detached cells relative to spread cells (S4A and B). There is therefore an inverse relationship between integrin-FAK signalling and ROCK-MLC2 activity, consistent with findings from FAK gene deletion experiments. In the former case, we do not rely on gene deletion cell clones.

      Significance

      The studies by Masalmeh provide interesting findings associating FAK expression with changes in mitochondrial morphology, energy metabolism, and glutamate uptake. According to the authors model, FAK expression is supporting a glioblastoma stem cell like phenotype in vitro and tumor growth in vivo. What remains unclear is the mechanistic connection to cell changes and whether or not these are be dependent on intrinsic FAK activity or as the Frame group has previously published, potentially FAK nuclear localization. The associations with MTFR1L phosphorylation and effects by Rho kinase inhibition are likely indirect and remind this reviewer of long-ago studies with FAK-null fibroblasts that exhibit epithelial characteristics, still express PYK2, exhibited elevated RhoA GTPase activity. Some of these phenotypes were linked to changes in RhoGEF and RhoGAP signaling with FAK and/or Pyk2. At a minimum, it would be informative to know whether Pyk2 signaling is relevant for observed phenotypes and whether the authors can further support their associations with FAK-targeted or FAK-Pyk2-targeted inhibitors or PROTACs.

      __Response: __

      Deleting the gene encoding FAK in mouse embryonic fibroblasts leads to elevated Pyk2 expression (Sieg, 2000). However, in the GBM stem cell model we used here, Pyk2 was not expressed (determined by both transcriptomics and proteomics). We have included Figure S1E to show that PYK2 expression was undetectable in FAK -/- and FAK Rx cells at the RNA level (Figure S1F). We conclude that there is no compensatory increase in Pyk2 upon FAK loss in these cells. In the transformed neural stem cell model of GBM, we do not consistently or robustly detect nuclear FAK.

      Review #2

      Masalmeh and colleagues employ a neural stem/progenitor cell-based glioma model (NPE cells) to investigate the role of Focal Adhesion Kinase (FAK) in GBM, with a focus on potential links between the regulation of morphological/adhesive and metabolic GBM cell properties. For this, the authors employ wt cells alongside newly generated FAK-KO and -reexpressing cells, as well as pharmacological interventions to probe the relevance of specific signaling pathways. The authors´ main claims are that FAK crucially modulates glioma cell morphology, cell-cell and cell-substrate interactions and motility, as well as their metabolism, and that these effects translate to changes to relevant in vivo properties such as invasion and tumor growth.

      My main issues are with the model chosen by the authors.

      As per the methods section, generation of FAK-KO and -"Rx" NPE cells entailed protracted selection/expansion processes, which may have resulted in inadvertent selection for cellular/molecular properties unrelated to the desired one (loss or gain of FAK expression) and which may have had cascading effects on NPE cells. The authors nonetheless repeatedly claim the parameters they quantify, such as mitochondrial or cytoskeletal properties or metabolic features, to have directly resulted from FAK loss or reintroduction. Examples of such causal inferences are to be found in lines 123, 134/135, 165, 181. Such causal claims are, in my view, unsupported.

      Acute perturbation of FAK expression/activity, genetically or pharmacologically, followed by a rapid assessment of the processes under investigation, would be needed to begin to assess causality, even if acute genetic perturbations may be technically challenging as sufficient gene expression reduction or restoration to physiologically relevant levels may be hard to achieve.

      Response:

      We would like to first comment on the model we used here, which we think will clarify the validity of our approach. The model is a transformed stem cell model of GBM that was published in (Gangoso et al., Cell, 2021) and is now used regularly in the GBM field. As mentioned in the response to Reviewer 1, we have added text (page 4 and 5 in the revised manuscript) and a new supplementary figure (Figure S1D) clarifying that the morphological changes we observed were consistent across multiple FAK -/- clones, showing this was not due to any inter-clonal variability. We also added images showing that the morphological changes were apparent at 48 h after nucleofecting FAK -/- cells with the FAK‑expressing vector specifically (not the empty vector), prior to starting G418 selection to enrich for FAK‑expressing cells (Figure S1C), addressing the worry that clonal variation and selection was the cause of the FAK-dependent phenotypes we observed. We believe that our model provides a type of well controlled, clean genetic cancer cell system of a type that is commonly used in cancer cell biology, allowing us to attribute phenotypes to individual proteins.

      We have also carried out a more acute treatment by using the FAK inhibitor VS4718 to perturb FAK kinase activity and assessed the effects on glycolysis and glutamine oxidation after 48h treatment (Figure S2D, E and F). We found that treating the transformed neural stem cells (parental population) with FAK inhibitor (300nM VS4718) decreases glucose incorporation into glycolysis intermediates and glutamine incorporation into TCA cycle intermediates, consistent with a role for FAK’s kinase activity in maintaining glycolysis and glutamine oxidation.

      The employed pharmacological modulation of ROCK activity is the only approach that, given the presumably acute nature of the treatment, may have allowed the authors to probe the proposed functional links. The methods section of the manuscript does not however comprise details as to the duration of these treatments, which leaves open the possibility of long-term treatment having been carried out (data shown in Figure 5B refers to 72hr treatment).

      __Response: __

      We have added the duration of the treatment to the Methods section and Figure Legends, to clarify that cells were treated with ROCK inhibitors for 24h, before assessing the effects on mictochondria (Figure 4C, D, S4C and D) and glutamine oxidation (Figure 5A, and S5). For metabolic activity by AlamarBlue assay, cells were treated with ROCK inhibitors for 72h (Figure 5B).

      Even in the case of ROCK inhibitor experiments, it is however unclear if and how the effects on cell morphology and adhesion, mitochondrial organization and metabolic activity may be connected to each other and, if at all, to FAK expression.

      Given the above uncertainties due to the nature of the model and experimental approaches, it is hard to assess the reliability and thus the relevance of the findings.

      Response:

      FAK suppresses ROCK activity (as judged by pMLC2 S19, Figure 4A and B). Treating FAK -/- cells with two different ROCK inhibitors restored mesenchymal-like cell morphology, mitochondrial morphology and glutamine oxidation. As mentioned above, to strengthen our evidence for the antagonistic role of FAK in ROCK-MLC2 signalling, we have now introduced an experiment whereby integrin-FAK signalling was disrupted through treatment with a detachment agent (Accutase), and subsequently maintaining the cells in suspension in laminin-free medium. We assessed pMLC2 S19 levels (a measure of ROCK activity) relating this to FAK phosphorylation that is supressed after integrin disengagement. These results were evaluated relative to spread wild type cells growing on laminin where Integrin-FAK signalling was active (Figure S4A and B). We observed an inverse relationship between Integrin-FAK signalling and ROCK-MLC2 activity in keeping with our conclusions (Figure 4A and B).

      Experimental support for the ability of cell-substrate interaction modulation to concomitantly impact cellular metabolism and motility/invasion would be significant both in terms of advancing our understanding of glioma cell biology and of its translational potential, but the evidence being provided is at best compatible with the proposed model.

      Response: We carried out a new experiment to support the ability of cell-substrate interaction modulation to impact metabolism; specifically, we inhibited cell-substrate interactions by plating the cells on Poly-2-hydroxyethyl methacrylate (Poly 2-HEMA)-coated dishes. This suppressed FAK phosphorylation at Y397, as expected, with concomitant reduction in glutamine utilisation in the TCA cycle (Figure S3A, B and C).

      My background/expertise is in developmental and adult neurogenesis, in vivo modelling of gliomagenesis and cell fate control/reprogramming, with a focus on molecular mechanisms of differentiation and quantitative aspects of lineage dynamics; molecular details of the control of cellular metabolism, cell-cell adhesion and cytoskeletal dynamics are not core expertise of mine.

      We appreciate this reviewer’s expertise are not necessarily in the cancer cell biology and genetic intervention aspects of our study. We hope that the explanations we have provided satisfy the reviewer that our conclusions are valid.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      Review of Masalmeh et al.

      Title: "FAK modulates glioblastoma stem cell energetics..."

      Previous studies have implicated FAK and the related tyrosine kinase PYK2 in glioblastoma growth, cell migration, and invasion. Herein, using a murine stem cell model of glioblastoma, the authors used CRISPR to inactivate FAK, FAK-null cells selected and cloned, and lentiviral re-expression of murine FAK in the FAK-null cells (termed FAK Rx) was accomplished. FAK-/- cells were shown to possess epithelial characteristics whereas FAK Rx cells expressed mesenchymal markers and increased cell migration/invasion in vitro. Comparisons between FAK-/- and FAK Rx cells showed that FAK re-expressed increased mitochondrial respiration and amino acid uptake. This was associated with FAK Rx cells exhibiting filamentous mitochondrial morphology (potentially an OXPHOS phenotype) and decreased levels of MTFR1L S235 phosphorylation (implicated in mito morphology fragmentation). Mito and epithelial cell morphology of FAK-/- cells was reversed by treatment with Rho-kinase inhibitors that also increased mito metabolism and cell viability. Last, FAK-dependent glioblastoma tumor growth was shown by comparisons of FAK-/- and FAK Rx implantation studies.

      The studies by Masalmeh provide interesting findings associating FAK expression with changes in mitochondrial morphology, energy metabolism, and glutamate uptake. According to the authors model, FAK expression is supporting a glioblastoma stem cell like phenotype in vitro and tumor growth in vivo. What remains unclear is the mechanistic connection to cell changes and whether or not these are be dependent on intrinsic FAK activity or as the Frame group has previously published, potentially FAK nuclear localization. The associations with MTFR1L phosphorylation and effects by Rho kinase inhibition are likely indirect and remind this reviewer of long-ago studies with FAK-null fibroblasts that exhibit epithelial characteristics, still express PYK2, exhibited elevated RhoA GTPase activity. Some of these phenotypes were linked to changes in RhoGEF and RhoGAP signaling with FAK and/or Pyk2. At a minimum, it would be informative to know whether Pyk2 signaling is relevant for observed phenotypes and whether the authors can further support their associations with FAK-targeted or FAK-Pyk2-targeted inhibitors or PROTACs.

      Some questions that would enhance potential impact.

      1. Cell generation. Please describe the analysis of FAK-/- clones in more detail. The "low viability" phenotype needs further explanation with regard to clonal expansion and growth characteristics?
      2. Figure 1F: need further support of MET change upon FAK KO and EMT reversion.
      3. Fig. 2: Need further support if FAK effects impact glycolysis or oxidative phosphorylation in particular as implicated by the stem cell model.
      4. Is there a combinatorial potential between FAKi and chemotherapies used for glioblastoma. Need to build upon past studies.
      5. The notation of changes in glucose transporter expression should be followed up with regard to the potential that FAK-expressing cells may have different uptake of carbon sources and other amino acids. Altered uptake could be one potential explanation for increase glycolysis and glutamine flux.
      6. It would be helpful to support the confocal microscopy of mitos with EM.
      7. Lack of FAK expression with increased MTFR1 phosphorylation is difficult to interpret.
      8. Need to have better support between loss of FAK and the increase in Rho signaling. Use of Rho kinase inhibitors is very limited and the context to FAK (and or Pyk2) remains unclear. Past studies have linked integrin adhesion to ECM as a linkage between FAK activation and the transient inhibition of RhoA GTP binding. Is integrin signaling and FAK involved in the cell and metabolism phenotypes in this new model?

      Significance

      The studies by Masalmeh provide interesting findings associating FAK expression with changes in mitochondrial morphology, energy metabolism, and glutamate uptake. According to the authors model, FAK expression is supporting a glioblastoma stem cell like phenotype in vitro and tumor growth in vivo. What remains unclear is the mechanistic connection to cell changes and whether or not these are be dependent on intrinsic FAK activity or as the Frame group has previously published, potentially FAK nuclear localization. The associations with MTFR1L phosphorylation and effects by Rho kinase inhibition are likely indirect and remind this reviewer of long-ago studies with FAK-null fibroblasts that exhibit epithelial characteristics, still express PYK2, exhibited elevated RhoA GTPase activity. Some of these phenotypes were linked to changes in RhoGEF and RhoGAP signaling with FAK and/or Pyk2. At a minimum, it would be informative to know whether Pyk2 signaling is relevant for observed phenotypes and whether the authors can further support their associations with FAK-targeted or FAK-Pyk2-targeted inhibitors or PROTACs.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review): 

      In this study, Ma et al. aimed to determine previously uncharacterized contributions of tissue autofluorescence, detector afterpulse, and background noise on fluorescence lifetime measurement interpretations. They introduce a computational framework they named "Fluorescence Lifetime Simulation for Biological Applications (FLiSimBA)" to model experimental limitations in Fluorescence Lifetime Imaging Microscopy (FLIM) and determine parameters for achieving multiplexed imaging of dynamic biosensors using lifetime and intensity. By quantitatively defining sensor photon effects on signal-to-noise in either fitting or averaging methods of determining lifetime, the authors contradict any claims of FLIM sensor expression insensitivity to fluorescence lifetime and highlight how these artifacts occur differently depending on the analysis method. Finally, the authors quantify how statistically meaningful experiments using multiplexed imaging could be achieved. 

      A major strength of the study is the effort to present results in a clear and understandable way given that most researchers do not think about these factors on a day-to-day basis. The model code is available and written in Matlab, which should make it readily accessible, although a version in other common languages such as Python might help with dissemination in the community. One potential weakness is that the model uses parameters that are determined in a

      specific way by the authors, and it is not clear how vastly other biological tissue and microscope setups may differ from the values used by the authors. 

      Overall, the authors achieved their aims of demonstrating how common factors

      (autofluorescence, background, and sensor expression) will affect lifetime measurements and they present a clear strategy for understanding how sensor expression may confound results if not properly considered. This work should bring to awareness an issue that new users of lifetime biosensors may not be aware of and that experts, while aware, have not quantitatively determined the conditions where these issues arise. This work will also point to future directions for improving experiments using fluorescence lifetime biosensors and the development of new sensors with more favorable properties. 

      We appreciate the comments and helpful suggestions. We now also include FLiSimBA simulation code in Python in addition to Matlab to make it more accessible to the community.

      One advantage of FLiSimBA is that the simulation package is flexible and adaptable, allowing users to input parameters based on the specific sensors, hardware, and autofluorescence measurements for their biological and optical systems. We used parameters based on a FRETbased sensor, measured autofluorescence from mouse tissue, and measured dark count/after pulse of our specific GaAsP PMT in this manuscript as examples. In Discussion and Materials and methods, we now emphasize this advantage and further clarify how these parameters can be adapted to diverse tissues, imaging systems, and sensors based on individual experiments. We further explain that these input parameters will not affect the conclusions of our study, but the specific input parameters would alter the quantitative thresholds.

      Reviewer #2 (Public review): 

      Summary: 

      By using simulations of common signal artefacts introduced by acquisition hardware and the sample itself, the authors are able to demonstrate methods to estimate their influence on the estimated lifetime, and lifetime proportions, when using signal fitting for fluorescence lifetime imaging. 

      Strengths: 

      They consider a range of effects such as after-pulsing and background signal, and present a range of situations that are relevant to many experimental situations. 

      Weaknesses: 

      A weakness is that they do not present enough detail on the fitting method that they used to estimate lifetimes and proportions. The method used will influence the results significantly. They seem to only use the "empirical lifetime" which is not a state of the art algorithm. The method used to deconvolve two multiplexed exponential signals is not given. 

      We appreciate the comments and constructive feedback. Our revision based on the reviewer’s suggestions has made our manuscript clearer and more user friendly. We originally described the detail of the fitting methods in Materials and methods. Given the importance of these methodological details for evaluating the conclusions of this study, we have moved the description of the fitting method from Materials and methods to Results. In addition, we provide further clarification and more details of the rationale of using these different methods of lifetime estimates in Discussion to aid users in choosing the best metric for evaluating fluorescence lifetime data.

      More specifically, we modified our writing to highlight the following.

      (1) In Results, we describe that lifetime histograms were fitted to Equation 3 with the GaussNewton nonlinear least-square fitting algorithm and the fitted P<sub1</sub> was used as lifetime estimation.

      (2) In Results, we clarify that our simulation of multiplexed imaging was modeled with two sensors, each displaying a single exponential decay, but the two sensors have different decay constants. We also describe that Equation 3 with the Gauss-Newton nonlinear least-square fitting algorithm was used to deconvolve the two multiplexed exponential signals (Fig. 8)

      Reviewer #3 (Public review): 

      Summary: 

      This study presents a useful computational tool, termed FLiSimBA. The MATLAB-based FLiSimBA simulations allow users to examine the effects of various noise factors (such as autofluorescence, afterpulse of the photomultiplier tube detector, and other background signals) and varying sensor expression levels. Under the conditions explored, the simulations unveiled how these factors affect the observed lifetime measurements, thereby providing useful guidelines for experimental designs. Further simulations with two distinct fluorophores uncovered conditions in which two different lifetime signals could be distinguished, indicating multiplexed dynamic imaging may be possible. 

      Strengths: 

      The simulations and their analyses were done systematically and rigorously. FliSimba can be useful for guiding and validating fluorescence lifetime imaging studies. The simulations could define useful parameters such as the minimum number of photons required to detect a specific lifetime, how sensor protein expression level may affect the lifetime data, the conditions under which the lifetime would be insensitive to the sensor expression levels, and whether certain multiplexing could be feasible. 

      Weaknesses: 

      The analyses have relied on a key premise that the fluorescence lifetime in the system can be described as two-component discrete exponential decay. This means that the experimenter should ensure that this is the right model for their fluorophores a priori and should keep in mind that the fluorescence lifetime of the fluorophores may not be perfectly described by a twocomponent discrete exponential (for which alternative algorithms have been implemented: e.g., Steinbach, P. J. Anal. Biochem. 427, 102-105, (2012)). In this regard, I also couldn't find how good the fits were for each simulation and experimental data to the given fitting equation (Equation 2, for example, for Figure 2C data). 

      We thank the reviewer for the constructive feedback. We agree that the FLiSimBA users should ensure that the right decay equations are used to describe the fluorescent sensors. In this study, we used a FRET-based PKA sensor FLIM-AKAR to provide proof-of-principle demonstration of the capability of FLiSimBA. The donor fluorophore of FLIM-AKAR, truncated monomeric enhanced GFP, displays a single exponential decay. FLIM-AKAR, a FRET-based sensor, displays a double exponential decay. The time constants of the two exponential components were determined and reported previously (Chen, et al, Neuron (2017)).  Thus, a double exponential decay equation with known τ<sub>1</sub> and τ<sub>2</sub> was used for both simulation and fitting. The goodness of fit is now provided in Supplementary Fig. 1 for both simulated and experimental data. In addition to referencing our prior study characterizing the double exponential decay model of FLIM-AKAR in Materials and methods, we have emphasized in Discussion the versality of FLiSimBA to adapt to different sensors, tissues, and analysis methods, and the importance of using the right mathematical models to describe the fluorescence decay of specific sensors. 

      Also, in Figure 2C, the 'sensor only' simulation without accounting for autofluorescence (as seen in Sensor + autoF) or afterpulse and background fluorescence (as seen in Final simulated data) seems to recapitulate the experimental data reasonably well. So, at least in this particular case where experimental data is limited by its broad spread with limited data points, being able to incorporate the additional noise factors into the simulation tool didn't seem to matter too much.  

      In the original Fig 2C, the sensor fluorescence was much higher than the contributions from autofluorescence, afterpulse, and background signals, resulting in minimal effects of these other factors, as the reviewer noted. This original figure was based on photon counts from single neurons expressing FLIM-AKAR. For the rest of the manuscript, photon counts were based on whole fields of view (FOV). Since the FOV includes cells that do not express fluorescent sensors, the influence of autofluorescence, dark currents, and background is much more pronounced, as shown in Fig. 2B. 

      Both approaches – using photon counts from the whole FOV or from individual neurons – have their justifications. Photon counts from the whole FOV simulate data from fluorescence lifetime photometry (FLiP), whereas photon counts from individual neurons simulate data from fluorescence lifetime imaging microscopy (FLIM). However, the choice of approach does not affect the conclusions of the manuscript, as a range of photon count values are simulated. To maintain consistency throughout the manuscript, we have revised the photon counts in this figure (now Supplementary Fig. 1C) to match those from the whole FOV.

      Additionally, we have made some modifications in our analyses of Supplementary Fig. 1C and Fig. 2B, detailed in the “FLIM analysis” section of Materials and methods. For instance, to minimize system artifact interference at the histogram edges, we now use a narrower time range (1.8 to 11.5 ns) for fitting and empirical lifetime calculation.

      Reviewer #1 (Recommendations for the authors): 

      (1) The authors report how autofluorescence was measured from "imaged brain slices from mice at postnatal 15 to 19 days of age without sensor expression." However, it remains unclear how many acute slices and animals were used (for example, were all 15um x 15um FOV from a single slice) and if mouse age affects autofluorescence quantification. Furthermore, would in vivo measurements have different autofluorescence conditions given that blood flow would be active? It would help if the authors more clearly explained how reliable their autofluorescence measurement is by clarifying how they obtained it, whether this would vary across brain areas, and whether in vitro vs in vivo conditions would affect autofluorescence. 

      We have added description in Materials and methods that for autofluorescence ‘Fluorescence decay histograms from 19 images of two brain slices from a single mouse were averaged.’ We have added in Discussion that users should carefully ‘measure autofluorescence that matches the age, brain region, and data collection conditions (e.g., ex vivo or in vivo) of their tissue…’, and emphasize that FLiSimBA offers customization of inputs, and it is important for users to adapt the inputs such as autofluorescence to their experimental conditions. We also clarify in Discussion that the change of input parameters such as autofluorescence across age and brain region would not affect the general insights from this study, but will affect quantitative values.

      (2) Does sensor expression level issues arise more with in-utero electroporation compared to AAV-based delivery of biosensors? A brief comment on this in the discussion may help as most users in the field today may be using AAV strategies to deliver biosensors.

      In our experience, in-utero electroporation results in higher sensor expression than AAV-based delivery, and so pose less concern for expression-level dependence. However, both delivery methods can result in expression level dependence, especially with a sensor that is not bright. We have added in Discussion ‘For a sensor with medium brightness delivered via in utero electroporation, adeno-associated virus, or as a knock-in gene, the brightness may not always fall within the expression level-independent regime.’

      (3) Figure 1. Should the x-axis on the top figures be "Time (ns)" instead of "Lifetime (ns)"?

      Similarly in Figure 8A&B, wouldn't it make more sense to have the x-axis be Time not Lifetime?

      The x-axis labels in Fig. 1 and Fig. 8A-8B have been changed to ‘Time (ns)’.   

      (4) Figure 2b: why is the empirical lifetime close to 3.5ns? Shouldn't it be somewhere between

      2.14 and 0.69? 

      In our empirical lifetime calculation, we did not set the peak channel to have a time of 0.0488 ns (i.e. the laser cycle 12.5 ns divided by 256 time channels). Rather, we set the first time channel within a defined calculation range (i.e. 1.8 ns in Supplementary Fig. 1B) to have a time of 0.0488 ns (i.e.). Thus, the empirical lifetime exceeds 2.14 ns and depends on the time range of the histogram used for calculation. 

      For Fig. 2B and Supplementary Fig. 1C, we have now adjusted the range to 1.8-11.5 ns to eliminate FLIM artifacts at the histogram edges in our experimental data, resulting in an empirical lifetime around 2.255 ns. In contrast, the range for calculating the empirical lifetime of simulated data in the rest of the study (e.g. Fig. 4D) is 0.489-11.5 ns, yielding a larger lifetime of ~3.35 ns. 

      We have clarified these details and our rationale in Materials and methods.

      (5) Figure 2b: how come the afterpulse+background contributes more to the empirical lifetime than the autofluorescence (shorter lifetime). This was unclear in the results text why autofluorescence photons did not alter empirical lifetime as much as did the afterpulse/background.

      With a histogram range from 1.8 ns to 11.5 ns used in Fig. 2B, the empirical lifetime for FLIM-AKAR sensor fluorescence, autofluorescence, and background/afterpulse are: 2-2.3 ns, around 1.69 ns, and around 4.90 ns. The larger difference of background/afterpulse from FLIM-AKAR sensor fluorescence leads to larger influence of afterpulse+background than autofluorescence. We have added an explanation of this in Results.

      (6) One overall suggestion for an improvement that could help active users of lifetime biosensors understand the consequences would be to show either a real or simulated example of a "typical experiment" conducted using FLIM-AKAR and how an incorrect interpretation could be drawn as a consequence of these artifacts. For example, do these confounds affect experiments involving comparisons across animals more than within-subject experiments such as washing a drug onto the brain slice, and the baseline period is used to normalize the change in signal? I think this type of direct discussion will help biosensor users more deeply grasp how these factors play out in common experiments being conducted.

      We have added the following in Discussion, ‘…While this issue is less problematic when the same sample is compared over short periods (e.g. minutes), It can lead to misinterpretation when fluorescence lifetime is compared across prolonged periods or between samples when comparison is made across chronic time periods or between samples with different sensor expression levels. For example, apparent changes in fluorescence lifetime observed over days, across cell types, or subcellular compartments may actually reflect variations in sensor expression levels rather than true differences in biological signals (Fig. 6), Therefore, considering biologically realistic factors in FLiSimBA is essential, as it qualitatively impacts the conclusions.’

      Reviewer #2 (Recommendations for the authors): 

      The paper would be improved with more detail on the fitting methods, and the use of state-of-theart methods. Consult for example the introduction of this paper where many methods are listed: https://www.mdpi.com/1424-8220/22/19/7293

      We have moved the description of the Gauss-Newton nonlinear least-square fitting algorithm from Materials and methods to Results to enhance clarity. We appreciate the reviewer’s suggestion to combine FLiSimBA with various analysis methods. However, the primary focus of our manuscript is to call for attention of how specific contributing factors in biological experiments influence FLIM data, and to provide a tool that rigorously considers these factors to simulate FLIM data, which can then be used for fitting. Therefore, we did not expand the scope of our manuscript. Instead, we have added in the Discussion that ‘‘FLiSimBA can be used to test multiple fitting methods and lifetime metrics as an exciting future direction for identifying the best analysis method for specific experimental conditions’, citing relevant references.

      I would also improve the content of the GitHub repository as it is very hard to identify to source code used for simulation and fitting. 

      We have reorganized and relabeled our GitHub repository and now have three folders labeled as ‘Simulation_inMatlab’, ‘DataAnalysis_inMatlab’, and ‘SimulationAnalysis_inPython’. We also updated the clarification of the contents of each folder in the README file.

      Reviewer #3 (Recommendations for the authors): 

      (1) P. 10 "For example, to detect a P1 change of 0.006 or a lifetime change of 5 ps with one sample measurement in each comparison group, approximately 300,000 photons are needed." If I am reading the graphs in Figures 3B and C, this sentence is talking about the red line. However, the intersection of 0.006 in the MDD of P1 in 3B and red is not 3E5 photons. And the intersection of 0.005 ns and red in 3C is not 3E5 photons either. Are you sure you are talking about n=1? Maybe the values are correct for the blue curve with n=5.

      Thank you for catching our error. We have corrected the text to ‘with five sample measurements’.

      (2) Figure 2 (B) legend: It would be helpful to specify what is being compared in the legend. For example, consider revising "* p < 0.05 vs sensor only; n.s. not significant vs sensor + autoF; # p < 0.05 vs sensor + autoF. Two-way ANOVA with Šídák's multiple comparisons test" to "* p <0.05 for sensor + auto F (cyan) vs sensor only; n.s. not significant for final simulated data (purple) vs sensor + autoF; # p < 0.05 for final simulated data (purple) vs sensor + autoF. Twoway ANOVA with Šídák's multiple comparisons test".

      We’ve made the change and thanks for the suggestion to make it clearer.

      (3) Figure 2 (c) Can you please show the same Two-way ANOVA test values for Experimental vs. Sensor only and for Experimental vs. Sensor + autoF? Currently, the value (n.s.) is marked only for Experimental vs. Final simulation. Given that the experimental data are sparse (compared to the simulations), it seems likely that there may be no significant difference among the 3 different simulations regarding how well they match the experimental data. Also, can you specify the P1 and P2 of the experimental data  used to generate the simulated data on this panel? Also, what is the reason why P1=0.5 was used for panels A and B, instead of the value matching the experimental value?

      As the reviewer suggested, we have included statistical tests in the figure (now Supplementary Fig. 1C). Please see our response to the Public Review of Reviewer 3’s comments as well as our changes in Materials and Methods on other changes and their rationale for this figure. We have now specified the P<sub>1</sub> value of the experimental data used to generate the simulated data on this panel both in Figure Legends and Materials and Methods. Based on the suggestion, we have now used the same P<sub>1</sub> value in Fig. 2B.

    1. Based on Figure 9.3.29.3.2\PageIndex{2}, we see that the hypotenuse equals 555, so sinθ=35sin⁡θ=35\sin θ=35, sin θ=35sin θ=35\sin θ=35, and cosθ=−45cos⁡θ=−45\cos θ=−45.

      I believe there is a divisor missing therefore based on the triangle sin(x) = 3/5 opposite over hypotenuse and cos(x) = -4/5 adjacent over hypotenuse

    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      Summary

      The study by Araoyinbo et al. explores the role of the RNA-binding protein Mei2 in fission yeast zygotic development. It highlights Mei2's cytosolic functions, its interaction with P-bodies, and nucleocytoplasmic shuttling. Mei2's regulation by Mei3 and Pat1, and the importance of its RNA recognition motifs (RRM1 and RRM3) are also discussed.

      The main conclusion of the manuscript is somewhat unexpected from previous studies about Mei2. Particularly, the cytoplasmic function of Mei2 is a novel point in this field.

      Lots of experiments have been done to make the scenario of the manuscript. The experiments and results are technically sound, and I potentially agree with the interpretation by the authors. It would require some more explanation as well as additional experiments to conclude in the way the authors wish to do.

      Major points

      1. Page 4. "Taken together, these results show that fertilization, and Mei3 expression in particular, promote Mei2 nuclear export." It is also possible that Mei2-NLS-GFP was degraded somewhere in the cell (as Mei2 may be still shuttling even if NLS was fused) upon mating (120 min onwards in Fig2D) rather than exported to the cytoplasm. In mei3∆ (Fig 2E) Mei2-NLS-GFP might be somehow escaped from the degradation. Also, nuclear signal of Mei2 is very bright but cytosolic signal seems vague. I wonder the entire results in the manuscript could be interpreted from the viewpoint of degradation/protein stability/protein amount, rather than regulation of localization such as nuclear import and export.
      2. Page 4. "We conclude that RRM1 promotes nuclear import of Mei2." This may be true, but is it also possible that RRM1 inhibits nuclear export of Mei2? This type of possible dual explanation can be applied to the entire manuscript. This is expected to be neutralized or clarified at each point.
      3. Page 5. "Thus, diminishing nuclear Pat1 levels does not compromise its roles during growth and mating." It is interesting for me to find that Pat1-NLS induced ectopic meiosis. This is a fine finding. I wonder just addition of NLS (basic residues) at the C-terminus of Pat1 might deteriorate the activity of Pat1, apart from localization shift. Is it possible to exclude this possibility by making NES-Pat1-NLS-3GFP fusion, in which NLS and NES are fused doubly and distally, because proximal double fusion such as Pat1-NLS-NES-3GFP might just mutually cancel the NLS NES activities.
      4. In general in the Results section. What confused me is when each event occurred. Nutritional conditions, -N but not yet conjugated, after conjugation, premeiotic S or meiotic prophase (or even later). It is particularly hard to catch the story when the timing issue and the location issue (nuclear and cytosolic localization, NLS and NES...) are discussed at the same time. Explanation in chronological order, hopefully at the earlier stages such as explanation for Figures 2 and 3, would be appreciated. The model shown in Figure 8 is quite helpful for my understanding.

      Minor points

      1. "Fertilization" in the title, and "Mei2 is expressed in gametes" in the main text on pare 2. Authors try to generalize fission yeast mating as fertilization of higher organisms as both are events in which two haploids conjugate. I personally do not agree with this type of explanation. This is mainly because S. pombe conjugation (mating) is a part of sexual differentiation and therefore is biologically distinct from fertilization of higher organisms. S. pombe grows and divides in the haploid state, which is distinct from general gametes. To avoid such confusion, I would propose authors to neutralize expression throughout the manuscript.
      2. I found quite a few "surprising(ly)", which are hopefully neutralized, as it is somewhat emotional.

      Significance

      General assessment: strengths and limitations:

      Strengths: It provides novel understanding of molecular mechanisms of meiotic initiation of fission yeast. Technically sound. Lots of experiments. Limitations: The story is very confusing and difficult to catch. Explanation can be simplified.

      Advance: compare the study to existing published knowledge: does it fill a gap? What kind of advance does it make (conceptual, clinical, fundamental, methodological, incremental,,,,)? It is a big advancement. It is conceptually novel regarding how meiosis is initiated in fission yeast.

      Audience: which communities will be interested/influenced, what kind of audience (broad, specialized, clinical, basic research, applied science, fields and subfields,,,) It is mainly for audience of basic research, biology, molecular mechanism of gene explanation, meiosis or yeast cellular events. For non-yeast researchers, this manuscript is probably very hard to read/understand, although the authors tried to generalize yeast-specific events with general words.

      Describe your expertise:

      Yeast genetics, Meiosis, Cell biology, Gene expression regulation

    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Summary

      This manuscript presents a large-scale comparative genomics analysis of Salmonella genomes to identify and characterize the repertoire of Type VI Secretion System (T6SS) effectors. The authors combine bioinformatic predictions with experimental validation of one novel toxin domain (Tox-Act1), revealing a unique catalytic activity not previously reported in bacterial toxins. While the study is comprehensive and offers valuable insights into T6SS diversity, the insufficient description of computational methods and limited accessibility of underlying data reduce reproducibility and impact.

      Major comments

      1. The computational methods are inadequately described in the Materials and Methods section, and the authors did not provide the underlying datasets. These omissions make it impossible to reproduce the analysis or to apply the approach to other organisms.
      2. The criteria used to distinguish between T6SS effectors and non-effectors are unclear. The reliance on proximity to structural genes ("guilt-by-association") is insufficient and may have led to the omission of cargo effectors not proximal to these structural genes.
      3. No information is provided in the Materials and Methods section about the graph-based clustering strategy mentioned in the main text (Rows 109-111), including the Jaccard index and Louvain algorithm.
      4. The definition and identification of T6SS subtypes, including the use of the term "orphan," are not explained (Rows 111-112).
      5. The phylogenetic analysis of the newly identified domain Tox-Act1 lacks consistency and detail. For example, Rows 324-326 state: "To predict the function of Tox-Act1, we sought to understand its evolutionary relationship by constructing a phylogenetic tree using the sequences of Tox-Act1, TseH and additional permuted members, such as LRAT and YiiX." However, this contradicts Rows 342-344 and Figure 4A, which describe the phylogenetic tree as being built from permuted NlpC/P60 members, and indicate that a single query was used for PSI-BLAST, marked with a red star. It is unclear whether Tox-Act1, TseH, or another sequence was used as the initial PSI-BLAST query.
      6. The Tox-Act1 domain investigated is labeled as an acyltransferase, but the evidence presented supports only phospholipid-degrading activity. In my opinion, the naming should better reflect the activity demonstrated by the data.
      7. Table S1 should include representative protein accessions for each T6SS toxin domain. This is essential for evaluating the novelty of the identified domains and for enabling their use in future analyses. The repeated use of "This study" (96 times) as a reference, without further detail, is confusing and unhelpful. In my view, referencing the current study is appropriate only when the manuscript provides sufficient information on the corresponding domain.
      8. In general, the authors should place greater emphasis on ensuring that the proteins and genomes analyzed in this study can be reliably identified. Genomic accessions and locus tags should be traceable in public databases such as NCBI, and the supplemental information must correspond accurately to the main text. For example, I was unable to find information on FD01543424_00914, which was used as the query for the alignment of STox_15 (the name used in the supplemental information, while in the main text it is referred to as Tox-Act1; see related comment below).
      9. A supplementary table listing all Salmonella effectors and their domain annotations is missing. This is essential for transparency, reproducibility, and future use of the data.
      10. The GitHub repository contains a large volume of data and code but lacks detailed documentation and clear instructions, including example files. This greatly limits reproducibility and usability. The current organization of the repository makes it difficult to locate specific results; for example, Tox-Act1 is referred to as STox_15 in the GitHub files, but this is not mentioned in the manuscript. The authors should improve data organization and provide a README file for clarity.

      Minor comments

      1. The introduction should discuss previous work on Salmonella T6SS effectors, including Blondel et al. (2023) (ref 71 in the manuscript), Amaya et al. (2022), and Amaya et al. (2024).
      2. In Figure 1C, genomic examples should include strain names and locus tags.
      3. In Figure 1F, 'ND' should be replaced with 'Unknown' or 'Not Determined'.
      4. Figure 1E is overly complex and, in my opinion, does not add value, especially since the accompanying text is sufficient on its own. Moreover, the authors acknowledge that their initial analysis missed the similarity between Tox-Act1 and both DUF4105 and the TseH effector, which raises concerns about the accuracy and usefulness of this graph.
      5. Figure 3D lacks information about the number of replicates (n=?).
      6. Discrepancies in domain annotations:
        • Row 232: STox_47 is missing from Table S1.
        • Row 233: STox_18 is pore-forming and STox_53 is a nuclease (per Table S1), which contradicts the main text.
      7. Multiple grammatical and typographical errors exist throughout the text, including:
        • Row 41: "provide" should be "provides"
        • Rows 131, 222: "immunities" should be "immunity proteins"
        • Rows 170, 253, 288: "thee" should be "three"
        • Row 388: "corresponds" should be "correspond"
        • Row 389: "chomatogram" should be "chromatogram"
      8. Rows 257-259: The claim that PAAR and RHS domains assist in translocation across the bacterial inner membrane is presented as fact, but this is only a hypothesis and should be stated more cautiously.
      9. Figure 3A: The selection of representative genomic loci is unclear. For example, FD01843896 is shown in the figure, but cloning was performed using FD01848827, and the HHPred analysis was based on FD01543424. The rationale for using different sequences at each step should be clarified.
      10. Rows 296-299: The absence of a secretion assay in the study is notable. If this is due to the inability to activate the SPI-6 T6SS of Salmonella enterica serovar Typhimurium, as discussed in these lines, it should be explicitly mentioned in the text.
      11. Figure 4C (sequence logo) is not described in the Materials and Methods section.
      12. Row 467: The retrieval date of the gff files from the 10KSG database is missing.
      13. Rows 474-476: The domain models used for T6SS cluster prediction are not described.

      Significance

      This is a comprehensive study involving a large number of Salmonella genomes, potentially identifying many new T6SS effectors and toxic activities. One new domain analyzed in this work is experimentally investigated and shown to have a unique catalytic activity not previously observed in toxins. However, the bioinformatic methods are not described in sufficient detail, making it difficult to assess or reproduce the work. Protein accession numbers are missing, even for representative toxins, and locus tags are not traceable, making the identified effectors not readily accessible. There are many inaccuracies throughout the text and supplemental data. The Tox-Act1 domain investigated is labeled as an acyltransferase, but the evidence only supports phospholipid-degrading activity. While the study includes many graphs and histograms, they often obscure the main findings. Consequently, the audience is likely to be limited.

      Nevertheless, despite these concerns, I believe this is an important work that could be valuable to the broad community once a more thorough revision is undertaken, not only by addressing the specific comments raised, but also by rechecking the analyses, reorganizing the presentation, and ensuring that all data and annotations are clearly accessible and traceable.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      Summary:

      The manuscript titled "Genome-directed study reveals the diversity of Salmonella T6SS effectors and identifies a novel family of lipid-targeting antibacterial toxins" presents a comprehensive in silico analysis of T6SS-associated effector and immunity genes across approximately 10,000 Salmonella genomes. In addition, the authors selected one of the newly identified effectors, Tox-Act1, for detailed biochemical characterization. To my knowledge, this study represents the most extensive genome-wide mining effort to date for T6SS-associated effectors and immunity proteins in Salmonella, employing a range of state-of-the-art computational prediction tools. The in vitro enzymatic characterization of Tox-Act1 further validates the in silico approach and adds a novel functional perspective to the dataset. Overall, the study provides a rich and comprehensive dataset. However, for readers without a strong bioinformatics background, the logic and workflow of the in silico prediction pipeline may be challenging to follow. Consequently, my comments focus primarily on the biochemical analysis of Tox-Act1, rather than the computational aspects of the study.

      Major comments:

      1. In Figure 3, the authors first demonstrated that Tox-Act1 and Imm-Act1 constitute a functional antibacterial toxin-immunity pair using a heterologous E. coli expression system. They then proceeded to an in vivo mouse colonization model, showing that prey cells lacking the tox-act1/imm-act1 locus exhibited reduced competitiveness when co-infected with a Salmonella strain carrying the endogenous tox-act1, compared to a ∆tssL mutant. As this is the first report identifying and characterizing Tox-Act1 function in Salmonella, the authors should provide additional experimental evidence addressing the following key points: (i) Whether Tox-Act1 is secreted by Salmonella in a T6SS-dependent manner; (ii) Whether target cells lacking imm-act1 (in either Salmonella or E. coli) can be intoxicated by Salmonella secreting Tox-Act1; (iii) Whether the observed competitive advantage in vitro conferred by Tox-Act1 is dependent on its phospholipase activity. Given that Salmonella T6SS can be activated by hns deletion, such experiments should be feasible and are crucial for the functional validation of any newly identified T6SS effector. Addressing these points would substantially strengthen the mechanistic basis of the study and reinforce the biological importance and relevance of Tox-Act1.
      2. In Figure 4, the authors present the evolutionary relationship between Tox-Act1 and the previously identified T6SS effector TseH from Vibrio, and they propose that these two effectors may share similar enzymatic activities and overlapping cellular targets. Given the ongoing debate and unresolved questions regarding the biochemical function of TseH, the authors should leverage their established in vitro phospholipase assay to test whether TseH exhibits phospholipase activity similar to that of Tox-Act1. Demonstrating such activity would not only substantiate the proposed functional conservation but also provide critical biochemical insight into a long-standing question in the T6SS field.
      3. In Figures 5C and 5D, the authors performed lipidomic analyses on E. coli cells heterologously expressing Tox-Act1 and reported that specific phospholipid species are altered in a manner dependent on Tox-Act1's phospholipase activity. However, the data presented in Figure 5D only include changes in the abundance of PG, FFA, LPG, and LPE. To provide a comprehensive overview of the lipidomic alterations, the authors should present the full dataset of all identified phospholipid species. This is essential to evaluate the extent and specificity of lipid remodeling induced by Tox-Act1. It is currently unclear whether the observed reduction in PG is the only statistically significant change or if additional lipid species were similarly affected but not shown. Furthermore, the authors claim that Tox-Act1 functions as a phospholipase A1. However, in Figures 5A and 5B, the signal corresponding to intact phospholipids remains relatively high, raising concerns about the apparent weak enzymatic activity in this assay. This observation contrasts with previously characterized phospholipase toxins in the antibacterial toxin field, such as Tle1 from Burkholderia, which exhibit robust activity under in vitro conditions. To substantiate the enzymatic potency of Tox-Act1 and clarify this discrepancy, the authors should include a side-by-side comparison using the same in vitro assay with a well-established phospholipase toxin (e.g., Tle1) as a positive control. This would allow for a direct evaluation of the relative enzymatic strength of Tox-Act1 and support the interpretation of its lipid-targeting function.

      Minor Comments:

      1. Line 32: Please specify "Type VI Secretion System (T6SS)" when first introducing the term in the abstract, to ensure clarity for a broad readership.
      2. There are inconsistencies between the numerical values reported in the main text and those shown in the figures. For instance, the manuscript repeatedly states that approximately 10,000 Salmonella genomes were analyzed in the in silico search, whereas Figure 1 indicates a total of 10,419 genomes. Similarly, Line 108 mentions 42,560 genomic sites, yet Figure 1 displays a count of 49,080. Please ensure that all numerical data are consistent across the manuscript and figures to avoid confusion or misinterpretation.
      3. The definition of "Orphan clusters" is not provided. Please specify the criteria used to define these clusters and clarify the rationale for grouping them separately from the other clusters (i1-i4) shown in Figure 1A. It would be helpful to explicitly state how they differ from the canonical clusters.
      4. Lines 114-119: The sentence structure in this section is overly long and difficult to follow. Please revise this portion for clarity and conciseness to ensure that the intended message is clearly conveyed.
      5. The color coding in Figure 1C is incomplete; only a few categories are indicated in the legend. Please revise the legend to include all color codes used in the figure for accurate interpretation.
      6. Lines 278-280: The authors state that "cells lysed without losing their rod shape, which suggests that the peptidoglycan was not affected... indicating that this is not the target of Tox-Act1." Please provide appropriate references or supporting evidence for this interpretation. Clarification is needed to explain the morphological criteria being used to infer peptidoglycan integrity.
      7. Please define "competitive index" in the legend of Figure 3D to ensure the metric is clearly understood by readers unfamiliar with the term.
      8. It is unclear to me why the author use (data not shown) in Line 315. Please provide evidence to support the claim in the paragraph.
      9. In Figure 4D, the authors compare the activity of wild-type and catalytic mutant Tox-Act1, but protein expression levels are not shown. Please include immunoblot or other relevant data to confirm equivalent expression of both constructs, to rule out differential expression as a confounding factor.

      Referee cross-commenting

      I agree with Reviewer #3 that the authors should provide more details on their search for better reproducibility.

      Significance

      This manuscript presents a large-scale in silico analysis of Salmonella T6SS effectors and immunity proteins, accompanied by the biochemical characterization of a novel phospholipase effector, Tox-Act1. The genome-wide dataset is comprehensive, representing the most extensive mining effort of its kind to date. The study is strengthened by in vitro validation of Tox-Act1 activity and its role in interbacterial competition. However, the manuscript would benefit from additional experimental data to confirm key mechanistic aspects, including T6SS-dependent secretion of Tox-Act1, its toxicity toward target cells lacking immunity, and the contribution of phospholipase activity to its antibacterial function. Comparative assays with established T6SS phospholipases (e.g., Tle1) are recommended to clarify enzymatic potency. Further, the authors should apply their phospholipase assay to test TseH activity and resolve long-standing questions in the field. Several areas also require clarification or correction, including inconsistencies in reported genome counts, incomplete figure legends, unclear terminology (e.g., "Orphan clusters"), and missing experimental controls (e.g., protein expression levels, full lipidomic dataset). Minor edits to improve clarity and consistency are also suggested. Overall, the study is significant and of high potential impact but requires additional experimental validation and revisions to improve clarity and completeness.

    1. Reviewer #1 (Public review):

      Summary:

      The authors make a bold claim that a combination of repetitive transcranial magnetic stimulation (intermittent theta burst-iTBS) and transcranial alternating current stimulation (gamma tACS) causes slight improvements in memory in a face/name/profession task.

      Strengths:

      The idea of stimulating the human brain non-invasively is very attractive because, if it worked, it could lead to a host of interesting applications. The current study aims to evaluate one such exciting application.

      Weaknesses:

      (1) The title refers to the "precuneus-hippocampus" network. A clear definition of what is meant by this terminology is lacking. More importantly, mechanistic evidence that the precuneus and the hippocampus are involved in the potential effects of stimulation remains unconvincing.

      (2) The question of the extent to which the stimulation approach and the stimulation parameters used in these experiments causes specific and functionally relevant neural effects remains open. Invasive recordings that could address this question remain out of the scope of this non-invasive study. The authors conducted scalp EEG experiments in an attempt to address this question using non-invasive methods. However, the results shown in Fig. 3 are unclear. The results are inconsistently reported in units of microvolts squared in some panels (3A, 3B) and in units of microvolts in other panels (3C). Also, there is insufficient consideration of potential contamination by signal components reflecting eye movements, other muscle artifacts, or another volume-conducted signal reflecting aggregate activity inside the brain.

      (3) Figure 3 indicates "Precuneus oscillatory activity ...", but evidence that the activity presented reflects precuneus activity is lacking. The maps shown at the bottom of Figure 3C suggest that the EEG signals recorded with scalp EEG reflect activity generated across a wide spatial range, with a peak encompassing at least tens of centimeters. Thus, evidence that effects specifically reflect precuneus activity, as the paper's title and text throughout the manuscript suggest, is lacking.

      (4) The paper as currently presented (e.g., Figure 3) also lacks rigorous evidence of relevant oscillatory activity. Prior to filtering EEG signals in a particular frequency band, clear evidence of oscillations in the frequency band of interest should be shown (e.g., demonstration of a clear peak that emerges naturally in the frequency range of interest when spectral analysis is applied to "raw" signals). The authors claim that gamma oscillations change because of the stimulation, but a clear peak in the gamma range prior to stimulation is not apparent in the data as currently presented. Thus, the extent to which spectral measurements during stimulation reflect physiological gamma oscillations remains unclear.

      (5) Concerns remain regarding the rigor of statistical analyses in the revised manuscript (see also point 8 below). Figure 3B shows an undefined statistical test with p<0.05. The statistical test that was used is not explained. Also, a description of how corrections for multiple comparisons were made is missing. Figures 3A and 3C are not accompanied by statistics, making the results difficult to interpret. For Figure 4C, a claim was made based on a significant p-value for one statistical test and a non-significant p-value in another test. This is a common statistical mistake (see Figure 1 and accompanying discussion in Makin and Orban de Xivry (2019) Science Forum: Ten common statistical mistakes to watch out for when writing or reviewing a manuscript. eLife 8:e48175).

      (6) In the second question posed in the original review, I highlighted that it was unclear how such stimulation would produce memory enhancement. The authors replied that, in the absence of mechanisms, there are many other studies that suffer from the same problem. This raises the question of placebo effects. The paper does not sufficiently address or discuss the possibility that any potential stimulation effects may reflect placebo effects.

      (7) The third major concern in the original review was the lack of evidence for a mechanism that is specific to the precuneus. Evidence for specific involvement of the precuneus remains lacking in the revised manuscript. The authors state: "the non-invasive stimulation protocol was applied to an individually identified precuneus for each participant". However, the meaning of this statement is unclear. Specifically, it is unclear how the authors know that they are specifically targeting the precuneus. Without directly recording from the precuneus and directly demonstrating effects, which is outside of the scope of the study, specific involvement of the precuneus seems speculative. Also, it does not seem as though a figure was included in the paper to show how the stimulation protocol specifically targets the precuneus. In their response to the original reviews, the authors state that posterior medial parietal areas are the only regions that show significant differences following the stimulation, but they did not cite a specific figure, or statistics reported in the text, that show this. In any event, posterior medial parietal areas encompass a wide area of the brain, so this would still not provide evidence for an effect specifically involving the precuneus.

      (8) Regarding chance levels, it is unfortunate that the authors cannot quantify what chance levels are in the immediate and delayed recall conditions. This makes interpretation of the results challenging. In the immediate and delayed conditions, the authors state that the chance level is 33%. It would be useful to mark this in the figures. If I understand correctly, chance is 33% in Fig. 2A. If this is the case and if I am interpreting the figure correctly:<br /> Gray bars for the sham condition appear to be below chance (~20-25%). Why is this condition associated with an accuracy level that is lower than chance?<br /> Cyan bars and red bars do not appear to be significantly different from chance (i.e., 33%), with red slightly higher than cyan. What statistic was performed to obtain the level of significance indicated in the figure? The highest average value for the red condition appears to be around 35%. More details are needed to fully explain this figure and to support the claims associated with this figure.

      (9) In the revised version of the paper, the authors did not address concerns associated with the block design (please see question 4d in the original review).

      In sum, this study presents an admirable aspirational goal, the notion that a non-invasive stimulation protocol could modulate activity in specific brain regions to enhance memory. However, the evidence presented at the behavioral level and at the mechanistic level (e.g. the putative involvement of specific brain regions) remains unconvincing.

    2. Reviewer #3 (Public review):

      Summary:

      Borghi and colleagues present results from 4 experiments aimed at investigating the effects of dual <sub>γ</sub>tACS and iTBS stimulation of the precuneus on behavioral and neural markers of memory formation. In their first experiment (n = 20), they find that a 3-minute offline (i.e., prior to task completion) stimulation that combines both techniques leads to superior memory recall performance in an associative memory task immediately after learning associations between pictures of faces, names, and occupation, as well as after a 15-minute delay, compared to iTBS alone (+ tACS sham) or no stimulation (sham for both iTBS and tACS). Performance in a second task probing short-term memory was unaffected by the stimulation condition. In a second experiment (n = 10), they show that these effects persist over 24 hours and up to a full week after initial stimulation. A third (n = 14) and fourth (n = 16) experiment were conducted to investigate neural effects of the stimulation protocol. The authors report that, once again, only combined iTBS and <sub>γ</sub>tACS increases gamma oscillatory activity and neural excitability (as measured by concurrent TMS-EEG) specific to the stimulated area at the precuneus compared to a control region, as well as precuneus-hippocampus functional connectivity (measured by resting state MRI), which seemed to be associated with structural white matter integrity of the bilateral middle longitudinal fasciculus (measured by DTI).

      Strengths:

      Combining non-invasive brain stimulation techniques is a novel, potentially very powerful method to maximize the effects of these kinds of interventions that are usually well-tolerated and thus accepted by patients and healthy participants. It is also very impressive that the stimulation-induced improvements in memory performance resulted from a short (3 min) intervention protocol. If the effects reported here turn out to be as clinically meaningful and generalizable across populations as implied, this approach could represent a promising avenue for treatment of impaired memory functions in many conditions.

      Methodologically, this study is expertly done! I don't see any serious issues with the technical setup in any of the experiments. It is also very commendable that the authors conceptually replicated the behavioral effects of experiment 1 in experiment 2 and then conducted two additional experiments to probe the neural mechanisms associated with these effects. This certainly increases the value of the study and the confidence in the results considerably.

      The authors used a within-subject approach in their experiments, which increases statistical power and allows for stronger inferences about the tested effects. They also used to individualize stimulation locations and intensities, which should further optimize the signal-to-noise ratio.

      Weaknesses:

      I think one of the major weaknesses of this study is the overall low sample size in all of the experiments (between n = 10 and n = 20). This is, as I mentioned when discussing the strengths of the study, partly mitigated by the within-subject design and individualized stimulation parameters. The authors mention that they performed a power analysis but this analysis seemed to be based on electrophysiological readouts similar to those obtained in experiment 3. It is thus unclear whether the other experiments were sufficiently powered to reliably detect the behavioral effects of interest. In the revised manuscript, the authors provide post-hoc sensitivity analyses that help contextualize the strength of the findings.

      While the authors went to great lengths trying to probe the neural changes likely associated with the memory improvement after stimulation, it is impossible from their data to causally relate the findings from experiments 3 and 4 to the behavioral effects in experiments 1 and 2. This is acknowledged by the authors and there are good methodological reasons for why TMS-EEG and fMRI had to be collected in separate experiments, but readers should keep in mind that this limits inferences about how exactly dual iTBS and <sub>γ</sub>tACS of the precuneus modulate learning and memory.

    3. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The authors claim that they can use a combination of repetitive transcranial magnetic stimulation (intermittent theta burst-iTBS) and transcranial alternating current stimulation (gamma tACS) to cause slight improvements in memory in a face/name/profession task.

      Strengths:

      The idea of stimulating the human brain non-invasively is very attractive because, if it worked, it could lead to a host of interesting applications. The current study aims to evaluate one such exciting application.

      Weaknesses:

      (1) It is highly unclear what, if anything, transpires in the brain with non-invasive stimulation. To cite one example of many, a rigorous study in rats and human cadavers, compellingly showed that traditional parameters of transcranial electrical stimulation lead to no change in brain activity due to the attenuation by the soft tissue and skull (Mihály Vöröslakos et al Nature Communications 2018): https://www.nature.com/articles/s41467-018-02928-3. It would be very useful to demonstrate via invasive neurophysiological recordings that the parameters used in the current study do indeed lead to any kind of change in brain activity. Of course, this particular study uses a different non-invasive stimulation protocol.

      Thank you for raising the important issue regarding the actual neurophysiological effects of non-invasive brain stimulation. Unfortunately, invasive neurophysiological recordings in humans for this type of study are not feasible due to ethical constraints, while studies on cadavers or rodents would not fully resolve our question. Indeed, the authors of the cited study (Mihály Vöröslakos et al., Nature Communications, 2018) highlight the impossibility of drawing definitive conclusions about the exact voltage required in the in-vivo human brain due to significant differences between rats and humans, as well as the in-vivo human brain and cadavers due to alterations in electrical conductivity that occur in postmortem tissue. Huang and colleagues addressed the difficulties in reaching direct evidence of non-invasive brain stimulation (NIBS) effects in a review published in Clinical Neurophysiology in 2017. They conclude that the use of EEG to assess brain response to TMS has great potential for a less indirect demonstration of plasticity mechanisms induced by NIBS in humans.

      To address this challenge, we conducted Experiments 3 and 4, which respectively examined the neurophysiological and connectivity changes induced by the stimulation in a non-invasive manner using TMS-EEG and fMRI. The observed changes in brain oscillatory activity (increased gamma oscillatory activity), cortical excitability (enhanced posteromedial parietal cortex reactivity), and brain connectivity (strengthened connections between the precuneus and hippocampi) provided evidence of the effects of our non-invasive brain stimulation protocol, further supporting the behavioral data.

      Additionally, we carefully considered the issue of stimulation distribution and, in response, performed a biophysical modeling analysis and E-field calculation using the parameters employed in our study (see Supplementary Materials).

      We acknowledge that further exploration of this aspect would be highly valuable, and we agree that it is worth discussing both as a technical limitation and as a potential direction for future research. We therefore, modify the discussion accordingly (main text, lines 280-289).

      “Although we studied TMS and tACS propagation through the E-field modeling and observed an increase in the precuneus gamma oscillatory activity, excitability and connectivity with the hippocampi, we cannot exclude that our results might reflect the consequences of stimulating more superficial parietal regions other than the precuneus nor report direct evidence of microscopic changes in the brain after the stimulation. Invasive neurophysiological recordings in humans for this type of study are not feasible due to ethical constraints. Studies on cadavers or rodents would not fully resolve our question due to significant differences between them (i.e. rodents do not have an anatomical correspondence while cadavers have an alterations in electrical conductivity occurring in postmortem tissue). However, further exploration of this aspect in future studies would help in the understanding of γtACS+iTBS effects.”

      (2) If there is any brain activity triggered by the current stimulation parameters, then it is extremely difficult to understand how this activity can lead to enhancing memory. The brain is complex. There are hundreds of neuronal types. Each neuron receives precise input from about 10,000 other neurons with highly tuned synaptic strengths. Let us assume that the current protocol does lead to enhancing (or inhibiting) simultaneously the activity of millions of neurons. It is unclear whether there is any activity at all in the brain triggered by this protocol, it is also unclear whether such activity would be excitatory, or inhibitory. It is also unclear how many neurons, let alone what types of neurons would change their activity. How is it possible that this can lead to memory enhancement? This seems like using a hammer to knock on my laptop and hope that the laptop will output a new Mozart-like sonata.

      Thank you for your comment. As you correctly point out, we still do not have precise knowledge of which neurons—and to what extent—are activated during non-invasive brain stimulation in humans. However, this challenge is not limited to brain stimulation but applies to many other therapeutic interventions, including psychiatric medications, without limiting their use.

      Nevertheless, a substantial body of research has investigated the mechanisms underlying the efficacy of TMS and tACS in producing behavioral after-effects, primarily through its ability to induce long-term potentiation (Bliss & Collingridge, The Journal of Physiology, 1993a; Ridding & Rothwell, Nature Reviews Neuroscience, 2007; Huang et al., Clinical Neurophysiology, 2017; Koch et al., Neuroimage 2018; Koch et al., Brain 2022; Jannati et al., Neuropsychopharmacology, 2023; Wischnewski et al., Trends in Cognitive Science, 2023; Griffiths et al., Trends in Neuroscience, 2023).

      We acknowledge that we took this important aspect for granted. We consequently expanded the introduction accordingly (main text, lines 48-60).

      “Repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS) are two forms of NIBS widely used to enhance memory performances (Grover et al., 2022; Koch et al., 2018; Wang et al., 2014). rTMS, based on the principle of Faraday, induces depolarization of cortical neuronal assemblies and leads to after-effects that have been linked to changes in synaptic plasticity involving mechanisms of long-term potentiation (LTP) (Huang et al., 2017; Jannati et al., 2023). On the other hand, tACS causes rhythmic fluctuations in neuronal membrane potentials, which can bias spike timing, leading to an entrainment of the neural activity (Wischnewski et al., 2023). In particular, the induction of gamma oscillatory a has been proposed to play an important role in a type of LTP known as spike timing-dependent plasticity, which depends on a precise temporal delay between the firing of a presynaptic and a postsynaptic neuron (Griffiths and Jensen, 2023). Both LTP and gamma oscillations have a strong link with memory processes such as encoding (Bliss and Collingridge, 1993; Griffiths and Jensen, 2023; Rossi et al., 2001), pointing to rTMS and tACS as good candidates for memory enhancement.”

      (3) Even if there is any kind of brain activation, it is unclear why the authors seem to be so sure that the precuneus is responsible. Are there neurophysiological data demonstrating that the current protocol only activates neurons in the precuneus? Of note, the non-invasive measurements shown in Figure 3 are very weak (Figure 3A top and bottom look very similar, and Figure 3C left and right look almost identical). Even if one were to accept the weak alleged differences in Figure 3, there is no indication in this figure that there is anything specific to the precuneus, rather a whole brain pattern. This would be the kind of minimally rigorous type of evidence required to make such claims. In a less convincing fashion, one could look at different positions of the stimulation apparatus. This would not be particularly compelling in terms of making a statement about the precuneus. But at least it would show that the position does matter, and over what range of distances it matters, if it matters.

      Thank you for your feedback. Our assumption that the precuneus plays a key role in the observed effects is based on several factors:

      (1) The non-invasive stimulation protocol was applied to an individually identified precuneus for each participant. Given existing evidence on TMS propagation, we can reasonably assume that the precuneus was at least a mediator of the observed effects (Ridding & Rothwell, Nature Reviews Neuroscience 2007). For further details about target identification and TMS and tACS propagation, please refer to the MRI data acquisition section in the main text and Biophysical modeling and E-field calculation section in the supplementary materials.

      (2) To investigate the effects of the neuromodulation protocol on cortical responses, we conducted a whole-brain analysis using multiple paired t-tests comparing each data point between different experimental conditions. To minimize the type I error rate, data were permuted with the Monte Carlo approach and significant p-values were corrected with the false discovery rate method (see the Methods section for details). The results identified the posterior-medial parietal areas as the only regions showing significant differences across conditions.

      (3) To control for potential generalized effects, we included a control condition in which TMS-EEG recordings were performed over the left parietal cortex (adjacent to the precuneus). This condition did not yield any significant results, reinforcing the cortical specificity of the observed effects.

      However, as stated in the Discussion, we do not claim that precuneus activity alone accounts for the observed effects. As shown in Experiment 4, stimulation led to connectivity changes between the precuneus and hippocampus, a network widely recognized as a key contributor to long-term memory formation (Bliss & Collingridge, Nature 1993). These connectivity changes suggest that precuneus stimulation triggered a ripple effect extending beyond the stimulation site, engaging the broader precuneus-hippocampus network.

      Regarding Figure 3A, it represents the overall expression of oscillatory activity detected by TMS-EEG. Since each frequency band has a different optimal scaling, the figure reflects a graphical compromise. A more detailed representation of the significant results is provided in Figure 3B. The effect sizes for gamma oscillatory activity in the delta T1 and T2 conditions were 0.52 and 0.50, respectively, which correspond to a medium effect based on Cohen’s d interpretation.

      We add a paragraph in the discussion to improve the clarity of the manuscript regarding this important aspect (lines 193-198).

      “Given the existing evidence on TMS propagation and the computation of the Biophysical model with the Efield, we can reasonably assume that the individually identified PC was a mediator of the observed effects (Ridding and Rothwell, 2007). Moreover, we observed specific cortical changes in the posteromedial parietal areas, as evidenced by the whole-brain analysis conducted on TMS-EEG data and the absence of effect on the lateral posterior parietal cortex used as a control condition.”

      (4) In the absence of any neurophysiological documentation of a direct impact on the brain, an argument in this type of study is that the behavioral results show that there must be some kind of effect. I agree with this argument. This is also the argument for placebo effects, which can be extremely powerful and useful even if the mechanism is unrelated to what is studied. Then let us dig into the behavioral results.

      Hoping to have already addressed your concern regarding the neurophysiological impact of the stimulation on the brain, we would like to emphasize that the behavioral results were obtained controlling for placebo effects. This was achieved by having participants perform the task under different stimulation conditions, including a sham condition.

      4a. There does not seem to be any effect on the STMB task, therefore we can ignore this.

      4b. The FNAT task is minimally described in the supplementary material. There are no experimental details to understand what was done. What was the size of the images? How long were the images presented for? Were there any repetitions of the images? For how long did the participants study the images? Presumably, all the names and occupations are different? What were the genders of the faces? What is chance level performance? Presumably, the same participant saw different faces across the different stimulation conditions. If not, then there can be memory effects across different conditions that are even more complex to study. If yes, then it would be useful to show that the difficulty is the same across the different stimuli.

      We thank you for signaling the lack in the description of FNAT task. We added the information required in the supplementary information (lines 93-101).

      “Each picture's face size was 19x15cm. In the learning phase, faces were shown along with names and occupations for 8 seconds each (totaling approximately 2 minutes). During immediate recall, the faces were displayed alone for 8 seconds. In the delayed recall and recognition phase, pictures were presented until the subject provided answers. We used a different set of stimuli for each stimulation condition, resulting in a total of 3 parallel task forms balanced across conditions and session order. All parallel forms comprised 6 male and 6 female faces; for each sex, there were 2 young adults (around 30 years old), 2 middle-aged adults (around 50 years old), and 2 elderly adults (around 70 years old). Before the experiments, we conducted a pilot study to ensure no differences existed between the parallel forms of the task.”

      The chance level in the immediate and delayed recall is not quantifiable since the participants had to freely recall the name and the occupation without a multiple choice. In the recognition, the chance level was around 33% (since the possible answers were 3).

      4c. Although not stated clearly, if I understand FNAT correctly, the task is based on just 12 presentations. Each point in Figure 2A represents a different participant. Unfortunately, there is no way of linking the performance of individual participants across the conditions with the information provided. Lines joining performance for each participant would be useful in this regard. Because there are only 12 faces, the results are quantized in multiples of 100/12 % in Figure 3A. While I do not doubt that the authors did their homework in terms of the statistical analyses, it is difficult to get too excited about these 12 measurements. For example, take Figure 3A immediate condition TOTAL, arguably the largest effect in the whole paper. It seems that on average, the participants may remember one more face/name/occupation.

      Thank you for the suggestion. We added graphs showing lines linking the performance of individual participants across conditions to improve clarity, please see Fig.2 revised. We apologize for the lack of clarity in the description of the FNAT. As you correctly pointed out, we used the percentage based on the single association between face, name and occupation (12 in total). However, each association consisted of three items, resulting in a total of 36 items to learn and associate – we added a paragraph to make it more explicit in the manuscript (lines 425-430).

      “We considered a correct association when a subject was able to recall all the information for each item (i.e. face, name and occupation), resulting in a total of 36 items to learn and associate. To further investigate the effect on FNAT we also computed a partial recall score accounting for those items where subjects correctly matched only names with faces (FNAT NAME) and only occupations with faces (FNAT OCCUPATION). See supplementary information for score details.”

      In the example you mentioned, participants were, on average, able to correctly recall and associate three more items compared to the other conditions. While this difference may not seem striking at first glance, it is important to consider that we assessed memory performance after a single, three-minute stimulation session. Similar effects are typically observed only after multiple stimulation sessions (Koch et al., NeuroImage, 2018; Grover et al., Nature Neuroscience, 2022). Moreover, memory performance changes are often measured by a limited set of stimuli due to methodological constraints related to memory capacity. For example, Rey Auditory Verbal learning task, requiring to learn and recall 15 words, is a typical test used to detect memory changes (Koch et al., Neuroimage, 2018; Benussi et al., Brain stimulation 2021; Benussi et al., Annals of Neurology, 2022). 

      4d. Block effects. If I understand correctly, the experiments were conducted in blocks. This is always problematic. Here is one example study that articulated the big problems in block designs (Li et al TPAMI 2021):https://ieeexplore.ieee.org/document/9264220

      Thank you for the interesting reference. According to this paper, in a block design, EEG or fMRI recordings are performed in response to different stimuli of a given class presented in succession. If this is the case, it does not correspond to our experimental design where both TMS-EEG and fMRI were conducted in resting state on different days according to the different stimulation conditions.

      4e. Even if we ignore the lack of experimental descriptions, problems with lack of evidence of brain activity, the minimalistic study of 12 faces, problems with the block design, etc. at the end of the day, the results are extremely weak. In FNAT, some results are statistically significant, some are not. The interpretation of all of this is extremely complex. Continuing with Figure 3A, it seems that the author claims that iTBS+gtACS > iTBS+sham-tACS, but iTBS+gtACS ~ sham+sham. I am struggling to interpret such a result. When separating results by name and occupation, the results are even more perplexing. There is only one condition that is statistically significant in Figure 3A NAME and none in the occupation condition.

      Thank you again for your feedback. Hoping to have thoroughly addressed your initial concerns in our previous responses, we now move on to your observations regarding the behavioral results, assuming you were referring to Figure 2A. The main finding of this study is the improvement in long-term memory performance, specifically the ability to correctly recall the association between face, name, and occupation (total FNAT), which was significantly enhanced in both Experiments 1 and 2. However, we also aimed to explore the individual contributions of name and occupation separately to gain a deeper understanding of the results. Our analysis revealed that the improvement in total FNAT was primarily driven by an increase in name recall rather than occupation recall. We understand that this may have caused some confusion. We consequently modified the manuscript in the (lines 97-99; 107-111; 425-430) to make it clearer and moved the graph relative to FNAT NAME and OCCUPATION from fig.2 in the main text to fig. S4 in supplementary information.

      “Dual iTBS+γtACS increased the performances in recalling the association between face, name and occupation (FNAT accuracy) both for the immediate (F<sub>2,38</sub>=7.18; p =0.002; η<sup>2</sup><sub>p</sub>=0.274) and the delayed (F<sub>2,38</sub>=5.86; p =0.006; η<sup>2</sup><sub>p</sub>=0.236) recall performances (Fig. 2, panel A).”

      “The in-depth analysis of the FNAT accuracy investigating the specific contribution of face-name and face-occupation recall reveald that dual iTBS+γtACS increased the performances in the association between face and name (FNAT NAME) delayed recall (F<sub>2,38</sub> =3.46; p =0.042; η<sup>2</sup>p =0.154; iTBS+γtACS vs. sham-iTBS+sham-tACS: 42.9±21.5 % vs. 33.8±19 %; p=0.048 Bonferroni corrected) (Fig. S4, supplementary information).”

      “We considered a correct association when a subject was able to recall all the information for each item (i.e. face, name and occupation), resulting in a total of 36 items to learn and associate. To further investigate the effect on FNAT we also computed a partial recall score accounting for those items where subjects correctly matched only names with faces (FNAT NAME) and only occupations with faces (FNAT OCCUPATION). See supplementary information for score details.”

      Regarding the stimulation conditions, your concerns about the performance pattern (iTBS+gtACS > iTBS+sham-tACS, but iTBS+gtACS ~ sham+sham) are understandable. However, this new protocol was developed precisely in response to the variability observed in behavioral outcomes following non-invasive brain stimulation, particularly when used to modulate memory functions (Corp et al., 2020; Pabst et al., 2022). As discussed in the manuscript, it is intended as a boost to conventional non-invasive brain stimulation protocols, leveraging the mechanisms outlined in the Discussion section.

      (5) In sum, it would be amazing to be able to use non-invasive stimulation for any kind of therapeutic purpose as the authors imagine. More work needs to be done to convince ourselves that this kind of approach is viable. The evidence provided in this study is weak.

      We hope our response will be carefully considered, fostering a constructive exchange and leading to a reassessment of your evaluation.

      Reviewer #2 (Public review):

      Summary:

      The manuscript "Dual transcranial electromagnetic stimulation of the precuneus-hippocampus network boosts human long-term memory" by Borghi and colleagues provides evidence that the combination of intermittent theta burst TMS stimulation and gamma transcranial alternating current stimulation (γtACS) targeting the precuneus increases long-term associative memory in healthy subjects compared to iTBS alone and sham conditions. Using a rich dataset of TMS-EEG and resting-state functional connectivity (rs-FC) maps and structural MRI data, the authors also provide evidence that dual stimulation increased gamma oscillations and functional connectivity between the precuneus and hippocampus. Enhanced memory performance was linked to increased gamma oscillatory activity and connectivity through white matter tracts.

      Strengths:

      The combination of personalized repetitive TMS (iTBS) and gamma tACS is a novel approach to targeting the precuneus, and thereby, connected memory-related regions to enhance long-term associative memory. The authors leverage an existing neural mechanism engaged in memory binding, theta-gamma coupling, by applying TMS at theta burst patterns and tACS at gamma frequencies to enhance gamma oscillations. The authors conducted a thorough study that suggests that simultaneous iTBS and gamma tACS could be a powerful approach for enhancing long-term associative memory. The paper was well-written, clear, and concise.

      Weaknesses:

      (1) The study did not include a condition where γtACS was applied alone. This was likely because a previous work indicated that a single 3-minute γtACS did not produce significant effects, but this limits the ability to isolate the specific contribution of γtACS in the context of this target and memory function

      Thank you for your comments. As you pointed out, we did not include a condition where γtACS was applied alone. This decision was based on the findings of Guerra et al. (Brain Stimulation 2018), who investigated the same protocol and reported no aftereffects. Given the substantial burden of the experimental design on patients and our primary goal of demonstrating an enhancement of effects compared to the standalone iTBS protocol, we decided to leave out this condition. However, you raise an important aspect that should be further discussed, we modified the limitation section accordingly (lines 290-297).

      “We did not assess the effects of γtACS alone. This decision was based on the findings of Guerra et al. (Guerra et al., 2018), who investigated the same protocol and reported no aftereffects. Given the substantial burden of the experimental design on patients and our primary goal of demonstrating an enhancement of effects compared to the standalone iTBS protocol, we decided to leave out this condition. While examining the effects of γtACS alone could help isolate its specific contribution to this target and memory function, extensive research has shown that achieving a cognitive enhancement aftereffect with tACS alone typically requires around 20–25 minutes of stimulation (Grover et al., 2023).”

      (2) The authors applied stimulation for 3 minutes, which seems to be based on prior tACS protocols. It would be helpful to present some rationale for both the duration and timing relative to the learning phase of the memory task. Would you expect additional stimulation prior to recall to benefit long-term associative memory?

      Thank you for your comment and for raising this interesting point. As you correctly noted, the protocol we used has a duration of three minutes, a choice based on previous studies demonstrating its greater efficacy with respect to single stimulation from a neurophysiological point of view. Specifically, these studies have shown that the combined stimulation enhanced gamma-band oscillations and increased cortical plasticity (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022). Given that the precuneus (Brodt et al., Science 2018; Schott et al., Human Brain Mapping 2018), gamma oscillations (Osipova et al., Journal of Neuroscience 2006; Deprés et al., Neurobiology of Aging 2017; Griffiths et al., Trends in Neurosciences 2023), and cortical plasticity (Brodt et al., Science 2018) are all associated with memory formation and encoding processes, we decided to apply the co-stimulation immediately before it to enhance the efficacy. We added this paragraph to the manuscript rationale (lines 48-60).

      “Repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS) are two forms of NIBS widely used to enhance memory performances (Grover et al., 2022; Koch et al., 2018; Wang et al., 2014). rTMS, based on the principle of Faraday, induces depolarization of cortical neuronal assemblies and leads to after-effects that have been linked to changes in synaptic plasticity involving mechanisms of long-term potentiation (LTP) (Huang et al., 2017; Jannati et al., 2023). On the other hand, tACS causes rhythmic fluctuations in neuronal membrane potentials, which can bias spike timing, leading to an entrainment of the neural activity (Wischnewski et al., 2023). In particular, the induction of gamma oscillatory a has been proposed to play an important role in a type of LTP known as spike timing-dependent plasticity, which depends on a precise temporal delay between the firing of a presynaptic and a postsynaptic neuron (Griffiths and Jensen, 2023). Both LTP and gamma oscillations have a strong link with memory processes such as encoding (Bliss and Collingridge, 1993; Griffiths and Jensen, 2023; Rossi et al., 2001), pointing to rTMS and tACS as good candidates for memory enhancement.”

      Regarding the question of whether stimulation could also benefit recall, the answer is yes. We can speculate that repeating the stimulation before recall might provide an additional boost. This is supported by evidence showing that both the precuneus and gamma oscillations are involved in recall processes (Flanagin et al., Cerebral Cortex 2023; Griffiths et al., Trends in Neurosciences 2023). Furthermore, previous research suggests that reinstating the same brain state as during encoding can enhance recall performance (Javadi et al., The Journal of Neuroscience 2017). We added this consideration to the discussion (lines 305-311).

      “Future studies should further investigate the effects of stimulation on distinct memory processes. In particular, stimulation could be applied before retrieval (Rossi et al., 2001), to better elucidate its specific contribution to the observed enhancements in memory performance. Additionally, it would be worth examining whether repeated stimulation - administered both before encoding and before retrieval - could produce a boosting effect. This is especially relevant in light of findings showing that matching the brain state between retrieval and encoding can significantly enhance memory performance (Javadi et al., 2017).”

      (3) How was the burst frequency of theta iTBS and gamma frequency of tACS chosen? Were these also personalized to subjects' endogenous theta and gamma oscillations? If not, were increases in gamma oscillations specific to patients' endogenous gamma oscillation frequencies or the tACS frequency?

      The stimulation protocol was chosen based on previous studies (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022).  Gamma tACS sinusoid frequency wave was set at 70 Hz while iTBS consisted of ten bursts of three pulses at 50 Hz lasting 2 s, repeated every 10 s with an 8 s pause between consecutive trains, for a total of 600 pulses total lasting 190 s (see iTBS+γtACS neuromodulation protocol section). In particular, the theta iTBS has been inspired by protocols used in animal models to elicit LTP in the hippocampus (Huang et al., Neuron 2005). Consequently, neither Theta iTBS nor the gamma frequency of tACS were personalized. The increase in gamma oscillations was referred to the patient’s baseline and did not correspond to the administrated tACS frequency.

      (4) The authors do a thorough job of analyzing the increase in gamma oscillations in the precuneus through TMS-EEG; however, the authors may also analyze whether theta oscillations were also enhanced through this protocol due to the iTBS potentially targeting theta oscillations. This may also be more robust than gamma oscillations increases since gamma oscillations detected on the scalp are very low amplitude and susceptible to noise and may reflect activity from multiple overlapping sources, making precise localization difficult without advanced techniques.

      Thank you for the suggestion. We analyzed theta oscillations, finding no changes.

      (5) Figure 4: Why are connectivity values pre-stimulation for the iTBS and sham tACS stimulation condition so much higher than the dual stimulation? We would expect baseline values to be more similar.

      We acknowledge that the pre-stimulation connectivity values for the iTBS and sham tACS conditions appear higher than those for the dual stimulation condition. However, as noted in our statistical analyses, there were no significant differences at baseline between conditions (p-FDR= 0.3514), suggesting that any apparent discrepancy is due to natural variability rather than systematic bias. One potential explanation for these differences is individual variability in baseline connectivity measures, which can fluctuate due to factors such as intrinsic neural dynamics, participant state, or measurement noise. Despite these variations, our statistical approach ensures that any observed post-stimulation effects are not confounded by pre-existing differences.

      (6) Figure 2: How are total association scores significantly different between stimulation conditions, but individual name and occupation associations are not? Further clarification of how the total FNAT score is calculated would be helpful.

      We apologize for any lack of clarity. The total FNAT score reflects the ability to correctly recall all the information associated with a person—specifically, the correct pairing of the face, name, and occupation. Participants received one point for each triplet they accurately recalled. The scores were then converted into percentages, as detailed in the Face-Name Associative Task Construction and Scoring section in the supplementary materials.

      Total FNAT was the primary outcome measure. However, we also analyzed name and occupation recall separately to better understand their partial contributions. Our analysis revealed that the improvement in total FNAT was primarily driven by an increase in name recall rather than occupation recall.

      We acknowledge that this distinction may have caused some confusion. To improve clarity, we revised the manuscript accordingly (lines 97-98; 107-111; 425-430).

      “Dual iTBS+γtACS increased the performances in recalling the association between face, name and occupation (FNAT accuracy) both for the immediate (F<sub>2,38</sub>=7.18 ;p=0.002; η<sup>2</sup><sub>p</sub>=0.274) and the delayed (F<sub>2,38</sub>=5.86;p=0.006; η<sup>2</sup><sub>p</sub>=0.236) recall performances (Fig. 2, panel A).”

      “The in-depth analysis of the FNAT accuracy investigating the specific contribution of face-name and face-occupation recall revealed that dual iTBS+γtACS increased the performances in the association between face and name (FNAT NAME) delayed recall (F<sub>2,38</sub> =3.46; p =0.042; η<sup>2</sup>p =0.154; iTBS+γtACS vs. sham-iTBS+sham-tACS: 42.9±21.5 % vs. 33.8±19 %; p=0.048 Bonferroni corrected) (Fig. S4, supplementary information).”

      “We considered a correct association when a subject was able to recall all the information for each item (i.e. face, name and occupation), resulting in a total of 36 items to learn and associate. To further investigate the effect on FNAT we also computed a partial recall score accounting for those items where subjects correctly matched only names with faces (FNAT NAME) and only occupations with faces (FNAT OCCUPATION). See supplementary information for score details.”

      We also moved the data regarding the specific contribution of name and occupation recall in the supplementary information (fig.S4) and further specified how we computed the score in the score (lines 102-104).

      “The score was computed by deriving an accuracy percentage index dividing by 12 and multiplying by 100 the correct association sum. The partial recall scores were computed in the same way only considering the sum of face-name (NAME) and face-occupation (OCCUPATION) correctly recollected.”

      Reviewer #3 (Public review):

      Summary:

      Borghi and colleagues present results from 4 experiments aimed at investigating the effects of dual γtACS and iTBS stimulation of the precuneus on behavioral and neural markers of memory formation. In their first experiment (n = 20), they found that a 3-minute offline (i.e., prior to task completion) stimulation that combines both techniques leads to superior memory recall performance in an associative memory task immediately after learning associations between pictures of faces, names, and occupation, as well as after a 15-minute delay, compared to iTBS alone (+ tACS sham) or no stimulation (sham for both iTBS and tACS). Performance in a second task probing short-term memory was unaffected by the stimulation condition. In a second experiment (n = 10), they show that these effects persist over 24 hours and up to a full week after initial stimulation. A third (n = 14) and fourth (n = 16) experiment were conducted to investigate the neural effects of the stimulation protocol. The authors report that, once again, only combined iTBS and γtACS increase gamma oscillatory activity and neural excitability (as measured by concurrent TMS-EEG) specific to the stimulated area at the precuneus compared to a control region, as well as precuneus-hippocampus functional connectivity (measured by resting-state MRI), which seemed to be associated with structural white matter integrity of the bilateral middle longitudinal fasciculus (measured by DTI).

      Strengths:

      Combining non-invasive brain stimulation techniques is a novel, potentially very powerful method to maximize the effects of these kinds of interventions that are usually well-tolerated and thus accepted by patients and healthy participants. It is also very impressive that the stimulation-induced improvements in memory performance resulted from a short (3 min) intervention protocol. If the effects reported here turn out to be as clinically meaningful and generalizable across populations as implied, this approach could represent a promising avenue for the treatment of impaired memory functions in many conditions.

      Methodologically, this study is expertly done! I don't see any serious issues with the technical setup in any of the experiments (with the only caveat that I am not an expert in fMRI functional connectivity measures and DTI). It is also very commendable that the authors conceptually replicated the behavioral effects of experiment 1 in experiment 2 and then conducted two additional experiments to probe the neural mechanisms associated with these effects. This certainly increases the value of the study and the confidence in the results considerably.

      The authors used a within-subject approach in their experiments, which increases statistical power and allows for stronger inferences about the tested effects. They are also used to individualize stimulation locations and intensities, which should further optimize the signal-to-noise ratio.

      Weaknesses:

      I want to state clearly that I think the strengths of this study far outweigh the concerns I have. I still list some points that I think should be clarified by the authors or taken into account by readers when interpreting the presented findings.

      I think one of the major weaknesses of this study is the overall low sample size in all of the experiments (between n = 10 and n = 20). This is, as I mentioned when discussing the strengths of the study, partly mitigated by the within-subject design and individualized stimulation parameters. The authors mention that they performed a power analysis but this analysis seemed to be based on electrophysiological readouts similar to those obtained in experiment 3. It is thus unclear whether the other experiments were sufficiently powered to reliably detect the behavioral effects of interest. That being said, the authors do report significant effects, so they were per definition powered to find those. However, the effect sizes reported for their main findings are all relatively large and it is known that significant findings from small samples may represent inflated effect sizes, which may hamper the generalizability of the current results. Ideally, the authors would replicate their main findings in a larger sample. Alternatively, I think running a sensitivity analysis to estimate the smallest effect the authors could have detected with a power of 80% could be very informative for readers to contextualize the findings. At the very least, however, I think it would be necessary to address this point as a potential limitation in the discussion of the paper.

      Thank you for the observation. As you mentioned, our power analysis was based on our previous study investigating the same neuromodulation protocol with a corresponding experimental design. The relatively small sample could be considered a possible limitation of the study which we will add to the discussion. A fundamental future step will be to replay these results on a larger population, however, to strengthen our results we performed the sensitivity analysis you suggested.

      In detail, we performed a sensitivity analysis for repeated-measures ANOVA with α=0.05 and power(1-β)=0.80 with no sphericity correction. For experiment 1, a sensitivity analysis with 1 group and 3 measurements showed a minimal detectable effect size of f=0.524 with 20 participants. In our paper, the ANOVA on total FNAT immediate performance revealed an effect size of η<sup>2</sup>=0.274 corresponding to f=0.614; the ANOVA on FNAT delayed performance revealed an effect size of η<sup>2</sup>=0.236 corresponding to f=0.556. For experiment 2, a sensitivity analysis for total FNAT immediate performance (1 group and 3 measurements) showed a minimal detectable effect size of f=0.797 with 10 participants. In our paper, the ANOVA on total FNAT immediate performance revealed an effect size of η<sup>2</sup>=0.448 corresponding to f=0.901. The sensitivity analysis for total FNAT delayed performance (1 group and 6 measurements) showed a minimal detectable effect size of f=0.378 with 10 participants. In our paper, the ANOVA on total FNAT delayed performance revealed an effect size of η<sup>2</sup>=0.484 corresponding to f=0.968. Thus, the sensitivity analysis showed that both experiments were powered enough to detect the minimum effect size computed in the power analysis. We have now added this information to the manuscript and we thank the reviewer for her/his suggestion in the statistical analysis and results section (lines 99-100; 127-128; 130-131; 543-545).

      “The sensitivity analysis showed a minimal detectable effect size of  η<sup>2</sup>=0.215 with 20 participants.”

      “The sensitivity analysis showed a minimal detectable effect size of  η<sup>2</sup>=0.388 with 10 participants.”

      “The sensitivity analysis showed a minimal detectable effect size of η<sup>2</sup>=0.125 with 10 participants.”

      “Since we do not have an a priori effect size for experiment 1 and 2, we performed a sensitivity power analysis to ensure that these experiments were able to detect the minimum effect size with 80% power and alpha level of 0.05.”

      It seems that the statistical analysis approach differed slightly between studies. In experiment 1, the authors followed up significant effects of their ANOVAs by Bonferroni-adjusted post-hoc tests whereas it seems that in experiment 2, those post-hoc tests where "exploratory", which may suggest those were uncorrected. In experiment 3, the authors use one-tailed t-tests to follow up their ANOVAs. Given some of the reported p-values, these choices suggest that some of the comparisons might have failed to reach significance if properly corrected. This is not a critical issue per se, as the important test in all these cases is the initial ANOVA but non-significant (corrected) post-hoc tests might be another indicator of an underpowered experiment. My assumptions here might be wrong, but even then, I would ask the authors to be more transparent about the reasons for their choices or provide additional justification. Finally, the authors sometimes report exact p-values whereas other times they simply say p < .05. I would ask them to be consistent and recommend using exact p-values for every result where p >= .001.

      Thank you again for the suggestions. Your observations are correct, we used a slightly different statistical depending on our hypothesis. Here are the details:

      In experiment 1, we used a repeated-measure ANOVA with one factor “stimulation condition” (iTBS+γtACS; iTBS+sham-tACS; sham-iTBS+sham-tACS). Following the significant effect of this factor we performed post-hoc analysis with Bonferroni correction.

      In experiment 2, we used a repeated-measures with two factors “stimulation condition” and “time”. As expected, we observed a significant effect of condition, confirming the result of experiment 1, but not of time. Thus, this means that the neuromodulatory effect was present regardless of the time point. However, to explore whether the effects of stimulation condition were present in each time point we performed some explorative t-tests with no correction for multiple comparisons since this was just an explorative analysis.

      In experiment 3, we used the same approach as experiment 1. However, since we had a specific hypothesis on the direction of the effect already observed in our previous study, i.e. increase in spectral power (Maiella et al., Scientific Report 2022), our tests were 1-tailed.

      For the p-values, we corrected the manuscript reporting the exact values for every result.

      While the authors went to great lengths trying to probe the neural changes likely associated with the memory improvement after stimulation, it is impossible from their data to causally relate the findings from experiments 3 and 4 to the behavioral effects in experiments 1 and 2. This is acknowledged by the authors and there are good methodological reasons for why TMS-EEG and fMRI had to be collected in sperate experiments, but it is still worth pointing out to readers that this limits inferences about how exactly dual iTBS and γtACS of the precuneus modulate learning and memory.

      Thank you for your comment. We fully agree with your observation, which is why this aspect has been considered in the study's limitations. To address your concern, we add this sentence to the limitation discussion (lines 299-301).

      “Consequently, these findings do not allow precise inferences regarding the specific mechanisms by which dual iTBS and γtACS of the precuneus modulate learning and memory.”

      There were no stimulation-related performance differences in the short-term memory task used in experiments 1 and 2. The authors argue that this demonstrates that the intervention specifically targeted long-term associative memory formation. While this is certainly possible, the STM task was a spatial memory task, whereas the LTM task relied (primarily) on verbal material. It is thus also possible that the stimulation effects were specific to a stimulus domain instead of memory type. In other words, could it be possible that the stimulation might have affected STM performance if the task taxed verbal STM instead? This is of course impossible to know without an additional experiment, but the authors could mention this possibility when discussing their findings regarding the lack of change in the STM task.

      Thank you for your interesting observation. We argue that the intervention primarily targeted long-term associative memory formation, as our findings demonstrated effects only on FNAT. However, as you correctly pointed out, we cannot exclude the possibility that the stimulation may also influence short-term verbal associative memory. We add this aspect when discussing the absence of significant findings in the STM task (lines 205-210).

      “Visual short-term associative memory, measured by STBM performance, was not modulated by any experimental condition. Even if we cannot exclude the possibility that the stimulation could have influenced short-term verbal associative memory, we expected this result since short-term associative memory is known to rely on a distinct frontoparietal network while FNAT, used to investigate long-term associative memory, has already been associated with the neural activity of the PC and the hippocampus (Parra et al., 2014; Rentz et al., 2011).”

      While the authors discuss the potential neural mechanisms by which the combined stimulation conditions might have helped memory formation, the psychological processes are somewhat neglected. For example, do the authors think the stimulation primarily improves the encoding of new information or does it also improve consolidation processes? Interestingly, the beneficial effect of dual iTBS and γtACS on recall performance was very stable across all time points tested in experiments 1 and 2, as was the performance in the other conditions. Do the authors have any explanation as to why there seems to be no further forgetting of information over time in either condition when even at immediate recall, accuracy is below 50%? Further, participants started learning the associations of the FNAT immediately after the stimulation protocol was administered. What would happen if learning started with a delay? In other words, do the authors think there is an ideal time window post-stimulation in which memory formation is enhanced? If so, this might limit the usability of this procedure in real-life applications.

      Thank you for your comment and for raising these important points.

      We hypothesized that co-stimulation would enhance encoding processes. Previous studies have shown that co-stimulation can enhance gamma-band oscillations and increase cortical plasticity (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022). Given that the precuneus (Brodt et al., Science 2018; Schott et al., Human Brain Mapping 2018), gamma oscillations (Osipova et al., Journal of Neuroscience 2006; Deprés et al., Neurobiology of Aging 2017; Griffiths et al., Trends in Neurosciences 2023), and cortical plasticity (Brodt et al., Science 2018) have all been associated with encoding processes, we decided to apply co-stimulation before the encoding phase, to boost it. We enlarged the introduction to specify the link between neural mechanisms and the psychological process of the encoding (lines 55-60).

      “In particular, the induction of gamma oscillatory activity has been proposed to play an important role in a type of LTP known as spike timing-dependent plasticity, which depends on a precise temporal delay between the firing of a presynaptic and a postsynaptic neuron (Griffiths and Jensen, 2023). Both LTP and gamma oscillations have a strong link with memory processes such as encoding (Bliss and Collingridge, 1993; Griffiths and Jensen, 2023; Rossi et al., 2001), pointing to rTMS and tACS as good candidates for memory enhancement.”

      We applied the co-stimulation immediately before the learning phase to maximize its potential effects. While we observed a significant increase in gamma oscillatory activity lasting up to 20 minutes, we cannot determine whether the behavioral effects we observed would have been the same with a co-stimulation applied 20 minutes before learning. Based on existing literature, a reduction in the efficacy of co-stimulation over time could be expected (Huang et al., Neuron 2005; Thut et al., Brain Topography 2009). However, we hypothesize that multiple stimulation sessions might provide an additional boost, helping to sustain the effects over time (Thut et al., Brain Topography 2009; Koch et al., Neuroimage 2018; Koch et al., Brain 2022).

      Regarding the absence of further forgetting in both stimulation conditions, we think that the clinical and demographical characteristics of the sample (i.e. young and healthy subjects) explain the almost absence of forgetting after one week.

      Reviewer #1 (Recommendations for the authors):

      To address the concerns, the authors should:

      (1) Include invasive neuronal recordings (e.g., in rats or monkeys if not possible in humans) demonstrating that the current stimulation protocol leads to direct changes in brain activity.

      We understand the interest of the first reviewer in the understanding of neurophysiological correlates of the stimulation protocol, however, we are skeptical about this request as we think it goes beyond the aims of the study. As already mentioned in the response to the reviewer, invasive neurophysiological recordings in humans for this type of study are not feasible due to ethical constraints. At the same time, studies on cadavers or rodents would not fully resolve the question. Indeed, the authors of the study cited by the reviewer (Mihály Vöröslakos et al., Nature Communications, 2018) highlight the impossibility of drawing definitive conclusions about the exact voltage required in the in-vivo human brain due to significant differences between rats and humans, as well as the in-vivo human cadavers due to alterations in electrical conductivity that occur in postmortem tissue. Huang and colleagues addressed the difficulties in reaching direct evidence of non-invasive brain stimulation (NIBS) effects in a review published in Clinical Neurophysiology in 2017. They conclude that the use of EEG to assess brain response to TMS has a great potential for a less indirect demonstration of plasticity mechanisms induced by NIBS in humans.

      It is exactly to meet the need to investigate the changes in brain activity after the stimulation protocol that we conducted Experiments 3 and 4. These experiments respectively examined the neurophysiological and connectivity changes induced by the stimulation in a non-invasive manner using TMS-EEG and fMRI. The observed changes in brain oscillatory activity (increased gamma oscillatory activity), cortical excitability (enhanced posteromedial parietal cortex reactivity), and brain connectivity (strengthened connections between the precuneus and hippocampi) provided evidence of the effects of our non-invasive brain stimulation protocol, further supporting the behavioral data.

      Additionally, we carefully considered the issue of stimulation distribution and, in response, performed a biophysical modeling analysis and E-field calculation using the parameters employed in our study (see Supplementary Materials).

      Acknowledging the reviewer's point of view, we modified the manuscript accordingly, discussing this aspect both as a technical limitation and as a potential direction for future research (main text, lines 280-289).

      “Although we studied TMS and tACS propagation through the E-field modeling and observed an increase in the precuneus gamma oscillatory activity, excitability and connectivity with the hippocampi, we cannot exclude that our results might reflect the consequences of stimulating more superficial parietal regions other than the precuneus nor report direct evidence of microscopic changes in the brain after the stimulation. Invasive neurophysiological recordings in humans for this type of study are not feasible due to ethical constraints. Studies on cadavers or rodents would not fully resolve our question due to significant differences between them (i.e. rodents do not have an anatomical correspondence while cadavers have an alterations in electrical conductivity occurring in postmortem tissue). However, further exploration of this aspect in future studies would help in the understanding of γtACS+iTBS effects.”

      (2) Address all the technical questions about the experimental design.

      We addressed all the technical questions about the experimental design.

      (3) Repeat the experiments with randomized trial order and without a block design.

      The experiments were conducted with randomized trial order and we did not use a block design.

      (4) Add many more faces to the study. It is extremely difficult to draw any conclusion from merely 12 faces. Ideally, there would be lots of other relevant memory experiments where the authors show compelling positive results.

      We understand your perplexity about drawing conclusions from 12 faces, however, this is not the case. As we explained in the response reviewer, the task we implemented did not rely on the recall of merely 12 faces. Instead, participants had to correctly learn, associate and recall 12 faces, 12 names and 12 occupations for a total of 36 items. To improve the clarity of the manuscript, we added a paragraph to make this aspect more explicit (lines 425-430).

      “We considered a correct association when a subject was able to recall all the information for each item (i.e. face, name and occupation), resulting in a total of 36 items to learn and associate. To further investigate the effect on FNAT we also computed a partial recall score accounting for those items where subjects correctly matched only names with faces (FNAT NAME) and only occupations with faces (FNAT OCCUPATION). See supplementary information for score details.”

      The behavioral changes we observed are similar to those who are typically observed after multiple stimulation sessions (Koch et al., NeuroImage, 2018; Grover et al., Nature Neuroscience, 2022, Benussi et al., Annals of Neurology, 2022). Moreover, memory performance changes are often measured by a limited set of stimuli due to methodological constraints related to memory capacity. For example, Rey Auditory Verbal learning task, requiring to learn and recall 15 words, is a typical test used to detect memory changes (Koch et al., Neuroimage, 2018; Benussi et al., Brain stimulation 2021; Benussi et al., Annals of Neurology, 2022). 

      (5) Provide a clear explanation of the apparent randomness of which results are statistically significant or not in Figure 3. But perhaps with many more experiments, a lot more memory evaluations, many more stimuli, and addressing all the other technical concerns, either the results will disappear or there will be a more interpretable pattern of results.

      We provided explanations for all the concerns shown by the reviewer.

      Reviewer #2 (Recommendations for the authors):

      Minor comments:

      (1) Figure 4: Why are connectivity values pre-stimulation for the iTBS and sham tACS stimulation condition so much higher than the dual stimulation? We would expect baseline values to be more similar.

      We acknowledge that the pre-stimulation connectivity values for the iTBS and sham tACS conditions appear higher than those for the dual stimulation condition. However, as noted in our statistical analyses, there were no significant differences at baseline between conditions (p-FDR= 0.3514), suggesting that any apparent discrepancy is due to natural variability rather than systematic bias. One potential explanation for these differences is individual variability in baseline connectivity measures, which can fluctuate due to factors such as intrinsic neural dynamics, participant state, or measurement noise. Despite these variations, our statistical approach ensures that any observed post-stimulation effects are not confounded by pre-existing differences.

      (2) Figure 2: How are total association scores significantly different between stimulation conditions, but individual name and occupation associations are not? Further clarification of how the total FNAT score is calculated would be helpful.

      We apologize for any lack of clarity. The total FNAT score reflects the ability to correctly recall all the information associated with a person—specifically, the correct pairing of the face, name, and occupation. Participants received one point for each triplet they accurately recalled. The scores were then converted into percentages, as detailed in the Face-Name Associative Task Construction and Scoring section in the supplementary materials.

      Total FNAT was the primary outcome measure. However, we also analyzed name and occupation recall separately to better understand their partial contributions. Our analysis revealed that the improvement in total FNAT was primarily driven by an increase in name recall rather than occupation recall.

      We acknowledge that this distinction may have caused some confusion. To improve clarity, we revised the manuscript accordingly (lines 97-98; 107-111; 425-430).

      “Dual iTBS+γtACS increased the performances in recalling the association between face, name and occupation (FNAT accuracy) both for the immediate (F<sub>2,38</sub>=7.18; p=0.002; η<sup>2</sup><sub>p</sub>=0.274) and the delayed (F<sub>2,38</sub>=5.86; p =0.006; η<sup>2</sup><sub>p</sub>=0.236) recall performances (Fig. 2, panel A).”

      “The in-depth analysis of the FNAT accuracy investigating the specific contribution of face-name and face-occupation recall revealed that dual iTBS+γtACS increased the performances in the association between face and name (FNAT NAME) delayed recall (F<sub>2,38</sub> =3.46; p =0.042; η<sup>2</sup>p =0.154; iTBS+γtACS vs. sham-iTBS+sham-tACS: 42.9±21.5 % vs. 33.8±19 %; p=0.048 Bonferroni corrected) (Fig. S4, supplementary information).”

      “We considered a correct association when a subject was able to recall all the information for each item (i.e. face, name and occupation), resulting in a total of 36 items to learn and associate. To further investigate the effect on FNAT we also computed a partial recall score accounting for those items where subjects correctly matched only names with faces (FNAT NAME) and only occupations with faces (FNAT OCCUPATION). See supplementary information for score details.”

      We also moved the data regarding the specific contribution of name and occupation recall in the supplementary information (fig.S4) and further specified how we computed the score in the score (lines 102-104).

      “The score was computed by deriving an accuracy percentage index dividing by 12 and multiplying by 100 the correct association sum. The partial recall scores were computed in the same way only considering the sum of face-name (NAME) and face-occupation (OCCUPATION) correctly recollected.”

      Reviewer #3 (Recommendations for the authors):

      A very small detail, in the caption for Figure 2A, OCCUPATION is described as being shown on the 'left' but it should be 'right'.

      We corrected this error.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      (1) Figure 1: It might be simpler to streamline  acronyms for different test cases, e.g,  E01contra, E01 ipsi (rather than EO1IPS), E02, and control. Thus, it would be possible to label  each of the three schematic panels as E01, E02, control.

      Please describe what the dots in the brain mean and move the V1 label so it does not occlude  dots.

      Please make clear that the "track reconstructions" are the bright spheres in the micrographs (there are track-like elements in some micrographs which may be tears or?)

      Thank you. We relabeled the groups as control, EO1contra, EO1ipsi, and EO2. These were  changed in all figures and in the document at several places.

      We indicated in the new caption that “Dots schematize ocular dominance columns”.

      We indicated that electrode track penetrations were the “(bright spots at right/posterior)”.

      (2) Figure 2: Should "horizontal" be vertical (line  556) of the caption? When describing the  scale bar for firing rate, please explain the meaning of italicized vs regular font.

      Please make the purple lines in Figures I and J easier to see (invisible in my PDF).

      Not quite clear what is significantly different from what when viewing the figure at a glance.  Would it be possible to clarify using standard methods?

      Yes, it should say vertical, thank you. We explained the italics (they denote the standard scale  bar size if no number is provided.)

      We changed the purple lines to yellow in all figures.

      We added comparison bars that help indicate significance.

      (3) Figures 3-5. Please make corrections like those  noted above.

      Yes, we applied the previous changes to Figures 3 - 5.

      (4) Minor. Sometimes the authors spell out temporal  frequency and sometimes abbreviate it.  Perhaps adopt a consistent style.

      Fixed, thanks.

      Reviewer #2 (Public Review):

      (1) The assessment of the tuning properties is  based on fits to the data. Presumably,  neurons for which the fits were poor were excluded? It would be useful to know what the criteria  were, how many neurons were excluded, and whether there was a significant difference  between the groups in the numbers of neurons excluded (which could further point to  differences between the groups).

      Yes, this is an important omission, thank you for catching it. We now write in methods (line 213):  “ Inclusion/exclusion: For each stimulus type, we examined  the set of all responses to visual  stimuli and blanks with an ANOVA test to evaluate the null hypothesis that the mean response  to all of these stimuli were the same; cells with a p<0.05 to this visual responsiveness test were  included in fits and analyses, and cells with p>0.05 were excluded. ”

      (2) For the temporal frequency data, low- and high-frequency  cut-offs are defined, but then  only used for the computation of the bandwidth. Given that the responses to low temporal  frequencies change profoundly with premature eye opening, it would be useful to directly  compare the low- and high-frequency cut-offs between groups, in addition to the index that is  currently used.

      We now provide this data in Figure 3 - figure supplement  1 .

      (3) In addition to the tuning functions and firing  rates that have been analyzed so far, are  there any differences in the temporal profiles of neural responses between the groups  (sustained versus transient responses, rates of adaptation, latency)? If the temporal dynamics  of the responses are altered significantly, that could be part of an explanation for the altered  temporal tuning.

      This is a great topic for future studies. Unfortunately, with drifting gratings, it is difficult to  establish these properties, which could be better assessed with standing or  square-wave-modulated gratings or other stimuli. We did not run standing gratings in our battery  of stimuli for this initial study.

      (4) It would be beneficial for the general interpretation  of the results to extend the discussion. First, it would be useful to provide a more detailed discussion of what type of visual information might make it through the closed eyelids (the natural state), in contrast to the structured  information available through open eyes. Second, it would be useful to highlight more clearly  that these data were collected in peripheral V1 by discussing what might be expected in  binocular, more central V1 regions. Third, it would be interesting to discuss the observed  changes in firing rates in the context of the development of inhibitory neurons in V1 (which still  undergo significant changes through the time period of premature visual experience chosen  here).

      Thank you, good ideas. Let’s take these three suggestions in turn.

      First, in the discussion, we added a subsection “ Biology  of early development in mustelids ” that  focuses on the developmental conditions of wild and laboratory animals:

      In the wild, mustelids raise their young in nests in the ground, in cavities such as holes in trees  or caves, or in areas of dense vegetation (Ruggiero et al. 1994). They may move the young  from one nest to another as they grow, but otherwise the young are primarily in the relatively  dark nest. It is highly likely that some light penetrates and that information about the 24-hour  cycle is available, but the light is likely to be dim and unlikely to provide a basis for high  luminance, high contrast stimulation through the closed lids. The animals begin to spend  substantial time outside the nest after eye opening.

      The ferret is a domesticated strain of the European polecat. In laboratory settings, ferret  jills give birth and keep their kits in a nest box. A laboratory typically maintains a 24-hour cycle  with 12 or 14 hours of light, and the light reaching the closed lids must first pass through the  cage, the nest box, and the nesting material. Therefore, developing ferrets have an obvious  circadian light signal but the light available for image formation is likely dim and of low contrast.

      Although the light that reaches the close lids in developing ferrets is likely to be relatively  dim, and any image-forming signal passing through the closed lids would be highly filtered in  luminance, spatial frequency, and contrast, it is important to remember that visual input before  natural eye opening (through the closed lids) can drive activity in retina, LGN, and cortex  (Huttenlocher 1967, Chapman and Stryker 1993, Krug et al., 2001, Akerman et al., 2002,Akerman et al., 2004). Further, orientation selectivity can be observed through the closed lids  (Krug et al., 2001), indicating that some coarse image-forming information does make it through  the closed lids.

      Second, we added text speculating about binocular cortex (lines 492 - 500): … our recordings  were performed in monocular cortex so that we could be sure of the developmental condition of  the eye that drove the classic responses. It is interesting to speculate about what might occur  more centrally in binocular visual cortex. Ocular dominance shifts are not induced when one eye  is opened prematurely (Issa et al 1999), indicating that ocular dominance plasticity is not  engaged at this early stage, but one might imagine that the impacts on temporal frequency and  spontaneous firing rates would still be present.

      Third, on inhibition, we added a paragraph (lines 502 - 509):

      We introduced premature patterned vision at a time when cortical inhibition is undergoing  substantial changes. GABAergic signaling has already undergone its switch (Ben-Ari, 2002)  from providing primarily depolarizing input to hyperpolarizing input by P21-23 (Mulholland et al.,  2021). In the days prior to eye opening, inhibitory cells exhibit activity that is closely associated  with the emerging functional modules that will reflect orientation columns (Mulholland et al.,  2021), but do not yet exhibit selectivity to orientation, in contrast to excitatory neurons, which do  exhibit selectivity to orientation at that time (Chang and Fitzpatrick, 2022).

      (5) In the methods section, the statement 'actively  kept in nesting box' is unclear. Presumably  this means that the jill prevents the kits from leaving the nesting box? It also would be worth at  least mentioning in this context that there obviously are still visual events in the nesting box too.

      Thanks. We improved this description (lines 118 - 121):  Ferret kits in laboratory housing receive  limited visual stimulation through their closed lids, as the mother actively keeps the kits in their  relatively dark nest . In order to ensure that animals  with early-opened eyes actually had  patterned visual experience  (and animals with closed  lids had the same stimulation filtered  through the lids) , animals were brought to the lab  for 2 hours a day for 4 consecutive days  beginning at P25.

      (6) The stimulus presentation could be more clearly  described. Is every stimulus presented in  an individual trial (surrounded by periods with a blank screen), or are all stimuli shown as a  continuous sequence? The description of the parameter screening is also potentially confusing  ('orientation was co-varied with stimuli consisting of drifting gratings at different spatial  frequencies' sounds as if there are separate stimuli for orientation; might be better to say  something like 'in the first set, orientation, spatial frequency, ... were covaried...')

      Yes, thank you, we fixed this (lines 184 - 201). We deleted the text indicated and added a  sentence “Each individual grating stimulus was full screen and had a single set of parameters  (direction, spatial frequency, temporal frequency), and was separated from the other stimuli by a  gray screen interstimulus interval.”. We also deleted a repetition of 100% contrast in the  description of the second set.

      (7) Description of low-pass index is unclear. What  is the 'largest temporal frequency response  observed'? The maximum response or the response to the largest temporal frequency tested?

      Thanks. We added a paragraph at line 236:

      We defined a low pass index as the response to the lowest temporal frequency tested (in this case 0.5 Hz) to the maximum response obtained to the set of temporal frequencies shown. LPI =  R(TF=0.5 Hz)/max(R(TF=0.5Hz), R(TF=1Hz), … R(TF=32Hz)).  If a cell exhibited the highest  firing for a temporal frequency of 0.5 Hz, then it would have an low pass index of 1. If it  exhibited a similar firing rate in response to a temporal frequency of 0.5 Hz even if the preferred  temporal frequency were higher, then the low pass index would still be near 1. If the cell  responded poorly at a temporal frequency of 0.5 Hz, then it would have a low pass index near 0.

      (8) The discussion should also cite the results  of strobe-reared cats by Pasternak et al (1981  and 1985).

      Thank you for pointing out the omission. We now write (lines 430-435):  Cats raised in a  strobe-light environment (mostly after eye opening) exhibited strong changes in subsequent  direction selectivity (Kennedy and Orban 1983; Humphrey and Saul 1998)  and behavioral  sensitivity to motion (Pasternak et al., 1981; Pasternak et al., 1985) that partially recovers with  motion detection training . However, temporal frequency  tuning of these animals has not been  reported in detail.  Pasternak et al (1981) reported  that strobe-reared ferrets exhibited greater  difficulty in distinguishing slow moving stimuli from static stimuli compared to controls, an  ability that slightly improved with practice, suggesting possible temporal frequency deficits.

      (9) Finally, it would be useful to include a mention  of the early development of MT in  marmosets in the discussion of impacts of prematurity on motion vision (Bourne & Rosa 2006).

      Yes, thank you. We cited Bourne & Rosa and also Lempel and Nielsen (for ferret PSS). (Lines  492-501):

      Several other basic mechanistic questions remain unanswered. It is unclear where in the visual  circuit cascade these deficits first arise. Does the lateral geniculate nucleus or retina exhibit  altered temporal frequency tuning? Is the influence of the patterned visual stimulation  instructive, so that if one provided premature stimulation with only certain temporal frequencies,  one would see selectivity for those temporal frequencies, or would tuning always be broad?  Other questions remain concerning the top-down influence on V1 from “higher” motion areas  such as MT (monkeys) or PSS (ferret); MT exhibits mature neural markers earlier than V1  (Bourne and Rosa, 2006), and suppression of PSS impacts motion selectivity in V1 (Lempel and  Nielsen, 2021).  Future studies will be needed to  address these questions.

    2. Reviewer #2 (Public review):

      In this paper, Griswold and Van Hooser investigate what happens if animals are exposed to patterned visual experience too early, before its natural onset. To this end, they make use of the benefits of the ferret as a well-established animal model for visual development. Ferrets naturally open their eyes around postnatal day 30; here, Griswold and Van Hooser opened either one or both eyes prematurely. Subsequent recordings in the mature primary visual cortex show that while some tuning properties like orientation and direction selectivity developed normally, the premature visual exposure triggered changes in temporal frequency tuning and overall firing rates. These changes were widespread, in that they occurred even for neurons responding to the eye that was not opened prematurely. These results demonstrate that the nature of the visual input well before eye opening can have profound consequences on the developing visual system.

      The conclusions of this paper are well supported by the data, but in the initially submitted version of the paper, there were a few questions regarding the data processing and suggestions for the discussion:

      (1) The assessment of the tuning properties is based on fits to the data. Presumably, neurons for which the fits were poor were excluded? It would be useful to know what the criteria were, how many neurons were excluded, and whether there was a significant difference between the groups in the numbers of neurons excluded (which could further point to differences between the groups).

      (2) For the temporal frequency data, low- and high-frequency cut-offs are defined, but then only used for the computation of the bandwidth. Given that the responses to low temporal frequencies change profoundly with premature eye opening, it would be useful to directly compare the low- and high-frequency cut-offs between groups, in addition to the index that is currently used.

      (3) In addition to the tuning functions and firing rates that have been analyzed so far, are there any differences in the temporal profiles of neural responses between the groups (sustained versus transient responses, rates of adaptation, latency)? If the temporal dynamics of the responses are altered significantly, that could be part of an explanation for the altered temporal tuning.

      (4) It would be beneficial for the general interpretation of the results to extend the discussion. First, it would be useful to provide a more detailed discussion of what type of visual information might make it through the closed eyelids (the natural state), in contrast to the structured information available through open eyes. Second, it would be useful to highlight more clearly that these data were collected in peripheral V1 by discussing what might be expected in binocular, more central V1 regions. Third, it would be interesting to discuss the observed changes in firing rates in the context of the development of inhibitory neurons in V1 (which still undergo significant changes through the time period of premature visual experience chosen here).

    1. Mức điểm 2: Gia sư có thể sử dụng các công cụ ClassIn cơ bản và trao quyền cho học sinh chủ động tương tác với các công cụ giảng dạy. Mức điểm 3: Gia sư sử dụng hiệu quả các công cụ ClassIn cơ bản và nâng cao (VD: poll, timer, breakout room) và trao quyền cho học sinh chủ động tương tác với các công cụ giảng dạy. Mức điểm 4: Gia sư sử dụng hiệu quả và trao quyền cho học sinh tương tác với các công cụ ClassIn cơ bản và nâng cao (VD: poll, timer, breakout room). Gia sư cũng có thể sử dụng hiệu quả các web học trực tuyến khác (VD: Kahoot, Random Wheel, Blooket).

      Hiện tại em đã sử dụng tốt các công cụ cơ bản và có trao quyền cho học sinh tương tác. Tuy nhiên, em chưa thấy rõ tính ứng dụng thực tiễn của các công cụ nâng cao, hoặc thậm chí chưa biết đến sự tồn tại của một số công cụ đó 😲. Em mong được hướng dẫn thêm các ví dụ cụ thể để hiểu cách áp dụng hiệu quả hơn.

    2. Mức điểm 2: Gia sư ghi nhận nỗ lực của học sinh và khen ngợi học sinh chung chung (VD: Great job, good girl, wonderful). Mức điểm 3: Gia sư có khen và động viên học sinh chung chung + gọi tên học sinh + ngôn ngữ cơ thể (VD: Great job, Nam + thumbs up). Mức điểm 4: Gia sư có khen và động viên học sinh + gọi tên học sinh + dùng ngôn ngữ cơ thể và có nêu ra cụ thể sự tiến bộ của học sinh (VD: Great job, Nam, now you can remember five words instead of four + thumbs up).

      Hiện tại em thường sử dụng lời khen ngắn gọn, đơn giản như “Good job!”, “Yes!”, “OK” nhằm giúp học sinh nhận biết rằng mình đang làm đúng hoặc sai. Em cho rằng:

      ✅ Mục tiêu chính của lời khen là phản hồi kịp thời, giúp học sinh điều chỉnh hành vi, không nhất thiết phải cụ thể hoặc phức tạp.

      🧠 Em đề cao sự tự chủ của học sinh – em mong các em học cách tự đánh giá, tự nhận ra sự tiến bộ và cảm thấy vui vì chính mình, chứ không hoàn toàn phụ thuộc vào lời khen từ giáo viên.

      🤝 Em hiểu rằng việc khen ngợi cụ thể, sát sao có thể giúp học sinh thấy được sự quan tâm và xây dựng mối quan hệ tốt hơn, nhưng điều này cũng đòi hỏi thời gian, quan sát kỹ và sự đầu tư cảm xúc lớn từ giáo viên.

      🎯 Em đồng ý rằng mình nên cố gắng quan tâm hơn, đặc biệt với những học sinh còn rụt rè, nhút nhát, chưa có khả năng tự đánh giá bản thân. Tuy nhiên, em mong có sự linh hoạt trong cách tiếp cận – để giáo viên có thể lựa chọn giữa khen ngợi cụ thể hay đơn giản, tùy theo hoàn cảnh và phong cách dạy học của mình.

    3. Mức điểm 2: Gia sư tổng kết lại toàn bộ nội dung của bài học. Mức điểm 3: Gia sư sử dụng các phương pháp khác nhau để tổng kết lại những nội dung mà học sinh gặp khó khăn trong bài học. Mức điểm 4: Gia sư tổ chức các hoạt động hiệu quả, sáng tạo (game) để giúp học sinh tổng kết các nội dung quan trọng trong bài học.

      Hiện tại, em đang thực hiện tổng kết bài học một cách đơn giản: nhắc lại các điểm chính và đặt một vài câu hỏi kiểm tra kiến thức để học sinh trả lời ☺️

      Em quan niệm rằng sau khi đã hoàn thành quá trình giảng dạy, phần tổng kết chỉ cần nhẹ nhàng, giúp học sinh nhìn lại nhanh kiến thức đã học, không nhất thiết phải tổ chức quá cầu kỳ.

    4. Mức điểm 2: Gia sư sử dụng các hình ảnh gợi ý và đồ vật để kiểm tra sự hiểu biết của học sinh. Mức điểm 3: Gia sư sử dụng đa dạng phương pháp (cử chỉ, ngôn ngữ cơ thể, hình ảnh và đồ vật) để giúp học sinh giao tiếp. Mức điểm 4: Gia sư ghi nhận và mở rộng những chia sẻ của học sinh dựa trên nhận thức và kinh nghiệm của học sinh/giáo viên.

      Hiện tại em đang ở mức điểm 2 – em có sử dụng hình ảnh và đồ vật để hỗ trợ học sinh giao tiếp. Tuy nhiên, em gặp một số khó khăn để tiến xa hơn:

      🔍 Kết nối sâu sắc là điều không dễ: Ngay cả với giáo viên là người Việt như em, việc thiết lập những kết nối sáng tạo và thực sự sâu sắc với học sinh là điều rất khó, vì bị giới hạn bởi cả ngôn ngữ, văn hóa lẫn bối cảnh lớp học.

      🙁 Câu hỏi mở thường không có “mở”: Những dạng câu hỏi như “Do you like...?” hoặc “What do you do after school?” về lý thuyết là "câu hỏi mở", nhưng trên thực tế chỉ dẫn đến những câu trả lời ngắn, không tạo được đà tương tác.

      🔤 Năng lực ngôn ngữ là rào cản đôi chiều: * Học sinh có vốn tiếng Anh còn hạn chế, nên dù có động lực chia sẻ, các em cũng khó diễn đạt. * Giáo viên cũng không thể “vượt ngôn ngữ” để dẫn dắt sâu, trừ khi có kỹ thuật hỗ trợ cực kỳ cụ thể và phù hợp với trình độ.

      🧠 Khái niệm “hỗ trợ phát triển ngôn ngữ” rất mơ hồ nếu không được làm rõ: Việc kỳ vọng giáo viên "phản hồi và mở rộng trải nghiệm học sinh" cần có mô hình, ví dụ minh họa cụ thể. Nếu không, giáo viên rất dễ rơi vào tình trạng “biết nên làm gì, nhưng không biết làm sao”.

      📌 Em nghĩ rằng ngay cả đội học liệu cũng sẽ gặp khó khăn trong việc clarify (làm rõ) yêu cầu này nếu không tiếp cận một cách hệ thống:

      🎯 Kỳ vọng của em: Em không mong hướng dẫn hoàn hảo, nhưng rất cần những chỉ dẫn đủ cụ thể – đơn giản – hiệu quả để: * Vượt qua sự mơ hồ * Làm được điều nhỏ trước, rồi mới đến sáng tạo sâu

    5. Mức điểm 2: Gia sư đặt những câu hỏi liên quan để liên hệ kiến thức nền của học sinh với các khái niệm chính của bài học. Mức điểm 3: Gia sư vận dụng những phương pháp sáng tạo (video/ câu truyện) để tạo cơ hội liên hệ kiến thức nền và trải nghiệm của học sinh với các khái niệm chính của bài học. Mức điểm 4: Gia sư tạo cơ hội cho học sinh thảo luận theo cặp/nhóm để liên hệ kiến thức nền và trải nghiệm của học sinh với bài học.

      Hiện tại, em mới đạt được mức 2 – em có thể đặt các câu hỏi liên quan để liên hệ kiến thức nền của học sinh với bài học. Tuy nhiên, để đạt được mức 3 và 4, em nhận thấy cần đầu tư thêm thời gian cho việc chuẩn bị bài giảng (tìm kiếm video, hình ảnh, tình huống, hoạt động phù hợp...). Em hy vọng bên học liệu có thể hỗ trợ thiết kế sẵn các ý tưởng khởi động sáng tạo hoặc hoạt động liên hệ trải nghiệm để giảm tải phần chuẩn bị cho giáo viên ạ.

    6. Mức điểm 1: Gia sư đưa ra các hướng dẫn bằng ngôn từ một cách rõ ràng trong mỗi hoạt động giảng dạy. Mức điểm 2: Gia sư sử dụng hiệu quả bộ câu hỏi kiểm tra hướng dẫn (Instruction Checking Questions - ICQs) để kiểm tra mức độ hiểu của học sinh về các chỉ dẫn. Mức điểm 3: Giáo viên đưa hướng dẫn một cách hiệu quả bằng cách sử dụng lời nói và ngôn ngữ cơ thể để giúp học sinh hiểu rõ những gì họ cần làm trong một hoạt động. Mức điểm 4: Học sinh có thể hiểu và thực hành được ít nhất 80% hoạt động trong lớp theo hướng dẫn của Gia sư trong các hoạt động/nhiệm vụ.

      Em đang ở mức điểm 1. Trong giờ học, em thường đưa ra hướng dẫn bằng lời một cách rõ ràng, sau đó kiểm tra sự hiểu của học sinh bằng cách quan sát hành vi thực tế đúng/sai (true/false behaviour checking) – ví dụ như học sinh có làm đúng yêu cầu không – thay vì sử dụng các câu hỏi kiểm tra chỉ dẫn (ICQs). Em thấy đây là cách nhanh và hiệu quả trong bối cảnh lớp học hiện tại.

      Ngoài ra, em rất ấn tượng với cách sử dụng ngôn ngữ cơ thể của một số giáo viên để tăng sự rõ ràng và sinh động. Tuy nhiên, em chưa dành thời gian luyện tập kỹ năng này, nên vẫn chưa áp dụng được nhiều. Em mong muốn sẽ cải thiện điều này trong thời gian tới.

    1. 8???? # ??????? 9 ??? ????/ # )l?+?? ?%- .//???? j0q-R-??????? ?? ??ª?? )n??? ?? £ ? <} )Q %?."š .Q ?? ?75? ³07 9?3U?? KL?3?O-??O?? ?? 6?}?? # ?)- )'U?? < <€ )? »? ?‹q? ?? <', M?‚?W. ¼• k? Ty? !? ??^%‚* J??q ?? ?6?4,Q ??½ T< ? %-Q U* ›?!??? 6?X #?$¤? ƒ" ??+,?{j?+" ??" )?%! ?? 2?! ? . 3U+?? # ??'?? ? Z?¾ 6?4,]? K75?j5 : "??c ??? ??%?? ?… ? ??? ??³ ??? T<???? M?, / ?? # <??4??" =Q )3???? ?? Z??? ?- 4, - ¿?}?'?)#%?~be5( )???q (??? ?75 ›?!u # ) ? £ €?? ?.s…? /%4Š . ?+3? T 5?3!?? # 2?! ̄!Š (??? ?<^ ?<}?\a~š8. ?" n?3???? ?'??? ???????? .<+??" ? 4 ?? ?75 ?< F ? B # KcdQ ?? A5Q ?? ? ??? œ -j?????? ›?!??? 6?X # T< ? %-Q .? ) '‘ ??<^? ?+3? T 5?!?? # I?]\a”b8 .?"T< ? %-Q ????, ›?,? ?5??? ??- ,? ????? ™%‚" ?+3? T 5?3!?? # ?<^? ?\a””8. ?"6%^]? $?% /".?%-???+?? <4Š <? ? <?€? =] ?. ?" T 3À # ?3??!??4S?" ?+? U? ?A&?m? ?- ????? ?\aa\8. 6?4,Q ??½ T< ? %-Q U ?; ?? 6?X #? .? A?3?S? <', < ̈Q ?%0<?? ‡ 8?3, )3C 73+? ?3; ?? Q<- )Q Á"? ?T< ? %-Q 6?4,Q # R"?'?? $Q ???`,\ae~ ±?%" ? 4??? ?8–f? μ?L < - ?+? T U,. ??? ?'!S? K75 #?–? ?+ -˜ ™%‚ T<, ??4?? ?3?"?+?? <0??? ?Z?C ?? ??????? ??????? ?+4? ?? PÂ?%F? ?? ??4? ?? ® Z?C ?.a ?T<3 ? %-Q ? ?€? ?? 6?4,]? A5Q $Q ? 0q /?? ‡ ? œ '? ? n? ?? )??; ? ???????? ??????? # R¾ ?Q (?0 0 # // )Ã? J? C?[} U??? ??'0 6?4,Q.\b ?]? ??3+? ???'+C]? ??H??? ?? < < ?? ?! $?0 )Q T< ? %-Q ?, ¶ ,? ?3??? ? c??d?????? ???* ??????%???? ??+?????0 ?g<!?? ??H??? œ -? ?????????? ???'?. š(?0 ?,%4X .???4? ?? ?@?? ??& ? D @EF @*G ???@? ™ ?›-?? PC ? ?\a. {™ ?›-???? PC ??{. a™ ?›-???? PC ??\b{. \b™ ?›-???? PC ??\a.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      Phytophathogens including fungal pathogens such as F. graminearum remain a major threat to agriculture and food security. Several agriculturally relevant fungicides including the potent Quinofumelin have been discovered to date, yet the mechanisms of their action and specific targets within the cell remain unclear. This paper sets out to contribute to addressing these outstanding questions.

      We appreciate the reviewer's accurate summary of our manuscript.

      Strengths:

      The paper is generally well-written and provides convincing data to support their claims for the impact of Quinofumelin on fungal growth, the target of the drug, and the potential mechanism. Critically the authors identify an important pyrimidine pathway dihydroorotate dehydrogenase (DHODH) gene FgDHODHII in the pathway or mechanism of the drug from the prominent plant pathogen F. graminearum, confirming it as the target for Quinofumelin. The evidence is supported by transcriptomic, metabolomic as well as MST, SPR, molecular docking/structural biology analyses.

      We appreciate the reviewer's recognition of the strengths of our manuscript.

      Weaknesses:

      Whilst the study adds to our knowledge about this drug, it is, however, worth stating that previous reports (although in different organisms) by Higashimura et al., 2022 https://pmc.ncbi.nlm.nih.gov/articles/PMC9716045/ had already identified DHODH as the target for Quinofumelin and hence this knowledge is not new and hence the authors may want to tone down the claim that they discovered this mechanism and also give sufficient credit to the previous authors work at the start of the write-up in the introduction section rather than in passing as they did with reference 25? other specific recommendations to improve the text are provided in the recommendations for authors section below.

      We appreciate the reviewer's suggestion. In the revised manuscript, we have incorporated the reference in the introduction section and expanded the discussion of previous work on quinofumelin by Higashimura et al., 2022 in the discussion section to more effectively contextualize their contributions. Moreover, we have made revisions and provided responses in accordance with the recommendations.

      Reviewer #2 (Public review):

      Summary:

      In the current study, the authors aim to identify the mode of action/molecular mechanism of characterized a fungicide, quinofumelin, and its biological impact on transcriptomics and metabolomics in Fusarium graminearum and other Fusarium species. Two sets of data were generated between quinofumelin and no treatment group, and differentially abundant transcripts and metabolites were identified. The authors further focused on uridine/uracil biosynthesis pathway, considering the significant up- and down-regulation observed in final metabolites and some of the genes in the pathways. Using a deletion mutant of one of the genes and in vitro biochemical assays, the authors concluded that quinofumelin binds to the dihydroorotate dehydrogenase.

      We appreciate the reviewer's accurate summary of our manuscript.

      Strengths:

      Omics datasets were leveraged to understand the physiological impact of quinofumelin, showing the intracellular impact of the fungicide. The characterization of FgDHODHII deletion strains with supplemented metabolites clearly showed the impact of the enzyme on fungal growth.

      We appreciate the reviewer's recognition of the strengths of our manuscript.

      Weaknesses:

      Some interpretation of results is not accurate and some experiments lack controls. The comparison between quinofumelin-treated deletion strains, in the presence of different metabolites didn't suggest the fungicide is FgDHODHII specific. A wild type is required in this experiment.

      Potential Impact: Confirming the target of quinofumelin may help understand its resistance mehchanism, and further development of other inhibitory molecules against the target.

      The manuscript would benefit more in explaining the study rationale if more background on previous characterization of this fungicide on Fusarium is given.

      We appreciate the reviewer's suggestion. Under no treatment with quinofumelin, mycelial growth remains normal and does not require restoration. In the presence of quinofumelin treatment, the supplementation of downstream metabolites in the de novo pyrimidine biosynthesis pathway can restore mycelial growth that is inhibited by quinofumelin. The wild-type control group is illustrated in Figure 4. Figure 5b depicts the phenotypes of the deletion mutants. With respect to the relationship among quinofumelin, FgDHODHII, and other metabolites, quinofumelin specifically targets the key enzyme FgDHODHII in the de novo pyrimidine biosynthesis pathway, disrupting the conversion of dihydroorotate to orotate, which consequently inhibits the synthesis downstream metabolites including uracil. In our previous study, quinofumelin not only exhibited excellent antifungal activity against the mycelial growth and spore germination of F. graminearum, but also inhibited the biosynthesis of deoxynivalenol (DON). We have added this part to the introduction section.

      Reviewer #3 (Public review):

      Summary:

      The manuscript shows the mechanism of action of quinofumelin, a novel fungicide, against the fungus Fusarium graminearum. Through omics analysis, phenotypic analysis, and in silico approaches, the role of quinofumelin in targeting DHODH is uncovered.

      We appreciate the reviewer's accurate summary of our manuscript.

      Strengths:

      The phenotypic analysis and mutant generation are nice data and add to the role of metabolites in bypassing pyrimidine biosynthesis.

      We appreciate the reviewer's recognition of the strengths of our manuscript.

      Weaknesses:

      The role of DHODH in this class of fungicides has been known and this data does not add any further significance to the field. The work of Higashimura et al is not appreciated well enough as they already showed the role of quinofumelin upon DHODH II.

      There is no mention of the other fungicide within this class ipflufenoquin, as there is ample data on this molecule.

      We appreciate the reviewer's suggestion. We sincerely appreciate the reviewer's insightful comment regarding the work of Higashimura et al. We agree that their investigation into the role of quinofumelin in DHODH II inhibition provides critical foundational insights for this field. In the revised manuscript, we have incorporated the reference in the introduction section and expanded the discussion of their work in the discussion section to more effectively contextualize their contributions. The information regarding action mechanism of ipflufenoquin against filamentous fungi was added in discussion section.

      Reviewer #1 (Recommendations for the authors):

      (1) Given that the DHODH gene had been identified as a target earlier, could the authors perform blast experiments with this gene instead and let us know the percentage similarity between the FgDHODHII gene and the Pyricularia oryzae class II DHODH gene in the report by Higashimura et al., 2022.

      BLAST experiment revealed that the percentage similarity between the FgDHODHII gene and the class II DHODH gene of P. oryzae was 55.41%. We have added the description ‘Additionally, the amino acid sequence of the FgDHODHII exhibits 55.41% similarity to that of DHODHII from Pyricularia oryzae, as previously reported (Higashimura et al., 2022)’ in section Results.

      (2) Abstract:

      The authors started abbreviating new terms e.g. DEG, DMP, etc but then all of a sudden stopped and introduced UMP with no full meaning of the abbreviation. Please give the full meaning of all abbreviations in the text, UMP, STC, RM, etc.

      We have provided the full meaning for all abbreviations as requested.

      (3) Introduction section:

      The introduction talks very little about the work of other groups on quinofumelin. Perhaps add this information in and reference them including the work of Higashimura et al., 2022 which has done quite significant work on this topic but is not even mentioned in the background

      We have added the work of other groups on quinofumelin in section introduction.

      (4) General statements:

      Please show a model of the pyrimidine pathway that quinofumelin attacks to make it easier for the reader to understand the context. They could just copy this from KEGG

      We have added the model (Fig. 7).

      (5) Line 186:

      The authors did a great job of demonstrating interactions with the Quinofumelin and went to lengths to perform MST, SPR, molecular docking, and structural biology analyses yet in the end provide no details about the specific amino acid residues involved in the interaction. I would suggest that site-directed mutagenesis studies be performed on FgDHODHII to identify specific amino acid residues that interact with Quinofumelin and show that their disruption weakens Quinofumelin interaction with FgDHODHII.

      Thank you for this insightful suggestion. We fully agree with the importance of elucidating the interaction mechanism. At present, we are conducting site-directed mutagenesis studies based on interaction sites from docking results and the mutation sites of FgDHODHII from the resistant mutants; however, due to the limitations in the accuracy of existing predictive models, this work remains ongoing. Additionally, we are undertaking co-crystallization experiments of FgDHODHII with quinofumelin to directly and precisely reveal their interaction pattern

      (6) Line 76:

      What is the reference or evidence for the statement 'In addition, quinofumelin exhibits no cross-resistance to currently extensively used fungicides, indicating its unique action target against phytopathogenic fungi.

      If two fungicides share the same mechanism of action, they will exhibit cross resistance. Previous studies have demonstrated that quinofumelin retains effective antifungal activity against fungal strains resistant to commercial fungicides, indicating that quinofumelin does not exhibit cross-resistance with other commercially available fungicides and possesses a novel mechanism of action. Additionally, we have added the relevant inference.

      (7) Line 80-82:

      Again, considering the work of previous authors, this target is not newly discovered. Please consider toning down this statement 'This newly discovered selective target for antimicrobial agents provides a valuable resource for the design and development of targeted pesticides.'

      We have rewritten the description of this sentence.

      (8) Line 138: If the authors have identified DHODH in experimental groups (I assume in F. graminearum), what was the exact locus tag or gene name in F. graminearum, and why not just continue with this gene you identified or what is the point of doing a blast again to find the gene if the DHODH gene if it already came up in your transcriptomic or metabolic studies? This unfortunately doesn't make sense but could be explained better.

      The information of FgDHODHII (gene ID: FGSG_09678) has been added. We have revised this part.

      Reviewer #2 (Recommendations for the authors):

      (1) Line 40:

      Please add a reference.

      We have added the reference

      (2) Line 47:

      Please add a reference.

      We have added the reference.

      (3) Line 50:

      The lack of target diversity in existing fungicides doesn't necessarily serve as a reason for discovering new targets being more challenging than identifying new fungicides within existing categories, please consider adjusting the argument here. Instead, the authors can consider reasons for the lack of new targets in the field.

      We have revised the description.

      (4) Line 63:

      Please cite your source with the new technology.

      We have added the reference.

      (5) Line 68:

      What are you referring to for "targeted medicine", do you have a reference?

      We have revised the description and the reference.

      (6) Line 74:

      One of the papers referred to "quinoxyfen", what are the similarities and differences between the two? Please elaborate for the readership.

      Quinoxyfen, similar to quinofumelin, contains a quinoline ring structure. It inhibits mycelial growth by disrupting the MAP kinase signaling pathway in fungi (https://www.frac.info). In addition, quinoxyfen still exhibits excellent antifungal activity against the quinofumelin-resistant mutants (the findings from our group), indicating that action mechanism for quinofumelin and quinoxyfen differ.

      (7) Line 84:

      Please introduce why RNA-Seq was designed in the study first. What were the groups compared? How was the experiment set up? Without this background, it is hard to know why and how you did the experiment.

      According to your suggestions, we have added the description in Section Results. In addition, the experimental process was described in Section Materials and methods as follows: A total of 20 mL of YEPD medium containing 1 mL of conidia suspension (1×105 conidia/mL) was incubated with shaking (175 rpm/min) at 25°C. After 24 h, the medium was added with quinofumelin at a concentration of 1 μg/mL, while an equal amount of dimethyl sulfoxide was added as the control (CK). The incubation continued for another 48 h, followed by filtration and collection of hyphae. Carry out quantitative expression of genes, and then analyze the differences between groups based on the results of DESeq2 for quantitative expression.

      (8) Figures:

      The figure labeling is missing (Figures 1,2,3 etc). Please re-order your figure to match the text

      The figures have been inserted.

      (9) Line. 97:

      "Volcano plot" is a common plot to visualize DEGs, you can directly refer to the name.

      We have revised the description.

      (10) Figure 1d, 1e:

      Can you separate down- and up-regulated genes here? Does the count refer to gene number?

      The expression information for down- and up-regulated genes is presented in Figure 1a and 1b. However, these bubble plots do not distinguish down- and up-regulated genes. Instead, they only display the significant enrichment of differentially expressed genes in specific metabolic pathways. To more clearly represent the data, we have added the detailed counts of down- and up-regulated genes for each metabolic pathway in Supplementary Table S1 and S2. Here, the term "count" refers to differentially expressed genes that fall within a certain pathway.

      (11) Line 111:

      Again, no reasoning or description of why and how the experiment was done here.

      Based on the results of KEGG enrichment analysis, DEMs are associated with pathways such as thiamine metabolism, tryptophan metabolism, nitrogen metabolism, amino acid sugar and nucleotide sugar metabolism, pantothenic acid and CoA biosynthesis, and nucleotide sugar production compounds synthesis. To specifically investigate the metabolic pathways involved action mechanism of quinofumelin, we performed further metabolomic experiments. Therefore, we have added this description according the reviewer’s suggestions.

      (12) Figure 2a:

      It seems many more metabolites were reduced than increased. Is this expected? Due to the antifungal activity of this compound, how sick is the fungus upon treatment? A physiological study on F. graminearum (in a dose-dependent manner) should be done prior to the omics study. Why do you think there's a stark difference between positive and negative modes in terms of number of metabolites down- and up-regulated?

      Quinofumelin demonstrates exceptional antifungal activity against Fusarium graminearum. The results indicate that the number of reduced metabolites significantly exceeds the number of increased metabolites upon quinofumelin treatment. Mycelial growth is markedly inhibited under quinofumelin exposure. Prior to conducting omics studies, we performed a series of physiological and biochemical experiments (refer to Qian Xiu's dissertation https://paper.njau.edu.cn/openfile?dbid=72&objid=50_49_57_56_49_49&flag=free). Upon quinofumelin treatment, the number of down-regulated metabolites notably surpasses that of up-regulated metabolites compared to the control group. Based on the findings from the down-regulated metabolites, we conducted experiments by exogenously supplementing these metabolites under quinofumelin treatment to investigate whether mycelial growth could be restored. The results revealed that only the exogenous addition of uracil can restore mycelial growth impaired by quinofumelin.

      Quinofumelin exhibits an excellent antifungal activity against F. graminearum. At a concentration of 1 μg/mL, quinofumelin inhibits mycelial growth by up to 90%. This inhibitory effect indicates that life activities of F. graminearum are significantly disrupted by quinofumelin. Consequently, there is a marked difference in down- and up-regulated metabolites between quinofumelin-treated group and untreated control group. The detailed results were presented in Figures 1 and 2.

      (13) Figure 2e:

      This is a good analysis. To help represent the data more clearly, the authors can consider representing the expression using fold change with a p-value for each gene.

      To more clearly represent the data, we have incorporated the information on significant differences in metabolites in the de novo pyrimidine biosynthesis pathway, as affected by quinofumelin, in accordance with the reviewer’s suggestions.

      (14) Line 142:

      Please indicate fold change and p-value for statistical significance. Did you validate this by RT-qPCR?

      We validated the expression level of the DHODH gene under quinofumelin treatment using RT-qPCR. The results indicated that, upon treatment with the EC50 and EC90 concentrations of quinofumelin, the expression of the DHODH gene was significantly reduced by 11.91% and 33.77%, respectively (P<0.05). The corresponding results have been shown in Figure S4.

      (15) Line 145:

      It looks like uracil is the only metabolite differentially abundant in the samples - how did you conclude this whole pathway was impacted by the treatment?

      The experiments involving the exogenous supplementation of uracil revealed that the addition of uracil could restore mycelial growth inhibited by quinofumelin. Consequently, we infer that quinofumelin disrupts the de novo pyrimidine biosynthesis pathway. In addition, as uracil is the end product of the de novo pyrimidine biosynthesis pathway, the disruption of this pathway results in a reduction in uracil levels.

      (16) Figure 3:

      What sequence was used as the root of the tree? Why were the species chosen? Since the BLAST query was Homo sapiens sequence, would it be good to use that as the root?

      FgDHODHII sequence was used as the root of the tree. These selected fungal species represent significant plant-pathogenic fungi in agriculture production. According to your suggestion, we have removed the BLAST query of Homo sapiens in Figure 3.

      (17) Figure 4:

      How were the concentrations used to test chosen?

      Prior to this experiment, we carried out concentration-dependent exogenous supplementation experiments. The results indicated that 50 μg/mL of uracil can fully restore mycelial growth inhibited by quinofumelin. Consequently, we chose 50 μg/mL as the testing concentration.

      (18) Line 164:

      Why do you hypothesize supplementing dihydroorotate would restore resistance? The metabolite seemed accumulated in the treatment condition, whereas downstream metabolites were comparable or even depleted. The DHODH gene expression was suppressed. Would accumulation of dihydroorotate be associated with growth inhibition by quinofumelin? Please include the hypothesis and rationale for the experimental setup.

      DHODH regulates the conversion of dihydroorotate to orotate in the de novo pyrimidine biosynthesis pathway. The inhibition of DHODH by quinofumelin results in the accumulation of dihydroorotate and the depletion of the downstream metabolites, including UMP, uridine and uracil. Consequently, downstream metabolites were considered as positive controls, while upstream metabolite dihydroorotate served as a negative control. This design further demonstrates DHODH as action target of quinofumelin against F. graminearum. In addition, the accumulation of dihydroorotate is not associated with growth inhibition by quinofumelin; however, but the depletion of downstream metabolites in the de novo pyrimidine biosynthesis pathway is closely associated with growth inhibition by quinofumelin.

      (19) Line 168:

      I'm not sure if this conclusion is valid from your results in Figure 4 showing which metabolites restore growth.

      o minimize the potential influence of strain-specific effects, five strains were tested in the experiments shown in Figure 4. For each strain, the first row (first column) corresponds to control condition, while second row (first column) represents treatment with 1 μg/mL of quinofumelin, which completely inhibits mycelial growth. The second row (second column) for each strain represents the supplementation with 50 μg/mL of dihydroorotate fails to restore mycelial growth inhibited by quinofumelin. In contrast, the second row (third column, fourth column, fifth colomns) for each strain demonstrated that the supplementation of 50 μg/mL of UMP, uridine and uracil, respectively, can effectively restore mycelial growth inhibited by quinofumelin.

      (20) Figure 5a:

      The fact you saw growth of the deletion mutant means it's not lethal. However, the growth was severely inhibited.

      Our experimental results indicate that the growth of the deletion mutant is lethal. The mycelial growth observed originates from mycelial plugs that were not exposed to quinofumelin, rather than from the plates amended with quinofumelin.

      (21) Figure 5b:

      Would you expect different restoration of growth in the presence of quinofumelin vs. no treatment? The wild type control is missing here. Any conclusions about the relationship between quinofumelin, FgDHODHII, and other metabolites in the pathway?

      Under no treatment with quinofumelin, mycelial growth remains normal and does not require restoration. In the presence of quinofumelin treatment, the supplementation of downstream metabolites in the de novo pyrimidine biosynthesis pathway can restore mycelial growth that is inhibited by quinofumelin. The wild-type control group is illustrated in Figure 4. Figure 5b depicts the phenotypes of the deletion mutants. With respect to the relationship among quinofumelin, FgDHODHII, and other metabolites, quinofumelin specifically targets the key enzyme FgDHODHII in the de novo pyrimidine biosynthesis pathway, disrupting the conversion of dihydroorotate to orotate, which consequently inhibits the synthesis downstream metabolites including uracil.

      (22) Figure 6b:

      Lacking positive and negative controls (known binder and non-binder). What does the Kd (in comparison to other interactions) indicate in terms of binding strength?

      We tested the antifungal activities of publicly reported DHODH inhibitors (such as leflunomide and teriflunomide) against F. graminearum. The results showed that these inhibitors exhibited no significant inhibitory effects against the strain PH-1. Therefore, we lacked an effective chemical for use as a positive control in subsequent experiments. Biacore experiments offers detailed insights into molecular interactions between quinofumelin and DHODHII. As shown in Figure 6b, the left panel illustrates the time-dependent kinetic curve of quinofumelin binding to DHODHII. Within the first 60 s after quinofumelin was introduced onto the DHODHII surface, it bound to the immobilized DHODHII on the chip surface, with the response value increasing proportionally to the quinofumelin concentration. Following cessation of the injection at 60 s, quinofumelin spontaneously dissociated from the DHODHII surface, leading to a corresponding decrease in the response value. The data fitting curve presented on the right panel indicates that the affinity constant KD of quinofumelin for DHODHII is 6.606×10-6 M, which falls within the typical range of KD values (10-3 ~ 10-6 M) for protein-small molecule interaction patterns. A lower KD value indicates a stronger affinity; thus, quinofumelin exhibits strong binding affinity towards DHODHII.

      Reviewer #3 (Recommendations for the authors):

      The authors should add information about the other molecule within this class, ipflufenoquin, and what is known about it. There are already published data on its mode of action on DHODH and the role of pyrimidine biosynthesis.

      We have added the information regarding action mechanism of ipflufenoquin against filamentous fungi in discussion section.

      The work of Higashimura et al is not appreciated well enough as they already showed the role of quinofumelin upon DHODH II.

      We sincerely appreciate the reviewer's insightful comment regarding the work of Higashimura et al. We agree that their investigation into the role of quinofumelin in DHODH II inhibition provides critical foundational insights for this field. In the revised manuscript, we have incorporated the reference in the introduction section and expanded the discussion of their work in the discussion section to more effectively contextualize their contributions.

      It is unclear how the protein model was established and this should be included. What species is the molecule from and how was it obtained? How are they different from Fusarium?

      The three-dimensional structural model of F. graminearum DHODHII protein, as predicted by AlphaFold, was obtained from the UniProt database. Additionally, a detailed description along with appropriate citations has been incorporated in the ‘Manuscript’ file.

    1. Lastly, we conducted exploratory analyses where we sequentially omitted 1 to 5 dimensions of RU-SATED (i.e., six 5-dimension scores excluding regularity, satisfaction, alertness, timing, efficiency, or duration; fifteen 4-dimension scores excluding regularity-satisfaction, regularity-alertness, regularity-timing, etc.; twenty 3-dimension scores excluding regularity-satisfaction-alertness, etc.; fifteen 2-dimension scores including just regularity-satisfaction, regularity-alertness, etc.; six 1-dimension scores of individual dimensions). We then examined associations of each partial RU-SATED score with MoCA T-score, NIHTB T-score, and percent predicted values for gait speed and grip strength, adjusting for the same covariates as the primary analysis.

      Wondering if I should include this or not (I have not included the results for this part yet).

    Annotators

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Manuscript number: RC-2023-02191

      Corresponding author: Jan Rehwinkel

      1. General Statements

      The authors wish to thank all three reviewers and the Review Commons team for carefully evaluating our study. We have addressed all points raised as detailed below.

      We have thoroughly revised our bulk RNAseq analysis, which is now performed at the transcript level using the latest GENCODE release. We have updated Figure 3 and associated supplementary figures and tables. This change from gene to transcript level was important for accurate motif analysis as requested by reviewer 2: matching promoters to individual IFN-regulated transcripts – rather than aggregating all promoters per gene – avoids significant signal dilution. This strategy yields higher-resolution expression data and is biologically preferable. Indeed, several well characterised IFN-regulated RNAs (e.g., the ADAR1-202 transcript encoding the p150 isoform) originate from promoters located far from the constitutive promoters of their host genes. In our revised manuscript, we now provide in the new supplementary figure 13 the requested promoter motif analysis. Using two computational approaches – de novo motif search and analysis of a curated motif database – we find strong enrichment of interferon-stimulated response elements (ISREs) in promoters of type I IFN regulated transcripts. No other motifs reached similarly high levels of enrichment, and our analysis did not reveal differences between different type I IFNs. These new data show that all type I IFNs engage a common regulatory pathway, supporting our overall conclusion that different type I IFNs do not induce qualitatively different responses in PBMCs.

      Regrettably, in the process of analysing the bulk RNAseq data at transcript level, we noticed that our original lncRNA analysis contained numerous false positives. Closer inspection showed that many “differentially expressed” LNCipedia models were likely not full-length transcripts and commonly shared a single IFN-induced set of exons that artificially inflated expression estimates for every overlapping model. To correct this issue, we replaced LNCipedia with the latest high-quality non-coding RNA catalogue from GENCODE, most entries of which were defined by full-length RNA sequencing [1]. We also tightened our filtering criteria and now report only transcripts that are robustly expressed in our dataset and are either classified as high-confidence by GENCODE or robustly supported at every splice junction by our RNAseq.

      We hope our manuscript is sufficiently improved and suitable for publication in PLoS Biology. New or revised text is highlighted in green in our revised manuscript.

      2. Point-by-point description of the revisions


      Reviewer #1

      Evidence, reproducibility and clarity:

      The study can be directly connected to a landmark paper in the field (Mostafavi et al. , Cell 2016). By comparison with this study, the authors use improved technologies to address the question if and how responses to type I IFN differ between human peripheral blood-derived cells types. In line with Mostafavi et al. the authors conclude that only a comparably low number of interferon-stimulated genes (ISG) is induced in all cell types and that considerable differences exist between cell types in the IFN-induced transcriptome. The authors address a second relevant aspect, whether and how the many different subtypes of type I IFN differ in the way they engage IFN signals to produce transcriptome changes. The data lead the authors to conclude that any differences are of quantitative rather than qualitative nature.

      The authors' conclusions are based on a mass cytometry approach to phenotype STAT activation in different cell types, bulk RNA sequencing to study ISG expression in PBMC, and single cell sequencing to study ISG responses in individual cell types. The data are solid, clear and reproducible in biological replicates (eg different blood donors).

      Significance: While some of the data can be considered confirmatory, the comprehensive analysis of cell-type specificity and IFN-I subtype specificity advances the field and provides a reference for future analyses. The study is complete and there is no obvious lack of a critical experiment. The number of scientists interested in the multitude of open questions around type I IFN is large, thus the study is likely to attract a broad readership.

      We thank the reviewer for her/his positive assessment of our study.

      The biggest limitation is to my opinion the low sequencing depth of scRNAseq which is clearly the downside of this technology. Using 11 hematopoietic cell types and bulk RNA sequencing the total number of ISG was determined to be 975 by Mostafavi et al. and the core ISG numbered 166. This is in stark contrast to this studies' 10 core ISG. The authors limitations paragraph should discuss the fact that scRNAseq reduces the overall ISG number that can be analyzed.

      Thank you for this valid comment. We amended the limitations paragraph as requested. We agree that the Mostafavi et al. 2016 Cell paper [2] is important but note that there are many differences to our study: Mostafavi et al. use mice, a seemingly very high IFN dose (10,000 Units) and microarrays (not RNAseq).

      A minor point concerns the 25 supplementary figures of the study. There must be a better way to support the conclusions with the necessary data.

      We agree that our supplementary materials are extensive. However, this is not unusual for studies reporting multiple large datasets. We would be delighted to organise our supplementary information differently in due course according to journal guidelines.



      Reviewer #2

      Evidence, reproducibility and clarity:

      The manuscript entitled “Single-cell analysis of signalling and transcriptional responses to type I interferon" by Rigby et al. examines the response to type I IFN subtypes in PBMCs using an integrative proteomics and transcriptomics approach. Some of the analysis could be deepened to provide better insights into what governs the magnitude of change in gene expression as well as the cell type-specific response to expression and generate more excitement for the study.

      We thank the reviewer for evaluating our study and the suggestions made.

      *Major Comments: *

      • Although the authors appropriately conclude that type I IFNs induce qualitatively similar, the response is not quantitatively similar. What elements in the promoters of ISGs make them more responsive to IFN subtypes? (PMID: 32847859) We thank the reviewer for the suggestion to study the promoters of genes regulated by type I IFNs. The analyses outlined below were performed by A. Fedorov, who is now a new co-author of our study. To investigate promoter features that might underlie the observed transcriptional responses across type I IFNs, we first performed a de novo*motif search using STREME [3] on our bulk RNAseq dataset (Figure 3). Specifically, we compared the promoters of transcripts that were up- or down-regulated by each IFN subtype (e.g., IFN-β-induced) either with one another or with promoters of robustly expressed RNAs that remained unresponsive to any treatment. No significant motifs emerged from these comparisons, except when we compared promoters of IFN-induced transcripts to the background set of unresponsive RNAs. This comparison consistently yielded strong enrichment of interferon-stimulated response element (ISRE)-like motifs in the promoters of up-regulated RNAs (new Figure S13a).

      Next, we conducted a complementary analysis using known transcription factor (TF) motifs from the JASPAR database [4]. We screened all promoters of annotated RNAs using clustered JASPAR motifs and Z-standardised motif scores relative to all high-confidence GENCODE RNAs, including those not expressed in PBMCs. We reasoned that TFs actively mediating IFN responses would likely bind promoters with high motif scores (Z ≥ 2), while promoters with low scores (Z ≤ -1) would represent an unregulated background. This approach produced two sets of RNAs per TF cluster: putatively regulated and unregulated. We then restricted each set to RNAs expressed in our dataset and associated each transcript with its estimated fold change in response to each type I IFN, regardless of statistical significance. Next, we compared median fold changes between the likely regulated and unregulated sets across all TF clusters and IFN subtypes (Figure S13b). Among all tested TF motifs, only the ISRE-like cluster showed strong and consistent associations with transcriptional changes across all IFN subtypes. We also observed statistically significant but much weaker associations for other TFs, including a known negative regulator of innate antiviral signaling, NRF1 [5]. However, effect sizes for these motifs were dwarfed by those of ISRE-like motifs, suggesting that no JASPAR TFs other than those within the ISRE-like cluster play a major role in PBMCs under our conditions. Overall, these findings support the idea that all type I IFNs engage a common regulatory pathway, differing primarily in the magnitude rather than the nature of their transcriptional effects.

      How do they relate to the activation of kinases by IFN subtypes?

      We did not analyse the activation of the canonical kinases (i.e., TYK2 and JAK1) downstream of IFNAR. This would be interesting and may be possible using phospho-specific antibodies to these kinases in our CyTOF setup. However, this would require a very large investment of time and resources to identify specific antibodies, optimise a new CyTOF staining panel and to acquire and analyse new datasets. We therefore believe this should be pursued as a separate future study.

      *Are there distinct features that dictate differential responses in monocytes and lymphocytes? *

      Following the computational approach described above, we applied STREME to identify DNA motifs that could distinguish promoters associated with monocyte- and lymphocyte-specific ISGs. Regrettably, this analysis did not yield any significant motifs, likely due in part to the limited number of genes in each category.

      • Figure 2a, d-h - Consider using the same scale for all heatmaps. This will allow for comparison of pSTATs median expression. Consider increasing the range in the color scale as some of the subtle changes in STAT phosphorylation across subtypes are not well appreciated. This also applies to Supplementary figures related to Figure 2.*

      Thank you for this suggestion. We tried using the same scale for all heatmaps. However, given that the values for pSTAT1 are higher than those for other pSTATs, the resulting heatmaps did not show differences for the other pSTATs well. We therefore decided to leave these panels unchanged. Please also note that Figures 2b and S3b provide comparison between pSTATs (and other markers) using the same scale.

      Minor Comments:

      • The title of subsections are a bit generic (e.g "Analysis of the signalling response to type I IFNs using mass cytometry". Consider updating them to reflect some of the findings from each analysis.* Thank you for this suggestion. We have amended sub-headers accordingly.

      • Figure 3 and S3 - Increase the heatmap scale to better appreciate changes in gene expression.*

      The scales have been enlarged for better visibility as requested.

      • Consider combining panel a and b in figure S7 for better contrasts of the response to IFNa1 or IFNb. *

      Thank you for the suggestion. We combined these panels.

      • Figure 4 - The authors could visualize ISGs that are unique across IFN types or cell types. *

      Figure 5 and several accompanying supplementary figures already depict ISGs unique to IFN subtypes or cell types. Whilst we appreciate the suggestion, we prefer not to add additional figures to avoid redundancies.

      • The gene ontology analysis should be performed with higher statistical stringency to capture the most significant IFN responsive processes. *

      Thank you for this comment. We changed the presentation of the GO analysis in Fig S11 by sorting on p-value (instead of % of hits in category). We hope this shows more clearly that GO category enrichment amongst genes encoding IFN-induced transcripts had high statistical significance (log10 p-values of about -5 or lower for many categories).

      Significance:* ** The authors provide an extensive compendium of cell type specific changes in response to type I IFN stimulation. They have created a public repository which extends the value of this dataset. *

      Audience: *** This is a valuable resource for immunologists, virologists, and bioinformaticians.*

      Thank you for these encouraging comments.



      Reviewer #3


      Evidence, reproducibility and clarity:

      *Summary *

      Rigby and collaborators analyzed the signaling responses and changes in gene expression of human PBMCs stimulated with different IFN type I subtypes, using mass cytometry, bulk and single-cell RNA sequencing. Their study represents the first single-cell atlas of human PBMCs stimulated with five type I IFN subtypes. The generated datasets are useful resources for anyone interested in innate immunity. The data and the methods are well presented. We thus recommend publication.

      Thank you for your positive assessment of our work and for recommending publication.

      *Major comments: *

      • *

      *Two of the key conclusions are not very convincing. *

      • *

      First, the authors claim that the magnitude of the responses varied between the 5 types of IFNs, however, as they point out in the 'limitation' paragraph, doses of the different IFNs were normalized using bioactivity. Knowing that this bioactivity is based on assays performed on A549 lung cells, this normalization likely induces a bias. How do the authors explain similar antiviral bioactivity but differing magnitudes of modulation of ISG expression? Would the authors expect the same differences of expression between the several IFNs tested in A549 cells? We thus recommend being very cautious when comparing magnitude of the response between the 5 types of IFNs.

      We thank the reviewer for this important point and included the following reasoning in our discussion:

      “An important technical consideration for our study was the normalisation of type I IFN doses used to treat cells (see also ‘Limitations of the study’ below). We relied on bioactivity (U/ml) that is measured by the manufacturer of recombinant type I IFNs using a cytopathic effect (CPE) inhibition assay. In brief, the lung cancer cell line A549 is treated with type I IFN and is infected with the cytopathic encephalomyocarditis virus (EMCV). Control cells not treated with IFN are killed by EMCV, whereas cells treated with sufficient IFN survive. How, then, is it possible that different type I IFNs induce differing magnitudes of STAT phosphorylation and ISG expression despite being used at the same bioactivity? Cell survival in the CPE inhibition assay may be due to one or a few ISGs. Indeed, single ISGs can mediate powerful antiviral defence. For example, MX1 is crucial for host defence against influenza A virus [6]. Thus, similar bioactivity of different IFNs in A549 cells against EMCV-triggered cell death may not reflect the breadth of effects on many ISGs. Moreover, IFN-induced survival of A549 cells following EMCV infection is a binary readout. Induction of the relevant ISG(s) mediating protection beyond a threshold required for cell survival is unlikely to register in this assay. Thus, similar antiviral bioactivity (in the CPE inhibition assay) and differing magnitudes of modulation of ISG expression (at transcriptome level) are compatible.”

      We believe inclusion of this paragraph demonstrates an appropriate level of caution in our data interpretation. Further, we would expect to make similar observations if we were to apply transcriptomic analysis to A549 cells treated with different type I IFNs. However, given our focus in this study on primary, normal cells, we decided not to pursue work with the transformed and lab adapted A549 cell line.

      Second, the qualitatively different responses to type I IFN subtypes claimed by the authors were not apparent. This seems true at the level of the bulk population (Fig. S10) but not at cell-type level (Fig. S15/S16).

      We believe there may be a misunderstanding here. In relation to Figure S10, we do not claim “qualitatively different responses to type I IFN subtypes”. Instead, we conclude that “differences in expression between the different type I IFNs were quantitative” (page 8; lines 229-230, now: 238-239). Moreover, Figures S15/S16 (now: S16/S17) do not refer to analyses of responses to different type I IFN subtypes.

      The authors state (line 311-312) that 'Consistent with our bulk RNAseq data, differences were again quantitative rather than qualitative' at the cell-type level. The response between cell types seems very different to us since a core set of only 10 ISGs are shared by all cell types and all 5 type I IFNs. Knowing that the expression of hundreds, sometimes thousands of genes, are induced by IFN, this seems like a rather small overlap (and thus qualitatively different responses). Fig S15 and S16 nicely illustrate that the responses are qualitatively different between cell-type. Please modify this conclusion accordingly.

      Thank you for highlighting this. The statement in lines 311-312 does not refer to differences between cell types but to differences between type I IFN subtypes. We are sorry this was not clear and changed this sentence (now lines 357-358). Furthermore, we have made it clearer in the revised text that qualitative differences were observed between cell types (e.g. lines 329 and 350-352).

      *No additional experiments are needed to support the claims. However, we believe that two additional analyses could provide useful information. *

      • *

      The levels of IFNAR1 and IFNAR2 expressed at the plasma membrane probably vary between cell types and may thus influence the magnitude of the IFN response. While it would be difficult to measure these levels by flow cytometric analysis on the different cell types, could the authors extract information from their scRNAseq analysis on the expression level of IFNAR1/2 in all cell types? This would give a hint about potential differences in expression (and thus in magnitude).

      We analysed IFNAR1/2 transcript levels in our scRNAseq dataset (Figure R1 below). Unfortunately, for many cells, IFNAR1 and IFNAR2 transcripts were not detected (see width of violin plots at zero), probably due to low sequencing depth inherent to scRNAseq analysis. We therefore prefer not to draw conclusions from these data.

      Could the authors investigate further the expression of lncRNAs at the single-cell levels? It would be useful to also define a core set of lncRNAs that are shared between cell types and IFN subtypes. If such a core set does not exist (since lncRNAs are less conserved than coding genes), it would be nice to mention it.

      Thank you for this suggestion. The expression of lncRNAs is generally lower than protein-coding genes, resulting in high drop-out rates in 10X datasets. Indeed, Zhao et al. comment that “current development of single-cell technologies may not yet be optimized for lncRNA detection and quantification” [7]. We only detected a small number of lncRNAs in our scRNAseq analysis, and only four lncRNAs were significantly differentially expressed between cell types. We thus could not perform a meaningful analysis of lncRNAs in our scRNAseq dataset. This is now mentioned in the limitations paragraph at the end of the manuscript.

      Minor comments:

      There is a typo in line 355 Fig.4C =>6C.

      Thank you for spotting this.

      ***Referees cross-commenting** *

      We agree with Reviewer 1 that the low sequencing depth of scRNAseq restricts the analysis and must be discussed in the 'limitation' paragraph. This would explain why the authors identified only 10 ISGs that are common to all cell types and all 5 IFN subtypes. Of note, as a comparison, Shaw et al (10.1371/journal.pbio.2004086) identified a core set of 90 ISGs that are upregulated upon IFN treatment in cells isolated mainly from kidney and skin of nine mammalian species ("core mammalian ISGs"). It is thus expected that stimulated blood cells isolated from a single mammalian species share more than 10 ISGs.

      We amended the limitations section as requested. Shaw et al. [8] used a single type I IFN (universal or IFNα, depending on species) at a very high dose (1000 U/ml). Taken together with the use of bulk RNAseq in this study, it is unsurprising that our work identified fewer core ISGs. We believe our small list of core ISGs is nonetheless both a high confidence and a high utility set of ISGs: these genes are induced by multiple type I IFNs, in all major cell types in blood and their regulation can be measured even when sequencing depth is low.

      Significance (Required)

      *Multiple single-cell RNAseq analysis of PBMCs, stimulated or not, have been previously performed in multiple contexts (for instance with PBMCs isolated from the blood of patients infected with influenza virus or SARS-CoV-2). The technical advance is thus limited. *

      • *

      *However, the work represents a conceptual advance for the field since it provides the first single-cell atlas of PBMCs stimulated with five type-I IFN subtypes. The generated datasets represent a great resource for anyone interested in innate immunity (virologists, immunologists and cancerologists). *

      • *

      Of note, we are studying innate immunity in the context of RNA virus infection but we have no expertise on scRNA sequencing. We may thus have missed a flaw in the analyses.

      We thank the reviewer for their positive assessment of the advances of our study and the value of our IFN resource.

      A

      B

      C

      D

      Figure R1. IFNAR1/2 expression in scRNAseq data.

      Violin plots showing expression of IFNAR1 (A,C) or IFNAR2 (B,D) in different cell types. In (A,B), data were pooled across conditions. In (C,D), data are shown separately for unstimulated control cells and cells stimulated with different type I IFNs.

      References

      Kaur G, Perteghella T, Carbonell-Sala S, Gonzalez-Martinez J, Hunt T, Madry T, et al. GENCODE: massively expanding the lncRNA catalog through capture long-read RNA sequencing. bioRxiv. 2024. Epub 20241031. doi: 10.1101/2024.10.29.620654. PubMed PMID: 39554180; PubMed Central PMCID: PMCPMC11565817. Mostafavi S, Yoshida H, Moodley D, LeBoite H, Rothamel K, Raj T, et al. Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell. 2016;164(3):564-78. Epub 2016/01/30. doi: 10.1016/j.cell.2015.12.032. PubMed PMID: 26824662; PubMed Central PMCID: PMCPMC4743492. Bailey TL. STREME: accurate and versatile sequence motif discovery. Bioinformatics. 2021;37(18):2834-40. doi: 10.1093/bioinformatics/btab203. PubMed PMID: 33760053; PubMed Central PMCID: PMCPMC8479671. Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic acids research. 2024;52(D1):D174-D82. doi: 10.1093/nar/gkad1059. PubMed PMID: 37962376; PubMed Central PMCID: PMCPMC10767809. Zhao T, Zhang J, Lei H, Meng Y, Cheng H, Zhao Y, et al. NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity. The EMBO journal. 2023;42(16):e113258. Epub 20230706. doi: 10.15252/embj.2022113258. PubMed PMID: 37409632; PubMed Central PMCID: PMCPMC10425878. Grimm D, Staeheli P, Hufbauer M, Koerner I, Martinez-Sobrido L, Solorzano A, et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(16):6806-11. Epub 20070410. doi: 10.1073/pnas.0701849104. PubMed PMID: 17426143; PubMed Central PMCID: PMCPMC1871866. Zhao X, Lan Y, Chen D. Exploring long non-coding RNA networks from single cell omics data. Comput Struct Biotechnol J. 2022;20:4381-9. Epub 20220804. doi: 10.1016/j.csbj.2022.08.003. PubMed PMID: 36051880; PubMed Central PMCID: PMCPMC9403499. Shaw AE, Hughes J, Gu Q, Behdenna A, Singer JB, Dennis T, et al. Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses. PLoS Biol. 2017;15(12):e2004086. Epub 2017/12/19. doi: 10.1371/journal.pbio.2004086. PubMed PMID: 29253856.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      The manuscript entitled "Single-cell analysis of signalling and transcriptional responses to type I interferon" by Rigby et al. examines the response to type I IFN subtypes in PBMCs using an integrative proteomics and transcriptomics approach. Some of the analysis could be deepened to provide better insights into what governs the magnitude of change in gene expression as well as the cell type-specific response to expression and generate more excitement for the study.

      Major Comments:

      1. Although the authors appropriately conclude that type I IFNs induce qualitatively similar, the response is not quantitatively similar. What elements in the promoters of ISGs make them more responsive to IFN subtypes? (PMID: 32847859) How do they relate to the activation of kinases by IFN subtypes? Are there distinct features that dictate differential responses in monocytes and lymphocytes?
      2. Figure 2a, d-h - Consider using the same scale for all heatmaps. This will allow for comparison of pSTATs median expression. Consider increasing the range in the color scale as some of the subtle changes in STAT phosphorylation across subtypes are not well appreciated. This also applies to Supplementary figures related to Figure 2.

      Minor Comments:

      1. The title of subsections are a bit generic (e.g "Analysis of the signalling response to type I IFNs using mass cytometry". Consider updating them to reflect some of the findings from each analysis.
      2. Figure 3 and S3 - Increase the heatmap scale to better appreciate changes in gene expression.
      3. Consider combining panel a and b in figure S7 for better contrasts of the response to IFNa1 or IFNb.
      4. Figure 4 - The authors could visualize ISGs that are unique across IFN types or cell types.
      5. The gene ontology analysis should be performed with higher statistical stringency to capture the most significant IFN responsive processes.

      Significance

      Significance:

      The authors provide an extensive compendium of cell type specific changes in response to type I IFN stimulation. They have created a public repository which extends the value of this dataset.

      Audience:

      This is a valuable resource for immunologists, virologists, and bioinformaticians.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      This manuscript provides an initial characterization of three new missense variants of the PLCG1 gene associated with diverse disease phenotypes, utilizing a Drosophila model to investigate their molecular effects in vivo. Through the meticulous creation of genetic tools, the study assesses the small wing (sl) phenotype - the fly's ortholog of PLCG1 - across an array of phenotypes from longevity to behavior in both sl null mutants and variants. The findings indicate that the Drosophila PLCG1 ortholog displays aberrant functions. Notably, it is demonstrated that overexpression of both human and Drosophila PLCG1 variants in fly tissue leads to toxicity, underscoring their pathogenic potential in vivo.

      Strengths:

      The research effectively highlights the physiological significance of sl in Drosophila. In addition, the study establishes the in vivo toxicity of disease-associated variants of both human PLCG1 and Drosophila sl.

      Weaknesses:

      The study's limitations include the human PLCG1 transgene's inability to compensate for the Drosophila sl null mutant phenotype, suggesting potential functional divergence between the species. This discrepancy signals the need for additional exploration into the mechanistic nuances of PLCG1 variant pathogenesis, especially regarding their gain-of-function effects in vivo.

      Overall:

      The study offers compelling evidence for the pathogenicity of newly discovered disease-related PLCG1 variants, manifesting as toxicity in a Drosophila in vivo model, which substantiates the main claim by the authors. Nevertheless, a deeper inquiry into the specific in vivo mechanisms driving the toxicity caused by these variants in Drosophila could significantly enhance the study's impact.

      Reviewer #2 (Public Review):

      The manuscript by Ma et al. reports the identification of three unrelated people who are heterozygous for de novo missense variants in PLCG1, which encodes phospholipase C-gamma 1, a key signaling protein. These individuals present with partially overlapping phenotypes including hearing loss, ocular pathology, cardiac defects, abnormal brain imaging results, and immune defects. None of the patients present with all of the above phenotypes. PLCG1 has also been implicated as a possible driver for cell proliferation in cancer.

      The three missense variants found in the patients result in the following amino acid substitutions: His380Arg, Asp1019Gly, and Asp1165Gly. PLCG1 (and the closely related PLCG2) have a single Drosophila ortholog called small wing (sl). sl-null flies are viable but have small wings with ectopic wing veins and supernumerary photoreceptors in the eye. As all three amino acids affected in the patients are conserved in the fly protein, in this work Ma et al. tested whether they are pathogenic by expressing either reference or patient variant fly or human genes in Drosophila and determining the phenotypes produced by doing so.

      Expression in Drosophila of the variant forms of PLCG1 found in these three patients is toxic; highly so for Asp1019Gly and Asp1165Gly, much more modestly for His380Arg. Another variant, Asp1165His which was identified in lymphoma samples and shown by others to be hyperactive, was also found to be toxic in the Drosophila assays. However, a final variant, Ser1021Phe, identified by others in an individual with severe immune dysregulation, produced no phenotype upon expression in flies.

      Based on these results, the authors conclude that the PLCG1 variants found in patients are pathogenic, producing gain-of-function phenotypes through hyperactivity. In my view, the data supporting this conclusion are robust, despite the lack of a detectable phenotype with Ser1021Phe, and I have no concerns about the core experiments that comprise the paper.

      Figure 6, the last in the paper, provides information about PLCG1 structure and how the different variants would affect it. It shows that the His380, Asp1019, and Asp1165 all lie within catalytic domains or intramolecular interfaces and that variants in the latter two affect residues essential for autoinhibition. It also shows that Ser1021 falls outside the key interface occupied by Asp1019, but more could have been said about the potential effects of Ser1021Phe.

      Overall, I believe the authors fully achieved the aims of their study. The work will have a substantial impact because it reports the identification of novel disease-linked genes, and because it further demonstrates the high value of the Drosophila model for finding and understanding gene-disease linkages.

      Reviewer #3 (Public Review):

      Summary:

      The paper attempts to model the functional significance of variants of PLCG2 in a set of patients with variable clinical manifestations.

      Strengths:

      A study attempting to use the Drosophila system to test the function of variants reported from human patients.

      Weaknesses:

      Additional experiments are needed to shore up the claims in the paper. These are listed below.

      Major Comments:

      (1) Does the pLI/ missense constraint Z score prediction algorithm take into consideration whether the gene exhibits monoallelic or biallelic expression?

      To our knowledge, pLI and missense Z don't consider monoallelic or biallelic expression. Instead, they reflect sequence constraint and are calculated based on the observed versus expected variant frequencies in population databases.

      (2) Figure 1B: Include human PLCG2 in the alignment that displays the species-wide conserved variant residues.

      We have updated Figure 1B and incorporated the alignment of PLCG2.

      (3) Figure 4A:

      Given that

      (i) sl is predicted to be the fly ortholog for both mammalian PLCγ isozymes: PLCG1 and PLCG2 [Line 62]

      (ii) they are shown to have non-redundant roles in mammals [Line 71]

      (iii) reconstituting PLCG1 is highly toxic in flies, leading to increased lethality.

      This raises questions about whether sl mutant phenotypes are specifically caused by the absence of PLCG1 or PLCG2 functions in flies. Can hPLCG2 reconstitution in sl mutants be used as a negative control to rule out the possibility of the same?

      The studies about the non-redundant roles of PLCG1 and PLCG2 mainly concern the immune system.

      We have assessed the phenotypes in the sl<sup>T2A</sup>/Y; UAS-hPLCG2 flies. Expression of human PLCG2 in flies is also toxic and leads to severely reduced eclosion rate.

      We have updated the manuscript with these results, and included the eclosion rate of sl<sup>T2A</sup>/Y; UAS-hPLCG2 flies in the new Figure 4B.

      (4) Do slT2A/Y; UAS-PLCG1Reference flies survive when grown at 22{degree sign}C? Since transgenic fly expressing PLCG1 cDNA when driven under ubiquitous gal4s, Tubulin and Da, can result in viable progeny at 22{degree sign}C, the survival of slT2A/Y; UAS-PLCG1Reference should be possible.

      The eclosion rate of sl<sup>T2A</sup>/Y >PLCG1<sup>Reference</sup> flies at 22°C is slightly higher than at 25°C, but remains severely reduced compared to the UAS-Empty control. We have presented these results in the updated Figure S3.

      and similarly

      Does slT2A flies exhibit the phenotypes of (i) reduced eclosion rate (ii) reduced wing size and ectopic wing veins and (iii) extra R7 photoreceptor in the fly eye at 22{degree sign}C?

      The mutant phenotypes are still observed at 22 °C.

      If so, will it be possible to get a complete rescue of the slT2A mutant phenotypes with the hPLCG1 cDNA at 22{degree sign}C? This dataset is essential to establish Drosophila as an ideal model to study the PLCG1 de novo variants.

      Thank you for the suggestion. It is difficult to directly assess the rescue ability of the PLCG1 cDNAs due to the toxicity. However, our ectopic expression assays show that the variants are more toxic than the reference with variable severities, suggesting that the variants are deleterious.

      The ectopic expression strategy has been used to evaluate the consequence of genetic variants and has significantly contributed to the interpretation of their pathogenicity in many cases (reviewed in Her et al., Genome, 2024, PMID: 38412472).

      (5) Localisation and western blot assays to check if the introduction of the de novo mutations can have an impact on the sub-cellular targeting of the protein or protein stability respectively.

      Thank you for the suggestion.

      We expressed PLCG1 cDNAs in the larval salivary glands and performed antibody staining (rabbit anti-Human PLCG1; 1:100, Cell Signaling Technology, #5690). The larval salivary gland are composed of large columnar epithelia cells that are ideal for analyzing subcellular localization of proteins. The PLCG1 proteins are cytoplasmic and localize near the cell surface, with some enrichment in the plasma membrane region. The variant proteins are detected, and did not show significant difference in expression level or subcellular distribution compared to the reference. We did not include this data.

      (6) Analysing the nature of the reported gain of function (experimental proof for the same is missing in the manuscript) variants:

      Instead of directly showing the effect of introducing the de novo variant transgenes in the Drosophila model especially when the full-length PLCG1 is not able to completely rescue the slT2A phenotype;

      (i) Show that the gain-of-function variants can have an impact on the protein function or signalling via one of the three signalling outputs in the mammalian cell culture system: (i) inositol-1,4,5-trisphosphate production, (ii) intracellular Ca2+ release or (iii) increased phosphorylation of extracellular signal-related kinase, p65, and p38.

      We appreciate the reviewer’s suggestion. We utilized the CaLexA (calcium-dependent nuclear import of LexA) system (Masuyama et al., J Neurogenet, 2012, PMID: 22236090) to assess the intracellular Ca<sup>2+</sup> change associated with the expression of PLCG1 cDNAs in fly wing discs. The results show that, compared to the reference, expression of the D1019G or D1165G variants leads to elevated intracellular Ca<sup>2+</sup> levels, similar to the hyperactive S1021F and D1165H variants. However, the H380R or L597F variants did not show a detectable phenotype in this assay. These results suggest that D1019G and D1165G are hyperactive variants, whereas H380R and L597F variant are not, or their effect is too mild to be detected in this assay. We have updated the related sections in the manuscript and Figures 5A and S5.

      OR

      (ii) Run a molecular simulation to demonstrate how the protein's auto-inhibited state can be disrupted and basal lipase activity increased by introducing D1019G and D1165G, which destabilise the association between the C2 and cSH2 domains. The H380R variant may also exhibit characteristics similar to the previously documented H335A mutation which leaves the protein catalytically inactive as the residue is important to coordinate the incoming water molecule required for PIP2 hydrolysis.

      We utilized the DDMut platform, which predicts changes in the Gibbs Free Energy (ΔΔG) upon single and multiple point mutations (Zhou et al., Nucleic Acid Res, 2023, PMID: 37283042), to gain insight into the molecular dynamics changes of variants. The results are now presented in Figure S7.

      Additionally, we performed Molecular dynamics (MD) simulations. The results show that, similar to the hyperactive D1165H variant, the D1019G and D11656G variants exhibit increased disorganization, with a higher root mean square deviations (RMSD) compared to the reference PLCG1.The data are also presented in the updated Figure S7.

      (7) Clarify the reason for carrying out the wing-specific and eye-specific experiments using nub-gal4 and eyless-gal4 at 29˚C despite the high gal4 toxicity at this temperature.

      We used high temperature and high expression level to see if the mild H380R and L597F variants could show phenotypes in this condition.

      The toxicity of the two strong variants (D1019G and D1165G) has been consistently confirmed in multiple assays at different temperatures.

      (8) For the sake of completeness the authors should also report other variants identified in the genomes of these patients that could also contribute to the clinical features.

      Thank you!

      The additional variants and their potential contributions to the clinical features are listed and discussed in Table 1 and its legend.

      Reviewer #1 (Recommendations For The Authors):

      The manuscript's significant contribution is tempered by a lack of comprehensive analysis using the generated genetic reagents in Drosophila. To enhance our understanding of the PLCG1 orthologs, I suggest the following:

      (1) A more detailed molecular analysis to distinguish the actions of sl variants from the wild-type could be very informative. For example, utilizing the HA-epitope tag within the current UAS-transgenes could reveal more about the cellular dynamics and abundance of these variants, potentially elucidating mechanisms beyond gain-of-function.

      We appreciate the reviewer’s suggestion. The UAS-sl cDNA constructs contain stop codon and do not express an HA-epitope tag. Alternatively, we utilized commercially available antibodies against human PLCG1 antibodies to assess the subcellular localization and protein stability by expressing the reference and variant PLCG1 cDNAs in Drosophila larval salivary glands. The reference proteins are cytoplasmic with some enrichment along the plasma membrane. However, we did not observe significant differences between the reference and variant proteins in this assay. We did not include this data.

      (2) I suggest further investigating the relative contributions of developmental processes and acute (Adult) effects on the sl-variant phenotypes observed. For example, employing systems that allow for precise temporal control of gene expression, such as the temperature-sensitive Gal80, could differentiate between these effects, shedding light on the mechanisms that affect longevity and locomotion. This knowledge would be vital for a deeper understanding of the corresponding human disorders and for developing therapeutic interventions.

      We appreciate the reviewer’s suggestion. We utilized Tub-GAL4, Tub-GAL80<sup>ts</sup> to drive the expression of sl wild-type or variant cDNAs, and performed temperature shifts after eclosion to induce expression of the cDNAs only in adult flies. The sl<sup>D1184G</sup> variant (corresponding to PLCG1<sup>D1165G</sup>) caused severely reduced lifespan and the flies mostly die within 10 days. The sl<sup>D1041G</sup> variant (corresponding to PLCG1<sup>D1019G</sup>) led to reduced longevity and locomotion. The sl<sup>H384R</sup> variant (corresponding to PLCG1<sup>H380R</sup>) showed only a mild effect on longevity and no significant effect on climbing ability. These results suggest that the two strong variants (sl<sup>D1041G<sup> and sl<sup>D1184G</sup>) contribute to both developmental and acute effects while the H384R variant mainly contributes to developmental stages.

      I also suggest a more refined analysis of overexpression toxicity. Rather than solely focusing on ubiquitous transgene expression, overexpressing transgene in endogenous pattern using sl-t2a-Gal4 may yield a more nuanced understanding of the pathogenic mechanisms of gain-of-function mutations, particularly in the pathogenesis associated with these variants exclusively located in the coding regions.

      We appreciate the reviewer’s suggestion. We therefore performed the experiments using sl<sup>T2A</sup> to drive overexpression ofPLCG1cDNAs in heterozygous female progeny with one copy of wild-type sl+ (sl<sup>T2A</sup>/ yw > UAS-cDNAs). In this context, expression of PLCG1<sup>Reference<sup>, PLCG1<sup>H380R</sup>orPLCG1<sup>L597F</sup> is viable whereas expression of PLCG1<sup>D1019G</sup> or PLCG1<sup>D1165G</sup> is lethal, suggesting that the PLCG1<sup>D1019G</sup> and PLCG1<sup>D1165G</sup> variants exert a strong dominant toxic effect while the PLCG1<sup>H380R</sup>and PLCG1<sup>L597F<sup> are comparatively milder. Similar patterns have been consistently observed in other ectopic expression assays with varying degrees of severity. These results are updated in the manuscript and figures.

      Reviewer #2 (Recommendations For The Authors):

      The work in the paper could be usefully extended by determining the effects of expressing His380Phe and His380Ala in flies. These variants suppress PLCG1 activity, so their phenotype, if any, would be predicted not to be the same as His380Arg. Determining this would add further strength to the conclusions of the paper.

      We thank the reviewer for the constructive suggestions! We have tested the enzymatic-dead H380A variant, which still exhibits toxicity when expressed in sl<sup>T2A</sup>/Y hemizygous flies, but it is not toxic in heterozygous females suggesting that the reduced eclosion rate is likely not directly associated with enzymatic activity. We have updated the manuscript and figures accordingly.

    1. Reviewer #1 (Public review):

      Summary:

      The authors use longitudinal in vivo 1-photon calcium recordings in mouse prefrontal cortex throughout the learning of an odor-guided spatial memory task, with the goal of examining the development of task-related prefrontal representations over the course of learning in different task stages and during sleep sessions. They report replication of their previous results, Muysers et al. 2025, that task and representations in prefrontal cortex arise de novo after learning, comprising of goal selective cells that fire selectively for left or right goals during the spatial working memory component of the task, and generalized task phase selective cells that fire equivalently in the same place irrespective of goal, together comprising task-informative cells. The number of task-informative cells increases over learning, and covariance structure changes resulting in increased sequential activation in the learned condition, but with limited functional relevance to task representation. Finally, the authors report that similar to hippocampal trajectory replay, prefrontal sequences are replayed at reward locations.

      Strengths:

      The major strength of the study is the use of longitudinal recordings, allowing identification of task-related activity in the prefrontal cortex that emerges de novo after learning, and identification of sub-second sequences at reward wells.

      Weaknesses:

      (1) The study mainly replicates the authors' previously reported results about generalized and trajectory-specific coding of task structure by prefrontal neurons, and stable and changing representations over learning (Muysers et al., 2024, PMID: 38459033; Muysers et al., 2025, PMID: 40057953), although there are useful results about changes in goal-selective and task-phase selective cells over learning. There are basic shortcomings in the scientific premise of two new points in this manuscript, that of the contribution of pre-existing spatial representations, and the role of replay sequences in the prefrontal cortex, both of which cannot be adequately tested in this experimental design.

      (2) The study denotes neurons that show precise spatial firing equivalently irrespective of goal, as generalized task representations, and uses this as a means to testing whether pre-existing spatial representations can contribute to task coding and learning. A previous study using this data has already shown that these neurons preferentially emerge during task learning (Muysers et al., 2025, PMID: 40057953). Furthermore, in order to establish generalization for abstract task rules or cognitively flexibility, as motivated in the manuscript, there is a need to show that these neurons "generalize" not just to firing in the same position during learning of a given task, but that they can generalize across similar tasks, e.g., different mazes with similar rules, different rules with similar mazes, new odor-space associations, etc. For an adequate test of pre-existing spatial structure, either a comparison task, as in the examples above, is needed, or at least a control task in which animals can run similar trajectories without the task contingencies. An unambiguous conclusion about pre-existing spatial structure is not possible without these controls.

      (3) The scientific premise for the test of replay sequences is motivated using hippocampal activity in internally guided spatial working memory rule tasks (Fernandez-Ruiz et al., 2019, PMID: 31197012; Kay et al., PMID: 32004462; Tang et al., 2021, PMID: 33683201), and applied here to prefrontal activity in a sensory-cue guided spatial memory task (Muysers et al., 2024, PMID: 38459033; Symanski et al., PMID: 36480255; Taxidis et al, 2020, PMID: 32949502). There are several issues with the conclusion in the manuscript that prefrontal replay sequences are involved in evaluating behavioral outcomes rather than planning future outcomes.

      (4) First, odor sampling in odor-guided memory tasks is an active sensory processing state that leads to beta and other oscillations in olfactory regions, hippocampus, prefrontal cortex, and many other downstream networks, as documented in a vast literature of studies (Martin et al., 2007, PMID: 17699692; Kay, 2014, PMID: 24767485; Martin et al., 2014; Ramirez-Gordillo, 2022, PMID: 36127136; Symanski et al., 2022, PMID: 36480255). This is an active sensory state, not conducive to internal replay sequences, unlike references used in this manuscript to motivate this analysis, which are hippocampal spatial memory studies with internally guided rather than sensory-cue guided decisions, where internal replay is seen during immobility at reward wells. These two states cannot be compared with the expectation of finding similar replay sequences, so it is trivially expected that internal replay sequences will not be seen during odor sampling.

      (5) Second, sequence replay is not the only signature of reactivation. Many studies have quantified prefrontal replay using template matching and reactivation strength metrics that do not involve sequences (Peyrache et al., 2009, PMID: 19483687; Sun et al., 2024, PMID: 38872470). Third, previous studies have explicitly shown that prefrontal activity can be decoded during odor sampling to predict future spatial choices - this uses sensory-driven ensemble activity in prefrontal cortex and not replay, as odor sampling leads to sensory driven processing and recall rather than a reactivation state (Symanski et al., 2022, PMID: 36480255). It is possible that 1-photon recordings do not have the temporal resolution and information about oscillatory activity to enable these kinds of analyses. Therefore, an unambiguous conclusion about the existence and role of prefrontal reactivation is not possible in this experimental and analytical design.

    2. Reviewer #3 (Public review):

      In the study, the authors performed longitudinal 1P calcium imaging of mouse mPFC across 8 weeks during learning of an olfactory-guided task, including habituation, training, and sleep periods. The task had 3 arms. Odor was sampled at the end of the middle arm (named the "Sample" period). The animal then needed to run to one of the two other arms (R or L) based on the odor. The whole period until they reached the end of one of the choice arms was the "Outward" period. The time at the reward end was the "Reward" period. They noted several changes from the learning condition to the learned condition (there are some questions for the authors interspersed):

      (1) They classified cells in a few ways. First, each cell was classified as SI (spatially informative) if it had significantly more spatial information than shuffled activity, and ~50% of cells ended up being SI cells. Then, among the SI cells, they classified a cell as a TC (task cell) if it had statistically similar activity maps for R versus L arms, and a GC (goal arm cell) otherwise. Note that there are 4 kinds of these cells: outer arm TCs and GCs, and middle arm TCs and GCs (with middle arm GCs essentially being like "splitter cells" since they are not similarly active in the middle arm for R versus L trials). There was an increase in TCs from the learning to the learned condition sessions.

      (2) They analyze activity sequences across cells. They extracted 500 ms duration bursts (defined as periods of activity > 0.5 standard deviations over what I assume is the mean - if so, the authors can add "over the mean" to the burst definition in the methods). They first noted that the resulting "Burst rates were significantly larger during behavioral epochs than during sleep and during periods of habituation to the arena", and "Moreover, burst rates during correct trials were significantly lower than during error trials". For the sequence analysis, they only considered bursts consisting of at least 5 active cells. A cell's activity within the burst was set to the center of mass of calcium activity. Then they took all the sequences from all learned and learning sessions together and hierarchically clustered them based on Spearman's rank correlation between the order of activity in each pair of sequences (among the cells active in both). The iterative hierarchical clustering process produces groups (clusters) of sequences such that there are multiple repeats of sequences within a cluster. Different sequences are expressed across all the longitudinally recorded sessions. They noted "large differences of sequence activation between learning and learned condition, both in the spatial patterns (example animal in Figure 3D) and the distribution of the sequences (Figures 3D, E). Rastermap plots (Figure 3D) also reveal little similarity of sequence expression between task and habituation or sleep condition." They also note that the difference in the sequences between learning and learned conditions was larger than the difference between correct and error trials within each condition. They conclude that during task learning, new representations are established, as measured by the burst sequence content. They do additional analyses of the sequence clusters by assessing the spatial informativeness (SI) of each sequence cluster. Over learning, they find an increase in clusters that are spatially informative (clusters that tend to occur in specific locations). Finally, they analyzed the SI clusters in a similar manner to SI cells and classified them as task phase selective sequences (TSs) and goal arm selective sequences (GSs), and did some further analysis. However, they themselves conclude that the frequency of TSs and GSs is limited (I believe because most sequence clusters were non-SI - the authors can verify this and write it in the text?). In the discussion, they say, "In addition to GSs and TSs, we found that most of the recurring sequences are not related to behavior".

      (3) As an alternative to analyzing individual cells and sequences of individual cells, they then look for trajectory replay using Bayesian population decoding of location during bursts. They analyze TS bursts, GS bursts, and non-SI bursts. They say "we found correlations of decoded position with time bin (within a 500 ms burst) strongly exceeding chance level only during outward and reward phase, for both GSs and TSs (Fig 4H)." Figure 4H shows distributions indicating statistically significant bias in the forward direction (using correlations of decoded location versus time bin across 10 bins of 50 ms each within each 500-ms burst). They find that the Outward trajectories appear to reflect the actual trajectory during running itself, so they are likely not replay. But the sequences at the Reward are replay as they do not reflect the current location. Furthermore, replay at the Reward is in the forward direction (unlike the reverse replay at Reward seen in the hippocampus), and this replay is only seen in the learned and not the learning condition. At the same time, they find that replay is not seen during odor Sampling, from which they conclude there is no evidence of replay used for planning. Instead, they say the replay at the Reward could possibly be for evaluation during the Reward phase, though this would only be for the learned condition. They conclude "Together with our finding of strong changes in sequence expression after learning (Figure 3E) these findings suggest that a representation of task develops during learning, however, it does not reflect previous network structure." I am not sure what is meant here by the second part of this sentence (after "however ..."). Is it the idea that the replay represents network structure, and the lack of Reward replay in the learning condition means that the network structure must have been changed to get to the learned condition? Please clarify.

      This study provides valuable new information about the evolution of mPFC activity during the learning of an odor-based 2AFC T-maze-like task. They show convincing evidence of changes in single-cell tuning, population sequences, and replay events. They also find novel forward replay at the Reward, and find that this is present only after the animal has learned the task. In the discussion, the authors note "To our knowledge, this study identified for the first time fast recurring neural sequence activity from 1-p calcium data, based on correlation analysis."

      (1) There are some statements that are not clear, such as at the end of the introduction, where the authors write, "Both findings suggest that the mPFC task code is locally established during learning." What is the reasoning behind the "locally established" statement? Couldn't the learning be happening in other areas and be inherited by the mPFC? Or are the authors assuming that newly appearing sequences within a 500-ms burst period must be due to local plasticity? I have also pointed out a question about the statement "however, it does not reflect previous network structure" in (3) above.

      (2) The threshold for extracting burst events (0.5 standard deviations, presumably above the mean, but the authors should verify this) seems lower than what one usually sees as a threshold for population burst detection. What fraction of all data is covered by 500 ms periods around each such burst? However, it is potentially a strength of this work that their results are found by using this more permissive threshold.

    1. Reviewer #1 (Public review):

      Summary:

      This manuscript provides an open-source tool including hardware and software, and a dataset to facilitate and standardize behavioral classification in laboratory mice. The hardware for behavioral phenotyping was extensively tested for safety. The software is GUI-based, facilitating the usage of this tool across the community of investigators who do not have a programming background. The behavioral classification tool is highly accurate, and the authors deposited a large dataset of annotations and pose tracking for many strains of mice. This tool has great potential for behavioral scientists who use mice across many fields; however, there are many missing details that currently limit the impact of this tool and publication.

      Strengths:

      (1) There is software-hardware integration for facilitating cross-lab adaptation of the tool and minimizing the need to annotate new data for behavioral classification.

      (2) Data from many strains of mice were included in the classification and genetic analyses in this manuscript.

      (3) A large dataset was annotated and deposited for the use of the community.

      (4) The GUI-based software tool decreases barriers to usage across users with limited coding experience.

      Weaknesses:

      (1) The authors only report the quality of the classification considering the number of videos used for training, but not considering the number of mice represented or the mouse strain. Therefore, it is unclear if the classification model works equally well in data from all the mouse strains tested, and how many mice are represented in the classifier dataset and validation.

      (2) The GUI requires pose tracking for classification, but the software provided in JABS does not do pose tracking, so users must do pose tracking using a separate tool. Currently, there is no guidance on the pose tracking recommendations and requirements for usage in JABS. The pose tracking quality directly impacts the classification quality, given that it is used for the feature calculation; therefore, this aspect of the data processing should be more carefully considered and described.

      (3) Many statistical and methodological details are not described in the manuscript, limiting the interpretability of the data presented in Figures 4,7-8. There is no clear methods section describing many of the methods used and equations for the metrics used. As an example, there are no details of the CNN used to benchmark the JABS classifier in Figure 4, and no details of the methods used for the metrics reported in Figure 8.

    2. Reviewer #2 (Public review):

      Summary:

      This manuscript presents the JAX Animal Behavior System (JABS), an integrated mouse phenotyping platform that includes modules for data acquisition, behavior annotation, and behavior classifier training and sharing. The manuscript provides details and validation for each module, demonstrating JABS as a useful open-source behavior analysis tool that removes barriers to adopting these analysis techniques by the community. In particular, with the JABS-AI module, users can download and deploy previously trained classifiers on their own data, or annotate their own data and train their own classifiers. The JABS-AI module also allows users to deploy their classifiers on the JAX strain survey dataset and receive an automated behavior and genetic report.

      Strengths:

      (1) The JABS platform addresses the critical issue of reproducibility in mouse behavior studies by providing an end-to-end system from rig setup to downstream behavioral and genetic analyses. Each step has clear guidelines, and the GUIs are an excellent way to encourage best practices for data storage, annotation, and model training. Such a platform is especially helpful for labs without prior experience in this type of analysis.

      (2) A notable strength of the JABS platform is its reuse of large amounts of previously collected data at JAX Labs, condensing this into pretrained pose estimation models and behavioral classifiers. JABS-AI also provides access to the strain survey dataset through automated classifier analyses, allowing large-scale genetic screening based on simple behavioral classifiers. This has the potential to accelerate research for many labs by identifying particular strains of interest.

      (3) The ethograph analysis will be a useful way to compare annotators/classifiers beyond the JABS platform.

      Weaknesses:

      (1) The manuscript as written lacks much-needed context in multiple areas: what are the commercially available solutions, and how do they compare to JABS (at least in terms of features offered, not necessarily performance)? What are other open-source options? How does the supervised behavioral classification approach relate to the burgeoning field of unsupervised behavioral clustering (e.g., Keypoint-MoSeq, VAME, B-SOiD)? What kind of studies will this combination of open field + pose estimation + supervised classifier be suitable for? What kind of studies is it unsuited for? These are all relevant questions that potential users of this platform will be interested in.

      (2) Throughout the manuscript, I often find it unclear what is supported by the software/GUI and what is not. For example, does the GUI support uploading videos and running pose estimation, or does this need to be done separately? How many of the analyses in Figures 4-6 are accessible within the GUI?

      (3) While the manuscript does a good job of laying out best practices, there is an opportunity to further improve reproducibility for users of the platform. The software seems likely to perform well with perfect setups that adhere to the JABS criteria, but it is very likely that there will be users with suboptimal setups - poorly constructed rigs, insufficient camera quality, etc. It is important, in these cases, to give users feedback at each stage of the pipeline so they can understand if they have succeeded or not. Quality control (QC) metrics should be computed for raw video data (is the video too dark/bright? are there the expected number of frames? etc.), pose estimation outputs (do the tracked points maintain a reasonable skeleton structure; do they actually move around the arena?), and classifier outputs (what is the incidence rate of 1-3 frame behaviors? a high value could indicate issues). In cases where QC metrics are difficult to define (they are basically always difficult to define), diagnostic figures showing snippets of raw data or simple summary statistics (heatmaps of mouse location in the open field) could be utilized to allow users to catch glaring errors before proceeding to the next stage of the pipeline, or to remove data from their analyses if they observe critical issues.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for the authors):

      Suggestions:

      Although this study has an impressive dataset, I felt that some parts of the discussion would benefit from further explanation, specifically when discussing the differences in female aggression direction between groups with different sex compositions. In the discussion is suggested that males buffer female-on-female aggression and that they 'support' lower-ranking females (see line 212), however, the study only tested the sex composition of the group and does not provide any evidence of this buffering. Thus, I would suggest adding more information on how this buffering or protection from males might manifest (for example, listing male behaviours that might showcase this protection) or referencing other studies that support this claim. Another example of this can be found in lines 223-224, which suggests that females choose lower-ranking individuals when they are presented with a larger pool of competitors; however, in lines 227-228, it's stated that this result contradicts previous work in baboons, which makes the previous claim seem unjustified. I recommend adding other examples from studies that support the results of this paper and adding a line that addresses reasons why these differences between gorillas and baboons might be caused (for example, different social dynamics or ecological constraints). In addition, I suggest the inclusion of physiological data such as direct measures of energy expenditure, caloric intake, or hormone levels, as it would strengthen the claims made in the second paragraph of the discussion. However, I understand this might not be possible due to data or time constraints, so I suggest adding more robust justification on why lactation and pregnancy were used as a proxy for energetic need. In the methods (lines 127-128), it is unclear which phase of the pregnancy or lactation is more energetically demanding. I would also suggest adding a comment on the limitations of using reproductive state to infer energetic need. Lastly, if the data is available, I believe it would be interesting to add body size and age of the females or the size difference between aggressor and target as explanatory variables in the models to test if physiological characteristics influence female-on-female aggression.

      Male support:

      We have now added more references (Watts 1994, 1997) and enriched our arguments regarding male presence buffering aggression. Previous research suggests that male gorillas may support lower-ranking females and they may intervene in female-female conflicts (Sicotte 2002). Unfortunately, our dataset did not allow us to test for male protection. We conduct proximity scans every 10 minutes and these scans are not associated to each interaction, meaning that we cannot reliably test if proximity to a male influences the likelyhood to receive aggression.

      Number of competitors and choice of weaker competitors:

      We added a very relevant reference in humans, showing that people choose weaker competitors when they have they can choose. We removed the example to baboons because it used sex ratio and the relevance to our study was not that straightforward.

      Reproductive state as a proxy for energetic needs:

      We now mention clearly that reproductive state is an indirect measure of energetic needs.

      We rephrased our methods to: “Lactation is often considered more energetically demanding than pregnancy as a whole but the latest stages of pregnancy are highly energetically demanding, potentially even more than lactation”

      Unfortunately, we do not have access to physiological and body size data. Regarding female age, for many females, ages are estimates with errors up to a decade, and thus, we choose not to use them as a reliable predictor. Having accurate values for all these variables, would indeed be very valuable and improve the predicting power of our study.

      Recommendations for writing and presentation:

      Overall, the manuscript is well-organised and well-written, but there are certain areas that could improve in clarity. In the introduction, I believe that the term 'aggression heuristic' should be introduced earlier and properly defined in order to accommodate a broader audience. The main question and aims of the study are not stated clearly in the last paragraph of the introduction. In the methods, I think it would improve the clarity to add a table for the classification of each type of agonistic interactions instead of naming them in the text. For example, a table that showcase the three intensity categories (severe, mild and moderate), than then dives into each behaviour (e.g. hit, bite, attack, etc.) and a short description of these behaviours, I think this would be helpful since some of the behaviours mentioned can be confusing (what's the difference between attack, hit and fight?). In addition, in line 104, it states that all interactions were assigned equal intensity, which needs to be explained.

      We now define aggression heuristics in both the abstract and the first paragraph of the introduction. We have also explained aggressive interactions that their nature was not obvious from their names. Hopefully, these explanations make clear the differences among the recorded behaviours.

      We have now specified that the “equal intensity” refers to avoidances and displacements used to infer power relationships: “We assigned to all avoidance/displacement interactions equal intensity, that is, equal influence to the power relationship of the interacting individuals”

      Minor corrections:

      (1) In line 41, there is a 1 after 'similar'. I am unsure if it's a mistake or a reference.

      We corrected the typo.

      (2) In lines 68-69, there is mention of other studies, but no references are provided.

      We added citations as suggested.

      (3) Remove the reference to Figure 1 (line 82) from the introduction; the figure should be referenced in the text just before the image, however, your figure is in a different section.

      We removed the reference as suggested.

      (4) Line 98 and 136, it's written 'ad libtum' but the correct spelling is 'ad libitum'.

      We corrected the typo.

      (5) Figure 3, remove the underscores between the words in the axis titles.

      We removed the underscores.

      Reviewer #2 (Recommendations for the authors):

      Here, I have outlined some specific suggestions that require attention. Addressing these comments will enhance the readability and enhance the quality of the manuscript.

      (1) L69. Add citation here, indicating the studies focusing on aggression rates.

      We added citations as suggested.

      (2) L88. The study periods used in this study and the authors' previous study (Reference 11) are different. So please add one table as Table 1 showing the details info on the sampling efforts and data included in their analysis of this study. For example, the study period, the numbers of females and males, sampling hours, the number of avoidance/displacement behaviors used to calculate individual Elo-ratings, and the number of mild/moderate/severe aggressive interactions, etc.

      We have now added another table, as suggested (new Table 1) and we have also made clear that we used the hierarchies presented in detail in (Smit & Robbins 2025).

      (3) L103. If readers do not look over Reference 25 on purpose, they do not know what the authors want to talk about and why they mention the optimized Elo-rating method. Clarify this statement and add more content explaining the differences between the two methods, or just remove it.

      We rephrased the text and in response to the previous comment, we clearly state that there are more details about our approach in Smit & Robbins 2025. At the end of the relevant sentence, we added the following parenthesis “(see “traditional Elo rating method”; we do not use the “optimized Elorating method” as it yields similar results and it is not widely used)” and we removed the sentence referring to the optimized Elo-rating method.

      (4) L110. Here, the authors stated that the individual with the standardized Elo-score 1 was the highest-ranking. L117, the "aggression direction" score of each aggressive interaction was the standardized Elo-score of the aggressor, subtracting that of the recipient. So, when the "aggression direction" score was 1, it should mean that the aggressor was the highest-ranking and the recipient was the lowest-ranking female. This is not as the authors stated in L117-120 (where the description was incorrectly reversed). Please clarify.

      The highest ranking individual has indeed Elo_score equal to 1 and we calculated the interaction score (or "aggression direction score") of each aggressive interaction by subtracting the standardized Elo-score of the aggressor from that of the recipient (Elo_recepient – Elo_aggressor). So, when the aggressor is the lowest-ranking female (Elo_score=0) and the recipient the highestranking female one (Elo_score=1), the "aggression direction score" is 1-0 = 1.

      (5) Regarding point 3 of the Public Review, please also revise/expand the paragraph L193-208 in the Discussion section accordingly.

      Please see our response to the public review. We have enriched the results section, added pairwise comparisons in a new table (Table 2) and modified the discussion accordingly.

      (6) Table 1. It's not clear why authors added the column 'Aggression Rate' but did not provide any explanation in the Methods/Results section. How did they calculate the correlation between each tested variable and the "overall adult female aggression rates"? Correlating the number of females in the first trimester of female pregnancy with the female aggression rates in each study group? What did the correlation coefficients mean? L202-204 may provide some hints as to why the authors introduced the Aggression Rate. But it should be made clear in the previous text.

      We now added more details in the legend of the table to make our point clear: “To highlight that aggression rates can increase due to increase in interactions of different score, we also include the effect of some of the tested variables on overall adult female aggression rates, based on results of linear mixed effects models from (Smit & Robbins 2024).”  We did not include detailed methods to calculate those results because they are detailed in (Smit & Robbins 2024). We find it valuable to show the results of both aggression rates and aggression directionality according to the same predictor variables as a means to clarify that aggression rates and aggression directionality are not always coordinated to one another (they do not always change in a consistent manner relative to one another).

      (7) L166.This is not rigorous. Please rephrase. There is only one western gorilla group containing only one resident male included in the analysis.

      We have toned down our text: “Our results did not show any significant difference between femalefemale aggression patterns within the one western and four mountain gorillas groups”

      (8) L167. I don't think the interaction scores in the third trimester of female pregnancy were significantly higher than those in the first trimester. The same concern applies in L194-195.

      We have now added a new table with post hoc pairwise comparisons among the different reproductive states that clarifies that.

      (9) L202. There is no column 'Aggression rates' in Table 1 of Reference 11.

      We have rephrased to make clear that we refer to Table 1 of the present study.

      (10) L204-205. Reference 49. Maybe not a proper citation here. This claim requires stronger evidence or further justification. Additionally, please rephrase and clarify the arguments in L204208 for better readability and precision.

      We have added three more references and rephrased to clarify our argument.

      Reviewer #3 (Recommendations for the authors):

      (1) Line 41: The word "similar" is misspelled.

      We corrected the typo.

    1. Reviewer #3 (Public review):

      Summary:

      The paper studies learning rules in a simple sigmoidal recurrent neural network setting. The recurrent network has a single layer of 10 to 40 units. It is first confirmed that feedback alignment (FA) can learn a value function in this setting. Then so-called bio-plausible constraints are added: (1) when value weights (readout) is non-negative, (2) when the activity is non-negative (normal sigmoid rather than downscaled between -0.5 and 0.5), (3) when the feedback weights are non-negative, (4) when the learning rule is revised to be monotic: the weights are not downregulated. In the simple task considered all four biological features do not appear to impair totally the learning.

      Strengths:

      (1) The learning rules are implemented in a low-level fashion of the form: (pre-synaptic-activity) x (post-synaptic-activity) x feedback x RPE. Which is therefore interpretable in terms of measurable quantities in the wet-lab.

      (2) I find that non-negative FA (FA with non negative c and w) is the most valuable theoretical insight of this paper: I understand why the alignment between w and c is automatically better at initialization.

      (3) The task choice is relevant, since it connects with experimental settings of reward conditioning with possible plasticity measurements.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Summary:

      The study "Monitoring of Cell-free Human Papillomavirus DNA in Metastatic or Recurrent Cervical Cancer: Clinical Significance and Treatment Implications" by Zhuomin Yin and colleagues focuses on the relationship between cell-free HPV (cfHPV) DNA and metastatic or recurrent cervical cancer patients. It expands the application of cfHPV DNA in tracking disease progression and evaluating treatment response in cervical cancer patients. The study is overall well-designed, including appropriate analyses.

      Strengths:

      The findings provide valuable reference points for monitoring drug efficacy and guiding treatment strategies in patients with recurrent and metastatic cervical cancer. The concordance between HPV cfDNA fluctuations and changes in disease status suggests that cfDNA could play a crucial role in precision oncology, allowing for more timely interventions. As with similar studies, the authors used Droplet Digital PCR to measure cfDNA copy numbers, a technique that offers ultrasensitive nucleic acid detection and absolute quantification, lending credibility to the conclusions.

      Weaknesses:

      Despite including 28 clinical cases, only 7 involved recurrent cervical cancer, which may not be sufficient to support some of the authors' conclusions fully. Future studies on larger cohorts could solidify HPV cfDNA's role as a standard in the personalized treatment of recurrent cervical cancer patients.

      (1) The authors should provide source data for Figures 2, 3, and 4 as supplementary material.

      We greatly appreciate your evaluation of our study and fully agree with the limitations you have pointed out. We appreciate your constructive feedback. Based on your suggestions, we have made the following additions to the article. We have realized that the information provided in Figures 2, 3, and 4 is limited. Therefore, we have presented the original data from Figures 2, 3, and 4 in tabular form in Supplementary Table 2.

      (2) Description of results in Figure 2: Figure 2 would benefit from clearer annotations regarding HPV virus subtypes. For example, does the color-coding in Figure 2B imply that all samples in the LR subgroup are of type HPV16? If that is the case, is it possible that detection variations are due to differences in subtype detection efficiency rather than cfDNA levels? The authors should clarify these aspects. Annotation of Figure 2B suggests that the p-value comes from comparing the LR and LN + H + DSM groups. This should be clarified in the legend. If this p-value comes from comparing HPV cfDNA copies for the (LR, LNM, HM) and (LN + HM, LN + HM + DSM) groups, did the authors carry out post-hoc pairwise comparisons? It would be helpful to include acronyms for these groups in the legend also.

      We fully agree with your point regarding the need for clearer labeling of HPV genotypes in Figures 2B and 2C. If each data point could be color-coded to represent the HPV genotype, Figures 2B and 2C would be clearer and provide more information. However, we must acknowledge that due to the limitations of our current graphing software and our graphical expertise, we were unable to fully represent each HPV genotype in the figures. To address this, we have presented the data in Supplementary Table 2. This table shows the HPV genotype for each patient, the corresponding metastasis patterns, and the baseline HPV copy numbers. We hope this will address the limitation of insufficient information in Figure 2.

      The point you raised regarding whether the differences in detection results might stem from variations in subtype detection efficiency rather than cfDNA levels is a valid limitation of this study. Due to the limited sample size, we did not perform subgroup analyses based on different HPV genotypes, which may have introduced bias in the results presented in Figures 2B and 2C. In response, we have added the following clarification in the discussion section (lines 416-422) and addressed this limitation in the limitations section (lines 499-502). Based on your suggestion, we believe that it is essential to expand the sample size and perform subgroup analysis of the baseline copy numbers for each HPV genotype before treatment. We hope to achieve this goal in future studies.

      Thank you for your thoughtful comments regarding the statistical analyses in the study. The p-value in Figure 2B comes from the comparison among five groups, using a two-sided Kruskal-Wallis test. Your suggestion to perform post-hoc pairwise comparisons is excellent and has made the data presentation in the article more rigorous. Following your advice, we conducted pairwise comparisons between the groups. We used the Mann-Whitney U test to compare HPV cfDNA copy numbers between two groups. Since the LR group only had one value, it could not be included in the pairwise comparisons. Significant differences were observed in two comparisons: LNM vs. LN + H + DSM (P = 0.006) and HM vs. LN + H + DSM (P = 0.036). No significant differences were found between the other groups: LNM vs. HM (P = 0.768), LNM vs. LN + HM (P = 0.079), HM vs. LN + HM (P = 0.112), and LN + HM vs. LN + H + DSM (P = 0.145), as determined by the Mann-Whitney U test  (Figure 2B). (Lines 258-263).

      Thank you for your thoughtful suggestion regarding the inclusion of group acronyms in the legends of Figures 2B and 2C. Including the full names corresponding to the abbreviations would indeed enhance clarity. While we attempted to add both acronyms and full names to the figure legend, the full names were too lengthy and impacted the figure's presentation. Therefore, we have provided the full names corresponding to the abbreviations in the figure caption below, to help readers easily understand the abbreviations used in the figure.

      (3) Interpretation of results in Figure 2 and elsewhere: Significant differences detected in Figure 2B could imply potential associations between HPV cfDNA levels (or subtypes) and recurrence/metastasis patterns. Figure 2C shows that there is a difference in cfDNA levels between the groups compared, suggesting an association but this would not necessarily be a direct "correlation". Overall, interpretation of statistical findings would benefit from more precise language throughout the text and overstatement should be avoided.

      Thank you for your insightful comments regarding the interpretation of results in Figure 2 and elsewhere. We acknowledge that there are several limitations in this study, and the interpretation of the results should be more careful and cautious. Indeed, in the results section, there were issues with inaccurate wording and exaggeration. We have made revisions in the discussion section, which are presented as follows: Preliminary results indicate that baseline HPV cfDNA levels may be linked to recurrence/metastasis patterns, potentially reflecting tumor burden and spread (Lines 411-413). Additionally, we have also made changes in the conclusion section, which are presented as follows: The baseline copy number of HPV cfDNA may be associated with metastatic patterns, thereby reflecting tumor burden and the extent of spread to some extent (Lines 511-513).

      (4) The authors state that six patients showed cfDNA elevation with clinically progressive disease, yet only three are represented in Figure 3B1 under "Patients whose disease progressed during treatment." What is the expected baseline variability in cfDNA for patients? If we look at data from patients with early-stage cancer would we see similar fluctuations? And does the degree of variability vary for different HPV subtypes? Without understanding the normal fluctuations in cfDNA levels, interpreting these changes as progression indicators may be premature.

      Thank you for your feedback. We appreciate your thorough review and attention to detail. Six cervical squamous cell carcinoma (SCC) patients exhibited elevated HPV cfDNA levels as their clinical condition progressed. In the previous Figures 3A1 and 3A2, we only presented data from three patients, as we initially believed that displaying the cfDNA curves from three patients would offer a clearer view, while including six patients might lead to overlap and reduce clarity. However, this may have caused confusion for readers. Based on your suggestion, we have revised Figure 3A1 to include the cfDNA curves for all six patients who with squamous cell carcinoma who experienced clinical disease progression during treatment (Figure 3A1), along with the corresponding SCC-Ag curves (Figure 3A2).

      Thank you for highlighting the issue of baseline variability in HPV cfDNA. This is indeed a limitation of our study, which did not address this aspect. If baseline variability is defined as changes in HPV cfDNA levels measured at different time points before treatment in the same patient, fluctuations at different time points are inevitable and objective. Following your suggestion, we have added a discussion on baseline variability in the limitations section of the manuscript to provide readers with a more objective understanding of our study's findings (Lines 501-502).In future studies, we will incorporate baseline variability into the research design to better understand pre-treatment HPV cfDNA fluctuations and provide support for clinical decision-making.

      (5) It would be helpful if where p-values are given, the test used to derive these values was also stated within parentheses e.g. (P < 0.05, permutation test with Benjamini-Hochberg procedure).

      Thank you for your valuable suggestions and examples. Following your advice, we have included the statistical test methods used to obtain the p-values in parentheses wherever they appear in the results section. Additionally, we have specified the statistical test methods for the p-values below the figures in the results section.

      Reviewer #2 (Public review):

      Summary:

      The authors conducted a study to evaluate the potential of circulating HPV cell-free DNA (cfDNA) as a biomarker for monitoring recurrent or metastatic HPV+ cervical cancer. They analyzed serum samples from 28 patients, measuring HPV cfDNA levels via digital droplet PCR and comparing these to squamous cell carcinoma antigen (SCC-Ag) levels in 26 SCC patients, while also testing the association between HPV cfDNA levels and clinical outcomes. The main hypothesis that the authors set out to test was whether circulating HPV cfDNA levels correlated with metastatic patterns and/or treatment response in HPV+ CC.

      The main claims put forward by the paper are that:

      (1) HPV cfDNA was detected in all 28 CC patients enrolled in the study and levels of HPV cfDNA varied over a median 2-month monitoring period.

      (2) 'Median baseline' HPV cfDNA varied according to 'metastatic pattern' in individual patients.

      (3) Positivity rate for HPV cfDNA was more consistent than SCC-Ag.

      (4) In 20 SCC patients monitored longitudinally, concordance with changes in disease status was 90% for HPV cfDNA.

      This study highlights HPV cfDNA as a promising biomarker with advantages over SCC-Ag, underscoring its potential for real-time disease surveillance and individualized treatment guidance in HPV-associated cervical cancer.

      Strengths:

      This study presents valuable insights into HPV+ cervical cancer with potential translational significance for management and guiding therapeutic strategies. The focus on a non-invasive approach is particularly relevant for women's cancers, and the study exemplifies the promising role of HPV cfDNA as a biomarker that could aid personalized treatment strategies.

      Weaknesses:

      While the authors acknowledge the study's small cohort and variability in sequential sampling protocols as a limitation, several revisions should be made to ensure that (1) the findings are presented in a way that aligns more closely with the data without overstatement and (2) that the statistical support for these findings is made more clear. Specific suggestions are outlined below.

      (1) Line 54 in the abstract refers to 'combined multiple-metastasis pattern' but it is not clear what this refers to at this point in the text.

      Thank you for your detailed feedback. You are correct that the "combined multi-metastatic pattern" was not adequately explained in the abstract, which may have caused confusion. To address this, we have clarified the definitions of the combined multi-metastatic pattern and single-metastatic pattern in lines 53-55 of the manuscript. Patients with a combined multi-metastatic pattern (lymph node + hematogenous ± diffuse serosal metastasis)  exhibited a higher median baseline HPV cfDNA level compared to those with a single-metastasis pattern (local recurrence, lymph node metastasis, or hematogenous metastasis) (P = 0.003).

      (2) Line 90 The reference to 'prospective clinical study (NCT03175848) in primary stage IVB CC to investigate the role of radiotherapy (RT) in combination therapy' seems not to be at all relevant at this point in the text. I would limit the description of this study to the methods.

      Thank you for your thoughtful and thorough review. Your suggestions are highly relevant. Upon further reflection, we recognized that this sentence was redundant in its original placement. Following your recommendation, we have removed it from this section and moved it to the methods section (Lines 109-111). The revised statement is as follows: "Notably, 19 cases from the primary CC group participated in our prospective clinical study (NCT03175848), focused on stage IVB cervical cancer."

      (3) Line 56 refers to HPV cfDNA levels (range 0.3-16.9) but what units?

      Thank you for your feedback regarding the manuscript format. While you highlighted this specific issue, we have since identified several other instances of omitted units in parentheses throughout the manuscript. We acknowledge that such formatting oversights can create ambiguity for readers. Following your suggestions, we have corrected all such issues in the manuscript. We greatly appreciate your careful and thorough review.

      (4) Lines 247-248 claim that higher baseline HPV cfDNA levels correlated with a more substantial post-chemotherapy decrease. This correlation should be statistically validated, and the p-value should be included.

      Thank you for your insightful comments, which highlighted an issue with this sentence. Upon review, I have made the necessary revisions. Since no statistical analysis was conducted and the P-value was not provided, the original sentence was imprecise. Given the small sample size, statistical analysis is not feasible. I have revised the sentence as follows: “For patients in whom systemic cytotoxic chemotherapy was effective, a significant decrease in HPV cfDNA levels could be detected after chemotherapy” (Lines 297-298).

      (5) The authors mention that baseline samples were collected "between Day -14 and Day +30 preceding initial treatment." If Day -14 indicates two weeks before treatment, then this would imply some samples were taken up to 30 days post-treatment. This notation should be clarified. To what extent might outliers or more extreme values in Figure 2 driven by variability in how baseline sampling was carried out?

      Thank you for your insightful comments. Undoubtedly, this is indeed a major limitation of our study. These factors could lead to a certain degree of bias in the detection data. The primary reason is that the study was conducted during the COVID-19 pandemic, making it sometimes difficult to conduct sampling regularly. In accordance with your suggestion, I have already added this part of the content to the results section of the article (Lines 266-275). We have also included the variation in baseline sampling as a limitation in the discussion section (Lines 497-499). In future studies, we will strive to improve the study design by ensuring baseline samples are collected prior to treatment, thereby enhancing the reliability of statistical and analytical results.

      (6) Would be useful to amend Figure 1 to show a subset of patients with SCC and a subset of patients who underwent longitudinal monitoring.

      Thank you for your detailed suggestion. Including a subset of pathological types could indeed add more information to Figure 1. However, regarding the pathological types of the patients in this group, we have listed them in Table 1 and Supplementary Table 2. Among the 28 patients, 26 are diagnosed with squamous cell carcinoma, so 92.9% of the patients in this study have squamous cell carcinoma. To avoid making Figure 1 too complex, we decided not to include the pathological type in the figure.

      (7) Line 120 "a time point matching or closely following HPV cfDNA sampling" - what is the time range for 'closely following' here? A couple of hours or days after sampling?

      Thank you for your detailed feedback. Based on your suggestion, we have revised the sentence as follows:

      "For patients with squamous cell CC in the sequential sampling group, concurrent SCC-Ag testing was performed at a time point that matched, or was within 7 days before or after, the HPV cfDNA sampling." (Line 123-125)

      (8) Lines 178-190 and lines 179-180 seem to make exactly the same point.

      Thank you very much for your careful review. Indeed, these two sentences were repetitive and conveyed the same point. I have removed the previous sentence here (lines 206-207).

      (9) In Figure 4, please indicate the number of patients in each group in the legend e.g. HPV16+ (n=x number of patients).

      Thank you for your feedback on the details of Figure 4 and the examples provided. We have updated Figure 4 according to your suggestions and included the number of patients in each group in the figure legend.

      (10) Lines 322-3 'HPV cfDNA predicted treatment response or disease progression at an earlier time point than imaging assessments' - based on the data available and the numbers of patients, I would argue that this is too bold a claim.

      Thank you very much for pointing out this issue. We fully agree with your view. We have modified this sentence as follows: "Secondly, dynamically monitored HPV cfDNA levels appeared to predict treatment response and disease progression. " (Lines 391-392).

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This fundamental work employed multidisciplinary approaches and conducted rigorous experiments to study how a specific subset of neurons in the dorsal striatum (i.e., "patchy" striatal neurons) modulates locomotion speed depending on the valence of the naturalistic context.

      Strengths:

      The scientific findings are novel and original and significantly advance our understanding of how the striatal circuit regulates spontaneous movement in various contexts.

      We appreciate the reviewer’s positive evaluation.

      Weaknesses:

      This is extensive research involving various circuit manipulation approaches. Some of these circuit manipulations are not physiological. A balanced discussion of the technical strengths and limitations of the present work would be helpful and beneficial to the field. Minor issues in data presentation were also noted.

      We have incorporated the recommended discussion of technical limitations and addressed the physiological plausibility of our manipulations on Page 33 of the revised Discussion section. Specifically, we wrote:

      “Judicious interpretation of the present data must consider the technical limitations of the various methods and circuit-level manipulations applied. Patchy neurons are distributed unevenly across the extensive structure of the striatum, and their targeted manipulation is constrained by viral spread in the dorsal striatum. Somatic calcium imaging using single-photon microscopy captures activity from only a subset of patchy neurons within a narrow focal plane beneath each implanted GRIN lens. Similarly, limitations in light diffusion from optical fibers may reduce the effective population of targeted fibers in both photometry and optogenetic experiments. For example, the more modest locomotor slowing observed with optogenetic activation of striatonigral fibers in the SNr compared to the stronger effects seen with Gq-DREADD activation across the dorsal striatum could reflect limited fiber optic coverage in the SNr. Alternatively, it may suggest that non-striatonigral mechanisms also contribute to generalized slowing. Our photometry data does not support a role for striatopallidal projections from patchy neurons in movement suppression. The potential contribution of intrastriatal mechanisms, discussed earlier, remains to be empirically tested. Although the behavioral assays used were naturalistic, many of the circuit-level interventions were not. Broad ablation or widespread activation of patchy neurons and their efferent projections represent non-physiological manipulations. Nonetheless, these perturbation results are interpreted alongside more naturalistic observations, such as in vivo imaging of patchy neuron somata and axon terminals, to form a coherent understanding of their functional role”.

      Reviewer #2 (Public review):

      Hawes et al. investigated the role of striatal neurons in the patch compartment of the dorsal striatum. Using Sepw1-Cre line, the authors combined a modified version of the light/dark transition box test that allows them to examine locomotor activity in different environmental valence with a variety of approaches, including cell-type-specific ablation, miniscope calcium imaging, fiber photometry, and opto-/chemogenetics. First, they found ablation of patchy striatal neurons resulted in an increase in movement vigor when mice stayed in a safe area or when they moved back from more anxiogenic to safe environments. The following miniscope imaging experiment revealed that a larger fraction of striatal patchy neurons was negatively correlated with movement speed, particularly in an anxiogenic area. Next, the authors investigated differential activity patterns of patchy neurons' axon terminals, focusing on those in GPe, GPi, and SNr, showing that the patchy axons in SNr reflect movement speed/vigor. Chemogenetic and optogenetic activation of these patchy striatal neurons suppressed the locomotor vigor, thus demonstrating their causal role in the modulation of locomotor vigor when exposed to valence differentials. Unlike the activation of striatal patches, such a suppressive effect on locomotion was absent when optogenetically activating matrix neurons by using the Calb1-Cre line, indicating distinctive roles in the control of locomotor vigor by striatal patch and matrix neurons. Together, they have concluded that nigrostriatal neurons within striatal patches negatively regulate movement vigor, dependent on behavioral contexts where motivational valence differs.

      We are grateful for the reviewer’s thorough summary of our main findings.

      In my view, this study will add to the important literature by demonstrating how patch (striosomal) neurons in the striatum control movement vigor. This study has applied multiple approaches to investigate their functionality in locomotor behavior, and the obtained data largely support their conclusions. Nevertheless, I have some suggestions for improvements in the manuscript and figures regarding their data interpretation, accuracy, and efficacy of data presentation.

      We appreciate the reviewer’s overall positive assessment and have made substantial improvements to the revised manuscript in response to reviewers’ constructive suggestions. 

      (1) The authors found that the activation of the striatonigral pathway in the patch compartment suppresses locomotor speed, which contradicts with canonical roles of the direct pathway. It would be great if the authors could provide mechanistic explanations in the Discussion section. One possibility is that striatal D1R patch neurons directly inhibit dopaminergic cells that regulate movement vigor (Nadal et al., Sci. Rep., 2021; Okunomiya et al., J Neurosci., 2025). Providing plausible explanations will help readers infer possible physiological processes and give them ideas for future follow-up studies.

      We have added the recommended data interpretation and future perspectives on Page 30 of the revised Discussion section. Specifically, we wrote:

      “Potential mechanisms by which striatal patchy neurons reduce locomotion involve the suppression of dopamine availability within the striatum. Dopamine, primarily supplied by neurons in the SNc and VTA, broadly facilitates locomotion (Gerfen and Surmeier 2011, Dudman and Krakauer 2016). Recent studies have shown that direct activation of patchy neurons leads to a reduction in striatal dopamine levels, accompanied by decreased walking speed (Nadel, Pawelko et al. 2021, Dong, Wang et al. 2025, Okunomiya, Watanabe et al. 2025). Patchy neuron projections terminate in structures known as “dendron bouquets”, which enwrap SNc dendrites within the SNr and can pause tonic dopamine neuron firing (Crittenden, Tillberg et al. 2016, Evans, Twedell et al. 2020). The present work highlights a role for patchy striatonigral inputs within the SN in decelerating movement, potentially through GABAergic dendron bouquets that limit dopamine release back to the striatum (Dong, Wang et al. 2025). Additionally, intrastriatal collaterals of patch spiny projection neurons (SPNs) have been shown to suppress dopamine release and associated synaptic plasticity via dynorphin-mediated activation of kappa opioid receptors on dopamine terminals (Hawes, Salinas et al. 2017). This intrastriatal mechanism may further contribute to the reduction in striatal dopamine levels and the observed decrease in locomotor speed, representing a compelling avenue for future investigation.”

      (2) On page 14, Line 301, the authors stated that "Cre-dependent mCheery signals were colocalized with the patch marker (MOR1) in the dorsal striatum (Fig. 1B)". But I could not find any mCherry on that panel, so please modify it.

      We have included representative images of mCherry and MOR1 staining in Supplementary Fig. S1 of the revised manuscript.

      (3) From data shown in Figure 1, I've got the impression that mice ablated with striatal patch neurons were generally hyperactive, but this is probably not the case, as two separate experiments using LLbox and DDbox showed no difference in locomotor vigor between control and ablated mice. For the sake of better interpretation, it may be good to add a statement in Lines 365-366 that these experiments suggest the absence of hyperactive locomotion in general by ablating these specific neurons.

      As suggested by the reviewer, we have added the following statement on Page 17 of the revised manuscript: “These data also indicate that PA elevates valence-specific speed without inducing general hyperactivity”.

      (4) In Line 536, where Figure 5A was cited, the author mentioned that they used inhibitory DREADDs (AAV-DIO-hM4Di-mCherrry), but I could not find associated data on Figure 5. Please cite Figure S3, accordingly.

      We have added the citation for the now Fig. S4 on Page 25 of the revised manuscript.

      (5) Personally, the Figure panel labels of "Hi" and "ii" were confusing at first glance. It would be better to have alternatives.

      As suggested by the reviewer, we have now labeled each figure panel with a distinct single alphabetical letter.

      (6) There is a typo on Figure 4A: tdTomata → tdTomato

      We have made the correction on the figure.

      Reviewer #3 (Public review):

      Hawes et al. combined behavioral, optical imaging, and activity manipulation techniques to investigate the role of striatal patch SPNs in locomotion regulation. Using Sepw1-Cre transgenic mice, they found that patch SPNs encode locomotion deceleration in a light-dark box procedure through optical imaging techniques. Moreover, genetic ablation of patch SPNs increased locomotion speed, while chemogenetic activation of these neurons decreased it. The authors concluded that a subtype of patch striatonigral neurons modulates locomotion speed based on external environmental cues. Below are some major concerns:

      The study concludes that patch striatonigral neurons regulate locomotion speed. However, unless I missed something, very little evidence is presented to support the idea that it is specifically striatonigral neurons, rather than striatopallidal neurons, that mediate these effects. In fact, the optogenetic experiments shown in Fig. 6 suggest otherwise. What about the behavioral effects of optogenetic stimulation of striatonigral versus striatopallidal neuron somas in Sepw1-Cre mice?

      Our photometry data implicate striatonigral neurons in locomotor slowing, as evidenced by a negative cross-correlation with acceleration and a negative lag, indicating that their activity reliably precedes—and may therefore contribute to—deceleration. In contrast, photometry results from striatopallidal neurons showed no clear correlation with speed or acceleration.

      Figure 6 demonstrates that optogenetic manipulation within the SNr of Sepw1-Cre<sup>+</sup> striatonigral axons recapitulated context-dependent locomotor changes seen with Gq-DREADD activation of both striatonigral and striatopallidal Sepw1-Cre<sup>+</sup> cells in the dorsal striatum but failed to produce the broader locomotor speed change observed when targeting all Sepw1-Cre<sup>+</sup> cells in the dorsal striatum using either ablation or Gq-DREADD activation. The more subtle speed-restrictive phenotype resulting from ChR activation in the SNr could, as the reviewer suggests, implicate striatopallidal neurons in broad locomotor speed regulation. However, our photometry data indicate that this scenario is unlikely, as activity of striatopallidal Sepw1-Cre<sup>+</sup> fibers is not correlated with locomotor speed. Another plausible explanation is that the optogenetic approach may have affected fewer striatonigral fibers, potentially due to the limited spatial spread of light from the optical fiber within the SNr. Broad locomotor speed change in LDbox might require the recruitment of a larger number of striatonigral fibers than we were able to manipulate with optogenetics. We have added discussion of these technical limitations to the revised manuscript. Additionally, we now discuss the possibility that intrastriatal collaterals may contribute to reduced local dopamine levels by releasing dynorphin, which acts on kappa opioid receptors located on dopamine fibers (Hawes, Salinas et al. 2017), thereby suppressing dopamine release.

      The reviewer also suggests an interesting experiment involving optogenetic stimulation of striatonigral versus striatopallidal somata in Sepw1-Cre mice. While we agree that this approach would yield valuable insights, we have thus far been unable to achieve reliable results using retroviral vectors. Moreover, selectively targeting striatopallidal terminals optogenetically remains technically challenging, as striatonigral fibers also traverse the pallidum, and the broad anatomical distribution of the pallidum complicates precise targeting. This proposed work will need to be pursued in a future study, either with improved retrograde viral tools or the development of additional mouse lines that offer more selective access to these neuronal populations as we documented recently (Dong, Wang et al. 2025).

      In the abstract, the authors state that patch SPNs control speed without affecting valence. This claim seems to lack sufficient data to support it. Additionally, speed, velocity, and acceleration are very distinct qualities. It is necessary to clarify precisely what patch neurons encode and control in the current study.

      We believe the reviewer’s interpretation pertains to a statement in the Introduction rather than the Abstract: “Our findings reveal that patchy SPNs control the speed at which mice navigate the valence differential between high- and low-anxiety zones, without affecting valence perception itself.” Throughout our study, mice consistently preferred the dark zone in the Light/Dark box, indicating intact perception of the valence differential between illuminated areas. While our manipulations altered locomotor speed, they did not affect time spent in the dark zone, supporting the conclusion that valence perception remained unaltered. We appreciate the reviewer’s insight and agree it is an intriguing possibility that locomotor responses could, over time, influence internal states such as anxiety. We addressed this in the Discussion, noting that while dark preference was robust to our manipulations, future studies are warranted to explore the relationship between anxious locomotor vigor and anxiety itself.

      We report changes in scalar measures of animal speed across Light/Dark box conditions and under various experimental manipulations. Separately, we show that activity in both patchy neuron somata and striatonigral fibers is negatively correlated with acceleration—indicating a positive correlation with deceleration. Notably, the direction of the cross-correlational lag between striatonigral fiber activity and acceleration suggests that this activity precedes and may causally contribute to mouse deceleration, thereby influencing reductions in speed. To clarify this, we revised a sentence in the Results section: “Moreover, patchy neuron efferent activity at the SNr may causally contribute to deceleration, as indicated by the negative cross-correlational lag, thereby reducing animal speed.”. We also updated the Discussion to read: “Together, these data specifically implicate patchy striatonigral neurons in slowing locomotion by acting within the SNr to drive deceleration.”

      One of the major results relies on chemogenetic manipulation (Figure 5). It would be helpful to demonstrate through slice electrophysiology that hM3Dq and hM4Di indeed cause changes in the activity of dorsal striatal SPNs, as intended by the DREADD system. This would support both the positive (Gq) and negative (Gi) findings, where no effects on behavior were observed.

      We were unable to perform this experiment; however, hM3Dq has previously been shown to be effective in striatal neurons (Alcacer, Andreoli et al. 2017). The lack of effect observed in Gi-DREADD mice serves as an unintended but valuable control, helping to rule out off-target effects of the DREADD agonist JHU37160 and thereby reinforcing the specificity of hM3Dq-mediated activation in our study. We have now included an important caveat regarding the Gi-DREADD results, acknowledging the possibility that they may not have worked effectively in our target cells: “Potential explanations for the negative results in Gi-DREADD mice include inherently low basal activity among patchy neurons or insufficient expression of GIRK channels in striatal neurons, which may limit the effectiveness of Gi-coupling in suppressing neuronal activity (Shan, Fang et al. 2022).

      Finally, could the behavioral effects observed in the current study, resulting from various manipulations of patch SPNs, be due to alterations in nigrostriatal dopamine release within the dorsal striatum?

      We agree that this is an important potential implication of our work, especially given that we and others have shown that patchy striatonigral neurons provide strong inhibitory input to dopaminergic neurons involved in locomotor control (Nadel, Pawelko et al. 2021, Lazaridis, Crittenden et al. 2024, Dong, Wang et al. 2025, Okunomiya, Watanabe et al. 2025). Accordingly, we have expanded the discussion section to include potential mechanistic explanations that support and contextualize our main findings.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Here are some minor issues for the authors' reference:

      (1) This work supports the motor-suppressing effect of patchy SPNs, and >80% of them are direct pathway SPNs. This conclusion is not expected from the traditional basal ganglia direct/indirect pathway model. Most experiments were performed using nonphysiological approaches to suppress (i.e., ablation) or activate (i.e., continuous chemo-optogenetic stimulation). It remains uncertain if the reported observations are relevant to the normal biological function of patchy SPNs under physiological conditions. Particularly, under what circumstances an imbalanced patch/matrix activity may be induced, as proposed in the sections related to the data presented in Figure 6. A thorough discussion and clarification remain needed. Or it should be discussed as a limitation of the present work.

      We have added discussion and clarification of physiological limitations in response to reviewer feedback. Additionally, we revised the opening sentence of an original paragraph in the discussion section to emphasize that it interprets our findings in the context of more physiological studies reporting natural shifts in patchy SPN activity due to cognitive conflict, stress, or training. The revised opening sentence now reads: “Together with previous studies of naturally occurring shifts in patchy neuron activation, these data illustrate ethologically relevant roles for a subgroup of genetically defined patchy neurons in behavior.”

      (2) Lines 499-500: How striato-nigral cells encode speed and deceleration deserves a thorough discussion and clarification. These striatonigral cells can target both SNr GABAergic neurons and dendrites of the dopaminergic neurons. A discussion of microcircuits formed by the patchy SPNs axons in the SNr GABAergic and SNC DAergic neurons should be presented.

      We have added this point at lines 499–500, including a reference to a relevant review of microcircuitry. Additionally, we expanded the discussion section to address microcircuit mechanisms that may underlie our main findings.

      (3) Line 70: "BNST" should be spelled out at the first time it is mentioned.

      This has been done.

      (4) Line 133: only GCaMP6 was listed in the method, but GCaMP8 was also used (Figure 4). Clarification or details are needed.

      Thank you for your careful attention to detail. We have corrected the typographical errors in the Methods section. Specifically, in the Stereotaxic Injections section, we corrected “GCaMP83” to “GCaMP8s.” In the Fiber Implant section, we removed the incorrect reference to “GCaMP6s” and clarified that GCaMP8s was used for photometry, and hChR2 was used for optogenetics.

      (5) Line 183: Can the authors describe more precisely what "a moment" means in terms of seconds or minutes?

      This has been done.

      (6) Line 288: typo: missing / in ΔF.

      Thank you this has been fixed.

      (7) Line 301-302: the statement of "mCherry and MOR1 colocalization" does not match the images in Figure 1B.

      This has been corrected by proving a new Supplementary Figure S1.

      (8) Related to the statement between Lines 303-304: Figure 1c data may reflect changes in MOR1 protein or cell loss. Quantification of NeuN+ neurons within the MOR1 area would strengthen the conclusion of 60% of patchy cell loss in Figure 1C.

      Since the efficacy of AAV-FLEX-taCasp3 in cell ablation has been well established in our previous publications and those of others (Yang, Chiang et al. 2013, Wu, Kung et al. 2019), we do not believe the observed loss of MOR1 staining in Fig. 1C merely reflects reduced MOR1 expression. Moreover, a general neuronal marker such as NeuN may not reliably detect the specific loss of patchy neurons in our ablation model, given the technical limitations of conventional cell-counting methods like MBF’s StereoInvestigator, which typically exhibit a variability margin of 15–20%.

      (9) Lines 313-314: "Similarly, PA mice demonstrated greater stay-time in the dark zone (Figure 1E)." Revision is needed to better reflect what is shown in Figure 1E and avoid misunderstandings.

      Thank you this has been addressed.

      (10) The color code in Figure 2Gi seems inconsistent with the others? Clarifications are needed.

      Color coding in Figure 2Gi differs from that in 2Eii out of necessity. For example, the "Light" cells depicted in light blue in 2Eii are represented by both light gray and light red dots in 2Gi. Importantly, Figure 2G does not encode specific speed relationships; instead, any association with speed is indicated by a red hue.

      (11) Lines 538-539: the statement of "Over half of the patch was covered" was not supported by Figure 5C. Clarification is needed.

      Thank you. For clarity, we updated the x-axis labels in Figures 1C and 5C from “% area covered” to “% DS area covered,” and defined “DS” as “dorsal striatal” in the corresponding figure legends. Additionally, we revised the sentence in question to read: “As with ablation, histological examination indicated that a substantial fraction of dorsal patch territories, identified through MOR1 staining, were impacted (Fig. 5C).”

      (12) Figure 3: statistical significance in Figure 3 should be labeled in various panels.

      We believe the reviewer's concern pertains to the scatter plot in panel F—specifically, whether the data points are significantly different from zero. In panel 3F, the 95% confidence interval clearly overlaps with zero, indicating that the results are not statistically significant.

      (13) Figures 6D-E: no difference in the speed of control mice and ChR2 mice under continuous optical stimulation was not expected. It was different from Gq-DRADDS study in Figure 5E-F. Clarifications are needed.

      For mice undergoing constant ChR2 activation of Sepw1-Cre<sup>+</sup> SNr efferents, overall locomotor speed does not differ from controls. However, the BIL (bright-to-illuminated) effect on zone transitions is disrupted: activating Sepw1-Cre<sup>+</sup> fibers in the SNr blunts the typical increase in speed observed when mice flee from the light zone toward the dark zone. This impaired BIL-related speed increase upon exiting the light was similarly observed in the Gq-DREADD cohort. The reviewer is correct that this optogenetic manipulation within the SNr did not produce the more generalized speed reductions seen with broader Gq-DREADD activation of all Sepw1-Cre<sup>+</sup> cells in the dorsal striatum. A likely explanation is the difference in targeting—ChR2 specifically activates SNr-bound terminals, whereas Gq-DREADD broadly activates entire Sepw1-Cre<sup>+</sup> cells. Notably, many of the generalized speed profile changes observed with chemogenetic activation are opposite to those resulting from broad ablation of Sepw1-Cre<sup>+</sup> cells.

      The more subtle speed-restrictive phenotype observed with ChR2 activation targeted to the SNr may suggest that fewer striatonigral fibers were affected by this technique, possibly due to the limited spread of light from the fiber optic. Broad locomotor speed change in LDbox might require the recruitment of a larger number of striatonigral fibers than we were able to manipulate with an optogenetic approach. Alternatively, it could indicate that non-striatonigral Sepw1-Cre+ projections—such as striatopallidal or intrastriatal pathways—play a role in more generalized slowing. If striatopallidal fibers contributed to locomotor slowing, we would expect to see non-zero cross-correlations between neural activity and speed or acceleration, along with negative lag indicating that neural activity precedes the behavioral change. However, our fiber photometry data do not support such a role for Sepw1-Cre+ striatopallidal fibers.

      We have also referenced the possibility that intrastriatal collaterals could suppress striatal dopamine levels, potentially explaining the stronger slowing phenotype observed when the entire striatal population is affected, as opposed to selectively targeting striatonigral terminals.

      These technical considerations and interpretive nuances have been incorporated and clarified in the revised discussion section.

      (14) Lines 632: "compliment": a typo?

      Yes, it should be “complement”.

      (15) Figure 4 legend: descriptions of panels A and B were swapped.

      Thank you. This has been corrected.

      6) Friedman (2020) was listed twice in the bibliography (Lines 920-929).

      Thank you. This has been corrected.

      Reviewer #3 (Recommendations for the authors):

      It will be helpful to label and add figure legends below each figure.

      Thank you for the suggestion.

      Editor's note:

      Should you choose to revise your manuscript, if you have not already done so, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and, where appropriate, 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript. We noted some instances where only p values are reported.

      Readers would also benefit from coding individual data points by sex and noting N/sex.

      We have included detailed statistical information in the revised manuscript. Both male and female mice were used in all experiments in approximately equal numbers. Since no sex-related differences were observed, we did not report the number of animals by sex.

      References

      Alcacer, C., L. Andreoli, I. Sebastianutto, J. Jakobsson, T. Fieblinger and M. A. Cenci (2017). "Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy." J Clin Invest 127(2): 720-734.

      Crittenden, J. R., P. W. Tillberg, M. H. Riad, Y. Shima, C. R. Gerfen, J. Curry, D. E. Housman, S. B. Nelson, E. S. Boyden and A. M. Graybiel (2016). "Striosome-dendron bouquets highlight a unique striatonigral circuit targeting dopamine-containing neurons." Proc Natl Acad Sci U S A 113(40): 11318-11323.

      Dong, J., L. Wang, B. T. Sullivan, L. Sun, V. M. Martinez Smith, L. Chang, J. Ding, W. Le, C. R. Gerfen and H. Cai (2025). "Molecularly distinct striatonigral neuron subtypes differentially regulate locomotion." Nat Commun 16(1): 2710.

      Dudman, J. T. and J. W. Krakauer (2016). "The basal ganglia: from motor commands to the control of vigor." Curr Opin Neurobiol 37: 158-166.

      Evans, R. C., E. L. Twedell, M. Zhu, J. Ascencio, R. Zhang and Z. M. Khaliq (2020). "Functional Dissection of Basal Ganglia Inhibitory Inputs onto Substantia Nigra Dopaminergic Neurons." Cell Rep 32(11): 108156.

      Gerfen, C. R. and D. J. Surmeier (2011). "Modulation of striatal projection systems by dopamine." Annual review of neuroscience 34: 441-466.

      Hawes, S. L., A. G. Salinas, D. M. Lovinger and K. T. Blackwell (2017). "Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through kappa-opioid receptors." J Physiol 595(16): 5637-5652.

      Lazaridis, I., J. R. Crittenden, G. Ahn, K. Hirokane, T. Yoshida, A. Mahar, V. Skara, K. Meletis, K. Parvataneni, J. T. Ting, E. Hueske, A. Matsushima and A. M. Graybiel (2024). "Striosomes Target Nigral Dopamine-Containing Neurons via Direct-D1 and Indirect-D2 Pathways Paralleling Classic Direct-Indirect Basal Ganglia Systems." bioRxiv.

      Nadel, J. A., S. S. Pawelko, J. R. Scott, R. McLaughlin, M. Fox, M. Ghanem, R. van der Merwe, N. G. Hollon, E. S. Ramsson and C. D. Howard (2021). "Optogenetic stimulation of striatal patches modifies habit formation and inhibits dopamine release." Sci Rep 11(1): 19847.

      Okunomiya, T., D. Watanabe, H. Banno, T. Kondo, K. Imamura, R. Takahashi and H. Inoue (2025). "Striosome Circuitry Stimulation Inhibits Striatal Dopamine Release and Locomotion." J Neurosci 45(4).

      Shan, Q., Q. Fang and Y. Tian (2022). "Evidence that GIRK Channels Mediate the DREADD-hM4Di Receptor Activation-Induced Reduction in Membrane Excitability of Striatal Medium Spiny Neurons." ACS Chem Neurosci 13(14): 2084-2091.

      Wu, J., J. Kung, J. Dong, L. Chang, C. Xie, A. Habib, S. Hawes, N. Yang, V. Chen, Z. Liu, R. Evans, B. Liang, L. Sun, J. Ding, J. Yu, S. Saez-Atienzar, B. Tang, Z. Khaliq, D. T. Lin, W. Le and H. Cai (2019). "Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning." Cell Rep 28(5): 1167-1181 e1167.

      Yang, C. F., M. C. Chiang, D. C. Gray, M. Prabhakaran, M. Alvarado, S. A. Juntti, E. K. Unger, J. A. Wells and N. M. Shah (2013). "Sexually dimorphic neurons in the ventromedial hypothalamus govern mating in both sexes and aggression in males." Cell 153(4): 896-909.

    1. Ces variations ponctuelles s’inscrivent dans une longue histoire de changements de la vitesse de rotation de la Terre. Par exemple, « la durée du jour semble être passée de 6 millisecondes de moins que vingt-quatre heures en 1660 à environ 4 secondes de plus en 1910 », avait indiqué l’Observatoire naval des Etats-Unis en 2022. Des différences bien plus fortes « il y a soixante-dix millions d’années », où les dinosaures vivaient des « journées de 23 heures 30 ». Plus loin encore, « des coraux fossilisés d’il y a 430 millions d’années indiquent que les jours […] duraient environ 21 heures », précise le service américain.Plus récemment, « la durée du jour a augmenté de 60 millisecondes en moyenne depuis 2000 avant Jésus-Christ », soit une augmentation progressive de 2 millisecondes par siècle, note Christian Bizouard. Cette accélération de la vitesse de rotation de la planète bleue s’explique « par le frottement causé par les marées, qui font que la Terre perd peu à peu son énergie », développe le spécialiste.

      When dinosaurs were alive, the days were 23.5 hours long, but because of the tidal friction against the earth, the earth has been slowly losing energy, resulting in longer days

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary: 

      During early Drosophila pupal development, a subset of larval abdominal muscles (DIOMs) is remodelled using an autophagy-dependent mechanism. 

      To better understand this not very well studied process, the authors have generated a transcriptomics time course using dissected abdominal muscles of various stages from wild-type and autophagy-deficient mutants. The authors have further identified a function for BNIP3 in muscle mitophagy using this system. 

      Strengths: 

      (1) The paper does provide a detailed mRNA time course resource for DIOM remodeling. 

      (2) The paper does find an interesting BNIP3 loss of function phenotype, a block of mitophagy during muscle remodeling, and hence identifies a specific linker between mitochondria and the core autophagy machinery. This adds to the mechanism of how mitochondria are degraded. 

      (3) Sophisticated fly genetics demonstrates that the larval muscle mitochondria are, to a large extent, degraded by autophagy during DIOM remodeling. 

      Weaknesses: 

      (1) Mitophagy during DIOM remodeling is not novel (earlier papers from Fujita et al.). 

      (2) The transcriptomics time course data are not well connected to the autophagy part. Both could be separated into 2 independent manuscripts. 

      (3) The muscle phenotypes need better quantifications, both for the EM and light microscopy data in various figures. 

      (4) The transcriptomics data are hard to browse in the provided PDF format. 

      Thank you for reviewing our manuscript and for your feedback. While we understand and appreciate the suggestion to divide the manuscript into two separate studies, we believe that presenting the work as a single manuscript is more appropriate. This is because the time-course RNA-seq of DIOMs provides critical insight into BNIP3-mediated mitophagy during DIOM remodeling, which ties together the two components of our study. In response to Reviewer #1’s recommendations, we have quantified data from both EM and confocal images, and we have revised the RNA counts table in Supplementary File 1 accordingly. Please see our detailed responses and revisions on the following pages.

      Reviewer #2 (Public review): 

      Summary: 

      Autophagy (macroautophagy) is known to be essential for muscle function in flies and mammals. To date, many mitophagy (selective mitochondrial autophagy) receptors have been identified in mammals and other species. While the loss of mitophagy receptors has been shown to impair mitochondrial degradation (e.g., OPTN and NDP52 in Parkin-mediated mitophagy and NIX and BNIP3 in hypoxia-induced mitophagy) at the level of cultured cells, it remains unclear, especially under physiological conditions in vivo. In this study, the authors revealed that one of the receptors BNIP3 plays a critical role in mitochondrial degradation during muscle remodeling in vivo. 

      Overall, the manuscript provides solid evidence that BNIP3 is involved in mitophagy during muscle remodeling with in vivo analyses performed. In particular, all experiments in this study are well-designed. The text is well written and the figures are very clear. 

      Strengths: 

      (1) In each experiment, appropriate positive and negative controls are used to indicate what is responsible for the phenomenon observed by the authors: e.g. FIP200, Atg18, Stx17 siRNAs during DIOM remodeling in Figure 2 and Full, del-LIR, del-MER in Figure 5. 

      (2) Although the transcriptional dynamics of DIOM remodeling during metamorphosis is autophagy-independent, the transcriptome data obtained by the authors would be valuable for future studies. 

      (3) In addition to the simple observation that loss of BNIP3 causes mitochondrial accumulation, the authors further observed that, by combining siRNA against STX17, which is required for fusion of autophagosomes with lysosomes, BNIP3 KO abolishes mitophagosome formation, which will provide solid evidence for BNIP3-mediated mitophagy. Furthermore, using a Gal80 temperature-sensitive approach, the authors showed that mitochondria derived from larval muscle, but not those synthesized during hypertrophy, remain in BNIP3 KO fly muscles. 

      Weaknesses: 

      (1) Because BNIP3 KO causes mitochondrial accumulation, it is expected that adult flies will have some physiological defects, but this has not been fully analyzed or sufficiently mentioned in the manuscript. 

      (2) In Figure 5, the authors showed that BNIP3 binds to Atg18a by co-IP, but no data are provided on whether MER-mut or del-MER attenuates the affinity for Atg18a. 

      Thank you for pointing out the critical issues in the previous version of our manuscript. In this revision, we have conducted several physiological assays using BNIP3 KO flies, as well as co-IP experiments to confirm that the DMER weakens the interaction with Atg18a. We have also addressed all the recommendations provided. Please see our detailed point-by-point responses below.

      Reviewer #3 (Public review): 

      Summary: 

      Fujita et al build on their earlier, 2017 eLife paper that showed the role of autophagy in the developmental remodeling of a group of muscles (DIOM) in the abdomen of Drosophila. Most larval muscles undergo histolysis during metamorphosis, while DIOMs are programmed to regrow after initial atrophy to give rise to temporary adult muscles, which survive for only 1 day after eclosion of the adult flies (J Neurosci. 1990;10:403-1. and BMC Dev Biol 16, 12, 2016). The authors carry out transcriptomics profiling of these muscles during metamorphosis, which is in agreement with the atrophy and regrowth phases of these muscles. Expression of the known mitophagy receptor BNIP3/NIX is high during atrophy, so the authors have started to delve more into the role of this protein/mitophagy in their model. BNIP3 KO indeed impairs mitophagy and muscle atrophy, which they convincingly demonstrate via nice microscopy images. They also show that the already known Atg8a-binding LIR and Atg18a-binding MER motifs of human NIX are conserved in the Drosophila protein, although the LIR turned out to be less critical for in vivo protein function than the MER motif. 

      Strengths: 

      Established methodology, convincing data, in vivo model. 

      Weaknesses: 

      The significance for Drosophila physiology and for human muscles remains to be established. 

      Thank you for reviewing our manuscript. In response to the comment, we have performed lifespan, adult locomotion, and eclosion assays in BNIP3 KO flies. Although we observed substantial mitochondrial accumulation in the DIOMs of BNIP3 KO flies, no significant differences were detected in these physiological assays under our experimental conditions. We plan to further investigate the physiological role of BNIP3 in flies and extend our studies to human muscle in future work. Please see our detailed responses below.

      Reviewer #1 (Recommendations for the authors): 

      Major points: 

      (1) Unfortunately, the RNA counts file table in Supplementary file 1 is a PDF and not an Excel sheet. The labelling makes it unclear from which time points and genotype the listed values on the 650-page files are. 

      We have now corrected the labelling of time points and genotypes in Supplementary File 1 to improve clarity and have provided the updated Excel file.

      Looking at these counts it seems that sarcomere genes (Mhc, bt, sls, wupA, TpnC ) are 10x to 100x lower in sample "ctrl_1" compared to the three other control samples. Which time point is that? It is essential to have access to the full dataset, wild type and autophagy-deficient, to be able to assess the quality of the RNA SEQ data. These need to be deposited in a public database or to be provided in a useful format. 

      Thank you for pointing that out. In the previous version, “Ctrl_1” referred to the Control sample at 1 day APF, when atrophy occurs. We have corrected the labeling in Supplementary File 1 accordingly and have deposited the RNA-seq data to GEO, where it is now publicly available (GSE293359).

      (2) Which statistical test was used to assess the differences in muscle volumes in Figure 2E? I was not able to find a table with the measured data.

      In Figure 2E, we used the Mann-Whitney test for statistical analysis. The raw data used for quantification have also been provided (Supplementary File 2).

      The shown volumes do not correlate with the scheme shown in Figure 2A, in particular at the larval stage the muscle seems much larger.

      We have revised the schematic models of muscle cells in Figures 1C and 2A in accordance with the reviewer’s suggestion.

      (3) It is important to remember that adult Drosophila muscles are not homogenous, at least not the adult leg and abdominal muscles, as they are organised as tubes with myofibrils closer to the surface, and nuclei as well as mitochondria largely in the centre (see PMID 33828099). Hence, only showing a single plane in the muscle images can be very misleading. The authors should at least provide virtual XZ-cross section views in Figure 3G to ensure that similar muscle planes are compared. This applies to the interpretation of both, the mitochondria and the myofibril phenotypes in wildtype vs BNIP3-KO. 

      Thank you for your comment. As suggested, we have added XZ-cross-sectional views in Figure 3G. The XY plane corresponds to a central section of the Z-stack, as indicated in the figure.

      (4) The EM images are nice, however only 2 of the 4 conditions shown were quantified. As the section plane can be misleading, at least several planes should be analysed also for wild type and BNIP3-KO, and not only for stx17 RNAi and the double mutant. 

      In response to the comment, we quantified the TEM images of wild-type and BNIP3-KO DIOMs and added the resulting graph to Figure 4C. The corresponding raw data have also been provided (Supplementary File 2).

      (5) How was Figure 5D, 5D' quantified? What corresponds to "regular", "medium", "high"? A statistical test is missing. I would rather conclude that MIR and LIR are redundant as double mutant appears to be stronger than both singles. This is also concluded in some sections of the text, so the authors seem to contradict themselves. Why not measure the mitochondria areas as done in Figure 6A' instead? 

      In the previous version, we manually categorized pooled, blinded images from different genotypes. However, as the reviewer pointed out, this approach was not quantitative. In the revised version, we analyzed the images using ImageJ to quantify the mitochondrial area per cell. Statistical significance was assessed using the Kruskal-Wallis test. Accordingly, we have revised Figure 5D, the method section, and the figure legend.

      (6) Figure 6B data seem to come from a single image per genotype only. At least 3 or 4 animals should be measured and the values reported. 

      We analyzed Pearson’s correlation coefficients (R values) from at least five images per genotype and performed statistical analysis. The resulting quantification is presented in Figure 6B’, and the corresponding text has been revised accordingly.

      (7) As BNIP3 mutants are viable, it would be interesting to report if they can fly and how long they live. 

      Additional data on adult lifespan, climbing ability, and elapsed time for eclosion in BNIP3 KO flies have been included as supplemental information (Figure 3-figure supplement 2). No significant differences were observed in those assays under our experimental conditions.

      (8) The transcriptomics data are not well linked to the autophagy mechanism. In particular, the mutant transcriptomics data are confusing, as the abstract seems to suggest that blocking autophagy impacts transcriptomics, which is not (strongly) the case. I would at least re-write this part, as it is currently misleading and sparks wrong expectations to the reader. Also throughout the text, the authors need to make clear if there are transcriptomic changes or not and if there are, how these are linked to autophagy. 

      In the abstract, we described the findings as “transcriptional dynamics independent of autophagy” (line 49) because the loss of autophagy had only a minimal effect on transcriptional changes. This conclusion is supported by the data presented in our manuscript. In the result section, we state: “In contrast to our prediction, the knockdown of Atg18a, FIP200, or Stx17 only had a slight impact on transcriptomic dynamics in DIOM remodeling (Fig. 2C), with only minor changes detected (Fig. 2-figure supplement 2G)” (lines 199-201). In the Discussion section, we further note: “The transcriptional dynamics associated with DIOM remodeling are largely independent of autophagy (Fig.2). Instead, our RNA-seq data suggest that it is regulated primarily by ecdysone signaling, with minimal influence from autophagy inhibition” (lines 326-328).

      (9) No table with the measured data is provided. 

      We have provided the raw data files corresponding to all quantified results as Supplementary File 2.

      Minor points: 

      (1) To my knowledge, it is standard to indicate the time after puparium formation in hours, instead of days, (e.g. 24h, 48h etc.). 

      Thank you for the comments. In our previous publications on DIOM remodeling during metamorphosis (PMID: 28063257 and 33077556), we used days rather than hours to indicate developmental time points. To maintain consistency across our studies, we have chosen to continue using days in the present manuscript.

      (2) "Myofibrils typically form beneath the sarcolemma (Mao et al., 2022; Sanger et al., 2010); therefore, when mitochondria accumulate, myofibrils are restricted to the cell periphery." This is quite a general statement that does not always hold, in particular not in Drosophila flight muscles and likely also not in abdominal muscles (see PMIDs 29846170, 28174246). 

      Thank you for pointing that out. We rewrote the sentence as follows: In the absence of BNIP3, mitochondria derived from the larval muscle accumulate and cluster in the cell center, physically obstructing myofibril formation during hypertrophy and restricting myofibrils to the cell periphery (Fig. 6E) (lines 392-394).

      Reviewer #2 (Recommendations for the authors): 

      Suggestions for improved or additional experiments, data or analyses. 

      The authors should test, by a co-IP experiment, whether BNIP3 mutants lose the interaction with HA-Atg18a. 

      As requested, we tested the effect of MER deletion on the interaction between BNIP3 and Atg18a in co-IP experiment. As shown in the new Fig. 5C, the deletion of MER weakened the interaction. This result was confirmed in three independent experiments. Its corresponding text has also been revised as follows: “We confirmed that HA-tagged Drosophila Atg18a co-immunoprecipitated with GFP-tagged full-length Drosophila BNIP3, and that this interaction was attenuated by the deletion of the MER (residues 42-53) (Fig. 5C)” (lines 270-273).

      Minor corrections to the text and figures 

      (1) In the list of authors, Kawaguchi Kohei could be Kohei Kawaguchi_._ 

      Thank you very much. It has been corrected.

      (2) In Fig3D, other receptors (Zonda, CG12511, Key, Ref2P) should be mentioned briefly. 

      Thank you for the suggestion. We have revised the sentences as follows: “The time course RNA-seq data (Fig. 1 and 2) indicated that, among the known mitophagy regulators, only BNIP3 was robustly expressed in 1 d APF DIOMs. In contrast, Zonda, CG12511, Pink1, Park, Key, Ref(2)P, and IKKe—the Drosophila orthologs of FKBP8, FUNDC1, PINK1, Parkin, Optineurin, p62, and TBK1, respectively—showed little or undetectable expression at this stage (Fig. 3D).” (lines 230-234).

      Reviewer #3 (Recommendations for the authors): 

      Remarks: 

      (1) What is the consequence of impaired muscle remodeling on the organismal level? Is the eclosion of adult flies impaired? One could think of assays for this, such as quantifying failed eclosions and/or video microscopy of the eclosion process. Is muscle function impaired? One could measure the contractile force of isolated fibers during electrical stimulation as well, etc. I believe that showing the physiological importance of muscle remodeling would be the biggest advantage that could arise from using a complete animal model.

      We appreciate the comments. We have added data on adult lifespan, climbing ability, and the elapsed time for eclosion in BNIP3 KO flies as supplemental information (Figures 3-figure supplement 2). In BNIP3 KO DIOMs, despite the massive accumulation of mitochondria, an organized peripheral myofibril layer with contractile function is retained. However, we have not measured the contractile force of isolated muscle cells due to technical limitations. We plan to address this in future studies.

      A related note is that I missed the proper discussion of the function and fate of these short-lived adult muscles (please see references in my summary). 

      We have added a sentence regarding the function and fate of DIOMs in the introduction (lines 80-82) as follows: “The remodeled adult DIOMs function during eclosion, persist for approximately 12 hours, and are subsequently eliminated via programmed cell death (Kimura and Truman, 1990; J Neurosci. 1990;10:403-1)”.

      (2) I don't think that "data not shown" should be used these days, when supplemental data allow the inclusion of not-so-critical results. 

      We have added the data as Figure 5-figure supplement 2. As shown in the figure, overexpression of GFP-BNIP3 in 3IL BWMs did not induce the formation of tdTomato-positive autolysosomes, which are abundantly accumulated in DIOMs at 1 and 2 d APF.

      (3) The term "naked mitochondria" does not sound scientific enough to this reviewer. I suggest "cytosolic mitochondria" or "unengulfed mitochondria". 

      In accordance with the reviewer’s suggestion, we have replaced “naked mitochondria” with “unengulfed mitochondria” (lines 251 and 670).

    1. Joint Public Review:

      In this manuscript, Wafer and Tandon et al. present a thoughtful and well-designed genetic screen for regulators of adipose remodeling using zebrafish as a model system. The authors cross-referenced several human adipocyte-related transcriptomic and genetic association datasets to identify candidate genes, which they then tested in zebrafish. Importantly, the authors devised an unbiased microscopy-based screening platform to document quantitative adipose phenotypes with whole animal imaging, while also employing rigorous statistical methods. From their screen, the authors identified 6 genes that resulted in robust adipose phenotypes out of a total of 25 that were tested. Overall, this work will be a useful resource for the field because of both the genes identified and the quantitative, rigorous screening pipeline. However, there are limitations that preclude a definitive distinction between developmental and remodeling effects that should be acknowledged and discussed, or addressed with new experiments.

      Strengths:

      (1) This work combines multiple omic datasets to identify candidate genes that informed a CRISPR-based screen to identify genes underlying adipose tissue development and adaptation. This approach offers a new avenue to improve our understanding and testing of new genetic mechanisms underlying the development of obesity.

      (2) Using a clever screening approach, this study identifies new genes that are associated with adipose tissue lipid droplet size change. Importantly, the study provides further validation using a stable CRISPR line to show the phenotype in basal and high-fat diet conditions.

      (3) The experiments are well-designed and rigorous. Sample sizes are large. Statistical analyses are highly rigorous, contributing to a high-quality study.

      Weaknesses:

      (1) The image quantification established in Figures 3 and 4 and used in CRISPR screening showed the relationship among zebrafish development, adipose tissue size, and lipid droplet size. Although adipose tissue development patterning is linked with adipose tissue adaptation, as shown by the evidence provided in this paper, it will be more powerful if the imaging method and pipeline were established to directly access the adipose tissue plasticity rather than just the developmental patterning. Furthermore, the authors should perform additional analysis of their existing data to more accurately determine lipid droplet size along the AP axis in response to HFD.

      (2) In the absence of tissue-specific manipulations, definitively establishing the mechanisms underlying the genetic regulation of adipose tissue physiology presents limitations.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      Two important factors in visual performance are the resolving power of the lens and the signal-to-noise ratio of the photoreceptors. These both compete for space: a larger lens has improved resolving power over a smaller one, and longer photoreceptors capture more photons and hence generate responses with lower noise. The current paper explores the tradeoff of these two factors, asking how space should be allocated to maximize eye performance (measured as encoded information).

      Your summary is clear, concise and elegant. The competition is not just for space, it is for space, materials and energy. We  now emphasise that we are considering these three costs in our rewrites of the Abstract and the first paragraph of the Discussion.  

      Strengths:

      The topic of the paper is interesting and not well studied. The approach is clearly described and seems appropriate (with a few exceptions - see weaknesses below). In most cases, the parameter space of the models are well explored and tradeoffs are clear.  

      Weaknesses:

      Light level

      The calculations in the paper assume high light levels (which reduces the number of parameters that need to be considered). The impact of this assumption is not clear. A concern is that the optimization may be quite different at lower light levels. Such a dependence on light level could explain why the model predictions and experiment are not in particularly good agreement. The paper would benefit from exploring this issue.

      Thank you for raising this point. We briefly explained in our original Discussion, under Understanding the adaptive radiation of eyes (Version 1, Iines 756 – 762), how our method can be modified to investigate eyes adapted for lower light levels. We have some thoughts on how eyes might be adapted. In general, transduction rates are increased by increasing D, reducing f, increasing d<sub>rh</sub> and increasing L . In addition, d<sub>rh</sub> is increased to allow for a larger D within the constraint of eye radius/corneal surface area, and to avoid wasteful oversampling (the changes in D, f and d<sub>rh</sub> increase acceptance angle ∆ρ). We suspect that in eyes optimised for the efficient use of space, materials and energy the increases in L will be relatively small, first because  increasing D, reducing f and increasing d<sub>rh</sub> are much more effective at increasing transduction rate than increasing L. Second, increasing sensitivity by reducing f decreases the cost Vo whereas increasing sensitivity by increasing L increases the cost V<sub>ph</sub>. This disadvantage, together with exponential absorption, might explain why L is only 10% - 20% longer in the apposition eyes of nocturnal bees (Somanathan et al, J. comp. Physiol. A195, 571583, 2009). Because this line of argument is speculative and enters new territory, we have not included it in our revised version. We already present a lot of new material for readers to digest, and we agree with referee 2 that “It is possible to extend the theory to other types of eyes, although it would likely require more variables and assumptions/constraints to the theory. It is thus good to introduce the conceptual ideas without overdoing the applications of the theory”. Nonetheless, we take your point that some of the eyes in our data set might be adapted for lower light levels, and we have rewritten the Discussion section, How efficiently do insects allocate resources within their apposition eyes accordingly. On line 827 – 843 we address the assumption that eyes are adapted for full daylight,  and also take the opportunity  to mention two more reasons for increasing the eye parameter p: namely increasing image velocity (Snyder, 1979), and constructing  bright zones that increase the detectability of small targets (van Hateren et al., 1989; Straw et al., 2006).

      Discontinuities

      The discontinuities and non-monotonicity of the optimal parameters plotted in Figure 4 are concerning. Are these a numerical artifact? Some discussion of their origin would be quite helpful.

      Good points, we now address the discontinuities in the Results, where they are first observed (lines 311 - 319) 

      Discrepancies between predictions and experiment

      As the authors clearly describe, experimental measurements of eye parameters differ systematically from those predicted. This makes it difficult to know what to take away from the paper. The qualitative arguments about how resources should be allocated are pretty general, and the full model seems a complex way to arrive at those arguments. Could this reflect a failure of one of the assumptions that the model rests on - e.g. high light levels, or that the cost of space for photoreceptors and optics is similar? Given these discrepancies between model and experiment, it is also hard to evaluate conclusions about the competition between optics and photoreceptors (e.g. at the end of the abstract) and about the importance for evolution (end of introduction).

      Your misgivings boil down to two issues: what use is a model that fails to fit the data, and do we need a complicated model to show something that seems to be intuitively obvious?  Our study is useful because it introduces new approaches, methods, factors and explanations which advance our analysis and understanding of eye design and evolution. Your comments make it clear that we failed to get this message across and we have revised the manuscript accordingly. We have rewritten the Abstract and the first paragraph of the Discussion to emphasise the value of our new measure of cost, specific volume, by including more of its practical advantages. In particular, our use of specific volume 1) opens the door to the morphospace of all eyes of given type and cost. 2) This allows one to construct performance surfaces across morphospace that not only identify optima, but by evaluating the sub-optimal cast light on efficiency and adaptability. 3) Shows that photoreceptor energy costs have a major impact on design and efficiency, and 4) allows us to calculate and compare the capacities and efficiencies of compound eyes and simple eyes using a superior measure of cost. It is also possible that your dissatisfaction was deepened by disappointment. The first sentence of our original Abstract said that the goal of design is to maximize performance, so you might have expected to see that eyes are optimised.  Given that optimization provides cast iron proof that a system is designed to be efficient, and previous studies of coding by fly LMCs (Laughlin, 1981; Srinivasan et al., 1982 & van Hateren 1992) validated Barlow’s Efficient Coding Hypothesis by showing that coding is optimised, your expectation is reasonable. However, our investigation of how the allocation of resources to optics and photoreceptors affects an eye’s performance, efficiency and design does not depend a priori  on finding optima, therefore we have removed the “maximized”. Our revised Abstract now says, “to improve performance”.  

      In short, our study illustrates an old adage in statistics “All models fail to fit, but some are useful”. As is often the case, the way in which our model fails is useful. In the original version of the Results and Discussion, we argued that the allocation of resources is efficient, and identified factors that can, in principle, explain the scattering of data points. Indeed, our modelling identifies two of these deficiencies; a lack of data on species-specific energy usage, and the need for models that quantify the relationship between the quality of the captured image and the behavioural tasks for which an eye might be specialised. Thus, by examining the model’s failings we identify critical factors and pose new questions for future research.  We have rewritten the Discussion section How efficiently do insects allocate resources…. to make these points. We hope that these revisions will convince you that we have established a starting point for definitive studies, invented a vehicle that has travelled far enough to discover new territory, and shown that it can be modified to cope with difficult terrain.

      Turning to the need for a complicated model, because the costs and benefits depend on elementary optics and geometry, we too thought that there ought to be a simple model. However, when we tried to formulate a simple set of equations that approximate the definitive findings of our more complicated model we discovered that this is not as straightforward as we thought.  Many of the parameters in our model interact to determine costs and benefits, and many of these interactions are non-linear (e.g. the volumes of shells in spheres involve quadratic and cubic terms, and information depends on the log of a square root). So, rather than hold back publication of our complicated model, we decided to explain how it works as clearly as we can and demonstrate its value.

      In response to your final comment, “it is hard to evaluate conclusions about the competition between optics and photoreceptors (e.g. at the end of the abstract) and about the importance for evolution (end of introduction)”, we stand by our original argument. There must be competition in an eye of fixed cost, and because competition favours a heavy investment in photoreceptors, both in theory and in practice, it  is a significant factor in eye design. A match between investments in optics and photoreceptors is predicted by theory and observed in fly NS eyes, therefore this is a design principle. As for evolution, no one would deny that it is important to view the adaptive radiation of eyes through a cost-benefit lens. Our lens is the first to view the whole eye, optics and photoreceptor array, and the first to treat the costs of space, materials and energy. Although the view through our lens is a bit fuzzy, it reveals that costs, benefits and trade-offs are important. Thus we have established a promising starting point for a new and more comprehensive cost-benefit approach to understanding eye design and evolution.  As for the involvement of genes, when there are heritable changes in phenotype genes must be involved and if, as we suggest, efficient resource allocation is beneficial, the developmental mechanisms responsible for allocating resources to optics and photoreceptor array will be playing a formative role in eye evolution.

      Reviewer #2 (Public Review):

      Summary:

      In short, the paper presents a theoretical framework that predicts how resources should be optimally distributed between receptors and optics in eyes.

      Strengths:

      The authors build on the principle of resource allocation within an organism and develop a formal theory for optimal distribution of resources within an eye between the receptor array and the optics. Because the two parts of eyes, receptor arrays and optics, share the same role of providing visual information to the animal it is possible to isolate these from resource allocation in the rest of the animal. This allows for a novel and powerful way of exploring the principles that govern eye design. By clever and thoughtful assumptions/constraints, the authors have built a formal theory of resource allocation between the receptor array and the optics for two major types of compound eye as well as for camera-type eyes. The theory is formalized with variables that are well characterized in a number of different animal eyes, resulting in testable predictions.

      The authors use the theory to explain a number of design features that depend on different optimal distribution of resources between the receptor array and the optics in different types of eyes. As an example, they successfully explain why eye regions with different spatial resolution should be built in different ways. They also explain differences between different types of eyes, such as long photoreceptors in apposition compound eyes and much shorter receptors in camera type eyes. The predictive power in the theory is impressive.

      To keep the number of parameters at a minimum, the theory was developed for two types of compound eye (neural superposition, and apposition) and for camera-type eyes. It is possible to extend the theory to other types of eyes, although it would likely require more variables and assumptions/constraints to the theory. It is thus good to introduce the conceptual ideas without overdoing the applications of the theory.

      The paper extends a previous theory, developed by the senior author, that develops performance surfaces for optimal cost/benefit design of eyes. By combining this with resource allocation between receptors and optics, the theoretical understanding of eye design takes a major leap and provides entirely new sets of predictions and explanations for why eyes are built the way they are.

      The paper is well written and even though the theory development in the Results may be difficult to take in for many biologists, the Discussion very nicely lists all the major predictions under separate headings, and here the text is more tuned for readers that are not entirely comfortable with the formalism of the Results section. I must point out though that the Results section is kept exemplary concise. The figures are excellent and help explain concepts that otherwise may go above the head of many biologists.

      We are heartened by your appreciation of our manuscript - it persuaded us not to undertake extensive revisions – thank you.

      Reviewer #3 (Public Review):

      Summary:

      This is a proposal for a new theory for the geometry of insect eyes. The novel costbenefit function combines the cost of the optical portion with the photoreceptor portion of the eye. These quantities are put on the same footing using a specific (normalized) volume measure, plus an energy factor for the photoreceptor compartment. An optimal information transmission rate then specifies each parameter and resource allocation ratio for a variable total cost. The elegant treatment allows for comparison across a wide range of species and eye types. Simple eyes are found to be several times more efficient across a range of eye parameters than neural superposition eyes. Some trends in eye parameters can be explained by optimal allocation of resources between the optics and photoreceptors compartments of the eye.

      Strengths:

      Data from a variety of species roughly align with rough trends in the cost analysis, e.g. as a function of expanding the length of the photoreceptor compartment.

      New data could be added to the framework once collected, and many species can be compared.

      Eyes of different shapes are compared.

      Weaknesses:

      Detailed quantitative conclusions are not possible given the approximations and simplifying assumptions in the models and poor accounting for trends in the data across eye types.

      Reviewer #1 (Recommendations For The Authors):

      Figure 1: Panel E defines the parameters described in panel d. Consider swapping the order of those panels (or defining D and Delta Phi in the figure legend for d). Order follows narrative, eye types then match 

      We think that you are referring to Figure 1. We modified the legend.

      Lines 143-145: How does a different relative cost impact your results?

      Thank you for raising this question. Because our assumption that relative costs are the same is our starting point, and for optics it is not an obvious mistake, we do not raise your question here. We address your question where you next raise it because, for photoreceptors the assumption is obviously wrong.  We now emphasise that our method for accounting for photoreceptor energy costs can be applied to other costs. 

      Lines 187-190: Same as above - how do your results change if this assumption is not accurate?

      We have revised our manuscript to emphasise that we are dealing with the situation in which our initial assumption (costs per unit volume are equal) breaks down. On (lines 203 - 208) we write “ However, this assumption breaks down when we consider specific metabolic rates. To enable and power phototransduction, photoreceptors have an exceptionally high specific metabolic rate (energy consumed per gram, and hence unit volume, per second) (Laughlin et al., 1998; Niven et al., 2007; Pangršič et al., 2005). We account for this extra cost by applying an energy surcharge, S<sub>E</sub>. To equate…. 

      We also revised part of the Discussion section, Specific volume is a useful measure of cost to make it clear that we are able take account for situations in which the costs per unit volume are not equal, and we give our treatment of photoreceptor energy costs as an example of how this is done. On lines 626 - 640 we say  

      Cost estimates can be adjusted for situations in which costs per unit volume are not equal, as illustratedby our treatment of photoreceptor energy consumption.  To support transduction the photoreceptor array has an exceptionally high metabolic rate (Laughlin et al., 1998; Niven et al., 2007; Pangršič et al., 2005). We account forthis higher energy cost by using the animal’s specific metabolic rate (power per unit mass and hence power per unit volume) to convert an array’s power consumption into an equivalent volume (Methods). Photoreceptor ion pumps are the major consumers of energy and the smaller contribution of pigmented glia (Coles, 1989) is included in our calculation of the energy tariff K<sub>E</sub>. (Methods) The higher costs of materials and their turnover in the photoreceptor array can be added the energy tariff K<sub>E</sub> but given the magnitude of the light-gated current (Laughlin et al., 1998) the relative increase will be very small. Thus for our intents and purposes the effects of these additional costs are covered by our models. For want of sufficient data…”.

      Reviewer #2 (Recommendations For The Authors):

      A few comments for consideration by the authors:

      (1) In the abstract, Maybe give another example explaining why other eyes should be different to those of fast diurnal insects.

      This worthwhile extrapolation is best kept to the Discussion.

      (2) Would it be worthwhile mentioning that the photopigment density is low in rhabdoms compared to vertebrate outer segments? This will have major effects on the relative size of retina and optics.

      Thank you, we now make this good point in the Discussion (lines 698-702).

      (3) It took me a while to understand what you mean by an energy tariff. For the less initiated reader many other variables may be difficult to comprehend. A possible remedy would be to make a table with all variables explained first very briefly in a formal way and then explained again with a few more words for readers less fluent in the formalism.

      A very useful suggestion. We have taken your advice (p.4).

      (4) The "easy explanation" on lines 356-357 need a few more words to be understandable.

      We have expanded this argument, and corrected a mistake, the width of the head front to back is not 250 μm, it is 600 μm (lines 402-407)

      (5) Maybe devote a short paragraph in the Discussion to other types of eye, such as optical superposition eyes and pinhole eyes. This could be done very shortly and without formalism. I'm sure the authors already have a good idea of the optimal ratio of receptor arrays and optics in these eye types.

      We do not discuss this because we have not found a full account of the trade-offs and their  effects on costs and benefits. We hope that our analysis of apposition and simple eyes will encourage people to analyse the relationships between costs and benefits in other eye types. To this end we pointed out in the Discussion that recent advances in imaging and modelling could be helpful.

      (6)  Could the sentence on lines 668-671 be made a little clearer?

      “Efficiency is also depressed by increasing the photoreceptor energy tariff K<sub>E</sub>, and in line with the greater impact of photoreceptor energy costs in simple eyes, the reduction in efficiency is much greater in simple eyes (Figure 8b).0.

      We replaced this sentence with “In both simple and apposition eyes efficiency is reduced by increasing the photoreceptor energy tariff K<sub>E</sub>. This effect is much greater in simple eyes, thus as found for reductions in photoreceptor length (Figure 7b),K<sub>E</sub> has more impact on the design of simple eyes” (lines749 – 752).

      (7)  I have some reservations about the text on lines 789-796. The problem is that optics can do very little to improve the performance of a directional photoreceptor where delrho should optimally be very wide. Here, membrane folding is the only efficient way to improve performance (SNR). The option to reduce delrho for better performance comes later when simultaneous spatial resolution (multiple pixels) is introduced.

      Yes, we have been careless. We have rewritten this paragraph to say (lines 920-931)

      “Two key steps in the evolution of eyes were the stacking of photoreceptive membranes to absorb more photons, and the formation of optics to intercept more photons and concentrate them according to angle of incidence to form an image (Nilsson, 2013, 2021). Our modelling of well-developed image forming eyes shows that to improve performance stacked membranes (rhabdomeres) compete with optics for the resources invested in an eye, and this competition profoundly influences both form and function. It is likely that competition between optics and photoreceptors was shaping eyes as lenses evolved to support low resolution spatial vision. Thus the developmental mechanisms that allocate resources within modern high resolution eyes (Casares & MacGregor, 2021), by controlling cell size and shape, and as our study emphasises, gradients in size and shape across an eye, will have analogues or homologues in more ancient eyes. Their discovery….” (lines 920-931

      Reviewer #3 (Recommendations For The Authors):

      Suggestions for major revisions:

      While the approach is novel and elegant, the results from the analysis of insect morphology do not broadly support the optimization argument and hardly constrain parameters, like the energy tariff value, at all. The most striking result of the paper is the flat plateau in information across a broad range of shape parameters and the length, and resolution trend in Figure 5.

      At no point in the Results and Discussion do we argue that resource allocation is optimized. Indeed, we frequently observe that it is not. Our mistake was to start the Abstract by observing that animals evolve to minimise costs. We have rewritten the Abstract accordingly.

      The information peaks are quite shallow. This might actually be a very important and interesting result in the paper - the fact that the information plateaus could give the insect eye quite a wide range of parameters to slide between while achieving relatively efficient sensing of the environment. Instead of attempting to use a rather ad hoc and poorly supported measure of energetics in PR cost, perhaps the pitch could focus on this flexibility. K<sub>E</sub> does not seem to constrain eye parameters and does not add much to the paper.

      We agree, being able to construct performance surfaces across morphospace is an important advance in the field of eye design and evolution, and the performance surface’s flat top has interesting implications for the evolution of adaptations. Encouraged by your remarks, we have rewritten the Abstract and the introductory paragraph of the Discussion to draw attention to these points. 

      We are disappointed that we failed to convince you that our energy tariff, K<sub>E</sub> , is no better than a poorly supported ad hoc parameter that does not add much to the paper. In our opinion a resource allocation model that ignores photoreceptor energy consumption is obviously inadequate because the high energy cost of phototransduction is both wellknown and considered to be a formative factor in eye evolution (Niven and Laughlin, 2008). One of the advantages of modelling is that one can assess the impact of factors that are known to be present, are thought to be important, but have not been quantified. We followed standard modelling practice by introducing a cost that has the same units as the other costs and, for good physiological reasons, increases linearly with the number of microvilli, according to K<sub>E</sub>. We then vary this unknown cost parameter to discover when and why it is significant. We were pleased to discover that we could combine data on photoreceptor energy demands and whole animal metabolic rates to establish the likely range of K<sub>E</sub>. This procedure enabled us to unify the cost-benefit analyses of optics and photoreceptors, and to discover that realistic values of K<sub>E</sub> have a profound impact on the structure and performance of an efficient eye. We hope that this advance will encourage people to collect the data needed to evaluate K<sub>E</sub>.To emphasise the importance of K<sub>E</sub> and dispel doubts associated with the failure of the model to fit the data, we have revised two sections:  Flies invest efficiently in costly photoreceptor arrays in the Results, and How efficiently do insects allocate resources within their apposition eyes?  in the Discussion. These rewrites also explain why it is impossible for us to infer K<sub>E</sub> by adjusting its value so that the model’s predictions fit the data.

      The graphics after Figure 3 are quite dense and hard to follow. None of the plateau extent shown in Fig 3 is carried through to the subsequent plots, which makes the conclusions drawn from these figures very hard to parse. If the peak information occurs on a flat plateau, it would be more helpful to see those ranges of parameters displayed in the figures.

      Ideally one should do as you suggest and plot the extent of the plateau, but in our situation this is not very helpful. In the best data set, flies, optimised models predict D well, get close to ∆φ in larger eyes, and demonstrate that these optimum values are not very sensitive to K<sub>E</sub> L is a different matter, it is very sensitive to K<sub>E</sub> L which, as we show (and frequently remind) is poorly constrained by experimental data. The best we can do is estimate the envelope of L vs C<sub>tot</sub>  curves, as defined by a plausible range of K<sub>E</sub>L . Because most of the plateau boundaries you ask for will fall within this envelope, plotting them does little to clear the fog of uncertainty. We note that all three referees agree that our model can account for two robust trends, i) in apposition eyes L increase with optical resolving power and acuity, both within individual eyes and among eyes of different sizes, and ii) L is much longer is apposition eyes than in simple eyes. Nonetheless, the scatter of data points and their failure to fit creates a bad impression. We gave a number of reasons why the model does not fit the data points, but these were scattered throughout the Results and Discussion and, as referees 1 and 3 point out, this makes it difficult to draw convincing conclusions. To rectify this failing, we have rewritten two sections, in the Results Flies invest efficiently in costly photoreceptor arrays and in the Discussion, How efficiently do insects allocate resources within their apposition eyes?, to discuss these reasons en bloc, draw conclusions and suggest how better data and refinements to modelling could resolve these issues.  

      Throughout the figures, the discontinuities in the optimal cuts through parameter space are not sufficiently explained.

      We added a couple of sentences that address the “jumps” (lines 313 – 318)

      None of the data seems to hug any of the optimal lines and only weakly follow the trends shown in the plots. This makes interpretation difficult for the reader and should be better explained. The text can be a little telegraphic in the Results after roughly page 10, and requires several readings to glean insight into the manuscript's conclusions.

      We revised the Results section in which we compare the best data set, flies’  NS eyes with theoretical predictions, Flies invest efficiently in costly photoreceptor arrays,  to expand our interpretation of the data and clarify our arguments. The remaining sections have not been expanded. In the next section, which is on fused rhabdom apposition eyes, our interpretation of the scattering of data points follows the same line of argument. The remaining Results sections are entirely theoretical.  

      Overall, the rough conclusions outlined in the Results seem moderately supported by the matches of the data to the optimal information transmission cuts through parameter space, but only weakly.

      We agree, more data is required to test and refine our theoretical predictions.

      The Discussion is long and well-argued, and contains the most cogent writing in the manuscript.

      Thank you: this is most pleasing. We submitted our study to eLife because it allows longer Discussions, but we worried that ours was too long. However, we felt that our extensive Discussion was necessary for two reasons. First, we are introducing a new approach to understanding of eye design and evolution. Second, because the data on eye morphology and costs are limited, we had to make a number of assumptions and by discussing these, warts and all, we hoped to encourage experimentalists to gather more data and focus their efforts on the most revealing material.  

      Minor comments:

      We have acted upon most of your minor comments and we confine our remarks to our disagreements. We are grateful for your attention to details that we \textshould have picked up on.  

      It's a more standard convention to say "cost-benefit" rather than with a colon. 

      "equation" should be abbreviated "eq" or "eqn", never with a "t"

      when referring to the work of van Hateren, quote the paper and the database using "van Hateren" not just "Hateren"

      small latex note: use "\textit{SNR}" to get the proper formatting for those letters when in the math environment

      Line 100-110: "f" is introduced, but only f' is referenced in the figure. This should be explained in order. d_rh is not included in the figure. Also in this section, d_rh/f is also referenced before \Delta \rho_rf, which is the same quantity, without explanation.  

      Figure 1 shows eye structure and geometry. f’ is a lineal dimension of the eye but f is not, so f is not shown in Fig 1e. We eliminated the confusion surrounding ∆ρ<sub>rh</sub>  by deleting “and changing the acceptance angle of the photoreceptive waveguide ∆ρ<sub>rh</sub> (Snyder, 1979)”.  

      Fig 1 caption: this says "From dorsal to ventral," then describes trends that run ventral to dorsal, which is a confusing typo.

      Fig 3 - adding some data points to these plots might help the reader understand how (or if) K_E is constrained by the data.

      It is not possible to add data points because to total cost, Ctot ,is unknown.

      Fig 4c (and in other subplots): the jumps in L with C_tot could be explained better in the text - it wasn't clear to this reviewer why there are these discontinuities.

      Dealt with in the revised text (lines  310-318).

      Fig 4d: The caption for this subplot could be more clearly written.

      We have rewritten the subscript for subplot 4d.

      Fig 5 and other plots with data: please indicate which symbols are samples from the same species. This info is hard to reconstruct from the tables.

      We have revised Figure 5 accordingly. Species were already indicated in Figure 6.

      Line 328: missing equation number

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The objective of this research is to understand how the expression of key selector transcription factors, Tal1, Gata2, Gata3, involved in GABAergic vs glutamatergic neuron fate from a single anterior hindbrain progenitor domain is transcriptionally controlled. With suitable scRNAseq, scATAC-seq, CUT&TAG, and footprinting datasets, the authors use an extensive set of computational approaches to identify putative regulatory elements and upstream transcription factors that may control selector TF expression. This data-rich study will be a valuable resource for future hypothesis testing, through perturbation approaches, of the many putative regulators identified in the study. The data are displayed in some of the main and supplemental figures in a way that makes it difficult to appreciate and understand the authors' presentation and interpretation of the data in the Results narrative. Primary images used for studying the timing and coexpression of putative upstream regulators, Insm1, E2f1, Ebf1, and Tead2 with Tal1 are difficult to interpret and do not convincingly support the authors' conclusions. There appears to be little overlap in the fluorescent labeling, and it is not clear whether the signals are located in the cell soma nucleus.

      Strengths:

      The main strength is that it is a data-rich compilation of putative upstream regulators of selector TFs that control GABAergic vs glutamatergic neuron fates in the brainstem. This resource now enables future perturbation-based hypothesis testing of the gene regulatory networks that help to build brain circuitry.

      We thank Reviewer #1 for the thoughtful assessment and recognition of the extensive datasets and computational approaches employed in our study. We appreciate the acknowledgment that our efforts in compiling data-rich resources for identifying putative regulators of key selector transcription factors (TFs)—Tal1, Gata2, and Gata3—are valuable for future hypothesis-driven research.

      Weaknesses:

      Some of the findings could be better displayed and discussed.

      We acknowledge the concerns raised regarding the clarity and interpretability of certain figures, particularly those related to expression analyses of candidate upstream regulators such as Insm1, E2f1, Ebf1, and Tead2 in relation to Tal1. We agree that clearer visualization and improved annotation of fluorescence signals are crucial to accurately support our conclusions. In our revised manuscript, we will enhance image clarity and clearly indicate sites of co-expression for Tal1 and its putative regulators, ensuring the results are more readily interpretable. Additionally, we will expand explanatory narratives within the figure legends to better align the figures with the results section.

      Reviewer #2 (Public review):

      Summary:

      In the manuscript, the authors seek to discover putative gene regulatory interactions underlying the lineage bifurcation process of neural progenitor cells in the embryonic mouse anterior brainstem into GABAergic and glutamatergic neuronal subtypes. The authors analyze single-cell RNA-seq and single-cell ATAC-seq datasets derived from the ventral rhombomere 1 of embryonic mouse brainstems to annotate cell types and make predictions or where TFs bind upstream and downstream of the effector TFs using computational methods. They add data on the genomic distributions of some of the key transcription factors and layer these onto the single-cell data to get a sense of the transcriptional dynamics.

      Strengths:

      The authors use a well-defined fate decision point from brainstem progenitors that can make two very different kinds of neurons. They already know the key TFs for selecting the neuronal type from genetic studies, so they focus their gene regulatory analysis squarely on the mechanisms that are immediately upstream and downstream of these key factors. The authors use a combination of single-cell and bulk sequencing data, prediction and validation, and computation.

      We also appreciate the thoughtful comments from Reviewer #2, highlighting the strengths of our approach in elucidating gene regulatory interactions that govern neuronal fate decisions in the embryonic mouse brainstem. We are pleased that our focus on a critical cell-fate decision point and the integration of diverse data modalities, combined with computational analyses, has been recognized as a key strength.

      Weaknesses:

      The study generates a lot of data about transcription factor binding sites, both predicted and validated, but the data are substantially descriptive. It remains challenging to understand how the integration of all these different TFs works together to switch terminal programs on and off.

      Reviewer #2 correctly points out that while our study provides extensive data on predicted and validated transcription factor binding sites, clearly illustrating how these factors collectively interact to regulate terminal neuronal differentiation programs remains challenging. We acknowledge the inherently descriptive nature of the current interpretation of our combined datasets.

      In our revision, we will clarify how the different data types support and corroborate one another, highlighting what we consider the most reliable observations of TF activity. Additionally, we will revise the discussion to address the challenges associated with interpreting the highly complex networks of interactions within the gene regulatory landscape.

      We sincerely thank both reviewers for their constructive feedback, which we believe will significantly enhance the quality and accessibility of our manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The results in Figure 3 and several associated supplements are mainly a description/inventory of putative CREs some of which are backed to some extent by previous transgenic studies. But given the way the authors chose to display the transgenic data in the Supplements, it is difficult to fully appreciate how well the transgenic data provide functional support. Take, for example, the Tal +40kb feature that maps to a midbrain enhancer: where exactly does +40kb map to the enhancer region? Is Tal +40kb really about 1kb long? The legend in Supplemental Figure 6 makes it difficult to interpret the bar charts; what is the meaning of: features not linked to gene -Enh? Some of the authors' claims are not readily evident or are inscrutable. For example, Tal locus features accessible in all cell groups are not evident (Fig 2A,B). Other cCREs are said to closely correlate with selector expression for example, Tal +.7kb and +40kb. However, inspection of the data seems to indicate that the two cCREs have very different dynamics and only +40kb seems to correlate with the expression track above it. Some features are described redundantly such as the Gata2 +22 kb, +25.3 kb, and +32.8 kb cCREs above and below the Gata3 cCRE. What is meant by: The feature is accessible at 3' position early, and gains accessibility at 5' positions ... Detailed feature analysis later indicated the binding of Nkx6-1 and Ascl1 that are expressed in the rV2 neuronal progenitors, at 3' positions, and binding of Insm1 and Tal1 TFs that are activated in early precursors, at 5' positions (Figure 3C).

      To allow easier assessment of the overlap of the features described in this study in reference to the transgenic studies, we have added further information about the scATAC features, cCREs and previously published enhancers, as well as visual schematics of the feature-enhancer overlaps in the Supplementary table 4. The Supplementary Table 4 column contents are also now explained in detail in the table legend (under the table). We hope those changes make the feature descriptions clearer. To answer the reviewer's question about the Tal1+40kb enhancer, the length of the published enhancer element is 685 bp and the overlapping scATAC feature length is 2067 bp (Supplementary Table 3, sheet Tal1, row 103).

      The legend and the chart labelling in the Supplementary Figure 5 (formerly Supplementary figure 6) have been elaborated, and the shown categories explained more clearly.

      Regarding the features at the Tal1 locus, the text has been revised and the references to the features accessible in all cell groups were removed. These features showed differences in the intensity of signal but were accessible in all cell groups. As the accessibility of these features does not correlate with Tal1 expression, they are of less interest in the context of this paper.

      The gain in accessibility of the +0.7kb and +40 kb features correlates with the onset of Tal1 RNA expression. This is now more clearly stated in the text, as " For example, the gain in the accessibility of Tal1 cCREs at +0.7 and +40 kb correlated temporally with the expression of Tal1 mRNA (Figure 2B), strongly increasing in the earliest GABAergic precursors (GA1) and maintained at a lower level in the more mature GABAergic precursor groups (GA2-GA6), " (Results, page 4). The reviewer is right that the later dynamics of the +0.7 and +40 cCREs differ and this is now stated more clearly in the text (Results, page 5, last chapter).

      The repetition in the description of the Gata2 +22 kb, +25.3 kb, and +32.8 kb cCREs has been removed.

      The Tal1 +23 kb cCRE showed within-feature differences in accessibility signal. This is explained in the text on page 5, referring to the relevant figure 2A, showing the accessibility or scATAC signal in cell groups and the features labelled below, and 3C, showing the location of the Nkx6-1 and Ascl1 binding sites in this feature: "The Tal1 +23 kb cCRE contained two scATAC-seq peaks, having temporally different patterns of accessibility. The feature is accessible at 3' position early, and gains accessibility at 5' positions concomitant with GABAergic differentiation (Figure 2A, accessibility). Detailed feature analysis later indicated that the 3' end of this feature contains binding sites of Nkx6-1 and Ascl1 that are expressed in the rV2 neuronal progenitors, while the 5' end contains TF binding sites of Insm1 and Tal1 TFs that are activated in early precursors (described below, see Figure 3C)."

      (2) Supplementary Figure 3 is not presented in the Results.

      Essential parts of previous Supplementary Figure 3 have been incorporated into the Figure 4 and the previous Supplementary Figure omitted.

      (3) The significance of Figure 3 and the many related supplements is difficult to understand. A large number of footprints with wide-ranging scores, many very weak or unbound, are displayed in the various temporal cell groups in different epigenomic regions of Tal1 and Vsx2. The footprints for GA1 and Ga2 are combined despite Tal1 showing stronger expression in GA1 and stronger accessibility (Figure 2). Many possibilities are outlined in the Results for how the many different kinds of motifs in the cCREs might bind particular TFs to control downstream TF expression, but no experiments are performed to test any of the possibilities. How well do the TOBIAS footprints align with C&T peaks? How was C&T used to validate footprints? Are Gata2, 3, and Vsx2 known to control Tal1 expression from perturbation experiments?

      Figure 3 and related supplements present examples of the primary data and summarise the results of comprehensive analysis. The methods of identifying the selector TF regulatory features and the regulators are described in the Methods (Materials and Methods page 16). Briefly, the correlation between feature accessibility and selector TF RNA expression (assessed by the LinkPeaks score and p-value) were used to select features shown in the Figure 3.

      We are aware of differences in Tal1 expression and accessibility between GA1 and GA2. However, number of cells in GA2 was not high enough for reliable footprint calculations and therefore we opted for combining related groups throughout the rV2 lineage for footprinting.

      As suggested, CUT&Tag could be used to validate the footprinting results with some restrictions. In the revised manuscript, we included analysis of CUT&Tag peak location and footprints similarly to an earlier study (Eastman et al. 2025). In summary, we analysed whether CUT&Tag peaks overlap locations in which footprinting was also recognized and vice versa. Per each TF with CUT&Tag data we calculated a) Total number of CUT&Tag consensus peaks b) Total number of bound TFBS (footprints) c) Percentage of CUT&Tag overlapping bound TFBS d) Percentage of bound TFBS overlapping CUT&Tag. These results are shown in Supplementary Table 6 and in Supplementary figure 11 with analysis described in Methods (Materials and Methods, page 19). There is considerable overlap between CUT&Tag peaks and bound footprints, comparable to one shown in Eastman et al. 2025. However, these two methods are not assumed to be completely matching for several reasons: binding by related/redundant TFs, antigen masking in the TF complex, chromatin association without DNA binding, etc. In addition, some CUT&Tag peaks with unbound footprints could arise from non-rV2 cells that were part of the bulk CUT&Tag analysis but not of the scATAC footprint analysis.

      The evidence for cross-regulation of selector genes and the regulation of Tal1 by Gata2, Gata3 and Vsx2 is now discussed (Discussion, chapter Selector TFs directly autoregulate themselves and cross-regulate each other, page 12-13). The regulation of Tal1 expression by Vsx2 has, to our knowledge, not been earlier studied.

      (4) Figure 4 findings are problematic as the primary images seem uninterpretable and unconvincing in supporting the authors' claims. There is a lack of clear evidence in support of TF coexpression and that their expression precedes Tal1.

      Figure 4 has been entirely redrawn with higher resolution images and a more logical layout. In the revised Figure 4, only the most relevant ISH images are shown and arrowheads are added showing the colocalization of the mRNA in the cell cytoplasm. Next to the plots of RNA expression along the apical-basal axis of r1, an explanatory image of the quantification process is added (Figure 4D).

      (5) What was gained from also performing ChromVAR other than finding more potential regulators and do the results of the two kinds of analyses corroborate one another? What is a dual GATA:TAL BS?

      Our motivation for ChromVAR analysis is now more clearly stated in the text (Results, page 9): “In addition to the regulatory elements of GABAergic fate selectors, we wanted to understand the genome-wide TF activity during rV2 neuron differentiation. To this aim we applied ChromVAR (Schep et al., 2017)" Also, further explanation about the Tal1and Gata binding sites has been added in this chapter (Results, page 9).

      The dual GATA:Tal BS (TAL1.H12CORE.0.P.B) is a 19-bp motif that consists of an E-box and GATA sequence, and is likely bound by heteromeric Gata2-Tal1 TF complex, but may also be bound by Gata2, Gata3 or Tal1 TFs separately. The other TFBSs of Tal1 contain a strong E-box motif and showed either a lower activity (TAL1.H12CORE.1.P.B) or an earlier peak of activity in common precursors with a decline after differentiation (TAL1.H12CORE.2.P.B) (Results, page 9).

      (6) The way the data are displayed it is difficult to see how the C&T confirmed the binding of Ebf1 and Insm1, Tal1, Gata2, and Gata3 (Supplementary Figures 9-11). Are there strong footprints (scores) centered at these peaks? One can't assess this with the way the displays are organized in Figure 3. What is the importance of the H3K4me3 C&T? Replicate consistency, while very strong for some TFs, seems low for other TFs, e.g. Vsx2 C&T on Tal1 and Gata2. The overlaps do not appear very strong in Supplementary Figure 10. Panels are not letter labeled.

      We have added an analysis of footprint locations within the CUT&Tag peaks (Supplementary Figure 11). The Figure shows that the footprints are enriched at the middle regions of the CUT&Tag peaks, which is expected if TF binding at the footprinted TFBS site was causative for the CUT&Tag peaks.

      The aim of the Supplementary Figures 9-11 (Supplementary Figures 8-10 in the revised manuscript) was to show the quality and replicability of the CUT&Tag.

      The anti-H3K4me3 antibody, as well as the anti-IgG antibody, was used in CUT&Tag as part of experiment technical controls. A strong CUT&Tag signal was detected in all our CUT&Tag experiments with H3K4me3. The H3K4me3 signal was not used in downstream analyses.

      We have now labelled the H3K4me3 data more clearly as "positive controls" in the Supplementary Figure 8. The control samples are shown only on Supplementary Figure 8 and not in the revised Supplementary Figure 10, to avoid repetition. The corresponding figure legends have been modified accordingly.

      To show replicate consistency, the genome view showing the Vsx2 CUT&Tag signal at Gata2 gene has been replaced by a more representative region (Supplementary Figure 8, Vsx2). The Vsx2 CUT&Tag signal at the Gata2 locus is weak, explaining why the replicability may have seemed low based on that example.

      Panel labelling is added on Supplementary Figures S8, S9, S10.  

      (7) It would be illuminating to present 1-2 detailed examples of specific target genes fulfilling the multiple criteria outlined in Methods and Figure 6A.

      We now present examples of the supporting evidence used in the definition of selector gene target features and target genes. The new Supplementary Figure 12 shows an example gene Lmo1 that was identified as a target gene of Tal1, Gata2 and Gata3.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors perform CUT&Tag to ask whether Tal1 and other TFs indeed bind putative CREs computed. However, it is unclear whether some of the antibodies (such as Gata3, Vsx2, Insm1, Tead2, Ebf1) used are knock-out validated for CUT&Tag or a similar type of assay such as ChIP-seq and therefore whether the peaks called are specific. The authors should either provide specificity data for these or a reference that has these data. The Vsx2 signal in Figure S9 looks particularly unconvincing.

      Information about the target specificity of the antibodies can be found in previous studies or in the product information. The references to the studies have been now added in the Methods (Materials and Methods, CUT&Tag, pages 18-19). Some of the antibodies are indeed not yet validated for ChIP-seq, Cut-and-run or CUT&Tag. This is now clearly stated in the Materials and Methods (page 19): "The anti-Ebf1, anti-Tal1, anti-IgG and anti-H3K4me3 antibodies were tested on Cut-and-Run or ChIP-seq previously (Boller et al., 2016b; Courtial et al., 2012) and Cell Signalling product information). The anti-Gata2 and anti-Gata3 antibodies are ChIP-validated ((Ahluwalia et al., 2020a) and Abcam product information). There are no previous results on ChIP, ChIP-seq or CUT&Tag with the anti-Insm1, anti-Tead2 and anti-Vsx2 antibodies used here. The specificity and nuclear localization have been demonstrated in immunohistochemistry with anti-Vsx2 (Ahluwalia et al., 2020b) and anti-Tead2 (Biorbyt product information). We observed good correlation between replicates with anti-Insm1, similar to all antibodies used here, but its specificity to target was not specifically tested". We admit that specificity testing with knockout samples would increase confidence in our data. However, we have observed robust signals and good replicability in the CUT&Tag for the antibodies shown here.

      Vsx2 CUT&Tag signal at the loci previously shown in Supplementary Figure S9 (now Supplementary Figure 8) is weak, explaining why the replicability may seem low based on those examples. The genome view showing the Vsx2 CUT&Tag signal at Gata2 gene locus in Supplementary Figure 8 (previously Supplementary figure 9) has now been replaced by a view of Vsx2 locus that is more representative of the signal.

      (2) It is unclear why the authors chose to focus on the transcription factor genes described in line 626 as opposed to the many other putative TFs described in Figure 3/Supplementary Figure 8. This is the major challenge of the paper - the authors are trying to tell a very targeted story but they show a lot of different names of TFs and it is hard to follow which are most important.

      We agree with the reviewer that the process of selection of the genes of interest is not always transparent. We are aware that interpretations of a paper are based on the known functions of the putative regulatory TFs, however additional aspects of regulation could be revealed even if the biological functions of all the TFs were known. This is now stated in the Discussion “Caveats of the study” chapter. It would be relevant to study all identified candidate genes, but as often is the case, our possibilities were limited by the availability of materials (probes, antibodies), time, and financial resources. In the revised manuscript, we now briefly describe the biological processes related to the selected candidate regulatory TFs of the Tal1 gene (Results, page 8, "Pattern of expression of the putative regulators of Tal1 in the r1"). We hope this justifies the focus on them in our RNA co-expression analysis. The TFs analysed by RNAscope ISH are examples, which demonstrate alignment of the tissue expression patterns with the scRNA-seq data, suggesting that the dynamics of gene expression detected by scRNA-seq generally reflects the pattern of expression in the developing brainstem.

      (3) How is the RNA expression level in Figure 5B and 4D-L computed? These are the clusters defined by scATAC-seq. Is this an inferred RNA expression? This should be made more clear in the text.

      The charts in Figures 5B and 4G,H,I show inferred RNA expression. The Y-axis labels have now been corrected and include the term inferred’. RNA expression in the scATAC-seq cell clusters is inferred from the scRNA-seq cells after the integration of the datasets.

      (4) The convergence of the GABA TFs on a common set of target genes reminds me of a nice study from the Rubenstein lab PMID: 34921112 that looked at a set of TFs in cortical progenitors. This might be a good comparison study for the authors to use as a model to discuss the convergence data.

      We thank the reviewer for bringing this article to our attention. The article is now discussed in the manuscript (Discussion, page 11).

      (5) The data in Figure 4, the in-situ figure, needs significant work. First, the images especially B, F, and J appear to be of quite low resolution, so they are hard to see. It is unclear exactly what is being graphed in C, G, and K and it does not seem to match the text of the results section. Perhaps better labeling of the figure and a more thorough description will make it clear. It is not clear how D, H, and L were supposed to relate to the images - presumably, this is a case where cell type is spatially organized, but this was unclear in the text if this is known and it needs to be more clearly described. Overall, as currently presented this figure does not support the descriptions and conclusions in the text.

      Figure 4 has been entirely redrawn with higher resolution images and more logical layout. In the revised Figure 4, the ISH data and the quantification plots are better presented; arrows showing the colocalization of the mRNA in the cell cytoplasm were added; and an explanatory image of the quantification process is added on (D).

      Minor points

      (1) Helpful if the authors include scATAC-seq coverage plots for neuronal subtype markers in Figure 1/S1.

      We are unfortunately uncertain what is meant with this request. Subtype markers in Figure 1/S1 scATAC-seq based clusters are shown from inferred RNA expression, and therefore these marker expression plots do not have any coverage information available.

      (2) The authors in line 429 mention the testing of features within TADs. They should make it clear in the main text (although tadmap is mentioned in the methods) that this is a prediction made by aggregating HiC datasets.

      Good point and that this detail has been added to both page 3 and 16.

      (3) The authors should include a table with the phastcons output described between lines 511 and 521 in the main or supplementary figures.

      We have now clarified int the text that we did not recalculate any phastcons results, we merely used already published and available conservation score per nucleotide as provided by the original authors (Siepel et al. 2005). (Results, page 5: revised text is " To that aim, we used nucleotide conservation scores from UCSC (Siepel et al., 2005). We overlaid conservation information and scATAC-seq features to both validate feature definition as well as to provide corroborating evidence to recognize cCRE elements.")

      (4) It is very difficult to read the names of the transcription factor genes described in Figure 3B-D and Supplementary Figure 8 - it would be helpful to resize the text.

      The Figures 3B-D and Supplementary Figure 7 (former Supplementary figure 8) have been modified, removing unnecessary elements and increasing the size of text.

      (5) It is unclear what strain of mouse is used in the study - this should be mentioned in the methods.

      Outbred NMRI mouse strain was used in this study. Information about the mouse strain is added in Materials and Methods: scRNA-seq samples (page 14), scATAC-seq samples (page 15), RNAscope in situ hybridization (page 17) and CUT&Tag (page 18).

      (6) Text size in Figure 6 should be larger. R-T could be moved to a Supplementary Figure.

      The Figure 6 has been revised, making the charts clearer and the labels of charts larger. The Figure 6R-S have been replaced by Supplementary table 8 and the Figure 6T is now shown as a new Figure (Figure 7).

      Additional corrections in figures

      Figure 6 D,I,N had wrong y-axis scale. It has been corrected, though it does not have an effect on the interpretation of the data as Pos.link and Neg.link counts were compared to each other’s (ratio).

      On Figure 2B, the heatmap labels were shifted making it difficult to identify the feature name per row. This is now corrected.

    1. Reviewer #2 (Public review):

      The mechanisms governing autophagic membrane expansion remain incompletely understood. ATG2 is known to function as a lipid transfer protein critical for this process; however, how ATG2 is coordinated with the broader autophagic machinery and endomembrane systems has remained elusive. In this study, the authors employ an elegant proximity labeling approach and identify two ER-Golgi intermediate compartment (ERGIC)-localized proteins-Rab1 and ARFGAP1-as novel regulators of ATG2 during autophagic membrane expansion.

      Their findings support a model in which autophagosome formation occurs within a specialized subdomain of the ER that is enriched in both ER exit sites (ERES) and ERGIC, providing valuable mechanistic insight. The overall study is well-executed and offers an important contribution to our understanding of autophagy.

      Specific Comments

      (1) Integration with Prior Literature<br /> The data convincingly implicate the ERES-ERGIC interface in autophagosome biogenesis. It would strengthen the manuscript to discuss previous studies reporting ERES and ERGIC remodeling and formation of ERERS-ERGIC contact sites (PMID: 34561617; PMID: 28754694) in the context of the current findings.

      (2) Experimental Conditions<br /> In Figures 2A-C and Figure 4, it is unclear how the cells were treated. Were they starved in EBSS? This information should be included in the corresponding figure legends.

      (3) LC3 Lipidation vs. Cleavage<br /> In Figure 2A, ARFGAP1 knockdown appears to reduce LC3 lipidation without affecting Halo-LC3 cleavage. Clarifying this observation would help readers better understand the functional specificity of ARFGAP1 in the pathway.

      (4) Use of HT-mGFP in Figure 2C<br /> It should be clarified whether the assay in Figure 2C was performed in the presence of HT-mGFP. Explaining the rationale would aid the interpretation of the results.

      (5) COPII Inhibition Strategy<br /> The authors used the dominant-active SAR1(H79G) mutant to inhibit COPII function. While this is effective in in vitro budding assays, the GDP-locked mutant SAR1(T39N) has been shown to be more effective in blocking COPII-mediated trafficking in cells. Including SAR1(T39N) in the analysis would provide stronger support for the conclusions.

    2. Reviewer #3 (Public review):

      The manuscript by Fuller et al describes a crosstalk between ARTG2A with components of the early secretory pathway, namely RAB1A and ARFGAP1. They show that ATG2A is recruited to membranes positive for RAB1A, which they also show to interact with ATG2A. In agreement with earlier findings by other groups, silencing RAB1A negatively affects autophagy. While ARFGAP1 was also found on ATG2A-positive membranes, silencing ARFGAP1 had no impact on autophagy. Notably, these ARFGAP1-positive membranes are not Golgi membranes.

      The findings are interesting, and in general, the data are of good quality; however, I have outstanding questions. An answer to any of these questions might strengthen the manuscript:

      (1) Are the membranes to which ATG2A is recruited a form of ERGIC?

      (2) Figure 3A/B: Is it possible to show a better example? The difference is barely detectable by eye. Since immunoblotting is not really a quantitative method, I think that such a weak effect is prone to be wrong. Is there another tool/assay to validate this result?

      (3) Is the curvature-sensitive region of ARFGAP1 required for its co-localization with ATG2A?

      (4) What does Rab1A do? What is its effector? Or does the GTPase itself remodel the membrane?

      (5) What about Arf1? It appears that the role of ARFGAP1 is unrelated to Arf1 and COPI? Thus, one would predict that Arf1 does not localize to these structures and does not affect ATG2A function.

      (6) Does ARFGAP1 promote fission of the membrane from its donor compartment?

      (7) What are ARFGAP1 and Rab1A recruited to? What is the lipid composition or protein that recruits these two players to regulate autophagy?

    1. Reviewer #3 (Public review):

      Summary:

      In their study McDermott et al. investigate the neurocomputational mechanism underlying sensory prediction errors. They contrast two accounts: representational sharpening and dampening. Representational sharpening suggests that predictions increase the fidelity of the neural representations of expected inputs, while representational dampening suggests the opposite (decreased fidelity for expected stimuli). The authors performed decoding analyses on EEG data, showing that first expected stimuli could be better decoded (sharpening), followed by a reversal during later response windows where unexpected inputs could be better decoded (dampening). These results are interpreted in the context of opposing process theory (OPT), which suggests that such a reversal would support perception to be both veridical (i.e., initial sharpening to increase the accuracy of perception) and informative (i.e., later dampening to highlight surprising, but informative inputs).

      Strengths:

      The topic of the present study is of significant relevance for the field of predictive processing. The experimental paradigm used by McDermott et al. is well designed, allowing the authors to avoid several common confounds in investigating predictions, such as stimulus familiarity and adaptation. The introduction of the manuscript provides a well written summery of the main arguments for the two accounts of interest (sharpening and dampening), as well as OPT. Overall, the manuscript serves as a good overview of the current state of the field.

      Weaknesses:

      In my opinion some details of the methods, results and manuscript raise some doubts about the reliability of the reported findings. Key concerns are:

      (1) In the previous round of comments, I noted that: "I am not fully convinced that Figures 3A/B and the associated results support the idea that early learning stages result in dampening and later stages in sharpening. The inference made requires, in my opinion, not only a significant effect in one-time bin and the absence of an effect in other bins. Instead to reliably make this inference one would need a contrast showing a difference in decoding accuracy between bins, or ideally an analysis not contingent on seemingly arbitrary binning of data, but a decrease (or increase) in the slope of the decoding accuracy across trials. Moreover, the decoding analyses seem to be at the edge of SNR, hence making any interpretation that depends on the absence of an effect in some bins yet more problematic and implausible". The authors responded: "we fitted a logarithmic model to quantify the change of the decoding benefit over trials, then found the trial index for which the change of the logarithmic fit was < 0.1%. Given the results of this analysis and to ensure a sufficient number of trials, we focused our further analyses on bins 1-2". However, I do not see how this new analysis addresses the concern that the conclusion highlights differences in decoding performance between bins 1 and 2, yet no contrast between these bins are performed. While I appreciate the addition of the new model, in my current understanding it does not solve the problem I raised. I still believe that if the authors wish to conclude that an effect differs between two bins they must contrast these directly and/or use a different appropriate analysis approach.

      Relatedly, the logarithmic model fitting and how it justifies the focus on analysis bin 1-2 needs to be explained better, especially the rationale of the analysis, the choice of parameters (e.g., why logarithmic, why change of logarithmic fit < 0.1% as criterion, etc), and why certain inferences follow from this analysis. Also, the reporting of the associated results seems rather sparse in the current iteration of the manuscript.

      (2) A critical point the authors raise is that they investigate the buildup of expectations during training. They go on to show that the dampening effect disappears quickly, concluding: "the decoding benefit of invalid predictions [...] disappeared after approximately 15 minutes (or 50 trials per condition)". Maybe the authors can correct me, but my best understanding is as follows: Each bin has 50 trials per condition. The 2:1 condition has 4 leading images, this would mean ~12 trials per leading stimulus, 25% of which are unexpected, so ~9 expected trials per pair. Bin 1 represents the first time the participants see the associations. Therefore, the conclusion is that participants learn the associations so rapidly that ~9 expected trials per pair suffice to not only learn the expectations (in a probabilistic context) but learn them sufficiently well such that they result in a significant decoding difference in that same bin. If so, this would seem surprisingly fast, given that participants learn by means of incidental statistical learning (i.e. they were not informed about the statistical regularities). I acknowledge that we do not know how quickly the dampening/sharpening effects develop, however surprising results should be accompanied with a critical evaluation and exceptionally strong evidence (see point 1). Consider for example the following alternative account to explain these results. Category pairs were fixed across and within participants, i.e. the same leading image categories always predicted the same trailing image categories for all participants. Some category pairings will necessarily result in a larger representational overlap (i.e., visual similarity, etc.) and hence differences in decoding accuracy due to adaptation and related effects. For example, house  barn will result in a different decoding performance compared to coffee cup  barn, simply due to the larger visual and semantic similarity between house and barn compared to coffee cup and barn. These effects should occur upon first stimulus presentation, independent of statistical learning, and may attenuate over time e.g., due to increasing familiarity with the categories (i.e., an overall attenuation leading to smaller between condition differences) or pairs.

      (3) In response to my previous comment, why the authors think their study may have found different results compared to multiple previous studies (e.g. Han et al., 2019; Kumar et al., 2017; Meyer and Olson, 2011), particularly the sharpening to dampening switch, the authors emphasize the use of non-repeated stimuli (no repetition suppression and no familiarity confound) in their design. However, I fail to see how familiarity or RS could account for the absence of sharpening/dampening inversion in previous studies.

      First, if the authors argument is about stimulus novelty and familiarity as described by Feuerriegel et al., 2021, I believe this point does not apply to the cited studies. Feuerriegel et al., 2021 note: "Relative stimulus novelty can be an important confound in situations where expected stimulus identities are presented often within an experiment, but neutral or surprising stimuli are presented only rarely", which indeed is a critical confound. However, none of the studies (Han et al., 2019; Richter et al., 2018; Kumar et al., 2017; Meyer and Olson, 2011) contained this confound, because all stimuli served as expected and unexpected stimuli, with the expectation status solely determined by the preceding cue. Thus, participants were equally familiar with the images across expectation conditions.

      Second, for a similar reason the authors argument for RS accounting for the different results does not hold either in my opinion. Again, as Feuerriegel et al. 2021 correctly point out: "Adaptation-related effects can mimic ES when the expected stimuli are a repetition of the last-seen stimulus or have been encountered more recently than stimuli in neutral expectation conditions." However, it is critical to consider the precise design of previous studies. Taking again the example of Han et al., 2019; Kumar et al., 2017; Meyer and Olson, 2011. To my knowledge none of these studies contained manipulations that would result in a more frequent or recent repetition of any specific stimulus in the expected compared to unexpected condition. The crucial manipulation in all these previous studies is not that a single stimulus or stimulus feature (which could be subject to familiarity or RS) determines the expectation status, but rather the transitional probability (i.e. cue-stimulus pairing) of a particular stimulus given the cue. Therefore, unless I am missing something critical, simple RS seems unlikely to differ between expectation condition in the previous studies and hence seems implausible to account for differences in results compared to the current study.

      Moreover, studies cited by the authors (e.g. Todorovic & de Lange, 2012) showed that RS and ES are separable in time, again making me wonder how avoiding stimulus repetition should account for the difference in the present study compared to previous ones. I am happy to be corrected in my understanding, but with the currently provided arguments by the authors I do not see how RS and familiarity can account for the discrepancy in results.

      I agree with the authors that stimulus familiarity is a clear difference compared to previous designs, but without a valid explanation why this should affect results I find this account rather unsatisfying. I see the key difference in that the authors manipulated category predictability, instead of exemplar prediction - i.e. searching for a car instead of your car. However, if results in support of OPT would indeed depend on using novel images (i.e. without stimulus repetition), would this not severely limit the scope of the account and hence also its relevance? Certainly, the account provided by the authors casts the net wider and tries to explain visual prediction. Relatedly, if OPT only applies during training, as the authors seem to argue, would this again not significantly narrow the scope of the theory? Combined these two caveats would seem to demote the account from a general account of prediction and perception to one about perception during very specific circumstances. In my understanding the appeal of OPT is that it accounts for multiple challenges faced by the perceptual system, elegantly integrating them into a cohesive framework. Most of this would be lost by claiming that OPT's primary prediction would only apply to specific circumstances - novel stimuli during learning of predictions. Moreover, in the original formulation of the account, as outlined by Press et al., I do not see any particular reason why it should be limited to these specific circumstances. This does of course not mean that the present results are incorrect, however it does require an adequate discussion and acknowledgement in the manuscript.

      Impact:

      McDermott et al. present an interesting study with potentially impactful results. However, given my concerns raised in this and the previous round of comments, I am not entirely convinced of the reliability of the results. Moreover, the difficulty of reconciling some of the present results with previous studies highlights the need for more convincing explanations of these discrepancies and a stronger discussion of the present results in the context of the literature.

    2. Author response:

      The following is the authors’ response to the original reviews

      Public reviews:

      Reviewer 1 (Public Review):

      Many thanks for the positive and constructive feedback on the manuscript.

      This study reveals a great deal about how certain neural representations are altered by expectation and learning on shorter and longer timescales, so I am loath to describe certain limitations as 'weaknesses'. But one limitation inherent in this experimental design is that, by focusing on implicit, task-irrelevant predictions, there is not much opportunity to connect the predictive influences seen at the neural level to the perceptual performance itself (e.g., how participants make perceptual decisions about expected or unexpected events, or how these events are detected or appear).

      Thank you for the interesting comment. We now discuss the limitation of task-irrelevant prediction . In brief, some studies which showed sharpening found that task demands were relevant, while some studies which showed dampening were based on task-irrelevant predictions, but it is unlikely that task relevance - which was not manipulated in the current study - would explain the switch between sharpening and dampening that we observe within and across trials.

      The behavioural data that is displayed (from a post-recording behavioural session) shows that these predictions do influence perceptual choice - leading to faster reaction times when expectations are valid. In broad strokes, we may think that such a result is broadly consistent with a 'sharpening' view of perceptual prediction, and the fact that sharpening effects are found in the study to be larger at the end of the task than at the beginning. But it strikes me that the strongest test of the relevance of these (very interesting) EEG findings would be some evidence that the neural effects relate to behavioural influences (e.g., are participants actually more behaviourally sensitive to invalid signals in earlier phases of the experiment, given that this is where the neural effects show the most 'dampening' a.k.a., prediction error advantage?)

      Thank you for the suggestion. We calculated Pearson’s correlation coefficients for behavioural responses (difference in mean reaction times), neural responses during the sharpening effect (difference in decoding accuracy), and neural responses during the dampening effect for each participant, which resulted in null findings.

      Reviewer 2 (Public Review):

      Thank you for your helpful and constructive comments on the manuscript.

      The strength in controlling for repetition effects by introducing a neutral (50% expectation) condition also adds a weakness to the current version of the manuscript, as this neutral condition is not integrated into the behavioral (reaction times) and EEG (ERP and decoding) analyses. This procedure remained unclear to me. The reported results would be strengthened by showing differences between the neutral and expected (valid) conditions on the behavioral and neural levels. This would also provide a more rigorous check that participants had implicitly learned the associations between the picture category pairings.

      Following the reviewer's suggestion, we have included the neutral condition in the behavioural analysis and performed a repeated measures ANOVA on all three conditions.

      It is not entirely clear to me what is actually decoded in the prediction condition and why the authors did not perform decoding over trial bins in prediction decoding as potential differences across time could be hidden by averaging the data. The manuscript would generally benefit from a more detailed description of the analysis rationale and methods.

      In the original version of the manuscript, prediction decoding aimed at testing if the upcoming stimulus category can be decoded from the response to the preceding ( leading) stimulus. However, in response to the other Reviewers’ comments we have decided to remove the prediction decoding analysis from the revised manuscript as it is now apparent that prediction decoding cannot be separated from category decoding based on pixel information.

      Finally, the scope of this study should be limited to expectation suppression in visual perception, as the generalization of these results to other sensory modalities or to the action domain remains open for future research.

      We have clarified the scope of the study in the revised manuscipt .

      Reviewer 3 (Public Review):

      Thank you for the thought-provoking and interesting comments and suggestions.

      (1) The results in Figure 2C seem to show that the leading image itself can only be decoded with ~33% accuracy (25% chance; i.e. ~8% above chance decoding). In contrast, Figure 2E suggests the prediction (surprisingly, valid or invalid) during the leading image presentation can be decoded with ~62% accuracy (50% chance; i.e. ~12% above chance decoding). Unless I am misinterpreting the analyses, it seems implausible to me that a prediction, but not actually shown image, can be better decoded using EEG than an image that is presented on-screen.

      Following this and the remaining comments by the Reviewer (see below), we have decided to remove the prediction analysis from the manuscript. Specifically, we have focused on the Reviewer’s concern that it is implausible that image prediction would be better decoded that an image that is presented on-screen. This led us to perform a control analysis, in which we tried to decode the leading image category based on pixel values alone (rather than on EEG responses). Since this decoding was above chance, we could not rule out the possibility that EEG responses to leading images reflect physical differences between image categories. This issue does not extend to trailing images, as the results of the decoding analysis based on trailing images are based on accuracy comparisons between valid and invalid trials, and thus image features are counterbalanced. We would like to thank the Reviewer for raising this issue

      (2) The "prediction decoding" analysis is described by the authors as "decoding the predictable trailing images based on the leading images". How this was done is however unclear to me. For each leading image decoding the predictable trailing images should be equivalent to decoding validity (as there were only 2 possible trailing image categories: 1 valid, 1 invalid). How is it then possible that the analysis is performed separately for valid and invalid trials? If the authors simply decode which leading image category was shown, but combine L1+L2 and L4+L5 into one class respectively, the resulting decoder would in my opinion not decode prediction, but instead dissociate the representation of L1+L2 from L4+L5, which may also explain why the time-course of the prediction peaks during the leading image stimulus-response, which is rather different compared to previous studies decoding predictions (e.g. Kok et al. 2017). Instead for the prediction analysis to be informative about the prediction, the decoder ought to decode the representation of the trailing image during the leading image and inter-stimulus interval. Therefore I am at present not convinced that the utilized analysis approach is informative about predictions.

      In this analysis, we attempted to decode ( from the response to leading images) which trailing categories ought to be presented. The analysis was split between trials where the expected category was indeed presented (valid) vs. those in which it was not (invalid). The separation of valid vs invalid trials in the prediction decoding analysis served as a sanity check as no information about trial validity was yet available to participants. However, as mentioned above, we have decided to remove the “prediction decoding” analysis based on leading images as we cannot disentangle prediction decoding from category decoding.

      (3) I may be misunderstanding the reported statistics or analyses, but it seems unlikely that >10  of the reported contrasts have the exact same statistic of Tmax= 2.76 . Similarly, it seems implausible, based on visual inspection of Figure 2, that the Tmax for the invalid condition decoding (reported as Tmax = 14.903) is substantially larger than for the valid condition decoding (reported as Tmax = 2.76), even though the valid condition appears to have superior peak decoding performance. Combined these details may raise concerns about the reliability of the reported statistics.

      Thank you for bringing this to our attention. This copy error has now been rectified.

      (4) The reported analyses and results do not seem to support the conclusion of early learning resulting in dampening and later stages in sharpening. Specifically, the authors appear to base this conclusion on the absence of a decoding effect in some time-bins, while in my opinion a contrast between time-bins, showing a difference in decoding accuracy, is required. Or better yet, a non-zero slope of decoding accuracy over time should be shown ( not contingent on post-hoc and seemingly arbitrary binning).

      Thank you for the helpful suggestion. We have performed an additional analysis to address this issue, we calculated the trial-by-trial time-series of the decoding accuracy benefit for valid vs. invalid for each participant and averaged this benefit across time points for each of the two significant time windows. Based on this, we fitted a logarithmic model to quantify the change of this benefit over trials, then found the trial index for which the change of the logarithmic fit was < 0.1% (i.e., accuracy was stabilized). Given the results of this analysis and to ensure a sufficient number of trials, we focussed our further analyses on bins 1-2 to directly assess the effects of learning. This is explained in more detail in the revised manuscript .

      (5) The present results both within and across trials are difficult to reconcile with previous studies using MEG (Kok et al., 2017; Han et al., 2019), single-unit and multi-unit recordings (Kumar et al., 2017; Meyer & Olson 2011), as well as fMRI (Richter et al., 2018), which investigated similar questions but yielded different results; i.e., no reversal within or across trials, as well as dampening effects with after more training. The authors do not provide a convincing explanation as to why their results should differ from previous studies, arguably further compounding doubts about the present results raised by the methods and results concerns noted above.

      The discussion of these findings has been expanded in the revised manuscript . In short, the experimental design of the above studies did not allow for an assessment of these effects prior to learning. Several of them also used repeated stimuli (albeit some studies changed the pairings of stimuli between trials), potentially allowing for RS to confound their results.

      Recommendations for the Authors:

      Reviewer 1 (Recommendations for the authors):

      (1) On a first read, I was initially very confused by the statement on p.7 that each stimulus was only presented once - as I couldn't then work out how expectations were supposed to be learned! It became clear after reading the Methods that expectations are formed at the level of stimulus category (so categories are repeated multiple times even if exemplars are not). I suspect other readers could have a similar confusion, so it would be helpful if the description of the task in the 'Results' section (e.g., around p.7) was more explicit about the way that expectations were generated, and the (very large) stimulus set that examples are being drawn from.

      Following your suggestion, we have clarified the paradigm by adding details about the categories and the manner in which expectations are formed.

      (2) p.23: the authors write that their 1D decoding images were "subjected to statistical inference amounting to a paired t-test between valid and invalid categories". What is meant by 'amounting to' here? Was it a paired t-test or something statistically equivalent? If so, I would just say 'subjected to a paired t-test' to avoid any confusion, or explaining explicitly which statistic inference was done over.

      We have rephrased this as “subjected to (1) a one-sample t-test against chance-level, equivalent to a fixed-effects analysis, and (2) a paired t-test”.

      Relatedly, this description of an analysis amounting to a 'paired t-test' only seems relevant for the sensory decoding and memory decoding analyses (where there are validity effects) rather than the prediction decoding analysis. As far as I can tell the important thing is that the expected image category can be decoded, not that it can be decoded better or worse on valid or invalid trials.

      In the previous version of the manuscript, the comparison of prediction decoding between valid and invalid trials was meant as a sanity check. However, in response to the other Reviewers’ comments we have decided to remove the prediction decoding analysis from the revised manuscript due to confounds.

      It would be helpful if authors could say a bit more about how the statistical inferences were done for the prediction decoding analyses and the 'condition against baseline' contrasts (e.g., when it is stated that decoding accuracy in valid trials *,in general,* is above 0 at some cluster-wise corrected value). My guess is that this amounts to something like a one-sample t-test - but it may be worth noting that one-sample t-tests on information measures like decoding accuracy cannot support population-level inference, because these measures cannot meaningfully be below 0 (see Allefeld et al, 2016).

      When testing for decoding accuracy against baseline, we used one-sample t-tests against chance level (rather than against 0) throughout the manuscript. We now clarify in the manuscript that this corresponds to a fixed-effects analysis (Allefeld et al., 2016). In contrast, when testing for differences in decoding accuracy between valid and invalid conditions, we used paired-sample t-tests. As mentioned above, the prediction decoding analysis has been removed from the analysis.

      (3) By design, the researchers focus on implicit predictive learning which means the expectations being formed are ( by definition) task-irrelevant. I thought it could be interesting if the authors might speculate in the discussion on how they think their results may or may not differ when predictions are deployed in task-relevant scenarios -  particularly given that some studies have found sharpening effects do not seem to depend on task demands ( e.g., Kok et al, 2012 ; Yon et al, 2018)  while other studies have found that some dampening effects do seem to depend on what the observer is attending to ( e.g., Richter et al, 2018) . Do these results hint at a possible explanation for why this might be? Even if the authors think they don't, it might be helpful to say so!

      Thank you for the interesting comment. We have expanded on this in the revised manuscript.

      Reviewer 2  (Recommendations for the authors):

      Methods/results

      (1) The goal of this study is the assessment of expectation effects during statistical learning while controlling for repetition effects, one of the common confounds in prediction suppression studies (see, Feuerriegel et al., 2021). I agree that this is an important aspect and I assume that this was the reason why the authors introduced the P=0.5 neutral condition (Figure 1B, L3). However, I completely missed the analyses of this condition in the manuscript. In the figure caption of Figure 1C, it is stated that the reaction times of the valid, invalid, and neutral conditions are shown, but only data from the valid and invalid conditions are depicted. To ensure that participants had built up expectations and had learned the pairing, one would not only expect a difference between the valid and invalid conditions but also between the valid and neutral conditions. Moreover, it would also be important to integrate the neutral condition in the multivariate EEG analysis to actually control for repetition effects. Instead, the authors constructed another control condition based on the arbitrary pairings. But why was the neutral condition not compared to the valid and invalid prediction decoding results? Besides this, I also suggest calculating the ERP for the neutral condition and adding it to Figure 2A to provide a more complete picture.

      As mentioned above, we have included the neutral condition in the behavioural analysis, as outlined in the revised manuscript. We have also included a repeated measures ANOVA on all 3 conditions. The purpose of the neutral condition was not to avoid RS, but rather to provide a control condition. We avoided repetition by using individual, categorised stimuli. Figure 1C has been amended to include the neutral condition). In response to the remaining comments, we have decided to remove the prediction decoding analysis from the manuscript.

      (2) One of the main results that is taken as evidence for the OPT is that there is higher decoding accuracy for valid trials (indicate sharpening) early in the trial and higher decoding accuracy for invalid trials (indicate dampening) later in the trial. I would have expected this result for prediction decoding that surprisingly showed none of the two effects. Instead, the result pattern occurred in sensory decoding only, and partly (early sharpening) in memory decoding. How do the authors explain these results? Additionally, I would have expected similar results in the ERP; however, only the early effect was observed. I missed a more thorough discussion of this rather complex result pattern. The lack of the opposing effect in prediction decoding limits the overall conclusion that needs to be revised accordingly.

      Since sharpening vs. dampening rests on the comparison between valid and invalid trials, evidence for sharpening vs. dampening could only be obtained from decoding based on responses to trailing images. In prediction decoding (removed from the current version), information about the validity of the trial is not yet available. Thus, our original plan was to compare this analysis with the effects of validity on the decoding of trailing images (i.e. we expected valid trials to be decoded more accurately after the trailing image than before). The results of the memory decoding did mirror the sensory decoding of the trailing image in that we found significantly higher decoding accuracy of the valid trials from 123-180 ms. As with the sensory decoding, there was a tendency towards a later flip (280-296 ms) where decoding accuracy of invalid trials became nominally higher, but this effect did not reach statistical significance in the memory decoding.

      (3) To increase the comprehensibility of the result pattern, it would be helpful for the reader to clearly state the hypotheses for the ERP and multivariate EEG analyses. What did you expect for the separate decoding analyses? How should the results of different decoding analyses differ and why? Which result pattern would (partly, or not) support the OPT?

      Our hypotheses are now stated in the revised manuscript.

      (4) I was wondering why the authors did not test for changes during learning for prediction decoding. Despite the fact that there were no significant differences between valid and invalid conditions within-trial, differences could still emerge when the data set is separated into bins. Please test and report the results.

      As mentioned above, we have decided to remove the prediction decoding analysis from the current version of the manuscript.

      (5) To assess the effect of learning the authors write: 'Given the apparent consistency of bins 2-4, we focused our analyses on bins 1-2.' Please explain what you mean by 'apparent consistency'. Did you test for consistency or is it based on descriptive results? Why do the authors not provide the complete picture and perform the analyses for all bins? This would allow for a better assessment of changes over time between valid and invalid conditions. In Figure 3, were valid and invalid trials different in any of the QT3 or QT4 bins in sensory or memory encoding?

      We have performed an additional analysis to address this issue. The reasoning behind the decision to focus on bins 1-2 is now explained in the revised manuscript. In short, fitting a learning curve to trial-by-trial decoding estimates indicates that decoding stabilizes within <50% of the trials. To quantify changes in decoding occurring within these <50% of the trials while ensuring a sufficient number of trials for statistical comparisons, we decided to focus on bins 1-2 only.

      (6) Please provide the effect size for all statistical tests.

      Effect sizes have now been provided.

      (7) Please provide exact p-values for non-significant results and significant results larger than 0.001.

      Exact p-values have now been provided.

      (8) Decoding analyses: I suppose there is a copy/paste error in the T-values as nearly all T-values on pages 11 and 12 are identical (2.76) leading to highly significant p-values (0.001) as well as non-significant effects (>0.05). Please check.

      Thank you for bringing this to our attention. This error has now been corrected.

      (9) Page 12:  There were some misleading phrases in the result section. To give one example: 'control analyses was slightly above change' - this sounds like a close to non-significant effect, but it was indeed a highly significant effect of p<0.001. Please revise.

      This phrase was part of the prediction decoding analysis and has therefore been removed.

      (10) Sample size: How was the sample size of the study be determined (N=31)? Why did only a subgroup of participants perform the behavioral categorization task after the EEG recording? With a larger sample, it would have been interesting to test if participants who showed better learning (larger difference in reaction times between valid and invalid conditions) also showed higher decoding accuracies.

      This has been clarified in the revised manuscript. In short, the larger sample size of N=31 was based on previous research; ten participants were initially tested as part of a pilot which was then expanded to include the categorisation task.

      (11) I assume catch trials were removed before data analyses?

      We have clarified that catch trials were indeed removed prior to analyses.

      (12) Page 23, 1st line: 'In each, the decoder...' Something is missing here.

      Thank you for bringing this to our attention, this sentence has now been rephrased as “In both valid and invalid analyses” in the revised manuscript.

      Discussion

      (1) The analysis over multiple trials showed dampening within the first 15 min followed by sharpening. I found the discussion of this finding very lengthy and speculative (page 17). I recommend shortening this part and providing only the main arguments that could stimulate future research.

      Thank you for the suggestion. Since Reviewer 3 has requested additional details in this part of the discussion, we have opted to keep this paragraph in the manuscript. However, we have also made it clearer that this section is relatively speculative and the arguments provided for the across trials dynamics are meant to stimulate further research.

      (2) As this task is purely perceptual, the results support the OPT for the area of visual perception. For action, different results have been reported. Suppression within-trial has been shown to be larger for expected than unexpected features of action targets and suppression even starts before the start of the movement without showing any evidence for sharpening ( e.g., Fuehrer et al., 2022, PNAS). For suppression across trials, it has been found that suppression decreases over the course of learning to associate a sensory consequence to a specific action (e.g., Kilteni et al., 2019, ELife). Therefore, expectation suppression might function differently in perception and action (an area that still requires further research). Please clarify the scope of your study and results on perceptual expectations in the introduction, discussion, and abstract.

      We have clarified the scope of the study in the revised manuscript.

      Figures

      (1) Figure 1A: Add 't' to the arrow to indicate time.

      This has been rectified.

      (2) Figure 3:  In the figure caption, sensory and memory decoding seem to be mixed up. Please correct. Please add what the dashed horizontal line indicates.

      Thank you for bringing this to our attention, this has been rectified.

      Reviewer 3  (Recommendations for the authors):

      I applaud the authors for a well-written introduction and an excellent summary of a complicated topic, giving fair treatment to the different accounts proposed in the literature. However, I believe a few additional studies should be cited in the Introduction, particularly time-resolved studies such as Han et al., 2019; Kumar et al., 2017; Meyer and Olson, 2011. This would provide the reader with a broader picture of the current state of the literature, as well as point the reader to critical time-resolved studies that did not find evidence in support of OPT, which are important to consider in the interpretation of the present results.

      The introduction has been expanded to include the aforementioned studies in the revised manuscript.

      Given previous neuroimaging studies investigating the present phenomenon, including with time-resolved measures (e.g. Kok et al., 2017; Han et al., 2019; Kumar et al., 2017; Meyer & Olson 2011), why do the authors think that their data, design, or analysis allowed them to find support for OPT but not previous studies? I do not see obvious modifications to the paradigm, data quantity or quality, or the analyses that would suggest a superior ability to test OPT predictions compared to previous studies. Given concerns regarding the data analyses (see points below), I think it is essential to convincingly answer this question to convince the reader to trust the present results.

      The most obvious alteration to the paradigm is the use of non-repeated stimuli. Each of the above time-resolved studies utilised repeated stimuli (either repeated, identical stimuli, or paired stimuli where pairings are changed but the pool of stimuli remains the same), allowing for RS to act as a confound as exemplars are still presented multiple times. By removing this confound, it is entirely plausible that we may find different time-resolved results given that it has been shown that RS and ES are separable in time (Todorovic & de Lange, 2012). We also test during learning rather than training participants on the task beforehand. By foregoing a training session, we are better equipped to assess OPT predictions as they emerge. In our across-trial results, learning appears to take place after approximately 15 minutes or 432 trials, at which point dampening reverses to sharpening. Had we trained the participants prior to testing, this effect would have been lost.

      What is actually decoded in the "prediction decoding" analysis? The authors state that it is "decoding the predictable trailing images based on the leading images" (p.11). The associated chance level (Figure 2E) is indicated as 50%. This suggests that the classes separated by the SVM are T6 vs T7. How this was done is however unclear. For each leading image decoding the predictable trailing images should be equivalent to decoding validity (as there are only 2 possible trailing images, where one is the valid and the other the invalid image). How is it then possible that the analysis is performed separately for valid and invalid trials? Are the authors simply decoding which leading image was shown, but combine L1+L2 and L4+L5 into one class respectively? If so, this needs to be better explained in the manuscript. Moreover, the resulting decoder would in my opinion not decode the predicted image, but instead learn to dissociate the representation of L1+L2 from L4+L5, which may also explain why the time course of the prediction peaks during the leading image stimulus-response, which is rather different compared to previous studies decoding (prestimulus) predictions (e.g. Kok et al. 2017). If this is indeed the case, I find it doubtful that this analysis relates to prediction. Instead for the prediction analysis to be informative about the predicted image the authors should, in my opinion, train the decoder on the representation of trailing images and test it during the prestimulus interval.

      As mentioned above, the prediction decoding analysis has been removed from the manuscript. The prediction decoding analysis was intended as a sanity check, as validity information was not yet available to participants.

      Related to the point above, were the leading/trailing image categories and their mapping to L1, L2, etc. in Figure 1B fixed across subjects? I.e. "'beach' and 'barn' as 'Leading' categories would result in 'church' as a 'Trailing' category with 75% validity" (p.20) for all participants? If so, this poses additional problems for the interpretation of the analysis discussed in the point above, as it may invalidate the control analyses depicted in Figure 2E, as systematic differences and similarities in the leading image categories could account for the observed results.

      Image categories and their mapping were indeed fixed across participants. While this may result in physical differences and similarities between images influencing results, counterbalancing categories across participants would not have addressed this issue. For example, had we swapped “beach” with “barn” in another participant, physical differences between images may still be reflected in the prediction decoding. On the other hand, counterbalancing categories across trials was not possible given our aim of examining the initial stages of learning over trials. Had we changed the mappings of categories throughout the experiment for each participant, we would have introduced reversal learning and nullified our ability to examine the initial stages of learning under flat priors. In any case, the prediction decoding analysis has been removed from the manuscript, as outlined above.

      Why was the neutral condition L3 not used for prediction decoding? After all, if during prediction decoding both the valid and invalid image can be decoded, as suggested by the authors, we would also expect significant decoding of T8/T9 during the L3 presentation.

      In the neutral condition, L3 was followed by T8 vs. T9 with 50% probability, precluding prediction decoding. While this could have served as an additional control analysis for EEG-based decoding, we have opted for removing prediction decoding from the analysis. However, in response to the other Reviewers’ comments, the neutral condition has now been included in the behavioral analysis.

      The following concern may arise due to a misunderstanding of the analyses, but I found the results in Figures 2C and 2E concerning. If my interpretation is correct, then these results suggest that the leading image itself can only be decoded with ~33% accuracy (25% chance; i.e. ~8% above chance decoding). In contrast, the predicted (valid or invalid) image during the leading image presentation can be decoded with ~62% accuracy (50% chance; i.e. ~12% above chance decoding). Does this seem reasonable? Unless I am misinterpreting the analyses, it seems implausible to me that a prediction but not actually shown image can be better decoded than an on-screen image. Moreover, to my knowledge studies reporting decoding of predictions can (1) decode expectations just above chance level (e.g. Kok et al., 2017; which is expected given the nature of what is decoded) and (2) report these prestimulus effects shortly before the anticipated stimulus onset, and not coinciding with the leading image onset ~800ms before the predicted stimulus onset. For the above reasons, the key results reported in the present manuscript seem implausible to me and may suggest the possibility of problems in the training or interpretation of the decoding analysis. If I misunderstood the analyses, the analysis text needs to be refined. If I understood the analyses correctly, at the very least the authors would need to provide strong support and arguments to convince the reader that the effects are reliable (ruling out bias and explaining why predictions can be decoded better than on-screen stimuli) and sensible (in the context of previous studies showing different time-courses and results).

      As explained above, we have addressed this concern by performing an additional analysis, implementing decoding based on image pixel values. Indeed we could not rule out the possibility that “prediction” decoding reflected stimulus differences between leading images.

      Relatedly, the authors use the prestimulus interval (-200 ms to 0 ms before predicted stimulus onset) as the baseline period. Given that this period coincides with prestimulus expectation effects ( Kok et al., 2017) , would this not result in a bias during trailing image decoding? In other words, the baseline period would contain an anticipatory representation of the expected stimulus ( Kok et al., 2017) , which is then subtracted from the subsequent EEG signal, thereby allowing the decoder to pick up on this "negative representation" of the expected image. It seems to me that a cleaner contrast would be to use the 200ms before leading image onset as the baseline.

      The analysis of trailing images aimed at testing specific hypotheses related to differences between decoding accuracy in valid vs. invalid trials. Since the baseline was by definition the same for both kinds of trials (since information about validity only appears at the onset of the trailing image), changing the baseline would not affect the results of the analysis. Valid and invalid trials would have the same prestimulus effect induced by the leading image.

      Again, maybe I misunderstood the analyses, but what exactly are the statistics reported on p. 11 onward? Why is the reported Tmax identical for multiple conditions, including the difference between conditions? Without further information this seems highly unlikely, further casting doubts on the rigor of the applied methods/analyses. For example: "In the sensory decoding analysis based on leading images, decoding accuracy was above chance for both valid (Tmax= 2.76, pFWE < 0.001) and invalid trials (Tmax= 2.76, pFWE < 0.001) from 100 ms, with no significant difference between them (Tmax= 2.76, pFWE > 0.05) (Fig. 2C)" (p.11).

      Thank you for bringing this to our attention. As previously mentioned, this copy error has been rectified in the revised manuscript.

      Relatedly, the statistics reported below in the same paragraph also seem unusual. Specifically, the Tmax difference between valid and invalid conditions seems unexpectedly large given visual inspection of the associated figure: "The decoding accuracy of both valid (Tmax = 2.76, pFWE < 0.001) and invalid trials (Tmax = 14.903, pFWE < 0.001)" (p.12). In fact, visual inspection suggests that the largest difference should probably be observed for the valid not invalid trials (i.e. larger Tmax).

      This copy error has also been rectified in the revised manuscript.

      Moreover, multiple subsequent sections of the Results continue to report the exact same Tmax value. I will not list all appearances of "Tmax = 2.76" here but would recommend the authors carefully check the reported statistics and analysis code, as it seems highly unlikely that >10 contrasts have exactly the same Tmax. Alternatively, if I misunderstand the applied methods, it would be essential to better explain the utilized method to avoid similar confusion in prospective readers.

      This error has also now been rectified. As mentioned above the prediction decoding analysis has been removed.

      I am not fully convinced that Figures 3A/B and the associated results support the idea that early learning stages result in dampening and later stages in sharpening. The inference made requires, in my opinion, not only a significant effect in one-time bin and the absence of an effect in other bins. Instead to reliably make this inference one would need a contrast showing a difference in decoding accuracy between bins, or ideally an analysis not contingent on seemingly arbitrary binning of data, but a decrease ( or increase) in the slope of the decoding accuracy across trials. Moreover, the decoding analyses seem to be at the edge of SNR, hence making any interpretation that depends on the absence of an effect in some bins yet more problematic and implausible.

      Thank you for the helpful suggestion. As previously mentioned we fitted a logarithmic model to quantify the change of the decoding benefit over trials, then found the trial index for which the change of the logarithmic fit was < 0.1 %. Given the results of this analysis and to ensure a sufficient number of trials, we focussed our further analyses on bins 1-2 . This is explained in more detail in the revised manuscript.

      Relatedly, based on the literature there is no reason to assume that the dampening effect disappears with more training, thereby placing more burden of proof on the present results. Indeed, key studies supporting the dampening account (including human fMRI and MEG studies, as well as electrophysiology in non-human primates) usually seem to entail more learning than has occurred in bin 2 of the present study. How do the authors reconcile the observation that more training in previous studies results in significant dampening, while here the dampening effect is claimed to disappear with less training?

      The discussion of these findings has been expanded on in the revised manuscript. As previously outlined, many of the studies supporting dampening did not explicitly test the effect of learning as they emerge, nor did they control for RS to the same extent.

      The Methods section is quite bare bones. This makes an exact replication difficult or even impossible. For example, the sections elaborating on the GLM and cluster-based FWE correction do not specify enough detail to replicate the procedure. Similarly, how exactly the time points for significant decoding effects were determined is unclear (e.g., p. 11). Relatedly, the explanation of the decoding analysis, e.g. the choice to perform PCA before decoding, is not well explained in the present iteration of the manuscript. Additionally, it is not mentioned how many PCs the applied threshold on average resulted in.

      Thank you for this suggestion, we have described our methods in more detail.

      To me, it is unclear whether the PCA step, which to my knowledge is not the default procedure for most decoding analyses using EEG, is essential to obtain the present results. While PCA is certainly not unusual, to my knowledge decoding of EEG data is frequently performed on the sensor level as SVMs are usually capable of dealing with the (relatively low) dimensionality of EEG data. In isolation this decision may not be too concerning, however, in combination with other doubts concerning the methods and results, I would suggest the authors replicate their analyses using a conventional decoding approach on the sensory level as well.

      Thank you for this suggestion, we have explained our decision to use PCA in the revised manuscript.

      Several choices, like the binning and the focus on bins 1-2 seem rather post-hoc. Consequently, frequentist statistics may strictly speaking not be appropriate. This further compounds above mentioned concerns regarding the reliability of the results.

      The reasoning behind our decision to focus on bins 1-2 is now explained in more detail in the revised manuscript.

      A notable difference in the present study, compared to most studies cited in the introduction motivating the present experiment, is that categories instead of exemplars were predicted.

      This seems like an important distinction to me, which surprisingly goes unaddressed in the Discussion section. This difference might be important, given that exemplar expectations allow for predictions across various feature levels (i.e., even at the pixel level), while category predictions only allow for rough (categorical) predictions.

      The decision to use categorical predictions over exemplars lies in the issue of RS, as it is impossible to control for RS while repeating stimuli over many trials. This has been discussed in more detail in the revised manuscript.

      While individually minor problems, I noticed multiple issues across several figures or associated figure texts. For example: Figure 1C only shows valid and invalid trials, but the figure text mentions the neutral condition. Why is the neutral condition not depicted but mentioned here? Additionally, the figure text lacks critical information, e.g. what the asterisk represents. The error shading in Figure 2 would benefit from transparency settings to not completely obscure the other time-courses. Increasing the figure content and font size within the figure (e.g. axis labels) would also help with legibility (e.g. consider compressing the time-course but therefore increasing the overall size of the figure). I would also recommend using more common methods to indicate statistical significance, such as a bar at the bottom of the time-course figure typically used for cluster permutation results instead of a box. Why is there no error shading in Figure 2A but all other panels? Fig 2C-F has the y-axis label "Decoding accuracy (%)" but certainly the y-axis, ranging roughly from 0.2 to 0.7, is not in %. The Figure 3 figure text gives no indication of what the error bars represent, making it impossible to interpret the depicted data. In general, I would recommend that the authors carefully revisit the figures and figure text to improve the quality and complete the information.

      Thank you for the suggestions. Figure 1C now includes the neutral condition. Asterisks denote significant results. The font size in Figure 2C-E has been increased. The y-axis on Figure 2C-E has been amended to accurately reflect decoding accuracy in percentage. Figure 2A has error shading, however, the error is sufficiently small that the error shading is difficult to see. The error bars in Figure 3 have been clarified.

      Given the choice of journal (eLife), which aims to support open science, I was surprised to find no indication of (planned) data or code sharing in the manuscript.

      Plans for sharing code/data are now outlined in the revised manuscript.

      While it is explained in sufficient detail later in the Methods section, it was not entirely clear to me, based on the method summary at the beginning of the Results section, whether categories or individual exemplars were predicted. The manuscript may benefit from clarifying this at the start of the Results section.

      Thank you for this suggestion, following this and suggestions from other reviewers, the experimental paradigm and the mappings between categories has been further explained in the revised manuscript, to make it clearer that predictions are made at the categorical level.

      "Unexpected trials resulted in a significantly increased neural response 150 ms after image onset" (p.9). I assume the authors mean the more pronounced negative deflection here. Interpreting this, especially within the Results section as "increased neural response" without additional justification may stretch the inferences we can make from ERP data; i.e. to my knowledge more pronounced ERPs could also reflect increased synchrony. That said, I do agree with the authors that it is likely to reflect increased sensory responses, it would just be useful to be more cautious in the inference.

      Thank you for the interesting comment, this has been rephrased as a “more pronounced negative deflection” in the revised manuscript.

      Why was the ERP analysis focused exclusively on Oz? Why not a cluster around Oz? For object images, we may expect a rather wide dipole.

      Feuerriegel et al (2021) have outlined issues questioning the robustness of univariate analyses for ES, as such we opted for a targeted ROI approach on the channel showing peak amplitude of the visually evoked response (Fig. 2B). More details on this are in the revised manuscript.           

      How exactly did the authors perform FWE? The description in the Method section does not appear to provide sufficient detail to replicate the procedure.

      FWE as implemented in SPM is a cluster-based method of correcting for multiple comparisons using random field theory. We have explained our thresholding methods in more detail in the revised manuscript.

      If I misunderstand the authors and they did indeed perform standard cluster permutation analyses, then I believe the results of the timing of significant clusters cannot be so readily interpreted as done here (e.g. p.11-12); see: Maris & Oostenveld 2007; Sassenhagen & Dejan 2019.

      All statistics were based on FWE under random field theory assumptions (as implemented in SPM) rather than on cluster permutation tests (as implemented in e.g.  Fieldtrip)

      Why did the authors choose not to perform spatiotemporal cluster permutation for the ERP results?

      As mentioned above, we opted to target our ERP analyses on Oz due to controversies in the literature regarding univariate effects of ES (Feuerriegel et al., 2021).

      Some results, e.g. on p.12 are reported as T29 instead of Tmax. Why?

      As mentioned above, prediction decoding analyses have been removed from the manuscript.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      1. General Statements

      We would like to thank all reviewers assigned by Review Commons for their thoughtful and constructive feedback, which helped us to further improve the quality and clarity of our manuscript. In this study, we developed a novel fluorescence-based live-cell imaging platform for detecting mitochondria-endoplasmic reticulum contact sites (MERCS), which we named MERCdRED. This system enables quantitative analysis of MERCS dynamics in living cells by combining stable gene expression of dimerization-dependent fluorescent proteins with single-cell cloning. Using this tool, we uncovered a nutrient-dependent regulatory mechanism of MERCS formation mediated by the ER-localized tethering protein PDZD8. We appreciate that all the reviewers acknowledged the methodological robustness of this work. In response to reviewers' comments, we will significantly improve the manuscript by adding the live-cell imaging to assess the reversible propertyof MERCdRED, and investigating the physiological impacts of MERCS remodeling in regulating metabolism in response to nutrient starvation. We believe that both the methodological advance and the biological findings presented in this study will be of broad interest to the cell biology community.

      1. Description of the planned revisions

      Reviewer #1 (Evidence, reproducibility and clarity (Required)):

      Summary: In this study, the authors successfully established a stable cell line expressing MERCdRED, a dimerization-dependent fluorescent protein (ddFP)-based sensor for monitoring mitochondrial-ER contact sites (MERCS). Through light and electron microscopy analyses, they demonstrated that MERCS formation is regulated by nutrient availability and requires PDZD8. While the work is technically sound and well-presented, the biological implications of nutrient-dependent MERCS regulation remain underexplored.

      Major Concerns: Although the manuscript is methodologically robust and suitable for a Methods-type article, its biological significance is limited. The findings primarily serve as proof-of-concept for the MERCdRED tool, without substantially advancing our understanding of MERCS regulation.

      We appreciate the reviewer for acknowledging the methodological robustness of our study. We would like to respectfully emphasize that, using the MERCdRED cell system, we uncovered the distinct features of MERCS dynamics by comparing structures of various sizes (Figure 4A-D). Furthermore, we discovered an unexpected biological finding: nutrient starvation leads to a reduction in MERCS formation, which contrasts with previous reports using cell lines (former Figure 4E-H). Additionally, we revealed that PDZD8 mediates nutrient-dependent MERCS regulation (former Figure 4E-H).

      To clarify these findings, we have now separated the former Figure 4 into two distinct figures (now Figure 4 and 5). Furthermore, to assess the functional relevance of PDZD8-mediated MERCS regulation upon nutritional change, we will perform rescue experiments by overexpressing PDZD8 in starved cells, along with a metabolomic analysis in these conditions. We will add these new data in Figure 6.

      Taken together, we believe that our data provide novel mechanistic insights into how MERCS are modulated and utilized for the regulation of metabolism under physiological stress, thereby contributing to a deeper understanding of the roles and regulation of MERCS beyond the scope of a mere proof-of-concept study.

      Reviewer #1 (Significance (Required)):

      To enhance the impact of the study, the authors could use this sensor to investigate novel biological questions-such as the molecular pathways linking nutrient sensing to MERCS dynamics-or explore downstream activities of nutrient-dependent MERCS formation. Deeper mechanistic insights would significantly strengthen the work's contribution to the field.

      We thank the reviewer for their constructive suggestions. We fully agree that the MERCdRED cell system has great potential for investigating upstream signaling pathways regulating MERCS dynamics, as well as the downstream consequences of nutrient-dependent MERCS modulation. As mentioned above, this study already presents important findings, including the discovery of PDZD8 as a key protein linking the nutrient starvation and MERCS remodeling, and a relationship between MERCS dynamics and contact site size.

      To further assess the biological consequence of the MERCS remodeling, we will perform metabolomics analysis in PDZD8-overexpressing cells under starved conditions.

      Additionally, to further reinforce the utility of MERCdRED and extend the findings presented in this study, we performed live-cell imaging experiments using MERCdRED. The preliminary results demonstrated dynamic and reversible changes in MERCS in response to nutrient starvation and subsequent recovery (Please see the response to Reviewer 3 below, Reviewer-only Figure 1).

      These new data will significantly strengthen the contribution of this study to the field.

      Reviewer #2 (Evidence, reproducibility and clarity (Required)):

      This manuscript entitled "Live-cell imaging reveals nutrient-dependent dynamics of ER-mitochondria contact formation via PDZD8" by Saeko Aoyama-Ishiwatari et al., describes a novel methodology for visualizing contacts between mitochondria and the endoplasmic reticulum (MERCs) by fluorescence microscopy. Inter-organelle contacts, defined as membrane proximities below ~30 nm, fall below the diffraction limit of conventional light microscopy. The method developed by Hirabayashi's laboratory leverages dimerization-dependent fluorescence complementation to create a reporter capable of both visualizing and quantifying ER-mitochondria contacts (MERCs).

      Reviewer #2 (Significance (Required)):

      This timely study provides a valuable and innovative approach to overcoming a longstanding technical limitation in the field, enabling dynamic analysis of ER-mitochondria contacts.

      We appreciate the reviewer for recognizing the timeliness and innovation of our work.

      Reviewer #3 (Evidence, reproducibility and clarity (Required)):

      In this manuscript, the authors develop a new system to study mitochondrial-ER contact sites in living mouse embryonic fibroblast cells and explore the impact that nutritent starvation has on these contact sites in real time. By stably expressing a bicistroic reporter construct of a dimerization-dependent fluorescent protein that will generate a signal once the two moities, one anchored in the ER by Sec61b, and the other anchored in the outer membrane of mitochondria, via TOM20, comme in close apposition. This cell model is validated using sofisticated CLEM experiments and via the ablation of known regulators of MERCs, such as PDZD8 and FKBP8.

      Major comments

      The authors claim to have developed a new for the study of MERCs. They indeed have benchmarked this system using very sophisticated CLEM approaches and through the ablation of known regulators of MERCs, all of which is very carefully performed and convincing.

      We appreciate the reviewer for acknowledging our efforts in the development and validation of the MERCdRED system presented in this study.

      They argue that the generation of a stable cell line via lentiviral delivery is an improvement over the transient transfection approaches that have been applied in the past (see cited references), which I would generally agree. However, they have not contrasted or compared their system to the widly-used SLPICs system from the Tito Cali group (Vallese, F. et al. An expanded palette of improved SPLICS reporters detects multiple organelle contacts in vitro and in vivo. Nat. Commun. 11, 6069 (2020)) which measures bi and tri-partite interactions with other membrane contacts, including mitochondria and ER at two specific distances, which in my opinion has been more extensivley used to study cell and tissue physiology. They accurately point out that the reversability of this and other systems is challenging and it would be important to define highlight whether the current system allows the study of reversible MERCs. It does not appear as though the reversability of MERCs has been explored in this study.

      We thank the reviewer for these thoughtful suggestions and agree that further investigation into the reversibility of MERCS using the MERCdRED system would be valuable. Following the reviewer's suggestion, we performed a live-cell imaging experiment using MERCdRED to monitor dynamic changes in MERCS in response to nutrient starvation and subsequent recovery. The preliminary results were obtained as shown in Reviewer-only Figure 1, which strongly suggests the utility of MERCdRED for detecting reversible MERCS formation. The data will be added in Figure 5 if the reproducibility is confirmed. This new data set highlights the distinct utility of the MERCdRED system in studying MERCS dynamics.

      We acknowledge that the SPLICS system has been widely adopted for studying membrane contact sites. In the revised manuscript, we will include a comparative discussion of MERCdRED, SPLICS, and other existing MERCS reporters, particularly with respect to their capabilities in capturing the reversible nature of these contacts.

      The genetic (PDZD8, FKBP8) and nutritional (starvation) interventions are very helpful to benchmark the system. The description of the methods and data appear to be reproducible and the stastical analyses are acceptable.

      We thank the reviewer for their positive evaluation of our data and analyses.

      Minor comments

      As mentioned above, it would be helpful to reference and compare the current study in the context of reversability, which the current MERCdRED system has the potential to provide beyond the state-of-the-art.

      We thank the reviewer for this helpful suggestion. We will include additional discussion comparing the reversibility of the MERCdRED system with that of existing tools, highlighting the potential advantages of MERCdRED in capturing dynamic and reversible MERCS.

      Reviewer #3 (Significance (Required)):

      Significance

      The major strength of this study is the development of a stable cell line that allows for the study of MERCs, which has the potential to study the reversible nature of these membrane contact sites. It is debatable as a stable cell line rather than a transient transfection offers a major advancement, even if it does make the study of the system more straightforward, especially if the phenomenon of reversibilty is to be explored.I believe that the CLEM study offers a very informative and precise way to benchmark the ddFP system. Defining how MERC formation and separation (once again the reversibility discovery) have impacts in cell physiology beyond the distances altered by starvation would improve the study. Examining the impact on calcium homeostasis, lipid metabolism, and other aspects of biology that are known to be influenced by MERCs would be interesting. As such, there are no new conceptual, mechanistic, or functional advances, simply minor technical advances in the creation of a stable cell line followed by very solid benchmarking experiments. More complex tri-partite interactions, studied elsewhere, which are conceptually very important for cell and organelle biology, have not been attempted here. Similarly, the notion of studied different types of MERCs, which have been proposed to be important for cell biology, has not been explored using this single reporter. The target audience for this study is one that is interested in membrane contact sites and quantitative biology. My expertise is in mitochondrial fluorescence imaging and biology. I am not an expert in CLEM.

      We thank the reviewer for their thoughtful and detailed comments. We would like to respectfully emphasize that the establishment of a clonal cell line has enabled us to uncover a striking and unexpected biological finding-namely, that nutrient starvation leads to a reduction, rather than an increase, in MERCS formation, and that this change is regulated by PDZD8. This observation directly contradicts previous reports and highlights the value of our robust and quantitative system for re-evaluating previously held assumptions.

      We agree that demonstrating the reversibility of MERCS formation using our system would further strengthen the utility and reliability of the MERCdRED platform. To address this, as mentioned above, we performed a live-cell imaging to assess the dynamic reversibility of MERCS formation (Reviewer-only Figure 1) and will add the results in the revised manuscript.

      We agree that investigation of tri-partite interactions is conceptually important for understanding the broader landscape of organelle communication. However, assessing tri-partite organelle contacts is beyond the scope of this study. We recognize that this is one of the key directions for future studies and believe that the MERCdRED platform is a promising tool for exploring such complex interactions.

      Regarding different types of MERCS, we would like to clarify that our study does address this point to some extent. We identified distinct features of MERCS behavior by comparing structures of different sizes-an aspect that, to our knowledge, has not been previously examined. These findings contribute conceptually to our understanding of the dynamic and heterogeneous nature of ER-mitochondria contacts.

      We believe that our methodological development provides important mechanistic insights into MERCS dynamics, as described above. In line with the reviewer's suggestion, we will investigate the physiological impacts of MERCS remodeling in regulating metabolism in response to nutrient starvation. We hope these forthcoming data will further enhance the biological relevance of our findings.

      Taken together, we believe our study provides both a solid technical advance and novel mechanistic insights into MERCS biology, which will be of interest to researchers working on membrane contact sites, organelle dynamics, and cell physiology.

      We will revise the manuscript to more clearly convey the significance and implications of this study.

      1. Description of the revisions that have already been incorporated in the transferred manuscript

      Reviewer #2

      Major points:

      In Figure 1E (and the rest of the manuscript), the meaning of the label "MERCdRED on Mito" is unclear. A portion of the MERCdRED signal does not co-localize with mitochondria. The authors should clearly define what "MERCdRED on Mito" represents which appears to be the intensity of the MERCdRED signal within the mitochondrial mask. How about the global MERCdRED signal intensity? When the authors knocked-out PDZD8, did the global fluorescence intensity of the MERCdRED signal decrease?

      As the reviewer pointed out, some red signals appear outside of mitochondria in MERCdRED cells, which are presumably due to autofluorescence. While the global red channel fluorescence intensity also decreased upon PDZD8 conditional knockout (cKO), as shown in Reviewer-only Figure 2A, the reduction was less pronounced than the decrease observed when only the red signals on mitochondria were measured (Reviewer-only Figure 2B). We consider the mitochondrial red signals to represent MERCdRED signals, and we agree that the label "MERCdRED on Mito" may be misleading. To improve clarity, we revised the figure labels as follows: "MERCdRED" was changed to "Red channel," and "MERCdRED on Mito" was changed to "MERCdRED (Red signals on Mito)."

      1. While the authors demonstrate that MERCdRED can quantify a reduction in MERCs (e.g., in PDZD8 knockout conditions), it would be valuable to assess its sensitivity to increases in MERCs as well. For example, previous work from the authors (Nakamura et al., 2025) showed that FKBP8 overexpression leads to an increase in MERCs.

      We thank the reviewer for suggesting this valuable experiment. To assess whether the dynamic range of MERCdRED covers increased MERCS formation, we overexpressed PDZD8 in MERCdRED cells. Notably, PDZD8 overexpression resulted in a significant increase in MERCdRED signal intensity, demonstrating that the system is indeed capable of detecting enhanced MERCS formation. These new data were added in the revised manuscript as new Figure 3D-E.

      Minor points: 1. Please revise the sentence "First, signals from MERCdRED fluorescence overlapped with the mitochondrial marker Tomm20-iRFP were detected by confocal microscopy in living cells."

      We revised this sentence to "First, fluorescence from MERCdRED and the mitochondrial marker Tomm20-iRFP wasdetected by confocal microscopy in living cells."

      1. Description of analyses that authors prefer not to carry out

      Reviewer #2

      Major points: 1. The authors claim that their construct enables balanced expression of the RA and GB moieties of the reporter. This should be substantiated by showing protein expression levels via Western blot analysis.

      We thank the reviewer for pointing this out. In our system, Tomm20-GB and RA-Sec61β are expressed from a single plasmid using a self-cleaving P2A peptide sequence, which ensures that the two proteins are produced in equimolar amounts upon translation. Therefore, their expression levels are expected to be approximately equal. Given that comparing the expression levels of these two proteins by Western blotting would require extensive work, including obtaining reconstituted proteins to normalize band intensities, but remains inconclusive due to the semi-quantitative nature of the method, we have decided not to pursue this approach.

      Minor points:

      1. In Figure 2, the ER structures are not segmented in the EM images. It would enhance the manuscript to show the three-dimensional spatial relationship between mitochondria and the ER, rather than only highlighting the regions identified as contacts.

      We agree that visualizing the entire ER structure would enhance the reader's understanding of the three-dimensional spatial relationship between mitochondria and the ER. However, complete segmentation of the ER in EM images is extremely labor-intensive. Given the scope and focus of this study, we have decided not to include full ER segmentation in this manuscript.

    1. Reviewer #2 (Public review):

      In this manuscript, the authors present a model to explain how working memory (WM) encodes both existence and timing simultaneously using transient synaptic augmentation. A simple yet intriguing idea.

      The model presented here has the potential to explain what previous theories like 'active maintenance via attractors' and 'liquid state machine' do not, and describe how novel sequences are immediately stored in WM. Altogether, the topic is of great interest to those studying higher cognitive processes, and the conclusions the authors draw are certainly thought-provoking from an experimental perspective. However, several questions remain that need to be addressed.

      The study relates to the well-known computational theory for working memory, which suggests short-term synaptic facilitation is required to maintain working memory, but doesn't rely on persistent spiking. This previous theory appears similar to the proposed theory, except for the change from facilitation to augmentation. A more detailed explanation of why the authors use augmentation instead of facilitation in this paper is warranted: is the facilitation too short to explain the whole process of WM? Can the theory with synaptic facilitation also explain the immediate storage of novel sequences in WM?

      In Figure 1, the authors mention that synaptic augmentation leads to an increased firing rate even after stimulus presentation. It would be good to determine, perhaps, what the lowest threshold is to see the encoding of a WM task, and whether that is biologically plausible.

      In the middle panel of Figure 4, after 15-16 sec, when the neuronal population prioritizes with the second retro-cue, although the second retro-cue item's synaptic spike dominates, why is the augmentation for the first retro-cue item higher than the second-cue augmentation until the 20 sec?

    2. Author response:

      Reviewer #1 (Public Review):

      (1) The network they propose is extremely simple. This simplicity has pros and cons: on the one hand, it is nice to see the basic phenomenon exposed in the simplest possible setting. On the other hand, it would also be reassuring to check that the mechanism is robust when implemented in a more realistic setting, using, for instance, a network of spiking neurons similar to the one they used in the 2008 paper. The more noisy and heterogeneous the setting, the better.

      The choice of a minimal model to illustrate our hypothesis is deliberate. Our main goal was to suggest a physiologically-grounded mechanism to rapidly encode temporally-structured information (i.e., sequences of stimuli) in Working Memory, where none was available before. Indeed, as discussed in the manuscript, previous proposals were unsatisfactory in several respects. In view of our main goal, we believe that a spiking implementation is beyond the scope of the present work.

      We would like to note that the mechanism originally proposed in Mongillo et al. (2008), has been repeatedly implemented, by many different groups, in various spiking network models with different levels of biological realism (see, e.g., Lundquivst et al. (2016), for an especially ‘detailed’ implementation) and, in all cases, the relevant dynamics has been observed. We take this as an indication of ‘robustness’; the relevant network dynamics doesn’t critically depend on many implementation details and, importantly, this dynamics is qualitatively captured by a simple rate model (see, e.g., Mi et al. (2017)).

      In the present work, we make a relatively ‘minor’ (from a dynamical point of view) extension of the original model, i.e., we just add augmentation. Accordingly, we are fairly confident that a set of parameters for the augmentation dynamics can be found such that the spiking network behaves, qualitatively, as the rate model. A meaningful study, in our opinion, then would require extensively testing the (large) parameters’ space (different models of augmentation?) to see how the network behavior compares with the relevant experimental observations (which ones? behavioral? physiological?). As said above, we believe that this is beyond the scope of the present work.       

      This being said, we definitely agree with the reviewer that not presenting a spiking implementation is a limitation of the present work. We will clearly acknowledge, and discuss, this limitation in the revised version.

      (2) One major issue with the population spike scenario is that (to my knowledge) there is no evidence that these highly synchronized events occur in delay periods of working memory experiments. It seems that highly synchronized population spikes would imply (a) a strong regularity of spike trains of neurons, at odds with what is typically observed in vivo (b) high synchronization of neurons encoding for the same item (and also of different items in situations where multiple items have to be held in working memory), also at odds with in vivo recordings that typically indicate weak synchronization at best. It would be nice if the authors at least mention this issue, and speculate on what could possibly bridge the gap between their highly regular and synchronized network, and brain networks that seem to lie at the opposite extreme (highly irregular and weakly synchronized). Of course, if they can demonstrate using a spiking network simulation that they can bridge the gap, even better.

      Direct experimental evidence (in monkeys) in support of the existence of highly synchronized events -- to be identified with the ‘population spikes’ of our model -- during the delay period of a memory task is available in the literature and we have cited it, i.e., Panichello et al. (2024). In the revised version, we will provide an explicit discussion of the results of Panichello et al. (2024) and how these results directly relate to our model. After submission, we became aware of another experimental study (in humans) specifically dealing with sequence memory, i.e., Liebe et al. (2025). Their results, again, are fully consistent with our model. We will also provide an explicit discussion of these results in the revised version.

      We note that there is no fundamental contradiction between highly synchronized events in ‘small’ neural populations (e.g., a cell assembly) on one hand, and temporally irregular (i.e., Poisson-like) spiking at the single-neuron level and weakly synchronized activity at the network level, on the other hand. This was already illustrated in our original publication, i.e., Mongillo et al. (2008) (see, in particular, Fig. S2).

      We further note that the mechanism we propose to encode temporal order -- a temporal gradient in the synaptic efficacies brought about by synaptic augmentation -- would also work if the memory of the items is maintained by ‘tonic’ persistent activity (i.e., without highly synchronized events), provided this activity occurs at suitably low rates such as to prevent the saturation of the synaptic augmentation.

      We will include a detailed discussion of these points in the revised version.

      Reviewer #2 (Public Review):

      The study relates to the well-known computational theory for working memory, which suggests short-term synaptic facilitation is required to maintain working memory, but doesn't rely on persistent spiking. This previous theory appears similar to the proposed theory, except for the change from facilitation to augmentation. A more detailed explanation of why the authors use augmentation instead of facilitation in this paper is warranted: is the facilitation too short to explain the whole process of WM? Can the theory with synaptic facilitation also explain the immediate storage of novel sequences in WM?

      In the model, synaptic dynamics displays both short-term facilitation and augmentation (and shortterm depression). Indeed, synaptic facilitation, alone, would be too short-lived to encode novel sequences. This is illustrated in Fig. 1B. We will provide a more detailed discussion of this point in the revised version. 

      In Figure 1, the authors mention that synaptic augmentation leads to an increased firing rate even after stimulus presentation. It would be good to determine, perhaps, what the lowest threshold is to see the encoding of a WM task, and whether that is biologically plausible.

      We believe that this comment is related to the above point. The reviewer is correct; augmentation alone would require fairly long stimulus presentations to encode an item in WM. ‘Fast’ encoding, indeed, is guaranteed by the presence of short-term facilitation. We will emphasize this important point in the revised version.

      In the middle panel of Figure 4, after 15-16 sec, when the neuronal population prioritizes with the second retro-cue, although the second retro-cue item's synaptic spike dominates, why is the augmentation for the first retro-cue item higher than the second-cue augmentation until the 20 sec?

      This is because of the slow build-up and slow decay of the augmentation. When the second item is prioritized, and the corresponding neuronal population re-activates, its augmentation level starts to increase. At the same time, as the first item is now de-prioritized and the corresponding neuronal population is now silent, its augmentation level starts to decrease. Because of the ‘slowness’ of both processes (i.e., augmentation build-up and decay), it takes about 5 seconds for the augmentation level of the second item to overcome the augmentation level of the first item.

      We note that the slow time scales of the augmentation dynamics, consistently with experimental observations, are necessary for our mechanism to work.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors introduce a novel algorithm for the automatic identification of longrange axonal projections. This is an important problem as modern high-throughput imaging techniques can produce large amounts of raw data, but identifying neuronal morphologies and connectivities requires large amounts of manual work. The algorithm works by first identifying points in three-dimensional space corresponding to parts of labelled neural projections, these are then used to identify short sections of axons using an optimisation algorithm and the prior knowledge that axonal diameters are relatively constant. Finally, a statistical model that assumes axons tend to be smooth is used to connect the sections together into complete and distinct neural trees. The authors demonstrate that their algorithm is far superior to existing techniques, especially when dense labelling of the tissue means that neighbouring neurites interfere with the reconstruction. Despite this improvement, however, the accuracy of reconstruction remains below 90%, so manual proofreading is still necessary to produce accurate reconstructions of axons.

      Strengths:

      The new algorithm combines local and global information to make a significant improvement on the state-of-the-art for automatic axonal reconstruction. The method could be applied more broadly and might have applications to reconstructions of electron microscopy data, where similar issues of highthroughput imaging and relatively slow or inaccurate reconstruction remain.

      We thank the reviewer for their positive comments and for taking the time to review our manuscript. We are truly grateful that the reviewer recognized the value of our method in automatically reconstructing long-range axonal projections. While we report that our method achieves reconstruction accuracy of approximately 85%, we fully acknowledge that manual proofreading is still necessary to ensure accuracy greater than 95%. We also appreciate the reviewer’s insightful suggestion regarding the potential adaptation of our algorithm for reconstructing electron microscopy (EM) data, where similar challenges in high-throughput imaging and relatively slow or inaccurate reconstruction persist. We look forward to exploring ways to integrate our method with EM data in future work.

      Weaknesses:

      There are three weaknesses in the algorithm and manuscript.

      (1) The best reconstruction accuracy is below 90%, which does not fully solve the problem of needing manual proofreading.

      We sincerely appreciate the reviewer's valuable insights regarding reconstruction accuracy. Indeed, as illustrated in Figure S4, our current best automated reconstruction accuracy on fMOST data is still below 90%. This indicates that manual proofreading remains essential to ensure reliability.

      For the reconstruction of long-range axonal projections, ensuring the accuracy of the reconstruction process necessitates manual revision of the automatically generated results. Existing literature has demonstrated that a higher accuracy in automatic reconstruction correlates with a reduced need for manual revisions, thereby facilitating an accelerated reconstruction process (Winnubst et al., Cell 2019; Liu et al., Nature Methods 2025).

      As the reviewer rightly points out, achieving an accuracy exceeding 95% currently necessitates manual proofreading. Although our method does not completely eliminate this requirement, it significantly alleviates the proofreading workload by: 1) Minimizing common errors in regions with dense neuron distributions; 2) Providing more reliable initial reconstructions; and 3) Reducing the number of corrections needed during the proofreading process.

      In the future, we will continue to enhance our reconstruction framework. As imaging systems achieve higher signal-to-noise ratios and deep learning techniques facilitate more accurate foreground detection, we anticipate that our method will attain even greater reconstruction accuracy. Furthermore, we plan to develop a software system capable of predicting potential error locations in our automated reconstruction results, thereby streamlining manual revisions. This approach distinguishes itself from existing models by obviating the need for individual traversal of the brain regions associated with each neuron reconstruction.

      (2) The 'minimum information flow tree' model the authors use to construct connected axonal trees has the potential to bias data collection. In particular, the assumption that axons should always be as smooth as possible is not always correct. This is a good rule-of-thumb for reconstructions, but real axons in many systems can take quite sharp turns and this is also seen in the data presented in the paper (Figure 1C). I would like to see explicit acknowledgement of this bias in the current manuscript and ideally a relaxation of this rule in any later versions of the algorithm.

      We appreciate the reviewer's insightful opinion regarding the potential bias introduced by our minimum information flow tree model. The reviewer is absolutely correct in noting that while axon smoothness serves as a useful reconstruction heuristic, it should not be treated as an absolute constraint given that real axons can exhibit sharp turns (as shown in Figure 1C). In response to this valuable feedback, we add explicit discussion of this limitation in Discussion section as follow: “Finally, the minimal information flow tree’s fundamental assumption, that axons should be as smooth as possible does not always hold true.

      In fact, real axons can take quite sharp turns leading the algorithm to erroneously separate a single continuous axon into disjoint neurites.”

      In our reconstruction process, the post-processing approach partially mitigates erroneous reconstructions derived from this rule. Specifically: The minimum information flow tree will decompose such structures into two separate branches (Fig. S7A), but the decomposition node is explicitly recorded. The newly decomposed branches attempt to reconnect by searching for plausible neurites starting from their head nodes (determined by the minimum information flow tree). If no connectable neurites are found, the branch is automatically reconnected to its originally recorded decomposition node (Fig. S7B). In Fig.S7C, two reconstruction examples demonstrate the effectiveness of the post-processing approach.

      As pointed out by the reviewers, the proposed rule for revising neuron reconstruction does not encompass all scenarios. Relaxing the constraints of this rule may lead to numerous new erroneous connections. Currently, the proposed rule is solely based on the positions of neurite centerlines and does not integrate information regarding the intensity of the original images or segmentation data. Incorporating these elements into the rule could potentially reduce reconstruction errors. 

      (3) The writing of the manuscript is not always as clear as it could be. The manuscript would benefit from careful copy editing for language, and the Methods section in particular should be expanded to more clearly explain what each algorithm is doing. The pseudo-code of the Supplemental Information could be brought into the Methods if possible as these algorithms are so fundamental to the manuscript.

      We sincerely thank the reviewer for these valuable suggestions to improve our manuscript’s clarity and methodological presentation. We have implemented the following revisions:

      (1) Language Enhancement: we have conducted rigorous internal linguistic reviews to address grammatical inaccuracies and improve textual clarity.

      (2) Methods Expansion and Pseudo-code Integration: we have incorporated all relevant derivations from the Supplementary Materials into the Methods section, with additional explanatory text to clarify the purpose and implementation of each algorithm. All mathematical formulations have been systematically rederived with modifications to variable nomenclature, subscript/superscript notations and identified errors in the original submission. All pseudocode from Supplementary Materials has been integrated into their corresponding methods subsection.

      Reviewer #2 (Public review):

      In this manuscript, Cai et al. introduce PointTree, a new automated method for the reconstruction of complex neuronal projections. This method has the potential to drastically speed up the process of reconstructing complex neurites. The authors use semi-automated manual reconstruction of neurons and neurites to provide a 'ground-truth' for comparison between PointTree and other automated reconstruction methods. The reconstruction performance is evaluated for precision, recall, and F1-score and positions. The performance of PointTree compared to other automated reconstruction methods is impressive based on these 3 criteria.

      As an experimentalist, I will not comment on the computational aspects of the manuscript. Rather, I am interested in how PointTree's performance decreases in noisy samples. This is because many imaging datasets contain some level of background noise for which the human eye appears essential for the accurate reconstruction of neurites. Although the samples presented in Figure 5 represent an inherent challenge for any reconstruction method, the signal-to-noise ratio is extremely high (also the case in all raw data images in the paper). It would be interesting to see how PointTree's performance changes in increasingly noisy samples, and for the author to provide general guidance to the scientific community as to what samples might not be accurately reconstructed with PointTree.

      We thank the reviewer for her/his time reviewing our manuscript and the interest on how PointTree perform on noisy samples. It is important to clarify that PointTree is solely responsible for the reconstruction of neurons from the foreground regions of neural images. The foreground regions of these neuronal images are obtained through a deep learning segmentation network. In cases where the image has a low signal-to-noise ratio, if the segmentation network can accurately identify the foreground areas, then PointTree will be able to accurately reconstruct neurons. In fact, existing deep learning networks have demonstrated their capability to effectively extract foreground regions from low signal-to-noise ratio images; therefore, PointTree is well-suited for processing neuronal images characterized by low signal-to-noise ratios.

      In the revised manuscript, we conducted experiments on datasets with varying signal-to-noise ratios (SNR). The results demonstrate that Unet3D is capable of identifying the foreground regions in low-SNR images, thereby supporting the assertion that PointTree has broad applicability across diverse neuronal imaging datasets. 

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      It would be interesting to see how PointTree's performance changes in increasingly noisy samples, and for the author to provide general guidance to the scientific community as to what samples might not be accurately reconstructed with PointTree.

      We extend our heartfelt gratitude to the reviewer for their insightful suggestion concerning experiments involving different noisy samples. Here are the details of the datasets used:

      LSM dataset: Mean SNR = 5.01, with 25 samples, and a volume size of 192×192×192.

      fMOST dataset: Mean SNR = 8.68, with 25 samples, and a volume size of 192×192×192.

      HD-fMOST dataset: Mean SNR = 11.4, with 25 samples, and a volume size of 192×192×192.

      The experimental results reveal that, thanks to the deep learning network's robust feature extraction capabilities, even when working with low-SNR data (as depicted in Figure 4B, first two columns of the top row), satisfactory segmentation results (Figure 4B, first two columns of the third row) were achieved. These results laid a solid foundation for subsequent accurate reconstruction.

      PointTree demonstrated consistent mean F1-scores of 91.0%, 90.0%, and 93.3% across the three datasets, respectively. This underscores its reconstruction robustness under varying SNR conditions when supported by the segmentation network. For more in-depth information, please refer to the manuscript section titled "Reconstruction of data with different signal-to-noise ratios" and Figure 4.

    1. Author Response:

      The following is the authors’ response to the previous reviews

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, the authors investigated how partial loss of SynGap1 affects inhibitory neurons derived from the MGE in the auditory cortex, focusing on their synaptic inputs and excitability. While haplo-insufficiently of SynGap1 is known to lead to intellectual disabilities, the underlying mechanisms remain unclear.

      Strengths:

      The questions are novel

      Weaknesses:

      Despite the interesting and novel questions, there are significant issues regarding the experimental design and potential misinterpretations of key findings. Consequently, the manuscript contributes little to our understanding of SynGap1 loss mechanisms.

      Major issues in the second version of the manuscript:

      In the review of the first version there were major issues and contradictions with the sEPSC and mEPSC data, and were not resolved after the revision, and the new control experiments rather confirmed the contradiction.

      In the original review I stated: "One major concern is the inconsistency and confusion in the intermediate conclusions drawn from the results. For instance, while the sEPSC data indicates decreased amplitude in PV+ and SOM+ cells in cHet animals, the frequency of events remains unchanged. In contrast, the mEPSC data shows no change in amplitudes in PV+ cells, but a significant decrease in event frequency. The authors conclude that the former observation implies decreased excitability. However, traditionally, such observations on mEPSC parameters are considered indicative of presynaptic mechanisms rather than changes of network activity. The subsequent synapse counting experiments align more closely with the traditional conclusions. This issue can be resolved by rephrasing the text. However, it would remain unexplained why the sEPSC frequency shows no significant difference. If the majority of sEPSC events were indeed mediated by spiking (which is blocked by TTX), the average amplitudes and frequency of mEPSCs should be substantially lower than those of sEPSCs. Yet, they fall within a very similar range, suggesting that most sEPSCs may actually be independent of action potentials. But if that was indeed the case, the changes of purported sEPSC and mEPSC results should have been similar." Contradictions remained after the revision of the manuscript. On one hand, the authors claimed in the revised version that "We found no difference in mEPSC amplitude between the two genotypes (Fig. 1g), indicating that the observed difference in sEPSC amplitude (Figure 1b) could arise from decreased network excitability". On the other hand, later they show "no significative difference in either amplitude or inter-event intervals between sEPSC and mEPSC, suggesting that in acute slices from adult A1, most sEPSCs may actually be AP independent." The latter means that sEPSCs and mEPSCs are the same type of events, which should have the same sensitivity to manipulations.

      We thank the reviewer for the detailed comments. Our results suggest a diverse population of PV+ cells, with varying reliance on action potential-dependent and -independent release. Several PV+ cells indeed show TTX sensitivity (reduced EPSC event amplitudes following TTX application: See new Supplementary Figure 2b-e), but their individual responses are diluted when all cells are pooled together. To account for this variability, we recorded sEPSC followed by mEPSC from more mice of both genotypes (new Figure 1f-j). Further, following the editors and reviewers’ suggestions, we removed speculations about the role of network activity changes.

      In summary, our data confirmed that TTX blocked APs in PV+ cells and that recordings were stable as indicated by lack of changes in series resistance during the recording period in our experimental setup (new Suppl. Figure 2f-i). We found no difference in mEPSC amplitude between the two genotypes (Fig. 1g, right), indicating that the observed difference in sEPSC amplitude (Figure 1c, right) could be due to impaired AP-dependent release in cHet mice and the presence of large-amplitude sEPSCs that are preferentially affected by TTX in control mice (new Suppl. Figure 2b-e). Conversely, cHet mice showed longer inter-mEPSC time interval (cumulative distribution in Figure 1g, left), and significantly lower charge transfer and DQ*f (Figure 1j) compared to controls littermates, suggesting a decrease of glutamatergic presynaptic release sites onto PV+ cells. 

      Concerns about the quality of the synapse counting experiments were addressed by showing additional images in a different and explaining quantification. However, the admitted restriction of the analysis of excitatory synapses to the somatic region represent a limitation, as they include only a small fraction of the total excitation - even if, the slightly larger amplitudes of their EPSPs are considered.

      We agree with the reviewer that restricting the anatomical analysis of excitatory synapses to PV cell somatic region is a limitation, as highlighted it in the discussion of the revised manuscript. Recent studies, based on serial block-face scanning electron microscopy, suggest that cortical PV+ interneurons receive more robust excitatory inputs to their perisomatic region as compared to pyramidal neurons (see for example, Hwang et al. 2021, Cerebral Cortex, http://doi.org/10.1093/cercor/bhaa378). It is thus possible that putative glutamatergic synapses, analysed by vGlut1/PSD95 colocalisation around PV+ cell somata, may be representative of a substantially major excitatory input population. Since analysing putative excitatory synapses onto PV+ dendrites would be difficult and require a much longer time, we re-phrased the text to more clearly highlight the rationale and limitation of this approach.

      New experiments using paired-pulse stimulation provided an answer to issues 3 and 4. Note that the numbering of the Figures in the responses and manuscript are not consistent.

      We are glad that the reviewer found that the new paired-pulse experiments answered previously raised concerns. We corrected the discrepancy in figure numbers in the manuscript. Thank you for noticing.

      I agree that low sampling rate of the APs does not change the observed large differences in AP threshold, however, the phase plots are still inconsistent in a sense that there appears to be an offset, as all values are shifted to more depolarized membrane potentials, including threshold, AP peak, AHP peak. This consistent shift may be due to a non-biological differences in the two sets of recordings, and, importantly, it may negate the interpretation of the I/f curves results (Fig. 5e).

      We agree with the reviewers that higher sampling rate would allow to more accurately assess different parameters, such as AP peak, half-width, rise time, etc., while it would not affect the large differences in AP threshold we observed between control and mutant mice. Since the phase plots to not add to our result analysis, we removed them from the revised manuscript. 

      Additional issues:

      The first paragraph of the Results mentioned that the recorded cells were identified by immunolabelling and axonal localization. However, neither the Results nor the Methods mention the criteria and levels of measurements of axonal arborization.

      Recorded MGE-derived interneurons were filled with biocytin, and their identity was confirmed by immunolabeling for neurochemical markers (PV or SST) and analysis of anatomical properties. In particular, whole biocytin-positive immunolabelled neurons were acquired using a Leica SP8-DLS confocal microscope (20x objective, NA 0.75; Z-step 1 1μm).  For each imaged neuron, which was the result of multiple merged confocal stacks, we visually determined the spatial distribution across cortical layers of the axonal arbor and whether its dendrites carried spines.  We added this information in the method section. Furthermore, to better represent our methodological approach, we added a new figure (Supplemental Figure 1) including 1) two examples of PV+ interneurons, showing dendrites devoid of spines and axons spreading from Layer II to Layer V (new Suppl. Figure 1a); and 2) two examples of SST+ interneurons showing dendritic with spines and axons projecting from Layer IV to Layer I where they gave rise to multiple collaterals (new Suppl. Figure 1b).  

      The other issues of the first review were adequately addressed by the Authors and the manuscript improved by these changes.

      We are happy the reviewer found that the other issues were well addressed.

      Reviewer #3 (Public review):

      This paper compares the synaptic and membrane properties of two main subtypes of interneurons (PV+, SST+) in the auditory cortex of control mice vs mutants with Syngap1 haploinsufficiency. The authors find differences between control and mutants in both interneuron populations, although they claim a predominance in PV+ cells. These results suggest that altered PVinterneuron functions in the auditory cortex may contribute to the network dysfunctions observed in Syngap1 haploinsufficiency-related intellectual disability.

      The subject of the work is interesting, and most of the approach is rather direct and straightforward, which are strengths. There are also some methodological weaknesses and interpretative issues that reduce the impact of the paper.

      (1) Supplementary Figure 3: recording and data analysis. The data of Supplementary Figure 3 show no differences either in the frequency or amplitude of synaptic events recorded from the same cell in control (sEPSCs) vs TTX (mEPSCs). This suggests that, under the experimental conditions of the paper, sEPSCs are AP-independent quantal events. However, I am concerned by the high variability of the individual results included in the Figure. Indeed, several datapoints show dramatically different frequencies in control vs TTX, which may be explained by unstable recording conditions. It would be important to present these data as time course plots, so that stability can be evaluated. Also, the claim of lack of effect of TTX should be corroborated by positive control experiments verifying that TTX is working (block of action potentials, for example). Lastly, it is not clear whether the application of TTX was consistent in time and duration in all the experiments and the paper does not clarify what time window was used for quantification.

      We understand the reviewer’s concern about high variability. To account for this variability, we recorded sEPSC followed by mEPSC from more mice of both genotypes (see new Figure 1f-j). We confirmed that TTX worked as expected several times through the time course of this study, in different aliquots prepared from the same TTX vial that was used for all experiments. The results of the last test we performed, showing that TTX application blocks action potentials in a PV+ cell, are depicted in new Suppl. Figure 2a. Furthermore, new Suppl. Figure 2f-i shows series resistance (Rs) over time for 4 different PV+ interneurons, indicating recording stability. These results are representative of the entire population of recorded neurons, which we have meticulously analysed one by one. TTX was applied using the same protocol for all recorded neurons. In particular, sEPSCs were first sampled over a 2 min period. A TTX (1μM; Alomone Labs)-containing solution was then perfused into the recording chamber at a flow rate of 2 mL/min. We then waited for 5 min before sampling mEPSCs over a 2 min period. We added this information in the revised manuscript methods.

      (2)  Figure 1 and Supplementary Figure 3: apparent inconsistency. If, as the authors claim, TTX does not affect sEPSCs (either in the control or mutant genotype, Supplementary Figure 3 and point 1 above), then comparing sEPSC and mEPSC in control vs mutants should yield identical results. In contrast, Figure 1 reports a _selective_ reduction of sEPSCs amplitude (not in mEPSCs) in mutants, which is difficult to understand. The proposed explanation relying on different pools of synaptic vesicles mediating sEPSCs and mEPSCs does not clarify things. If this was the case, wouldn't it also imply a decrease of event frequency following TTX addition? However, this is not observed in Supplementary Figure 3. My understanding is that, according to this explanation, recordings in control solution would reflect the impact of two separate pools of vesicles, whereas, in the presence of TTX, only one pool would be available for release. Therefore, TTX should cause a decrease in the frequency of the recorded events, which is not what is observed in Supplementary Figure 3.

      To account for the large variability and clarify these results, we recorded sEPSCs followed by mEPSCs from more mice of both genotypes (new Figure 1f-j). We found no difference in mEPSC amplitude between the two genotypes (Fig. 1g, right), indicating that the observed difference in sEPSC amplitude (Figure 1c, right) could be due to impaired AP-dependent release in cHet mice and the presence of large-amplitude sEPSCs that are preferentially affected by TTX in control mice (new Suppl. Figure 2b-e). Conversely, cHet mice showed longer inter-mEPSC time interval (cumulative distribution in Figure 1g, left), and significantly lower charge transfer and DQ*f (Figure 1j) compared to controls littermates, suggesting a decrease of glutamatergic presynaptic release sites. We rephrased the text in the revised manuscript according to the updated data and, following the reviewer’s suggestions, we removed speculations relying on different pools of synaptic vesicles.

      (3) Figure 1: statistical analysis. Although I do appreciate the efforts of the authors to illustrate both cumulative distributions and plunger plots with individual data, I am confused by how the cumulative distributions of Figure 1b (sEPSC amplitude) may support statistically significant differences between genotypes, but this is not the case for the cumulative distributions of Figure 1g (inter mEPSC interval), where the curves appear even more separated. A difference in mEPSC frequency would also be consistent with the data of Supplementary Fig 2b, which otherwise are difficult to reconciliate. I would encourage the authors to use the Kolmogorov-Smirnov rather than a t-test for the comparison of cumulative distributions.

      We thank the reviewer for this thoughtful suggestion. We recorded more mice of both genotypes and the updated data now show a significant difference between the cumulative distributions of the inter mEPSC intervals recorded from the two genotypes (new Figure 1g). For statistical analysis, we based our conclusion on the statistical results generated by LMM, modelling animal as a random effect and genotype as fixed effect. We used this statistical analysis because we considered the number of mice as independent replicates and the number of cells in each mouse as repeated measures (Berryer et al. 2016; Heggland et al., 2019; Yu et al., 2022). For cumulative distributions, the same number of events was chosen randomly from each cell and analysed by LMM, modelling animal as a random effect and genotype as fixed effect. The reason we decided to use LMM for our statistical analyses is based on the growing concern over reproducibility in biomedical research and the ongoing discussion on how data are analysed (see for example, Yu et al (2022), Neuron 110:21-35 https://doi: 10.1016/j.neuron.2021.10.030; Aarts et al. (2014). Nat Neurosci 17, 491–496. https://doi.org/10.1038/nn.3648). We acknowledge that patch-clamp data has been historically analysed using t-test and analysis of variance (ANOVA), or equivalent nonparametric tests. However, these tests assume that individual observations (recorded neurons in this case) are independent of each other. Whether neurons from the same mouse are independent or correlated variables is an unresolved question, but does not appear to be likely from a biological point of view. Statisticians have developed effective methods to analyze correlated data, including LMM.

      (4) Methods. I still maintain that a threshold at around -20/-15 mV for the first action potential of a train seems too depolarized (see some datapoints of Fig 5c and Fig7c) for a healthy spike. This suggest that some cells were either in precarious conditions or that the capacitance of the electrode was not compensated properly.

      As suggested by the reviewer, in the revised figures we excluded the neurons with threshold at -20/-15 mV. In addition, we performed statistical analysis with and without these cells (data reported below) and found that whether these cells are included or excluded, the statistical significance of the results does not change.

      Fig.5c: including the 2 outliers from cHet group with values of -16.5 and 20.6 mV: 42.6±1.01 mV in control, n=33 cells from 15 mice vs -35.3±1.2 mV in cHet, n=40 cells from 17 mice, ***p<0.001, LMM; excluding the 2 outliers from cHet group -42.6±1.01 mV in control, n=33 cells from 15 mice vs -36.2±1.1 mV in cHet, n=38 cells from 17 mice, ***p<0.001, LMM.

      Fig.7c: including the 2 outliers from cHet group with values of -16.5 and 20.6 mV: 43.4±1.6 mV in control, n=12 cells from 9 mice vs -33.9±1.8 mV in cHet, n=24 cells from 13 mice, **p=0.002, LMM; excluding the 2 outliers from cHet group -43.4±1.6 mV in control, n=12 cells from 9 mice vs -35.4±1.7 mV in cHet, n=22 cells from 13 mice, *p=0.037, LMM.

      (5) The authors claim that "cHet SST+ cells showed no significant changes in active and passive membrane properties (Figure 8d,e); however, their evoked firing properties were affected with fewer AP generated in response to the same depolarizing current injection".

      This sentence is intrinsically contradictory. Action potentials triggered by current injections are dependent on the integration of passive and active properties. If the curves of Figure 8f are different between genotypes, then some passive and/or active property MUST have changed. It is an unescapable conclusion. The general _blanket_ statement of the authors that there are no significant changes in active and passive properties is in direct contradiction with the current/#AP plot.

      We agreed with the reviewer and rephrased the abstract, results and discussion according to better represent the data. As discussed in the previous revision, it's possible that other intrinsic factors, not assessed in this study, may have contributed to the effect shown in the current/#AP plot. 

      (6) The phase plots of Figs 5c, 7c, and 7h suggest that the frequency of acquisition/filtering of current-clamp signals was not appropriate for fast waveforms such as spikes. The first two papers indicated by the authors in their rebuttal (Golomb et al., 2007; Stevens et al., 2021) did not perform a phase plot analysis (like those included in the manuscript). The last work quoted in the rebuttal (Zhang et al., 2023) did perform phase plot analysis, but data were digitized at a frequency of 20KHz (not 10KHz as incorrectly indicated by the authors) and filtered at 10 kHz (not 2-3 kHz as by the authors in the manuscript). To me, this remains a concern.

      We agree with the reviewer that higher sampling rate would allow to more accurately assess different AP parameters, such as AP peak, half-width, rise time, etc. The papers were cited in context of determining AP threshold, not performing phase plot analysis. We apologize for the confusion and error. Finally, we removed the phase plots since they did not add relevant information. 

      (7)  The general logical flow of the manuscript could be improved. For example, Fig 4 seems to indicate no morphological differences in the dendritic trees of control vs mutant PV cells, but this conclusion is then rejected by Fig 6. Maybe Fig 4 is not necessary. Regarding Fig 6, did the authors check the integrity of the entire dendritic structure of the cells analyzed (i.e. no dendrites were cut in the slice)? This is critical as the dendritic geometry may affect the firing properties of neurons (Mainen and Sejnowski, Nature, 1996).

      As suggested by the reviewer, we removed Fig.4. All the reconstructions used for dendritic analysis contained intact cells with no evidently cut dendrites.

    1. 1) You'll receive an email linking you back to this page for your reference 2) You will try out the Charting Clarity Method the next week at work 3) You will see small wins and start building a foundation that protects you 4) I will email you a few times a week with other tips and ways to help

      I wonder whether you can change the layout here so it's a 4-column design with a matching icon for each idea?

    1. hat he may join with thee in endeavor.” 2(Thus) Gilgamish solves (his) dream. 3Enkidu sitting before the hierodule 4 5[   ] forgot where he was born.

      Hierodule: a sacred temple prostitute.

      In this scene, something profound happens Enkidu experiences a loss of memory; he forgets where he was born. This detail gives us a lens to view him not just as a character fulfilling a destiny, but as a human being undergoing a deep personal transformation. It reflects a universal theme of losing one’s past to become someone new something still relatable today. The hierodule represents more than physical intimacy; she symbolizes a gateway into civilization and human society. Her presence also lends the scene a religious tone, contrasting with translations that use the simpler phrase “the woman.” This reinforces the text’s ancient and mythic atmosphere rather than framing it in a modern or emotionally raw way.

    1. destroyer

      增量阅读并非注意力的“杀手”

      在增量学习中,正确选择学习材料至关重要。许多文本或视频并不适合进行增量处理。一位从未尝试过增量学习的 SuperMemo 用户写道:

      “在增量阅读中,文章的结构和质量之所以如此重要,有没有可能是因为学习的真正瓶颈在于我们的大脑本身(例如大脑皮层的可塑性速度)?如果我们每天只能吸收X条知识——一旦试图学得更多,就会对大脑造成损害呢?这里有一个想法:如果你用新知识让大脑超载,它将没有时间在你已知的事物之间建立起有意义的联系,那么你的知识可能会退化成只能回答知识竞赛式的琐碎问题。

      解决任何重大问题都需要长时间的专注。我担心,信息成瘾(每天接触200条零碎信息)会导致注意力缺失。你的大脑习惯了每15秒就获得一些“闪亮”的新鲜事物(一条新推文、一张有趣的图片、一个新的头条新闻等等),所以当你让它花4个小时专注于一件事时,它就会不听使唤。我想,在还没有网上冲浪的时代,我更能专注于一件事。

      所以,用一种耸人听闻的小报标题风格来说,增量阅读可能就是注意力的终极杀手!!!”

      在提到注意力、记忆瓶颈、“有意义的联系”等方面时,上述推理不无道理。但是,将 SuperMemo 与网络成瘾者们使用的 Twitter 或 Facebook 相提并论是极其不准确的!在增量阅读中,所获得的“奖励”是基于高质量的学习,而不是那些“闪亮或有趣”的东西。当然,没什么能阻止用户将“闪亮/有趣”的东西导入 SuperMemo。正因如此,最终奖励的性质也将取决于个人的性格和自律能力。

      如果遵循推荐的规则来使用:增量阅读应当能极大地提升注意力(正如在《增量学习的优势》一文中所解释的那样)。

      学习速度的瓶颈

      大脑皮层的可塑性确实是学习过程中的瓶颈。如果你不采用间隔重复法,那么所有速读和快速学习的努力都可能付诸东流,因为间隔重复最终决定了建立长期记忆的速度。请记住,在增量阅读中,阅读材料的总量可能非常庞大,然而,在理想情况下,最终进入学习流程的项目数量是相对较少的(通常每天10-20条,而不是200条!)。阅读和筛选的过程需要花费大量时间,但这样才能“淘”出那些能在长远带来最大价值的黄金知识。

      记忆的超载与睡眠的作用

      正是对“超载”的担忧,导致记忆瓶颈这一概念的出现。你固然可以用过量的信息让你的学习过程超载,但你不太可能“让你的长期记忆超载”。睡眠时所进行的遗忘和“垃圾回收”机制,正是为了防止这个问题(指记忆超载)而专门演化出来的。无论你多么努力地去学习过量的事实,遗忘机制都会清理掉多余的部分,而睡眠中的记忆优化则会确保你建立起所有必要的“有意义的联系”。当然,这一切只有在你获得所需全部睡眠(例如,避免使用闹钟、安眠药、熬夜等)的情况下才会发生。

      更多信息请见:《睡眠中的神经优化》

      学习 vs. 解决问题

      诚然,解决问题需要高度的专注力。但在理想世界里,你应该为(1)学习和(2)解决问题分配专门的时间段。用科维(Covey)的术语来说,你的学习提升的是你的“产能” (Production Capacity),而你解决问题的时间则是你的“产出” (Production) 时间。当然,当你在信息不足的情况下解决问题时,你也可以将这两个时间段结合起来。增量阅读正是应对此类情况的理想工具。你可以将新信息的流入与创造性工作、解决问题结合起来,同时保持对当前问题的最大专注度。这一点在《增量学习的优势:创造力》一文中有过解释。你可以通过使用增量阅读的各种工具,尤其是“搜索与回顾”(search&review)** 以及 “分支回顾”(branch review),来优化对单一主题的专注程度。

      另请参阅:《增量式问题解决》

    1. Navigating Failures in Pods With Devices

      Summary: Navigating Failures in Pods With Devices

      This article examines the unique challenges Kubernetes faces in managing specialized hardware (e.g., GPUs, accelerators) within AI/ML workloads, and explores current pain points, DIY solutions, and the future roadmap for more robust device failure handling.

      Why AI/ML Workloads Are Different

      • Heavy Dependence on Specialized Hardware: AI/ML jobs require devices like GPUs, with hardware failures causing significant disruptions.
      • Complex Scheduling: Tasks may consume entire machines or need coordinated scheduling across nodes due to device interconnects.
      • High Running Costs: Specialized nodes are expensive; idle time is wasteful.
      • Non-Traditional Failure Models: Standard Kubernetes assumptions (like treating nodes as fungible, or pods as easily replaceable) don’t apply well; failures can trigger large-scale restarts or job aborts.

      Major Failure Modes in Kubernetes With Devices

      1. Kubernetes Infrastructure Failures

        • Multiple actors (device plugin, kubelet, scheduler) must work together; failures can occur at any stage.
        • Issues include pods failing admission, poor scheduling, or pods unable to run despite healthy hardware.
        • Best Practices: Early restarts, close monitoring, canary deployments, use of verified device plugins and drivers.
      2. Device Failures

        • Kubernetes has limited built-in ability to handle device failures—unhealthy devices simply reduce the allocatable count.
        • Lacks correlation between device failure and pod/container failure.
        • DIY Solutions:
          • Node Health Controllers: Restart nodes if device capacity drops, but these can be slow and blunt.
          • Pod Failure Policies: Pods exit with special codes for device errors, but support is limited and mostly for batch jobs.
          • Custom Pod Watchers: Scripts or controllers watch pod/device status, forcibly delete pods attached to failed devices, prompting rescheduling.
      3. Container Code Failures

        • Kubernetes can only restart containers or reschedule pods, with limited expressiveness about what counts as failure.
        • For large AI/ML jobs: Orchestration wrappers restart failed main executables, aiming to avoid expensive full job restart cycles.
      4. Device Degradation

        • Not all device issues result in outright failure; degraded performance now occurs more frequently (e.g., one slow GPU dragging down training).
        • Detection and remediation are largely DIY; Kubernetes does not yet natively express "degraded" status.

      Current Workarounds & Limitations

      • Most device-failure strategies are manual or require high privileges.
      • Workarounds are often fragile, costly, or disruptive.
      • Kubernetes lacks standardized abstractions for device health and device importance at pod or cluster level.

      Roadmap: What’s Next for Kubernetes

      SIG Node and Kubernetes community are focusing on:

      • Improving core reliability: Ensuring kubelet, device manager, and plugins handle failures gracefully.
      • Making Failure Signals Visible: Initiatives like KEP 4680 aim to expose device health at pod status level.
      • Integration With Pod Failure Policies: Plans to recognize device failures as first-class events for triggering recovery.
      • Pod Descheduling: Enabling pods to be rescheduled off failed/unhealthy devices, even with restartPolicy: Always.
      • Better Handling for Large-Scale AI/ML Workloads: More granular recovery, fast in-place restarts, state snapshotting.
      • Device Degradation Signals: Early discussions on tracking performance degradation, but no mature standard yet.

      Key Takeaway

      Kubernetes remains the platform of choice for AI/ML, but device- and hardware-aware failure handling is still evolving. Most robust solutions are still "DIY," but community and upstream investment is underway to standardize and automate recovery and resilience for workloads depending on specialized hardware.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reviewer #1

      Major points

      • *

        • The introduction describes the effects of different environmental cues and aging on fibroblast phenotype, but it would be good to note the developmental origins of dermal fibroblasts, which specifies their fate and function (Driskell et al, Nature 2013).* Our response:

      In accordance with the reviewers' suggestions, we have incorporated a summary of prior research regarding the developmental origins of dermal fibroblasts into lines 53–56 of the Introduction.

      • In Fig 2, how do TEWL measurements compare to constructs without an epidermal layer or human skin? It may seem obvious that barrier function would be negligible in these models, but it would be a helpful negative control for interpreting the relative effects of vasculature on barrier function.*

      We appreciate your valuable comments regarding the accurate interpretation of TEWL measurements. Estimated TEWL values for human skin have been reported in a systematic review and meta-analysis by Kottner et al. Specifically, the estimated TEWL (95% CI) for individuals aged 18–64 years varies by anatomical site: 15.4 (13.9–17.0) g/m²h for the right cheek, 6.5 (6.2–6.8) g/m²h for the midvolar right forearm, and 36.3 (29.5–43.1) g/m²h for the right palm. In comparison, the TEWL of our EDV model was 9.68 g/m²h, a value relatively close to that of human skin.

      We also considered measuring TEWL in artificial skin models lacking epidermis. However, we found that such models remain moist due to culture medium, and pressing the measurement probe against them risks water droplets adhering to the sensor and causing damage. Although we recognize the significance of this measurement as a negative control, we refrained from conducting it due to the limitations of the equipment.

      This information has been added to the Results section, lines 178–182.

      • *

      • The mechanical measurements in Fig 2 are a nice idea, but it is a bit difficult to interpret without comparison to other conditions (e.g. human skin) or by reporting more universal mechanical parameters (e.g. Young's modulus).*

      We greatly appreciate your insightful comments regarding the interpretation of skin viscoelasticity measurements using the Cutometer. The Cutometer is a device that applies negative pressure to the skin to elevate its surface, allowing for the calculation of biomechanical properties based on the temporal changes in skin displacement. Notably, the R7 parameter—defined as the ratio of immediate retraction after pressure release to the maximum deformation during suction—has been shown to correlate significantly with age.

      In this study, we evaluated HSEs under the same measurement conditions as those used in previous human clinical studies. Accordingly, we have cited past Cutometer data for human skin and discussed the relationship between those findings and our HSE measurements. These revisions have been made to lines 205–215.

      We determined that performing Cutometer measurements on human skin would be impractical due to the ethical committee procedures and associated costs. Although evaluating Young’s modulus using techniques such as AFM to assess the mechanical properties of collagen fibers is a fascinating and informative approach, we have opted not to pursue this analysis due to the substantial time and cost required for sample preparation.

      • The induction of region-specific fibroblast markers is interesting and a bit unexpected since all the fibroblasts came from the same source before seeding into HSEs. The conclusions require additional support from quantification of the IF staining in Fig 3.*

      Our response:

      Thank you for your valuable advice on strengthening the conclusion of our manuscript. We are currently conducting quantitative analysis through manual counting across multiple fields for all mesenchymal cell markers and Vimentin immunostaining data presented in Fig. 3.

      • *

      • Likewise, could the authors clarify whether the cells were passaged before seeding into the HSE, and if so, what passage number. Could passaging affect the responses observed? Please add a discussion point about this.*

      Our response:

      For all cell types, passage 4 or 5 cells were utilized for the reconstitution of human skin equivalents (HSE). Indeed, Philippeos et al. demonstrated that while CD39, CD90, and CD36 are detectable in primary CD31⁻CD45⁻Ecad⁻ dermal cells, the expression of CD39 is lost after a single passage. In contrast, CD90 and CD36 remain detectable for up to four passages. These findings underscore the impact of in vitro culture on the depletion of fibroblast marker expression. Since we employed NHDFs that had undergone four to five passages for HSE reconstruction, it is reasonable to assume that these cells had already lost specific fibroblast subpopulations, including CD39⁺ cells. Consistent with this, our scRNA-seq analysis revealed that most fibroblasts cultured in 2D formed an artificial population comprising cells in the S and G2M phases, along with secretory-reticular fibroblasts. Additionally, immunohistochemical analysis confirmed a near-complete absence of CD39⁺, CD90⁺, FAP⁺, NG2⁺, and αSMA⁺ cells in the dermis of both D and DV models, further indicating that serial passaging significantly reduces the expression of markers associated with papillary fibroblasts, reticular fibroblasts, and pericytes. Interestingly, the introduction of vascular endothelial cells into the HSE appears to facilitate a partial restoration of fibroblast heterogeneity in cells passaged four to five times. However, whether this effect can be replicated in more extensively passaged fibroblasts remains to be verified. It is well established that excessive passaging induces cellular senescence, leading to reduced proliferative and differentiation capacities in mesenchymal stem cells. Therefore, it is conceivable that fibroblasts beyond a certain passage number may fail to recapitulate dermal mesenchymal cell heterogeneity, even in the presence of endothelial cells.

      We have added this discussion to the revised manuscript on lines 372-385, 391–397, and 470-471. However, due to the prolonged culture period required, we regret that we are unable to perform the additional validation experiments at this time.

      • The scRNA-seq suggests that the in vitro populations do not discriminate between secretory papillary and pro-inflammatory fibroblasts. Could the authors add some further analysis or discussion regarding this point?*

      Our response:

      We are currently conducting an additional enrichment analysis on fibroblast subpopulations #0, 1, 2, 6, 8, and 11, identified through UMAP analysis integrating HSE and human skin datasets. We believe that this analysis will elucidate the functional characteristics of each in vitro subpopulation and enable us to speculate on the underlying factors contributing to the observed differences from the human skin analysis results.

      • In Fig 6, it will be important to add quantification of epidermal thickness and differentiation marker expression to support the conclusions.*

      Our response:

      Thank you for your valuable advice regarding quantitative analysis. We are currently measuring the thickness of the entire epidermal layer, the CK5-positive cell layer, and the CK10-positive cell layer based on HE-stained and IHC-stained images.

      • A key question is how NP and AA conditions affect the fibroblast populations as this seems to be a key factor in HSE maturation and would then link back to the previous sections. It would be good to stain for fibroblast markers in these samples.*

      Our response:

      We are grateful for your insightful comments, which are crucial for a more precise understanding of the physiological relevance of the NP culture model. In response, we are currently undertaking additional analyses to investigate the expression patterns of dermal mesenchymal markers under both NP and AA conditions.

      • As noted above, the ability of the vasculature to direct differentiation of a common fibroblast population into different phenotypes is one of the key findings of the study. To strengthen these observations, could additional analysis of the transcriptional data be possible. For example, would trajectory analysis potentially show how the different populations are evolving or related? In addition, could the CellChat analysis be performed between the vasculature and the different populations in Fig 5, which are mapped to in vivo populations? This might be a more relevant analysis than the populations in Fig 4.*

      Our response:

      As pointed out by reviewers, we acknowledge that elucidating the process and underlying mechanisms by which fibroblasts, whose heterogeneity is compromised in 2D culture, re-differentiate into distinct dermal mesenchymal subtypes constitutes a critical additional analysis to strengthen our findings. Accordingly, we are currently conducting trajectory analysis using Monocle3. This includes identifying branch points that regulate the differentiation of dermal mesenchymal clusters shown in Fig. 4b, as well as predicting transcription factors and cell signaling pathways playing pivotal roles at those branch points. Furthermore, we are planning a CellChat analysis between vascular endothelial cells and dermal mesenchymal cells. We anticipate that integrating the results of these two analyses will provide valuable insights into the differentiation processes of dermal mesenchymal cells, particularly the induction of perivascular cell differentiation.

      • *

      • *

      Reviewer #1

      Minor points

      • *

        • The abstract states that enabling in vitro evaluation of drug efficacy using methodologies that are identical to those used in human clinical studies. This seems to be an over interpretation of the study and not well supported by the data. Please consider revising or removing.*

      Our Response:

      Upon thorough consideration, we have deleted the statements that may be regarded as exaggerated (line 26-28 and 346-348).

      • Check referencing formatting in lines 118-121*

      Our Response:

      We appreciate your attention to the reference format error. The necessary revisions have been completed.

      Reviewer #2 Major comments:

        • Despite its strengths, the study has several limitations that warrant further investigation. The authors describe a "senescent-like" phenotype under nutrient-poor (NP) conditions, yet do not provide direct evidence of cellular senescence using canonical markers such as SA-β-gal staining, p16^INK4a or p21 expression, or SASP profiling-weakening their aging-related conclusions.*

      Our Response

      Thank you for your valuable advice, which has helped clarify the physiological phenomena modeled by the NP condition. We are planning additional experiments involving histological analysis, including SA-β-gal staining and the detection of p16^INK4a and/or p21.

      • The 500 μM dose of ascorbic acid (AA), while within the reported range for skin models, is at the higher end compared to commonly used concentrations (100-300 μM) and lacks justification via dose/response data. Normal physiological levels and changes in aging dermis should be referenced in discussion. AA is also an additive in their standard HSE media, but this was not sufficiently emphasized to draw attention. Would its removal from the baseline media make a difference?*

      Our Response

      We sincerely appreciate the important comment regarding the rationale behind the ascorbic acid concentration used in the culture medium. As Reviewer 3 rightly pointed out, concentrations around 100–300 μM are commonly employed in general in vitro assays. In our artificial skin model, we opted for a concentration of 500 μM AA in the growth medium based on two considerations: (1) the model contains a high cell density of approximately 4 × 10⁶ cells immediately after reconstruction, which is expected to result in substantial AA consumption, and (2) AA is not sufficiently stable in culture medium. Given the relatively long medium exchange interval of 48–72 hours, we deemed it necessary to maintain a certain AA level throughout this period. While no rigorous dose–response validation has been conducted, we have confirmed that this concentration does not induce toxicity or abnormalities in skin morphogenesis.

      As part of the revision, we considered revisiting the basal medium formulation; however, due to the significant time and resource demands, we have decided to forgo further optimization at this stage.

      As described on lines 307–311, the NP medium was formulated to evaluate the potential impact of age-related declines in plasma component transport. We apologize for any confusion regarding the relationship between the HSE growth medium and the NP medium. In response to the reviewer’s suggestion, we have added clarifying explanations and cautionary notes regarding the composition and rationale of these two media in both the Results and Methods sections (line 307-311 and 634-636).

      • Mechanistically, fibroblast heterogeneity is attributed to keratinocyte and vascular signals, but the signaling pathways involved (e.g., Wnt, TGF-β, VEGF) are not directly examined. Validating which paracrine factors (VEGF, PDGF, LAMA5, KGF) are mediating fibroblast transitions using inhibitors or RNA profiling could shed more light.*

      Our response:

      As pointed out by reviewers, we acknowledge that elucidating the process and underlying mechanisms by which fibroblasts, whose heterogeneity is compromised in 2D culture, re-differentiate into distinct dermal mesenchymal subtypes constitutes a critical additional analysis to strengthen our findings. Accordingly, we are currently conducting trajectory analysis using Monocle3. This includes identifying branch points that regulate the differentiation of dermal mesenchymal clusters shown in Fig. 4b, as well as predicting transcription factors and cell signaling pathways playing pivotal roles at those branch points. Furthermore, we are planning a CellChat analysis between vascular endothelial cells and dermal mesenchymal cells. We anticipate that integrating the results of these two analyses will provide valuable insights into the differentiation processes of dermal mesenchymal cells, particularly the induction of perivascular cell differentiation. We fully recognize that validation using specific inhibitors is crucial to substantiate the mechanisms suggested by the scRNA-seq analysis. However, given that the reconstruction and reanalysis of the artificial skin model requires more than three months, we have decided not to include these experiments in the current revision and instead consider them as important subjects for future investigation.

      Minor comments: 1. The role of pericytes is also underexplored; while their presence is confirmed, functional assays or transcriptomic analyses to elucidate their contribution to ECM remodeling or vascular stability are not fully explored. The origin of pericyte-like cells remains uncertain without lineage tracing or barcoding to distinguish whether they derive from fibroblasts, endothelial cells, or culture artifacts. Since they observe induced differentiation of fibroblast-like cells in 3D culture, it would be compelling to reconstruct differentiation trajectories (pseudotime analysis) from progenitor states to papillary/reticular/pericyte-like states from their scRNAseq data.

      Our respnse:

      This point will be addressed and validated through our response to Major Comment 3 from Reviewer #2.

      • Although AA enhanced collagen production and elasticity in the vascularized EDV model, the lack of response in the ED model is not addressed mechanistically.*

      Our response

      We have planned additional experiments to examine two hypotheses regarding the mechanism underlying the improved responsiveness of the EDV model to AA. The first hypothesis posits that the behavior of ascorbic acid uptake in the cells constituting the EDV model differs from that in the ED model. To investigate this, we plan to analyze the expression patterns of transporter genes potentially involved in the uptake and efflux of ascorbic acid, such as SVCT1 (SLC23A1), SVCT2 (SLC23A2), GLUT1 (SLC2A1), GLUT3 (SLC2A3), GLUT4 (SLC2A4), and MRP4, using scRNA-seq data. The second hypothesis suggests that the absence of bFGF signaling and low FBS treatment under NP conditions may affect subpopulations of dermal mesenchymal cells in the HSEs. To test this, we plan to analyze the expression patterns of dermal mesenchymal cell markers by IHC under NP and AA conditions, following the same approach as shown in Fig. 3.

      • The omission of immune cells which are key players in skin aging and homeostasis could increase physiological relevance of the model.*

      Our response:

      As rightly noted by Reviewer 2, immune cells are integral to skin aging and the maintenance of tissue homeostasis, underscoring the necessity of incorporating them into future research models. Nonetheless, the primary aim of the present study is to elucidate the influence of vascular endothelial cells on dermal mesenchymal cell heterogeneity and to establish an in vitro research model specifically addressing this heterogeneity, with particular emphasis on perivascular cells. Accordingly, we would prefer to consider the analysis of immune cells as a subject for future investigation.

      • The exclusive use of standard HUVECs may not fully capture the behavior of tissue-specific microvascular endothelial cells, potentially limiting the fidelity of the vascular niche.*

      In this study, we opted to use HUVECs as vascular endothelial cells due to their relative ease of expansion in culture. Consequently, we acknowledge the potential limitation in fully recapitulating the functions of tissue-specific endothelial cells. To address this concern, we have revised and expanded the Discussion section on lines 352–356.

      Reviewer #3 Major comments:

        • Are the key conclusions convincing? The core claim-that tricellular interactions recapitulate dermal mesenchymal heterogeneity and enhance skin functionality-is well-supported by histology, immunohistochemistry, functional assays (TEWL, elasticity), and scRNA-seq.
      1. Should the authors qualify some of their claims as preliminary or speculative, or remove them altogether? The assertion that HSEs enable "identical" methodology to clinical studies (p. 2, line 29) is exaggerated. While elasticity was measured via Cutometer (used clinically), the model lacks immune/neural components and long-term stability for full translational equivalence.* Our Response:

      Upon thorough consideration, we have deleted the statements that may be regarded as exaggerated (line 26-28 and 346-348).

      • Would additional experiments be essential to support the claims of the paper? Request additional experiments only where necessary for the paper as it is, and do not ask authors to open new lines of experimentation. Adequacy of Experimental Evidence & Need for Additional Experiments: No essential control appears to be missing: the authors include conditions {plus minus}ascorbic acid and {plus minus}vascular cells to isolate those effects. One could suggest a few additional experiments to further bolster the conclusions, but they are not strictly required for the main message. For example, to pinpoint the contribution of each mesenchymal subset, the authors could engineer HSE variants lacking one component at a time (omit pericytes or use only papillary vs. only reticular fibroblasts) to see how each omission affects barrier or elasticity. This would directly confirm each cell type's role. However, such experiments may be technically involved (especially isolating pure papillary vs. reticular fibroblast populations and ensuring viability in 3D culture) and might be beyond the scope of a single study. Another possible extension could be mechanistic assays, such as examining specific molecular signals: e.g., testing if blocking known paracrine factors from pericytes or fibroblast subsets diminishes the observed improvements. Given that pericytes can secrete laminin-511 and other factors that promote keratinocyte growth, the authors might, in future work, explore whether such factors mediate the enhanced epidermal proliferation seen with the vascularized HSE. Overall, the current data are sufficiently convincing that additional experiments are not absolutely necessary for publication.
      • Are the suggested experiments realistic in terms of time and resources? It would help if you could add an estimated cost and time investment for substantial experiments-*

      Our response

      We are deeply grateful for the reviewer’s constructive feedback. As rightly pointed out, cell ablation and mechanistic assays utilizing signaling inhibitors to assess the contribution of individual mesenchymal subsets are indispensable for reinforcing our findings and claims. However, as the reviewer has also indicated, these experiments would require no less than four months to complete. Consequently, we have opted to forgo high-cost additional experiments such as the optimization of HSE construction protocols and inhibitor-based assays. Instead, we are proactively conducting mechanism-oriented analyses using our existing scRNA-seq and histological datasets. Specifically, we are currently implementing an integrated approach combining Monocle3 and CellChat to pinpoint critical branch points in dermal mesenchymal cell differentiation and to elucidate the signaling pathways orchestrating these bifurcations.

      • Are the experiments adequately replicated and statistical analysis adequate? The manuscript's data are presented in a manner that generally supports reproducibility. The authors state that all data are presented as "mean {plus minus} SD" (Methods, p.36). This is acceptable and clearly reported. However, I suggest that the authors consider using mean {plus minus} SEM for specific datasets where the primary goal is to assess statistical significance between groups - for example, for the Ki67-positive cell proliferation data (Fig. 6c) - as SEM better reflects the precision of the group mean for inferential comparisons. In contrast, for functional measures that inherently exhibit biological variation across samples (e.g., TEWL, skin elasticity), using mean {plus minus} SD remains fully appropriate, as SD reflects true inter-sample variability. To improve clarity and reproducibility, I encourage the authors to briefly state in the Methods or figure legends why SD or SEM is used in each case, in line with best practice guidelines.*

      Our Response:

      We appreciate your guidance regarding appropriate statistical analysis and data presentation. We planned to revise the depiction of error margins in accordance with best practice guidelines.

      Reviewer #3 Minor comments: 1. For Figure 4e, it would be helpful if the authors could clarify in the figure legend or Methods whether the heatmap shows log-normalized expression values (as derived from the Seurat object) or z-scored expression across cells or samples. This distinction affects the interpretation of relative versus absolute expression levels of the collagen and elastic fiber-related genes, which are central to the study's conclusions about ECM remodeling.

      Our response:

      Thank you for pointing out the inconsistency in data representation. We have revised the manuscript to clearly indicate that Fig. 4e presents the Z-score normalized average expression levels.

      • Typos: "factr" → "factor" (p. 16, line 244); "severl" → "several" (p. 22, line 367).

      *

      Our response

      Thanks for pointing out the typo, we have corrected it.

      Reviewer #4

      Minor Points:

        • The human skin control in Fig. 1c seems thinner than normal and would suggest that the ED and EDV models are hyperproliferative. Replacing the control with one that shows normal thickness would prevent incorrect conclusions of the data.* Our response:

      In accordance with the reviewer’s suggestion, the display area of the human skin image in Fig. 1c has been modified.

      KI67 and TEWL readings for human skin as controls for Fig. 2b-c would help gauge how the organoids perform and whether they are abnormal. What is the elasticity index for facial sagging?

      Thank you for your valuable advice, which has deepened our understanding of the evaluation results of HSEs. We are currently planning and conducting an additional analysis by including the quantification of Ki67-positive cells in human skin samples. Regarding the assessment of skin barrier and viscoelasticity using TEWL and Cutometer measurements, we have reffered data from previous clinical studies and added an explanation of the functional differences between HSEs and human skin.

      • Ascorbic acid utilizes SLC23A1 and SLC23A2 to transport across cell membranes. Are their expression more pronounced in cluster 14 fibroblasts? This would help connect the scRNA-seq data to the ascorbic acid experiments.

      *

      Our response:

      We appreciate the valuable suggestions provided to investigate the mechanisms underlying the altered VC responsiveness observed in the EDV model. We plan to analyze the expression patterns of transporter genes potentially involved in the uptake and efflux of ascorbic acid, such as SVCT1 (SLC23A1), SVCT2 (SLC23A2), GLUT1 (SLC2A1), GLUT3 (SLC2A3), GLUT4 (SLC2A4), and MRP4, using scRNA-seq data.

      There seems to be quite a bit of variability between replicant immunostains, in particular, vimentin in Fig. 3. Can the authors discuss this variability and whether any of the HSE organoid combinations reduced this variability?

      Our response:

      Thank you for your comments regarding the immunostaining. A reanalysis of the data, including newly acquired immunostaining images during the revision process, is planned.

      • Please provide number of replicates throughout figure legends.*

      Our response:

      Thank you for your valuable advice. We have added the number of replicates to all figure legends.

      • Line 148 states "E and EV models were transparent and extremely soft", should read "E and ED models".*

      Our response:

      The photographic data for the EV and ED models in Fig. 1b was incorrect and has therefore been corrected. We sincerely apologize for our oversight. As it was actually the E and EV models that appeared transparent, the description in the text remains unchanged.

      • Line 150-151 states "In the E and EV models, an abnormal epidermis lacking a basal cell layer formed". The Krt5 staining in Figure 2 clearly shows a basal cell layer in these models, albeit abnormal. Stating that this the abnormal epidermis displayed a disrupted basal cell layer or columnar shape of basal cells were disrupted is more appropriate. In addition, these results do not show "crosstalk between NHEKs and NHDFs is essential for epithelialization" as the E and EV organoid models show epithelial stratification.*

      Our response:

      We sincerely appreciate your insightful guidance regarding the accurate presentation of the histological analysis results. Accordingly, we have revised lines 154–156 in the Results section in line with your recommendations.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #4

      Evidence, reproducibility and clarity

      The manuscript by Kimura et al. define how epidermal morphogenesis in human skin equivalents (HSE) differ by combining vascular endothelial cells, epidermal keratinocytes, and dermal fibroblasts using staining and single-cell RNA-sequencing (scRNA-seq). The three cell system (EDV) displayed higher levels of Ki67+ cells, decreased levels of TEWL, and higher elasticity in comparison to the keratinocyte and fibroblast HSE system (ED). The overall structural morphology between the two systems is quite similar, though the expression of cytokeratin markers varies. EDV organoids specifically express COL1 and COL4 collagen markers surrounding the blood vessels. VEGF-VEGFR1 signaling between endothelia-fibroblasts seems to be pronounced in the EDV organoids according to scRNA-seq, suggesting active signaling between these two cell types. And ascorbic acid appeared to help nutrient poor ED and EDV organoids proliferate compared to controls. This work is well detailed and interesting, helping to define how endothelial cells function to make HSE organoids more faithfully mimic in vivo human skin. Only minor clarifications detailed below are needed.

      1. The human skin control in Fig. 1c seems thinner than normal and would suggest that the ED and EDV models are hyperproliferative. Replacing the control with one that shows normal thickness would prevent incorrect conclusions of the data.
      2. KI67 and TEWL readings for human skin as controls for Fig. 2b-c would help gauge how the organoids perform and whether they are abnormal. What is the elasticity index for facial sagging?
      3. Ascorbic acid utilizes SLC23A1 and SLC23A2 to transport across cell membranes. Are their expression more pronounced in cluster 14 fibroblasts? This would help connect the scRNA-seq data to the ascorbic acid experiments.
      4. There seems to be quite a bit of variability between replicant immunostains, in particular, vimentin in Fig. 3. Can the authors discuss this variability and whether any of the HSE organoid combinations reduced this variability?
      5. Please provide number of replicates throughout figure legends.
      6. Line 148 states "E and EV models were transparent and extremely soft", should read "E and ED models".
      7. Line 150-151 states "In the E and EV models, an abnormal epidermis lacking a basal cell layer formed". The Krt5 staining in Figure 2 clearly shows a basal cell layer in these models, albeit abnormal. Stating that this the abnormal epidermis displayed a disrupted basal cell layer or columnar shape of basal cells were disrupted is more appropriate. In addition, these results do not show "crosstalk between NHEKs and NHDFs is essential for epithelialization" as the E and EV organoid models show epithelial stratification.

      Significance

      This work is well detailed and interesting, helping to define how endothelial cells function to make HSE organoids more faithfully mimic in vivo human skin. Only minor clarifications detailed below are needed.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      The study develops a tricellular human skin equivalent (HSE) model incorporating epidermal keratinocytes (NHEKs), dermal fibroblasts (NHDFs), and vascular endothelial cells (HUVECs). This model autonomously organizes pericytes, papillary fibroblasts, and reticular fibroblasts, mimicking in vivo dermal mesenchymal heterogeneity. The EDV model (all three cell types) demonstrates enhanced epidermal barrier function (reduced TEWL), dermal elasticity, collagen deposition, and vascular organization compared to simpler models. Single-cell RNA-seq confirms the emergence of pericyte-like and fibroblast subpopulations resembling in vivo counterparts. Nutrient-poor (NP) culture replicates aging phenotypes (reduced proliferation, barrier dysfunction, disordered collagen), rescued by ascorbic acid (AA), highlighting vascular cells' role in skin homeostasis. However, several key methodological clarifications (e.g., heatmap normalization, statistical reporting), more precise qualification of certain claims, and enhanced contextualization within the literature are needed before the work can be considered suitable for publication; I therefore recommend major revision.

      Major comments:

      1. Are the key conclusions convincing?<br /> The core claim-that tricellular interactions recapitulate dermal mesenchymal heterogeneity and enhance skin functionality-is well-supported by histology, immunohistochemistry, functional assays (TEWL, elasticity), and scRNA-seq.
      2. Should the authors qualify some of their claims as preliminary or speculative, or remove them altogether? The assertion that HSEs enable "identical" methodology to clinical studies (p. 2, line 29) is exaggerated. While elasticity was measured via Cutometer (used clinically), the model lacks immune/neural components and long-term stability for full translational equivalence.
      3. Would additional experiments be essential to support the claims of the paper? Request additional experiments only where necessary for the paper as it is, and do not ask authors to open new lines of experimentation. Adequacy of Experimental Evidence & Need for Additional Experiments: No essential control appears to be missing: the authors include conditions {plus minus}ascorbic acid and {plus minus}vascular cells to isolate those effects. One could suggest a few additional experiments to further bolster the conclusions, but they are not strictly required for the main message. For example, to pinpoint the contribution of each mesenchymal subset, the authors could engineer HSE variants lacking one component at a time (omit pericytes or use only papillary vs. only reticular fibroblasts) to see how each omission affects barrier or elasticity. This would directly confirm each cell type's role. However, such experiments may be technically involved (especially isolating pure papillary vs. reticular fibroblast populations and ensuring viability in 3D culture) and might be beyond the scope of a single study. Another possible extension could be mechanistic assays, such as examining specific molecular signals: e.g., testing if blocking known paracrine factors from pericytes or fibroblast subsets diminishes the observed improvements. Given that pericytes can secrete laminin-511 and other factors that promote keratinocyte growth, the authors might, in future work, explore whether such factors mediate the enhanced epidermal proliferation seen with the vascularized HSE. Overall, the current data are sufficiently convincing that additional experiments are not absolutely necessary for publication.
      4. Are the suggested experiments realistic in terms of time and resources? It would help if you could add an estimated cost and time investment for substantial experiments

      5. Are the data and the methods presented in such a way that they can be reproduced? Yes
      6. Are the experiments adequately replicated and statistical analysis adequate? The manuscript's data are presented in a manner that generally supports reproducibility. The authors state that all data are presented as "mean {plus minus} SD" (Methods, p.36). This is acceptable and clearly reported. However, I suggest that the authors consider using mean {plus minus} SEM for specific datasets where the primary goal is to assess statistical significance between groups - for example, for the Ki67-positive cell proliferation data (Fig. 6c) - as SEM better reflects the precision of the group mean for inferential comparisons. In contrast, for functional measures that inherently exhibit biological variation across samples (e.g., TEWL, skin elasticity), using mean {plus minus} SD remains fully appropriate, as SD reflects true inter-sample variability. To improve clarity and reproducibility, I encourage the authors to briefly state in the Methods or figure legends why SD or SEM is used in each case, in line with best practice guidelines.

      Minor comments:

      1. For Figure 4e, it would be helpful if the authors could clarify in the figure legend or Methods whether the heatmap shows log-normalized expression values (as derived from the Seurat object) or z-scored expression across cells or samples. This distinction affects the interpretation of relative versus absolute expression levels of the collagen and elastic fiber-related genes, which are central to the study's conclusions about ECM remodeling.
      2. Typos: "factr" → "factor" (p. 16, line 244); "severl" → "several" (p. 22, line 367).

      Significance

      The study innovatively reconstructs dermal mesenchymal heterogeneity using commercially available cells and autonomous tricellular interactions, bypassing costly cell-sorting approaches. This democratizes complex HSE models for broader labs. This study demonstrates that vascularization is critical not only for nutrient supply but for instructing fibroblast/pericyte differentiation and ECM organization. The NP+AA paradigm (Fig. 6) offers a facile in vitro model for skin aging interventions, highlighting AA's efficacy via perivascular mechanisms.

      Audience: Tissue engineers, dermatologists, cosmetic/pharma researchers (anti-aging screening), and developmental biologists studying mesenchymal niche regulation.

      Placement in existing literature: Recent advances in skin tissue engineering have highlighted the importance of dermal fibroblast heterogeneity in skin homeostasis and regeneration. Single-cell transcriptomic studies (Tabib et al., J Invest Dermatol 2018; Solé-Boldo et al., Commun Biol 2020) have established that papillary and reticular fibroblasts exhibit distinct gene expression and functional roles. Prior engineered skin models incorporating fibroblast subtypes (Moreira et al., Biomater Sci 2023) or pericytes (Paquet-Fifield et al., J Clin Invest 2009) demonstrated improvements in vascularization or epidermal differentiation. However, a unified 3D human skin equivalent integrating vascular cells, pericytes, and spatially organized fibroblast subpopulations has not been systematically achieved. The present work by Kimura et al. advances the field by demonstrating that autonomous interaction among keratinocytes, endothelial cells, pericytes, and heterogeneous fibroblasts significantly enhances both barrier function and dermal elasticity, thus bringing engineered skin models closer to physiological skin. This addresses a key gap between prior single-cell descriptive studies and functional tissue engineering.

      Define your field of expertise with a few keywords: experimental dermatology, skin cancer, tissue engineering and 3D skin models, cell biology, tumor microenvironment, and the skin microbiome and barrier function.

    4. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      The manuscript by Kimura et al investigates the role of different cell populations in the development of human skin equivalents (HSEs). The observe that the addition of vascular endothelial cells to HSEs improves epidermal differentiation and barrier function, alongside differentiation of fibroblasts into papillary, reticular, and pericyte like mesenchymal cells. The authors also use single-cell transcriptomics to characterise the gene signatures and putative signalling pathway in the fibroblasts. Finally, the authors use nutrient poor medium and ascorbic acid to modulate HSE develop.

      One of the most significant questions arising from the findings is how the presence of vasculature can induce differentiation of fibroblasts from a common population, especially given that previous studies have shown that fibroblast identity is programmed during development. Some specific comments and suggestions for improving the manuscript are listed below.

      Major points:

      1. The introduction describes the effects of different environmental cues and aging on fibroblast phenotype, but it would be good to note the developmental origins of dermal fibroblasts, which specifies their fate and function (Driskell et al, Nature 2013).
      2. In Fig 2, how do TEWL measurements compare to constructs without an epidermal layer or human skin? It may seem obvious that barrier function would be negligible in these models, but it would be a helpful negative control for interpreting the relative effects of vasculature on barrier function.
      3. The mechanical measurements in Fig 2 are a nice idea, but it is a bit difficult to interpret without comparison to other conditions (e.g. human skin) or by reporting more universal mechanical parameters (e.g. Young's modulus).
      4. The induction of region-specific fibroblast markers is interesting and a bit unexpected since all the fibroblasts came from the same source before seeding into HSEs. The conclusions require additional support from quantification of the IF staining in Fig 3.
      5. Likewise, could the authors clarify whether the cells were passaged before seeding into the HSE, and if so, what passage number. Could passaging affect the responses observed? Please add a discussion point about this.
      6. The scRNA-seq suggests that the in vitro populations do not discriminate between secretory papillary and pro-inflammatory fibroblasts. Could the authors add some further analysis or discussion regarding this point?
      7. In Fig 6, it will be important to add quantification of epidermal thickness and differentiation marker expression to support the conclusions.
      8. A key question is how NP and AA conditions affect the fibroblast populations as this seems to be a key factor in HSE maturation and would then link back to the previous sections. It would be good to stain for fibroblast markers in these samples.
      9. As noted above, the ability of the vasculature to direct differentiation of a common fibroblast population into different phenotypes is one of the key findings of the study. To strengthen these observations, could additional analysis of the transcriptional data be possible. For example, would trajectory analysis potentially show how the different populations are evolving or related? In addition, could the CellChat analysis be performed between the vasculature and the different populations in Fig 5, which are mapped to in vivo populations? This might be a more relevant analysis than the populations in Fig 4.

      Minor points:

      1. The abstract states that enabling in vitro evaluation of drug efficacy using methodologies that are identical to those used in human clinical studies. This seems to be an over interpretation of the study and not well supported by the data. Please consider revising or removing.
      2. Check referencing formatting in lines 118-121

      Significance

      Overall, the study represents a systematic analysis of how vasculature contributes to skin model development, and the impact on fibroblast differentiation is an interesting observation. It would have been more impactful if some of the pathways and genes were followed up with mechanistic studies, but the findings are still useful to the field. Likewise, further insight into exactly how the vasculature regulates fibroblast phenotype would add to the impact as this is an unexpected but important finding.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review): 

      Summary: 

      The paper by Lee and Ouellette explores the role of cyclic-d-AMP in chlamydial developmental progression. The manuscript uses a collection of different recombinant plasmids to up- and down-regulate cdAMP production, and then uses classical molecular and microbiological approaches to examine the effects of expression induction in each of the transformed strains. 

      Strengths: 

      This laboratory is a leader in the use of molecular genetic manipulation in Chlamydia trachomatis and their efforts to make such efforts mainstream is commendable. Overall, the model described and defended by these investigators is thorough and significant.

      Thank you for these comments.

      Weaknesses: 

      The biggest weakness in the document is their reliance on quantitative data that is statistically not significant, in the interpretation of results. These challenges can be addressed in a revision by the authors. 

      Thank you for these comments. We point out that, while certain RT-qPCR data may not be statistically significant, our RNAseq data indicate late genes are, as a group, statistically significantly increased when increasing c-di-AMP levels and decreased when decreasing c-di-AMP levels. We do not believe running additional experiments to “achieve” statistical significance in the RT-qPCR data is worthwhile. We hope the reviewer agrees with this assessment.

      We have also included new data in this revised manuscript, which we believe further strengthens aspects of the conclusions linked to individual expression of full-length DacA isoforms. We have also quantified inclusion areas and bacterial sizes for critical strains.

      Reviewer #2 (Public review): 

      Summary: 

      This manuscript describes the role of the production of c-di-AMP on the chlamydial developmental cycle. Chlamydia are obligate intracellular bacterial pathogens that rely on eukaryotic host cells for growth. The chlamydial life cycle depends on a cell form developmental cycle that produces phenotypically distinct cell forms with specific roles during the infectious cycle. The RB cell form replicates amplifying chlamydia numbers while the EB cell form mediates entry into new host cells disseminating the infection to new hosts. Regulation of cell form development is a critical question in chlamydia biology and pathogenesis. Chlamydia must balance amplification (RB numbers) and dissemination (EB numbers) to maximize survival in its infection niche. The main findings In this manuscript show that overexpression of the dacA-ybbR operon results in increased production of c-di-AMP and early expression of the transitionary gene hctA and late gene omcB. The authors also knocked down the expression of the dacA-ybbR operon and reported a reduction in the expression of both hctA and omcB. The authors conclude with a model suggesting the amount of c-di-AMP determines the fate of the RB, continued replication, or EB conversion. Overall, this is a very intriguing study with important implications however the data is very preliminary and the model is very rudimentary and is not well supported by the data. 

      Thank you for your comments. Chlamydia is not an easy experimental system, but we have done our best to address the reviewer’s concerns in this revised submission.

      Describing the significance of the findings: 

      The findings are important and point to very exciting new avenues to explore the important questions in chlamydial cell form development. The authors present a model that is not quantified and does not match the data well. 

      Describing the strength of evidence: 

      The evidence presented is incomplete. The authors do a nice job of showing that overexpression of the dacA-ybbR operon increases c-di-AMP and that knockdown or overexpression of the catalytically dead DacA protein decreases the c-di-AMP levels. However, the effects on the developmental cycle and how they fit the proposed model are less well supported. 

      dacA-ybbR ectopic expression: 

      For the dacA-ybbR ectopic expression experiments they show that hctA is induced early but there is no significant change in OmcB gene expression. This is problematic as when RBs are treated with Pen (this paper) and (DOI 10.1128/MSYSTEMS.00689-20) hctA is expressed in the aberrant cell forms but these forms do not go on to express the late genes suggesting stress events can result in changes in the developmental expression kinetic profile. The RNA-seq data are a little reassuring as many of the EB/Late genes were shown to be upregulated by dacA-ybbR ectopic expression in this assay.

      As the reviewer notes, we also generated RNAseq data, which validates that late gene transcripts (including sigma28 and sigma54 regulated genes) are statistically significantly increased earlier in the developmental cycle in parallel to increased c-di-AMP levels. The lack of statistical significance in the RT-qPCR data for omcB, which shows a trend of higher transcripts, is less concerning given the statistically significantly RNAseq dataset. We have reported the data from three replicates for the RT-qPCR and do not think it would be worthwhile to attempt more replicates in an attempt to “achieve” statistical significance.

      We recognize that hctA may also increase during stress as noted by the Grieshaber Lab. In re-evaluating these data, we decided to remove the Penicillin-linked studies from the manuscript since they detract from the focus of the story we are trying to tell given the potential caveat the reviewer mentions.

      The authors also demonstrate that this ectopic expression reduces the overall growth rate but produces EBs earlier in the cycle but overall fewer EBs late in the cycle. This observation matches their model well as when RBs convert early there is less amplification of cell numbers. 

      dacA knockdown and dacA(mut) 

      The authors showed that dacA knockdown and ectopic expression of the dacA mutant both reduced the amount of c-di-AMP. The authors show that for both of these conditions, hctA and omcB expression is reduced at 24 hpi. This was also partially supported by the RNA-seq data for the dacA knockdown as many of the late genes were downregulated. However, a shift to an increase in RB-only genes was not readily evident. This is maybe not surprising as the chlamydial inclusion would just have an increase in RB forms and changes in cell form ratios would need more time points.

      Thank you for this comment. We agree that it is not surprising given the shift in cell forms. The reduction in hctA transcripts argues against a stress state as noted above by the reviewer, and the RNAseq data from dacA-KD conditions indicates at least that secondary differentiation has been delayed. We agree that more time points would help address the reviewer’s point, but the time and cost to perform such studies is prohibitive with an obligate intracellular bacterium.

      Interestingly, the overall growth rate appears to differ in these two conditions, growth is unaffected by dacA knockdown but is significantly affected by the expression of the mutant. In both cases, EB production is repressed. The overall model they present does not support this data well as if RBs were blocked from converting into EBs then the growth rate should increase as the RB cell form replicates while the EB cell form does not. This should shift the population to replicating cells. 

      We agree that it seems that perturbing c-di-AMP production by knockdown or overexpressing the mutant DacA(D164N) has different impacts on chlamydial growth. We have generated new data, which we believe addresses this. Overexpressing membrane-localized DacA isoforms is clearly detrimental to chlamydiae as noted in the manuscript. However, when we removed the transmembrane domain and expressed N-terminal truncations of these isoforms, we observed no effects of overexpression on chlamydial morphology or growth. Importantly, for the wild-type full-length or truncated isoforms, overexpressing each resulted in the same level of c-di-AMP production, further supporting that the negative effect of overexpressing the wild-type full-length is linked to its membrane localization and not c-di-AMP levels. These data have been included as new Figure 3. These data indicate that too much DacA in the membrane is disruptive and suggest that the balance of DacA to YbbR is important since overexpression of both did not result in the same phenotype. This is further described in the Discussion.

      As it relates to knockdown of dacA-ybbR, we have essentially removed/reduced the amount of these proteins from the membrane and have blocked the production of c-di-AMP. This is fundamentally different from overexpression.

      Overall this is a very intriguing finding that will require more gene expression data, phenotypic characterization of cell forms, and better quantitative models to fully interpret these findings. 

      Reviewer #1 (Recommendations for the authors): 

      There is a generally consistent set of experiments conducted with each of the mutant strains, allowing a straightforward examination of the effects of each transformant. There are a few general and specific things that need to be addressed for both the benefit of the reader and the accuracy of interpretation. The following is a list of items that need to be addressed in the document, with an overall goal of making it more readable and making the interpretations more quantitatively defended. 

      Specific comments: 

      (1) The manuscript overall is wordy and there are quite a few examples of text in the results that should be in the discussion (examples include lines 224-225, 248-262, 282-288, 304-308) the manuscript overall could use a careful editing for verbosity. 

      Thank you for this comment. We have removed some of the indicated sentences. However, to maintain the flow and logic of the manuscript, some statements may have been preserved to help transition between sections. As far as verbosity, we have tried to be as clear as possible in our descriptions of the results to minimize ambiguity. Others who read our manuscript appreciated the thoroughness of our descriptions.

      (2) There is also a trend in the document to base fact statements on qualitative and quantitative differences that do not approach statistical significance. Examples of this include the following: lines 156-158, 190-192, 198-199, 230-232, 239-242, 292-293). This is something the authors need to be careful about, as these different statistically insignificant differences may tend to multiply a degree of uncertainty across the entire manuscript. 

      We have quantified inclusion areas and tried to remove instances of qualitative assessments as noted by the reviewer. In regards to some of the transcripts, we can only report the data as they are. In some cases, there are trends that are not statistically significant, but it would seem to be inaccurate to state that they were unchanged. In other cases, a two-fold or less difference in transcript levels may be statistically significant but biologically insignificant. A reader can and should make their own conclusions.

      (3) Any description of inclusion or RB size being modestly different needs to be defended with microscopic quantification. 

      We have quantified inclusion areas and RB sizes and tried to remove instances of qualitative assessments as noted by the reviewer.

      (4) It would be very helpful to reviewers if there was a figure number added to each figure in the reviewer-delivered text. 

      Added.

      (5) Figure 1A: This should indicate that the genes indicated beneath each developmental form are on high (I think that is what that means). 

      We have reorganized Figure 1 to better improve the flow.

      (6) Figure 1B is exactly the same as the three images in Figure 8B. I would delete this in Figure 1. This relates to comment 9. 

      We presented this intentionally to clearly illustrate to the reader, who may not be knowledgeable in this area, what we propose is happening in the various strains. As such, we respectfully disagree and have left this aspect of the figure unchanged.

      (7) Figure 1D: It is not clear if the period in E.V has any meaning. I think this is just a typo. Also, the color coding needs to be indicated here. What do the gray bars represent? The labeling for the gene schematic for dacA-KDcom should not be directly below the first graph in D. This makes the reader think this is a label for the graph. This can be accomplished if the image in panel B is removed and the first graph in panel D is moved into B. This will make a better figure. 

      We have reorganized Figure 1 to better improve the flow.

      (8) Figure 2 C, G: The utility of these panels is not clear. For them to have any value, they need to be expressed in genome copies. If they are truly just a measure of chlamydia genomic DNA, they have minimal utility to the reader. There are similar panels in several other figures. 

      We have reported genome copies as suggested in lieu of ng gDNA for these measurements. Importantly, it does not alter any interpretations.

      (9) I am not sure about the overall utility of Figure 8. Granted, a summary of their model is useful, but the cartoons in the figure are identical or very nearly identical to model figures shown in two other publications from the same group (PMID: 39576108, 39464112) These are referenced at least tangentially in the current manuscript (Jensen paper- now published- and ref 53). Because the model has been published before, if they are to be included, there needs to be a direct comparison of the results in each of these three papers, as they basically describe the same developmental process. The model images should also be referenced directly to the first of the other papers.

      This was intentional so that readers familiar with our work will see the similarities between these systems. We have added additional comments in the Discussion related to our newly published work. As an aside, Dr. Lee generated the first version of the figure that was adapted by others in the lab. It is perhaps unlucky that those other studies have been published before his work.

    1. Reviewer #3 (Public review):

      Summary:

      Using an approach developed by the authors (FluidFM) combined with FLIM, they discover that a mechanical force applied over the cell nucleus triggers mechanical responses dependent on the Lamina composition.

      Strengths:

      The authors present a new approach to study mechano-transduction in living cells, with which they uncover lamin-dependent properties of the nucleus.

      Weaknesses:

      (1) The transfer of the mechanical response from the Lamina to the ER is not fully covered.

      (2) In Figure 4D, WT dots are the same for each compartment. Why do the authors not make one graph for each compartment with WT, A-KO, B-KD, and A-KO/B-KD together?

      (2) In Figure 1E, the authors showed well how the probe deforms the nucleus. It is not indicated in the material and methods section or in the figure legend, where, in Z, the acquisition of FLIM images was made or if it is a maximum projection. I assume it was made at a plane in the middle of the nucleus to see the nuclear envelope border and the ER at the same time. Did the authors look at the nuclear membrane facing upward, where most of the deformation should occur? Are there more lifetime changes? In Figure D, before injection of CytoD, we can clearly see a difference at the pyramidal indentation site with two different lifetime colors.

      (3) A great result of this article regards the importance of Lamins, A and B, in triggering the response to a mechanical force applied to the nucleus. Could 3D imaging for LaminA and LaminB be performed at the different time points of indentation to see how the lamins meshworks are deformed and how they return to basal state? This could be correlated with the FLIM results described in the article.

      (4) Lamins form a meshwork underneath the nuclear membrane. They are connected to the cytoskeletons mainly by the LINC complex. Results presented here show that the cytoskeletons are implicated in transferring the stimulus from the nuclear envelope to the ER. Could the author perform the same experiments using Nesprin-2 or/and Nesprin-1 or/and SUN1/2 knockdowns to determine if this transmission is occurring through the LINC complex or rather in a passive way by modifying the nuclear close surroundings?

      (5) The authors used cytoskeleton drugs, CytoD and Nocodazole, with their FluidFM probe, but did not show if the drugs actually worked and to what extent by performing actin or microtubule stainings. In the original paper describing FluidFM, 15s were enough to obtain a full FITC-positive cell after injection. Here, the experiments are around 5 minutes long. I therefore interrogate the rationale behind the injection of the drugs compared to direct incubation, besides affecting only the cell currently under indentation.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Given the importance that these coupling mechanisms have been given in theory, this is a timely and important contribution to the literature in terms of determining whether these theoretical assumptions hold true in human data.

      Thank you!

      I did not follow the logic behind including spindle amplitude in the meta-analysis. This is not a measure of SO-spindle coupling (which is the focus of the review), unless the authors were restricting their analysis of the amplitude of coupled spindles only. It doesn't sound like this is the case though. The effect of spindle amplitude on memory consolidation has been reviewed in another recent meta-analysis (Kumral et al, 2023, Neuropsychologia). As this isn't a measure of coupling, it wasn't clear why this measure was included in the present meta-analysis. You could easily make the argument that other spindle measures (e.g., density, oscillatory frequency) could also have been included, but that seems to take away from the overall goal of the paper which was to assess coupling.

      Indeed, spindle amplitude refers to all spindle events rather than only coupled spindles. This choice was made because we recognized the challenge of obtaining relevant data from each study—only 4 out of the 23 included studies performed their analyses after separating coupled and uncoupled spindles. This inconsistency strengthens the urgency and importance of this meta-analysis to standardize the methods and measures used for future analysis on SO-SP coupling and beyond. We agree that focusing on the amplitude of coupled spindles would better reveal their relations with coupling, and we have discussed this limitation in the manuscript.

      Nevertheless, we believe including spindle amplitude in our study remains valuable, as it served several purposes. First, SO-SP coupling involves the modulation between spindle amplitude and slow oscillation phase. Different studies have reported conflicting conclusions regarding how overall spindle amplitude was related to coupling as an indicator of oscillation strength overnight– some found significant correlations (e.g., Baena et al., 2023), while others did not (e.g., Roebber et al., 2022). This discrepancy highlights an indirect but potentially crucial insight into the role of spindle amplitude in coupling dynamics. Second, in studies related to SO-SP coupling, spindle amplitude is one of the most frequently reported measures along with other coupling measures that significantly correlated with oversleep memory improvements (e.g. Kurz et al., 2023; Ladenbauer et al., 2021; Niknazar et al., 2015), so we believe that including this measure can provide a more comprehensively review of the existing literature on SO-SP coupling. Third, incorporating spindle amplitude allows for a direct comparison between the measurement of coupling and individual events alone in their contribution to memory consolidation– a question that has been extensively explored in recent research. (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023). Finally, spindle amplitude was identified as the most important moderator for memory consolidation in Kumral et al.'s (2023) meta-analysis. By including it in our analysis, we sought to replicate their findings within a broader framework and introduce conceptual overlaps with existing reviews. Therefore, although we were not able to selectively include coupled spindles, there is still a unique relation between spindle amplitude and SO-SP coupling that other spindle measures do not have. 

      Originally, we also intended to include coupling density or counts in the analysis, which seems more relevant to the coupling metrics. However, the lack of uniformity in methods used to measure coupling density posed a significant limitation. We hope that our study will encourage consistent reporting of all relevant parameters in future research, allowing future meta-analyses to incorporate these measures comprehensively. We have added this discussion to the revised version of the manuscript (p. 3) to further clarify these points.

      All other citations were referenced in the manuscript.

      At the end of the first paragraph of section 3.1 (page 13), the authors suggest their results "... further emphasise the role of coupling compared to isolated oscillation events in memory consolidation". This had me wondering how many studies actually test this. For example, in a hierarchical regression model, would coupled spindles explain significantly more variance than uncoupled spindles? We already know that spindle activity, independent of whether they are coupled or not, predicts memory consolidation (e.g., Kumral meta-analysis). Is the variance in overnight memory consolidation fully explained by just the coupled events? If both overall spindle density and coupling measures show an equal association with consolidation, then we couldn't conclude that coupling compared to isolated events is more important.

      While primary coupling measurements, including coupling phase and strength, showed strong evidence for their associations with memory consolidation, measures of spindles, including spindle amplitude, only exhibited limited evidence (or “non-significant” effect) for their association with consolidation. These results are consistent with multiple empirical studies using different techniques (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023), which reported that coupling metrics are more robust predictors of consolidation and synaptic plasticity than spindle or slow oscillation metrics alone. However, we agree with the reviewer that we did not directly separate the effect between coupled and uncoupled spindles, and a more precise comparison would involve contrasting the “coupling of oscillation events” with ”individual oscillation events” rather than coupling versus isolated events.

      We recognized that Kumral and colleagues’ meta-analysis reported a moderate association between spindle measures and memory consolidation (e.g., for spindle amplitude-memory association they reported an effect size of approximately r = 0.30). However, one of the advantages of our study is that we actively cooperated with the authors to obtain a large number of unreported and insignificant data relevant to our analysis, as well as separated data that were originally reported under mixed conditions. This approach decreases the risk of false positives and selective reporting of results, making the effect size more likely to approach the true value. In contrast, we found only a weak effect size of r = 0.07 with minimal evidence for spindle amplitude-memory relation. However, we agree with the reviewer that using a more conservative term in this context would be a better choice since we did not measure all relevant spindle metrics including the density.

      To improve clarity in our manuscript, we have revised the statement to: “Together with other studies included in the review, our results suggest a crucial role of coupling but did not support the role of spindle events alone in memory consolidation,” and provide relevant references (p. 13). We believe this can more accurately reflect our findings and the existing literature to address the reviewer’s concern.

      It was very interesting to see that the relationship between the fast spindle coupling phase and overnight consolidation was strongest in the frontal electrodes. Given this, I wonder why memory promoting fast spindles shows a centro-parietal topography? Surely it would be more adaptive for fast spindles to be maximally expressed in frontal sites. Would a participant who shows a more frontal topography of fast spindles have better overnight consolidation than someone with a more canonical centro-parietal topography? Similarly, slow spindles would then be perfectly suited for memory consolidation given their frontal distribution, yet they seem less important for memory.

      Regarding the topography of fast spindles and their relationship to memory consolidation, we agree this is an intriguing issue, and we have already developed significant progress in this topic in our ongoing work, and have found evidence that participants with a more frontal topography of fast spindles show better overnight consolidation. These findings will be presented in our future publications. We share a few relevant observations: First, there are significant discrepancies in the definition of “slow spindle” in the field. Some studies defined slow spindle from 9-12 Hz (e.g. Mölle et al., 2011; Kurz et al., 2021), while others performed the event detection within a range of 11-13/14 Hz and found a frontal-dominated topography (e.g. Barakat et al., 2011; D'Atri et al., 2018). Compounding this issue, individual and age differences in spindle frequency are often overlooked, leading to challenges in reliably distinguishing between slow and fast spindles. Some studies have reported difficulty in clearly separating the two types of spindles altogether (e.g., Hahn et al., 2020). Moreover, a critical factor often ignored in past research is the propagating nature of both slow oscillations and spindles across the cortex, where spindles are coupled with significantly different phases of slow oscillations (see Figure 5). In addition, the frontal region has the strongest and most active SOs as its origin site, which may contribute to the role of frontal coupling. In contrast, not all SOs propagate from PFC to centro-parietal sites. The reviewer also raised an interesting idea that slow spindles would be perfectly suited for memory consolidation given their frontal distribution. We propose that one possible explanation is that if SOs couple exclusively with slow SPs, they may lose their ability to coordinate inter-area activity between centro-parietal and frontal regions, which could play a critical role in long-range memory transmission across hippocampus, thalamus, and prefrontal cortex. This hypothesis requires investigation in future studies. We believe a better understanding of coupling in the context of the propagation of these waves will help us better understand the observed frontal relationship with consolidation. Therefore, we believe this result supports our conclusion that coupling precision is more important than intensity, and we have addressed this in revised manuscript (pp. 15-16).

      The authors rightly note the issues with multiple comparisons in sleep physiology and memory studies. Multiple comparison issues arise in two ways in this literature. First are comparisons across multiple electrodes (many studies now use high-density systems with 64+ channels). Second are multiple comparisons across different outcome variables (at least 3 ways to quantify coupling (phase, consistency, occurrence) x 2 spindle types (fast, slow). Can the authors make some recommendations here in terms of how to move the field forward, as this issue has been raised numerous times before (e.g., Mantua 2018, Sleep; Cox & Fell 2020, Sleep Medicine Reviews for just a couple of examples). Should researchers just be focusing on the coupling phase? Or should researchers always report all three metrics of coupling, and correct for multiple comparisons? I think the use of pre-registration would be beneficial here, and perhaps could be noted by the authors in the final paragraph of section 3.5, where they discuss open research practices.

      There are indeed multiple methods that we can discuss, including cluster-based and non-parametric methods, etc., to correct for multiple comparisons in EEG data with spatiotemporal structures. In addition, encouraging the reporting of all tested but insignificant results, at least in supplementary materials, is an important practice that helps readers understand the findings with reduced bias. We agree with the reviewer’s suggestions and have added more information in section 3.4-3.5 (p. 17) to advocate for a standardized “template” used to report effect sizes and correct multiple comparisions in future research.

      We advocate for the standardization of reporting all three coupling metrics– phase, strength, and prevalence (density, count, and/or percentage coupled). Each coupling metric captures distinct a property of the coupling process and may interact with one another (Weiner et al., 2023). Therefore, we believe it is essential to report all three metrics to comprehensively explore their different roles in the “how, what, and where” of long-distance communication and consolidation of memory. As we advance toward a deeper understanding of the relationship between memory and sleep, we hope this work establishes a standard for the standardization, transparency, and replication of relevant studies.

      Reviewer #2 (Public review):

      Regarding the Moderator of Age: Although the authors discuss the limited studies on the analysis of children and elders regarding age as a moderator, the figure shows a significant gap between the ages of 40 and 60. Furthermore, there are only a few studies involving participants over the age of 60. Given the wide distribution of effect sizes from studies with participants younger than 40, did the authors test whether removing studies involving participants over 60 would still reveal a moderator effect?

      We agree that there is an age gap between younger and older adults, as current studies often focus on contrasting newly matured and fully aged populations to amplify the effect, while neglecting the gradual changes in memory consolidation mechanisms across the aging spectrum. We suggest that a non-linear analysis of age effects would be highly valuable, particularly when additional child and older adult data become available.

      In response to the reviewer’s suggestion, we re-tested the moderation effect of age after excluding effect sizes from older adults. The results revealed a decrease in the strength of evidence for phase-memory association due to increased variability, but were consistent for all other coupling parameters. The mean estimations also remained consistent (coupling phase-memory relation: -0.005 [-0.013, 0.004], BF10 = 5.51, the strength of evidence reduced from strong to moderate; coupling strength-memory relation: -0.005 [-0.015, 0.008], BF10 = 4.05, the strength of evidence remained moderate). These findings align with prior research, which typically observed a weak coupling-memory relationship in older adults during aging (Ladenbauer et al, 2021; Weiner et al., 2023) but not during development (Hahn et al., 2020; Kurz et al., 2021; Kurz et al., 2023). Therefore, this result is not surprising to us, and there are still observable moderate patterns in the data. We have reported these additional results in the revised manuscript (pp. 6, 11), and interpret “the moderator effect of age in the phase-memory association becomes less pronounced during development after excluding the older adult data”. We believe the original findings including the older adult group remain meaningful after cautious interpretation, given that the older adult data were derived from multiple studies and different groups, and they represent the aging effects.

      Reviewer #3 (Public review):

      First, the authors conclude that "SO-SP coupling should be considered as a general physiological mechanism for memory consolidation". However, the reported effect sizes are smaller than what is typically considered a "small effect”.

      While we acknowledge the concern about the small effect sizes reported in our study, it is important to contextualize these findings within the field of neuroscience, particularly memory research. Even in individual studies, small effect sizes are not uncommon due to the inherent complexity of the mechanisms involved and the multitude of confounding variables. This is an important factor to be considered in meta-analyses where we synthesize data from diverse populations and experimental conditions. For example, the relationship between SO-slow SP coupling and memory consolidation in older adults is expected to be insignificant.

      As Funder and Ozer (2019) concluded in their highly cited paper, an effect size of r = 0.3 in psychological and related fields should be considered large, with r = 0.4 or greater likely representing an overestimation and rarely found in a large sample or a replication. Therefore, we believe r = 0.1 should not be considered as a lower bound of the small effect. Bakker et al. (2019) also advocate for a contextual interpretation of the effect size. This is particularly important in meta-analyses, where the results are less prone to overestimation compared to individual studies, and we cooperated with all authors to include a large number of unreported and insignificant results. In this context, small correlations may contain substantial meaningful information to interpret. Although we agree that effect sizes reported in our study are indeed small at the overall level, they reflect a rigorous analysis that incorporates robust evidence across different levels of moderators. Our moderator analyses underscore the dynamic nature of coupling-memory relationships, with stronger associations observed in moderator subgroups that have historically exhibited better memory performance, particularly after excluding slow spindles and older adults. For example, both the coupling phase and strength of frontal fast spindles with slow oscillations exhibited "moderate-to-large" correlations with the consolidation of different types of memory, especially in young adults, with r values ranging from 0.18 to 0.32. (see Table S9.1-9.4). We have included discussion about the influence of moderators and hierarchical structures on the dynamics of coupling-memory associations (pp. 17, 20). In addition, we have updated the conclusion to be “SO-fast SP coupling should be considered as a general physiological mechanism for memory consolidation” (p. 1).

      Second, the study implements state-of-the-art Bayesian statistics. While some might see this as a strength, I would argue that it is the greatest weakness of the manuscript. A classical meta-analysis is relatively easy to understand, even for readers with only a limited background in statistics. A Bayesian analysis, on the other hand, introduces a number of subjective choices that render it much less transparent.

      This kind of analysis seems not to be made to be intelligible to the average reader. It follows a recent trend of using more and more opaque methods. Where we had to trust published results a decade ago because the data were not openly available, today we must trust the results because the methods can no longer be understood with reasonable effort.

      This becomes obvious in the forest plots. It is not immediately apparent to the reader how the distributions for each study represent the reported effect sizes (gray dots). Presumably, they depend on the Bayesian priors used for the analysis. The use of these priors makes the analyses unnecessarily opaque, eventually leading the reader to question how much of the findings depend on subjective analysis choices (which might be answered by an additional analysis in the supplementary information).

      We appreciate the reviewer for sharing this viewpoint and we value the opportunity to clarify some key points. To address the concern about clarity, we have included more details in the methods section explaining how to interpret Bayesian statistics including priors, posteriors, and Bayes factors, making our results more accessible to those less familiar with this approach.

      On the use of Bayesian models, we believe there may have been a misunderstanding. Bayesian methods, far from being "opaque" or overly complex, are increasingly valued for their ability to provide nuanced, accurate, and transparent inferences (Sutton & Abrams, 2001; Hackenberger, 2020; van de Schoot et al., 2021; Smith et al., 1995; Kruschke & Liddell, 2018). It has been applied in more than 1,200 meta-analyses as of 2020 (Hackenberger, 2020). In our study, we used priors that assume no effect (mean set to 0, which aligns with the null) while allowing for a wide range of variation to account for large uncertainties. This approach reduces the risk of overestimation or false positives and demonstrates much-improved performance over traditional methods in handling variability (Williams et al., 2018; Kruschke & Liddell, 2018). In addition, priors can also increase transparency, since all assumptions are formally encoded and open to critique or sensitivity analysis. In contrast, frequentist methods often rely on hidden or implicit assumptions such as homogeneity of variance, fixed-effects models, and independence of observations that are not directly testable. Sensitivity analyses reported in the supplemental material (Table S9.1-9.4) confirmed the robustness of our choices of priors– our results did not vary by setting different priors.

      As Kruschke and Liddell (2018) described, “shrinkage (pulling extreme estimates closer to group averages) helps prevent false alarms caused by random conspiracies of rogue outlying data,” a well-known advantage of Bayesian over traditional approaches. This explains the observed differences between the distributions and grey dots in the forest plots, which is an advantage of Bayesian models in handling heterogeneity. Unlike p-values, which can be overestimated with a large sample size and underestimated with a small sample size, Bayesian methods make assumptions explicit, enabling others to challenge or refine them– an approach aligned with open science principles (van de Schoot et al., 2021). For example, a credible interval in Bayesian model can be interpreted as “there is a 95% probability that the parameter lies within the interval.”, while a confidence interval in frequentist model means “In repeated experiments, 95% of the confidence intervals will contain the true value.” We believe the former is much more straightforward and convincing for readers to interpret. We will ensure our justification for using Bayesian models is more clearly presented in the manuscript (pp. 21-23).

      We acknowledge that even with these justifications, different researchers may still have discrepancies in their preferences for Bayesian and frequentist models. To increase the effort of transparent reporting, we have also reported the traditional frequentist meta-analysis results in Supplemental Material 10 to justify the robustness of our analysis, which suggested non-significant differences between Bayesian and frequentist models. We have included clearer references in the updated version of the manuscript to direct readers to the figures that report the statistics provided by traditional models.

      However, most of the methods are not described in sufficient detail for the reader to understand the proceedings. It might be evident for an expert in Bayesian statistics what a "prior sensitivity test" and a "posterior predictive check" are, but I suppose most readers would wish for a more detailed description. However, using a "Markov chain Monte Carlo (MCMC) method with the no-U-turn Hamiltonian Monte Carlo (HMC) sampler" and checking its convergence "through graphical posterior predictive checks, trace plots, and the Gelman and Rubin Diagnostic", which should then result in something resembling "a uniformly undulating wave with high overlap between chains" is surely something only rocket scientists understand. Whether this was done correctly in the present study cannot be ascertained because it is only mentioned in the methods and no corresponding results are provided. 

      We appreciate the reviewer’s concerns about accessibility and potential complexity in our descriptions of Bayesian methods. Our decision to provide a detailed account serves to enhance transparency and guide readers interested in replicating our study. We acknowledge that some terms may initially seem overwhelming. These steps, such as checking the MCMC chain convergence and robustness checks, are standard practices in Bayesian research and are analogous to “linearity”, “normality” and “equal variance” checks in frequentist analysis. In addition, Hamiltonian Monte Carlo (HMC) is the default algorithm Stan (the software we used to fit Bayesian models) uses to sample from the posterior distribution in Bayesian models. It is a type of MCMC method designed to be faster and more efficient than traditional sampling algorithms, especially for complex or high-dimensional models. We have added exemplary plots in the supplemental material S4.1-4.3 and the method section (pp. 21-22) to explain the results and interpretation of these convergence checks. We hope this will help address any concerns about methodological rigor.

      In one point the method might not be sufficiently justified. The method used to transform circular-linear r (actually, all references cited by the authors for circular statistics use r² because there can be no negative values) into "Z_r", seems partially plausible and might be correct under the H0. However, Figure 12.3 seems to show that under the alternative Hypothesis H1, the assumptions are not accurate (peak Z_r=~0.70 for r=0.65). I am therefore, based on the presented evidence, unsure whether this transformation is valid. Also, saying that Z_r=-1 represents the null hypothesis and Z_r=1 the alternative hypothesis can be misinterpreted, since Z_r=0 also represents the null hypothesis and is not half way between H0 and H1.

      First, we realized that in the title of Figures 12.2 and 12.3. “true r = 0.35” and “true r = 0.65” should be corrected as “true r_z” (note that we use r_z instead of Z_r in the revised manuscript per your suggestion). The method we used here is to first generate an underlying population that has null (0), moderate (0.35), or large (0.65) r_z correlations, then test whether the sampling distribution drawn from these populations followed a normal distribution across varying sample sizes. Nevertheless, the reviewer correctly noticed discrepancies between the reported true r_z and its sampling distribution peak. This discrepancy arises because, when generating large population data, achieving exact values close to a strong correlation like r_z = 0.65 is unlikely. We loop through simulations to generate population data and ensure their r_z values fall within a threshold. For moderate effect sizes (e.g., r_z = 0.35), this is straightforward using a narrow range (0.34 < r_z < 0.35). However, for larger effect sizes like r_z = 0.65, a wider range (0.6 < r_z < 0.7) is required. therefore sometimes the population we used to draw the sample has a r_z slightly deviated from 0.65. This remains reasonable since the main point of this analysis is to ensure that a large r_z still has a normal sampling distribution, but not focus specifically on achieving r_z = 0.65.

      We acknowledge that this variability of the range used was not clearly explained in supplemental material 12 and it is not accurate to report “true r_z = 0.65”. In the revised version, we have addressed this issue by adding vertical lines to each subplot to indicate the r_z of the population we used to draw samples, making it easier to check if it aligns with the sampling peak. In addition, we have revised the title to “Sampling distributions of r_z drawn from strong correlations

      (r_z = 0.6-0.7)”. We confirmed that population r_z and the peak of their sampling distribution remain consistent under both H0 and H1 in all sample sizes with n > 25, and we hope this explanation can fully resolve your concern.

      We agree with the reviewer that claiming r_z = -1 represents the null hypothesis is not accurate. The circlin r_z = 0 is better analogous to Pearson’s r = 0 since both represent the mean drawn from the population under the null hypothesis. In contrast, the mean effect size under null will be positive in the raw circlin r, which is one of the important reasons for the transformation. To provide a more accurate interpretation, we updated Table 6 to describe the following strength levels of evidence: no effect (r < 0), null (r = 0), small (r = 0.1), moderate (r = 0.3), and large (r =0.5). We thank the reviewer again for their valuable feedback.

      Reviewer #2 (Recommendations for the authors):

      (1) There is an extra space in the Notes of Figure 1. "SW R sharp-wave ripple.".

      We thank the reviewer for pointing this out. We have confirmed that the "extra space" is not an actual error but a result of how italicized Times New Roman font is rendered in the LaTeX format. We believe that the journal’s formatting process will resolve this issue.

      (2) In the introduction, slow oscillations (SO) are defined with a frequency of 0.16-4 Hz, sleep spindles (SP) at 8-16 Hz, and sharp-wave ripples (SWR) at 80-300 Hz. The term "fast oscillation" (FO) is first introduced with the clarification "SPs in our case." However, on page 2, the authors state, "SO-FO coupling involving SWRs, SPs, and SOs..." There seems to be a discrepancy in the definition of FO; does it consistently refer to SPs and SWRs throughout the article?

      We appreciate the reviewer’s observation regarding the potential ambiguity of the term "FO." In our manuscript, "FO" is used as a general term to describe the interaction of a "relatively faster oscillation" with a "relatively slower oscillation" in the phase-amplitude coupling mechanism, therefore it is not intended to exclusively refer to SPs or SWRs. For example, it is usually used to describe SO–SP–SWR couplings during sleep memory studies, but Theta–Alpha–Gamma couplings in wakeful memory studies. To address this confusion, we removed the phrase "SPs in our case" and explicitly use "SPs" when referring to spindles. In addition, we have replaced "fast oscillation" with "faster oscillation" to emphasize that it is used in a relative sense (p. 1), rather than to refer to a specific oscillation. Also, we only retained the term “FO” when introducing the PAC mechanism.

      (3) On page 2, the first paragraph contains the phrase: "...which occur in the precise hierarchical temporal structure of SO-FO coupling involving SWRs, SPs, and SOs ..." Since "SO-FO" refers to slow and fast oscillations, it is better to maintain the order of frequencies, suggesting it as: SOs, SPs, and SWRs.

      We sincerely thank the reviewer for their valuable suggestion. We have updated the sentence to maintain the correct order from the lowest to the highest frequencies in the revised version (p. 2).

      (4) References should be provided:

      a “Studies using calcium imaging after SP stimulation explained the significance of the precise coupling phase for synaptic plasticity.".

      b. "Electrophysiology evidence indicates that the association between memory consolidation and SO-SP coupling is influenced by a variety of behavioral and physiological factors under different conditions."

      c. "Since some studies found that fast SPs predominate in the centroparietal region, while slow SPs are more common in the frontal region, a significant amount of studies only extracted specific types of SPs from limited electrodes. Some studies even averaged all electrodes to estimate coupling..."

      This is a great point.  These have been referenced as follows:

      a. Rephrased: “Studies using calcium imaging and SP stimulation explained the significance of the precise coupling phase for synaptic plasticity.” We changed “after” to “and” to reflect that these were conducted as two separate experiments. This is a summary statement, with relevant citations provided in the following two sentences of the paragraph, including Niethard et al., 2018, and Rosanova et al., 2005. (p. 2)

      b. Included diverse sources of evidence: “Electrophysiology evidence from studies included in our meta-analysis (e.g. Denis et al., 2021; Hahn et al., 2020; Mylonas et al., 2020) and others (e.g. Bartsch et al., 2019; Muehlroth et al., 2019; Rodheim et al., 2023) reported that the association between memory consolidation and SO-SP coupling is influenced by a variety of behavioral and physiological factors under different conditions.” (p. 3)

      c. Added references and more details: “Since some studies found that fast SPs predominate in the centroparietal region, while slow SPs are more common in the frontal region, a significant amount of studies selectively extracted specific types of SPs from limited electrodes (e.g. Dehnavi et al., 2021; Perrault et al., 2019; Schreiner et al., 2021). Some studies even averaged all electrodes in their spectral and/or time-series analysis to estimate metrics of oscillations and their couplings (e.g. Denis et al., 2022; Mölle et al., 2011; Nicolas et al., 2022).” (p. 4)

      Reviewer #3 (Recommendations for the authors):

      There are a number of terms that are not clearly defined or used:

      (1) SP amplitude. Does this mean only the amplitude of coupled spindles or of spindles in general?

      This refers to the amplitude of spindles in general. We clarified this in the revised text (and see response to reviewer #1, point #1).

      (2) The definition of a small effect

      We thank the reviewer again for raising this important question. As we responded in the public review, small effect sizes are common in neuroscience and meta-analyses due to the complexity of the underlying mechanisms and the presence of numerous confounding variables and hierarchical levels. To help readers better interpret effect sizes, we changed rigid ranges to widely accepted benchmarks for effect size levels in neuroscience research: small (r=0.1), moderate (r=0.3), and large (r=0.5; Cohen, 1988). We also noted that an evidence and context-based framework will provide a more practical way to interpret the observed effect sizes compared to rigid categorizations.

      (3) Can a BF10 based on experimental evidence actually be "infinite" and a probability actually be 1.00?

      We appreciate the reviewer for highlighting this potential confusion. The formula used to calculate BF10 is P(data | H1) / P(data | H0). In the experimental setting with an informative prior, an ‘infinite’ BF10 value indicates that all posterior samples are overwhelmingly compatible with H1 given the data and assumptions (Cox et al., 2023; Heck et al., 2023; Ly et al., 2016). In such cases, the denominator P(data | H0) becomes vanishingly small, leading BF10 to converge to infinity. This scenario occurs when the probability of H1 converges to 1 (e.g., 0.9999999999…).

      It is a well-established convention in Bayesian statistics to report the Bayes factor as "infinity" in cases where the evidence is overwhelmingly strong, and BF10 exceeds the numerical limits of the computation tools to become effectively infinite. To address this ambiguity, we added a footnote in the revised version of the manuscript to clarify the interpretation of an 'infinite' BF10 . (p. 8)

      (4) Z_r should be renamed to r_z or similar. These are not Z values (-inf..+inf), but r values (-1..1).

      We thank the reviewers for their suggestions. We agree that r_z would provide a clearer and more accurate interpretation, while z is more appropriate for referring to Fisher's z-transformed r (see point (5)). We have updated the notation accordingly.

      (5) Also, it remains quite unclear at which points in the analyses, "r" values or "Fisher's z transformed r" values are used. Assumptions of normality should only apply to the transformed values. However, the formulas for the random effects model seem to assume normality for r values.

      The correlation values were z-transformed during preprocessing to ensure normality and the correct estimation of sampling variances before running the models. The outputs were then back-transformed to raw r values only when reporting the results to help readers interpret the effect size. We mentioned this in Section 5.5.1, therefore the normality assumptions are not a concern. We have updated the notation r to z (-inf..+inf) in the formula of the random and mixed effect models in the revised version of the manuscript (p. 22).

      Language

      (1) Frequency. In the introduction, the authors use "frequency" when they mean something like the incidence of spindles.

      We agree that the term "frequency" has been used inconsistently to describe both the incidence of events and the frequency bands of oscillations. We have replaced "frequency" with "prevalence" to refer to the incidence of coupling events where applicable (p. 3).

      (2) Moderate and mediate. These two terms are usually meant to indicate two different types of causal influences.

      Thanks for the reviewer’s suggestions. We agree that "moderate" is more appropriate to describe moderators in this study since it does not directly imply causality. We have replaced mediate with moderate in relevant contexts.

      (3) "the moderate effect of memory task is relatively weak": "moderator effect" or "moderate effect"?

      We appreciate the reviewer for pointing out this mistake. We have updated the term to "moderator effect" in Section 2.2.2 (p. 6).

      (4) "in frontal regions we found a latest coupled but most precise and strong SO-fast SP coupling" Meaning?

      We thank the reviewer for bringing this concern of clarity to our attention. By 'latest,' we refer to the delayed phase of SO-fast SP coupling observed in the frontal regions compared to the central and parietal regions (see Figure 5), "Precise and strong" describes the high precision and strength of phase-locking between the SO up-state and the fast SP peak in these regions. We have rephrased this sentence to be: “We found that SO-fast SP coupling in the frontal region occurred at the latest phase observed across all regions, characterized by the highest precision and strength of phase-locking.” to improve clarity (p. 9).

      (5) Figure 5 and others contain angles in degrees and radians.

      We appreciate the reviewer pointing out this inconsistency. We have updated the manuscript and supplementary material to consistently use radians throughout.

    1. Reviewer #2 (Public review):

      The revised manuscript by Altan et al. includes some real improvements to the visualizations and explanations of the authors' thesis statement with respect to fMRI measurements of pRF sizes. In particular, the deposition of the paper's data has allowed me to probe and refine several of my previous concerns. While I still have major concerns about how the data are presented in the current draft of the manuscript, my skepticism about data quality overall has been much alleviated. Note that this review focuses almost exclusively on the fMRI data as I was satisfied with the quality of the psychophysical data and analyses in my previous review.

      Major Concerns

      (I) Statistical Analysis

      In my previous review, I raised the concern that the small sample size combined with the noisiness of the fMRI data, a lack of clarity about some of the statistics, and a lack of code/data likely combine to make this paper difficult or impossible to reproduce as it stands. The authors have since addressed several aspects of this concern, most importantly by depositing their data. However their response leaves some major questions, which I detail below.

      First of all, the authors claim in their response to the previous review that the small sample size is not an issue because large samples are not necessary to obtain "conclusive" results. They are, of course, technically correct that a small sample size can yield significant results, but the response misses the point entirely. In fact, small samples are more likely than large samples to erroneously yield a significant result (Button et al., 2013, DOI:10.1038/nrn3475), especially when noise is high. The response by the authors cites Schwarzkopf & Huang (2024) to support their methods on this front. After reading the paper, I fail to see how it is at all relevant to the manuscript at hand or the criticism raised in the previous review. Schwarzkopf & Huang propose a statistical framework that is narrowly tailored to situations where one is already certain that some phenomenon (like the adaptation of pRF size to spatial frequency) either always occurs or never occurs. Such a framework is invalid if one cannot be certain that, for example, pRF size adapts in 98% of people but not the remaining 2%. Even if the paper were relevant to the current study, the authors don't cite this paper, use its framework, or admit the assumptions it requires in the current manuscript. The observation that a small dataset can theoretically lead to significance under a set of assumptions not appropriate for the current manuscript is not a serious response to the concern that this manuscript may not be reproducible.

      To overcome this concern, the authors should provide clear descriptions of their statistical analyses and explanations of why these analyses are appropriate for the data. Ideally, source code should be published that demonstrates how the statistical tests were run on the published data. (I was unable to find any such source code in the OSF repository.) If the effects in the paper were much stronger, this level of rigor might not be strictly necessary, but the data currently give the impression of being right near the boundary of significance, and the manuscript's analyses needs to reflect that. The descriptions in the text were helpful, but I was only able to approximately reproduce the authors analyses based on these descriptions alone. Specifically, I attempted to reproduce the Mood's median tests described in the second paragraph of section 3.2 after filtering the data based on the criteria described in the final paragraph of section 3.1. I found that 7/8 (V1), 7/8 (V2), 5/8 (V3), 5/8 (V4), and 4/8 (V3A) subjects passed the median test when accounting for the (40) multiple comparisons. These results are reasonably close to those reported in the manuscript and might just differ based on the multiple comparisons strategy used (which I did not find documented in the manuscript). However, Mood's median test does not test the direction of the difference-just whether the medians are different-so I additionally required that the median sigma of the high-adapted pRFs be greater than that of the low-adapted pRFs. Surprisingly, in V1 and V3, one subject each (not the same subject) failed this part of the test, meaning that they had significant differences between conditions but in the wrong direction. This leaves 6/8 (V1), 7/8 (V2), 4/8 (V3), 5/8 (V4), and 4/8 (V3A) subjects that appear to support the authors' conclusions. As the authors mention, however, this set of analyses runs the risk of comparing different parts of cortex, so I also performed Wilcox signed-rank tests on the (paired) vertex data for which both the high-adapted and low-adapted conditions passed all the authors' stated thresholds. These results largely agreed with the median test (only 5/8 subjects significant in V1 but 6/8 in in V3A, other areas the same, though the two tests did not always agree which subjects had significant differences). These analyses were of course performed by a reviewer with a reviewer's time commitment to the project and shouldn't be considered a replacement for the authors' expertise with their own data. If the authors think that I have made a mistake in these calculations, then the best way to refute them would be to publish the source code they used to threshold the data and to perform the same tests.

      Setting aside the precise values of the relevant tests, we should also consider whether 5 of 8 subjects showing a significant effect (as they report for V3, for example) should count as significant evidence of the effect? If one assumes, as a null hypothesis, that there is no difference between the two conditions in V3 and that all differences are purely noise, then a binomial test across subjects would be appropriate. Even if 6 of 8 subjects show the effect, however (and ignoring multiple comparisons), the p-value of a one-sided binomial test is not significant at the 0.05 level (7 of 8 subjects is barely significant). Of course, a more rigorous way to approach this question could be something like an ANOVA, and the authors use an ANOVA analysis of the medians in the paragraph following their use of Mood's median test. However, ANOVA assumes normality, and the authors state in the previous paragraph that they employed Mood's median test because "the distribution of the pRF sizes is zero-bounded and highly skewed" so this choice does not make sense. The Central Limits Theorem might be applied to the medians in theory, but with only 8 subjects and with an underlying distribution of pRF sizes that is non-negative, the relevant data will almost certainly not be normally distributed. These tests should probably be something like a Kruskal-Wallis ANOVA on ranks.

      All of the above said, my intuition about the data is currently that there are significant changes to the adapted pRF size in V2. I am not currently convinced that the effects in other visual areas are significant, and I suspect that the paper would be improved if authors abandoned their claims that areas other than V2 show a substantial effect. Importantly, I don't think this causes the paper to lose any impact-in fact, if the authors agree with my assessments, then the paper might be improved by focusing on V2. Specifically, the authors' already discuss psychophysical work related to the perception of texture on pages 18 and 19 and link it to their results. V2 is also implicated in the perception of texture (see, for example, Freeman et al., 2013; DOI:10.1038/nn.3402; Ziemba et al., 2016, DOI:10.1073/pnas.1510847113; Ziemba et al., 2019; DOI:10.1523/JNEUROSCI.1743-19.2019) and so would naturally be the part of the visual cortex where one might predict that spatial frequency adaptation would have a strong effect on pRF size. This neatly connects the psychophysical and imaging sides of this project and could make a very nice story out of the present work.

      (II) Visualizations

      The manuscript's visual evidence regarding the pRF data also remains fairly weak (but I found the pRF size comparisons in the OSF repository and Figure S1 to be better evidence-more in the next paragraph). The first line of the Results section still states, "A visual inspection on the pRF size maps in Figure 4c clearly shows a difference between the two conditions, which is evident in all regions." As I mentioned in my previous review, I don't agree with this claim (specifically, that it is clear). My impression when I look at these plots is of similarity between the maps, and, where there is dissimilarity, of likely artifacts. For example, the splotch of cortex near the upper vertical meridian (ventral boundary) of V1 that shows up in yellow in the upper plot but not the lower plot also has a weirdly high eccentricity and a polar angle near the opposite vertical meridian: almost certainly not the actual tuning of that patch of cortex. If this is the clearest example subject in the dataset, then the effect looks to me to be very small and inconsistently distributed across the visual areas. That said, I'm not convinced that the problem here is the data-rather, I think it's just very hard to communicate a small difference in parameter tuning across a visual area using this kind of side-by-side figure. I think that Figure S2, though noisy (as pRF maps typically are), is more convincing than Figure 4c, personally. For what it's worth, when looking at the data myself, I found that plotting log(𝜎(H) / 𝜎(L)), which will be unstable when noise causes 𝜎(H) or 𝜎(L) to approach zero, was less useful than plotting plotting (𝜎(H) - 𝜎(L)) / (𝜎(H) + 𝜎(L)). This latter quantity will be constrained between -1 and 1 and shows something like a proportional change in the pRF size (and thus should be more comparable across eccentricity).

      In my opinion, the inclusion of the pRF size comparison plots in the OSF repository and Figure S1 made a stronger case than any of the plots of the cortical surface. I would suggest putting these on log-log plots since the distribution of pRF size (like eccentricity) is approximately exponential on the cortical surface. As-is, it's clear in many plots that there is a big splotch of data in the compressed lower left corner, but it's hard to get a sense for how these should be compared to the upper right expanse of the plots. It is frequently hard to tell whether there is a greater concentration of points above or below the line of equality in the lower left corner as well, and this is fairly central to the paper's claims. My intuition is that the upper right is showing relatively little data (maybe 10%?), but these data are very emphasized by the current plots.
The authors might even want to consider putting a collection of these scatter-plots (or maybe just subject 007, or possible all subjects' pRFs on a single scatter-plot) in the main paper and using these visualizations to provide intuitive supporting for the main conclusions about the fMRI data (where the manuscript currently use Figure 4c for visual intuition).

      Minor Comments

      (1) Although eLife does not strictly require it, I would like to see more of the authors' code deposited along with the data (especially the code for calculating the statistics that were mentioned above). I do appreciate the simulation code that the authors added in the latest submission (largely added in response to my criticism in the previous reviews), and I'll admit that it helped me understand where the authors were coming from, but it also contains a bug and thus makes a good example of why I'd like to see more of the authors' code. If we set aside the scientific question of whether the simulation is representative of an fMRI voxel (more in Minor Comment 5, below), Figures 1A and the "AdaptaionEffectSimulated.png" file from the repository (https://osf.io/d5agf) imply that only small RFs were excluded in the high-adapted condition and only large RFs were excluded in the low-adapted condition. However, the script provided (SimlatePrfAdaptation.m: https://osf.io/u4d2h) does not do this. Lines 7 and 8 of the script set the small and large cutoffs at the 30th and 70th percentiles, respectively, then exclude everything greater than the 30th percentile in the "Large RFs adapted out" condition (lines 19-21) and exclude anything less than the 70th percentile in the "Small RFs adapted out" condition (lines 27-29). So the figures imply that they are representing 70% of the data but they are in fact representing only the most extreme 30% of the data. (Moreover, I was unable to run the script because it contains hard-coded paths to code in someone's home directory.) Just to be clear, these kinds of bugs are quite common in scientific code, and this bug was almost certainly an honest mistake.

      (2) I also noticed that the individual subject scatter-plots of high versus low adapted pRF sizes on the OSF seem to occasionally have a large concentration of values on the x=0 and y=0 axes. This isn't really a big deal in the plots, but the manuscript states that "we denoised the pRF data to remove artifactual vertices where at least one of the following criteria was met: (1) sigma values were equal to or less than zero ..." so I would encourage the authors to double-check that the rest of their analysis code was run with the stated filtering.

      (3) The manuscript also says that the median test was performed "on the raw pRF size values". I'm not really sure what the "raw" means here. Does this refer to pRF sizes without thresholding applied?

      (4) The eccentricity data are much clearer now with the additional comments from the authors and the full set of maps; my concerns about this point have been met.

      (5) Regarding the simulation of RFs in a voxel (setting aside the bug), I will admit both to hoping for a more biologically-grounded situation and to nonetheless understanding where the authors are coming from based on the provided example. What I mean by biologically-grounded: something like, assume a 2.5-mm isotropic voxel aligned to the surface of V1 at 4{degree sign} of eccentricity; the voxel would span X to Y degrees of eccentricity, and we predict Z neurons with RFs in this voxel with a distribution of RF sizes at that eccentricity from [reference], etc. eventually demonstrating a plausible pRF size change commensurate to the paper's measurements. I do think that a simulation like this would make the paper more compelling, but I'll acknowledge that it probably isn't necessary and might be beyond the scope here.

    1. Reviewer #2 (Public review):

      Summary:

      The manuscript "Dual transcranial electromagnetic stimulation of the precuneus-hippocampus network boosts human long-term memory" by Borghi and colleagues provides evidence that the combination of intermittent theta burst TMS stimulation and gamma transcranial alternating current stimulation (γtACS) targeting the precuneus increases long-term associative memory in healthy subjects compared to iTBS alone and sham conditions. Using a rich dataset of TMS-EEG and resting-state functional connectivity (rs-FC) maps and structural MRI data, the authors also provide evidence that dual stimulation increased gamma oscillations and functional connectivity between the precuneus and hippocampus. Enhanced memory performance was linked to increased gamma oscillatory activity and connectivity through white matter tracts.

      Strengths:

      The combination of personalized repetitive TMS (iTBS) and gamma tACS is a novel approach to targeting the precuneus, and thereby, connected memory-related regions to enhance long-term associative memory. The authors leverage an existing neural mechanism engaged in memory binding, theta-gamma coupling, by applying TMS at theta burst patterns and tACS at gamma frequencies to enhance gamma oscillations. The authors conducted a thorough study that suggests that simultaneous iTBS and gamma tACS could be a powerful approach for enhancing long-term associative memory. The paper was well-written, clear, and concise.

      Weaknesses:

      (1) The study did not include a condition where γtACS was applied alone. This was likely because a previous work indicated that a single 3-minute γtACS did not produce significant effects, but this limits the ability to isolate the specific contribution of γtACS in the context of this target and memory function

      (2) The authors applied stimulation for 3 minutes, which seems to be based on prior tACS protocols. It would be helpful to present some rationale for both the duration and timing relative to the learning phase of the memory task. Would you expect additional stimulation prior to recall to benefit long-term associative memory?

      (3) How was the burst frequency of theta iTBS and gamma frequency of tACS chosen? Were these also personalized to subjects' endogenous theta and gamma oscillations? If not, were increases in gamma oscillations specific to patients' endogenous gamma oscillation frequencies or the tACS frequency?

      (4) The authors do a thorough job of analyzing the increase in gamma oscillations in the precuneus through TMS-EEG; however, the authors may also analyze whether theta oscillations were also enhanced through this protocol due to the iTBS potentially targeting theta oscillations. This may also be more robust than gamma oscillations increases since gamma oscillations detected on the scalp are very low amplitude and susceptible to noise and may reflect activity from multiple overlapping sources, making precise localization difficult without advanced techniques.

      (5) Figure 4: Why are connectivity values pre-stimulation for the iTBS and sham tACS stimulation condition so much higher than the dual stimulation? We would expect baseline values to be more similar.

      (6) Figure 2: How are total association scores significantly different between stimulation conditions, but individual name and occupation associations are not? Further clarification of how the total FNAT score is calculated would be helpful.

    2. Reviewer #3 (Public review):

      Summary:

      Borghi and colleagues present results from 4 experiments aimed at investigating the effects of dual γtACS and iTBS stimulation of the precuneus on behavioral and neural markers of memory formation. In their first experiment (n = 20), they found that a 3-minute offline (i.e., prior to task completion) stimulation that combines both techniques leads to superior memory recall performance in an associative memory task immediately after learning associations between pictures of faces, names, and occupation, as well as after a 15-minute delay, compared to iTBS alone (+ tACS sham) or no stimulation (sham for both iTBS and tACS). Performance in a second task probing short-term memory was unaffected by the stimulation condition. In a second experiment (n = 10), they show that these effects persist over 24 hours and up to a full week after initial stimulation. A third (n = 14) and fourth (n = 16) experiment were conducted to investigate the neural effects of the stimulation protocol. The authors report that, once again, only combined iTBS and γtACS increase gamma oscillatory activity and neural excitability (as measured by concurrent TMS-EEG) specific to the stimulated area at the precuneus compared to a control region, as well as precuneus-hippocampus functional connectivity (measured by resting-state MRI), which seemed to be associated with structural white matter integrity of the bilateral middle longitudinal fasciculus (measured by DTI).

      Strengths:

      Combining non-invasive brain stimulation techniques is a novel, potentially very powerful method to maximize the effects of these kinds of interventions that are usually well-tolerated and thus accepted by patients and healthy participants. It is also very impressive that the stimulation-induced improvements in memory performance resulted from a short (3 min) intervention protocol. If the effects reported here turn out to be as clinically meaningful and generalizable across populations as implied, this approach could represent a promising avenue for the treatment of impaired memory functions in many conditions.

      Methodologically, this study is expertly done! I don't see any serious issues with the technical setup in any of the experiments (with the only caveat that I am not an expert in fMRI functional connectivity measures and DTI). It is also very commendable that the authors conceptually replicated the behavioral effects of experiment 1 in experiment 2 and then conducted two additional experiments to probe the neural mechanisms associated with these effects. This certainly increases the value of the study and the confidence in the results considerably.

      The authors used a within-subject approach in their experiments, which increases statistical power and allows for stronger inferences about the tested effects. They are also used to individualize stimulation locations and intensities, which should further optimize the signal-to-noise ratio.

      Weaknesses:

      I want to state clearly that I think the strengths of this study far outweigh the concerns I have. I still list some points that I think should be clarified by the authors or taken into account by readers when interpreting the presented findings.

      I think one of the major weaknesses of this study is the overall low sample size in all of the experiments (between n = 10 and n = 20). This is, as I mentioned when discussing the strengths of the study, partly mitigated by the within-subject design and individualized stimulation parameters. The authors mention that they performed a power analysis but this analysis seemed to be based on electrophysiological readouts similar to those obtained in experiment 3. It is thus unclear whether the other experiments were sufficiently powered to reliably detect the behavioral effects of interest. That being said, the authors do report significant effects, so they were per definition powered to find those. However, the effect sizes reported for their main findings are all relatively large and it is known that significant findings from small samples may represent inflated effect sizes, which may hamper the generalizability of the current results. Ideally, the authors would replicate their main findings in a larger sample. Alternatively, I think running a sensitivity analysis to estimate the smallest effect the authors could have detected with a power of 80% could be very informative for readers to contextualize the findings. At the very least, however, I think it would be necessary to address this point as a potential limitation in the discussion of the paper.

      It seems that the statistical analysis approach differed slightly between studies. In experiment 1, the authors followed up significant effects of their ANOVAs by Bonferroni-adjusted post-hoc tests whereas it seems that in experiment 2, those post-hoc tests where "exploratory", which may suggest those were uncorrected. In experiment 3, the authors use one-tailed t-tests to follow up their ANOVAs. Given some of the reported p-values, these choices suggest that some of the comparisons might have failed to reach significance if properly corrected. This is not a critical issue per se, as the important test in all these cases is the initial ANOVA but non-significant (corrected) post-hoc tests might be another indicator of an underpowered experiment. My assumptions here might be wrong, but even then, I would ask the authors to be more transparent about the reasons for their choices or provide additional justification. Finally, the authors sometimes report exact p-values whereas other times they simply say p < .05. I would ask them to be consistent and recommend using exact p-values for every result where p >= .001.

      While the authors went to great lengths trying to probe the neural changes likely associated with the memory improvement after stimulation, it is impossible from their data to causally relate the findings from experiments 3 and 4 to the behavioral effects in experiments 1 and 2. This is acknowledged by the authors and there are good methodological reasons for why TMS-EEG and fMRI had to be collected in sperate experiments, but it is still worth pointing out to readers that this limits inferences about how exactly dual iTBS and γtACS of the precuneus modulate learning and memory.

      There were no stimulation-related performance differences in the short-term memory task used in experiments 1 and 2. The authors argue that this demonstrates that the intervention specifically targeted long-term associative memory formation. While this is certainly possible, the STM task was a spatial memory task, whereas the LTM task relied (primarily) on verbal material. It is thus also possible that the stimulation effects were specific to a stimulus domain instead of memory type. In other words, could it be possible that the stimulation might have affected STM performance if the task taxed verbal STM instead? This is of course impossible to know without an additional experiment, but the authors could mention this possibility when discussing their findings regarding the lack of change in the STM task.

      While the authors discuss the potential neural mechanisms by which the combined stimulation conditions might have helped memory formation, the psychological processes are somewhat neglected. For example, do the authors think the stimulation primarily improves the encoding of new information or does it also improve consolidation processes? Interestingly, the beneficial effect of dual iTBS and γtACS on recall performance was very stable across all time points tested in experiments 1 and 2, as was the performance in the other conditions. Do the authors have any explanation as to why there seems to be no further forgetting of information over time in either condition when even at immediate recall, accuracy is below 50%? Further, participants started learning the associations of the FNAT immediately after the stimulation protocol was administered. What would happen if learning started with a delay? In other words, do the authors think there is an ideal time window post-stimulation in which memory formation is enhanced? If so, this might limit the usability of this procedure in real-life applications.

    3. Author Response:

      Public Reviews:

      Reviewer #1 (Public review):

      Weaknesses:

      (1) It remains unclear how this stimulation protocol is proposed to enhance memory. Memories are believed to be stored by precise inputs to specific neurons and highly tuned changes in synaptic strengths. It remains unclear whether proposed neural activity generated by the stimulation reflects the activation of specific memories or generally increased activity across all classes of neurons.

      Thank you for raising the important issue of the actual neurophysiological effects of non-invasive brain stimulation. Unfortunately, invasive neurophysiological recordings in humans for this type of study are not feasible due to ethical constraints, while studies on cadavers or rodents would not fully resolve our question. Indeed, the authors of the cited study (Mihály Vöröslakos et al., Nature Communications, 2018) highlight the impossibility of drawing definitive conclusions about the exact voltage required in the in-vivo human brain due to significant differences between rats and humans, as well as the in-vivo human brain and cadavers due to alterations in electrical conductivity that occur in postmortem tissue.

      We acknowledge that further exploration of this aspect would be highly valuable, and we agree that it is worth discussing both as a technical limitation and as a potential direction for future research, we therefore modify the manuscript correspondingly. However, to address the challenge of in vivo recordings, we conducted Experiments 3 and 4, which respectively examined the neurophysiological and connectivity changes induced by the stimulation in a non-invasive manner. The observed changes in brain oscillatory activity (increased gamma oscillatory activity), cortical excitability (enhanced posteromedial parietal cortex reactivity), and brain connectivity (strengthened connections between the precuneus and hippocampi) provided evidence of the effects of our non-invasive brain stimulation protocol, further supporting the behavioral data.

      Additionally, we carefully considered the issue of stimulation distribution and, in response, performed a biophysical modeling analysis and E-field calculation using the parameters employed in our study (see Supplementary Materials).

      (2) The claim that effects directly involve the precuneus lacks strong support. The measurements shown in Figure 3 appear to be weak (i.e., Figure 3A top and bottom look similar, and Figure 3C left and right look similar). The figure appears to show a more global brain pattern rather than effects that are limited to the precuneus. Related to this, it would perhaps be useful to show the different positions of the stimulation apparatus. This could perhaps show that the position of the stimulation matters and could perhaps illustrate a range of distances over which position of the stimulation matters.

      Thank you for your feedback. We will improve the clarity of the manuscript to better address this important aspect. Our assumption that the precuneus plays a key role in the observed effects is based on several factors:

      (1) The non-invasive stimulation protocol was applied to an individually identified precuneus for each participant. Given existing evidence on TMS propagation, we can reasonably assume that the precuneus was at least a mediator of the observed effects (Ridding & Rothwell, Nature Reviews Neuroscience 2007). For further details about target identification and TMS and tACS propagation, please refer to the MRI data acquisition section in the main text and Biophysical modeling and E-field calculation section in the supplementary materials.

      (2) To investigate the effects of the neuromodulation protocol on cortical responses, we conducted a whole-brain analysis using multiple paired t-tests comparing each data point between different experimental conditions. To minimize the type I error rate, data were permuted with the Monte Carlo approach and significant p-values were corrected with the false discovery rate method (see the Methods section for details). The results identified the posterior-medial parietal areas as the only regions showing significant differences across conditions.

      (3) To control for potential generalized effects, we included a control condition in which TMS-EEG recordings were performed over the left parietal cortex (adjacent to the precuneus). This condition did not yield any significant results, reinforcing the cortical specificity of the observed effects.

      However, as stated in the Discussion, we do not claim that precuneus activity alone accounts for the observed effects. As shown in Experiment 4, stimulation led to connectivity changes between the precuneus and hippocampus, a network widely recognized as a key contributor to long-term memory formation (Bliss & Collingridge, Nature 1993). These connectivity changes suggest that precuneus stimulation triggered a ripple effect extending beyond the stimulation site, engaging the broader precuneus-hippocampus network.

      Regarding Figure 3A, it represents the overall expression of oscillatory activity detected by TMS-EEG. Since each frequency band has a different optimal scaling, the figure reflects a graphical compromise. A more detailed representation of the significant results is provided in Figure 3B. The effect sizes for gamma oscillatory activity in the delta T1 and T2 conditions were 0.52 and 0.50, respectively, which correspond to a medium effect based on Cohen’s d interpretation.

      (3) Behavioral results showing an effect on memory would substantiate claims that the stimulation approach produces significant changes in brain activity. However, placebo effects can be extremely powerful and useful, and this should probably be mentioned. Also, in the behavioral results that are currently presented, there are several concerns:

      a) There does not appear to be a significant effect on the STMB task.

      b) The FNAT task is minimally described in the supplementary material. Experimental details that would help the reader understand what was done are not described. Experimental details are missing for: the size of the images, the duration of the image presentation, the degree of image repetition, how long the participants studied the images, whether the names and occupations were different, genders of the faces, and whether the same participant saw different faces across the different stimulation conditions. Regarding the latter point, if the same participant saw the same faces across the different stimulation conditions, then there could be memory effects across different conditions that would need to be included in the statistical analyses. If participants saw different faces across the different stimulus conditions, then it would be useful to show that the difficulty was the same across the different stimuli.

      We thank you for signaling the lack in the description of FNAT task. We will add all the information required to the manuscript.

      In the meantime, here we provide the answers to your questions. The size of the images 19x15cm. They were presented in the learning phase and the immediate recall for 8 seconds each, while in the delayed recall they were shown (after the face recognition phase) until the subject answered. The learning phase, where name and occupation were shown together with the faces, lasted around 2 minutes comprising the instructions. We used a different set of stimuli for each stimulation condition, for a total of 3 parallel task forms balanced across the condition and order of sessions. All the parallel forms were composed of 6 male and 6 female faces, for each sex there were 2 young adults (aged around 30 years old), 2 middle adults (aged around 50 years old), and 2 old adults (aged around 70 years old). Before the experiments, we ran a pilot study to ensure there were no differences between the parallel forms of the task. We can provide the task with its parallel form upon request. The chance level in the immediate and delayed recall is not quantifiable since the participants had to freely recall the name and the occupation without a multiple choice. In the recognition, the chance level was around 33% (since the possible answers were 3).

      c) Also, if I understand FNAT correctly, the task is based on just 12 presentations, and each point in Figure 2A represents a different participant. How the performance of individual participants changed across the conditions is unclear with the information provided. Lines joining performance measurements across conditions for each participant would be useful in this regard. Because there are only 12 faces, the results are quantized in multiples of 100/12 % in Figure 3A. While I do not doubt that the authors did their homework in terms of the statistical analyses, it seems as though these 12 measurements do not correspond to a large effect size. For example, in Figure 3A for the immediate condition (total), it seems that, on average, the participants may remember one more face/name/occupation.

      We will add another graph to the manuscript with lines connecting each participant's performance. Unfortunately, we were not able to incorporate it in the box-and-whisker plot.

      We apologize for the lack of clarity in the description of the FNAT. As you correctly pointed out, we used the percentage based on the single association between face, name and occupation (12 in total). However, each association consisted of three items, resulting in a total of 36 items to learn and associate – we will make it more explicit in the manuscript.

      In the example you mentioned, participants were, on average, able to recall three more items compared to the other conditions. While this difference may not seem striking at first glance, it is important to consider that we assessed memory performance after a single, three-minute stimulation session. Similar effects are typically observed only after multiple stimulation sessions (Koch et al., NeuroImage, 2018; Grover et al., Nature Neuroscience, 2022).

      d) Block effects. If I understand correctly, the experiments were conducted in blocks. This is potentially problematic. An example study that articulates potential problems associated with block designs is described in Li et al (TPAMI 2021, https://ieeexplore.ieee.org/document/9264220). It is unclear if potential problems associated with block designs were taken into consideration.

      Thank you for the interesting reference. According to this paper, in a block design, EEG or fMRI recordings are performed in response to different stimuli of a given class presented in succession. If this is the case, it does not correspond to our experimental design where both TMS-EEG and fMRI were conducted in a resting state on different days according to the different stimulation conditions.

      e) In the FNAT portion of the paper, some results are statistically significant, while others are not. The interpretation of this is unclear. In Figure 3A, it seems as though the authors claim that iTBS+gtACS > iTBS+sham-tACS, but iTBS+gtACS ~ sham+sham. The interpretation of such a result is unclear. Results are also unclear when separated by name and occupation. There is only one condition that is statistically significant in Figure 3A in the name condition, and no significant results in the occupation condition. In short, the statistical analyses, and accompanying results that support the authors’ claims, should be explained more clearly.

      Thank you again for your feedback. We will work on making the large amount of data we reported easier to interpret.

      Hoping to have thoroughly addressed your initial concerns in our previous responses, we now move on to your observations regarding the behavioral results, assuming you were referring to Figure 2A. The main finding of this study is the improvement in long-term memory performance, specifically the ability to correctly recall the association between face, name, and occupation (total FNAT), which was significantly enhanced in both Experiments 1 and 2. However, we also aimed to explore the individual contributions of name and occupation separately to gain a deeper understanding of the results. Our analysis revealed that the improvement in total FNAT was primarily driven by an increase in name recall rather than occupation recall. We understand that this may have caused some confusion. Therefore we will clarify this in the manuscript and consider presenting the name and occupation in a separate plot.

      Regarding the stimulation conditions, your concerns about the performance pattern (iTBS+gtACS > iTBS+sham-tACS, but iTBS+gtACS ~ sham+sham) are understandable. However, this new protocol was developed precisely in response to the variability observed in behavioral outcomes following non-invasive brain stimulation, particularly when used to modulate memory functions (Corp et al., 2020; Pabst et al., 2022). As discussed in the manuscript, it is intended as a boost to conventional non-invasive brain stimulation protocols, leveraging the mechanisms outlined in the Discussion section.

      Reviewer #2 (Public review):

      Weaknesses:

      (1) The study did not include a condition where γtACS was applied alone. This was likely because a previous work indicated that a single 3-minute γtACS did not produce significant effects, but this limits the ability to isolate the specific contribution of γtACS in the context of this target and memory function

      Thank you for your comments. As you pointed out, we did not include a condition where γtACS was applied alone. This decision was based on the findings of Guerra et al. (Brain Stimulation 2018), who investigated the same protocol and reported no aftereffects. Given the substantial burden of the experimental design on patients and our primary goal of demonstrating an enhancement of effects compared to the standalone iTBS protocol, we decided to leave out this condition. However, we agree that investigating the effects of γtACS alone is an interesting and relevant aspect worthy of further exploration. In line with these observations, we will expand the discussion on this point in the study’s limitations section.

      (2) The authors applied stimulation for 3 minutes, which seems to be based on prior tACS protocols. It would be helpful to present some rationale for both the duration and timing relative to the learning phase of the memory task. Would you expect additional stimulation prior to recall to benefit long-term associative memory?

      Thank you for your comment and for raising this interesting point. As you correctly noted, the protocol we used has a duration of three minutes, a choice based on previous studies demonstrating its greater efficacy with respect to single stimulation from a neurophysiological point of view. Specifically, these studies have shown that the combined stimulation enhanced gamma-band oscillations and increased cortical plasticity (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022). Given that the precuneus (Brodt et al., Science 2018; Schott et al., Human Brain Mapping 2018), gamma oscillations (Osipova et al., Journal of Neuroscience 2006; Deprés et al., Neurobiology of Aging 2017; Griffiths et al., Trends in Neurosciences 2023), and cortical plasticity (Brodt et al., Science 2018) are all associated with encoding processes, we decided to apply the co-stimulation immediately before it to enhance the efficacy.

      Regarding the question of whether stimulation could also benefit recall, the answer is yes. We can speculate that repeating the stimulation before recall might provide an additional boost. This is supported by evidence showing that both the precuneus and gamma oscillations are involved in recall processes (Flanagin et al., Cerebral Cortex 2023; Griffiths et al., Trends in Neurosciences 2023). Furthermore, previous research suggests that reinstating the same brain state as during encoding can enhance recall performance (Javadi et al., The Journal of Neuroscience 2017).

      We will expand the study rationale and include these considerations in the future directions section.

      (3) How was the burst frequency of theta iTBS and gamma frequency of tACS chosen? Were these also personalized to subjects' endogenous theta and gamma oscillations? If not, were increases in gamma oscillations specific to patients' endogenous gamma oscillation frequencies or the tACS frequency?

      The stimulation protocol was chosen based on previous studies (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022). Gamma tACS sinusoid frequency wave was set at 70 Hz while iTBS consisted of ten bursts of three pulses at 50 Hz lasting 2 s, repeated every 10 s with an 8 s pause between consecutive trains, for a total of 600 pulses total lasting 190 s (see iTBS+γtACS neuromodulation protocol section). In particular, the theta iTBS has been inspired by protocols used in animal models to elicit LTP in the hippocampus (Huang et al., Neuron 2005). Consequently, neither Theta iTBS nor the gamma frequency of tACS were personalized. The increase in gamma oscillations was referred to the patient’s baseline and did not correspond to the administrated tACS frequency.

      (4) The authors do a thorough job of analyzing the increase in gamma oscillations in the precuneus through TMS-EEG; however, the authors may also analyze whether theta oscillations were also enhanced through this protocol due to the iTBS potentially targeting theta oscillations. This may also be more robust than gamma oscillations increases since gamma oscillations detected on the scalp are very low amplitude and susceptible to noise and may reflect activity from multiple overlapping sources, making precise localization difficult without advanced techniques.

      Thank you for the suggestion. We analyzed theta oscillations finding no changes.

      (5) Figure 4: Why are connectivity values pre-stimulation for the iTBS and sham tACS stimulation condition so much higher than the dual stimulation? We would expect baseline values to be more similar.

      We acknowledge that the pre-stimulation connectivity values for the iTBS and sham tACS conditions appear higher than those for the dual stimulation condition. However, as noted in our statistical analyses, there were no significant differences at baseline between conditions (p-FDR= 0.3514), suggesting that any apparent discrepancy is due to natural variability rather than systematic bias. One potential explanation for these differences is individual variability in baseline connectivity measures, which can fluctuate due to factors such as intrinsic neural dynamics, participant state, or measurement noise. Despite these variations, our statistical approach ensures that any observed post-stimulation effects are not confounded by pre-existing differences.

      (6) Figure 2: How are total association scores significantly different between stimulation conditions, but individual name and occupation associations are not? Further clarification of how the total FNAT score is calculated would be helpful.

      We apologize for any lack of clarity. The total FNAT score reflects the ability to correctly recall all the information associated with a person—specifically, the correct pairing of the face, name, and occupation. Participants received one point for each triplet they accurately recalled. The scores were then converted into percentages, as detailed in the Face-Name Associative Task Construction and Scoring section in the supplementary materials.

      Total FNAT was the primary outcome measure. However, we also analyzed name and occupation recall separately to better understand their individual contributions. Our analysis revealed that the improvement in total FNAT was primarily driven by an increase in name recall rather than occupation recall.

      We acknowledge that this distinction may have caused some confusion. To improve clarity, we will revise the manuscript accordingly and consider presenting name and occupation recall in separate plots.

      Reviewer #3 (Public review):

      Weaknesses:

      I want to state clearly that I think the strengths of this study far outweigh the concerns I have. I still list some points that I think should be clarified by the authors or taken into account by readers when interpreting the presented findings.

      I think one of the major weaknesses of this study is the overall low sample size in all of the experiments (between n = 10 and n = 20). This is, as I mentioned when discussing the strengths of the study, partly mitigated by the within-subject design and individualized stimulation parameters. The authors mention that they performed a power analysis but this analysis seemed to be based on electrophysiological readouts similar to those obtained in experiment 3. It is thus unclear whether the other experiments were sufficiently powered to reliably detect the behavioral effects of interest. That being said, the authors do report significant effects, so they were per definition powered to find those. However, the effect sizes reported for their main findings are all relatively large and it is known that significant findings from small samples may represent inflated effect sizes, which may hamper the generalizability of the current results. Ideally, the authors would replicate their main findings in a larger sample. Alternatively, I think running a sensitivity analysis to estimate the smallest effect the authors could have detected with a power of 80% could be very informative for readers to contextualize the findings. At the very least, however, I think it would be necessary to address this point as a potential limitation in the discussion of the paper.

      Thank you for the observation. As you mentioned, our power analysis was based on our previous study investigating the same neuromodulation protocol with a corresponding experimental design. The relatively small sample could be considered a possible limitation of the study which we will add to the discussion. A fundamental future step will be to replay these results on a larger population, however, to strengthen our results we performed the sensitivity analysis you suggested.

      In detail, we performed a sensitivity analysis for repeated-measures ANOVA with α=0.05 and power(1-β)=0.80 with no sphericity correction. For experiment 1, a sensitivity analysis with 1 group and 3 measurements showed a minimal detectable effect size of f=0.524 with 20 participants. In our paper, the ANOVA on total FNAT immediate performance revealed an effect size of η2\=0.274 corresponding to f=0.614; the ANOVA on FNAT delayed performance revealed an effect size of η2 =0.236 corresponding to f=0.556. For experiment 2, a sensitivity analysis for total FNAT immediate performance (1 group and 3 measurements) showed a minimal detectable effect size of f=0.797 with 10 participants. In our paper, the ANOVA on total FNAT immediate performance revealed an effect size of η2 =0.448 corresponding to f=0.901. The sensitivity analysis for total FNAT delayed performance (1 group and 6 measurements) showed a minimal detectable effect size of f=0.378 with 10 participants. In our paper, the ANOVA on total FNAT delayed performance revealed an effect size of η2 =0.484 corresponding to f=0.968. Thus, the sensitivity analysis showed that both experiments were powered enough to detect the minimum effect size computed in the power analysis. We have now added this information to the manuscript and we thank the reviewer for her/his suggestion.

      It seems that the statistical analysis approach differed slightly between studies. In experiment 1, the authors followed up significant effects of their ANOVAs by Bonferroni-adjusted post-hoc tests whereas it seems that in experiment 2, those post-hoc tests where "exploratory", which may suggest those were uncorrected. In experiment 3, the authors use one-tailed t-tests to follow up their ANOVAs. Given some of the reported p-values, these choices suggest that some of the comparisons might have failed to reach significance if properly corrected. This is not a critical issue per se, as the important test in all these cases is the initial ANOVA but non-significant (corrected) post-hoc tests might be another indicator of an underpowered experiment. My assumptions here might be wrong, but even then, I would ask the authors to be more transparent about the reasons for their choices or provide additional justification. Finally, the authors sometimes report exact p-values whereas other times they simply say p < .05. I would ask them to be consistent and recommend using exact p-values for every result where p >= .001.

      Thank you again for the suggestions. Your observations are correct, we used a slightly different statistical depending on our hypothesis. Here are the details:

      In experiment 1, we used a repeated-measure ANOVA with one factor “stimulation condition” (iTBS+γtACS; iTBS+sham-tACS; sham-iTBS+sham-tACS). Following the significant effect of this factor we performed post-hoc analysis with Bonferroni correction.

      In experiment 2, we used a repeated-measures with two factors “stimulation condition” and “time”. As expected, we observed a significant effect of condition, confirming the result of experiment 1, but not of time. Thus, this means that the neuromodulatory effect was present regardless of the time point. However, to explore whether the effects of stimulation condition were present in each time point we performed some explorative t-tests with no correction for multiple comparisons since this was just an explorative analysis.

      In experiment 3, we used the same approach as experiment 1. However, since we had a specific hypothesis on the direction of the effect already observed in our previous study, i.e. increase in spectral power (Maiella et al., Scientific Report 2022), our tests were 1-tailed.

      For the p-values, we will correct the manuscript reporting the exact values for every result.

      While the authors went to great lengths trying to probe the neural changes likely associated with the memory improvement after stimulation, it is impossible from their data to causally relate the findings from experiments 3 and 4 to the behavioral effects in experiments 1 and 2. This is acknowledged by the authors and there are good methodological reasons for why TMS-EEG and fMRI had to be collected in sperate experiments, but it is still worth pointing out to readers that this limits inferences about how exactly dual iTBS and γtACS of the precuneus modulate learning and memory.

      Thank you for your comment. We fully agree with your observation, which is why this aspect has been considered in the study's limitations. To address your concern, we will further emphasize the fact that our findings do not allow precise inferences regarding the specific mechanisms by which dual iTBS and γtACS of the precuneus modulate learning and memory.

      There were no stimulation-related performance differences in the short-term memory task used in experiments 1 and 2. The authors argue that this demonstrates that the intervention specifically targeted long-term associative memory formation. While this is certainly possible, the STM task was a spatial memory task, whereas the LTM task relied (primarily) on verbal material. It is thus also possible that the stimulation effects were specific to a stimulus domain instead of memory type. In other words, could it be possible that the stimulation might have affected STM performance if the task taxed verbal STM instead? This is of course impossible to know without an additional experiment, but the authors could mention this possibility when discussing their findings regarding the lack of change in the STM task.

      Thank you for your insightful observation. We argue that the intervention primarily targeted long-term associative memory formation, as our findings demonstrated effects only on FNAT. However, as you correctly pointed out, we cannot exclude the possibility that the stimulation may also influence short-term verbal associative memory. We will acknowledge this potential effect when discussing the absence of significant findings in the STM task.

      While the authors discuss the potential neural mechanisms by which the combined stimulation conditions might have helped memory formation, the psychological processes are somewhat neglected. For example, do the authors think the stimulation primarily improves the encoding of new information or does it also improve consolidation processes? Interestingly, the beneficial effect of dual iTBS and γtACS on recall performance was very stable across all time points tested in experiments 1 and 2, as was the performance in the other conditions. Do the authors have any explanation as to why there seems to be no further forgetting of information over time in either condition when even at immediate recall, accuracy is below 50%? Further, participants started learning the associations of the FNAT immediately after the stimulation protocol was administered. What would happen if learning started with a delay? In other words, do the authors think there is an ideal time window post-stimulation in which memory formation is enhanced? If so, this might limit the usability of this procedure in real-life applications.

      Thank you for your comment and for raising these important points.

      We hypothesized that co-stimulation would enhance encoding processes. Previous studies have shown that co-stimulation can enhance gamma-band oscillations and increase cortical plasticity (Guerra et al., Brain Stimulation 2018; Maiella et al., Scientific Reports 2022). Given that the precuneus (Brodt et al., Science 2018; Schott et al., Human Brain Mapping 2018), gamma oscillations (Osipova et al., Journal of Neuroscience 2006; Deprés et al., Neurobiology of Aging 2017; Griffiths et al., Trends in Neurosciences 2023), and cortical plasticity (Brodt et al., Science 2018) have all been associated with encoding processes, we decided to apply co-stimulation before the encoding phase, to boost it.

      We applied the co-stimulation immediately before the learning phase to maximize its potential effects. While we observed a significant increase in gamma oscillatory activity lasting up to 20 minutes, we cannot determine whether the behavioral effects we observed would have been the same with a co-stimulation applied 20 minutes before learning. Based on existing literature, a reduction in the efficacy of co-stimulation over time could be expected (Huang et al., Neuron 2005; Thut et al., Brain Topography 2009). However, we hypothesize that multiple stimulation sessions might provide an additional boost, helping to sustain the effects over time (Thut et al., Brain Topography 2009; Koch et al., Neuroimage 2018; Koch et al., Brain 2022).

      Regarding the absence of further forgetting in both stimulation conditions, we think that the clinical and demographical characteristics of the sample (i.e. young and healthy subjects) explain the almost absence of forgetting after one week.

    1. Reviewer #1 (Public review):

      Summary:

      In this study, Liu et al use optogenetics and genetically encoded neuromodulator sensors to test the extent to which dopamine neuron stimulation produces striatal serotonin release, and vice versa. The study is timely given growing interest in dopamine/serotonin interactions and in the context of recent work showing bidirectional and dynamic regulation of striatal dopamine by another neuromodulator, acetylcholine. The authors find that striatal dopamine and serotonin afferents function largely independently, with dopamine neuron stimulation producing no striatal serotonin release and serotonin neuron stimulation producing minimal striatal dopamine release. This work will inform future work seeking to dissect the contributions of striatal dopamine, serotonin, and their interactions to various motivated behaviors. While the paper's main conclusions are adequately supported (see Strengths), additional controls and experiments would significantly broaden the paper's impact (see Weaknesses). Finally, this draft of the work is poorly presented with numerous errors, omissions, and inconsistencies evident throughout the text and the figures that should be addressed.

      Strengths:

      The study employs optogenetic stimulation simultaneously with fiber photometry recording of dopamine or serotonin release measured with genetically encoded sensors. These methods are state-of-the-art, offering tighter temporal control compared to pharmacological methods for manipulating dopamine and serotonin and improved selectivity over techniques like electrochemistry and microdialysis used to record neuromodulator release in previous studies on the subject. As a result, the paper's main conclusions are well supported.

      Weaknesses:

      (1) The electrophysiology experiments in Figure 3 are only tangentially related to the focus of the study, and their findings are almost entirely irrelevant to the paper's main conclusions. The results of these experiments are also not novel. Glutamate corelease from 5HT neurons has been previously shown, including in the OFC and VTA (Ren et al, 2018, Cell, McDevitt et al, 2014, Cell Rep, Liu et al 2014, Neuron; and others). The authors should explain more clearly what they think these data add to the manuscript and/or consider removing them altogether.

      (2) Related to the point above, as far as I can tell, the only value the electrophysiology data add is to suggest that perhaps activation of serotonin neurons may drive minimal striatal dopamine release via glutamate corelease in the VTA. The evidence provided in this version of the manuscript is insufficient to support that claim, but the manuscript would be significantly strengthened if the authors tested this hypothesis more directly. One way to do that could be to stimulate serotonin axons in the striatum (as opposed to the serotonin cell bodies) and record striatal dopamine release. A complementary anatomical approach would be to use retrograde tracing to test whether the DR 5HT neurons projecting to the striatum are the same or different from the VTA projecting population.

      (3) The findings would be strengthened by the addition of a fluorophore-only control group lacking opsin expression in all experiments in Figures 1 and 2.

      (4) The experiment of stimulating serotonin neurons and recording serotonin release in the NAc was not performed. It would be useful to be able to compare the magnitudes of evoked serotonin release in these two striatal regions, though it is not central to the main claims of the paper.

      (5) The interpretation of the results from Figure 2 is described inconsistently throughout the manuscript. The title implies there is significant crosstalk between the dopamine and serotonin systems. The abstract calls the crosstalk "transient", which is a description of its temporal dynamics, not its magnitude. Then the introduction figures and discussion all suggest the crosstalk is minimal. I suggest the authors describe the main findings - minimal crosstalk between the dopamine and serotonin systems - clearly and consistently in the title, abstract, and main text.

    2. Reviewer #3 (Public review):

      The authors suggest that the small release of DA may be due to a release of glutamate from DRN 5-HT neurons to the VTA that stimulates weakly and in a transient fashion the VTA DA neurons, which in the end, produce a transient and small release of DA in the NAc.

      Their findings give more information on the previously reported complex and partial known crosstalk between 5-HT and DA in the NAc.

      I only have some minor concerns about the manuscript:

      (1) In Figure 2F, there is a missing curve for 5-HT in NAc. Besides, the legend shows n=2, making it difficult to perform statistical analysis with that data.

      (2) In Figure 3, the use of NBQX/AP5 is shown, but it is not mentioned either in the methodology or in the discussion. What is the meaning of those results?

      (3) Line 98 compares results from two different places of stimulation. The results are related to stimulation in the VTA, but the comparison indicates that the stimulation was made in the DRN.

      (4) If the release of 5-HT in Nac does not occur, it needs to be precise in the abstract that 5-HT is released in the dorsal striatum (DS) but not in the NAc (line 19).

      (5) Be consistent with the way you mention the 5-HT neurons. For example, in lines from 106 to 119, SERT neurons are used. Previously, 5-HT neurons were used.

      (6) There are several points of confusion when referring to the figures, making the text difficult to follow because the text explains something that is not shown in the figure cited.

    1. Author response:

      Point-by-point description of the revisions

      Reviewer #1 (Evidence, reproducibility and clarity):

      The study is well-executed and provides many interesting leads for further experimental studies, which makes it very important. One of the significant hypotheses in this context is metazoan Wnt Lipocone domain interactions with lipids, which remain to be explored.

      The manuscript is generally navigable for interesting reading despite being content-rich. Overall, the figures are easy to follow.

      We thank the reviewer for the thoughtful and favorable assessment.

      Major comments:

      I urge the authors to consider creating a first figure summarizing the broad approach and process involved in discovering the lipocone superfamily. This would help the average reader easily follow the manuscript.

      It will be helpful to have the final model/synthesis figure, which provides a take-home message that combines the main deductions from Fig 1c, Fig 4, Fig 5, and Fig 6 to provide an eagle's eye view (also translating the arguments on Page 38 last para into this potential figure).

      We have generated a two-part figure that synthesizes these two requests, also in line with the recommendations made by Reviewer 3. Depending on the accepting Review Commons journal, we plan to either submit this as a graphical abstract/TOC figure (as suggested by Reviewer 3) or as a single figure. We prefer starting with the first approach as it will keep our figure count the same.

      Minor comments:

      Fig 1C: The authors should provide a statistical estimate of the difference in transmembrane tendency scores between the "membrane" and "globular" versions of the Lipocone domains.

      To address this, we calculated group-wise differences using the Kruskal-Wallis nonparametric test, followed by Dunn’s test with Bonferroni correction for a more stringent evaluation. The results of which are presented as a critical difference diagram in the new Supplementary Figure S3. The analysis is explained in the Methods section of the revised manuscript, and the statistically significant difference is mentioned in the text. This analysis identifies three groups of significantly different Lipocone families based on their transmembrane tendency: those predicted (or known) to associate with the prokaryotic membranes, those predicted to be diffusible, and a small number of families residing eukaryotic ER membranes or bacterial outer membranes.

      Reviewer #2 (Evidence, reproducibility and clarity):

      This is a remarkable study, one of a kind. The authors trace the entire huge superfamily containing Wnt proteins which origins remained obscure before this work. Even more amazingly, they show that Wnts originated from transmembrane enzymes. The work is masterfully executed and presented. The conclusions are strongly supported by multiple lines of evidence. Illustrations are beautifully crafted. This is an exemplary work of how modern sequence and structure analysis methods should be used to gain unprecedented insights into protein evolution and origins.

      We thank the reviewer for the positive evaluation of our work.

      Minor comments.

      (1) In fig 1, VanZ structure looks rather different from the rest and is a more tightly packed helical bundle. It might be useful for the readers to learn more about the arguments why authors consider this family to be homologous with the rest, and what caused these structural changes in packing of the helices.

      First, the geometry of an α-helix can be approximated as a cylinder, resulting in contact points that are relatively small. Fewer contact constraints can lead to structural variation in the angular orientations between the helices of an all α-helical domain, resulting in some dispersion in space of the helical axes. As a result, some of the views can be a bit confounding when presented as static 2D images. Second, of the two VanZ clades the characteristic structure similar to the other superfamily members is more easily seen in the VanZ-2 clade (as illustrated in supplementary Figure S2).    

      Importantly, the membership of the VanZ domains was recovered via significant hits in our sequence analysis of the superfamily. Importantly, when the sequence alignments of the active site are compared (Figure 2), VanZ retains the conserved active site residue positions, which are predicted to reside spatially in the same location and project into an equivalent active site pocket as seen in the other families in the superfamily. Further, this sequence relationship is captured by the edges in the network in Figure 1B: multiple members of the superfamily show edges indicating significant relationships with the two VanZ families (e.g., HHSearch hits of probability greater than 90%; p<0.0001 are observed between VanZ-1 and Skillet-DUF2809, Skillet-1, Skillet-4, YfiM-1, YfiM-DUF2279, Wok, pPTDSS, and cpCone-1). Thus, they occupy relatively central locations in the sequence similarity network, indicating a consistent sequence similarity connection to multiple other families.

      (2) Fig. 4 color bars before names show a functional role. How does the blue bar "described for the first time" fits into this logic? Maybe some other way to mark this (an asterisk?) could be better to resolve this sematic inconsistency.

      We have shifted the blue bars into asterisks, which follow family names, now stated in the updated legend.

      Reviewer #3 (Evidence, reproducibility and clarity):

      The manuscript by Burroughs et al. uses informatic sequence analysis and structural modeling to define a very large, new superfamily which they dub the Lipocone superfamily, based on its function on lipid components and cone-shaped structure. The family includes known enzymatic domains as well as previously uncharacterized proteins (30 families in total). Support for the superfamily designation includes conserved residues located on the homologous helical structures within the fold. The findings include analyses that shed light on important evolutionary relationships including a model in which the superfamily originated as membrane proteins where one branch evolved into a soluble version. Their mechanistic proposals suggest possible functions for enzymes currently unassigned. There is also support for the evolutionary connection of this family with the human immune system. The work will be of interest to those in the broad areas of bioinformatics, enzyme mechanisms, and evolution. The work is technically well performed and presented.

      We appreciate the positive evaluation of our work by the reviewer.

      Referees cross-commenting

      All the comments seem useful to me. I like Reviewer 1's suggestion for a flowchart showing the methodology. I think the summarizing figure suggested could be a TOC abstracvt, which many journals request.

      To accommodate this comment (along with Reviewer 1’s comments), we have generated a two-part figure containing the methodology flowchart and the summary of findings. Combining the two provides some before-and-after symmetry to a TOC figure, while also avoiding further inflation of the figure count, which would likely be an issue at one or more of the Review Commons journals.

      The authors may wish to consider the following points (page numbers from PDF for review):

      (1) It would be useful in Fig 1A, either in main text or the supporting information, to also have a an accompanying topology diagram- I like the coloring of the helices to show the homology but the connections between them are hard to follow

      We acknowledge the reviewer’s concern as one shared by ourselves. We have placed such a topology diagram in Figure 1A, and now refer to it at multiple points in the manuscript text.

      (2) Page: 6- In the paragraph marked as an example- please call out Fig1A when the family mentioned is described (I believe SAA is described as one example)

      We have added these pointers in the text, where appropriate.

      (3) Page: 7- The authors state "these 'hydrophobic families' often evince a deeper phyletic distribution pattern than the less-hydrophobic families (Figure S1), implying that the ancestral version of the superfamily was likely a TM domain" there should be more explanation or information here - I am not certain from looking at FigS1 what a deeper phyletic distribution pattern means. Perhaps explaining for a single example? I also see that this important point is discussed in the conclusions- it is useful to point to the conclusion here.

      Our use of the ‘deeper’ in this context is meant to convey the concept that more widely conserved families/clades (both across and within lineages) suggest an earlier emergence. In the Lipocone superfamily, this phylogenetic reasoning supports an evolutionary scenario where the membrane-inserted versions generally emerged early, while the solubilized versions, which are found in relatively fewer lineages, emerged later.

      To address this objectively, we have calculated a simple phyletic distribution metric that combines the phyletic spread of a Lipocone clade with its depth within individual lineages, which is then plotted as a bargraph (Supplemental Figure S1). Briefly, this takes the width of the bar as the phyletic spread across the number of distinct taxonomic lineages and its height as a weighted mean of occurrence within each lineage (depth). The latter helps dampen the effects of sampling bias. In the resulting graph, lineages with a lower height and width are likely to have been derived later than those with a greater height and width. A detailed description clarifying this has been added to the Methods section of the revised manuscript. The results support two statements that are made in the text: 1) that the Wok and VanZ clades are the most widely and deeply represented clades in the superfamily, and 2) that the predicted transmembrane versions tend to be more widely and deeply distributed. We have also added a statement in the results with a pointer to Figure S1 to clarify this point raised by the referee.

      (4) For figure 3 I would suggest instead of coloring by atom type- to color the leaving group red and the group being added blue so the reader can see where the moieties start and end in substrates and products

      We have retained the atom type coloring in the figure for ease of visualizing the atom types. However, to address the reviewer’s concern, we have added dashed colored circles to highlight attacking and leaving groups in the reactions. The legend has been updated accordingly.

      (5) Page: 13- The authors state "While the second copy in these versions is catalytically inactive, the H1' from the second duplicate displaces the H1 from the first copy," So this results in a "sort of domain swap" correct? It may be more clear to label both copies in Figure 3 upper right so it is easier for the reader to follow.

      We have added these labels to the updated Figure S4 (formerly S3).

      (6) The authors state "In addition to the fusion to the OMP β-barrel, the YfiM-DUF2279 family (Figure 5H) shows operonic associations with a secreted MltG-like peptidoglycan lytic transglycosylase (127,128), a lipid anchored cytochrome c heme-binding domain (129), a phosphoglucomutase/phosphomannomutase enzyme (130), a GNAT acyltransferase (131), a diaminopimelate (DAP) epimerase (132), and a lysozyme like enzyme (133). In a distinct operon, YfiM-DUF2279 is combined with a GT-A glycosyltransferase domain (79), a further OMP β-barrel, and a secreted PDZ-like domain fused to a ClpP-like serine protease (134,135) (Figure 5H)." this combination of enzymes sounds like those in the pathways for oligosaccharide synthesis which is cytoplasmic but the flippase acts to bring the product to the periplasm. Please make sure it is clear that these enzymes may act at different faces of the membrane.

      We have made that point explicit in the revised manuscript in the paragraph following the above-quoted statement.

      (7) Page: 21- the authors should remove the unpublished observations on other RDD domain or explain or cite them

      The analysis of the RDD domain is a part of a distinct study whose manuscript we are currently preparing, and explaining its many ramifications would be outside the scope of this manuscript. Moreover, placing even an account of it in this manuscript would break its flow and take the focus away from the Lipocone superfamily. Further, its inclusion of the RDD story would substantially increase the size of the manuscript. However, it is commonly fused to the Lipocone domain; hence, it would be remiss if we entirely remove a reference to it. Accordingly, we retain a brief account of the RDD-fused Lipocone domains in the revised manuscript that is just sufficient to make the relevant functional case”.

      (8) Page: 34- The authors state "For instance, the emergence of the outer membrane in certain bacteria was potentially coupled with the origin of the YfiM and Griddle clades (Figure 4)." I don't see origin point indicated in figure 4 (emergence of outer membrane- this may be helpful to indicate in some way- also I am not certain what the dashed circles in Fig 4 are indicating- its not in the legend?

      This annotation has been added to the revised Figure 4, and the point of recruitment is indicated with a  “X” sign, along with a clarification in the legend regarding the dashed circles.

      (9) In terms of the hydrophobicity analysis, it would be good to mark on the plot (Fig 1C) one or two examples of lipocone members with known structure that are transmembrane proteins as a positive control

      We have added these markers (colored triangles and squares for these families to the plot.

      Grammar, typos

      Page: 3- abstract severance is an odd word to use for hydrolysis or cleavage

      We have changed to “cleavage”.

      Page: 5- "While the structure of Wnt was described over a decade prior" should read "Although the structure of ..."

      Page 7 - "One family did not yield a consistent prediction for orientation"- please state which family

      Page: 8 "While the ancestral pattern is noticeably degraded in the metazoan Wnt (Met-Wnt) family, it is strongly preserved in the prokaryotic Min-Wnt family." Should read "Although the ancestral..."

      throughout- please replace solved with experimentally determined to be clear and avoid jargon

      Please replace "TelC severs the link" with "TelC cleaves the bond "

      We have made the above changes.

      Page: 19- the authors state "a lipobox-containing synaptojanin superfamily phosphoesterase (125) and a secreted R-P phosphatase (126) (see Figure 6, Supplementary Data)" I was uncertain if the authors meant Fig S6 or they meant see Fig 6 and something else in supplementary data. Please fix.

      In this pointer, we intended to flag the relevant gene neighborhoods in both Figures 5H and 6, as well as highlight the additional examples contained in the Supplementary Data. We have updated the point

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reviewer #1 (Evidence, reproducibility and clarity (Required)):*

      As stated by the authors in the introduction, the RNA-binding protein Sxl is foundational to understanding sex determination in Drosophila. Sxl has been extensively studied as the master regulator of female sex determination in the soma, where it is known to initiate an alternative splicing cascade leading to the expression of DsxF. Additionally, Sxl has been shown to be responsible for keeping X chromosome dosage compensation off in females, while males hyperactivate their X chromosome. While these roles have been well defined, the authors explore an aspect of Sxl that is quite separate from its role as master regulator of female fate. They describe Sxl-RAC, a Sxl isoform that is expressed in the male and female nervous system. Using several genomic techniques, the authors conclude that the Sxl-RAC isoform associates with chromatin in a similar pattern to the RNA polymerase II/III subunit, Polr3E, and Sxl depends on Polr3E for chromatin-association. Further, neuronal loss of Sxl causes changes in lifetime and geotaxis in a similar manner as loss of Polr3E. The work is thorough and significant and should be appropriate for publication if a few issues can be addressed.

      Major Concerns:*

      * 1) How physiological is the Sxl chromatin-association assay? As binding interactions are concentration-dependent, how similar is Sxl-DAM expression to wt Sxl expression in neurons? In addition, does the Sxl-DAM protein function as a wt Sxl protein? Does UAS-Sxl-DAM rescue any Sxl loss phenotypes?*

      Author response:

      As Reviewer 3 correctly notes, Targeted DamID relies on ribosomal re-initiation (codon slippage) to produce only trace amounts of the Dam-fusion protein. By design, this results in expression levels that are significantly lower than those of the endogenous protein. As such, the experiment can be interpreted within a near–wild-type context, rather than as an overexpression model. The primary aim of this experiment was to determine whether Sxl associates with chromatin, and our dataset provides clear evidence supporting such binding.

      2) Is Polr3E chromatin-association also dependent on Sxl? They should do the reciprocal experiment to their examination of Sxl chromatin-association in Polr3E knockdown. This might also help address point 1-if wt Sxl is normally required for aspects of Polr3E chromatin binding, then concerns about whether the Sxl-DAM chromatin-association is real or artifactual would be assuaged.

      Author response:

      This is an interesting thought, however, if Sxl were required for Polr3E recruitment to RNA Pol III, then, in most male Drosophila melanogaster cells, Polr3E would not be incorporated, and males would not be viable (as it is essential for Pol III activity). While it is possible that there could be a subtle effect on Polr3E recruitment, such an experiment, would not alter the central conclusion of our study - that Sxl is recruited to chromatin (accessory to the Pol III complex) via Polr3E.

      Minor concerns:

      * The observed Sxl loss of function phenotypes are somewhat subtle (although perhaps any behavior phenotype at all is a plus). Did they try any other behaviour assays-courtship, learning/memory, anything else at all to test nervous system function?*


      Author response:

      Given the exploratory nature of this study, we focused on broader behavioural and transcriptional assays.

      While well written, it is sometimes difficult to understand how the experiment was performed or what genotypes were used without looking into the methods sections. One example is they should describe the nature of the Sxl-DAM fusion protein clearly in the results.

      Author response:

      We will revise these sections to improve clarity and ensure there is no confusion.

      * Reviewer #1 (Significance (Required)):

      This manuscript represents a dramatic change in our thinking about the action of the Sex-lethal protein. Previously, Sxl was known as the master regulator of both sex determination and dosage compensation, and performed these roles as an RNA-binding protein affecting RNA splicing and translational regulation. Here, the authors describe a sex-non-specific role of Sxl in the male and female nervous system. Further, this activity appears independent of Sxl's RNA binding activity and instead Sxl functions as a chromatin-associating protein working with the RNA pol2/3 factor Polr3E to regulate gene expression. Thus, this represents a highly significant finding. *

      Reviewer #2 (Evidence, reproducibility and clarity (Required)):*

      Summary: In this paper, the authors report on an unexpected activity for Sex lethal (Sxl) (a known splicing regulator that functions in sex determination and dosage compensation) in binding to chromatin. They show, using DamID, that Sxl binds to approximately the same chromatin regions as Polr3E (a subunit of RNA Pol III). They show that this binding to chromatin is unaffected by mutations in the RNA binding domains or by deletions of either N or C terminal regions of the Sxl protein. This leads the authors to conclude that Sxl must bind to chromatin through some interacting protein working through the central region of the Sxl protein. They show that Sxl binding is dependent on Polr3E function. They show that male-specific neuronal knockdown of Sxl gives similar phenotypes to knockdown of Polr3E in terms of lethality and improved negative geotaxis. They show gene expression changes with knockdown of Sxl in male adult neurons - mainly that metabolic and pigmentation genes go down in expression. They also show that expression of a previously discovered male adult specific form of Sxl (that does not have splicing activity) in the same neurons also leads to changes in gene expression, including more upregulated than downregulated tRNAs. But they don't see (or don't show) that the same tRNA genes are down with knockdown of Sxl. Nonetheless, based on these findings, they suggest that Sxl plays an important role in regulating Pol III activity through the Polr3E subunit.

      Major comments:

      *

      *To be honest, I'm not convinced that the conclusions drawn from this study are correct. The fact that every mutant form of Sxl shows the same result from the DamID labelling is a little concerning. I would like to see independent evidence of the SxlRac protein binding chromatin. *

      Do antibodies against this form (or any form) of Sxl bind chromatin in salivary gland polytene chromosomes, for example? Does Sxl from other insects where Sxl has no role in sex determination bind chromatin?


      __Author Response: __

      Regarding the reviewer’s overall concerns about the legitimacy of the Sxl binding data:

      1. i) The fold differences between Dam-Sxl-mutants and the Dam-only control are very robust (up to 9 log2 fold change (500-fold change)), which is higher than what we observe with most transcription factors using Targeted DamID.
      2. ii) We observed that Sxl binding was significantly reduced upon knockdown of Polr3E, confirming that the signal we observe is biologically specific and not due to technical noise or background. iii) If the concern relates to potential Sxl binding in non-neuronal tissues such as salivary glands, we would like to clarify that all DamID constructs were expressed under elav-GAL4, a pan-neuronal driver. Furthermore, dissections were performed to isolate larval brains, with salivary glands carefully removed. This ensures that chromatin profiles were derived from neuronal tissue exclusively.

      3. iv) Salivary gland polytene chromosome staining with a Sxl antibody in a closely related species (Drosophila virilis) show __binding of Sxl to chromatin __in both sexes (Bopp et al., 1996). We will include more text in the revised manuscript to emphasise these points.

      Do antibodies against this form (or any form) of Sxl bind chromatin in salivary gland polytene chromosomes, for example? Does Sxl from other insects where Sxl has no role in sex determination bind chromatin?

      Author Response:

      Prior work in Drosophila virilis (where Sxl is also required for sex determination and Sxl-RAC is conserved) has already demonstrated Sxl-chromatin association (using a full-length Sxl antibody) in salivary glands using polytene chromosome spreads (Bopp et al., 1996). Binding is observed in both sexes and across the genome, reflecting our observations. We will incorporate this into the revised discussion to support the chromatin-binding role of Sxl across species.

      There is a clear and long-overlooked precedent for Sxl's alternative, sex-independent roles, findings that have been largely overshadowed by the gene’s canonical function. Our study not only validates and extends these observations but also brings much-needed attention to this understudied aspect of fundamental biology.

      Bopp D, Calhoun G, Horabin JI, Samuels M, Schedl P. Sex-specific control of Sex-lethal is a conserved mechanism for sex determination in the genus Drosophila. Development. 1996 Mar;122(3):971-82. doi: 10.1242/dev.122.3.971. PMID: 8631274.

      I would like to see independent evidence of the SxlRac protein binding chromatin.

      * *__Author Response: __

      We do not believe this is necessary:

      1. i) Our data demonstrated that a large N-terminal truncation of Sxl (removing far more of the N-terminal region than is absent in Sxl-RAC) does not impair chromatin binding.
      2. ii) Our deletion experiments show that it is the central domain __of Sxl that is required for chromatin association (as removal of the N-or C-terminal domain has no effect). This central domain is __unaffected in Sxl-RAC. iii) Independent Y2H experiments have shown that it is exclusively the__ RBD-1 __(RNA binding domain 1) of the central domain of Sxl that interacts with Polr3E (Dong et al., 1999). Sxl-RAC contains this region, therefore will be recruited by Polr3E.

      iv) Review 3 also believes that this is not necessary (see cross-review below) and highlights the robustness of the Y2H experiments performed by Dong et al., 1999.

      • *

      Also, given that their DamID experiments reveal that Sxl binds half of the genes encoded in the Drosophila genome, finding that it binds around half of the tRNA genes is perhaps not surprising.


      __Author Response: __

      Our data show that Sxl binds to a range of Pol III-transcribed loci, and this binding pattern supports the proposed model that Sxl plays a broader regulatory role in Pol III activity. Within these Pol III targets, tRNA genes represent a specific and biologically relevant subset. The emphasis on tRNAs is not to suggest they are the exclusive or primary targets of Sxl, but rather to__ highlight a functionally important class of Pol III-transcribed elements__ that align with the model we are proposing. We will revise the text to better reflect this framing and avoid any confusion regarding the scope of Sxl’s binding profile.

      *I would like to see evidence beyond citing a 1999 yeast two-hybrid study that Sxl and Polr3E directly interact with one another. *


      Author response:

      We do not believe this is necessary (these points were also mentioned above):

      1. i) The Dong et al., 1999 study was highly comprehensive in its characterisation of Sxl binding to Polr3E.
      2. ii) Our DamID data provide strong complementary evidence for this interaction: knockdown of Polr3E robustly reduces Sxl’s recruitment to chromatin, strongly supporting the relevance of the interaction in vivo. iii) Review 3 highlights the robustness of the Y2H experiments performed by Dong et al., 1999.

      In my opinion, the differences in lethality observed with loss of Sxl versus control are unlikely to be meaningful given the different genetic backgrounds. The similar defects in negative geotaxis could be meaningful, but I'm unsure how often this phenotype is observed. What other class of genes affect negative geotaxis? It's a little unclear why having reduced expression of metabolic and pigment genes or of tRNAs would improve neuronal function.


      Author response:

      While the differences in survival were indeed subtle, they were statistically significant and thus warranted inclusion. Our primary aim in this section was to demonstrate that knockdown of Sxl or Polr3E results in comparable behavioural and transcriptional phenotypes, suggesting overlapping functional roles. In this context, we believe the data were presented transparently and effectively support our interpretation.

      Regarding the negative geotaxis phenotype, we appreciate the reviewer’s interest and agree that it is both intriguing and atypical. For this reason, we performed the assay multiple times, particularly in Polr3e knockdowns, to confirm the robustness of the result. To address potential confounding variables, we carefully selected control lines that account for genetic background and transgene insertion site, including KK controls and attP40-matched lines. We also employed multiple independent RNAi lines targeting Sxl to validate the phenotype across different genetic backgrounds.

      Although the observed improvement in climbing is unexpected, it is not without precedent in the RNA polymerase III field. Notably, Malik et al. (2024) demonstrated that heterozygous Polr3DEY/+ mutants exhibit a significantly delayed decline in climbing ability with age. We allude to this in the discussion and will revise the text to emphasise this connection more explicitly.

      Finally, while we recognise that negative geotaxis is a relatively broad assay and thus does not pinpoint the precise cellular mechanisms involved, we interpret the phenotype as suggesting a neural basis and a functional role for Sxl in the nervous system.

      One would expect that not just the same classes of genes would be affected by loss and overexpression of Sxl, but the same genes would be affected - are the same genes changing in opposite directions in the two experiments or just the same classes of genes. Likewise, are the same genes changing expression in the same direction with both Sxl and the Polr3E loss? Also, why are tRNA genes not also affected with Sxl loss. Finally, they describe the changes in gene expression as being in male adult neurons, but the sequencing was done of entire heads - so no way of knowing which cell type is showing differential gene expression.

      Author response:

      While we do examine gene classes, our approach also includes pairwise correlation analyses of gene expression changes between specific genotypes. Notably, we observed a significant positive correlation between Polr3e knockdowns and Sxl knockdowns, and a significant negative correlation between Sxl-RAC–expressing flies and Sxl knockdowns. Furthermore, we examined Sxl-DamID target genes within our RNA-seq datasets and found a consistent relationship between Sxl targets and genes differentially expressed in Polr3e knockdowns.

      Regarding the Pol III qPCR results, we note that tRNA expression changes may require a longer duration of RNAi induction (e.g., beyond 4 days) to become apparent, especially given that phenotypic effects such as changes in lifespan and negative geotaxis only emerge after 20 days or more. It is also plausible that Sxl knockdown leads to a partial reduction in Pol III efficiency, which may not be readily detectable through bulk Pol III qPCRs. We are willing to repeat Pol III qPCRs at later timepoints to further investigate this trend.

      Finally, we infer that gene expression changes observed in our RNA-seq data are of neuronal origin, as all knockdown and overexpression constructs used in this study were driven pan-neuronally using elav-/nSyb-GAL4. While we acknowledge that bulk RNA-seq does not provide cell-type resolution, tissue-specific assumptions are widely used in the field when driven by a relevant promoter.

      I'm also not sure what I'm supposed to be seeing in panel 5F (or in the related supplemental figure) and if it has any meaning - If they are using the Sxl-T2A-Gal4 to drive mCherry, I think one would expect to see expression since Sxl transcripts are made in both males and in females. Also, one would expect to see active protein expression (OPP staining) in most cells of the adult male brain and I think that is what is observed, but again, I'm not sure what I'm supposed to be looking at given the absence of any arrows or brackets in the figures.

      Author Response:

      Due to the presence of the T2A tag and the premature stop codon in exon 3 of early male Sxl transcripts, GAL4 expression is not expected in males unless the head-specific SxlRAC isoform is produced. The aim of panel 5F is to demonstrate the spatial overlap between SxlRAC expression (as we are examining male brains) and regions of elevated protein synthesis, as detected by OPP staining.

      To quantitatively assess this relationship, we performed colocalisation analysis using ImageJ, which showed a positive correlation between Sxl and OPP signal intensity, supporting this interpretation. It is also evident from our images that regions with lower levels of protein synthesis (such as the neuropil - as shown in independent studies Villalobos-Cantor et al., 2023) concurrently lack Sxl-related signal. We have highlighted regions in Fig. 5 exhibiting higher/lower levels of Sxl/OPP signal to better illustrate this relationship. We can also test the effects of knockdown/overexpression on general protein synthesis if required.

      Villalobos-Cantor S, Barrett RM, Condon AF, Arreola-Bustos A, Rodriguez KM, Cohen MS, Martin I. Rapid cell type-specific nascent proteome labeling in Drosophila. Elife. 2023 Apr 24;12:e83545. doi: 10.7554/eLife.83545. PMID: 37092974; PMCID: PMC10125018.

      Minor comments:

      * Line 223 - 225 - I believe that it is expected that Sxl transcripts would be broadly expressed in the male and female adult, given that it is only the spliced form of the transcript that is female specific in expression. *

      As explained above, the only isoform that will be ‘trapped’ by the T2A-GAL4 in males is the Sxl-RAC isoform (as the other isoforms contain premature stop codons). Our immunohistochemistry data indicate that Sxl-RAC is expressed in the male brain, specifically in neurons. Therefore, knockdown experiments in males will reduce all mRNA isoforms, of which, Sxl-RAC is the only one producing a protein.

      Line 236 - 238 - Sentence doesn't make sense.

      We have addressed and clarified this.

      Reviewer #2 (Significance (Required)):

      It would be significant to discover that a gene previously thought to function in only sex determination and dosage compensation also moonlights as a regulator of RNA polymerase III activity. Unfortunately, I am not convinced by the work presented in this study that this is the case.

      My expertise is in Drosophila biology, including development, transcription, sex determination, morphogenesis, genomics, transcriptomics, DNA binding

      Reviewer #3 (Evidence, reproducibility and clarity (Required)):*

      Storer, McClure and colleagues use genome-wide DNA-protein binding assays, transcriptomics, and genetics to work out that Drosophila Sxl, widely known as an RNA-binding protein which functions as a splicing factor to determine sex identity in Drosophila and related species, is also a chromatin factor that can stimulate transcription by Pol III and Pol II of genes involved with metabolism and protein homeostasis, specifically some encoding tRNAs.

      The evidence for the tenet of the paper -- that Sxl acts as a chromatin regulator with Polr3E, activating at least some of its targets with either Pol III or Pol II -- is logical and compelling, the paper is well written and the figures well presented. Of course, more experiments could always be wished for and proposed, but I think this manuscript could be published in many journals with just a minor revision not involving additional experiments. I have a few specific comments below, all minor.*

      Scientific points: - The approach taken for the evaluation of Sxl DNA-binding activity in Fig2 is not entirely clear. I assume these are crosses of elav-Gal4 x different UAS- lines, then using males or females for UAS-Sxl-Full-Length. But what about the others? Were the experiments done in males only? This is hinted at in the main text but not explicitly indicated in the figure or the methods (at least, that I could easily find). And is this approach extended to all other experiments? Longevity? Climbing assays? Considering the role of Sxl, it may be helpful to be fastidiously systematic with this.


      Author Response:

      We have revised the wording to ensure greater clarity. Males were used for all survival and behavioural experiments (as only males can be leveraged for knocking down Sxl-RAC without affecting the canonical Sxl-F isoform).

      - In the discussion, lines 360-61, the authors say: Indeed, knockdown of Polr3E leads to a loss of Sxl binding to chromatin, suggesting a cooperative mechanism. Maybe I am misunderstanding the authors, but when I read "cooperation" in this context I think of biochemical cooperative binding. This is possible, but I do not think a simple 'requirement' test can suggest specifically that this mechanistic feature of biochemical binding is at play. I would expect, for starters, a reciprocal requirement for binding (which is not tested), and some quantitative features that would be difficult to evaluate in vivo. I do not think cooperative binding needs to be invoked anyway, as the authors do not make any specific point or prediction about it. But if they do think this is going on, I think it would need to be referred to as a speculation.


      Author Response:

      We appreciate that the original wording may have been unclear and will revise the text to more accurately reflect a functional relationship, rather than implying direct cooperation.

      - In lines 428-432, the authors discuss the ancestral role of Sxl and make a comparison with ELAV, in the context of an RNA-binding protein that has molecular functions beyond those of a splicing factor, considering the functions of ELAV in RNA stability and translation, and finishing with "suggesting that similar regulatory mechanisms may be at play". I do not understand this latter sentence. Which mechanisms are these? Are the authors referring to the molecular activities of ELAV and SXL? But what would be the similarity? SXL seems to have a dual capacity to bind RNA and protein interactors, which allows it to work both in chromatin-level regulation as well as post-transcriptionally in splicing; but ELAV seems rather to take advantage of its RNA binding function to make it work in multiple RNA-related contexts, all post-transcriptional. I do not see an obvious parallel beyond the fact that RNA binding proteins can function at different levels of gene expression regulation -- but I would not say this parallel are "similar regulatory mechanisms", so I find the whole comparison a bit confusing.


      Author Response:

      We have reduced this section, as it is largely speculative and intended to highlight potential, though indirect, links in higher organisms. Our goal was primarily to illustrate the possibility that Sxl may have an ancestral role distinct from its well-characterised function, and to suggest a potential avenue for future research into ELAV2’s involvement in chromatin or Pol III regulation.

      - One aspect of the work that I find is missing in the discussion is the possibility that the simultaneous capacity of Sxl for RNA binding and Polr3E binding: are these mutually exclusive? if so, are they competitive or hierarchical? how would they be coordinated anyway?


      Author Response:

      This is an interesting point, and we have expanded on it further in the Discussion section.

      - The only aspect of the paper where I found that one could make an experimental improvement is the claim that Sxl induces the expression of genes that have the overall effect of stimulating protein synthesis. The OPP experiment shows a correlation between the expression of Sxl and the rate of protein synthesis initiation. However, a more powerful experiment would be, rather obviously, to introduce Sxl knock-down in the same experiment, and observe whether in Sxl-expressing neurons the incorporation of OPP is reduced. I put this forth as a minor point because the tenet of the paper would not be affected by the results (though the perception of importance of the newly described function could be reinforced).

      • *

      Author Response:

      This could be a valid experiment and we are prepared to perform it if required.

      - In a similar way, it would be interesting to know whether the recruitment of Polr3E and Sxl to chromatin is co-dependent or Sxl follows Polr3E. This is also a minor point because this would possibly refine the mechanism of recruitment but does not alter the main discovery.

      Author Response:

      We have addressed a similar point for Reviewer 2 (see below) and will include a Discussion point for this:

      If Sxl were required for Polr3E recruitment to RNA Pol III, then, in most male Drosophila melanogaster cells, Polr3E would not be incorporated, and males would not be viable (as it is essential for Pol III activity). While it is possible that there could be a subtle effect on Polr3E recruitment, such an experiment, would not alter the central conclusion of our study - that Sxl is recruited to chromatin (accessory to the Pol III complex) via Polr3E.

      * Figures and reporting:

      • In Figure 2, it would be helpful to see the truncation coordinate for the N and C truncations.

      • In Figure 3D, genomic coordinates are missing.

      • In Figure 3E, the magnitude in the Y axis is not entirely clear (at least not to me). How is the amount of binding across the genome quantified? Is this the average amplitude of normalised TaDa signal across the genome? Or only within binding intervals?

      • Figure S3E-F: it would be interesting to show the degree of overlap between the downregulated genes that are also binding targets (regardless of the outcome).

      • Figure 5C-E: similarly to Figure S3, it would be interesting to know how the transcriptional effects compare with the binding targets.

      • Authors use Gehan-Breslow-Wilcoxon to test survival, which is a bit unusual, as it gives more weight to the early deaths (which are rare in most Drosophila longevity experiments). Is there any rationale behind this? It may be even favour their null hypothesis.*


      Author response:

      Thank you for the detailed feedback on our figures. We have__ incorporated__ the suggested changes.

      We agree that examining the overlap between Sxl binding sites and transcriptional changes is valuable, and we aimed to highlight this in the pie charts shown in Figures S3 and S5. If the reviewer is suggesting a more explicit quantification of the proportion of Sxl-Dam targets with significant transcriptomic changes, we are happy to include this analysis in the final version of the manuscript.

      As noted in the Methods, both Gehan–Breslow–Wilcoxon (GBW) and Kaplan–Meier tests were used. The significance in Figure 4a is specific to the GBW test, which we indicated by describing the effect as mild. Our focus here is not on the magnitude of survival differences, but on the consistent trends observed in both Polr3e and Sxl knockdowns.

      Writing and language:*

      • Introduction finishes without providing an outline of the findings (which is fine by me if that is what the authors wanted).

      • In lines 361-5, the authors say "We speculate that this interaction not only facilitates Pol III transcription but may also influence chromatin architecture and RNA Pol II-driven transcription as observed with Pol III regulation in other organisms". "This interaction" refers to Polr3E-Sxl-DNA interaction and with "Pol III transcription" I presume the authors refer to transcription executed by Pol III. I am not clear about the meaning of the end of the sentence "as observed with Pol III regulation in other organisms". What is the observation, exactly? That Pol III modifies chromatin in Pol II regulated loci, or that Pol III interactors change chromatin architecture?

      • DPE abbreviation is not introduced (and only used once).

      • A few typos: Line 41 ...splicing of the Sxl[late] transcripts, which is [ARE?] constitutively transcribed (Keyes et al.,... Line 76 ...sexes but appears restricted to the nervous system [OF] male pupae and adults (Cline et Line 289 ...and S41). To assess any effect [ON]translational output, O-propargyl-puromycin (OPP)o Line 323 ...illustrating that the majority (72%) changes in tRNA levels [ARE] due to upregulation...hi Line 402 ...it was discovered [WE DISCOVERED] Line 792 ...Sxl across chromosomes X, 2 L/R, 3 L/R and 4. The y-axis represents the log[SYMBOL] ratio... This happens in other figure legends as well.*


      Author response:

      Thank you for the detailed feedback, we have clarified and incorporated the suggested changes.

      **Referee Cross-commenting***

      Reviewer 1 asks how physiological is the Sxl chromatin-association assay. I think the loss of association in Polr3E knock-down and the lack of association of other splicing factors goes a long way into answering this question. It is true that having positive binding data specifically for Sxl-RAC and negative binding data for a deletion mutant of the RMM domain would provide more robust conclusions (see below), but I am not sure it is completely necessary -- though this will depend on which journal the authors want to send the paper to.

      I think that the comment of reviewer 1 about the levels of expression of Sxl-DAM does not apply here because of the way TaDa works - it relies on codon slippage to produce minimal amounts of the DAM fusion protein, so by construction it will be expressed at much lower levels than the endogenous protein.

      Reviewer 1 also asks whether Polr3E chromatin-association is also dependent on Sxl, to round up the model and also as a way to address whether Sxl association to chromatin is real. While I agree with this on the former aim (this would be a nice-to-have), I think I disagree on the latter; there is no need for Polr3E recruitment to depend on Sxl for Sxl association to chromatin to be physiologically relevant. Polr3E is a peripheral component of Pol III and unlikely to depend on a factor of restricted expression like Sxl to interact with chromatin. The recruitment of Sxl could well be entirely 'hierarchical' and subject to Polr3E.

      Revewer 2 is concerned with the fact that every mutant form of Sxl shows the same result from the DamID labelling. I have to agree with this to a point. A deletion mutant of RMM domains would address this. Microscopy evidence in salivary glands would be nice, certainly, but the system may not lend itself to this particular interaction, which might be short-lived and/or weak. I do not immediately see the relevance of the chromatin binding capacity of non-Drosophilidae Sxl -- though it might indicate that the impact of the discovery is less likely to go beyond this group.

      Reviewer 2 does not find surprising that some tRNA genes (less than half) are regulated by Sxl. I think the value of that observation is just qualitative, as tRNAs are Pol III-produced transcripts, but their point is correct. A hypergeometric test could settle this.

      Reviewer 2 is concerned that the evidence of direct interaction between Sxl and Polr3E is a single 1999 two-hybrid study. But that paper contains also GST pull-downs that narrow down the specific domains that mediate binding, and perform the binding in competitive salt conditions. I think it is enough. The author team, I think, are not biochemists, so finding the right collaborators and performing these experiments would take time that I am not sure is warranted.

      Reviewer 2 is also concerned that the longevity assays may not be meaningful due to the difference in genetic backgrounds. This is a very reasonable concern (which I would extend to the climbing assays - any quantitative phenotype is sensitive to genetic background). However, I think the authors here may have already designed the experiment with this in mind - the controls express untargeted RNAi constructs, but I lose track of which one is control of which. This should be clarified in Methods.

      Other comments are in line, I think, with what I have pointed out and I generally agree with everything else that has been said.

      Reviewer #3 (Significance (Required)):

      Drosophila Sxl is widely known as an RNA-binding protein which functions as a splicing factor to determine sex identity in Drosophila and related species. It is a favourite example of how splicing factors and alternative can have profound influence in biology and used cleverly in the molecular circuitry of the cell to enact elegant regulatory decisions.

      In this work, Storer, McClure and colleagues use genome-wide DNA-protein binding assays, transcriptomics, and genetics to work out that Sxl is also a chromatin factor with an sex-independent, neuron-specific role in stimulating transcription by Pol III and Pol II, of genes involved with metabolism and protein homeostasis, including some encoding tRNAs.

      This opens a large number of interesting biological questions that range from biochemistry, gene regulation or neurobiology to evolution. How is the simultaneous capacity of binding RNA and chromatin (with the same protein domain, RRM) regulated/coordinated? How did this dual activity evolve and which one is the ancestral one? How many other RRM-containin RNA-binding proteins can also bind chromatin? How is Sxl recruited to chromatin to both Pol II and Pol III targets and are they functionally related? If so, how is the coordination of cellular functions activated through different RNA polymerases taking place and what is the role of Sxl in this? What are the functional consequences to neuronal biology? Does this affect similarly all Sxl-expressing neurons?

      The evidence for the central tenet of the paper -- that Sxl acts as a chromatin regulator with Polr3E, activating at least some of its targets with either Pol III or Pol II -- is logical and compelling, the paper is well written and the figures well presented. Of course, more experiments could always be wished for and proposed, but I think this manuscript could be published in many journals with just a minor revision not involving additional experiments.*

      Reviewer #4 (Evidence, reproducibility and clarity (Required)):

      *The convincing analysis demonstrates a role for the Drosophila Sex determining gene sex lethal in controlling aspects of transcription in the nervous system independent of its role in splicing. Interaction with an RNA Pol III subunit mediating Sxl association with chromatin and similar knockdown phenotypes strongly support the role of Sxl in the regulation of neuronal metabolism. Given that Sxl is an evolutionary recent acquisition for sex determination, the study may reveal an ancestral role for Sxl.

      The conclusions are well justified by the datasets presented and I have no issues with the study or the interpretation. Throughout the work is well referenced, though perhaps the authors might take a look at Zhang et al (2014) (PMID: 24271947) for an interesting evolutionary perspective for the discussion.*

      Author Response:

      Thank you for the thoughtful suggestion. We will be sure to incorporate the findings from Zhang et al. regarding the evolution of the sex determination pathway.

      *I have some minor comments for clarification:

      There is no Figure 2b, should be labelled 2 or label TaDa plots as 2b

      Clarify if Fig 2 data are larval or adult *

      *Larval

      Fig 3d - are these replicates or female and male?

      Please elaborate on tub-GAL80[ts] developmental defects

      Fig 4e, are transcriptomics done with the VDRC RNAi line? The VDRC and BDSC RNAi lines exhibit different behaviours - former has "better" survival and Better negative geotaxis, the latter seems to have poorer survival but little geotaxis effect?*

      *Fig S3 - volcano plot for Polr3E?

      Fig S4a - legend says downregulated genes?

      The discussion should at least touch on the fact that Sxl amorphs (i.e. Sxl[fP7B0] are male viable and fertile, emphasising that the newly uncovered role is not essential.*

      Author Response:

      We agree with the suggestions outlined in the comments and have made the appropriate revisions.

      Reviewer #4 (Significance (Required)):*

      A nonessential role for Sxl in the nervous system independent of sex-determination contributes to better understanding a) the evolution of sex determining mechanisms, b) the role of RNA PolIII in neuronal homeostasis and c) more widely to the neuronal aging field. I think this well-focused study reveals a hitherto unsuspected role for Sxl.*

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #4

      Evidence, reproducibility and clarity

      The convincing analysis demonstrates a role for the Drosophila Sex determining gene sex lethal in controlling aspects of transcription in the nervous system independent of its role in splicing. Interaction with an RNA Pol III subunit mediating Sxl association with chromatin and similar knockdown phenotypes strongly support the role of Sxl in the regulation of neuronal metabolism. Given that Sxl is an evolutionary recent acquisition for sex determination, the study may reveal an ancestral role for Sxl.

      The conclusions are well justified by the datasets presented and I have no issues with the study or the interpretation. Throughout the work is well referenced, though perhaps the authors might take a look at Zhang et al (2014) (PMID: 24271947) for an interesting evolutionary perspective for the discussion. I have some minor comments for clarification:

      There is no Figure 2b, should be labelled 2 or label TaDa plots as 2b

      Clarify if Fig 2 data are larval or adult

      Fig 3d - are these replicates or female and male?

      Please elaborate on tub-GAL80[ts] developmental defects

      Fig 4e, are transcriptomics done with the VDRC RNAi line? The VDRC and BDSC RNAi lines exhibit different behaviours - former has "better" survival and Better negative geotaxis, the latter seems to have poorer survival but little geotaxis effect?

      Fig S3 - volcano plot for Polr3E?

      Fig S4a - legend says downregulated genes?

      The discussion should at least touch on the fact that Sxl amorphs (i.e. Sxl[fP7B0] are male viable and fertile, emphasising that the newly uncovered role is not essential

      Significance

      A nonessential role for Sxl in the nervous system independent of sex-determination contributes to better understanding a) the evolution of sex determining mechanisms, b) the role of RNA PolIII in neuronal homeostasis and c) more widely to the neuronal aging field. I think this well-focused study reveals a hitherto unsuspected role for Sxl.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Storer, McClure and colleagues use genome-wide DNA-protein binding assays, transcriptomics, and genetics to work out that Drosophila Sxl, widely known as an RNA-binding protein which functions as a splicing factor to determine sex identity in Drosophila and related species, is also a chromatin factor that can stimulate transcription by Pol III and Pol II of genes involved with metabolism and protein homeostasis, specifically some encoding tRNAs.

      The evidence for the tenet of the paper -- that Sxl acts as a chromatin regulator with Polr3E, activating at least some of its targets with either Pol III or Pol II -- is logical and compelling, the paper is well written and the figures well presented. Of course, more experiments could always be wished for and proposed, but I think this manuscript could be published in many journals with just a minor revision not involving additional experiments. I have a few specific comments below, all minor.

      Scientific points:

      • The approach taken for the evaluation of Sxl DNA-binding activity in Fig2 is not entirely clear. I assume these are crosses of elav-Gal4 x different UAS- lines, then using males or females for UAS-Sxl-Full-Length. But what about the others? Were the experiments done in males only? This is hinted at in the main text but not explicitly indicated in the figure or the methods (at least, that I could easily find). And is this approach extended to all other experiments? Longevity? Climbing assays? Considering the role of Sxl, it may be helpful to be fastidiously systematic with this.
      • In the discussion, lines 360-61, the authors say: Indeed, knockdown of Polr3E leads to a loss of Sxl binding to chromatin, suggesting a cooperative mechanism. Maybe I am misunderstanding the authors, but when I read "cooperation" in this context I think of biochemical cooperative binding. This is possible, but I do not think a simple 'requirement' test can suggest specifically that this mechanistic feature of biochemical binding is at play. I would expect, for starters, a reciprocal requirement for binding (which is not tested), and some quantitative features that would be difficult to evaluate in vivo. I do not think cooperative binding needs to be invoked anyway, as the authors do not make any specific point or prediction about it. But if they do think this is going on, I think it would need to be referred to as a speculation.
      • In lines 428-432, the authors discuss the ancestral role of Sxl and make a comparison with ELAV, in the context of an RNA-binding protein that has molecular functions beyond those of a splicing factor, considering the functions of ELAV in RNA stability and translation, and finishing with "suggesting that similar regulatory mechanisms may be at play". I do not understand this latter sentence. Which mechanisms are these? Are the authors referring to the molecular activities of ELAV and SXL? But what would be the similarity? SXL seems to have a dual capacity to bind RNA and protein interactors, which allows it to work both in chromatin-level regulation as well as post-transcriptionally in splicing; but ELAV seems rather to take advantage of its RNA binding function to make it work in multiple RNA-related contexts, all post-transcriptional. I do not see an obvious parallel beyond the fact that RNA binding proteins can function at different levels of gene expression regulation -- but I would not say this parallel are "similar regulatory mechanisms", so I find the whole comparison a bit confusing.
      • One aspect of the work that I find is missing in the discussion is the possibility that the simultaneous capacity of Sxl for RNA binding and Polr3E binding: are these mutually exclusive? if so, are they competitive or hierarchical? how would they be coordinated anyway?
      • The only aspect of the paper where I found that one could make an experimental improvement is the claim that Sxl induces the expression of genes that have the overall effect of stimulating protein synthesis. The OPP experiment shows a correlation between the expression of Sxl and the rate of protein synthesis initiation. However, a more powerful experiment would be, rather obviously, to introduce Sxl knock-down in the same experiment, and observe whether in Sxl-expressing neurons the incorporation of OPP is reduced. I put this forth as a minor point because the tenet of the paper would not be affected by the results (though the perception of importance of the newly described function could be reinforced).
      • In a similar way, it would be interesting to know whether the recruitment of Polr3E and Sxl to chromatin is co-dependent or Sxl follows Polr3E. This is also a minor point because this would possibly refine the mechanism of recruitment but does not alter the main discovery.

      Figures and reporting:

      • In Figure 2, it would be helpful to see the truncation coordinate for the N and C truncations.
      • In Figure 3D, genomic coordinates are missing.
      • In Figure 3E, the magnitude in the Y axis is not entirely clear (at least not to me). How is the amount of binding across the genome quantified? Is this the average amplitude of normalised TaDa signal across the genome? Or only within binding intervals?
      • Figure S3E-F: it would be interesting to show the degree of overlap between the downregulated genes that are also binding targets (regardless of the outcome).
      • Figure 5C-E: similarly to Figure S3, it would be interesting to know how the transcriptional effects compare with the binding targets.
      • Authors use Gehan-Breslow-Wilcoxon to test survival, which is a bit unusual, as it gives more weight to the early deaths (which are rare in most Drosophila longevity experiments). Is there any rationale behind this? It may be even favour their null hypothesis.

      Writing and language:

      • Introduction finishes without providing an outline of the findings (which is fine by me if that is what the authors wanted).
      • In lines 361-5, the authors say "We speculate that this interaction not only facilitates Pol III transcription but may also influence chromatin architecture and RNA Pol II-driven transcription as observed with Pol III regulation in other organisms". "This interaction" refers to Polr3E-Sxl-DNA interaction and with "Pol III transcription" I presume the authors refer to transcription executed by Pol III. I am not clear about the meaning of the end of the sentence "as observed with Pol III regulation in other organisms". What is the observation, exactly? That Pol III modifies chromatin in Pol II regulated loci, or that Pol III interactors change chromatin architecture?
      • DPE abbreviation is not introduced (and only used once).
      • A few typos: Line 41 ...splicing of the Sxl[late] transcripts, which is [ARE?] constitutively transcribed (Keyes et al.,... Line 76 ...sexes but appears restricted to the nervous system [OF] male pupae and adults (Cline et Line 289 ...and S41). To assess any effect [ON]translational output, O-propargyl-puromycin (OPP)o Line 323 ...illustrating that the majority (72%) changes in tRNA levels [ARE] due to upregulation...hi Line 402 ...it was discovered [WE DISCOVERED] Line 792 ...Sxl across chromosomes X, 2 L/R, 3 L/R and 4. The y-axis represents the log[SYMBOL] ratio... This happens in other figure legends as well.

      Referee Cross-commenting

      Reviewer 1 asks how physiological is the Sxl chromatin-association assay. I think the loss of association in Polr3E knock-down and the lack of association of other splicing factors goes a long way into answering this question. It is true that having positive binding data specifically for Sxl-RAC and negative binding data for a deletion mutant of the RMM domain would provide more robust conclusions (see below), but I am not sure it is completely necessary -- though this will depend on which journal the authors want to send the paper to.

      I think that the comment of reviewer 1 about the levels of expression of Sxl-DAM does not apply here because of the way TaDa works - it relies on codon slippage to produce minimal amounts of the DAM fusion protein, so by construction it will be expressed at much lower levels than the endogenous protein.

      Reviewer 1 also asks whether Polr3E chromatin-association is also dependent on Sxl, to round up the model and also as a way to address whether Sxl association to chromatin is real. While I agree with this on the former aim (this would be a nice-to-have), I think I disagree on the latter; there is no need for Polr3E recruitment to depend on Sxl for Sxl association to chromatin to be physiologically relevant. Polr3E is a peripheral component of Pol III and unlikely to depend on a factor of restricted expression like Sxl to interact with chromatin. The recruitment of Sxl could well be entirely 'hierarchical' and subject to Polr3E.

      Revewer 2 is concerned with the fact that every mutant form of Sxl shows the same result from the DamID labelling. I have to agree with this to a point. A deletion mutant of RMM domains would address this. Microscopy evidence in salivary glands would be nice, certainly, but the system may not lend itself to this particular interaction, which might be short-lived and/or weak. I do not immediately see the relevance of the chromatin binding capacity of non-Drosophilidae Sxl -- though it might indicate that the impact of the discovery is less likely to go beyond this group.

      Reviewer 2 does not find surprising that some tRNA genes (less than half) are regulated by Sxl. I think the value of that observation is just qualitative, as tRNAs are Pol III-produced transcripts, but their point is correct. A hypergeometric test could settle this.

      Reviewer 2 is concerned that the evidence of direct interaction between Sxl and Polr3E is a single 1999 two-hybrid study. But that paper contains also GST pull-downs that narrow down the specific domains that mediate binding, and perform the binding in competitive salt conditions. I think it is enough. The author team, I think, are not biochemists, so finding the right collaborators and performing these experiments would take time that I am not sure is warranted.

      Reviewer 2 is also concerned that the longevity assays may not be meaningful due to the difference in genetic backgrounds. This is a very reasonable concern (which I would extend to the climbing assays - any quantitative phenotype is sensitive to genetic background). However I think the authors here may have already designed the experiment with this in mind - the controls expres untargeted RNAi constructs, but I lose track of which one is control of which. This should be clarified in Methods.

      Other comments are in line, I think, with what I have pointed out and I generally agree with everything else that has been said.

      Significance

      Drosophila Sxl is widely known as an RNA-binding protein which functions as a splicing factor to determine sex identity in Drosophila and related species. It is a favourite example of how splicing factors and alternative can have profound influence in biology and used cleverly in the molecular circuitry of the cell to enact elegant regulatory decisions.

      In this work, Storer, McClure and colleagues use genome-wide DNA-protein binding assays, transcriptomics, and genetics to work out that Sxl is also a chromatin factor with an sex-independent, neuron-specific role in stimulating transcription by Pol III and Pol II, of genes involved with metabolism and protein homeostasis, including some encoding tRNAs.

      This opens a large number of interesting biological questions that range from biochemistry, gene regulation or neurobiology to evolution. How is the simultaneous capacity of binding RNA and chromatin (with the same protein domain, RRM) regulated/coordinated? How did this dual activity evolve and which one is the ancestral one? How many other RRM-containin RNA-binding proteins can also bind chromatin? How is Sxl recruited to chromatin to both Pol II and Pol III targets and are they functionally related? If so, how is the coordination of cellular functions activated through different RNA polymerases taking place and what is the role of Sxl in this? What are the functional consequences to neuronal biology? Does this affect similarly all Sxl-expressing neurons?

      The evidence for the central tenet of the paper -- that Sxl acts as a chromatin regulator with Polr3E, activating at least some of its targets with either Pol III or Pol II -- is logical and compelling, the paper is well written and the figures well presented. Of course, more experiments could always be wished for and proposed, but I think this manuscript could be published in many journals with just a minor revision not involving additional experiments.

    1. I am sincerely grateful to the editors and peer reviewers at MetaROR for their detailed feedback and valuable comments and suggestions. I have addressed each point below.

      Handling Editor

      1. However, the article’s progression and arguments, along with what it seeks to contribute to the literature need refinement and clarification. The argument for PRC is under-developed due to a lack of clarity about what the article means by scientific

      communication. Clarity here might make the endorsement of PRC seem like less of a foregone conclusion.

      The structure of the paper (and discussion) has changed significantly to address the feedback.

      2. I strongly endorse the main theme of most of the reviews, which is that the progression and underlying justifications for this article’s arguments needs a great deal of work. In my view, this article’s main contribution seems to be the evaluation of the three peer review models against the functions of scientific communication. I say ‘seems to be’ because the article is not very clear on that and I hope you will consider clarifying what your manuscript seeks to add to the existing work in this field. In any case, if that assessment of the three models is your main contribution, that part is somewhat underdeveloped. Moreover, I never got the sense that there is clear agreement in the literature about what the tenets of scientific communication are. Note that scientific communication is a field in its own right.

      I have implemented a more rigorous approach to argumentation in response. “Scientific communication” was replaced by “scholarly communication.”

      3. I also agree that paper is too strongly worded at times, with limitations and assumptions in the analysis minimised or not stated. For example, all of the typologies and categories drawn could easily be reorganised and there is a high degree of subjectivity in this entire exercise. Subjective choices should be highlighted and made salient for the reader. Note that greater clarity, rigour, and humility may also help with any alleged or actual bias.

      I have incorporated the conceptual framework and description of the research methodology. However, the

      Discussion section reflects my personal perspective in some points, which I have explicitly highlighted to ensure clarity.

      4. I agree with Reviewer 3 that the ‘we’ perspective is distracting.

      This has been fixed.

      5. The paragraph starting with ‘Nevertheless’ on page 2 is very long.

      The text was restructured.

      6. There are many points where language could be shortened for readability, for example:

      Page 3: ‘decision on publication’ could be ‘publication decision’.

      Page 5: ‘efficiency of its utilization’ could be ‘its efficiency’.

      Page 7: ‘It should be noted…’ could be ‘Note that…’.

      I have proofread the text.

      7. Page 7: ‘It should be noted that..’ – this needs a reference.

      This statement has been moved to the Discussion section, paraphrased, and reference added.

      “It should be also noted that peer review innovations pull in opposing directions, with some aiming to increase efficiency and reduce costs, while others aim to promote rigor and increase costs

      (Kaltenbrunner et al., 2022).”

      8. I’m not sure that registered reports reflect a hypothetico-deductive approach (page 6). For instance, systematic reviews (even non-quantitative ones) are often published as registered reports and Cochrane has required this even before the move towards registered reports in quantitative psychology.

      I have added this clarification.

      9. I agree that modular publishing sits uneasily as its own chapter.

      Modular publishing has been combined with registered reports into the deconstructed publication group of

      models, now Section 5.1.

      10. Page 14: ‘The "Publish-Review-Curate" model is universal that we expect to be the future of scientific publishing. The transition will not happen today or tomorrow, but in the next 5-10 years, the number of projects such as eLife, F1000Research, Peer Community in, or MetaROR will rapidly increase’. This seems overly strong (an example of my larger critique and that of the reviewers).

      This part of the text has been rewritten.

      Reviewer 1

      11. For example, although Model 3 is less chance to insert bias to the readers, it also weakens the filtering function of the review system. Let’s just think about the dangers of machine-generated articles, paper-mills, p-hacked research reports and so on. Although the editors do some pre-screening for the submissions, in a world with only Model 3 peer review the literature could easily get loaded with even more ‘garbage’ than in a model where additional peers help the screening.

      I think that generated text is better detected by software tools. At the same time, I tried and described the pros and cons of different models in a more balanced way in the concluding section.

      12. Compared to registered reports other aspects can come to focus that Model 3 cannot cover. It’s the efficiency of researchers’ work. In the care of registered reports, Stage 1 review can still help researchers to modify or improve their research design or data collection method. Empirical work can be costly and time-consuming and post-publication review can only say that “you should have done it differently then it

      would make sense”.

      Thank you very much for this valuable contribution, I have added this statement at P. 11.

      13. Finally, the author puts openness as a strength of Model 3. In my eyes, openness is a separate question. All models can work very openly and transparently in the right circumstances. This dimension is not an inherent part of the models.

      I think that the model, providing peer reviews to all the submissions, ensures maximum transparency. However, I have made effort to make the wording more balanced and distinguish my personal perspective from the literature.

      14. In conclusion, I would not make verdict over the models, instead emphasize the different functions they can play in scientific communication.

      This idea has been reflected now in the concluding section.

      15. A minor comment: I found that a number of statements lack references in the Introduction. I would have found them useful for statements such as “There is a point of view that peer review is included in the implicit contract of the researcher.”

      Thank you for your feedback. I have implemented a more rigorous approach to argumentation in response.

      Reviewer 2

      16. The primary weakness of this article is that it presents itself as an 'analysis' from which they 'conclude' certain results such as their typology, when this appears clearly to be an opinion piece. In my view, this results in a false claim of objectivity which detracts from what would otherwise be an interesting and informative, albeit subjective, discussion, and thus fails to discuss the limitations of this approach.

      I have incorporated the conceptual framework and description of the research methodology. However, the

      Discussion section reflects my personal perspective in some points, which I have explicitly highlighted to ensure clarity.

      17. A secondary weakness is that the discussion is not well structured and there are some imprecisions of expression that have the potential to confuse, at least at first.

      The structure of the paper (and discussion) has changed significantly.

      18. The evidence and reasoning for claims made is patchy or absent. One instance of the former is the discussion of bias in peer review. There are a multitude of studies of such bias and indeed quite a few meta-analyses of these studies. A systematic search could have been done here but there is no attempt to discuss the totality of this literature. Instead, only a few specific studies are cited. Why are these ones chosen? We have no idea. To this extent I am not convinced that the references used here are the most appropriate.

      I have reviewed the existing references and incorporated additional sources. However, the study does not claim to conduct a systematic literature review; rather, it adopts an interpretative approach to literature analysis.

      19. Instances of the latter are the claim that "The most well-known initiatives at the moment are ResearchEquals and Octopus" for which no evidence is provided, the claim that "we believe that journal-independent peer review is a special case of Model 3" for which no further argument is provided, and the claim that "the function of being the "supreme judge" in deciding what is "good" and "bad" science is taken on by peer review" for which neither is provided.

      Thank you for your feedback. I have implemented a more rigorous approach to argumentation in response.

      20. A particular example of this weakness, which is perhaps of marginal importance to the overall paper but of strong interest to this reviewer is the rather odd engagement with history within the paper. It is titled "Evolution of Peer Review" but is really focussed on the contemporary state-of-play. Section 2 starts with a short history of peer review in scientific publishing, but that seems intended only to establish what is

      described as the 'traditional' model of peer review. Given that that short history had just shown how peer review had been continually changing in character over centuries - and indeed Kochetkov goes on to describe further changes - it is a little difficult to work out what 'traditional' might mean here; what was 'traditional' in 2010 was not the same as what was 'traditional' in 1970. It is not clear how seriously this history is being taken. Kochetkov has earlier written that "as early as the beginning of the 21st century, it was argued that the system of peer review is 'broken'" but of course criticisms - including fundamental criticisms - of peer review are much older than this. Overall, this use of history seems designed to privilege the

      experience of a particular moment in time, that coincides with the start of the metascience reform movement.

      While the paper addresses some aspects of peer review history, it does not provide a comprehensive examination of this topic. A clarifying statement to this effect has been included in the methodology section.

      “… this section incorporates elements of historical analysis, it does not fully qualify as such because primary sources were not directly utilized. Instead, it functions as an interpretative literature review, and one that is intentionally concise, as a comprehensive history of peer review falls outside the scope of this research”.

      21. Section 2 also demonstrates some of the second weakness described, a rather loose structure. Having moved from a discussion of the history of peer review to detail the first model, 'traditional' peer review, it then also goes on to describe the problems of this model. This part of the paper is one of the best - and best - evidenced. Given the importance of it to the main thrust of the discussion it should probably have been given more space as a Section all on its own.

      This section (now Section 4) has been extended, see also previous comment.

      22. Another example is Section 4 on Modular Publishing, in which Kochetkov notes "Strictly speaking, modular publishing is primarily an innovative approach for the publishing workflow in general rather than specifically for peer review."

      Kochetkov says "This is why we have placed this innovation in a separate category" but if it is not an innovation in peer review, the bigger question is 'Why was it included in this article at all?'.

      Modular publishing has been combined with registered reports into the deconstructed publication group of models, now Section 5.1.

      23. One example of the imprecisions of language is as follows. The author also shifts between the terms 'scientific communication' and 'science communication' but, at least in many contexts familiar to this reviewer, these are not the same things, the former denoting science-internal dissemination of results through publication (which the author considers), conferences and the like (which the author specifically excludes) while the latter denotes the science-external public dissemination of scientific findings to non-technical audiences, which is entirely out of scope for this article.

      Thank you for your remark. As a non- native speaker, I initially did not grasp the distinction between the terms. However, I believe the phrase ‘scholarly communication’ is the most universally applicable term. This adjustment has now been incorporated into the text.

      24. A final note is that Section 3, while an interesting discussion, seems largely derivative from a typology of Waltman, with the addition of a consideration of whether a reform is 'radical' or 'incremental', based on how 'disruptive' the reform is. Given that this is inherently a subjective decision, I wonder if it might not have been more informative to consider 'disruptiveness' on a scale and plot it accordingly. This would allow for some range to be imagined for each reform as well; surely reforms might be more or less disruptive depending on how they are implemented. Given that each reform is considered against each model, it is somewhat surprising that this is not presented in a tabular or graphical form.

      Ultimately, I excluded this metric due to its current reliance on purely subjective judgment. Measuring 'disruptiveness', e.g., through surveys or interviews remains a task for future research. 

      25. Reconceptualize this as an opinion piece. Where systematic evidence can be drawn upon to make points, use that, but don't be afraid to just present a discussion from what is clearly a well-informed author.

      I cannot definitively classify this work as an opinion piece. In fact, this manuscript synthesizes elements of a literature review, research article, and opinion essay. My idea was to integrate the strengths of all three genres.

      26. Reconsider the focus on history and 'evolution' if the point is about the current state of play and evaluation of reforms (much as I would always want to see more studies on the history and evolution of peer review).

      I have revised the title to better reflect the study’s scope and explicitly emphasize its focus on contemporary developments in the field.

      “Peer Review at the Crossroads”

      27. Consider ways in which the typology might be expanded, even if at subordinate level.

      I have updated the typology and introduced the third tier, where it is applicable (see Fig.2).

      Reviewer 3

      28. In my view, the biggest issue with the current peer review system is the low quality of reviews, but the manuscript only mentions this fleetingly. The current system facilitates publication bias, confirmation bias, and is generally very inconsistent. I think this is partly due to reviewers’ lack of accountability in such a closed peer review system, but I would be curious to hear the author’s ideas about this, more elaborately than they provide them as part of issue 2.

      I have elaborated on this issue in the footnote.

      29. I’m missing a section in the introduction on what the goals of peer review are or should be. You mention issues with peer review, and these are mostly fair, but their importance is only made salient if you link them to the goals of peer review. The author does mention some functions of peer review later in the paper, but I think it would be good to expand that discussion and move it to a place earlier in the manuscript.

      The functions of peer review are summarized in the first paragraph of Introduction.

      30. Table 1 is intuitive but some background on how the author arrived at these categorizations would be welcome.

      When is something incremental and when is something radical? Why are some innovations included but not others (e.g., collaborative peer review, see https://content.prereview.org/how-collaborative-peer-review-can-

      transform-scientific-research/)?

      Collaborative peer review, namely, Prereview was mentioned in the context of Model 3 (Publish-Review-Curate). However, I have extended this part of the paper.

      31. “Training of reviewers through seminars and online courses is part of the strategies of many publishers. At the same time, we have not been able to find statistical data or research to assess the effectiveness of such training.” (p. 5)  There is some literature on this, although not recent. See work by Sara Schroter for example, Schroter et al., 2004; Schroter et al., 2008)

      Thank you very much, I have added these studies and a few more recent ones.

      32. “It should be noted that most initiatives aimed at improving the quality of peer review simultaneously increase the costs.” (p. 7) This claim needs some support. Please explicate why this typically is the case and how it should impact our evaluations of these initiatives.

      I have moved this part to the Discussion section.

      33. I would rephrase “Idea of the study” in Figure 2 since the other models start with a tangible output (the manuscript). This is the same for registered reports where they submit a tangible report including hypotheses, study design, and analysis plan. In the same vein, I think study design in the rest of the figure might also not be the best phrasing. Maybe the author could use the terminology used by COS (Stage 1 manuscript, and Stage 2 manuscript, see Details & Workflow tab of https://www.cos.io/initiatives/registered-reports). Relatedly, “Author submits the first version of the manuscript” in the first box after the ‘Manuscript (report)’ node maybe a confusing phrase because I think many researchers see the first version of the manuscript as the stage 1 report sent out for stage 1 review.

      Thank you very much. Stage 1 and Stage 2 manuscripts look like suitable labelling solution.

      34. One pathway that is not included in Figure 2 is that authors can decide to not conduct the study when improvements are required. Relatedly, in the publish- review-curate model, is revising the manuscripts based on the reviews not optional as well? Especially in the case of 3a, authors can hardly be forced to make changes even though the reviews are posted on the platform.

      All the four models imply a certain level of generalization; thus, I tried to avoid redundant details. However, I have added this choice to the PRC model (now, Model 4).

      35. I think the author should discuss the importance of ‘open identities’ more. This factor is now not explicitly included in any of the models, while it has been found to be one of the main characteristics of peer review systems (Ross-Hellauer, 2017).

      This part has been extended.

      36. More generally, I was wondering why the author chose these three models and not others. What were the inclusion criteria for inclusion in the manuscript? Some information on the underlying process would be welcome, especially when claims like “However, we believe that journal-independent peer review is a special case of Model 3 (“Publish-Review-Curate”).” are made without substantiation.

      The study included four generalized models of peer review that involved some level of abstraction.

      37. Maybe it helps to outline the goals of the paper a bit more clearly in the introduction. This helps the reader to know what to expect.

      The Introduction has been revised including the goal and objectives.

      38. The Modular Publishing section is not inherently related to peer review models, as you mention in the first sentence of that paragraph. As such, I think it would be best to omit this section entirely to maintain the flow of the paper. Alternatively, you could shortly discuss it in the discussion section but a separate paragraph seems too much from my point of view.

      Modular publishing has been combined with registered reports into the fragmented publishing group of models, now in Section 5.

      39. Labeling model 3 as post-publication review might be confusing to some readers. I believe many researchers see post-publication review as researchers making comments on preprints, or submitting commentaries to journals. Those activities are substantially different from the publish-review-curate model so I think it is important to distinguish between these types.

      The label was changed into Publish-Review-Curate model.

      40. I do not think the conclusions drawn below Table 3 logically follow from the earlier text. For example, why are “all functions of scientific communication implemented most quickly and transparently in Model 3”? It could be that the entire process takes longer in Model 3 (e.g. because reviewers need more time), so that Model 1 and Model 2 lead to outputs quicker. The same holds for the following claim: “The additional costs arising from the independent assessment of information based on open reviews are more than compensated by the emerging opportunities for scientific pluralism.” What is the empirical evidence for this? While I personally do think that Model 3 improves on Model 1, emphatic statements like this require empirical evidence. Maybe the author could provide some suggestions on how we can attain this evidence. Model 2 does have some empirical evidence underpinning its validity (see Scheel, Schijen, Lakens, 2021; Soderberg et al., 2021; Sarafoglou et al. 2022) but more meta-research inquiries into the effectiveness and cost- benefits ratio of registered reports would still be welcome in general.

      The Discussion section has been substantially revised to address this point. While I acknowledge the current scarcity of empirical studies on innovative peer review models, I have incorporated a critical discussion of this methodological gap. I am grateful for the suggested literature on RRs, which I have now integrated into the relevant subsection.

      41. What is the underlaying source for the claim that openness requires three conditions?

      I have made effort to clarify within the text that this reflects my personal stance.

      42. “If we do not change our approach, science will either stagnate or transition into other forms of communication.” (p. 2) I don’t think this claim is supported sufficiently strongly. While I agree there are important problems in peer review, I think would need to be a more in-depth and evidence-based analysis before claims like this can be made.

      The sentence has been rephrased.

      43. On some occasions, the author uses “we” while the study is single authored.

      This has been fixed.

      44. Figure 1: The top-left arrow from revision to (re-)submission is hidden

      I have updated Figure 1.

      45. “The low level of peer review also contributes to the crisis of reproducibility in scientific research (Stoddart, 2016).” (p. 4) I assume the author means the low quality of peer review.

      This has been fixed.

      46. “Although this crisis is due to a multitude of factors, the peer review system bears a significant responsibility for it.” (p. 4)

      This is also a big claim that is not substantiated

      I have paraphrased this sentence as

      “While multiple factors drive this crisis, deficiencies in the peer review process

      remain a significant contributor.” and added a footnote.

      47. “Software for automatic evaluation of scientific papers based on artificial intelligence (AI) has emerged relatively recently” (p. 5) The author could add RegCheck (https://regcheck.app/) here, even though it is still in development. This tool is especially salient in light of the finding that preregistration-paper checks are rarely done as part of reviews (see Syed, 2023)

      Thank you very much, I have added this information.

      48. There is a typo in last box of Figure 1 (“decicion” instead of “decision”). I also found typos in the second box of Figure 2, where “screns” should be “screens”, and the author decision box where “desicion” should be “decision”

      This has been fixed.

      49. Maybe it would be good to mention results blinded review in the first paragraph of 3.2. This is a form of peer review where the study is already carried out but reviewers are blinded to the results. See work by Locascio (2017), Grand et al. (2018), and Woznyj et al. (2018).

      Thanks, I have added this (now section 5.2)

      50. Is “Not considered for peer review” in figure 3b not the same as rejected? I feel that it is rejected in the sense that neither the manuscript not the reviews will be posted on the platform.

      Changed into “Rejected”

      51. “In addition to the projects mentioned, there are other platforms, for example, PREreview12, which departs even more radically from the traditional review format due to the decentralized structure of work.” (p. 11) For completeness, I think it would be helpful to add some more information here, for example why exactly decentralization is a radical departure from the traditional model.

      I have extended this passage.

      52. “However, anonymity is very conditional - there are still many “keys” left in the manuscript, by which one can determine, if not the identity of the author, then his country, research group, or affiliated organization.” (p.11) I would opt for the neutral “their” here instead of “his”, especially given that this is a paragraph about equity and inclusion.

      This has been fixed.

      53. “Thus, “closeness” is not a good way to address biases.” (p. 11) This might be a straw man argument because I don’t believe researchers have argued that it is a good method to combat biases. If they did, it would be good to cite them here. Alternatively, the sentence could be omitted entirely.

      I have omitted the sentence.

      54. I would start the Modular Publishing section with the definition as that allows readers to interpret the other statements better.

      Modular publishing has been combined with registered reports into the deconstructed publication group of

      models, now in Section 5, general definition added.

      55. It would be helpful if the Models were labeled (instead of using Model 1, Model 2, and Model 3) so that readers don’t have to think back what each model involved.

      All the models represent a kind of generalization, which is why non-detailed labels are used. The text labels may vary depending on the context.

      56. Table 2: “Decision making” for the editor’s role is quite broad, I recommend to specify and include what kind of decisions need to be made.

      Changed into “Making accept/reject decisions”

      57. Table 2: “Aim of review” – I believe the aim of peer review differs also within these models (see the “schools of thought” the author mentions earlier), so maybe a statement on what the review entails would be a better way to phrase this.

      Changed into “What does peer review entail?”

      58. Table 2: One could argue that the object of the review’ in Registered Reports is

      also the manuscript as a whole, just in different stages. As such, I would phrase this differently.

      Current wording fits your remark

      “Manuscript in terms of study design and execution”

      Reviewer 4

      59. Page 3: It’s hard to get a feel for the timeline given the dates that are described. We have peer review becoming standard after WWII (after 1945), definitively established by the second half of the century, an example of obligatory peer review starting in 1976, and in crisis by the end of the 20th century. I would consider adding

      examples that better support this timeline – did it become more common in specific journals before 1976? Was the crisis by the end of the 20th century something that happened over time or something that was already intrinsic to the institution? It doesn’t seem like enough time to get established and then enter crisis, but more details/examples could help make the timeline clear. Consider discussing the benefits of the traditional model of peer review.

      This section has been extended.

      60. Table 1 – Most of these are self- explanatory to me as a reader, but not all. I don’t know what a registered report refers to, and it stands to reason that not all of these innovations are familiar to all readers. You do go through each of these sections, but that’s not clear when I initially look at the table. Consider having a more informative caption. Additionally, the left column is “Course of changes” here but “Directions” in text. I’d pick one and go with it for consistency.

      Table 1 has been replaced by Figure 2. I have also extended text descriptions, added definitions.

      61. With some of these methods, there’s the ability to also submit to a regular journal. Going to a regular journal presumably would instigate a whole new round of review, which may or may not contradict the previous round of post-publication review and would increase the length of time to publication by going through both types. If someone has a goal to publish in a journal, what benefit would they get by going through the post-publication review first, given this extra time?

      Some of these platforms, e.g., F1000, Lifecycle Journal, replace conventional journal publishing. Modular publishing allows for step-by-step feedback from peers.

      An important advantage of RRs over other peer review models lies in their capacity to enhance research efficiency. By conducting peer review at Stage 1, researchers gain the opportunity to refine their study design or data collection protocols before empirical work begins.

      Other models of review can offer critiques such as "the study should have been conducted differently" without

      actionable opportunity for improvement. The key motivation for having my paper reviewed in MetaROR is the quality of peer review – I have never received so many comments, frankly! Moreover, platforms such as MetaROR usually have partnering journals.

      62. There’s a section talking about institutional change (page 14). It mentions that openness requires three conditions – people taking responsibility for scientific communication, authors and reviewers, and infrastructure. I would consider adding some discussion of readers and evaluators. Readers have to be willing to accept these papers as reliable, trustworthy, and respectable to read and use the information in them.

      Evaluators such as tenure committees and potential employers would need to consider papers submitted through these approaches as evidence of scientific scholarship for the effort to be worthwhile for scientists.

      I have omitted these conditions and employed the Moore’s Technology Adoption Life Cycle. Thank you very much for your comment!

      63. Based on this overview, which seems somewhat skewed towards the merits of these methods (conflict of interest, limited perspective on downsides to new methods/upsides to old methods), I am not quite ready to accept this effort as equivalent of a regular journal and pre-publication peer review process. I look forward to learning more about the approach and seeing this review method in action and as it develops.

      The Discussion section has been substantially revised to address this point. While I acknowledge the current scarcity of empirical studies on innovative peer review models, I have incorporated a critical discussion of this methodological gap.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper concerns mechanisms of foraging behavior in C. elegans. Upon removal from food, C. elegans first executes a stereotypical local search behavior in which it explores a small area by executing many random, undirected reversals and turns called "reorientations." If the worm fails to find food, it transitions to a global search in which it explores larger areas by suppressing reorientations and executing long forward runs (Hills et al., 2004). At the population level, the reorientation rate declines gradually. Nevertheless, about 50% of individual worms appear to exhibit an abrupt transition between local and global search, which is evident as a discrete transition from high to low reorientation rate (Lopez-Cruz et al., 2019). This observation has given rise to the hypothesis that local and global search correspond to separate internal states with the possibility of sudden transitions between them (Calhoun et al., 2014). The main conclusion of the paper is that it is not necessary to posit distinct internal states to account for discrete transitions from high to low reorientation rates. On the contrary, discrete transitions can occur simply because of the stochastic nature of the reorientation behavior itself.

      Strengths:

      The strength of the paper is the demonstration that a more parsimonious model explains abrupt transitions in the reorientation rate.

      Weaknesses:

      (1) Use of the Gillespie algorithm is not well justified. A conventional model with a fixed dt and an exponentially decaying reorientation rate would be adequate and far easier to explain. It would also be sufficiently accurate - given the appropriate choice of dt - to support the main claims of the paper, which are merely qualitative. In some respects, the whole point of the paper - that discrete transitions are an epiphenomenon of stochastic behavior - can be made with the authors' version of the model having a constant reorientation rate (Figure 2f).

      We apologize, but we are not sure what the reviewer means by “fixed dt”. If the reviewer means taking discrete steps in time (dt), and modeling whether a reorientation occurs, we would argue that the Gillespie algorithm is a better way to do this because it provides floating-point precision, rather than a time resolution limited by dt, which we hopefully explain in the updated text (Lines 107-192).

      The reviewer is correct that discrete transitions are an epiphenomenon of stochastic behavior as we show in Figure 2f. However, abrupt stochastic jumps that occur with a constant rate do not produce persistent changes in the observed rate because it is by definition, constant. The theory that there are local and global searches is based on the observation that individual worms often abruptly change their reorientation rates. But this observation is only true for a fraction of worms. We are trying to argue that the reason why this is not observed for all, or even most worms is because these are the result of stochastic sampling, not a sudden change in search strategy.

      (2) In the manuscript, the Gillespie algorithm is very poorly explained, even for readers who already understand the algorithm; for those who do not it will be essentially impossible to comprehend. To take just a few examples: in Equation (1), omega is defined as reorientations instead of cumulative reorientations; it is unclear how (4) follows from (2) and (3); notation in (5), line 133, and (7) is idiosyncratic. Figure 1a does not help, partly because the notation is unexplained. For example, what do the arrows mean, what does "*" mean?

      We apologize for this, you are correct, 𝛀 is cumulative reorientations, and we have edited the text for clarity (Lines 107-192):

      We apologize for the arrow notation confusion. Arrow notation is commonly used in pseudocode to indicate variable assignment, and so we used it to indicate variable assignment updates in the algorithm.

      We added Figure 2a to help explain the Gillespie algorithm for people who are unfamiliar with it, but you are correct, some notation, like probabilities, were left unexplained. We have added more text to the figure legend. Hopefully this additional text, along with lines 105-190, provide better clarification.

      (3) In the model, the reorientation rate dΩ⁄dt declines to zero but the empirical rate clearly does not. This is a major flaw. It would have been easy to fix by adding a constant to the exponentially declining rate in (1). Perhaps fixing this obvious problem would mitigate the discrepancies between the data and the model in Figure 2d.

      You are correct that the model deviates slightly at longer times, but this result is consistent with Klein et al. that show a continuous decline of reorientations. However, we have added a constant to the model (b, Equation 2), since an infinite run length is likely not physiological.

      (4) Evidence that the model fits the data (Figure 2d) is unconvincing. I would like to have seen the proportion of runs in which the model generated one as opposed to multiple or no transitions in reorientation rate; in the real data, the proportion is 50% (Lopez). It is claimed that the "model demonstrated a continuum of switching to non-switching behavior" as seen in the experimental data but no evidence is provided.

      We should clarify that the 50% proportion cited by López-Cruz was based on an arbitrary difference in slopes, and by assessing the data visually (López-Cruz, Figure S2). We added a comment in the text to clarify this (Lines 76 – 78). We sought to avoid this subjective assessment by plotting the distribution of slopes and transition times produced by the method used in López-Cruz. We should also clarify by what we meant by “a continuum of switching and non-switching” behavior. Both the transition time distributions and the slope-difference distributions do not appear to be the result of two distributions (the distributions in Figure 1 are not bimodal). This is unlike roaming and dwelling on food, where two distinct distributions of behavioral metrics can be identified based on speed and angular speed (Flavell et al, 2009, Fig S2a).

      Based on the advice of Reviewer #3, we have also modeled the data using different starting amounts of M (M<sub>0</sub>). By definition, an initial value of M<sub>0</sub> = 1 is a two-state switching strategy; the worm either uses a reorientation rate of a (when M = 1) or b (when M = 0). As expected, this does produce a bimodal distribution of slope differences (Figure 3b), which is significantly different than the experimental distribution (Figure 3c). We have added a new section to explain this in more detail (Lines 253 – 297).

      (5) The explanation for the poor fit between the model and data (lines 166-174) is unclear. Why would externally triggered collisions cause a shift in the transition distribution?

      Thank you, we rewrote the text to clarify this better (Lines 227-233). There were no externally triggered collisions; 10 animals were used per experiment. They would occasionally collide during the experiment, but these collisions were excluded from the data that were provided. However, worms are also known to increase reorientations when they encounter a pheromone trail, and it is unknown (from this dataset) which orientations may have been a result of this phenomenon.

      (6) The discussion of Levy walks and the accompanying figure are off-topic and should be deleted.

      Thank you, we agree that this topic is tangential, and we removed it.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors build a statistical model that stochastically samples from a timeinterval distribution of reorientation rates. The form of the distribution is extracted from a large array of behavioral data, and is then used to describe not only the dynamics of individual worms (including the inter-individual variability in behavior), but also the aggregate population behavior. The authors note that the model does not require assumptions about behavioral state transitions, or evidence accumulation, as has been done previously, but rather that the stochastic nature of behavior is "simply the product of stochastic sampling from an exponential function".

      Strengths:

      This model provides a strong juxtaposition to other foraging models in the worm. Rather than evoking a behavioral transition function (that might arise from a change in internal state or the activity of a cell type in the network), or evidence accumulation (which again maps onto a cell type, or the activity of a network) - this model explains behavior via the stochastic sampling of a function of an exponential decay. The underlying model and the dynamics being simulated, as well as the process of stochastic sampling, are well described and the model fits the exponential function (Equation 1) to data on a large array of worms exhibiting diverse behaviors (1600+ worms from Lopez-Cruz et al). The work of this study is able to explain or describe the inter-individual diversity of worm behavior across a large population. The model is also able to capture two aspects of the reorientations, including the dynamics (to switch or not to switch) and the kinetics (slow vs fast reorientations). The authors also work to compare their model to a few others including the Levy walk (whose construction arises from a Markov process) to a simple exponential distribution, all of which have been used to study foraging and search behaviors.

      Weaknesses:

      This manuscript has two weaknesses that dampen the enthusiasm for the results. First, in all of the examples the authors cite where a Gillespie algorithm is used to sample from a distribution, be it the kinetics associated with chemical dynamics, or a Lotka-Volterra Competition Model, there are underlying processes that govern the evolution of the dynamics, and thus the sampling from distributions. In one of their references, for instance, the stochasticity arises from the birth and death rates, thereby influencing the genetic drift in the model. In these examples, the process governing the dynamics (and thus generating the distributions from which one samples) is distinct from the behavior being studied. In this manuscript, the distribution being sampled is the exponential decay function of the reorientation rate (lines 100-102). This appears to be tautological - a decay function fitted to the reorientation data is then sampled to generate the distributions of the reorientation data. That the model performs well and matches the data is commendable, but it is unclear how that could not be the case if the underlying function generating the distribution was fit to the data.

      Thank you, we apologize that this was not clearer. In the Lotka-Volterra model, the density of predators and prey are being modeled, with the underlying assumption that rates of birth and death are inherently stochastic. In our model, the number of reorientations are being modeled, with the assumption (based on the experiments), that the occurrence of reorientations is stochastic, just like the occurrence (birth) of a prey animal is stochastic. However, the decay in M is phenomenological, and we speculate about the nature of M later in the manuscript.

      You are absolutely right that the decay function for M was fit to the population average of reorientations and then sampled to generate the distributions of the reorientation data. This was intentional to show that the parameters chosen to match the population average would produce individual trajectories with comparable stochastic “switching” as the experimental data. All we’re trying to show really is that observed sudden changes in reorientation that appear persistent can be produced by a stochastic process without resorting to binary state assignments. In Calhoun, et al 2014 it is reported all animals produced switch-like behavior, but in Klein et al, 2017 it is reported that no animals showed abrupt transitions. López-Cruz et al seem to show a mix of these results, which can easily be explained by an underlying stochastic process.

      The second weakness is somewhat related to the first, in that absent an underlying mechanism or framework, one is left wondering what insight the model provides.

      Stochastic sampling a function generated by fitting the data to produce stochastic behavior is where one ends up in this framework, and the authors indeed point this out: "simple stochastic models should be sufficient to explain observably stochastic behaviors." (Line 233-234). But if that is the case, what do we learn about how the foraging is happening? The authors suggest that the decay parameter M can be considered a memory timescale; which offers some suggestion, but then go on to say that the "physical basis of M can come from multiple sources". Here is where one is left for want: The mechanisms suggested, including loss of sensory stimuli, alternations in motor integration, ionotropic glutamate signaling, dopamine, and neuropeptides are all suggested: these are basically all of the possible biological sources that can govern behavior, and one is left not knowing what insight the model provides. The array of biological processes listed is so variable in dynamics and meaning, that their explanation of what governs M is at best unsatisfying. Molecular dynamics models that generate distributions can point to certain properties of the model, such as the binding kinetics (on and off rates, etc.) as explanations for the mechanisms generating the distributions, and therefore point to how a change in the biology affects the stochasticity of the process. It is unclear how this model provides such a connection, especially taken in aggregate with the previous weakness.

      Providing a roadmap of how to think about the processes generating M, the meaning of those processes in search, and potential frameworks that are more constrained and with more precise biological underpinning (beyond the array of possibilities described) would go a long way to assuaging the weaknesses.

      Thank you, these are all excellent points. We should clarify that in López-Cruz et al, they claim that only 50% of the animals fit a local/global search paradigm. We are simply proposing there is no need for designating local and global searches if the data don’t really support it. The underlying behavior is stochastic, so the sudden switches sometimes observed can be explained by a stochastic process where the underlying rate is slowing down, thus producing the persistently slow reorientation rate when an apparent “switch” occurs. What we hope to convey is that foraging doesn’t appear to follow a decision paradigm, but instead a gradual change in reorientations which for individual worms, can occasionally produce reorientation trajectories that appear switch-like.

      As for M, you are correct, we should be more explicit, and we have added text (Lines 319-359) to expand upon its possible biological origin.

      Reviewer #3 (Public review):

      Summary:

      This intriguing paper addresses a special case of a fundamental statistical question: how to distinguish between stochastic point processes that derive from a single "state" (or single process) and more than one state/process. In the language of the paper, a "state" (perhaps more intuitively called a strategy/process) refers to a set of rules that determine the temporal statistics of the system. The rules give rise to probability distributions (here, the probability for turning events). The difficulty arises when the sampling time is finite, and hence, the empirical data is finite, and affected by the sampling of the underlying distribution(s). The specific problem being tackled is the foraging behavior of C. elegans nematodes, removed from food. Such foraging has been studied for decades, and described by a transition over time from 'local'/'area-restricted' search'(roughly in the initial 10-30 minutes of the experiments, in which animals execute frequent turns) to 'dispersion', or 'global search' (characterized by a low frequency of turns). The authors propose an alternative to this two-state description - a potentially more parsimonious single 'state' with time-changing parameters, which they claim can account for the full-time course of these observations.

      Figure 1a shows the mean rate of turning events as a function of time (averaged across the population). Here, we see a rapid transient, followed by a gradual 4-5 fold decay in the rate, and then levels off. This picture seems consistent with the two-state description. However, the authors demonstrate that individual animals exhibit different "transition" statistics (Figure 1e) and wish to explain this. They do so by fitting this mean with a single function (Equations 1-3).

      Strengths:

      As a qualitative exercise, the paper might have some merit. It demonstrates that apparently discrete states can sometimes be artifacts of sampling from smoothly time-changing dynamics. However, as a generic point, this is not novel, and so without the grounding in C. elegans data, is less interesting.

      Weaknesses:

      (1) The authors claim that only about half the animals tested exhibit discontinuity in turning rates. Can they automatically separate the empirical and model population into these two subpopulations (with the same method), and compare the results?

      Thank you, we should clarify that the observation that about half the animals exhibit discontinuity was not made by us, but by López-Cruz et al. The observed fraction of 50% was based on a visual assessment of the dual regression method we described. We added text (Lines 76-79) to clarify this. To make the process more objective, we decided to simply plot the distributions of the metrics they used for this assessment to see if two distinct populations could be observed. However, the distributions of slope differences and transition times do not produce two distinct populations. Our stochastic approach, which does not assume abrupt state-transitions, also produces comparable distributions. To quantify this, we have added a section varying M<sub>0</sub>, including setting M<sub>0</sub> to 1, so that the model by definition is a switch model. This model performs the worst (Lines 253-296, Figure 3).

      (2) The equations consider an exponentially decaying rate of turning events. If so, Figure 2b should be shown on a semi-logarithmic scale.

      We chose to not do this because this average is based on the number of discrete reorientation events observed within a 2-minute window. The range of events ranges from 0 to 6 (hence a rate of 0.5-3 min<sup>-1</sup>), which does not span one order of magnitude. Instead, we included a heat map (Figure 1a, Figure 2b bottom panel) which shows the density that the average is based on. We hope this provides some clarity to the reader.

      (3) The variables in Equations 1-3 and the methods for simulating them are not well defined, making the method difficult to follow. Assuming my reading is correct, Omega should be defined as the cumulative number of turning events over time (Omega(t)), not as a "turn" or "reorientation", which has no derivative. The relevant entity in Figure 1a is apparently <Omega (t)>, i.e. the mean number of events across a population which can be modelled by an expectation value. The time derivative would then give the expected rate of turning events as a function of time.

      Thank you, you are correct. Please see response to Reviewer #1.

      (4) Equations 1-3 are cryptic. The authors need to spell out up front that they are using a pair of coupled stochastic processes, sampling a hidden state M (to model the dynamic turning rate) and the actual turn events, Omega(t), separately, as described in Figure 2a. In this case, the model no longer appears more parsimonious than the original 2-state model. What then is its benefit or explanatory power (especially since the process involving M is not observable experimentally)?

      Thank you, yes we see how as written this was confusing. In our response to Reviewer #1, and in the text, we added an important detail:

      While reorientations are modeled as discrete events, which is observationally true, the amount of M at time t=0 is chosen to be large (M<sub>0</sub> = 1000), so that over the timescale of 40 minutes, the decay in M is practically continuous. This ensures that sudden changes in reorientations are not due to sudden changes in M, but due to the inherent stochasticity of reorientations.

      However you are correct that if M was chosen to have a binary value of 0 or 1, then this would indeed be the two state model. We added a new section to address this (Lines 253-287, Figure 3). Unlike the experiments, the two-state model produces bimodal distributions in slope and transition times, and these distributions are significantly different than the experimental data (Figure 3).

      (5) Further, as currently stated in the paper, Equations 1-3 are only for the mean rate of events. However, the expectation value is not a complete description of a stochastic system. Instead, the authors need to formulate the equations for the probability of events, from which they can extract any moment (they write something in Figure 2a, but the notation there is unclear, and this needs to be incorporated here).

      Thank you, yes please see our response to Reviewer #1. We have clarified the text in Lines 105-190.

      (6) Equations 1-3 have three constants (alpha and gamma which were fit to the data, and M0 which was presumably set to 1000). How does the choice of M0 affect the results?

      Thank you, this is a good question. We address this in lines 253-296. Briefly, the choice of M<sub>0</sub> does not have a strong effect on the results, unless we set it to M<sub>0</sub>, which by definition, creates a two-state model. This model was significantly different than the experimental data, relative to the other models (Figure 3c).

      (7) M decays to near 0 over 40 minutes, abolishing omega turns by the end of the simulations. Are omega turns entirely abolished in worms after 30-40 minutes off food? How do the authors reconcile this decay with the leveling of the turning rate in Figure 1a?

      Yes, Reviewer #1 recommended adding a baseline reorientation rate which we did for all models (Equation 2). However, we should also note that in Klein et al they observed a continuous decay over 50 minutes. Though realistically, it is likely not plausible that worms will produce infinitely long runs at long time points.

      (8) The fit given in Figure 2b does not look convincing. No statistical test was used to compare the two functions (empirical and fit). No error bars were given (to either). These should be added. In the discussion, the authors explain the discrepancy away as experimental limitations. This is not unreasonable, but on the flip side, makes the argument inconclusive. If the authors could model and simulate these limitations, and show that they account for the discrepancies with the data, the model would be much more compelling.

      To do this, I would imagine that the authors would need to take the output of their model (lists of turning times) and convert them into simulated trajectories over time. These trajectories could be used to detect boundary events (for a given size of arena), collisions between individuals, etc. in their simulations and to see their effects on the turn statistics.

      Thank you, we have added dashed lines to indicate standard deviation to Figures 2b and 3a. After running the models several times, we found that some of the small discrepancies noted (like s<sub>1</sub>-s<sub>2</sub> < 0 for experiments but not the model), were spurious due to these data points being <1% of the data, so we cut this from the text. To compare how similar the continuous (M<sub>0</sub> > 1) and discrete (M<sub>0</sub> = 1) models were to the experimental data, we calculated a Jensen-Shannon distance for the models, and found that the discrete model was significantly more dissimilar to the experimental data than the continuous models (Lines 289-296, Figure 3c).

      (9) The other figures similarly lack any statistical tests and by eye, they do not look convincing. The exception is the 6 anecdotal examples in Figure 2e. Those anecdotal examples match remarkably closely, almost suspiciously so. I'm not sure I understood this though - the caption refers to "different" models of M decay (and at least one of the 6 examples clearly shows a much shallower exponential). If different M models are allowed for each animal, this is no longer parsimonious. Are the results in Figure 2d for a single M model? Can Figure 2e explain the data with a single (stochastic) M model?

      We certainly don’t want the panels in Figure 2e to be suspicious! These comparisons were drawn from calculating the correlations between all model traces and all experimental traces, and then choosing the top hits. Every time we run the simulation, we arrive at a different set of examples. Since it was recommended we add a baseline rate, these examples will be a completely different set when we run the simulation, again.

      We apologize for the confusion regarding M. Since the worms do not all start out with identical reorientation rates, we drew the initial M value from a distribution centered on M<sub>0</sub> to match the initial distribution of observed experimental rates (Lines 206-214). However, the decay in M (γ), as well as α and β, are the same for all in silico animals.

      (10) The left axes of Figure 2e should be reverted to cumulative counts (without the normalization).

      Thank you, we made this change.

      (11) The authors give an alternative model of a Levy flight, but do not give the obvious alternative models:<br /> a) the 1-state model in which P(t) = alpha exp (-gamma t) dt (i.e. a single stochastic process, without a hidden M, collapsing equations 1-3 into a single equation).

      b) the originally proposed 2-state model (with 3 parameters, a high turn rate, a low turn rate, and the local-to-global search transition time, which can be taken from the data, or sampled from the empirical probability distributions). Why not? The former seems necessary to justify the more complicated 2-process model, and the latter seems necessary since it's the model they are trying to replace. Including these two controls would allow them to compare the number of free parameters as well as the model results. I am also surprised by the Levy model since Levy is a family of models. How were the parameters of the Levy walk chosen?

      Thank you, we removed this section completely, as it is tangential to the main point of the paper.

      (12) One point that is entirely missing in the discussion is the individuality of worms. It is by now well known that individual animals have individual behaviors. Some are slow/fast, and similarly, their turn rates vary. This makes this problem even harder. Combined with the tiny number of events concerned (typically 20-40 per experiment), it seems daunting to determine the underlying model from behavioral statistics alone.

      Thank you, yes we should have been more explicit in the reasoning behind drawing the initial M from a distribution (response to comment #9). We assume that not every worm starts out with the same reorientation rate, but that some start out fast (high M) and some start out slow (low M). However, we do assume M decays with the same kinetics, which seems sufficient to produce the observed phenomena. Multiple decay rates are not needed to replicate the experimental data.

      (13) That said, it's well-known which neurons underpin the suppression of turning events (starting already with Gray et al 2005, which, strangely, was not cited here). Some discussion of the neuronal predictions for each of the two (or more) models would be appropriate.

      Thank you, yes we will add Gray et al, but also the more detailed response to Reviewer #2 (Lines 319-359 of manuscript).

      (14) An additional point is the reliance entirely on simulations. A rigorous formulation (of the probability distribution rather than just the mean) should be analytically tractable (at least for the first moment, and possibly higher moments). If higher moments are not obtainable analytically, then the equations should be numerically integrable. It seems strange not to do this.

      Thank you for suggesting this. For the Levy section (which we cut) this would have been an improvement. However, since the distributions of slope differences and transition times are based on a recursive algorithm, rather than an analytical formulation, we decided to use the Jensen-Shannon divergence to compare distributions (Lines 272-296, Figure 3c) since this is a parameter-free approach.

      In summary, while sample simulations do nicely match the examples in the data (of discontinuous vs continuous turning rates), this is not sufficient to demonstrate that the transition from ARS to dispersion in C. elegans is, in fact, likely to be a single 'state', or this (eq 1-3) single state. Of course, the model can be made more complicated to better match the data, but the approach of the authors, seeking an elegant and parsimonious model, is in principle valid, i.e. avoiding a many-parameter model-fitting exercise.

      As a qualitative exercise, the paper might have some merit. It demonstrates that apparently discrete states can sometimes be artifacts of sampling from smoothly time-changing dynamics. However, as a generic point, this is not novel, and so without the grounding in C. elegans data, is less interesting.

      Thank you, we agree that this is a generic phenomenon, which is partly why we did this. The data from López-Cruz seem to agree in part with Calhoun et al, that claim abrupt transitions occur, and Klein et al, which claim they do not occur. Since the underlying phenomenon is stochastic, we propose the mixed observations of sudden and gradual changes in search strategy are simply the result of a stochastic process, which can produce both phenomena for individual observations. We hope this work can help clarify why sudden changes in search strategy are not consistently observed. We propose a simple hypothesis that there is no change in search strategy. The reorientation rate decays in time, and due to the stochastic nature of this behavior, what appears as a sudden change for individual observations is not due to an underlying decision, but rather the result of a stochastic process.

    2. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #2 (Public reviews):

      Weaknesses:

      This manuscript has two weaknesses that dampen the enthusiasm for the results. First, in all of the examples the authors cite where a Gillespie algorithm is used to sample from a distribution, be it the kinetics associated with chemical dynamics, or a Lotka-Volterra Competition Model, there are underlying processes that govern the evolution of the dynamics, and thus the sampling from distributions. In one of their references for instance, the stochasticity arises from the birth and death rates, thereby influencing the genetic drift in the model. In these examples, the process governing the dynamics (and thus generating the distributions from which one samples) are distinct from the behavior being studied. In this manuscript, the distribution being sampled from is the exponential decay function of the reorientation rate (lines 100-102). This appears to be tautological - a decay function fitted to the reorientation data is then sampled to generate the distributions of the reorientation data. That the model performs well, and matches the data is commendable, but it is unclear how that could not be the case if the underlying function generating the distribution was fit to the data.

      To use the Lotka-Volterra model as an analogy, the changing reorientation rate (like a changing rate of prey growth) is tied to the decay in M (like a loss of predators). You could infer the loss of predators by measuring the changing rate of prey growth. In our case, we infer the loss of M by observing the changing reorientation rate. In the LotkaVolterra model, the prey growth rate is negatively associated with predator numbers, but in our model, the reorientation rate is positively associated with M, hence a loss in M leads to a decay in the reorientation rate.

      You are correct that the decay parameters fit to the average should produce a distribution of in silico data that reproduce this average result (Figure 3a). However, this does not necessarily mean that these kinetic parameters should produce the same distributions of switch kinetics observed in Figure 3b. Indeed, a binary model (𝑴 ∈ {𝟎, 𝟏}), which produces an average distribution that matches the average experimental data (Figure 3a) produces a fundamentally different (bimodal) distribution of switch distributions in Figure 3b.

      The second weakness is somewhat related to the first, in that absent an underlying mechanism or framework, one is left wondering what insight the model provides. Stochastic sampling a function generated by fitting the data to produce stochastic behavior is where one ends up in this framework, and the authors indeed point this out: "simple stochastic models should be sufficient to explain observably stochastic behaviors." (Line 233-234). But if that is the case, what do we learn about how the foraging is happening. The authors suggest that the decay parameter M can be considered a memory timescale; which offers some suggestion, but then go on to say that the "physical basis of M can come from multiple sources". Here is where one is left for want: The mechanisms suggested, including loss of sensory stimuli, alternations in motor integration, ionotropic glutamate signaling, dopamine, and neuropeptides are all suggested: this is basically all of the possible biological sources that can govern behavior, and one is left not knowing what insight the model provides. The array of biological processes listed are so variable in dynamics and meaning, that their explanation of what govern M is at best unsatisfying. Molecular dynamics models that generate distributions can point to certain properties of the model, such as the binding kinetics (on and off rates, etc.) as explanations for the mechanisms generating the distributions, and therefore point to how a change in the biology affects the stochasticity of the process. It is unclear how this model provides such a connection, especially taken in aggregate with the previous weakness.

      Providing a roadmap of how to think about the processes generating M, the meaning of those processes in search, and potential frameworks that are more constrained and with more precise biological underpinning (beyond the array of possibilities described) would go a long way to assuaging the weaknesses.

      The insight we (hopefully) are trying to convey is that individual observations of apparent state-switching behavior does not necessarily imply that a state change is actually happening if a large fraction of the population is not producing this behavior. This same observation can be recreated by invoking a stochastic process, which we already know is how reorientation occurrences behave in the first place. Apparent switches to global foraging are simply due to the reorientation rate decaying in time, not necessarily due to a sudden state change. We modeled a stochastic binary switch (when M0=1) which produced a bimodal distribution of switch kinetics (Figure 3b) which was different than the experimental distribution. The biological basis of M is not addressed here, but we clarified the language on lines 342 and 343 to reinforce that it likely represents the timescales of AIA and ADE activities. We reiterated what was described in López-Cruz et al to convey that molecularly, what is governing the timescales of these two neurons is not trivial, and likely multi-faceted.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The presentation of the Gillespie algorithm, though much improved, is tough going and for many biologists will be a barrier to appreciation of what was done and what was achieved. I found the description of the algorithm generated by AI (ChatGTP) to be more accessible and the example given to be better related to the present application of the algorithm. This might provide a template for a more accessible description of the model.

      We are glad the newer draft is clearer, and apologize it is still difficult to read. We made a few changes that hopefully clarify some points (see below).

      It is unclear how instances of >1 transition were automatically distinguished from instances with 1 transition. A related point is how the transition-finding algorithm was kept from detecting too many transitions, as it seems that any quadruplet of points defines a slope change.

      In López-Cruz et al, >1 transitions (and all transitions) were distinguished by eye after running the findchangepts function. We added a clarifying statement on lines 78 and 79 to illuminate this point. As noted on line 72, the function itself only fits two regressions, so by definition, it can only define one transition. This is why we decided to plot the distribution of slope and transition parameters in the first place; to see if there was a clear bimodal distribution (as observed for other observably binary states, like roaming and dwelling). This was not the case for the experimental data, but was observed in the in silico data if we forced the algorithm to be a two-state model (Figure 3b, M0 = 1).

      Line 113-4: I was confused by the distinction between the probability of observing an event and the propensity for it to occur. Are the authors implying that some events occur but are not observed?

      We apologize for this confusion, and added some phrasing in Lines 115-130 to address this. The propensity is analogous to the rate of a reaction. Given this rate, the probability of seeing Ω+1 reorientations in the infinitesimal time interval dt is the product of the propensity and the probability the current state is Ω reorientations.

      Line 120: Shouldn't propensity at t = 0 be alpha + beta?

      Yes, thank you for catching this. We fixed it.

      Why was it necessary to posit two decay processes (equations 2 and 5?). Wouldn't one suffice?

      Thank you, we have added some text to clarify this point (lines 129-132). The Gillespie algorithm models discrete temporal events, which are explicitly dependent on the current state of the system. Since the propensity itself is changing in time, it implies that it is coupled to another state variable that is changing in time, i.e. another propensity. Since an exponential decay is sufficient to model the decay in reorientations, this implies that the reorientation propensity is coupled to a first order decay propensity (equations 4-5).

      Line 145: ...sudden changes in [reorientation rate] are not due to...

      Thank you, we have corrected this (Line 157).

      Fig. 2d: Legend implies (but fails to state) that each dot is a worm, raising the question of how single worms with multiple transitions were plotted in this graph as they would have more than one transition point.

      Thank you, we updated the legend. Multiple transitions are not quantified with the tworegression approach. Prior observations, such as by López-Cruz, were simply done by eye.

      Line 153: Does i denote either process 1 or 2?

      Yes, i is the subscript for each propensity ai. We have added text on line 166 to clarify this.

      Line 159: Confusing. If an "event" is a reorientation event and a "transition" is a discrete change in slope of Omega vs t, then "The probability that no events will occur for ALL transitions in this time interval" makes no sense.

      Thank you, we have reworded this part (Lines 169-172) to be clearer.

      Equation 17:Unclear what index i refers to

      Thank you, we have changed this to index to j, and modified the text on line 228 to reflect this.

      Line 227-9: Unclear how collisions are thought to have caused the shift in experimental distribution.

      We have clarified the text on lines 246 and 250. Collisions are not being referred to here, but instead the crossing of pheromone trails. This is purely speculative.

      Line 310-317. If M rises on food, then worms should reorient more on food than after long times off food, when M has decayed. But worms don't reorient much on food; they behave as though M is low. This seems like a contradiction, unless one supposes instead that M is low on food and after long times off food but spikes when food is removed.

      Thank you, we have added clarifying language on lines 333-336 to address this point. Worm behavior is fundamentally different on food, as worms transition to a dwell/roam behavioral dynamic which is fundamentally different than foraging behavior while off food.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      1. General Statements

      • This manuscript represents a full revision incorporating all reviewer recommendations; the additional follow-up experiments and expanded analyses will be presented in dedicated subsequent manuscripts.
      • Congenital dyserythropoietic anemia type I (CDA-I) is a rare hereditary disease characterized by ineffective erythropoiesis and mutations in Codanin1 and CDIN1.
      • Our study reveals the structural and functional dynamics of the CDIN1-Codanin1 complex, shedding light on the molecular mechanisms of protein-protein interactions implicated in CDA-I pathology.
      • The main goal of our study was to examine the interaction between CDIN1 and the C‑terminal binding domain of Codanin1 using complementary biophysical approaches.
      • We quantified binding and identified interacting regions of Codanin1 and CDIN1.
      • We found that CDA-I-associated mutations in interacting regions disturb CDIN1‑Codanin1 complex.
      • We proposed a hypothetical molecular model of CDIN1-Codanin1 role in CDA-I hallmarks development.
      • Our initial studies on BioRxiv (2023) have been cited by leading publications in the field (Jeong, Frater et al. 2025, Sedor and Shao 2025, Nature Communications) and prompted further research on this topic.

      2. Point-by-point description of the revisions

      *Here we provide a point-by-point reply describing the revisions already carried out and included in the transferred manuscript. *

      Reply to the reviewers

      Reviewer #1 – Evidence, reproducibility and clarity

      This is a rigorous biophysical characterization of a protein-protein interaction relevant to CDA-1 disease. The two proteins were purified in an E. coli host but CD and DLS was performed to ensure that the purified protein is well folded. An impressive native protein EMSA was used to show a 1:1 complex. While common for protein-nucleic acid complexes, EMSAs are much more challenging with protein complexes. A higher-running complex, likely a heterotetramer was implied at higher protein concentrations. These results were supported with SEC-MALS analysis and analytic ultracentrifugation analysis. Thermophoresis and ITC were used to report a nanomolar affinity of the proteins for each other. SEC-SAXS supported the conclusions about stoichiometry and composition inferred from the earlier methods and suggested that the dimerization interface comes from CDIN1. Next HDX-MS was used to identify putative interface residues, which were then mutated in each of the proteins and assessed for binding using coimmunoprecipitation. This study uses at least 10 orthogonal biophysical and/or biochemical methodologies to characterize an important protein-protein interaction and the analysis is clear and so is the writing. I couldn't (reading it once) find any grammatical or other errors in the text or figures. This manuscript is top-quality and suitable for publication.

      __Reviewer #1 – Significance __

      Such detailed structural and mechanistic studies are greatly lacking in many clinical conditions for which mutations are known (unless they cause cancer, neurodegenerative disease, and so on). We need more such studies on disease topics! This study will be of interest to the hematologic diseases community.

      1. Response – ____Significance

      We thank Reviewer #1 for the thoughtful and encouraging evaluation of our work. We are particularly grateful for recognizing the significance of studying protein-protein interaction in the context of CDA-I disease, as well as the rigor and clarity of our biophysical and biochemical characterization.

      We appreciate the reviewer's acknowledgment of the challenges associated with native protein EMSAs. We are pleased that our use of multiple orthogonal techniques was recognized as a strength of the study. We are gratified that the comprehensiveness and coherence of our data and the manuscript's clarity were well received.

      We thank the reviewer for noting the broader impact of our findings on the hematologic disease community. As highlighted, there is a pressing need for a mechanistic understanding of non-oncologic, non-neurodegenerative diseases, and our studies address this gap.

      We are honored by the reviewer's endorsement of our manuscript as "top-quality and suitable for publication". We value the reviewer's highly supportive and motivating feedback.

      __Reviewer #2 – 1. Evidence, reproducibility and clarity __

      This manuscript presents structural and biochemical characterization of the interaction between CDIN1 and the C-terminal domain of Codanin1, shedding light on a complex implicated in Congenital Dyserythropoietic Anemia Type I (CDA-I). While the authors provide valuable structural insights and identify disease-associated mutations that impair CDIN1-Codanin1 binding, I think several important concerns should be addressed to strengthen both the mechanistic claims and their functional relevance.

      Contradiction Between Stoichiometry Models:

      The authors propose that CDIN1 and Codanin1Cterm primarily form a heterodimer in vitro. However, this appears to contradict previous reports indicating a tetra-heteromeric arrangement. Additionally, while CDIN1 homodimerize seems confusing to me, do the authors suggest it is stable without Codanin1? This seems contrary to findings that CDIN1 is unstable in the absence of Codanin1 (Sedor, S.F., Shao, S. nature comm 2025, Swickley, G., Bloch, Y., Malka, L. et al 2020 BMC Mol and Cell Biol). These inconsistencies raise concerns about whether the observed stoichiometries are physiologically relevant or artifacts of in vitro reconstitution, especially since full-length Codanin1 was not studied.

      2.1 Response ____– Consistent stoichiometry of Codanin1Cterm

      We thank Reviewer #2 for raising critical points regarding the stoichiometry and physiological relevance of the CDIN1-Codanin1 interaction. The following response clarifies the rationale and interpretation in relation to previous findings.

      Stoichiometry of CDIN1-Codanin1Cterm complex:

      Recent Cryo-EM studies of full-length Codanin1 (Jeong, Frater et al. 2025, Sedor and Shao 2025) suggest independent internal dimerization domains (452-798 and 841-1000 amino acid residue) driving homodimer formation, with each Codanin1 monomer binding one CDIN1 via the C-terminal region (1005-1227 amino acid residue), resulting in a tetra-heteromeric complex. Therefore, the complete assembly appears as a dimer of heterodimers in the full-length context.

      In our study, Codanin1 was truncated to retain only the CDIN1-binding C-terminus (1005-1227 amino acid residues), eliminating the homodimerization ability of Codanin1. Hence, in the case of truncated Codanin1Cterm, the minimal complex we observe is a 1:1 heterodimer of CDIN1-Codanin1Cterm, which is fully consistent with the equimolar stoichiometry of CDIN1-Codanin1 complex seen in the full-length structure.

      Stability and oligomeric state of CDIN1 in the absence of Codanin1:

      We concur with the reviewer that Sedor et al. (2025) and Swickley et al. (2020) reported decreased CDIN1 levels in cells lacking Codanin1, implying in vivo dependence of CDIN1 on Codanin1 partner for stability (Swickley, Bloch et al. 2020, Sedor and Shao 2025). The purified CDIN1 is monodisperse (Supplementary Figure 2D), exhibits thermal stability with a melting temperature of 48 °C (Supplementary Figure 2E), and displays proper folding as indicated by CD measurements (Supplementary Figure 2B). Additionally, SAXS profiles of CDIN1 correspond to AlphaFold predictions (Fig. 2B). Together, our findings indicate that the recombinant CDIN1 forms a stable conformation in vitro without Codanin1. To the best of our knowledge, no previous research has directly identified the endogenous oligomeric states of CDIN1 within cellular content.

      We fully acknowledge that future analysis of the full-length Codanin1-CDIN1 assembly in a cellular context will be necessary for understanding physiological stoichiometries. As outlined in the General statements, our study focuses on the C-terminus of Codanin1 to describe the binding interface and complex biophysical properties of the CDIN-Codanin1Cterm complex.

      __Reviewer #2 – ____2. Unvalidated Functional Claims: __

      The manuscript identifies several CDA-I-associated mutations that disrupt CDIN1-Codanin1 interaction. However, the authors do not test how these mutations affect the biological function of the complex, particularly its role in ASF1 sequestration or histone trafficking. Given the central importance of this axis in their disease model, functional validation (e.g., ASF1 localization, histone deposition assays) is necessary to support these mechanistic conclusions.

      2.2 Response – ____Hypothetical model as discussion merit

      We thank the reviewer for the comment regarding the functional implications of CDA-I-associated mutations and their potential impact on ASF1 sequestration and histone trafficking hypothesized within the Discussion. We fully agree that understanding the downstream biological consequences of disrupted CDIN1-Codanin1 interaction is critical for elucidating the full molecular basis of CDA-I pathogenesis.

      In the Future research directions of the Discussion, we have acknowledged and emphasized the need for follow-up studies using erythroblast cell lines to determine whether specific disease-associated mutations disrupt CDIN1-Codanin1 binding, leading to functional defects relevant to erythropoiesis and nuclear architecture typical for CDA-I disease.

      However, as we respectfully note in General Statements, the main aim of the present study was to provide a rigorous biophysical characterization of the CDIN1-Codanin1Cterm interaction. Proposed cellular experiments, though relevant, are beyond the conceptual scope of the presented studies.

      Reviewer #2 – ____3. Speculative and Potentially Contradictory Model:

      The proposed model suggests that CDIN1 competes with ASF1 for Codanin1 binding, thereby indirectly promoting histone delivery to the nucleus. However, emerging data indicate that Codanin1, CDIN1, and ASF1 can form a stable ternary complex, calling into question this competitive binding hypothesis (Sedor, S.F., Shao, S. nature comm 2025). The authors do not acknowledge or discuss these findings, and the model in its current form may therefore be oversimplified or inaccurate.

      2.3 Response – ____Hypothetical model fully aligned with current knowledge

      We fully acknowledged and discussed in the current manuscript the recent findings demonstrating that Codanin1, CDIN1, and ASF1 can form a ternary complex (Sedor, S.F., Shao, S. Nature Comm. 2025; Jeong, T. K. et al. Nature Comm. 2025). Our revised model was updated accordingly to reflect the collaborative binding of Codanin1, CDIN1, and ASF1, and is presented in alignment with published data.

      While earlier versions of our work published on the BioRxiv server (May 26, 2023) proposed a competitive hypothesis, the current manuscript incorporates recent literature and prior reviewer feedback to offer a refined model. We believe that the updated hypothesis suggests a plausible mechanism for how CDIN1 modulates Codanin1 function, which will be further tested in future cellular studies.

      Reviewer #2 – 4. Significance:

      Overall, the study adds to our structural understanding of CDIN1 and Codanin1 interactions, but the functional interpretations are currently speculative, and in some cases in conflict with existing literature. The manuscript would benefit significantly from addressing these discrepancies, incorporating relevant data on ASF1, and clarifying whether the observed assemblies reflect physiological complexes.

      __2.4 Response – Significance __

      We thank Reviewer #2 for the constructive feedback. As noted in General Statements, our current manuscript is primarily dedicated to defining the molecular architecture and interactions of the CDIN1–Codanin1Cterm core interface. We agree that follow-up ASF1‑dependent functional assays will be critical to fully validate observed assemblies, but these experiments lie outside the scope of the present study and are ongoing in our laboratory.

      To address the reviewer's concern about possible speculative interpretation, we have:

      • Used cautious language in Results and Discussion to prevent overstatement (e.g., page 31, line 754, “leads” exchanged to “may contribute” in legend of Fig. 4).
      • Described in the Discussion how our results enhance and add understanding to the body of published structural data of CDIN1–Codanin1Cterm.
      • Updated our hypothetical model in Fig. 4 to be fully in line with published data.
      • Clearly stated that the working hypothesis is connected with a subset of CDA-I mutations (p. 31, l. 758-759, “The proposed model represents a working hypothesis relating to a subset of CDA-I mutations and is not currently substantiated by experimental evidence at the cellular level.”)
      • Stated in Future research directions of Discussion that functional validation, including ASF1, will motivate future critical studies, p. 32, l. 771-773: “The ability of Codanin1 to interact with both CDIN1 and ASF1 motivates further investigation of how CDIN1 and ASF1 affect the function of full-length Codanin1, which even recent cryo-EM data has not addressed yet.”
      • Highlighted the necessity of complementary in vivo studies in erythroblast cell lines to determine if CDA-I-related mutations in CDIN1-Codanin1 interaction region cause typical CDA-I phenotypes, aiming to clarify the molecular mechanisms of inherited CDA-I anemia. We state in Future research directions in Discussion, p. 32, l. 774-780: “…follow-up research utilizing erythroblast model cell lines must be conducted to determine if specific mutations that disrupt CDIN1-Codanin1 binding also affect ASF1 localization and cause a phenotype typical of CDA-I. In future work, additional Codanin1 mutations, including those outside the C-terminal region, should be evaluated to determine how the mutations affect ASF1’s nuclear concentration and subcellular localization. The proposed research directions will provide additional deeper insights into the underlying mechanisms of the molecular origin of inherited anemia CDA-I.” We believe that the revisions objectively clarify the significance and the limits of the current work and set the stage for the detailed functional studies to follow.

      __Reviewer #3 – Evidence, reproducibility and clarity: __

      Congenital Dyserythropoietic Anemia Type I (CDA I) is an autosomal recessive disorder characterized by ineffective erythropoiesis and distinctive nuclear morphology ("Swiss cheese" heterochromatin) in erythroblasts. CDA I is caused by mutations in CDAN1 and CDIN1. Codanin1, encoded by CDAN1, is part of the cytosolic ASF1-H3.1-H4-Importin-4 complex, which regulates histone trafficking to the nucleus. CDIN1 has been shown to bind the C-terminal domain of Codanin-1, but until now, pathogenic mutations had not been directly linked to the disruption of this interaction.

      In this study, the authors used biophysical techniques to characterize the interaction between Codanin-1's C-terminal region (residues 1005-1227) and CDIN1, demonstrating high-affinity, equimolar binding. HDX-MS identified interaction hotspots, and disease-associated mutations in these regions disrupted complex formation. The authors propose that such disruption prevents ASF1 sequestration in the cytoplasm, thereby reducing nuclear histone levels and contributing to the chromatin abnormalities seen in CDA I.

      Major Comments:

      1. Use of Codanin-1 Fragment:

      Most experiments were conducted using only the C-terminal 223 amino acids of Codanin-1. While this region is known to bind CDIN1, it is unclear whether its conformation is maintained in the context of the full-length protein. This could affect binding properties and structural interpretations. The authors should discuss how structural differences between the isolated C-terminus and the full-length Codanin-1 may influence the conclusions.

      Response of authors ____#3

      3.1 Response: Use of Codanin-1 Fragment as biding part to CDIN1

      We thank the reviewer for the important observation regarding the use of the C-terminal fragment of Codanin1. As noted in the manuscript (e.g., p. 30, line 721 and p. 32, line 761), we fully acknowledge that the truncation of Codanin1 may influence its conformational dynamics or contextual folding relative to the full-length protein.

      However, several lines of evidence suggest that the C-terminal 223 amino acid residues—responsible for CDIN1 binding—are structurally autonomous and have minimal intramolecular contacts with upstream regions. Published cryo-EM and biochemical data (Jeong, Frater et al. 2025, Sedor and Shao 2025), in conjunction with AlphaFold structural predictions (Fig. 2D) and our co-immunoprecipitation assays (Fig. 3F), consistently support a model wherein the CDIN1-binding region is flexible and spatially isolated from the core structural domains of Codanin1. Additionally, results from our co-immunoprecipitation assay (Fig. 3F) indicate that full-length Codanin1 and truncated Codanin1Cterm interact with CDIN1 similarly, further supporting the isolated manner of the C-terminal fragment. The available data together imply that the C-terminal fragment used in our study retains its native conformation and binding properties when expressed independently.

      While our findings are confined to the interaction domain and do not reflect full-length Codanin1’s architecture, we believe the use of the C-terminal minimal fragment of Codanin1 enables precise dissection of the CDIN1-binding interface and yields mechanistic insights without introducing significant structural artifacts.

      We agree with the reviewer that future work incorporating full-length Codanin1, especially in a cellular context, will be instrumental to fully characterize higher-order assembly and regulatory functions.

      __Reviewer #3 – 2. ____Graphical Abstract and Domain Independence: __

      The graphical abstract presents the Codanin-1 C-terminus as an independent domain, but no direct evidence is provided to support its structural autonomy in vivo.

      The authors should clarify whether the C-terminal region functions as a distinct domain in the context of the full-length protein.

      __3.2 Response –____ Independent C-terminal domain __

      We thank the reviewer for bringing up the question of the independence of the C-terminal domain. Although direct in vivo proof of C-terminal autonomy is not yet available, published cryo-EM structures of full-length Codanin1, our biophysical characterization, and AlphaFold models all consistently indicate that the C-terminal 223 amino acid residues of Codanin1 form a structurally independent binding module. In the graphical abstract, we illustrated the C‑terminal domain as a loosely connected part of Codanin1 to highlight its independence and to emphasize the specific focus of our studies.

      To articulate limitations of our studies focused on the C-terminal part of Codanin1, we stated in the Functional implications of CDA-I-related mutations in the Discussion, p. 30, l. 721-724: “However, our measurements do not exclude the possible role of the disordered regions in full-length Codanin1. For example, CDIN1 could potentially stabilize full-length Codanin1 by rearranging the disordered regions into a more condensed structure, thereby augmenting the structural stability of Codanin1.”

      Reviewer #3 – 3.____Pathogenic Mutations Beyond the Binding Site:

      The study highlights a triplet mutation that impairs CDIN1 binding. However, most CDA I‑associated mutations in CDAN1 are dispersed across the entire protein and may not affect CDIN1 interaction directly.

      The authors should discuss alternative mechanisms by which mutations in other regions of Codanin-1 might cause disease.

      3.3 Response – Pathogenic mutations outside the binding site – alternative mechanisms

      We appreciate the reviewer noting that most CDA-I-associated CDAN1 mutations are outside the CDIN1-Codanin1 binding site and suggesting alternative mechanisms. In the revised Discussion, we added a paragraph on alternative pathogenic models, p. 29, l. 702-713:

      "Our study centers on the CDIN1-binding C-terminus, however, most CDA-I-associated CDAN1 mutations lie elsewhere and probably act through alternative mechanisms. Mutations such as P672L and F868I in the LOBE2 (452-798 amino acid residue) and F868I in the coiled-coil (841-1000 amino acid residue) domains may disturb Codanin1 homodimerization and higher-order complex assembly, directly affecting ASF1 sequestration (Jeong, T. K. et al. Nature Comm. 2025). Other mutant variants may also interfere with ASF1 sequestration, nuclear targeting, or chromatin-remodeling functions, while destabilizing mutations may induce misfolding and proteasomal degradation. Moreover, CDA-I-associated mutations, such as R714W and R1042W, might compromise the interaction between Codanin1 and ASF1 (Ask, Jasencakova et al. 2012). Collectively, the complementary alternative pathogenic mechanisms associated with Codanin1 mutations in distal regions and mutations in CDIN1‑binding C-terminus of Codanin1 may contribute to erythroid dysfunction in CDA-I."

      Reviewer #3 – 4. ____Contradictory Functional Models:

      Ask et al. (EMBO J, 2012) reported that Codanin-1 depletion increases nuclear ASF1 and accelerates DNA replication. This contrasts with the current hypothesis that disruption of the Codanin-1/CDIN1 complex reduces nuclear ASF1.

      The authors should attempt to reconcile this apparent contradiction, possibly by proposing a context-specific or dual-function model for Codanin-1 in histone trafficking.

      3.4 Response – ____Clarified explanation of hypothetical functional model

      We thank the reviewer for raising this point, which improved the clarity of our work. There is no real discrepancy between Ask et al. and our findings; both agree that Codanin1 restrains ASF1 in the cytoplasm. Ask et al. examined the complete loss of Codanin1, which abolishes cytoplasmic ASF1 sequestration and thus leads to maximal nuclear accumulation. We suggest the CDA-I-associated mutations selectively disrupt the CDIN1-Codanin1 interface, releasing ASF1 from the cytoplasm into the nucleus.

      To enhance clarity, we now state in the legend of Figure 4 describing the hypothesis (p. 31, l. 752-753): "…CDA-I-associated mutations prevent CDIN1-Codanin1 complex formation, thus prevent ASF1 sequestration to cytoplasm; ASF1 remains accumulated in nucleus."

      Reviewer #3 – 5. ____Conclusions and Claims:

      The proposed model of CDA I pathogenesis (Fig. 4) is plausible but not yet fully supported by the available data. The authors suggest that disruption of the Codanin-1/CDIN1 interaction leads to nuclear histone depletion, but this has not been experimentally confirmed.

      Claims about the general pathogenesis of CDA I should be clearly qualified as hypothetical and applicable to a subset of mutations. The presence and localization of ASF1 in the nucleus following disruption of the Codanin-1/CDIN1 complex should be tested experimentally.

      3.5 Response – __Tempered ____conclusions and claims: __

      We thank the reviewer for underscoring the need to temper our conclusions and to distinguish hypotheses from available results. We fully agree that our Fig. 4 model—linking disruption of the Codanin1-CDIN1 interface to nuclear histone imbalance—remains a working hypothesis, currently supported by indirect biochemical and structural data.

      Accordingly, we have:

      • Revised the text to explicitly state that this model is hypothetical and pertains to a subset of CDA-I-associated CDAN1 mutations. Specifically, we

      • Added to the last paragraph of the section Functional implications of CDA-I-related mutations in Discussion (p. 31, l. 744-749): “In considering functional implications of our findings within available data, it is essential to qualify that mechanistic claims regarding the general pathogenesis of CDA-I remain hypothetical and are restricted to a specific subset of mutations. Furthermore, direct experimental validation, such as immunolocalization or live-cell imaging, to assess ASF1’s nuclear presence and distribution following disruption of the CDIN1-Codanin1 complex is required to substantiate the proposed model.”

      • Included in the legend of Fig. 4: ”The proposed model represents a working hypothesis relating to a subset of CDA-I mutations and is not currently substantiated by experimental evidence at the cellular level.”
      • Replaced any associated definitive language (e.g., “leads to”) with qualified phrasing (e.g., “may contribute to”) in the legend of Fig. 4.
      • Clarified in the Discussion that direct measurement of nuclear ASF1 redistribution and histone levels following interface disruption has not yet been performed. Specifically, we added to the section Functional implications of CDA-I-related mutations in Discussion (p. 30, l. 734-735): “It should be noted, however, that direct quantification of nuclear ASF1 redistribution and histone levels after CDIN1-Codanin1 disruption has not yet been conducted.” Although experimental verification of nuclear ASF1 localization upon CDIN1-Codanin1 complex disruption falls beyond the current manuscript’s scope, we acknowledge its importance and have emphasized the need for such studies in future work within the Future research directions of the Discussion. Specifically, we concluded by stating (p. 32, l. 774-776): “Finally, follow‑up research utilizing erythroblast model cell lines must be conducted to determine if specific mutations that disrupt CDIN1-Codanin1 binding, also affect ASF1 localization and cause a phenotype typical of CDA-I.”

      __Reviewer #3 – 6.____Broader Mutation Analysis and ASF1 Localization: __

      To strengthen the link between Codanin-1/CDIN1 disruption and disease pathogenesis, it would be important to test the effects of additional CDAN1 mutations, including those outside the C-terminal region. Similarly, the impact on ASF1 nuclear concentration and localization should be directly assessed. These experiments would significantly bolster the central hypothesis. If feasible, they should be pursued or at least acknowledged as important future directions.

      3.6 Response – Broader mutation analysis and ASF1 localization in future directions

      We thank Reviewer #3 for emphasizing the value of a broader mutation survey and direct ASF1 localization studies. As noted above, our current manuscript is centered on delineating the molecular architecture of the CDIN1-Codanin1Cterm core interface; comprehensive mutational analyses outside the C-terminal binding region and ASF1-dependent functional assays will be critical to extend these findings but fall beyond the scope of the present work and will be the objective of our following studies. To address the reviewer’s concern, we have:

      • Expanded the Future Directions section to specify that additional CDA-I-linked CDAN1 variants, including non-C-terminal mutations, and quantitative assessments of ASF1 nuclear localization will be the subject of ongoing and planned investigations. Specifically, we added (p. 32, l. 776-778):” In future work, additional Codanin1 mutations, including those outside the C-terminal region, should be evaluated to determine how the mutations affect ASF1’s nuclear concentration and subcellular localization.”

      • Emphasized the need for complementary in vivo validation in erythroblast models to confirm whether the disturbance of CDIN1-Codanin1 binding recapitulates CDA-I phenotypes. We acknowledged the need for cell-line studies in future work within the Future research directions of Discussion (p. 32, l. 774-776): “Finally, follow-up research utilizing erythroblast model cell lines must be conducted to determine if specific mutations that disrupt CDIN1-Codanin1 binding, also affect ASF1 localization and cause a phenotype typical of CDA-I.” We believe these changes more precisely delimit the scope and significance of the current study while laying out a clear roadmap for the essential follow-up experiments.

      Reviewer #3 – 7. ____Rigor and Presentation and Cross-commenting

      __Minor Comments: __

      • Methods and Reproducibility:

      The experimental methods are well described, and the results appear reproducible.

      • Presentation:

      The text and figures are clear and well organized.

      Referee Cross-commenting

      I agree with reviewer 1 that the paper presents detailed structure study of Codanin-1 and CDIN1 protein. However, as reviewer 2 claims functional studies are missing and therefore the hypothesis regarding the pahtogenesis of CDAI is speculaltive especially with no studies regarding ASF1.

      3____.7 Response ____–____ Rigor and Presentation and Cross-commenting:

      We thank the reviewers for their positive appraisal of our results' reproducibility, presentation, and method descriptions. We also appreciate the cross-comment that, while our structural analysis of the CDIN1-Codanin1 complex is thorough, functional validation, particularly regarding ASF1, remains to be addressed.

      As outlined above, we have revised the manuscript to:

      • Emphasize that pathogenic hypotheses drawn from structural data are provisional (refer to Responses 2.2, 2.3, and 3.5).
      • Include follow-up studies for ASF1 localization assays and broader mutation profiling in our Future Directions (refer to Responses 2.4, 3.5, 3.6).
      • Integrate cautious language throughout to clearly delineate verified findings from model-based speculation (refer to Responses 2.4, 3.5, 3.6). The implemented adjustments ensure that the current work is positioned as a detailed structural and interaction foundation, upon which the essential functional studies will build. We believe that all extensions and clarifications fully satisfy the reviewers’ collective recommendations.

      __Reviewer #3 –____ Significance: __

      Nature and Significance of the Advance:

      This study extends prior work (e.g., Swickley et al., BMC Mol Cell Biol 2020; Shroff et al., Biochem J 2020) on Codanin-1/CDIN1 interaction by applying high-resolution biophysical techniques to identify mutations that disrupt this complex. It provides a plausible cellular mechanism by which specific mutations may lead to CDA I through impaired histone trafficking.

      Nevertheless, key question remains: How do mutations outside the Codanin-1 C-terminus contribute to the pathology?

      3.8 Response – Significance:

      • We thank Reviewer #3 for this important point. Although our work specifically dissects the C-terminal CDIN1-binding domain of Codanin1, we fully acknowledge that CDA-I-associated mutations throughout Codanin1 may operate via additional mechanisms. To address the additional mechanisms, we have added a new paragraph describing other possible pathogenic models to the Discussion (please refer to Response 3.3).
      • We also fully acknowledged the need for systematic functional assays of non-C-terminal mutations and their impact on ASF1 localization (please refer to Response 3.6).
      • We revised the text to clarify how mutations beyond the C-terminus may contribute to CDA-I pathogenesis and present the significance of our current structural analyses, biophysical characterizations, and molecular insights as a foundation for future research (please refer to Response 3.6). __Audience: __

      • Molecular and cellular biologists investigating nuclear-cytoplasmic trafficking mechanisms

      • Hematologists and geneticists studying rare red cell disorders
      • Clinicians managing CDA I patients and researchers exploring targeted therapies __Reviewer Expertise: __

      Pediatric hematologist with over 20 years of research experience in CDA I, including the initial identification of CDAN1 and the elucidation of Codanin-1's role in embryonic erythropoiesis. Not a specialist in the biophysical techniques used in this study.

      References

      Ask, K., Z. Jasencakova, P. Menard, Y. Feng, G. Almouzni and A. Groth (2012). "Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply." The EMBO Journal 31(8): 2013–2023.

      Jeong, T.-K., R. C. M. Frater, J. Yoon, A. Groth and J.-J. Song (2025). "CODANIN-1 sequesters ASF1 by using a histone H3 mimic helix to regulate the histone supply." Nature Communications 16(1): 2181.

      Sedor, S. F. and S. Shao (2025). "Mechanism of ASF1 engagement by CDAN1." Nature Communications 16(1): 2599.

      Swickley, G., Y. Bloch, L. Malka, A. Meiri, S. Noy-Lotan, A. Yanai, H. Tamary and B. Motro (2020). "Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease." Molecular and Cell Biology 21(1).

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Congenital Dyserythropoietic Anemia type I (CDA I) is an autosomal recessive disorder characterized by ineffective erythropoiesis and distinctive nuclear morphology ("Swiss cheese" heterochromatin) in erythroblasts. CDA I is caused by mutations in CDAN1 and CDIN1. Codanin-1, encoded by CDAN1, is part of the cytosolic ASF1-H3.1-H4-Importin-4 complex, which regulates histone trafficking to the nucleus. CDIN1 has been shown to bind the C-terminal domain of Codanin-1, but until now, pathogenic mutations had not been directly linked to the disruption of this interaction. In this study, the authors used biophysical techniques to characterize the interaction between Codanin-1's C-terminal region (residues 1005-1227) and CDIN1, demonstrating high-affinity, equimolar binding. HDX-MS identified interaction hotspots, and disease-associated mutations in these regions disrupted complex formation. The authors propose that such disruption prevents ASF1 sequestration in the cytoplasm, thereby reducing nuclear histone levels and contributing to the chromatin abnormalities seen in CDA I.

      Major Comments:

      1. Use of Codanin-1 Fragment: Most experiments were conducted using only the C-terminal 223 amino acids of Codanin-1. While this region is known to bind CDIN1, it is unclear whether its conformation is maintained in the context of the full-length protein. This could affect binding properties and structural interpretations. The authors should discuss how structural differences between the isolated C-terminus and the full-length Codanin-1 may influence the conclusions.
      2. Graphical Abstract and Domain Independence: The graphical abstract presents the Codanin-1 C-terminus as an independent domain, but no direct evidence is provided to support its structural autonomy in vivo. The authors should clarify whether the C-terminal region functions as a distinct domain in the context of the full-length protein.
      3. Pathogenic Mutations Beyond the Binding Site: The study highlights a triplet mutation that impairs CDIN1 binding. However, most CDA I-associated mutations in CDAN1 are dispersed across the entire protein and may not affect CDIN1 interaction directly. The authors should discuss alternative mechanisms by which mutations in other regions of Codanin-1 might cause disease.
      4. Contradictory Functional Models: Ask et al. (EMBO J, 2012) reported that Codanin-1 depletion increases nuclear ASF1 and accelerates DNA replication. This contrasts with the current hypothesis that disruption of the Codanin-1/CDIN1 complex reduces nuclear ASF1. The authors should attempt to reconcile this apparent contradiction, possibly by proposing a context-specific or dual-function model for Codanin-1 in histone trafficking.
      5. Conclusions and Claims: The proposed model of CDA I pathogenesis (Fig. 4) is plausible but not yet fully supported by the available data. The authors suggest that disruption of the Codanin-1/CDIN1 interaction leads to nuclear histone depletion, but this has not been experimentally confirmed. Claims about the general pathogenesis of CDA I should be clearly qualified as hypothetical and applicable to a subset of mutations. The presence and localization of ASF1 in the nucleus following disruption of the Codanin-1/CDIN1 complex should be tested experimentally.
      6. Broader Mutation Analysis and ASF1 Localization: To strengthen the link between Codanin-1/CDIN1 disruption and disease pathogenesis, it would be important to test the effects of additional CDAN1 mutations, including those outside the C-terminal region. Similarly, the impact on ASF1 nuclear concentration and localization should be directly assessed. These experiments would significantly bolster the central hypothesis. If feasible, they should be pursued or at least acknowledged as important future directions.

      Minor Comments:

      • Methods and Reproducibility: The experimental methods are well described, and the results appear reproducible.
      • Presentation: The text and figures are clear and well organized.

      Referee Cross-commenting

      I agree with reviewer 1 that the paper present detailed strucutre study of Codann-1 and CDIN1 protein. However, as reviewer 2 claims functional studies are missing and therefore the hypothesis regarding the pahtogenesis of CDAI is speculaltive especially with no studies regarding ASF1.

      Significance

      Nature and Significance of the Advance:

      This study extends prior work (e.g., Swickley et al., BMC Mol Cell Biol 2020; Shroff et al., Biochem J 2020) on Codanin-1/CDIN1 interaction by applying high-resolution biophysical techniques to identify mutations that disrupt this complex. It provides a plausible cellular mechanism by which specific mutations may lead to CDA I through impaired histone trafficking. Nevertheless, key question remains: How do mutations outside the Codanin-1 C-terminus contribute to the pathology?

      Audience:

      Molecular and cellular biologists investigating nuclear-cytoplasmic trafficking mechanisms Hematologists and geneticists studying rare red cell disorders Clinicians managing CDA I patients and researchers exploring targeted therapies

      Reviewer Expertise:

      Pediatric hematologist with over 20 years of research experience in CDA I, including the initial identification of CDAN1 and the elucidation of Codanin-1's role in embryonic erythropoiesis. Not a specialist in the biophysical techniques used in this study

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reply to the Reviewers

      I would like to thank the reviewers for their comments and interest in the manuscript and the study.

      Reviewer #1

      1. I would assume that there are RNA-seq and/or ChIP-seq data out there produced after knockdown of one or more of these DBPs that show directional positioning.

      The directional positioning of CTCF-binding sites at chromatin interaction sites was analyzed by CRISPR experiment (Guo Y et al. Cell 2015). We found that the machine learning and statistical analysis showed the same directional bias of CTCF-binding motif sequence and RAD21-binding motif sequence at chromatin interaction sites as the experimental analysis of Guo Y et al. (lines 229-253, Figure 3b, c, d and Table 1). Since CTCF is involved in different biological functions (Braccioli L et al. Essays Biochem. 2019 ResearchGate webpage), the directional bias of binding sites may be reduced in all binding sites including those at chromatin interaction sites (lines 68-73). In our study, we investigated the DNA-binding sites of proteins using the ChIP-seq data of DNA-binding proteins and DNase-seq data. We also confirmed that the DNA-binding sites of SMC3 and RAD21, which tend to be found in chromatin loops with CTCF, also showed the same directional bias as CTCF by the computational analysis.

      __2. Figure 6 should be expanded to incorporate analysis of DBPs not overlapping CTCF/cohesin in chromatin interaction data that is important and potentially more interesting than the simple DBPs enrichment reported in the present form of the figure. __

      Following the reviewer's advice, I performed the same analysis with the DNA-binding sites that do no overlap with the DNA-binding sites of CTCF and cohesin (RAD21 and SMC3) (Fig. 6 and Supplementary Fig. 4). The result showed the same tendency in the distribution of DNA-binding sites. The height of a peak on the graph became lower for some DNA-binding proteins after removing the DNA-binding sites that overlapped with those of CTCF and cohesin. I have added the following sentence on lines 435 and 829: For the insulator-associated DBPs other than CTCF, RAD21, and SMC3, the DNA-binding sites that do not overlap with those of CTCF, RND21, and SMC3 were used to examine their distribution around interaction sites.

      3. Critically, I would like to see use of Micro-C/Hi-C data and ChIP-seq from these factors, where insulation scores around their directionally-bound sites show some sort of an effect like that presumed by the authors - and many such datasets are publicly-available and can be put to good use here.

      As suggested by the reviewer, I have added the insulator scores and boundary sites from the 4D nucleome data portal as tracks in the UCSC genome browser. The insulator scores seem to correspond to some extent to the H3K27me3 histone marks from ChIP-seq (Fig. 4a and Supplementary Fig. 3). We found that the DNA-binding sites of the insulator-associated DBPs were statistically overrepresented in the 5 kb boundary sites more than other DBPs (Fig. 4d). The direction of DNA-binding sites on the genome can be shown with different colors (e.g. red and green), but the directionality of insulator-associated DNA-binding sites is their overall tendency, and it may be difficult to notice the directionality from each binding site because the directionality may be weaker than that of CTCF, RAD21, and SMC3 as shown in Table 1 and Supplementary Table 2. We also observed the directional biases of CTCF, RAD21, and SMC3 by using Micro-C chromatin interaction data as we estimated, but the directionality was more apparent to distinguish the differences between the four directions of FR, RF, FF, and RR using CTCF-mediated ChIA-pet chromatin interaction data (lines 287 and 288).

       I found that the CTCF binding sites examined by a wet experiment in the previous study may not always overlap with the boundary sites of chromatin interactions from Micro-C assay (Guo Y et al. *Cell* 2015). The chromatin interaction data do not include all interactions due to the high sequencing cost of the assay, and include less long-range interactions due to distance bias. The number of the boundary sites may be smaller than that of CTCF binding sites acting as insulators and/or some of the CTCF binding sites may not be locate in the boundary sites. It may be difficult for the boundary location algorithm to identify a short boundary location. Due to the limitations of the chromatin interaction data, I planned to search for insulator-associated DNA-binding proteins without using chromatin interaction data in this study.
      
       I discussed other causes in lines 614-622: Another reason for the difference may be that boundary sites are more closely associated with topologically associated domains (TADs) of chromosome than are insulator sites. Boundary sites are regions identified based on the separation of numerous chromatin interactions. On the other hand, we found that the multiple DNA-binding sites of insulator-associated DNA-binding proteins were located close to each other at insulator sites and were associated with distinct nested and focal chromatin interactions, as reported by Micro-C assay. These interactions may be transient and relatively weak, such as tissue/cell type, conditional or lineage-specific interactions.
      
       Furthermore, I have added the statistical summary of the analysis in lines 372-395 as follows: Overall, among 20,837 DNA-binding sites of the 97 insulator-associated proteins found at insulator sites identified by H3K27me3 histone modification marks (type 1 insulator sites), 1,315 (6%) overlapped with 264 of 17,126 5kb long boundary sites, and 6,137 (29%) overlapped with 784 of 17,126 25kb long boundary sites in HFF cells. Among 5,205 DNA-binding sites of the 97 insulator-associated DNA-binding proteins found at insulator sites identified by H3K27me3 histone modification marks and transcribed regions (type 2 insulator sites), 383 (7%) overlapped with 74 of 17,126 5-kb long boundary sites, 1,901 (37%) overlapped with 306 of 17,126 25-kb long boundary sites. Although CTCF-binding sites separate active and repressive domains, the limited number of DNA-binding sites of insulator-associated proteins found at type 1 and 2 insulator sites overlapped boundary sites identified by chromatin interaction data. Furthermore, by analyzing the regulatory regions of genes, the DNA-binding sites of the 97 insulator-associated DNA-binding proteins were found (1) at the type 1 insulator sites (based on H3K27me3 marks) in the regulatory regions of 3,170 genes, (2) at the type 2 insulator sites (based on H3K27me3 marks and gene expression levels) in the regulatory regions of 1,044 genes, and (3) at insulator sites as boundary sites identified by chromatin interaction data in the regulatory regions of 6,275 genes. The boundary sites showed the highest number of overlaps with the DNA-binding sites. Comparing the insulator sites identified by (1) and (3), 1,212 (38%) genes have both types of insulator sites. Comparing the insulator sites between (2) and (3), 389 (37%) genes have both types of insulator sites. From the comparison of insulator and boundary sites, we found that (1) or (2) types of insulator sites overlapped or were close to boundary sites identified by chromatin interaction data.
      

      4. The suggested alternative transcripts function, also highlighted in the manuscripts abstract, is only supported by visual inspection of a few cases for several putative DBPs. I believe this is insufficient to support what looks like one of the major claims of the paper when reading the abstract, and a more quantitative and genome-wide analysis must be adopted, although the authors mention it as just an 'observation'.

      According to the reviewer's comment, I performed the genome-wide analysis of alternative transcripts where the DNA-binding sites of insulator-associated proteins are located near splicing sites. The DNA-binding sites of insulator-associated DNA-binding proteins were found within 200 bp centered on splice sites more significantly than the other DNA-binding proteins (Fig. 4e and Table 2). I have added the following sentences on lines 405 - 412: We performed the statistical test to estimate the enrichment of insulator-associated DNA-binding sites compared to the other DNA-binding proteins, and found that the insulator-associated DNA-binding sites were significantly more abundant at splice sites than the DNA-binding sites of the other proteins (Fig 4e and Table 2; Mann‒Whitney U test, p value 5. Figure 1 serves no purpose in my opinion and can be removed, while figures can generally be improved (e.g., the browser screenshots in Figs 4 and 5) for interpretability from readers outside the immediate research field.

      I believe that the Figure 1 would help researchers in other fields who are not familiar with biological phenomena and functions to understand the study. More explanation has been included in the Figures and legends of Figs. 4 and 5 to help readers outside the immediate research field understand the figures.

      6. Similarly, the text is rather convoluted at places and should be re-approached with more clarity for less specialized readers in mind.

      Reviewer #2's comments would be related to this comment. I have introduced a more detailed explanation of the method in the Results section, as shown in the responses to Reviewer #2's comments.

      Reviewer #2

      1. Introduction, line 95: CTCF appears two times, it seems redundant.

      On lines 91-93, I deleted the latter CTCF from the sentence "We examine the directional bias of DNA-binding sites of CTCF and insulator-associated DBPs, including those of known DBPs such as RAD21 and SMC3".

      2. Introduction, lines 99-103: Please stress better the novelty of the work. What is the main focus? The new identified DPBs or their binding sites? What are the "novel structural and functional roles of DBPs" mentioned?

      Although CTCF is known to be the main insulator protein in vertebrates, we found that 97 DNA-binding proteins including CTCF and cohesin are associated with insulator sites by modifying and developing a machine learning method to search for insulator-associated DNA-binding proteins. Most of the insulator-associated DNA-binding proteins showed the directional bias of DNA-binding motifs, suggesting that the directional bias is associated with the insulator.

       I have added the sentence in lines 96-99 as follows: Furthermore, statistical testing the contribution scores between the directional and non-directional DNA-binding sites of insulator-associated DBPs revealed that the directional sites contributed more significantly to the prediction of gene expression levels than the non-directional sites. I have revised the statement in lines 101-110 as follows: To validate these findings, we demonstrate that the DNA-binding sites of the identified insulator-associated DBPs are located within potential insulator sites, and some of the DNA-binding sites in the insulator site are found without the nearby DNA-binding sites of CTCF and cohesin. Homologous and heterologous insulator-insulator pairing interactions are orientation-dependent, as suggested by the insulator-pairing model based on experimental analysis in flies. Our method and analyses contribute to the identification of insulator- and chromatin-associated DNA-binding sites that influence EPIs and reveal novel functional roles and molecular mechanisms of DBPs associated with transcriptional condensation, phase separation and transcriptional regulation.
      

      3. Results, line 111: How do the SNPs come into the procedure? From the figures it seems the input is ChIP-seq peaks of DNBPs around the TSS.

      On lines 121-124, to explain the procedure for the SNP of an eQTL, I have added the sentence in the Methods: "If a DNA-binding site was located within a 100-bp region around a single-nucleotide polymorphism (SNP) of an eQTL, we assumed that the DNA-binding proteins regulated the expression of the transcript corresponding to the eQTL".

      4. Again, are those SNPs coming from the different cell lines? Or are they from individuals w.r.t some reference genome? I suggest a general restructuring of this part to let the reader understand more easily. One option could be simplifying the details here or alternatively including all the necessary details.

      On line 119, I have included the explanation of the eQTL dataset of GTEx v8 as follows: " The eQTL data were derived from the GTEx v8 dataset, after quality control, consisting of 838 donors and 17,382 samples from 52 tissues and two cell lines". On lines 681 and 865, I have added the filename of the eQTL data "(GTEx_Analysis_v8_eQTL.tar)".

      5. Figure 1: panel a and b are misleading. Is the matrix in panel a equivalent to the matrix in panel b? If not please clarify why. Maybe in b it is included the info about the SNPs? And if yes, again, what is then difference with a.

      The reviewer would mention Figure 2, not Figure 1. If so, the matrices in panels a and b in Figure 2 are equivalent. I have shown it in the figure: The same figure in panel a is rotated 90 degrees to the right. The green boxes in the matrix show the regions with the ChIP-seq peak of a DNA-binding protein overlapping with a SNP of an eQTL. I used eQTL data to associate a gene with a ChIP-seq peak that was more than 2 kb upstream and 1 kb downstream of a transcriptional start site of a gene. For each gene, the matrix was produced and the gene expression levels in cells were learned and predicted using the deep learning method. I have added the following sentences to explain the method in lines 133 - 139: Through the training, the tool learned to select the binding sites of DNA-binding proteins from ChIP-seq assays that were suitable for predicting gene expression levels in the cell types. The binding sites of a DNA-binding protein tend to be observed in common across multiple cell and tissue types. Therefore, ChIP-seq data and eQTL data in different cell and tissue types were used as input data for learning, and then the tool selected the data suitable for predicting gene expression levels in the cell types, even if the data were not obtained from the same cell types.

      6. Line 386-388: could the author investigate in more detail this observation? Does it mean that loops driven by other DBPs independent of the known CTCF/Cohesin? Could the author provide examples of chromatin structural data e.g. MicroC?

      As suggested by the reviewer, to help readers understand the observation, I have added Supplementary Fig. S4c to show the distribution of DNA-binding sites of "CTCF, RAD21, and SMC3" and "BACH2, FOS, ATF3, NFE2, and MAFK" around chromatin interaction sites. I have modified the following sentence to indicate the figure on line 501: Although a DNA-binding-site distribution pattern around chromatin interaction sites similar to those of CTCF, RAD21, and SMC3 was observed for DBPs such as BACH2, FOS, ATF3, NFE2, and MAFK, less than 1% of the DNA-binding sites of the latter set of DBPs colocalized with CTCF, RAD21, or SMC3 in a single bin (Fig. S4c).

       In Aljahani A et al. *Nature Communications* 2022, we find that depletion of cohesin causes a subtle reduction in longer-range enhancer-promoter interactions and that CTCF depletion can cause rewiring of regulatory contacts. Together, our data show that loop extrusion is not essential for enhancer-promoter interactions, but contributes to their robustness and specificity and to precise regulation of gene expression. Goel VY et al. *Nature Genetics* 2023 mentioned in the abstract: Microcompartments frequently connect enhancers and promoters and though loss of loop extrusion and inhibition of transcription disrupts some microcompartments, most are largely unaffected. These results suggested that chromatin loops can be driven by other DBPs independent of the known CTCF/Cohesin.
      
      I added the following sentence on lines 569-577: The depletion of cohesin causes a subtle reduction in longer-range enhancer-promoter interactions and that CTCF depletion can cause rewiring of regulatory contacts. Another group reported that enhancer-promoter interactions and transcription are largely maintained upon depletion of CTCF, cohesin, WAPL or YY1. Instead, cohesin depletion decreased transcription factor binding to chromatin. Thus, cohesin may allow transcription factors to find and bind their targets more efficiently. Furthermore, the loop extrusion is not essential for enhancer-promoter interactions, but contributes to their robustness and specificity and to precise regulation of gene expression.
      
       FOXA1 pioneer factor functions as an initial chromatin-binding and chromatin-remodeling factor and has been reported to form biomolecular condensates (Ji D et al. *Molecular Cell* 2024). CTCF have also found to form transcriptional condensate and phase separation (Lee R et al. *Nucleic acids research* 2022). FOS was found to be an insulator-associated DNA-binding protein in this study and is potentially involved in chromatin remodeling, transcription condensation, and phase separation with the other factors such as BACH2, ATF3, NFE2 and MAFK. I have added the following sentence on line 556: FOXA1 pioneer factor functions as an initial chromatin-binding and chromatin-remodeling factor and has been reported to form biomolecular condensates.
      

      7. In general, how the presented results are related to some models of chromatin architecture, e.g. loop extrusion, in which it is integrated convergent CTCF binding sites?

      Goel VY et al. Nature Genetics 2023 identified highly nested and focal interactions through region capture Micro-C, which resemble fine-scale compartmental interactions and are termed microcompartments. In the section titled "Most microcompartments are robust to loss of loop extrusion," the researchers noted that a small proportion of interactions between CTCF and cohesin-bound sites exhibited significant reductions in strength when cohesin was depleted. In contrast, the majority of microcompartmental interactions remained largely unchanged under cohesin depletion. Our findings indicate that most P-P and E-P interactions, aside from a few CTCF and cohesin-bound enhancers and promoters, are likely facilitated by a compartmentalization mechanism that differs from loop extrusion. We suggest that nested, multiway, and focal microcompartments correspond to small, discrete A-compartments that arise through a compartmentalization process, potentially influenced by factors upstream of RNA Pol II initiation, such as transcription factors, co-factors, or active chromatin states. It follows that if active chromatin regions at microcompartment anchors exhibit selective "stickiness" with one another, they will tend to co-segregate, leading to the development of nested, focal interactions. This microphase separation, driven by preferential interactions among active loci within a block copolymer, may account for the striking interaction patterns we observe.

       The authors of the paper proposed several mechanisms potentially involved in microcompartments. These mechanisms may be involved in looping with insulator function. Another group reported that enhancer-promoter interactions and transcription are largely maintained upon depletion of CTCF, cohesin, WAPL or YY1. Instead, cohesin depletion decreased transcription factor binding to chromatin. Thus, cohesin may allow transcription factors to find and bind their targets more efficiently (Hsieh TS et al. *Nature Genetics* 2022). Among the identified insulator-associated DNA-binding proteins, Maz and MyoD1 form loops without CTCF (Xiao T et al. *Proc Natl Acad Sci USA* 2021 ; Ortabozkoyun H et al. *Nature genetics* 2022 ; Wang R et al. *Nature communications* 2022). I have added the following sentences on lines 571-575: Another group reported that enhancer-promoter interactions and transcription are largely maintained upon depletion of CTCF, cohesin, WAPL or YY1. Instead, cohesin depletion decreased transcription factor binding to chromatin. Thus, cohesin may allow transcription factors to find and bind their targets more efficiently. I have included the following explanation on lines 582-584: Maz and MyoD1 among the identified insulator-associated DNA-binding proteins form loops without CTCF.
      
       As for the directionality of CTCF, if chromatin loop anchors have some structural conformation, as shown in the paper entitled "The structural basis for cohesin-CTCF-anchored loops" (Li Y et al. *Nature* 2020), directional DNA binding would occur similarly to CTCF binding sites. Moreover, cohesin complexes that interact with convergent CTCF sites, that is, the N-terminus of CTCF, might be protected from WAPL, but those that interact with divergent CTCF sites, that is, the C-terminus of CTCF, might not be protected from WAPL, which could release cohesin from chromatin and thus disrupt cohesin-mediated chromatin loops (Davidson IF et al. *Nature Reviews Molecular Cell Biology* 2021). Regarding loop extrusion, the 'loop extrusion' hypothesis is motivated by in vitro observations. The experiment in yeast, in which cohesin variants that are unable to extrude DNA loops but retain the ability to topologically entrap DNA, suggested that in vivo chromatin loops are formed independently of loop extrusion. Instead, transcription promotes loop formation and acts as an extrinsic motor that extends these loops and defines their final positions (Guerin TM et al. *EMBO Journal* 2024). I have added the following sentences on lines 543-547: Cohesin complexes that interact with convergent CTCF sites, that is, the N-terminus of CTCF, might be protected from WAPL, but those that interact with divergent CTCF sites, that is, the C-terminus of CTCF, might not be protected from WAPL, which could release cohesin from chromatin and thus disrupt cohesin-mediated chromatin loops. I have included the following sentences on lines 577-582: The 'loop extrusion' hypothesis is motivated by in vitro observations. The experiment in yeast, in which cohesin variants that are unable to extrude DNA loops but retain the ability to topologically entrap DNA, suggested that in vivo chromatin loops are formed independently of loop extrusion. Instead, transcription promotes loop formation and acts as an extrinsic motor that extends these loops and defines their final positions.
      
       Another model for the regulation of gene expression by insulators is the boundary-pairing (insulator-pairing) model (Bing X et al. *Elife* 2024) (Ke W et al. *Elife* 2024) (Fujioka M et al. *PLoS Genetics* 2016). Molecules bound to insulators physically pair with their partners, either head-to-head or head-to-tail, with different degrees of specificity at the termini of TADs in flies. Although the experiments do not reveal how partners find each other, the mechanism unlikely requires loop extrusion. Homologous and heterologous insulator-insulator pairing interactions are central to the architectural functions of insulators. The manner of insulator-insulator interactions is orientation-dependent. I have summarized the model on lines 559-567: Other types of chromatin regulation are also expected to be related to the structural interactions of molecules. As the boundary-pairing (insulator-pairing) model, molecules bound to insulators physically pair with their partners, either head-to-head or head-to-tail, with different degrees of specificity at the termini of TADs in flies (Fig. 7). Although the experiments do not reveal how partners find each other, the mechanism unlikely requires loop extrusion. Homologous and heterologous insulator-insulator pairing interactions are central to the architectural functions of insulators. The manner of insulator-insulator interactions is orientation-dependent.
      

      8. Do the authors think that the identified DBPs could work in that way as well?

      The boundary-pairing (insulator-pairing) model would be applied to the insulator-associated DNA-binding proteins other than CTCF and cohesin that are involved in the loop extrusion mechanism (Bing X et al. Elife 2024) (Ke W et al. Elife 2024) (Fujioka M et al. PLoS Genetics 2016).

       Liquid-liquid phase separation was shown to occur through CTCF-mediated chromatin loops and to act as an insulator (Lee, R et al. *Nucleic Acids Research* 2022). Among the identified insulator-associated DNA-binding proteins, CEBPA has been found to form hubs that colocalize with transcriptional co-activators in a native cell context, which is associated with transcriptional condensate and phase separation (Christou-Kent M et al. *Cell Reports* 2023). The proposed microcompartment mechanisms are also associated with phase separation. Thus, the same or similar mechanisms are potentially associated with the insulator function of the identified DNA-binding proteins. I have included the following information on line 554: CEBPA in the identified insulator-associated DNA-binding proteins was also reported to be involved in transcriptional condensates and phase separation.
      

      9. Also, can the authors comment about the mechanisms those newly identified DBPs mediate contacts by active processes or equilibrium processes?

      Snead WT et al. Molecular Cell 2019 mentioned that protein post-transcriptional modifications (PTMs) facilitate the control of molecular valency and strength of protein-protein interactions. O-GlcNAcylation as a PTM inhibits CTCF binding to chromatin (Tang X et al. Nature Communications 2024). I found that the identified insulator-associated DNA-binding proteins tend to form a cluster at potential insulator sites (Supplementary Fig. 2d). These proteins may interact and actively regulate chromatin interactions, transcriptional condensation, and phase separation by PTMs. I have added the following explanation on lines 584-590: Furthermore, protein post-transcriptional modifications (PTMs) facilitate control over the molecular valency and strength of protein-protein interactions. O-GlcNAcylation as a PTM inhibits CTCF binding to chromatin. We found that the identified insulator-associated DNA-binding proteins tend to form a cluster at potential insulator sites (Fig. 4f and Supplementary Fig. 3c). These proteins may interact and actively regulate chromatin interactions, transcriptional condensation, and phase separation through PTMs.

      10. Can the author provide some real examples along with published structural data (e.g. the mentioned micro-C data) to show the link between protein co-presence, directional bias and contact formation?

      Structural molecular model of cohesin-CTCF-anchored loops has been published by Li Y et al. Nature 2020. The structural conformation of CTCF and cohesin in the loops would be the cause of the directional bias of CTCF binding sites, which I mentioned in lines 539 - 543 as follows: These results suggest that the directional bias of DNA-binding sites of insulator-associated DBPs may be involved in insulator function and chromatin regulation through structural interactions among DBPs, other proteins, DNAs, and RNAs. For example, the N-terminal amino acids of CTCF have been shown to interact with RAD21 in chromatin loops.

       To investigate the principles underlying the architectural functions of insulator-insulator pairing interactions, two insulators, Homie and Nhomie, flanking the *Drosophila even skipped *locus were analyzed. Pairing interactions between the transgene Homie and the eve locus are directional. The head-to-head pairing between the transgene and endogenous Homie matches the pattern of activation (Fujioka M et al. *PLoS Genetics* 2016).
      

      Reviewer #3

      Major Comments:

      1. Some of these TFs do not have specific direct binding to DNA (P300, Cohesin). Since the authors are using binding motifs in their analysis workflow, I would remove those from the analysis.

      When a protein complex binds to DNA, one protein of the complex binds to the DNA directory, and the other proteins may not bind to DNA. However, the DNA motif sequence bound by the protein may be registered as the DNA-binding motif of all the proteins in the complex. The molecular structure of the complex of CTCF and Cohesin showed that both CTCF and Cohesin bind to DNA (Li Y et al. Nature 2020). I think there is a possibility that if the molecular structure of a protein complex becomes available, the previous recognition of the DNA-binding ability of a protein may be changed. Therefore, I searched the Pfam database for 99 insulator-associated DNA-binding proteins identified in this study. I found that 97 are registered as DNA-binding proteins and/or have a known DNA-binding domain, and EP300 and SIN3A do not directory bind to DNA, which was also checked by Google search. I have added the following explanation in line 257 to indicate direct and indirect DNA-binding proteins: Among 99 insulator-associated DBPs, EP300 and SIN3A do not directory interact with DNA, and thus 97 insulator-associated DBPs directory bind to DNA. I have updated the sentence in line 20 of the Abstract as follows: We discovered 97 directional and minor nondirectional motifs in human fibroblast cells that corresponded to 23 DBPs related to insulator function, CTCF, and/or other types of chromosomal transcriptional regulation reported in previous studies.

      2. I am not sure if I understood correctly, by why do the authors consider enhancers spanning 2Mb (200 bins of 10Kb around eSNPs)? This seems wrong. Enhancers are relatively small regions (100bp to 1Kb) and only a very small subset form super enhancers.

      As the reviewer mentioned, I recognize enhancers are relatively small regions. In the paper, I intended to examine further upstream and downstream of promoter regions where enhancers are found. Therefore, I have modified the sentence in lines 929 - 931 of the Fig. 2 legend as follows: Enhancer-gene regulatory interaction regions consist of 200 bins of 10 kbp between -1 Mbp and 1 Mbp region from TSS, not including promoter.

      3. I think the H3K27me3 analysis was very good, but I would have liked to see also constitutive heterochromatin as well, so maybe repeat the analysis for H3K9me3.

      Following the reviewer's advice, I have added the ChIP-seq data of H3K9me3 as a truck of the UCSC Genome Browser. The distribution of H3K9me3 signal was different from that of H3K27me3 in some regions. I also found the insulator-associated DNA-binding sites close to the edges of H3K9me3 regions and took some screenshots of the UCSC Genome Browser of the regions around the sites in Supplementary Fig. 3b. I have modified the following sentence on lines 974 - 976 in the legend of Fig. 4: a Distribution of histone modification marks H3K27me3 (green color) and H3K9me3 (turquoise color) and transcript levels (pink color) in upstream and downstream regions of a potential insulator site (light orange color). I have also added the following result on lines 356 - 360: The same analysis was performed using H3K9me3 marks, instead of H3K27me3 (Fig. S3b). We found that the distribution of H3K9me3 signal was different from that of H3K27me3 in some regions, and discovered the insulator-associated DNA-binding sites close to the edges of H3K9me3 regions (Fig. S3b).

      4. I was not sure I understood the analysis in Figure 6. The binding site is with 500bp of the interaction site, but micro-C interactions are at best at 1Kb resolution. They say they chose the centre of the interaction site, but we don't know exactly where there is the actual interaction. Also, it is not clear what they measure. Is it the number of binding sites of a specific or multiple DBP insulator proteins at a specific distance from this midpoint that they recover in all chromatin loops? Maybe I am missing something. This analysis was not very clear.

      The resolution of the Micro-C assay is considered to be 100 bp and above, as the human nucleome core particle contains 145 bp (and 193 bp with linker) of DNA. However, internucleosomal DNA is cleaved by endonuclease into fragments of multiples of 10 nucleotides (Pospelov VA et al. Nucleic Acids Research 1979). Highly nested focal interactions were observed (Goel VY et al. Nature Genetics 2023). Base pair resolution was reported using Micro Capture-C (Hua P et al. Nature 2021). Sub-kilobase (20 bp resolution) chromatin topology was reported using an MNase-based chromosome conformation capture (3C) approach (Aljahani A et al. Nature Communications 2022). On the other hand, Hi-C data was analyzed at 1 kb resolution. (Gu H et al. bioRxiv 2021). If the resolution of Micro-C interactions is at best at 1 kb, the binding sites of a DNA-binding protein will not show a peak around the center of the genomic locations of interaction edges. Each panel shows the number of binding sites of a specific DNA-binding protein at a specific distance from the midpoint of all chromatin interaction edges. I have modified and added the following sentences in lines 593-597: High-resolution chromatin interaction data from a Micro-C assay indicated that most of the predicted insulator-associated DBPs showed DNA-binding-site distribution peaks around chromatin interaction sites, suggesting that these DBPs are involved in chromatin interactions and that the chromatin interaction data has a high degree of resolution. Base pair resolution was reported using Micro Capture-C.

      Minor Comments:

      1. PIQ does not consider TF concentration. Other methods do that and show that TF concentration improves predictions (e.g., ____https://www.biorxiv.org/content/10.1101/2023.07.15.549134v2____or ____https://pubmed.ncbi.nlm.nih.gov/37486787____/). The authors should discuss how that would impact their results.

      The directional bias of CTCF binding sites was identified by ChIA-pet interactions of CTCF binding sites. The analysis of the contribution scores of DNA-binding sites of proteins considering the binding sites of CTCF as an insulator showed the same tendency of directional bias of CTCF binding sites. In the analysis, to remove the false-positive prediction of DNA-binding sites, I used the binding sites that overlapped with a ChIP-seq peak of the DNA-binding protein. This result suggests that the DNA-binding sites of CTCF obtained by the current analysis have sufficient quality. Therefore, if the accuracy of prediction of DNA-binding sites is improved, although the number of DNA-binding sites may be different, the overall tendency of the directionality of DNA-binding sites will not change and the results of this study will not change significantly.

       As for the first reference in the reviewer's comment, chromatin interaction data from Micro-C assay does not include all chromatin interactions in a cell or tissue, because it is expensive to cover all interactions. Therefore, it would be difficult to predict all chromatin interactions based on machine learning. As for the second reference in the reviewer's comment, pioneer factors such as FOXA are known to bind to closed chromatin regions, but transcription factors and DNA-binding proteins involved in chromatin interactions and insulators generally bind to open chromatin regions. The search for the DNA-binding motifs is not required in closed chromatin regions.
      

      2. DeepLIFT is a good approach to interpret complex structures of CNN, but is not truly explainable AI. I think the authors should acknowledge this.

      In the DeepLIFT paper, the authors explain that DeepLIFT is a method for decomposing the output prediction of a neural network on a specific input by backpropagating the contributions of all neurons in the network to every feature of the input (Shrikumar A et al. ICML 2017). DeepLIFT compares the activation of each neuron to its 'reference activation' and assigns contribution scores according to the difference. DeepLIFT calculates a metric to measure the difference between an input and the reference of the input.

       Truly explainable AI would be able to find cause and reason, and to make choices and decisions like humans. DeepLIFT does not perform causal inferences. I did not use the term "Explainable AI" in our manuscript, but I briefly explained it in Discussion. I have added the following explanation in lines 623-628: AI (Artificial Intelligence) is considered as a black box, since the reason and cause of prediction are difficult to know. To solve this issue, tools and methods have been developed to know the reason and cause. These technologies are called Explainable AI. DeepLIFT is considered to be a tool for Explainable AI. However, DeepLIFT does not answer the reason and cause for a prediction. It calculates scores representing the contribution of the input data to the prediction.
      
       Furthermore, to improve the readability of the manuscript, I have included the following explanation in lines 159-165: we computed DeepLIFT scores of the input data (i.e., each binding site of the ChIP-seq data of DNA-binding proteins) in the deep leaning analysis on gene expression levels. DeepLIFT compares the importance of each input for predicting gene expression levels to its 'reference or background level' and assigns contribution scores according to the difference. DeepLIFT calculates a metric to measure the difference between an input and the reference of the input.
      
    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Summary:

      Osato and Hamada propose a systematic approach to identify DNA binding proteins that display directional binding. They used a modified Deep Learning method (DEcode) to investigate binding profiles of 1356 DBP from GTRD database at promoters (30 of 100bp bins around TSS) and enhancers (200 bins of 10Kb around eSNPs) and use this to predict expression of 25,071 genes in Fibroblasts, Monocytes, HMEC and NPC. This method achieves a good prediction power (Spearman correlation between predicted and actual expression of 0.74). They then use PIQ, and overlap predicted binding sites with actual ChIP-seq data to investigate the motifs of TFs that are controlling gene expression. They find 99 insulator proteins showing either a specific directional bias or minor non-directional bias, corresponding to 23 DBP previously reported to have insulator function. Of the 23 proteins they identify as regulating enhancer promoter interactions, 13 are associated with CTCF. They also show that there are significantly more insulator proteins binding sites at borders of polycomb domains, transcriptionally active or boundary regions based on chromatin interactions than other proteins.

      Major Comments:

      1. Some of these TFs do not have specific direct binding to DNA (P300, Cohesin). Since the authors are using binding motifs in their analysis workflow, I would remove those from the analysis.
      2. I am not sure if I understood correctly, by why do the authors consider enhancers spanning 2Mb (200 bins of 10Kb around eSNPs)? This seems wrong. Enhancers are relatively small regions (100bp to 1Kb) and only a very small subset form super enhancers.
      3. I think the H3K27me3 analysis was very good, but I would have liked to see also constitutive heterochromatin as well, so maybe repeat the analysis for H3K9me3.
      4. I was not sure I understood the analysis in Figure 6. The binding site is with 500bp of the interaction site, but micro-C interactions are at best at 1Kb resolution. They say they chose the centre of the interaction site, but we don't know exactly where there is the actual interaction. Also, it is not clear what they measure. Is it the number of binding sites of a specific or multiple DBP insulator proteins at a specific distance from this midpoint that they recover in all chromatin loops? Maybe I am missing something. This analysis was not very clear.

      Minor comments:

      1. PIQ does not consider TF concentration. Other methods do that and show that TF concentration improves predictions (e.g., https://www.biorxiv.org/content/10.1101/2023.07.15.549134v2 or https://pubmed.ncbi.nlm.nih.gov/37486787/). The authors should discuss how that would impact their results.
      2. DeepLIFT is a good approach to interpret complex structures of CNN, but is not truly explainable AI. I think the authors should acknowledge this.

      Referee Cross-Commenting

      I would like to mention that I agree with the comments of reviewers 1 and 2.

      Significance

      General assessment:

      This is the first study to my knowledge that attempts to use Deep Learning to identify insulators and directional biases in binding. One of the limitations is that no additional methods were used to show that these DBP have directional binding bias. It is not necessarily to employ additional methods, but it would definitely strengthen the paper.

      Advancements:

      This is a useful catalogue of potential DNA binding proteins of interest, beyond just CTCF. Some known TFs are there, but also new ones are found.

      Audience:

      Basic research mainly, with particular focus on chromatin conformation and TF binding fields.

      My expertise:

      ML/AI methods in genomics, TF binding models, epigenetics and 3D chromatin interactions.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      In this work, the authors describe a deep learning computational tool to identity binding motifs of DNA binding proteins associated to insulators that led to the discovery of 99 motifs related to insulation. This is in turn related to chromatin architecture and highlight the importance of directional bias in order to form chromatin loops.

      In general, there are some aspects to be clarified and better explored to make stronger conclusions. In particular, there are some aspects to clarify in the text about the Machine Learning procedure (see my points below). In addition, I have some general questions about the biological implications of the discussed findings, listed in detail in the following list.

      Also, I encourage the authors to integrate the current presentation of the data with other (published) data about chromatin architecture, to make more robust the claims and go deeper into the biological implications of the current work. Se my list below.

      It follows a specific list of relevant points to be addressed:

      Specific points:

      1. Introduction, line 95: CTCF appears two times, it seems redundant;
      2. Introduction, lines 99-103: Please stress better the novelty of the work. What is the main focus? The new identified DPBs or their binding sites? What are the "novel structural and functional roles of DBPs" mentioned?
      3. Results, line 111: How do the SNPs come into the procedure? From the figures it seems the input is ChIP-seq peaks of DNBPs around the TSS;
      4. Again, are those SNPs coming from the different cell lines? Or are they from individuals w.r.t some reference genome? I suggest a general restructuring of this part to let the reader understand more easily. One option could be simplifying the details here or alternatively including all the necessary details;
      5. Figure 1: panel a and b are misleading. Is the matrix in panel a equivalent to the matrix in panel b? If not please clarify why. Maybe in b it is included the info about the SNPs? And if yes, again, what is then difference with a.
      6. Line 386-388: could the author investigate in more detail this observation? Does it mean that loops driven by other DBPs independent of the known CTCF/Cohesin? Could the author provide examples of chromatin structural data e.g. MicroC?
      7. In general, how the presented results are related to some models of chromatin architecture, e.g. loop extrusion, in which it is integrated convergent CTCF binding sites?
      8. Do the authors think that the identified DBPs could work in that way as well?
      9. Also, can the authors comment about the mechanisms those newly identified DBPs mediate contacts by active processes or equilibrium processes?
      10. Can the author provide some real examples along with published structural data (e.g. the mentioned micro-C data) to show the link between protein co-presence, directional bias and contact formation?

      Significance

      In this work, the authors describe a deep learning computational tool to identity binding motifs of DNA binding proteins associated to insulators that led to the discovery of 99 motifs related to insulation. This is in turn related to chromatin architecture and highlight the importance of directional bias in order to form chromatin loops.

      In general, chromatin organization is an important topic in the context of a constantly expanding research field. Therefore, the work is timely and could be useful for the community. The paper appears overall well written and the figures look clear and of good quality. Nevertheless, there are some aspects to be clarified and better explored to make stronger conclusions. In particular, there are some aspects to clarify in the text about the Machine Learning procedure (see list of specific points). In addition, I have some general questions about the biological implications of the discussed findings, listed in detail in the above reported points.

    1. Reviewer #2 (Public review):

      Summary:

      The authors use the TRAP2 mouse line to label dentate gyrus cells active during and enriched environment paradigm and cut brain slices from these animals one week later to determine whether granule cells (GC) and semilunar granule cells (SGC) labelled during the exposure share common features. They particularly focus on the role of SGCs and potential circuit mechanisms by which they could be selectively embedded in the labelled assembly. The authors claim that SGCs are disproportionately recruited into IEG expressing assemblies due to intrinsic firing characteristics but cannot identify any contributing circuit connectivity motives in the slice preparation, although they claim that an increased correlation between spontaneous synaptic currents in the slice could signify common synaptic inputs as the source of assembly formation.

      Strengths:

      The authors chose a timely and relevant question, namely, how memory-bearing neuronal assemblies, or 'engrams', are established and maintained in the dentate gyrus. After the initial discovery of such memory-specific ensembles of immediate-early gene expressing engrams in 2012 (Ramirez et al.) this issue has been explored by several high-profile studies that have considerably expanded our understanding of the underlying molecular and cellular mechanisms, but still leave a lot of unanswered questions.

      Weaknesses:

      (1) The authors claim that recurrent excitation from SGCs onto GCs or other SGCs is irrelevant because they did not find any connections in 32 simultaneous recordings (plus 63 in the next experiment). Without a demonstration that other connections from SGCs (e.g. onto mossy cells or interneurons) are preserved in their preparation and if so at what rates, it is unclear whether this experiment is indicative of the underlying biology or the quality of the preparation. The argument that spontaneous EPSCs are observed is not very convincing as these could equally well arise from severed axons (in fact we would expect that the vast majority of inputs are not from local excitatory cells). The argument on line 418 that SGCs have compact axons isn't particularly convincing either given that the morphologies from which they were derived were also obtained in slice preparations and would be subject to the same likelihood of severing the axon. Finally, even in paired slice recordings from CA3 pyramidal cells the experimentally detected connectivity rates are only around 1% (Guzman et al., 2016). The authors would need to record from a lot more than 32 pairs (and show convincing positive controls regarding other connections) to make the claim that connectivity is too low to be relevant.

      The authors now provide evidence that at least some synaptic connections are preserved by recruiting GC assemblies with channelrhodopsin, resulting in feedback inhibition which supports their argument.

      (2) Another concern is that optogenetic GC stimulation rarely ever evokes feedback inhibition onto other cells which contrasts with both other in vitro (e.g. Braganza et al., 2020) and in vivo studies (Stefanelli et al., 2016) studies. Without a convincing demonstration that monosynaptic connections between SGCs/GCs and interneurons in both directions is preserved at least at the rates previously described in other slice studies (e.g. Geiger et al., 1997, Neuron, Hainmueller et al., 2014, PNAS, Savanthrapadian et al., 2014, J. Neurosci). The authors now provide evidence that at least some synaptic connections are preserved by stimulating a random subset of granule cells optogenetically, although it still remains unclear how the rate of connectivity compares to other studies or a live organism.

      (3) Probably the most convincing finding in this study is the higher zero-time lag correlation of spontaneous EPSCs in labelled vs. unlabeled pairs. Unfortunately, the authors use spontaneous EPSCs to begin with, which likely represent a mixture of spontaneous release from severed axons, minis, and coordinated discharge from intact axon segments or entire neurons, make it very hard to determine the meaning and relevance of this finding. The authors now show the baseline EPSC rates and conventional Cross correlograms (CCG; see e.g. English et al., 2017, Neuron; Senzai and Buzsaki, 2017, Neuron) lending more support to this conclusion.

      (4) Finally, one of the biggest caveats of the study is that the ensemble is labelled a full week before the slice experiment and thereby represents a latent state of a memory rather than encoding, consolidation, or recall processes. The authors acknowledge that in the discussion but they should also be mindful of this when discussing other (especially in vivo) studies and comparing their results to these. For instance, Pignatelli et al 2018 show drastic changes in GC engram activity and features driven by behavioral memory recall, so the results of the current study may be very different if slices were cut immediately after memory acquisition (if that was possible with a different labelling strategy), or if animals were re-exposed to the enriched environment right before sacrificing the animal. The authors discuss this limitation appropriately.

      There are also a few minor issues limiting the extent of interpretations of the data:

      (1) Only about 7% of the 'engram' cells are re-activated one week after exposure (line 147), it is unclear how meaningful this assembly is given the high number of cells that may either be labelled unrelated to the EE or no longer be part of the memory-related ensemble.

      (2) Line 215: The wording '32 pairwise connections examined' suggests that there actually were synaptic connections; would recommend altering the wording to 'simultaneously recorded cells examined' to avoid confusion.

    2. Author Response:

      The following is the authors’ response to the previous reviews

      Reviewer #1 (Public Review):

      (1) I think the article is a little too immature in its current form. I'd recommend that the authors work on their writing. For example, the objectives of the article are not completely clear to me after reading the manuscript, composed of parts where the authors seem to focus on SGCs, and others where they study "engram" neurons without differentiating the neuronal type (Figure 5). The next version of the manuscript should clearly establish the objectives and sub-aims.

      We now provide clarification for focusing on the labeling status versus the cell types in figure 5. Since figure 5 focuses on inputs to labeled pairs versus Labeledunlabeled pairs the pairs include mixed groups with GCs and SGCs. Since the question pertains to inputs rather than cell types, we did not specifically distinguish the cell types. This is now explained in the text on page 15:  “Note that since the intent was to determine the input correlation depending on labeling status of the cell pairs rather than based on cell type, we do not explicitly consider whether analyzed cell pairs included GCs or SGCs.”

      (2) In addition, some results are not entirely novel (e.g., the disproportionate recruitment as well as the distinctive physiological properties of SGCs), and/or based on correlations that do not fully support the conclusions of the article. In addition to re-writing, I believe that the article would benefit from being enriched with further analyses or even additional experiments before being resubmitted in a more definitive form.

      We now indicate the data comparing labeled versus unlabeled SGCs is novel. Moreover, we also highlight that (1) recruitment of SGCs has not been previously examined in Barnes Maze or Enriched Environment, (2) that our unbiased morphological analysis of SGC recruitment is more robust than subsampling of recorded neurons in prior studies and (3) that our data show that prior may have overestimated SGC recruitment to engrams. Thus, the data characterized as “not novel” are essential for appropriate analysis of behaviorally tagged neurons which is the thrust of our study.  

      Reviewer #2 (Public Review):

      (1) The authors conclude that SGCs are disproportionately recruited into cfos assemblies during the enriched environment and Barnes maze task given that their classifier identifies about 30% of labelled cells as SGCs in both cases and that another study using a different method (Save et al., 2019) identified less than 5% of an unbiased sample of granule cells as SGCs. To make matters worse, the classifier deployed here was itself established on a biased sample of GCs patched in the molecular layer and granule cell layer, respectively, at even numbers (Gupta et al., 2020). The first thing the authors would need to show to make the claim that SGCs are disproportionately recruited into memory ensembles is that the fraction of GCs identified as SGCs with their own classifier is significantly lower than 30% using their own method on a random sample of GCs (e.g. through sparse viral labelling). As the authors correctly state in their discussion, morphological samples from patch-clamp studies are problematic for this purpose because of inherent technical issues (i.e. easier access to scattered GCs in the molecular layer).

      We now clarify, on page 9, that a trained investigator classified cell types based on predefined morphological criteria.  No automated classifiers were used to assign cell types in the current study.

      (2) The authors claim that recurrent excitation from SGCs onto GCs or other SGCs is irrelevant because they did not find any connections in 32 simultaneous recordings (plus 63 in the next experiment). Without a demonstration that other connections from SGCs (e.g. onto mossy cells or interneurons) are preserved in their preparation and if so at what rates, it is unclear whether this experiment is indicative of the underlying biology or the quality of the preparation. The argument that spontaneous EPSCs are observed is not very convincing as these could equally well arise from severed axons (in fact we would expect that the vast majority of inputs are not from local excitatory cells). The argument on line 418 that SGCs have compact axons isn't particularly convincing either given that the morphologies from which they were derived were also obtained in slice preparations and would be subject to the same likelihood of severing the axon. Finally, even in paired slice recordings from CA3 pyramidal cells the experimentally detected connectivity rates are only around 1% (Guzman et al., 2016). The authors would need to record from a lot more than 32 pairs (and show convincing positive controls regarding other connections) to make the claim that connectivity is too low to be relevant.

      We have conducted additional control experiments (detailed in response to Editorial comment #3), in which we replicated the results of Stefanelli et al (2016) identifying that optogenetic activation of a focal cohort of ChR2 expressing granule cells leads to robust feedback inhibition of adjacent granule cells. These control experiments demonstrate that the slice system supports the feedback inhibitory circuit which requires GC/SGC to hilar neuron synapses.

      (3) Another troubling sign is the fact that optogenetic GC stimulation rarely ever evokes feedback inhibition onto other cells which contrasts with both other in vitro (e.g. Braganza et al., 2020) and in vivo studies (Stefanelli et al., 2016) studies. Without a convincing demonstration that monosynaptic connections between SGCs/GCs and interneurons in both directions is preserved at least at the rates previously described in other slice studies (e.g. Geiger et al., 1997, Neuron, Hainmueller et al., 2014, PNAS, Savanthrapadian et al., 2014, J. Neurosci), the notion that this setting could be closer to naturalistic memory processing than the in vivo experiments in Stefanelli et al. (e.g. lines 443-444) strikes me as odd. In any case, the discussion should clearly state that compromised connectivity in the slice preparation is likely a significant confound when comparing these results.

      We have conducted additional control experiments (detailed in response to Editorial comment #3), in which we replicated the results of Stefanelli et al identifying that optogenetic activation of a focal cohort of ChR2 expressing granule cells leads to robust feedback inhibition of adjacent granule cells. These control experiments demonstrate that the slice system in our studies support the feedback inhibitory circuit detailed in prior studies. We also clarify that Stefanelli study labeled random neurons and did not examine natural behavioral engrams and  discuss (on page 20) the correspondence/consistency of our results with that of Braganza et al 2020.

      (4) Probably the most convincing finding in this study is the higher zero-time lag correlation of spontaneous EPSCs in labelled vs. unlabeled pairs. Unfortunately, the fact that the authors use spontaneous EPSCs to begin with, which likely represent a mixture of spontaneous release from severed axons, minis, and coordinated discharge from intact axon segments or entire neurons, makes it very hard to determine the meaning and relevance of this finding. At the bare minimum, the authors need to show if and how strongly differences in baseline spontaneous EPSC rates between different cells and slices are contributing to this phenomenon. I would encourage the authors to use low-intensity extracellular stimulation at multiple foci to determine whether labelled pairs really share higher numbers of input from common presynaptic axons or cells compared to unlabeled pairs as they claim. I would also suggest the authors use conventional Cross correlograms (CCG; see e.g. English et al., 2017, Neuron; Senzai and Buzsaki, 2017, Neuron) instead of their somewhat convoluted interval-selective correlation analysis to illustrate codependencies between the event time series. The references above also illustrate a more robust approach to determining whether peaks in the CCGs exceed chance levels.

      We have included data on sEPSC frequency in the recorded cell pairs (Supplemental Fig 4) and have also conducted additional experiments and present data demonstrating that labeled cell show higher sEPSC frequency and amplitude than corresponding unlabeled cells in both cell types (new Fig 5).  We also include data from new  experiments to show that over 50% of the sEPSCs represent action potential driven events (Supplemental fig 3). 

      We thank the reviewer for the suggestion to explore alternative methods of analyses including CCGs to further strengthen our findings. We have now conducted CCGs on the same data set and report that “The dynamics of the cross-correlograms generated from our data sets using previously established methods to evaluate monosynaptic connectivity (Bartho et al., 2004; Senzai and Buzsaki, 2017) parallelled that of the CCP plots (Supplemental Fig. 6) illustrating that the methods similarly capture co-dependencies between event time series. We note, here, that while the CCG and CCP are qualitatively similar, the magnitude of the peaks were different, due to the sparseness of synaptic events. 

      (5) Finally, one of the biggest caveats of the study is that the ensemble is labelled a full week before the slice experiment and thereby represents a latent state of a memory rather than encoding consolidation, or recall processes. The authors acknowledge that in the discussion but they should also be mindful of this when discussing other (especially in vivo) studies and comparing their results to these. For instance, Pignatelli et al 2018 show drastic changes in GC engram activity and features driven by behavioral memory recall, so the results of the current study may be very different if slices were cut immediately after memory acquisition (if that was possible with a different labelling strategy), or if animals were re-exposed to the enriched environment right before sacrificing the animal.

      As noted by the reviewer, we fully acknowledge and are cognizant of the concern that slices prepared a week after labeling may not reflect ongoing encoding. Although our data show that labeled cells are reactivated in higher proportion during recall, we have discussed this caveat and will include alternative experimental strategies in the discussion.

      Reviewer #3 (Public Review):

      (1) Engram cells are (i) activated by a learning experience, (ii) physically or chemically modified by the learning experience, and (iii) reactivated by subsequent presentation of the stimuli present at the learning experience (or some portion thereof), resulting in memory retrieval. The authors show that exposure to Barnes Maze and the enriched environment-activated semilunar granule cells and granule cells preferentially in the superior blade of the dentate gyrus, and a significant fraction were reactivated on re-exposure. However, physical or chemical modification by experience was not tested. Experience modifies engram cells, and a common modification is the Hebbian, i.e., potentiation of excitatory synapses. The authors recorded EPSCs from labeled and unlabeled GCs and SGCs. Was there a difference in the amplitude or frequency of EPSCs recorded from labeled and unlabeled cells?

      We have included data on sEPSC frequency in the recorded cell pairs (Supplemental Fig 4) and have also conducted additional experiments and report and present data demonstrating that labeled cell show higher sEPSC frequency and amplitude than corresponding unlabeled cells in both cell types (new Fig 5).  We also include data from new  experiments to show that over 50% of the sEPSCs represent action potential driven events (Supplemental fig 3).

      (2) The authors studied five sequential sections, each 250 μm apart across the septotemporal axis, which were immunostained for c-Fos and analyzed for quantification. Is this an adequate sample? Also, it would help to report the dorso-ventral gradient since more engram cells are in the dorsal hippocampus. Slices shown in the figures appear to be from the dorsal hippocampus. 

      We thank the reviewer for the comment. We analyzed sections along the dorsoventral gradient. As explained in the methods, there is considerable animal to animal variability in the number of labeled cells which was why we had to use matched littermate pairs in our experiments This variability could render it difficult to tease apart dorsoventral differences. 

      (3) The authors investigated the role of surround inhibition in establishing memory engram SGCs and GCs. Surprisingly, they found no evidence of lateral inhibition in the slice preparation. Interneurons, e.g., PV interneurons, have large axonal arbors that may be cut during slicing.

      Similarly, the authors point out that some excitatory connections may be lost in slices. This is a limitation of slice electrophysiology.

      We have conducted additional control experiments (detailed in response to Editorial comment #3), in which we replicated the results of Stefanelli et al identifying that optogenetic activation of a focal cohort of ChR2 expressing granule cells leads to robust feedback inhibition of adjacent granule cells. These control experiments demonstrate that the slice system supports the feedback inhibitory circuit detailed in prior studies. 

      We now discuss (page 21) that “the possibility that slice recordings lead to underestimation of feedback dendritic inhibition cannot be ruled out.”

      Reviewer #1 (Recommendations for the authors):

      (1) I struggle to understand the added value of the Barnes Maze data (Figures 1 and S1), since the authors then focus on the EE for practical reasons. In particular, the analysis of mouse performance (presented in supplemental Figure 1) does not seem traditional to me. For example, instead of the 3 classical exploration strategies (i.e., random, serial, direct), the authors describe 6, and assign each of these strategies a score based on vague criteria (why are "long corrected" and "focused research" both assigned a score of 0.5?). Unless I'm mistaken, no other classic parameters are described (e.g., success rate, latency, number of errors). If the authors decide to keep the BM results, I recommend better justifying its existence and adding more details, including in the method section. Otherwise, perhaps they should consider withdrawing it. Even if we had to use two different behavioral contexts, wouldn't it have made sense to use, in addition to the EE, the fear conditioning test, which is widely used in the study of engrams? Under these conditions (Stefanelli et al., 2016), the number of cells recruited after fear conditioning seems sufficient to reproduce the analyses presented in Figures 2-5 and determine whether or not lateral inhibition is dependent on the type of context (Stefanelli and colleagues suggest significant strong lateral inhibition during fear conditioning, whereas the data from Dovek and colleagues suggest quite the opposite after exposure to EE).

      The Barnes Maze data was included to evaluate the DG ensemble activation during a dentate dependent non-fear based behavioral task. This is now introduced and explained in the results. We have now included plots of the primary latency and number of errors in finding the escape hole to confirm the improvement over time (Supplemental Fig. 1). We specifically used the BUNS analysis to evaluate the use of spatial strategy and show that by day 6, day of tamoxifen induction, the mice are using a spatial strategy for navigation. Our approach to evaluate exploration strategy is based on criteria published in Illouz et al 2016. This is now detailed in the methods on page 25. We hope that  the inclusion of the supplemental data and revisions to methods and results address the concerns regarding Barnes Maze experiments. 

      Regarding Stefanelli et al., 2016, please note that the study adopted random labeling of neurons using a CaMKII promotor driven reporter expression which they activated during spatial exploration of fear conditioning behaviors. As such labeled neurons in the Stefanelli study were NOT behaviorally driven, rather they were optically activated. This is now clarified in the text. The main drive for our study was to evaluate behaviorally tagged neurons which is novel, distinct from the Stefanelli study, and, we would argue, more behaviorally realistic and relevant.

      Additionally, the lateral inhibition observed in Stafanelli et al was in response to activation of GCs labeled by virally mediate CAMKII-driven ChR2 expression. Using a similar labeling approach, new control data presented in Supplemental fig. 3 show that we are fully able to replicate the lateral inhibition observed by Stefanalli et al. These control experiments further suggest that the sparse and distributed GC/SGC ensembles activated during non-aversive behavioral tasks may not be sufficient to elicit robust lateral inhibition as has been observed when a random population of adjacent neurons are activated. Our findings are also consistent with observations by Barganza et al., 2020. This is now Discussed on page 21.

      (2) The authors recorded sEPSCs received by recruited and non-recruited GCs and SGCs after EE exposure. However, it appears that they studied them very little, apart (from a temporal correlation analysis (Figure 5). Yet it would be interesting to determine whether or not the four neuronal populations possess different synaptic properties. 

      What is the frequency and amplitude of sEPSCs in GCs and SGCs recruited or not after EE exposure? Similarly, can the author record the sIPSCs received by dentate gyrus engram and non-engram GCs and SGCs? If so, what is their frequency and amplitude?

      As suggested by the editorial comment #2, we how include data on the frequency and amplitude of the sEPSCs in GCs and SGCs used in our analysis of figure 5. Given the low numbers of unlabeled SGCs and labeled GCs in our paired recordings (Supplemental Fig. 5), we choose not to use this data set for analysis of cell-type and labeling based differences in EPSC parameters. However, we have previously reported that sIPSC frequency is higher in SGCs than in GCs. Additionally, we have identified that sEPSC frequency in SGCs is higher than in GC (Dovek et al, in preprint, DOI: 10.1101/2025.03.14.643192).  

      To specifically address reviewer concerns, we have conducted new recorded EPSCs in a cohort of labeled and unlabeled GCs and SGCs and present data demonstrating that labeled cell show higher sEPSC frequency and amplitude than corresponding unlabeled cells in both cell types (new Fig 5). These experiments were conducted in TRAP2-tdT labeled cells which were not stable in cesium based recordings. As such we, we deferred the IPSC analysis for later and restricted analysis to sEPSCs for this study. 

      (3) Previous data showed that dentate gyrus neurons that are recruited or not in a given context could exhibit distinct morphological characteristics (Pléau et al. 2021) and biochemical content (Penk expression, Erwin et al., 2020). In order to enrich the electrophysiological data presented in Figure 2, could the authors take advantage of the biocytin filling to perform a morphological and biochemical comparison of the different neuronal types (i.e., GCs and SGCs recruited or not after EE)?

      Thank you for this suggestion. Unfortunately, detailed morphometry and biochemical analysis on labeled and unlabeled neurons was not conducted as part of this study as our focus was on circuit differences. In our experience, unless the sections are imaged soon after staining, the sections are suboptimal for detailed morphological reconstruction and analysis. Our ongoing studies suggest that PENK is an activity marker and not a selective marker for SGCs and we are undertaking transcriptomic analysis to identify molecular differences between GCs and SGCs. We respectfully submit that these experiments are outside the scope of this study.

      (4) Figures 3 and 4 show only schematic diagrams and representative data. No quantification is shown. Instead of pie charts showing the identity of each pair (which I find unnecessary), I'll use pie charts representing the % of each pair in which an excitatory or inhibitory drive was recorded (with the corresponding n).

      Please note that we did not observe evoked synaptic potentials in any except one pair precluding the possibility of quantification. However, we submit that it is important for the readers to have information on the number of pairs and the types of pre-post synaptic pairs in which the connections were tested.

      (5) Figure 3: Given that GCs form very few recurrences in non-pathological conditions, it hardly surprises me that they form few or no local glutamatergic connections. In contrast, this result surprises me more for SGCs, whose axons form collaterals in the dentate gyrus granular and molecular layers (Williams et al., 2007; Save et al., 2019). To control the reliability of their conditions, could the authors check whether SGCs do indeed form connections with hilar mossy cells, as has been reported in the past? To test whether this lack of interconnectivity is specific to neurons belonging to the same engram (or not), could the authors test whether or not the stimulation of labeled GCs/SGCs (via membrane depolarization or even optogenetics) generates EPSCs in unlabeled GCs?

      As suggested by the reviewer, we have examined whether widefield optical activation of all labeled neurons including GCs and SGCs lead to EPSCs in unlabeled GCs (63 cells tested). However, we did not observe eEPSCs. This data is presented on page 13, (Fig 4F) in the results and discussed on page 20. Since the wide field stimulation should activate terminals and lead to release even if the axon is severed, our data suggest the glutamatergic drive from SGC to GC may be limited.

      As noted above, we have demonstrated the presence of lateral inhibition consistent with data in Stefanelli et al in our new supplementary figure 3. We have also shown that sustained SGC firing upon perforant path stimulations is associated with sustained firing in hilar interneurons (Afrasiabi et al., 2022) indicating presence of the SGC to hilar connectivity in our slice preparation. Therefore, we choose not to undertake challenging 2P guided paired recording of SGCs and mossy cells adjacent to SGC axon terminals reported in Williams et al 2007 to replicate the 9%  SGC to MC synaptic connections. These 2P guided slice physiology studies are outside the technical scope of our study.

      (6) Figure 4: The results are relatively in contradiction with the strong lateral inhibition reported in the past (Stefanelli et al., 2016), but the experimental conditions are different in the two studies. Stimulation of a single labeled GC or SGC may not be sufficient to activate an inhibitory neuron, and for the latter to inhibit an unlabeled GC or SGC. Is it possible to measure the sIPSCs received by unlabelled neurons during optogenetic stimulation of all labelled neurons? Could the authors verify whether under their experimental conditions GCs and SGCs do indeed form connections with interneurons, as reported before? Finally, Stefanelli and colleagues (2016) suggest that lateral inhibition is provided by dendrites- targeting somatostatin interneurons. If the authors are recording in the soma, could they underestimate more distal inhibitory inputs? If so, could they record the dendrites of unlabeled neurons?

      Our new control data (Supplementary Fig. 3) using an AAV mediated CAMKII promotor driven random expression of ChR2 on GCs, similar to Stefanelli et al (2016) demonstrates our ability replicate the lateral inhibition observed by Stefanalli et al. (2016). Thus, our findings more accurately represent lateral inhibition supported by a sparse behaviorally labeled cohort than findings of Stefanelli et al based on randomly labeled neurons. This is now discussed on page 22-23. We respectfully submit that dendritic recordings are outside the scope of the current study.

      We also discuss the possibility that somatic recordings may under sample dendritic inhibitory inputs on page 23 “the possibility that slice recordings lead to underestimation of feedback dendritic inhibition cannot be ruled out.”

      (7) Figure 5: For ease of reading, I would substantially simplify the Results section related to Figure 5, keeping only the main general points of the analysis and the results themselves. The details of the analysis strategy, and the justification for the choices made, are better placed in the Method section (I advise against "data not shown").

      We thank the reviewer for the suggestion to improve accessibility of the results and have moved text related to justification of strategy and controls to the methods. We have also removed references to data not shown.

      (8) Figure 5: why do the authors no longer discriminate between GCs and SGCs?

      Since figure 5 focuses on inputs to labeled pairs versus labeled-unlabeled pairs the pairs include mixed groups with GCs and SGCs. Since the question pertains to inputs rather than cell types, we did not specifically distinguish the cell types. This is now explained in the text on page 15.

      (9) Figure 5: I would like to know more about the temporally connected inputs and their implication in context-dependent recruitment of dentate gyrus neurons. What could be the origin of the shared input received by the neurons recruited after EE exposure? For example, do labeled neurons receive more (temporally correlated or not) inputs from the entorhinal cortex (or any other upstream brain region) than unlabeled neurons? Is there any way (e.g., PP stimulation or any kind of manipulation) to test the causal relationship between temporally correlated input and the context-dependent recruitment of a given neuron?

      We appreciate the reviewer’s comments on the need to examine the source and nature of the correlated inputs to behaviorally labeled neurons. However, the suggested experiments are nontrivial as artificial stimulation of afferent fibers is unlikely to be selective for labeled and unlabeled cells. Given the complexities in design, implementation and interpretation of these experiments we respectfully submit that these are outside the scope of the current study.

      Reviewer #2 (Recommendations for the authors):

      There are a few minor issues limiting the extent of interpretations of the data:

      (1) Only about 7% of the 'engram' cells are re-activated one week after exposure (line 147), it is unclear how meaningful this assembly is given the high number of cells that may either be labelled unrelated to the EE or no longer be part of the memory-related ensemble.

      We now discuss (page 22-23) that the % labeling is consistent with what has been observed in the DG 1 week after fear conditioning (DeNardo et al., 2019) and discuss the caveat that all labeled cells may not represent an engram.  

      (2) Line 215: The wording '32 pairwise connections examined' suggests that there actually were synaptic connections, would recommend altering the wording to 'simultaneously recorded cells examined' to avoid confusion.

      Revised as suggested

    1. Author Response:

      The following is the authors’ response to the previous reviews

      Reviewer #1 (Public Review):

      Summary

      While DNA sequence divergence, differential expression, and differential methylation analysis have been conducted between humans and the great apes to study changes that "make us human", the role of lncRNAs and their impact on the human genome and biology has not been fully explored. In this study, the authors computationally predict HSlncRNAs as well as their DNA Binding sites using a method they have developed previously and then examine these predicted regions with different types of enrichment analyses. Broadly, the analysis is straightforward and after identifying these regions/HSlncRNAs the authors examined their effects using different external datasets.

      I no longer have any concerns about the manuscript as the authors have addressed my comments in the first round of review.

      We thank the reviewer for the valuable comments, which have helped us improve the manuscript.

      Reviewer #2 (Public Review):

      Lin et al attempt to examine the role of lncRNAs in human evolution in this manuscript. They apply a suite of population genetics and functional genomics analyses that leverage existing data sets and public tools, some of which were previously built by the authors, who clearly have experience with lncRNA binding prediction. However, I worry that there is a lack of suitable methods and/or relevant controls at many points and that the interpretation is too quick to infer selection. While I don't doubt that lncRNAs contribute to the evolution of modern humans, and certainly agree that this is a question worth asking, I think this paper would benefit from a more rigorous approach to tackling it.

      I thank the authors for their revisions to the manuscript; however, I find that the bulk of my comments have not been addressed to my satisfaction. As such, I am afraid I cannot say much more than what I said last time, emphasising some of my concerns with regards to the robustness of some of the analyses presented. I appreciate the new data generated to address some questions, but think it could be better incorporated into the text - not in the discussion, but in the results.

      We thank the reviewer for the careful reading and valuable comments. In this round of revision, we address the two main concerns: (1) there is a lack of suitable methods and/or relevant controls at many points, and (2) the interpretation is too quick to infer selection. Based on these comments, we have carefully revised all sections of the manuscript, including the Introduction, Results, Discussion, and Materials and Methods.

      In addition, we have performed two new analyses. Based on the two analyses, we have added one figure and two sections to Results, two sections to Materials and Methods, one figure to Supplementary Notes, and two tables to Supplementary Tables. These results were obtained using new methods and provided more support to the main conclusion.

      To be more responsible, we re-look into the comments made in the first round and respond to them further. The following are point-to-point responses to comments.

      Since many of the details in the Responses-To-Comments are available in published papers and eLife publishes Responses-To-Comments, we do not greatly revise supplementary notes to avoid ostensibly repeating published materials.

      “lack of suitable methods and/or relevant controls”.

      We carefully chose the methods, thresholds, and controls in the study; now, we provide clearer descriptions and explanations.

      (1) We have expanded the last paragraph in Introduction to briefly introduce the methods, thresholds, and controls.

      (2) In many places in Results and Materials and Methods, revisions are made to describe and justify methods, thresholds, and controls.

      (3) Some methods, thresholds, and controls have good consensus, such as FDR and genome-wide background, but others may not, such as the number of genes that greatly differ between humans and chimpanzees. Now, we describe our reasons for the latter situation. For example, we explain that “About 5% of genes have significant sequence differences in humans and chimpanzees, but more show expression differences due to regulatory sequences. We sorted target genes by their DBS affinity and, to be prudential, chose the top 2000 genes (DBS length>252 bp and binding affinity>151) and bottom 2000 genes (DBS length<60 bp but binding affinity>36) to conduct over-representation analysis”.

      (4) We also carefully choose proper words to make descriptions more accurate.

      Responses to the suggestion “new data generated could be better incorporated into the text”.

      (1) We think that this sentence “The occurrence of HS lncRNAs and their DBSs may have three situations – (a) HS lncRNAs preceded their DBSs, (b) HS lncRNAs and their DBSs co-occurred, (c) HS lncRNAs succeeded their DBSs. Our results support the third situation and the rewiring hypothesis”, previously in Discussion, should be better in section 2.3. We have revised it and moved it into the second paragraph of section 2.3.

      (2) Our two new analyses generated new data, and we describe them in Results.

      (3) It is possible to move more materials from Supplementary Notes to the main text, but it is probably unnecessary because the main text currently has eight sub-sections, two tables, and four figures.

      Responses to the comment “the interpretation is too quick to infer selection”.

      (1) When using XP-CLR, iSAFE, Tajima's D, Fay-Wu's H, the fixation index (Fst), and linkage disequilibrium (LD) to detect selection signals, we used the widely adopted parameters and thresholds but did not mention this clearly in the original manuscript. Now, in the first sentence of the second paragraph of section 2.4, we add the phrase “with widely-used parameters and thresholds” (more details are available in section 4.7 and Supplementary Notes).

      (2) It is not the first time we used these tests. Actually, we used these tests in two other studies (Tang et al. Uncovering the extensive trade-off between adaptive evolution and disease susceptibility. Cell Rep. 2022; Tang et al. PopTradeOff: A database for exploring population-specificity of adaptive evolution, disease susceptibility, and drug responsiveness. Comput Struct Biotechnol J. 2023). In this manuscript, section 2.5 and section 4.12 describe how we use these tests to detect signals and infer selection. We also cite the above two published papers from which the reader can obtain more details.

      (3) Also, in section 2.4, we stress that “Signals in considerable DBSs were detected by multiple tests, indicating the reliability of the analysis”.

      To further respond to the comments of “lack of suitable methods” and “this paper would benefit from a more rigorous approach to tackling it”, we have performed two new analyses. The results of the new analyses agree well with previous results and provide new support for the main conclusion. The result of section 2.5 is novel and interesting.

      We write in Discussion “Two questions are how mouse-specific lncRNAs specifically rewire gene expression in mice and how human- and mouse-specific rewiring influences the cross-species transcriptional differences”. To investigate whether the rewiring of gene expression by HS lncRNA in humans is accidental in evolution, we have made further genomic and transcriptomic analyses (Lin et al. Intrinsically linked lineage-specificity of transposable elements and lncRNAs reshapes transcriptional regulation species- and tissue-specifically. doi: https://doi.org/10.1101/2024.03.04.583292). To verify the obtained conclusions, we analyzed the spermatogenesis data from multiple species and obtained supporting evidence (not published).

      I note some specific points that I think would benefit from more rigorous approaches, and suggest possible ways forward for these.

      Much of this work is focused on comparing DNA binding domains in human-unique long-noncoding RNAs and DNA binding sites across the promoters of genes in the human genome, and I think the authors can afford to be a bit more methodical/selective in their processing and filtering steps here. The article begins by searching for orthologues of human lncRNAs to arrive at a set of 66 human-specific lncRNAs, which are then characterised further through the rest of the manuscript. Line 99 describes a binding affinity metric used to separate strong DBS from weak DBS; the methods (line 432) describe this as being the product of the DBS or lncRNA length times the average Identity of the underlying TTSs. This multiplication, in fact, undoes the standardising value of averaging and introduces a clear relationship between the length of a region being tested and its overall score, which in turn is likely to bias all downstream inference, since a long lncRNA with poor average affinity can end up with a higher score than a short one with higher average affinity, and it's not quite clear to me what the biological interpretation of that should be. Why was this metric defined in this way?

      (1) Using RNA:DNA base-pairing rules, other DBS prediction programs return just DBSs with lengths. Using RNA:DNA base-pairing rules and a variant of Smith-Waterman local alignment, LongTarget returns DBSs with lengths and identity values together with DBDs (local alignment makes DBDs and DBSs predicted simultaneously). Thus, instead of measuring lncRNA/DNA binding based on DBS length, we measure lncRNA/DNA binding based on both DBS length and DBD/DBS identity (simply called identity, which is the percentage of paired nucleotides in the RNA and DNA sequences). This allows us to define “binding affinity”. One may think that binding affinity is a more complex function of length and identity. But, according to in vitro studies (see the review Abu Almakarem et al. 2012 and citations therein, and see He et al. 2015 and citations therein), the strength of a triplex is determined by all paired nucleotides (i.e., triplet). Thus, binding affinity=length * identity is biologically reasonable.

      (2) Further, different from predicting DBS upon individual base-pairing rules such as AT-G and CG-C, LongTarget integrates base-pairing rules into rulesets, each covering A, T, C, and G (see the two figures below, which are from He et al 2015). This makes every nucleotide in the RNA and DNA sequences comparable and allows the computation of identity.

      (3) On whether LongTarget may predict unreasonably long DBSs. Three technical features of LongTarget make this highly unlikely (and more unlikely than other programs). The three features are (a) local alignment, (b) gap penalty, and (c) TT penalty (He et al. 2015).

      (4) Some researchers may think that a higher identity threshold (e.g., 0.8 or even higher) makes the predicted DBSs more reliable. This is not true. To explore plausible identity values, we analyzed the distribution of Kcnq1ot1’s DBSs in the large Kcnq1 imprinting region (which contains many known imprinted genes). We found that a high threshold for identity (e.g., 0.8) will make DBSs in many known imprinted genes fail to be predicted. Upon our analysis of many lncRNAs and upon early in vitro experiments, plausible identity values range from 0.4 to 0.8.

      (5) Is it necessary or advisable to define an identity threshold? Since identity values from 0.4 to 0.8 are plausible and identity is a property of a DBS but does not reflect the strength of the whole triplex, it is more reasonable to define a threshold for binding affinity to control predicted DBSs. As explained above, binding affinity = length*identity is a reasonable measure of the strength of a triplex. The default threshold is 60, and given an identity of 0.6 in many triplexes, a DBS with affinity=60 is about 100 bp. Compared with TF binding sites (TFBS), 100 bp is quite long. As we explain in the main text, “taking a DBS of 147 bp as an example, it is extremely unlikely to be generated by chance (p < 8.2e-19 to 1.5e-48)”.

      (6) How to validate predicted DBSs? Validation faces these issues. (a) DBDs are predicted on the genome level, but target transcripts are expressed in different tissues and cells. So, no single transcriptomic dataset can validate all predicted DBSs of a lncRNA. No matter using what techniques and what cells, only a small portion of predicted DBSs can be experimentally captured (validated). (b) The resolution of current experimental techniques is limited; thus, experimentally identified DBSs (i.e., “peaks”) are much longer than computationally predicted DBSs. (c) Experimental results contain false positives and false negatives. So, validation (or performance evaluation) should also consider the ROC curves (Wen et al. 2022).

      (7) As explained above, a long DBS may have a lower binding affinity than a short DBS. A biological interpretation is that the long DBS may accumulate mutations that decrease its binding ability gradually.

      There is also a strong assumption that identified sites will always be bound (line 100), which I disagree is well-supported by additional evidence (lines 109-125). The authors show that predicted NEAT1 and MALAT1 DBS overlap experimentally validated sites for NEAT1, MALAT1, and MEG3, but this is not done systematically, or genome-wide, so it's hard to know if the examples shown are representative, or a best-case scenario.

      (1) We did not make this assumption. Apparently, binding depends on multiple factors, including co-expression of genes and specific cellular context.

      (2) On the second issue, “this is not done systematically, or genome-wide”. We did genome-wide but did not show all results (supplementary fig 2 shows three genomic regions, which are impressively good). In Wen et al. 2022, we describe the overall results.

      It's also not quite clear how overlapping promoters or TSS are treated - are these collapsed into a single instance when calculating genome-wide significance? If, eg, a gene has five isoforms, and these differ in the 3' UTR but their promoter region contains a DBS, is this counted five times, or one? Since the interaction between the lncRNA and the DBS happens at the DNA level, it seems like not correcting for this uneven distribution of transcripts is likely to skew results, especially when testing against genome-wide distributions, eg in the results presented in sections 5 and 6. I do not think that comparing genes and transcripts putatively bound by the 40 HS lncRNAs to a random draw of 10,000 lncRNA/gene pairs drawn from the remaining ~13500 lncRNAs that are not HS is a fair comparison. Rather, it would be better to do many draws of 40 non-HS lncRNAs and determine an empirical null distribution that way, if possible actively controlling for the overall number of transcripts (also see the following point).

      (1) We predicted DBSs in the promoter region of 179128 Ensembl-annotated transcripts and did not merge DBSs (there is no need to merge them). If multiple transcripts share the same TSS, they may share the same DBS, which is natural.

      (2) If the DBSs of multiple transcripts of a gene overlap, the overlap does not raise a problem for lncRNA/DNA binding analysis in specific tissues because usually only one transcript is expressed in a tissue. Therefore, there is no such situation “If, e.g., a gene has five isoforms, and these differ in the 3' UTR but their promoter region contains a DBS, is this counted five times, or one?”

      (3) It is unclear to us what “it seems like not correcting for this uneven distribution of transcripts is likely to skew results” means. Regarding testing against genome-wide distributions, statistically, it is beneficial to make many rounds of random draws genome-wide, but this will take a huge amount of time. Since more variables demand more rounds of drawing, to our knowledge, this is not widely practiced in large-scale transcriptomic data analyses.

      (4) If the difference (result) is small thus calls for rigorous statistical testing, making many rounds of random draws genome-wide is necessary. In our results, “45% of these pairs show a significant expression correlation in specific tissues (Spearman's |rho| >0.3 and FDR <0.05). In contrast, when randomly sampling 10000 pairs of lncRNAs and protein-coding transcripts genome-wide, the percent of pairs showing this level of expression correlation (Spearman's |rho| >0.3 and FDR <0.05) is only 2.3%”.

      Thresholds for statistical testing are not consistent, or always well justified. For instance, in line 142 GO testing is performed on the top 2000 genes (according to different rankings), but there's no description of the background regions used as controls anywhere, or of why 2000 genes were chosen as a good number to test? Why not 1000, or 500? Are the results overall robust to these (and other) thresholds? Then line 190 the threshold for downstream testing is now the top 20% of genes, etc. I am not opposed to different thresholds in principle, but they should be justified.

      (1) We used the g:Profiler program to perform over-representation analysis to identify enriched GO terms. This analysis is used to determine what pre-defined gene sets (GO terms) are more present (over-represented) in a list of “interesting” genes than what would be expected by chance. Specifically, this analysis is often used to examine whether the majority of genes in a pre-defined gene set fall in the extremes of a list: the top and bottom of the list, for example, may correspond to the largest differences in expression between the two cell types. g:Profiler always takes the whole genome as the reference; that is why we did not mention the whole genome reference. We now add in section 2.2 “(with the whole genome as the reference)”.

      (2) Why choosing 2000 but not 2500 genes is somewhat subjective. We now explain that “About 5% of genes have significant sequence differences in humans and chimpanzees, but more show expression differences due to regulatory sequences. We sorted target genes by their DBS affinity and, to be prudential, chose the top 2000 genes (DBS length>252 bp and binding affinity>151) and bottom 2000 genes (DBS length<60 bp but binding affinity>36) to conduct over-representation analysis”.

      Likewise, comparing Tajima's D values near promoters to genome-wide values is unfair, because promoters are known to be under strong evolutionary constraints relative to background regions; as such it is not surprising that the results of this comparison are significant. A fairer comparison would attempt to better match controls (eg to promoters without HS lncRNA DBS, which I realise may be nearly impossible), or generate empirical p-values via permutation or simulation.

      We used these tests to detect selection signals in DBSs but not in the whole promoter regions. Using promoters without HS lncRNA DBS as the control also has risks because promoter regions contain other kinds of regulatory sequences.

      There are huge differences in the comparisons between the Vindija and Altai Neanderthal genomes that to me suggest some sort of technical bias or the such is at play here. e.g. line 190 reports 1256 genes to have a high distance between the Altai Neanderthal and modern humans, but only 134 Vindija genes reach the same threshold of 0.034. The temporal separation between the two specimens does not seem sufficient to explain this difference, nor the difference between the Altai Denisovan and Neanderthal results (2514 genes for Denisovan), which makes me wonder if it is a technical artefact relating to the quality of the genome builds? It would be worth checking.

      We feel it is hard to know whether or not the temporal separation between these specimens is sufficient to explain the differences because many details of archaic humans and their genomes remain unknown and because mechanisms determining genotype-phenotype relationships remain poorly known. After 0.034 was determined, these numbers of genes were determined accordingly. We chose parameters and thresholds that best suit the most important requirements, but these parameters and thresholds may not best suit other requirements; this is a problem for all large-scale studies.     

      Inferring evolution: There are some points of the manuscript where the authors are quick to infer positive selection. I would caution that GTEx contains a lot of different brain tissues, thus finding a brain eQTL is a lot easier than finding a liver eQTL, just because there are more opportunities for it. Likewise, claims in the text and in Tables 1 and 2 about the evolutionary pressures underlying specific genes should be more carefully stated. The same is true when the authors observe high Fst between groups (line 515), which is only one possible cause of high Fst - population differentiation and drift are just as capable of giving rise to it, especially at small sample sizes.

      (1) We add in Discussion that “Finally, not all detected signals reliably indicate positive selection”.

      (2) Our results are that more signals are detected in CEU and CHB than in YRI; this agrees all population genetics studies and implies that our results are not wrongly biased because more samples and larger samples were obtained from CEU and CHB.

    1. Reviewer #3 (Public review):

      Summary:

      In this manuscript, Yamauchi and colleagues combine all-atom and coarse-grained MD simulations to investigate the mechanism of DNA translocation by prokaryotic SMC complexes. Their multiscale approach is well-justified and supports a segment-capture model in which ATP-dependent conformational changes lead to the unidirectional translocation of DNA. A key insight from the study is that asymmetry in the kleisin path enforces directionality. The work introduces an innovative computational framework that captures key features of SMC motor action, including DNA binding, conformational switching, and translocation.

      This work is well executed and timely, and the methodology offers a promising route for probing other large molecular machines where ATP activity is essential.

      Strengths:

      This manuscript introduces an innovative yet simple method that merges all-atom and coarse-grained, purely equilibrium, MD simulations to investigate DNA translocation by SMC complexes, which is triggered by activated ATP processes. Investigating the impact of ATP on large molecular motors like SMC complexes is extremely challenging, as ATP catalyses a series of chemical reactions that take and keep the system out of equilibrium. The authors simulate the ATP cycle by cycling through distinct equilibrium simulations where the force field changes according to whether the system is assumed to be in the disengaged, engaged, and V-shaped states; this is very clever as it avoids attempting to model the non-equilibrium process of ATP hydrolysis explicitly. This equilibrium switching approach is shown to be an effective way to probe the mechanistic consequences of ATP binding and hydrolysis in the SMC complex system.

      The simulations reveal several important features of the translocation mechanism. These include identifying that a DNA segment of ~200 bp is captured in the engaged state and pumped forward via coordinated conformational transitions, yielding a translocation step size in good agreement with experimental estimates. Hydrogen bonding between DNA and the top of the ATPase heads is shown to be critical for segment capturtrans, as without it, translocation is shown to fail. Finally, asymmetry in the kleisin subunit path is shown to be responsible for unidirectionally.

      This work highlights how molecular simulations are an excellent complement to experiments, as they can exploit experimental findings to provide high-resolution mechanistic views currently inaccessible to experiments. The findings of these simulations are plausible and expand our understanding of how ATP hydrolysis induces directional motion of the SMC complex.

      Weaknesses:

      There are aspects of the methodology and modelling assumptions that are not clear and could be better justified. The major ones are listed below:

      (1) The all-atom MD simulations involve a 47-bp DNA duplex interacting with the ATPase heads, from which key residues involved in hydrogen bonding are identified. However, DNA mechanics-including flexibility and hydrogen bond formation-are known to be sequence-dependent. The manuscript uses a single arbitrary sequence but does not discuss potential biases. Could the authors comment on how sequence variability might affect binding geometry or the number of hydrogen bonds observed?

      (2) A key feature of the coarse-grained model is the inclusion of a specific hydrogen-bonding potential between DNA and residues on the ATPase heads. The authors select the top 15 hydrogen-bond-forming residues from the all-atom simulations (with contact probability > 0.05), but the rationale for this cutoff is not explained. Also, the strength of hydrogen bonds in coarse-grained models can be sensitive to context. How did the authors calibrate the strength of this interaction relative to electrostatics, and did they test its robustness (e.g., by varying epsilon or residue set)? Could this interaction be too strong or too weak under certain ionic conditions? What happens when salt is changed?

      (3) To enhance sampling, the translocation simulations are run at 300 mM monovalent salt. While this is argued to be physiological for Pyrococcus yayanosii, such a concentration also significantly screens electrostatics, possibly altering the interaction landscape between DNA and protein or among protein domains. This may significantly impact the results of the simulations. Why did the authors not use enhanced sampling methods to sample rare events instead of relying on a high-salt regime to accelerate dynamics?

      (4) Only a small fraction of the simulated trajectories complete successful translocation (e.g., 45 of 770 in one set), and this is attributed to insufficient simulation time. While the authors are transparent about this, it raises questions about the reliability of inferred success rates and about possible artefacts (e.g., DNA trapping in coiled-coil arms). Could the authors explore or at least discuss whether alternative sampling strategies (e.g., Markov State Models, transition path sampling) might address this limitation more systematically?

    1. Reviewer #2 (Public review):

      Based on the controversy of whether the Desmodium intercrop emits bioactive volatiles that repel the fall armyworm, the authors conducted this study to assess the effects of the volatiles from Desmodium plants in the push-pull system on behavior of FAW oviposition. This topic is interesting and the results are valuable for understanding the push-pull system for the management of FAW, the serious pest. The methodology used in this study is valid, leading to reliable results and conclusions. I just have a few concerns and suggestions for the improvement of this paper:

      (1) The volatiles emitted from D. incanum were analyzed and their effects on the oviposition behavior of FAW moth were confirmed. However, it would be better and useful to identify the specific compounds that are crucial for the success of the push-pull system.

      (2) That would be good to add "symbols" of significance in Figure 4 (D).

      (3) Figure A is difficult for readers to understand.

      (4) It will be good to deeply discuss the functions of important volatile compounds identified here with comparison with results in previous studies in the discussion better.

      Comments on revisions:

      The authors addressed all my concerns, and I believe that the current version is appropriate for publication.

    2. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The manuscript of Odermatt et al. investigates the volatiles released by two species of Desmodium plants and the response of herbivores to maize plants alone or in combination with these species. The results show that Desmodium releases volatiles in both the laboratory and the field. Maize grown in the laboratory also released volatiles, in a similar range. While female moths preferred to oviposit on maize, the authors found no evidence that Desmodium volatiles played a role in lowering attraction to or oviposition on maize.

      Strengths:

      The manuscript is a response to recently published papers that presented conflicting results with respect to whether Desmodium releases volatiles constitutively or in response to biotic stress, the level at which such volatiles are released, and the behavioral effect it has on the fall armyworm. These questions are relevant as Desmodium is used in a textbook example of pest-suppressive sustainable intercropping technology called push-pull, which has supported tens of thousands of smallholder farmers in suppressing moth pests in maize. A large number of research papers over more than two decades have implied that Desmodium suppresses herbivores in push-pull intercropping through the release of large amounts of volatiles that repel herbivores. This premise has been questioned in recent papers. Odermatt et al. thus contribute to this discussion by testing the role of odors in oviposition choice. The paper confirms that ovipositing FAW preferred maize, and also confirmed that odors released from Desmodium appeared not important in their bioassays.

      The paper is a welcome addition to the literature and adds quality headspace analyses of Desmodium from the laboratory and the field. Furthermore, the authors, some of whom have since long contributed to developing push-pull, also find that Desmodium odors are not significant in their choice between maize plants. This advances our knowledge of the mechanisms through which push-pull suppresses herbivores, which is critically important to evolving the technique to fit different farming systems and translating this mechanism to fit with other crops and in other geographical areas.

      Thank you for your careful assessment of our manuscript.

      Weaknesses:

      Below I outline the major concerns:

      (1) Clear induction of the experimental plants, and lack of reflective discussion around this: from literature data and previous studies of maize and Desmodium, it is clear that the plants used in this study, particularly the Desmodium, were induced. Maize appeared to be primarily manually damaged, possibly due to sampling (release of GLV, but little to no terpenoids, which is indicative of mostly physical stress and damage, for example, one of the coauthor's own paper Tamiru et al. 2011), whereas Desmodium releases a blend of many compounds (many terpenoids indicative of herbivore induction). Erdei et al. also clearly show that under controlled conditions maize, silver leaf and green leaf Desmodium release volatiles in very low amounts. While the condition of the plants in Odermatt et al. may be reflective of situations in push-pull fields, the authors should elaborate on the above in the discussion (see comments) such that the readers understand that the plant's condition during the experiments. This is particularly important because it has been assumed that Desmodium releases typical herbivore-induced volatiles constitutively, which is not the case (see Erdei et al. 2024). This reflection is currently lacking in the manuscript.

      We acknowledge the need for a more reflective discussion on the possible causes of volatile emission due to physical damage. Although the field plants were carefully handled, it is possible that some physical stress may have contributed to the release of volatiles, such as green leaf volatiles (GLVs). We ensured the revised manuscript reflects this nuanced interpretation (lines 282 – 286). However, we also explained more clearly that our aim was to capture the volatile emission of plants used by farmers under realistic conditions and moth responses to these plants, not to be able to attribute the volatile emission to a specific cause (lines 115 – 117). We revised relevant passages throughout the results and discussion to ensure that we do not make any claims about the reason for volatile emissions, and that our claims regarding these plants and their headspace being representative of the system as practiced by farmers are supported. In the revised manuscript we provide a new supplementary table S2 that additionally shows the classification of the identified substances, which also shows that the majority of the substances that were found in the headspace of the sampled plants of Desmodium intortum or Desmodium incanum are monoterpenes, sesquiterpenes, or aromatic compounds, and not GLVs (that are typically emitted following damage).

      (2) Lack of controls that would have provided context to the data: The experiments lack important controls that would have helped in the interpretation:

      2a The authors did not control the conditions of the plants. To understand the release of volatiles and their importance in the field, the authors should have included controlled herbivory in both maize and Desmodium. This would have placed the current volatile profiles in a herbivory context. Now the volatile measurements hang in midair, leading to discussions that are not well anchored (and should be rephrased thoroughly, see eg lines 183-188). It is well known that maize releases only very low levels of volatiles without abiotic and biotic stressors. However, this changes upon stress (GLVs by direct, physical damage and eg terpenoids upon herbivory, see above). Erdei et al. confirm this pattern in Desmodium. Not having these controls, means that the authors need to put the data in the context of what has been published (see above).

      We appreciate this concern. Our study aimed to capture the real-world conditions of push-pull fields, where Desmodium and maize grow in natural environments without the direct induction of herbivory for experimental purposes (lines 115 – 117). We agree that in further studies it would be important to carry out experiments under different environmental conditions, including herbivore damage. However, this was not within the scope of the present study.

      2b It would also have been better if the authors had sampled maize from the field while sampling Desmodium. Together with the above point (inclusion of herbivore-induced maize and Desmodium), the levels of volatile release by Desmodium would have been placed into context.

      We acknowledge that sampling maize and other intercrop plants, such as edible legumes, alongside Desmodium in the push-pull field would have allowed us to make direct comparisons of the volatile profiles of different plants in the push-pull system under shared field conditions. Again, this should be done in future experiments but was beyond the scope of the present study. Due to the amount of samples we could handle given cost and workload, we chose to focus on Desmodium because there is much less literature on the volatile profiles of field-grown Desmodium than maize plants in the field: we are aware of one study attempting to measure field volatile profiles from Desmodium intortum (Erdei et al. 2024) and no study attempting this for Desmodium incanum. We pointed out this justification for our focus on Desmodium in the manuscript (lines 435 - 439). Additionally, we suggested in the discussion that future studies should measure volatile profiles from all plants commonly used in push-pull systems alongside Desmodium (lines 267 – 269).

      2c To put the volatiles release in the context of push-pull, it would have been important to sample other plants which are frequently used as intercrop by smallholder farmers, but which are not considered effective as push crops, particularly edible legumes. Sampling the headspace of these plants, both 'clean' and herbivore-induced, would have provided a context to the volatiles that Desmodium (induced) releases in the field - one would expect unsuccessful push crops to not release any of these 'bioactive' volatiles (although 'bioactive' should be avoided) if these odors are responsible for the pest suppressive effect of Desmodium. Many edible intercrops have been tested to increase the adoption of push-pull technology but with little success.

      We very much agree that such measurements are important for the longer-term research program in this field. But again, for the current study this would have exploded the size of the required experiment. Regarding bioactivity, we have been careful to use the phrase "potentially bioactive" solely when referring to findings from the literature (lines 99–103), in order to avoid making any definitive claims about our own results.

      Because of the lack of the above, the conclusions the authors can draw from their data are weakened. The data are still valuable in the current discussion around push-pull, provided that a proper context is given in the discussion along the points above.

      We think our revisions made the specific aims of this study more explicit and help to avoid misleading claims.

      (3) 'Tendency' of the authors to accept the odor hypothesis (i.e. that Desmodium odors are responsible for repelling FAW and thereby reduce infestation in maize under push-pull management) in spite of their own data: The authors tested the effects of odor in oviposition choice, both in a cage assay and in a 'wind tunnel'. From the cage experiments, it is clear that FAW preferred maize over Desmodium, confirming other reports (including Erdei et al. 2024). However, when choosing between two maize plants, one of which was placed next to Desmodium to which FAW has no tactile (taste, structure, etc), FAW chose equally. Similarly in their wind tunnel setup (this term should not be used to describe the assay, see below), no preference was found either between maize odor in the presence or absence of Desmodium. This too confirms results obtained by Erdei et al. (but add an important element to it by using Desmodium plants that had been induced and released volatiles, contrary to Erdei et al. 2024). Even though no support was found for repellency by Desmodium odors, the authors in many instances in the manuscript (lines 30-33, 164-169, 202, 279, 284, 304-307, 311-312, 320) appear to elevate non-significant tendencies as being important. This is misleading readers into thinking that these interactions were significant and in fact confirming this in the discussion. The authors should stay true to their own data obtained when testing the hypothesis of whether odors play a role in the pest-suppressive effect of push-pull.

      We appreciate this feedback and agree that we may have overstated claims that could not be supported by strict significance tests. However, we believe that non-significant tendencies can still provide valuable insights. In the revised version of the manuscript, we ensured a clear distinction between statistically significant findings and non-significant trends and remove any language that may imply stronger support for the odor hypothesis than what the data show in all the lines that were mentioned.

      (4) Oviposition bioassay: with so many assays in close proximity, it is hard to certify that the experiments are independent. Please discuss this in the appropriate place in the discussion.

      We have pointed this out in the submitted manuscript in lines 275 – 279. Furthermore, we included detailed captions to figure 4 - supporting figure 3 & figure 4 - supporting figure 4. We are aware that in all such experiments there is a danger of between-treatment interference, which we pointed out for our specific case. We stated that with our experimental setup we tried to minimize interference between treatments by spacing and temporal staggering. We would like to point out that this common caveat does not invalidate experimental designs when practicing replication and randomization. We assume that insects are able to select suitable oviposition sites in the background of such confounding factors under realistic conditions.

      (5) The wind tunnel has a number of issues (besides being poorly detailed):

      5a. The setup which the authors refer to as a 'wind tunnel' does not qualify as a wind tunnel. First, there is no directional flow: there are two flows entering the setup at opposite sides. Second, the flow is way too low for moths to orient in (in a wind tunnel wind should be presented as a directional cue. Only around 1.5 l/min enters the wind tunnel in a volume of 90 l approximately, which does not create any directional flow. Solution: change 'wind tunnel' throughout the text to a dual choice setup /assay.)

      We agree with these criticisms and changed the terminology accordingly from ‘wind tunnel’ to ‘dual choice assay’. We have now conducted an additional experiment which we called ‘no-choice assay’ that provides conditions closer to a true wind tunnel. The setup of the added experiment features an odor entry point at only one side of the chamber to create a more directional airflow. Each treatment (maize alone, maize + D. intortum, maize + D. incanum, and a control with no plants) was tested separately, with only one treatment conducted per evening to avoid cross-contamination, as described in the methods section of the no-choice assay.

      5b. There is no control over the flows in the flight section of the setup. It is very well possible that moths at the release point may only sense one of the 'options'. Please discuss this.

      We added this to the discussion (lines 369 – 374). The new no-choice assays also address this concern by using a setup with laminar flow.

      5c. Too low a flow (1,5 l per minute) implies a largely stagnant air, which means cross-contamination between experiments. An experiment takes 5 minutes, but it takes minimally 1.5 hours at these flows to replace the flight chamber air (but in reality much longer as the fresh air does not replace the old air, but mixes with it). The setup does not seem to be equipped with e.g. fans to quickly vent the air out of the setup. See comments in the text. Please discuss the limitations of the experimental setup at the appropriate place in the discussion.

      We added these limitations to the discussion and addressed these concerns with new experiments (see answer 5a).

      5d. The stimulus air enters through a tube (what type of tube, diameter, length, etc) containing pressurized air (how was the air obtained into bags (type of bag, how is it sealed?), and the efflux directly into the flight chamber (how, nozzle?). However, it seems that there is no control of the efflux. How was leakage prevented, particularly how the bags were airtight sealed around the plants? 

      We added the missing information to the methods and provided details about types of bags, manufacturers, and pre-treatments in the method section. In short, PTFE tubes connected bagged plants to the bioassay setup and air was pumped in at an overpressure, so leakage was not eliminated but contamination from ambient air was avoided.

      5e. The plants were bagged in very narrowly fitting bags. The maize plants look bent and damaged, which probably explains the GLVs found in the samples. The Desmodium in the picture (Figure 5 supplement), which we should assume is at least a representative picture?) appears to be rather crammed into the bag with maize and looks in rather poor condition to start with (perhaps also indicating why they release these volatiles?). It would be good to describe the sampling of the plants in detail and explain that the way they were handled may have caused the release of GLVs.

      We included a more detailed description of the plant handling and bagging processes to the methods to clarify how the plants were treated during the dual-choice and the no-choice assays reported in the revised manuscript. We politely disagree that the maize plants were damaged and the Desmodium plants not representative of those encountered in the field. The plants were grown in insect-proof screen houses to prevent damage by insects and carefully curved without damaging them to fit into the bag. The Desmodium plant pictured was D. incanum, which has sparser foliage and smaller leaves than D. intortum.

      (6) Figure 1 seems redundant as a main figure in the text. Much of the information is not pertinent to the paper. It can be used in a review on the topic. Or perhaps if the authors strongly wish to keep it, it could be placed in the supplemental material.

      We think that Figure 1 provides essential information about the push-pull system and the FAW. To our knowledge, this partly contradictory evidence so far has not been synthesized in the literature. We realize that such a figure would more commonly be provided in a review article, but we do not think that the small number of studies on this topic so far justify a stand-alone review. Instead, the introduction to our manuscript includes a brief review of these few studies, complemented by the visual summary provided in Figure 1 and a detailed supplementary table.

      Reviewer #2 (Public review):

      Based on the controversy of whether the Desmodium intercrop emits bioactive volatiles that repel the fall armyworm, the authors conducted this study to assess the effects of the volatiles from Desmodium plants in the push-pull system on behavior of FAW oviposition. This topic is interesting and the results are valuable for understanding the push-pull system for the management of FAW, the serious pest. The methodology used in this study is valid, leading to reliable results and conclusions. I just have a few concerns and suggestions for improvement of this paper:

      (1) The volatiles emitted from D. incanum were analyzed and their effects on the oviposition behavior of FAW moth were confirmed. However, it would be better and useful to identify the specific compounds that are crucial for the success of the push-pull system.

      We fully agree that identifying specific volatile compounds responsible for the push-pull effect would provide valuable insights into the underlying mechanisms of the system. However, the primary focus of this study was to address the still unresolved question whether Desmodium emits detectable or “significant” amounts of volatiles at all under field conditions, and the secondary aim was to test whether we could demonstrate a behavioral effect of Desmodium headspace on FAW moths. Before conducting our experiments, we carefully considered the option of using single volatile compounds and synthetic blends in bioassays. We decided against this because we judged that the contradictory evidence in the literature was not a sufficient basis for composing representative blends. Furthermore, we think it is an important first step to test f. or behavioral responses to the headspaces of real plants. We consider bioassays with pure compounds to be important for confirmation and more detailed investigation in future studies. There was also contradictory evidence in the literature regarding moth responses to plants. We thus opted to focus on experiments with whole plants to maintain ecological relevance.

      (2) That would be good to add "symbols" of significance in Figure 4 (D).

      We report the statistical significance of the parameters in Figure 4 (D) in Table 3, which shows the mixed model applied for oviposition bioassays. While testing significance between groups is a standard approach, we used a more robust model-based analysis to assess the effects of multiple factors simultaneously. We provided a cross-reference to Table 3 from the figure description of Figure 4 (D) for readers to easily find the statistical details.

      (3) Figure A is difficult for readers to understand.

      Unfortunately, it is not entirely clear which specific figure is being referred to as "Figure A" in this comment. We tried to keep our figures as clear as possible.

      (4) It will be good to deeply discuss the functions of important volatile compounds identified here with comparison with results in previous studies in the discussion better.

      Our study does not provide strong evidence that specific volatiles from Desmodium plants are important determinants of FAW oviposition or choice in the push-pull system. Therefore, we prefer to refrain from detailed discussions of the potential importance of individual compounds. However, in the revised version, we provide an additional table S2 which identifies the overlap with volatiles previously reported from Desmodium, as only the total numbers are summarized in the discussion of the submitted paper.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The points raised are largely self-explanatory as to what needs to be done to fully resolve them. At a minimum the text needs to be seriously revised to:

      (1) reflect the data obtained.

      (2) reflect on the limitations of their experimental setup and data obtained.

      (3) put the data obtained and its limitations in what these tell us and particularly what not. Ideally, additional headspace measurements are taken, including from herbivory and 'clean' maize and Desmodium (in which there is better control of biotic and abiotic stress), as well as other crops commonly planted as companion crops with maize (but none of them reducing pest pressure).

      Thank you for this summary. Please see our detailed responses above.

      In addition to the main points of critique provided above, I have provided additional comments in the text (https://elife-rp.msubmit.net/elife-rp_files/2024/07/18/00134767/00/134767_0_attach_28_25795_convrt.pdf). These elaborate on the above points and include some new ones too. These are the major points of critique, which I hope the authors can address.

      Thank you very much for these detailed comments.

      Reviewer #2 (Recommendations for the authors):

      It is important to note that the original push-pull system was developed against stemborers and involved Napier grass (still used) around the field, which attracts stemborer moths, and Molasses grass as the intercrop that repels the moths and attracts parasitoids. Later, Molasses grass was replaced by desmodiums because it is a legume that fixes nitrogen and therefore can increase nitrate levels in the soil, but most importantly because it prevents germination of the parasitic Striga weed. The possible repellent effect of desmodium on pests and attraction of natural enemies was never properly tested but assumed, probably to still be able to use the push-pull terminology. This "mistake" should be recognized here and in future publications. It is a real pity that the controversy over the repellent effect of desmodium distracts from the amazing success of the push-pull system, also against the fall armyworm.

      We thank the reviewer for pointing out these issues, which are part of the reason for our Figure 1 and why we would like to keep it. We have described this development of the system in the introduction to better present the push-pull system. Our aim in Figure 1 and Table S1 is to highlight both the evidence of the system's success, and the gaps in our understanding, regarding specifically control of damage from the FAW.

    1. Reviewer #1 (Public review):

      Summary:

      This paper addresses an important and topical issue: how temporal context, at various time scales, affects various psychophysical measures, including reaction times, accuracy, and localization. It offers interesting insights, with separate mechanisms for different phenomena, which are well discussed.

      Strengths:

      The paradigm used is original and effective. The analyses are rigorous.

      Weaknesses:

      Here I make some suggestions for the authors to consider. Most are stylistic, but the issue of precision may be important.

      (1) The manuscript is quite dense, with some concepts that may prove difficult for the non-specialist. I recommend spending a few more words (and maybe some pictures) describing the difference between task-relevant and task-irrelevant planes. Nice technique, but not instantly obvious. Then we are hit with "stimulus-related", which definitely needs some words (also because it is orthogonal to neither of the above).

      (2) While I understand that the authors want the three classical separations, I actually found it misleading. Firstly, for a perceptual scientist to call intervals in the order of seconds (rather than milliseconds), "micro" is technically coming from the raw prawn. Secondly, the divisions are not actually time, but events: micro means one-back paradigm, one event previously, rather than defined by duration. Thirdly, meso isn't really a category, just a few micros stacked up (and there's not much data on this). And macro is basically patterns, or statistical regularities, rather than being a fixed time. I think it would be better either to talk about short-term and long-term, which do not have the connotations I mentioned. Or simply talk about "serial dependence" and "statistical regularities". Or both.

      (3) More serious is the issue of precision. Again, this is partially a language problem. When people use the engineering terms "precision" and "accuracy" together, they usually use the same units, such as degrees. Accuracy refers to the distance from the real position (so average accuracy gives bias), and precision is the clustering around the average bias, usually measured as standard deviation. Yet here accuracy is percent correct: also a convention in psychology, but not when contrasting accuracy with precision, in the engineering sense. I suggest you change "accuracy" to "percent correct". On the other hand, I have no idea how precision was defined. All I could find was: "mixture modelling was used to estimate the precision and guess rate of reproduction responses, based on the concentration (k) and height of von Mises and uniform distributions, respectively". I do not know what that means.

      (4) Previous studies show serial dependence can increase bias but decrease scatter (inverse precision) around the biased estimate. The current study claims to be at odds with that. But are the two measures of precision relatable? Was the real (random) position of the target subtracted from each response, leaving residuals from which the inverse precision was calculated? (If so, the authors should say so..) But if serial dependence biases responses in essentially random directions (depending on the previous position), it will increase the average scatter, decreasing the apparent precision.

      (5) I suspect they are not actually measuring precision, but location accuracy. So the authors could use "percent correct" and "localization accuracy". Or be very clear what they are actually doing.

    2. Reviewer #2 (Public review):

      Summary:

      This study investigates the influence of prior stimuli over multiple time scales in a position discrimination task, using pupillometry data and a reanalysis of EEG data from an existing dataset. The authors report consistent history-dependent effects across task-related, task-unrelated, and stimulus-related dimensions, observed across different time scales. These effects are interpreted as reflecting a unified mechanism operating at multiple temporal levels, framed within predictive coding theory.

      Strengths:

      The goal of assessing history biases over multiple time scales is interesting and resonates with both classic (Treisman & Williams, 1984) and recent work (Fritsche et al., 2020; Gekas et al., 2019). The manipulations used to distinguish task-related, unrelated, and stimulus-related reference frames are original and promising.

      Weaknesses:

      I have several concerns regarding the text, interpretation, and consistency of the results, outlined below:

      (1) The abstract should more explicitly mention that conclusions about feedforward mechanisms were derived from a reanalysis of an existing EEG dataset. As it is, it seems to present behavioral data only.

      (2) The EEG task seems quite different from the others, with location and color changes, if I understand correctly, on streaks of consecutive stimuli shown every 100 ms, with the task involving counting the number of target events. There might be different mechanisms and functions involved, compared to the behavioral experiments reported.

      (3) How is the arbitrary choice of restricting EEG decoding to a small subset of parieto-occipital electrodes justified? Blinks and other artifacts could have been corrected with proper algorithms (e.g., ICA) (Zhang & Luck, 2025) or even left in, as decoders are not necessarily affected by noise. Moreover, trials with blinks occurring at the stimulus time should be better removed, and the arbitrary selection of a subset of electrodes, while reducing the information in input to the decoder, does not account for trials in which a stimulus was missed (e.g., due to blinks).

      (4) The artifact that appears in many of the decoding results is puzzling, and I'm not fully convinced by the speculative explanation involving slow fluctuations. I wonder if a different high-pass filter (e.g., 1 Hz) might have helped. In general, the nature of this artifact requires better clarification and disambiguation.

      (5) Given the relatively early decoding results and surprisingly early differences in decoding peaks, it would be useful to visualize ERPs across conditions to better understand the latencies and ERP components involved in the task.

      (6) It is unclear why the precision derived from IEM results is considered reliable while the accuracy is dismissed due to the artifact, given that both seem to be computed from the same set of decoding error angles (equations 8-9).

      (7) What is the rationale for selecting five past events as the meso-scale? Prior history effects have been shown to extend much further back in time (Fritsche et al., 2020).

      (8) The decoding bias results, particularly the sequence of attraction and repulsion, appear to run counter to the temporal dynamics reported in recent studies (Fischer et al., 2024; Luo et al., 2025; Sheehan & Serences, 2022).

      (9) The repulsive component in the decoding results (e.g., Figure 3h) seems implausibly large, with orientation differences exceeding what is typically observed in behavior.

      (10) The pattern of accuracy, response times, and precision reported in Figure 3 (also line 188) resembles results reported in earlier work (Stewart, 2007) and in recent studies suggesting that integration may lead to interference at intermediate stimulus differences rather than improvement for similar stimuli (Ozkirli et al., 2025).

      (11) Some figures show larger group-level variability in specific conditions but not others (e.g., Figures 2b-c and 5b-c). I suggest reporting effect sizes for all statistical tests to provide a clearer sense of the strength of the observed effects.

      (12) The statement that "serial dependence is associated with sensory stimuli being perceived as more similar" appears inconsistent with much of the literature suggesting that these effects occur at post-perceptual stages (Barbosa et al., 2020; Bliss et al., 2017; Ceylan et al., 2021; Fischer et al., 2024; Fritsche et al., 2017; Sheehan & Serences, 2022).

      (13) If I understand correctly, the reproduction bias (i.e., serial dependence) is estimated on a small subset of the data (10%). Were the data analyzed by pooling across subjects?

      (14) I'm also not convinced that biases observed in forced-choice and reproduction tasks should be interpreted as arising from the same process or mechanism. Some of the effects described here could instead be consistent with classic priming.

    1. Author Response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review): 

      This study is focused on identifying unique, innovative surface markers for mature Achilles tendons by combining the latest multi-omics approaches and in vitro evaluation, which would address the knowledge gap of the controversial identity of TPSCs with unspecific surface markers. The use of multi-omics technologies, in vivo characterization, in vitro standard assays of stem cells, and in vitro tissue formation is a strength of this work and could be applied for other stem cell quantification in musculoskeletal research. The evaluation and identification of Cd55 and Cd248 in TPSCs have not been conducted in tendons, which is considered innovative. Additionally, the study provided solid sequencing data to confirm co-expressions of Cd55 and Cd248 with other well-described surface markers such as Ly6a, Tpp3, Pdgfra, and Cd34. Generally, the data shown in the manuscript support the claims that the identified surface antigens mark TPSCs in juvenile tendons.

      However, there are missing links between scientific questions aimed to be addressed in Introduction and Methodology/Results. If the study focuses on unsatisfactory healing responses of mature tendons and understanding of mature TPSCs, at least mature Achilles tendons from more than 12-week-old mice and their comparison with tendons from juvenile/neonatal mice should be conducted. However, either 2-week or 6-weekold mice, used for characterization here, are not skeletally mature, Additionally, there is a lack of complete comparison of TPSCs between 2-week and 6-week-old mice in the transcriptional and epigenetic levels.

      In order to distinguish TPSCs and characterize their epigenetic activities, the authors used scRNA-seq, snRNA-seq, and snATAC-seq approaches. The integration, analysis, and comparison of sequencing data across assays and/or time points is confusing and incomplete. For example, it should be more comprehensive to integrate both scRNA-seq and snRNA-seq data (if not, why both assays were used for Achilles tendons of both 2-week and 6-week timepoints). snRNA-seq and snATAC-seq data of 6-week-old mice were separately analyzed. No comparison of difference and similarity of TPSCs of 2-week and 6-week-old mice was conducted.

      Given the goal of this work to identify specific TPSC markers, the specificity of Cd55 and Cd248 for TPSCs is not clear. First, based on the data shown here, Cd55 and Cd248 mark the same cell population which is identified by Ly6a, TPPP3, and Pdgfra. Although, for instance, Cd34 is expressed by other tissues as discussed here, no data/evidence is provided by this work showing that Cd55 and Cd248 are not expressed by other musculoskeletal tissues/cells. Second, the immunostaining of Cd55 and Cd248 doesn't support their specificity. What is the advantage of using Cd55 and Cd248 for TPSCs compared to using other markers?

      Reviewer #2 (Public review): 

      Summary: 

      The molecular signature of tendon stem cells is not fully identified. The endogenous location of tendon stem cells within the native tendon is also not fully elucidated. Several molecular markers have been identified to isolate tendon stem cells but they lack tendon specificity. Using the declining tendon repair capacity of mature mice, the authors compared the transcriptome landscape and activity of juvenile (2 weeks) and mature (6 weeks) tendon cells of mouse Achilles tendons and identified CD55 and CD248 as novel surface markers for tendon stem cells. CD55+ CD248+ FACS-sorted cells display a preferential tendency to differentiate into tendon cells compared to CD55neg CD248neg cells.

      Strengths: 

      The authors generated a lot of data on juvenile and mature Achilles tendons, using scRNAseq, snRNAseq, and ATACseq strategies. This constitutes a resource dataset.

      Weaknesses: 

      The analyses and validation of identified genes are not complete and could be pushed further. The endogenous expression of newly identified genes in native tendons would be informative. The comparison of scRNAseq and snRNAseq datasets for tendon cell populations would strengthen the identification of tendon cell populations. 

      Reviewer #3 (Public review): 

      Summary: 

      In their report, Tsutsumi et al., use single nucleus transcriptional and chromatin accessibility analyses of mouse achilles tendon in an attempt to uncover new markers of tendon stem/progenitor cells. They propose CD55 and CD248 as novel markers of tendon stem/progenitor cells. 

      Strengths: 

      This is an interesting and important research area. The paper is overall well written.

      Weaknesses: 

      Major problems: 

      (1) It is not clear what tissue exactly is being analyzed. The authors build a story on tendons, but there is little description of the dissection. The authors claim to detect MTJ and cartilage cells, but not bone or muscle cells. The tendon sheath is known to express CD55, so the population of "progenitors" may not be of tendon origin.

      (2) Cluster annotations are seemingly done with a single gene. Names are given to cells without functional or spatial validation. For example, MTJ cells are annotated based on Postn, but it is never shown that Postn is only expressed at the MTJ, and not in other anatomical locations in the tendon. 

      (3) The authors compare their data to public data based on interrogating single genes in their dataset. It is now standard practice to integrate datasets (eg, using harmony), or at a minimum using gene signatures built into Seurat (eg AddModuleScore).

      (4) Progenitor populations (SP1, SP2). The authors claim these are progenitors but show very clearly that they express macrophage genes. What are they, macrophages or fibroblasts?

      (5) All omics analysis is done on single data points (from many mice pooled). The authors make many claims on n=1 per group for readouts dependent on sample number (eg frequency of clusters).

      (6) The scRNAseq atlas in Figure 1 is made by analyzing 2W and 6W tendons at the same time. The snRNAseq and ATACseq atlas are built first on 2W data, after which the 6W data is compared. Why use the 2W data as a reference?

      Why not analyze the two-time points together as done with the scRNAseq? 

      (7) Figure 5: The authors should show the gating strategy for FACS. Were non-fibroblasts excluded (eg, immune cells, endothelia...etc). Was a dead cell marker used? If not, it is not surprising that fibroblasts form colonies and express fibroblast genes when compared to CD55-CD248- immune cells, dead cells, or debris. Can control genes such as Ptprc or Pecam1 be tested to rule out contamination with other cell types?

      Minor problems: 

      (1) Report the important tissue processing details: type of collagenase used. Viability before loading into 10x machine.

      Reviewer #1 (Recommendations for the authors): 

      (1) Better healing responses in neonatal mice than mature mice have been well appreciated in the field and differences in ECM environment, immune responses, and cell function might account for varied injury results. However, direct evidence/data between better healing and abundant TSPCs needs to be discussed in the Introduction. 

      We agree with this insightful comment. We have now enhanced our introduction to include a more direct discussion of the relationship between better healing responses in neonatal mice and the abundance of TSPCs. We specifically highlighted how Howell et al. (2017) demonstrated that tendons in juvenile mice can regenerate functional tissue after injury, while this ability is lost in mature mice. Based on this observation, we articulated our hypothesis that juvenile mouse tendons likely contain abundant TSPCs, which potentially explains their superior healing capacity. Additionally, we have added a statement emphasizing that "investigating TSPCs biology is important for understanding tendon regeneration and homeostasis" (lines 61-62), which clearly articulates the central role that TSPCs play in tendon repair processes and tissue maintenance.

      (2) 6-week-old mouse Achilles tendons are not mature enough and clinically relevant to understand the deficiency of regenerative capacity of TPSCs for undesired healing. If the goal of this study is to identify TSPCs of mature tendons, evaluation of Achilles tendons from at least 12-week-old mice is more reasonable. 

      We agree with this insightful comment. We have now enhanced our introduction to include a more direct discussion of the relationship between better healing responses in neonatal mice and the abundance of TSPCs. We specifically highlighted how Howell et al. (2017) demonstrated that tendons in juvenile mice can regenerate functional tissue after injury, while this ability is lost in mature mice. Based on this observation, we articulated our hypothesis that juvenile mouse tendons likely contain abundant TSPCs, which potentially explains their superior healing capacity. Additionally, we have added a statement emphasizing that "investigating TSPCs biology is important for understanding tendon regeneration and homeostasis" (lines 61-62), which clearly articulates the central role that TSPCs play in tendon repair processes and tissue maintenance.

      (3) 40-60 mouse Achilles tendons pooled for one sample seems a lot and there is mixed/missed information about how many total cells were collected for each sample and how they were used for different sequencing assays. This could raise the concern that cell digestion was not complete and possibly abundant resident cells might be missed for sequencing analysis.

      We agree with this insightful comment. We have now enhanced our introduction to include a more direct discussion of the relationship between better healing responses in neonatal mice and the abundance of TSPCs. We specifically highlighted how Howell et al. (2017) demonstrated that tendons in juvenile mice can regenerate functional tissue after injury, while this ability is lost in mature mice. Based on this observation, we articulated our hypothesis that juvenile mouse tendons likely contain abundant TSPCs, which potentially explains their superior healing capacity. Additionally, we have added a statement emphasizing that "investigating TSPCs biology is important for understanding tendon regeneration and homeostasis" (lines 61-62), which clearly articulates the central role that TSPCs play in tendon repair processes and tissue maintenance.

      (4) The methods section has necessary information missing, which could create confusion for readers. Which time points are used for scRNA-seq and snATAC-seq? Which time points of cells are integrated and analyzed regarding each assay/combined assays? Why is transcriptional expression evaluated by both scRNA-seq and snRNA-seq and is there any technological difference between the two assays?

      We have thoroughly revised the Methods section to clearly specify which time points were used for each assay (line 132-133 and line 148-149). We have also clarified how cells from different time points were integrated and analyzed (lines 167-170, 179-184 and 494-502). Regarding the use of both scRNA-seq and snRNA-seq, we have explained that this complementary approach allowed us to capture both cytoplasmic and nuclear transcripts, providing a more comprehensive view of gene expression profiles while also enabling direct integration with snATAC-seq data. Comparison of similarity between scRNA-seq integration data (2-week and 6-week) and snRNA-seq (2-week) clusters confirmed that the clusters in each data set are almost correlated. We added the dot plot and correlation data in supplemental figure 5. Additionally, we have included comprehensive lists of differentially expressed genes (DEGs) for each identified cluster across all datasets (supplementary tables 1-15), which provide detailed molecular signatures for each cell population and facilitate cross-dataset comparisons.

      (5) snATAC-sequencing data seems to be used to only confirm the findings by snRNA-seq and snATAC-sequencing data is not well explored. This assay directly measures/predicts transcription factor activities and epigenetic changes, which might be more accurate in inferring transcription factors from RNA sequencing data using the R package SCENIC.

      We appreciate the reviewer's insightful comment regarding the utilization of our snATAC-seq data. We agree that snATAC-seq provides valuable direct measurements of chromatin accessibility and transcription factor binding sites that can complement inference-based approaches like SCENIC. To address this concern, we have revised our manuscript to better emphasize the value of our snATAC-seq data in transcription factor activity evaluation. We have modified our text (lines 570-574). This modification emphasizes that our integrated approach leverages the strengths of both methodologies, with snATAC-seq providing direct measurements of chromatin accessibility and transcription factor binding sites that can validate and enhance the inference-based predictions from SCENIC analysis of RNA-seq data.

      (6) The image quality of immunostaining of Cd55 and Cd248 is low. The images show that only part of the tendon sheath has positive staining. Co-localization of Cd55 and Cd248 can't be found.

      We agree with the reviewer regarding the limitations of our immunostaining images. To obtain clearer images, we used paraffin sections for our analysis. Additionally, the antibodies for CD55 and CD248 required different antigen retrieval conditions to work effectively, which unfortunately prevented us from performing co-immunostaining to directly demonstrate co-localization. Despite these technical limitations, we have optimized the processing and imaging parameters to improve the quality of the immunostaining images in Figure 5A. These improved images more clearly demonstrate the expression of CD55 and CD248 in the tendon sheath, although in separate sections. The consistent localization patterns observed in these separate stainings, together with our FACS and functional analyses of double-positive cells, strongly support their co-expression in the same cell population. We have also updated the corresponding Methods section (lines 260-272) to include these optimized immunostaining protocols for better reproducibility.

      (7) Only TEM data of tendon construct formed by sorted cells are shown. Results of mechanical tests will be super helpful to show the capacity of these TPSCs for tendon assembly.

      We appreciate the reviewer's suggestion regarding mechanical testing. We would like to direct the reviewer's attention to Figure 5I in our manuscript, where we have already included tensile strength measurements of the tendon construct. These mechanical test results demonstrate the functional capacity of CD55/CD248+ cells to form tendon-like tissue with appropriate mechanical properties, providing quantitative evidence of their ability for tendon assembly.

      (8) Cells negative for CD55/CD248 could be mixed cell populations, including hematopoietic lineages, cells from tendon mid substance, immune cells, and/or endothelial cells. Under induction of tri-lineage media, these mixed cell populations could process different, unpredicted phenotypes (shown by no increased gene expression of tenogenic, chondrogenic, and osteogenic markers after induction). Higher tenogenic gene expressions of TPSCs after induction don't mean that TPSCs are induced into tenocytes if compared to unknown cell populations with/without similar induction. Additionally, PCR data in Figure 5 presented as ΔΔCT, with unclear biological meanings, is challenging to interpret.

      We appreciate the reviewer's suggestion regarding mechanical testing. We would like to direct the reviewer's attention to Figure 5I in our manuscript, where we have already included tensile strength measurements of the tendon construct. These mechanical test results demonstrate the functional capacity of CD55/CD248+ cells to form tendon-like tissue with appropriate mechanical properties, providing quantitative evidence of their ability for tendon assembly.

      Reviewer #2 (Recommendations for the authors): 

      The aim of this study was to identify novel markers for tendon stem cells. The authors used the fact that tendon cells of juvenile tendons have a greater ability to regenerate versus mature tendons. scRNAseq, snRNAseq, and snATACseq datasets were generated and analyzed in juvenile and mature Achilles tendons (mice). 

      The authors generated a lot of data that could be exploited further to show that these two novel surface tendon markers are more tendon-specific than those previously identified. Another concern is that there is no robust data indicative of the endogenous location of CD55+ CD248+ cells in the native tendon. Same comments for the transcription factors regulating the transcription of CD55 and CD248 and that of Scx and Mkx. A validation of the ATACseq data with a location in native tendons would be pertinent.

      The analysis was performed by comparing 2 sub-clusters of the same datasets and not between the two stages. Given the introduction highlighting the differential ability to regenerate between the two stages, the comparison between the two stages was somehow expected. I wonder if there is an explanation for the absence of analysis between the two stages.

      The authors have all the datasets to (bioinformatically) compare scRNAseq and snRNAseq datasets. This comparative analysis would strengthen the clustering of tendon cell populations at both stages. The labeling/identification of clusters associated with tendon cell populations is not obvious. I am surprised that there is no tendon sheath cluster such as endotenon or peritenon. A discussion on the different tendon cell populations (tendon clusters) is lacking.

      (1) Choice of the three markers 

      The authors chose three genes known to be markers for tendon stem cells, Tppp3, PdgfRa, and Ly6a, and investigated clusters (or subclusters) that co-express these three genes. Except for Tppp3, the other two genes lack tendonspecificity. Ly6a is a stem cell marker and is recognized to be a marker of epi/perimysium in fetal and perinatal stages in mouse limbs (PMID: 39636726). Pdgfra is a generic marker of all connective tissue fibroblasts. Could it be that the identification of the two novel surface markers was biased with this choice? The identification of CD55 and CD248 has been done by comparing DEGs between cluster 4 (SP2) and cluster 1 (SP1). What about an unbiased comparison of both clusters 4 and 1 (or individual clusters) between mature and juvenile samples? The reader expected such a comparison since it was introduced as the rationale of the paper to compare juvenile and mature tendon cells.

      We selected Tppp3, PdgfRa, and Ly6a based on established literature identifying them as TSPC markers (Harvey et al., 2019; Tachibana et al., 2022). While only Tppp3 has tendon specificity, these genes collectively represent reliable TSPC markers currently available.

      Our identification of CD55 and CD248 came from comparing SP2 and SP1 clusters that showed these three markers plus tendon development genes. We did compare juvenile and mature samples as shown in Figure 1G, revealing decreased stem/progenitor marker expression with maturation. Additionally, we performed a comprehensive comparison between 2-week and 6-week samples visualized as a heatmap in Supplemental Figure 3, which clearly demonstrates the transcriptional changes that occur during tendon maturation. We have also provided the complete lists of differentially expressed genes for each identified cluster

      (supplementary tables 1-15), allowing for unbiased examination of cluster-specific gene signatures across developmental stages.

      Our functional validation confirmed CD55/CD248 positive cells express Tppp3, PdgfRa, and Ly6a while demonstrating high clonogenicity and tenogenic differentiation capacity, confirming their TSPC identity.

      (2) Concerns with cluster identification 

      The cluster11, named as MTJ cluster, in 2-week scRNAseq datasets was not detected in 6-week scRNAseq datasets (Figure 1A). Does it mean that MTJ disappears at 6 weeks in Achilles tendons? In the snRNAseq MTJ cluster was defined on the basis of Postn expression. «Cluster 11, with high Periostin (Postn) expression, was classified as a myotendinous junction (MTJ).» Line 379.

      What is the basis/reference to set a link between Postn and MTJ? 

      Could the CA clusters be enthesis clusters? Is there any cartilage in the Achilles tendon?

      If there are MTJ clusters, one could expect to see clusters reflecting tendon attachment to cartilage/bone.

      I am surprised to see no cluster reflecting tendon attachments (endotenon or peritenon).

      Cluster 9 was identified as a proliferating cluster in scRNAseq datasets. Does the Cell Cycle Regression step have been performed?

      Thank you for highlighting these important questions about our cluster identification. The MTJ cluster (cluster 11) appears reduced but not absent in 6-week samples. We based our MTJ classification on Postn expression, which is enriched at the myotendinous junction, as documented by Jacobson et al. (2020) in their proteome analysis of myotendinous junctions. We have added this reference to the manuscript to provide clear support for our cluster annotation (lines 400-401).

      Regarding the CA cluster, these cells express chondrogenic markers but are not enthesis clusters. We have revised our manuscript to acknowledge that these could potentially represent enthesis cells, as you suggested (lines 412-414). While Achilles tendons themselves don't contain cartilage, our digestion process likely captured some adjacent cartilaginous tissues from the calcaneus insertion site.

      We acknowledge the absence of clearly defined endotenon/epitenon clusters. We have added more comprehensive explanations about peritenon tissues in our manuscript (lines 431-433 and 584-585), noting that previous studies (Harvey et al., 2019) have reported that Tppp3-positive populations are localized to the peritenon, and our SP clusters might also reflect peritenon-derived cells. This additional context helps clarify the potential tissue origins of our identified cell populations.

      For the proliferating cluster (cluster 9), we confirmed high expression of cell cycle markers (Mki67, Stmn1) but did not perform cell cycle regression to maintain biological relevance of proliferation status in our analysis. We have clarified this methodological decision in the revised Methods section.

      (3) What is the meaning of all these tendon clusters in scRNAseq snRNAseq and snATACseq? The authors described 2 or 3 SP clusters (depending on the scRNAseq or snRNAseq datasets), 2 CT clusters, 1 MTJ cluster, and 1CA cluster. Do genes with enriched expression in these different clusters correspond to different anatomical locations in native tendons? Are there endotenon and peritenon clusters? Is there a correlation between clusters (or subclusters) expressing stem cell markers and peritenon as described for Tppp3

      Thank you for this important question about the biological significance of our identified clusters. The multiple tendon-related clusters we identified likely represent distinct cellular states and differentiation stages rather than strictly discrete anatomical locations. The SP clusters (stem/progenitor cells) express markers consistent with tendon progenitors reported in the literature, including Tppp3, which has been described in the peritenon. As we mentioned in our response to the previous question, we have added more comprehensive explanations about peritenon tissues in our manuscript (Lines 432-433 and 584-585), noting that previous studies (Harvey et al., 2019) have reported that Tppp3-positive populations are localized to the peritenon, and our SP clusters might reflect peritenon-derived cells. Our immunohistochemistry data in Figure 5A further confirms that CD55/CD248 positive cells are localized primarily to the tendon sheath region, similar to the localization pattern of Tppp3 reported by Harvey et al. (2019). The tenocyte clusters (TC) represent mature tendon cells within the fascicles, and their distinct transcriptional profiles suggest heterogeneity even within mature tenocytes. The MTJ cluster specifically expresses genes enriched at the myotendinous junction, while the CA cluster likely represents cells from the enthesis region, as you suggested. In the revised manuscript, we have clarified this interpretation and added additional discussion about the relationship between cluster identity and anatomical localization, particularly regarding the SP clusters and their correlation with peritenon regions.

      (4) The use of single-cell and single-nuclei RNAseq strategies to analyze tendon cell populations in juvenile and mature tendons is powerful, but the authors do not exploit these double analyses. A comparison between scRNAseq and snRNAseq datasets (2 weeks and 6 weeks) is missing. The similar or different features at the level of the clustering or at the level of gene expression should be explained/shown and discussed. This analysis should strengthen the clustering of tendon cell populations at both stages. In the same line, why are there 3 SP clusters in snRNAseq versus 2 SP clusters in scRNAseq? The MTJ cluster R2-5 expressing Sox9 should be discussed.

      Thank you for highlighting this important gap. We have conducted a comprehensive comparison between scRNA-seq and snRNA-seq datasets, revealing substantial correlation between cell populations identified by both methodologies. We've added a detailed dot plot visualization and correlation heatmap in Supplemental Figure 5 that demonstrates the relationships between clusters across datasets. The additional SP cluster in snRNA-seq likely reflects the greater sensitivity of nuclear RNA sequencing in capturing certain cell states that might be missed during whole-cell isolation. Our analysis shows this SP3 cluster represents a transitional state between stem/progenitor cells and differentiating tenocytes. Regarding the Sox9-expressing MTJ cluster R2-5, we have expanded our discussion in the revised manuscript (lines 500502) to address this finding, incorporating relevant references (Nagakura et al., 2020) that describe Sox9 expression at the myotendinous junction. This expression pattern suggests that cells at this specialized interface may maintain developmental plasticity between tendon and cartilage fates, which is consistent with the transitional nature of this anatomical region.

      (5) The claim of "high expression of CD55 and CD248 in the tendon sheath" is not supported by the experiments. The images of immunostaining (Figure 5A) are not very convincing. It is not explained if these are sections of 3Dtendon constructs or native tendons. The expression in 3D-tendon constructs is not informative, since tendon sheaths are not present. The endogenous expression of the transcription factors regulating tendon gene expression would be informative to localize tendon stem cells in native tendons.

      Thank you for this important critique. We agree that the original immunostaining images were not sufficiently convincing. To address this, we have used paraffin sections and optimized our staining protocols to improve image quality. It's worth noting that CD55 and CD248 antibodies required different antigen retrieval conditions to work effectively, which unfortunately prevented us from performing coimmunostaining to directly demonstrate co-localization in the same section. Despite these technical limitations, we have significantly improved the quality of the immunostaining images in Figure 5A with enhanced processing and imaging parameters 

      The improved images more clearly demonstrate the preferential expression of CD55 and CD248 in the tendon sheath/peritenon regions. The consistent localization patterns observed in these separate stainings, together with our FACS and functional analyses of double-positive cells, strongly support their coexpression in the same cell population.

      In the revised manuscript, we have also improved the figure legends to clearly indicate the nature of the tissue samples and updated the methods section to provide more detailed protocols for the immunostaining procedures used.

      Your suggestion regarding transcription factor visualization is valuable. While beyond the scope of our current study, we agree that examining the endogenous expression of regulatory transcription factors like Klf3 and Klf4 would provide additional insights into tendon stem cell localization in native tendons, and we plan to pursue this in future work

      Minor concerns:

      (1) Lines 392-397 « To identify progenitor populations within these clusters, we analyzed expression patterns of previously reported markers Tppp3 and Pdgfra (Harvey et al., 2019; Tachibana, et al., 2022), along with the known stem/progenitor cell marker Ly6a (Holmes et al., 2007; Sung et al., 2008; Hittinger et al., 2013; Sidney et al., 2014; Fang et al., 2022). We identified subclusters within clusters 1 and 4 showing high expression of these genes, which we defined as SP1 and SP2. SP2 exhibited the highest expression of these genes, suggesting it had the strongest progenitor characteristics.» Please cite relevant Figures. Feature and violin plots (scRNAseq) across all cells (not for the only 2 SP1 and SP2 clusters) of Tppp3, Pdgfra and Ly6a are missing.

      Thank you for pointing out this important oversight. We have modified the manuscript to clarify that the text in question describes Figure 1B. Additionally, we have added new feature plots showing the expression of Tppp3, Pdgfra, and Ly6a across all cells in supplymental figure 1B

      (2) The labeling of clusters with numbers in single-cell, single nuclei RNAseq, and ATACseq is difficult to follow.

      We appreciate your feedback on this issue. We recognize that the numerical labeling system across different datasets (scRNA-seq, snRNA-seq, and snATAC-seq) makes it difficult to track the same cell populations. To address this, we have added Supplemental Figure 5, which clearly shows the correspondence between cell populations in single-cell and single-nucleus RNA-seq datasets.

      (3) Figure 1C. It is not clear from the text and Figure legend if the DEGs are for the merged 2 and 6 weeks. If yes, an UMAP of the merged datasets of 2 and 6 weeks would be useful.

      We appreciate your feedback on this issue. We recognize that the numerical labeling system across different datasets (scRNA-seq, snRNA-seq, and snATAC-seq) makes it difficult to track the same cell populations. To address this, we have added Supplemental Figure 5, which clearly shows the correspondence between cell populations in single-cell and single-nucleus RNA-seq datasets.

      (4) Along the Text, there are a few sentences with obscure rationale. Here are a few examples (not exhaustive):

      Abstract 

      “Combining single-nucleus ATAC and RNA sequencing analyses revealed that Cd55 and Cd248 positive fractions in tendon tissue are TSPCs, with this population decreasing at 6 weeks.”

      The rationale of this sentence is not clear. How can single-nucleus ATAC and RNA sequencing analyses identify Cd55 and Cd248 positive fractions as tendon stem cells?

      Thank you for highlighting this unclear statement in our abstract. We agree that the previous wording did not adequately explain how our sequencing analyses identified CD55 and CD248 positive cells as TSPCs. We have revised this sentence to clarify that our multi-modal approach (combining scRNA-seq, snRNA-seq, and snATAC-seq) enabled us to identify Cd55 and Cd248 positive populations as TSPCs based on their co-expression with established TSPC markers such as Tppp3, Pdgfra, and Ly6a. This comprehensive analysis across different sequencing modalities provided strong evidence for their identity as tendon stem/progenitor cells, which we further validated through functional assays. The revised abstract now more clearly communicates the logical progression of our analysis and findings

      Line 80-82 

      “Cd34 is known to be highly expressed in mouse embryonic limb buds at E14.5 compared to E11.5 (Havis et al., 2014), making it a potential marker for TSPCs.”

      The rationale of this sentence is not clear. How can "the fact to be expressed in E14.5 mouse limbs" be an indicator of being a "potential marker of tendon stem cells"?

      Thank you for highlighting this unclear statement in our abstract. We agree that the previous wording did not adequately explain how our sequencing analyses identified CD55 and CD248 positive cells as TSPCs. We have revised this sentence to clarify that our multi-modal approach (combining scRNA-seq, snRNA-seq, and snATAC-seq) enabled us to identify Cd55 and Cd248 positive populations as TSPCs based on their co-expression with established TSPC markers such as Tppp3, Pdgfra, and Ly6a. This comprehensive analysis across different sequencing modalities provided strong evidence for their identity as tendon stem/progenitor cells, which we further validated through functional assays. The revised abstract now more clearly communicates the logical progression of our analysis and findings

      Line 611 

      “Recent reports have highlighted the role of the Klf family in limb development (Kult et al., 2021), suggesting its potential importance in tendon differentiation”

      Why does the "role of Klf family in limb development" suggest an "importance in tendon differentiation"?

      Thank you for highlighting this logical gap in our manuscript. You're right that involvement in limb development doesn't necessarily indicate specific importance in tendon differentiation. We've revised this statement to more accurately reflect current knowledge, noting that while Klf factors are involved in limb development, their specific role in tendon differentiation requires further investigation (lines 658-659). This revised text better aligns with our findings of Klf3 and Klf4 expression in tendon progenitor cells without making unsupported claims about their functional significance

      Reviewer #3 (Recommendations for the authors): 

      In addition to the points highlighted above some additional points are listed below.

      (1) Case in point: the authors claim CD55 and CD248 are found at the tendon sheath (line 541), which is not part of the tendon proper (although the IHC seems to show green in the epi/endotenon).

      Thank you for highlighting this logical gap in our manuscript. You're right that involvement in limb development doesn't necessarily indicate specific importance in tendon differentiation. We've revised this statement to more accurately reflect current knowledge, noting that while Klf factors are involved in limb development, their specific role in tendon differentiation requires further investigation (lines 658-659). This revised text better aligns with our findings of Klf3 and Klf4 expression in tendon progenitor cells without making unsupported claims about their functional significance

      (2) All cell types seem to express collagen based on Figure 1B, so either there is serious background contamination (eg, ambient RNA), or an error in data analysis.

      Thank you for highlighting this logical gap in our manuscript. You're right that involvement in limb development doesn't necessarily indicate specific importance in tendon differentiation. We've revised this statement to more accurately reflect current knowledge, noting that while Klf factors are involved in limb development, their specific role in tendon differentiation requires further investigation (lines 658-659). This revised text better aligns with our findings of Klf3 and Klf4 expression in tendon progenitor cells without making unsupported claims about their functional significance

      Minor problems: 

      (1) The figures are confusingly formatted. It is hard to go between cluster numbers and names. Clusters of similar cell types (eg progenitors) are not grouped to facilitate comparison, as ordering is based on cluster number).

      Thank you for highlighting this logical gap in our manuscript. You're right that involvement in limb development doesn't necessarily indicate specific importance in tendon differentiation. We've revised this statement to more accurately reflect current knowledge, noting that while Klf factors are involved in limb development, their specific role in tendon differentiation requires further investigation (lines 658-659). This revised text better aligns with our findings of Klf3 and Klf4 expression in tendon progenitor cells without making unsupported claims about their functional significance

      (2) The introduction does not distinguish between findings in mice and man. A lot of confusion in the tendon literature probably arises from interspecies differences, which are rarely addressed. 

      We appreciate this important point about species distinctions. We have revised our introduction to clearly identify species-specific findings by adding the term "murine" before TSPC references when discussing mouse studies (lines 64, 66, 70, 75, 100, and 108). We agree that interspecies differences are important considerations in tendon biology research, particularly when translating findings between animal models and humans. Our study focuses specifically on mouse models, and we have been careful not to overgeneralize our conclusions to human tendon biology without appropriate evidence. This clarification helps readers better contextualize our findings within the broader tendon literature landscape.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      (1) The use of single-cell RNA and TCR sequencing is appropriate for addressing potential relationships between gene expression and dual TCR.

      Thank you for your detailed review and suggestions. The main advantages of scRNA+TCR-seq are as follows: (1) It enables comparative analysis of features such as the ratio of single TCR paired T cells to dual TCR paired T cells at the level of a large number of individual T cells, through mRNA expression of the α and β chains. In the past, this analysis was limited to a small number of T cells, requiring isolation of single T cells, PCR amplification of the α and β chains, and Sanger sequencing; (2) While analyzing TCR paired T cell characteristics, it also allows examination of mRNA expression levels of transcription factors in corresponding T cells through scRNA-seq.

      (2) The data confirm the presence of dual TCR Tregs in various tissues, with proportions ranging from 10.1% to 21.4%, aligning with earlier observations in αβ T cells.

      Thank you very much for your detailed review and suggestions. Early studies on dual TCR αβ T cells have been very limited in number, with reported proportions of dual TCR T cells ranging widely from 0.1% to over 30%. In contrast, scRNA+TCR-seq can monitor over 5,000 single and paired TCRs, including dual paired TCRs, in each sample, enabling more precise examination of the overall proportion of dual TCR αβ T cells. It is important to note that our analysis focuses on T cells paired with functional α and β chains, while T cells with non-functional chain pairings and those with a single functional chain without pairing were excluded from the total cell proportion analysis. Previous studies generally lacked the ability to determine expression levels of specific chains in T cells without dual TCR pairings.

      (3) Tissue-specific patterns of TCR gene usage are reported, which could be of interest to researchers studying T cell adaptation, although these were more rigorously analyzed in the original works.

      Thank you very much for your detailed review and suggestions. T cell subpopulations exhibit tissue specificity; thus, we conducted a thorough investigation into Treg cells from different tissue sites. This study builds upon the original by innovatively analyzing the differences in VDJ rearrangement and CDR3 characteristics of dual TCR Treg cells across various tissues. This provides new insights and directions for the potential existence of “new Treg cell subpopulations” in different tissue locations. The results of this analysis suggest the necessity of conducting functional experiments on dual TCR Treg cells at both the TCR protein level and the level of effector functional molecules.

      (4) Lack of Novelty: The primary findings do not substantially advance our understanding of dual TCR expression, as similar results have been reported previously in other contexts.

      Thank you for your detailed review and suggestions. Early research on dual TCR T cells primarily relied on transgenic mouse models and in vitro experiments, using limited TCR alpha chain or TCR beta chain antibody pairings. Flow cytometry was used to analyze a small number of T cells to estimate dual TCR T cell proportion. No studies have yet analyzed dual TCR Treg cell proportion, V(D)J recombination, and CDR3 characteristics at high throughput in physiological conditions. The scRNA+TCR-seq approach offers an opportunity to conduct extensive studies from an mRNA perspective. With high-throughput advantages of single-cell sequencing technology, researchers can analyze transcriptomic and TCR sequence characteristics of all dual TCR Treg cells within a study sample, providing new ideas and technical means for investigating dual TCR T cell proportions, characteristics, and origins under different physiological and pathological states.

      (5) Incomplete Evidence: The claims about tissue-specific differences lack sufficient controls (e.g., comparison with conventional T cells) and functional validation (e.g., cell surface expression of dual TCRs).

      Thank you for your detailed review and suggestions. This study indeed only analyzed dual TCR Treg cells from different tissue locations based on the original manuscript, without a comparative analysis of other dual TCR T cell subsets corresponding to these tissue locations. The main reason for this is that, in current scRNA+TCR-seq studies of different tissue locations, unless specific T cell subsets are sorted and enriched, the number of T cells obtained from each subset is very low, making a detailed comparative analysis impossible. In the results of the original manuscript, we observed a relatively high proportion of dual TCR Treg cell populations in various tissues, with differences in TCR composition and transcription factor expression. Following the suggestions, we have included additional descriptions in R1, citing the study by Tuovinen et al., which indicates that the proportion of dual TCR Tregs in lymphoid tissues is higher than other T cell types. This will help understand the distribution characteristics of dual TCR Treg cells in different tissues and provide a basis for mRNA expression levels to conduct functional experiments on dual TCR Treg cells in different tissue locations.

      (6) Methodological Weaknesses: The diversity analysis does not account for sample size differences, and the clonal analysis conflates counts and clonotypes, leading to potential misinterpretation.

      We thank you for your review and suggestions. In response to your question about whether the diversity analysis considered the sample size issue, we conducted a detailed review and analysis. This study utilized the inverse Simpson index to evaluate TCR diversity of Treg cells. A preliminary analysis compared the richness and evenness of single TCR Treg cell and dual TCR Treg cell repertoires. The two datasets analyzed were from four mouse samples with consistent processing and sequencing conditions. However, when analyzing single TCR Tregs and dual TCR Tregs from various tissues, differences in detected T cell numbers by sequencing cannot be excluded from the diversity analysis. Following recommendations, we provided additional explanations in R1: CDR3 diversity analysis indicates TCR composition of dual TCR Treg cells exhibits diversity, similar to single TCR Treg cells; however, diversity indices of single TCR Tregs and dual TCR Tregs are not suitable for statistical comparison. Regarding the "clonal analysis" you mentioned, we define clonality based on unique TCR sequences; cells with identical TCR sequences are part of the same clone, with ≥2 counts defined as expansion. For example, in Blood, there are 958 clonal types and 1,228 cells, of which 449 are expansion cells. In R1, we systematically verified and revised clonal expansion cells across all tissue samples according to a unified standard.

      (7) Insufficient Transparency: The sequence analysis pipeline is inadequately described, and the study lacks reproducibility features such as shared code and data.

      Thank you for your review and suggestions. Based on the original manuscript, we have made corresponding detailed additions in R1, providing further elaboration on the analysis process of shared data, screening methods, research codes, and tools. This aims to offer readers a comprehensive understanding of the analytical procedures and results.

      (8) Weak Gene Expression Analysis: No statistical validation is provided for differential gene expression, and the UMAP plots fail to reveal meaningful clustering patterns.

      Thank you very much for your review and suggestions. Based on your recommendations, we conducted an initial differential expression analysis of the top 10 mRNA molecules in single TCR Treg and dual TCR Treg cells using the DESeq2 R package in R1, with statistical significance determined by Padj < 0.05. Regarding the clustering patterns in the UMAP plots, since the analyzed samples consisted of isolated Treg cell subpopulations that highly express immune suppression-related genes, we did not perform a more detailed analysis of subtypes and expression gene differences. This study primarily aims to explore the proportions of single TCR and dual TCR Treg cells from different tissue sources, as well as the characteristics of CDR3 composition, with a focus on showcasing the clustering patterns of samples from different tissue origins and various TCR pairing types.

      (9) A quick online search reveals that the same authors have repeated their approach of reanalysing other scientists' publicly available scRNA-VDJ-seq data in six other publications,In other words, the approach used here seems to be focused on quick re-analyses of publicly available data without further validation and/or exploration.

      Thank you for your review and suggestions. Most current studies utilizing scRNA+TCR-seq overlook analysis of TCR pairing types and related research on single TCR and dual TCR T cell characteristics. Through in-depth analysis of shared scRNA+TCR-seq data from multiple laboratories, we discovered a significant presence of dual TCR T cells in high-throughput T cell research results that cannot be ignored. In this study, we highlight the higher proportion of dual TCR Tregs in different tissue locations, which exhibits a certain degree of tissue specificity, suggesting these cells may participate in complex functional regulation of Tregs. This finding provides new ideas and a foundation for further research into dual TCR Treg functions. However, as reviewers pointed out, findings from scRNA+TCR-seq at the mRNA level require additional functional experiments on dual TCR T cells at the protein level. We have supplemented our discussion in R1 based on these suggestions.

      Reviewer #2 (Public review):

      (1)The existence of dual TCR expression by Tregs has previously been demonstrated in mice and humans (Reference #18 and Tuovinen. 2006. Blood. 108:4063; Schuldt. 2017. J Immunol. 199:33, both omitted from references). The presented results should be considered in the context of these prior important findings.

      Thank you very much for your review and suggestions. Based on the original manuscript, we have supplemented our reading, understanding, and citation of closely related literature (Tuovinen, 2006, Blood, 108:4063 (line 44,line175 in R1); Schuldt, 2017, J Immunol, 199:33 (line 44,line178 in R1)). We once again appreciate the valuable comments from the reviewers, and we will refer to these in our subsequent dual TCR T cell research.

      (2) This demonstration of dual TCR Tregs is notable, though the authors do not compare the frequency of dual TCR co-expression by Tregs with non-Tregs. This limits interpreting the findings in the context of what is known about dual TCR co-expression in T cells.

      Thank you very much for your review and suggestions. This analysis is primarily based on the scRNA+TCR-seq study of sorted Treg cells, where we found the proportions and distinguishing features of dual TCR Treg cells in different tissue sites. Given the diversity and complexity of Treg function, conducting a comparative analysis of the origins of dual TCR Treg cells and non-T cells with dual TCRs will be a meaningful direction. Currently, peripheral induced Treg cells can originate from the conversion of non-Treg cells; however, little is known about the sources and functions of dual TCR Treg cell subsets in both central and peripheral sites. In R1, we have supplemented the discussion regarding the possible origins and potential applications of the "novel dual TCR Treg" subsets.

      (3) Comparison of gene expression by single- and dual TCR Tregs is of interest, but as presented is difficult to interpret. Statistical analyses need to be performed to provide statistical confidence that the observed differences are true.

      Thank you very much for your review and suggestions. Based on your recommendations, we performed an initial differential expression analysis of the top 10 mRNA molecules in single TCR Treg and dual TCR Treg cells using the DESeq2 R package in R1, with a statistical significance threshold of Padj<0.05 for comparisons.

      (4) The interpretations of the gene expression analyses are somewhat simplistic, focusing on the single-gene expression of some genes known to have a function in Tregs. However, the investigators miss an opportunity to examine larger patterns of coordinated gene expression associated with developmental pathways and differential function in Tregs (Yang. 2015. Science. 348:589; Li. 2016. Nat Rev Immunol. Wyss. 2016. 16:220; Nat Immunol. 17:1093; Zenmour. 2018. Nat Immunol. 19:291).

      Thank you for your review and suggestions. This study is based on publicly available scRNA+TCR-seq data from different organ sites generated by the original authors, focusing on sorted and enriched Treg cells within each tissue sample. However, there was no corresponding research on other cell types in each tissue sample, preventing analysis of other cells and factors involved in development and differentiation of single TCR Treg and dual TCR Treg. The literature suggested by the reviewer indicates that development, differentiation, and function of Treg cells have been extensively studied, resulting in significant advances. It also highlights complexity and diversity of Treg origins and functions. This research aims to investigate "novel dual TCR Treg cell subpopulations" that may exhibit tissuespecific differences found in the original authors' studies of Treg cells across different organ sites. This suggests further experimental research into their development, differentiation, origin, and functional gene expression as an important direction, which we have supplemented in the discussion section of R1.

      Reviewer #3 (Public review):

      (1) Definition of Dual TCR and Validity of Doublet Removal:This study analyzes Treg cells with Dual TCR, but it is not clearly stated how the possibility of doublet cells was eliminated. The authors mention using DoubletFinder for detecting doublets in scRNA-seq data, but is this method alone sufficient?We strongly recommend reporting the details of doublet removal and data quality assessment in the Supplementary Data.

      Thank you very much for your review and suggestions. In the analysis of the shared scRNA+TCR-seq data across multiple laboratories, as you mentioned, this study employed the DoubletFinder R package to exclude suspected doublets. Additionally, we used the nCount values of individual cells (i.e., the total sequencing reads or UMI counts for each cell) as auxiliary parameters to further optimize the assessment of cell quality. Generally, due to the possibility that doublet cells may contain gene expression information from two or more cells, their nCount values are often abnormally high. In this study, all cells included in the analysis had nCount values not exceeding 20,000. Among the five tissue sample datasets, we further utilized hashtag oligonucleotide (HTO) labeling (where HTO labeling provides each cell with a unique barcode to differentiate cells from different tissue sources. By analyzing HTO labels, doublets and negative cells can be accurately identified) to eliminate doublets and negative cells.After the removal of chimeric cells, all samples exhibited T cells that possessed two or more TCR clones. This phenomenon validates the reliability of the methodological approach employed in this study and indicates that the analytical results accurately reflect the proportion of dual TCR T cells. Based on the recommendations of the reviewers, we have supplemented and clarified the methods and discussion sections in the manuscript. It is particularly noteworthy that in our analysis, the discussed dual TCR Treg cells and single TCR Treg cells specifically refer to those T cells that possess both functional α and β chains, which are capable of forming TCR. We have excluded from this analysis any Treg cells that possess only a single functional α or β chain and do not form TCR pairs, as well as those Treg cells in which the α or β chains involved in TCR pairing are non-functional.

      (2) In Figure 3D, the proportion of Dual TCR T cells (A1+A2+B1+B2) in the skin is reported to be very high compared to other tissues. However, in Figure 4C, the proportion appears lower than in other tissues, which may be due to contamination by non-Tregs. The authors should clarify why it was necessary to include non-Tregs as a target for analysis in this study. Additionally, the sensitivity of scRNA-seq and TCR-seq may vary between tissues and may also be affected by RNA quality and sequencing depth in skin samples, so the impact of measurement bias should be assessed.

      We deeply appreciate your review and constructive comments. Based on the original manuscript, we have further supplemented and elaborated on the uniqueness and relative proportions of double TCR T cell pairs in skin tissue samples in Section R1. Due to the scarcity of T cells in skin samples, we included some non-Treg cells during single-cell RNA sequencing and TCR sequencing to obtain a sufficient number of cells for effective analysis. The presence of non-regulatory T cells may indeed impact the statistical representation of double TCR T cells as well as the related comparative analyses, as noted by the reviewer. T cells with A1+A2+B1+B2 type double TCR pairings are primarily found within the non-regulatory T cell population in the skin. In response to this point, we have provided a detailed explanation of this analytical result in the revised manuscript R1. Furthermore, concerning the two datasets included in the study, we conducted a comparative analysis in R1, exploring how factors such as sequencing depth at different tissue sites might introduce biases in our findings, which we have thoroughly elaborated upon in the discussion section. We thank you once again for your valuable suggestions.

      (3) Issue of Cell Contamination:In Figure 2A, the data suggest a high overlap between blood, kidney, and liver samples, likely due to contamination. Can the authors effectively remove this effect? If the dataset allows, distinguishing between blood-derived and tissue-resident Tregs would significantly enhance the reliability of the findings. Otherwise, it would be difficult to separate biological signals from contamination noise, making interpretation challenging.

      We thank you for your review and suggestions. We have carefully verified data sources for tissues such as blood, kidneys, and liver. In the study by Oliver T et al., various techniques were employed to differentiate between leukocytes from blood and those from tissues, ensuring accurate identification of leukocytes from tissue samples. First, anti-CD45 antibody was injected intravenously to label cells in the vasculature, verifying that analyzed cells were indeed resident in the tissue. Second, prior to dissection and cell collection, authors performed perfusion on anesthetized mice to reduce contamination of tissue samples by leukocytes from the vasculature. Additionally, during single-cell sequencing, authors utilized HTO technology to avoid overlap between cells from different tissues.

      Analysis of the scRNA+TCR-seq data shared by the original authors revealed highly overlapping TCR sequences in blood, kidney, and liver, despite distinct cell labels associated with each tissue. While these techniques minimize overlap of cells from different sources, they cannot completely rule out the potential impact of this technical issue. As suggested, we have provided additional clarification in R1 of the manuscript regarding this phenomenon of high overlap in the kidney, liver, and blood, indicating that the possibility of Treg migration from blood to kidney and liver cannot be entirely excluded.

      (4) Inconsistency Between CDR3 Overlap and TCR Diversity:The manuscript states that Single TCR Tregs have a higher CDR3 overlap, but this contradicts the reported data that Dual TCR Tregs exhibit lower TCR diversity (higher 1/DS score). Typically, when TCR diversity is low (i.e., specific clones are concentrated), CDR3 overlap is expected to increase. The authors should carefully address this discrepancy and discuss possible explanations.

      Thank you for your review and suggestions. Regarding the potential relationship between CDR3 overlap and TCR diversity, in samples with consistent sequencing depth, lower diversity indeed corresponds to a higher proportion of CDR3 overlap. In our analysis of scRNA+TCR-seq data, we found that single TCR Tregs exhibit both higher diversity and CDR3 overlap, seemingly presenting contradictory analytical results (i.e., dual TCR Tregs show lower TCR diversity and CDR3 overlap). In R1, we supplemented the analysis of possible reasons: the presence of multiple TCR chains in dual TCR Treg cells may lead to a higher uniqueness of CDR3 due to multiple rearrangements and selections, resulting in lower CDR3 overlap; the lower diversity of dual TCR Tregs may be related to the number of T cells sequenced in each sample. The CDR3 diversity analysis in this study merely suggests that the TCR composition of dual TCR Treg cells is diverse, similar to that of single TCR Tregs. However, the diversity indices of single TCR Tregs and dual TCR Tregs are not suitable for statistical comparative analysis. A more in-depth and specific analysis of the diversity and overlap of the VDJ recombination mechanisms and CDR3 composition in dual TCR Tregs during development will be an important technical means to elucidate the function of dual TCR Treg cells.

      (5) Functional Evaluation of Dual TCR Tregs:This study indicates gene expression differences among tissue-resident Dual TCR T cells, but there is no experimental validation of their functional significance. Including functional assays, such as suppression assays or cytokine secretion analysis, would greatly enhance the study's impact.

      We sincerely appreciate your review and suggestions: In this analysis of scRNA+TCR-seq data, we innovatively discovered a higher proportion of dual TCR Treg cells in different tissue sites, which exhibited differences in tissue characteristics. Furthermore, we conducted a comparative analysis of the homogeneity and heterogeneity between single TCR Treg and dual TCR Treg cells. This result provides a foundation for further research on the origin and characteristics of dual TCR Treg cells in different tissue sites, offering new insights for understanding the complexity and functional diversity of Treg cells. Based on your suggestions, we have supplemented R1 with the feasibility of further exploring the functions of tissue-resident dual TCR T cells and the necessity for potential application research.

      (6) Appropriateness of Statistical Analysis:When discussing increases or decreases in gene expression and cell proportions (e.g., Figure 2D), the statistical methods used (e.g., t-test, Wilcoxon, FDR correction) should be explicitly described. They should provide detailed information on the statistical tests applied to each analysis.

      Thank you for your review and suggestions: Based on the original manuscript, we have supplemented the specific statistical methods for the differences in cell proportions and gene expression in R1.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1:

      (1) Developmental time series:

      It was not entirely clear how this experiment relates to the rest of the manuscript, as it does not compare any effects of transport within or across species.

      Implemented Changes:  

      The importance of species arrival timing for community assembly is addressed in both the introduction and discussion. To accommodate the reviewer’s concerns and further emphasize this point, we have added a clarifying sentence to the results section and included an illustrative example with supporting literature in the discussion.

      Results: Clarifying the timing of initial microbial colonization is essential for determining whether and how priority effects mediate community assembly of vertically transmitted microbes in early life, or whether these microbes arrive into an already established microbial landscape. We used non-sterile frogs of our captive laboratory colony (…)

      Discussion: For example, early microbial inoculation has been shown to increase the relative abundance of beneficial taxa such as Janthinobacterium lividum (Jones et al., 2024), whereas efforts to introduce the same probiotic into established adult communities have not led to long-term persistence (Bletz, 2013; Woodhams et al., 2016).  

      (2) Cross-foster experiment:

      The "heterospecific transport" tadpoles were manually brushed onto the back of the surrogate frog, while the "biological transport" tadpoles were picked up naturally by the parent. It is a little challenging to interpret the effect of caregiver species since it is conflated with the method of attachment to the parent. I noticed that the uptake of Os-associated microbes by Os-transported tadpoles seemed to be higher than the uptake of Rv-associated microbes by Rv-associated tadpoles (comparing the second box from the left to the rightmost boxplot in panel S2C). Perhaps this could be a technical artifact if manual attachment to Os frogs was more efficient than natural attachment to Rv frogs.

      I was also surprised to see so much of the tadpole microbiome attributed to Os in tadpoles that were not transported by Os frogs (25-50% in many cases). It suggests that SourceTracker may not be effectively classifying the taxa.

      Implemented Changes:  

      Methods (Study species, reproductive strategies and life history): Oophaga sylvatica (Os) (Funkhouser, 1956; CITES Appendix II, IUCN Conservation status: Near Threatened) is a large, diurnal poison frog (family Dendrobatidae) inhabiting lowland and submontane rainforests in Colombia and Ecuador. While male Os care for the clutch of up to seven eggs, females transport 1-2 tadpoles at a time to water-filled leaf axils where tadpoles complete their development (Pašukonis et al., 2022; Silverstone, 1973; Summers, 1992). Notably, females return regularly to these deposition sites to provision their offspring with unfertilized eggs.

      Discussion: Most poison frogs transport tadpoles on their backs, but the mechanism of adherence remains unclear. Similar to natural conditions, tadpoles that are experimentally placed onto a caregiver’s back also gradually adhere to the dorsal skin, where they remain firmly attached for several hours as the adult navigates dense terrain. Although transport durations were standardized, species-specific factors- such as microbial density at the contact site, microbial taxa identity, and skin physiology such as moisture -could influence microbial transmission between the transporting frog and the tadpole. While these differences may have contributed to varying transmission efficacies observed between the two frog species in our experiment, none of these factors should compromise the correct microbial source assignment. We thus conclude that transporting frogs serve as a source of microbiota for transported tadpoles. However, further studies on species-specific physiological traits and adherence mechanisms are needed to clarify what modulates the efficacy of microbial transmission during transport, both under experimental and natural conditions.  

      Methods (Vertical transmission): Cross-fostering tadpoles onto non-parental frogs has been used previously to study navigation in poison frogs (Pašukonis et al., 2017). According to our experience, successful adherence to both parent and heterospecific frogs depends on the developmental readiness of tadpoles, which must have retracted their gills and be capable of hatching from the vitelline envelope through vigorous movement. Another factor influencing cross-fostering success is the docility of the frog during initial attachment, as erratic movements easily dislodge tadpoles before adherence is established. Rv are small, jumpy frogs that are easily stressed by handling, making experimental fostering of tadpoles—even their own— impractical. Therefore, we favored an experimental design where tadpoles initiate natural transport and parental frogs pick them up with a 100% success rate. We chose the poison frog Os as foster frogs because adults are docile, parental care in this species involves transporting tadpoles, and skin microbial communities differ from Rv- a critical prerequisite for our SourceTracker analysis. The use of the docile Os as the foster species enabled a 100% cross-fostering success rate, with no notable differences in adherence strength after six hours.

      Methods (Sourcetracker Analysis): To assess training quality, we evaluated model selfassignment using source samples. We selected the model trained on a dataset rarefied to the read depth of the adult frog sample with the lowest read count (48162 reads), as it showed the best overall self-assignment performance, whereas models trained on datasets rarefied to the lowest overall read depth performed worse. Unlike studies using technical replicates, our source samples represent distinct biological individuals and sampling timepoints, where natural microbiome variability is expected within each source category. Consequently, we considered self-assignment rates above 70% acceptable. All source samples were correctly assigned to their respective categories (Rv, Os, or control), but with varying proportions of reads assigned as 'Unknown'. Adult frog sources were reliably selfidentified with high confidence (Os: 97.2% median, IQR = 1.4; Rv: 76.3% median, IQR = 38.1). Adult R. variabilis frogs displayed a higher proportion of 'Unknown' assignments compared to O. sylvatica, likely reflecting greater biological variability among individuals and/or a higher proportion of rare taxa not well captured in the training set. The control tadpole source showed lower self-assignment accuracy (median = 30.5%, IQR = 17.1), as expected given the low microbial biomass of these samples, which resulted in low read depth. Low readdepth limits the information available to inform the iterative updating steps in Gibbs sampling and reduces confidence in source assignments. We therefore verified the robustness of our results by performing the second Sourcetracker analysis as described above, training the model only on adult sources and assigning all tadpoles, including lowbiomass controls, as sinks (as described above). Self-assignment rates for the second training set varied (O. sylvatica: 79.2% median, IQR = 29; R. variabilis: 96.6% median, IQR = 3.7), while results remained consistent across analyses, supporting the reliability of our findings.

      (3) Cross-species analysis:

      Like the developmental time series, this analysis doesn't really address the central question of the manuscript. I don't think it is fair for the authors to attribute the difference in diversity to parental care behavior, since the comparison only includes n=2 transporting species and n=1 non-transporting species that differ in many other ways. I would also add that increased diversity is not necessarily an expectation of vertical transmission. The similarity between adults and tadpoles is likely a more relevant outcome for vertical transmission, but the authors did not find any evidence that tadpole-adult similarity was any higher in species with tadpole transport. In fact, tadpoles and adults were more similar in the non-transporting species than in one of the transporting species (lines 296-298), which seems to directly contradict the authors' hypothesis. I don't see this result explained or addressed in the Discussion.

      To address the reviewer’s concerns, we implemented the following changes:  

      Results:

      We rephrased the following sentence from the results part:  

      “These variations may therefore be linked to differing reproductive traits: Af and Rv lay terrestrial egg clutches and transport hatchlings to water, whereas Ll, a non-transporting species, lays eggs directly in water.”

      To read

      “These variations may therefore reflect differences in life history traits among the three species.”

      We moved the information on differing reproductive strategies into the Discussion, where it contributes to a broader context alongside other life history traits that may influence community diversity.

      Discussion (1): We added to our discussion that increased microbial diversity was not an expected outcome of vertical transmission.

      “However, increased microbial diversity is not a known outcome of vertical transmission, and further studies across a broader range of transporting and non-transporting species are needed to assess the role of transport in shaping diversity of tadpole-associated microbial communities.”

      Discussion (2): Likewise, communities associated with adults and tadpoles of transporting species were no more similar than those of non-transporting species. While poison frog tadpoles do acquire caregiver-specific microbes during transport, most of these microbes do not persist on the tadpoles' skin long-term. This pattern can likely be attributed to the capacity of tadpole skin- and gut microbiota to flexibly adapt to environmental changes (Emerson & Woodley, 2024; Santos et al., 2023; Scarberry et al., 2024). It may also reflect the limited compatibility of skin microbiota from terrestrial adults with aquatic habitats or tadpole skin, which differs structurally from that of adults (Faszewski et al., 2008). As a result, many transmitted microbes are probably outcompeted by microbial taxa continuously supplied by the aquatic environment. Interestingly, microbial communities of the non-transporting Ll were more similar to their adult counterparts than those of poison frogs. This pattern might reflect differences in life history among the species. While adult Ll commonly inhabit the rock pools where their tadpoles develop, adults of the two poison frog species visit tadpole nurseries only sporadically for deposition. These differences in habitat use may result in adult Ll hosting skin microbiota that are better adapted to aquatic environments as compared to Rv and Af. Additionally, their presence in the tadpoles’ habitat could make Ll a more consistent source of microbiota for developing tadpoles.

      (4) Field experiment: The rationale and interpretation of the genus-level network are not clear, and the figure is not legible. What does it mean to "visualize the microbial interconnectedness" or to be a "central part of the community"? The previous sentences in this paragraph (lines 337-343) seem to imply that transfer is parent-specific, but the genuslevel network is based on the current adult frogs, not the previous generation of parents that transported them. So it is not clear that the distribution or co-distribution of these taxa provides any insight into vertical transmission dynamics.

      Implemented Changes:  

      We appreciate the reviewer’s close reading and understand how the inclusion of the network visualization without further clarification may have led to confusion. To clarify, the network was constructed from all adult frogs in the population, including—but not limited to—the parental frogs examined in the field experiment. We do not make any claims about the origin of the microbial taxa found on parental frogs. Rather, our aim was to illustrate how genera retained on tadpoles (following potential vertical transmission) contribute to the skin microbial communities of adult frogs of this population beyond just the parental individuals. This finding supports the observation that these retained taxa are generally among the most abundant in adult frogs. However, since this information is already presented in Table S8 and the figure is not essential to the main conclusions, we have removed Supplementary Figure S5 and the accompanying sentence: “A genus-level network constructed from 44 adult frogs shows that the retained genera make up a central part of the community of adult Rv in wild populations (Fig. S5).” We have adjusted the Methods section accordingly.

      Reviewer #2:

      I did not find any major weaknesses in my review of this paper. The work here could potentially benefit from absolute abundance levels for shared ASVs between adults and tadpoles to more thoroughly understand the influences of vertical transmission that might be masked by relative abundance counts. This would only be a minor improvement as I think the conclusions from this work would likely remain the same, however.

      In response to the reviewer’s suggestion, we estimated the absolute abundance of specific ASVs for all samples of tadpoles in which Sourcetracker identified shared ASVs between adults and tadpoles. The resulting scaled absolute abundance values (in copies/μL and copies per tadpole) are provided in Table S10, and a description of the method has been incorporated into the revised Methods section of the manuscript. To support the robustness of this approach in our dataset, we additionally designed an ASV-specific system for ASV24902-Methylocella. Candidate primers were assessed for specificity by performing local BLASTn alignments against the full set of ASV sequences identified in the respective microbial communities of tadpoles. We optimized the annealing temperature via gradient PCR and confirmed primer specificity through Sanger sequencing of the PCR product (Forward: 5′–GAGCACGTAGGCGGATCT–3′ Reverse: 5′–GGACTACNVGGGTWTCTAAT–3′). Using this approach, we confirmed that the relative abundance of ASV24902 (18.05% in the amplicon sequencing data) closely matched its proportion of the absolute 16S rRNA copy number in transported tadpole 6 (18.01%). While we intended to quantify all shared ASVs, we were limited to this single target due to insufficient material for optimizing the assays. As this particular ASV was also detected in the water associated with the same tadpole, we chose not to include this confirmation in the manuscript. Nevertheless, the close match supports the reliability of our approach for scaling absolute abundances in this dataset.

      Results: Absolute abundances of shared ASVs likely originating from the parental source pool (as identified by Sourcetracker) after one month of growth ranged from 7804 to 172326 copies per tadpole (Table S10).

      Methods: Quantitative analysis of 16S rRNA copy numbers with digital PCR (dPCR)

      Absolute abundances were estimated for ASVs that were shared between tadpoles after a one-month growth period and their respective caregivers, and for which Sourcetracker analysis identified the caregiver as a likely source of microbiota. We followed the quantitative sequencing framework described by Barlow et al. (2020), measuring total microbial load via digital PCR (dPCR) with the same universal 16S rRNA primers used to amplify the v4 region in our sequencing dataset. Absolute 16S rRNA copy numbers obtained from dPCR were then multiplied by the relative abundances from our amplicon sequencing dataset to calculate ASV-specific scaled absolute abundances. All dPCR reactions were carried out on a QIAcuity Digital PCR System (Qiagen) using Nanoplates with a 8.5K partition configuration, using the following cycling program: 95°C for 2 minutes, 40 cycles of 95°C for 30 seconds and 52°C for 30 seconds and 72°C for 1 minute, followed by 1 cycle of 40°C for 5 minutes. Reactions were prepared using the QIAcuity EvaGreen PCR Kit (Qiagen, Cat. No. 250111) with 2 µL of DNA template per reaction, following the manufacturer's protocol, and included a negative no-template control and a cleaned and sequenced PCR product as positive control. Samples were measured in triplicates and serial dilutions were performed to ensure accurate quantification. Data were processed with the QIAcuity Software Suite (v3.1.0.0). The threshold was set based on the negative and positive controls in 1D scatterplots. We report mean copy numbers per microliter with standard deviations, correcting for template input, dPCR reaction volume, and dilution factor. Mean copy numbers per tadpole were additionally calculated by accounting for the DNA extraction (elution) volume.  

      Recommendations for the authors:

      Reviewer #1:

      (1) Figure 1b summarizes the ddPCR data as a binary (detected/not detected), but this contradicts the main text associated with this figure, which describes bacteria as present, albeit in low abundances, in unhatched embryos (lines 145-147). Could the authors keep the diagram of tadpole development, which I find very useful, but add the ddPCR data from Figure S1c instead of simply binarizing it as present/absent?

      We appreciate the reviewer’s positive feedback on the clarity of the figure. We agree that presenting the ddPCR data in a more quantitative manner provides a more accurate representation of bacterial abundance across developmental stages. In response, we have retained the developmental diagram, as suggested, and replaced the binary (detected/not detected) information in Figure 1B with rounded mean values for each stage. To complement this, we have included mean values and standard deviations in Table S1. The corresponding text in the main manuscript and legends has been revised accordingly to reflect these changes.  

      (2) More information about the foster species, Oophaga sylvatica, would be helpful. Are they sympatric with Rv? Is their transporting behavior similar to that of Rv?

      We thank the reviewer for this helpful comment. In response, we have added further details on the biology and parental care behavior of Oophaga sylvatica, including information on its distribution range. The species does not overlap with Ranitomeya variabilis at the specific study site where the field work was conducted, although the species are sympatric in other countries. These additions have been incorporated into the Methods section under "Study species, reproductive strategies, and life history."  

      (3) Plotting the proportion of each tadpole microbiome attributed to R. variabilis and the proportion attributed to O. sylvatica on the same plot is confusing, as these points are nonindependent and there is no way for the reader to figure out which points originated from the same tadpole. I would suggest replacing Figure 1D with Figure S2C, which (if I understand correctly) displays the same data, but is separated according to source.

      We agree with the reviewer that Figure S2C allows for clearer interpretation of our results. In response, we implemented the suggested change and replaced Figure 1D with the alternative visualization previously shown in Figure S2C, which displays the same data separated by source. To provide readers with a complementary overview of the full dataset, we have retained the original combined plot in the supplementary material as Figure S2D.

      (4) On the first read, I found the use of "transport" in the cross-fostering experiment confusing until I understood that they weren't being transported "to" anywhere in particular, just carried for 6 hours. A change of phrasing might help readers here.

      We acknowledge the reviewer’s concern and have replaced “transported” with “carried” to avoid confusion for readers who may be unfamiliar with the behavioral terminology. However, because “transport” is the term widely used by specialists to describe this behavior, we now introduce it in the context of the experimental design with the following phrasing:

      “For this design, sequence-based surveys of amplified 16S rRNA genes were used to assess the composition of skin-associated microbial communities on tadpoles and their adult caregivers (i.e., the frogs carrying the tadpoles, typically referred to as ‘transporting’ frogs).”

      (5) "Horizontal transfer" typically refers to bacteria acquired from other hosts, not environmental source pools (line 394).

      We addressed this concern by rephrasing the sentence in the Discussion to avoid potential confusion. The revised text now reads:

      “Across species, newborns might acquire bacteria not only through transfer from environmental source pools and other hosts (…)”  

      (6) The authors suggest that tadpole transport may have evolved in Rv and Af to promote microbial diversity because "increased microbial diversity is linked to better health outcomes" (lines 477-479). It is often tempting to assume that more diversity is always better/more adaptive, but this is not universally true. The fact that the Ll frogs seem to be doing fine in the same environment despite their lower microbiome diversity suggests that this interpretation might be too far of a reach based on the data here.

      We appreciate the reviewer’s concern, agree that increased microbial diversity is not inherently advantageous and have revised the paragraph to make this clearer.  

      “While increased microbial diversity is not inherently advantageous, it has been associated with beneficial outcomes such as improved immune function, lower disease risk, and enhanced fitness in multiple other vertebrate systems.”

      However, rather than claiming that greater diversity is always advantageous, we suggest that this possibility should not be excluded and consider it a relevant aspect of a comprehensive discussion. We also note that whether poison frog tadpoles perform equally well with lower microbial diversity remains an open question. Drawing such conclusions would require experimental validation and cannot be inferred from comparisons with an evolutionarily distant species that differs in life history.

      Reviewer #2:

      (1) Figure 2: Are the data points in C a subset (just the tadpoles for each species) of B? The numbers look a little different between them. The number of observed ASVs in panel B for Rv look a bit higher than the observed ASVs in panel C.

      The data shown in panel C are indeed a subset of the samples presented in panel B, focusing specifically on tadpoles of each species. The slight differences in the number of observed ASVs between panels result from differences in rarefaction depth between comparisons: due to variation in sequencing depth across species and life stages, we performed rarefaction separately for each comparison in order to retain the highest number of taxa while ensuring comparability within each group. Although we acknowledge that this is not a standard approach, we found that results were consistent when rarefying across the full dataset, but chose the presented approach to better accommodate variation in our sample structure. This methodological detail is described in the Methods section:

      “All alpha diversity analyses were conducted with datasets rarefied to 90% of the read number of the sample with the fewest reads in each comparison and visualized with boxplots.”

      It is also noted in the figure legend: “The dataset was separately rarefied to the lowest read depth f each comparison.” We hope this clarification adequately addresses the reviewer’s concern and therefore have not made additional changes.

      (2) Lines 304-305: in the Figure 4B plot, there appear to be 12 transported tadpoles and 8 non-transported tadpoles.

      Thank you for catching this. We have corrected the plot and the associated statistics (alpha and beta diversity) in the results section as well as in the figure. Importantly, the correction did not affect any other results, and the overall findings and interpretations remain unchanged.  

      (3) Line 311: I think this should be Figure 4B.

      (4) Line 430: tadpole transport.

      (5) Line 431: I believe commas need to surround this phrase "which range from a few hours to several days depending on the species (Lötters et al., 2007; McDiarmid & Altig, 1999; Pašukonis et al., 2019)".

      We thank the reviewer for the thorough review and have corrected all typographical and formatting errors noted in comments (3) – (5).

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for the authors): 

      One minor question would be whether the authors could expand more on the application of END-Seq to examine the processive steps of the ALT mechanism? Can they speculate if the ssDNA detected in ALT cells might be an intermediate generated during BIR (i.e., is the ssDNA displaced strand during BIR) or a lesion? Furthermore, have the authors assessed whether ssDNA lesions are due to the loss of ATRX or DAXX, either of which can be mutated in the ALT setting?

      We appreciate the reviewer’s insightful questions regarding the application of our assays to investigate the nature of the ssDNA detected in ALT telomeres. Our primary aim in this study was to establish the utility of END-seq and S1-END-seq in telomere biology and to demonstrate their applicability across both ALT-positive and -negative contexts. We agree that exploring the mechanistic origins of ssDNA would be highly informative, and we anticipate that END-seq–based approaches will be well suited for such future studies. However, it remains unclear whether the resolution of S1-END-seq is sufficient to capture transient intermediates such as those generated during BIR. We have now included a brief speculative statement in the revised discussion addressing the potential nature of ssDNA at telomeres in ALT cells.

      Reviewer #2 (Recommendations for the authors):

      How can we be sure that all telomeres are equally represented? The authors seem to assume that END-seq captures all chromosome ends equally, but can we be certain of this? While I do not see an obvious way to resolve this experimentally, I recommend discussing this potential bias more extensively in the manuscript.

      We thank the reviewer for raising this important point. END-seq and S1-END-seq are unbiased methods designed to capture either double-stranded or single-stranded DNA that can be converted into blunt-ended double-stranded DNA and ligated to a capture oligo. As such, if a subset of telomeres cannot be processed using this approach, it is possible that these telomeres may be underrepresented or lost. However, to our knowledge, there are no proposed telomeric structures that would prevent capture using this method. For example, even if a subset of telomeres possesses a 5′ overhang, it would still be captured by END-seq. Indeed, we observed the consistent presence of the 5′-ATC motif across multiple cell lines and species (human, mouse, and dog). More importantly, we detected predictable and significant changes in sequence composition when telomere ends were experimentally altered, either in vivo (via POT1 depletion) or in vitro (via T7 exonuclease treatment). Together, these findings support the robustness of the method in capturing a representative and dynamic view of telomeres across different systems.

      That said, we have now included a brief statement in the revised discussion acknowledging that we cannot fully exclude the possibility that a subset of telomeres may be missed due to unusual or uncharacterized structures

      I believe Figures 1 and 2 should be merged.

      We appreciate the reviewer’s suggestion to merge Figures 1 and 2. However, we feel that keeping them as separate figures better preserves the logical flow of the manuscript and allows the validation of END-seq and its application to be presented with appropriate clarity and focus. We hope the reviewer agrees that this layout enhances the clarity and interpretability of the data.

      Scale bars should be added to all microscopy figures.

      We thank the reviewer for pointing this out. We have now added scale bars to all the microscopy panels in the figures and included the scale details in the figure legends.

      Reviewer #3 (Recommendations for the authors):

      Overall, the discussion section is lacking depth and should be expanded and a few additional experiments should be performed to clarify the results.

      We thank the reviewer for the suggestions. Based on this reviewer’s comments and comments for the other reviewers, we incorporated several points into the discussion. As a result, we hope that we provide additional depth to our conclusions.

      (1) The finding that the abundance of variant telomeric repeats (VTRs) within the final 30 nucleotides of the telomeric 5' ends is similar in both telomerase-expressing and ALT cells is intriguing, but the authors do not address this result. Could the authors provide more insight into this observation and suggest potential explanations? As the frequency of VTRs does not seem to be upregulated in POT1-depleted cells, what then drives the appearance of VTRs on the C-strand at the very end of telomeres? Is CST-Pola complex responsible?

      The reviewer raises a very interesting and relevant point. We are hesitant at this point to speculate on why we do not see a difference in variant repeats in ALT versus non-ALT cells, since additional data would be needed. One possibility is that variant repeats in ALT cells accumulate stochastically within telomeres but are selected against when they are present at the terminal portion of chromosome ends. However, to prove this hypothesis, we would need error-free long-read technology combined with END-seq. We feel that developing this approach would be beyond the scope of this manuscript.

      (2) The authors also note that, in ALT cells, the frequency of VTRs in the first 30 nucleotides of the S1-END-SEQ reads is higher compared to END-SEQ, but this finding is not discussed either. Do the authors think that the presence of ssDNA regions is associated with the VTRs? Along this line, what is the frequency of VTRs in the END-SEQ analysis of TRF1-FokI-expressing ALT cells? Is it also increased? Has TRF1-FokI been applied to telomerase-expressing cells to compare VTR frequencies at internal sites between ALT and telomerase-expressing cells?

      Similarly to what is discussed above, short reads have the advantage of being very accurate but do not provide sufficient length to establish the relative frequency of VTRs across the whole telomere sequence. The TRF1-FokI experiment is a good suggestion, but it would still be biased toward non-variant repeats due to the TRF1-binding properties. We plan to address these questions in a future study involving long-read sequencing and END-seq capture of telomeres.

      Finally, in these experiments (S1-END-SEQ or END-SEQ in TRF1-Fok1), is the frequency of VTRs the same on both the C- and the G-rich strands? It is possible that the sequences are not fully complementary in regions where G4 structures form.

      We thank the reviewer for this observation. While we do observe a higher frequency of variant telomeric repeats (VTRs) in the first 30 nucleotides of S1-END-seq reads compared to END-seq in ALT cells, we are currently unable to determine whether this difference is significant, as an appropriate control or matched normalization strategy for this comparison is lacking. Therefore, we refrain from overinterpreting the biological relevance of this observation.

      The reviewer is absolutely correct. Our calculation did not exclude the possibility of extrachromosomal DNA as a source of telomeric ssDNA. We have now addressed this point in our discussion.

      The reviewer is correct in pointing out that we still do not know what causes ssDNA at telomeres in ALT cells. Replication stress seems the most logical explanation based on the work of many labs in the field. However, our data did not reveal any significant difference in the levels of ssDNA at telomeres in non-ALT cells based on telomere length. We used the HeLa1.2.11 cell line (now clarified in the Materials section), which is the parental line of HeLa1.3 and has similarly long telomeres (~20 kb vs. ~23 kb). Despite their long telomeres and potential for replication-associated challenges such as G-quadruplex formation, HeLa1.2.11 cells did not exhibit the elevated levels of telomeric ssDNA that we observed in ALT cells (Figure 4B). Additional experiments are needed to map the occurrence of ssDNA at telomeres in relation to progression toward ALT.

      (3) Based on the ratio of C-rich to G-rich reads in the S1-END-SEQ experiment, the authors estimate that ALT cells contain at least 3-5 ssDNA regions per chromosome end. While the calculation is understandable, this number could be discussed further to consider the possibility that the observed ratios (of roughly 0.5) might result from the presence of extrachromosomal DNA species, such as C-circles. The observed increase in the ratio of C-rich to G-rich reads in BLM-depleted cells supports this hypothesis, as BLM depletion suppresses C-circle formation in U2OS cells. To test this, the authors should examine the impact of POLD3 depletion on the C-rich/G-rich read ratio. Alternatively, they could separate high-molecular-weight (HMW) DNA from low-molecular-weight DNA in ALT cells and repeat the S1-END-SEQ in the HMW fraction.

      The reviewer is absolutely correct. Our calculation did not exclude the possibility of extrachromosomal DNA as a source of telomeric ssDNA. We have now addressed this point in our discussion.

      (4) What is the authors' perspective on the presence of ssDNA at ALT telomeres? Do they attribute this to replication stress? It would be helpful for the authors to repeat the S1-END-SEQ in telomerase-expressing cells with very long telomeres, such as HeLa1.3 cells, to determine if ssDNA is a specific feature of ALT cells or a result of replication stress. The increased abundance of G4 structures at telomeres in HeLa1.3 cells (as shown in J. Wong's lab) may indicate that replication stress is a factor. Similar to Wong's work, it would be valuable to compare the C-rich/G-rich read ratios in HeLa1.3 cells to those in ALT cells with similar telomeric DNA content.

      The reviewer is correct in pointing out that we still do not know what causes ssDNA at telomeres in ALT cells. Replication stress seems the most logical explanation based on the work of many labs in the field. However, our data did not reveal any significant difference in the levels of ssDNA at telomeres in non-ALT cells based on telomere length. We used the HeLa1.2.11 cell line (now clarified in the Materials section), which is the parental line of HeLa1.3 and has similarly long telomeres (~20 kb vs. ~23 kb). Despite their long telomeres and potential for replication-associated challenges such as G-quadruplex formation, HeLa1.2.11 cells did not exhibit the elevated levels of telomeric ssDNA that we observed in ALT cells (Figure 4B). Additional experiments are needed to map the occurrence of ssDNA at telomeres in relation to progression toward ALT.

      Finally, Reviewer #3 raises a list of minor points:

      (1) The Y-axes of Figure 4 have been relabeled to account for the G-strand reads.

      (2) Statistical analyses have been added to the figures where applicable.

      (3) The manuscript has been carefully proofread to improve clarity and consistency throughout the text and figure legends

      (4) We have revised the text to address issues related to the lack of cross-referencing between the supplementary figures and their corresponding legends.

    1. Author Response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review): 

      Summary: 

      Genome-wide association studies have been an important approach to identifying the genetic basis of human traits and diseases. Despite their successes, for many traits, a substantial amount of variation cannot be explained by genetic factors, indicating that environmental variation and individual 'noise' (stochastic differences as well as unaccounted for environmental variation) also play important roles. The authors' goal was to address whether gene expression variation in genetically identical individuals, driven by historical environmental differences and 'noise', could be used to predict reproductive trait differences. 

      Strengths: 

      To address this question, the authors took advantage of genetically identical C. elegans individuals to transcriptionally profile 180 adult hermaphrodite individuals that were also measured for two reproductive traits. A major strength of the paper is its experimental design. While experimenters aim to control the environment that each worm experiences, it is known that there are small differences that each worm experiences even when they are grown together on the same agar plate - e.g. the age of their mother, their temperature, the amount of food they eat, and the oxygen and carbon dioxide levels depending on where they roam on the plate. Instead of neglecting this unknown variation, the authors design the experiment up front to create two differences in the historical environment experienced by each worm: 1) the age of its mother and 2) 8 8-hour temperature difference, either 20 or 25 {degree sign}C. This helped the authors interpret the gene expression differences and trait expression differences that they observed. 

      Using two statistical models, the authors measured the association of gene expression for 8824 genes with the two reproductive traits, considering both the level of expression and the historical environment experienced by each worm. Their data supports several conclusions. They convincingly show that gene expression differences are useful for predicting reproductive trait differences, predicting ~25-50% of the trait differences depending on the trait. Using RNAi, they also show that the genes they identify play a causal role in trait differences. Finally, they demonstrate an association with trait variation and the H3K27 trimethylation mark, suggesting that chromatin structure can be an important causal determinant of gene expression and trait variation. 

      Overall, this work supports the use of gene expression data as an important intermediate for understanding complex traits. This approach is also useful as a starting point for other labs in studying their trait of interest. 

      We thank the reviewer for their thorough articulation of the strengths of our study.  

      Weaknesses: 

      There are no major weaknesses that I have noted. Some important limitations of the work (that I believe the authors would agree with) are worth highlighting, however: 

      (1) A large remaining question in the field of complex traits remains in splitting the role of non-genetic factors between environmental variation and stochastic noise. It is still an open question which role each of these factors plays in controlling the gene expression differences they measured between the individual worms. 

      Yes, we agree that this is a major question in the field. In our study, we parse out differences driven between known historical environmental factors and unknown factors, but the ‘unknown factors’ could encompass both unknown environmental factors and stochastic noise.

      (2) The ability of the authors to use gene expression to predict trait variation was strikingly different between the two traits they measured. For the early brood trait, 448 genes were statistically linked to the trait difference, while for egg-laying onset, only 11 genes were found. Similarly, the total R2 in the test set was ~50% vs. 25%. It is unclear why the differences occur, but this somewhat limits the generalizability of this approach to other traits. 

      We agree that the difference in predictability between the two traits is interesting. A previous study from the Phillips lab measured developmental rate and fertility across Caenorhabditis species and parsed sources of variation (1). Results indicated that 83.3% of variation in developmental rate was explained by genetic variation, while only 4.8% was explained by individual variation. In contrast, for fertility, 63.3% of variation was driven by genetic variation and 23.3% was explained by individual variation. Our results, of course, focus only on predicting the individual differences, but not genetic differences, for these two traits using gene expression data. Considering both sets of results, one hypothesis is that we have more power to explain nongenetic phenotypic differences with molecular data if the trait is less heritable, which is something that could be formally interrogated with more traits across more strains.

      (3) For technical reasons, this approach was limited to whole worm transcription. The role of tissue and celltype expression differences is important to the field, so this limitation is important. 

      We agree with this assessment, and it is something we hope to address with future work.

      Reviewer #2 (Public review): 

      Summary: 

      This paper measures associations between RNA transcript levels and important reproductive traits in the model organism C. elegans. The authors go beyond determining which gene expression differences underlie reproductive traits, but also (1) build a model that predicts these traits based on gene expression and (2) perform experiments to confirm that some transcript levels indeed affect reproductive traits. The clever study design allows the authors to determine which transcript levels impact reproductive traits, and also which transcriptional differences are driven by stochastic vs environmental differences. In sum, this is a rather comprehensive study that highlights the power of gene expression as a driver of phenotype, and also teases apart the various factors that affect the expression levels of important genes. 

      Strengths: 

      Overall, this study has many strengths, is very clearly communicated, and has no substantial weaknesses that I can point to. One question that emerges for me is about the extent to which these findings apply broadly. In other words, I wonder whether gene expression levels are predictive of other phenotypes in other organisms. I

      think this question has largely been explored in microbes, where some studies (PMID: 17959824) but not others (PMID: 38895328) find that differences in gene expression are predictive of phenotypes like growth rate. Microbes are not the primary focus here, and instead, the discussion is mainly focused on using gene expression to predict health and disease phenotypes in humans. This feels a little complicated since humans have so many different tissues. Perhaps an area where this approach might be useful is in examining infectious single-cell populations (bacteria, tumors, fungi). But I suppose this idea might still work in humans, assuming the authors are thinking about targeting specific tissues for RNAseq. 

      In sum, this is a great paper that really got me thinking about the predictive power of gene expression and where/when it could inform about (health-related) phenotypes. 

      We thank the reviewer for recognizing the strengths of our study. We are also interested in determining the extent to which predictive gene expression differences operate in specific tissues.

      Reviewer #3 (Public review): 

      Summary: 

      Webster et al. sought to understand if phenotypic variation in the absence of genetic variation can be predicted by variation in gene expression. To this end they quantified two reproductive traits, the onset of egg laying and early brood size in cohorts of genetically identical nematodes exposed to alternative ancestral (two maternal ages) and same generation life histories (either constant 20C temperature or 8-hour temperature shift to 25C upon hatching) in a two-factor design; then they profiled genome-wide gene expression in each individual. 

      Using multiple statistical and machine learning approaches, they showed that, at least for early brood size, phenotypic variation can be quite well predicted by molecular variation, beyond what can be predicted by life history alone. 

      Moreover, they provide some evidence that expression variation in some genes might be causally linked to phenotypic variation. 

      Strengths: 

      (1) Cleverly designed and carefully performed experiments that provide high-quality datasets useful for the community. 

      (2) Good evidence that phenotypic variation can be predicted by molecular variation. 

      We thank the reviewer for recognizing the strengths of our study.

      Weaknesses:  

      What drives the molecular variation that impacts phenotypic variation remains unknown. While the authors show that variation in expression of some genes might indeed be causal, it is still not clear how much of the molecular variation is a cause rather than a consequence of phenotypic variation. 

      We agree that the drivers of molecular variation remain unknown. While we addressed one potential candidate (histone modifications), there is much to be done in this area of research. We agree that, while some gene expression differences cause phenotypic changes, other gene expression differences could in principle be downstream of phenotypic differences.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      I have a number of suggestions that I believe will improve the Methods section. 

      (1) Strain N2-PD1073 will probably be confusing to some readers. I recommend spelling out that this is the Phillips lab version of N2.

      Thank you for this suggestion; we have added additional explanation of this strain in the Methods.

      (2) I found the details of the experimental design confusing, and I believe a supplemental figure will help. I have listed the following points that could be clarified: 

      a. What were the biological replicates? How many worms per replicate?

      Biological replicates were defined as experiments set up on different days (in this case, all biological replicates were at least a week apart), and the biological replicate of each worm can be found in Supplementary File 1 on the Phenotypic Data tab.

      b. I believe that embryos and L4s were picked to create different aged P0s, and eggs and L4s were picked to separate plates? Is this correct?

      Yes, this is correct.

      c. What was the spread in the embryo age?

      We assume this is asking about the age of the F1 embryos, and these were laid over the course of a 2-hour window.  

      d. While the age of the parents is different, there are also features about their growth plates that will be impacted by the experimental design. For example, their pheromone exposure is different due to the role that age plays in the combination of ascarosides that are released. It is worth noting as my reading of the paper makes it seem that parental age is the only thing that matters.

      The parents (P0) of different ages likely have differential ascaroside exposure because they are in the vicinity of other similarly aged worms, but the F1 progeny were exposed to their parents for only the 2-hour egg-laying window, in an attempt to minimize this type of effect as much as possible.  

      e. Were incubators used for each temperature?

      Yes.

      f. In line 443, why approximately for the 18 hours? How much spread?

      The approximation was based on the time interval between the 2-hour egg-laying window on Day 4 and the temperature shift on Day 5 the following morning. The timing was within 30 minutes of 18 hours either direction.

      g.  In line 444, "continually left" is confusing. Does this mean left in the original incubator?

      Yes, this means left in the incubator while the worms shifted to 25°C were moved. To avoid confusion, we re-worded this to state they “remained at 20°C while the other half were shifted to 25°C”.

      h. In line 445, "all worms remained at 20 {degree sign}C" was confusing to me as to what it indicated. I assume, unless otherwise noted, the animals would not be moved to a new temperature.

      This was an attempt to avoid confusion and emphasize that all worms were experiencing the same conditions for this part of the experiment.  

      i. What size plates were the worms singled onto?

      They were singled onto 6-cm plates.

      j. If a figure were to be made, having two timelines (with respect to the P0 and F1) might be useful.

      We believe the methods should be sufficient for someone who hopes to repeat the experiment, and we believe the schematic in Figure 1A labeling P0 and F1 generations is sufficient to illustrate the key features of the experimental design.

      k. Not all eggs that are laid end up hatching. Are these censored from the number of progeny calculations?

      Yes, only progeny that hatched and developed were counted for early brood.

      (3) For the lysis, was the second transfer to dH20 also a wash step?

      Yes.

      (4) What was used for the Elution buffer?

      We used elution buffer consisting of 10 mM Tris, 0.1 mM EDTA. We have added this to the “Cell lysate generation” section of the methods

      (5) The company that produced the KAPA mRNA-seq prep kit should be listed.

      We added that the kit was from Roche Sequencing Solutions.

      (6) For the GO analysis - one potential issue is that the set of 8824 genes might also be restricted to specific GO categories. Was this controlled for?

      We originally did not explicitly control for this and used the default enrichGO settings with OrgDB = org.Ce.eg.db as the background set for C. elegans. We have now repeated the analysis with the “universe” set to the 8824-gene background set. This did not qualitatively change the significant GO terms, though some have slightly higher or lower p-values. For comparison purposes, we have added the background-corrected sets to the GO_Terms tab of Supplementary File 1 with each of the three main gene groups appended with “BackgroundOf8824”.

      Reviewer #2 (Recommendations for the authors): 

      (1) The abstract, introduction, and experimental design are well thought through and very clear.

      Thank you.

      (2) Figure 1B could use a clearer or more intuitive label on the horizontal axis. The two examples help. Maybe the genes (points) on the left side should be blue to match Figure 1C, where the genes with a negative correlation are in the blue cluster.

      Thank you for these suggestions. We re-labeled the x-axis as “Slope of early brood vs. gene expression (normalized by CPM)”, which we hope gives readers a better intuition of what the coefficient from the model is measuring. We also re-colored the points previously colored red in Figure 1B to be color-coded depending on the direction of association to match Figure 1C, so these points are now color-coded as pink and purple.  

      (3) If red/blue are pos/neg correlated genes in 1C, perhaps different colors should be used to label ELO and brood in Figures 2 and 3. Green/purple?

      We appreciate this point, but since we ended up using the cluster colors of pink and purple in Figure 1, we opted to leave Figures 2 and 3 alone with the early brood and ELO colorcoding of red and blue.

      (4) I am unfamiliar with this type of beta values, but I thought the explanation and figure were very clear. It could be helpful to bold beta1 and beta2 in the top panels of Figure 2, so the readers are not searching around for those among all the other betas. It could also be helpful to add an English phrase to the vertical axes inFigures 2C and 2D, in addition to the beta1 and beta2. Something like "overall effect (beta1)" and"environment-controlled effect (beta2)". Or maybe "effect of environment + stochastic expression differences

      (beta1)" and "effect of stochastic expression differences alone (beta2)". I guess those are probably too big to fit on the figure, but it might be nice to have a label somewhere on this figure connecting them to the key thing you are trying to measure - the effect of gene expression and environment.

      Thank you for these suggestions. We increased the font sizes and bolded β1 and β2 in Figure 2A-B. In Figure 2C-D, we added a parenthetical under β1 to say “(env + noise)” and β2 to say “(noise)”. We agree that this should give the reader more intuition about what the β values are measuring.  

      Reviewer #3 (Recommendations for the authors): 

      The authors collected individuals 24 hours after the onset of egg laying for transcriptomic profiling. This is a well-designed experiment to control for the physiological age of the germline. However, this does not properly control for somatic physiological age. Somatic age can be partially uncoupled from germline age across individuals, and indeed, this can be due to differences in maternal age (Perez et al, 2017). This is because maternal age is associated with increased pheromone exposure (unless you properly controlled for it by moving worms to fresh plates), which causes a germline-specific developmental delay in the progeny, resulting in a delayed onset of egg production compared to somatic development (Perez et al. 2021). You control for germline age, therefore, it is likely that the progeny of day 1 mothers are actually somatically older than the progeny of day 3 mothers. This would predict that many genes identified in these analyses might just be somatic genes that increase or decrease their expression during the young adult stage. 

      For example, the abundance of collagen genes among the genes negatively associated (including col-20, which is the gene most significantly associated with early brood) is a big red flag, as collagen genes are known to be changing dynamically with age. If variation in somatic vs germline age is indeed what is driving the expression variation of these genes, then the expectation is that their expression should decrease with age. Vice versa, genes positively associated with early brood that are simply explained by age should be increasing.  So I would suggest that the authors first check this using time series transcriptomic data covering the young adult stage they profiled. If this is indeed the case, I would then suggest using RAPToR ( https://github.com/LBMC/RAPToR ), a method that, using reference time series data, can estimate physiological age (including tissue-specific one) from gene expression. Using this method they can estimate the somatic physiological age of their samples, quantify the extent of variation in somatic age across individuals, quantify how much of the observed differences in expressions are explained just by differences in somatic age and correct for them during their transcriptomic analysis using the estimated soma age as a covariate (https://github.com/LBMC/RAPToR/blob/master/vignettes/RAPToR-DEcorrection-pdf.pdf). 

      This should help enrich a molecular variation that is not simply driven by hidden differences between somatic and germline age. 

      To first address some of the experimental details mentioned for our paper, parents were indeed moved to fresh plates where they were allowed to lay embryos for two hours and then removed. Thus, we believe this minimizes the effects of ascarosides as much as possible within our design. As shown in the paper, we also identified genes that were not driven by parental age and for all genes quantified to what extent each gene’s association was driven by parental age. Thus, it is unlikely that differences in somatic and germline age is the sole explanatory factor, even if it plays some role. We also note that we accounted for egg-laying onset timing in our experimental design, and early brood was calculated as the number of progeny laid in the first 24 hours of egg-laying, where egg-laying onset was scored for each individual worm to the hour. The plot of each worm’s ELO and early brood traits is in Figure S1. Nonetheless, we read the RAPToR paper with interest, as we highlighted in the paper that germline genes tend to be positively associated with early brood while somatic genes tend to be negatively associated. While the RAPToR paper discusses using tissue-specific gene sets to stage genetically diverse C. elegans RILs, the RAPToR reference itself was not built using gene expression data acquired from different C. elegans tissues and is based on whole worms, typically collected in bulk. I.e., age estimates in RILs differ depending on whether germline or somatic gene sets are used to estimate age when the the aging clock is based on N2 samples. Thus, it is unclear whether such an approach would work similarly to estimate age in single worm N2 samples. In addition, from what we can tell, the RAPToR R package appears to implement the overall age estimate, rather than using the tissue-specific gene sets used for RILs in the paper. Because RAPToR would be estimating the overall age of our samples using a reference that is based on fewer samples than we collected here, and because we already know the overall age of our samples measured using standard approaches, we believe that estimating the age with the package would not give very much additional insight.  

      Bonferroni correction: 

      First, I think there is some confusion in how the author report their p-values: I don't think the authors are using a cut-off of Bonferroni corrected p-value of 5.7 x 10-6 (it wouldn't make sense). It's more likely that they are using a Bonferroni corrected p of 0.05 or 0.1, which corresponds to a nominal p value of 5.7 x 10-6, am I right?

      Yes, we used a nominal p-value of 5.7 x 10-6 to correspond to a Bonferroni-corrected p-value of 0.05, calculated as 0.05/8824. We have re-worded this wherever Bonferroni correction was mentioned.

      Second, Bonferroni is an overly stringent correction method that has now been substituted by the more powerful Benjamini Hochberg method to control the false discovery rate. Using this might help find more genes and better characterize the molecular variation, especially the one associated with ELO?

      We agree that Bonferroni is quite stringent and because we were focused on identifying true positives, we may have some false negatives. Because all nominal p-values are included in the supplement, it is straightforward for an interested reader to search the data to determine if a gene is significant at any other threshold.   

      Minor comments: 

      (1) "In our experiment, isogenic adult worms in a common environment (with distinct historical environments) exhibited a range of both ELO and early brood trait values (Fig S1A)" I think this and the figure is not really needed, Figure S1B is already enough to show the range of the phenotypes and how much variation is driven by the life history traits.

      We agree that the information in S1A is also included in S1B, but we think it is a little more straightforward if one is primarily interested in viewing the distribution for a single trait.

      (2) Line 105 It should be Figure S2, not S3.

      Thank you for catching this mistake.

      (3) Gene Ontology on positive and negatively associated genes together: what about splitting the positive and negative?

      We have added a split of positive and negative GO terms to the GO_Terms tab of Supplement File 1. Broadly speaking, the most enriched positively associated genes have many of the same GO terms found on the combined list that are germline related (e.g., involved in oogenesis and gamete generation), whereas the most enriched negatively associated genes have GO terms found on the combined list that are related to somatic tissues (e.g., actin cytoskeleton organization, muscle cell development). This is consistent with the pattern we see for somatic and germline genes shown in Figure 4.

      (4) A lot of muscle-related GOs, can you elaborate on that?

      Yes, there are several muscle-related GOs in addition to germline and epidermis. While we do not know exactly why from a mechanistic perspective these muscle-related terms are enriched, it may be important to note that many of these terms have highly overlapping sets of genes which are listed in Supplementary File 1. For example, “muscle system process” and “muscle contraction” have the exact same set of 15 genes causing the term to be significantly enriched. Thus, we tend to not interpret having many GO terms on a given tissue as indicating that the tissue is more important than others for a given biological process. While it is clear there are genes related to muscle that are associated with early brood, it is not yet clear that the tissue is more important than others.  

      (5) "consistent with maternal age affecting mitochondrial gene expression in progeny " - has this been previously reported?

      We do not believe this particular observation has been reported. It is important to note that these genes are involved in mitochondrial processes, but are expressed from the nuclear rather than mitochondrial genome. We re-worded the quoted portion of the sentence to say “consistent with parental age affecting mitochondria-related gene expression in progeny”.

      (6) PCA: "Therefore, the optimal number of PCs occurs at the inflection points of the graph, which is after only7 PCs for early brood (R2 of 0.55) but 28 PCs for ELO (R2 of 0.56)." 

      Not clear how this is determined: just graphically? If yes, there are several inflection points in the plot. How did you choose which one to consider? Also, a smaller component is not necessarily less predictive of phenotypic variation (as you can see from the graph), so instead of subsequently adding components based on the variance, they explain the transcriptomic data, you might add them based on the variance they explain in the phenotypic data? To this end, have you tried partial least square regression instead of PCA? This should give gene expression components that are ranked based on how much phenotypic variance they explain.  

      Thank you for this thoughtful comment. We agree that, unlike for Figure 3B, there is some interpretation involved on how many PCs is optimal because additional variance explained with each PC is not strictly decreasing beyond a certain number of PCs. Our assessment was therefore made both graphically and by looking at the additional variance explained with each additional PC. For example, for early brood, there was no PC after PC7 that added more than 0.04 to the R2. We could also have plotted early brood and ELO separately and had a different ordering of PCs on the x-axis. By plotting the data this way, we emphasized that the factors that explain the most variation in the gene expression data typically explain most variation in the phenotypic data.  

      (7) The fact that there are 7 PC of molecular variation that explain early brood is interesting. I think the authors can analyze this further. For example, could you perform separate GO enrichment for each component that explains a sizable amount of phenotypic variance? Same for the ELO.  

      Because each gene has a PC loading in for each PC, and each PC lacks the explanatory power of combined PCs, we believe doing GO Terms on the list of genes that contribute most to each PC is of minimal utility. The power of the PCA prediction approach is that it uses the entire transcriptome, but the other side of the coin is that it is perhaps less useful to do a gene-bygene based analysis with PCA. This is why we separately performed individual gene associations and 10-gene predictive analyses. However, we have added the PC loadings for all genes and all PCs to Supplementary File 1.

      (8) Avoid acronyms when possible (i.e. ELO in figures and figure legends could be spelled out to improve readability).

      We appreciate this point, but because we introduced the acronym both in Figure 1 and the text and use it frequently, we believe the reader will understand this acronym. Because it is sometimes needed (especially in dense figures), we think it is best to use it consistently throughout the paper.

      (9) Multiple regression: I see the most selected gene is col-20, which is also the most significantly differentially expressed from the linear mixed model (LMM). But what is the overlap between the top 300 genes in Figure 3F and the 448 identified by the LMM? And how much is the overlap in GO enrichment?

      Genes that showed up in at least 4 out of 500 iterations were selected more often than expected by chance, which includes 246 genes (as indicated by the red line in Figure 3F). Of these genes, 66 genes (27%) are found in the set of 448 early brood genes. The proportion of overlap increases as the number of iterations required to consider a gene predictive increases, e.g., 34% of genes found in 5 of 500 iterations and 59% of genes found in 10 of 500 iterations overlap with the 448 early brood genes. However, likely because of the approach to identify groups of 10 genes that are predictive, we do not find significant GO terms among the 246 genes identified with this approach after multiple test correction. We think this makes sense because the LMM identifies genes that are individually associated with early brood, whereas each subsequent gene included in multiple regression affects early brood after controlling for all previous genes. These additional genes added to the multiple regression are unlikely to have similar patterns as genes that are individually correlated with early brood.  

      (10) Elastic nets: prediction power is similar or better than multiple regression, but what is the overlap between genes selected by the elastic net (not presented if I am not mistaken) and multiple regression and the linear mixed model?

      For the elastic net models, we used a leave-one-out cross validation approach, meaning there were separate models fit by leaving out the trait data for each worm, training a model using the trait data and transcriptomic data for the other worms, and using the transcriptomic data of the remaining worm to predict the trait data. By repeating this for each worm, the regressions shown in the paper were obtained. Each of these models therefore has its own set of genes. Of the 180 models for early brood, the median model selects 83 genes (range from 72 to 114 genes). Across all models, 217 genes were selected at least once. Interestingly, there was a clear bimodal distribution in terms of how many models a given gene was selected for: 68 genes were selected in over 160 out of 180 models, while 114 genes were selected in fewer than 20 models (and 45 genes were selected only once). Therefore, we consider the set of 68 genes as highly robustly selected, since they were selected in the vast majority of models. This set of 68 exhibits substantial overlap with both the set of 448 early brood-associated genes (43 genes or 63% overlap) and the multiple regression set of 246 genes (54 genes or 79% overlap). For ELO, the median model selected 136 genes (range of 96 to 249 genes) and a total of 514 genes were selected at least once. The distribution for ELO was also bimodal with 78 genes selected over 160 times and 255 genes selected fewer than 20 times. This set of 78 included 6 of the 11 significant ELO genes identified in the LMM.  We have added tabs to Supplementary File 1 that include the list of genes selected for the elastic net models as well as a count of how many times they were selected out of 180 models.

      (11) In other words, do these different approaches yield similar sets of genes, or are there some differences?

      In the end, which approach is actually giving the best predictive power? From the perspective of R2, both the multiple regression and elastic net models are similarly predictive for early brood, but elastic net is more predictive for ELO. However, in presenting multiple approaches, part of our goal was identifying predictive genes that could be considered the ‘best’ in different contexts. The multiple regression was set to identify exactly 10 genes, whereas the elastic net model determined the optimal number of genes to include, which was always over 70 genes. Thus, the elastic net model is likely better if one has gene expression data for the entire transcriptome, whereas the multiple regression genes are likely more useful if one were to use reporters or qRTPCR to measure a more limited number of genes.  

      (12) Line 252: "Within this curated set, genes causally affected early brood in 5 of 7 cases compared to empty vector (Figure 4A).

      " It seems to me 4 out of 7 from Figure 4A. In Figure 4A the five genes are (1) cin-4, (2) puf5; puf-7, (3) eef-1A.2, (4) C34C12.8, and (5) tir-1. We did not count nex-2 (p = 0.10) or gly-13 (p = 0.07), and empty vector is the control.

      (13) Do puf-5 and -7 affect total brood size or only early brood size? Not clear. What's the effect of single puf-5 and puf-7 RNAi on brood?

      We only measured early brood in this paper, but a previous report found that puf-5 and puf-7 act redundantly to affect oogenesis, and RNAi is only effective if both are knocked down together(2). We performed pilot experiments to confirm that this was the case in our hands as well.  

      (14)  To truly understand if the noise in expression of Puf-5 and /or -7 really causes some of the observed difference in early brood, could the author use a reporter and dose response RNAi to reduce the level of puf-5/7 to match the lower physiological noise range and observe if the magnitude of the reduction of early brood by the right amount of RNAi indeed matches the observed physiological "noise" effect of puf-5/7 on early brood?

      We agree that it would be interesting to do the dose response of RNAi, measure early brood, and get a readout of mRNA levels to determine the true extent of gene knockdown in each worm (since RNAi can be noisy) and whether this corresponds to early brood when the knockdown is at physiological levels. While we believe we have shown that a dose response of gene knockdown results in a dose response of early brood, this additional analysis would be of interest for future experiments.

      (15) Regulated soma genes (enriched in H3K27me3) are negatively correlated with early brood. What would be the mechanism there? As mentioned before, it is more likely that these genes are just indicative of variation in somatic vs germline age (maybe due to latent differences in parental perception of pheromone).

      We can think of a few potential mechanisms/explanations, but at this point we do not have a decisive answer. Regulated somatic genes marked with H3K27me3 (facultative heterochromatin) are expressed in particular tissues and/or at particular times in development. In this study and others, genes marked with H3K27me3 exhibit more gene expression noise than genes with other marks. This could suggest that there are negative consequences for the animal if genes are expressed at higher levels at the wrong time or place, and one interpretation of the negative association is that higher expressed somatic genes results in lower fitness (where early brood is a proxy for fitness). Another related interpretation is that there are tradeoffs between somatic and germline development and each individual animal lands somewhere on a continuum between prioritizing germline or somatic development, where prioritizing somatic integrity (e.g. higher expression of somatic genes) comes at a cost to the germline resulting in fewer progeny. Additional experiments, including measurements of histone marks in worms measured for the early brood trait, would likely be required to more decisively answer this question.  

      (16) Line 151: "Among significant genes for both traits, β2 values were consistently lower than β1 (Figures 2CD), suggesting some of the total effect size was driven by environmental history rather than pure noise".

      We are interpreting this quote as part of point 17 below.

      (17) It looks like most of the genes associated with phenotypes from the univariate model have a decreased effect once you account for life history, but have you checked for cases where the life history actually masks the effect of a gene? In other words, do you have cases where the effect of gene expression on a phenotype is only (or more) significant after you account for the effect of life history (β2 values higher than β1)?

      This is a good question and one that we did not explicitly address in the paper because we focused on beta values for genes that were significant in the univariate analysis. Indeed, for the sets of 448 early brood genes ad 11 ELO genes, there are no genes for which β2 is larger than β1. In looking at the larger dataset of 8824 genes, with a Bonferroni-corrected p-value of 0.05, there are 306 genes with a significant β2 for early brood. The majority (157 genes) overlap with the 448 genes significant in the univariate analysis and do not have a higher β2 than β1. Of the remaining genes, 72 of these have a larger β2 than β1. However, in most cases, this difference is relatively small (median difference of 0.025) and likely insignificant. There are only three genes in which β1 is not nominally significant, and these are the three genes with the largest difference between β1 and β2 with β2 being larger (differences of 0.166, 0.155, and 0.12). In contrast, the median difference between β1 and β2 the 448 genes (in which β1 is larger) is 0.17, highlighting the most extreme examples of β2 > β1 are smaller in magnitude than the typical case of β1 > β2. For ELO, there are no notable cases where β2 > β1. There are eight genes with a significant β2 value, and all of these have a β1 value that is nominally significant. Therefore, while this phenomenon does occur, we find it to be relatively rare overall. For completeness, we have added the β1 and β2 values for all 8824 genes as a tab in Supplementary File 1.

    1. Author Response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review): 

      Summary: 

      The authors address a fundamental question for cell and tissue biology using the skin epidermis as a paradigm and ask how stratifying self-renewing epithelia induce differentiation and upward migration in basal dividing progenitor cells to generate suprabasal barrier-forming cells that are essential for a functional barrier formed by such an epithelium. The authors show for the first time that an increase in intracellular actomyosin contractility, a hallmark of barrier-forming keratinocytes, is sufficient to trigger terminal differentiation. Hence the data provide in vivo evidence of the more general interdependency of cell mechanics and differentiation. The data appear to be of high quality and the evidences are strengthened through a combination of different genetic mouse models, RNA sequencing, and immunofluorescence analysis. 

      To generate and maintain the multilayered, barrier-forming epidermis, keratinocytes of the basal stem cell layer differentiate and move suprabasally accompanied by stepwise changes not only in gene expression but also in cell morphology, mechanics, and cell position. Whether any of these changes is instructive for differentiation itself and whether consecutive changes in differentiation are required remains unclear. Also, there are few comprehensive data sets on the exact changes in gene expression between different states of keratinocyte differentiation. In this study, through genetic fluorescence labeling of cell states at different developmental time points the authors were able to analyze gene expression of basal stem cells and suprabasal differentiated cells at two different stages of maturation: E14 (embryonic day 14) when the epidermis comprises mostly two functional compartments (basal stem cells and suprabasal socalled intermediate cells) and E16 when the epidermis comprise three (living) compartments where the spinous layer separates basal stem cells from the barrier-forming granular layer, as is the case in adult epidermis. Using RNA bulk sequencing, the authors developed useful new markers for suprabasal stages of differentiation like MafB and Cox1. The transcription factor MafB was then shown to inhibit suprabasal proliferation in a MafB transgenic model. 

      The data indicate that early in development at E14 the suprabasal intermediate cells resemble in terms of RNA expression, the barrier-forming granular layer at E16, suggesting that keratinocytes can undergo either stepwise (E16) or more direct (E14) terminal differentiation. 

      Previous studies by several groups found an increased actomyosin contractility in the barrierforming granular layer and showed that this increase in tension is important for epidermal barrier formation and function. However, it was not clear whether contractility itself serves as an instructive signal for differentiation. To address this question, the authors use a previously published model to induce premature hypercontractility in the spinous layer by using spastin overexpression (K10-Spastin) to disrupt microtubules (MT) thereby indirectly inducing actomyosin contractility. A second model activates myosin contractility more directly through overexpression of a constitutively active RhoA GEF (K10-Arhgef11CA). Both models induce late differentiation of suprabasal keratinocytes regardless of the suprabasal position in either spinous or granular layer indicating that increased contractility is key to induce late differentiation of granular cells. A potential weakness of the K10-spastin model is the disruption of MT as the primary effect which secondarily causes hypercontractility. However, their previous publications provided some evidence that the effect on differentiation is driven by the increase in contractility (Ning et al. cell stem cell 2021). Moreover, the data are confirmed by the second model directly activating myosin through RhoA. These previous publications already indicated a role for contractility in differentiation but were focused on early differentiation. The data in this manuscript focus on the regulation of late differentiation in barrier-forming cells. These important data help to unravel the interdependencies of cell position, mechanical state, and differentiation in the epidermis, suggesting that an increase in cellular contractility in most apical positions within the epidermis can induce terminal differentiation. Importantly the authors show that despite contractility-induced nuclear localization of the mechanoresponsive transcription factor YAP in the barrier-forming granular layer, YAP nuclear localization is not sufficient to drive premature differentiation when forced to the nucleus in the spinous layer. 

      Overall, this is a well-written manuscript and a comprehensive dataset. Only the RNA sequencing result should be presented more transparently providing the full lists of regulated genes instead of presenting just the GO analysis and selected target genes so that this analysis can serve as a useful repository. The authors themselves have profited from and used published datasets of gene expression of the granular cells. Moreover, some of the previous data should be better discussed though. The authors state that forced suprabasal contractility in their mouse models induces the expression of some genes of the epidermal differentiation complex (EDC). However, in their previous publication, the authors showed that major classical EDC genes are actually not regulated like filaggrin and loricrin (Muroyama and Lechler eLife 2017). This should be discussed better and necessitates including the full list of regulated genes to show what exactly is regulated. 

      We thank the reviewers for their suggestions and comments.

      Thank you for the suggestion to include gene lists. We had an excel document with all this data but neglected to upload it with the initial manuscript. This includes all the gene signatures for the different cell compartments across development. We also include a tab that lists all EDC genes and whether they were up-regulated in intermediate cells and cells in which contractility was induced. Further, we note that all the RNA-Seq datasets are available for use on GEO (GSE295753).  

      In our previous publication, we indeed included images showing that loricrin and filaggrin were both still expressed in the differentiated epidermis in the spastin mutant. Both Flg and Lor mRNA were up in the RNA-Seq (although only Flg was statistically significant), though we didn’t see a notable change in protein levels. It is unclear whether this is just difficult to see on top of the normal expression, or whether there are additional levels of regulation where mRNA levels are increased but protein isn’t. That said, our data clearly show that other genes associated with granular fate were increased in the contractile skin. 

      Reviewer #2 (Public review): 

      Summary: 

      The manuscript from Prado-Mantilla and co-workers addresses mechanisms of embryonic epidermis development, focusing on the intermediate layer cells, a transient population of suprabasal cells that contributes to the expansion of the epidermis through proliferation. Using bulk-RNA they show that these cells are transcriptionally distinct from the suprabasal spinous cells and identify specific marker genes for these populations. They then use transgenesis to demonstrate that one of these selected spinous layer-specific markers, the transcription factor MafB is capable of suppressing proliferation in the intermediate layers, providing a potential explanation for the shift of suprabasal cells into a non-proliferative state during development. Further, lineage tracing experiments show that the intermediate cells become granular cells without a spinous layer intermediate. Finally, the authors show that the intermediate layer cells express higher levels of contractility-related genes than spinous layers and overexpression of cytoskeletal regulators accelerates the differentiation of spinous layer cells into granular cells. 

      Overall the manuscript presents a number of interesting observations on the developmental stage-specific identities of suprabasal cells and their differentiation trajectories and points to a potential role of contractility in promoting differentiation of suprabasal cells into granular cells. The precise mechanisms by which MafB suppresses proliferation, how the intermediate cells bypass the spinous layer stage to differentiate into granular cells, and how contractility feeds into these mechanisms remain open. Interestingly, while the mechanosensitive transcription factor YAP appears deferentially active in the two states, it is shown to be downstream rather than upstream of the observed differences in mechanics. 

      Strengths: 

      The authors use a nice combination of RNA sequencing, imaging, lineage tracing, and transgenesis to address the suprabasal to granular layer transition. The imaging is convincing and the biological effects appear robust. The manuscript is clearly written and logical to follow. 

      Weaknesses: 

      While the data overall supports the authors' claims, there are a few minor weaknesses that pertain to the aspect of the role of contractility, The choice of spastin overexpression to modulate contractility is not ideal as spastin has multiple roles in regulating microtubule dynamics and membrane transport which could also be potential mechanisms explaining some of the phenotypes. Use of Arghap11 overexpression mitigates this effect to some extent but overall it would have been more convincing to manipulate myosin activity directly. It would also be important to show that these manipulations increase the levels of F-actin and myosin II as shown for the intermediate layer. It would also be logical to address if further increasing contractility in the intermediate layer would enhance the differentiation of these cells. 

      We agree with the reviewer that the development of additional tools to precisely control myosin activity will be of great use to the field. That said, our series of publications has clearly demonstrated that ablating microtubules results in increased contractility and that this phenocopies the effects of Arhgef11 induced contractility. Further, we showed that these phenotypes were rescued by myosin inhibition with blebbistatin. Our prior publications also showed a clear increase in junctional acto-myosin through expression of either spastin or Arhgef11, as well as increased staining for the tension sensitive epitope of alpha-catenin (alpha18).  We are not aware of tools that allow direct manipulation of myosin activity that currently exist in mouse models.  

      The gene expression analyses are relatively superficial and rely heavily on GO term analyses which are of course informative but do not give the reader a good sense of what kind of genes and transcriptional programs are regulated. It would be useful to show volcano plots or heatmaps of actual gene expression changes as well as to perform additional analyses of for example gene set enrichment and/or transcription factor enrichment analyses to better describe the transcriptional programs 

      We have included an excel document that lists all the gene signatures. In addition, a volcano plot is included in the new Fig 2, Supplement 1. All our NGS data are deposited in GEO for others to perform these analyses. As the paper does not delve further into transcriptional regulation, we do not specifically present this information in the paper.  

      Claims of changes in cell division/proliferation changes are made exclusively by quantifying EdU incorporation. It would be useful to more directly look at mitosis. At minimum Y-axis labels should be changed from "% Dividing cells" to % EdU+ cells to more accurately represent findings 

      We changed the axis label to precisely match our analysis. We note that Figure 1, Supplement 1 also contains data on mitosis.  

      Despite these minor weaknesses the manuscript is overall of high quality, sheds new light on the fundamental mechanisms of epidermal stratification during embryogenesis, and will likely be of interest to the skin research community. 

      Reviewer #3 (Public review): 

      Summary: 

      This is an interesting paper by Lechler and colleagues describing the transcriptomic signature and fate of intermediate cells (ICs), a transient and poorly defined embryonic cell type in the skin. ICs are the first suprabasal cells in the stratifying skin and unlike later-developing suprabasal cells, ICs continue to divide. Using bulk RNA seq to compare ICs to spinous and granular transcriptomes, the authors find that IC-specific gene signatures include hallmarks of granular cells, such as genes involved in lipid metabolism and skin barrier function that are not expressed in spinous cells. ICs were assumed to differentiate into spinous cells, but lineage tracing convincingly shows ICs differentiate directly into granular cells without passing through a spinous intermediate. Rather, basal cells give rise to the first spinous cells. They further show that transcripts associated with contractility are also shared signatures of ICs and granular cells, and overexpression of two contractility inducers (Spastin and ArhGEF-CA) can induce granular and repress spinous gene expression. This contractility-induced granular gene expression does not appear to be mediated by the mechanosensitive transcription factor, Yap. The paper also identifies new markers that distinguish IC and spinous layers and shows the spinous signature gene, MafB, is sufficient to repress proliferation when prematurely expressed in ICs. 

      Strengths: 

      Overall this is a well-executed study, and the data are clearly presented and the findings convincing. It provides an important contribution to the skin field by characterizing the features and fate of ICs, a much-understudied cell type, at high levels of spatial and transcriptomic detail. The conclusions challenge the assumption that ICs are spinous precursors through compelling lineage tracing data. The demonstration that differentiation can be induced by cell contractility is an intriguing finding and adds a growing list of examples where cell mechanics influence gene expression and differentiation. 

      Weaknesses: 

      A weakness of the study is an over-reliance on overexpression and sufficiency experiments to test the contributions of MafB, Yap, and contractility in differentiation. The inclusion of loss-offunction approaches would enable one to determine if, for example, contractility is required for the transition of ICs to granular fate, and whether MafB is required for spinous fate. Second, whether the induction of contractility-associated genes is accompanied by measurable changes in the physical properties or mechanics of the IC and granular layers is not directly shown. The inclusion of physical measurements would bolster the conclusion that mechanics lies upstream of differentiation. 

      We agree that loss of function studies would be useful. For MafB, these have been performed in cultured human keratinocytes, where loss of MafB and its ortholog cMaf results in a phenotype consistent with loss of spinous differentiation (Pajares-Lopez et al, 2015). Due to the complex genetics involved, generating these double mutant mice is beyond the scope of this study. Loss of function studies of myosin are also complicated by genetic redundancy of the non-muscle type II myosin genes, as well as the role for these myosins in cell division and in actin cross linking in addition to contractility. In addition, we have found that these myosins are quite stable in the embryonic intestine, with loss of protein delayed by several days from the induction of recombination. Therefore, elimination of myosins by embryonic day e14.5 with our current drivers is not likely possible. Generation of inducible inhibitors of contractility is therefore a valuable future goal. 

      Several recent papers have used AFM of skin sections to probe tissue stiffness. We have not attempted these studies and are unclear about the spatial resolution and whether, in the very thin epidermis at these stages, we could spatially resolve differences. That said, we previously assessed the macro-contractility of tissues in which myosin activity was induced and demonstrated that there was a significant increase in this over a tissue-wide scale (Ning et al, Cell Stem Cell, 2021).  

      Finally, whether the expression of granular-associated genes in ICs provides them with some sort of barrier function in the embryo is not addressed, so the role of ICs in epidermal development remains unclear. Although not essential to support the conclusions of this study, insights into the function of this transient cell layer would strengthen the overall impact.  

      By traditional dye penetration assays, there is no epidermal barrier at the time that intermediate cells exist. One interpretation of the data is that cells are beginning to express mRNAs (and in some cases, proteins) so that they are able to rapidly generate a barrier as they become granular cells. In addition, many EDC genes, important for keratinocyte cornification and barrier formation, are not upregulated in ICs at E14.5. We have attempted experiments to ablate intermediate cells with DTA expression - these resulted in inefficient and delayed death and thus did not yield strong conclusions about the role of intermediate cells. Our findings that transcriptional regulators of granular differentiation (such as Grhl3 and Hopx) are also present in intermediate cells, should allow future analysis of the effects of their ablation on the earliest stages of granular differentiation from intermediate cells. In fact, previous studies have shown that Grhl3 null mice have disrupted barrier function at embryonic stages (Ting et al, 2005), supporting the role of ICs in being important for barrier formation. (?)

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      Overall, this is a well-written manuscript and a comprehensive dataset. Only the RNA sequencing result should be presented more transparently providing the full lists of regulated genes instead of presenting just the GO analysis and selected target genes so that this analysis can serve as a useful repository. The authors themselves have profited from and used the published dataset of gene expression of the granular cells. Moreover, some of the previous data should be better discussed though. The authors state that forced suprabasal contractility in their mouse models induces the expression of some genes of the epidermal differentiation complex (EDC). However, in their previous publication, the authors showed that major classical EDC genes are actually not regulated like filaggrin and loricrin (Muroyama and Lechler eLife 2017). This should be discussed better and necessitates including the full list of regulated genes to show what exactly is regulated. 

      A general point regarding statistics throughout the manuscript. It seems like regular T-tests or ANOVAs have been used assuming Gaussian distribution for sample sizes below N=5 which is technically not correct. Instead, non-parametric tests like e.g. the Mann-Whitney test should be used. Since Graph-Pad was used for statistics according to the methods this is easy to change. 

      Figure 1: It would be good to show the FACS plot of the analyzed and sorted population in the supplementary figures. 

      If granular cells can be analyzed and detected by FACS, why were they not included in the RNA sequencing analysis? 

      Figure 1 supplement 1c: cell division numbers are analyzed from only 2 mice and the combined 5 or 4 fields of view are used for statistics using a test assuming normal distribution which is not really appropriate. Means per mice should be used or if accumulated field of views are used, the number should be increased using more stringent tests. Otherwise, the p-values here clearly overstate the significance. 

      Granular cells could not be specifically isolated in the approach we used. The lectin binds to both upper spinous and granular cells. For this reason, we relied on a separate granular gene list as described.

      For Figure 1 Supplement 1, we removed the statistical analysis and use it simply as a validation of the data in Figure 1.  

      Figure 2: It is not completely clear on which basis the candidate genes were picked. They are described to be the most enriched but how do they compare to the rest of the enriched genes. The full list of regulated genes should be provided. 

      Some markers for IC or granular layer are verified either by RNA scope or immunofluorescence. Is there a technical reason for that? It would be good to compare protein levels for all markers.  Figure 2-Supplement 1: There is no statement about the number of animals that these images are representative for. 

      We have included a volcano plot to show where the genes picked reside. We have also included the full gene lists for interested readers. 

      When validated antibodies were available, we used them. When they were not, we performed RNA-Scope to validate the RNA-Seq dataset. 

      We have included animal numbers in the revised Fig 2-Supplement 2 legend (previously Fig 2Supplement 1).  

      Figure 4b: It would be good to include the E16 spinous cells to get an idea of how much closer ICs are to the granular population. 

      We have included a new Venn diagram showing the overlap between each of the IC and spinous signatures with the granular cell signature in Fig 4B. Overall, 36% of IC signature genes are in common with granular cells, while just 20% of spinous genes overlap.  

      Reviewer #2 (Recommendations for the authors): 

      (1)  Figure 6B is confusing as y-axis is labeled as EdU+ suprabasal cells whereas basal cells are also quantified. 

      We have altered the y-axis title to make it clearer.  

      (2)  Not clear why HA-control is sometimes included and sometimes not. 

      We include the HA when it did not disrupt visualization of the loss of fluorescence. As it was uniform in most cases, we excluded it for clarity in some images. HA staining is now included in Fig 3C.

      (3)  The authors might reconsider the title as it currently is somewhat vague, to more precisely represent the content of the manuscript. 

      We thank the reviewer for the suggestion. We considered other options but felt that this gave an overview of the breadth of the paper.  

      Reviewer #3 (Recommendations for the authors): 

      (1)  ICs are shown to express Tgm1 and Abca12, important for cornified envelope function and formation of lamellar bodies. Do ICs provide any barrier function at E14.5? 

      By traditional dye penetration assays, there is no epidermal barrier at the time that intermediate cells exist. One interpretation of the data is that cells are beginning to express mRNAs (and in some cases, proteins) so that they are able to rapidly generate a barrier as they become granular cells.  

      (2)  Genes associated with contractility are upregulated in ICs and granular cells. And ICs have higher levels of F-actin, MyoIIA, alpha-18, and nuclear Yap. Does this correspond to a measurable difference in stiffness? Can you use AFM to compare to physical properties of ICs, spinous, and granular cells? 

      Several recent papers have used AFM of skin sections to probe tissue stiDness. We have not attempted these studies and are unclear about the spatial resolution and whether in the very thin epidermis at these stages whether we could spatially resolve diDerences. It is also important to note that this tissue rigidity is influenced by factors other than contractility. That said, we previously assessed the macro-contractility of tissues in which myosin activity was induced and demonstrated that there was a significant increase in this over a tissue-wide scale (Ning et al, Cell Stem Cell, 2021).

      (3)  Overexpression of two contractility inducers (spastin and ArhGEF-CA) can induce granular gene expression and repress spinous gene expression, suggesting differentiation lies downstream of contractility. Is contractility required for granular differentiation? 

      This is an important question and one that we hope to directly address in the future. Published studies have shown defects in tight junction formation and barrier function in myosin II mutants. However, a thorough characterization of differentiation was not performed.  

      (4)  ICs are a transient cell type, and it would be important to know what is the consequence of the epidermis never developing this layer. Does it perform an important temporary structural/barrier role, or patterning information for the skin?

      We have attempted experiments to ablate intermediate cells with DTA expression - this resulted in ineDicient and delayed death and thus did not yield strong conclusions. Our findings that transcriptional regulators of granular diDerentiation (such as Grhl3 and Hopx) are also present in intermediate cells, should allow future analysis of the eDects of their ablation on the earliest stages of granular diDerentiation from intermediate cells.

    1. Reviewer #3 (Public Review):

      Summary:

      Protein overexpression is widely used in experimental systems to study the function of the protein, assess its (beneficial or detrimental) effects in disease models, or challenge cellular systems involved in synthesis, folding, transport, or degradation of proteins in general. Especially at very high expression levels, protein-specific effects and general effects of a high protein load can be hard to distinguish. To overcome this issue, Fujita et al. use the previously established genetic tug-of-war system to identify proteins that can be expressed at extremely high levels in yeast cells with minimal protein-specific cytotoxicity (high 'neutrality'). They focus on two versions of the protein mox-GFP, the fluorescent version and a point mutation that is non-fluorescent (mox-YG) and is the most 'neutral' protein on their screen. They find that massive protein expression (up to 40% of the total proteome) results in a nitrogen starvation phenotype, likely inactivation of the TORC1 pathway, and defects in ribosome biogenesis in the nucleolus.

      Strengths:

      This work uses an elegant approach and succeeds in identifying proteins that can be expressed at surprisingly high levels with little cytotoxicity. Many of the changes they see have been observed before under protein burden conditions, but some are new and interesting. This work solidifies previous hypotheses about the general effects of protein overexpression and provides a set of interesting observations about the toxicity of fluorescent proteins (that is alleviated by mutations that render them non-fluorescent) and metabolic enzymes (that are less toxic when mutated into inactive versions).

      Weaknesses:

      The data are generally convincing, however in order to back up the major claim of this work - that the observed changes are due to general protein burden and not to the specific protein or condition - a broader analysis of different conditions would be highly beneficial.

      Major points:

      (1) The authors identify several proteins with high neutrality scores but only analyze the effects of mox/mox-YG overexpression in depth. Hence, it remains unclear which molecular phenotypes they observe are general effects of protein burden or more specific effects of these specific proteins. To address this point, a proteome (and/or transcriptome) of at least a Gpm1-CCmut expressing strain should be obtained and compared to the mox-YG proteome. Ideally, this analysis should be done simultaneously on all strains to achieve a good comparability of samples, e.g. using TMT multiplexing (for a proteome) or multiplexed sequencing (for a transcriptome). If feasible, the more strains that can be included in this comparison, the more powerful this analysis will be and can be prioritized over depth of sequencing/proteome coverage.

      (2) The genetic tug-of-war system is elegant but comes at the cost of requiring specific media conditions (synthetic minimal media lacking uracil and leucine), which could be a potential confound, given that metabolic rewiring, and especially nitrogen starvation are among the observed phenotypes. I wonder if some of the changes might be specific to these conditions. The authors should corroborate their findings under different conditions. Ideally, this would be done using an orthogonal expression system that does not rely on auxotrophy (e.g. using antibiotic resistance instead) and can be used in rich, complex mediums like YPD. Minimally, using different conditions (media with excess or more limited nitrogen source, amino acids, different carbon source, etc.) would be useful to test the robustness of the findings towards changes in media composition.

      (3) The authors suggest that the TORC1 pathway is involved in regulating some of the changes they observed. This is likely true, but it would be great if the hypothesis could be directly tested using an established TORC1 assay.

      (4) The finding that the nucleolus appears to be virtually missing in mox-YG-expressing cells (Figure 6B) is surprising and interesting. The authors suggest possible mechanisms to explain this and partially rescue the phenotype by a reduction-of-function mutation in an exosome subunit. I wonder if this is specific to the mox-YG protein or a general protein burden effect, which the experiments suggested in point 1 should address. Additionally, could a mox-YG variant with a nuclear export signal be expressed that stays exclusively in the cytosol to rule out that mox-YG itself interferes with phase separation in the nucleus?

      Minor points:

      (5) It would be great if the authors could directly compare the changes they observed at the transcriptome and proteome levels. This can help distinguish between changes that are transcriptionally regulated versus more downstream processes (like protein degradation, as proposed for ribosome components).

    1. Reviewer #2 (Public review):

      Summary:

      This study investigates a low abundance microRNA signature in extracellular vesicles to subtype pancreatic cancer and for early diagnosis. In this revision, there remain several major and minor issues.

      Strengths:

      The authors did a comprehensive job with numerous analyses of moderately sized cohorts to describe the clinical and translational significance of their miRNA signature.

      Weaknesses:

      The weaknesses of the study largely revolve around a lack of clarity about the methodology used and the validation of their findings.

      (1) The WGCNA analysis was critical to identify the EV miRNAs associated with imaging features, but the "cut-off criteria" for MM and GS have no clear justification. How were these cut-offs determined? How sensitive were the results to these cut-offs?

      (2) The authors now clarify that patients for the sub-study on differentiating early stage from benign pancreatic lesions were matched by age and that the benign pancreatic lesions were predominantly IPMNs. This scientific design is flawed. The CT features extracted likely differentiate solid from cystic pancreatic lesions, and the miRNA signature is doing the same. The authors need to incorporate the following benign controls into their imaging analysis and their EV miRNA analysis: pancreatitis and normal pancreata.

      (3) For the radiomics features, the authors should include an additional external validation set to better support the ability to use these features reproducibly, especially given that the segmentation was manual and reliant on specific people.

      (4) The DF selection process still lacks cited references as originally requested in the first review.

      (5) In Figure 2, more quantitative details are needed in the manuscript. The reviewers failed to incorporate this and only responded in their rebuttal. Add details to the manuscript as originally requested.

      (6) It is still not clear what Figure 4A is illustrating as regards to model performance. The authors need to state in the manuscript very clearly what they are showing in the figure and what the modules represent.

      (7) Figure 5 and the descriptions for the public serum miRNA datasets need more details. Were these pancreatic cancers all adenocarcinoma, what stage, age range, sex distribution, comorbid conditions were the cases? Were the controls all IPMNs or were there other conditions in the controls?

      (8) The subtype results in figures 6 and 7 are not convincing. An association on univariate analysis is not sufficient. The explanation that clinical data is not available to do a multivariable analysis indicates that the authors do not have the ability to claim that they have identified unique subtypes that have clinical relevance. A thorough evaluation of the prognostic significance and the associated molecular features of these tumors is needed.

      Summary:

      There remain key details and validation experiments to better support the conclusions of the study.

    2. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The manuscript by Shi et al, has utilized multiple imaging datasets and one set of samples for analyzing serum EV-miRNAs & EV-RNAs to develop an EV miRNA signature associated with disease-relevant radiomics features for early diagnosis of pancreatic cancer. CT imaging features (in two datasets (UMMD & JHC and WUH) were derived from pancreatic benign disease patients vs pancreatic cancer cases), while circulating EV miRNAs were profiled from samples obtained from a different center (DUH). The EV RNA signature from external public datasets (GSE106817, GSE109319, GSE113486, GSE112264) were analyzed for differences in healthy controls vs pancreatic cancer cases. The miRNAs were also analyzed in the TCGA tissue miRNA data from normal adjacent tissue vs pancreatic cancer.

      Strengths:

      The concept of developing EV miRNA signatures associated with disease relevant radiomics features is a strength.

      Weaknesses:

      While the overall concept of developing EV miRNA signature associated with radiomics features is interesting, the findings reported are not convincing for the reasons outlined below:

      (1) Discrepant datasets for analyzing radiomic features with EV-miRNAs: It is not justified how CT images (UMMD & JHC and WUH) and EV-miRNAs (DUH) on different subjects and centers/cohorts shown in Figures 1 &2 were analyzed for association. It is stated that the samples were matched according to age but there is no information provided for the stages of pancreatic cancer and the kind of benign lesions analyzed in each instance.

      Thank you to the reviewer for the valuable comments. We acknowledge that the radiomics data and EV-miRNA data were derived from different patient cohorts. The primary aim of this study was to explore the integration of data from different omics sources in an exploratory manner to identify potential shared biological features.

      We have revised the Methods section accordingly. Regarding the imaging data, we mainly performed batch effect correction on CT images from different centers to eliminate variability. As you correctly pointed out, the EV-miRNA data and CT images from DUH were matched by age. Since all the patients we included had early-stage pancreatic cancer, and the benign pancreatic lesions were predominantly IPMN, we did not specifically highlight this aspect. However, we have now clarified this approach in the data collection section. Thank you for your attention.

      (2) The study is focused on low-abundance miRNAs with no adequate explanation of the selection criteria for the miRNAs analyzed.

      We used MAD (Median Absolute Deviation) to filter low-abundance miRNAs in the manuscript, as this concept was introduced by us for the first time in this context, and we acknowledge that there is still considerable room for refinement and improvement.

      (3) While EV-miRNAs were profiled or sequenced (not well described in the Methods section) with two different EV isolation methods, the authors used four public datasets of serum circulating miRNAs to validate the findings. It would be better to show the expression of the three miRNAs in the additional dataset(s) of EV-miRNAs and compare the expressions of the three EV-miRNAs in pancreatic cancer with healthy and benign disease controls.

      Thank you for your suggestion. We have attempted to identify available EV-miRNA datasets; however, due to current limitations in data access, we opted to use serum samples for validation. In our follow-up studies, we are already in the process of collecting relevant EV samples for further validation.

      (4) It is not clear how the 12 EV-miRNAs in Figure 4C were identified.

      These 12 EV-miRNAs were identified through WGCNA analysis and are associated with the high-risk group.

      (5) Box plots in Figures 4D-F and G-I of three miRNAs in serum and tissue should show all quantitative data points.

      We have completed the revisions. Kindly review them at your convenience.

      (6) What is the GBM model in Figure 5?

      Thank you to the reviewer for raising this question. The "GBM model" referred to in Figure 5 is a classification model built using the Gradient Boosting Machine (GBM) algorithm, designed to predict the diagnostic status of pancreatic cancer by integrating EV-miRNA expression and radiomics features. We implemented the model using the `GradientBoostingClassifier` from the scikit-learn library (version 1.2.2), and optimized the model’s hyperparameters—including learning rate, maximum depth, and number of trees—within a five-fold cross-validation framework. The training process and performance evaluation of the model, including the ROC curve and AUC values, are presented in Figure 5.

      (7) What are the AUCs of individual EV-miRNAs integrated as a panel of three EV-miRNAs?

      Thanks for your comments, Our GBM model integrates the panel of these three EV-miRNAs.

      (8) The authors could have compared the performance of CA19-9 with that of the three EV-miRNAs.

      Since our main focus is on the panel of three EV-miRNAs, we did not present the AUC for each individual miRNA separately. However, we have included the performance of CA19-9 in our dataset as a reference. The predictive AUC for CA19-9 is 0.843 (95% CI, 0.762–0.924).

      (9) How was the diagnostic performance of the three EV-miRNAs in the two molecular subtypes identified in Figure 6&7? Do the C1 & C2 clusters correlate with the classical/basal subtypes, staging, and imaging features?

      Thank you to the reviewer for raising this important question. In fact, our EV panel is primarily designed to distinguish between normal and tumor samples, whereas both C1 and C2 represent tumor subtypes, and thus the panel is not applicable for diagnostic purposes in this context. Additionally, our subtypes are novel and do not align with the conventional classical and basal-like gene expression profiles. Furthermore, the C1 subtype is more frequently observed in stage III tumors (Figure 6J) and is associated with distinct imaging features such as higher texture heterogeneity and lower CT density.

      Reviewer #2 (Public review):

      Summary:

      This study investigates a low abundance microRNA signature in extracellular vesicles to subtype pancreatic cancer and for early diagnosis. There are several major questions that need to be addressed. Numerous minor issues are also present.

      Strengths:

      The authors did a comprehensive job with numerous analyses of moderately sized cohorts to describe the clinical and translational significance of their miRNA signature.

      Weaknesses:

      There are multiple weaknesses of this study that should be addressed:

      (1) The description of the datasets in the Materials and Methods lacks details. What were the benign lesions from the various hospital datasets? What were the healthy controls from the public datasets? No pancreatic lesions? No pancreatic cancer? Any cancer history or other comorbid conditions? Please define these better.

      We sincerely thank the reviewer for the detailed and important suggestions regarding sample definition. Indeed, the source of the datasets and the definition of control groups are critical for ensuring the rigor and interpretability of the study. In response to this comment, we have added clarifications in the revised "Materials and Methods" section.

      First, for the benign lesion group derived from various clinical centers (DUH, UMMD, WUH, etc.), we have carefully reviewed the pathological and clinical records and defined these samples as histologically confirmed non-malignant pancreatic lesions, primarily IPMN. All patients in the benign lesion group had no diagnosis of pancreatic cancer at the time of sample collection, and for cohorts with available follow-up data, no evidence of malignant progression was observed within at least six months.

      Second, the healthy control group from public databases was derived from healthy individuals.

      Finally, to eliminate potential confounding factors, we excluded any samples with a history of other malignancies (e.g., breast cancer, colorectal cancer, etc.) from all datasets with available clinical information, to ensure the specificity of the EV-miRNA expression analysis.

      (2) It is unclear how many of the controls and cases had both imaging for radiomics and blood for biomarkers.

      Due to limitations in resource availability, our study does not include samples with both CT imaging and serological data from the same individuals. Instead, we integrated blood samples and CT imaging data collected from different clinical centers.

      (3) The authors should define the imaging methods and protocols used in more detail. For the CT scans, what slice thickness? Was a pancreatic protocol used? What phase of contrast is used (arterial, portal venous, non-contrast)? Any normalization or pre-processing?

      Thank you to the reviewer for the professional suggestions regarding the imaging section. We have added detailed technical information on CT imaging in the revised Materials and Methods section. All CT images were acquired using a 64-slice multidetector spiral CT scanner, with a standard slice thickness of 1.0–1.5 mm and a reconstruction interval of 1 mm. All pancreatic cancer patients underwent a standard pancreatic protocol triphasic contrast-enhanced CT examination, which included non-contrast, arterial phase (approximately 25–30 seconds), and portal venous phase (approximately 65–70 seconds) imaging.

      For the radiomics analysis, images from the portal venous phase were selected, as this phase provides consistent clarity in delineating tumor boundaries and surrounding vasculature. To ensure data consistency, all imaging data underwent preprocessing, including resampling, intensity normalization of grayscale values (standardized using z-score normalization to a mean of 0 and a standard deviation of 1), and N4 bias field correction to address potential low-frequency signal inhomogeneities.

      (4) Who performed the segmentation of the lesions? An experienced pancreatic radiologist? A student? How did the investigators ensure that the definition of the lesions was performed correctly? Raidomics features are often sensitive to the segmentation definitions.

      All lesion segmentations were performed on portal venous phase contrast-enhanced CT images. Manual delineation was conducted using 3D Slicer (version 4.11) by two radiologists with extensive experience in pancreatic tumor diagnosis. A consensus was reached between the two radiologists on the ROI definition criteria prior to analysis.

      To further assess the robustness of radiomic features to segmentation boundary variations, we selected a subset of representative cases and created “expanded/shrunk ROIs” by adding or subtracting a 2-pixel margin at the lesion boundary. Feature extraction was then repeated, and the coefficient of variation (CV) for the main features included in the model was found to be below 10%, indicating that the model is stable with respect to minor boundary fluctuations.

      (5) Figure 1 is full of vague images that do not convey the study design well. Numbers from each of the datasets, a summary of what data was used for training and for validation, definitions of all of the abbreviations, references to the Roman numerals embedded within the figure, and better labeling of the various embedded graphs are needed. It is not clear whether the graphs are real results or just artwork to convey a concept. I suspect that they are just artwork, but this remains unclear.

      We thank the reviewer for the detailed feedback on Figure 1. We would like to clarify that Figure 1 is a conceptual schematic intended to visually illustrate the overall design of the study, the relationships among different data modules, and the logical sequence of the analytical strategy. It is not meant to present actual results or quantitative details.

      Regarding the reviewer’s concerns about sample sizes, the division between training and validation cohorts, explanations of specific abbreviations, and the precise meaning of each panel, we have provided comprehensive and detailed clarifications in Figure 2.

      (6) The DF selection process lacks important details. Please reference your methods with the Boruta and Lasso models. Please explain what machine learning algorithms were used. There is a reference in the "Feature selection.." section of "the model formula listed below" but I do not see a model formula below this paragraph.

      We thank the reviewer for the thoughtful and detailed comments on the feature selection strategy. We first applied the Boruta algorithm (based on random forests, implemented using the Boruta R package) to the original feature set—which included both radiomics and EV-miRNA features—to identify variables that consistently demonstrated importance across multiple rounds of random resampling.

      Subsequently, we used LASSO regression with five-fold cross-validation to further reduce the dimensionality of the Boruta-selected features and to construct the final feature set used for modeling. The formula for the model is as follows: each regression coefficient is multiplied by the corresponding feature expression level, and the resulting products are summed to generate the Risk Score.

      (7) In Figure 2, more quantitative details are needed. How are patients dichotomized into non-obese and obese? What does alcohol/smoking mean? Is it simply no to both versus one or the other as yes? These two risk factors should be separated and pack years of smoking should be reported. The details of alcohol use should also be provided. Is it an alcohol abuse history? Any alcohol use, including social drinking? Similarly, "diabetes" needs to be better explained. Type I, type II, type 3c? P values should be shown to demonstrate any statistically significant differences in the proportions of the patients from one dataset to another.

      Our definition of obesity was based on the standard BMI threshold (30 kg/m²). A history of smoking or alcohol consumption was defined as continuous use for more than one year. Specific details regarding smoking and alcohol use were recorded at baseline under the category of “smoking/alcohol history”; unfortunately, we did not collect follow-up data on these variables. As for diabetes, only type II diabetes was documented. Statistically significant p-values have been added. Thank you.

      (8) In the section "Different expression radiomic features between pancreatic benign lesions and aggressive tumors", there is a reference to "MUJH" for the first time. What is this? There is also the first reference to "aggressive tumors" in the section. Do the authors just mean the cases? Otherwise there is no clear definition of "aggressive" (vs. indolent) pancreatic cancer. This terminology of tumor "aggressiveness" either needs to be removed or better defined.

      We have corrected the abbreviation (MUJH); it should in fact be JHC. Additionally, regarding the term "aggressive," we have reviewed the literature and used it to convey the highly malignant nature of pancreatic cancer.

      (9) Figure 3 needs to have the specific radiomic features defined and how these features were calculated. Labeling them as just f1, f2, etc is not sufficient for another group to replicate the results independently.

      We have presented these features in Supplementary Table 1. Kindly refer to it for details.

      (10) It is not clear what Figure 4A illustrates as regards model performance. What do the different colors represent, and what are the models used here? This is very confusing.

      This represents the correlation between WGCNA modules and miRNAs. Different module colors indicate distinct miRNA clusters—for example, the green module contains 12 miRNAs grouped together. The colors themselves do not carry any intrinsic meaning.

      (11) Figure 5 shows results for many more model runs than the described 10, please explain what you are trying to convey with each row. What are "Test A" and "Test B"? There is no description in the manuscript of what these represent. In the figure caption, there is a reference to "our center data" which is not clear. Be more specific about what that data is.

      We have indicated this using arrows in Figure 5 from Test A/B/C. Please check.

      (12) Figure 6 describes the subtypes identified in this study, but the authors do not show a multi-variable cox proportional hazards model to show that this subtype classification independently predicts DFS and OS when incorporating confounding variables. This is essential to show the subtypes are clinically relevant. In particular, the authors need to account for the stage of the patients, and receipt of chemotherapy, surgery, and radiation. If surgery was done, we need to know whether they had R1 or R0 resection. The details about the years in which patients were included is also important.

      We sincerely thank the reviewer for this critical comment. We fully agree that incorporating a multivariate Cox proportional hazards model to control for potential confounding factors would provide a more robust validation of the independent prognostic value of our proposed subtypes for DFS and OS.

      However, as the clinical data used in this study were retrospectively collected and access to certain variables is currently restricted, we were only able to obtain limited clinical information. At this stage, we are unable to systematically include key variables such as tumor staging, adjuvant chemoradiotherapy regimens, and resection margin status (R0 vs. R1), which prevents us from performing a rigorous multivariate Cox analysis.

      Similarly, regarding the postoperative resection status, after reviewing the original surgical reports and pathology records, we regret to confirm that margin status (R0 vs. R1) is missing in a substantial portion of cases, making it unsuitable for reliable statistical analysis.

      We fully acknowledge this as a limitation of the current study and have explicitly addressed it in the Discussion section. To address this gap, we are currently designing a more comprehensive prospective cohort study, which will allow us to validate the clinical independence and utility of the proposed subtypes in future research.

      (13) How do these subtypes compare to other published subtypes?

      We sincerely thank the reviewer for raising this important point. Clusters 1 and 2 represent a novel molecular classification proposed for the first time in this study, driven by EV-miRNA profiles. This classification approach is conceptually independent from traditional transcriptome-based subtyping systems, such as the classical/basal-like subtypes, as well as other existing classification schemes. Comparisons with previously reported subtypes and validation of clinical relevance will require further investigation in future studies.

      Reviewer #3 (Public review):

      Summary:

      The authors appear to be attempting to identify which patients with benign lesions will progress to cancer using a liquid biomarker. They used radiomics and EV miRNAs in order to assess this.

      Strengths:

      It is a strength that there are multiple test datasets. Data is batch-corrected. A relatively large number of patients is included. Only 3 miRNAs are needed to obtain their sensitivity and specificity scores.

      Weaknesses:

      This manuscript is not clearly written, making interpretation of the quality and rigor of the data very difficult. There is no indication from the methods that the patients in their cohorts who are pancreatic cancer patients (from the CT images) had prior benign lesions, limiting the power of their analysis. The data regarding the cluster subtypes is very confusing. There is no discussion or comparison if these two clusters are just representing classical and basal subtypes (which have been well described).

      Sorry,we don’t have the data of record from patients, in addition, Regarding the relationship between Cluster 1/Cluster 2 and classical subtypes:We are very grateful for the reviewer’s insightful question. We would like to clarify that Clusters 1 and 2, as shown in Figures 6 and 7, are derived from a novel EV-miRNA–driven molecular classification proposed for the first time in this study. This classification system is constructed independently of the traditional transcriptome-based classical/basal-like subtypes.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      There are errors in reference citations and several typos, misspellings, and grammatical errors throughout the manuscript.

      We have made the necessary revisions.

      Reviewer #2 (Recommendations for the authors):

      (1) Were the radiomic features associated with the subtypes and prognostic in the subset of patients who had CT scans?

      Unfortunately, there are no corresponding CT imaging results available for these cases, as the genes were identified based on predicted miRNA targets and were not derived from patients who had undergone CT scans.

      (2) There is a whole body of literature on prognostic imaging-based subtypes of pancreatic cancer that needs to be cited.

      Thank you for your suggestion. We have cited the relevant references accordingly in the manuscript.

      (3) Similarly, the authors should be more comprehensive about prognostic and early detection markers for miRNAs for pancreatic cancer. Early detection markers really should be described separately from prognostic markers. The authors did not do a PROBE phase 3 study, so early detection is not really relevant. Please see https://edrn.nci.nih.gov/about-edrn/five-phase-approach-and-prospective-specimen-collection-retrospective-blinded-evaluation-study-design/

      The primary objective of our study is early detection. We acknowledge the absence of third-phase validation results, which we will address in the limitations section. Additionally, the subtype classification represents our secondary objective.

      (4) If they want to couch this as a PROBE phase 2 study, then they should review the PROBE guidelines and ensure they are meeting standards. Many of the comments above regarding methodologies, definitions, and patient cohort descriptions would address this concern.

      We have revised the Methods section accordingly. Please kindly review the updated version.

      (5) The entire manuscript needs to have a review for the use of the English language. There are numerous typos and grammatical errors that make this manuscript difficult to follow and hard to interpret.

      We have revised the Methods section accordingly. Please kindly review the updated version.

      (6) In the section on "Definition and identification of low abundance EV-derived miRNA transcripts", provide a reference for the "edger" function.

      We have revised the Methods section accordingly. Please kindly review the updated version.

      (7) In the Abstract: The purpose section only mentions early diagnosis as the goal of this study. It seems subtyping is also a major goal, but it is not mentioned.

      The primary objective of our study is early detection.Additionally, the subtype classification represents our secondary objective.so,we didn’t add it in the purpose.

      (8) The experimental design fails to describe any of the 8 datasets that were used. How many patients? What were the ethnic and racial backgrounds, which is one of the key aspects of this study and mentioned in the title? What range of stages? When were the images and the blood collected in relation to diagnosis? Over what time frame were the patients included? What patients were excluded, if any? These details are important to understand the materials used, along with the methods to design the signatures and models.

      We have revised the Methods section accordingly. Please kindly review the updated version.

      (9) Again, the purpose section of the abstract does not align with the rest of the study, including the description of the experimental design. The last sentence of the experimental design section mentions predicting drug sensitivity and survival, which is unrelated to the aim of early diagnosis.

      We have revised the Methods section accordingly. Please kindly review the updated version.

      (10) The results section lacks key details to indicate the impact of the work. Vague descriptions of the findings are not sufficient. The performance of the biomarkers to differentiate benign from malignant lesions, hazard ratios, survival times, and p values should be reported for key results.

      Our aim was to develop an integrated panel for diagnostic purposes; therefore, we provided the AUC to evaluate its performance. However, since this is a diagnostic model, we did not include hazard ratios or survival time data.

      (11) What are "tow" molecular subtypes of pancreatic cancer? Did you mean "two"? What system was used to subtype the pancreatic cancers? Is some new subtyping or a previously published method to subtype the disease?

      Yes, it means two, previously published method.In method part, we have describe it.

      Reviewer #3 (Recommendations for the authors):

      The writing of this manuscript needs extensive re-wording and clarification to increase the readability and interpretability of the data presented. The authors could include a dataset of pancreatic cancer patient imaging data where the status of prior benign lesions was detected (as opposed to patients with benign lesions that do not develop pancreatic cancer). The authors could also address if their clusters 1 and 2 are representing (or are correlated with) the classical and basal subtypes that have been well described for pancreatic cancer.

      Thank you to the reviewer for the constructive comments. We sincerely appreciate your careful review, particularly regarding language clarity, data interpretability, and subtype correlation. To enhance the readability and scientific precision of the manuscript, we have conducted a thorough revision and language polishing throughout the text, improving logical structure, terminology consistency, and clarity in result descriptions. We have especially reinforced the Methods and Discussion sections to better explain key analytical steps and data interpretation.

      We fully understand the reviewer’s suggestion to include information on “the presence of benign lesions prior to pancreatic cancer diagnosis.” However, due to the retrospective nature of our study, the current imaging and EV-miRNA datasets do not contain systematically collected follow-up annotations of this type. Therefore, it is not feasible to incorporate such data into the present manuscript.

      That said, we fully recognize the importance of this direction. In future studies, we plan to evaluate longitudinal samples to investigate the dynamic changes in EV-miRNAs and imaging features during the progression from premalignant to malignant states, aiming to clarify their potential value for early cancer warning.

      Regarding the relationship between Cluster 1/Cluster 2 and classical subtypes:We are very grateful for the reviewer’s insightful question. We would like to clarify that Clusters 1 and 2, as shown in Figures 6 and 7, are derived from a novel EV-miRNA–driven molecular classification proposed for the first time in this study. This classification system is constructed independently of the traditional transcriptome-based classical/basal-like subtypes.

      Although we attempted a cross-comparison with existing TCGA subtypes, differences in data origin, analysis modality (EV-miRNA vs. tissue transcriptome), and limitations in sample matching prevent us from establishing a direct correspondence. In the revised Discussion, we have emphasized that these two classification approaches are complementary rather than equivalent, reflecting different dimensions of tumor heterogeneity. Further integrative multi-omics studies will be needed to validate their biological significance and clinical utility.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reviewer #1 (Evidence, reproducibility and clarity (Required)):

      The authors provide a detailed characterization of the tumor microenvironment (TME) of 91 ovarian cancer patients, broken down in long and short-term survivors (post 5 years). The focus on the role of a subgroup of T cells, gamma/delta γδ) T cells with reported anti but also pro tumorigenic properties, Prior work of the lab has established a link between a subgroup of γδ T cells expressing CD73 and poor prognosis, due to the ability of these cells to produce immunosuppressive cytokines, such as IL10 or IL8 and the production of adenosine, by CD73, in the micromilieu. The data is further backed up by the analysis of fresh tumor specimens and tissue culture work.

      Here they continue this story by investigating the TME using tumor microarrays (91 samples), single cell RNA seq (12 patients), imaging mass cytometry (> 30 samples) and flow cytometry (form confirmatory purposes) to define cellular neighborhoods of CD73+ and CD73- γδ T cells. This revealed differences in cellular composition and spatial transcriptome analysis further helped to define the transcriptomes in γδ T cells, cancer cells and cancer associated fibroblasts.

      The authors conclude the in ovarian cancer γδ T cells expressing CD73 dampen anti-tumor immunity and propose detection and evaluation of CD73+ γδ T cells as prognostic marker.

      The manuscript is well written, and despite its descriptive nature, easy to follow. Data is presented in a clear and easy to read fashion.

      Reviewer #1 (Significance (Required)):

      Using a well characterized cohort of ovarian cancer patients with detailed clinical follow up the authors report on the predictive power of a subset of γδ T cells expressing CD73, with immune suppressive / regulatory capacity, reading out patient survival in high grade serous ovarian cancer, a still deadly disease. As such the identification of reliable markers predicting survival is a clear medical need. These findings contrast others made in different solid cancers, suggesting tumor type specific differences, which are only starting to emerge, but are of clear clinical relevance.

      What is unclear to me and needs to be addressed, is if these patient specimens were taken before or after initial therapy, whether the samples have been stratified according the treatment that they got, assuming it will be mostly platinum compounds (but maybe not), and that the p53 status of the tumors are (if genetics are available this would help to add some granularity to the study that, as it stands is largely descriptive, even though with extremely high resolution. This data should be available and could be integrated.

      We thank the reviewer for this insightful and constructive comment. We agree that clinical context and treatment stratification are essential to strengthen the interpretation and translational value of our findings.

      We confirm that all tumor samples used in this study were obtained prior to any systemic treatment, i.e., before first-line chemotherapy, during the Biopsy realized for the diagnosis. This information has now been clearly stated in the Methods and Results section (page 4, line 103) and also in Table S1.

      Although our primary aim was not to evaluate correlations with mutational status, we recognize the critical role that tumor genetics play in shaping the immune microenvironment. Using available clinical genomics data, we found that the TP53 mutational status of our cohort aligns with that of previous analyses. As expected for high-grade serous ovarian cancer (HGSOC), nearly all tumors exhibited TP53 mutations (present in 95% of patients). Due to the lack of variability in TP53 status, no meaningful stratification was observed based on this factor. This information has been added in the Materials and methods part (page 4 lines 104 to 106)

      Some minor issues

      • I would stick to CD73, and not mix it with NT5E, which is confusing at first (Fig 2).

      We appreciate this suggestion. To clarify the nomenclature and avoid confusion, we have consistently indicated throughout the text and figure legends that NT5E refers to the CD73 gene.

      • I would ask to compare the overall survival of CD73+ between densities - is it still significantly different in fig 1 - meaning is it about density, CD73 expression, or both. Comparing survival of tumors with a low density of CD73+ γδ T cells does not seem to be different from those having a low density of CD73- γδ T cells, which could be considered in data interpretation. Same for high density tumors.

      In the manuscript, the term “density” specifically refers to the density of γδ____ T cells and not the density of CD73 molecules expressed by these cells. Additionally, it is not feasible to conduct a density analysis of molecules using the data obtained from immunofluorescence (IF) staining of sample sections.

      Kaplan-Meier analyses were performed to assess patient survival based on the density of total γδ____ T cells, as well as the subsets of CD73⁺ and CD73⁻ γδ T cells. The results indicate that a higher density of γδ____ T cells is associated with poorer patient survival, with a more pronounced effect seen in those with a high density of CD73⁺ γδ T cells compared to those with CD73⁻ γδ T cells.

      As the reviewer pointed out, patients with a low density of CD73⁺ γδ T cells do not show significantly different survival outcomes compared to those with a low density of CD73⁻ γδ T cells (IC50 for low CD73⁺ = 6.0 years vs. IC50 for low CD73⁻ = 6.2 years). In response, we have revised the corresponding sentence in the text and included the IC50 values for greater clarity and informativeness (page 9).

      • figure 1, caption should include the word "patients" at the end, I guess.

      The modification has been done.

      • labelling and font can be improved in many panels, eg. the dot plots in Fig 2, panel B, right, same for panel C and D

      We appreciate the feedback on figure presentation. We have now updated Figure 2 with improved labeling, consistent font size, and enhanced resolution to ensure better readability across all panels, particularly panels B–D. The revised figure has been updated in the main manuscript.

      Reviewer #2 (Evidence, reproducibility and clarity (Required)):

      In this manuscript ("Deciphering the tumor-infiltrating CD73+ regulatory γδ T cell ecosystem associated with poor survival of patients with ovarian cancer"), Chabab et al. report on the phenotype and location of CD73+ γδ T cells in ovarian cancer. CD73+ γδ T cells can be immunosuppressive via the production of cytokines (IL-8, IL-10) and the expression of PD-L1. Here, the authors investigated the phenotype and location of CD73+ and -neg γδ T cells in ovarian cancers with a particular focus on the cells surrounding the γδ T cells in the tumour.

      Overall, the study is informative and well-performed. However, the way some of the data are presented does not allow to fully evaluate them. Besides this, this reviewer only has some minor comments.

      General comments:

      • The data provided in this manuscript are descriptive/correlative, and as such, causation cannot be inferred. Therefore, the language needs to reflect this; statements like "we investigated the impact of CD73+ regulatory γδ T cells in ovarian cancer" (L89) and "CD73+ γδ T cells were in close contact with more aggressive tumor cells" (L426), among others, are incorrect without functional data. The authors are advised to adjust the text throughout.

      We thank the reviewer for this thoughtful point. We have amended the text to make it consistent with the data.

      • Please make the figure legends self-explanatory without the need to search for the information in the M&M. For example, the graphs in fig1 and 3 contain many dots, but it is not explained what these dots represent. Please also add n for each experiment shown and state how often the experiment was performed independently.

      As requested by the reviewer, we have revised the figure legends to make them more explicit. We have indicated the number of biological replicates (n) and how many times each experiment was performed independently. This information has been added to each legend where consistent and relevant, to ensure clarity and reproducibility.

      • It would be helpful for the reader if abbreviations introduced in the M&M were also explained the first time they appeared in the results section.

      This point has been addressed as requested by the reviewer.

      • Please explain all abbreviations, e.g. FIGO, CST, NT5E, etc.
      • L235: typo 'that' instead of 'than'; L258 'reduced'; L259 'fig1d-f'; L451f twice 'CD73+'; 'naive' instead of 'naïve' throughout; SF2 legend: '2f' instead of '3f', SF9 legend: '1.105'.
      • L280ff: "Tumor cells ... were the most important cell type" - it may be clearer to use 'most frequent';

      All these points have been addressed.

      M&M - Please be consistent, if you provide catalogue numbers or dilutions (antibody, reagents) [which is good, maybe even adding the RRID number], do so for all items.

      This point has been addressed as requested by the reviewer.

      • The M&M does not state for the CAFs how long they were cultured before the supernatant was taken for the cytokine measurements.

      This point has been added in M&M section.

      • For the IL-6 ELISA, it is stated that the "cells were harvested"; what happened to them, and how do you get any SN from these cells?

      We have amended the protocol of IL-6 Elisa in M&M section for clarification.

      Figures Fig.1: - The authors used the word 'predict' in the heading, which seems not appropriate for a retrospective study; something like 'correlate' seems better.

      The word “predict” has been replaced by “correlate” as suggested by the reviewer.

      • Similarly, the title of the figure legends claims that the 'impact of γδ T cells' is shown, while only a correlation is presented.

      The title of the figure has been modified

      • For Fig1a-c, only summary data are presented. Please add exemplary pictures as well.

      Pictures of IF have been added as Supplementary Fig 1.

      • For Fig1d-f, the label for the x-axis is missing.

      The figure has been corrected.

      Fig.2 - It seems funny to call the patients 'naïve', maybe 'untreated' is clearer.

      We appreciate this suggestion and agree that ‘untreated’ is a clearer and more appropriate term in this context. We have replaced all instances of ‘naïve’ with ‘untreated’ throughout the manuscript to avoid ambiguity.

      • The graph in Fig2e does not allow comparing the cell frequencies properly. This would require either bar graphs or a table. Furthermore, the statistical analysis is missing. Without that, a statement like "associated with higher proportion of CAFs" (L265) is not supported.

      We thank the reviewer for this valuable observation. In response, we have replaced the original visualization in Figure 2E with grouped bar graphs showing the mean ± SEM of the relative proportions of each major cell type in the NT5E_low and NT5E_high groups, based on the median split. This format allows for clearer visual comparison of cell frequencies across conditions.

      Furthermore, we performed statistical comparisons using a t-test (a parametric test) on each population to evaluate differences in cell type proportions between the two groups. The results indicate a significantly higher proportion of CAFs and γδ T cells in the NT5E_high tumor profile. The corresponding p-values are provided in the figure legend. We hope this revised analysis and clearer presentation address the reviewer’s concerns.

      Fig.3 - For Fig3b+c, the IMC are derived from 4 patients (not clear for the flow data)

      As stated in both the figure legend and the text, the IMC analysis was conducted on 38 ROIs from four patient samples, while the flow cytometry analysis was performed on tumor samples from seven ovarian cancer patients.

      • did the authors noticed differences between patients?

      "As shown in new Figures 3b and 3c, no significant differences were observed between patients. Each individual patient is represented by a different color."

      • For Fig3e, the description in the text does not reflect the figure, e.g. cluster 1 does not show LAG3 expression, but this is claimed in the text (other descriptions are off as well).

      The text describing Fig. 3e has been amended in the new version of the manuscript.

      • In Fig3h, the authors stain cytokines in γδ T cells purified from ovarian cancer samples. The text seems to imply that the cytokine staining was performed directly ex vivo, without an in vitro stimulation of the cells, e.g. with PMA/ionomycin (if so, the description is missing). In any case, the values appear surprisingly high. Exemplary data are needed to clarify how the gating was done (for γδ T cells and the cytokines) and what the primary data looked like.

      The protocol has been amended in the “Materials and Methods” section. A gating strategy and primary data analysis from one representative patient are included in a supplementary Figure 4c.

      We agree with the reviewer’s comments that it is surprising that γδ T cell stimulation is not required for IL-8, IL10 and IFNγ production. However, one possible explanation is the high reactivity of γδ T cells compared to other T cell subsets, as well as their localization in the tumor microenvironment rather than in healthy tissue or blood.

      • In Fig3h, it is not clear what is meant with "IL-8 / IL-10", please explain.

      This analysis shows the percentage of cells that are positive for both IL-8 and IL-10.

      The figure and its legend have been amended for clarity.

      Fig.4 - Please provide the values and the statistical analyses for all cell populations.

      We performed statistical analyses (Wilcoxon signed-rank test) for all cell populations and provide the data in the Supplementary Fig. 5A. However, due to the heterogeneity of ROIs, a significant difference was observed for tumor cells, which were more prevalent more in the neighborhood of CD73- than CD73+ γδ T cells (p

      Fig.5/6 - In Fig5, the authors state that 8 cell populations were differentially enriched around CD73+ or -neg γδ T cells. However, in Fig4, only 4 of these populations are mentioned. Please add the remaining 4 to fig4 and name the 8 clusters in fig5 in line with the gating strategy used in fig4.

      We thank the reviewer for highlighting that the description of Figure 5 in our text was unclear. We have revised the text for clarification and specify that based on Supplementary Figure 7, which shows the number of cells for each cell type found in the neighborhood of all γδ T cell subsets (CD73- and CD73+) in all ROIs. We decided to perform phenotypic analysis on only four cell types (those with a sufficient cell counts), setting the cutoff at 700 cells.

      The four cell types are analyzed in Figures 5 and 6. Figure 5A shows tumor cells, with eight clusters identified, while Figure 5B represents fibroblasts, with seven clusters identified. Figure 6A shows CD4 T cells, with eight clusters, and Figure 6B CD8 T cells, with ten clusters.

      • Furthermore, the authors want to show in fig5 how the phenotype of these 8 cell populations differs depending on whether they are close to CD73+/- γδT cells. tSNE plots do not allow illustrating this (BTW: the plots lack the colour code). The frequencies of the cell types/phenotypes in the vicinity of CD73+/- γδ T cells need to be depicted differently (e.g. bar graphs). Furthermore, the claim that differences are observed, needs to be supported by showing the statistical values obtained. The same argument applies to Fig6 and SF8.

      We have added the code color of tSNE plots in Figures 5, 6, and SF9. The tables in Supplementary Figure 8 show the percentage of cells in each cluster within the vicinity of CD73+/- γδ T cells, allowing for an investigation of the neighborhood of each γδ T cell subset.

      • Fig6: This reviewer disagrees with the notion that the expression of HLA-DR or CD279 is enough to imply a functional state of the cell.

      As requested by the reviewer, we have amended the text to clarify that: “Cluster analysis revealed that CD4+ T cells in contact with effector γδ T cells (i.e., the CD73- subset) express HLA-DR and/or PD-1, both activation markers.”

      Supplements - SF2a: please check the labels; how can CD8+ CD4+ cells be labelled 'CD8 T cells' and why do the authors exclude the possibility that e.g. B cells could express HLA-DR?

      We thank the reviewer for pointing out the error in Figure 2a, which has now been corrected. The CD8+ cells have been relabeled as 'CD8 T cells,' and the B cells are now shown expressing HLA-DR.

      • SF7 is not clear to this reviewer. If the clusters represent different cell types, how can e.g. tumours be found in all of them?

      We believe the reviewer is referring to SF9 rather than SF7 in this comment. SF9 analyzes γδ T cells in proximity to CD73+ and CD73- γδ T cells. As in Figures 5 and 6, γδ T cell neighbors of CD73+ and CD73- γδ T cells were identified, and a clustering analysis revealed five distinct clusters. Tumor cells was not analyzed in this figure. We have clarified the text to prevent confusion

      • SF9b lacks a negative control and a statistical analysis, and SF9c lacks the summary data and statistical analysis.

      As requested by the reviewer, we have performed statistical analysis for SF9b and added a negative control. Additionally, we have included summary data with a statistical analysis in SF9c.

      • In the text, the authors state, "We and others reported that in ovarian tumors, IL-6 is mainly produced by CAFs and induces CD73 expression by γδ T cells (Extended Data Fig. 9 and 15)." The data in SF9b are not enough to make this claim and reference 15 is a review article that does not even mention 'IL-6'. This needs to be corrected.

      We have updated Supplementary Figure 9B to provide more robust data. We thank the reviewer for pointing out our error. The publication we intend to cite is a research article, not a review.” Hu G, Cheng P, Pan J, Wang S, Ding Q, Jiang Z, et al. An IL6-Adenosine Positive Feedback Loop between CD73+ γδ Tregs and CAFs Promotes Tumor Progression in Human Breast Cancer. Cancer Immunol Res. 2020;8:1273–86.” we made the correction in the manuscript.

      Reviewer #2 (Significance (Required)):

      In this manuscript ("Deciphering the tumor-infiltrating CD73+ regulatory γδ T cell ecosystem associated with poor survival of patients with ovarian cancer"), Chabab et al. report on the phenotype and location of CD73+ γδ T cells in ovarian cancer.

      CD73+ γδ T cells can be immunosuppressive via the production of cytokines (IL-8, IL-10) and the expression of PD-L1. Here, the authors investigated the phenotype and location of CD73+ and -neg γδ T cells in ovarian cancers with a particular focus on the cells surrounding the γδ T cells in the tumour.

      Overall, the study is informative and well-performed. However, the way some of the data are presented does not allow to fully evaluate them. Besides this, this reviewer only has some minor comments.

      To enable a full evaluation of the data, we have added new figures, amended others, and clarified certain points in the text, hoping that the reviewer will find these modifications sufficient to consider our manuscript for publication.

      Reviewer #3 (Evidence, reproducibility and clarity (Required)):

      In this article, Chabab et al. analyze sample from ovarian cancer patients, with a specific focus on gamma-delta T cells (Tγδ). The authors claim that CD73+ cells are associated with poor prognosis in ovarian cancer, and that CD73 expression is correlated with the composition and polarization of the microenvironment. Using imaging mass cytometry data, they also claim that the neighborhoods of CD73+ and CD73- Tγδ cells differs in composition.

      Major comments: - The prognostic value of CD73/NT5E is analyzed in TCGA-Ovarian RNAseq data. In the context of this article, it is implied that this should reflect CD73 expression by Tγδ but it is likely that other cell types are contributing to bulk CD73 expression.

      We appreciate the reviewer’s insightful comment. In fact, due to low proportion of Tγδ in TME we have stratified on NT5E total expression. We agree that this signal likely includes contributions from multiple cell types beyond γδ T cells, such as cancer-associated fibroblasts and endothelial cells, which are also known to express CD73 (NT5E gene).

      The stratification of patient based on NT5E total expression showed an association between high NT5E expression and poorer overall survival and increase in Tγδ gene markers (TRDC, TRGC1/2) and percentage of cells (Fig2E) in the patient cohort (Fig2C). To clarify this point, we have revised the Results and Discussion sections to explicitly state that the TCGA-based survival analysis reflects total intratumoral NT5E enrichment and cannot be attributed specifically to γδ T cells. We now refer to this analysis as an independent validation of the clinical relevance of CD73, while noting that its cell-type-specific contribution remains to be resolved in future studies using spatial transcriptomics or deconvolution approaches.

      • In the analysis of scRNAseq data, multiple public datasets are aggregated and the overall level of CD73 is used for stratification. Is this stratification confounded by dataset of origin?

      We thank the reviewer for raising this critical point regarding potential batch effects and dataset-driven bias in our stratification strategy. To address this, we performed additional analyses to assess whether NT5E (CD73) expression is confounded by dataset of origin.

      First, we verified that all single-cell datasets (GSE147082, GSE241221, and GSE235931) were processed using a harmonized integration workflow, including SCTransform normalization and integration using Seurat’s reciprocal PCA approach, which effectively minimizes batch-related variability.

      • The last part of the results discusses the role of IL6 produced by CAFs on Tγδ, but very little data is shown to support the proposed mechanisms. The authors report expression of CD73 by flow cytometry on blood-sorted Tγδ following culture with IL2, IL6, IL21. The data shown however only represents one donor and should therefore be repeated on multiple donors.

      We appreciate the reviewer’s insightful comment. We have added data and updated Supplementary Figure 9 to provide more robust findings. Regarding the role of IL-6, our data in ovarian cancer are consistent with the study by Hu et al. in breast cancer, which reports an IL-6-Adenosine Positive Feedback Loop between CD73+ γδ Tregs and CAFs that promotes tumor progression in human breast cancer."

      Minor comments:

      • The authors stratify their cohort by Tγδ density but I could not find the threshold used for stratification

      The threshold has been added in figure and text.

      • Labels for CD8+ and CD4+CD8+ T cells are swapped in Extended Data Fig 2A

      The correction of figure has been made.

      • The legend of graphs shown in multiple panels (for instance: Fig 3F) are not very clear: is each dot representing the average expression of one cluster in one patient?
      • In figure 3G there is no color scale, the authors need to add it with appropriate units so that readers can interpret the data shown

      These points have all been amended and corrected in the next version of the manuscript.

      Reviewer #3 (Significance (Required)):

      This paper shows interesting imaging mass cytometry data of ovarian cancer specimens. The focus on CD73 expression by Tγδ is fairly specific, although the exonucleotidases pathway involving CD73 is currently extensively studied for its immunosuppressive role.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      In this manuscript ("Deciphering the tumor-infiltrating CD73+ regulatory γδ T cell ecosystem associated with poor survival of patients with ovarian cancer"), Chabab et al. report on the phenotype and location of CD73+ gd T cells in ovarian cancer. CD73+ gd T cells can be immunosuppressive via the production of cytokines (IL-8, IL-10) and the expression of PD-L1. Here, the authors investigated the phenotype and location of CD73+ and -neg gd T cells in ovarian cancers with a particular focus on the cells surrounding the gd T cells in the tumour. Overall, the study is informative and well-performed. However, the way some of the data are presented does not allow to fully evaluate them. Besides this, this reviewer only has some minor comments.

      General comments:

      • The data provided in this manuscript are descriptive/correlative, and as such, causation cannot be inferred. Therefore, the language needs to reflect this; statements like "we investigated the impact of CD73+ regulatory γδ T cells in ovarian cancer" (L89) and "CD73+ γδ T cells were in close contact with more aggressive tumor cells" (L426), among others, are incorrect without functional data. The authors are advised to adjust the text throughout.
      • Please make the figure legends self-explanatory without the need to search for the information in the M&M. For example, the graphs in fig1 and 3 contain many dots, but it is not explained what these dots represent. Please also add n for each experiment shown and state how often the experiment was performed independently.
      • It would be helpful for the reader if abbreviations introduced in the M&M were also explained the first time they appeared in the results section.
      • Please explain all abbreviations, e.g. FIGO, CST, NT5E, etc.
      • L235: typo 'that' instead of 'than'; L258 'reduced'; L259 'fig1d-f'; L451f twice 'CD73+'; 'naive' instead of 'naïve' throughout; SF2 legend: '2f' instead of '3f', SF9 legend: '1.105'.
      • L280ff: "Tumor cells ... were the most important cell type" - it may be clearer to use 'most frequent';

      M&M

      • Please be consistent, if you provide catalogue numbers or dilutions (antibody, reagents) [which is good, maybe even adding the RRID number], do so for all items.
      • The M&M does not state for the CAFs how long they were cultured before the supernatant was taken for the cytokine measurements.
      • For the IL-6 ELISA, it is stated that the "cells were harvested"; what happened to them, and how do you get any SN from these cells?

      Figures

      Fig.1:

      • The authors used the word 'predict' in the heading, which seems not appropriate for a retrospective study; something like 'correlate' seems better.
      • Similarly, the title of the figure legends claims that the 'impact of gd T cells' is shown, while only a correlation is presented.
      • For Fig1a-c, only summary data are presented. Please add exemplary pictures as well.
      • For Fig1d-f, the label for the x-axis is missing.

      Fig.2

      • It seems funny to call the patients 'naïve', maybe 'untreated' is clearer.
      • The graph in Fig2e does not allow comparing the cell frequencies properly. This would require either bar graphs or a table. Furthermore, the statistical analysis is missing. Without that, a statement like "associated with higher proportion of CAFs" (L265) is not supported.

      Fig.3

      • For Fig3b+c, the IMC are derived from 4 patients (not clear for the flow data) - did the authors noticed differences between patients?
      • For Fig3e, the description in the text does not reflect the figure, e.g. cluster 1 does not show LAG3 expression, but this is claimed in the text (other descriptions are off as well).
      • In Fig3h, the authors stain cytokines in gd T cells purified from ovarian cancer samples. The text seems to imply that the cytokine staining was performed directly ex vivo, without an in vitro stimulation of the cells, e.g. with PMA/ionomycin (if so, the description is missing). In any case, the values appear surprisingly high. Exemplary data are needed to clarify how the gating was done (for gd T cells and the cytokines) and what the primary data looked like.
      • In Fig3h, it is not clear what is meant with "IL-8 / IL-10", please explain.

      Fig.4

      • Please provide the values and the statistical analyses for all cell populations.

      Fig.5/6

      • In Fig5, the authors state that 8 cell populations were differentially enriched around CD73+ or -neg gd T cells. However, in Fig4, only 4 of these populations are mentioned. Please add the remaining 4 to fig4 and name the 8 clusters in fig5 in line with the gating strategy used in fig4.
      • Furthermore, the authors want to show in fig5 how the phenotype of these 8 cell populations differs depending on whether they are close to CD73+/- gdT cells. tSNE plots do not allow illustrating this (BTW: the plots lack the colour code). The frequencies of the cell types/phenotypes in the vicinity of CD73+/- gd T cells need to be depicted differently (e.g. bar graphs). Furthermore, the claim that differences are observed, needs to be supported by showing the statistical values obtained. The same argument applies to Fig6 and SF8.
      • Fig6: This reviewer disagrees with the notion that the expression of HLA-DR or CD279 is enough to imply a functional state of the cell.

      Supplements

      • SF2a: please check the labels; how can CD8+ CD4+ cells be labelled 'CD8 T cells' and why do the authors exclude the possibility that e.g. B cells could express HLA-DR?
      • SF7 is not clear to this reviewer. If the clusters represent different cell types, how can e.g. tumours be found in all of them?
      • SF9b lacks a negative control and a statistical analysis, and SF9c lacks the summary data and statistical analysis.
      • In the text, the authors state, "We and others reported that in ovarian tumors, IL-6 is mainly produced by CAFs and induces CD73 expression by γδ T cells (Extended Data Fig. 9 and 15)." The data in SF9b are not enough to make this claim and reference 15 is a review article that does not even mention 'IL-6'. This needs to be corrected.

      Significance

      In this manuscript ("Deciphering the tumor-infiltrating CD73+ regulatory γδ T cell ecosystem associated with poor survival of patients with ovarian cancer"), Chabab et al. report on the phenotype and location of CD73+ gd T cells in ovarian cancer. CD73+ gd T cells can be immunosuppressive via the production of cytokines (IL-8, IL-10) and the expression of PD-L1. Here, the authors investigated the phenotype and location of CD73+ and -neg gd T cells in ovarian cancers with a particular focus on the cells surrounding the gd T cells in the tumour. Overall, the study is informative and well-performed. However, the way some of the data are presented does not allow to fully evaluate them. Besides this, this reviewer only has some minor comments.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary: Zhu et al., investigate the cellular defects in glia as a result of loss in DEGS1/ifc encoding the dihydroceramide desaturase. Using the strength of Drosophila and its vast genetic toolkit, they find that DEGS1/ifc is mainly expressed in glia and its loss leads to profound neurodegeneration. This supports a role for DEGS1 in the developing larval brain as it safeguards proper CNS development. Loss of DEGS1/ifc leads to dihydroceramide accumulation in the CNS and induces alteration in the morphology of glial subtypes and a reduction in glial number. Cortex and ensheathing glia appeared swollen and accumulated internal membranes. Astrocyte-glia on the other hand displayed small cell bodies, reduced membrane extension and disrupted organization in the dorsal ventral nerve cord. They also found that DEGS1/ifc localizes primarily to the ER. Interestingly, the authors observed that loss of DEGS1/ifc drives ER expansion and reduced TGs and lipid droplet numbers. No effect on PC and PE and a slight increase in PS.

      The conclusions of this paper are well supported by the data. The study could be further strengthened by a few additional controls and/or analyses.

      Strengths:

      This is an interesting study that provides new insight into the role of ceramide metabolism in neurodegeneration.

      The strength of the paper is the generation of LOF lines, the insertion of transgenes and the use of the UAS-GAL4/GAL80 system to assess the cell-autonomous effect of DEGS1/ifc loss in neurons and different glial subtypes during CNS development.

      The imaging, immunofluorescence staining and EM of the larval brain and the use of the optical lobe and the nerve cord as a readout are very robust and nicely done.

      Drosophila is a difficult model to perform core biochemistry and lipidomics but the authors used the whole larvae and CNS to uncover global changes in mRNA levels related to lipogenesis and the unfolded protein responses as well as specific lipid alterations upon DEGS1/ifc loss.

      Weaknesses:

      (1) The authors performed lipidomics and RTqPCR on whole larvae and larval CNS from which it is impossible to define the cell type-specific effects. Ideally, this could be further supported by performing single cell RNAseq on larval brains to tease apart the cell-type specific effect of DEGS1/ifc loss.

      We agree that using scRNAseq or pairing FACS-sorting of individual glial subtypes with bulk RNAseq would help tease apart the cell-type specific effects of DEGS1/ifc loss on glial cells. At this time, however, this approach extends beyond the scope of the current paper and means of the lab. 

      (2) It's clear from the data that the accumulation of dihydroceramide in the ER triggers ER expansion but it remains unclear how or why this happens. Additionally, the authors assume that, because of the reduction in LD numbers, that the source of fatty acids comes from the LDs. But there is no data testing this directly.

      As CERT, the protein that transports ceramide from the ER to the Golgi, is far more efficient at transporting ceramide than dihydroceramide, we speculate that dihydroceramide accumulates in the ER due to inefficient transport from the ER to the Golgi by CERT. We state this model more explicitly in the results under the subheading “Reduction of dihydroceramide synthesis suppresses the ifc CNS phenotype”.

      We agree with the point on lipid droplet. We observe a correlation, not a causation, between reduction of lipid droplets and a large expansion of ER membrane. We have tried to clarify the text in the last paragraph of the discussion to make this point more clearly. See also response to reviewer 2 point 3. 

      (3) The authors performed a beautiful EMS screen identifying several LOF alleles in ifc. However, the authors decided to only use KO/ifcJS3. The paper could be strengthened if the authors could replicate some of the key findings in additional fly lines.

      We agree. We replicated the observed cortex glia swelling, ER expansion in cortex glia, and observed increase in neuronal cell death markers in late-third instar larvae mutant for either the ifcjs1 or ifcjs2 allele. These data are now provided as Supplementary Figure 7.

      (4) The authors use M{3xP3-RFP.attP}ZH-51D transgene as a general glial marker. However, it would be advised to show the % overlap between the glial marker and the RFP since a lot of cells are green positive but not per se RFP positive and vice versa.

      We visually reexamined the expression of the 3xP3 RFP transgene relative to FABP labeling for cortex glia, Ebony for astrocyte-like glia, and the Myr-GFP transgene driven by glial-subtype specific GAL4 driver lines for perineurial, subperineurial, and ensheathing glia. We note that RFP localizes to the nucleus cytoplasm while FABP and Ebony localize to the cytoplasm and Myr-GFP to the cell membrane. Thus, an observed lack of overlap of expression between RFP and the other markers can arise to differential localization of the two markers in the same cells (see, for example, Fig. S2D where Myr-GFP expression in the nuclear envelope encircles that of RFP in the nucleus. Through visual inspection of five larval-brain complexes for each glial subtype marker, we found that essentially all cortex, SPG, and ensheathing glia expressed RFP. Similarly, nearly all astrocyte-like glia also expressed RFP, but they expressed RFP at significantly lower levels than that observed for cortex, SPG, or ensheathing glia. This analysis also confirmed that most perineurial glia do not express RFP. The 3xP3 M{3xP3-RFP.attP}ZH-51D transgene then labels most glia in the Drosophila CNS. We have added text to Supplementary Figure 2 noting the above observations as to which glial cells express RFP. 

      (5) The authors indicate that other 3xP3 RFP and GFP transgenes at other genomic locations also label most glia in the CNS. Do they have a preferential overlap with the different glial subtypes?

      We assessed three different types of 3xP3 RFP and GFP transgenes: M{3xP3RFP.attp} transgenes (n=4), Mi{GFP[E.3xP3]=ET1} transgenes (n=3), and

      Tl{GFP[3xP3.cLa]=CRIMIC.TG4} transgenes (n>6). All labeled cortex glia, but different lines exhibited differential labeling of astrocyte and ensheathing glia. These data are now included as Supplementary Figure 3.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Zhu et al. describes phenotypes associated with the loss of the gene ifc using a Drosophila model. The authors suggest their findings are relevant to understanding the molecular underpinnings of a neurodegenerative disorder, HLD-18, which is caused by mutations in the human ortholog of ifc, DEGS1.

      The work begins with the authors describing the role for ifc during fly larval brain development, demonstrating its function in regulating developmental timing, brain size, and ventral nerve cord elongation. Further mechanistic examination revealed that loss of ifc leads to depleted cellular ceramide levels as well as dihydroceramide accumulation, eventually causing defects in ER morphology and function. Importantly, the authors showed that ifc is predominantly expressed in glia and is critical for maintaining appropriate glial cell numbers and morphology. Many of the key phenotypes caused by the loss of fly ifc can be rescued by overexpression of human DEGS1 in glia, demonstrating the conserved nature of these proteins as well as the pathways they regulate. Interestingly, the authors discovered that the loss of lipid droplet formation in ifc mutant larvae within the cortex glia, presumably driving the deficits in glial wrapping around axons and subsequent neurodegeneration, potentially shedding light on mechanisms of HLD-18 and related disorders.

      Strengths:

      Overall, the manuscript is thorough in its analysis of ifc function and mechanism. The data images are high quality, the experiments are well controlled, and the writing is clear.

      Weaknesses:

      (1) The authors clearly demonstrated a reduction in number of glia in the larval brains of ifc mutant flies. What remains unclear is whether ifc loss leads to glial apoptosis or a failure for glia to proliferate during development. The authors should distinguish between these two hypotheses using apoptotic markers and cell proliferation markers in glia.

      To address this point, we used phospho-histone H3 to assess mitotic index in the thoracic CNS of wild-type versus ifc mutant late third instar larvae and found a mild, but significant reduction in mitotic index in ifc mutant relative to wild-type nerve cords. We also assessed the ability of glial-specific expression of the potent anti-apoptotic gene p35 to rescue the observed loss of cortex glia phenotype in the thoracic region of the CNS of otherwise ifc mutant larvae and observed a clear increase in cortex glia in the presence versus the absence of glial-specific p35 expression (p<3 x 10-4). These data are now provided as Supplementary Figure S8 in the paper and referred to on page 8.

      (2) It is surprising that human DEGS1 expression in glia rescues the noted phenotypes despite the different preference for sphingoid backbone between flies and mammals. Though human DEGS1 rescued the glial phenotypes described, can animal lethality be rescued by glial expression of human DEGS1? Are there longer-term effects of loss of ifc that cannot be compensated by the overexpression of human DEGS1 in glia (age-dependent neurodegeneration, etc.)?

      We note explicitly that while glial expression of human DEGS1 does provide rescuing activity, it only partially rescues the ifc mutant CNS phenotype in contrast to glial expression of Drosophila ifc, which fully rescues this phenotype. Thus, the relative activity of human DEGS1 is far below that of Drosophila ifc when assayed in flies. To quantify the functional difference between the two transgenes, we assessed the ability of glial expression of fly ifc or of human DEGS1 to rescue the lethality of otherwise ifc mutant larvae: Glial expression of ifc was sufficient to rescue the adult viability of 57.9% of ifc mutant flies based on expected Mendelian ratios (n=2452), whereas glial expression of DEGS1 was sufficient to rescue just 3.9% of ifc mutant flies (n=1303), uncovering a ~15-fold difference in the ability of the two transgenes to rescue the lethality of otherwise ifc mutant flies. In the absence of either transgene, no ifc mutant larvae reached adulthood (n=1030). These data are now provided in the text on page 9 of the revised manuscript. 

      (3) The mechanistic link between the loss of ifc and lipid droplet defects is missing. How do defects in ceramide metabolism alter triglyceride utilization and storage? While the author's argument that the loss of lipid droplets in larval glia will lead to defects in neuronal ensheathment, a discussion of how this is linked to ceramides needs to be added.

      We have revised the text to address this point. We speculate that the apparent increased demand for membrane phospholipid synthesis may drive the depletion of lipid droplets, providing a link to ifc function and ceramides. Below we provide the rewritten last paragraph; the underlined section is the new text.  

      “The expansion of ER membranes coupled with loss of lipid droplets in ifc mutant larvae suggests that the apparent demand for increased membrane phospholipid synthesis may drive lipid droplet depletion, as lipid droplet catabolism can release free fatty acids to serve as substrates for lipid synthesis. At some point, the depletion of lipid droplets, and perhaps free fatty acids as well, would be expected to exhaust the ability of cortex glia to produce additional membrane phospholipids required for fully enwrapping neuronal cell bodies. Under wild-type conditions, many lipid droplets are present in cortex glia during the rapid phase of neurogenesis that occurs in larvae. During this phase, lipid droplets likely support the ability of cortex glia to generate large quantities of membrane lipids to drive membrane growth needed to ensheathe newly born neurons. Supporting this idea, lipid droplets disappear in the adult Drosophila CNS when neurogenesis is complete and cortex glia remodeling stops. We speculate that lipid droplet loss in ifc mutant larvae contributes to the inability of cortex glia to enwrap neuronal cell bodies. Prior work on lipid droplets in flies has focused on stress-induced lipid droplets generated in glia and their protective or deleterious roles in the nervous system. Work in mice and humans has found that more lipid droplets are often associated with the pathogenesis of neurodegenerative diseases, but our work correlates lipid droplet loss with CNS defects. In the future, it will be important to determine how lipid droplets impact nervous system development and disease.”

      (4) On page 10, the authors use the words "strong" and "weak" to describe where ifc is expressed. Since the use of T2A-GAL4 alleles in examining gene expression is unable to delineate the amount of gene expression from a locus, the terms "broad" and "sparse" labeling (or similar terms) should be used instead.

      The ifc T2A-GAL4 insert in the ifc locus reports on the transcription of the gene. We agree that GAL4 system will not reflect amount of gene expression differences when the expression levels are not dramatically different. However, when the expression levels differ dramatically, as in our case, GAL4 system can reflect this difference in the expression of a reporter gene.  We reworded this section to suggest that ifc is transcribed at higher levels in glia as compared to neurons. We can’t use sparse or broad, as ifc is expressed in all, or at least in most, glia and neurons. The new text is as follows:” Using this approach, we observed strong nRFP expression in all glial cells (Figures 4D and S10A) and modest nRFP expression in all neurons (Figures 4E and S10B), suggesting ifc is transcribed at higher levels in glial cells than neurons in the larval CNS.”  

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript, the authors report three novel ifc alleles: ifc[js1], ifc[js2], and ifc[js3]. ifc[js1] and ifc[js2] encode missense mutations, V276D and G257S, respectively. ifc[js3] encodes a nonsense mutation, W162*. These alleles exhibit multiple phenotypes, including delayed progression to the late-third larval instar stage, reduced brain size, elongation of the ventral nerve cord, axonal swelling, and lethality during late larval or early pupal stages.

      Further characterization of these alleles the authors reveals that ifc is predominantly expressed in glia and localizes to the endoplasmic reticulum (ER). The expression of ifc gene governs glial morphology and survival. Expression of fly ifc cDNA or human DEGS1 cDNA specifically in glia, but not neurons, rescues the CNS phenotypes of ifc mutants, indicating a crucial role for ifc in glial cells and its evolutionary conservation. Loss of ifc results in ER expansion and loss of lipid droplets in cortex glia. Additionally, loss of ifc leads to ceramide depletion and accumulation of dihydroceramide. Moreover, it increases the saturation levels of triacylglycerols and membrane phospholipids. Finally, the reduction of dihydroceramide synthesis suppresses the CNS phenotypes associated with ifc mutations, indicating the key role of dihydroceramide in causing ifc LOF defects.

      Strengths:

      This manuscript unveils several intriguing and novel phenotypes of ifc loss-of-function in glia. The experiments are meticulously planned and executed, with the data strongly supporting their conclusions.

      Weaknesses:

      I didn't find any obvious weakness.

      Reviewer #1 (Recommendations For The Authors):

      Additional minor comments below:

      (1) The authors state that TGs are the building blocks of membrane phospholipids. This is not exactly true. The breakdown of TGs can result in free FAs which can be used for membrane phospholipid synthesis. Also, membrane phospholipids can also be generated from free FAs that were never in TGs.

      To address this point, we have reworked a number of sentences in the text. On page 12 we reworded two small sections to the following: 

      “In the CNS, lipid droplets form primarily in cortex glia[29] and are thought to contribute to membrane lipid synthesis through their catabolism into free fatty acids versus acting as an energy source in the brain.[41] Consistent with the possibility that increased membrane lipid synthesis drives lipid droplet reduction, RNA-seq assays of dissected nerve cords revealed that loss of ifc drove transcriptional upregulation of genes that promote membrane lipid biogenesis”

      As TG breakdown results in free fatty acids that can be used for membrane phospholipid synthesis, we asked if changes in TG levels and saturation were reflected in the levels or saturation of the membrane phospholipids phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS).

      (2) Figure 5J what does the dotted line indicate? Please specify in the figure legend or remove it.

      We have added the following text in the figure legend: Dotted line indicates a log2 fold change of 0.5 in the treatment group compared to the control group.

      (3) The text for your graphs is hard to read. Please make the font larger.

      We have increased font size to enhance the readability of the figures.

      (4) The authors mentioned that driving ifc expression in neurons rescues the phenotypes (ref 17). While the glial-specific role presented in this study is robust. I think some readers would appreciate some discussion of this study in light of the data presented here.

      We have added the below text on page 10 to address this point.

      “Results of our gene rescue experiments conflict with a prior study on ifc in which expression of ifc in neurons was found to rescue the ifc phenotype. In this context, we note that elav-GAL4 drives UASlinked transgene expression not just in neurons, but also in glia at appreciable levels, and thus needs to be paired with repo-GAL80 to restrict GAL4-mediated gene expression to neurons. Thus, “off-target” expression in glial cells may account for the discrepant results. It is, however, more difficult to reconcile how neuronal or glial expression of ifc would rescue the observed lethality of the ifc-KO chromosome given the presence additional lethal mutations in the 21E2 region of the second chromosome.”

      (5) While the analysis of fatty acid saturation is experimentally well done. I'm not really sure what the significance of this data is.

      We included this information as a reference for future analysis of additional genes in the ceramide biogenesis pathway, as we expect that alteration of the levels and saturation levels of PE, PC, and PS in cell membranes may underlie key changes in the biophysical properties of glial cell membranes and their ability to enwrap or infiltrate their targets. Thus, we expect the significance of these data to grow as more work is done on additional members of the ceramide pathway in the nervous system in flies and other systems.  

      Reviewer #2 (Recommendations For The Authors):

      (1) There is a typo at the top of page 11: "internal membranes and fail enwrap neurons" is missing the word "to" before "enwrap"

      The typo was fixed.

      (2)  PMID: 36718090 should be included in the discussion of SPT and ORMDL complex in human disease.

      The reference was added.

      Reviewer #3 (Recommendations For The Authors):

      In this manuscript, the authors report three novel ifc alleles: ifc[js1], ifc[js2], and ifc[js3]. ifc[js1] and ifc[js2] encode missense mutations, V276D and G257S, respectively. ifc[js3] encodes a nonsense mutation, W162*. These alleles exhibit multiple phenotypes, including delayed progression to the late-third larval instar stage, reduced brain size, elongation of the ventral nerve cord, axonal swelling, and lethality during late larval or early pupal stages.

      Further characterization of these alleles the authors reveals that ifc is predominantly expressed in glia and localizes to the endoplasmic reticulum (ER). The expression of ifc gene governs glial morphology and survival. Expression of fly ifc cDNA or human DEGS1 cDNA specifically in glia, but not neurons, rescues the CNS phenotypes of ifc mutants, indicating a crucial role for ifc in glial cells and its evolutionary conservation. Loss of ifc results in ER expansion and loss of lipid droplets in cortex glia. Additionally, loss of ifc leads to ceramide depletion and accumulation of dihydroceramide. Moreover, it increases the saturation levels of triacylglycerols and membrane phospholipids. Finally, the reduction of dihydroceramide synthesis suppresses the CNS phenotypes associated with ifc mutations, indicating the key role of dihydroceramide in causing ifc LOF defects.

      In summary, this manuscript unveils several intriguing and novel phenotypes of ifc loss-of-function in glia. The experiments are meticulously planned and executed, with the data strongly supporting their conclusions. I have no additional comments and fully support the publication of this manuscript in eLife.

      The authors also note that they added one paragraph to the discussion that addresses the possibility that the increased detection of cell death markers could arise due to the inability of glial cells to remove cellular debris. The text of this paragraph is provided below:

      We note that cortex glia are the major phagocytic cell of the CNS and phagocytose neurons targeted for apoptosis as part of the normal developmental process.23-26  Thus, while we favor the model that ifc triggers neuronal cell death due to glial dysfunction, it is also possible that increased detection of dying neurons arises due at least in part to a decreased ability of cortex glia to clear dying neurons from the CNS. At present, the large number of neurons that undergo developmentally programmed cell death combined with the significant disruption to brain and ventral nerve cord morphology caused by loss of ifc function render this question difficult to address.Additional evidence does, however, support the idea that loss of ifc function drives excess neuronal cell death: Clonal analysis in the fly eye reveals that loss of ifc drives photoreceptor neuron degeneration17, indicating that loss of ifc function drives neuronal cell death; cortex-glia specific depletion of CPES, which acts downstream of ifc, disrupts neuronal function and induces photosensitive epilepsy in flies59, indicating that genes in the ceramide pathway can act nonautonomously in glia to regulate neuronal function; recent genetic studies reveal that other glial cells can compensate for impaired cortex glial cell function by phagocytosing dying neurons62, and we observe that the cell membranes of subperineurial glia enwrap dying neurons in ifc mutant larvae (Fig. S14), consistent with similar compensation occurring in this background, and in humans, loss of function mutations in DEGS1 cause neurodegeneration.7-9 Clearly, future work is required to address this question for ifc/DEGS1 and perhaps other members of the ceramide biogenesis pathway.

    1. Reviewer #2 (Public review):

      Summary:

      The authors aimed to investigate how IL-4 modulates the reactive state of microglia in the context of neuropathic pain. Specifically, they sought to determine whether IL-4 drives an increase in CD11c+ microglial cells, a population associated with anti-inflammatory responses, and whether this change is linked to the suppression of neuropathic pain. The study employs a combination of behavioral assays, pharmacogenetic manipulation of microglial populations, and characterization of microglial markers to address these questions.

      Strengths:

      Strengths: The methodological approach in this study is robust, providing convincing evidence for the proposed mechanism of IL-4-mediated microglial regulation in neuropathic pain. The experimental design is well thought out, utilizing two distinct neuropathic pain models (SpNT and SNI), each yielding different outcomes. The SpNT model demonstrates spontaneous pain remission and an increase in the CD11c+ microglial population, which correlates with pain suppression. In contrast, the SNI model, which does not show spontaneous pain remission, lacks a significant increase in CD11c+ microglia, underscoring the specificity of the observed phenomenon. This design effectively highlights the role of the CD11c+ microglial population in pain modulation. The use of behavioral tests provides a clear functional assessment of IL-4 manipulation, and pharmacogenetic tools allow for precise control of microglial populations, minimizing off-target effects. Notably, the manipulation targets the CD11c promoter, which presumably reduces the risk of non-specific ablation of other microglial populations, strengthening the experimental precision. Moreover, the thorough characterization of microglial markers adds depth to the analysis, ensuring that the changes in microglial populations are accurately linked to the behavioral outcomes.

      Weaknesses:

      One potential limitation of the study is that the mechanistic details of how IL-4 induces the observed shift in microglial populations are not fully explored. While the study demonstrates a correlation between IL-4 and CD11c+ microglial cells, a deeper investigation into the specific signaling pathways and molecular processes driving this population shift would greatly strengthen the conclusions. Additionally, the paper does not clearly integrate the findings into the broader context of microglial reactive state regulation in neuropathic pain.

      Comments on revisions:

      In the revised manuscript, the authors have successfully addressed my previous concerns as well as the other reviewers. I do not have further concerns about this study.

    2. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):  

      Summary: 

      Kohno et al. examined whether the anti-inflammatory cytokine IL-4 attenuates neuropathic pain by promoting the emergence of antinociceptive microglia in the dorsal horn of the spinal cord. In two models of neuropathic pain following peripheral nerve injury, intrathecal administration of IL-4 once a day for 3 days from day 14 to day 17 after injury, attenuates hypersensitivity to mechanical stimuli in the hind paw ipsilateral to nerve injury. Such an antinociceptive effect correlates with a higher number of CD11c+microglia in the dorsal horn of the spinal cord which is the termination area for primary afferent fibres injured in the periphery. Interestingly, CD11c+ microglia emerge spontaneously in the dorsal horn in concomitance with the resolution of pain in the spinal nerve model of pain, but not in the spared nerve injury model where pain does not resolve, confirming that this cluster of microglia is involved in resolution pain. 

      Based on existing evidence that the receptor for IL-4, namely IL-4R, is expressed by microglia, the authors suggest that IL-4R mediates IL-4 effect in microglia including up-regulation of Igf1 mRNA. They have previously reported that IGF-1 can attenuate pain neuron activity in the spinal cord. 

      Strengths:

      This study includes cutting-edge techniques such as flow cytometry analysis of microglia and transgenic mouse models. 

      Weaknesses:

      The conclusion of this paper is supported by data, but the interpretation of some data requires clarification.  

      We appreciate the reviewer's careful reading of our paper.  According to the reviewer's comments, we have performed new immunohistochemical experiments and added some discussion in the revised manuscript (please see the point-by-point responses below).

      Reviewer #2 (Public review):

      Summary:

      The authors aimed to investigate how IL-4 modulates the reactive state of microglia in the context of neuropathic pain. Specifically, they sought to determine whether IL-4 drives an increase in CD11c+ microglial cells, a population associated with anti-inflammatory responses and whether this change is linked to the suppression of neuropathic pain. The study employs a combination of behavioral assays, pharmacogenetic manipulation of microglial populations, and characterization of microglial markers to address these questions. 

      Strengths: 

      The methodological approach in this study is robust, providing convincing evidence for the proposed mechanism of IL-4-mediated microglial regulation in neuropathic pain. The experimental design is well thought out, utilizing two distinct neuropathic pain models (SpNT and SNI), each yielding different outcomes. The SpNT model demonstrates spontaneous pain remission and an increase in the CD11c+ microglial population, which correlates with pain suppression. In contrast, the SNI model, which does not show spontaneous pain remission, lacks a significant increase in CD11c+ microglia, underscoring the specificity of the observed phenomenon. This design effectively highlights the role of the CD11c+ microglial population in pain modulation. The use of behavioral tests provides a clear functional assessment of IL-4 manipulation, and pharmacogenetic tools allow for precise control of microglial populations, minimizing off-target effects. Notably, the manipulation targets the CD11c promoter, which presumably reduces the risk of non-specific ablation of other microglial populations, strengthening the experimental precision. Moreover, the thorough characterization of microglial markers adds depth to the analysis, ensuring that the changes in microglial populations are accurately linked to the behavioral outcomes. 

      Weaknesses: 

      One potential limitation of the study is that the mechanistic details of how IL-4 induces the observed shift in microglial populations are not fully explored. While the study demonstrates a correlation between IL-4 and CD11c+ microglial cells, a deeper investigation into the specific signaling pathways and molecular processes driving this population shift would greatly strengthen the conclusions. Additionally, the paper does not clearly integrate the findings into the broader context of microglial reactive state regulation in neuropathic pain.  

      We thank the reviewer for these insightful comments on our paper.  As the reviewer's suggested, further investigation of the specific signaling pathways and molecular processes by which IL-4 induces a transition of spinal microglia to the CD11c+ state would strengthen our conclusion and also provide important clues to discovering new therapeutic targets.  In revising the manuscript, we have included this in the Discussion section (line 264-267), and we hope that future studies clarify these points.  As for the additional comment, we have added a brief summary of existing research on microglial function in neuropathic pain at the beginning of the Discussion section (line 188–196).

      Reviewer #1 (Recommendations for the authors):

      The conclusions of this paper are supported by data, but the interpretation of some data requires clarification. 

      (1) In Figure 1D and Figure 7 C, CD11c+ microglia numbers are higher in contralateral dorsal horns after IL-4 administration despite IL-4 having no effect on pain thresholds. The authors should discuss these findings.  

      As the reviewer pointed out, IL-4 increased the number of CD11c<sup>+</sup> microglia in the contralateral spinal dorsal horn (SDH) but did not affect pain thresholds in the contralateral hindpaw.  The data seem to be related to the selective effect of CD11c+ microglia and their factors (especially IGF1) on nerve injury-induced pain hypersensitivity.  In fact, depletion of CD11c+ spinal microglia and intrathecal administration of IGF1 do not elevate pain threshold of the contralateral hindpaw (Science 376: 86–90, 2022).  We have added above statement in the Discussion section (line 208– 213).

      (2)  Do monocytes infiltrate the dorsal horn and DRG after intrathecal injections?

      To address this reviewer's comment, we performed new immunohistochemical experiments to analyze monocytes in the SDH using an antibody for CD169 (a marker for bone marrow-derived monocytes/macrophages, but not for resident microglia) (J Clin Invest 122: 3063– 3087, 2012; Cell Rep 3: 605–614, 2016) and found no CD169+ monocytes in the SDH parenchyma after SpNT.  Consistent with this data, we have previously demonstrated that few bone marrow-derived monocytes/macrophages are recruited to the SDH after SpNT (Sci Rep 6: 23701, 2016).  Similarly, no CD169+ monocytes in the SDH parenchyma were observed in SpNT mice treated intrathecally with PBS or IL-4 (Figure 1—figure supplement 1A).

      In the DRG, CD169 is constitutively expressed in macrophages.  Thus, in accordance with a recent report showing that monocytes infiltrating the DRG are positive for chemokine (C-C motif) receptor 2 (CCR2) (J Exp Med 221: e20230675, 2024), we analyzed CCR2+ cells and found that CCR2+ IBA1dim monocytes were observed in the capsule and parenchyma of the DRG of naive mice (Figure 1—figure supplement 1B).  After SpNT, CCR2+ IBA1dim monocytes in the DRG parenchyma increased.  Intrathecal treatment of IL-4 increased CCR2+ IBA1dim cells in the DRG capsule.  However, the involvement of these monocytes in the DRG in IL-4-induced alleviation of neuropathic pain is unclear and warrants further investigation.  In revising the manuscript, we have included additional data (Figure 1—figure supplement 1) and corresponding text in the Results (line 112–114) and Discussion section (line 218–222).

      (3) In Figure 4, depletion of CD11c+ cells in dorsal root ganglia (DRG) ameliorates neuropathic thresholds but does not alter the anti-nociceptive effect of IL-4 injected intrathecal. It appears that CD11c+ macrophages in DRG have an opposite role to CD11c+ microglia in the spinal cord. Please discuss this result. 

      We apologize for the confusion.  The aim of the experiments in Figure 4 was to examine the contribution of CD11c+ cells in the DRG to the pain-alleviating effect of intrathecal IL-4.  For this aim, we depleted CD11c+ cells in the DRG (but not in the SDH) by intraperitoneal injection of diphtheria toxin (DTX) immediately after the behavioral measurements performed on day 17 (Fig. 4A, B).  On day 18, the paw withdrawal threshold of DTX-treated mice was almost similar to that of PBS-treated mice, indicating that the depletion of CD11c+ cells in the DRG does not affect the pain-alleviating effect of IL-4.  These data are in stark contrast to those obtained from mice with depletion of CD11c+ cells in the SDH by intrathecal DTX (the depletion canceled the IL-4's effect) (Figure 2A).  Thus, it is conceivable that CD11c+ cells in the DRG are not involved in the IL-4-induced alleviating effect on neuropathic pain.  Because the confusion might be related to the statement in this paragraph of the initial version, we thus modified our statements to make this point more clearly (line 133–139).

      Reviewer #2 (Recommendations for the authors):

      A discussion addressing how these results fit into existing research on microglial function in pain would enhance the study's impact.

      A brief summary of existing research on microglial function in neuropathic pain has been included at the beginning of the Discussion section (line 188–196).

      It would be helpful for the authors to elaborate on the implications of their findings within the larger landscape of immune regulation in neuropathic pain.

      Our present findings showed an ability of IL-4, known as a T-cell-derived factor, to increase CD11c+ microglia and to control neuropathic pain.  Furthermore, recent studies have also indicated that immune cells such as CD8+ T cells infiltrating into the spinal cord (Neuron 113: 896-911.e9, 2025), and regulatory T cells (eLife 10: e69056, 2021; Science 388: 96–104, 2025) and MRC1+ macrophages in the spinal meninges (Neuron 109: 1274–1282, 2021) have important roles in regulating microglial states and neuropathic pain.  Thus, these findings provide new insights into the mechanisms of the neuro-immune interactions that regulate neuropathic pain.  In revising the manuscript, we have added above statement in the Discussion section (line 254–260).

      Furthermore, a discussion on how these findings could inform the development of targeted therapies that modulate microglial populations in a controlled, disease-specific manner would be valuable. Exploring how these insights could lead to novel treatment strategies for neuropathic pain could provide important future directions for the research and broader clinical applications.

      We appreciate the reviewer's valuable suggestion.  Our current data, demonstrating that IL-4 increases CD11c+ microglia without affecting the total number of microglia, could open a new avenue for developing strategies to modulate microglial subpopulations through molecular targeting, which may lead to new analgesics.  However, given IL-4's association with allergic responses, targeting microglia-selective molecules involved in shifting microglia toward the CD11c+ state—such as intracellular signaling molecules downstream of IL-4 receptors—may offer a more selective and safer therapeutic approach.  Moreover, since CD11c+ microglia have been implicated in other CNS diseases [e.g., Alzheimer disease (Cell 169: 1276–1290, 2017), amyotrophic lateral sclerosis (Nat Neurosci 25: 26–38, 2022), and multiple sclerosis (Front Cell Neurosci 12: 523, 2019)], further investigations into the mechanisms driving CD11c+ microglia induction could provide insights into novel therapeutic strategies not only for neuropathic pain but also for other CNS diseases.  In revising the manuscript, we have added above statement in the Discussion section (line 260–271).

    1. Reviewer #1 (Public review):

      The study by Lotonin et al. investigates correlates of protection against African swine fever virus (ASFV) infection. The study is based on a comprehensive work, including the measurement of immune parameters using complementary methodologies. An important aspect of the work is the temporal analysis of the immune events, allowing for the capture of the dynamics of the immune responses induced after infection. Also, the work compares responses induced in farm and SPF pigs, showing the latter an enhanced capacity to induce a protective immunity. Overall, the results obtained are interesting and relevant for the field. The findings described in the study further validate work from previous studies (critical role of virus-specific T cell responses) and provide new evidence on the importance of a balanced innate immune response during the immunization process. This information increases our knowledge on basic ASF immunology, one of the important gaps in ASF research that needs to be addressed for a more rational design of effective vaccines. Further studies will be required to corroborate that the results obtained based on the immunization of pigs by a not completely attenuated virus strain are also valid in other models, such as immunization using live attenuated vaccines.

      While overall the conclusions of the work are well supported by the results, I consider that the following issues should be addressed to improve the interpretation of the results:

      (1) An important issue in the study is the characterization of the infection outcome observed upon Estonia 2014 inoculation. Infected pigs show a long period of viremia, which is not linked to clinical signs. Indeed, animals are recovered by 20 days post-infection (dpi), but virus levels in blood remain high until 141 dpi. This is uncommon for ASF acute infections and rather indicates a potential induction of a chronic infection. Have the authors analysed this possibility deeply? Are there lesions indicative of chronic ASF in infected pigs at 17 dpi (when they have sacrificed some animals) or, more importantly, at later time points? Does the virus persist in some tissues at late time points, once clinical signs are not observed? Has all this been tested in previous studies?

      (2) Virus loads post-Estonia infection significantly differ from whole blood and serum (Figure 1C), while they are very similar in the same samples post-challenge. Have the authors validated these results using methods to quantify infectious particles, such as Hemadsorption or Immunoperoxidase assays? This is important, since it would determine the duration of virus replication post-Estonia inoculation, which is a very relevant parameter of the model.

      (3) Related to the previous points, do the authors consider it expected that the induction of immunosuppressive mechanisms during such a prolonged virus persistence, as described in humans and mouse models? Have the authors analysed the presence of immunosuppressive mechanisms during the virus persistence phase (IL10, myeloid-derived suppressor cells)? Have the authors used T cell exhausting markers to immunophenotype ASFV Estonia-induced T cells?

      (4) A broader analysis of inflammatory mediators during the persistence phase would also be very informative. Is the presence of high VLs at late time points linked to a systemic inflammatory response? For instance, levels of IFN are still higher at 11 dpi than at baseline, but they are not analysed at later time points.

      (5) The authors observed a correlation between IL1b in serum before challenge and protection. The authors also nicely discuss the potential role of this cytokine in promoting memory CD4 T cell functionality, as demonstrated in mice previously. However, the cells producing IL1b before ASFV challenge are not identified. Might it be linked to virus persistence in some organs? This important issue should be discussed in the manuscript.

      (6) The lack of non-immunized controls during the challenge makes the interpretation of the results difficult. Has this challenge dose been previously tested in pigs of the age to demonstrate its 100% lethality? Can the low percentage of protected farm pigs be due to a modulation of memory T and B cell development by the persistence of the virus, or might it be related to the duration of the immunity, which in this model is tested at a very late time point? Related to this, how has the challenge day been selected? Have the authors analysed ASFV Estonia-induced immune responses over time to select it?

      (7) Also, non-immunized controls at 0 dpc would help in the interpretation of the results from Figure 2C. Do the authors consider that the pig's age might influence the immune status (cytokine levels) at the time of challenge and thus the infection outcome?

      (8) Besides anti-CD2v antibodies, anti-C-type lectin antibodies can also inhibit hemadsorption (DOI: 10.1099/jgv.0.000024). Please correct the corresponding text in the results and discussion sections related to humoral responses as correlates of protection. Also, a more extended discussion on the controversial role of neutralizing antibodies (which have not been analysed in this study), or other functional mechanisms such as ADCC against ASFV would improve the discussion.

    2. Author Response:

      Reviewer #1 (Public review):

      The study by Lotonin et al. investigates correlates of protection against African swine fever virus (ASFV) infection. The study is based on a comprehensive work, including the measurement of immune parameters using complementary methodologies. An important aspect of the work is the temporal analysis of the immune events, allowing for the capture of the dynamics of the immune responses induced after infection. Also, the work compares responses induced in farm and SPF pigs, showing the latter an enhanced capacity to induce a protective immunity. Overall, the results obtained are interesting and relevant for the field. The findings described in the study further validate work from previous studies (critical role of virus-specific T cell responses) and provide new evidence on the importance of a balanced innate immune response during the immunization process. This information increases our knowledge on basic ASF immunology, one of the important gaps in ASF research that needs to be addressed for a more rational design of effective vaccines. Further studies will be required to corroborate that the results obtained based on the immunization of pigs by a not completely attenuated virus strain are also valid in other models, such as immunization using live attenuated vaccines.

      While overall the conclusions of the work are well supported by the results, I consider that the following issues should be addressed to improve the interpretation of the results:

      We thank Reviewer #1 for their thoughtful and constructive feedback, which will significantly contribute to improving the clarity and quality of our manuscript. Below, we respond to each of the reviewer’s comments and outline the revisions we plan to incorporate.

      (1) An important issue in the study is the characterization of the infection outcome observed upon Estonia 2014 inoculation. Infected pigs show a long period of viremia, which is not linked to clinical signs. Indeed, animals are recovered by 20 days post-infection (dpi), but virus levels in blood remain high until 141 dpi. This is uncommon for ASF acute infections and rather indicates a potential induction of a chronic infection. Have the authors analysed this possibility deeply? Are there lesions indicative of chronic ASF in infected pigs at 17 dpi (when they have sacrificed some animals) or, more importantly, at later time points? Does the virus persist in some tissues at late time points, once clinical signs are not observed? Has all this been tested in previous studies?

      Tissue samples were tested for viral loads only at 17 dpi during the immunization phase, and long-term persistence of the virus in tissues has not been assessed in our previous studies. At 17 dpi, lesions were most prominently observed in the lymph nodes of both farm and SPF pigs. In a previous study using the Estonia 2014 strain (doi: 10.1371/journal.ppat.1010522), organs were analyzed at 28 dpi, and no pathological signs were detected. This finding calls into question the likelihood of chronic infection being induced by this strain.

      (2) Virus loads post-Estonia infection significantly differ from whole blood and serum (Figure 1C), while they are very similar in the same samples post-challenge. Have the authors validated these results using methods to quantify infectious particles, such as Hemadsorption or Immunoperoxidase assays? This is important, since it would determine the duration of virus replication post-Estonia inoculation, which is a very relevant parameter of the model.

      We did not perform virus titration but instead used qPCR as a sensitive and standardized method to assess viral genome loads. Although qPCR does not distinguish between infectious and non-infectious virus, it provides a reliable proxy for relative viral replication and clearance dynamics in this model. Unfortunately, no sample material remains from this experiment, but we agree that subsequent studies employing infectious virus quantification would be valuable for further refining our understanding of viral persistence and replication following Estonia 2014 infection.

      (3) Related to the previous points, do the authors consider it expected that the induction of immunosuppressive mechanisms during such a prolonged virus persistence, as described in humans and mouse models? Have the authors analysed the presence of immunosuppressive mechanisms during the virus persistence phase (IL10, myeloid-derived suppressor cells)? Have the authors used T cell exhausting markers to immunophenotype ASFV Estonia-induced T cells?

      We agree with the reviewer that the lack of long-term protection can be linked to immunosuppressive mechanisms, as demonstrated for genotype I strains (doi: 10.1128/JVI.00350-20). The proposed markers were not analyzed in this study but represent important targets for future investigation. We will address this point in the discussion.

      (4) A broader analysis of inflammatory mediators during the persistence phase would also be very informative. Is the presence of high VLs at late time points linked to a systemic inflammatory response? For instance, levels of IFNa are still higher at 11 dpi than at baseline, but they are not analysed at later time points.

      While IFN-α levels remain elevated at 11 dpi, this response is typically transient in ASFV infection and likely not linked to persistent viremia. We agree that analyzing additional inflammatory markers at later time points would be valuable, and future studies should be designed to further understand viral persistence.

      (5) The authors observed a correlation between IL1b in serum before challenge and protection. The authors also nicely discuss the potential role of this cytokine in promoting memory CD4 T cell functionality, as demonstrated in mice previously. However, the cells producing IL1b before ASFV challenge are not identified. Might it be linked to virus persistence in some organs? This important issue should be discussed in the manuscript.

      We agree that identifying the cellular source of IL-1β prior to challenge is important, and this should be addressed in subsequent studies. We will include a discussion on the potential link between elevated IL-1β levels and virus persistence in certain organs.

      (6) The lack of non-immunized controls during the challenge makes the interpretation of the results difficult. Has this challenge dose been previously tested in pigs of the age to demonstrate its 100% lethality? Can the low percentage of protected farm pigs be due to a modulation of memory T and B cell development by the persistence of the virus, or might it be related to the duration of the immunity, which in this model is tested at a very late time point? Related to this, how has the challenge day been selected? Have the authors analysed ASFV Estonia-induced immune responses over time to select it?

      In our previous study, intramuscular infection with ~3–6 × 10² TCID₅₀/mL led to 100% lethality (doi: 10.1371/journal.ppat.1010522), which is notably lower than the dose used in the present study, although the route here was oronasal. The modulation of memory responses could be more thoroughly assessed in future studies using exhaustion markers. The challenge time point was selected based on the clearance of the virus from blood and serum. We agree that the lack of protection in some animals is puzzling and warrants further investigation, particularly to assess the role of immune duration, potential T cell exhaustion caused by viral persistence, or other immunological factors that may influence protection. Based on our experience, vaccine virus persistence alone does not sufficiently explain the lack-of-protection phenomenon. We will incorporate these important aspects into the revised discussion.

      (7) Also, non-immunized controls at 0 dpc would help in the interpretation of the results from Figure 2C. Do the authors consider that the pig's age might influence the immune status (cytokine levels) at the time of challenge and thus the infection outcome?

      We support the view that including non-immunized controls at 0 dpc would strengthen the interpretation of cytokine dynamics and will consider this in future experimental designs. Regarding age, while all animals were within a similar age range at the time of challenge, we acknowledge that age-related differences in immune status could influence baseline cytokine levels and infection outcomes, and this is an important factor to consider.

      (8) Besides anti-CD2v antibodies, anti-C-type lectin antibodies can also inhibit hemadsorption (DOI: 10.1099/jgv.0.000024). Please correct the corresponding text in the results and discussion sections related to humoral responses as correlates of protection. Also, a more extended discussion on the controversial role of neutralizing antibodies (which have not been analysed in this study), or other functional mechanisms such as ADCC against ASFV would improve the discussion.

      The relevant text in the Results and Discussion sections will be revised accordingly, and the discussion will be extended to more thoroughly address the roles of antibodies.

      Reviewer #2 (Public review):

      Summary:

      In the current study, the authors attempt to identify correlates of protection for improved outcomes following re-challenge with ASFV. An advantage is the study design, which compares the responses to a vaccine-like mild challenge and during a virulent challenge months later. It is a fairly thorough description of the immune status of animals in terms of T cell responses, antibody responses, cytokines, and transcriptional responses, and the methods appear largely standard. The comparison between SPF and farm animals is interesting and probably useful for the field in that it suggests that SPF conditions might not fully recapitulate immune protection in the real world. I thought some of the conclusions were over-stated, and there are several locations where the data could be presented more clearly.

      Strengths:

      The study is fairly comprehensive in the depth of immune read-outs interrogated. The potential pathways are systematically explored. Comparison of farm animals and SPF animals gives insights into how baseline immune function can differ based on hygiene, which would also likely inform interpretation of vaccination studies going forward.

      Weaknesses:

      Some of the conclusions are over-interpreted and should be more robustly shown or toned down. There are also some issues with data presentation that need to be resolved and data that aren't provided that should be, like flow cytometry plots.

      We appreciate the feedback from the Reviewer #2 and acknowledge the concerns raised regarding data presentation. In the revised manuscript, we will clarify our conclusions where needed and ensure that interpretations are better aligned with the data shown.

    1. Reviewer #1 (Public review):

      Summary:

      Li et al describe a novel form of melanosome based iridescence in the crest of an Early Cretaceous enantiornithine avialan bird from the Jehol Group.

      This is an interesting manuscript that describes never before seen melanosome structures and explores fossilised feathers through new methods. This paper creates an opening for new work to explore coloration in extinct birds.

      Strengths:

      A novel set of methods applied to the study of fossil melanosomes.

      Comments on revised version:

      The authors provided a response to the previous 9 issues, for which additional response is provided here:

      (1) I respectfully disagree with the authors justification regarding the crest. They show one specimen of Confuciusornis with short feathers (which appears to be a unique feature of this species, possibly related to the fact it is beaked) but what about the more primitive Eoconfuciusornis, a referred specimen of which superficially has an enormous "crest" (Zheng et al 2017), as does Changchengornis (Ji et al 1999). Regardless, it would make more sense compare this new specimen to other enantiornithines. Although limited by the preservation of body feathers, which is not all that common, the following published enantiornithines also exhibit a "crest": bohaiornithid indet. (Peteya et al 2017); Brevirostruavis (Li et al 2021); Dapingfangornis (Li et al 2006); Eoenantiornis (Zhou et al 2005); Grabauornis (Dalsatt etal 2014); Junornis (Liu et al 2017); Longirostravis (Hou etal 2004); Monoenantiornis (Hu & O'Connor 2016); Neobohaiornis (Shen etal 2024); Orienantiornis (Liu etal 2019); Parabohaironis (Wang 2023); Parapengornis (Hu etal 2015); Paraprotopteryx (Zheng et al 2007); and every specimen of Protopteryx. In fact, every single published enantiornithine that preserves any feathering on the head has the feathers preserved perpendicular to the bone (in fact, the body feathers on all parts of the bed are splayed at a right angle to the bone due to compression), as shown in the confuciuornis specimen image provided by the authors. Since it is highly improbable they all had crests, the authors have no justification for the interpretation that this new specimen was crested. This does not mean that the feathers were not iridescent or take away from the novel methods these authors have used to explore preserved feathers.

      (2) Yes, this is possible, but see above for the very strong argument against interpretation of these feathers as forming a crest.

      (3) This just further makes the point that the isolated feather is not likely from the head. Since the neck feathers are missing, it is more likely that it is these feathers that have been disarticulated (and sampled) from the neck region rather than from the very complete looking head feathers; this has significant implications with regards to the birds colour pattern.

      (4) Thank you for acknowledging taphonomy.

      (5) An interesting hypothesis and one I look forward to seeing explored in the future.

      (6) Since the compression is in a single direction, in fact it is not reasonable to assume that distortion would be random. One might predict similar distortion, as with the feathers (spread out from the bone at a 90˚ angle) and bone (crushed), which are all compressed in a single direction. However, I agree that such a consistent discovery suggests it is not an artifact of preservation, and only further studies will elucidate this

      (7) I still fail to detect this hexagonal pattern - could machine learning be used to quantify this pattern? The random arrangement of white arrows does little to clarify the authors interpretations.

      (8) Great to see additional sampling

      (9) Thank you for the explanation.

    1. Author Response:

      The following is the authors’ response to the previous reviews

      Reviewer #1 (Public Review):

      Summary:

      This paper introduces a new class of machine learning models for capturing how likely a specific nucleotide in a rearranged IG gene is to undergo somatic hypermutation. These models modestly outperform existing state-of-the-art efforts, despite having fewer free parameters. A surprising finding is that models trained on all mutations from non-functional rearrangements give divergent results from those trained on only silent mutations from functional rearrangements.

      Strengths:

      (1) The new model structure is quite clever and will provide a powerful way to explore larger models.

      (2) Careful attention is paid to curating and processing large existing data sets.

      (3) The authors are to be commended for their efforts to communicate with the developers of previous models and use the strongest possible versions of those in their current evaluation.

      Thank you very much for your comments. We especially appreciate the last comment, as we have indeed tried hard to do so.

      Weaknesses:

      (1) 10x/single cell data has a fairly different error profile compared to bulk data. A synonymous model should be built from the same briney dataset as the base model to validate the difference between the two types of training data.

      Thank you for pointing this out.

      We have repeated the same analysis with synonymous mutations derived from the bulk-sequenced tang dataset for Figure 4 and the supplementary figure. The conclusion remains the same. We used tang because only the out-of-frame sequences were available to us for the briney dataset, as we were using preprocessing from the Spisak paper.<br /> The fact that both the 10x and the tang data give the same results bolsters our claim.

      (2) The decision to test only kernels of 7, 9, and 11 is not described. The selection/optimization of embedding size is not explained. The filters listed in Table 1 are not defined.

      We have added the following to the Models subsection to further explain these decisions:

      “The hyperparameters for the models (Table 1) were selected with a run of Optuna (Akiba et al., 2019) early in the project and then fixed. Further optimization was not pursued because of the limited performance differences between the existing models.”

      Reviewer #2 (Public Review):

      Summary:

      This work offers an insightful contribution for researchers in computational biology, immunology, and machine learning. By employing a 3-mer embedding and CNN architecture, the authors demonstrate that it is possible to extend sequence context without exponentially increasing the model's complexity.

      Key findings:

      (1) Efficiency and Performance: Thrifty CNNs outperform traditional 5-mer models and match the performance of significantly larger models like DeepSHM.

      (2)Neutral Mutation Data: A distinction is made between using synonymous mutations and out-of-frame sequences for model training, with evidence suggesting these methods capture different aspects of SHM or different biases.

      (3) Open Source Contributions: The release of a Python package and pre-trained models adds practical value for the community.

      Thank you for your positive comments. We believe that we have been clear about the modest improvements (e.g., the abstract says “slight improvement”), and we discuss the data limitations extensively. If there are ways we can do this more effectively, we are happy to hear them.

      Reviewer #3 (Public Review):

      Summary:

      Sung et al. introduce new statistical models that capture a wider sequence context of somatic hypermutation with a comparatively small number of additional parameters. They demonstrate their model’s performance with rigorous testing across multiple subjects and datasets.

      Strengths:

      Well-motivated and defined problem. Clever solution to expand nucleotide context. Complete separation of training and test data by using different subjects for training vs testing. Release of open-source tools and scripts for reproducibility.

      Thank you for your positive comments.

      Weaknesses:

      This study could be improved with better descriptions of dataset sequencing technology, sequencing depth, etc.

      We have added columns to Table 3 that report sequencing technology and depth for each dataset.

      Reviewer #1 (Recommendations for the Authors):

      (1) There seems to be a contradiction between Tables 2 and 3 as to whether the Tang et al. dataset was used to train models or only to test them.

      Thank you for catching this. The "purpose" column in Table 3 was for the main analysis, while Table 2 is describing only models trained to compare with DeepSHM. Explaining this seems more work than it's worth, so we simply removed that column from Table 2. The dataset purposes are clear from the text.

      (2) In Figure 4, I assume the two rows correspond to the Briney and Tang datasets, as in Figure 2, but this is not explicitly described.

      Yes, you are correct. We added an explanation in the caption of Figure 4.

      (3) Figure 2, supplement 1 should include a table like Table 1 that describes these additional models.

      We have added an explanation in the caption to Table 1 that "Medium" and "Large" refer to specific hyperparameter choices. The caption to Figure 2, supplement 1 now describes the corresponding hyperparameter choices for "Small" thrifty models.

      (4) On line 378 "Therefore in either case" seems extraneous.

      Indeed. We have dropped those words.

      (5) In the last paragraph of the Discussion, only the attempt to curate the Ford dataset is described. I am not sure if you intended to discuss the Rodriguez dataset here or not.

      Thank you for pointing this out. We have updated the Materials and Methods section to include our attempts to recover data from Rodriguez et al., 2023.

      (6) Have you looked to see if Soto et al. (Nature 2019) provides usable data for your purposes?

      Thank you for making us aware of this dataset!

      We assessed it but found that the recovery of usable out-of-frame sequences was too low to be useful for our analysis. We now describe this evaluation in the paper.

      (7) Cui et al. note a high similarity between S5F and S5NF (r=0.93). Does that constrain the possible explanations for the divergence you see?

      This is an excellent point.

      We don't believe the correlation observed in Cui and our results are incompatible. Our point is not that the two sources of neutral data are completely different but that they differ enough to limit generalization. Also, the Spearman correlation in Cui is 0.86, which aligns with our observed drop in R-precision.

      (8) Are you able to test the effects of branch length or background SHM on the model?

      We're unsure what is meant by “background SHM.”<br /> We did try joint optimization of branch length and model parameters, but it did not improve performance. Differences in clone size thresholds do exist between datasets, but Figure 3 suggests that tang is better sequence data.

      (9) Would the model be expected to scale up to a kernel of, say, 50? Would that help yield biological insight?

      We did not test such large models because larger kernels did not improve performance.

      While your suggestion is intriguing, distinguishing biological effects from overfitting would be difficult. We explore biological insights more directly in our recent mechanistic model paper (Fisher et al., 2025), which is now cited in a new paragraph on biological conclusions.

      Reviewer #2 (Recommendations for the Authors):

      (1) Consider applying a stricter filtration approach to the Briney dataset to make it more comparable to the Tang dataset.

      Thank you. We agree that differences in datasets are interesting, though model rankings remain consistent. We now include supplementary figures comparing synonymous and out-of-frame models from the tang dataset.

      (2) You omit mutations between the unmutated germline and the MRCA of each tree. Why?

      The inferred germline may be incorrect due to germline variation or CDR3 indels, which could introduce spurious mutations. Following Spisak et al. (2020), we exclude this branch.<br /> Yes, singletons are discarded: ~28k in tang and ~1.1M in jaffe.

      (3) Could a unified model trained on both data types offer further insights?

      We agree and present such an analysis in Figure 4.

      (4) Tree inference biases from parent-child distances may impact the results.

      While this is an important issue, all models are trained on the same trees, so we expect any noise or bias to be consistent. Different datasets help confirm the robustness of our findings.

      (5) Simulations would strengthen validation.

      We focused on real datasets, which we view as a strength. While simulations could help, designing a meaningful simulation model would be nontrivial. We have clarified this point in the manuscript.

      Reviewer #3 (Recommendations for the Authors):

      There are typos in lines 109, 110, 301, 307, and 418.

      Thank you, we have corrected them.

    1. Author Response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The authors revisit the specific domains/signals required for the redirection of an inner nuclear membrane protein, emerin, to the secretory pathway. They find that epitope tagging influences protein fate, serving as a cautionary tale for how different visualisation methods are used. Multiple tags and lines of evidence are used, providing solid evidence for the altered fate of different constructs.

      Strengths:

      This is a thorough dissection of domains and properties that confer INM retention vs secretion to the PM/lysosome, and will serve the community well as a caution regarding the placement of tags and how this influences protein fate.

      Weaknesses:

      Biogenesis pathways are not explored experimentally: it would be interesting to know if the lysosomal pool arrives there via the secretory pathway (eg by engineering a glycosylation site into the lumenal domain) or by autophagy, where failed insertion products may accumulate in the cytoplasm and be degraded directly from cytoplasmic inclusions.

      This manuscript is a Research Advance that follows previous work that we published in eLife on this topic (Buchwalter et al., eLife 2019; PMID 31599721). In that prior publication, we showed that emerin-GFP arrives at the lysosome by secretion and exposure at the PM, followed by internalization. While we state these previous findings in this manuscript, we did not explicitly restate here how we came to that conclusion. In the 2019 study, we (i) engineered in a glycosylation site, which demonstrated that emerin-GFP receives complex, Endo H-resistant N-glycans, indicating passage through the Golgi; (ii) performed cell surface labeling, which confirmed that emerin accesses the PM; and interfered with (iii) the early secretory pathway using brefeldin A and with (iv) lysosomal function using bafilomycin A1. Further, we ruled out autophagy as a major contributor to emerin trafficking by treating cells with the PI3K inhibitor KU55933, which had no effect on emerin’s lysosomal delivery.

      It would be helpful if the topology of constructs could be directly demonstrated by pulse-labelling and protease protection. It's possible that there are mixed pools of both topologies that might complicate interpretation.

      We demonstrate that emerin’s TMD inserts in a tail-anchored orientation (C terminus in ER lumen) by appending a GFP tag to either the N or C terminus, followed by anti-GFP antibody labeling of unpermeabilized cells (Fig. 1G). This shows the preferred topology of emerin’s wild type TMD.

      As the reviewer points out, it is possible that our manipulations of the TMD sequence (Fig. 2D-E) alter its preferred topology of membrane insertion. We addressed this question by performing anti-GFP and anti-emerin antibody labeling of the less hydrophobic TMD mutant (EMD-TMDm-GFP) after selective permeabilization of the plasma membrane (Figure 2 supplement, panel F). If emerin biogenesis is normal, the GFP tag should face the ER lumen while the emerin antibody epitope should be cytosolic. If the fidelity of emerin’s membrane insertion is impaired, the GFP tag could be exposed to the cytosol (flipped orientation), which would be detected by anti-GFP labeling upon plasma membrane permeabilization. We find that the C-terminal GFP tag is completely inaccessible to antibody when the PM is selectively permeabilized with digitonin, but is readily detected when all intracellular membranes are permeabilized with Triton-X-100. These data confirm that mutating emerin’s TMD does not disrupt the protein’s membrane topology.

      Reviewer #2 (Public review):

      In this manuscript, Mella et al. investigate the effect of GFP tagging on the localization and stability of the nuclear-localized tail-anchored (TA) protein Emerin. A previous study from this group showed that C-terminally GFP-tagged Emerin protein traffics to the plasma membrane and reaches lysosomes for degradation. It is suggested that the C-terminal tagging of tail-anchored proteins shifts their insertion from the post-translational TRC/GET pathway to the co-translational SRP-mediated pathway. The authors of this paper found that C-terminal GFP tagging causes Emerin to localize to the plasma membrane and eventually reach lysosomes. They investigated the mechanism by which Emerin-GFP moves to the secretory pathway. By manipulating the cytosolic domain and the hydrophobicity of the transmembrane domain (TMD), the authors identify that an ER retention sequence and strong TMD hydrophobicity contribute to Emerin trafficking to the secretory pathway. Overall, the data are solid, and the knowledge will be useful to the field. However, the authors do not fully answer the question of why C-terminally GFP-tagged Emerin moves to the secretory pathway. Importantly, the authors did not consider the possible roles of GFP in the ER lumen influencing Emerin trafficking to the secretory pathway.

      Reviewer #2 (Recommendations for the authors):

      Major concerns:

      (1) The authors suggest that an ER retention sequence and high hydrophobicity of Emerin TMD contribute to its trafficking to the secretory pathway. However, these two features are also present in WT Emerin, which correctly localizes to the inner nuclear membrane. Additionally, the authors show that the ER retention sequence is normally obscured by the LEM domain. The key difference between WT Emerin and Emerin-GFP is the presence of GFP in the ER lumen. The authors missed investigating the role of GFP in the ER lumen in influencing Emerin trafficking to the secretory pathway. It is likely that COPII carrier vesicles capture GFP protein in the lumen as part of the bulk flow mechanism for transport to the Golgi compartment. The authors could easily test this by appending a KDEL sequence to the C-terminus of GFP; this should now redirect the protein to the nucleus.

      We agree with the reviewer’s point that the presence of lumenal GFP somehow promotes secretion of emerin from the ER, likely at the stage of enhancing its packaging into COPII vesicles. We struggle to think about how to interpret the KDEL tagging experiment that the reviewer proposes, as the KDEL receptor predominantly recycles soluble proteins from the Golgi to the ER, while emerin is a membrane protein; and we have shown that emerin already contains a putative COPI-interacting RRR recycling motif in its cytosolic domain.

      Nevertheless, we agree with the reviewer that it is worthwhile to test the possibility that addition of GFP to emerin’s C-terminus promotes capture by COPII vesicles. We have evaluated this question by performing temperature block experiments to cause cargo accumulation within stalled COPII-coated ER exit sites, then comparing the propensity of various untagged and tagged emerin variants to enrich in ER exit sites as judged by colocalization with the COPII subunit Sec31a. These data now appear in Figure 4 supplement 1. These experiments indicate that emerin-GFP samples ER exit sites significantly more than does untagged emerin. Further, the ER exit site enrichment of emerin-GFP is dampened by shortening emerin’s TMD. We do not see further enrichment of any emerin variant in ER exit sites when COPII vesicle budding is stalled by low temperature incubation, implying that emerin lacks any positive sorting signals that direct its selective enrichment in COPII vesicles. Altogether, these data indicate that both emerin’s long and hydrophobic TMD and the addition of a lumenal GFP tag increase emerin’s propensity to sample ER exit sites and undergo non-selective, “bulk flow” ER export.

      (2) The authors nicely demonstrate that the hydrophobicity of Emerin TMD plays a role in its secretory trafficking. I wonder if this feature may be beneficial for cells to degrade newly synthesized Emerin via the lysosomal pathway during mitosis, as the nuclear envelope breakdown may prevent the correct localization of newly synthesized Emerin. The authors could test Emerin localization during mitosis. Such findings could add to the physiological significance of their findings. At the minimum, they should discuss this possibility.

      We thank the reviewer for this insightful suggestion. It is attractive to speculate that secretory trafficking might enable lysosomal degradation of emerin during mitosis, when its lamin anchor has been depolymerized. However, we think it is unlikely that mitotic trafficking contributes significantly to the turnover flux of untagged emerin; if it did, we would expect to see higher steady state levels and/or slowed turnover of emerin mutants that cannot traffic to the lysosome. We did not observe this outcome. Instead, mutations that enhance (RA) or impair (TMDm) emerin trafficking had no effect on the untagged protein’s steady-state levels (Fig. 4G).

      Minor concerns:

      (1) On page 7, the authors note that "FLAG-RA construct was not poorly expressed relative to WR, in contrast with RA-GFP (Figures S3C, 2I)." The expression levels of these proteins cannot be compared across two different blots.

      We apologize for this confusion; we were implying two distinct comparisons to internal controls present on each blot. We have adjusted the text to read “FLAG-RA construct was not poorly expressed relative to FLAG-WT (Fig. S3C) in contrast to RA-GFP compared to WT-GFP (Fig. 2I).”

      (2) In the first paragraph of the discussion, the authors suggest that aromatic amino acids facilitate trafficking to lysosomes. However, they only replaced aromatic amino acids with alanine residues. If they want to make this claim, they should test other amino acids, particularly hydrophobic amino acids such as leucine.

      The reviewer may be inferring more import from our statement than we intended. We focused on these aromatic residues within the TMD because they contribute strongly to its overall hydrophobicity. Experimentally, we determined that nonconservative alanine substitutions of these aromatic residues inhibited trafficking. We do not state and do not intend to imply that the aromatic character of these residues specifically influences trafficking propensity, and we agree with the reviewer that to test such a question would require additional substitutions with non-aromatic hydrophobic amino acids.

      We realize that our phrasing may have been misleading by opening with discussion of the aromatic amino acids; in the revised discussion paragraph, we instead lead with discussion of TMD hydrophobicity, and then state how the specific substitutions we made affect trafficking.

      Reviewing Editor comments:

      While reviewer 1 did not provide any recommendations to the authors, I agree with this reviewer that the authors should validate the topology of their tagged proteins (at least for the one used to draw key conclusions). Given that Emerin is a tail-anchored protein, having a big GFP tag at the C-terminus could mess up ER insertion, causing the protein to take a wrong topology or even be mislocalized in the cytosol, particularly under overexpression conditions. In either case, it can be subject to quality control-dependent clearance via either autophagy, ERphagy, or ER-to-lysosome trafficking. I think that the authors should try a few straightforward experiments such as brefeldin A treatment or dominant negative Sar1 expression to test whether blocking conventional ER-to-Golgi trafficking affects lysosomal delivery of Emerin. I also think that the authors should discuss their findings in the context of the RESET pathway reported previously (PMID: 25083867). The ER stress-dependent trafficking of tagged Emerin to the PM and lysosomes appears to follow a similar trafficking pattern as RESET, although the authors did not demonstrate that Emerin traffic to lysosomes via the PM. In this regard, they should tone down their conclusion and discuss their findings in the context of the RESET pathway, which could serve as a model for their substrate.

      We agree that validating the topology of TMD mutants is important, and now include these experiments in the revised manuscript (please see our response to Reviewer 1 above).

      Please see our response to Reviewer 1’s public review; we previously determined that emerin-GFP undergoes ER-to-Golgi trafficking (see our 2019 study).

      We recognize the major parallels between our findings and the RESET pathway. In our 2019 study, we found that similarly to other RESET cargoes, emerin-GFP travels through the secretory pathway, is exposed at the PM, and is then internalized and delivered to lysosomes. We discussed these strong parallels to RESET in our 2019 study. In this revised manuscript, we now also point out the parallels between emerin trafficking and RESET and cite the 2014 study by Satpute-Krishnan and colleagues (PMID 25083867)

    1. Author Response:

      The following is the authors response to the original reviews.

      Reviewer #1 (Public review): 

      Summary: 

      The authors report four cryoEM structures (2.99 to 3.65 Å resolution) of the 180 kDa, full-length, glycosylated, soluble Angiotensin-I converting enzyme (sACE) dimer, with two homologous catalytic domains at the N- and C-terminal ends (ACE-N and ACE-C). ACE is a protease capable of effectively degrading Aβ. The four structures are C2 pseudo-symmetric homodimers and provide insight into sACE dimerization. These structures were obtained using discrete classification in cryoSPARC and show different combinations of open, intermediate, and closed states of the catalytic domains, resulting in varying degrees of solvent accessibility to the active sites. 

      To deepen the understanding of the gradient of heterogeneity (from closed to open states) observed with discrete classification, the authors performed all-atom MD simulations and continuous conformational analysis of cryo-EM data using cryoSPARC 3DVA, cryoDRGN, and RECOVAR. cryoDRGN and cryoSPARC 3DVA revealed coordinated open-closed transitions across four catalytic domains, whereas RECOVAR revealed independent motion of two ACE-N domains, also observed with cryoSPARC-focused classification. The authors suggest that the discrepancy in the results of the different methods for continuous conformational analysis in cryo-EM could result from different approaches used for dimensionality reduction and trajectory generation in these methods. 

      Strengths: 

      This is an important study that shows, for the first time, the structure and the snapshots of the dynamics of the full-length sACE dimer. Moreover, the study highlights the importance of combining insights from different cryo-EM methods that address questions difficult or impossible to tackle experimentally while lacking ground truth for validation. 

      Weaknesses: 

      The open, closed, and intermediate states of ACE-N and ACE-C in the four cryo-EM structures from discrete classification were designated quantitatively (based on measured atomic distances on the models fitted into cryo-EM maps, Figure 2D). Unfortunately, atomic models were not fitted into cryo-EM maps obtained with cryoSPARC 3DVA, cryoDRGN, and RECOVAR, and the open/closed states in these cases were designated based on qualitative analysis. As the authors clearly pointed out, there are many other methods for continuous conformational heterogeneity analysis in cryo-EM. Among these methods, some allow analyzing particle images in terms of atomic models, like MDSPACE (Vuillemot et al., J. Mol. Biol. 2023, 435:167951), which result in one atomic model per particle image and can help in analyzing cooperativity of domain motions through measuring atomic distances or angular differences between different domains (Valimehr et al., Int. J. Mol. Sci. 2024, 25: 3371). This could be discussed in the article. 

      Reviewer #2 (Public review): 

      Summary: 

      The manuscript presents a valuable contribution to the field of ACE structural biology and dynamics by providing the first complete full-length dimeric ACE structure in four distinct states. The study integrates cryo-EM and molecular dynamics simulations to offer important insights into ACE dynamics. The depth of analysis is commendable, and the combination of structural and computational approaches enhances our understanding of the protein's conformational landscape. However, the strength of evidence supporting the conclusions needs refinement, particularly in defining key terms, improving structural validation, and ensuring consistency in data analysis. Addressing these points through major revisions will significantly improve the clarity, rigor, and accessibility of the study to a broader audience, allowing it to make a stronger impact in the field. 

      Strengths: 

      The integration of cryo-EM and MD simulations provides valuable insights into ACE dynamics, showcasing the authors' commitment to exploring complex aspects of protein structure and function. This is a commendable effort, and the depth of analysis is appreciated. 

      Weaknesses: 

      Several aspects of the manuscript require further refinement to improve clarity and scientific rigor as detailed in my recommendations for the authors. 

      Reviewer #3 (Public review): 

      Summary: 

      Mancl et al. report four Cryo-EM structures of glycosylated and soluble Angiotensin-I converting enzyme (sACE) dimer. This moves forward the structural understanding of ACE, as previous analysis yielded partially denatured or individual ACE domains. By performing a heterogeneity analysis, the authors identify three structural conformations (open, intermediate open, and closed) that define the openness of the catalytic chamber and structural features governing the dimerization interface. They show that the dimer interface of soluble ACE consists of an N-terminal glycan and protein-protein interaction region, as well as C-terminal protein-protein interactions. Further heterogeneity mining and all-atom molecular dynamic simulations show structural rearrangements that lead to the opening and closing of the catalytic pocket, which could explain how ACE binds its substrate. These studies could contribute to future drug design targeting the active site or dimerization interface of ACE. 

      Strengths: 

      The authors make significant efforts to address ACE denaturation on cryo-EM grids, testing various buffers and grid preparation techniques. These strategies successfully reduce denaturation and greatly enhance the quality of the structural analysis. The integration of cryoDRGN, 3DVA, RECOVAR, and all-atom simulations for heterogeneity analysis proves to be a powerful approach, further strengthening the overall experimental methodology. 

      Weaknesses: 

      In general, the findings are supported by experimental data, but some experimental details and approaches could be improved. For example, CryoDRGN analysis is limited to the top 5 PCA components for ease of comparison with cryoSPARC 3DVA, but wouldn't an expansion to more components with CryoDRGN potentially identify further conformational states? The authors also say that they performed heterogeneity analysis on both datasets but only show data for one. The results for the first dataset should be shown and can be included in supplementary figures. In addition, the authors mention that they were not successful in performing cryoSPARC 3DFLex analysis, but they do not show their data or describe the conditions they used in the methods section. These data should be added and clearly described in the experimental section. 

      Some cryo-EM data processing details are missing. Please add local resolution maps, box sizes, and Euler angle distributions and reference the initial PDB model used for model building. 

      Reviewer #1 (Recommendations for the authors): <br /> Major point: 

      The authors could discuss the use of continuous conformational heterogeneity analysis methods that analyze particle images in terms of atomic models, based on MD simulations, like MDSPACE (Vuillemot et al., J. Mol. Biol. 2023, 435:167951). MDSPACE can be used on a dataset preprocessed with cryoSPARC or Relion by discrete classification to reduce compositional heterogeneity and obtain initial particle poses. It results in one atomic model per particle image and can help in analyzing the cooperativity of domain motions by measuring atomic distances or angular differences between different domains (Valimehr et al., Int. J. Mol. Sci. 2024, 25: 3371). 

      We agree that MDSPACE is a promising and useful tool for analysis, and are excited to implement such a method. Prior to manuscript submission, we have had discussions with the primary author, Slavica Jonic, about how we may employ her software in our analysis. Unfortunately, we were unable to overcome significant computational issues, notably MDSPACE’s lack of GPU functionality, which prevent us from employing MDSPACE in a reasonable manner for our dataset. We hope to employ MDSPACE in future work, once the computational issues have been addressed, and have added a section on MDSPACE to the discussion in an effort to increase the visibility of MDSPACE, as we feel it is an exciting approach that deserves more visibility. We have added a substantial discussion on this point, specifically on MDspace as follows:

      line 565-574

      Similarly, MDSPACE holds tremendous promise as a method for investigating conformational dynamics from cryo-EM data (61). MDSPACE integrates cryo-EM particle data with short MD simulations to fit atomic models into each particle image through an iterative process which extracts dynamic information. However, the lack of GPU-enabled processing for MDSPACE requires either a dedicated a computational setup that diverges from most other cryo-EM software, or access to a CPU-based supercomputer, which severely limits the accessibility of such software. Despite these challenges, both 3DFlex and MDSPACE use promising approaches to study protein conformational dynamics. We look forward to exploring effective methods to incorporate these strategies into our future research.

      Minor points: 

      (1) Lines 348-350: "The discrepancy in population size between these clusters is likely due to bias in the initial particle poses, rather than a subunit-specific preference for the open state." Which bias? The cluster size is related to conformations, not to poses. 

      We hope to emphasize that the assignment of particles to either the OC or CO cluster is likely due to the particle orientation within the complete dimer refinement, and the discrepancy in size between OC and CO clusters does not necessarily indicate a domain specific preference for one state or another, which would carry allosteric implications. This remains a possibility, but we hope to avoid over-interpretation of our results with the statement above.

      The statement was altered to now read:

      Line 418-423

      “The discrepancy in population size between these clusters is likely due to bias in the initial particle orientation, rather than a subunit-specific preference for the open state. As the O/C state and the C/O state are 180 degree rotations of each other, particle assignment to either cluster is likely influenced by the initial particle orientation of the complete dimer, and we currently lack the data to discern any allosteric implication to the orientation assignment.”

      (2) Line 519: "Micrographs with a max CTF value worse than 4Å were removed from the dataset,..." (also, lines 822-823 in supplementary material). <br /> Do you want to say that micrographs with a resolution worse than 4 A were removed? 

      Max CTF value was replaced with CTF fit resolution to properly match the parameter used in Cryosparc.

      (3) Figure 2C: The black lines are barely visible. Can you make them thicker and in red color? 

      The figure has been amended.

      (4) Figure 2D: The values for Chain A and Chain B in the second row (ACE-C) of sACE-3.05 columns are 17.9 (I) (Chain A) and 13.9 (C) (Chain B). Shouldn't they be reversed (13.9 (C) (Chain A) and 17.9 (I) (Chain B))? 

      The values are now correct. sACE-3.65 chains were flipped in the table, and the updated color scheme should make it easier to map the values from the table to their corresponding structure.

      Reviewer #2 (Recommendations for the authors): 

      The manuscript presents the first complete full-length dimeric ACE structure. The integration of cryo-EM and MD simulations provides valuable insights into ACE dynamics, showcasing the authors' commitment to exploring complex aspects of protein structure and function. This is a commendable effort, and the depth of analysis is appreciated. However, several aspects of the manuscript require further refinement to improve clarity and scientific rigor. In the view of this reviewer, a major revision is necessary. Please see the detailed comments below: 

      (1) Definition of "Conformational Heterogeneity": The term "conformational heterogeneity" should be clearly defined when citing references 27-29. <br /> References 27 and 29 use MD simulations, which reveal "conformational flexibility" rather than "conformational heterogeneity" as observed in cryo-EM data. A more precise distinction should be made. 

      We have changed the term “conformational heterogeneity” to the broader “conformational dynamics

      (2) Figure Adjustments for Clarity: <br /> Figure 1B: A scale bar is needed for accurate representation. 

      A 100 Angstrom scale bar was added to figure 1B.

      Figure 2A, B: Using a Cα trace representation would improve clarity and make structural differences more apparent. 

      We found using a Cα trace representation makes the figure too confusing and impossible to determine individual structural elements. Everything just becomes a jumble of lines.

      Additionally, a Cα displacement vs. residue index plot (with Figure 1A placed along the x-axis) should be included alongside Figures 2A and B to provide quantitative insight into structural variations. 

      This analysis has been combined with several other suggestions and now comprises a new figure 4.

      (3) Structural Resolution and Validation: <br /> Euler angle distribution and 3D-FSC analysis should be provided to help the audience assess how these factors influence the resolution of each structure. <br /> Local resolution analysis in Relion should be included to determine if there are dynamic differences among the four structures. <br /> To enhance structural interpretation, the manuscript would benefit from showcasing examples of bulky side-chain densities (e.g., Trp, Phe, Tyr) for each of the four structures. 

      Information is included in Figure S3 and S5.

      (4) Glycan Modeling Considerations: <br /> Since the resolution of cryo-EM does not allow for precise glycan composition determination, additional experimental validation (e.g., Glyco-MS) would strengthen the modeling. If experimental support is unavailable, appropriate references should be cited to justify the modeled glycans. 

      Minimal glycan modeling was performed with the goal of demonstrating that the protein is glycosylated. We have highlighted that we chose 12 N-linked glycosylation sites that have the observed extra density, an indication that glycan should be present and modeled them with complex glycans in the manuscript.  

      (5) Advanced Cryo-EM and MD Analyses: 3DFlex Analysis: <br /> It is recommended that the authors explore 3DFlex to better capture conformational variability. CryoSPARC's community support can assist in proper implementation. 

      We have incorporated our 3Dflex analysis in our discussion as follows:

      Line 553-565

      Surprisingly, we did not observe such motion using cryoSPARC 3DFlex, a neural network-based method analyzing our cryo-EM data of sACE (54). Central to the working of cryoSPARC 3DFlex is the generation of a tetrahedral mesh used to calculate deformations within the particle population. Proper generation of the mesh is critical for obtaining useful results and must often be determined empirically. Despite several attempts, we were unable to obtain results from 3DFlex comparable to what we observed with our other methods. Even using the results from our 3DVA as prior input to 3DFlex, the largest conformational change we observed was a slight wiggling at the bottom of the D3a subdomain (Movie S12). The authors of 3DFlex note that 3DFlex struggles to model intricate motions, and the implementation of custom tetrahedral meshes currently requires a non-cyclical fusion strategy between mesh segments. Given these limitations, and the complexity of sACE conformational dynamics, it appears that sACE, as a system, is not well-suited to analysis via 3DFlex in its current implementation.

      (6) Movie Consistency: <br /> The MD simulation movies should use the same color coding as the first four movies for consistency. Similarly, the 3DVar analysis map should be color-coded to enhance interpretability. 

      MD simulation movies are re-colored.

      (7) MD Simulations - Data Extraction and Validation: <br /> The manuscript includes several long-timescale MD simulations, but further analysis is needed to extract meaningful dynamic information. Suggested analyses include: <br /> a. RMSF (Root Mean Square Fluctuation) Analysis: Calculate RMSF from MD trajectories and compare it with local resolution variations in cryo-EM maps. 

      RMSF values were included in the new figure 4 along with structural depictions colored by RMSF value to localize variation to the structure.

      b. Assess whether regions exhibiting lower dynamics correspond to higher resolution in cryo-EM. 

      Information is added to Figure 4, Figure S3, S5, S6.

      c. Compare RMSF between simulations with and without glycans to identify potential effects. 

      This has been done in Figure 4.

      d. Clustering Analysis: Use the four solved structures as reference states to cluster MD simulation trajectories. Determine if the population states observed in MD simulations align with cryo-EM findings. 

      This has been done in supplementary figure S10.

      e. Principal Component Analysis (PCA): Perform PCA on MD trajectories and compare with dynamics inferred from cryo-EM analyses (3DVar, cryoDRGN, and RECOVAR) to ensure consistency. 

      This has been done in supplementary figure S11.

      f. Correction of RMSF Analysis or the y-axis label in Figure S9: The RMSF values cannot be negative by definition. The authors should carefully review the code used for this calculation or explicitly define the metric being measured. 

      The Y-axis label has been corrected to clarify that the plot depicts the change in RMSF values when comparing the glycosylated and non-glycosylated MD simulations.

      (8) Discussion on Coordinated Motion and Allostery: <br /> The discussion of coordinated motion and allosteric regulation between sACE-N domains should be explicitly connected to experimental evidence mentioned in the introduction: <br /> "Enzyme kinetics analysis suggests negative cooperativity between two catalytic domains (31-33). However, ACE also exhibits positive synergy toward Ab cleavage and allostery to enhance the activity of its binding partner, the bradykinin receptor (11, 34)." 

      (9) The authors should elaborate on how their new insights provide a mechanistic explanation for these experimental observations. 

      (10) Connection to Therapeutic Implications: <br /> The discussion section should more explicitly connect the structural findings to potential therapeutic applications, which would significantly enhance the impact of the study. 

      These three points (8-10) were addressed in a significant overhaul to the discussion section.

      In summary, this study makes a valuable contribution to the field of ACE structural biology and dynamics. The combination of cryo-EM and MD simulations is particularly powerful, and with major revisions, this manuscript has the potential to make a strong impact. Addressing the points outlined above will significantly improve clarity, strengthen the scientific claims, and enhance the manuscript's accessibility to a broader audience. I appreciate the authors' rigorous approach to this complex topic and encourage them to refine their work to fully highlight the significance of their findings. 

      Reviewer #3 (Recommendations for the authors): 

      (1) The authors incorrectly refer to their ACE construct as full-length throughout the manuscript. Given that they are purifying the soluble region (aa 1-1231), saying full-length ACE is not the correct nomenclature. I suggest removing full-length and using soluble ACE (sACE) throughout the text. 

      We utilize the term full-length to highlight the fact that our structures contain both the N and C domains for both subunits in the dimer, in contrast to the previously published ACE cryo-EM structure. We have clarified in the text that we refer to the full-length soluble region of ACE (sACE), and sACE is used to specifically refer to our construct throughout the text, except when referring to ACE in a more generalized biological context in the introduction and discussion.

      (2) The authors could show differences between the different structural states by measuring and displaying the alpha carbon distances. For example, in Figures 2A, B, 3A, and 4B and C. 

      Alpha carbon displacements for each residue have been added to the new figure 4.

      (3) Most figures, with a few exceptions (Figures 2 and S11), are of low quality. Perhaps they are not saved in the same format. In addition, the color schemes used throughout the figures and movies are not consistent. For example, in Figure 1 D2 domains are in green, while they appear yellow in Figure 2 and later. Please double-check all coloring schemes and keep them consistent throughout the manuscript. In addition, it would be good to keep the labeling of the domains in the subsequent figures, as it is difficult to remember which domain is which throughout the manuscript. 

      We are unsure of how to address the low quality issue, our files and the online versions appear to be of suitable high quality. We will work with editorial staff to ensure all files are of suitable quality. The color scheme has been revised throughout the manuscript to ensure consistency and better differentiate between domains and chains.

      (4) Figure 1. Indicate exactly where in panel A ACE-N ends and ACE-C starts. Also, the pink and magenta, as well as aqua vs. light blue, are hard to distinguish. 

      We have updated coloring scheme.

      (5) Figure 2. In the figure legend, the use of brackets for defining closed, intermediate, and open states is confusing, given that the panels are also described with brackets, and some letters match between them. Using a hyphen or bolding the abbreviations could help. Also, define chains A and B, make the black lines that I assume indicate distances in C bold or thicker as they are very hard to see in the figure, and add to the legend what those lines mean. 

      The abbreviations have been changed from parentheses to quotes, and suggestions have been implemented.

      (6) Figure 4 is confusing as shown. Since the authors mention the general range of motion in sACE-N first in the text, wouldn't it make more sense to show panel B first and then panel A? Also, can you point and label the "tip connecting the two long helices of the D1a subdomain" in the figure? It is not clear to me where this region is in B. In addition, add a description of the arrows in B and C to the figure legend. 

      Most changes incorporated. The order should make more sense now in light of other changes.

      (7) Figure 5. Can the authors add a description to the legend as to what the arrows indicate and their thickness? 

      Done

      (8) Add a scale bar to the micrograph images in the supplementary figures. 

      Figure S2 and S4 need the scale bar.

      (9) Provide a more comprehensive description of buffers used in the DF analysis, as this information could be useful to others. 

      We have included the data in Table S1.<br /> (10) Line 51: Reference format not consistent with other references: (Wu et al., 2023). 

      Fixed

      (11) Line 66: Define "ADAM". 

      The definition has been added.

      (12) Line 90: The authors say: Recent open state structures of sACE-N, sACE monomer, and a sACE-N dimer, along with molecular dynamics (MD) simulations of sACE-C, have begun to reveal the conformational heterogeneity, though it remains under-studied (27-29)." Can the authors clarify what "it" refers to? The full-length ACE, sACE, or its specific domains? 

      The sentence now reads: Recent open state structures of sACE-N, sACE monomer, and a sACE-N dimer, along with molecular dynamics (MD) simulations of sACE-C, have begun to reveal ACE conformational dynamics, though they remain under-studied (29-31).

      (13) Line 204: "The comparison of our dimeric sACE cryoEM structures of reveals the conformational dynamics of sACE catalytic domains." The second "of" should be removed. 

      Fixed<br /> (14) Line 268: "From room mean square fluctuation (RMSF) analysis..." "room" should be replaced with "root."

      Fixed

    1. Reviewer #1 (Public review):

      Summary:

      This study utilizes polarized second-harmonic generation (pSHG) microscopy to investigate myosin conformation in the relaxed state, distinguishing between the disordered, actin-accessible ON state and the ordered, energy-conserving OFF state. By pharmacologically modulating the ON/OFF equilibrium with a myosin activator (2-deoxyATP) and inhibitor (Mavacamten), the authors demonstrate that pSHG can sensitively quantify the ON/OFF ratio in both skeletal and cardiac muscle. Validation with X-ray diffraction supports the accuracy of the method. Applying this approach to a hypertrophic cardiomyopathy model, the study shows that R403Q/MYH7-mutated minipigs exhibit an increased ON state fraction relative to controls. This difference is eliminated under saturating concentrations of myosin modulators, indicating that the ON/OFF balance can be pharmacologically shifted to its extremes. Additionally, ATPase assays reveal elevated resting ATPase activity in R403Q samples, which persists even when the ON state is saturated, suggesting that increased energy consumption in this mutation is driven by both a shift toward the ON state and inherently higher myosin ATPase activity.

      Strengths:

      This is a well-written and well-conducted study that clearly reveals the power of SHG microscopy. The study clearly establishes the great utility of SHG to study thick filament regulation.

      Weaknesses:

      (1) Several studies have shown that the ON state of the thick filament is sensitive to both temperature and filament lattice spacing, with a common recommendation to conduct skinned fiber experiments at temperatures above 27{degree sign}C and in the presence of dextran to better preserve physiological conditions. The authors should clarify the experimental temperature used in their skinned fiber studies, indicate whether dextran was included, and discuss whether adherence to these recommended conditions would have impacted their results.

      (2) On page 13, the authors report the proportion of disordered heads as approximately 30% in wild-type and 65% in R403Q fibers. They should clarify whether these values represent the percentage of total myosin heads, or rather the percentage of heads that are responsive to Mavacamten and dATP.

      (3) In Figure 5, regarding ATPase measurements, the content of contractile material per unit volume of muscle preparation will influence the results. Did the authors account for this variable, and if not, how might it have affected the conclusions?

      (4) For readers primarily interested in assessing the ON/OFF state of thick filaments, could the authors list the specific advantages of polarized second harmonic generation (pSHG) microscopy compared to X-ray diffraction?

      (5) Given that many data points were derived from the same fiber or myocyte, how did the authors address the risk of type I errors due to non-independence of measurements? Was a nested or hierarchical statistical approach used?

    2. Reviewer #2 (Public review):

      Summary:

      In striated muscle, myosin motors can dynamically switch between an energy-conserving OFF state and an activated ON state. This switching is important for meeting the body's needs under different physiological conditions, and previous studies have shown that disease-causing mutations associated with cardiomyopathies can affect the population of these states, leading to aberrant contractility. Studying these structural states in muscle has previously only been possible via X-ray diffraction, which requires access to a beam line. Here, Arecchi et al. demonstrate that polarized second-harmonic generation microscopy (pSGH), a technique that is more accessible, can be used to probe the ON/OFF states of myosin in both permeabilized and intact muscle.

      Strengths:

      (1) There is an outstanding need in the field to better understand the regulation of the ON/OFF states of myosin. Currently, this is studied using X-ray diffraction, meaning that it is accessible to only a few labs. The authors demonstrate that pSGH can be used to probe the ON/OFF states of myosin both in intact and permeabilized muscle. This is a significant advance, since it makes it possible to study these states in a standard research laboratory.

      (2) The authors demonstrate that this approach can be employed in both skeletal and cardiac muscle. Importantly, it works with both porcine and mouse cardiac muscle, which are two of the most important animal models for preclinical studies.

      (3) The authors manipulate the ON/OFF equilibrium using both drugs and a genetic model of hypertrophic cardiomyopathy that has been shown to modulate the ON/OFF equilibrium. Their results generally agree with previous studies conducted using X-ray diffraction as well as biochemical measurements of myosin autoinhibition.

      Weaknesses:

      (1) While the application of pSGH to the ON/OFF equilibrium is an important advance, there are limited new biological insights since the perturbations used here have been extensively characterized in previous studies.

      (2) SGH has previously been applied to study the nucleotide-dependent orientation of myosin motors in the sarcomere (PMID: 20385845). The authors have previously interpreted the value of gamma as being a readout of lever arm position, but here, it is interpreted as a measure of ON/OFF equilibrium. When this technique is applied to intact muscle, it is not clear how to deconvolve the contributions of lever arm angle from the ON/OFF population (especially where there is a mix of states that give rise to the gamma value). This is an important limitation that is not discussed in the manuscript.

      (3) The R403Q mutation has previously been shown to cause an increase in ATP usage. Here, the authors measure an elevated basal ATPase rate under relaxing conditions, and they interpret this as showing increased myosin ATPase activity intrinsic to the motors; however, care should be used in interpreting these results. Work from the Spudich lab has shown that the R403Q mutation can appear as increasing motor function in some assays but depressing motor function in others (see PMID: 32284968, 26601291). Moreover, the actin-activated ATPase rate is an order of magnitude higher than the basal ATPase rate, and thus, small changes in the basal ATPase rate are unlikely to be important for physiology.

      (4) The authors interpret some of their data based on the assumption that the high concentrations of drugs cause the myosin to either adopt 100% OFF or ON states. This assumption is not validated, limiting the ability to interpret the fraction of myosins in the ON/OFF states.

      (5) The ATPase measurements are innovative but hard to interpret. dATP and ATP do not have identical ATPase kinetics, meaning that it is hard to deconvolve whether the elevated ATPase rate with dATP is due to changes in the ON/OFF population and/or intrinsic ATPase activity. Similarly, mavacamten reduces the rate of phosphate release from myosin, and this effect is not strictly coupled to the formation of the OFF state (e.g., see PMID: 40118457). As such, it is difficult to deconvolve drug-based changes in the inherent ATPase kinetics of the myosin from changes in the OFF-state population.

    3. Reviewer #3 (Public review):

      Summary:

      This is a very interesting paper extending the use of SHG to the study of relaxed muscle and its use to assess the order-disorder (and on /off) states of myosin heads in the thick filament. The work convincingly shows that SHG and the parameter gamma provide a reliable measure of the state of the myosin heads in a range of different relaxed muscle fibres, both intact and skinned, and in myofibrils. In mini pig cardiac fibres, the use of dATP and mavacamten increased or decreased the number of heads in the disordered state, respectively. On the assumption that these treatments push myosins fully into the disordered or ordered state, then this allows the fraction of ordered heads to be assessed under a wide variety of conditions. It is unfortunate that dATP treatment was not used (as mavacmten was) on rabbit psoas and mouse samples to further test this hypothesis.

      The results with the myosin mutant R403Q support the idea that this mutation reduces the fraction of myosin heads in the ordered state and that mavacamten can recover the WT situation.

      The results from SHG were compared with parallel studies using X-rays to validate the conclusions. Independent fibre ATPase data further support the conclusions.

      The work is solid and provides a novel approach to assessing the activity state of muscle thick filaments. The authors point out some of the potential uses of this approach in the future, including time-resolved SHG measurements. Indeed, jumps in mavacamten or dATP concentration with time-resolved SHG could measure the rates of entry and exit from the ordered, off state of the filament. A measurement is urgently needed in the field.

      Strengths:

      (1) The SHG signal is convincingly shown to assess the fraction of ordered/disordered myosin heads in the thick filament of a variety of muscle fibres.

      (2) The results are similar for rabbit psoas, mouse, and minipig cardiac fibres. Skinning the fibres and production of myofibrils do not change the SHG signal.

      (3) Use of myosin R403Q mutant in mini pig confirms a loss of ordered myosin heads, and the ordered heads can be recovered by mavacamten.

      (4) Parallel X-ray scattering and ATPase data support the conclusions.

      (5) Assuming that dATP and mavacamten generate 100% disordered vs ordered myosin heads respectively, then the percentage of ordered heads can be calculated for a variety of conditions.

      Weaknesses:

      (1) Issues like the effect of fibre disarray and lattice spacing on the SHG signal are not well defined.

      (2) The, now well-defined heterogeneity of thick filament structure is not acknowledged.

      (3) dATP was only used on minipig cardiac fibres. The effect of dATP on rabbit psoas and mouse cardiac fibres would be a useful comparison and would help validate the calculation of % ordered heads.

    1. Reviewer #1 (Public review):

      Summary:

      This manuscript presents findings on the adaptation mechanisms of Saccharomyces cerevisiae under extreme stress conditions. The authors try to generalize this to adaptation to stress tolerance. A major finding is that S. cerevisiae evolves a quiescence-like state with high trehalose to adapt to freeze-thaw tolerance independent of their genetic background. The manuscript is comprehensive, and each of the conclusions is well supported by careful experiments.

      Strengths:

      This is excellent interdisciplinary work.

      Weaknesses: .

      I have questions regarding the overall novelty of the proposal, which I would like the authors to explain.

      (1) Earlier papers have shown that loss of ribosomal proteins, that slow growth, leads to better stress tolerance in S. cerevisiae. Given this, isn't it expected that any adaptation that slows down growth would, overall, increase stress tolerance? Even for other systems, it has been shown that slowing down growth (by spore formation in yeast or bacteria/or dauer formation in C. elegans) is an effective strategy to combat stress and hence is a likely route to adaptation. The authors stress this as one of the primary findings. I would like the authors to explain their position, detailing how their findings are unexpected in the context of the literature.

      (2) Convergent evolution of traits: I find the results unsurprising. When selecting for a trait, if there is a major mode to adapt to that stress, most of the strains would adapt to that mode, independent of the route. According to me, finding out this major route was the objective of many of the previous reports on adaptive evolution. The surprising part in the previous papers (on adaptive evolution of bacteria or yeast) was the resampling of genes that acquired mutations in multiple replicates of an evolution experiments, providing a handle to understand the major genetic route or the molecular mechanism that guides the adaptation (for example in this case it would be - what guides the over-accumulation of trehalose). I fail to understand why the authors find the results surprising, and I would be happy to understand that from the authors. I may have missed something important.

      (3) Adaptive evolution would work on phenotype, as all of selective evolution is supposed to. So, given that one of the phenotypes well-known in literature to allow free-tolerance is trehalose accumulation, I think it is not surprising that this trait is selected. For me, this is not a case of "non-genetic" adaptation as the authors point out: it is likely because perturbation of many genes can individually result in the same outcome - upregulation of trehalose accumulation. Thereby, although the adaptation is genetic, it is not homogeneous across the evolving lines - the end result is. Do the authors check that the trait is actually a non-genetic adaptation, i.e., if they regrow the cells for a few generations without the stress, the cells fall back to being similarly only partially fit to freeze-thaw cycles? Additionally, the inability to identify a network that is conserved in the sequencing does not mean that there is no regulatory pathway. A large number of cryptic pathways may exist to alter cellular metabolic states.<br /> This is a point in continuation of point #2, and I would like to understand what I have missed.

      (4) To propose the convergent nature, it would be important to check for independently evolved lines and most probably more than 2 lines. It is not clear from their results section if they have multiple lines that have evolved independently.

      (5) For the genomic studies, it is not clear if the authors sequenced a pool or a single colony from the evolved strains. This is an important point, since an average sequence will miss out on many mutations and only focus on the mutations inherited from a common ancestral cell. It is also not clear from the section.

    1. Reviewer #3 (Public review):

      Summary:

      This study aims to develop and characterize phenylhydrazone-based small molecules that selectively activate the ATF6 arm of the unfolded protein response by covalently modifying a subset of ER-resident PDIs. The authors identify AA263 as a lead scaffold and optimize its structure to generate analogs with improved potency and ATF6 selectivity, notably AA263-20. These compounds are shown to restore proteostasis and functional expression of disease-associated misfolded proteins in cellular models involving both secretory (AAT-Z) and membrane (GABAA receptor) proteins. The findings provide valuable chemical tools for modulating ER proteostasis and may serve as promising leads for therapeutic development targeting protein misfolding diseases.

      Strengths:

      (1) The study presents a well-defined chemical biology framework integrating proteomics, transcriptomics, and disease-relevant functional assays.

      (2) Identification and optimization of a new electrophilic scaffold (AA263) that selectively activates ATF6 represents a valuable advance in UPR-targeted pharmacology.

      (3) SAR studies are comprehensive and logically drive the development of more potent and selective analogs such as AA263-20.

      (4) Functional rescue is demonstrated in two mechanistically distinct disease models of protein misfolding-one involving a secretory protein and the other a membrane protein-underscoring the translational relevance of the approach.

      Weaknesses:

      (1) ATF6 activation is primarily inferred from reporter assays and transcriptional profiling; however, direct evidence of ATF6 cleavage is lacking.

      (2) While the mechanism involving PDI modification and ATF6 activation is plausible, it remains incompletely characterized.

      (3) No in vivo data are provided, leaving the pharmacological feasibility and bioavailability of these compounds in physiological systems unaddressed.

    1. Therapy speak is the incorrect use of jargon from psychology, especially jargon related to psychotherapy and mental health.[1] It tends to be linguistically prescriptive and formal in tone.[2] Therapy speak is related to psychobabble and buzzwords.[3][4][5] It is vulnerable to miscommunication and relationship damage as a result of the speaker not fully understanding the terms they are using, as well as using the words in a weaponized or abusive manner.[4][6] Therapy speak is not generally used by therapists during psychotherapy sessions.
    1. Reviewer #1 (Public review):

      Summary:

      This study provided key experimental evidence for the "Solstice-as-Phenology-Switch Hypothesis" through two temperature manipulation experiments.

      Strengths:

      The research is data-rich, particularly in exploring the effects of pre- and post-solstice cooling, as well as daytime versus nighttime cooling, on bud set timing, showcasing significant innovation. The article is well-written, logically clear, and is likely to attract a wide readership.

      Weaknesses:

      However, there are several issues that need to be addressed.

      (1) In Experiment 1, significant differences were observed in the impact of cooling in July versus August. July cooling induced a delay in bud set dates that was 3.5 times greater in late-leafing trees compared to early-leafing ones, while August cooling induced comparable advances in bud set timing in both early- and late-leafing trees. The study did not explain why the timing (July vs. August) resulted in different mechanisms. Can a link be established between phenology and photosynthetic product accumulation? Additionally, can the study differentiate between the direct warming effect and the developmental effect, and quantify their relative contributions?

      (2) The two experimental setups differed in photoperiod: one used a 13-hour photoperiod at approximately 4,300 lux, while the other used an ambient day length of 16 hours with a light intensity of around 6,900 lux. What criteria were used to select these conditions, and do they accurately represent real-world scenarios? Furthermore, as shown in Figure S1, significant differences in soil moisture content existed between treatments - could this have influenced the conclusions?

      (3) The authors investigated how changes in air temperature around the summer solstice affected primary growth cessation, but the summer solstice also marks an important transition in photoperiod. How can the influence of photoperiod be distinguished from the temperature effect in this context?

      (4) The study utilized potted trees in a controlled environment, which limits the generalization of the results to natural forests. Wild trees are subject to additional variables, such as competition and precipitation. Moreover, climate differences between years (2022 vs. 2023) were not controlled. As such, the conclusions may be overgeneralized to "all temperate tree species", as the experiment only involved potted European beech seedlings. The discussion would benefit from addressing species-specific differences.

    2. Reviewer #2 (Public review):

      In 'Developmental constraints mediate the summer solstice reversal of climate effects on European beech bud set', Rebindaine and co-authors report on two experiments on Fagus sylvatica where they manipulated temperatures of saplings between day and night and at different times of year. I enjoyed reading this paper and found it well written. I think the experiments are interesting, but I found the exact methods somewhat extreme compared to how the authors present them. Further, given that much of the experiment happened outside, I am not sure how much we can generalize from one year for each experiment, especially when conducted on one population of one species. I next expand briefly on these concerns and a few others.

      Concerns:

      (1) As I read the Results, I was surprised the authors did not give more information on the methods here. For example, they refer to the 'effect of July cooling' but never say what the cooling was. Once I read the methods, I feared they were burying this as the methods feel quite extreme given the framing of the paper. The paper is framed as explaining observational results of natural systems, but the treatments are not natural for any system in Europe that I have worked in. For example, a low of 2 {degree sign}C at night and 7 {degree sign}C during the day through the end of May and then 7/13 {degree sign}C in July is extreme. I think these methods need to be clearly laid out for the reader so they can judge what to make of the experiment before they see the results.

      (2) I also think the control is confounded with the growth chamber experience in Experiment 1. That is, the control plants never experience any time in a chamber, but all the treatments include significant time in a chamber. The authors mention how detrimental chamber time can be to saplings (indeed, they mention an aphid problem in experiment 2), so I think they need to be more upfront about this. The study is still very valuable, but again, we may need to be more cautious in how much we infer from the results.

      (3) I suggest the authors add a figure to explain their experiments, as they are very hard to follow. Perhaps this could be added to Figure 1?

      (4) Given how much the authors extrapolate to carbon and forests, I would have liked to see some metrics related to carbon assimilation, versus just information on timing.

      (5) Fagus sylvatica is an extremely important tree to European forests, but it also has outlier responses to photoperiod and other cues (and leafs out very late), so using just this species to then state 'our results likely are generalisable across temperate tree species' seems questionable at best.

      (6) Another concern relates to measuring the end of season (EOS). It is well known that different parts of plants shut down at different times, and each metric of end of season - budset, end of radial expansion, leaf coloring, etc - relates to different things. Thus, I was surprised that the authors ignore all this complexity and seem to equate leaf coloring with budset (which can happen MONTHS before leaf coloring often) and with other metrics. The paper needs a much better connection to the physiology of end of season and a better explanation for the focus on budset. Relatedly, I was surprised that the authors cite almost none of the literature on budset, which generally suggests it is heavily controlled by photoperiod and population-level differences in photoperiod cues, meaning results may be different with a different population of plants.

      (7) I didn't fully see how the authors' results support the Solstice as Switch hypothesis, since what timing mattered seemed to depend on the timing of treatment and was not clearly related to the solstice. Could it be that these results suggest the Solstice as Switch hypothesis is actually not well supported (e.g., line 135) and instead suggest that the pattern of climate in the summer months affects end-of-season timing?

    1. Ce document de synthèse analyse en profondeur l'importance des interventions de soutien à la parentalité pour le développement cognitif et socio-émotionnel des enfants, ainsi que pour la réduction des inégalités sociales.

      Il se base principalement sur les recherches et les méta-analyses présentées par Carlo Barone, sociologue et professeur à Sciences Po.

      Thèmes Principaux et Idées Clés

      1. L'impact Précoce et Cumulatif des Inégalités de Développement

      Manifestation Précoce des Inégalités: Les inégalités de développement se manifestent dès les premières années, voire les premiers mois de vie des enfants, et ont des répercussions à long terme sur leur réussite scolaire.

      Par exemple, le vocabulaire réceptif des enfants de 4 ans en France est fortement lié au niveau d'éducation des parents.

      Ce constat est "préoccupant parce que nous savons que le vocabulaire réceptif avec la conscience phonologique est un des deux prédicteurs les plus importants des apprentissages en lecture et en écriture à l'école primaire".

      Apprentissage Cumulatif et Plasticité Cérébrale: Tout apprentissage est cumulatif, et la plasticité cérébrale des enfants est maximale pendant les premières années de vie, soulignant "l'intérêt d'intervenir dès le plus jeune âge pour favoriser l'égalité des chances dans l'éducation"**.

      2. Les Limites des Interventions Éducatives Scolaires Seules

      • Concentration Exclusive sur l'Environnement Scolaire: Les politiques éducatives en France (dédoublement des classes, dispositifs d'aide aux devoirs) bien que produisant des effets, sont parfois "moins efficaces que l'on espérait notamment par rapport aux moyens financiers humains importants qui sont alloués".

      Une limite majeure est qu'elles "se concentrent uniquement sur l'environnement scolaire et n'interviennent pas sur les inégalités flagrantes entre les environnements familiaux".

      • Complémentarité des Approches: L'implicite est souvent qu'on ne peut ou ne devrait pas intervenir sur ce qui se passe à la maison, alors que "les deux stratégies d'intervention peuvent être complémentaires".

      3. Le Rôle Crucial et Souvent Sous-Estimé des Parents

      • Temps Passé avec les Enfants: Les parents passent un temps considérable avec leurs enfants, un temps qui a "augmenté au fil du temps", y compris le "temps de qualité" (activités de jeu, lecture).

      Cette augmentation est plus marquée pour les parents des catégories socio-professionnelles favorisées.

      • Influence Permanente: Contrairement aux enseignants et camarades de classe qui changent, les parents "constituent une influence permanente et à long terme".

      • Aspirations Éducatives Élevées: Les parents, y compris ceux issus de milieux défavorisés ou immigrés, ont des aspirations éducatives élevées pour leurs enfants.

      Une implication apparemment moindre de la part de familles socialement défavorisées "reflète probablement surtout un ensemble de barrières sociales auquel ces familles sont confrontées plutôt que un manque d'intérêt des parents pour le développement et la réussite scolaire de leurs enfants".

      • Manque de Connaissance et Barrières Informationnelles: Beaucoup de parents "ne réalisent pas à quel point ce qui se passe à la maison a des conséquences importantes pour ce qui se passe à l'école".

      Des activités comme la lecture, les jeux de société, la cuisine partagée sont des opportunités d'apprentissage informel, mais "tous les parents ne sont pas conscients du potentiel de ces apprentissages informels".

      Les parents des milieux populaires ont moins accès aux informations d'experts et à leur circulation dans leurs cercles sociaux.

      4. Typologie des Interventions de Soutien à la Parentalité

      Une revue de 109 études randomisées identifie quatre stratégies principales :

      • Compétences Langagières et Cognitives (36%): Encourager des activités stimulant les apprentissages informels (lecture, puzzles, jeux de société).

      • Développement Socio-émotionnel (25%): Stimuler la réceptivité et la réactivité des parents aux besoins développementaux des enfants.

      • Règles à la Maison (Moins Développé): Pratiques et routines familiales (usage des écrans, sommeil, devoirs) influençant les capacités d'autorégulation des enfants.

      • Approches Hybrides/Holistiques (20%): Combinaison des stratégies précédentes.

      5. Exemples d'Interventions et Leurs Leçons

      • Ready4K (États-Unis): Intervention par SMS ciblant les parents d'enfants de 2 à 4 ans.

      Envoi de trois SMS par semaine (information, suggestion, encouragement).

      "Les enfants avec des compétences langagières moins développées ont connu une amélioration importante de leur vocabulaire et leurs compétences langagère". Points forts :

      • Stratégie de Communication Innovante: Utilisation des SMS pour toucher un maximum de parents, y compris ceux qui ne peuvent pas se rendre aux réunions scolaires.

      • Adaptation aux Contraintes Parentales: Messages simples, en plusieurs langues, ne demandant pas un investissement de temps important, mais intégrant des activités ludiques dans les routines quotidiennes.

      "Concevoir des interventions qui prennent en compte l'ensemble des contraintes parentales et propose des conseils réalisables pour tous les parents".

      • Coût-Bénéfice Favorable: Environ 5 € par enfant par an.

      Intervention sur la Lecture Partagée (France):

      Étude menée par Carlo Barone et ses collègues.

      Distribution de flyers informatifs et prêt gratuit de livres adaptés à l'âge, avec des conseils pour rendre l'activité agréable et l'intégrer au rituel du coucher. Suivi par SMS et appels téléphoniques.

      • Résultats: Augmentation significative de la fréquence de lecture parentale, particulièrement chez les parents moins éduqués, et amélioration du vocabulaire des enfants issus de familles moins éduquées et bilingues.

      Ces effets ont persisté 6 mois après l'intervention.

      • Limites: Pas d'impact sur les familles complètement allophones.

      Les effets à long terme n'ont pas pu être observés.

      Méta-analyse sur la Lecture Parentale:

      Sur 30 études randomisées (0-6 ans), les interventions de "lecture dialogique" ont des impacts importants sur le développement langagier (25-26% d'écart type), tandis que les autres interventions ont des impacts très faibles.

      Cependant, les impacts positifs des interventions en lecture dialogique se concentrent principalement sur les familles socialement favorisées, suggérant un risque d'augmentation des inégalités.

      Les effets ont tendance à diminuer rapidement après l'intervention.

      6. Leçons des Méta-Analyses Générales

      Méta-analyse de Jeong et al. (2021) - 102 études (0-3 ans):

      • Deux Catégories d'Intervention: Messages de stimulation d'apprentissages informels et promotion de styles parentaux autoritatifs (chaleur et soutien élevés, attentes claires et cohérentes).

      • Impacts Multiples:

      • Effets positifs importants sur le développement cognitif (32% d'écart type) et langagier,

      • encourageants sur le développement socio-émotionnel et moteur, et sur la qualité de la relation parents-enfants.
      • Moins d'effet sur la santé mentale des parents.

      • Variabilité des Impacts: Grande variabilité dans l'efficacité des interventions, certains étant très efficaces, d'autres non.

      • Contextes Nationaux: Impacts moyens plus importants dans les pays en développement, mais restent significatifs dans les pays riches. Une autre méta-analyse (Francis Steves et al.) suggère une "transportabilité élevée" des interventions entre pays riches.

      • Combinaison des Approches: Les interventions les plus efficaces combinent la stimulation cognitive et la réceptivité parentale.

      • Format: Pas de différences systématiques d'efficacité entre les visites à domicile et les espaces communautaires, ni entre les programmes individuels et collectifs.

      C'est "une excellente nouvelle parce qu'évidemment les les coûts de ces formats sont très différents".

      • Méta-analyse de Prime et al. (0-6 ans): Confirme les conclusions de Jeong et al.

      • Hétérogénéité Sociale: Ces interventions se révèlent "plus efficaces sur les familles socialement favorisées".

      Cela pose un "dilemme potentiel entre l'objectif d'améliorer le niveau moyen de développement [...] et la réduction des inégalités". Une solution est de cibler les interventions sur les familles défavorisées, mais des interventions universalistes qui réduisent les inégalités seraient préférables.

      • Importance des Pères: Les interventions ciblant spécifiquement les pères sont encore rares et leurs résultats peu concluants, mais c'est une piste de recherche prometteuse.

      • Effets à Long Terme: La principale limite de ces méta-analyses est qu'elles ne considèrent que les effets à court terme.

      La durabilité des effets reste une question ouverte. "Nous ne sommes pas encore en mesure d'indiquer quels interventions produisent les effets les plus durables".

      7. Barrières Comportementales et Stratégies pour les Surmonter

      • Défis de l'Implication Parentale: Les parents peuvent être fatigués, stressés, manquer de temps, et nos messages "rivalisent avec toutes ces préoccupations pour attirer leur attention". Le passage de l'intention à l'action est difficile.

      • Nécessité de Plus que de Simples Informations: Fournir des informations et des conseils est utile mais souvent "insuffisant".

      Il faut "réussir à attirer l'attention des parents, rendre les contenus des interventions accessibles et pertinents par rapport au contexte de vie des parents, faire des demandes de temps raisonnables qui s'inscrivent dans les routines parentales, faire face au phénomène d'autocensure des parents notamment les parents plus socialement défavorisés et réussir à maintenir les parents impliqués dans la durée".

      • Incredible Years: Programme de groupe (10-14 parents, 3 mois) testé dans 8 pays européens (pas la France).

      Encourage des relations chaleureuses, le jeu interactif et une discipline constructive. Utilise des méthodes basées sur la pratique (résolution de problèmes, discussion de vidéos, jeux de rôles).

      L'accès aux réunions est facilité (garde d'enfants, transport). Résultats robustes et similaires pour les familles favorisées et défavorisées (30-38% d'écart type sur le développement cognitif et socio-émotionnel).

      8. Faciliter l'Accès aux Services de la Petite Enfance

      • Effets Positifs des Services de Qualité: L'accès à des services de petite enfance de bonne qualité a des effets positifs, surtout pour les enfants défavorisés.

      • Inégalités d'Accès en France: L'accès aux crèches et assistantes maternelles est "très inégalitaire en France", avec une sous-représentation des enfants de familles défavorisées et immigrées.

      Barrières à l'Accès:

      • Accessibilité: Critères d'éligibilité, distribution territoriale de l'offre.
      • Économiques: Coûts directs et coûts d'opportunité.
      • Informationnelles: Connaissance des coûts, critères, modalités de candidature.
      • Administratives: Difficultés à interagir avec la bureaucratie, remplir des formulaires.
      • Interventions Possibles: Atténuer les barrières informationnelles et administratives par des interventions qui "apportent des informations aux familles sur le fonctionnement de ces services [...] et qui les accompagnent dans le processus de candidature". Une étude en Allemagne a montré l'efficacité de ces dispositifs à réduire les inégalités d'accès.

      Conclusion Générale

      • Les interventions de soutien à la parentalité représentent un levier important et "trop souvent négligé par les décideurs politiques" pour favoriser le développement des enfants et réduire les inégalités.

      Elles sont "peu coûteuses" et offrent une grande flexibilité. L'accessibilité effective est primordiale pour leur efficacité et la durabilité de la réduction des inégalités.

      Cependant, ces interventions doivent être "complétées par d'autres types d'action de nature plus structurelle" (critères d'éligibilité, répartition de l'offre, levée des barrières linguistiques) et prendre en compte les inégalités socio-économiques plus larges (pauvreté, chômage, insécurité économique) qui peuvent entraver la réceptivité des parents.

      En somme, il est essentiel de comprendre et de cibler les défis spécifiques auxquels les familles sont confrontées pour concevoir des interventions pertinentes et efficaces.

    1. Reviewer #3 (Public review):

      Summary:

      Built on their previous pioneer expertise in studying RAD51 biology, in this paper, the authors aim to capture and investigate the structural mechanism of human RAD51 filament bound with a displacement loop (D-loop), which occurs during the dynamic synaptic state of the homologous recombination (HR) strand-exchange step. As the structures of both pre- and post-synaptic RAD51 filaments were previously determined, a complex structure of RAD51 filament during strand exchange is one of the key missing pieces of information for a complete understanding of how RAD51 functions in HR pathway. This paper aims to determine the high-resolution cryo-EM structure of RAD51 filament bound with D-loop. Combined with mutagenesis analysis and biophysical assays, the authors aim to investigate the D-loop DNA structure, RAD51 mediated strand separation and polarity, and a working model of RAD51 during HR strand invasion in comparison with RecA.

      Strengths:

      (1) The structural work and associated biophysical assays in this paper are solid, elegantly designed and interpreted.  These results provide novel insights into RAD51's function in HR.

      (2) The DNA substrate used was well designed, taking into consideration of the nucleotide number requirement of RAD51 for stable capture of donor DNA. This DNA substrate choice lays the foundation for successfully determining the structure of the RAD51 filament on D-loop DNA using single-partial cryo-EM.

      (3) The authors utilised their previous expertise in capping DNA ends using monometric streptavidin and combined their careful data collection and processing to determine the cryo-EM structure of full-length human RAD51 bound at D-loop in high resolution. This interesting structure forms the core part of this work and allows detailed mapping of DNA-DNA and DNA-protein interaction among RAD51, invading strands, and donor DNA arms (Figures 1, 2, 3, 4). The geometric analysis of D-loop DNA bound with RAD51 and EM density for homologous DNA pairing are also impressive (Figure S5). The previously disordered RAD51's L2-loop is now ordered and traceable in the density map and functions as a physical spacer when bound with D-loop DNA. Interestingly, the authors identified that the side chain position of F279 in the L2_loop of RAD51_H differs from other F279 residues in L2-loops of E, F and G protomers. This asymmetric binding of L2 loops and RAD51_NTD binding with donor DNA arms forms the basis of the proposed working model about the polarity on csDNA during RAD51-mediated strand exchange.

      (4) This work also includes mutagenesis analysis and biophysical experiments, especially EMSA, single-molecule fluorescence imaging using an optical tweezer, and DNA strand exchange assay, which are all suitable methods to study the key residues of RAD51 for strand exchange and D-loop formation (Figure 5).

      Weaknesses:

      (1) The proposed model for the 3'-5' polarity of RAD51-mediated strand invasion is based on the structural observations in the cryo-EM structure. This study lacks follow-up biochemical/biophysical experiments to validate the proposed model compared to RecA or developing methods to capture structures of any intermediate states with different polarity models.

      (2) The functional impact of key mutants designed based on structure has not been tested in cells to evaluate how these mutants impact the HR pathway.

      The significance of the work for the DNA repair field and beyond:

      Homologous recombination (HR) is a key pathway for repairing DNA double-strand breaks and involves multiple steps. RAD51 forms nucleoprotein filaments first with 3' overhang single-strand DNA (ssDNA), followed by a search and exchange with a homology strand. This function serves as the basis of an accurate template-based DNA repair during HR. This research addressed a long-standing challenge of capturing RAD51 bound with the dynamic synaptic DNA and provided the first structural insight into how RAD51 performs this function. The significance of this work extends beyond the discovery biology for the DNA repair field, into its medical relevance. RAD51 is a potential drug target for inhibiting DNA repair in cancer cells to overcome drug resistance. This work offers a structural understanding of RAD51's function with D-loop and provides new strategies for targeting RAD51 to improve cancer therapies.

    2. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):  

      Summary: 

      The paper describes the cryoEM structure of RAD51 filament on the recombination intermediate. In the RAD51 filament, the insertion of a DNA-binding loop called the L2 loop stabilizes the separation of the complementary strand for the base-pairing with an incoming ssDNA and the non-complementary strand, which is captured by the second DNA-binding channel called the site II. The molecular structure of the RAD51 filament with a recombination intermediate provides a new insight into the mechanism of homology search and strand exchange between ssDNA and dsDNA. 

      Strengths: 

      This is the first human RAD51 filament structure with a recombination intermediate called the D-loop. The work has been done with great care, and the results shown in the paper are compelling based on cryo-EM and biochemical analyses. The paper is really nice and important for researchers in the field of homologous recombination, which gives a new view on the molecular mechanism of RAD51-mediated homology search and strand exchange. 

      Weaknesses: 

      The authors need more careful text writing. Without page and line numbers, it is hard to give comments. 

      We would like to thank the reviewer for their kind words of appreciation of our work.

      Reviewer #2 (Public review):  

      Summary: 

      Homologous recombination (HR) is a critical pathway for repairing double-strand DNA breaks and ensuring genomic stability. At the core of HR is the RAD51-mediated strand-exchange process, in which the RAD51-ssDNA filament binds to homologous double-stranded DNA (dsDNA) to form a characteristic D-loop structure. While decades of biochemical, genetic, and single-molecule studies have elucidated many aspects of this mechanism, the atomic-level details of the strand-exchange process remained unresolved due to a lack of atomic-resolution structure of RAD51 D-loop complex. 

      In this study, the authors achieved this by reconstituting a RAD51 mini-filament, allowing them to solve the RAD51 D-loop complex at 2.64 Å resolution using a single particle approach. The atomic resolution structure reveals how specific residues of RAD51 facilitate the strand exchange reaction. Ultimately, this work provides unprecedented structural insight into the eukaryotic HR process and deepens the understanding of RAD51 function at the atomic level, advancing the broader knowledge of DNA repair mechanisms. 

      Strengths: 

      The authors overcame the challenge of RAD51's helical symmetry by designing a minifilament system suitable for single-particle cryo-EM, enabling them to resolve the RAD51 D-loop structure at 2.64 Å without imposed symmetry. This high resolution revealed precise roles of key residues, including F279 in Loop 2, which facilitates strand separation, and basic residues on site II that capture the displaced strand. Their findings were supported by mutagenesis, strand exchange assays, and single-molecule analysis, providing strong validation of the structural insights. 

      Weaknesses: 

      Despite the detailed structural data, some structure-based mutagenesis data interpretation lacks clarity. Additionally, the proposed 3′-to-5′ polarity of strand exchange relies on assumptions from static structural features, such as stronger binding of the 5′-arm-which are not directly supported by other experiments. This makes the directional model compelling but contradicts several well-established biochemical studies that support a 5'-to-3' polarity relative to the complementary strand (e.g., Cell 1995, PMID: 7634335; JBC 1996, PMID: 8910403; Nature 2008, PMID: 18256600). 

      Overall: 

      The 2.6 Å resolution cryoEM structure of the RAD51 D-loop complex provides remarkably detailed insights into the residues involved in D-loop formation. The high-quality cryoEM density enables precise placement of each nucleotide, which is essential for interpreting the molecular interactions between RAD51 and DNA. Particularly, the structural analysis highlights specific roles for key domains, such as the N-terminal domain (NTD), in engaging the donor DNA duplex. 

      This structural interpretation is further substantiated by single-molecule fluorescence experiments using the KK39,40AA NTD mutant. The data clearly show a significant reduction in D-loop formation by the mutant compared to wild-type, supporting the proposed functional role of the NTD observed in the cryoEM model. 

      However, the strand exchange activity interpretation presented in Figure 5B could benefit from a more rigorous experimental design. The current assay measures an increase in fluorescence intensity, which depends heavily on the formation of RAD51-ssDNA filaments. As shown in Figure S6A, several mutants exhibit reduced ability to form such filaments, which could confound the interpretation of strand exchange efficiency. To address this, the assay should either: (1) normalize for equivalent levels of RAD51-ssDNA filaments across samples, or (2) compare the initial rates of fluorescence increase (i.e., the slope of the reaction curve), rather than endpoint fluorescence, to better isolate the strand exchange activity itself. 

      We agree with the reviewer that the reduced filament-forming ability of some of the RAD51 mutants complicates a straightforward interpretation of their strand-exchange assay. Interestingly, the RAD51 mutants that appear most impaired are the esDNA-capture mutants that do not contact the ssDNA in the structure of the pre-synaptic filament. However, the RAD51 NTD mutants, that display the most severe defect in strand-exchange, have a near-WT filament forming ability.

      Based on the structural features of the D-loop, the authors propose that strand pairing and exchange initiate at the 3'-end of the complementary strand in the donor DNA and proceed with a 3'-to-5' polarity. This conclusion, drawn from static structural observations, contrasts with several well-established biochemical studies that support a 5'-to-3' polarity relative to the complementary strand (e.g., Cell 1995, PMID: 7634335; JBC 1996, PMID: 8910403; Nature 2008, PMID: 18256600). While the structural model is compelling and methodologically robust, this discrepancy underscores the need for further experiments. 

      We would like to thank the reviewer for highlighting the importance of our findings to our understanding of the mechanism of homologous recombination.

      The reviewer correctly points out that the polarity of strand exchange by RecA and RAD51 is an extensively researched topic that has been characterised in several authoritative studies. In our paper, we simply describe the mechanistic insights obtained from the structural D-loop models of RAD51 (our work) and RecA (Yang et al, PMID: 33057191).The structures illustrate a very similar mechanism of Dloop formation that proceeds with opposite polarity of strand exchange for RAD51 and RecA. Comparison of the D-loop structures for RecA and RAD51 provides an attractive explanation for the opposite polarity, as caused by the different positions of their dsDNA-binding domains in the filament structure. 

      We agree with the reviewer that further investigation will be needed for an adequate rationalisation of the available evidence. We will mention the relevant literature in the revised version of the manuscript.

      Reviewer #3 (Public review):  

      Summary: 

      Built on their previous pioneer expertise in studying RAD51 biology, in this paper, the authors aim to capture and investigate the structural mechanism of human RAD51 filament bound with a displacement loop (D-loop), which occurs during the dynamic synaptic state of the homologous recombination (HR) strand-exchange step. As the structures of both pre- and post-synaptic RAD51 filaments were previously determined, a complex structure of RAD51 filaments during strand exchange is one of the key missing pieces of information for a complete understanding of how RAD51 functions in the HR pathway. This paper aims to determine the high-resolution cryo-EM structure of RAD51 filament bound with the D-loop. Combined with mutagenesis analysis and biophysical assays, the authors aim to investigate the D-loop DNA structure, RAD51-mediated strand separation and polarity, and a working model of RAD51 during HR strand invasion in comparison with RecA. 

      Strengths: 

      (1) The structural work and associated biophysical assays in this paper are solid, elegantly designed, and interpreted.  These results provide novel insights into RAD51's function in HR. 

      (2) The DNA substrate used was well designed, taking into consideration the nucleotide number requirement of RAD51 for stable capture of donor DNA. This DNA substrate choice lays the foundation for successfully determining the structure of the RAD51 filament on D-loop DNA using single-particle cryo-EM. 

      (3) The authors utilised their previous expertise in capping DNA ends using monomeric streptavidin and combined their careful data collection and processing to determine the cryo-EM structure of full-length human RAD51 bound at the D-loop in high resolution. This interesting structure forms the core part of this work and allows detailed mapping of DNA-DNA and DNA-protein interaction among RAD51, invading strands, and donor DNA arms (Figures 1, 2, 3, 4). The geometric analysis of D-loop DNA bound with RAD51 and EM density for homologous DNA pairing is also impressive (Figure S5). The previously disordered RAD51's L2-loop is now ordered and traceable in the density map and functions as a physical spacer when bound with D-loop DNA. Interestingly, the authors identified that the side chain position of F279 in the L2_loop of RAD51_H differs from other F279 residues in L2-loops of E, F, and G protomers. This asymmetric binding of L2 loops and RAD51_NTD binding with donor DNA arms forms the basis of the proposed working model about the polarity of csDNA during RAD51-mediated strand exchange. 

      (4) This work also includes mutagenesis analysis and biophysical experiments, especially EMSA, singlemolecule fluorescence imaging using an optical tweezer, and DNA strand exchange assay, which are all suitable methods to study the key residues of RAD51 for strand exchange and D-loop formation (Figure 5). 

      Weaknesses: 

      (1) The proposed model for the 3'-5' polarity of RAD51-mediated strand invasion is based on the structural observations in the cryo-EM structure. This study lacks follow-up biochemical/biophysical experiments to validate the proposed model compared to RecA or developing methods to capture structures of any intermediate states with different polarity models. 

      (2) The functional impact of key mutants designed based on structure has not been tested in cells to evaluate how these mutants impact the HR pathway. 

      The significance of the work for the DNA repair field and beyond: 

      Homologous recombination (HR) is a key pathway for repairing DNA double-strand breaks and involves multiple steps. RAD51 forms nucleoprotein filaments first with 3' overhang single-strand DNA (ssDNA), followed by a search and exchange with a homologous strand. This function serves as the basis of an accurate template-based DNA repair during HR. This research addressed a long-standing challenge of capturing RAD51 bound with the dynamic synaptic DNA and provided the first structural insight into how RAD51 performs this function. The significance of this work extends beyond the discovery of biology for the DNA repair field, into its medical relevance. RAD51 is a potential drug target for inhibiting DNA repair in cancer cells to overcome drug resistance. This work offers a structural understanding of RAD51's function with the D-loop and provides new strategies for targeting RAD51 to improve cancer therapies. 

      We thank the reviewer for their positive comments on the significance of our work. Concerning the proposed polarity of strand exchange based on our structural finding, please see our reply to the previous reviewer; we agree with the reviewer that further experimentation will be needed to to reach a settled view on this.

      Testing the functional effects of the RAD51 mutants on HR in cells was not an aim of the current work but we agree that it would be a very interesting experiment, which would likely provide further important insights into the mechanism of strand exchange at the core of the HR reaction.

      Reviewer #1 (Recommendations for the authors):

      Major points:

      (1) Structural analysis showed a critical role of F279 in the L2 loop. However, the biochemical study showed that the F279A substitution did not provide a strong defect in the in vitro strand exchange, as shown in Figure 5B. Moreover, a previous study by Matsuo et al. FEBS J, 2006; ref 43) showed human RAD51-F279A is proficient in the in vitro strand exchange. These suggest that human RAD51 F279 is not critical for the strand exchange. The authors need more discussions of the role of F279 or the L2 for the RAD51-mediated reactions in the Discussion.

      In the strand-exchange essay of Figure 5B, the F279A mutant shows the mildest phenotype, in agreement with the findings of Matsuo et al. Accordingly, in the text we describe the F279A mutant as having a “modest impact” on strand-exchange.

      We have now added a brief comment to the relevant text, pointing out that the result of the strand exchange assay for F279A are in agreement with the previous findings by Matsuo et al., and adding the reference.

      (2) In some parts, the authors cited the newest references rather than the paper describing the original findings. For RAD51 paralogs, why are these three (refs 21,22, 23) selected here? For FIGNL1, why is only one (ref 24) chosen?

      The cited publications were chosen to acquaint the reader with the latest structural and mechanistic advances about the function of some of the most important and well-studied recombination mediator proteins. For completeness, we have now added a further reference for FIGNL1 - Ito, Masaru et al, Nat Comm, 2023 – in the Introduction, to provide the reader with an additional pointer to our current knowledge about the mechanism of FIGNL1 in Homologous Recombination.

      Minor points:

      (1) Page 3, line 1 in the second paragraph, the reaction of "HR": HR should be homology search and strand exchange. HR is used incorrectly throughout the text, please check them. Remove "strandexchange" from ATPases in line 2.

      We believe that HR is used correctly in this context, as we refer to the biochemical reactions of HR, which includes the search for homology and strand exchange.

      We have removed “strand-exchange” from ATPases in line 2, as requested by the reviewer.

      (2) Supplementary Figure 1B, C, "EMSA" experiment: Please indicate an experimental condition in the legend: how ssDNA and dsDNA were mixed with RAD51. In (B), this is not an actual EMSA result, but rather a native gel analysis of reaction products with the D-loop. In (C), was the binding of RAD51 to the pre-formed D-loop examined? Which is correct here? Moreover, why do the authors need streptavidin in this experiment? Please explain why this is necessary for the EMSA assay. Please show where is Cy3 or Cy5 labels on the DNAs should be shown in the schematic drawing.

      The conditions for the experiments of Supplementary figure 1B, C are reported in the Methods section.

      Panel B shows the mobility shifts of the ssDNA and dsDNA sequences in panel A, so it is appropriate to describe it as an EMSA.

      We did not examine the binding of RAD51 to a pre-formed D-loop.

      We used streptavidine in the experiment of Supplementary Figure 1C to show that streptavidine binding did not interfere with D-loop reconstitution.

      The position of the Cy3, Cy5 labels in the DNAs is reported in Table S1.

      (3) Figure S4B, page 6, line 6 from the top, 5'-arm and 3'-arm: please add them to the figure. And also, please explain what 5'-arm and 3'-arm are here in the text, as shown in lines 3-5 in the second paragraph of the same page.

      We thank the reviewer for spotting this slight incongruity. We have removed the reference to 5’- and 3’arms of the donor DNA in the initial description of the D-loop (first paragraph of the “D-loop structure” section, 6 lines from the top), as the nomenclature for the arms of the donor DNA is introduced more appropriately in the following paragraph. Thus, there is no need to re-label Figure S4B; we note that the 5’- and 3’-labels are added to the arms of the donor DNA in Figure S4D.

      (4) Page 7, line 4, and Figure 2E, "C24": C24 should be C26 here (Figure 2D shows that position 24 in esDNA is "T").

      We thank the reviewer for spotting this typo, that is now corrected in the revised version of Figure 2 and in the text.

      (5) Page 8, line 1, K284: It would be nice to show "K284" in Figure 3F.

      We have added the side chain of K284 to Figure 3F, as suggested by the reviewer.

      (6) Page 8, second paragraph, line 3 from the bottom, "5'-arm" should be "3'-arm" for the binding of RAD51A NTD to ds DNA (Figure 4D).

      We thank the reviewer for spotting this typo, that is now corrected in the revised version of the text.

      Reviewer #2 (Recommendations for the authors):

      I understand that the strand exchange polarity of RAD51 should be opposite to that of RecA. But in the RecA manuscript (Nature 2020), it states (in the extended figure 1) " Because the mini-filament consists of fused RecA protomers, it does not reflect the effects a preferential polarity of RecA polymerization might have on the directionality of strand exchange. Also, our strand exchange reactions do not include the single-stranded DNA binding protein SSB that is involved in strand exchange in vivo and may sequester released DNA strands."

      We are aware that the findings by Yang et al, 2020 were obtained with a multi-protomeric RecA chimera and that their construct might not therefore recapitulate a potential effect of RecA polymerisation on the directionality of strand-exchange. 

      Comparison of the RecA and RAD51 D-loop structures shows that RecA and RAD51 adopt the same asymmetric mechanism of D-loop formation, which begins at one arm of the donor DNA and proceeds with donor unwinding and strand invasion until the second arm is captured, completing D-loop formation. However, the cryoEM structures provide compelling evidence that, after engagement with the donor DNA, RecA and RAD51 proceed to unwind the donor with opposite polarity; the structures provide a clear rationale for this, because of the different position of their dsDNA-binding domains relative to the ATPase domain.

      We acknowledge that there exists an extensive body of literature that has investigated the polarity of strand exchange by RecA and RAD51 under a variety of experimental conditions, and we have added a brief comment to the text to reflect this, as well as some of the key citations. Undoubtedly, and as we also mention in our reply to the public reviews, further experimental work will be needed for a full reconciliation of the available evidence.

      Reviewer #3 (Recommendations for the authors):

      (1) I have a minor comment regarding the DNA shown in the structural figures in this work. The authors have used different colours to differentiate between isDNA, esDNA, and csDNA for easier interpretation. However, these colour codes are inconsistent across Figures 1, 2, 3, and 5. This inconsistency makes it difficult to interpret which strand is which, particularly for readers unfamiliar with D-loops and strand invasion. A consistent colour scheme for the DNA strands would enhance the quality of the structural figures.

      We appreciate the reviewer’s comment about the colour scheme of the strands in the D-loop. We chose a unique colour scheme for each figure, to help the reader focus on the particular structural features that we wanted to highlight in the figure. So for instance, in figure 1D we chose to highlight the relationship (complementary vs identical) of the donor DNA strands with the the invading strand; in figure 2, the emphasis is on distinguishing the homologously paired dsDNA (pink) from the exchanged strand (magenta), as a consequence of L2 loop binding; etc.

      (2) I have another comment regarding the rationale behind naming the RAD51 protomers (A to H) within the structure, which could confuse general readers if not clearly explained. In this paper, the RAD51 protomer is RAD51_A when closest to the 3' end of the isDNA. I assume the authors chose this order because HR generates a 3' ssDNA overhang before strand invasion. It would be beneficial for the introduction and results sections to mention this property of the 3' ssDNA overhang and the reasoning behind this naming strategy. This explanation will help readers understand how it differs from other naming orders used in RecA/RAD51 with ssDNA, where protomer A is closer to the 5' ssDNA.

      We thank the reviewer for their insightful comment. We chose to name as chain A the RAD51 protomer nearest to the 3’-end of the isDNA to be consistent with the naming scheme that we use for all our published RAD51 filament structures.

      (3) I have highlighted some text within this paper that has contradicting parts for authors to clarify and correct:

      "Overall, the structural features of the RAD51 D-loop provide a strong indication that strand pairing and exchange begins at the 3'-end of the complementary strand in the donor DNA and progresses with 3'-to5' polarity (Fig. 5F)"

      "The observed 5'-to-3' polarity of strand-exchange by RAD51 is opposite to the 3'-to-5' polarity of bacterial RecA (Fig. S8), that was determined based on cryoEM structures of RecA D-loops".

      We thank the reviewer for alerting us to this inconsistency that has now been corrected in the revised manuscript.

      (4) Figure S8 last model: NTD should be CTD in the title; Figure 2B: resolution scale bar needs A unit. We thank the reviewer for spotting this typo that has now been corrected in the revised version of figure S8. 

      We couldn’t find a missing resolution scale bar in Figure 2B; however, we have added a missing resolution bar with A unit to Fig. S3B.

    1. Reviewer #2 (Public review):

      Summary:

      Transcriptomics technologies play crucial roles in biological research. Technologies based on second-generation sequencing, such as Illumina RNA-seq, encounter significant challenges due to the short reads, particularly in isoform analysis. In contrast, third-generation sequencing technologies overcome the limitation by providing long reads, but they are much more expensive. The authors present a useful real-time strategy to minimize the cost of RNA sequencing with Oxford Nanopore Technologies (ONT). The revised manuscript demonstrates the utilities with four sets of experiments with convincing evidence: (1) comparation between two cell lines; (2) comparison of RNA preparation procedures; (3) comparation between heat-shock and control conditions; (4) comparison of genetic modified yeast strains. The strategy will probably guide biologists to conduct transcriptomics studies with ONT in a fast and cost-effective way, benefiting both fundamental research and clinical applications.

      Strengths:

      The authors have recently developed a computational tool called NanopoReaTA to perform real-time analysis when cDNA/RNA samples are sequencing with ONT (Wierczeiko et al., 2023). The advantage of real-time analysis is that sequencing can be terminated once sufficient data has been collected to save cost. In this study, the authors demonstrate how to perform comprehensive quality control during sequencing. Their results indicate that the real-time strategy is effective across different species and RNA preparation methods. The revised manuscript addresses most of the major and minor limitations identified in the previous version, including: (1) explicitly detailing the methodology for isoform analysis and presenting the corresponding results; (2) increasing sample sizes and providing a clear explanation of related considerations; (3) clarifying the issue of sequential analysis; and (4) incorporating a new heat-shock experiment that better reflects real-world biological research.

      Weaknesses:

      A key advantage of RNA sequencing using ONT is its ability to facilitate isoform analysis. The primary strength of real-time analysis lies in its potential to reduce costs for researchers while enabling significant biological discoveries related to isoforms. Although the authors explicitly describe their approach to isoform analysis and introduce a new experiment in the revised manuscript, the study still lacks a concrete example that clearly demonstrates the substantial impact of their tool and strategy. While such an example may be beyond the intended scope of the current work, its absence limits a better assessment of the significance of the findings. Because the evaluation of a methodological approach ultimately depends on the additional scientific value it provides in research. It is possible that the full potential of this tool will be demonstrated in future studies by the authors or other researchers.

      Furthermore, while the tool integrates a set of state-of-the-art methods, it does not introduce any novel methods. Consequently, the strength of evidence can be raised to "convincing".